archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,1.3909e-05,0.37482,0.40681,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,1.8524e-05,0.26399,0.31207,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00057531,0.23345,0.21034,1,1
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.024086,0.14255,0.13196,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.045233,0.12388,0.1132,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00054254,0.11832,0.14949,1,1
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.026142,-0.091286,-0.18669,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.048745,-0.097372,-0.22949,1,0
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.025096,-0.10996,-0.25663,1,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.02951,-0.11088,-0.21844,1,0
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0054671,-0.11584,-0.1684,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0003797,-0.12309,-0.19266,1,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.040368,-0.12702,-0.14563,1,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0042727,-0.12886,-0.19754,1,0
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0015882,-0.13676,-0.21268,1,0
1,GO HISTONE EXCHANGE,0.0080134,-0.13825,-0.21128,1,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.006955,-0.13914,-0.23201,1,0
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0021907,-0.14661,-0.19205,1,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0040644,-0.15882,-0.29141,1,0
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00057531,-0.15934,-0.25506,1,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0031545,-0.16025,-0.25007,1,0
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00072571,-0.1719,-0.26442,1,0
1,GO OTIC VESICLE DEVELOPMENT,0.028348,-0.17519,-0.21665,1,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0019699,-0.1769,-0.21831,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.037377,-0.17733,-0.18052,1,0
1,GO REGULATION OF GLUTAMATE SECRETION,0.02951,-0.18332,-0.38733,1,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.0018673,-0.1845,-0.25172,1,0
1,GO RETINOL METABOLIC PROCESS,0.0010798,-0.18583,-0.28154,1,0
1,GO PROTEIN TARGETING,3.0304e-05,-0.18841,-0.23047,1,0
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.6059e-05,-0.18868,-0.23714,1,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.0031545,-0.19171,-0.27567,1,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.00017019,-0.19225,-0.2422,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,1.4947e-05,-0.19504,-0.28718,1,0
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00021879,-0.1982,-0.2779,1,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.0016767,-0.20071,-0.28676,1,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.00048214,-0.2008,-0.25503,1,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.0034935,-0.20247,-0.27746,1,0
1,GO SPERM EGG RECOGNITION,0.0057394,-0.20301,-0.19652,1,0
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,9.5377e-05,-0.2046,-0.27427,1,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.0011418,-0.20567,-0.24955,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00015974,-0.20633,-0.29756,1,0
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0054671,-0.20725,-0.2401,1,0
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0092139,-0.20994,-0.25162,1,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.037377,-0.21028,-0.19632,1,0
1,GO RRNA METHYLATION,0.00060992,-0.21055,-0.29188,1,0
1,GO TRNA METABOLIC PROCESS,5.9985e-05,-0.21298,-0.30708,1,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.018736,-0.21354,-0.27866,1,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0017696,-0.21379,-0.28416,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,8.3641e-05,-0.21528,-0.26765,1,0
1,GO RNA CATABOLIC PROCESS,2.2907e-05,-0.21624,-0.2354,1,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,4.5779e-05,-0.21638,-0.31295,1,0
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0010798,-0.21816,-0.23405,1,0
1,GO TRNA PROCESSING,7.3279e-05,-0.21964,-0.30206,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,5.9985e-05,-0.2211,-0.2738,1,0
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00081392,-0.22116,-0.27486,1,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.00068502,-0.22305,-0.33206,1,0
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00014989,-0.22378,-0.27137,1,0
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.00040321,-0.22653,-0.27193,1,0
1,GO MALE MEIOSIS I,0.0066311,-0.22698,-0.35192,1,0
1,GO MIDBODY ABSCISSION,0.00068502,-0.22814,-0.30459,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.024086,-0.22992,-0.28937,1,0
1,GO TRNA WOBBLE BASE MODIFICATION,0.00010866,-0.23007,-0.33297,1,0
1,GO TRNA MODIFICATION,8.9327e-05,-0.2309,-0.3233,1,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00014062,-0.2322,-0.28185,1,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,5.2428e-05,-0.2344,-0.28323,1,0
1,GO RRNA MODIFICATION,0.00021879,-0.23443,-0.30545,1,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.00035748,-0.23491,-0.36181,1,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,7.8298e-05,-0.23605,-0.3535,1,0
1,GO DRUG CATABOLIC PROCESS,0.0023095,-0.23725,-0.28105,1,0
1,GO AMIDE BIOSYNTHETIC PROCESS,6.6813e-06,-0.2382,-0.28578,1,0
1,GO PSEUDOURIDINE SYNTHESIS,0.0010209,-0.24034,-0.28117,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.3909e-05,-0.24058,-0.29865,1,0
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.636e-05,-0.24159,-0.3222,1,0
1,GO PEPTIDYL ASPARAGINE MODIFICATION,3.0304e-05,-0.24262,-0.32914,1,0
1,GO RNA CAPPING,0.00048214,-0.24302,-0.28155,1,0
1,GO SENSORY PERCEPTION OF TASTE,0.00048214,-0.24312,-0.31581,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00031664,-0.24317,-0.25502,1,0
1,GO PEPTIDE METABOLIC PROCESS,7.7514e-06,-0.24428,-0.27903,1,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.00020554,-0.24587,-0.28148,1,0
1,GO REGULATION OF FERTILIZATION,0.00072571,-0.24644,-0.28005,1,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0044907,-0.24762,-0.25993,1,0
1,GO UBIQUINONE METABOLIC PROCESS,0.00018128,-0.24836,-0.30133,1,0
1,GO KINETOCHORE ORGANIZATION,0.0010798,-0.24856,-0.35317,1,0
1,GO SENSORY PERCEPTION OF SMELL,5.9985e-05,-0.24954,-0.26048,1,0
1,GO T CELL CYTOKINE PRODUCTION,0.0027019,-0.24975,-0.4913,1,0
1,GO T CELL CHEMOTAXIS,0.038848,-0.24988,-0.48699,1,0
1,GO OPSONIZATION,0.015776,-0.2504,-0.41089,1,0
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.636e-05,-0.2505,-0.30771,1,0
1,GO PROTEIN INSERTION INTO MEMBRANE,2.2907e-05,-0.2508,-0.32178,1,0
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,3.0304e-05,-0.25142,-0.31415,1,0
1,GO URONIC ACID METABOLIC PROCESS,0.00029789,-0.25175,-0.22176,1,0
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0047188,-0.25188,-0.46267,1,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.006955,-0.25294,-0.3132,1,0
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00011593,-0.25308,-0.32119,1,0
1,GO V D J RECOMBINATION,0.00057531,-0.25487,-0.33368,1,0
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0083971,-0.25601,-0.4986,1,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0028457,-0.25683,-0.32335,1,0
1,GO VITAMIN CATABOLIC PROCESS,0.007293,-0.2591,-0.28149,1,0
1,GO HYPERSENSITIVITY,0.02951,-0.25945,-0.53609,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.018736,-0.26038,-0.37902,1,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.0025648,-0.26166,-0.31637,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,5.7533e-06,-0.26236,-0.30938,1,0
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.035953,-0.26266,-0.42959,1,0
1,GO PROTEIN NITROSYLATION,0.00086166,-0.26277,-0.33071,1,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00012367,-0.26344,-0.37219,1,0
1,GO RNA SURVEILLANCE,0.00010181,-0.26376,-0.32444,1,0
1,GO MULTIVESICULAR BODY ORGANIZATION,1.9888e-05,-0.26504,-0.34977,1,0
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00017019,-0.26561,-0.2933,1,0
1,GO VIRION ASSEMBLY,8.3461e-06,-0.26624,-0.33809,1,0
1,GO DRUG METABOLIC PROCESS,3.7287e-05,-0.26679,-0.33045,1,0
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,6.6813e-06,-0.2688,-0.29043,1,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,8.9327e-05,-0.26882,-0.36171,1,0
1,GO RESPONSE TO FOOD,0.011063,-0.26994,-0.25164,1,0
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,4.8997e-05,-0.27032,-0.30075,1,0
1,GO T CELL MEDIATED IMMUNITY,0.0036751,-0.27043,-0.45716,1,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00024771,-0.27045,-0.35227,1,0
1,GO FOREBRAIN REGIONALIZATION,0.011063,-0.27068,-0.37087,1,0
1,GO ZINC ION HOMEOSTASIS,0.0016767,-0.27122,-0.32428,1,0
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0029965,-0.2732,-0.38644,1,0
1,GO T CELL MEDIATED CYTOTOXICITY,0.035953,-0.27325,-0.40584,1,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.00023283,-0.2733,-0.34519,1,0
1,GO POSITIVE REGULATION OF ACROSOME REACTION,0.0012758,-0.27395,-0.30307,1,0
1,GO TRNA METHYLATION,0.00011593,-0.27402,-0.34694,1,0
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.012106,-0.27493,-0.24998,1,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0010209,-0.27562,-0.35192,1,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.01266,-0.27573,-0.34053,1,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.008797,-0.27645,-0.29586,1,0
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,5.337e-06,-0.27756,-0.30199,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.020391,-0.27766,-0.43623,1,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0060238,-0.27882,-0.45372,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,0.007293,-0.27958,-0.27381,1,0
1,GO RESPONSE TO INSECTICIDE,0.008797,-0.28084,-0.34529,1,0
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.012106,-0.2811,-0.48062,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,3.9936e-05,-0.28131,-0.31336,1,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,2.8267e-05,-0.28148,-0.31389,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00031664,-0.28223,-0.27146,1,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,3.9936e-05,-0.28338,-0.36273,1,0
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00028019,-0.28408,-0.39078,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,8.3461e-06,-0.28566,-0.33909,1,0
1,GO KETONE BODY METABOLIC PROCESS,0.00042807,-0.28579,-0.25581,1,0
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0029965,-0.28774,-0.28757,1,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,4.2763e-05,-0.28796,-0.41158,1,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,5.6086e-05,-0.28822,-0.349,1,0
1,GO CELL REDOX HOMEOSTASIS,3.0304e-05,-0.28955,-0.36749,1,0
1,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00076864,-0.2905,-0.40582,1,0
1,GO SKELETAL MUSCLE TISSUE REGENERATION,7.3279e-05,-0.29091,-0.42313,1,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.0015882,-0.29092,-0.37073,1,0
1,GO INTERLEUKIN 17 PRODUCTION,0.0036751,-0.29109,-0.50916,1,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00011593,-0.29241,-0.31223,1,0
1,GO TONGUE DEVELOPMENT,0.00017019,-0.29303,-0.36115,1,0
1,GO MITOTIC CYTOKINETIC PROCESS,4.2763e-05,-0.29409,-0.38305,1,0
1,GO DETOXIFICATION,0.00051151,-0.29428,-0.27511,1,0
1,GO LIPOXYGENASE PATHWAY,0.0172,-0.29435,-0.2752,1,0
1,GO RETINA HOMEOSTASIS,4.2763e-05,-0.2944,-0.3166,1,0
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,1.4947e-05,-0.29466,-0.3766,1,0
1,GO RESPONSE TO CHEMOKINE,0.025096,-0.29486,-0.42343,1,0
1,GO RNA MODIFICATION,1.2939e-05,-0.29523,-0.36553,1,0
1,GO HISTONE SERINE PHOSPHORYLATION,0.00010181,-0.29579,-0.35998,1,0
1,GO PROSTANOID METABOLIC PROCESS,0.0003797,-0.29644,-0.40482,1,0
1,GO RESPONSE TO SALT,0.00028019,-0.29653,-0.34144,1,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,1.0403e-05,-0.29659,-0.3318,1,0
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,2.4576e-05,-0.29787,-0.3201,1,0
1,GO DENTATE GYRUS DEVELOPMENT,0.00051151,-0.29809,-0.33773,1,0
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.2907e-05,-0.29842,-0.39283,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,5.337e-06,-0.29862,-0.33393,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00033648,-0.29919,-0.33628,1,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.00031664,-0.29922,-0.30715,1,0
1,GO T CELL APOPTOTIC PROCESS,0.0027019,-0.29982,-0.45621,1,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,6.4139e-05,-0.29991,-0.3458,1,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.00068502,-0.30027,-0.29517,1,0
1,GO PHOTOTRANSDUCTION,4.9495e-06,-0.30095,-0.3702,1,0
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.0403e-05,-0.30132,-0.36168,1,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,8.3641e-05,-0.30142,-0.40427,1,0
1,GO GTP METABOLIC PROCESS,1.4947e-05,-0.30158,-0.35878,1,0
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,1.3909e-05,-0.30164,-0.34387,1,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,3.7287e-05,-0.30205,-0.4117,1,0
1,GO STARTLE RESPONSE,0.0038653,-0.30212,-0.40892,1,0
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.8267e-05,-0.30271,-0.37177,1,0
1,GO FEAR RESPONSE,4.5779e-05,-0.30286,-0.38182,1,0
1,GO RNA INTERFERENCE,0.00014062,-0.30352,-0.37481,1,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0020776,-0.30361,-0.2567,1,0
1,GO NUCLEOSOME ASSEMBLY,0.00024771,-0.30362,-0.34464,1,0
1,GO POSITIVE REGULATION OF CELL AGING,0.00086166,-0.30406,-0.26737,1,0
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.0012758,-0.30484,-0.33792,1,0
1,GO KINETOCHORE ASSEMBLY,0.0003797,-0.30487,-0.388,1,0
1,GO SIGNAL PEPTIDE PROCESSING,0.0012071,-0.30489,-0.3091,1,0
1,GO HEPATOCYTE DIFFERENTIATION,0.0017696,-0.30641,-0.32242,1,0
1,GO NUCLEOSIDE METABOLIC PROCESS,8.9843e-06,-0.3065,-0.33675,1,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,0.0049572,-0.30717,-0.43028,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00020554,-0.30724,-0.35802,1,0
1,GO CELLULAR AMIDE METABOLIC PROCESS,4.5891e-06,-0.30725,-0.32935,1,0
1,GO HOMOLOGOUS RECOMBINATION,8.3641e-05,-0.30762,-0.40848,1,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.00081392,-0.30874,-0.32868,1,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.0038653,-0.30894,-0.45646,1,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,1.1191e-05,-0.30901,-0.40519,1,0
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,6.2007e-06,-0.30908,-0.3668,1,0
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0003797,-0.30918,-0.36492,1,0
1,GO PLASMA MEMBRANE FUSION,0.0016767,-0.3094,-0.3231,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,5.9985e-05,-0.30969,-0.36649,1,0
1,GO RNA METHYLATION,5.2428e-05,-0.30984,-0.3855,1,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,8.9843e-06,-0.30993,-0.35513,1,0
1,GO EMBRYONIC AXIS SPECIFICATION,1.2035e-05,-0.31032,-0.38668,1,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.00091199,-0.311,-0.3634,1,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,6.4139e-05,-0.31152,-0.36791,1,0
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.007293,-0.31157,-0.48181,1,0
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.3909e-05,-0.31162,-0.37356,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00010866,-0.31229,-0.33461,1,0
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00012367,-0.31233,-0.39276,1,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.0011418,-0.31247,-0.37281,1,0
1,GO PROTEIN ADP RIBOSYLATION,5.6086e-05,-0.31257,-0.46619,1,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,4.8997e-05,-0.3126,-0.36223,1,0
1,GO PEPTIDYL ARGININE MODIFICATION,0.00026348,-0.31272,-0.28938,1,0
1,GO DNA REPLICATION INITIATION,0.00017019,-0.3131,-0.34658,1,0
1,GO ETHANOL METABOLIC PROCESS,0.00057531,-0.31345,-0.42917,1,0
1,GO MRNA METABOLIC PROCESS,2.1347e-05,-0.31354,-0.33089,1,0
1,GO METHIONINE METABOLIC PROCESS,0.00010181,-0.31362,-0.35137,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00068502,-0.31424,-0.38302,1,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,1.2035e-05,-0.31439,-0.39472,1,0
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.038848,-0.31512,-0.40784,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,0.00048214,-0.31534,-0.44354,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0047188,-0.31548,-0.31529,1,0
1,GO PEROXISOME ORGANIZATION,2.4576e-05,-0.31553,-0.34911,1,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,7.1973e-06,-0.3156,-0.33907,1,0
1,GO GLYCOSIDE METABOLIC PROCESS,5.2428e-05,-0.31565,-0.35384,1,0
1,GO SNRNA METABOLIC PROCESS,3.4805e-05,-0.31566,-0.34739,1,0
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,1.6059e-05,-0.3157,-0.36787,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0057394,-0.31628,-0.27105,1,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00017019,-0.31686,-0.36775,1,0
1,GO EATING BEHAVIOR,0.0036751,-0.31701,-0.32736,1,0
1,GO POLYAMINE METABOLIC PROCESS,0.00012367,-0.31713,-0.33733,1,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,5.7533e-06,-0.31715,-0.37098,1,0
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,8.3641e-05,-0.31729,-0.40912,1,0
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.248e-05,-0.31746,-0.41961,1,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0076456,-0.31779,-0.29501,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,5.9985e-05,-0.31781,-0.39252,1,0
1,GO SALIVA SECRETION,0.011063,-0.31843,-0.2692,1,0
1,GO MEIOTIC CELL CYCLE PROCESS,6.4139e-05,-0.31915,-0.40509,1,0
1,GO RESPONSE TO NITROSATIVE STRESS,0.00014062,-0.31918,-0.28678,1,0
1,GO CELL CELL RECOGNITION,0.00048214,-0.31938,-0.31698,1,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,5.2428e-05,-0.31946,-0.3581,1,0
1,GO REGULATION OF RELAXATION OF MUSCLE,0.011574,-0.31951,-0.4012,1,0
1,GO ETHANOL OXIDATION,0.0083971,-0.31974,-0.4388,1,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.00040321,-0.3199,-0.36207,1,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0019699,-0.32046,-0.27782,1,0
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0021907,-0.32046,-0.30207,1,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,2.4576e-05,-0.32072,-0.3812,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00332,-0.32242,-0.39167,1,0
1,GO REGULATION OF CHROMOSOME SEPARATION,3.0304e-05,-0.32247,-0.42575,1,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.7249e-05,-0.32269,-0.41157,1,0
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.015104,-0.32339,-0.45812,1,0
1,GO CELLULAR OXIDANT DETOXIFICATION,0.00029789,-0.32349,-0.29717,1,0
1,GO RESPONSE TO INTERLEUKIN 12,1.8524e-05,-0.32392,-0.38587,1,0
1,GO ATP METABOLIC PROCESS,5.7533e-06,-0.32418,-0.34384,1,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00081392,-0.32421,-0.36379,1,0
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00011593,-0.32438,-0.38899,1,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.00015974,-0.32475,-0.3847,1,0
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.1347e-05,-0.32486,-0.39871,1,0
1,GO SECRETION BY TISSUE,0.00011593,-0.32556,-0.33272,1,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,1.9888e-05,-0.32619,-0.37826,1,0
1,GO ACROSOME REACTION,0.00076864,-0.32626,-0.39143,1,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,7.8298e-05,-0.32747,-0.42109,1,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.9888e-05,-0.32756,-0.37639,1,0
1,GO RRNA CATABOLIC PROCESS,3.9936e-05,-0.32763,-0.43345,1,0
1,GO NADPH REGENERATION,5.2428e-05,-0.32784,-0.40508,1,0
1,GO ESTROGEN METABOLIC PROCESS,2.2907e-05,-0.32821,-0.33628,1,0
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,8.9843e-06,-0.32884,-0.3411,1,0
1,GO REGULATION OF PROTON TRANSPORT,5.6086e-05,-0.32978,-0.38335,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.33003,-0.35718,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0076456,-0.33009,-0.34658,1,0
1,GO MONONUCLEAR CELL MIGRATION,0.0083971,-0.33113,-0.47752,1,0
1,GO DNA DEAMINATION,0.017954,-0.33138,-0.33625,1,0
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,9.6689e-06,-0.33215,-0.35023,1,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,2.1347e-05,-0.3324,-0.4095,1,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0003797,-0.33242,-0.30527,1,0
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00086166,-0.33247,-0.45383,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.01266,-0.33281,-0.38671,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,1.6059e-05,-0.33284,-0.38723,1,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00020554,-0.33317,-0.38732,1,0
1,GO CELL KILLING,0.0080134,-0.33332,-0.39812,1,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,3.4805e-05,-0.33385,-0.34793,1,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.00033648,-0.33387,-0.31003,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,7.8298e-05,-0.33389,-0.38881,1,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00026348,-0.3344,-0.37359,1,0
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,5.7533e-06,-0.33445,-0.37119,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00091199,-0.33446,-0.51279,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00031664,-0.33449,-0.36843,1,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,9.5377e-05,-0.33465,-0.3842,1,0
1,GO SULFUR AMINO ACID METABOLIC PROCESS,7.7514e-06,-0.33481,-0.38712,1,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,3.4805e-05,-0.33485,-0.3575,1,0
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,4.9495e-06,-0.33502,-0.43392,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.00048214,-0.33558,-0.38033,1,0
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00068502,-0.33559,-0.51799,1,0
1,GO PEROXISOMAL TRANSPORT,2.2907e-05,-0.33576,-0.35007,1,0
1,GO MITOCHONDRION ORGANIZATION,4.9495e-06,-0.3359,-0.38473,1,0
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,4.2539e-06,-0.33595,-0.37079,1,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0020776,-0.33629,-0.37747,1,0
1,GO MITOCHONDRIAL TRANSPORT,8.3461e-06,-0.3365,-0.38646,1,0
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00011593,-0.33691,-0.2921,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.636e-05,-0.33714,-0.40669,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00020554,-0.33716,-0.51111,1,0
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.1191e-05,-0.33739,-0.45763,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00035748,-0.33751,-0.35272,1,0
1,GO RETINAL METABOLIC PROCESS,0.0096484,-0.33756,-0.3494,1,0
1,GO GERM CELL DEVELOPMENT,4.8997e-05,-0.33791,-0.37663,1,0
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,8.3641e-05,-0.33797,-0.32564,1,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.00011593,-0.3384,-0.32598,1,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00064645,-0.33884,-0.34624,1,0
1,GO EPOXYGENASE P450 PATHWAY,0.030713,-0.33897,-0.20773,1,0
1,GO PROTEIN HETEROTETRAMERIZATION,1.4947e-05,-0.33978,-0.43786,1,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.00010866,-0.33992,-0.38758,1,0
1,GO NEUTROPHIL MIGRATION,0.010101,-0.34012,-0.46194,1,0
1,GO FEEDING BEHAVIOR,0.00076864,-0.34036,-0.3686,1,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,1.7249e-05,-0.34037,-0.42596,1,0
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0012071,-0.34045,-0.47311,1,0
1,GO POSITIVE REGULATION OF CELL KILLING,0.017954,-0.34054,-0.42348,1,0
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,4.5779e-05,-0.34072,-0.38857,1,0
1,GO MYOBLAST MIGRATION,0.0028457,-0.34108,-0.35214,1,0
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.011063,-0.34136,-0.35706,1,0
1,GO DETECTION OF LIGHT STIMULUS,4.5891e-06,-0.34171,-0.38014,1,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00076864,-0.34178,-0.3904,1,0
1,GO MEIOTIC CELL CYCLE,2.636e-05,-0.34184,-0.43314,1,0
1,GO SPERMATID DIFFERENTIATION,0.00010866,-0.34197,-0.35586,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0014241,-0.34232,-0.45067,1,0
1,GO POSITIVE REGULATION OF FERTILIZATION,8.3641e-05,-0.34243,-0.3752,1,0
1,GO SNRNA TRANSCRIPTION,4.8997e-05,-0.3425,-0.39622,1,0
1,GO METAPHASE PLATE CONGRESSION,3.248e-05,-0.34306,-0.4322,1,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,2.2907e-05,-0.34324,-0.37601,1,0
1,GO MITOCHONDRIAL DNA REPLICATION,6.6813e-06,-0.34338,-0.42324,1,0
1,GO RESPONSE TO UV C,1.9888e-05,-0.34412,-0.48606,1,0
1,GO CELLULAR HORMONE METABOLIC PROCESS,4.2763e-05,-0.34458,-0.34448,1,0
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.007293,-0.34517,-0.33526,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0066311,-0.34533,-0.46993,1,0
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0014241,-0.34539,-0.27463,1,0
1,GO BICARBONATE TRANSPORT,0.00011593,-0.34548,-0.37536,1,0
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1.8524e-05,-0.34583,-0.35269,1,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,2.1347e-05,-0.3459,-0.4498,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0011418,-0.34597,-0.42197,1,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,3.248e-05,-0.34611,-0.45299,1,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,3.0304e-05,-0.34643,-0.3935,1,0
1,GO PEPTIDYL ARGININE METHYLATION,3.4805e-05,-0.34668,-0.40191,1,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,1.3909e-05,-0.34668,-0.35731,1,0
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00013188,-0.34715,-0.34019,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,9.5377e-05,-0.3475,-0.3678,1,0
1,GO PH REDUCTION,9.6689e-06,-0.34752,-0.41698,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,4.2763e-05,-0.348,-0.44849,1,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00057531,-0.34816,-0.35915,1,0
1,GO DENDRITIC CELL CHEMOTAXIS,0.020391,-0.34823,-0.5174,1,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,1.1191e-05,-0.34863,-0.40119,1,0
1,GO LIPID DIGESTION,0.041938,-0.34867,-0.27874,1,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00026348,-0.34877,-0.40277,1,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,2.636e-05,-0.3489,-0.42777,1,0
1,GO TERPENOID METABOLIC PROCESS,2.8267e-05,-0.349,-0.37423,1,0
1,GO NODAL SIGNALING PATHWAY,2.8267e-05,-0.34953,-0.34765,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,1.9888e-05,-0.34982,-0.43703,1,0
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,1.3909e-05,-0.35063,-0.39594,1,0
1,GO DETECTION OF VISIBLE LIGHT,6.2007e-06,-0.35065,-0.36916,1,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0080134,-0.35096,-0.43815,1,0
1,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0054671,-0.35106,-0.35607,1,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,1.6059e-05,-0.35107,-0.38069,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.013235,-0.35114,-0.48089,1,0
1,GO REGULATION OF BEHAVIOR,3.4805e-05,-0.35166,-0.40603,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0049572,-0.35207,-0.52589,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0029965,-0.35239,-0.40001,1,0
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.013834,-0.35259,-0.39317,1,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00010181,-0.35259,-0.34807,1,0
1,GO GLYCINE METABOLIC PROCESS,4.5779e-05,-0.35267,-0.38773,1,0
1,GO NEUTROPHIL CHEMOTAXIS,0.014457,-0.35271,-0.45844,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0003797,-0.35287,-0.35028,1,0
1,GO HOMOCYSTEINE METABOLIC PROCESS,9.5377e-05,-0.35345,-0.38125,1,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,5.9985e-05,-0.3535,-0.39997,1,0
1,GO LYMPHOCYTE CHEMOTAXIS,0.028348,-0.35353,-0.4617,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,4.2763e-05,-0.35384,-0.48404,1,0
1,GO MUSCLE CELL FATE COMMITMENT,6.4139e-05,-0.35432,-0.40998,1,0
1,GO ALPHA BETA T CELL PROLIFERATION,0.010101,-0.35432,-0.5428,1,0
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0018673,-0.35439,-0.40273,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,0.00086166,-0.35441,-0.35211,1,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,4.8997e-05,-0.35449,-0.37728,1,0
1,GO OOCYTE MATURATION,7.3279e-05,-0.3546,-0.40335,1,0
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00033648,-0.35466,-0.50617,1,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00042807,-0.35468,-0.36825,1,0
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00015974,-0.35472,-0.48817,1,0
1,GO MYELOID LEUKOCYTE MIGRATION,0.00068502,-0.35472,-0.50577,1,0
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0021907,-0.35478,-0.62195,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,5.6086e-05,-0.35492,-0.50522,1,0
1,GO ISOPRENOID METABOLIC PROCESS,2.1347e-05,-0.35519,-0.36491,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,1.2035e-05,-0.35564,-0.4292,1,0
1,GO RNA PROCESSING,1.7249e-05,-0.35576,-0.37954,1,0
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,1.2939e-05,-0.35587,-0.40473,1,0
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,1.2035e-05,-0.35629,-0.35649,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00096503,-0.35643,-0.32238,1,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00031664,-0.35649,-0.44992,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.030713,-0.35718,-0.43434,1,0
1,GO INTERFERON GAMMA PRODUCTION,0.0047188,-0.35735,-0.51641,1,0
1,GO AMINE METABOLIC PROCESS,2.636e-05,-0.3574,-0.33991,1,0
1,GO CHROMOSOME SEGREGATION,2.636e-05,-0.35757,-0.42631,1,0
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,6.6813e-06,-0.35766,-0.41198,1,0
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00015974,-0.35783,-0.45505,1,0
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00011593,-0.35811,-0.50083,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,2.4576e-05,-0.35813,-0.43735,1,0
1,GO TOLERANCE INDUCTION,0.019548,-0.35815,-0.61423,1,0
1,GO CELL CYCLE G2 M PHASE TRANSITION,1.2939e-05,-0.35856,-0.42335,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0092139,-0.35891,-0.48546,1,0
1,GO REGULATION OF MRNA BINDING,0.00012367,-0.35901,-0.38142,1,0
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,2.2907e-05,-0.35921,-0.41946,1,0
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,7.3279e-05,-0.35923,-0.36825,1,0
1,GO ZINC ION TRANSPORT,8.9843e-06,-0.35978,-0.39027,1,0
1,GO NUCLEOTIDE SALVAGE,0.00029789,-0.35981,-0.33128,1,0
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015882,-0.35982,-0.57098,1,0
1,GO KERATINOCYTE DIFFERENTIATION,0.00035748,-0.35984,-0.35245,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.0021907,-0.36,-0.41737,1,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0016767,-0.3601,-0.30934,1,0
1,GO ONE CARBON METABOLIC PROCESS,7.1973e-06,-0.36028,-0.38591,1,0
1,GO GLUTAMATE METABOLIC PROCESS,3.248e-05,-0.36043,-0.42198,1,0
1,GO TRANSCRIPTION BY RNA POLYMERASE III,9.6689e-06,-0.36051,-0.40599,1,0
1,GO PROSTATE GLAND GROWTH,0.00068502,-0.36147,-0.30953,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.01266,-0.3616,-0.49084,1,0
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00072571,-0.36168,-0.57525,1,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,7.3279e-05,-0.36169,-0.42029,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING,2.636e-05,-0.36183,-0.41554,1,0
1,GO INTERLEUKIN 10 PRODUCTION,0.006955,-0.36193,-0.53173,1,0
1,GO EXPLORATION BEHAVIOR,0.00035748,-0.36227,-0.43786,1,0
1,GO ACUTE PHASE RESPONSE,0.0010798,-0.36303,-0.43046,1,0
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00076864,-0.36336,-0.45099,1,0
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0083971,-0.36363,-0.52821,1,0
1,GO DNA PACKAGING,2.8267e-05,-0.36371,-0.44189,1,0
1,GO REGULATION OF ACROSOME REACTION,0.0034935,-0.36395,-0.33349,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017954,-0.36426,-0.48419,1,0
1,GO AMINE CATABOLIC PROCESS,0.00057531,-0.36449,-0.39889,1,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,3.9422e-06,-0.36485,-0.40731,1,0
1,GO RESPONSE TO NITRIC OXIDE,0.00014062,-0.36528,-0.43965,1,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.00010866,-0.36529,-0.33635,1,0
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00081392,-0.36579,-0.53045,1,0
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0024341,-0.36596,-0.48033,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,5.6086e-05,-0.36607,-0.44304,1,0
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0019699,-0.36609,-0.53796,1,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,6.4139e-05,-0.36628,-0.43032,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,1.2939e-05,-0.36665,-0.42687,1,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,4.8997e-05,-0.36674,-0.42179,1,0
1,GO PROTEIN LOCALIZATION TO ORGANELLE,6.2007e-06,-0.36711,-0.40698,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.4947e-05,-0.36722,-0.42535,1,0
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00042807,-0.36738,-0.38016,1,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0036751,-0.3674,-0.37836,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,7.3279e-05,-0.36749,-0.477,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.019548,-0.36757,-0.55125,1,0
1,GO ICOSANOID METABOLIC PROCESS,7.8298e-05,-0.36757,-0.40586,1,0
1,GO NEPHRON TUBULE FORMATION,0.00072571,-0.36787,-0.31783,1,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00081392,-0.36809,-0.36097,1,0
1,GO CHROMOSOME LOCALIZATION,1.8524e-05,-0.3681,-0.44975,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00028019,-0.36828,-0.45609,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.028348,-0.36845,-0.43626,1,0
1,GO CELLULAR KETONE METABOLIC PROCESS,4.2539e-06,-0.36891,-0.40988,1,0
1,GO REGULATION OF RNA BINDING,0.00012367,-0.369,-0.39766,1,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,5.7533e-06,-0.369,-0.40003,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00017019,-0.36902,-0.39076,1,0
1,GO INNATE IMMUNE RESPONSE,0.00020554,-0.36913,-0.50779,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0010798,-0.36938,-0.54945,1,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,1.9888e-05,-0.36943,-0.444,1,0
1,GO NUCLEOBASE METABOLIC PROCESS,0.00013188,-0.36947,-0.38108,1,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,8.3461e-06,-0.37024,-0.40056,1,0
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,3.0304e-05,-0.37035,-0.4078,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,8.9843e-06,-0.37036,-0.40773,1,0
1,GO SINGLE FERTILIZATION,7.3279e-05,-0.37039,-0.34791,1,0
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.37058,-0.40179,1,0
1,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0023095,-0.37098,-0.43032,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,1.0403e-05,-0.37105,-0.34596,1,0
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,6.8565e-05,-0.37147,-0.42133,1,0
1,GO RESPONSE TO L GLUTAMATE,2.1347e-05,-0.3717,-0.43623,1,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00020554,-0.37188,-0.41389,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.013834,-0.37197,-0.46695,1,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,8.3461e-06,-0.37205,-0.43885,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0047188,-0.37231,-0.43319,1,0
1,GO GRANULOCYTE MIGRATION,0.0047188,-0.37245,-0.48407,1,0
1,GO CILIUM MOVEMENT,0.00021879,-0.37262,-0.35986,1,0
1,GO TISSUE REGENERATION,0.00010181,-0.37289,-0.41018,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00018128,-0.37297,-0.40528,1,0
1,GO INTRACILIARY TRANSPORT,0.00040321,-0.37307,-0.36266,1,0
1,GO RESPONSE TO INTERFERON GAMMA,0.0029965,-0.37321,-0.55364,1,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,5.337e-06,-0.37346,-0.38604,1,0
1,GO SPERM MOTILITY,0.00010181,-0.3735,-0.35177,1,0
1,GO MITOCHONDRION MORPHOGENESIS,1.7249e-05,-0.37353,-0.39697,1,0
1,GO REGULATION OF T CELL MIGRATION,0.0021907,-0.37384,-0.50657,1,0
1,GO NUCLEOSOME ORGANIZATION,3.7287e-05,-0.37405,-0.4074,1,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00010866,-0.37466,-0.39817,1,0
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00096503,-0.37488,-0.54455,1,0
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,3.248e-05,-0.37498,-0.36871,1,0
1,GO SKELETAL MUSCLE CELL PROLIFERATION,3.9936e-05,-0.37512,-0.40889,1,0
1,GO DENDRITIC CELL MIGRATION,0.015104,-0.37514,-0.53244,1,0
1,GO REGULATION OF ATPASE ACTIVITY,0.00012367,-0.37547,-0.3487,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00021879,-0.37568,-0.39357,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0012071,-0.37576,-0.51198,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.248e-05,-0.3758,-0.40585,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,7.8298e-05,-0.37592,-0.36827,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00010866,-0.37602,-0.44245,1,0
1,GO REGULATION OF TOLERANCE INDUCTION,0.024086,-0.37623,-0.59222,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.7249e-05,-0.37645,-0.40974,1,0
1,GO RESPONSE TO BACTERIUM,0.00011593,-0.3767,-0.48423,1,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.013834,-0.37683,-0.53954,1,0
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,1.4947e-05,-0.37684,-0.39451,1,0
1,GO RESPONSE TO TOXIC SUBSTANCE,1.3909e-05,-0.37694,-0.37933,1,0
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0019699,-0.37699,-0.3976,1,0
1,GO SISTER CHROMATID SEGREGATION,2.8267e-05,-0.37704,-0.447,1,0
1,GO DNA CATABOLIC PROCESS,5.7533e-06,-0.37743,-0.4401,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,6.2007e-06,-0.3776,-0.40039,1,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,1.7249e-05,-0.3776,-0.40103,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00028019,-0.3777,-0.32634,1,0
1,GO COENZYME A METABOLIC PROCESS,1.0403e-05,-0.37781,-0.43278,1,0
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00024771,-0.37786,-0.53999,1,0
1,GO RESPONSE TO FUNGUS,0.0010798,-0.378,-0.38313,1,0
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,3.248e-05,-0.37801,-0.38561,1,0
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0011418,-0.37807,-0.5618,1,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.9495e-06,-0.37816,-0.42549,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,0.0027019,-0.37821,-0.49057,1,0
1,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00072571,-0.37822,-0.53736,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,3.9936e-05,-0.37836,-0.45728,1,0
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,6.6813e-06,-0.37844,-0.4719,1,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0057394,-0.37851,-0.45531,1,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.0003797,-0.37858,-0.38769,1,0
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,9.5377e-05,-0.37873,-0.39993,1,0
1,GO SECONDARY METABOLIC PROCESS,1.4947e-05,-0.37874,-0.38083,1,0
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00072571,-0.37887,-0.53441,1,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,3.7287e-05,-0.37897,-0.44216,1,0
1,GO MALE GAMETE GENERATION,2.636e-05,-0.37905,-0.39669,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0044907,-0.37918,-0.43221,1,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.00024771,-0.37939,-0.40965,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0083971,-0.37966,-0.53306,1,0
1,GO OXIDATIVE DEMETHYLATION,8.9327e-05,-0.38015,-0.41389,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,3.0304e-05,-0.38016,-0.40962,1,0
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.38017,-0.46127,1,0
1,GO HEART FIELD SPECIFICATION,0.00014989,-0.38026,-0.51254,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014241,-0.3806,-0.39532,1,0
1,GO DIGESTION,3.9936e-05,-0.38095,-0.35238,1,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.00010866,-0.38102,-0.42783,1,0
1,GO NCRNA TRANSCRIPTION,2.636e-05,-0.38155,-0.42728,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0013481,-0.38157,-0.50823,1,0
1,GO EXTRACELLULAR VESICLE BIOGENESIS,1.6059e-05,-0.38174,-0.48627,1,0
1,GO FERTILIZATION,3.7287e-05,-0.38175,-0.36146,1,0
1,GO NON MOTILE CILIUM ASSEMBLY,3.4805e-05,-0.38216,-0.45574,1,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,6.2007e-06,-0.38234,-0.39343,1,0
1,GO DETECTION OF STIMULUS,5.7533e-06,-0.38237,-0.38498,1,0
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,2.636e-05,-0.3825,-0.46356,1,0
1,GO OXIDATION REDUCTION PROCESS,4.5891e-06,-0.38258,-0.39295,1,0
1,GO RESPONSE TO MINERALOCORTICOID,8.9327e-05,-0.38305,-0.45904,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,6.4139e-05,-0.38324,-0.45555,1,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,5.7533e-06,-0.38326,-0.40882,1,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.7514e-06,-0.38341,-0.4222,1,0
1,GO TETRAPYRROLE METABOLIC PROCESS,8.3461e-06,-0.38355,-0.42099,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00091199,-0.38362,-0.51193,1,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.00042807,-0.38364,-0.35243,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,1.3909e-05,-0.38376,-0.41587,1,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,1.7249e-05,-0.38394,-0.36694,1,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,1.8524e-05,-0.38397,-0.4623,1,0
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.4947e-05,-0.38426,-0.39471,1,0
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0054671,-0.38452,-0.46275,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00026348,-0.38479,-0.32954,1,0
1,GO REGULATION OF CELL KILLING,0.0060238,-0.38537,-0.49413,1,0
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00014989,-0.38539,-0.42231,1,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,5.2428e-05,-0.38566,-0.41225,1,0
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,3.4805e-05,-0.38623,-0.37258,1,0
1,GO CHEMOSENSORY BEHAVIOR,1.8524e-05,-0.38658,-0.42598,1,0
1,GO CYTIDINE TO URIDINE EDITING,0.043559,-0.38661,-0.40066,1,0
1,GO REGULATION OF CENTROSOME CYCLE,1.2035e-05,-0.38695,-0.46051,1,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00012367,-0.38697,-0.37492,1,0
1,GO FEMALE GAMETE GENERATION,1.2035e-05,-0.38713,-0.42986,1,0
1,GO REGULATION OF DOPAMINE SECRETION,0.0013481,-0.38725,-0.45589,1,0
1,GO NAD BIOSYNTHETIC PROCESS,0.00057531,-0.3874,-0.45215,1,0
1,GO APOPTOTIC DNA FRAGMENTATION,1.0403e-05,-0.38763,-0.40213,1,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,5.337e-06,-0.3881,-0.42292,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0047188,-0.38825,-0.40377,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.2428e-05,-0.38825,-0.44489,1,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00015974,-0.38837,-0.44509,1,0
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0076456,-0.38839,-0.51679,1,0
1,GO ATP TRANSPORT,7.8298e-05,-0.3884,-0.45159,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.0403e-05,-0.38849,-0.44327,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.00014989,-0.38868,-0.33582,1,0
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0052065,-0.38892,-0.50179,1,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,2.4576e-05,-0.38895,-0.41123,1,0
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0019699,-0.38905,-0.49879,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,3.9936e-05,-0.38933,-0.43747,1,0
1,GO DNA DEPENDENT DNA REPLICATION,2.1347e-05,-0.38937,-0.44012,1,0
1,GO INSEMINATION,0.00031664,-0.38957,-0.41525,1,0
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00081392,-0.38961,-0.52316,1,0
1,GO ACID SECRETION,5.6086e-05,-0.38965,-0.3727,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.248e-05,-0.38967,-0.45665,1,0
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,8.3641e-05,-0.38969,-0.56313,1,0
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00010181,-0.38973,-0.37531,1,0
1,GO PEPTIDYL PROLINE MODIFICATION,5.7533e-06,-0.38981,-0.40813,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0012071,-0.39009,-0.46183,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.0031545,-0.3901,-0.49545,1,0
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,4.5891e-06,-0.3902,-0.41065,1,0
1,GO NEURON FATE COMMITMENT,0.0010798,-0.39051,-0.45358,1,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,2.4576e-05,-0.39066,-0.41896,1,0
1,GO CHROMOSOME SEPARATION,1.9888e-05,-0.39079,-0.47626,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024771,-0.39089,-0.56189,1,0
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,1.7249e-05,-0.39102,-0.42562,1,0
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0027019,-0.39104,-0.40011,1,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0010798,-0.39116,-0.54357,1,0
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,7.3279e-05,-0.39127,-0.38781,1,0
1,GO HEME METABOLIC PROCESS,1.0403e-05,-0.39133,-0.42504,1,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,1.7249e-05,-0.39148,-0.41478,1,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,1.0403e-05,-0.39152,-0.45049,1,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,1.1191e-05,-0.39155,-0.4699,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0040644,-0.39158,-0.57797,1,0
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,4.2763e-05,-0.39166,-0.46179,1,0
1,GO MRNA SPLICE SITE SELECTION,0.00021879,-0.39167,-0.47342,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00060992,-0.39178,-0.628,1,0
1,GO FUCOSE METABOLIC PROCESS,1.6059e-05,-0.39184,-0.40961,1,0
1,GO LEUKOCYTE CHEMOTAXIS,0.00054254,-0.39184,-0.51377,1,0
1,GO STEROID ESTERIFICATION,0.00051151,-0.39199,-0.43203,1,0
1,GO LYSINE METABOLIC PROCESS,0.00045436,-0.39229,-0.37125,1,0
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,5.6086e-05,-0.39229,-0.47497,1,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.00015974,-0.39252,-0.40504,1,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.012106,-0.3926,-0.43563,1,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,9.6689e-06,-0.39285,-0.49905,1,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00031664,-0.39286,-0.39072,1,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.00011593,-0.39296,-0.41803,1,0
1,GO CARDIOLIPIN METABOLIC PROCESS,1.9888e-05,-0.39308,-0.41215,1,0
1,GO RESPONSE TO BIOTIC STIMULUS,4.8997e-05,-0.39337,-0.49888,1,0
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0083971,-0.39343,-0.47927,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,6.8565e-05,-0.39351,-0.41524,1,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00010866,-0.39396,-0.52557,1,0
1,GO INTERLEUKIN 5 PRODUCTION,0.0066311,-0.39466,-0.43226,1,0
1,GO MANNOSYLATION,2.8267e-05,-0.39483,-0.44344,1,0
1,GO GENITALIA MORPHOGENESIS,0.00031664,-0.39488,-0.41565,1,0
1,GO HUMORAL IMMUNE RESPONSE,0.0060238,-0.3949,-0.41735,1,0
1,GO RNA SPLICING,3.248e-05,-0.395,-0.39643,1,0
1,GO LIPOPROTEIN CATABOLIC PROCESS,4.5779e-05,-0.39507,-0.46803,1,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,5.6086e-05,-0.39529,-0.39952,1,0
1,GO DNA REPLICATION CHECKPOINT,0.00021879,-0.39531,-0.4159,1,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,3.9422e-06,-0.3955,-0.43025,1,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00011593,-0.3958,-0.47659,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00042807,-0.39598,-0.54297,1,0
1,GO GLUTAMATE SECRETION,0.00057531,-0.39599,-0.49347,1,0
1,GO ETHANOL CATABOLIC PROCESS,0.00024771,-0.39609,-0.4178,1,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,6.6813e-06,-0.39613,-0.42648,1,0
1,GO REGULATION OF DNA BINDING,7.1973e-06,-0.39617,-0.4661,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0031545,-0.39641,-0.5527,1,0
1,GO CHROMATIN SILENCING,3.0304e-05,-0.39648,-0.44404,1,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,3.9936e-05,-0.39719,-0.42582,1,0
1,GO CHROMOSOME CONDENSATION,5.6086e-05,-0.39725,-0.49215,1,0
1,GO STEROID HORMONE SECRETION,0.00011593,-0.39726,-0.42236,1,0
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,1.8524e-05,-0.39766,-0.411,1,0
1,GO LIPOPROTEIN METABOLIC PROCESS,7.7514e-06,-0.39766,-0.45765,1,0
1,GO HISTONE H2B UBIQUITINATION,4.5779e-05,-0.39798,-0.4595,1,0
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,7.1973e-06,-0.39812,-0.43322,1,0
1,GO TRIGLYCERIDE METABOLIC PROCESS,4.5891e-06,-0.39844,-0.46483,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0016767,-0.39932,-0.39661,1,0
1,GO LEUKOCYTE APOPTOTIC PROCESS,0.00024771,-0.39943,-0.55217,1,0
1,GO REGULATION OF TRANSPOSITION,4.2763e-05,-0.39964,-0.45735,1,0
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,5.337e-06,-0.39975,-0.40422,1,0
1,GO T CELL MIGRATION,0.0021907,-0.39995,-0.57994,1,0
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,4.5779e-05,-0.39996,-0.56679,1,0
1,GO COBALAMIN METABOLIC PROCESS,3.248e-05,-0.40001,-0.43903,1,0
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.4805e-05,-0.40063,-0.44243,1,0
1,GO RESPONSE TO CADMIUM ION,2.636e-05,-0.40071,-0.43694,1,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,2.1347e-05,-0.40108,-0.47214,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.6086e-05,-0.40131,-0.48937,1,0
1,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.0042727,-0.40139,-0.5897,1,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,1.2939e-05,-0.40145,-0.42119,1,0
1,GO RESPONSE TO DIETARY EXCESS,4.5779e-05,-0.40146,-0.46635,1,0
1,GO THYROID GLAND DEVELOPMENT,3.0304e-05,-0.40151,-0.55393,1,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,2.4576e-05,-0.40152,-0.42464,1,0
1,GO SYMBIOTIC PROCESS,4.9495e-06,-0.40154,-0.42973,1,0
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00096503,-0.40155,-0.56585,1,0
1,GO CELL CYCLE DNA REPLICATION,5.2428e-05,-0.40171,-0.41882,1,0
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00051151,-0.40177,-0.30894,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.3461e-06,-0.40189,-0.45938,1,0
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.018736,-0.40196,-0.49616,1,0
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.021265,-0.40207,-0.6015,1,0
1,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,5.9985e-05,-0.40236,-0.37478,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.337e-06,-0.40249,-0.42381,1,0
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00051151,-0.40267,-0.55499,1,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.00010181,-0.40267,-0.50752,1,0
1,GO RESPONSE TO INTERLEUKIN 1,7.8298e-05,-0.40277,-0.43087,1,0
1,GO RESPONSE TO VITAMIN A,1.2035e-05,-0.40287,-0.39946,1,0
1,GO CELLULAR RESPONSE TO ALKALOID,1.7249e-05,-0.40317,-0.42548,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,2.1347e-05,-0.4032,-0.45556,1,0
1,GO HORMONE CATABOLIC PROCESS,0.00026348,-0.40324,-0.38137,1,0
1,GO GRANULOCYTE CHEMOTAXIS,0.0052065,-0.40358,-0.47744,1,0
1,GO VITAMIN METABOLIC PROCESS,5.7533e-06,-0.40368,-0.42557,1,0
1,GO NEURAL RETINA DEVELOPMENT,4.2763e-05,-0.40393,-0.45625,1,0
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0010798,-0.40394,-0.35701,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.0010209,-0.4041,-0.58958,1,0
1,GO ADHESION OF SYMBIONT TO HOST,0.0031545,-0.40427,-0.62663,1,0
1,GO GAMETE GENERATION,1.4947e-05,-0.40429,-0.42199,1,0
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,2.4576e-05,-0.4043,-0.55532,1,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,2.2907e-05,-0.40438,-0.42873,1,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00081392,-0.40468,-0.36064,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00057531,-0.40471,-0.41142,1,0
1,GO MRNA PROCESSING,2.4576e-05,-0.40478,-0.41585,1,0
1,GO ETHER METABOLIC PROCESS,1.0403e-05,-0.40481,-0.47645,1,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,1.0403e-05,-0.40491,-0.43987,1,0
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,7.1973e-06,-0.40537,-0.45474,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.010101,-0.40538,-0.46228,1,0
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,4.9495e-06,-0.40549,-0.44921,1,0
1,GO TRANSPOSITION,3.7287e-05,-0.40551,-0.43402,1,0
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1.6059e-05,-0.40578,-0.46908,1,0
1,GO MITOTIC RECOMBINATION,8.9327e-05,-0.40585,-0.45523,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00051151,-0.40585,-0.57292,1,0
1,GO NECROTIC CELL DEATH,2.1347e-05,-0.40589,-0.47858,1,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,3.9936e-05,-0.40595,-0.48798,1,0
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.0013481,-0.406,-0.58016,1,0
1,GO INTERLEUKIN 2 PRODUCTION,0.00068502,-0.40613,-0.59325,1,0
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,8.3461e-06,-0.40623,-0.45037,1,0
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00020554,-0.40632,-0.45312,1,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,6.2007e-06,-0.4064,-0.46605,1,0
1,GO INTERLEUKIN 4 PRODUCTION,0.0060238,-0.40659,-0.51435,1,0
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.8298e-05,-0.40665,-0.52828,1,0
1,GO PHAGOSOME ACIDIFICATION,2.2907e-05,-0.40674,-0.43215,1,0
1,GO MRNA MODIFICATION,0.00024771,-0.40709,-0.38767,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0038653,-0.4071,-0.44965,1,0
1,GO LEUKOCYTE MEDIATED IMMUNITY,3.7287e-05,-0.40712,-0.52927,1,0
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00012367,-0.4072,-0.57565,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00033648,-0.40728,-0.53467,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0052065,-0.40728,-0.49074,1,0
1,GO DENDRITE SELF AVOIDANCE,5.9985e-05,-0.40737,-0.49264,1,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,3.248e-05,-0.40743,-0.49948,1,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00076864,-0.40746,-0.48326,1,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00068502,-0.40764,-0.42461,1,0
1,GO FATTY ACID METABOLIC PROCESS,5.337e-06,-0.40772,-0.43434,1,0
1,GO DEFENSE RESPONSE,3.7287e-05,-0.40784,-0.52069,1,0
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0010209,-0.40831,-0.42175,1,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,4.5891e-06,-0.40838,-0.43471,1,0
1,GO REGULATION OF T CELL ACTIVATION,0.00023283,-0.40856,-0.55894,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,7.3279e-05,-0.40892,-0.55275,1,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,5.6086e-05,-0.40892,-0.37207,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,4.5779e-05,-0.40909,-0.4579,1,0
1,GO REGULATION OF DENDRITE EXTENSION,0.00035748,-0.40929,-0.51057,1,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00020554,-0.4094,-0.41406,1,0
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,8.3461e-06,-0.40955,-0.43376,1,0
1,GO REGULATION OF HISTONE UBIQUITINATION,1.0403e-05,-0.40962,-0.48465,1,0
1,GO PROTEIN MANNOSYLATION,2.2907e-05,-0.40974,-0.47415,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00024771,-0.40976,-0.49123,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,9.6689e-06,-0.40982,-0.43411,1,0
1,GO DNA RECOMBINATION,8.9843e-06,-0.40992,-0.46333,1,0
1,GO SENSORY PERCEPTION,5.7533e-06,-0.41008,-0.40895,1,0
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,6.8565e-05,-0.41013,-0.45289,1,0
1,GO TRANSITION METAL ION HOMEOSTASIS,2.2907e-05,-0.41014,-0.41448,1,0
1,GO CELLULAR DEFENSE RESPONSE,0.01266,-0.41016,-0.48165,1,0
1,GO PIGMENT BIOSYNTHETIC PROCESS,7.1973e-06,-0.41019,-0.42981,1,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,1.7249e-05,-0.41022,-0.46908,1,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.00091199,-0.41026,-0.39022,1,0
1,GO ANDROGEN METABOLIC PROCESS,6.8565e-05,-0.41027,-0.36218,1,0
1,GO INTERLEUKIN 1 PRODUCTION,0.00068502,-0.41044,-0.54547,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0019699,-0.41066,-0.46955,1,0
1,GO DNA CONFORMATION CHANGE,1.3909e-05,-0.41072,-0.47132,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,9.6689e-06,-0.41088,-0.44419,1,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00023283,-0.41088,-0.4278,1,0
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00012367,-0.4111,-0.5522,1,0
1,GO NIK NF KAPPAB SIGNALING,2.1347e-05,-0.41134,-0.46739,1,0
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,1.8524e-05,-0.41134,-0.5346,1,0
1,GO T CELL PROLIFERATION,0.00057531,-0.41138,-0.55245,1,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.00014989,-0.41156,-0.36068,1,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,1.4947e-05,-0.41165,-0.44847,1,0
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,9.6689e-06,-0.41169,-0.47948,1,0
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.41195,-0.43737,1,0
1,GO POSITIVE REGULATION OF TRANSLATION,8.9843e-06,-0.41207,-0.41739,1,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0015041,-0.41222,-0.56033,1,0
1,GO PROTEIN FOLDING,3.9936e-05,-0.41225,-0.4154,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,3.248e-05,-0.41241,-0.46538,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0003797,-0.41248,-0.43714,1,0
1,GO HISTONE H2A UBIQUITINATION,1.9888e-05,-0.41256,-0.48465,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00018128,-0.41266,-0.34692,1,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,4.5779e-05,-0.41276,-0.46051,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0012758,-0.41279,-0.55537,1,0
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,8.3461e-06,-0.41283,-0.43688,1,0
1,GO PROTEIN MONOUBIQUITINATION,1.3909e-05,-0.41287,-0.48985,1,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.4947e-05,-0.41296,-0.42438,1,0
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00072571,-0.41307,-0.56386,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0020776,-0.41316,-0.56877,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0034935,-0.41347,-0.47069,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00019306,-0.41361,-0.56772,1,0
1,GO ORGANELLE FISSION,1.0403e-05,-0.41361,-0.46918,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,3.4805e-05,-0.41368,-0.41719,1,0
1,GO AXONEME ASSEMBLY,0.0044907,-0.41377,-0.33854,1,0
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.030713,-0.41406,-0.38587,1,0
1,GO HEART INDUCTION,0.0020776,-0.4141,-0.42921,1,0
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00024771,-0.41412,-0.56835,1,0
1,GO IRON ION TRANSMEMBRANE TRANSPORT,2.1347e-05,-0.41448,-0.48969,1,0
1,GO MISMATCH REPAIR,1.2035e-05,-0.41448,-0.46638,1,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,3.248e-05,-0.41467,-0.41028,1,0
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,8.9327e-05,-0.41479,-0.43806,1,0
1,GO PHOTOPERIODISM,0.00026348,-0.4148,-0.39882,1,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,7.1973e-06,-0.41514,-0.45217,1,0
1,GO CELL CYCLE PHASE TRANSITION,8.3461e-06,-0.41524,-0.45127,1,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.0403e-05,-0.41526,-0.41211,1,0
1,GO REGULATION OF MULTI ORGANISM PROCESS,1.2939e-05,-0.4153,-0.40746,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,4.2763e-05,-0.41534,-0.54476,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0016767,-0.41584,-0.42009,1,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0052065,-0.41596,-0.49519,1,0
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00015974,-0.41613,-0.57994,1,0
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,4.5891e-06,-0.41614,-0.45117,1,0
1,GO NEURON FATE SPECIFICATION,0.0042727,-0.41622,-0.46288,1,0
1,GO ORGANIC ACID CATABOLIC PROCESS,5.7533e-06,-0.41652,-0.43716,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.8524e-05,-0.41655,-0.43931,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,5.9985e-05,-0.41666,-0.49375,1,0
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,4.9495e-06,-0.41688,-0.43665,1,0
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,4.8997e-05,-0.41704,-0.5404,1,0
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,5.6086e-05,-0.41755,-0.44066,1,0
1,GO REGULATION OF IMMUNE RESPONSE,7.3279e-05,-0.41758,-0.54507,1,0
1,GO REGULATION OF GONAD DEVELOPMENT,1.2035e-05,-0.41771,-0.44496,1,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,4.2763e-05,-0.4178,-0.394,1,0
1,GO TRANSITION METAL ION TRANSPORT,7.7514e-06,-0.41783,-0.4325,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,1.7249e-05,-0.4179,-0.4784,1,0
1,GO SEXUAL REPRODUCTION,1.3909e-05,-0.41792,-0.42021,1,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,2.636e-05,-0.418,-0.40154,1,0
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0010209,-0.418,-0.55022,1,0
1,GO ACUTE INFLAMMATORY RESPONSE,0.00029789,-0.41801,-0.46633,1,0
1,GO METHYLATION,7.1973e-06,-0.4181,-0.46186,1,0
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,7.8298e-05,-0.4182,-0.53561,1,0
1,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00018128,-0.41822,-0.57279,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0066311,-0.41837,-0.5198,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00020554,-0.41839,-0.4174,1,0
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.038848,-0.41849,-0.48587,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.024086,-0.41855,-0.57656,1,0
1,GO RESPONSE TO PROTOZOAN,0.0066311,-0.41879,-0.53597,1,0
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014062,-0.41889,-0.57312,1,0
1,GO IMMUNE RESPONSE TO TUMOR CELL,0.0021907,-0.41892,-0.47961,1,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.00014062,-0.41909,-0.47952,1,0
1,GO LEUKOCYTE CELL CELL ADHESION,0.00015974,-0.41914,-0.57381,1,0
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.4576e-05,-0.41917,-0.54468,1,0
1,GO RESPONSE TO DEXAMETHASONE,7.8298e-05,-0.41917,-0.42204,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,1.3909e-05,-0.41938,-0.47955,1,0
1,GO EPIDERMAL CELL DIFFERENTIATION,6.4139e-05,-0.41944,-0.40653,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,6.2007e-06,-0.41946,-0.44259,1,0
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,1.1191e-05,-0.41947,-0.443,1,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00081392,-0.41955,-0.37427,1,0
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.3909e-05,-0.41965,-0.47972,1,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,5.337e-06,-0.4197,-0.44109,1,0
1,GO HISTONE H2A ACETYLATION,8.9327e-05,-0.41975,-0.4213,1,0
1,GO RECOMBINATIONAL REPAIR,2.2907e-05,-0.41986,-0.49161,1,0
1,GO THIOESTER METABOLIC PROCESS,4.5891e-06,-0.4204,-0.4325,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.013235,-0.42046,-0.33361,1,0
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00015974,-0.42052,-0.56344,1,0
1,GO ADAPTIVE IMMUNE RESPONSE,0.0016767,-0.42056,-0.57869,1,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,3.9936e-05,-0.4207,-0.4827,1,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0010798,-0.42084,-0.50434,1,0
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00017019,-0.42091,-0.3951,1,0
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0040644,-0.42107,-0.46827,1,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.9495e-06,-0.42134,-0.44592,1,0
1,GO EPIDERMIS DEVELOPMENT,2.1347e-05,-0.42138,-0.44678,1,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,1.3909e-05,-0.42144,-0.47043,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00018128,-0.42161,-0.57613,1,0
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,2.2907e-05,-0.42173,-0.48633,1,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,8.9327e-05,-0.42181,-0.44706,1,0
1,GO MYELOID LEUKOCYTE ACTIVATION,2.4576e-05,-0.4219,-0.53897,1,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00011593,-0.42211,-0.40508,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00045436,-0.42226,-0.45533,1,0
1,GO REGULATION OF INNATE IMMUNE RESPONSE,6.4139e-05,-0.42233,-0.47596,1,0
1,GO LINOLEIC ACID METABOLIC PROCESS,3.9936e-05,-0.42252,-0.48862,1,0
1,GO POTASSIUM ION HOMEOSTASIS,1.6059e-05,-0.42269,-0.48602,1,0
1,GO REGULATION OF MRNA METABOLIC PROCESS,1.4947e-05,-0.4231,-0.44287,1,0
1,GO PANCREATIC JUICE SECRETION,0.00029789,-0.42319,-0.45435,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00023283,-0.42334,-0.53979,1,0
1,GO HORMONE METABOLIC PROCESS,1.7249e-05,-0.42335,-0.39934,1,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00040321,-0.42362,-0.56543,1,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0016767,-0.42368,-0.47325,1,0
1,GO SYNAPTIC VESICLE TRANSPORT,4.2763e-05,-0.42371,-0.54049,1,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,2.1347e-05,-0.42395,-0.44648,1,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,7.7514e-06,-0.42399,-0.5088,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,2.1347e-05,-0.42417,-0.48196,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0092139,-0.42419,-0.48411,1,0
1,GO REGULATION OF DEFENSE RESPONSE,1.4947e-05,-0.42437,-0.51208,1,0
1,GO DOPAMINE METABOLIC PROCESS,9.5377e-05,-0.42473,-0.46367,1,0
1,GO RESPONSE TO INTERLEUKIN 18,0.0029965,-0.42494,-0.58906,1,0
1,GO EMBRYONIC PATTERN SPECIFICATION,8.3461e-06,-0.42498,-0.45184,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,2.2907e-05,-0.42502,-0.47177,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.7249e-05,-0.42504,-0.46809,1,0
1,GO BRAIN MORPHOGENESIS,1.1191e-05,-0.42534,-0.51711,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,5.337e-06,-0.42535,-0.47078,1,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00031664,-0.42563,-0.41741,1,0
1,GO ALPHA BETA T CELL ACTIVATION,0.00042807,-0.42582,-0.58086,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,5.337e-06,-0.42588,-0.52347,1,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00042807,-0.42594,-0.46628,1,0
1,GO T CELL ACTIVATION,0.00011593,-0.42604,-0.56811,1,0
1,GO MYOTUBE CELL DEVELOPMENT,1.2035e-05,-0.42614,-0.43333,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.248e-05,-0.42618,-0.45305,1,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.5891e-06,-0.42656,-0.45808,1,0
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,1.7249e-05,-0.4266,-0.52768,1,0
1,GO PIGMENT METABOLIC PROCESS,6.2007e-06,-0.4269,-0.43868,1,0
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.0011418,-0.42699,-0.45194,1,0
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00023283,-0.427,-0.43163,1,0
1,GO SUPEROXIDE METABOLIC PROCESS,2.636e-05,-0.42702,-0.51707,1,0
1,GO REGULATION OF MRNA CATABOLIC PROCESS,8.9843e-06,-0.42714,-0.43142,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00017019,-0.42731,-0.57605,1,0
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.4274,-0.48403,1,0
1,GO FRUCTOSE METABOLIC PROCESS,1.6059e-05,-0.4275,-0.52729,1,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,4.5891e-06,-0.42766,-0.45672,1,0
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.2539e-06,-0.42769,-0.51051,1,0
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,4.5891e-06,-0.4277,-0.48381,1,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,1.8524e-05,-0.42775,-0.44396,1,0
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,4.9495e-06,-0.42803,-0.44292,1,0
1,GO INTERLEUKIN 12 PRODUCTION,0.0049572,-0.42804,-0.52954,1,0
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,1.2035e-05,-0.4282,-0.42692,1,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,3.0304e-05,-0.4282,-0.44644,1,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,4.5891e-06,-0.42821,-0.44963,1,0
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,8.9843e-06,-0.42877,-0.47806,1,0
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00064645,-0.42883,-0.57775,1,0
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.9985e-05,-0.42898,-0.37443,1,0
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,3.248e-05,-0.42917,-0.4746,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00015974,-0.42922,-0.56967,1,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00026348,-0.42927,-0.43331,1,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,8.3461e-06,-0.42935,-0.4243,1,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00020554,-0.42949,-0.40481,1,0
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00010866,-0.4297,-0.57398,1,0
1,GO RESPONSE TO PARATHYROID HORMONE,0.00048214,-0.43007,-0.4159,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00026348,-0.43027,-0.56243,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,7.7514e-06,-0.43036,-0.46108,1,0
1,GO LIVER REGENERATION,2.2907e-05,-0.43039,-0.42427,1,0
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,9.6689e-06,-0.43051,-0.4976,1,0
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.7287e-05,-0.43058,-0.49334,1,0
1,GO PYROPTOSIS,0.00028019,-0.4307,-0.42296,1,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,5.337e-06,-0.43082,-0.56043,1,0
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00017019,-0.43082,-0.52295,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.00019306,-0.43088,-0.41593,1,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,2.636e-05,-0.4309,-0.46763,1,0
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.1191e-05,-0.43097,-0.44074,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,0.0019699,-0.43105,-0.57335,1,0
1,GO REGULATION OF EXOSOMAL SECRETION,1.8524e-05,-0.43115,-0.52067,1,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,9.6689e-06,-0.43122,-0.40658,1,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,5.6086e-05,-0.43128,-0.4622,1,0
1,GO REGULATION OF MRNA PROCESSING,2.8267e-05,-0.43137,-0.47544,1,0
1,GO PIGMENT GRANULE LOCALIZATION,0.00010181,-0.43141,-0.421,1,0
1,GO CELLULAR LIPID CATABOLIC PROCESS,4.5891e-06,-0.43142,-0.49728,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00010866,-0.43143,-0.57454,1,0
1,GO EXTRACELLULAR TRANSPORT,0.00048214,-0.43151,-0.41723,1,0
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0012071,-0.43164,-0.53328,1,0
1,GO ACROSOME ASSEMBLY,0.00068502,-0.43167,-0.41293,1,0
1,GO CYTOKINE PRODUCTION,2.8267e-05,-0.43203,-0.55127,1,0
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00014989,-0.43206,-0.59115,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,5.6086e-05,-0.43207,-0.4721,1,0
1,GO INTERLEUKIN 1 BETA PRODUCTION,0.00045436,-0.43219,-0.57366,1,0
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.5779e-05,-0.43238,-0.54723,1,0
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.9843e-06,-0.43244,-0.46705,1,0
1,GO REGULATION OF RNA SPLICING,1.6059e-05,-0.4325,-0.4614,1,0
1,GO REGULATION OF PH,5.7533e-06,-0.43266,-0.47923,1,0
1,GO DOPAMINE TRANSPORT,0.00091199,-0.43268,-0.45868,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0031545,-0.43272,-0.41384,1,0
1,GO ACETYL COA METABOLIC PROCESS,6.6813e-06,-0.43274,-0.515,1,0
1,GO DNA METABOLIC PROCESS,8.9843e-06,-0.43277,-0.45621,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,9.6689e-06,-0.43283,-0.54574,1,0
1,GO SISTER CHROMATID COHESION,2.1347e-05,-0.43299,-0.49959,1,0
1,GO CENTROSOME SEPARATION,2.8267e-05,-0.43312,-0.48524,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.0014241,-0.43312,-0.43859,1,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.43314,-0.44855,1,0
1,GO DNA DEALKYLATION,9.6689e-06,-0.43356,-0.45818,1,0
1,GO REGULATION OF CELL ACTIVATION,6.8565e-05,-0.4336,-0.58437,1,0
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.9422e-06,-0.43365,-0.46167,1,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.4947e-05,-0.43372,-0.46071,1,0
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00014989,-0.4338,-0.40341,1,0
1,GO SYNAPTIC SIGNALING,1.9888e-05,-0.43388,-0.52531,1,0
1,GO CRISTAE FORMATION,2.636e-05,-0.434,-0.53138,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.9985e-05,-0.43402,-0.59948,1,0
1,GO RNA LOCALIZATION,2.4576e-05,-0.43407,-0.44373,1,0
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00014062,-0.4341,-0.59197,1,0
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00029789,-0.43425,-0.4389,1,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.00020554,-0.43427,-0.41622,1,0
1,GO MITOCHONDRIAL DEPOLARIZATION,5.9985e-05,-0.43434,-0.52031,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00054254,-0.4344,-0.50682,1,0
1,GO DNA MODIFICATION,6.2007e-06,-0.4344,-0.44794,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.4576e-05,-0.4345,-0.52052,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,3.9936e-05,-0.43453,-0.46126,1,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00019306,-0.43455,-0.45384,1,0
1,GO DETECTION OF BIOTIC STIMULUS,0.0018673,-0.43477,-0.51928,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,7.1973e-06,-0.4353,-0.45313,1,0
1,GO ACTIVATION OF IMMUNE RESPONSE,3.9936e-05,-0.43536,-0.54867,1,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0052065,-0.43542,-0.3878,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,1.6059e-05,-0.43546,-0.44693,1,0
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00011593,-0.43547,-0.55605,1,0
1,GO INFLAMMATORY RESPONSE,4.5779e-05,-0.43549,-0.55489,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00019306,-0.43559,-0.58406,1,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,4.2539e-06,-0.43575,-0.46159,1,0
1,GO VIRAL RELEASE FROM HOST CELL,1.0403e-05,-0.43586,-0.44824,1,0
1,GO MRNA 3 END PROCESSING,4.2763e-05,-0.43601,-0.43913,1,0
1,GO HISTONE UBIQUITINATION,1.8524e-05,-0.43604,-0.48527,1,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,2.4576e-05,-0.43607,-0.45629,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,2.636e-05,-0.43623,-0.48474,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.016475,-0.43655,-0.50044,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.2007e-06,-0.43667,-0.48087,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,1.7249e-05,-0.43686,-0.45372,1,0
1,GO RNA EXPORT FROM NUCLEUS,2.4576e-05,-0.43732,-0.45291,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0023095,-0.43773,-0.58668,1,0
1,GO PROTEIN OXIDATION,5.6086e-05,-0.43791,-0.45434,1,0
1,GO COPPER ION TRANSPORT,8.3641e-05,-0.43792,-0.43182,1,0
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00012367,-0.43808,-0.60084,1,0
1,GO IMMUNE EFFECTOR PROCESS,2.8267e-05,-0.43823,-0.54853,1,0
1,GO RESPONSE TO VIRUS,8.3641e-05,-0.43823,-0.5153,1,0
1,GO GMP METABOLIC PROCESS,8.3461e-06,-0.43826,-0.44317,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.0403e-05,-0.43828,-0.43885,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,4.9495e-06,-0.43828,-0.44716,1,0
1,GO LYMPHOCYTE ACTIVATION,4.5779e-05,-0.43828,-0.57604,1,0
1,GO LEARNING,1.3909e-05,-0.4383,-0.51066,1,0
1,GO CYTOKINE METABOLIC PROCESS,7.8298e-05,-0.4383,-0.56127,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.337e-06,-0.43841,-0.49485,1,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,5.337e-06,-0.43871,-0.49956,1,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,5.337e-06,-0.43892,-0.45165,1,0
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00019306,-0.43896,-0.5609,1,0
1,GO MALE SEX DETERMINATION,4.8997e-05,-0.43896,-0.49101,1,0
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.018736,-0.43898,-0.52671,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,1.4947e-05,-0.43901,-0.43262,1,0
1,GO SENSORY PERCEPTION OF PAIN,7.1973e-06,-0.43908,-0.48766,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,6.2007e-06,-0.43927,-0.4796,1,0
1,GO NATURAL KILLER CELL ACTIVATION,0.00019306,-0.43929,-0.56603,1,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00015974,-0.43946,-0.5597,1,0
1,GO TOXIN METABOLIC PROCESS,5.6086e-05,-0.43947,-0.417,1,0
1,GO NEUROTRANSMITTER SECRETION,0.00029789,-0.43952,-0.54422,1,0
1,GO RESPONSE TO OXYGEN RADICAL,1.9888e-05,-0.43953,-0.42566,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,7.1973e-06,-0.43968,-0.49601,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,3.248e-05,-0.44005,-0.49384,1,0
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,5.7533e-06,-0.44015,-0.48438,1,0
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,5.7533e-06,-0.4402,-0.5156,1,0
1,GO REGULATION OF RIBOSOME BIOGENESIS,6.6813e-06,-0.44021,-0.49589,1,0
1,GO CELL CHEMOTAXIS,0.00017019,-0.44026,-0.54024,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,5.7533e-06,-0.44031,-0.44201,1,0
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.636e-05,-0.44031,-0.46798,1,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,1.0403e-05,-0.44032,-0.49157,1,0
1,GO POSITIVE REGULATION OF VIRAL PROCESS,5.7533e-06,-0.44032,-0.50274,1,0
1,GO IMMUNOGLOBULIN SECRETION,0.00086166,-0.44046,-0.48879,1,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,9.5377e-05,-0.44063,-0.44252,1,0
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,3.0304e-05,-0.4407,-0.45951,1,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.00018128,-0.44072,-0.47794,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,9.6689e-06,-0.44079,-0.45444,1,0
1,GO LEUKOCYTE PROLIFERATION,0.00024771,-0.44087,-0.56448,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00031664,-0.44095,-0.56197,1,0
1,GO CELL FATE SPECIFICATION,8.9843e-06,-0.44102,-0.49517,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0027019,-0.4412,-0.48127,1,0
1,GO RESPONSE TO ALKALOID,1.0403e-05,-0.4413,-0.46687,1,0
1,GO CELLULAR IRON ION HOMEOSTASIS,3.0304e-05,-0.44134,-0.42033,1,0
1,GO REGULATION OF INFLAMMATORY RESPONSE,2.2907e-05,-0.44176,-0.54559,1,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,4.5891e-06,-0.44176,-0.50534,1,0
1,GO PRESYNAPSE ORGANIZATION,4.8997e-05,-0.44202,-0.51691,1,0
1,GO REGULATION OF TRANSLATIONAL TERMINATION,2.8267e-05,-0.44205,-0.45541,1,0
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00024771,-0.44225,-0.51429,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE,6.6813e-06,-0.44235,-0.48176,1,0
1,GO CELLULAR COPPER ION HOMEOSTASIS,1.2035e-05,-0.44241,-0.5114,1,0
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,6.8565e-05,-0.44252,-0.56964,1,0
1,GO NUCLEAR PORE ORGANIZATION,0.00029789,-0.44258,-0.47922,1,0
1,GO NEUTRAL LIPID METABOLIC PROCESS,4.5891e-06,-0.4426,-0.50898,1,0
1,GO REGULATION OF SENSORY PERCEPTION,1.9888e-05,-0.44263,-0.41388,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00028019,-0.44277,-0.50141,1,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,7.1973e-06,-0.44296,-0.45718,1,0
1,GO AXIS SPECIFICATION,8.9843e-06,-0.44307,-0.44776,1,0
1,GO LYMPHOCYTE MIGRATION,0.0023095,-0.44308,-0.54622,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,5.337e-06,-0.4431,-0.54257,1,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,3.7287e-05,-0.44314,-0.40526,1,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00031664,-0.44344,-0.46096,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00045436,-0.4437,-0.47154,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,8.9327e-05,-0.4437,-0.55376,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,6.4139e-05,-0.4441,-0.43528,1,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,7.1973e-06,-0.44417,-0.4592,1,0
1,GO TELOMERE ORGANIZATION,1.1191e-05,-0.44423,-0.4587,1,0
1,GO T CELL DIFFERENTIATION,6.4139e-05,-0.44423,-0.58701,1,0
1,GO CELLULAR RESPONSE TO UV,5.7533e-06,-0.44423,-0.47113,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,5.337e-06,-0.4444,-0.44919,1,0
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,6.2007e-06,-0.44441,-0.48674,1,0
1,GO DIGESTIVE SYSTEM PROCESS,2.2907e-05,-0.44443,-0.38708,1,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.00018128,-0.44443,-0.43577,1,0
1,GO CHEMOKINE PRODUCTION,0.00012367,-0.44444,-0.53623,1,0
1,GO CARNITINE METABOLIC PROCESS,0.00029789,-0.44455,-0.38619,1,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,1.7249e-05,-0.4447,-0.4293,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,2.2907e-05,-0.4447,-0.41187,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.7287e-05,-0.44489,-0.44381,1,0
1,GO INTERACTION WITH SYMBIONT,3.9936e-05,-0.44515,-0.43797,1,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,5.9985e-05,-0.44522,-0.50719,1,0
1,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00091199,-0.44532,-0.39759,1,0
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.017954,-0.44543,-0.48637,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,9.6689e-06,-0.44553,-0.45474,1,0
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0038653,-0.44554,-0.49387,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.7249e-05,-0.4456,-0.47029,1,0
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0083971,-0.44562,-0.63177,1,0
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00091199,-0.44597,-0.52283,1,0
1,GO URETER DEVELOPMENT,3.7287e-05,-0.4461,-0.48805,1,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,4.2539e-06,-0.44615,-0.49867,1,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,1.1191e-05,-0.44617,-0.4428,1,0
1,GO MICROTUBULE SEVERING,0.00017019,-0.44624,-0.48067,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,1.9888e-05,-0.4463,-0.50556,1,0
1,GO DNA DEMETHYLATION,1.0403e-05,-0.44635,-0.48547,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,4.9495e-06,-0.44635,-0.44867,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,1.8524e-05,-0.44645,-0.51121,1,0
1,GO CENTROSOME DUPLICATION,2.636e-05,-0.44653,-0.521,1,0
1,GO RESPONSE TO LEAD ION,6.2007e-06,-0.44654,-0.52848,1,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,2.1347e-05,-0.44663,-0.48415,1,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.00040321,-0.44666,-0.45747,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,3.9936e-05,-0.44668,-0.43996,1,0
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,4.9495e-06,-0.44669,-0.46216,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0012758,-0.44677,-0.49991,1,0
1,GO REGULATION OF NUCLEAR DIVISION,8.9843e-06,-0.44681,-0.47132,1,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00048214,-0.44693,-0.44607,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0017696,-0.44731,-0.52275,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,8.3461e-06,-0.4474,-0.59283,1,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,3.7287e-05,-0.44741,-0.43001,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,3.9936e-05,-0.44754,-0.46927,1,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,1.4947e-05,-0.44781,-0.56651,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00060992,-0.44796,-0.44543,1,0
1,GO DIOL BIOSYNTHETIC PROCESS,8.9843e-06,-0.448,-0.51816,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.2007e-06,-0.44801,-0.49412,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,2.636e-05,-0.4481,-0.4863,1,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,8.3461e-06,-0.44813,-0.41364,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0013481,-0.44814,-0.4865,1,0
1,GO REGULATION OF MITOTIC CELL CYCLE,7.1973e-06,-0.44846,-0.48367,1,0
1,GO G0 TO G1 TRANSITION,3.9936e-05,-0.44847,-0.47683,1,0
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00010866,-0.44847,-0.5543,1,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00033648,-0.44852,-0.51467,1,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,8.3461e-06,-0.44866,-0.47361,1,0
1,GO REGULATION OF LIPID TRANSPORT,9.6689e-06,-0.44869,-0.47386,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,2.4576e-05,-0.4487,-0.47251,1,0
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,5.337e-06,-0.44878,-0.492,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0017696,-0.44886,-0.44707,1,0
1,GO PROSTATE GLAND DEVELOPMENT,1.9888e-05,-0.44888,-0.50363,1,0
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,4.2539e-06,-0.44888,-0.4794,1,0
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,2.8267e-05,-0.44893,-0.55882,1,0
1,GO ZYMOGEN INHIBITION,0.0011418,-0.44895,-0.48062,1,0
1,GO LIPID OXIDATION,4.5891e-06,-0.44898,-0.45889,1,0
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00013188,-0.44905,-0.48125,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION,9.5377e-05,-0.44919,-0.58837,1,0
1,GO REGULATION OF CELL CYCLE PROCESS,7.7514e-06,-0.44941,-0.48125,1,0
1,GO REFLEX,0.0031545,-0.44945,-0.45815,1,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00026348,-0.44948,-0.50692,1,0
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,5.7533e-06,-0.44949,-0.45688,1,0
1,GO T CELL RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.44955,-0.51575,1,0
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00057531,-0.44972,-0.58751,1,0
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,7.1973e-06,-0.44982,-0.49203,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,8.3461e-06,-0.44986,-0.4588,1,0
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00017019,-0.44988,-0.56762,1,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.00020554,-0.45012,-0.54705,1,0
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,6.2007e-06,-0.45014,-0.48139,1,0
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0003797,-0.45017,-0.51066,1,0
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00048214,-0.45018,-0.45127,1,0
1,GO WALKING BEHAVIOR,9.6689e-06,-0.4503,-0.53615,1,0
1,GO AMINE TRANSPORT,0.00040321,-0.45043,-0.43727,1,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,1.1191e-05,-0.4507,-0.4493,1,0
1,GO UV DAMAGE EXCISION REPAIR,5.7533e-06,-0.45071,-0.52536,1,0
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,5.9985e-05,-0.45082,-0.65835,1,0
1,GO MACROMOLECULE CATABOLIC PROCESS,4.9495e-06,-0.45086,-0.46614,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,5.7533e-06,-0.45092,-0.45781,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00010181,-0.45099,-0.55954,1,0
1,GO ZYMOGEN ACTIVATION,3.7287e-05,-0.45106,-0.55457,1,0
1,GO HISTONE MONOUBIQUITINATION,2.636e-05,-0.45116,-0.49952,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,1.7249e-05,-0.45119,-0.50724,1,0
1,GO REGULATION OF LYASE ACTIVITY,6.2007e-06,-0.45127,-0.47537,1,0
1,GO NEURAL TUBE PATTERNING,0.00011593,-0.4513,-0.45027,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,4.9495e-06,-0.45151,-0.52027,1,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,5.337e-06,-0.45178,-0.49425,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,6.6813e-06,-0.4519,-0.47423,1,0
1,GO RESPONSE TO CORTICOSTEROID,1.7249e-05,-0.45192,-0.48407,1,0
1,GO POSITIVE REGULATION OF DNA BINDING,1.0403e-05,-0.45202,-0.4712,1,0
1,GO MYOBLAST PROLIFERATION,6.8565e-05,-0.45204,-0.45582,1,0
1,GO DNA REPLICATION,1.7249e-05,-0.4521,-0.47365,1,0
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.7514e-06,-0.45215,-0.45436,1,0
1,GO DOUBLE STRAND BREAK REPAIR,9.6689e-06,-0.45227,-0.50138,1,0
1,GO SUPEROXIDE ANION GENERATION,0.00018128,-0.45229,-0.53381,1,0
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,1.0403e-05,-0.45249,-0.53345,1,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,8.9843e-06,-0.45272,-0.51097,1,0
1,GO VACUOLAR ACIDIFICATION,7.1973e-06,-0.45272,-0.47772,1,0
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.4947e-05,-0.45277,-0.52936,1,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.00054254,-0.45282,-0.47636,1,0
1,GO CELL CYCLE PROCESS,8.3461e-06,-0.45289,-0.48798,1,0
1,GO STEROID METABOLIC PROCESS,5.337e-06,-0.45292,-0.46742,1,0
1,GO REGULATION OF VIRAL TRANSCRIPTION,1.4947e-05,-0.45299,-0.46787,1,0
1,GO CELL DIVISION,1.0403e-05,-0.45299,-0.48294,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0031545,-0.45301,-0.5457,1,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00013188,-0.45323,-0.43676,1,0
1,GO HISTAMINE SECRETION,0.0038653,-0.45325,-0.37322,1,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,4.2539e-06,-0.45331,-0.44853,1,0
1,GO MITOTIC CELL CYCLE,8.9843e-06,-0.4534,-0.48615,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.8524e-05,-0.4534,-0.42021,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.3279e-05,-0.4534,-0.4954,1,0
1,GO BILE ACID METABOLIC PROCESS,1.3909e-05,-0.4534,-0.44053,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00029789,-0.45357,-0.59937,1,0
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,6.2007e-06,-0.45361,-0.49077,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00064645,-0.45362,-0.41044,1,0
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0020776,-0.45375,-0.60511,1,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0010798,-0.45387,-0.39979,1,0
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,7.7514e-06,-0.45393,-0.4598,1,0
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00020554,-0.45411,-0.38089,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00035748,-0.45421,-0.53496,1,0
1,GO NEUROTRANSMITTER TRANSPORT,8.9327e-05,-0.45429,-0.53794,1,0
1,GO BLASTOCYST FORMATION,6.2007e-06,-0.45444,-0.46235,1,0
1,GO REGULATION OF CELL MATURATION,6.6813e-06,-0.45453,-0.46121,1,0
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00096503,-0.45463,-0.57128,1,0
1,GO RENAL ABSORPTION,0.00029789,-0.45464,-0.52379,1,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,7.3279e-05,-0.45467,-0.4416,1,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,1.0403e-05,-0.45491,-0.39959,1,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,2.636e-05,-0.45491,-0.49433,1,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,3.9422e-06,-0.45491,-0.51692,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,6.4139e-05,-0.45493,-0.60775,1,0
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.5779e-05,-0.45497,-0.62256,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00010181,-0.45497,-0.45903,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00010181,-0.455,-0.55491,1,0
1,GO MACROPHAGE APOPTOTIC PROCESS,0.0052065,-0.45505,-0.36217,1,0
1,GO IRON ION TRANSPORT,1.2035e-05,-0.45511,-0.47074,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,7.8298e-05,-0.45514,-0.51568,1,0
1,GO PROTEIN O LINKED MANNOSYLATION,1.0403e-05,-0.45516,-0.51315,1,0
1,GO REGULATION OF STEROL TRANSPORT,9.6689e-06,-0.45532,-0.52873,1,0
1,GO REGULATION OF CELL AGING,6.6813e-06,-0.45534,-0.46785,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,6.2007e-06,-0.45558,-0.47901,1,0
1,GO NADH METABOLIC PROCESS,1.4947e-05,-0.45565,-0.52806,1,0
1,GO MITOTIC SISTER CHROMATID COHESION,3.7287e-05,-0.45569,-0.48411,1,0
1,GO MRNA CLEAVAGE,3.7287e-05,-0.4557,-0.47672,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00014062,-0.45576,-0.49761,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00023283,-0.45577,-0.63604,1,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.8267e-05,-0.45583,-0.49747,1,0
1,GO NERVOUS SYSTEM PROCESS,7.1973e-06,-0.45599,-0.46913,1,0
1,GO MULTI ORGANISM PROCESS,9.6689e-06,-0.4561,-0.44858,1,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,3.7287e-05,-0.45613,-0.44159,1,0
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.7287e-05,-0.45629,-0.58428,1,0
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00019306,-0.45631,-0.5368,1,0
1,GO PROTEIN TRIMERIZATION,2.636e-05,-0.45633,-0.54814,1,0
1,GO MULTI ORGANISM LOCALIZATION,5.7533e-06,-0.45638,-0.49006,1,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.1191e-05,-0.45642,-0.44229,1,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,1.0403e-05,-0.45645,-0.44647,1,0
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,1.4947e-05,-0.45649,-0.48678,1,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.00051151,-0.45655,-0.40136,1,0
1,GO INTERLEUKIN 8 PRODUCTION,0.00024771,-0.45656,-0.57107,1,0
1,GO MICROTUBULE BASED MOVEMENT,3.7287e-05,-0.45686,-0.46623,1,0
1,GO SARCOMERE ORGANIZATION,3.7287e-05,-0.45694,-0.41571,1,0
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,4.5891e-06,-0.45694,-0.50232,1,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0054671,-0.45694,-0.48496,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.636e-05,-0.45703,-0.53331,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,1.9888e-05,-0.45704,-0.47556,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,7.7514e-06,-0.45708,-0.49722,1,0
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.2428e-05,-0.45708,-0.59232,1,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,6.2007e-06,-0.45727,-0.49502,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0010798,-0.45747,-0.59171,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION,4.8997e-05,-0.45766,-0.50637,1,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,5.7533e-06,-0.45771,-0.49543,1,0
1,GO DIET INDUCED THERMOGENESIS,6.8565e-05,-0.45784,-0.44862,1,0
1,GO ESTABLISHMENT OF RNA LOCALIZATION,2.2907e-05,-0.45808,-0.47214,1,0
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,1.2035e-05,-0.45815,-0.51854,1,0
1,GO ACTIVATED T CELL PROLIFERATION,0.00013188,-0.45819,-0.53953,1,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.3909e-05,-0.45849,-0.5541,1,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.7533e-06,-0.4586,-0.48568,1,0
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00023283,-0.45874,-0.45147,1,0
1,GO RESPONSE TO ETHANOL,7.1973e-06,-0.45883,-0.43583,1,0
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,4.2763e-05,-0.45883,-0.52337,1,0
1,GO FLUID TRANSPORT,0.00013188,-0.459,-0.49124,1,0
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00031664,-0.45923,-0.57139,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,9.5377e-05,-0.45926,-0.39777,1,0
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,6.6813e-06,-0.45929,-0.47392,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.45933,-0.52643,1,0
1,GO PROTEIN MATURATION,4.9495e-06,-0.45951,-0.48211,1,0
1,GO FUCOSYLATION,5.7533e-06,-0.45955,-0.52817,1,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,4.5891e-06,-0.45975,-0.46165,1,0
1,GO PLASMINOGEN ACTIVATION,0.00021879,-0.45978,-0.56378,1,0
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,4.5891e-06,-0.45988,-0.55723,1,0
1,GO FATTY ACID CATABOLIC PROCESS,9.6689e-06,-0.45993,-0.45871,1,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.6059e-05,-0.46021,-0.55263,1,0
1,GO HEXOSE CATABOLIC PROCESS,9.6689e-06,-0.46022,-0.51831,1,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,3.4805e-05,-0.46028,-0.53839,1,0
1,GO DNA GEOMETRIC CHANGE,1.3909e-05,-0.46052,-0.48685,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,1.6059e-05,-0.46055,-0.50813,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.0024341,-0.46055,-0.49543,1,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,1.2035e-05,-0.46073,-0.51653,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.1347e-05,-0.46095,-0.45096,1,0
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,6.2007e-06,-0.4612,-0.47586,1,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,1.2035e-05,-0.46121,-0.44722,1,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,4.2763e-05,-0.46132,-0.45201,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0019699,-0.46137,-0.57878,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0020776,-0.46138,-0.54938,1,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,4.9495e-06,-0.46176,-0.4897,1,0
1,GO RESPONSE TO LITHIUM ION,0.00026348,-0.46181,-0.42974,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,1.3909e-05,-0.46189,-0.47278,1,0
1,GO REGULATION OF CELL CYCLE ARREST,7.1973e-06,-0.46189,-0.49042,1,0
1,GO ACTIN NUCLEATION,6.2007e-06,-0.46193,-0.50225,1,0
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,2.1347e-05,-0.46196,-0.4401,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00033648,-0.46198,-0.56203,1,0
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,1.2035e-05,-0.4624,-0.49705,1,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,1.7249e-05,-0.4624,-0.44456,1,0
1,GO KETONE BIOSYNTHETIC PROCESS,1.4947e-05,-0.4624,-0.47116,1,0
1,GO MITOTIC NUCLEAR DIVISION,1.0403e-05,-0.46241,-0.49818,1,0
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00010181,-0.46249,-0.56597,1,0
1,GO METENCEPHALON DEVELOPMENT,7.7514e-06,-0.46257,-0.53134,1,0
1,GO TRIGLYCERIDE CATABOLIC PROCESS,3.4805e-05,-0.46266,-0.38975,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,5.7533e-06,-0.46282,-0.49212,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0020776,-0.46288,-0.49441,1,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00026348,-0.46289,-0.50068,1,0
1,GO ARGININE METABOLIC PROCESS,1.0403e-05,-0.46296,-0.49414,1,0
1,GO HEART FORMATION,3.248e-05,-0.46306,-0.49473,1,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.00014989,-0.46315,-0.49382,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00086166,-0.46318,-0.52326,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00023283,-0.46326,-0.47323,1,0
1,GO HYPOTHALAMUS DEVELOPMENT,1.2939e-05,-0.46332,-0.48923,1,0
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,9.5377e-05,-0.46336,-0.51553,1,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,9.6689e-06,-0.46337,-0.51782,1,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,8.9843e-06,-0.46343,-0.45288,1,0
1,GO COPPER ION HOMEOSTASIS,9.6689e-06,-0.46359,-0.49533,1,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00026348,-0.464,-0.40348,1,0
1,GO DENDRITE EXTENSION,0.00014989,-0.46405,-0.51589,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0012758,-0.46405,-0.61368,1,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00011593,-0.46432,-0.56301,1,0
1,GO DETECTION OF OTHER ORGANISM,0.0020776,-0.46432,-0.56646,1,0
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00019306,-0.46436,-0.61108,1,0
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,6.8565e-05,-0.46436,-0.61328,1,0
1,GO RESPONSE TO NICOTINE,3.4805e-05,-0.46439,-0.4562,1,0
1,GO DICARBOXYLIC ACID TRANSPORT,3.248e-05,-0.46452,-0.48767,1,0
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.5377e-05,-0.46458,-0.44828,1,0
1,GO CELLULAR RESPONSE TO VIRUS,2.2907e-05,-0.46478,-0.52349,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00014989,-0.46515,-0.48051,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00014062,-0.46525,-0.58603,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0076456,-0.46536,-0.45634,1,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,7.7514e-06,-0.46551,-0.49193,1,0
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.636e-05,-0.46553,-0.60745,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,1.3909e-05,-0.46563,-0.48854,1,0
1,GO CELL CYCLE,6.6813e-06,-0.46569,-0.49069,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,5.7533e-06,-0.4657,-0.50493,1,0
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0023095,-0.46571,-0.60126,1,0
1,GO ARACHIDONIC ACID SECRETION,1.6059e-05,-0.46572,-0.47972,1,0
1,GO CELLULAR RESPONSE TO RADIATION,5.7533e-06,-0.4659,-0.45361,1,0
1,GO POTASSIUM ION TRANSPORT,1.2939e-05,-0.46592,-0.4944,1,0
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.4576e-05,-0.46598,-0.58334,1,0
1,GO SKIN DEVELOPMENT,2.4576e-05,-0.46601,-0.46982,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.1347e-05,-0.46605,-0.56838,1,0
1,GO NCRNA CATABOLIC PROCESS,1.4947e-05,-0.4661,-0.46035,1,0
1,GO REGULATION OF CELL CELL ADHESION,3.4805e-05,-0.46631,-0.58765,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,3.4805e-05,-0.46646,-0.51212,1,0
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00060992,-0.46646,-0.51898,1,0
1,GO FEVER GENERATION,2.4576e-05,-0.46649,-0.47927,1,0
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.46665,-0.49903,1,0
1,GO FOLIC ACID METABOLIC PROCESS,1.2939e-05,-0.46673,-0.46448,1,0
1,GO STEROID CATABOLIC PROCESS,0.00064645,-0.46675,-0.43729,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.8565e-05,-0.46679,-0.5469,1,0
1,GO DETECTION OF CALCIUM ION,0.00017019,-0.46713,-0.444,1,0
1,GO RESPONSE TO UV,4.9495e-06,-0.46716,-0.50068,1,0
1,GO TYPE 2 IMMUNE RESPONSE,0.0015041,-0.46717,-0.54496,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0016767,-0.46723,-0.52024,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00048214,-0.46724,-0.40257,1,0
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,4.5891e-06,-0.46737,-0.47815,1,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,5.6086e-05,-0.46741,-0.42907,1,0
1,GO CHLORIDE TRANSPORT,6.2007e-06,-0.46743,-0.48758,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE,6.6813e-06,-0.46746,-0.51347,1,0
1,GO REGULATION OF PROTEIN ACETYLATION,3.9422e-06,-0.46752,-0.52202,1,0
1,GO CHROMATIN REMODELING,1.0403e-05,-0.4677,-0.50457,1,0
1,GO MITOTIC SPINDLE ASSEMBLY,6.8565e-05,-0.46773,-0.47227,1,0
1,GO CELLULAR PIGMENTATION,1.3909e-05,-0.46776,-0.42521,1,0
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,4.5891e-06,-0.46777,-0.53102,1,0
1,GO ALCOHOL CATABOLIC PROCESS,1.9888e-05,-0.46781,-0.46305,1,0
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,1.6059e-05,-0.46789,-0.55737,1,0
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,9.6689e-06,-0.46807,-0.445,1,0
1,GO MACROPHAGE MIGRATION,0.00051151,-0.46819,-0.54734,1,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,1.9888e-05,-0.46822,-0.46185,1,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,8.3641e-05,-0.46826,-0.48264,1,0
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,4.5891e-06,-0.46829,-0.5065,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,1.9888e-05,-0.46832,-0.53924,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.7514e-06,-0.46835,-0.44477,1,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,2.1347e-05,-0.46837,-0.51392,1,0
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0036751,-0.46843,-0.52868,1,0
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00026348,-0.46844,-0.53085,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.7514e-06,-0.46845,-0.44555,1,0
1,GO IMMUNOGLOBULIN PRODUCTION,2.2907e-05,-0.46852,-0.55766,1,0
1,GO MITOTIC CYTOKINESIS,9.6689e-06,-0.46867,-0.51783,1,0
1,GO IRON ION HOMEOSTASIS,2.8267e-05,-0.46882,-0.45113,1,0
1,GO STEROID BIOSYNTHETIC PROCESS,5.7533e-06,-0.46907,-0.45762,1,0
1,GO REGULATION OF HORMONE LEVELS,8.9843e-06,-0.46909,-0.46148,1,0
1,GO ORGANELLE ASSEMBLY,9.6689e-06,-0.46914,-0.48155,1,0
1,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.00010181,-0.46915,-0.435,1,0
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00014062,-0.46929,-0.48125,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,1.4947e-05,-0.46938,-0.50733,1,0
1,GO ALCOHOL METABOLIC PROCESS,4.5891e-06,-0.46948,-0.50012,1,0
1,GO ORGANELLE DISASSEMBLY,6.6813e-06,-0.46948,-0.50917,1,0
1,GO RESPONSE TO INTERLEUKIN 4,3.4805e-05,-0.46951,-0.52731,1,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.00028019,-0.46954,-0.39505,1,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,8.3461e-06,-0.46977,-0.50387,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.8997e-05,-0.46988,-0.52683,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.2939e-05,-0.46994,-0.57042,1,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,1.2035e-05,-0.46995,-0.51441,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00040321,-0.46997,-0.54011,1,0
1,GO RESPONSE TO X RAY,9.6689e-06,-0.47,-0.5376,1,0
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,5.337e-06,-0.47013,-0.4952,1,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,3.9936e-05,-0.47016,-0.54449,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.9936e-05,-0.47018,-0.52919,1,0
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0034935,-0.47041,-0.57712,1,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.3909e-05,-0.47043,-0.51191,1,0
1,GO LIPID CATABOLIC PROCESS,4.5891e-06,-0.47045,-0.49589,1,0
1,GO SINGLE STRAND BREAK REPAIR,1.0403e-05,-0.4705,-0.49603,1,0
1,GO PROTEIN TETRAMERIZATION,4.5891e-06,-0.47061,-0.48381,1,0
1,GO CELL CYCLE CHECKPOINT,1.0403e-05,-0.47062,-0.50175,1,0
1,GO THYMOCYTE APOPTOTIC PROCESS,0.00010866,-0.47071,-0.52043,1,0
1,GO MITOCHONDRIAL FUSION,0.00010181,-0.47097,-0.49356,1,0
1,GO IMPORT INTO NUCLEUS,4.5891e-06,-0.47098,-0.49159,1,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.2007e-06,-0.47101,-0.4788,1,0
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0019699,-0.47111,-0.5415,1,0
1,GO VIRAL RNA GENOME REPLICATION,8.3461e-06,-0.47123,-0.52297,1,0
1,GO FEMALE GENITALIA DEVELOPMENT,2.1347e-05,-0.47133,-0.45796,1,0
1,GO HISTONE H3 K4 METHYLATION,1.3909e-05,-0.47136,-0.51621,1,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.00048214,-0.47141,-0.45308,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.7287e-05,-0.47141,-0.60393,1,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,3.248e-05,-0.47142,-0.48324,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00024771,-0.47158,-0.75122,1,0
1,GO NUCLEAR TRANSPORT,5.7533e-06,-0.47167,-0.47893,1,0
1,GO ANIMAL ORGAN REGENERATION,1.3909e-05,-0.47169,-0.48222,1,0
1,GO LEUKOTRIENE METABOLIC PROCESS,0.00020554,-0.47188,-0.48261,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00011593,-0.47193,-0.47471,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,1.2035e-05,-0.47213,-0.47694,1,0
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,4.5891e-06,-0.47221,-0.48186,1,0
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00029789,-0.47225,-0.55695,1,0
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,2.2907e-05,-0.4723,-0.54792,1,0
1,GO HEAT GENERATION,8.3641e-05,-0.47236,-0.46033,1,0
1,GO PROGRAMMED NECROTIC CELL DEATH,2.4576e-05,-0.47239,-0.5311,1,0
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.7287e-05,-0.4724,-0.5201,1,0
1,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.026142,-0.47249,-0.72831,1,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.0010209,-0.47273,-0.49061,1,0
1,GO TRANSPORT ALONG MICROTUBULE,2.8267e-05,-0.47277,-0.51407,1,0
1,GO CELL ACTIVATION,1.2035e-05,-0.47295,-0.56145,1,0
1,GO DEVELOPMENTAL INDUCTION,1.8524e-05,-0.47299,-0.48161,1,0
1,GO PROTEIN POLYUBIQUITINATION,4.9495e-06,-0.473,-0.50115,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,3.0304e-05,-0.47302,-0.49279,1,0
1,GO DEFENSE RESPONSE TO VIRUS,0.00011593,-0.47306,-0.55633,1,0
1,GO LIPID EXPORT FROM CELL,2.8267e-05,-0.47319,-0.43005,1,0
1,GO T HELPER 1 CELL DIFFERENTIATION,0.0038653,-0.47333,-0.55668,1,0
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.010572,-0.47354,-0.46597,1,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,7.7514e-06,-0.47356,-0.44594,1,0
1,GO REGULATION OF CELL CYCLE,5.7533e-06,-0.47369,-0.49873,1,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,5.337e-06,-0.47369,-0.49718,1,0
1,GO NADP METABOLIC PROCESS,1.2939e-05,-0.47372,-0.45478,1,0
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,8.3461e-06,-0.47401,-0.4989,1,0
1,GO PARTURITION,2.2907e-05,-0.47404,-0.46519,1,0
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0060238,-0.47408,-0.55722,1,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,4.5779e-05,-0.4741,-0.48864,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,8.3641e-05,-0.47437,-0.51039,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0042727,-0.47453,-0.52701,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,4.5891e-06,-0.47457,-0.49504,1,0
1,GO THALAMUS DEVELOPMENT,0.0011418,-0.47464,-0.43727,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,5.7533e-06,-0.47467,-0.50293,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,8.3461e-06,-0.47467,-0.51322,1,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,7.7514e-06,-0.47493,-0.47837,1,0
1,GO LYMPHOCYTE DIFFERENTIATION,2.8267e-05,-0.47493,-0.59711,1,0
1,GO SYNAPSE MATURATION,0.00010181,-0.47506,-0.59379,1,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.8524e-05,-0.47514,-0.48703,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,7.8298e-05,-0.47529,-0.50478,1,0
1,GO RESPONSE TO LIGHT STIMULUS,5.337e-06,-0.4753,-0.47159,1,0
1,GO POSITIVE REGULATION OF DNA REPAIR,1.2939e-05,-0.47534,-0.52541,1,0
1,GO NAD METABOLIC PROCESS,9.6689e-06,-0.47539,-0.54956,1,0
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,3.4805e-05,-0.47558,-0.49554,1,0
1,GO VAGINA DEVELOPMENT,0.00019306,-0.47569,-0.49698,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,1.6059e-05,-0.47586,-0.54484,1,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,3.9936e-05,-0.47591,-0.48116,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,8.3641e-05,-0.47595,-0.49362,1,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,8.9327e-05,-0.47598,-0.56554,1,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,8.9843e-06,-0.47601,-0.56357,1,0
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,6.6813e-06,-0.47605,-0.46547,1,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.9843e-06,-0.47613,-0.50173,1,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,3.4805e-05,-0.47614,-0.46208,1,0
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,2.8267e-05,-0.47614,-0.55819,1,0
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00031664,-0.47626,-0.56464,1,0
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.7287e-05,-0.47635,-0.48794,1,0
1,GO SYNAPTIC VESICLE BUDDING,0.00011593,-0.47643,-0.5349,1,0
1,GO PREPULSE INHIBITION,0.00068502,-0.47646,-0.55241,1,0
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.2907e-05,-0.47647,-0.45543,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.248e-05,-0.47647,-0.61352,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00096503,-0.4766,-0.54462,1,0
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,3.9936e-05,-0.47662,-0.44282,1,0
1,GO REGULATION OF PEPTIDASE ACTIVITY,1.2035e-05,-0.47664,-0.49232,1,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1191e-05,-0.47673,-0.48202,1,0
1,GO NOTOCHORD DEVELOPMENT,0.00054254,-0.47675,-0.47632,1,0
1,GO EXECUTION PHASE OF APOPTOSIS,8.3461e-06,-0.47678,-0.48204,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,9.6689e-06,-0.47679,-0.49238,1,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00048214,-0.47689,-0.64831,1,0
1,GO MIDBRAIN DEVELOPMENT,7.7514e-06,-0.47701,-0.4716,1,0
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00332,-0.47719,-0.62058,1,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,6.2007e-06,-0.47723,-0.48638,1,0
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,5.7533e-06,-0.47732,-0.50776,1,0
1,GO POLYOL BIOSYNTHETIC PROCESS,4.9495e-06,-0.47736,-0.50239,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,2.636e-05,-0.47748,-0.52135,1,0
1,GO REPLICATION FORK PROCESSING,2.636e-05,-0.47753,-0.56946,1,0
1,GO REGULATION OF LIPID LOCALIZATION,7.1973e-06,-0.47756,-0.50201,1,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,7.1973e-06,-0.47768,-0.52015,1,0
1,GO PIGMENT GRANULE ORGANIZATION,1.4947e-05,-0.47769,-0.46863,1,0
1,GO APOPTOTIC SIGNALING PATHWAY,6.2007e-06,-0.47771,-0.50088,1,0
1,GO COGNITION,9.6689e-06,-0.47773,-0.50136,1,0
1,GO POSITIVE REGULATION OF CYTOKINESIS,1.4947e-05,-0.47774,-0.50128,1,0
1,GO LIPID IMPORT INTO CELL,7.7514e-06,-0.47776,-0.58819,1,0
1,GO PIGMENT ACCUMULATION,0.00057531,-0.47783,-0.53504,1,0
1,GO REGULATION OF CELLULAR PH,5.337e-06,-0.47786,-0.49826,1,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00017019,-0.47792,-0.4204,1,0
1,GO WATER TRANSPORT,0.00010866,-0.47799,-0.52508,1,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,7.7514e-06,-0.47802,-0.47695,1,0
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.4139e-05,-0.47819,-0.5558,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,4.2763e-05,-0.47825,-0.57765,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.0003797,-0.47831,-0.51224,1,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00013188,-0.47832,-0.52311,1,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,8.9843e-06,-0.47844,-0.50823,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,4.8997e-05,-0.47845,-0.53961,1,0
1,GO PROTEIN K63 LINKED UBIQUITINATION,3.9422e-06,-0.4785,-0.52133,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,3.4805e-05,-0.47857,-0.53021,1,0
1,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,6.2007e-06,-0.47877,-0.51429,1,0
1,GO MICROTUBULE BASED PROCESS,1.4947e-05,-0.47879,-0.50018,1,0
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0172,-0.47879,-0.49457,1,0
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0038653,-0.47881,-0.49551,1,0
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014989,-0.47882,-0.56989,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,2.636e-05,-0.47882,-0.53319,1,0
1,GO REGULATION OF SYMBIOTIC PROCESS,1.9888e-05,-0.47899,-0.51473,1,0
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.1973e-06,-0.47902,-0.55528,1,0
1,GO MECHANORECEPTOR DIFFERENTIATION,3.9422e-06,-0.4793,-0.52244,1,0
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,3.0304e-05,-0.47951,-0.43585,1,0
1,GO REGULATION OF DNA REPLICATION,1.6059e-05,-0.47955,-0.48471,1,0
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00024771,-0.47979,-0.51394,1,0
1,GO RESPONSE TO GAMMA RADIATION,7.7514e-06,-0.47982,-0.4834,1,0
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00076864,-0.48004,-0.60088,1,0
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,7.7514e-06,-0.48006,-0.51889,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.4803,-0.50977,1,0
1,GO HETEROTYPIC CELL CELL ADHESION,4.2763e-05,-0.48035,-0.56582,1,0
1,GO POSITIVE REGULATION OF HEMOPOIESIS,1.2939e-05,-0.48037,-0.58863,1,0
1,GO LIPID METABOLIC PROCESS,4.9495e-06,-0.48045,-0.49693,1,0
1,GO REGULATION OF MAST CELL ACTIVATION,1.8524e-05,-0.48051,-0.61666,1,0
1,GO NUCLEOTIDE PHOSPHORYLATION,4.5891e-06,-0.48052,-0.54047,1,0
1,GO GLIAL CELL APOPTOTIC PROCESS,1.9888e-05,-0.48056,-0.56741,1,0
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,1.7249e-05,-0.4806,-0.55533,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00011593,-0.48077,-0.58006,1,0
1,GO PORE COMPLEX ASSEMBLY,8.9843e-06,-0.48084,-0.50491,1,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,1.6059e-05,-0.48086,-0.4528,1,0
1,GO MESODERMAL CELL FATE COMMITMENT,3.7287e-05,-0.48089,-0.43283,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,4.2763e-05,-0.48094,-0.55807,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.6059e-05,-0.481,-0.56451,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,5.6086e-05,-0.48103,-0.48869,1,0
1,GO BRANCH ELONGATION OF AN EPITHELIUM,2.1347e-05,-0.4811,-0.46304,1,0
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00010866,-0.48113,-0.60682,1,0
1,GO REGULATION OF LIPASE ACTIVITY,1.2035e-05,-0.48114,-0.51199,1,0
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0049572,-0.48119,-0.48576,1,0
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0012071,-0.48131,-0.58339,1,0
1,GO BROWN FAT CELL DIFFERENTIATION,1.6059e-05,-0.48131,-0.46154,1,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,5.7533e-06,-0.48136,-0.50266,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,1.1191e-05,-0.48141,-0.56027,1,0
1,GO RESPONSE TO ETHER,3.9936e-05,-0.48161,-0.46098,1,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.48168,-0.51885,1,0
1,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,7.8298e-05,-0.48169,-0.53156,1,0
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.8267e-05,-0.48175,-0.48316,1,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,1.9888e-05,-0.48175,-0.47308,1,0
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00023283,-0.48177,-0.56591,1,0
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,5.2428e-05,-0.4818,-0.54566,1,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,6.6813e-06,-0.48192,-0.49476,1,0
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.00096503,-0.48205,-0.42785,1,0
1,GO NUCLEAR EXPORT,9.6689e-06,-0.48208,-0.49078,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,4.8997e-05,-0.48212,-0.47076,1,0
1,GO CHEMOKINE SECRETION,0.0028457,-0.48212,-0.57324,1,0
1,GO SYNAPSE ASSEMBLY,1.3909e-05,-0.48228,-0.57321,1,0
1,GO REGULATION OF SISTER CHROMATID COHESION,2.4576e-05,-0.48229,-0.53218,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,4.2539e-06,-0.48235,-0.49373,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,6.8565e-05,-0.48241,-0.56865,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,1.9888e-05,-0.48242,-0.55068,1,0
1,GO LIPID DROPLET ORGANIZATION,4.9495e-06,-0.48251,-0.50281,1,0
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,1.2035e-05,-0.48267,-0.5131,1,0
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00023283,-0.48269,-0.59097,1,0
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,9.5377e-05,-0.48275,-0.53672,1,0
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,4.9495e-06,-0.48281,-0.53837,1,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.0403e-05,-0.48286,-0.54379,1,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,5.7533e-06,-0.48293,-0.51947,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,5.6086e-05,-0.48293,-0.50003,1,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,4.5891e-06,-0.48294,-0.51823,1,0
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,4.5891e-06,-0.48298,-0.486,1,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,1.7249e-05,-0.48315,-0.4624,1,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,1.4947e-05,-0.48316,-0.50321,1,0
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,6.2007e-06,-0.48318,-0.56996,1,0
1,GO ASYMMETRIC CELL DIVISION,4.5891e-06,-0.4832,-0.54401,1,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,6.4139e-05,-0.48321,-0.4696,1,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.7249e-05,-0.48331,-0.5666,1,0
1,GO NEUROMUSCULAR PROCESS,1.1191e-05,-0.48353,-0.555,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,3.0304e-05,-0.48356,-0.54793,1,0
1,GO MITOTIC SPINDLE ORGANIZATION,3.0304e-05,-0.48368,-0.49615,1,0
1,GO HYPOTONIC RESPONSE,3.0304e-05,-0.48378,-0.52573,1,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00026348,-0.48385,-0.61464,1,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,8.9843e-06,-0.48392,-0.56871,1,0
1,GO DIOL METABOLIC PROCESS,1.3909e-05,-0.48396,-0.53513,1,0
1,GO RESPONSE TO RADIATION,4.9495e-06,-0.48433,-0.477,1,0
1,GO FC RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.48434,-0.53913,1,0
1,GO CILIUM ORGANIZATION,4.2763e-05,-0.48438,-0.47867,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,4.5779e-05,-0.48468,-0.61822,1,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,4.5891e-06,-0.4849,-0.5555,1,0
1,GO NEGATIVE T CELL SELECTION,0.013235,-0.48512,-0.55093,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00017019,-0.48516,-0.48009,1,0
1,GO CYTOKINE SECRETION,8.3641e-05,-0.48519,-0.54222,1,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,4.5891e-06,-0.48536,-0.48558,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,1.2035e-05,-0.48554,-0.51251,1,0
1,GO REGULATION OF ACTIN NUCLEATION,5.7533e-06,-0.48558,-0.5212,1,0
1,GO PEPTIDE HORMONE SECRETION,2.636e-05,-0.48568,-0.49507,1,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.2035e-05,-0.48585,-0.52307,1,0
1,GO B CELL MEDIATED IMMUNITY,0.00040321,-0.48594,-0.60754,1,0
1,GO CALCIUM MEDIATED SIGNALING,6.2007e-06,-0.48597,-0.50616,1,0
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.3909e-05,-0.48597,-0.56985,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,1.8524e-05,-0.48623,-0.56114,1,0
1,GO REGULATION OF PHAGOCYTOSIS,0.00011593,-0.48623,-0.62887,1,0
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,7.7514e-06,-0.48628,-0.53102,1,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,1.4947e-05,-0.48642,-0.41679,1,0
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,5.7533e-06,-0.48644,-0.47125,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.7249e-05,-0.48645,-0.49796,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.48652,-0.48983,1,0
1,GO PURINE NUCLEOTIDE TRANSPORT,2.2907e-05,-0.48664,-0.47272,1,0
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00020554,-0.48678,-0.616,1,0
1,GO HISTONE H2A MONOUBIQUITINATION,8.3641e-05,-0.48682,-0.49211,1,0
1,GO HISTONE H4 DEACETYLATION,8.3641e-05,-0.487,-0.43385,1,0
1,GO RESPONSE TO CYTOKINE,1.2035e-05,-0.48704,-0.55393,1,0
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,5.337e-06,-0.48704,-0.52087,1,0
1,GO RESPONSE TO WATER,2.1347e-05,-0.48712,-0.5022,1,0
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00026348,-0.48734,-0.65611,1,0
1,GO SKELETAL MUSCLE CONTRACTION,6.6813e-06,-0.48741,-0.49802,1,0
1,GO CATECHOLAMINE SECRETION,0.00081392,-0.48743,-0.47252,1,0
1,GO SPINDLE MIDZONE ASSEMBLY,2.2907e-05,-0.48755,-0.62913,1,0
1,GO LEUKOCYTE DIFFERENTIATION,1.2939e-05,-0.48758,-0.59754,1,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,6.2007e-06,-0.4876,-0.49503,1,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,6.6813e-06,-0.48761,-0.48265,1,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,1.3909e-05,-0.48762,-0.55311,1,0
1,GO GLIAL CELL PROLIFERATION,2.8267e-05,-0.48763,-0.53024,1,0
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.8565e-05,-0.48767,-0.54754,1,0
1,GO TRNA TRANSPORT,1.7249e-05,-0.48767,-0.52021,1,0
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.9843e-06,-0.48787,-0.53607,1,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,1.0403e-05,-0.48795,-0.49048,1,0
1,GO MACROPHAGE CHEMOTAXIS,0.0010209,-0.48798,-0.52491,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.2939e-05,-0.48801,-0.489,1,0
1,GO EXOCYTIC PROCESS,4.2763e-05,-0.48809,-0.56266,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00023283,-0.48813,-0.57917,1,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,5.7533e-06,-0.48814,-0.51615,1,0
1,GO REGULATION OF MYELINATION,1.2035e-05,-0.48821,-0.5114,1,0
1,GO APOPTOTIC PROCESS,5.7533e-06,-0.48822,-0.51461,1,0
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.9495e-06,-0.48848,-0.52969,1,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.7249e-05,-0.48857,-0.50929,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,4.5779e-05,-0.48859,-0.54924,1,0
1,GO BEHAVIOR,1.2035e-05,-0.48864,-0.51688,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,4.5891e-06,-0.48865,-0.52556,1,0
1,GO NCRNA EXPORT FROM NUCLEUS,1.4947e-05,-0.48866,-0.53645,1,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,5.9985e-05,-0.48873,-0.44326,1,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,8.9843e-06,-0.48878,-0.48576,1,0
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0014241,-0.48901,-0.56499,1,0
1,GO CELLULAR COMPONENT DISASSEMBLY,4.9495e-06,-0.48904,-0.50278,1,0
1,GO ADULT BEHAVIOR,4.5779e-05,-0.48909,-0.52041,1,0
1,GO FATTY ACID TRANSPORT,4.2539e-06,-0.48935,-0.51853,1,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,1.0403e-05,-0.48942,-0.55017,1,0
1,GO PROTEIN AUTOUBIQUITINATION,5.337e-06,-0.48942,-0.49961,1,0
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.7249e-05,-0.48949,-0.59849,1,0
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.6059e-05,-0.48964,-0.50676,1,0
1,GO STEROL METABOLIC PROCESS,6.2007e-06,-0.48968,-0.51254,1,0
1,GO RESPONSE TO OXIDATIVE STRESS,5.337e-06,-0.48975,-0.50335,1,0
1,GO RESPONSE TO PROSTAGLANDIN,5.9985e-05,-0.48975,-0.52935,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,4.8997e-05,-0.48979,-0.58685,1,0
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00028019,-0.48979,-0.60712,1,0
1,GO VASODILATION,3.7287e-05,-0.48999,-0.43988,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0023095,-0.49002,-0.57485,1,0
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.1973e-06,-0.4901,-0.5003,1,0
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,1.0403e-05,-0.4901,-0.51019,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00019306,-0.49011,-0.49677,1,0
1,GO TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.49021,-0.48063,1,0
1,GO PARAXIAL MESODERM DEVELOPMENT,6.8565e-05,-0.49022,-0.4626,1,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.49028,-0.47138,1,0
1,GO WATER HOMEOSTASIS,2.8267e-05,-0.49033,-0.48533,1,0
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00042807,-0.49038,-0.60723,1,0
1,GO PROTEIN HOMOOLIGOMERIZATION,6.6813e-06,-0.49042,-0.49863,1,0
1,GO RESPONSE TO FATTY ACID,7.1973e-06,-0.49042,-0.51437,1,0
1,GO EAR MORPHOGENESIS,1.3909e-05,-0.49056,-0.46807,1,0
1,GO STEM CELL DIFFERENTIATION,5.337e-06,-0.4906,-0.48612,1,0
1,GO SULFATION,3.248e-05,-0.49064,-0.49274,1,0
1,GO CELLULAR HOMEOSTASIS,5.337e-06,-0.49076,-0.5007,1,0
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.015776,-0.49079,-0.6202,1,0
1,GO MICROTUBULE BASED TRANSPORT,3.9936e-05,-0.49082,-0.50254,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,3.4805e-05,-0.49088,-0.47499,1,0
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,8.9843e-06,-0.49105,-0.51916,1,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,8.3461e-06,-0.49107,-0.52481,1,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00048214,-0.49113,-0.50197,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00018128,-0.49113,-0.5012,1,0
1,GO RIG I SIGNALING PATHWAY,1.3909e-05,-0.49119,-0.51434,1,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00010181,-0.49126,-0.5123,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,5.7533e-06,-0.49138,-0.51289,1,0
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.7249e-05,-0.49159,-0.48396,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.00096503,-0.49168,-0.47217,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0010798,-0.49174,-0.44659,1,0
1,GO DNA METHYLATION OR DEMETHYLATION,7.7514e-06,-0.49176,-0.48639,1,0
1,GO PROTEIN IMPORT,4.9495e-06,-0.49212,-0.4854,1,0
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,8.9843e-06,-0.49219,-0.49725,1,0
1,GO MAINTENANCE OF LOCATION IN CELL,4.9495e-06,-0.49222,-0.52663,1,0
1,GO ETHER BIOSYNTHETIC PROCESS,3.0304e-05,-0.49231,-0.52486,1,0
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,8.3461e-06,-0.49244,-0.53959,1,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.00011593,-0.49254,-0.47203,1,0
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.9936e-05,-0.49263,-0.55439,1,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,5.337e-06,-0.49266,-0.51305,1,0
1,GO FATTY ACID HOMEOSTASIS,7.1973e-06,-0.49269,-0.55026,1,0
1,GO GLYCOSYLATION,6.6813e-06,-0.49276,-0.49563,1,0
1,GO PROTEIN COMPLEX OLIGOMERIZATION,6.2007e-06,-0.49278,-0.50985,1,0
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00014989,-0.49284,-0.59891,1,0
1,GO VITAMIN BIOSYNTHETIC PROCESS,1.2035e-05,-0.49285,-0.59392,1,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.0304e-05,-0.49288,-0.60574,1,0
1,GO WHITE FAT CELL DIFFERENTIATION,4.5891e-06,-0.49289,-0.53402,1,0
1,GO LONG CHAIN FATTY ACID TRANSPORT,4.2539e-06,-0.49295,-0.50876,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,1.1191e-05,-0.49296,-0.51835,1,0
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,6.2007e-06,-0.49298,-0.49803,1,0
1,GO PROTEIN PROCESSING,5.7533e-06,-0.49298,-0.52118,1,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,1.2035e-05,-0.49302,-0.53223,1,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,9.6689e-06,-0.49316,-0.56211,1,0
1,GO COPII COATED VESICLE BUDDING,1.2035e-05,-0.4932,-0.49081,1,0
1,GO ENDOCRINE PROCESS,6.2007e-06,-0.49326,-0.52106,1,0
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,7.7514e-06,-0.49339,-0.47829,1,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,3.7287e-05,-0.49349,-0.50961,1,0
1,GO FATTY ACID BETA OXIDATION,6.2007e-06,-0.49354,-0.48479,1,0
1,GO HORMONE TRANSPORT,1.4947e-05,-0.49356,-0.48571,1,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,5.6086e-05,-0.49362,-0.57321,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,4.2539e-06,-0.49379,-0.54109,1,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,8.9843e-06,-0.49403,-0.51067,1,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.2035e-05,-0.49408,-0.49495,1,0
1,GO NEUROINFLAMMATORY RESPONSE,0.00013188,-0.49429,-0.65988,1,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.9843e-06,-0.49446,-0.51749,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.9843e-06,-0.49456,-0.51484,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.49461,-0.61192,1,0
1,GO SPINDLE ASSEMBLY,1.9888e-05,-0.49466,-0.49765,1,0
1,GO NEURON CELL CELL ADHESION,0.007293,-0.49472,-0.41797,1,0
1,GO VESICLE BUDDING FROM MEMBRANE,9.6689e-06,-0.49488,-0.50115,1,0
1,GO HISTAMINE TRANSPORT,0.00048214,-0.49495,-0.445,1,0
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00026348,-0.49522,-0.41312,1,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.00018128,-0.49522,-0.60519,1,0
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.248e-05,-0.49525,-0.59136,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.636e-05,-0.49531,-0.4919,1,0
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,1.1191e-05,-0.49547,-0.49301,1,0
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00015974,-0.49553,-0.54852,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.1191e-05,-0.49578,-0.50945,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,4.5891e-06,-0.49582,-0.49477,1,0
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,1.2939e-05,-0.49585,-0.55561,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.4959,-0.50425,1,0
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.2035e-05,-0.4959,-0.54847,1,0
1,GO REGULATION OF PEPTIDE TRANSPORT,5.337e-06,-0.49594,-0.53097,1,0
1,GO NEGATIVE REGULATION OF TRANSPORT,7.7514e-06,-0.49598,-0.48865,1,0
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,1.7249e-05,-0.49599,-0.69599,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.00010181,-0.49613,-0.52047,1,0
1,GO CELL PROLIFERATION IN HINDBRAIN,1.8524e-05,-0.49632,-0.49945,1,0
1,GO AMINO SUGAR METABOLIC PROCESS,9.6689e-06,-0.49636,-0.52379,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,6.2007e-06,-0.49653,-0.52272,1,0
1,GO BLASTODERM SEGMENTATION,1.7249e-05,-0.49668,-0.47758,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00015974,-0.49671,-0.46479,1,0
1,GO ENDOSOME ORGANIZATION,5.7533e-06,-0.49685,-0.51008,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.6059e-05,-0.49685,-0.55208,1,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,5.337e-06,-0.49685,-0.51988,1,0
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.6813e-06,-0.49687,-0.51504,1,0
1,GO RESPONSE TO UV B,4.2763e-05,-0.49691,-0.49715,1,0
1,GO CELL RECOGNITION,1.9888e-05,-0.49694,-0.4718,1,0
1,GO LOCOMOTORY BEHAVIOR,1.7249e-05,-0.49697,-0.56096,1,0
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,2.2907e-05,-0.49698,-0.51964,1,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,7.7514e-06,-0.49702,-0.50305,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0096484,-0.49707,-0.47146,1,0
1,GO NUCLEAR BODY ORGANIZATION,9.5377e-05,-0.49716,-0.49808,1,0
1,GO NEGATIVE REGULATION OF CELL DEATH,5.337e-06,-0.49725,-0.50696,1,0
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0044907,-0.49726,-0.55663,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,4.2539e-06,-0.49729,-0.52613,1,0
1,GO CYCLOOXYGENASE PATHWAY,0.0036751,-0.49732,-0.51074,1,0
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,2.636e-05,-0.49736,-0.47986,1,0
1,GO CATION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.49741,-0.49891,1,0
1,GO POSITIVE REGULATION OF ORGAN GROWTH,6.2007e-06,-0.49744,-0.54446,1,0
1,GO VIRAL GENOME REPLICATION,2.4576e-05,-0.49756,-0.53815,1,0
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,8.9843e-06,-0.49763,-0.51953,1,0
1,GO B CELL PROLIFERATION,0.00026348,-0.4977,-0.63485,1,0
1,GO RESPONSE TO ALCOHOL,5.7533e-06,-0.49776,-0.51883,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,4.5891e-06,-0.49781,-0.55385,1,0
1,GO INTERFERON ALPHA PRODUCTION,3.248e-05,-0.49784,-0.59974,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,1.1191e-05,-0.4979,-0.55757,1,0
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.2939e-05,-0.4979,-0.61496,1,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,1.2035e-05,-0.49801,-0.55925,1,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,8.3461e-06,-0.49811,-0.53014,1,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,7.1973e-06,-0.49823,-0.51666,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,7.1973e-06,-0.49826,-0.5865,1,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,1.7249e-05,-0.49831,-0.5205,1,0
1,GO RESPONSE TO TUMOR CELL,0.00060992,-0.49834,-0.49704,1,0
1,GO NEGATIVE REGULATION OF DNA REPLICATION,5.6086e-05,-0.4984,-0.46325,1,0
1,GO MITOTIC CELL CYCLE CHECKPOINT,1.0403e-05,-0.49845,-0.50802,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,4.5891e-06,-0.49858,-0.50223,1,0
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0003797,-0.49859,-0.50503,1,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.0403e-05,-0.49864,-0.47122,1,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,8.9843e-06,-0.49876,-0.59555,1,0
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.9888e-05,-0.49876,-0.60989,1,0
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.2035e-05,-0.49882,-0.56839,1,0
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,8.9843e-06,-0.49897,-0.49896,1,0
1,GO PHOSPHOLIPID HOMEOSTASIS,2.1347e-05,-0.49918,-0.52077,1,0
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,7.8298e-05,-0.49937,-0.43042,1,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,1.8524e-05,-0.49947,-0.52007,1,0
1,GO MATING BEHAVIOR,0.00013188,-0.49952,-0.47982,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,5.7533e-06,-0.4996,-0.53382,1,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,3.7287e-05,-0.49962,-0.51012,1,0
1,GO INORGANIC ANION TRANSPORT,4.9495e-06,-0.49973,-0.50267,1,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,1.7249e-05,-0.49974,-0.45145,1,0
1,GO MYOBLAST FUSION,3.7287e-05,-0.4998,-0.65015,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00023283,-0.49981,-0.48224,1,0
1,GO REGULATION OF PROTEOLYSIS,5.337e-06,-0.49988,-0.51338,1,0
1,GO REGULATION OF RESPONSE TO STRESS,5.337e-06,-0.49991,-0.53025,1,0
1,GO PROTEIN KINASE A SIGNALING,8.3461e-06,-0.49995,-0.48352,1,0
1,GO CATION TRANSPORT,6.6813e-06,-0.5001,-0.49166,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00048214,-0.50011,-0.42822,1,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,6.6813e-06,-0.50017,-0.45239,1,0
1,GO REGULATION OF STEM CELL PROLIFERATION,1.1191e-05,-0.50024,-0.51336,1,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.8267e-05,-0.50025,-0.48526,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.8524e-05,-0.50026,-0.51089,1,0
1,GO O GLYCAN PROCESSING,5.9985e-05,-0.5004,-0.46621,1,0
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,6.6813e-06,-0.50047,-0.54751,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.8997e-05,-0.50048,-0.54674,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0034935,-0.5005,-0.5019,1,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.4947e-05,-0.50057,-0.53241,1,0
1,GO HORMONE MEDIATED SIGNALING PATHWAY,5.7533e-06,-0.50071,-0.5057,1,0
1,GO REGENERATION,8.9843e-06,-0.50079,-0.50592,1,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,6.6813e-06,-0.50082,-0.4969,1,0
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.8524e-05,-0.50085,-0.5633,1,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,2.4576e-05,-0.50094,-0.5211,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,3.9936e-05,-0.50121,-0.51917,1,0
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.4947e-05,-0.50134,-0.50573,1,0
1,GO ION TRANSMEMBRANE TRANSPORT,5.337e-06,-0.50136,-0.50237,1,0
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,7.3279e-05,-0.50138,-0.57826,1,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,3.7287e-05,-0.5014,-0.55319,1,0
1,GO HINDBRAIN MORPHOGENESIS,2.2907e-05,-0.50143,-0.53536,1,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,1.8524e-05,-0.5016,-0.45137,1,0
1,GO RELAXATION OF MUSCLE,2.8267e-05,-0.50161,-0.51231,1,0
1,GO TRANSFERRIN TRANSPORT,1.2035e-05,-0.50164,-0.48479,1,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,8.3461e-06,-0.50165,-0.50378,1,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,5.337e-06,-0.50165,-0.55052,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,1.4947e-05,-0.50171,-0.54533,1,0
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00020554,-0.50172,-0.60687,1,0
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.2007e-06,-0.50174,-0.49224,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.5779e-05,-0.50181,-0.58704,1,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,9.6689e-06,-0.50185,-0.52173,1,0
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00014062,-0.50188,-0.65002,1,0
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00017019,-0.50191,-0.63764,1,0
1,GO PROTEIN HOMOTETRAMERIZATION,5.337e-06,-0.50191,-0.4888,1,0
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,7.7514e-06,-0.50196,-0.49385,1,0
1,GO REGULATION OF GLIOGENESIS,7.7514e-06,-0.5021,-0.50313,1,0
1,GO NUCLEOTIDE TRANSPORT,1.2939e-05,-0.50212,-0.48848,1,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,2.1347e-05,-0.50219,-0.50877,1,0
1,GO PROTEOLYSIS,5.337e-06,-0.50221,-0.51279,1,0
1,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0021907,-0.50247,-0.49175,1,0
1,GO POSITIVE REGULATION OF BINDING,6.2007e-06,-0.50249,-0.52116,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,3.7287e-05,-0.50257,-0.56175,1,0
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.337e-06,-0.50279,-0.52648,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.3909e-05,-0.50292,-0.50923,1,0
1,GO HISTONE H3 K9 TRIMETHYLATION,8.9843e-06,-0.50297,-0.56723,1,0
1,GO STEROL HOMEOSTASIS,3.9422e-06,-0.503,-0.55621,1,0
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,2.636e-05,-0.50322,-0.50985,1,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,1.9888e-05,-0.50327,-0.60273,1,0
1,GO CARBOHYDRATE HOMEOSTASIS,6.6813e-06,-0.5033,-0.51951,1,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,1.9888e-05,-0.50344,-0.48632,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,1.0403e-05,-0.50346,-0.51488,1,0
1,GO CENTRIOLE ASSEMBLY,2.1347e-05,-0.50351,-0.55298,1,0
1,GO NEUTROPHIL EXTRAVASATION,7.8298e-05,-0.50388,-0.64642,1,0
1,GO T CELL SELECTION,0.00086166,-0.50388,-0.59915,1,0
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.5039,-0.52534,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,4.9495e-06,-0.50396,-0.50977,1,0
1,GO GOLGI VESICLE BUDDING,1.0403e-05,-0.50403,-0.51278,1,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,9.5377e-05,-0.50405,-0.47122,1,0
1,GO CELLULAR ION HOMEOSTASIS,6.6813e-06,-0.50408,-0.50121,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,4.9495e-06,-0.5041,-0.51944,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00013188,-0.50431,-0.46069,1,0
1,GO METAL ION HOMEOSTASIS,6.6813e-06,-0.50431,-0.50383,1,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,6.2007e-06,-0.50435,-0.53088,1,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,5.337e-06,-0.5044,-0.53656,1,0
1,GO ADAPTATION OF SIGNALING PATHWAY,1.3909e-05,-0.5045,-0.55067,1,0
1,GO AMYLOID BETA FORMATION,5.337e-06,-0.50471,-0.56844,1,0
1,GO CYTOKINESIS,8.3461e-06,-0.50481,-0.5301,1,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.00028019,-0.50482,-0.51302,1,0
1,GO MACROPHAGE DIFFERENTIATION,3.9936e-05,-0.50495,-0.66777,1,0
1,GO PROTEIN METHYLATION,1.0403e-05,-0.50499,-0.52911,1,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,4.5779e-05,-0.50501,-0.55454,1,0
1,GO REGULATION OF HEMOPOIESIS,7.7514e-06,-0.50503,-0.55277,1,0
1,GO REGULATION OF CELL DEATH,5.337e-06,-0.50512,-0.51731,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.9843e-06,-0.50512,-0.50392,1,0
1,GO CARDIAC CHAMBER FORMATION,0.00020554,-0.50514,-0.52514,1,0
1,GO RESPONSE TO NUTRIENT,8.9843e-06,-0.50527,-0.52638,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,5.9985e-05,-0.50528,-0.62158,1,0
1,GO SPINDLE ORGANIZATION,1.7249e-05,-0.50531,-0.51753,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,4.9495e-06,-0.50533,-0.54801,1,0
1,GO CATECHOLAMINE UPTAKE,0.00042807,-0.50533,-0.48843,1,0
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00026348,-0.50539,-0.53498,1,0
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,3.4805e-05,-0.50541,-0.58676,1,0
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,5.7533e-06,-0.50543,-0.56742,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,5.7533e-06,-0.50546,-0.52683,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,5.6086e-05,-0.50547,-0.56326,1,0
1,GO MAST CELL ACTIVATION,1.4947e-05,-0.50548,-0.60916,1,0
1,GO INSULIN SECRETION,2.2907e-05,-0.50556,-0.50256,1,0
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.7249e-05,-0.50557,-0.58422,1,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,1.9888e-05,-0.50562,-0.49477,1,0
1,GO CELL MATURATION,8.9843e-06,-0.50567,-0.50734,1,0
1,GO LEUKOCYTE MIGRATION,3.9936e-05,-0.5057,-0.59014,1,0
1,GO CHOLESTEROL EFFLUX,5.337e-06,-0.50572,-0.56655,1,0
1,GO DNA INTEGRITY CHECKPOINT,1.1191e-05,-0.50575,-0.51225,1,0
1,GO RESPONSE TO HYDROPEROXIDE,7.3279e-05,-0.50579,-0.55883,1,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,2.636e-05,-0.50587,-0.4589,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.8524e-05,-0.5059,-0.58554,1,0
1,GO REGULATION OF INSULIN SECRETION,1.8524e-05,-0.50596,-0.5006,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,5.6086e-05,-0.506,-0.57627,1,0
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00042807,-0.50602,-0.53303,1,0
1,GO CELL CYCLE ARREST,4.9495e-06,-0.50603,-0.51505,1,0
1,GO STEROL TRANSPORT,4.5891e-06,-0.50603,-0.56671,1,0
1,GO REGULATION OF HORMONE SECRETION,1.2939e-05,-0.50604,-0.47915,1,0
1,GO TUMOR NECROSIS FACTOR SECRETION,5.6086e-05,-0.50612,-0.52383,1,0
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,6.6813e-06,-0.50626,-0.53446,1,0
1,GO RESPONSE TO CATECHOLAMINE,1.3909e-05,-0.50632,-0.51596,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.2539e-06,-0.50634,-0.55516,1,0
1,GO REGULATION OF VIRAL LIFE CYCLE,2.636e-05,-0.50639,-0.5464,1,0
1,GO LIPID BIOSYNTHETIC PROCESS,4.5891e-06,-0.50646,-0.5053,1,0
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,1.2939e-05,-0.50655,-0.50176,1,0
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0023095,-0.50668,-0.56157,1,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.3909e-05,-0.5067,-0.53454,1,0
1,GO CD40 SIGNALING PATHWAY,3.9936e-05,-0.50675,-0.61106,1,0
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0003797,-0.50684,-0.63896,1,0
1,GO NON RECOMBINATIONAL REPAIR,1.1191e-05,-0.50686,-0.50608,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,5.7533e-06,-0.50689,-0.52053,1,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,8.9843e-06,-0.50693,-0.50423,1,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,8.9843e-06,-0.50695,-0.47011,1,0
1,GO ERAD PATHWAY,7.7514e-06,-0.50698,-0.5551,1,0
1,GO MRNA METHYLATION,5.2428e-05,-0.50721,-0.5304,1,0
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,5.337e-06,-0.50734,-0.48284,1,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,2.2907e-05,-0.50743,-0.50672,1,0
1,GO T CELL LINEAGE COMMITMENT,0.00010181,-0.50754,-0.5694,1,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,9.6689e-06,-0.50756,-0.52092,1,0
1,GO GLYCEROLIPID CATABOLIC PROCESS,5.337e-06,-0.50757,-0.49891,1,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,4.5779e-05,-0.50764,-0.54192,1,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,4.9495e-06,-0.50765,-0.53716,1,0
1,GO NEURAL CREST FORMATION,0.0027019,-0.50788,-0.41248,1,0
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,2.1347e-05,-0.5079,-0.52102,1,0
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,5.337e-06,-0.50793,-0.55714,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0027019,-0.50794,-0.51242,1,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,5.2428e-05,-0.50807,-0.44721,1,0
1,GO PROTEIN STABILIZATION,8.3461e-06,-0.50828,-0.48307,1,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,1.2939e-05,-0.50832,-0.49838,1,0
1,GO MACROAUTOPHAGY,5.7533e-06,-0.50836,-0.52924,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,6.4139e-05,-0.50841,-0.53441,1,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,1.1191e-05,-0.50863,-0.52027,1,0
1,GO T CELL DIFFERENTIATION IN THYMUS,2.2907e-05,-0.50866,-0.58897,1,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,1.2035e-05,-0.50877,-0.51441,1,0
1,GO NEURONAL ACTION POTENTIAL,6.4139e-05,-0.50877,-0.4818,1,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.337e-06,-0.50882,-0.51573,1,0
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,1.6059e-05,-0.50885,-0.51876,1,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,9.6689e-06,-0.50886,-0.48964,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,4.5779e-05,-0.50896,-0.49988,1,0
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,5.7533e-06,-0.50896,-0.54185,1,0
1,GO SIGNAL RELEASE,9.6689e-06,-0.50897,-0.51792,1,0
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,1.9888e-05,-0.50907,-0.63886,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00031664,-0.50913,-0.40518,1,0
1,GO RESPONSE TO IONIZING RADIATION,6.2007e-06,-0.50913,-0.50293,1,0
1,GO HOMEOSTATIC PROCESS,5.7533e-06,-0.50917,-0.51563,1,0
1,GO RECEPTOR BIOSYNTHETIC PROCESS,4.2539e-06,-0.50925,-0.56698,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016767,-0.50933,-0.55051,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00020554,-0.50934,-0.54856,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.50938,-0.51544,1,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.50957,-0.47797,1,0
1,GO GLUCOSE METABOLIC PROCESS,6.6813e-06,-0.50971,-0.54589,1,0
1,GO ENGULFMENT OF APOPTOTIC CELL,8.9843e-06,-0.50974,-0.6251,1,0
1,GO REGULATION OF ATP METABOLIC PROCESS,3.9422e-06,-0.50981,-0.52454,1,0
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,6.8565e-05,-0.50989,-0.48184,1,0
1,GO LIVER MORPHOGENESIS,7.3279e-05,-0.50991,-0.54959,1,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,5.7533e-06,-0.50994,-0.54097,1,0
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0029965,-0.51001,-0.5516,1,0
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00010181,-0.51011,-0.58682,1,0
1,GO VESICLE TARGETING,1.6059e-05,-0.51012,-0.50846,1,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.9888e-05,-0.51013,-0.49853,1,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.636e-05,-0.51016,-0.53599,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00020554,-0.51041,-0.57412,1,0
1,GO ORGANELLE LOCALIZATION,6.2007e-06,-0.51049,-0.54645,1,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,4.9495e-06,-0.51054,-0.56636,1,0
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,6.6813e-06,-0.5106,-0.58683,1,0
1,GO FOREBRAIN CELL MIGRATION,6.2007e-06,-0.51073,-0.58387,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,6.6813e-06,-0.51079,-0.54265,1,0
1,GO REGULATION OF PROTEIN STABILITY,6.2007e-06,-0.5108,-0.49548,1,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,4.8997e-05,-0.51082,-0.55136,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,3.7287e-05,-0.51087,-0.52562,1,0
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,9.6689e-06,-0.51088,-0.5327,1,0
1,GO TYPE I INTERFERON PRODUCTION,6.2007e-06,-0.51088,-0.58596,1,0
1,GO INTERLEUKIN 6 PRODUCTION,3.4805e-05,-0.51101,-0.59182,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,3.9936e-05,-0.51106,-0.5128,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,3.248e-05,-0.51108,-0.55468,1,0
1,GO ION HOMEOSTASIS,6.2007e-06,-0.51119,-0.50486,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,2.2907e-05,-0.51124,-0.49281,1,0
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.7249e-05,-0.51129,-0.59796,1,0
1,GO SYNAPTIC VESICLE DOCKING,0.0015882,-0.51143,-0.64764,1,0
1,GO REGULATION OF CYCLASE ACTIVITY,5.337e-06,-0.51153,-0.50939,1,0
1,GO DENDRITIC CELL DIFFERENTIATION,0.0057394,-0.5116,-0.58503,1,0
1,GO MEMBRANE DOCKING,1.3909e-05,-0.51168,-0.5384,1,0
1,GO REGULATION OF VIRAL GENOME REPLICATION,5.6086e-05,-0.51172,-0.54182,1,0
1,GO PROTEIN DEPHOSPHORYLATION,4.9495e-06,-0.51194,-0.54293,1,0
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,6.2007e-06,-0.512,-0.53196,1,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,8.9327e-05,-0.512,-0.46184,1,0
1,GO GLUCOSE CATABOLIC PROCESS,1.8524e-05,-0.51206,-0.57176,1,0
1,GO THYMUS DEVELOPMENT,1.2035e-05,-0.51208,-0.50495,1,0
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.248e-05,-0.51216,-0.6394,1,0
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,7.1973e-06,-0.51245,-0.55868,1,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS,4.5891e-06,-0.51251,-0.54603,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,8.9327e-05,-0.51272,-0.60936,1,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.51275,-0.52231,1,0
1,GO EPITHELIAL CELL MATURATION,0.00017019,-0.51289,-0.49892,1,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.6059e-05,-0.51334,-0.58219,1,0
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,7.3279e-05,-0.51342,-0.61532,1,0
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.4576e-05,-0.51347,-0.68028,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION,5.7533e-06,-0.51348,-0.54308,1,0
1,GO RESPONSE TO INTERFERON BETA,0.0021907,-0.51352,-0.57509,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00010866,-0.51355,-0.55166,1,0
1,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00033648,-0.5137,-0.56092,1,0
1,GO REGULATION OF AMYLOID BETA FORMATION,6.2007e-06,-0.51373,-0.59336,1,0
1,GO B CELL APOPTOTIC PROCESS,1.8524e-05,-0.51389,-0.54665,1,0
1,GO RESPONSE TO DRUG,4.9495e-06,-0.51389,-0.5172,1,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,6.2007e-06,-0.51404,-0.53615,1,0
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,7.7514e-06,-0.51405,-0.54899,1,0
1,GO SPLEEN DEVELOPMENT,6.6813e-06,-0.5141,-0.54016,1,0
1,GO SPINAL CORD DEVELOPMENT,5.7533e-06,-0.51419,-0.5738,1,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.51424,-0.47596,1,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,7.1973e-06,-0.51435,-0.5248,1,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,3.9422e-06,-0.5144,-0.56134,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,5.337e-06,-0.51442,-0.53115,1,0
1,GO HISTONE H4 K16 ACETYLATION,9.6689e-06,-0.5145,-0.58384,1,0
1,GO RESPONSE TO DOPAMINE,1.9888e-05,-0.5145,-0.5025,1,0
1,GO REGULATION OF PROTEIN TARGETING,4.9495e-06,-0.51453,-0.55796,1,0
1,GO REGULATION OF B CELL DIFFERENTIATION,6.8565e-05,-0.51459,-0.67587,1,0
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0044907,-0.51484,-0.53523,1,0
1,GO TOR SIGNALING,4.2539e-06,-0.51492,-0.58176,1,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,4.9495e-06,-0.51492,-0.56332,1,0
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,8.3461e-06,-0.51494,-0.56226,1,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.6059e-05,-0.51494,-0.46571,1,0
1,GO AUTOPHAGOSOME MATURATION,6.2007e-06,-0.51497,-0.54216,1,0
1,GO CELL ADHESION MOLECULE PRODUCTION,0.00023283,-0.51512,-0.57811,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.7249e-05,-0.51537,-0.58143,1,0
1,GO OSTEOBLAST DEVELOPMENT,3.248e-05,-0.51542,-0.50322,1,0
1,GO HISTONE H3 ACETYLATION,5.337e-06,-0.51548,-0.56107,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.011063,-0.5155,-0.65769,1,0
1,GO MAINTENANCE OF LOCATION,5.337e-06,-0.51552,-0.53988,1,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.2939e-05,-0.51564,-0.56383,1,0
1,GO THYROID HORMONE METABOLIC PROCESS,3.9936e-05,-0.51566,-0.47138,1,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,7.1973e-06,-0.51576,-0.51429,1,0
1,GO REGULATION OF DNA RECOMBINATION,6.6813e-06,-0.51584,-0.54785,1,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0015041,-0.516,-0.46373,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,6.8565e-05,-0.51606,-0.55065,1,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,1.9888e-05,-0.5161,-0.56654,1,0
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.6059e-05,-0.51614,-0.4963,1,0
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00014062,-0.51614,-0.6115,1,0
1,GO FOREGUT MORPHOGENESIS,7.3279e-05,-0.5164,-0.52842,1,0
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.6813e-06,-0.51645,-0.50459,1,0
1,GO RESPONSE TO MURAMYL DIPEPTIDE,3.9936e-05,-0.5165,-0.65993,1,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,1.3909e-05,-0.51652,-0.53625,1,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,6.2007e-06,-0.51661,-0.49485,1,0
1,GO MEMBRANE INVAGINATION,2.4576e-05,-0.51663,-0.67023,1,0
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,4.9495e-06,-0.51669,-0.54503,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,3.248e-05,-0.5167,-0.59876,1,0
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.5377e-05,-0.51673,-0.56028,1,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,2.636e-05,-0.51684,-0.5218,1,0
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00057531,-0.51689,-0.51666,1,0
1,GO ION TRANSPORT,5.7533e-06,-0.517,-0.49537,1,0
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00045436,-0.51701,-0.43624,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,9.5377e-05,-0.51707,-0.58955,1,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,5.337e-06,-0.51708,-0.52705,1,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,6.6813e-06,-0.51716,-0.50982,1,0
1,GO PSEUDOPODIUM ORGANIZATION,0.00035748,-0.51732,-0.55444,1,0
1,GO SODIUM ION TRANSPORT,1.1191e-05,-0.51747,-0.49564,1,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.51748,-0.5739,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.0025648,-0.5175,-0.53603,1,0
1,GO T CELL HOMEOSTASIS,1.1191e-05,-0.51788,-0.51225,1,0
1,GO SECRETION,5.7533e-06,-0.51808,-0.5339,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0027019,-0.51816,-0.57736,1,0
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,1.7249e-05,-0.51816,-0.47082,1,0
1,GO DEPHOSPHORYLATION,4.9495e-06,-0.5182,-0.54216,1,0
1,GO MANGANESE ION TRANSPORT,3.4805e-05,-0.51838,-0.46847,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,5.6086e-05,-0.51847,-0.51846,1,0
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.51849,-0.54277,1,0
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00086166,-0.51849,-0.72173,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,8.3461e-06,-0.51853,-0.49125,1,0
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00017019,-0.51856,-0.54615,1,0
1,GO LYMPHOCYTE COSTIMULATION,0.00026348,-0.51864,-0.60795,1,0
1,GO EPIDERMIS MORPHOGENESIS,0.00045436,-0.51872,-0.49316,1,0
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.4576e-05,-0.51881,-0.54557,1,0
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,1.6059e-05,-0.51885,-0.5746,1,0
1,GO PROTEIN POLYGLUTAMYLATION,7.8298e-05,-0.51894,-0.48978,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,1.8524e-05,-0.51895,-0.52269,1,0
1,GO VITAMIN TRANSPORT,7.7514e-06,-0.51913,-0.4981,1,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,3.4805e-05,-0.5192,-0.59294,1,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,4.5891e-06,-0.5192,-0.54228,1,0
1,GO PROTEIN CATABOLIC PROCESS,5.337e-06,-0.51922,-0.53425,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,8.9843e-06,-0.51931,-0.51447,1,0
1,GO POSTSYNAPSE ORGANIZATION,1.3909e-05,-0.51935,-0.55811,1,0
1,GO CHEMICAL HOMEOSTASIS,6.6813e-06,-0.51945,-0.5092,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,9.5377e-05,-0.51948,-0.63235,1,0
1,GO VIRAL LIFE CYCLE,4.5891e-06,-0.51955,-0.54557,1,0
1,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0021907,-0.5196,-0.60102,1,0
1,GO PROTEIN O LINKED GLYCOSYLATION,1.0403e-05,-0.51979,-0.50388,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.013834,-0.5198,-0.67106,1,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,6.2007e-06,-0.51988,-0.50972,1,0
1,GO MALE GENITALIA DEVELOPMENT,4.2763e-05,-0.51996,-0.50936,1,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00054254,-0.52002,-0.48392,1,0
1,GO REGULATION OF CELL POPULATION PROLIFERATION,5.337e-06,-0.52002,-0.53972,1,0
1,GO RESPONSE TO ANTIBIOTIC,5.7533e-06,-0.52017,-0.49413,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,3.0304e-05,-0.52025,-0.50412,1,0
1,GO REGULATION OF COAGULATION,2.1347e-05,-0.52026,-0.60141,1,0
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,9.6689e-06,-0.52037,-0.56116,1,0
1,GO REGULATION OF CELL DIVISION,4.9495e-06,-0.52038,-0.54227,1,0
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,1.6059e-05,-0.5204,-0.58736,1,0
1,GO REGIONALIZATION,8.3461e-06,-0.52041,-0.51876,1,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,5.7533e-06,-0.52042,-0.54309,1,0
1,GO MECHANOSENSORY BEHAVIOR,0.0027019,-0.52044,-0.48057,1,0
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.0403e-05,-0.52044,-0.58694,1,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.52059,-0.55039,1,0
1,GO RNA STABILIZATION,6.6813e-06,-0.5206,-0.50818,1,0
1,GO GENITALIA DEVELOPMENT,7.7514e-06,-0.52061,-0.52269,1,0
1,GO TOXIN TRANSPORT,8.3461e-06,-0.52073,-0.54313,1,0
1,GO LONG TERM SYNAPTIC POTENTIATION,2.2907e-05,-0.52083,-0.53314,1,0
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,4.2539e-06,-0.5209,-0.50542,1,0
1,GO REGULATION OF PLATELET AGGREGATION,2.8267e-05,-0.52093,-0.6159,1,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00028019,-0.52099,-0.54787,1,0
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,7.1973e-06,-0.52113,-0.54498,1,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,4.9495e-06,-0.52116,-0.52545,1,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,8.9843e-06,-0.52124,-0.52823,1,0
1,GO HORMONE BIOSYNTHETIC PROCESS,2.636e-05,-0.5214,-0.46131,1,0
1,GO PEPTIDE CROSS LINKING,0.00031664,-0.52143,-0.57015,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,1.9888e-05,-0.52144,-0.55932,1,0
1,GO POSITIVE REGULATION OF TRANSPORT,5.7533e-06,-0.52152,-0.54243,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,8.9843e-06,-0.52157,-0.5314,1,0
1,GO RESPONSE TO OSMOTIC STRESS,6.6813e-06,-0.52158,-0.52383,1,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,4.9495e-06,-0.52159,-0.54994,1,0
1,GO PATTERN SPECIFICATION PROCESS,8.9843e-06,-0.52161,-0.52468,1,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,1.6059e-05,-0.52164,-0.53413,1,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.1191e-05,-0.52165,-0.50517,1,0
1,GO PROTEIN ACYLATION,6.6813e-06,-0.52167,-0.55282,1,0
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,5.7533e-06,-0.52176,-0.5534,1,0
1,GO PROTEIN ACETYLATION,5.7533e-06,-0.52176,-0.55699,1,0
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.4947e-05,-0.5218,-0.51094,1,0
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00028019,-0.52181,-0.55592,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.9495e-06,-0.52186,-0.55872,1,0
1,GO CEREBRAL CORTEX CELL MIGRATION,1.4947e-05,-0.52189,-0.61429,1,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,5.9985e-05,-0.5219,-0.49141,1,0
1,GO ERK1 AND ERK2 CASCADE,1.4947e-05,-0.52199,-0.5884,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00015974,-0.52215,-0.55699,1,0
1,GO CELLULAR RESPONSE TO MANGANESE ION,1.2035e-05,-0.52218,-0.51645,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.2428e-05,-0.52222,-0.54049,1,0
1,GO MITOTIC CHROMOSOME CONDENSATION,3.7287e-05,-0.52235,-0.60002,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,1.6059e-05,-0.52248,-0.55856,1,0
1,GO TISSUE HOMEOSTASIS,7.7514e-06,-0.52257,-0.53808,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,1.7249e-05,-0.52266,-0.5319,1,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,8.3461e-06,-0.52278,-0.55672,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00014062,-0.52283,-0.53222,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,5.337e-06,-0.52286,-0.55914,1,0
1,GO DNA METHYLATION,1.7249e-05,-0.52294,-0.50004,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.008797,-0.52302,-0.48032,1,0
1,GO EXOCYTOSIS,5.337e-06,-0.52305,-0.5609,1,0
1,GO CELL CELL SIGNALING,6.6813e-06,-0.52311,-0.5211,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,4.2539e-06,-0.52312,-0.53884,1,0
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0024341,-0.52321,-0.58235,1,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.52322,-0.51477,1,0
1,GO RESPONSE TO GLUCAGON,0.00011593,-0.52323,-0.51176,1,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,3.7287e-05,-0.52323,-0.5235,1,0
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,8.9327e-05,-0.52351,-0.61677,1,0
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,4.9495e-06,-0.52354,-0.57516,1,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,6.2007e-06,-0.52356,-0.50288,1,0
1,GO CEREBRAL CORTEX DEVELOPMENT,8.3461e-06,-0.52362,-0.6056,1,0
1,GO STRIATED MUSCLE CELL PROLIFERATION,7.7514e-06,-0.52375,-0.52663,1,0
1,GO METAL ION TRANSPORT,7.7514e-06,-0.52388,-0.50293,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.52406,-0.58663,1,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,6.6813e-06,-0.52431,-0.49697,1,0
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,6.6813e-06,-0.52442,-0.51602,1,0
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,7.7514e-06,-0.52454,-0.5033,1,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.5246,-0.52257,1,0
1,GO RESPONSE TO THYROID HORMONE,5.337e-06,-0.52498,-0.59348,1,0
1,GO RESPONSE TO GONADOTROPIN,2.636e-05,-0.52511,-0.51657,1,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,4.8997e-05,-0.52511,-0.45066,1,0
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,4.9495e-06,-0.52511,-0.51443,1,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,1.9888e-05,-0.52527,-0.47017,1,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,3.0304e-05,-0.52533,-0.52346,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.00010181,-0.52544,-0.45779,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.5255,-0.53103,1,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,6.2007e-06,-0.52554,-0.52997,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,5.7533e-06,-0.52571,-0.53634,1,0
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4947e-05,-0.52575,-0.56754,1,0
1,GO ANTEROGRADE AXONAL TRANSPORT,2.2907e-05,-0.52577,-0.5995,1,0
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,7.1973e-06,-0.52578,-0.56508,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,2.4576e-05,-0.52586,-0.49953,1,0
1,GO RESPONSE TO STARVATION,7.7514e-06,-0.52595,-0.52587,1,0
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,4.5891e-06,-0.52599,-0.57617,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,6.4139e-05,-0.52605,-0.47785,1,0
1,GO GOLGI LOCALIZATION,1.2035e-05,-0.52612,-0.48768,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,4.2539e-06,-0.52619,-0.56302,1,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00031664,-0.52633,-0.58525,1,0
1,GO NEGATIVE REGULATION OF SECRETION,6.2007e-06,-0.52638,-0.49591,1,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,5.6086e-05,-0.52655,-0.48753,1,0
1,GO RESPONSE TO SALT STRESS,5.2428e-05,-0.52659,-0.46144,1,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,9.6689e-06,-0.52659,-0.51679,1,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,6.4139e-05,-0.52667,-0.50134,1,0
1,GO CRANIAL NERVE DEVELOPMENT,1.9888e-05,-0.52672,-0.58995,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00018128,-0.52675,-0.51725,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00096503,-0.52675,-0.69862,1,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,1.1191e-05,-0.5268,-0.48126,1,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,4.9495e-06,-0.52682,-0.54669,1,0
1,GO MITOCHONDRION LOCALIZATION,1.7249e-05,-0.52684,-0.57553,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00011593,-0.52699,-0.45008,1,0
1,GO HINDBRAIN DEVELOPMENT,8.3461e-06,-0.52706,-0.54166,1,0
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,1.6059e-05,-0.52711,-0.57561,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.9985e-05,-0.52711,-0.59811,1,0
1,GO ER NUCLEUS SIGNALING PATHWAY,4.8997e-05,-0.52713,-0.50601,1,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.7249e-05,-0.52725,-0.57352,1,0
1,GO PYRUVATE METABOLIC PROCESS,5.337e-06,-0.52726,-0.54952,1,0
1,GO REGULATION OF ION TRANSPORT,6.6813e-06,-0.52731,-0.51133,1,0
1,GO PONS DEVELOPMENT,0.0021907,-0.52733,-0.56029,1,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.2035e-05,-0.52741,-0.53497,1,0
1,GO NEURON APOPTOTIC PROCESS,4.5891e-06,-0.52745,-0.53742,1,0
1,GO MYOTUBE DIFFERENTIATION,6.2007e-06,-0.52747,-0.57973,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,6.6813e-06,-0.52751,-0.55504,1,0
1,GO AMINO ACID TRANSPORT,9.6689e-06,-0.52753,-0.5381,1,0
1,GO REGULATION OF VESICLE FUSION,7.3279e-05,-0.52775,-0.6437,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,1.8524e-05,-0.52778,-0.52024,1,0
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9888e-05,-0.52783,-0.59197,1,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.52785,-0.53206,1,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.2007e-06,-0.52785,-0.58113,1,0
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00011593,-0.52786,-0.59567,1,0
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00040321,-0.52788,-0.61926,1,0
1,GO CELLULAR RESPONSE TO FATTY ACID,5.337e-06,-0.528,-0.52464,1,0
1,GO CHROMATIN ORGANIZATION,6.6813e-06,-0.52813,-0.55359,1,0
1,GO REGULATION OF SPINDLE ORGANIZATION,4.5779e-05,-0.52818,-0.49641,1,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,1.3909e-05,-0.52825,-0.50707,1,0
1,GO REGULATION OF PROTEIN IMPORT,4.9495e-06,-0.52841,-0.53367,1,0
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,5.337e-06,-0.52841,-0.53752,1,0
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.52844,-0.55215,1,0
1,GO REGULATION OF B CELL ACTIVATION,4.8997e-05,-0.52849,-0.64795,1,0
1,GO REGULATION OF PEPTIDE SECRETION,6.2007e-06,-0.52857,-0.53728,1,0
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,7.7514e-06,-0.52862,-0.51273,1,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.8524e-05,-0.52863,-0.45838,1,0
1,GO SEX DIFFERENTIATION,4.5891e-06,-0.52868,-0.5071,1,0
1,GO COMPLEMENT ACTIVATION,0.0029965,-0.52871,-0.60435,1,0
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.1191e-05,-0.52877,-0.55068,1,0
1,GO HISTONE METHYLATION,8.3461e-06,-0.52885,-0.56935,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,3.248e-05,-0.52887,-0.54772,1,0
1,GO RESPONSE TO AMINO ACID STARVATION,1.0403e-05,-0.52892,-0.54249,1,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,4.9495e-06,-0.52894,-0.57004,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,5.337e-06,-0.529,-0.54695,1,0
1,GO CGMP MEDIATED SIGNALING,1.1191e-05,-0.52908,-0.55236,1,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,7.7514e-06,-0.52909,-0.62375,1,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,4.9495e-06,-0.52922,-0.57897,1,0
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,7.1973e-06,-0.52925,-0.5699,1,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,1.9888e-05,-0.52929,-0.57615,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,1.2035e-05,-0.52931,-0.59866,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,1.6059e-05,-0.52948,-0.53014,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.337e-06,-0.52959,-0.56764,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,2.1347e-05,-0.5296,-0.54315,1,0
1,GO REGULATION OF GENE SILENCING,7.7514e-06,-0.52985,-0.53083,1,0
1,GO ANION TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.52991,-0.52217,1,0
1,GO POSITIVE REGULATION OF SECRETION,6.6813e-06,-0.52996,-0.51528,1,0
1,GO HEART VALVE FORMATION,0.00013188,-0.53011,-0.56994,1,0
1,GO PHOSPHOLIPID CATABOLIC PROCESS,5.7533e-06,-0.53014,-0.60123,1,0
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00076864,-0.53046,-0.65075,1,0
1,GO RESPONSE TO OXYGEN LEVELS,5.337e-06,-0.5305,-0.50684,1,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,3.248e-05,-0.53052,-0.56039,1,0
1,GO PALLIUM DEVELOPMENT,1.6059e-05,-0.53052,-0.54789,1,0
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,7.1973e-06,-0.53052,-0.51859,1,0
1,GO REGULATION OF MACROPHAGE MIGRATION,0.00015974,-0.53057,-0.60402,1,0
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,1.0403e-05,-0.53058,-0.53015,1,0
1,GO T HELPER CELL LINEAGE COMMITMENT,0.0010209,-0.53063,-0.61226,1,0
1,GO REGULATION OF CHROMATIN BINDING,8.9843e-06,-0.53064,-0.59643,1,0
1,GO SEX DETERMINATION,1.3909e-05,-0.53066,-0.50951,1,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,5.7533e-06,-0.53069,-0.5977,1,0
1,GO MONOAMINE TRANSPORT,0.00014989,-0.53076,-0.49778,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00020554,-0.53076,-0.61328,1,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,1.1191e-05,-0.53078,-0.53778,1,0
1,GO CALCINEURIN MEDIATED SIGNALING,5.7533e-06,-0.53079,-0.54664,1,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00010866,-0.53084,-0.52903,1,0
1,GO AGING,4.9495e-06,-0.53084,-0.53357,1,0
1,GO REGULATION OF METAL ION TRANSPORT,6.6813e-06,-0.53092,-0.52083,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION,8.3461e-06,-0.53103,-0.50432,1,0
1,GO SYNAPTIC VESICLE MATURATION,0.0049572,-0.53113,-0.55129,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.9495e-06,-0.53133,-0.53446,1,0
1,GO RNA POLYADENYLATION,5.6086e-05,-0.53134,-0.53728,1,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,3.0304e-05,-0.53135,-0.50555,1,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,4.9495e-06,-0.53143,-0.54096,1,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,1.6059e-05,-0.53148,-0.57463,1,0
1,GO REGULATION OF ODONTOGENESIS,1.3909e-05,-0.53149,-0.52567,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.00020554,-0.53153,-0.58231,1,0
1,GO MEMBRANE ORGANIZATION,5.337e-06,-0.53161,-0.55471,1,0
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,2.1347e-05,-0.53174,-0.53152,1,0
1,GO CELLULAR RESPONSE TO RETINOIC ACID,1.1191e-05,-0.5318,-0.54345,1,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,4.5891e-06,-0.53193,-0.54409,1,0
1,GO REGULATION OF CYTOKINESIS,8.9843e-06,-0.53196,-0.55298,1,0
1,GO REGULATION OF B CELL PROLIFERATION,0.00013188,-0.53202,-0.66856,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,1.7249e-05,-0.5322,-0.52293,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.53235,-0.5807,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,9.6689e-06,-0.53245,-0.68878,1,0
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.7287e-05,-0.53246,-0.61383,1,0
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,7.3279e-05,-0.53259,-0.59451,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,4.2763e-05,-0.53265,-0.55867,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.00045436,-0.53281,-0.6192,1,0
1,GO ASTROCYTE DIFFERENTIATION,7.7514e-06,-0.53296,-0.5851,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017019,-0.53316,-0.56928,1,0
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,3.9936e-05,-0.5333,-0.52793,1,0
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0012071,-0.53336,-0.57681,1,0
1,GO RETINA LAYER FORMATION,0.00010181,-0.53336,-0.56704,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION,2.1347e-05,-0.5334,-0.62025,1,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,4.5891e-06,-0.53348,-0.50235,1,0
1,GO RESPONSE TO NITROGEN COMPOUND,5.7533e-06,-0.5335,-0.5418,1,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.1347e-05,-0.53384,-0.58645,1,0
1,GO PHAGOSOME MATURATION,5.7533e-06,-0.53389,-0.54575,1,0
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00018128,-0.5339,-0.58232,1,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,1.0403e-05,-0.53396,-0.52458,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.53403,-0.64855,1,0
1,GO RESPONSE TO LIPID,5.7533e-06,-0.53405,-0.53563,1,0
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,5.7533e-06,-0.53414,-0.52335,1,0
1,GO MUSCLE FIBER DEVELOPMENT,1.1191e-05,-0.53421,-0.5349,1,0
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00019306,-0.53424,-0.5768,1,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,3.0304e-05,-0.53429,-0.53026,1,0
1,GO REGULATION OF LIPID KINASE ACTIVITY,7.7514e-06,-0.53438,-0.63596,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,6.6813e-06,-0.53452,-0.54376,1,0
1,GO POSITIVE REGULATION OF CELL DEATH,6.2007e-06,-0.53452,-0.54212,1,0
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0052065,-0.5347,-0.63639,1,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,4.5891e-06,-0.53496,-0.58003,1,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.00010866,-0.535,-0.57915,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.1191e-05,-0.53502,-0.51276,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.2939e-05,-0.5351,-0.49421,1,0
1,GO MACROPHAGE ACTIVATION,6.4139e-05,-0.53516,-0.65837,1,0
1,GO AXO DENDRITIC TRANSPORT,3.7287e-05,-0.5352,-0.60642,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.1973e-06,-0.53525,-0.57268,1,0
1,GO TELENCEPHALON DEVELOPMENT,8.9843e-06,-0.53534,-0.55814,1,0
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.2428e-05,-0.53539,-0.64008,1,0
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.53547,-0.5979,1,0
1,GO GRANULOCYTE DIFFERENTIATION,1.4947e-05,-0.53554,-0.63555,1,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,6.8565e-05,-0.53556,-0.48512,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,5.7533e-06,-0.53563,-0.53487,1,0
1,GO SULFATE TRANSPORT,2.4576e-05,-0.53564,-0.50098,1,0
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.00017019,-0.53572,-0.61126,1,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,1.0403e-05,-0.53578,-0.58162,1,0
1,GO SERTOLI CELL DIFFERENTIATION,6.2007e-06,-0.53578,-0.62196,1,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,4.2539e-06,-0.53579,-0.54883,1,0
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,5.2428e-05,-0.53583,-0.51215,1,0
1,GO MEMORY,1.1191e-05,-0.53589,-0.52622,1,0
1,GO VITAMIN D METABOLIC PROCESS,1.9888e-05,-0.53616,-0.59858,1,0
1,GO SENSORY ORGAN MORPHOGENESIS,7.1973e-06,-0.5362,-0.5311,1,0
1,GO CARDIOBLAST DIFFERENTIATION,1.7249e-05,-0.53627,-0.56194,1,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,1.2035e-05,-0.53631,-0.58367,1,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,1.2035e-05,-0.53632,-0.49527,1,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,7.3279e-05,-0.53636,-0.53754,1,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00014989,-0.5364,-0.53979,1,0
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,4.5779e-05,-0.53662,-0.57639,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,5.7533e-06,-0.53663,-0.54131,1,0
1,GO LYMPHOCYTE HOMEOSTASIS,1.1191e-05,-0.53667,-0.57262,1,0
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,4.5891e-06,-0.53672,-0.59283,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.337e-06,-0.53689,-0.58718,1,0
1,GO RESPONSE TO HYDROGEN PEROXIDE,1.2939e-05,-0.53696,-0.48736,1,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00045436,-0.53699,-0.54899,1,0
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.8267e-05,-0.53709,-0.66848,1,0
1,GO CELLULAR RESPONSE TO LIPID,4.9495e-06,-0.53721,-0.54839,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.7287e-05,-0.53723,-0.59223,1,0
1,GO REGULATION OF GLUCONEOGENESIS,5.337e-06,-0.53727,-0.59612,1,0
1,GO POLYOL METABOLIC PROCESS,4.9495e-06,-0.53729,-0.53466,1,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,9.6689e-06,-0.5373,-0.55364,1,0
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,1.7249e-05,-0.53732,-0.60532,1,0
1,GO LYTIC VACUOLE ORGANIZATION,4.5891e-06,-0.53739,-0.59212,1,0
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00011593,-0.53739,-0.54168,1,0
1,GO AMELOGENESIS,1.7249e-05,-0.53742,-0.56819,1,0
1,GO PHOSPHOLIPID TRANSPORT,4.9495e-06,-0.53749,-0.58835,1,0
1,GO VISUAL BEHAVIOR,1.1191e-05,-0.53752,-0.525,1,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,3.0304e-05,-0.53774,-0.51685,1,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.0403e-05,-0.53777,-0.55535,1,0
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,9.5377e-05,-0.53782,-0.64972,1,0
1,GO POSITIVE REGULATION OF SIGNALING,5.337e-06,-0.53783,-0.54679,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.9888e-05,-0.53807,-0.58089,1,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,5.9985e-05,-0.53807,-0.59277,1,0
1,GO CEREBELLAR CORTEX FORMATION,7.3279e-05,-0.53812,-0.5292,1,0
1,GO CELLULAR RESPONSE TO ATP,1.3909e-05,-0.53847,-0.51298,1,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.53851,-0.58274,1,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,4.9495e-06,-0.53858,-0.55776,1,0
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.2763e-05,-0.53865,-0.57964,1,0
1,GO AMYLOID FIBRIL FORMATION,1.2035e-05,-0.53876,-0.62657,1,0
1,GO RESPONSE TO STEROID HORMONE,5.337e-06,-0.53877,-0.5417,1,0
1,GO SYNCYTIUM FORMATION,1.7249e-05,-0.53877,-0.62783,1,0
1,GO THYMIC T CELL SELECTION,0.0017696,-0.53881,-0.58994,1,0
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.9495e-06,-0.53892,-0.53277,1,0
1,GO COLLECTING DUCT DEVELOPMENT,0.00014989,-0.539,-0.55464,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00040321,-0.53903,-0.57856,1,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,6.6813e-06,-0.53913,-0.53887,1,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.53921,-0.54177,1,0
1,GO ORGANELLE FUSION,1.1191e-05,-0.53934,-0.57092,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,7.7514e-06,-0.53937,-0.58891,1,0
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.337e-06,-0.53938,-0.55133,1,0
1,GO PEPTIDYL LYSINE MODIFICATION,5.7533e-06,-0.5394,-0.56013,1,0
1,GO HISTONE H3 K14 ACETYLATION,6.6813e-06,-0.5394,-0.60875,1,0
1,GO REGULATION OF TOR SIGNALING,4.2539e-06,-0.53956,-0.60091,1,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,8.9843e-06,-0.53956,-0.54799,1,0
1,GO CELLULAR RESPONSE TO SALT STRESS,0.00035748,-0.53964,-0.54049,1,0
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0403e-05,-0.53964,-0.6721,1,0
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,3.0304e-05,-0.53965,-0.6404,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.7533e-06,-0.53983,-0.54809,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.010101,-0.53983,-0.6796,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00013188,-0.54015,-0.46985,1,0
1,GO CELLULAR RESPONSE TO CAMP,1.2035e-05,-0.54017,-0.50096,1,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.5402,-0.56673,1,0
1,GO ANION TRANSPORT,5.7533e-06,-0.54022,-0.51127,1,0
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,5.9985e-05,-0.54033,-0.48074,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.9936e-05,-0.54063,-0.61429,1,0
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1191e-05,-0.54069,-0.55829,1,0
1,GO REGULATION OF CARDIAC CONDUCTION,2.8267e-05,-0.5407,-0.49073,1,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,7.1973e-06,-0.54084,-0.56249,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.00057531,-0.5409,-0.48365,1,0
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.1191e-05,-0.54098,-0.62728,1,0
1,GO HEAD DEVELOPMENT,7.7514e-06,-0.54104,-0.56523,1,0
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,5.337e-06,-0.54105,-0.53703,1,0
1,GO MEMBRANE BIOGENESIS,1.2035e-05,-0.54106,-0.57112,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,4.5891e-06,-0.54108,-0.55792,1,0
1,GO RESPONSE TO VITAMIN,8.3461e-06,-0.54132,-0.57564,1,0
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1.1191e-05,-0.54133,-0.55881,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,6.2007e-06,-0.54135,-0.56324,1,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,9.6689e-06,-0.54137,-0.58146,1,0
1,GO REGULATION OF CATABOLIC PROCESS,4.9495e-06,-0.54154,-0.53442,1,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.1191e-05,-0.54164,-0.5189,1,0
1,GO RESPONSE TO EPINEPHRINE,7.1973e-06,-0.54171,-0.56702,1,0
1,GO SOMITE DEVELOPMENT,4.9495e-06,-0.5418,-0.5502,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,4.5891e-06,-0.54181,-0.55107,1,0
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0092139,-0.54182,-0.78152,1,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00017019,-0.54185,-0.49469,1,0
1,GO STORE OPERATED CALCIUM ENTRY,4.2763e-05,-0.54188,-0.57665,1,0
1,GO PIGMENTATION,7.7514e-06,-0.5419,-0.47384,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.3909e-05,-0.54194,-0.5057,1,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,4.2539e-06,-0.54195,-0.52911,1,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,4.2763e-05,-0.54212,-0.50917,1,0
1,GO OSTEOCLAST DIFFERENTIATION,1.0403e-05,-0.54216,-0.62792,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00026348,-0.54219,-0.50187,1,0
1,GO REGULATION OF CELLULAR LOCALIZATION,5.337e-06,-0.54226,-0.56536,1,0
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00014989,-0.54229,-0.60222,1,0
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.9422e-06,-0.54229,-0.54886,1,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.3461e-06,-0.54231,-0.6087,1,0
1,GO AXONAL TRANSPORT,3.248e-05,-0.5425,-0.61956,1,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,4.5891e-06,-0.54251,-0.5613,1,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,4.2539e-06,-0.54258,-0.5633,1,0
1,GO ANION HOMEOSTASIS,5.337e-06,-0.54265,-0.56275,1,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,6.2007e-06,-0.54271,-0.55398,1,0
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.6059e-05,-0.54273,-0.60916,1,0
1,GO REGULATION OF RECEPTOR BINDING,2.2907e-05,-0.54288,-0.62998,1,0
1,GO RESPONSE TO METAL ION,6.2007e-06,-0.5429,-0.49533,1,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,4.5891e-06,-0.54293,-0.53672,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,4.9495e-06,-0.54294,-0.55941,1,0
1,GO SULFUR COMPOUND CATABOLIC PROCESS,6.2007e-06,-0.54302,-0.5478,1,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,6.6813e-06,-0.54303,-0.52931,1,0
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,5.2428e-05,-0.54303,-0.63063,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.337e-06,-0.54309,-0.5532,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00031664,-0.54314,-0.51082,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,5.7533e-06,-0.54316,-0.50676,1,0
1,GO SENSORY ORGAN DEVELOPMENT,7.1973e-06,-0.54321,-0.54331,1,0
1,GO INTERACTION WITH HOST,4.9495e-06,-0.54324,-0.56127,1,0
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.6689e-06,-0.54327,-0.55909,1,0
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,2.1347e-05,-0.5433,-0.55602,1,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,1.9888e-05,-0.5434,-0.51147,1,0
1,GO MICROVILLUS ORGANIZATION,5.2428e-05,-0.54341,-0.5206,1,0
1,GO MODULATION BY VIRUS OF HOST PROCESS,6.6813e-06,-0.54344,-0.53717,1,0
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.2763e-05,-0.54344,-0.59846,1,0
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,5.337e-06,-0.5435,-0.52487,1,0
1,GO AMYLOID BETA METABOLIC PROCESS,5.337e-06,-0.54359,-0.58048,1,0
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,4.9495e-06,-0.54372,-0.54628,1,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,6.6813e-06,-0.54376,-0.52579,1,0
1,GO FIBROBLAST PROLIFERATION,6.2007e-06,-0.54382,-0.56949,1,0
1,GO SEGMENTATION,4.5891e-06,-0.54417,-0.54803,1,0
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.3279e-05,-0.54426,-0.62232,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00048214,-0.54427,-0.57733,1,0
1,GO LIPID LOCALIZATION,4.9495e-06,-0.5443,-0.53552,1,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.8267e-05,-0.54436,-0.47371,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1.2035e-05,-0.54474,-0.58331,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.9985e-05,-0.54497,-0.5779,1,0
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.6059e-05,-0.54503,-0.47156,1,0
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,3.7287e-05,-0.54503,-0.57376,1,0
1,GO CELLULAR EXTRAVASATION,3.9936e-05,-0.54509,-0.66298,1,0
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,4.9495e-06,-0.54526,-0.57278,1,0
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,1.1191e-05,-0.54528,-0.52582,1,0
1,GO B CELL ACTIVATION,1.4947e-05,-0.54535,-0.61383,1,0
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,3.9422e-06,-0.5455,-0.56071,1,0
1,GO SECRETORY GRANULE ORGANIZATION,1.8524e-05,-0.54562,-0.53713,1,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,2.2907e-05,-0.54564,-0.60475,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,4.5779e-05,-0.54581,-0.61951,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,5.337e-06,-0.54587,-0.5484,1,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,4.5779e-05,-0.5459,-0.60173,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,6.6813e-06,-0.5459,-0.54698,1,0
1,GO REGULATION OF CHEMOTAXIS,2.4576e-05,-0.54595,-0.58012,1,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,4.9495e-06,-0.54606,-0.56105,1,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,2.2907e-05,-0.54611,-0.55557,1,0
1,GO PEPTIDYL LYSINE METHYLATION,8.3461e-06,-0.54625,-0.57225,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,6.2007e-06,-0.54635,-0.6279,1,0
1,GO ACYLGLYCEROL HOMEOSTASIS,6.6813e-06,-0.54648,-0.53598,1,0
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.8524e-05,-0.54653,-0.58308,1,0
1,GO REGULATION OF LIPID CATABOLIC PROCESS,6.6813e-06,-0.54655,-0.57869,1,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,8.9327e-05,-0.54659,-0.54363,1,0
1,GO CERAMIDE TRANSPORT,6.6813e-06,-0.54677,-0.61358,1,0
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,5.337e-06,-0.54686,-0.55448,1,0
1,GO RESPONSE TO IRON ION,9.6689e-06,-0.54693,-0.54245,1,0
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.4576e-05,-0.54703,-0.69946,1,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,4.5779e-05,-0.5472,-0.58589,1,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,7.1973e-06,-0.54722,-0.51711,1,0
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,5.337e-06,-0.54739,-0.55359,1,0
1,GO PEPTIDYL LYSINE ACETYLATION,6.2007e-06,-0.54741,-0.57087,1,0
1,GO CELL AGGREGATION,0.00057531,-0.54751,-0.4602,1,0
1,GO MYELOID CELL APOPTOTIC PROCESS,3.0304e-05,-0.54753,-0.54502,1,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,1.6059e-05,-0.54755,-0.56652,1,0
1,GO LIPID GLYCOSYLATION,6.2007e-06,-0.54757,-0.63207,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,5.9985e-05,-0.54759,-0.59368,1,0
1,GO CELL PROJECTION ASSEMBLY,1.0403e-05,-0.5476,-0.53829,1,0
1,GO CLATHRIN COAT ASSEMBLY,6.2007e-06,-0.54763,-0.60035,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,2.4576e-05,-0.54772,-0.53732,1,0
1,GO ORGANIC ANION TRANSPORT,5.7533e-06,-0.54777,-0.51393,1,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,7.1973e-06,-0.54788,-0.56881,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.0403e-05,-0.5479,-0.58559,1,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,6.2007e-06,-0.54797,-0.56421,1,0
1,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.00068502,-0.54799,-0.57112,1,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0012071,-0.54799,-0.49354,1,0
1,GO CELL FATE COMMITMENT,7.7514e-06,-0.548,-0.52314,1,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,1.6059e-05,-0.54817,-0.53531,1,0
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,5.337e-06,-0.54822,-0.54865,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.337e-06,-0.54822,-0.56696,1,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,7.1973e-06,-0.54831,-0.53566,1,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,4.2539e-06,-0.54845,-0.55973,1,0
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,6.2007e-06,-0.54847,-0.55758,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,3.9422e-06,-0.54853,-0.56087,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,4.9495e-06,-0.54856,-0.53577,1,0
1,GO SMOOTHENED SIGNALING PATHWAY,1.1191e-05,-0.54861,-0.54061,1,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,3.4805e-05,-0.54872,-0.56346,1,0
1,GO GLIAL CELL ACTIVATION,0.00024771,-0.54877,-0.67456,1,0
1,GO HISTONE H4 K5 ACETYLATION,1.3909e-05,-0.5488,-0.61258,1,0
1,GO RESPONSE TO DSRNA,1.2035e-05,-0.5488,-0.54976,1,0
1,GO REGULATION OF AMYLOID BETA CLEARANCE,3.248e-05,-0.54884,-0.65367,1,0
1,GO SEQUESTERING OF CALCIUM ION,1.0403e-05,-0.54884,-0.57154,1,0
1,GO INOSITOL METABOLIC PROCESS,0.00021879,-0.54933,-0.5386,1,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,1.2035e-05,-0.54939,-0.60504,1,0
1,GO SYNAPSE ORGANIZATION,8.3461e-06,-0.54939,-0.59783,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,8.3461e-06,-0.54948,-0.54586,1,0
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,7.7514e-06,-0.54981,-0.55402,1,0
1,GO ENSHEATHMENT OF NEURONS,6.2007e-06,-0.54984,-0.54851,1,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,1.0403e-05,-0.54989,-0.60643,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,4.2539e-06,-0.54992,-0.54346,1,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,2.2907e-05,-0.54995,-0.61499,1,0
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.2007e-06,-0.55,-0.57381,1,0
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,4.5891e-06,-0.55004,-0.56824,1,0
1,GO LIPID MODIFICATION,4.2539e-06,-0.55006,-0.53713,1,0
1,GO NERVE DEVELOPMENT,8.9843e-06,-0.55012,-0.62538,1,0
1,GO HISTONE H4 ACETYLATION,8.3461e-06,-0.55018,-0.59325,1,0
1,GO PROTEIN SUMOYLATION,7.1973e-06,-0.5502,-0.55713,1,0
1,GO INTERLEUKIN 13 PRODUCTION,0.0054671,-0.55022,-0.50754,1,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00035748,-0.55028,-0.50945,1,0
1,GO POSITIVE T CELL SELECTION,0.0011418,-0.55029,-0.62428,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,2.4576e-05,-0.55045,-0.54537,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,1.8524e-05,-0.55049,-0.65562,1,0
1,GO REGULATION OF TRANSPORT,5.7533e-06,-0.55062,-0.53253,1,0
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.7249e-05,-0.55063,-0.56307,1,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,5.7533e-06,-0.55082,-0.56067,1,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,7.7514e-06,-0.55083,-0.49867,1,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,4.9495e-06,-0.55083,-0.56085,1,0
1,GO RESPONSE TO KETONE,9.6689e-06,-0.55097,-0.52909,1,0
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,5.6086e-05,-0.55101,-0.63456,1,0
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,7.7514e-06,-0.55101,-0.61467,1,0
1,GO NEGATIVE REGULATION OF SIGNALING,5.337e-06,-0.55106,-0.56534,1,0
1,GO FORELIMB MORPHOGENESIS,4.8997e-05,-0.55107,-0.49679,1,0
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,4.5891e-06,-0.55118,-0.54685,1,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,4.5891e-06,-0.55123,-0.58739,1,0
1,GO REGULATION OF TELOMERASE ACTIVITY,9.6689e-06,-0.55136,-0.51237,1,0
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.337e-06,-0.55141,-0.55795,1,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,4.2539e-06,-0.55147,-0.55557,1,0
1,GO NEGATIVE REGULATION OF COAGULATION,0.00012367,-0.55149,-0.59306,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,7.1973e-06,-0.55151,-0.5723,1,0
1,GO RESPONSE TO FORSKOLIN,0.00014062,-0.55158,-0.59532,1,0
1,GO REGULATION OF HAIR CYCLE,3.7287e-05,-0.55168,-0.51539,1,0
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,5.7533e-06,-0.55169,-0.55042,1,0
1,GO ORGANELLE INHERITANCE,2.8267e-05,-0.55174,-0.52092,1,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,9.6689e-06,-0.55179,-0.51458,1,0
1,GO OLIGODENDROCYTE DEVELOPMENT,4.5891e-06,-0.55185,-0.58372,1,0
1,GO ASSOCIATIVE LEARNING,7.1973e-06,-0.55188,-0.53719,1,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,7.1973e-06,-0.55189,-0.57254,1,0
1,GO RHYTHMIC BEHAVIOR,6.2007e-06,-0.55195,-0.56147,1,0
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.4947e-05,-0.552,-0.63924,1,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,1.4947e-05,-0.55212,-0.58573,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.3461e-06,-0.55226,-0.57384,1,0
1,GO RESPONSE TO ATP,8.3461e-06,-0.5523,-0.53947,1,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.337e-06,-0.55231,-0.59202,1,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00060992,-0.55253,-0.62425,1,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,8.3461e-06,-0.55274,-0.54522,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.636e-05,-0.55277,-0.62589,1,0
1,GO MEMBRANE DISASSEMBLY,7.7514e-06,-0.55288,-0.63454,1,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.55297,-0.53631,1,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,4.5779e-05,-0.5531,-0.58104,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00023283,-0.55319,-0.66689,1,0
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,1.2035e-05,-0.55329,-0.52256,1,0
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012367,-0.55331,-0.72046,1,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,1.3909e-05,-0.55336,-0.53459,1,0
1,GO LIPID HOMEOSTASIS,4.2539e-06,-0.55367,-0.53928,1,0
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00068502,-0.55374,-0.47962,1,0
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,3.248e-05,-0.55375,-0.52368,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.3909e-05,-0.55389,-0.63721,1,0
1,GO REGULATION OF ORGAN GROWTH,7.7514e-06,-0.55397,-0.53613,1,0
1,GO NOREPINEPHRINE SECRETION,0.00024771,-0.55403,-0.5502,1,0
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,5.337e-06,-0.55406,-0.57596,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00014989,-0.5541,-0.57977,1,0
1,GO ACTIN MEDIATED CELL CONTRACTION,1.0403e-05,-0.55411,-0.53303,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,5.7533e-06,-0.55429,-0.57117,1,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,7.7514e-06,-0.55431,-0.64793,1,0
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,2.1347e-05,-0.55437,-0.65819,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00028019,-0.55445,-0.60121,1,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,3.9422e-06,-0.55455,-0.5924,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,8.3461e-06,-0.55455,-0.66647,1,0
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.9495e-06,-0.55456,-0.57954,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,6.8565e-05,-0.55466,-0.56946,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,5.337e-06,-0.55474,-0.56905,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,5.6086e-05,-0.55474,-0.63925,1,0
1,GO VESICLE ORGANIZATION,6.2007e-06,-0.55478,-0.55775,1,0
1,GO REGULATION OF ENDOCRINE PROCESS,9.6689e-06,-0.55479,-0.51051,1,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,4.8997e-05,-0.55481,-0.53377,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.00021879,-0.55487,-0.61965,1,0
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.2939e-05,-0.55494,-0.57033,1,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,1.3909e-05,-0.55495,-0.59257,1,0
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,3.9422e-06,-0.55499,-0.65586,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.2539e-06,-0.55509,-0.55451,1,0
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,8.3461e-06,-0.55519,-0.55708,1,0
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.1191e-05,-0.55522,-0.53913,1,0
1,GO REGULATION OF ICOSANOID SECRETION,5.9985e-05,-0.55526,-0.45376,1,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,4.2539e-06,-0.55532,-0.5839,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00013188,-0.55534,-0.62893,1,0
1,GO IMMUNE SYSTEM DEVELOPMENT,5.7533e-06,-0.55535,-0.56826,1,0
1,GO FOREBRAIN DEVELOPMENT,8.3461e-06,-0.55551,-0.56311,1,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,1.6059e-05,-0.55563,-0.53481,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.8298e-05,-0.55571,-0.50503,1,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,5.337e-06,-0.55575,-0.57108,1,0
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,2.1347e-05,-0.55577,-0.67922,1,0
1,GO EPITHELIUM DEVELOPMENT,6.6813e-06,-0.55577,-0.53217,1,0
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.5558,-0.57361,1,0
1,GO REGULATION OF PHOSPHORYLATION,5.337e-06,-0.55601,-0.56992,1,0
1,GO REGULATION OF DEPHOSPHORYLATION,4.9495e-06,-0.55601,-0.59834,1,0
1,GO ORGANELLE MEMBRANE FUSION,8.3461e-06,-0.55613,-0.60411,1,0
1,GO MALE SEX DIFFERENTIATION,4.5891e-06,-0.55621,-0.55363,1,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,5.337e-06,-0.55622,-0.52507,1,0
1,GO ANATOMICAL STRUCTURE MATURATION,7.7514e-06,-0.55631,-0.54438,1,0
1,GO NEURON MIGRATION,7.1973e-06,-0.5564,-0.62623,1,0
1,GO REGULATION OF SECRETION,5.7533e-06,-0.55652,-0.52828,1,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,6.6813e-06,-0.55674,-0.56868,1,0
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.55675,-0.58125,1,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,1.6059e-05,-0.55685,-0.518,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,7.8298e-05,-0.55689,-0.5989,1,0
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,5.337e-06,-0.55708,-0.55853,1,0
1,GO TRANSEPITHELIAL TRANSPORT,6.2007e-06,-0.55715,-0.5635,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,5.7533e-06,-0.55716,-0.54794,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,8.9843e-06,-0.5572,-0.54537,1,0
1,GO CGMP METABOLIC PROCESS,0.00014062,-0.55731,-0.54896,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,6.2007e-06,-0.55733,-0.57894,1,0
1,GO LEUKOCYTE HOMEOSTASIS,9.6689e-06,-0.55734,-0.6062,1,0
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,8.9843e-06,-0.5574,-0.50792,1,0
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.2939e-05,-0.55747,-0.60899,1,0
1,GO VITAMIN D BIOSYNTHETIC PROCESS,4.2763e-05,-0.5575,-0.68531,1,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,4.9495e-06,-0.55751,-0.58852,1,0
1,GO CIRCADIAN RHYTHM,7.7514e-06,-0.55756,-0.54728,1,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.3641e-05,-0.55758,-0.4806,1,0
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.636e-05,-0.55758,-0.64594,1,0
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0019699,-0.55773,-0.67392,1,0
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.9327e-05,-0.55773,-0.55361,1,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.7533e-06,-0.55779,-0.54826,1,0
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.7533e-06,-0.55786,-0.62149,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,8.3461e-06,-0.55812,-0.60085,1,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,5.6086e-05,-0.55814,-0.52184,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,6.2007e-06,-0.55817,-0.55204,1,0
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,1.2035e-05,-0.55821,-0.64255,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,4.2539e-06,-0.55834,-0.55356,1,0
1,GO REGULATION OF CHOLESTEROL EFFLUX,5.7533e-06,-0.5584,-0.61514,1,0
1,GO MEMBRANE FISSION,1.8524e-05,-0.55844,-0.61921,1,0
1,GO POLYOL CATABOLIC PROCESS,2.4576e-05,-0.55854,-0.51158,1,0
1,GO RESPONSE TO REDOX STATE,7.8298e-05,-0.55857,-0.51129,1,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.006955,-0.5586,-0.67244,1,0
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,5.337e-06,-0.55874,-0.57448,1,0
1,GO NEUROBLAST PROLIFERATION,1.6059e-05,-0.55886,-0.57509,1,0
1,GO RESPONSE TO INTERLEUKIN 7,1.1191e-05,-0.55888,-0.62645,1,0
1,GO ER OVERLOAD RESPONSE,5.6086e-05,-0.55888,-0.4749,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00026348,-0.55897,-0.49834,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.55903,-0.58515,1,0
1,GO SYNAPTIC VESICLE RECYCLING,1.4947e-05,-0.55906,-0.62107,1,0
1,GO REGULATION OF TELOMERE MAINTENANCE,8.9843e-06,-0.55914,-0.53543,1,0
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.4947e-05,-0.5592,-0.53536,1,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.00072571,-0.55921,-0.50727,1,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.1191e-05,-0.55927,-0.52592,1,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,5.7533e-06,-0.55957,-0.59065,1,0
1,GO DEVELOPMENTAL PIGMENTATION,7.7514e-06,-0.55966,-0.4984,1,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,1.2035e-05,-0.55972,-0.52597,1,0
1,GO DOSAGE COMPENSATION,3.0304e-05,-0.55972,-0.58708,1,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,8.3461e-06,-0.55974,-0.59848,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,5.7533e-06,-0.5598,-0.56663,1,0
1,GO ADAPTIVE THERMOGENESIS,6.2007e-06,-0.55987,-0.54402,1,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,7.3279e-05,-0.56003,-0.64026,1,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.9888e-05,-0.56013,-0.56719,1,0
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,7.7514e-06,-0.56032,-0.5732,1,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.00012367,-0.56038,-0.51493,1,0
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.0403e-05,-0.56045,-0.54129,1,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.4947e-05,-0.56046,-0.54626,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,1.3909e-05,-0.5605,-0.53607,1,0
1,GO REGULATION OF EXOCYTOSIS,8.9843e-06,-0.56061,-0.58679,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,4.2539e-06,-0.56077,-0.59187,1,0
1,GO RESPONSE TO ACETYLCHOLINE,0.00015974,-0.56077,-0.5626,1,0
1,GO NEGATIVE REGULATION OF CELL AGING,6.2007e-06,-0.56078,-0.55014,1,0
1,GO CERAMIDE METABOLIC PROCESS,3.9422e-06,-0.56082,-0.60373,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,7.7514e-06,-0.56097,-0.54336,1,0
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,4.9495e-06,-0.56102,-0.55072,1,0
1,GO REGULATION OF RECEPTOR RECYCLING,4.5891e-06,-0.56104,-0.56833,1,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.5891e-06,-0.56115,-0.55856,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0083971,-0.56124,-0.56203,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.9495e-06,-0.56124,-0.56622,1,0
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,5.337e-06,-0.56125,-0.54462,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,5.337e-06,-0.5615,-0.56537,1,0
1,GO VESICLE DOCKING,2.1347e-05,-0.56176,-0.58332,1,0
1,GO PROTEIN DESTABILIZATION,4.9495e-06,-0.56177,-0.59829,1,0
1,GO HYPEROSMOTIC RESPONSE,2.2907e-05,-0.56183,-0.54901,1,0
1,GO REGULATION OF HYDROLASE ACTIVITY,5.337e-06,-0.56185,-0.5626,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,5.337e-06,-0.5619,-0.57245,1,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.6059e-05,-0.56207,-0.61501,1,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,1.3909e-05,-0.56208,-0.57584,1,0
1,GO VESICLE LOCALIZATION,7.7514e-06,-0.56218,-0.56602,1,0
1,GO MITOCHONDRIAL FISSION,6.6813e-06,-0.5624,-0.58582,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,1.7249e-05,-0.56256,-0.58443,1,0
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,7.1973e-06,-0.56263,-0.63565,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,5.337e-06,-0.56265,-0.59948,1,0
1,GO VESICLE CARGO LOADING,8.9843e-06,-0.56273,-0.57511,1,0
1,GO PROTEIN LOCALIZATION TO NUCLEUS,4.5891e-06,-0.56275,-0.54413,1,0
1,GO CALCIUM ION IMPORT,1.1191e-05,-0.56277,-0.54851,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,5.337e-06,-0.56285,-0.5661,1,0
1,GO PROTEIN HYDROXYLATION,3.248e-05,-0.5629,-0.56498,1,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,4.2539e-06,-0.56291,-0.57849,1,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,1.0403e-05,-0.56296,-0.58165,1,0
1,GO RESPONSE TO MONOSACCHARIDE,5.337e-06,-0.56297,-0.55094,1,0
1,GO RESPONSE TO ORGANOPHOSPHORUS,9.6689e-06,-0.56301,-0.52591,1,0
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,6.2007e-06,-0.56301,-0.57056,1,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,1.6059e-05,-0.56312,-0.48008,1,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,6.2007e-06,-0.56319,-0.51028,1,0
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.1347e-05,-0.56319,-0.55595,1,0
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,4.9495e-06,-0.56319,-0.56736,1,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.00012367,-0.56342,-0.53477,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.0403e-05,-0.56346,-0.53621,1,0
1,GO CELLULAR RESPONSE TO KETONE,1.3909e-05,-0.56349,-0.52186,1,0
1,GO GENETIC IMPRINTING,2.1347e-05,-0.56351,-0.55285,1,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,8.3461e-06,-0.56355,-0.53363,1,0
1,GO REGULATION OF GLIAL CELL MIGRATION,5.2428e-05,-0.56376,-0.69651,1,0
1,GO FOAM CELL DIFFERENTIATION,1.2939e-05,-0.56387,-0.6001,1,0
1,GO RECEPTOR RECYCLING,4.9495e-06,-0.56393,-0.56737,1,0
1,GO HEART PROCESS,1.2035e-05,-0.5641,-0.51675,1,0
1,GO NEURON DEATH,4.5891e-06,-0.56419,-0.57016,1,0
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.5643,-0.5413,1,0
1,GO SKELETAL MUSCLE ADAPTATION,1.9888e-05,-0.56443,-0.53834,1,0
1,GO UTERUS DEVELOPMENT,3.4805e-05,-0.56446,-0.51832,1,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00014989,-0.5645,-0.6203,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.0403e-05,-0.5646,-0.57054,1,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,4.9495e-06,-0.56487,-0.57469,1,0
1,GO MATURE B CELL DIFFERENTIATION,3.9936e-05,-0.56508,-0.728,1,0
1,GO ECTODERM DEVELOPMENT,2.2907e-05,-0.5651,-0.46109,1,0
1,GO PEPTIDE SECRETION,6.6813e-06,-0.5651,-0.54049,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.7514e-06,-0.56518,-0.53512,1,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,8.9327e-05,-0.56519,-0.57891,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,4.5891e-06,-0.56522,-0.57591,1,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.9495e-06,-0.56528,-0.5493,1,0
1,GO RHYTHMIC PROCESS,7.1973e-06,-0.56529,-0.55525,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,5.337e-06,-0.56532,-0.56518,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,1.2035e-05,-0.56559,-0.55049,1,0
1,GO REGULATION OF MACROPHAGE ACTIVATION,5.9985e-05,-0.56566,-0.66591,1,0
1,GO REGULATION OF RESPONSE TO WOUNDING,5.337e-06,-0.56575,-0.60039,1,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1.4947e-05,-0.56576,-0.54055,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00091199,-0.56582,-0.6177,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,5.337e-06,-0.5659,-0.57854,1,0
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,5.337e-06,-0.56621,-0.56455,1,0
1,GO INTERMEMBRANE LIPID TRANSFER,3.9422e-06,-0.56622,-0.61432,1,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,7.1973e-06,-0.56641,-0.57511,1,0
1,GO PROTEIN PALMITOYLATION,0.00012367,-0.56658,-0.51473,1,0
1,GO NEGATIVE REGULATION OF WOUND HEALING,1.1191e-05,-0.56674,-0.59834,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,2.2907e-05,-0.56677,-0.57629,1,0
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,5.337e-06,-0.56677,-0.5827,1,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,1.2939e-05,-0.56679,-0.55894,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,4.5891e-06,-0.56679,-0.56829,1,0
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,7.1973e-06,-0.56686,-0.56361,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,8.9843e-06,-0.56686,-0.61573,1,0
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.56695,-0.60036,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,4.9495e-06,-0.56696,-0.58128,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,1.8524e-05,-0.56702,-0.62542,1,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,1.1191e-05,-0.56707,-0.57496,1,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.00018128,-0.56707,-0.50668,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,5.2428e-05,-0.5671,-0.62081,1,0
1,GO REGULATION OF SYNAPSE MATURATION,1.9888e-05,-0.56717,-0.66661,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,8.9327e-05,-0.56733,-0.6269,1,0
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,6.2007e-06,-0.56741,-0.60974,1,0
1,GO MOLTING CYCLE,1.3909e-05,-0.56744,-0.5397,1,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,1.3909e-05,-0.56773,-0.52962,1,0
1,GO REGULATION OF MRNA 3 END PROCESSING,9.5377e-05,-0.56792,-0.53329,1,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,9.6689e-06,-0.56809,-0.49663,1,0
1,GO PROTEIN POLYMERIZATION,5.337e-06,-0.56813,-0.58469,1,0
1,GO COVALENT CHROMATIN MODIFICATION,5.7533e-06,-0.56815,-0.57609,1,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,4.2539e-06,-0.56819,-0.5808,1,0
1,GO NEURON DIFFERENTIATION,8.3461e-06,-0.56841,-0.58682,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.2907e-05,-0.56848,-0.6611,1,0
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,1.6059e-05,-0.56877,-0.55456,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,2.4576e-05,-0.56878,-0.55082,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0015882,-0.56897,-0.54893,1,0
1,GO REGULATION OF NEURON DIFFERENTIATION,7.7514e-06,-0.56909,-0.61005,1,0
1,GO POSITIVE REGULATION OF WOUND HEALING,4.5891e-06,-0.56911,-0.60466,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.7249e-05,-0.56915,-0.59844,1,0
1,GO RESPONSE TO MISFOLDED PROTEIN,6.6813e-06,-0.56917,-0.65481,1,0
1,GO RESPONSE TO RETINOIC ACID,1.2939e-05,-0.56917,-0.55562,1,0
1,GO CELL CELL ADHESION,6.2007e-06,-0.5692,-0.58317,1,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.1191e-05,-0.56921,-0.53877,1,0
1,GO GLIOGENESIS,4.9495e-06,-0.56922,-0.56818,1,0
1,GO ORGANIC ACID TRANSPORT,6.2007e-06,-0.56927,-0.52047,1,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,7.7514e-06,-0.56929,-0.60839,1,0
1,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.00019306,-0.56941,-0.62798,1,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00060992,-0.56945,-0.57098,1,0
1,GO FEMALE SEX DIFFERENTIATION,5.7533e-06,-0.56946,-0.51432,1,0
1,GO REGULATION OF FIBRINOLYSIS,0.00029789,-0.5695,-0.53503,1,0
1,GO ASTROCYTE DEVELOPMENT,1.7249e-05,-0.56954,-0.6485,1,0
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.2539e-06,-0.5696,-0.58232,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.6813e-06,-0.56962,-0.62329,1,0
1,GO RESPIRATORY BURST,8.9327e-05,-0.56975,-0.61259,1,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.7249e-05,-0.5699,-0.56522,1,0
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,4.9495e-06,-0.5699,-0.57086,1,0
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.248e-05,-0.56995,-0.5662,1,0
1,GO MAST CELL MEDIATED IMMUNITY,6.2007e-06,-0.56996,-0.67074,1,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00042807,-0.56997,-0.68036,1,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,5.7533e-06,-0.57028,-0.57768,1,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,5.337e-06,-0.57029,-0.56661,1,0
1,GO SOMITOGENESIS,4.9495e-06,-0.5703,-0.57043,1,0
1,GO ERBB2 SIGNALING PATHWAY,4.5891e-06,-0.57039,-0.55491,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,1.7249e-05,-0.5704,-0.63038,1,0
1,GO INTESTINAL ABSORPTION,6.8565e-05,-0.57042,-0.55124,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,9.6689e-06,-0.57057,-0.55427,1,0
1,GO AUTOPHAGY OF NUCLEUS,4.9495e-06,-0.5707,-0.58785,1,0
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,7.1973e-06,-0.57074,-0.5726,1,0
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,4.5891e-06,-0.57074,-0.61545,1,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.00048214,-0.57078,-0.56248,1,0
1,GO IMPORT INTO CELL,6.6813e-06,-0.57085,-0.55167,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,8.9843e-06,-0.57091,-0.53749,1,0
1,GO INTESTINAL LIPID ABSORPTION,0.0027019,-0.571,-0.41347,1,0
1,GO REGULATION OF MRNA POLYADENYLATION,5.2428e-05,-0.57103,-0.58563,1,0
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,7.7514e-06,-0.57106,-0.57336,1,0
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,7.3279e-05,-0.57116,-0.65483,1,0
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.2428e-05,-0.57131,-0.62799,1,0
1,GO CELLULAR RESPONSE TO STARVATION,1.1191e-05,-0.57131,-0.53837,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,4.9495e-06,-0.57137,-0.55105,1,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.6813e-06,-0.57139,-0.58959,1,0
1,GO MYELOID CELL DIFFERENTIATION,5.337e-06,-0.57142,-0.60115,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.337e-06,-0.57148,-0.60484,1,0
1,GO RESPONSE TO LEPTIN,2.8267e-05,-0.57151,-0.51689,1,0
1,GO TELOMERE CAPPING,5.337e-06,-0.57157,-0.59117,1,0
1,GO TEMPERATURE HOMEOSTASIS,6.6813e-06,-0.57161,-0.54681,1,0
1,GO REGULATION OF FATTY ACID TRANSPORT,1.4947e-05,-0.57177,-0.52686,1,0
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,6.6813e-06,-0.57187,-0.54259,1,0
1,GO ANIMAL ORGAN MORPHOGENESIS,5.337e-06,-0.5719,-0.57368,1,0
1,GO NOSE DEVELOPMENT,0.0010798,-0.57203,-0.54519,1,0
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.4947e-05,-0.57209,-0.62134,1,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,1.9888e-05,-0.57209,-0.53533,1,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.00024771,-0.57214,-0.61198,1,0
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,6.2007e-06,-0.57222,-0.55698,1,0
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,9.5377e-05,-0.57228,-0.47938,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.57238,-0.52571,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,3.4805e-05,-0.57238,-0.54097,1,0
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,4.9495e-06,-0.57244,-0.62614,1,0
1,GO NEUROGENESIS,7.1973e-06,-0.57249,-0.58327,1,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,4.5891e-06,-0.57265,-0.57019,1,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,6.2007e-06,-0.57276,-0.5752,1,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,4.5891e-06,-0.57279,-0.57924,1,0
1,GO REGULATION OF HISTONE MODIFICATION,4.5891e-06,-0.5729,-0.58802,1,0
1,GO REGULATION OF AUTOPHAGY,5.337e-06,-0.57299,-0.57824,1,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,9.6689e-06,-0.573,-0.65871,1,0
1,GO RESPONSE TO AXON INJURY,6.2007e-06,-0.57306,-0.58346,1,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00010181,-0.57306,-0.51013,1,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.00010866,-0.57307,-0.55361,1,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00010181,-0.57314,-0.71246,1,0
1,GO MIRNA METABOLIC PROCESS,8.3461e-06,-0.57321,-0.58951,1,0
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.57326,-0.62856,1,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,1.6059e-05,-0.57331,-0.5837,1,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,5.337e-06,-0.57337,-0.66001,1,0
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,1.2035e-05,-0.57338,-0.5617,1,0
1,GO SEGMENT SPECIFICATION,1.4947e-05,-0.5737,-0.55032,1,0
1,GO ORGANIC CATION TRANSPORT,8.9843e-06,-0.57379,-0.53457,1,0
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.1973e-06,-0.57381,-0.5752,1,0
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.57385,-0.54193,1,0
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,2.2907e-05,-0.57401,-0.60516,1,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,7.1973e-06,-0.57412,-0.55225,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.0403e-05,-0.57413,-0.61211,1,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,1.0403e-05,-0.57418,-0.56035,1,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,4.9495e-06,-0.57419,-0.60457,1,0
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,5.337e-06,-0.57425,-0.57108,1,0
1,GO PROSTAGLANDIN SECRETION,6.4139e-05,-0.57433,-0.50557,1,0
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,5.7533e-06,-0.57434,-0.58299,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,6.6813e-06,-0.57437,-0.59419,1,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,5.7533e-06,-0.57454,-0.55757,1,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,2.8267e-05,-0.57462,-0.59953,1,0
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.017954,-0.57481,-0.75621,1,0
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,7.7514e-06,-0.57494,-0.69835,1,0
1,GO NEURON RECOGNITION,2.2907e-05,-0.57501,-0.59547,1,0
1,GO DISTAL TUBULE DEVELOPMENT,6.8565e-05,-0.57513,-0.69138,1,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00015974,-0.57515,-0.60295,1,0
1,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00023283,-0.57524,-0.76863,1,0
1,GO ACTION POTENTIAL,1.3909e-05,-0.57556,-0.54382,1,0
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00072571,-0.57558,-0.63581,1,0
1,GO RESPONSE TO HORMONE,5.7533e-06,-0.5756,-0.55031,1,0
1,GO NEUTRAL AMINO ACID TRANSPORT,6.2007e-06,-0.57569,-0.57816,1,0
1,GO PHAGOCYTOSIS,1.2035e-05,-0.57574,-0.66298,1,0
1,GO INTEGRIN ACTIVATION,7.8298e-05,-0.57577,-0.69735,1,0
1,GO MEMBRANE HYPERPOLARIZATION,3.4805e-05,-0.57582,-0.54093,1,0
1,GO CARBOHYDRATE TRANSPORT,5.7533e-06,-0.57587,-0.54697,1,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,1.4947e-05,-0.57592,-0.58242,1,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,3.0304e-05,-0.57593,-0.50785,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.7533e-06,-0.57595,-0.58674,1,0
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00040321,-0.57597,-0.75377,1,0
1,GO MUSCLE CELL PROLIFERATION,7.7514e-06,-0.57628,-0.58399,1,0
1,GO VACUOLE ORGANIZATION,5.337e-06,-0.57635,-0.58112,1,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,4.5891e-06,-0.57636,-0.57105,1,0
1,GO MUSCLE SYSTEM PROCESS,6.2007e-06,-0.57658,-0.54646,1,0
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,1.0403e-05,-0.57662,-0.573,1,0
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,8.9843e-06,-0.57665,-0.57702,1,0
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.2539e-06,-0.57688,-0.63708,1,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00014062,-0.57695,-0.60755,1,0
1,GO SPECIFICATION OF SYMMETRY,9.6689e-06,-0.57712,-0.52431,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,2.8267e-05,-0.57717,-0.62344,1,0
1,GO SEQUESTERING OF TRIGLYCERIDE,7.7514e-06,-0.5772,-0.57456,1,0
1,GO CARBOHYDRATE PHOSPHORYLATION,5.7533e-06,-0.57725,-0.60041,1,0
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,5.7533e-06,-0.57729,-0.59218,1,0
1,GO RESPONSE TO TYPE I INTERFERON,0.0010798,-0.5774,-0.6356,1,0
1,GO REGULATION OF GROWTH,6.2007e-06,-0.57751,-0.55818,1,0
1,GO CELLULAR RESPONSE TO X RAY,2.8267e-05,-0.57752,-0.60676,1,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,3.0304e-05,-0.57753,-0.57687,1,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,8.9843e-06,-0.57755,-0.61717,1,0
1,GO CHLORIDE ION HOMEOSTASIS,4.8997e-05,-0.57764,-0.54001,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,8.3461e-06,-0.57795,-0.57148,1,0
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,9.6689e-06,-0.57803,-0.59266,1,0
1,GO SPHINGOLIPID METABOLIC PROCESS,4.9495e-06,-0.57824,-0.5857,1,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,6.6813e-06,-0.5783,-0.57637,1,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.57831,-0.56604,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.2007e-06,-0.57838,-0.57382,1,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.2907e-05,-0.5785,-0.5655,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,6.8565e-05,-0.57853,-0.59792,1,0
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,4.9495e-06,-0.57867,-0.57687,1,0
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,9.6689e-06,-0.57871,-0.67284,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,5.7533e-06,-0.57876,-0.54663,1,0
1,GO RESPONSE TO POTASSIUM ION,1.1191e-05,-0.57882,-0.61274,1,0
1,GO REGULATION OF MUSCLE CONTRACTION,7.1973e-06,-0.57885,-0.51495,1,0
1,GO EMBRYO IMPLANTATION,2.2907e-05,-0.57887,-0.61328,1,0
1,GO REGULATION OF CALCIUM ION IMPORT,3.4805e-05,-0.57891,-0.57001,1,0
1,GO REGULATION OF SYSTEM PROCESS,8.3461e-06,-0.57892,-0.5269,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00019306,-0.57892,-0.5642,1,0
1,GO DENDRITE MORPHOGENESIS,1.6059e-05,-0.57909,-0.61008,1,0
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00048214,-0.57913,-0.65479,1,0
1,GO POSITIVE REGULATION OF CELL GROWTH,5.7533e-06,-0.57919,-0.58944,1,0
1,GO MAGNESIUM ION TRANSPORT,1.2939e-05,-0.57924,-0.58517,1,0
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,5.337e-06,-0.57927,-0.58351,1,0
1,GO SERTOLI CELL DEVELOPMENT,1.8524e-05,-0.57938,-0.59748,1,0
1,GO REGULATION OF TELOMERE CAPPING,4.9495e-06,-0.57938,-0.62418,1,0
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,1.3909e-05,-0.57939,-0.54638,1,0
1,GO MEMBRANE FUSION,7.7514e-06,-0.57939,-0.56527,1,0
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,3.9422e-06,-0.57942,-0.62639,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00014989,-0.57947,-0.51363,1,0
1,GO DENDRITE DEVELOPMENT,1.2035e-05,-0.5795,-0.60763,1,0
1,GO NEURON DEVELOPMENT,8.3461e-06,-0.57951,-0.60466,1,0
1,GO NATURAL KILLER CELL DIFFERENTIATION,2.2907e-05,-0.57961,-0.63569,1,0
1,GO MITOPHAGY,7.7514e-06,-0.57964,-0.63131,1,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,4.2539e-06,-0.57991,-0.58302,1,0
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,2.8267e-05,-0.58002,-0.58739,1,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,8.9843e-06,-0.58003,-0.57139,1,0
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,4.5891e-06,-0.5801,-0.58216,1,0
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00026348,-0.58012,-0.52352,1,0
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,9.5377e-05,-0.58012,-0.62372,1,0
1,GO LIPID STORAGE,4.9495e-06,-0.58014,-0.57297,1,0
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.9495e-06,-0.58023,-0.61947,1,0
1,GO RESPONSE TO COLD,9.6689e-06,-0.58046,-0.58108,1,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00012367,-0.58056,-0.62453,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.7514e-06,-0.58065,-0.63232,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00035748,-0.58074,-0.56455,1,0
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,1.4947e-05,-0.58074,-0.64468,1,0
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,7.7514e-06,-0.58086,-0.54677,1,0
1,GO HETEROCHROMATIN ORGANIZATION,6.6813e-06,-0.58095,-0.59613,1,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,7.1973e-06,-0.58107,-0.62651,1,0
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,8.3461e-06,-0.58108,-0.56338,1,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.2939e-05,-0.58133,-0.70211,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,5.337e-06,-0.58143,-0.58265,1,0
1,GO RESPONSE TO ENDOGENOUS STIMULUS,5.337e-06,-0.58144,-0.56283,1,0
1,GO RECEPTOR METABOLIC PROCESS,5.337e-06,-0.58148,-0.57488,1,0
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,5.7533e-06,-0.58153,-0.6631,1,0
1,GO MAINTENANCE OF CELL POLARITY,2.8267e-05,-0.5816,-0.54889,1,0
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,3.0304e-05,-0.58166,-0.59054,1,0
1,GO REGULATION OF MICROTUBULE BINDING,3.7287e-05,-0.58177,-0.68352,1,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,6.6813e-06,-0.58197,-0.55991,1,0
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0034935,-0.58199,-0.54978,1,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00072571,-0.58208,-0.574,1,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.1191e-05,-0.58226,-0.5116,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.6813e-06,-0.58232,-0.53901,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,5.6086e-05,-0.58237,-0.59732,1,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,6.6813e-06,-0.58241,-0.56773,1,0
1,GO REGULATION OF DNA METHYLATION,7.1973e-06,-0.5825,-0.57117,1,0
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,1.2035e-05,-0.58255,-0.66247,1,0
1,GO GROWTH,5.7533e-06,-0.58257,-0.56777,1,0
1,GO REGULATION OF ISOTYPE SWITCHING,8.3461e-06,-0.58265,-0.63636,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00018128,-0.58273,-0.52937,1,0
1,GO KERATAN SULFATE METABOLIC PROCESS,1.7249e-05,-0.58279,-0.62173,1,0
1,GO DIVALENT METAL ION EXPORT,7.3279e-05,-0.58285,-0.54918,1,0
1,GO MUSCLE CONTRACTION,7.1973e-06,-0.58286,-0.53898,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,8.3641e-05,-0.58305,-0.62191,1,0
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.7287e-05,-0.58309,-0.56682,1,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,5.337e-06,-0.58319,-0.58904,1,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,1.0403e-05,-0.58321,-0.63536,1,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.1191e-05,-0.58344,-0.58006,1,0
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,8.9843e-06,-0.58356,-0.5216,1,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,5.337e-06,-0.58362,-0.58532,1,0
1,GO AUTOPHAGOSOME ORGANIZATION,5.337e-06,-0.58375,-0.58035,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.6059e-05,-0.58376,-0.63704,1,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,5.7533e-06,-0.58383,-0.58092,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.4576e-05,-0.58388,-0.57775,1,0
1,GO POSITIVE REGULATION OF COAGULATION,1.4947e-05,-0.58396,-0.5954,1,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,5.7533e-06,-0.58399,-0.58784,1,0
1,GO RESPONSE TO COCAINE,3.4805e-05,-0.58412,-0.52804,1,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.6059e-05,-0.58416,-0.64449,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.8267e-05,-0.58434,-0.52558,1,0
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,4.8997e-05,-0.58434,-0.52085,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00014989,-0.58438,-0.55584,1,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,5.337e-06,-0.58449,-0.57477,1,0
1,GO B CELL HOMEOSTASIS,4.9495e-06,-0.58451,-0.68802,1,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,6.2007e-06,-0.58466,-0.56958,1,0
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,4.8997e-05,-0.58474,-0.63858,1,0
1,GO RESPONSE TO CALCIUM ION,1.1191e-05,-0.58482,-0.53167,1,0
1,GO STRIATED MUSCLE CONTRACTION,7.7514e-06,-0.58487,-0.53544,1,0
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,5.7533e-06,-0.58492,-0.55885,1,0
1,GO PEPTIDYL AMINO ACID MODIFICATION,4.5891e-06,-0.58497,-0.56902,1,0
1,GO CARDIAC CONDUCTION,1.9888e-05,-0.58501,-0.53904,1,0
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,2.8267e-05,-0.58519,-0.61452,1,0
1,GO REGULATION OF WOUND HEALING,5.7533e-06,-0.58521,-0.60082,1,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,6.6813e-06,-0.58528,-0.61676,1,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,7.1973e-06,-0.58529,-0.59339,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,7.7514e-06,-0.5853,-0.63225,1,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,5.9985e-05,-0.58537,-0.54691,1,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,4.5891e-06,-0.58538,-0.61495,1,0
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.337e-06,-0.58549,-0.57544,1,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,5.337e-06,-0.58576,-0.5992,1,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,1.1191e-05,-0.58577,-0.54935,1,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,3.0304e-05,-0.58581,-0.51047,1,0
1,GO MICROTUBULE POLYMERIZATION,2.636e-05,-0.58587,-0.60757,1,0
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,5.337e-06,-0.58599,-0.54,1,0
1,GO DEVELOPMENTAL GROWTH,6.2007e-06,-0.5861,-0.58711,1,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,4.2539e-06,-0.58614,-0.58322,1,0
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,3.9936e-05,-0.58641,-0.56142,1,0
1,GO NOTCH RECEPTOR PROCESSING,4.5779e-05,-0.58651,-0.58371,1,0
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00012367,-0.58659,-0.68521,1,0
1,GO NEGATIVE REGULATION OF GENE SILENCING,1.1191e-05,-0.58663,-0.55996,1,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,6.2007e-06,-0.58677,-0.56503,1,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,4.8997e-05,-0.58679,-0.66178,1,0
1,GO RESPONSE TO ACID CHEMICAL,6.2007e-06,-0.58688,-0.5538,1,0
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00014062,-0.58696,-0.65411,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00028019,-0.58697,-0.62085,1,0
1,GO REGULATION OF WNT SIGNALING PATHWAY,5.337e-06,-0.58703,-0.55988,1,0
1,GO REGULATION OF MAPK CASCADE,4.9495e-06,-0.58708,-0.6007,1,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.9888e-05,-0.58709,-0.51676,1,0
1,GO HISTONE H3 K9 MODIFICATION,5.7533e-06,-0.58724,-0.61027,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,6.2007e-06,-0.58726,-0.62073,1,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,1.1191e-05,-0.58733,-0.57173,1,0
1,GO NEUROTRANSMITTER UPTAKE,9.6689e-06,-0.58743,-0.52688,1,0
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.9422e-06,-0.58745,-0.61161,1,0
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,4.9495e-06,-0.5875,-0.61108,1,0
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00011593,-0.58751,-0.55962,1,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,2.1347e-05,-0.58756,-0.57618,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.248e-05,-0.58763,-0.54718,1,0
1,GO REGULATION OF HORMONE METABOLIC PROCESS,1.1191e-05,-0.58766,-0.67419,1,0
1,GO RESPONSE TO CAMP,1.1191e-05,-0.58768,-0.54451,1,0
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,5.7533e-06,-0.58783,-0.61461,1,0
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,4.9495e-06,-0.58794,-0.54445,1,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,7.7514e-06,-0.58803,-0.60258,1,0
1,GO BONE MINERALIZATION,9.6689e-06,-0.58805,-0.59744,1,0
1,GO REGULATION OF SODIUM ION TRANSPORT,1.4947e-05,-0.58813,-0.52607,1,0
1,GO MEMBRANE DEPOLARIZATION,1.7249e-05,-0.58815,-0.56507,1,0
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,4.9495e-06,-0.58819,-0.62844,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,3.0304e-05,-0.58824,-0.69552,1,0
1,GO INTERFERON BETA PRODUCTION,4.9495e-06,-0.58832,-0.65546,1,0
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,1.7249e-05,-0.58857,-0.62943,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00029789,-0.58869,-0.6809,1,0
1,GO NEUROTRANSMITTER REUPTAKE,1.2035e-05,-0.58871,-0.53732,1,0
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,2.2907e-05,-0.58876,-0.62971,1,0
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.5891e-06,-0.58879,-0.58458,1,0
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,7.1973e-06,-0.58881,-0.62835,1,0
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,9.5377e-05,-0.58883,-0.63086,1,0
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,5.337e-06,-0.5889,-0.58455,1,0
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,1.0403e-05,-0.58891,-0.5639,1,0
1,GO B CELL DIFFERENTIATION,8.9843e-06,-0.58893,-0.63928,1,0
1,GO INFLAMMATORY RESPONSE TO WOUNDING,9.5377e-05,-0.58896,-0.74597,1,0
1,GO DETERMINATION OF ADULT LIFESPAN,1.6059e-05,-0.589,-0.60043,1,0
1,GO REGULATION OF BLOOD PRESSURE,7.1973e-06,-0.58917,-0.53743,1,0
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,1.3909e-05,-0.58923,-0.58791,1,0
1,GO CELL PART MORPHOGENESIS,7.7514e-06,-0.58938,-0.62564,1,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.00081392,-0.58963,-0.51771,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,2.8267e-05,-0.58965,-0.6039,1,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,9.6689e-06,-0.58967,-0.60975,1,0
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,3.9422e-06,-0.58981,-0.59605,1,0
1,GO HISTONE H3 K27 METHYLATION,1.0403e-05,-0.58994,-0.66534,1,0
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,4.2763e-05,-0.59,-0.54563,1,0
1,GO MAST CELL MIGRATION,5.2428e-05,-0.59003,-0.59584,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.1191e-05,-0.59003,-0.55735,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.59005,-0.59993,1,0
1,GO REGULATION OF URINE VOLUME,1.4947e-05,-0.59006,-0.55834,1,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,7.1973e-06,-0.59007,-0.59678,1,0
1,GO REGULATION OF PROTEIN MATURATION,6.2007e-06,-0.59008,-0.57625,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0038653,-0.59015,-0.71743,1,0
1,GO EMBRYO DEVELOPMENT,5.7533e-06,-0.59015,-0.57388,1,0
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,7.7514e-06,-0.59033,-0.63313,1,0
1,GO AMINOGLYCAN METABOLIC PROCESS,5.337e-06,-0.59051,-0.62289,1,0
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.3909e-05,-0.59054,-0.54626,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,4.8997e-05,-0.59065,-0.60254,1,0
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.337e-06,-0.59072,-0.60885,1,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.337e-06,-0.59074,-0.6049,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00072571,-0.5908,-0.52612,1,0
1,GO FOREBRAIN NEURON DEVELOPMENT,6.4139e-05,-0.59082,-0.58226,1,0
1,GO MOVEMENT IN HOST ENVIRONMENT,6.6813e-06,-0.59092,-0.57988,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,4.2539e-06,-0.59117,-0.61366,1,0
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,7.1973e-06,-0.59127,-0.6083,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,7.7514e-06,-0.59136,-0.62984,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,7.7514e-06,-0.59138,-0.57166,1,0
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.6059e-05,-0.59146,-0.60749,1,0
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.9495e-06,-0.59152,-0.5842,1,0
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,5.7533e-06,-0.59159,-0.59955,1,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.7249e-05,-0.59182,-0.53261,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0011418,-0.5919,-0.57295,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,4.5779e-05,-0.59207,-0.52155,1,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,1.0403e-05,-0.59218,-0.58414,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,2.1347e-05,-0.59224,-0.59832,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00010866,-0.5924,-0.71152,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,6.2007e-06,-0.59246,-0.6729,1,0
1,GO LEFT RIGHT PATTERN FORMATION,0.00013188,-0.59251,-0.51084,1,0
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,4.5891e-06,-0.59257,-0.63466,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.0304e-05,-0.59258,-0.57468,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS,4.2539e-06,-0.59271,-0.58752,1,0
1,GO RESPONSE TO PROSTAGLANDIN E,4.5779e-05,-0.59272,-0.58979,1,0
1,GO MACROMOLECULE DEACYLATION,7.1973e-06,-0.59273,-0.56721,1,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,7.3279e-05,-0.5928,-0.5002,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0003797,-0.59298,-0.63396,1,0
1,GO PRIMARY MIRNA PROCESSING,8.9327e-05,-0.59305,-0.57987,1,0
1,GO CELL GROWTH,5.7533e-06,-0.59312,-0.58908,1,0
1,GO CELLULAR RESPONSE TO DRUG,4.5891e-06,-0.5932,-0.55602,1,0
1,GO POSITIVE REGULATION OF MAPK CASCADE,5.337e-06,-0.59325,-0.60386,1,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,6.6813e-06,-0.59327,-0.53915,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0010209,-0.59328,-0.55503,1,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,0.0011418,-0.59334,-0.58016,1,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,1.2035e-05,-0.59334,-0.58297,1,0
1,GO L AMINO ACID TRANSPORT,5.337e-06,-0.59339,-0.54678,1,0
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,4.2539e-06,-0.59361,-0.60388,1,0
1,GO REGULATION OF RESPIRATORY BURST,1.6059e-05,-0.59365,-0.56836,1,0
1,GO AXON DEVELOPMENT,7.7514e-06,-0.59374,-0.62643,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,4.5779e-05,-0.59385,-0.57462,1,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,4.5891e-06,-0.5939,-0.56614,1,0
1,GO PLACENTA DEVELOPMENT,6.6813e-06,-0.59393,-0.59175,1,0
1,GO CELLULAR RESPONSE TO DSRNA,1.3909e-05,-0.59396,-0.60337,1,0
1,GO REGULATION OF ACTIN FILAMENT LENGTH,4.9495e-06,-0.59403,-0.60493,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,8.9843e-06,-0.59408,-0.62724,1,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.00035748,-0.59409,-0.52399,1,0
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,6.2007e-06,-0.5942,-0.57571,1,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.2007e-06,-0.59424,-0.58837,1,0
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.6813e-06,-0.59429,-0.62002,1,0
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,8.3461e-06,-0.59447,-0.65117,1,0
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,8.9327e-05,-0.59447,-0.62336,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,4.8997e-05,-0.5945,-0.67504,1,0
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.337e-06,-0.5945,-0.6151,1,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.5891e-06,-0.5945,-0.65448,1,0
1,GO REGULATION OF CELL DEVELOPMENT,6.6813e-06,-0.59456,-0.59481,1,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,6.2007e-06,-0.59457,-0.60586,1,0
1,GO REGULATION OF BODY FLUID LEVELS,5.337e-06,-0.59462,-0.58927,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00019306,-0.59486,-0.54978,1,0
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,4.9495e-06,-0.59488,-0.58673,1,0
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,2.2907e-05,-0.59495,-0.67857,1,0
1,GO LYSOSOME LOCALIZATION,3.9422e-06,-0.59499,-0.63628,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.59506,-0.6574,1,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.59516,-0.54867,1,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,6.2007e-06,-0.5955,-0.58765,1,0
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,7.1973e-06,-0.5955,-0.55581,1,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,6.2007e-06,-0.59567,-0.60954,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,4.9495e-06,-0.59587,-0.59959,1,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.2007e-06,-0.59628,-0.61476,1,0
1,GO LONG TERM MEMORY,4.5779e-05,-0.59646,-0.54841,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,1.1191e-05,-0.59659,-0.60875,1,0
1,GO ENTRY INTO HOST,6.6813e-06,-0.59669,-0.61426,1,0
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,4.9495e-06,-0.59681,-0.58395,1,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.8298e-05,-0.59705,-0.57264,1,0
1,GO CELL CELL SIGNALING BY WNT,5.337e-06,-0.59715,-0.57156,1,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,6.6813e-06,-0.59724,-0.58461,1,0
1,GO REGULATION OF LIPID STORAGE,7.7514e-06,-0.59731,-0.61856,1,0
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.0023095,-0.59733,-0.61679,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,3.7287e-05,-0.59737,-0.592,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,1.8524e-05,-0.59747,-0.5536,1,0
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00019306,-0.59749,-0.65973,1,0
1,GO SPINDLE LOCALIZATION,7.1973e-06,-0.59749,-0.6134,1,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.4947e-05,-0.59761,-0.55079,1,0
1,GO MEGAKARYOCYTE DIFFERENTIATION,5.337e-06,-0.59767,-0.59534,1,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,5.9985e-05,-0.59773,-0.55445,1,0
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.337e-06,-0.59774,-0.64687,1,0
1,GO BIOMINERALIZATION,8.3461e-06,-0.59779,-0.60815,1,0
1,GO GLAND DEVELOPMENT,6.6813e-06,-0.59788,-0.57497,1,0
1,GO NEURAL CREST CELL DIFFERENTIATION,6.2007e-06,-0.59792,-0.58638,1,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,8.9843e-06,-0.59794,-0.63209,1,0
1,GO REGULATION OF CELL DIFFERENTIATION,5.337e-06,-0.59797,-0.58588,1,0
1,GO RESPONSE TO WOUNDING,5.337e-06,-0.59797,-0.62169,1,0
1,GO CELL PROLIFERATION IN FOREBRAIN,2.4576e-05,-0.59804,-0.62195,1,0
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,8.3461e-06,-0.59807,-0.64552,1,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,1.2939e-05,-0.59814,-0.6087,1,0
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,4.9495e-06,-0.59816,-0.60493,1,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,7.7514e-06,-0.59818,-0.61946,1,0
1,GO DEVELOPMENTAL MATURATION,9.6689e-06,-0.59822,-0.55517,1,0
1,GO REGULATION OF PROTEIN BINDING,5.337e-06,-0.59828,-0.58557,1,0
1,GO MUSCLE CELL DEVELOPMENT,6.6813e-06,-0.59853,-0.55298,1,0
1,GO SYNAPSE PRUNING,0.0047188,-0.59872,-0.71417,1,0
1,GO GLYCINE TRANSPORT,0.0013481,-0.5988,-0.52418,1,0
1,GO LIPOPROTEIN LOCALIZATION,3.0304e-05,-0.59889,-0.58756,1,0
1,GO NEURON MATURATION,6.2007e-06,-0.5989,-0.62698,1,0
1,GO CELLULAR GLUCAN METABOLIC PROCESS,1.0403e-05,-0.59896,-0.53385,1,0
1,GO REGULATION OF BIOMINERALIZATION,1.1191e-05,-0.59907,-0.6213,1,0
1,GO PANCREAS DEVELOPMENT,1.4947e-05,-0.59923,-0.56704,1,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,5.7533e-06,-0.59931,-0.60631,1,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,5.7533e-06,-0.59932,-0.60803,1,0
1,GO INTRACELLULAR STEROL TRANSPORT,4.5891e-06,-0.59933,-0.63401,1,0
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,5.337e-06,-0.59934,-0.57256,1,0
1,GO SENSORY SYSTEM DEVELOPMENT,5.7533e-06,-0.59948,-0.58927,1,0
1,GO SYNAPTIC VESICLE PRIMING,0.00045436,-0.5995,-0.61433,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,2.2907e-05,-0.59962,-0.51906,1,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,5.7533e-06,-0.59962,-0.58253,1,0
1,GO OVULATION CYCLE PROCESS,6.6813e-06,-0.59971,-0.57043,1,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,5.337e-06,-0.5998,-0.631,1,0
1,GO LENS FIBER CELL DIFFERENTIATION,7.1973e-06,-0.59982,-0.57657,1,0
1,GO MYELOID CELL HOMEOSTASIS,5.7533e-06,-0.59989,-0.59295,1,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,1.1191e-05,-0.59995,-0.65428,1,0
1,GO CIRCULATORY SYSTEM PROCESS,6.6813e-06,-0.60007,-0.55509,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.2035e-05,-0.60007,-0.54955,1,0
1,GO REGULATION OF BLOOD CIRCULATION,1.0403e-05,-0.6003,-0.53892,1,0
1,GO GLIAL CELL DEVELOPMENT,4.2539e-06,-0.60032,-0.60452,1,0
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,7.1973e-06,-0.60045,-0.63777,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,1.0403e-05,-0.6005,-0.62284,1,0
1,GO CAMERA TYPE EYE DEVELOPMENT,6.6813e-06,-0.60054,-0.57891,1,0
1,GO HAIR CELL DIFFERENTIATION,4.9495e-06,-0.6006,-0.61761,1,0
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,9.6689e-06,-0.60068,-0.59656,1,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.0015041,-0.60093,-0.55285,1,0
1,GO NEGATIVE REGULATION OF LIPID STORAGE,1.3909e-05,-0.60099,-0.60065,1,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,8.9843e-06,-0.60128,-0.6146,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,2.8267e-05,-0.60136,-0.55153,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,6.6813e-06,-0.60169,-0.62397,1,0
1,GO MAINTENANCE OF CELL NUMBER,7.1973e-06,-0.60181,-0.54099,1,0
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,2.8267e-05,-0.60193,-0.63602,1,0
1,GO CELL PROJECTION ORGANIZATION,8.3461e-06,-0.60196,-0.58146,1,0
1,GO CARDIAC MUSCLE CONTRACTION,1.3909e-05,-0.60198,-0.55078,1,0
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,5.337e-06,-0.60216,-0.60141,1,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,2.1347e-05,-0.60221,-0.56654,1,0
1,GO TRACHEA DEVELOPMENT,7.7514e-06,-0.60225,-0.6572,1,0
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,1.0403e-05,-0.60227,-0.6008,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00081392,-0.60237,-0.64834,1,0
1,GO OSTEOBLAST DIFFERENTIATION,6.2007e-06,-0.60239,-0.58347,1,0
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,5.337e-06,-0.60246,-0.58806,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,1.6059e-05,-0.60247,-0.60775,1,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.0403e-05,-0.60274,-0.64505,1,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.00010181,-0.60277,-0.59969,1,0
1,GO MEIOTIC SPINDLE ORGANIZATION,1.4947e-05,-0.60277,-0.6567,1,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,5.7533e-06,-0.60282,-0.62211,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,8.9843e-06,-0.60285,-0.57707,1,0
1,GO AXIS ELONGATION,1.3909e-05,-0.6031,-0.55102,1,0
1,GO RECEPTOR INTERNALIZATION,8.9843e-06,-0.60311,-0.57438,1,0
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,3.0304e-05,-0.60324,-0.58557,1,0
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,4.5891e-06,-0.60337,-0.59477,1,0
1,GO EPITHELIAL CELL PROLIFERATION,6.6813e-06,-0.60347,-0.5828,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00014989,-0.60353,-0.56287,1,0
1,GO PLATELET DEGRANULATION,1.9888e-05,-0.60354,-0.63335,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,6.2007e-06,-0.60362,-0.63583,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,1.4947e-05,-0.60369,-0.58597,1,0
1,GO ODONTOGENESIS,9.6689e-06,-0.6037,-0.58397,1,0
1,GO REGULATION OF TUBE SIZE,1.0403e-05,-0.60372,-0.52753,1,0
1,GO VOCALIZATION BEHAVIOR,0.00013188,-0.60376,-0.54442,1,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,1.9888e-05,-0.60387,-0.56721,1,0
1,GO NOTCH SIGNALING PATHWAY,5.7533e-06,-0.60392,-0.60785,1,0
1,GO RESPONSE TO CARBOHYDRATE,5.7533e-06,-0.60407,-0.55989,1,0
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.00010181,-0.60413,-0.56812,1,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,6.2007e-06,-0.60439,-0.60065,1,0
1,GO DENDRITIC SPINE DEVELOPMENT,1.2035e-05,-0.60442,-0.60312,1,0
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.2035e-05,-0.60443,-0.58465,1,0
1,GO REGULATION OF METANEPHROS DEVELOPMENT,2.1347e-05,-0.60465,-0.65903,1,0
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.2428e-05,-0.60487,-0.58903,1,0
1,GO RESPONSE TO PEPTIDE,5.7533e-06,-0.60516,-0.58097,1,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,2.4576e-05,-0.60523,-0.56835,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,1.0403e-05,-0.60582,-0.63344,1,0
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,5.7533e-06,-0.60584,-0.58556,1,0
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,6.6813e-06,-0.60606,-0.63753,1,0
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,5.337e-06,-0.60633,-0.64374,1,0
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,6.6813e-06,-0.60649,-0.6242,1,0
1,GO REGULATION OF VACUOLE ORGANIZATION,6.2007e-06,-0.60666,-0.58795,1,0
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.5891e-06,-0.60693,-0.60781,1,0
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.8524e-05,-0.607,-0.586,1,0
1,GO NEGATIVE REGULATION OF GROWTH,5.7533e-06,-0.60706,-0.57067,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,1.1191e-05,-0.60727,-0.65452,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.3461e-06,-0.6073,-0.65176,1,0
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,2.4576e-05,-0.60744,-0.65991,1,0
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,6.2007e-06,-0.60748,-0.57399,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.9495e-06,-0.60755,-0.5791,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,7.7514e-06,-0.60759,-0.58595,1,0
1,GO CELLULAR RESPONSE TO PH,1.6059e-05,-0.6076,-0.56926,1,0
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,6.6813e-06,-0.60764,-0.58685,1,0
1,GO HYALURONAN CATABOLIC PROCESS,8.3461e-06,-0.60779,-0.6202,1,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,8.9843e-06,-0.6078,-0.68656,1,0
1,GO LEUKOCYTE AGGREGATION,0.00068502,-0.60782,-0.67666,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.9422e-06,-0.60783,-0.76153,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,8.3461e-06,-0.60788,-0.61651,1,0
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.8524e-05,-0.60814,-0.67382,1,0
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00012367,-0.60818,-0.66663,1,0
1,GO CANONICAL WNT SIGNALING PATHWAY,5.7533e-06,-0.60831,-0.56723,1,0
1,GO APOPTOTIC CELL CLEARANCE,6.8565e-05,-0.60842,-0.70924,1,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,2.4576e-05,-0.60846,-0.59154,1,0
1,GO SMOOTH MUSCLE CELL PROLIFERATION,8.9843e-06,-0.60849,-0.6178,1,0
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,5.7533e-06,-0.60855,-0.58185,1,0
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,6.2007e-06,-0.60871,-0.68434,1,0
1,GO RESPONSE TO PEPTIDE HORMONE,5.7533e-06,-0.60873,-0.56463,1,0
1,GO REGULATION OF PROTEIN DEACETYLATION,1.1191e-05,-0.6088,-0.58503,1,0
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00048214,-0.6089,-0.70636,1,0
1,GO REGULATION OF ENDOCYTOSIS,6.2007e-06,-0.60895,-0.62495,1,0
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,8.9843e-06,-0.60918,-0.64643,1,0
1,GO RESPONSE TO INSULIN,5.337e-06,-0.60922,-0.56494,1,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,1.6059e-05,-0.60934,-0.57074,1,0
1,GO EXCRETION,1.6059e-05,-0.60947,-0.52148,1,0
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,9.5377e-05,-0.60947,-0.56414,1,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,1.1191e-05,-0.6099,-0.74488,1,0
1,GO PROTEIN KINASE B SIGNALING,6.2007e-06,-0.61004,-0.58173,1,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.61005,-0.58043,1,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,7.7514e-06,-0.61007,-0.6215,1,0
1,GO PHAGOCYTOSIS RECOGNITION,0.00014062,-0.61016,-0.63329,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,1.9888e-05,-0.61016,-0.59301,1,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,1.1191e-05,-0.61017,-0.60274,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,9.6689e-06,-0.61018,-0.61297,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,7.7514e-06,-0.61023,-0.72209,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,2.8267e-05,-0.61026,-0.66222,1,0
1,GO TISSUE MORPHOGENESIS,5.337e-06,-0.61027,-0.58513,1,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,9.6689e-06,-0.61039,-0.61461,1,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,5.7533e-06,-0.61048,-0.59083,1,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,3.0304e-05,-0.61051,-0.61494,1,0
1,GO BONE RESORPTION,1.4947e-05,-0.61071,-0.65164,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,7.7514e-06,-0.61072,-0.63427,1,0
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0003797,-0.61079,-0.52897,1,0
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,4.2763e-05,-0.61088,-0.66051,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,8.3461e-06,-0.61101,-0.54606,1,0
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,4.9495e-06,-0.61105,-0.68653,1,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,5.337e-06,-0.61152,-0.58241,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,4.9495e-06,-0.61155,-0.60566,1,0
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,8.9843e-06,-0.61163,-0.6545,1,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,5.2428e-05,-0.61182,-0.61634,1,0
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,5.6086e-05,-0.6119,-0.65208,1,0
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,6.4139e-05,-0.61195,-0.67475,1,0
1,GO ERYTHROCYTE HOMEOSTASIS,5.7533e-06,-0.61212,-0.58875,1,0
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,9.5377e-05,-0.61212,-0.62961,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.0304e-05,-0.61216,-0.59635,1,0
1,GO DEMETHYLATION,5.7533e-06,-0.61221,-0.59533,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,1.0403e-05,-0.61224,-0.60443,1,0
1,GO DEVELOPMENTAL CELL GROWTH,7.1973e-06,-0.61227,-0.62746,1,0
1,GO COAGULATION,5.337e-06,-0.61227,-0.63022,1,0
1,GO FIBRINOLYSIS,0.00019306,-0.61239,-0.60371,1,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,6.6813e-06,-0.61242,-0.60897,1,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.00091199,-0.61257,-0.5349,1,0
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,2.4576e-05,-0.61259,-0.5438,1,0
1,GO AMINOGLYCAN CATABOLIC PROCESS,9.6689e-06,-0.6127,-0.63642,1,0
1,GO CELL MOTILITY,5.337e-06,-0.61295,-0.61207,1,0
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,4.2763e-05,-0.6131,-0.67087,1,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,7.7514e-06,-0.61315,-0.6339,1,0
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,7.7514e-06,-0.61332,-0.62022,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,5.337e-06,-0.61341,-0.60924,1,0
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,7.7514e-06,-0.61356,-0.66385,1,0
1,GO NEURON REMODELING,2.636e-05,-0.61375,-0.67334,1,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,3.7287e-05,-0.61412,-0.60261,1,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,8.9843e-06,-0.61421,-0.60425,1,0
1,GO RESPONSE TO GROWTH HORMONE,1.1191e-05,-0.61422,-0.56547,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.1191e-05,-0.61425,-0.67123,1,0
1,GO VACUOLAR TRANSPORT,6.2007e-06,-0.6144,-0.60758,1,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,6.6813e-06,-0.61454,-0.58565,1,0
1,GO WOUND HEALING,5.337e-06,-0.6146,-0.64451,1,0
1,GO RESPONSE TO MECHANICAL STIMULUS,6.2007e-06,-0.61464,-0.60981,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,8.3641e-05,-0.61469,-0.59586,1,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,3.4805e-05,-0.61482,-0.56288,1,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,1.8524e-05,-0.61482,-0.7197,1,0
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,7.7514e-06,-0.61489,-0.58479,1,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,6.2007e-06,-0.61497,-0.60666,1,0
1,GO MUSCLE CELL MIGRATION,6.6813e-06,-0.61529,-0.66868,1,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,1.3909e-05,-0.61538,-0.62931,1,0
1,GO CRANIAL NERVE MORPHOGENESIS,1.8524e-05,-0.61548,-0.62512,1,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,4.9495e-06,-0.61552,-0.60573,1,0
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,1.4947e-05,-0.61556,-0.53681,1,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,5.7533e-06,-0.6156,-0.6271,1,0
1,GO HISTONE H3 DEACETYLATION,1.4947e-05,-0.61569,-0.54601,1,0
1,GO I KAPPAB PHOSPHORYLATION,8.3461e-06,-0.61572,-0.70179,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.4576e-05,-0.61582,-0.67363,1,0
1,GO LYMPH NODE DEVELOPMENT,6.6813e-06,-0.61585,-0.69111,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.61604,-0.57756,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,1.6059e-05,-0.61611,-0.62767,1,0
1,GO MYOFIBRIL ASSEMBLY,1.1191e-05,-0.6162,-0.59178,1,0
1,GO LOCALIZATION WITHIN MEMBRANE,1.0403e-05,-0.61622,-0.61921,1,0
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,5.7533e-06,-0.61624,-0.62867,1,0
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,6.6813e-06,-0.61628,-0.67197,1,0
1,GO SKIN EPIDERMIS DEVELOPMENT,1.0403e-05,-0.61637,-0.56957,1,0
1,GO NEURON PROJECTION EXTENSION,7.1973e-06,-0.6165,-0.64696,1,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,6.2007e-06,-0.61656,-0.6171,1,0
1,GO POSITIVE REGULATION OF LIPID STORAGE,7.1973e-06,-0.61658,-0.70421,1,0
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,6.2007e-06,-0.61659,-0.62625,1,0
1,GO STEM CELL PROLIFERATION,6.6813e-06,-0.61704,-0.59213,1,0
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,4.9495e-06,-0.61725,-0.62627,1,0
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,4.5891e-06,-0.6173,-0.57977,1,0
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,5.337e-06,-0.61735,-0.60734,1,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,8.3461e-06,-0.61736,-0.64327,1,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,2.8267e-05,-0.6174,-0.57257,1,0
1,GO APICAL PROTEIN LOCALIZATION,2.2907e-05,-0.61744,-0.57591,1,0
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,4.9495e-06,-0.61747,-0.57772,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,1.3909e-05,-0.61753,-0.57092,1,0
1,GO REGULATION OF ANION TRANSPORT,4.9495e-06,-0.61754,-0.55299,1,0
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,9.6689e-06,-0.61768,-0.60545,1,0
1,GO REGULATION OF MYOBLAST FUSION,0.0003797,-0.61782,-0.64642,1,0
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,1.0403e-05,-0.61791,-0.61901,1,0
1,GO RESPONSE TO ESTROGEN,5.337e-06,-0.61809,-0.59093,1,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.61811,-0.58299,1,0
1,GO METANEPHROS MORPHOGENESIS,1.3909e-05,-0.61816,-0.61417,1,0
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,6.2007e-06,-0.6183,-0.61702,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,7.3279e-05,-0.61831,-0.66326,1,0
1,GO HOMOTYPIC CELL CELL ADHESION,6.2007e-06,-0.61861,-0.66823,1,0
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.61876,-0.66919,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,5.7533e-06,-0.61881,-0.62737,1,0
1,GO NEURON PROJECTION REGENERATION,8.9843e-06,-0.61884,-0.6287,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.2007e-06,-0.61921,-0.59361,1,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,4.5891e-06,-0.61952,-0.60991,1,0
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,1.4947e-05,-0.62004,-0.60542,1,0
1,GO REGULATION OF ERBB SIGNALING PATHWAY,4.2539e-06,-0.62021,-0.62992,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.8524e-05,-0.62033,-0.61203,1,0
1,GO JNK CASCADE,5.337e-06,-0.62105,-0.63287,1,0
1,GO CYTOSKELETON ORGANIZATION,5.7533e-06,-0.6211,-0.59462,1,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,6.6813e-06,-0.6212,-0.61912,1,0
1,GO GAMMA DELTA T CELL ACTIVATION,4.2763e-05,-0.6213,-0.68228,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,7.7514e-06,-0.62143,-0.59343,1,0
1,GO PEPTIDYL SERINE MODIFICATION,5.337e-06,-0.62149,-0.62051,1,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,2.4576e-05,-0.62152,-0.58887,1,0
1,GO REGULATION OF BONE MINERALIZATION,1.6059e-05,-0.62163,-0.61948,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,5.337e-06,-0.62169,-0.6129,1,0
1,GO BRONCHUS DEVELOPMENT,0.00014989,-0.62171,-0.60098,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00012367,-0.62173,-0.76181,1,0
1,GO GLAND MORPHOGENESIS,1.1191e-05,-0.62187,-0.64576,1,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,6.2007e-06,-0.62188,-0.61093,1,0
1,GO REGULATION OF PLATELET ACTIVATION,4.8997e-05,-0.62201,-0.68699,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00010866,-0.62201,-0.56039,1,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,6.6813e-06,-0.62206,-0.59091,1,0
1,GO NEPHRIC DUCT DEVELOPMENT,1.8524e-05,-0.62208,-0.58921,1,0
1,GO REGULATION OF RUFFLE ASSEMBLY,6.6813e-06,-0.62225,-0.60461,1,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,4.5891e-06,-0.62232,-0.63131,1,0
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,1.7249e-05,-0.62237,-0.75286,1,0
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.4805e-05,-0.62248,-0.67667,1,0
1,GO HEPARIN METABOLIC PROCESS,1.9888e-05,-0.62257,-0.66608,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,4.9495e-06,-0.62264,-0.67337,1,0
1,GO REGULATION OF OSSIFICATION,8.3461e-06,-0.62279,-0.61028,1,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.00033648,-0.62295,-0.52836,1,0
1,GO LUNG MORPHOGENESIS,9.6689e-06,-0.62304,-0.64035,1,0
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,1.2939e-05,-0.62305,-0.62485,1,0
1,GO REGULATION OF GOLGI ORGANIZATION,4.8997e-05,-0.62324,-0.63356,1,0
1,GO LAMELLIPODIUM ORGANIZATION,6.2007e-06,-0.62327,-0.59061,1,0
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,8.3461e-06,-0.62332,-0.64033,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,4.9495e-06,-0.62336,-0.63509,1,0
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,4.5891e-06,-0.6234,-0.6196,1,0
1,GO ENDOCYTOSIS,5.7533e-06,-0.62353,-0.61833,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE,5.337e-06,-0.62365,-0.59268,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,6.4139e-05,-0.62372,-0.55311,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.2763e-05,-0.62399,-0.65199,1,0
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,4.5891e-06,-0.62417,-0.68709,1,0
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.2007e-06,-0.62419,-0.6372,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00015974,-0.62432,-0.54284,1,0
1,GO RESPONSE TO STEROL DEPLETION,5.7533e-06,-0.62447,-0.65048,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.1191e-05,-0.62447,-0.56774,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,0.00068502,-0.62449,-0.51726,1,0
1,GO AMYLOID BETA CLEARANCE,2.2907e-05,-0.62463,-0.69325,1,0
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,9.6689e-06,-0.62477,-0.61767,1,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,6.2007e-06,-0.62486,-0.65272,1,0
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,1.9888e-05,-0.62487,-0.63976,1,0
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00015974,-0.62488,-0.69656,1,0
1,GO GDP METABOLIC PROCESS,1.1191e-05,-0.62497,-0.53039,1,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,1.1191e-05,-0.62501,-0.57695,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,8.3461e-06,-0.62513,-0.5978,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,6.2007e-06,-0.62529,-0.63608,1,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,2.636e-05,-0.62535,-0.57375,1,0
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.2035e-05,-0.62539,-0.6304,1,0
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,5.337e-06,-0.62546,-0.60049,1,0
1,GO LUNG CELL DIFFERENTIATION,0.00013188,-0.62549,-0.51759,1,0
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,4.5891e-06,-0.6255,-0.61973,1,0
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.0403e-05,-0.62555,-0.63531,1,0
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,6.6813e-06,-0.62561,-0.64642,1,0
1,GO T CELL EXTRAVASATION,0.00029789,-0.62565,-0.66782,1,0
1,GO RUFFLE ASSEMBLY,7.7514e-06,-0.62567,-0.60347,1,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,4.2763e-05,-0.62571,-0.59528,1,0
1,GO SULFUR COMPOUND TRANSPORT,5.337e-06,-0.62596,-0.62855,1,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,5.337e-06,-0.62605,-0.62127,1,0
1,GO ACTIN FILAMENT BASED MOVEMENT,6.6813e-06,-0.62612,-0.60343,1,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.2539e-06,-0.62638,-0.63338,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,7.7514e-06,-0.62716,-0.62336,1,0
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00021879,-0.62725,-0.55989,1,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.2035e-05,-0.62746,-0.62784,1,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.4576e-05,-0.62761,-0.71727,1,0
1,GO PROTEIN LOCALIZATION TO VACUOLE,7.1973e-06,-0.62766,-0.625,1,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,1.4947e-05,-0.62767,-0.52228,1,0
1,GO NEURON PROJECTION GUIDANCE,7.1973e-06,-0.62773,-0.6639,1,0
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,7.1973e-06,-0.62789,-0.65272,1,0
1,GO SCHWANN CELL DEVELOPMENT,4.2539e-06,-0.62802,-0.65517,1,0
1,GO OLIGOPEPTIDE TRANSPORT,9.6689e-06,-0.62815,-0.59857,1,0
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,1.2035e-05,-0.62818,-0.72607,1,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,6.6813e-06,-0.62829,-0.64057,1,0
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,3.4805e-05,-0.62841,-0.605,1,0
1,GO PEPTIDYL TYROSINE MODIFICATION,5.337e-06,-0.62843,-0.64434,1,0
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,5.7533e-06,-0.62857,-0.62278,1,0
1,GO CHAPERONE MEDIATED AUTOPHAGY,2.636e-05,-0.62859,-0.53084,1,0
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,7.7514e-06,-0.62864,-0.59026,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,1.8524e-05,-0.6288,-0.71343,1,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,5.6086e-05,-0.62883,-0.74907,1,0
1,GO REGULATION OF CELL ADHESION,7.7514e-06,-0.62884,-0.65108,1,0
1,GO REGULATION OF CELLULAR EXTRAVASATION,6.4139e-05,-0.62892,-0.67556,1,0
1,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.018736,-0.62908,-0.76311,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,3.248e-05,-0.62922,-0.5448,1,0
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.337e-06,-0.62923,-0.57539,1,0
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,7.7514e-06,-0.62925,-0.60589,1,0
1,GO OPTIC NERVE DEVELOPMENT,0.00015974,-0.62936,-0.56826,1,0
1,GO TRABECULA FORMATION,2.1347e-05,-0.6295,-0.61704,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.9495e-06,-0.62954,-0.61152,1,0
1,GO SCHWANN CELL DIFFERENTIATION,4.2539e-06,-0.62955,-0.63764,1,0
1,GO TAXIS,7.7514e-06,-0.63,-0.59247,1,0
1,GO GERMINAL CENTER FORMATION,4.8997e-05,-0.63009,-0.80626,1,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,5.337e-06,-0.6301,-0.61818,1,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,3.9422e-06,-0.63015,-0.63999,1,0
1,GO AMINO ACID IMPORT,4.5891e-06,-0.63019,-0.59454,1,0
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.8565e-05,-0.63026,-0.66901,1,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,1.2035e-05,-0.63029,-0.59577,1,0
1,GO PROSTAGLANDIN TRANSPORT,3.248e-05,-0.63051,-0.58028,1,0
1,GO PHOSPHATE ION TRANSPORT,9.6689e-06,-0.63054,-0.61145,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,3.0304e-05,-0.63069,-0.60174,1,0
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,6.6813e-06,-0.63069,-0.6056,1,0
1,GO MEMBRANE RAFT ORGANIZATION,1.2035e-05,-0.63074,-0.71948,1,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,6.6813e-06,-0.63075,-0.62819,1,0
1,GO POSITIVE REGULATION OF NEURON DEATH,4.9495e-06,-0.63097,-0.60235,1,0
1,GO TUBE FORMATION,5.7533e-06,-0.63109,-0.57074,1,0
1,GO BIOLOGICAL ADHESION,6.2007e-06,-0.63127,-0.6268,1,0
1,GO INTRACELLULAR LIPID TRANSPORT,6.2007e-06,-0.63178,-0.61512,1,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00029789,-0.6318,-0.5871,1,0
1,GO RESPONSE TO MANGANESE ION,1.3909e-05,-0.63185,-0.58416,1,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.6059e-05,-0.63207,-0.57811,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,6.2007e-06,-0.63233,-0.62456,1,0
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,5.337e-06,-0.63246,-0.62359,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.1973e-06,-0.63264,-0.58672,1,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,5.337e-06,-0.63284,-0.64412,1,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,9.5377e-05,-0.63288,-0.74796,1,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,2.8267e-05,-0.63302,-0.53778,1,0
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,4.9495e-06,-0.63311,-0.58137,1,0
1,GO APPENDAGE DEVELOPMENT,7.7514e-06,-0.63331,-0.59939,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.2035e-05,-0.63348,-0.64163,1,0
1,GO ERBB SIGNALING PATHWAY,4.5891e-06,-0.63355,-0.60662,1,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,2.636e-05,-0.63367,-0.56753,1,0
1,GO MUSCLE ADAPTATION,4.9495e-06,-0.63373,-0.62825,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.3909e-05,-0.63376,-0.59373,1,0
1,GO ASTROCYTE ACTIVATION,9.6689e-06,-0.63387,-0.71298,1,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.00010181,-0.63388,-0.60368,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.6059e-05,-0.63408,-0.62718,1,0
1,GO REGULATION OF FATTY ACID OXIDATION,4.9495e-06,-0.63415,-0.59106,1,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.0403e-05,-0.63416,-0.59487,1,0
1,GO RESPONSE TO ANGIOTENSIN,4.5891e-06,-0.63431,-0.67418,1,0
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.1973e-06,-0.63432,-0.64861,1,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,1.3909e-05,-0.63433,-0.55165,1,0
1,GO INOSITOL LIPID MEDIATED SIGNALING,4.5891e-06,-0.63441,-0.64663,1,0
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,7.7514e-06,-0.63442,-0.6989,1,0
1,GO NEURON PROJECTION ORGANIZATION,8.3461e-06,-0.63447,-0.63504,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.5779e-05,-0.6348,-0.58728,1,0
1,GO POSITIVE REGULATION OF VASCULOGENESIS,2.1347e-05,-0.63481,-0.61541,1,0
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,2.2907e-05,-0.63498,-0.62869,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,8.3461e-06,-0.63516,-0.62711,1,0
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,6.6813e-06,-0.63524,-0.61535,1,0
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.3909e-05,-0.63526,-0.59242,1,0
1,GO RESPONSE TO INACTIVITY,1.4947e-05,-0.63546,-0.62765,1,0
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,1.2035e-05,-0.63558,-0.60619,1,0
1,GO GALACTOSE METABOLIC PROCESS,2.1347e-05,-0.63569,-0.58923,1,0
1,GO FAT CELL DIFFERENTIATION,7.7514e-06,-0.63576,-0.58588,1,0
1,GO REGULATION OF AXONOGENESIS,8.3461e-06,-0.63579,-0.68467,1,0
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.7514e-06,-0.63582,-0.7007,1,0
1,GO POST ANAL TAIL MORPHOGENESIS,7.7514e-06,-0.63583,-0.63871,1,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,1.2939e-05,-0.63602,-0.62099,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00048214,-0.63614,-0.59226,1,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,5.337e-06,-0.63622,-0.62453,1,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.0403e-05,-0.63625,-0.62011,1,0
1,GO STRIATED MUSCLE ADAPTATION,6.6813e-06,-0.63627,-0.63407,1,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,3.7287e-05,-0.63641,-0.55834,1,0
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.2007e-06,-0.63646,-0.61833,1,0
1,GO MEMBRANE REPOLARIZATION,2.4576e-05,-0.63648,-0.59729,1,0
1,GO CELLULAR COMPONENT MAINTENANCE,6.2007e-06,-0.63654,-0.63917,1,0
1,GO PLATELET AGGREGATION,6.2007e-06,-0.63659,-0.68445,1,0
1,GO PERICARDIUM DEVELOPMENT,1.4947e-05,-0.63674,-0.66512,1,0
1,GO MITRAL VALVE DEVELOPMENT,0.00012367,-0.63697,-0.64524,1,0
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.7533e-06,-0.63707,-0.63869,1,0
1,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,8.3641e-05,-0.6374,-0.75696,1,0
1,GO OVULATION CYCLE,7.1973e-06,-0.63741,-0.59673,1,0
1,GO HYALURONAN METABOLIC PROCESS,8.3461e-06,-0.63748,-0.63733,1,0
1,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00054254,-0.63754,-0.68602,1,0
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,1.2035e-05,-0.63758,-0.63947,1,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,3.7287e-05,-0.63764,-0.59476,1,0
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.7533e-06,-0.63765,-0.62451,1,0
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.2939e-05,-0.63774,-0.60507,1,0
1,GO REGULATION OF CELLULAR COMPONENT SIZE,5.337e-06,-0.63803,-0.61789,1,0
1,GO HISTONE DEACETYLATION,9.6689e-06,-0.63812,-0.58744,1,0
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,3.9422e-06,-0.63814,-0.6563,1,0
1,GO NEURAL CREST CELL MIGRATION,9.6689e-06,-0.63818,-0.60609,1,0
1,GO REGULATION OF ACTION POTENTIAL,7.7514e-06,-0.63824,-0.63378,1,0
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,4.2539e-06,-0.6383,-0.61883,1,0
1,GO REGULATION OF PROTEIN SUMOYLATION,9.6689e-06,-0.63836,-0.57684,1,0
1,GO HISTONE DEUBIQUITINATION,1.0403e-05,-0.63856,-0.66995,1,0
1,GO RESPONSE TO ACIDIC PH,2.4576e-05,-0.63866,-0.61031,1,0
1,GO COPII COATED VESICLE CARGO LOADING,6.2007e-06,-0.63903,-0.66007,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,1.3909e-05,-0.63904,-0.67774,1,0
1,GO LAMELLIPODIUM ASSEMBLY,7.1973e-06,-0.63906,-0.60204,1,0
1,GO ADRENAL GLAND DEVELOPMENT,3.248e-05,-0.63911,-0.59925,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.6059e-05,-0.63926,-0.61834,1,0
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.6086e-05,-0.63948,-0.69988,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,9.6689e-06,-0.63962,-0.65864,1,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,1.2035e-05,-0.63978,-0.5654,1,0
1,GO CHROMATIN DISASSEMBLY,6.8565e-05,-0.63982,-0.57918,1,0
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00091199,-0.6399,-0.82134,1,0
1,GO STEM CELL DIVISION,8.3461e-06,-0.63994,-0.65325,1,0
1,GO RUFFLE ORGANIZATION,6.6813e-06,-0.63994,-0.63998,1,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,6.2007e-06,-0.64028,-0.63487,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,4.5891e-06,-0.64028,-0.64197,1,0
1,GO LACTATION,3.0304e-05,-0.64031,-0.5918,1,0
1,GO MULTI ORGANISM CELLULAR PROCESS,1.1191e-05,-0.6405,-0.70565,1,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,4.2539e-06,-0.64053,-0.63796,1,0
1,GO NEUROBLAST DIVISION,6.6813e-06,-0.64056,-0.65198,1,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,8.3461e-06,-0.64083,-0.65398,1,0
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,7.1973e-06,-0.641,-0.62133,1,0
1,GO CARDIAC CHAMBER MORPHOGENESIS,5.337e-06,-0.64115,-0.64669,1,0
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,8.9843e-06,-0.64116,-0.69531,1,0
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,5.6086e-05,-0.64128,-0.63835,1,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,1.9888e-05,-0.6414,-0.65132,1,0
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.7533e-06,-0.64145,-0.66563,1,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,6.6813e-06,-0.64149,-0.65109,1,0
1,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,6.2007e-06,-0.64151,-0.67412,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,1.4947e-05,-0.64161,-0.56405,1,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,1.3909e-05,-0.6421,-0.63915,1,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,6.6813e-06,-0.64227,-0.63089,1,0
1,GO CELL JUNCTION ORGANIZATION,6.6813e-06,-0.64265,-0.63694,1,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,5.337e-06,-0.64276,-0.5884,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,2.2907e-05,-0.64279,-0.60382,1,0
1,GO REGULATION OF TORC1 SIGNALING,5.7533e-06,-0.64309,-0.64899,1,0
1,GO MATERNAL PLACENTA DEVELOPMENT,7.3279e-05,-0.64323,-0.61661,1,0
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.2035e-05,-0.64357,-0.59359,1,0
1,GO RESPIRATORY SYSTEM PROCESS,1.2035e-05,-0.64391,-0.6442,1,0
1,GO KERATINOCYTE PROLIFERATION,1.2939e-05,-0.64397,-0.59013,1,0
1,GO NEGATIVE REGULATION OF OSSIFICATION,7.7514e-06,-0.64434,-0.62698,1,0
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,5.7533e-06,-0.64464,-0.62346,1,0
1,GO TRANSCYTOSIS,1.7249e-05,-0.64487,-0.63573,1,0
1,GO RECEPTOR CLUSTERING,9.6689e-06,-0.64498,-0.64887,1,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,2.4576e-05,-0.6451,-0.68756,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,5.337e-06,-0.64512,-0.59523,1,0
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,5.337e-06,-0.64519,-0.63901,1,0
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,8.3461e-06,-0.64521,-0.64927,1,0
1,GO SPINAL CORD PATTERNING,3.0304e-05,-0.64525,-0.6662,1,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,8.9843e-06,-0.64543,-0.6427,1,0
1,GO STRESS GRANULE ASSEMBLY,1.7249e-05,-0.64547,-0.60733,1,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,8.9843e-06,-0.6456,-0.60418,1,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,4.2539e-06,-0.64563,-0.64819,1,0
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00010181,-0.64564,-0.58472,1,0
1,GO CHOLESTEROL STORAGE,7.1973e-06,-0.64586,-0.7145,1,0
1,GO CAMP METABOLIC PROCESS,1.1191e-05,-0.64597,-0.6543,1,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,7.1973e-06,-0.64633,-0.64685,1,0
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,8.9843e-06,-0.64643,-0.64524,1,0
1,GO PROTEIN TARGETING TO VACUOLE,8.9843e-06,-0.64651,-0.64413,1,0
1,GO REGULATION OF VASCULOGENESIS,9.6689e-06,-0.64664,-0.64396,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.6059e-05,-0.64672,-0.62729,1,0
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.64682,-0.63628,1,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,5.337e-06,-0.64702,-0.60696,1,0
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.9936e-05,-0.64721,-0.71411,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.2035e-05,-0.64731,-0.61784,1,0
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.2539e-06,-0.64755,-0.64664,1,0
1,GO POSITIVE REGULATION OF JNK CASCADE,4.5891e-06,-0.64757,-0.67686,1,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,1.0403e-05,-0.64774,-0.61943,1,0
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,5.337e-06,-0.6481,-0.64037,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION,7.7514e-06,-0.64819,-0.66002,1,0
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,1.2939e-05,-0.64822,-0.68774,1,0
1,GO ACTIN CYTOSKELETON REORGANIZATION,4.2539e-06,-0.64826,-0.67959,1,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,5.337e-06,-0.6483,-0.6783,1,0
1,GO CELL JUNCTION ASSEMBLY,5.7533e-06,-0.6484,-0.63765,1,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,1.0403e-05,-0.64841,-0.66083,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,7.1973e-06,-0.64843,-0.68753,1,0
1,GO EYE MORPHOGENESIS,5.337e-06,-0.64853,-0.60329,1,0
1,GO LOOP OF HENLE DEVELOPMENT,3.4805e-05,-0.64854,-0.69492,1,0
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,6.2007e-06,-0.64861,-0.7195,1,0
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00033648,-0.64862,-0.83484,1,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,7.7514e-06,-0.64871,-0.56453,1,0
1,GO UV PROTECTION,6.2007e-06,-0.64874,-0.60638,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,7.1973e-06,-0.64877,-0.64363,1,0
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,5.7533e-06,-0.64891,-0.62856,1,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,8.9843e-06,-0.649,-0.65906,1,0
1,GO PRO B CELL DIFFERENTIATION,2.4576e-05,-0.64901,-0.64424,1,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,1.4947e-05,-0.64915,-0.73217,1,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,7.7514e-06,-0.64918,-0.66895,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,5.9985e-05,-0.64924,-0.64927,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.4947e-05,-0.64939,-0.65846,1,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,2.636e-05,-0.64951,-0.64613,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.8524e-05,-0.64965,-0.61064,1,0
1,GO POSITIVE REGULATION OF ERAD PATHWAY,8.3461e-06,-0.64974,-0.63769,1,0
1,GO CELL JUNCTION MAINTENANCE,3.7287e-05,-0.64994,-0.62615,1,0
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,1.4947e-05,-0.64995,-0.61038,1,0
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.65023,-0.61741,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,1.9888e-05,-0.65024,-0.58195,1,0
1,GO CENTRIOLE CENTRIOLE COHESION,1.2035e-05,-0.65045,-0.74139,1,0
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,5.337e-06,-0.65053,-0.6253,1,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,1.3909e-05,-0.65053,-0.63503,1,0
1,GO ESTROUS CYCLE,3.7287e-05,-0.65054,-0.61477,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,6.6813e-06,-0.65064,-0.64491,1,0
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.7514e-06,-0.65082,-0.73444,1,0
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,3.4805e-05,-0.65126,-0.66128,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,7.8298e-05,-0.65142,-0.69203,1,0
1,GO PROTEOGLYCAN METABOLIC PROCESS,5.337e-06,-0.65143,-0.65751,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,5.7533e-06,-0.65157,-0.62602,1,0
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,6.6813e-06,-0.65171,-0.63229,1,0
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,6.2007e-06,-0.65186,-0.629,1,0
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.3909e-05,-0.65197,-0.64725,1,0
1,GO MAMMARY GLAND MORPHOGENESIS,1.4947e-05,-0.65238,-0.67673,1,0
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,4.5891e-06,-0.65265,-0.65839,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.337e-06,-0.65302,-0.6165,1,0
1,GO RESPONSE TO INTERFERON ALPHA,0.00040321,-0.65323,-0.7396,1,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,1.2939e-05,-0.65331,-0.60734,1,0
1,GO RNA DECAPPING,2.4576e-05,-0.65335,-0.5772,1,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,6.2007e-06,-0.6534,-0.67258,1,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,5.7533e-06,-0.65349,-0.66227,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,8.3461e-06,-0.65349,-0.63853,1,0
1,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,3.248e-05,-0.65356,-0.64169,1,0
1,GO CELL MORPHOGENESIS,7.1973e-06,-0.65357,-0.64148,1,0
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,3.9422e-06,-0.65358,-0.63614,1,0
1,GO SECONDARY PALATE DEVELOPMENT,7.7514e-06,-0.6536,-0.7046,1,0
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,6.6813e-06,-0.65363,-0.6234,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,1.2035e-05,-0.65364,-0.63632,1,0
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,4.9495e-06,-0.65366,-0.64407,1,0
1,GO AZOLE TRANSMEMBRANE TRANSPORT,7.1973e-06,-0.65386,-0.7103,1,0
1,GO MEMBRANE PROTEIN PROTEOLYSIS,3.9422e-06,-0.65418,-0.71059,1,0
1,GO RENAL SYSTEM PROCESS,6.6813e-06,-0.65438,-0.62082,1,0
1,GO PROTEIN DEMANNOSYLATION,4.9495e-06,-0.65456,-0.72129,1,0
1,GO SKELETAL SYSTEM MORPHOGENESIS,5.7533e-06,-0.65462,-0.63913,1,0
1,GO CELLULAR RESPONSE TO ETHANOL,2.4576e-05,-0.65466,-0.71154,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031664,-0.65474,-0.54412,1,0
1,GO REGULATION OF MUSCLE ADAPTATION,5.337e-06,-0.6548,-0.63662,1,0
1,GO TROPHOBLAST CELL MIGRATION,4.8997e-05,-0.65492,-0.59633,1,0
1,GO SELECTIVE AUTOPHAGY,1.0403e-05,-0.65502,-0.59306,1,0
1,GO DISACCHARIDE METABOLIC PROCESS,1.4947e-05,-0.65511,-0.63781,1,0
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,1.2939e-05,-0.65515,-0.66518,1,0
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,9.6689e-06,-0.65541,-0.60608,1,0
1,GO REGULATION OF MAP KINASE ACTIVITY,4.5891e-06,-0.65542,-0.65099,1,0
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,1.4947e-05,-0.65544,-0.73564,1,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.6059e-05,-0.65572,-0.58499,1,0
1,GO REGULATION OF TISSUE REMODELING,8.3461e-06,-0.65578,-0.69369,1,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,2.1347e-05,-0.65579,-0.57229,1,0
1,GO DECIDUALIZATION,0.00015974,-0.65593,-0.6384,1,0
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.1973e-06,-0.65602,-0.63559,1,0
1,GO RENAL WATER HOMEOSTASIS,2.1347e-05,-0.65632,-0.61498,1,0
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.2007e-06,-0.65645,-0.61856,1,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,7.1973e-06,-0.6566,-0.65184,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.5891e-06,-0.6567,-0.63845,1,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,2.1347e-05,-0.65678,-0.6947,1,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.65685,-0.69339,1,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.0047188,-0.65687,-0.63825,1,0
1,GO CELLULAR RESPONSE TO ALCOHOL,7.1973e-06,-0.65689,-0.64849,1,0
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,5.337e-06,-0.65706,-0.63853,1,0
1,GO CORTICAL CYTOSKELETON ORGANIZATION,6.2007e-06,-0.65708,-0.63669,1,0
1,GO ENTRY OF BACTERIUM INTO HOST CELL,7.7514e-06,-0.6571,-0.67063,1,0
1,GO NEGATIVE REGULATION OF MAPK CASCADE,5.337e-06,-0.6572,-0.64518,1,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,1.1191e-05,-0.6572,-0.5904,1,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,7.1973e-06,-0.65726,-0.66779,1,0
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,5.7533e-06,-0.65727,-0.64814,1,0
1,GO REGULATION OF MEMBRANE INVAGINATION,0.00012367,-0.65741,-0.72227,1,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,3.9936e-05,-0.65771,-0.54024,1,0
1,GO AMEBOIDAL TYPE CELL MIGRATION,5.337e-06,-0.65774,-0.65251,1,0
1,GO DETECTION OF MECHANICAL STIMULUS,8.9843e-06,-0.65804,-0.59423,1,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,6.6813e-06,-0.65816,-0.59841,1,0
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.8524e-05,-0.65838,-0.68768,1,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.00017019,-0.65853,-0.57697,1,0
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.65853,-0.58862,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,3.9936e-05,-0.65915,-0.60513,1,0
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,4.9495e-06,-0.65944,-0.67645,1,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,8.3641e-05,-0.65952,-0.71634,1,0
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,4.5891e-06,-0.65952,-0.6689,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.7287e-05,-0.66036,-0.60374,1,0
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.4576e-05,-0.66052,-0.7241,1,0
1,GO PROTEIN DEPOLYMERIZATION,4.9495e-06,-0.66065,-0.69886,1,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,1.0403e-05,-0.66078,-0.65069,1,0
1,GO SOMATIC STEM CELL DIVISION,0.00045436,-0.66078,-0.61812,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.0304e-05,-0.66121,-0.5999,1,0
1,GO CELL VOLUME HOMEOSTASIS,1.0403e-05,-0.66204,-0.58638,1,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,6.2007e-06,-0.66222,-0.61009,1,0
1,GO RESPONSE TO INTERLEUKIN 6,1.2035e-05,-0.66231,-0.70575,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00081392,-0.66233,-0.67795,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00014062,-0.66237,-0.63392,1,0
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00011593,-0.66257,-0.70198,1,0
1,GO GLIAL CELL MIGRATION,4.2539e-06,-0.66258,-0.68839,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00010866,-0.66258,-0.57994,1,0
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,3.248e-05,-0.66264,-0.68825,1,0
1,GO CIRCULATORY SYSTEM DEVELOPMENT,5.337e-06,-0.6627,-0.6485,1,0
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,5.7533e-06,-0.66272,-0.63627,1,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,9.6689e-06,-0.66291,-0.6539,1,0
1,GO HISTONE H3 K9 METHYLATION,8.3461e-06,-0.66336,-0.65313,1,0
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.6635,-0.59631,1,0
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.0403e-05,-0.66354,-0.70953,1,0
1,GO POST EMBRYONIC DEVELOPMENT,7.7514e-06,-0.66354,-0.62562,1,0
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,5.9985e-05,-0.66366,-0.75083,1,0
1,GO INCLUSION BODY ASSEMBLY,0.00076864,-0.66375,-0.56924,1,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,7.1973e-06,-0.66406,-0.63951,1,0
1,GO TUBE MORPHOGENESIS,5.337e-06,-0.66421,-0.65885,1,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.7249e-05,-0.66439,-0.62097,1,0
1,GO RESPONSE TO LIPOTEICHOIC ACID,0.00035748,-0.66458,-0.6412,1,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,5.7533e-06,-0.66458,-0.65807,1,0
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,1.8524e-05,-0.66488,-0.71805,1,0
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00017019,-0.66537,-0.66059,1,0
1,GO PROTEIN LOCALIZATION TO AXON,0.00026348,-0.66543,-0.64848,1,0
1,GO PINOCYTOSIS,5.7533e-06,-0.66558,-0.70684,1,0
1,GO ENAMEL MINERALIZATION,2.4576e-05,-0.66562,-0.68392,1,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,8.3461e-06,-0.66567,-0.62949,1,0
1,GO FIBROBLAST ACTIVATION,5.337e-06,-0.66578,-0.69096,1,0
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,1.2035e-05,-0.66606,-0.67517,1,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,5.7533e-06,-0.66627,-0.65179,1,0
1,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00045436,-0.6663,-0.56577,1,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,1.1191e-05,-0.66632,-0.69459,1,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,7.1973e-06,-0.66671,-0.70349,1,0
1,GO DENDRITIC SPINE MAINTENANCE,6.2007e-06,-0.66681,-0.68244,1,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,8.9327e-05,-0.66685,-0.63449,1,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,6.6813e-06,-0.66693,-0.58522,1,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,7.7514e-06,-0.66698,-0.62299,1,0
1,GO REGULATION OF CELL MORPHOGENESIS,5.7533e-06,-0.667,-0.65973,1,0
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,5.9985e-05,-0.66701,-0.6081,1,0
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,4.2539e-06,-0.66708,-0.6888,1,0
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00028019,-0.66726,-0.71324,1,0
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,1.6059e-05,-0.66733,-0.63092,1,0
1,GO TUBE DEVELOPMENT,5.337e-06,-0.66757,-0.63634,1,0
1,GO MITOCHONDRION DISTRIBUTION,1.0403e-05,-0.66762,-0.66887,1,0
1,GO MICROTUBULE ANCHORING,1.0403e-05,-0.66794,-0.66314,1,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.00014062,-0.66804,-0.59786,1,0
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,2.2907e-05,-0.66826,-0.62915,1,0
1,GO SPHINGOID METABOLIC PROCESS,5.337e-06,-0.66843,-0.66877,1,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,4.2539e-06,-0.66851,-0.66404,1,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,8.3461e-06,-0.66857,-0.65784,1,0
1,GO REGULATION OF PODOSOME ASSEMBLY,5.337e-06,-0.6688,-0.74055,1,0
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.9843e-06,-0.66882,-0.73105,1,0
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.8524e-05,-0.66889,-0.62757,1,0
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,5.7533e-06,-0.6689,-0.70419,1,0
1,GO PROTEIN LOCALIZATION TO LYSOSOME,9.6689e-06,-0.66903,-0.64126,1,0
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.66904,-0.66125,1,0
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,8.3461e-06,-0.66926,-0.60476,1,0
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,5.337e-06,-0.66963,-0.67121,1,0
1,GO RETROGRADE AXONAL TRANSPORT,2.1347e-05,-0.66975,-0.70107,1,0
1,GO ENDOTHELIAL CELL MIGRATION,6.2007e-06,-0.66985,-0.67118,1,0
1,GO TORC1 SIGNALING,4.9495e-06,-0.6702,-0.69122,1,0
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.00029789,-0.67032,-0.71208,1,0
1,GO HEART MORPHOGENESIS,6.2007e-06,-0.67079,-0.6182,1,0
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.5779e-05,-0.67096,-0.62719,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,7.7514e-06,-0.67101,-0.64046,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,1.0403e-05,-0.67121,-0.69227,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,3.9936e-05,-0.67137,-0.62745,1,0
1,GO ACTIN FILAMENT ORGANIZATION,5.337e-06,-0.67147,-0.63572,1,0
1,GO GLYCOLIPID CATABOLIC PROCESS,5.7533e-06,-0.6717,-0.75137,1,0
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,1.2035e-05,-0.67181,-0.63421,1,0
1,GO REVERSE CHOLESTEROL TRANSPORT,5.6086e-05,-0.67181,-0.70192,1,0
1,GO PEPTIDYL THREONINE MODIFICATION,5.7533e-06,-0.67187,-0.66038,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.6059e-05,-0.67196,-0.63348,1,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.3909e-05,-0.67205,-0.73205,1,0
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,5.2428e-05,-0.6722,-0.73196,1,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,4.9495e-06,-0.6722,-0.62917,1,0
1,GO RESPONSE TO STEROL,6.6813e-06,-0.67224,-0.72515,1,0
1,GO RELAXATION OF CARDIAC MUSCLE,2.8267e-05,-0.67239,-0.63916,1,0
1,GO MESODERMAL CELL DIFFERENTIATION,1.8524e-05,-0.67242,-0.60151,1,0
1,GO COLLATERAL SPROUTING,1.9888e-05,-0.67249,-0.69132,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,4.5891e-06,-0.67252,-0.62763,1,0
1,GO PLATELET ACTIVATION,4.9495e-06,-0.67288,-0.69775,1,0
1,GO LIPID PHOSPHORYLATION,4.9495e-06,-0.67333,-0.66926,1,0
1,GO REGULATION OF CELL SIZE,5.7533e-06,-0.67364,-0.65936,1,0
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,4.2539e-06,-0.67374,-0.67457,1,0
1,GO XENOBIOTIC TRANSPORT,8.9843e-06,-0.67383,-0.64951,1,0
1,GO REGULATION OF HISTONE DEACETYLATION,1.3909e-05,-0.6739,-0.59293,1,0
1,GO MULTICELLULAR ORGANISM GROWTH,5.337e-06,-0.6749,-0.6558,1,0
1,GO LIPID TRANSLOCATION,6.2007e-06,-0.67501,-0.67212,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,5.337e-06,-0.67549,-0.63448,1,0
1,GO REGULATION OF BONE REMODELING,1.1191e-05,-0.6759,-0.68475,1,0
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.67593,-0.69161,1,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.0403e-05,-0.67596,-0.64957,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00064645,-0.67617,-0.58087,1,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,5.337e-06,-0.67621,-0.61069,1,0
1,GO CELL CELL JUNCTION MAINTENANCE,3.7287e-05,-0.67651,-0.68341,1,0
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,1.6059e-05,-0.67652,-0.6722,1,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,8.9843e-06,-0.6766,-0.62045,1,0
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.4947e-05,-0.67666,-0.66406,1,0
1,GO FILOPODIUM ASSEMBLY,9.6689e-06,-0.67677,-0.66659,1,0
1,GO CYTOSOLIC TRANSPORT,5.337e-06,-0.67719,-0.67061,1,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,4.5891e-06,-0.67732,-0.63879,1,0
1,GO TISSUE MIGRATION,5.7533e-06,-0.67745,-0.67171,1,0
1,GO DENDRITIC TRANSPORT,1.9888e-05,-0.67807,-0.77291,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,9.6689e-06,-0.6781,-0.69009,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,1.0403e-05,-0.67818,-0.66712,1,0
1,GO CARTILAGE DEVELOPMENT,5.337e-06,-0.6782,-0.65862,1,0
1,GO CELLULAR RESPONSE TO STEROL,8.3461e-06,-0.67861,-0.6992,1,0
1,GO REGULATION OF MUSCLE HYPERTROPHY,6.2007e-06,-0.67867,-0.62039,1,0
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,5.7533e-06,-0.67894,-0.64104,1,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,5.337e-06,-0.67896,-0.72679,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,5.337e-06,-0.67899,-0.67278,1,0
1,GO NEURAL TUBE DEVELOPMENT,9.6689e-06,-0.67917,-0.59987,1,0
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,7.7514e-06,-0.67942,-0.67472,1,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0028457,-0.67962,-0.50677,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.1191e-05,-0.68001,-0.67192,1,0
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,6.2007e-06,-0.68014,-0.66709,1,0
1,GO P BODY ASSEMBLY,1.2939e-05,-0.6803,-0.69367,1,0
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,5.337e-06,-0.68041,-0.6458,1,0
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,2.636e-05,-0.68061,-0.67884,1,0
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,6.2007e-06,-0.68062,-0.66304,1,0
1,GO MYELOID CELL DEVELOPMENT,4.9495e-06,-0.6809,-0.70626,1,0
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,1.7249e-05,-0.68154,-0.63184,1,0
1,GO CARNITINE SHUTTLE,1.8524e-05,-0.6816,-0.58858,1,0
1,GO AXON EXTENSION,6.6813e-06,-0.68171,-0.68062,1,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,4.2539e-06,-0.68234,-0.72311,1,0
1,GO BEHAVIORAL RESPONSE TO PAIN,1.2035e-05,-0.68241,-0.60958,1,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,9.6689e-06,-0.6826,-0.67934,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00033648,-0.68265,-0.60783,1,0
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,6.2007e-06,-0.68281,-0.68362,1,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00011593,-0.68299,-0.66425,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,5.337e-06,-0.68365,-0.68179,1,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,8.3461e-06,-0.68378,-0.70966,1,0
1,GO HEMOGLOBIN METABOLIC PROCESS,1.6059e-05,-0.68395,-0.6116,1,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,6.4139e-05,-0.68409,-0.57911,1,0
1,GO LYSOSOMAL TRANSPORT,7.1973e-06,-0.6841,-0.66177,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY,5.337e-06,-0.68441,-0.64155,1,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,5.337e-06,-0.6845,-0.68508,1,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,8.3461e-06,-0.68474,-0.67592,1,0
1,GO PROTEIN DEGLYCOSYLATION,5.337e-06,-0.68484,-0.70927,1,0
1,GO RECEPTOR CATABOLIC PROCESS,4.9495e-06,-0.68494,-0.66643,1,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,5.337e-06,-0.68539,-0.68833,1,0
1,GO POSITIVE REGULATION OF PROTEIN BINDING,5.337e-06,-0.68578,-0.63054,1,0
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,2.636e-05,-0.68584,-0.7004,1,0
1,GO REGULATION OF GASTRULATION,1.4947e-05,-0.68596,-0.62061,1,0
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,8.3461e-06,-0.68605,-0.66758,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,5.7533e-06,-0.6863,-0.75635,1,0
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,7.7514e-06,-0.68649,-0.76146,1,0
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,6.2007e-06,-0.68656,-0.6515,1,0
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,1.6059e-05,-0.68663,-0.72311,1,0
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.5891e-06,-0.68675,-0.67411,1,0
1,GO VASCULATURE DEVELOPMENT,5.7533e-06,-0.68695,-0.69836,1,0
1,GO ACTIVATION OF MAPKK ACTIVITY,4.9495e-06,-0.68702,-0.72597,1,0
1,GO REGULATION OF BONE DEVELOPMENT,1.0403e-05,-0.68738,-0.71335,1,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,6.2007e-06,-0.68772,-0.67348,1,0
1,GO BONE MORPHOGENESIS,8.3461e-06,-0.68793,-0.66431,1,0
1,GO PHAGOLYSOSOME ASSEMBLY,5.337e-06,-0.68794,-0.72766,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,1.2035e-05,-0.68805,-0.70038,1,0
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,6.6813e-06,-0.68813,-0.63785,1,0
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,2.2907e-05,-0.68824,-0.68553,1,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,1.4947e-05,-0.68862,-0.64207,1,0
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,4.5891e-06,-0.68878,-0.6929,1,0
1,GO GANGLIOSIDE METABOLIC PROCESS,4.5891e-06,-0.68884,-0.68974,1,0
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,4.2539e-06,-0.68921,-0.7099,1,0
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,6.6813e-06,-0.68935,-0.62045,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,4.5891e-06,-0.68939,-0.70085,1,0
1,GO REGULATION OF ENDOCYTIC RECYCLING,7.1973e-06,-0.68982,-0.71351,1,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,5.7533e-06,-0.68984,-0.72436,1,0
1,GO RESPONSE TO HYDROXYUREA,1.9888e-05,-0.69092,-0.59856,1,0
1,GO OSTEOCLAST DEVELOPMENT,5.337e-06,-0.69119,-0.77582,1,0
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.248e-05,-0.69119,-0.77498,1,0
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,5.7533e-06,-0.69136,-0.76813,1,0
1,GO RESPONSE TO INTERLEUKIN 2,6.8565e-05,-0.69171,-0.72516,1,0
1,GO MOTOR NEURON AXON GUIDANCE,2.1347e-05,-0.69193,-0.61334,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,3.4805e-05,-0.69228,-0.67672,1,0
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.2007e-06,-0.69245,-0.63397,1,0
1,GO REGULATION OF FAT CELL DIFFERENTIATION,6.2007e-06,-0.69248,-0.64863,1,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,1.2035e-05,-0.69252,-0.72074,1,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,8.3461e-06,-0.69289,-0.66742,1,0
1,GO TRABECULA MORPHOGENESIS,8.3461e-06,-0.69289,-0.71732,1,0
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,3.248e-05,-0.69291,-0.66138,1,0
1,GO REGULATION OF MITOPHAGY,6.6813e-06,-0.69324,-0.70636,1,0
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,7.7514e-06,-0.69326,-0.64699,1,0
1,GO REGULATION OF VASCULATURE DEVELOPMENT,8.3461e-06,-0.69331,-0.68421,1,0
1,GO ACTIN FILAMENT BASED PROCESS,4.9495e-06,-0.69336,-0.64526,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,1.9888e-05,-0.69389,-0.66009,1,0
1,GO ERYTHROCYTE MATURATION,3.0304e-05,-0.69463,-0.62564,1,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,3.9422e-06,-0.69469,-0.68567,1,0
1,GO HISTONE H3 K4 TRIMETHYLATION,8.3461e-06,-0.69491,-0.75949,1,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,4.5891e-06,-0.69507,-0.68492,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.9495e-06,-0.6955,-0.6802,1,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,3.4805e-05,-0.69621,-0.62607,1,0
1,GO GASTRULATION,8.9843e-06,-0.69652,-0.65403,1,0
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,5.337e-06,-0.69673,-0.66771,1,0
1,GO GROWTH HORMONE SECRETION,0.00019306,-0.69674,-0.63446,1,0
1,GO RESPONSE TO LEUCINE,1.1191e-05,-0.69691,-0.70684,1,0
1,GO INNERVATION,0.00012367,-0.69692,-0.74933,1,0
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,4.5891e-06,-0.69698,-0.70099,1,0
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.2035e-05,-0.69707,-0.65961,1,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,7.7514e-06,-0.6971,-0.6733,1,0
1,GO RESPONSE TO PH,8.3461e-06,-0.69742,-0.63853,1,0
1,GO RESPONSE TO INTERLEUKIN 15,0.00013188,-0.69783,-0.78976,1,0
1,GO BONE REMODELING,1.1191e-05,-0.69797,-0.68745,1,0
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.6059e-05,-0.69807,-0.63494,1,0
1,GO BASIC AMINO ACID TRANSPORT,1.1191e-05,-0.69834,-0.70112,1,0
1,GO EMBRYONIC BODY MORPHOGENESIS,6.6813e-06,-0.69842,-0.69136,1,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,1.4947e-05,-0.69869,-0.66066,1,0
1,GO CONNECTIVE TISSUE DEVELOPMENT,5.7533e-06,-0.69881,-0.66471,1,0
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,7.1973e-06,-0.69882,-0.71055,1,0
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,4.9495e-06,-0.69915,-0.70874,1,0
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,8.3461e-06,-0.69951,-0.68232,1,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,3.0304e-05,-0.69957,-0.67203,1,0
1,GO RESPONSE TO ISCHEMIA,4.9495e-06,-0.69973,-0.69443,1,0
1,GO REGULATION OF CELL SHAPE,5.7533e-06,-0.69974,-0.69384,1,0
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,4.5891e-06,-0.7002,-0.67488,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,4.9495e-06,-0.70038,-0.69587,1,0
1,GO SMOOTH MUSCLE CELL MIGRATION,7.1973e-06,-0.70045,-0.73199,1,0
1,GO BLOOD VESSEL MORPHOGENESIS,6.2007e-06,-0.70081,-0.69704,1,0
1,GO NEURAL TUBE FORMATION,6.6813e-06,-0.7009,-0.614,1,0
1,GO OUTFLOW TRACT MORPHOGENESIS,6.2007e-06,-0.70107,-0.65406,1,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,6.6813e-06,-0.70149,-0.66999,1,0
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.8524e-05,-0.70175,-0.70568,1,0
1,GO REGULATION OF PINOCYTOSIS,3.9422e-06,-0.70188,-0.71882,1,0
1,GO OSTEOBLAST PROLIFERATION,2.1347e-05,-0.70215,-0.66687,1,0
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,8.3461e-06,-0.70221,-0.69935,1,0
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.4947e-05,-0.70259,-0.6784,1,0
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,6.2007e-06,-0.70264,-0.65057,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,1.0403e-05,-0.70312,-0.64545,1,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,4.2763e-05,-0.70336,-0.59802,1,0
1,GO INTRACELLULAR MRNA LOCALIZATION,9.6689e-06,-0.70367,-0.60913,1,0
1,GO CARDIAC SEPTUM DEVELOPMENT,3.9422e-06,-0.70368,-0.70938,1,0
1,GO PROTEIN KINASE C SIGNALING,1.3909e-05,-0.70386,-0.67021,1,0
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,6.2007e-06,-0.70395,-0.72096,1,0
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,5.2428e-05,-0.70401,-0.7207,1,0
1,GO REGULATION OF STEM CELL DIVISION,1.2939e-05,-0.70451,-0.70335,1,0
1,GO BONE DEVELOPMENT,6.6813e-06,-0.70493,-0.67376,1,0
1,GO PEPTIDE CATABOLIC PROCESS,3.9422e-06,-0.70534,-0.69815,1,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,1.6059e-05,-0.70541,-0.65184,1,0
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,8.9843e-06,-0.70574,-0.62405,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,5.7533e-06,-0.70592,-0.76307,1,0
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,7.1973e-06,-0.70597,-0.68112,1,0
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,1.0403e-05,-0.70648,-0.71172,1,0
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,6.6813e-06,-0.7071,-0.70448,1,0
1,GO METANEPHRIC NEPHRON DEVELOPMENT,5.7533e-06,-0.70735,-0.73706,1,0
1,GO ADHERENS JUNCTION ORGANIZATION,5.337e-06,-0.70772,-0.71233,1,0
1,GO CELL CELL JUNCTION ORGANIZATION,5.7533e-06,-0.70865,-0.64363,1,0
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.9495e-06,-0.70872,-0.68601,1,0
1,GO REGULATION OF CELL SUBSTRATE ADHESION,6.6813e-06,-0.70903,-0.73276,1,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,8.3461e-06,-0.70913,-0.65636,1,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.3909e-05,-0.70921,-0.66058,1,0
1,GO CELL SUBSTRATE ADHESION,5.7533e-06,-0.70932,-0.74846,1,0
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,1.2035e-05,-0.70949,-0.64719,1,0
1,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00091199,-0.70958,-0.64364,1,0
1,GO T HELPER 2 CELL DIFFERENTIATION,0.00060992,-0.71015,-0.63928,1,0
1,GO MAMMARY GLAND DEVELOPMENT,5.7533e-06,-0.71015,-0.65904,1,0
1,GO CELL CELL JUNCTION ASSEMBLY,5.337e-06,-0.71023,-0.61342,1,0
1,GO CELL JUNCTION DISASSEMBLY,5.9985e-05,-0.71033,-0.78519,1,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,1.0403e-05,-0.71057,-0.65726,1,0
1,GO ESTABLISHMENT OF CELL POLARITY,4.5891e-06,-0.7108,-0.68789,1,0
1,GO HISTONE H3 K36 METHYLATION,1.1191e-05,-0.71191,-0.72928,1,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,5.337e-06,-0.71234,-0.67794,1,0
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.7533e-06,-0.71251,-0.67372,1,0
1,GO GOLGI TO VACUOLE TRANSPORT,1.0403e-05,-0.71259,-0.71581,1,0
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,4.5891e-06,-0.71269,-0.68587,1,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.4805e-05,-0.71286,-0.634,1,0
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,6.6813e-06,-0.71306,-0.68891,1,0
1,GO EMBRYONIC HEMOPOIESIS,6.6813e-06,-0.71326,-0.70508,1,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,5.7533e-06,-0.71361,-0.72892,1,0
1,GO PROTEIN TARGETING TO LYSOSOME,1.1191e-05,-0.71368,-0.65522,1,0
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,1.2939e-05,-0.71369,-0.71938,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.337e-06,-0.71392,-0.69184,1,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,1.0403e-05,-0.714,-0.68048,1,0
1,GO REGULATION OF JUN KINASE ACTIVITY,5.337e-06,-0.7149,-0.69573,1,0
1,GO ACTIVATION OF JUN KINASE ACTIVITY,6.2007e-06,-0.71512,-0.74078,1,0
1,GO FORMATION OF PRIMARY GERM LAYER,1.1191e-05,-0.71524,-0.68063,1,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,1.9888e-05,-0.71551,-0.67229,1,0
1,GO TISSUE REMODELING,8.3461e-06,-0.71552,-0.71791,1,0
1,GO EMBRYONIC EYE MORPHOGENESIS,6.6813e-06,-0.71655,-0.70294,1,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,4.9495e-06,-0.71686,-0.67549,1,0
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,9.6689e-06,-0.71704,-0.74511,1,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,5.2428e-05,-0.71713,-0.64765,1,0
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,4.9495e-06,-0.71775,-0.69793,1,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,5.337e-06,-0.71836,-0.71885,1,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,4.9495e-06,-0.71862,-0.74864,1,0
1,GO NEGATIVE CHEMOTAXIS,7.1973e-06,-0.71874,-0.70194,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,1.9888e-05,-0.7192,-0.74323,1,0
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.2007e-06,-0.71923,-0.73268,1,0
1,GO INACTIVATION OF MAPK ACTIVITY,1.7249e-05,-0.71969,-0.63312,1,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,5.337e-06,-0.71992,-0.76192,1,0
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.6813e-06,-0.71996,-0.67539,1,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,7.7514e-06,-0.7203,-0.70359,1,0
1,GO ERYTHROCYTE DEVELOPMENT,7.7514e-06,-0.72058,-0.67808,1,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,9.6689e-06,-0.72101,-0.72234,1,0
1,GO ENDOTHELIAL CELL CHEMOTAXIS,4.2763e-05,-0.72102,-0.61299,1,0
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,9.6689e-06,-0.72123,-0.73181,1,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,1.0403e-05,-0.72129,-0.67001,1,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,1.1191e-05,-0.72229,-0.66549,1,0
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.1347e-05,-0.72254,-0.79197,1,0
1,GO ACTIN CROSSLINK FORMATION,7.7514e-06,-0.72301,-0.68982,1,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,2.8267e-05,-0.72321,-0.66608,1,0
1,GO ENDOTHELIAL CELL PROLIFERATION,7.1973e-06,-0.72397,-0.67073,1,0
1,GO REPLACEMENT OSSIFICATION,1.8524e-05,-0.7241,-0.66341,1,0
1,GO LAMELLIPODIUM MORPHOGENESIS,1.6059e-05,-0.72493,-0.62363,1,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,1.2939e-05,-0.72503,-0.6797,1,0
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,5.337e-06,-0.7254,-0.76327,1,0
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,4.5891e-06,-0.72574,-0.69137,1,0
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.2035e-05,-0.72639,-0.66496,1,0
1,GO ACTIVATION OF JNKK ACTIVITY,5.337e-06,-0.72669,-0.77133,1,0
1,GO CORPUS CALLOSUM DEVELOPMENT,1.2939e-05,-0.72682,-0.6955,1,0
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.72753,-0.76668,1,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,5.337e-06,-0.72768,-0.72648,1,0
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,5.337e-06,-0.72784,-0.71212,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,5.7533e-06,-0.72795,-0.6833,1,0
1,GO PULMONARY VALVE DEVELOPMENT,7.7514e-06,-0.72831,-0.79159,1,0
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,7.1973e-06,-0.7284,-0.73602,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,8.3461e-06,-0.72851,-0.66671,1,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,2.1347e-05,-0.72914,-0.59992,1,0
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,1.7249e-05,-0.72949,-0.77583,1,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,1.2035e-05,-0.72997,-0.67801,1,0
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,7.1973e-06,-0.73008,-0.69024,1,0
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.8565e-05,-0.73011,-0.83635,1,0
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,4.9495e-06,-0.73049,-0.67406,1,0
1,GO REGULATION OF FIBROBLAST MIGRATION,4.5891e-06,-0.73053,-0.6884,1,0
1,GO GLYCOPROTEIN CATABOLIC PROCESS,0.00012367,-0.73068,-0.68229,1,0
1,GO REGULATION OF MIRNA METABOLIC PROCESS,1.2035e-05,-0.73098,-0.72291,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,4.9495e-06,-0.73106,-0.76202,1,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,1.1191e-05,-0.73108,-0.69468,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,3.248e-05,-0.73118,-0.59216,1,0
1,GO REGULATION OF GTPASE ACTIVITY,4.9495e-06,-0.7313,-0.68213,1,0
1,GO EPITHELIAL CELL CELL ADHESION,9.6689e-06,-0.7322,-0.76159,1,0
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,5.337e-06,-0.73222,-0.70852,1,0
1,GO PROTEIN AUTOPHOSPHORYLATION,4.9495e-06,-0.73234,-0.70142,1,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,7.1973e-06,-0.73248,-0.76795,1,0
1,GO TUBULIN DEACETYLATION,7.8298e-05,-0.7332,-0.67203,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,6.6813e-06,-0.73321,-0.68715,1,0
1,GO CELL ADHESION MEDIATED BY INTEGRIN,3.248e-05,-0.7333,-0.79186,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.6059e-05,-0.73358,-0.68374,1,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,3.9936e-05,-0.73437,-0.70335,1,0
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.5891e-06,-0.73468,-0.72991,1,0
1,GO P38MAPK CASCADE,8.9843e-06,-0.73485,-0.73282,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,8.9843e-06,-0.73491,-0.66742,1,0
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,3.9936e-05,-0.735,-0.78926,1,0
1,GO FIBROBLAST MIGRATION,4.5891e-06,-0.73518,-0.68639,1,0
1,GO PLASMA MEMBRANE ORGANIZATION,4.9495e-06,-0.73522,-0.70015,1,0
1,GO LEYDIG CELL DIFFERENTIATION,0.00040321,-0.7359,-0.58527,1,0
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.1191e-05,-0.73625,-0.76116,1,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,8.9843e-06,-0.73634,-0.69957,1,0
1,GO REGULATION OF CELL MATRIX ADHESION,6.6813e-06,-0.73672,-0.74345,1,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,7.7514e-06,-0.73723,-0.72552,1,0
1,GO BONE CELL DEVELOPMENT,4.5891e-06,-0.73761,-0.76449,1,0
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,7.1973e-06,-0.73783,-0.81759,1,0
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,9.6689e-06,-0.73798,-0.70159,1,0
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,3.0304e-05,-0.73814,-0.62749,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,5.337e-06,-0.73839,-0.70323,1,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,1.4947e-05,-0.73841,-0.66003,1,0
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,4.9495e-06,-0.73845,-0.6868,1,0
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,5.7533e-06,-0.73858,-0.70256,1,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.7249e-05,-0.73889,-0.71061,1,0
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.2939e-05,-0.73898,-0.74264,1,0
1,GO LUTEINIZATION,1.2939e-05,-0.73944,-0.76493,1,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.4947e-05,-0.74054,-0.71606,1,0
1,GO PODOSOME ASSEMBLY,4.5891e-06,-0.74193,-0.80823,1,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,6.6813e-06,-0.74199,-0.70049,1,0
1,GO ALANINE TRANSPORT,6.6813e-06,-0.74201,-0.74333,1,0
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.7533e-06,-0.74218,-0.74473,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,0.00014989,-0.74249,-0.65192,1,0
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.2907e-05,-0.74315,-0.72692,1,0
1,GO LATERAL VENTRICLE DEVELOPMENT,1.2035e-05,-0.74353,-0.76151,1,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,6.2007e-06,-0.74432,-0.6648,1,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,1.4947e-05,-0.74492,-0.67069,1,0
1,GO DERMATAN SULFATE METABOLIC PROCESS,2.8267e-05,-0.74559,-0.73334,1,0
1,GO CELL MATRIX ADHESION,5.7533e-06,-0.74561,-0.76154,1,0
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,9.6689e-06,-0.7465,-0.69097,1,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,6.6813e-06,-0.74678,-0.72869,1,0
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,9.6689e-06,-0.7471,-0.75657,1,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,3.248e-05,-0.74792,-0.65838,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,3.248e-05,-0.74933,-0.72791,1,0
1,GO RNA DESTABILIZATION,1.1191e-05,-0.74961,-0.69927,1,0
1,GO NK T CELL DIFFERENTIATION,2.4576e-05,-0.75051,-0.76529,1,0
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.0403e-05,-0.75086,-0.69375,1,0
1,GO REGULATION OF VASCULAR PERMEABILITY,6.6813e-06,-0.75136,-0.67799,1,0
1,GO NEGATIVE REGULATION OF ANOIKIS,1.7249e-05,-0.75152,-0.78333,1,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.2539e-06,-0.75153,-0.76701,1,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.7533e-06,-0.75203,-0.69827,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.7533e-06,-0.75261,-0.70094,1,0
1,GO ENDOTHELIUM DEVELOPMENT,6.6813e-06,-0.75273,-0.71802,1,0
1,GO MONONUCLEAR CELL DIFFERENTIATION,1.2035e-05,-0.75292,-0.75543,1,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,5.7533e-06,-0.75325,-0.73722,1,0
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,5.337e-06,-0.75342,-0.68341,1,0
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,7.1973e-06,-0.75361,-0.76877,1,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,1.6059e-05,-0.75385,-0.69458,1,0
1,GO ANATOMICAL STRUCTURE REGRESSION,4.2763e-05,-0.75409,-0.68479,1,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.75435,-0.71748,1,0
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.5891e-06,-0.7548,-0.73253,1,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00010866,-0.7548,-0.71337,1,0
1,GO PULMONARY VALVE MORPHOGENESIS,8.9843e-06,-0.75484,-0.76671,1,0
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,5.7533e-06,-0.75485,-0.74882,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,9.6689e-06,-0.75577,-0.69193,1,0
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,1.6059e-05,-0.75627,-0.64642,1,0
1,GO COLLAGEN CATABOLIC PROCESS,4.5779e-05,-0.7565,-0.73105,1,0
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2939e-05,-0.75662,-0.6814,1,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,3.0304e-05,-0.75677,-0.69834,1,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,1.7249e-05,-0.75709,-0.77958,1,0
1,GO REGULATION OF CARTILAGE DEVELOPMENT,6.6813e-06,-0.75729,-0.69896,1,0
1,GO KERATINOCYTE MIGRATION,6.2007e-06,-0.75737,-0.70686,1,0
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.2907e-05,-0.75778,-0.73623,1,0
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,6.2007e-06,-0.75849,-0.67624,1,0
1,GO REGULATION OF AXON GUIDANCE,6.6813e-06,-0.75852,-0.74786,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,9.6689e-06,-0.75923,-0.6827,1,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,9.6689e-06,-0.75944,-0.72712,1,0
1,GO HEART VALVE DEVELOPMENT,4.9495e-06,-0.75959,-0.75864,1,0
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.337e-06,-0.75973,-0.69635,1,0
1,GO REGULATION OF ANOIKIS,1.1191e-05,-0.76024,-0.72505,1,0
1,GO PLATELET MORPHOGENESIS,5.337e-06,-0.76025,-0.73062,1,0
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,7.1973e-06,-0.76062,-0.78896,1,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,7.1973e-06,-0.76068,-0.76763,1,0
1,GO CHONDROCYTE DEVELOPMENT,1.2939e-05,-0.76081,-0.74143,1,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,1.2035e-05,-0.76091,-0.71564,1,0
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,8.9843e-06,-0.76194,-0.77731,1,0
1,GO STRESS FIBER ASSEMBLY,5.7533e-06,-0.76196,-0.68314,1,0
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,1.7249e-05,-0.76228,-0.79939,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,6.4139e-05,-0.76238,-0.68197,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,4.8997e-05,-0.76294,-0.66562,1,0
1,GO REGULATION OF NEURON MIGRATION,5.337e-06,-0.76295,-0.76017,1,0
1,GO CORONARY VASCULATURE MORPHOGENESIS,9.6689e-06,-0.76304,-0.76157,1,0
1,GO EPITHELIAL CELL MORPHOGENESIS,1.4947e-05,-0.76352,-0.71914,1,0
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,5.337e-06,-0.76392,-0.72242,1,0
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,5.7533e-06,-0.76487,-0.71444,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,7.1973e-06,-0.7657,-0.70197,1,0
1,GO BLEB ASSEMBLY,3.4805e-05,-0.76591,-0.75789,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,0.00026348,-0.76649,-0.68392,1,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,7.1973e-06,-0.76669,-0.72506,1,0
1,GO ACTIVATION OF GTPASE ACTIVITY,5.7533e-06,-0.76729,-0.72713,1,0
1,GO MEGAKARYOCYTE DEVELOPMENT,6.2007e-06,-0.76735,-0.75173,1,0
1,GO ACTIN FILAMENT BASED TRANSPORT,8.3461e-06,-0.76764,-0.74011,1,0
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.2907e-05,-0.76766,-0.81946,1,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,1.4947e-05,-0.76766,-0.74246,1,0
1,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,3.9936e-05,-0.76817,-0.67461,1,0
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,4.5891e-06,-0.76859,-0.7409,1,0
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,1.2035e-05,-0.76861,-0.7089,1,0
1,GO FACIAL NERVE MORPHOGENESIS,5.6086e-05,-0.76879,-0.68939,1,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,5.7533e-06,-0.76956,-0.71516,1,0
1,GO RESPONSE TO MUSCLE STRETCH,3.7287e-05,-0.76981,-0.7018,1,0
1,GO CERAMIDE CATABOLIC PROCESS,4.2539e-06,-0.76993,-0.76398,1,0
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,7.1973e-06,-0.77066,-0.76937,1,0
1,GO GAP JUNCTION ASSEMBLY,0.00014062,-0.77271,-0.73504,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.9888e-05,-0.77297,-0.7195,1,0
1,GO REGULATION OF SPROUTING ANGIOGENESIS,7.1973e-06,-0.77311,-0.71822,1,0
1,GO GLOMERULUS DEVELOPMENT,3.9422e-06,-0.77377,-0.80259,1,0
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,1.0403e-05,-0.77548,-0.72549,1,0
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,7.7514e-06,-0.77559,-0.75625,1,0
1,GO MYELIN MAINTENANCE,9.6689e-06,-0.77577,-0.67372,1,0
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.4947e-05,-0.77591,-0.70306,1,0
1,GO ENDODERM DEVELOPMENT,1.6059e-05,-0.77667,-0.72836,1,0
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,1.1191e-05,-0.77739,-0.76714,1,0
1,GO BASEMENT MEMBRANE ORGANIZATION,4.9495e-06,-0.77764,-0.78812,1,0
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,8.9843e-06,-0.77795,-0.76213,1,0
1,GO ENDOCYTIC RECYCLING,5.7533e-06,-0.77876,-0.70465,1,0
1,GO HIPPO SIGNALING,6.2007e-06,-0.78114,-0.74836,1,0
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.5891e-06,-0.78125,-0.76367,1,0
1,GO RESPONSE TO AMYLOID BETA,5.337e-06,-0.78154,-0.77604,1,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,2.636e-05,-0.7823,-0.75641,1,0
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,4.9495e-06,-0.78237,-0.79728,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,3.4805e-05,-0.78329,-0.66383,1,0
1,GO PROTEIN ACTIVATION CASCADE,0.00017019,-0.78342,-0.64749,1,0
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,2.8267e-05,-0.78364,-0.80046,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,8.9327e-05,-0.78371,-0.81357,1,0
1,GO ARTERY MORPHOGENESIS,6.2007e-06,-0.78437,-0.74933,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,8.9843e-06,-0.78457,-0.71917,1,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,4.2539e-06,-0.78531,-0.84163,1,0
1,GO GOLGI RIBBON FORMATION,5.337e-06,-0.78554,-0.80985,1,0
1,GO LUNG ALVEOLUS DEVELOPMENT,1.3909e-05,-0.78628,-0.75084,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,5.337e-06,-0.78813,-0.76121,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,6.6813e-06,-0.78818,-0.73684,1,0
1,GO BODY MORPHOGENESIS,8.3461e-06,-0.78847,-0.72338,1,0
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,1.1191e-05,-0.78951,-0.77531,1,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,1.0403e-05,-0.78953,-0.74552,1,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,4.9495e-06,-0.79048,-0.76981,1,0
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,1.1191e-05,-0.79074,-0.79241,1,0
1,GO NEUTROPHIL HOMEOSTASIS,7.1973e-06,-0.79157,-0.81554,1,0
1,GO COLLAGEN METABOLIC PROCESS,1.2035e-05,-0.7916,-0.79906,1,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,1.0403e-05,-0.79161,-0.757,1,0
1,GO BLOOD VESSEL REMODELING,5.337e-06,-0.79229,-0.78478,1,0
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,5.337e-06,-0.79277,-0.80649,1,0
1,GO REGULATION OF NEUTROPHIL ACTIVATION,5.9985e-05,-0.79291,-0.83226,1,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,1.7249e-05,-0.79317,-0.72706,1,0
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,6.6813e-06,-0.79407,-0.78511,1,0
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,7.1973e-06,-0.79421,-0.78564,1,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,4.5891e-06,-0.7948,-0.76618,1,0
1,GO HEMIDESMOSOME ASSEMBLY,0.0038653,-0.79576,-0.60698,1,0
1,GO SEMI LUNAR VALVE DEVELOPMENT,5.7533e-06,-0.79617,-0.78048,1,0
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,4.5891e-06,-0.79731,-0.78783,1,0
1,GO MICROTUBULE NUCLEATION,4.5779e-05,-0.79751,-0.70992,1,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,4.2539e-06,-0.79856,-0.77969,1,0
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.9495e-06,-0.79945,-0.76796,1,0
1,GO FOCAL ADHESION ASSEMBLY,5.7533e-06,-0.79983,-0.78536,1,0
1,GO CORONARY VASCULATURE DEVELOPMENT,3.9422e-06,-0.80022,-0.78345,1,0
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,5.7533e-06,-0.80024,-0.74731,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.337e-06,-0.80075,-0.79278,1,0
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,8.3461e-06,-0.80165,-0.73115,1,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,2.4576e-05,-0.80309,-0.6842,1,0
1,GO HEAD MORPHOGENESIS,1.3909e-05,-0.80374,-0.75061,1,0
1,GO VASCULAR WOUND HEALING,1.2035e-05,-0.80452,-0.79325,1,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,4.2539e-06,-0.80482,-0.76011,1,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,1.1191e-05,-0.80531,-0.74529,1,0
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00011593,-0.80574,-0.85656,1,0
1,GO AORTIC VALVE DEVELOPMENT,5.337e-06,-0.80779,-0.78509,1,0
1,GO EPIBOLY,7.1973e-06,-0.808,-0.75474,1,0
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,5.7533e-06,-0.80959,-0.76826,1,0
1,GO MRNA TRANSCRIPTION,4.5891e-06,-0.81072,-0.77249,1,0
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,8.9843e-06,-0.81139,-0.77529,1,0
1,GO FACE DEVELOPMENT,8.3461e-06,-0.81235,-0.75564,1,0
1,GO NEURON PROJECTION ARBORIZATION,8.3461e-06,-0.81343,-0.79072,1,0
1,GO LYMPHANGIOGENESIS,8.3461e-06,-0.81586,-0.74789,1,0
1,GO TOOTH MINERALIZATION,1.1191e-05,-0.81815,-0.76566,1,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,1.9888e-05,-0.8191,-0.74106,1,0
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.8997e-05,-0.81925,-0.72703,1,0
1,GO MACROPHAGE CYTOKINE PRODUCTION,8.9843e-06,-0.81929,-0.82329,1,0
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.1191e-05,-0.82102,-0.80183,1,0
1,GO DEFINITIVE HEMOPOIESIS,6.2007e-06,-0.82161,-0.79034,1,0
1,GO BONE TRABECULA MORPHOGENESIS,0.00010866,-0.82193,-0.8159,1,0
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00023283,-0.82477,-0.93304,1,0
1,GO PROTEIN DEMETHYLATION,7.1973e-06,-0.82492,-0.75573,1,0
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,6.2007e-06,-0.82521,-0.85456,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.8524e-05,-0.82663,-0.83356,1,0
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,5.7533e-06,-0.82673,-0.76831,1,0
1,GO ARTERY DEVELOPMENT,5.7533e-06,-0.82761,-0.76836,1,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,9.6689e-06,-0.82837,-0.76377,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,6.6813e-06,-0.8295,-0.8653,1,0
1,GO AORTA MORPHOGENESIS,3.9422e-06,-0.83074,-0.83412,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.636e-05,-0.83205,-0.81774,1,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,1.1191e-05,-0.83214,-0.74887,1,0
1,GO RESPONSE TO MAGNESIUM ION,7.3279e-05,-0.83254,-0.69039,1,0
1,GO POSITIVE REGULATION OF MITOPHAGY,8.3461e-06,-0.83661,-0.78417,1,0
1,GO REGULATION OF NEURON MATURATION,1.8524e-05,-0.83774,-0.69381,1,0
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,1.2035e-05,-0.83899,-0.76333,1,0
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,7.7514e-06,-0.84009,-0.74299,1,0
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,4.5891e-06,-0.84085,-0.83934,1,0
1,GO AORTA DEVELOPMENT,4.5891e-06,-0.8413,-0.8447,1,0
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,6.6813e-06,-0.84219,-0.79275,1,0
1,GO COLLAGEN BIOSYNTHETIC PROCESS,8.9843e-06,-0.84308,-0.83939,1,0
1,GO TRIGEMINAL NERVE DEVELOPMENT,5.2428e-05,-0.84309,-0.76892,1,0
1,GO ACTIN FILAMENT SEVERING,7.1973e-06,-0.84336,-0.76489,1,0
1,GO SECRETORY GRANULE LOCALIZATION,2.2907e-05,-0.84367,-0.79305,1,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,6.2007e-06,-0.84392,-0.82502,1,0
1,GO ENDODERM FORMATION,1.8524e-05,-0.8446,-0.77954,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,5.7533e-06,-0.84469,-0.77504,1,0
1,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,2.8267e-05,-0.84571,-0.74751,1,0
1,GO REGULATION OF KERATINOCYTE MIGRATION,4.9495e-06,-0.84584,-0.82321,1,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,7.7514e-06,-0.85048,-0.74863,1,0
1,GO LYMPH VESSEL MORPHOGENESIS,8.3461e-06,-0.85123,-0.7812,1,0
1,GO LOCOMOTOR RHYTHM,4.5891e-06,-0.85172,-0.81946,1,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,8.9843e-06,-0.85229,-0.7496,1,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,5.7533e-06,-0.85296,-0.81864,1,0
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,5.337e-06,-0.85694,-0.79183,1,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,1.0403e-05,-0.85741,-0.73652,1,0
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.9843e-06,-0.859,-0.78635,1,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00015974,-0.86143,-0.69956,1,0
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,5.7533e-06,-0.86213,-0.767,1,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,4.2539e-06,-0.86471,-0.82258,1,0
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,6.2007e-06,-0.86679,-0.78726,1,0
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,6.2007e-06,-0.86752,-0.80766,1,0
1,GO ENDOTHELIAL CELL DEVELOPMENT,5.7533e-06,-0.87074,-0.80775,1,0
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,4.9495e-06,-0.87519,-0.80561,1,0
1,GO EXTRACELLULAR MATRIX ASSEMBLY,8.9843e-06,-0.87593,-0.89426,1,0
1,GO DENSE CORE GRANULE TRANSPORT,8.3641e-05,-0.87745,-0.82323,1,0
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.0403e-05,-0.88511,-0.80841,1,0
1,GO PLASMA MEMBRANE TUBULATION,4.5891e-06,-0.8861,-0.81272,1,0
1,GO BASEMENT MEMBRANE ASSEMBLY,6.6813e-06,-0.88748,-0.87753,1,0
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,4.9495e-06,-0.88962,-0.8692,1,0
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,8.3461e-06,-0.89113,-0.79187,1,0
1,GO MYELIN ASSEMBLY,1.0403e-05,-0.89118,-0.76843,1,0
1,GO CELL MIGRATION IN HINDBRAIN,7.7514e-06,-0.89268,-0.80351,1,0
1,GO COLLAGEN FIBRIL ORGANIZATION,1.8524e-05,-0.89278,-0.90722,1,0
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,1.7249e-05,-0.89721,-0.86061,1,0
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,4.9495e-06,-0.89995,-0.84667,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,4.5891e-06,-0.9042,-0.94196,1,0
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,1.1191e-05,-0.90568,-0.9381,1,0
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,8.9843e-06,-0.90669,-0.91182,1,0
1,GO ENDODERMAL CELL DIFFERENTIATION,1.4947e-05,-0.9092,-0.85849,1,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,1.3909e-05,-0.91214,-0.82689,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,2.1347e-05,-0.91414,-0.92837,1,0
1,GO POSITIVE REGULATION OF NEURON MIGRATION,6.2007e-06,-0.91511,-0.9041,1,0
1,GO LYMPH VESSEL DEVELOPMENT,7.1973e-06,-0.91933,-0.83424,1,0
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,3.4805e-05,-0.92364,-0.76092,1,0
1,GO MACROPHAGE PROLIFERATION,5.6086e-05,-0.92574,-0.87663,1,0
1,GO HYALURONAN BIOSYNTHETIC PROCESS,7.1973e-06,-0.92603,-0.87285,1,0
1,GO ADHERENS JUNCTION ASSEMBLY,6.6813e-06,-0.92618,-0.86316,1,0
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,5.337e-06,-0.92655,-0.89904,1,0
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,4.2539e-06,-0.93067,-0.89853,1,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,6.2007e-06,-0.93762,-0.85546,1,0
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,7.7514e-06,-0.93953,-0.86715,1,0
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,8.9843e-06,-0.94111,-0.85936,1,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,8.9843e-06,-0.94297,-0.91293,1,0
1,GO DORSAL AORTA DEVELOPMENT,3.9422e-06,-0.94338,-0.88911,1,0
1,GO PROTEIN LOCALIZATION TO ENDOSOME,5.337e-06,-0.95664,-0.8634,1,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,1.2939e-05,-0.95881,-0.84194,1,0
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00023283,-0.95924,-0.7404,1,0
1,GO SKIN MORPHOGENESIS,1.6059e-05,-0.96257,-0.85982,1,0
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,1.1191e-05,-0.96551,-0.82319,1,0
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,3.9936e-05,-0.97458,-0.82561,1,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,6.6813e-06,-0.99135,-0.88634,1,0
1,GO ELASTIC FIBER ASSEMBLY,4.5779e-05,-1.0015,-0.94668,1,0
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.3909e-05,-1.0297,-0.85768,1,0
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.7249e-05,-1.0646,-0.89823,1,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,8.9843e-06,-1.1525,-1.0817,1,0
1,GO OXYGEN TRANSPORT,0.85555,0.13041,0.0091313,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.3148,0.088266,0.021365,0,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.41494,0.085132,0.016834,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.16602,0.0847,0.061293,0,0
1,GO XENOBIOTIC CATABOLIC PROCESS,1,0.054967,-0.019455,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.54223,0.050232,0.023453,0,0
1,GO REGULATION OF APPETITE,0.84314,0.046798,-0.074792,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.26442,0.038252,0.041525,0,0
1,GO TRANSLATIONAL INITIATION,0.33821,0.036647,0.043041,0,0
1,GO TRANSLATIONAL TERMINATION,0.86799,0.02812,-0.03797,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.33821,0.026493,0.040158,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.48117,0.026256,-0.080946,0,0
1,GO CYTOPLASMIC TRANSLATION,0.93062,0.017048,-0.0088496,0,0
1,GO PROTEASOME ASSEMBLY,0.68646,0.012827,-0.074684,0,0
1,GO PROTEIN NEDDYLATION,0.83078,0.0062265,-0.031709,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.84314,0.0060465,-0.018951,0,0
1,GO PROTEIN TARGETING TO MEMBRANE,0.64051,-0.017602,0.0062294,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.1475,-0.017736,-0.12072,0,0
1,GO GAS TRANSPORT,0.53179,-0.01985,-0.11335,0,0
1,GO TRANSLATIONAL ELONGATION,0.28529,-0.020085,-0.082375,0,0
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.76963,-0.020305,-0.028234,0,0
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.74555,-0.037637,-0.012516,0,0
1,GO VIRAL GENE EXPRESSION,0.2577,-0.03969,-0.0408,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.10468,-0.041045,-0.1363,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.74555,-0.041098,-0.042579,0,0
1,GO RIBOSOME ASSEMBLY,0.27821,-0.043131,-0.049608,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.214,-0.043843,-0.097043,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.52145,-0.045613,-0.059784,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.077559,-0.060854,-0.15666,0,0
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.35442,-0.068361,-0.053504,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.21989,-0.073507,-0.050311,0,0
1,GO PIRNA METABOLIC PROCESS,0.094909,-0.075898,-0.16501,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.96843,-0.077663,0.042598,0,0
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.077559,-0.07806,-0.12976,0,0
1,GO REGULATION OF RESPONSE TO FOOD,0.37964,-0.079022,-0.11736,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.52145,-0.08677,-0.15859,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.2259,-0.087178,-0.098238,0,0
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00096503,-0.089489,-0.20593,0,0
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.056456,-0.09365,-0.12467,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.10134,-0.094099,-0.13442,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0063209,-0.10476,-0.1747,0,0
1,GO RRNA 3 END PROCESSING,0.045233,-0.10841,-0.14736,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.17091,-0.11228,-0.14064,0,0
1,GO GTP BIOSYNTHETIC PROCESS,0.037377,-0.1158,-0.15993,0,0
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0052065,-0.11771,-0.20951,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.065157,-0.12189,-0.1505,0,0
1,GO UTP METABOLIC PROCESS,0.02951,-0.1279,-0.18303,0,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.0040644,-0.12958,-0.19682,0,0
1,GO TRNA 5 LEADER REMOVAL,0.13467,-0.1313,-0.11692,0,0
1,GO TRNA 5 END PROCESSING,0.098083,-0.13262,-0.13649,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.0025648,-0.13578,-0.15876,0,0
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.46168,-0.13832,-0.079184,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.025096,-0.13866,-0.18552,0,0
1,GO CELLULAR RESPIRATION,0.00060992,-0.13957,-0.1906,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.52145,-0.13981,-0.074018,0,0
1,GO SEQUESTERING OF METAL ION,0.094909,-0.14436,-0.17029,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.15655,-0.14494,-0.14107,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.021265,-0.14547,-0.17132,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0172,-0.14553,-0.20777,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.0076456,-0.15,-0.21206,0,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.0018673,-0.15259,-0.18727,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.034576,-0.15353,-0.19422,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.018736,-0.15453,-0.19229,0,0
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0038653,-0.15524,-0.15994,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0018673,-0.15616,-0.19579,0,0
1,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.5959,-0.15709,-0.10359,0,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.077559,-0.15936,-0.25284,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,1.7249e-05,-0.1594,-0.19544,0,0
1,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.0057394,-0.16102,-0.22409,0,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.1306,-0.16371,-0.18398,0,0
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.17091,-0.16462,-0.22722,0,0
1,GO REGULATION OF T CELL CHEMOTAXIS,0.060677,-0.16662,-0.39081,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0010209,-0.16798,-0.21953,0,0
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.00040321,-0.16833,-0.29337,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.056456,-0.16886,-0.19816,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0060238,-0.17127,-0.2453,0,0
1,GO PENTOSE METABOLIC PROCESS,0.00048214,-0.17245,-0.29048,0,0
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.074935,-0.18206,-0.18944,0,0
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0013481,-0.18366,-0.24893,0,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.006955,-0.18717,-0.21956,0,0
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0044907,-0.18932,-0.17437,0,0
1,GO RIBOSOME BIOGENESIS,0.00020554,-0.19109,-0.24044,0,0
1,GO PROTEIN DENEDDYLATION,0.018736,-0.19358,-0.20807,0,0
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00014062,-0.19517,-0.24002,0,0
1,GO QUINONE METABOLIC PROCESS,0.00011593,-0.20274,-0.24957,0,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00068502,-0.20335,-0.25028,0,0
1,GO KERATINIZATION,0.054439,-0.20476,-0.17752,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.0029965,-0.20645,-0.2496,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.011574,-0.20652,-0.21017,0,0
1,GO AEROBIC RESPIRATION,0.00017019,-0.20673,-0.22746,0,0
1,GO MATURATION OF LSU RRNA,0.013834,-0.20833,-0.18421,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,5.2428e-05,-0.21036,-0.30247,0,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.00096503,-0.21202,-0.21669,0,0
1,GO DNA LIGATION,0.00072571,-0.21787,-0.28345,0,0
1,GO RRNA METABOLIC PROCESS,5.6086e-05,-0.22392,-0.2833,0,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.010101,-0.22515,-0.21884,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.020391,-0.22571,-0.2741,0,0
1,GO MUCUS SECRETION,0.067497,-0.22769,-0.21559,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0052065,-0.22868,-0.2139,0,0
1,GO EOSINOPHIL CHEMOTAXIS,0.11163,-0.22929,-0.36771,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00020554,-0.22951,-0.32388,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0012758,-0.22955,-0.25444,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00017019,-0.23077,-0.3268,0,0
1,GO CYTOLYSIS,0.11524,-0.23194,-0.3228,0,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.027226,-0.23255,-0.23248,0,0
1,GO NCRNA 3 END PROCESSING,0.00021879,-0.2331,-0.27566,0,0
1,GO SPERM AXONEME ASSEMBLY,0.048745,-0.23396,-0.18642,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00010866,-0.23421,-0.30418,0,0
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,1.7249e-05,-0.23482,-0.30408,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00010181,-0.23492,-0.32429,0,0
1,GO CORNIFICATION,0.062884,-0.23804,-0.20051,0,0
1,GO VIRAL BUDDING,5.9985e-05,-0.23837,-0.32983,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.013834,-0.23947,-0.19597,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,1.6059e-05,-0.23981,-0.30166,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.0054671,-0.24067,-0.26402,0,0
1,GO SNORNA 3 END PROCESSING,0.00332,-0.24114,-0.26682,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.54223,-0.24241,-0.27771,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.0031545,-0.24251,-0.31743,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,8.9327e-05,-0.24253,-0.29781,0,0
1,GO TELOMERASE RNA LOCALIZATION,0.00091199,-0.24395,-0.24785,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,6.8565e-05,-0.24417,-0.29455,0,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.056456,-0.24486,-0.37088,0,0
1,GO NCRNA PROCESSING,4.8997e-05,-0.24708,-0.30511,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.007293,-0.24775,-0.30945,0,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00010866,-0.24859,-0.29582,0,0
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.022172,-0.24913,-0.28654,0,0
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.00031664,-0.24984,-0.24763,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.00035748,-0.24989,-0.3974,0,0
1,GO RNA 5 END PROCESSING,0.0010798,-0.25081,-0.26667,0,0
1,GO CHRONIC INFLAMMATORY RESPONSE,0.11894,-0.25112,-0.35416,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.010101,-0.25115,-0.20261,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.0015882,-0.25192,-0.26836,0,0
1,GO T CELL TOLERANCE INDUCTION,0.060677,-0.25212,-0.53108,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.00057531,-0.25435,-0.30603,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.056456,-0.25491,-0.32279,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,1.6059e-05,-0.25502,-0.33197,0,0
1,GO NCRNA METABOLIC PROCESS,2.2907e-05,-0.25646,-0.32058,0,0
1,GO LACTATE METABOLIC PROCESS,0.00014989,-0.25851,-0.31093,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,1.2035e-05,-0.2588,-0.33663,0,0
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.08303,-0.25883,-0.22142,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00086166,-0.25941,-0.30306,0,0
1,GO VIRAL LATENCY,7.8298e-05,-0.25972,-0.33896,0,0
1,GO NUCLEOSIDE SALVAGE,0.00011593,-0.26034,-0.29325,0,0
1,GO GASTRIC ACID SECRETION,0.00012367,-0.26469,-0.30234,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.048745,-0.26558,-0.18483,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,2.4576e-05,-0.26813,-0.34657,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0047188,-0.26886,-0.26045,0,0
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.058535,-0.26901,-0.37458,0,0
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,1.2035e-05,-0.26951,-0.2994,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00011593,-0.26967,-0.33776,0,0
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00029789,-0.27527,-0.33433,0,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.012106,-0.27629,-0.18852,0,0
1,GO POSTREPLICATION REPAIR,2.8267e-05,-0.27671,-0.35295,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.00057531,-0.27821,-0.32855,0,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,0.0016767,-0.27854,-0.28063,0,0
1,GO AMP METABOLIC PROCESS,3.7287e-05,-0.27856,-0.31007,0,0
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,2.8267e-05,-0.28004,-0.40228,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,2.4576e-05,-0.2813,-0.31861,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.00019306,-0.28189,-0.32794,0,0
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.00014989,-0.28193,-0.3661,0,0
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00076864,-0.28267,-0.2998,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0024341,-0.28362,-0.25907,0,0
1,GO MONOCYTE CHEMOTAXIS,0.052482,-0.28733,-0.40874,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.00072571,-0.2879,-0.29106,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,8.9327e-05,-0.29036,-0.33004,0,0
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,3.7287e-05,-0.29135,-0.35032,0,0
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00017019,-0.29424,-0.29541,0,0
1,GO OOCYTE DIFFERENTIATION,0.00015974,-0.29436,-0.36965,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.00010181,-0.29469,-0.34125,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.008797,-0.2953,-0.30458,0,0
1,GO TRANSLESION SYNTHESIS,2.1347e-05,-0.2963,-0.36919,0,0
1,GO AMINO ACID ACTIVATION,3.248e-05,-0.2964,-0.35739,0,0
1,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.052482,-0.29641,-0.60317,0,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,0.013235,-0.29961,-0.32626,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00042807,-0.30014,-0.29852,0,0
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.011063,-0.30031,-0.23457,0,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,2.1347e-05,-0.30088,-0.38276,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.00014062,-0.30106,-0.3126,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.015776,-0.30123,-0.3495,0,0
1,GO OOGENESIS,8.3641e-05,-0.30284,-0.36251,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.050584,-0.30321,-0.22596,0,0
1,GO MATURATION OF SSU RRNA,8.3641e-05,-0.30378,-0.30485,0,0
1,GO SNRNA PROCESSING,8.3641e-05,-0.30675,-0.35173,0,0
1,GO SNORNA METABOLIC PROCESS,0.00026348,-0.30682,-0.31871,0,0
1,GO TRNA CATABOLIC PROCESS,0.00029789,-0.30727,-0.42163,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,3.0304e-05,-0.30743,-0.3748,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0010209,-0.30766,-0.31001,0,0
1,GO GROOMING BEHAVIOR,0.0040644,-0.30947,-0.33231,0,0
1,GO NUCLEOTIDE EXCISION REPAIR,2.4576e-05,-0.31241,-0.36964,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.012106,-0.31243,-0.24363,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0054671,-0.31275,-0.29176,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,8.9843e-06,-0.31393,-0.35809,0,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.00012367,-0.31518,-0.28731,0,0
1,GO EOSINOPHIL MIGRATION,0.062884,-0.31542,-0.45265,0,0
1,GO MUSCLE FILAMENT SLIDING,0.00012367,-0.31606,-0.32048,0,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0044907,-0.31633,-0.25603,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00035748,-0.31646,-0.39254,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.0083971,-0.31684,-0.3525,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,1.8524e-05,-0.31819,-0.37487,0,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.00035748,-0.32149,-0.38207,0,0
1,GO RESPONSE TO ZINC ION,5.9985e-05,-0.32206,-0.37088,0,0
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00068502,-0.32207,-0.32686,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.00031664,-0.32238,-0.33565,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.074935,-0.32244,-0.39606,0,0
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00020554,-0.32421,-0.26559,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,2.8267e-05,-0.32471,-0.37661,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,9.5377e-05,-0.32586,-0.40336,0,0
1,GO DNA STRAND ELONGATION,0.00012367,-0.32921,-0.3799,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.0014241,-0.32997,-0.39631,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.00076864,-0.33045,-0.38251,0,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,7.8298e-05,-0.33061,-0.35373,0,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,2.636e-05,-0.33149,-0.37596,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.00051151,-0.33387,-0.32802,0,0
1,GO REGULATION OF LIGASE ACTIVITY,0.00035748,-0.33455,-0.36789,0,0
1,GO TRICARBOXYLIC ACID CYCLE,8.9843e-06,-0.33456,-0.39654,0,0
1,GO MATURATION OF 5 8S RRNA,0.00019306,-0.33459,-0.32392,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00068502,-0.33602,-0.352,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,5.9985e-05,-0.33852,-0.34823,0,0
1,GO MIDDLE EAR MORPHOGENESIS,0.00068502,-0.33896,-0.34694,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.9422e-06,-0.33944,-0.37227,0,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0015882,-0.33991,-0.34752,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,1.9888e-05,-0.34,-0.3773,0,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0003797,-0.34089,-0.37777,0,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,3.248e-05,-0.34254,-0.36431,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.00096503,-0.34307,-0.38345,0,0
1,GO BASE EXCISION REPAIR,2.636e-05,-0.34433,-0.38582,0,0
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.050584,-0.34664,-0.46741,0,0
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00012367,-0.34711,-0.32748,0,0
1,GO VIRAL TRANSLATION,0.00012367,-0.34827,-0.35141,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,8.9327e-05,-0.34936,-0.39053,0,0
1,GO SPERM CAPACITATION,0.0025648,-0.35112,-0.25841,0,0
1,GO GLUTATHIONE METABOLIC PROCESS,4.8997e-05,-0.35247,-0.33403,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.00060992,-0.35598,-0.34938,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.011574,-0.35696,-0.34977,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,9.5377e-05,-0.35735,-0.38149,0,0
1,GO SLEEP,2.4576e-05,-0.36027,-0.39984,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,7.7514e-06,-0.36129,-0.42646,0,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,5.337e-06,-0.36206,-0.38131,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,8.3461e-06,-0.36327,-0.41591,0,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,7.7514e-06,-0.36438,-0.42728,0,0
1,GO NUCLEAR ENVELOPE REASSEMBLY,1.6059e-05,-0.36494,-0.44086,0,0
1,GO REGULATION OF CENTROSOME DUPLICATION,2.2907e-05,-0.36508,-0.45639,0,0
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.054439,-0.36537,-0.4053,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00019306,-0.36741,-0.39649,0,0
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,3.9422e-06,-0.36837,-0.38885,0,0
1,GO EXIT FROM MITOSIS,1.4947e-05,-0.36911,-0.46919,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,5.6086e-05,-0.36947,-0.3835,0,0
1,GO RNA 3 END PROCESSING,3.4805e-05,-0.37036,-0.38832,0,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0096484,-0.37121,-0.43227,0,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.010101,-0.37188,-0.27237,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,2.8267e-05,-0.37305,-0.42883,0,0
1,GO REGULATION OF GTP BINDING,0.00048214,-0.37464,-0.40398,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,4.5779e-05,-0.37617,-0.38914,0,0
1,GO RESPONSE TO COPPER ION,0.0013481,-0.37642,-0.35735,0,0
1,GO MITOTIC CELL CYCLE ARREST,0.00012367,-0.37645,-0.41145,0,0
1,GO REGULATION OF DNA CATABOLIC PROCESS,4.2763e-05,-0.37658,-0.39347,0,0
1,GO REGULATION OF OOGENESIS,3.4805e-05,-0.37819,-0.42183,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,1.6059e-05,-0.37863,-0.43134,0,0
1,GO PROTEIN AUTOPROCESSING,2.4576e-05,-0.37876,-0.40049,0,0
1,GO HISTONE H3 K9 ACETYLATION,5.7533e-06,-0.37936,-0.46888,0,0
1,GO MESODERMAL CELL FATE SPECIFICATION,3.9936e-05,-0.3796,-0.43118,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00072571,-0.37996,-0.35594,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,4.5779e-05,-0.38033,-0.43274,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.0025648,-0.38132,-0.31854,0,0
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,3.4805e-05,-0.38293,-0.37207,0,0
1,GO HISTONE PHOSPHORYLATION,8.3461e-06,-0.38519,-0.48934,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,1.6059e-05,-0.38719,-0.42505,0,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00020554,-0.38742,-0.44232,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00031664,-0.3879,-0.45277,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00021879,-0.38891,-0.44126,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.337e-06,-0.38947,-0.44175,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,8.3641e-05,-0.38969,-0.42585,0,0
1,GO ALDITOL METABOLIC PROCESS,0.00010866,-0.3924,-0.37473,0,0
1,GO INTRACELLULAR PROTEIN TRANSPORT,6.2007e-06,-0.3931,-0.41772,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0012071,-0.39355,-0.5258,0,0
1,GO RESPONSE TO AMPHETAMINE,0.00018128,-0.39553,-0.36745,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.025096,-0.39554,-0.29525,0,0
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,6.6813e-06,-0.39567,-0.48188,0,0
1,GO ESTABLISHMENT OF TISSUE POLARITY,4.5891e-06,-0.39664,-0.46594,0,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.050584,-0.39764,-0.38332,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.00060992,-0.40076,-0.365,0,0
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,7.8298e-05,-0.40077,-0.36548,0,0
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,1.2939e-05,-0.40196,-0.44179,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.013235,-0.40218,-0.36024,0,0
1,GO CYSTEINE METABOLIC PROCESS,0.00015974,-0.40316,-0.41319,0,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.00086166,-0.40371,-0.40724,0,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,5.9985e-05,-0.40378,-0.40505,0,0
1,GO DNA REPAIR,1.0403e-05,-0.40487,-0.4499,0,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00017019,-0.4067,-0.33982,0,0
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,4.5779e-05,-0.40781,-0.39008,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00332,-0.40818,-0.3883,0,0
1,GO FAT CELL PROLIFERATION,2.2907e-05,-0.41,-0.4945,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,1.0403e-05,-0.41021,-0.47734,0,0
1,GO BLASTOCYST DEVELOPMENT,4.9495e-06,-0.41082,-0.42055,0,0
1,GO RESPONSE TO AMINE,3.9936e-05,-0.41431,-0.40101,0,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,2.1347e-05,-0.41437,-0.45822,0,0
1,GO GLYCEROL ETHER METABOLIC PROCESS,7.7514e-06,-0.41631,-0.47988,0,0
1,GO BIOLOGICAL PHASE,0.0024341,-0.41651,-0.39184,0,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0029965,-0.41758,-0.39901,0,0
1,GO REGULATION OF MESODERM DEVELOPMENT,0.0003797,-0.41778,-0.36504,0,0
1,GO ORGAN INDUCTION,6.8565e-05,-0.41868,-0.3883,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,8.3461e-06,-0.42032,-0.43114,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.00026348,-0.42161,-0.4281,0,0
1,GO AUTOPHAGIC CELL DEATH,3.0304e-05,-0.42434,-0.45017,0,0
1,GO TONGUE MORPHOGENESIS,0.00068502,-0.42631,-0.3672,0,0
1,GO PROTEIN REFOLDING,0.00054254,-0.42669,-0.35761,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,7.8298e-05,-0.42679,-0.44475,0,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00029789,-0.42738,-0.44071,0,0
1,GO CYTOKINETIC PROCESS,9.6689e-06,-0.42845,-0.49546,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,1.6059e-05,-0.42889,-0.41689,0,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.00013188,-0.42907,-0.4455,0,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0013481,-0.42915,-0.36204,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,2.8267e-05,-0.4294,-0.45038,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00024771,-0.42962,-0.46755,0,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0019699,-0.42975,-0.45018,0,0
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,1.2939e-05,-0.4299,-0.50756,0,0
1,GO PARENTAL BEHAVIOR,0.0063209,-0.43129,-0.45077,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,4.2763e-05,-0.43156,-0.48725,0,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,4.8997e-05,-0.4316,-0.52897,0,0
1,GO CATECHOLAMINE METABOLIC PROCESS,5.9985e-05,-0.43274,-0.4576,0,0
1,GO GABAERGIC NEURON DIFFERENTIATION,0.14312,-0.43295,-0.42333,0,0
1,GO BLASTOCYST GROWTH,4.9495e-06,-0.43527,-0.49235,0,0
1,GO C21 STEROID HORMONE METABOLIC PROCESS,3.7287e-05,-0.43701,-0.43323,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,4.5779e-05,-0.43706,-0.41127,0,0
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.2907e-05,-0.43826,-0.45098,0,0
1,GO INTRACELLULAR TRANSPORT,6.2007e-06,-0.43894,-0.45808,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,8.3461e-06,-0.43898,-0.45939,0,0
1,GO RRNA TRANSCRIPTION,9.6689e-06,-0.44004,-0.49115,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00014062,-0.44116,-0.45447,0,0
1,GO IMP BIOSYNTHETIC PROCESS,0.007293,-0.44189,-0.36246,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.00035748,-0.44247,-0.45372,0,0
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,7.7514e-06,-0.44351,-0.45791,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,3.248e-05,-0.44379,-0.45502,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,7.1973e-06,-0.4442,-0.48465,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00014989,-0.4451,-0.37526,0,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,5.7533e-06,-0.4476,-0.45655,0,0
1,GO MYOBLAST DIFFERENTIATION,8.9843e-06,-0.44806,-0.51292,0,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,7.3279e-05,-0.4487,-0.45143,0,0
1,GO CELLULAR RESPONSE TO IRON ION,0.00035748,-0.44885,-0.49761,0,0
1,GO SHORT TERM MEMORY,0.0003797,-0.44896,-0.47975,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,6.6813e-06,-0.44933,-0.49114,0,0
1,GO IMP METABOLIC PROCESS,0.0044907,-0.44987,-0.37578,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.00033648,-0.45073,-0.41802,0,0
1,GO PENILE ERECTION,0.00033648,-0.4512,-0.48037,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,5.7533e-06,-0.45144,-0.47011,0,0
1,GO COCHLEA DEVELOPMENT,1.4947e-05,-0.45271,-0.50803,0,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,5.7533e-06,-0.45528,-0.47038,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,2.2907e-05,-0.45548,-0.4401,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.9888e-05,-0.45553,-0.45264,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,2.636e-05,-0.45596,-0.47372,0,0
1,GO MRNA EXPORT FROM NUCLEUS,2.636e-05,-0.4568,-0.47699,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,6.2007e-06,-0.45715,-0.49789,0,0
1,GO REGULATION OF CENTRIOLE REPLICATION,2.2907e-05,-0.458,-0.50959,0,0
1,GO MATING,1.7249e-05,-0.45808,-0.47218,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.6059e-05,-0.45817,-0.46136,0,0
1,GO NUCLEUS ORGANIZATION,8.3461e-06,-0.45859,-0.49605,0,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.7533e-06,-0.45879,-0.45421,0,0
1,GO DE NOVO PROTEIN FOLDING,0.00054254,-0.45891,-0.41431,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,1.9888e-05,-0.46031,-0.48909,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,5.9985e-05,-0.46068,-0.48693,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,6.6813e-06,-0.4626,-0.48129,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,3.9422e-06,-0.46475,-0.57609,0,0
1,GO COCHLEA MORPHOGENESIS,1.0403e-05,-0.46512,-0.4706,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,6.6813e-06,-0.46562,-0.5539,0,0
1,GO ANIMAL ORGAN FORMATION,1.2035e-05,-0.46627,-0.50284,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,8.9327e-05,-0.46637,-0.56062,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,1.3909e-05,-0.46664,-0.48742,0,0
1,GO RESPONSE TO CAFFEINE,0.00013188,-0.46739,-0.44969,0,0
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,9.6689e-06,-0.46788,-0.48784,0,0
1,GO GLUTAMINE METABOLIC PROCESS,2.1347e-05,-0.46811,-0.48337,0,0
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00010181,-0.46886,-0.49697,0,0
1,GO REGULATION OF DNA REPAIR,1.2035e-05,-0.46963,-0.50072,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,6.6813e-06,-0.4697,-0.49517,0,0
1,GO MRNA TRANSPORT,2.4576e-05,-0.47004,-0.48368,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,9.6689e-06,-0.47108,-0.46761,0,0
1,GO POSITIVE REGULATION OF HEART RATE,4.8997e-05,-0.4714,-0.45778,0,0
1,GO SUCKLING BEHAVIOR,5.9985e-05,-0.47146,-0.59247,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,1.9888e-05,-0.47161,-0.4736,0,0
1,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,8.3641e-05,-0.473,-0.44041,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.47346,-0.5202,0,0
1,GO LENS FIBER CELL DEVELOPMENT,1.7249e-05,-0.47353,-0.53034,0,0
1,GO REGULATION OF HEART MORPHOGENESIS,1.8524e-05,-0.47397,-0.57881,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.1973e-06,-0.47436,-0.48947,0,0
1,GO DNA BIOSYNTHETIC PROCESS,5.7533e-06,-0.47438,-0.47337,0,0
1,GO PITUITARY GLAND DEVELOPMENT,0.00026348,-0.4748,-0.48702,0,0
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,7.1973e-06,-0.47671,-0.4805,0,0
1,GO INNER CELL MASS CELL PROLIFERATION,7.1973e-06,-0.47728,-0.5629,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,3.0304e-05,-0.47818,-0.51615,0,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,1.6059e-05,-0.47898,-0.47792,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,1.2939e-05,-0.47899,-0.5313,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,4.5779e-05,-0.47962,-0.49681,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.9888e-05,-0.47974,-0.46855,0,0
1,GO CHROMOSOME ORGANIZATION,8.9843e-06,-0.48103,-0.50772,0,0
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,8.9843e-06,-0.4816,-0.46426,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,9.6689e-06,-0.48186,-0.49808,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.00033648,-0.48263,-0.48163,0,0
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00042807,-0.48287,-0.54814,0,0
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.7533e-06,-0.48394,-0.49516,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,4.2763e-05,-0.48531,-0.43667,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,7.1973e-06,-0.48543,-0.50213,0,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,6.2007e-06,-0.48734,-0.4875,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.058535,-0.48736,-0.47432,0,0
1,GO RESPONSE TO VITAMIN D,3.248e-05,-0.48767,-0.54769,0,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,4.9495e-06,-0.48825,-0.53625,0,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,1.2939e-05,-0.48875,-0.48343,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,1.2035e-05,-0.48914,-0.52763,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,2.8267e-05,-0.48934,-0.46488,0,0
1,GO HEART TRABECULA FORMATION,8.3641e-05,-0.48987,-0.49666,0,0
1,GO RESPONSE TO CORTICOSTERONE,0.0014241,-0.49148,-0.48097,0,0
1,GO POLYOL TRANSPORT,0.00012367,-0.49169,-0.50379,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,7.7514e-06,-0.49174,-0.52037,0,0
1,GO REPRODUCTION,7.7514e-06,-0.49174,-0.47485,0,0
1,GO REGULATION OF DNA METABOLIC PROCESS,6.6813e-06,-0.49185,-0.50462,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,2.4576e-05,-0.49207,-0.4807,0,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,3.248e-05,-0.49248,-0.49727,0,0
1,GO REGULATION OF PROTEIN FOLDING,0.00040321,-0.49294,-0.44907,0,0
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00068502,-0.49388,-0.45319,0,0
1,GO NUCLEAR ENVELOPE ORGANIZATION,5.337e-06,-0.49396,-0.56682,0,0
1,GO COPULATION,0.00012367,-0.4947,-0.46328,0,0
1,GO REGULATION OF CELL FATE SPECIFICATION,7.8298e-05,-0.49597,-0.52419,0,0
1,GO CELLULAR SENESCENCE,6.2007e-06,-0.49632,-0.47568,0,0
1,GO GANGLION DEVELOPMENT,0.00086166,-0.49705,-0.51777,0,0
1,GO REPRODUCTIVE BEHAVIOR,0.00012367,-0.49714,-0.48325,0,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,0.33029,-0.49779,-0.34816,0,0
1,GO REGULATION OF NECROTIC CELL DEATH,4.5779e-05,-0.49846,-0.49253,0,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,5.6086e-05,-0.49955,-0.57769,0,0
1,GO DIENCEPHALON DEVELOPMENT,5.9985e-05,-0.49984,-0.4973,0,0
1,GO POSITIVE CHEMOTAXIS,6.8565e-05,-0.5003,-0.50708,0,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00024771,-0.50037,-0.52188,0,0
1,GO DETECTION OF TEMPERATURE STIMULUS,3.7287e-05,-0.50216,-0.53284,0,0
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,6.6813e-06,-0.50247,-0.51488,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0003797,-0.5026,-0.46758,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,2.4576e-05,-0.50295,-0.51459,0,0
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.3909e-05,-0.50483,-0.52078,0,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,6.2007e-06,-0.50491,-0.52363,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,5.337e-06,-0.50516,-0.53713,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,8.3461e-06,-0.5053,-0.49255,0,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,6.6813e-06,-0.50561,-0.53908,0,0
1,GO INNER EAR MORPHOGENESIS,1.2035e-05,-0.506,-0.47866,0,0
1,GO RESPONSE TO ACTIVITY,5.337e-06,-0.50605,-0.47858,0,0
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.00057531,-0.50653,-0.42169,0,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.00011593,-0.50654,-0.48437,0,0
1,GO GONADOTROPIN SECRETION,8.3641e-05,-0.50704,-0.47214,0,0
1,GO PROGESTERONE METABOLIC PROCESS,0.00010866,-0.50789,-0.49199,0,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,3.4805e-05,-0.50813,-0.50707,0,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00018128,-0.50861,-0.45476,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,4.2539e-06,-0.50885,-0.53386,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,5.6086e-05,-0.50897,-0.46908,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,6.6813e-06,-0.51068,-0.52487,0,0
1,GO GENE SILENCING,7.7514e-06,-0.51091,-0.51281,0,0
1,GO SODIUM ION HOMEOSTASIS,2.4576e-05,-0.5111,-0.48455,0,0
1,GO MULTICELLULAR ORGANISM AGING,7.1973e-06,-0.51118,-0.49782,0,0
1,GO REGULATION OF GLUCOSE IMPORT,4.9495e-06,-0.51126,-0.51218,0,0
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,6.2007e-06,-0.51131,-0.5287,0,0
1,GO REGULATION OF HEART RATE,1.1191e-05,-0.51153,-0.51553,0,0
1,GO REGULATION OF BINDING,5.7533e-06,-0.51304,-0.52831,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,7.1973e-06,-0.51321,-0.5305,0,0
1,GO NEGATIVE REGULATION OF BINDING,7.1973e-06,-0.51363,-0.5138,0,0
1,GO ATP BIOSYNTHETIC PROCESS,4.5891e-06,-0.51394,-0.50932,0,0
1,GO RESPONSE TO ABIOTIC STIMULUS,5.7533e-06,-0.51423,-0.50347,0,0
1,GO L GLUTAMATE IMPORT,2.1347e-05,-0.51615,-0.46693,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,5.7533e-06,-0.51835,-0.54373,0,0
1,GO MAINTENANCE OF PROTEIN LOCATION,6.2007e-06,-0.51843,-0.51117,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,4.9495e-06,-0.51964,-0.52019,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,1.2939e-05,-0.51992,-0.56181,0,0
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,7.7514e-06,-0.52117,-0.5135,0,0
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,8.9843e-06,-0.52162,-0.55201,0,0
1,GO L SERINE METABOLIC PROCESS,3.0304e-05,-0.52171,-0.50307,0,0
1,GO EAR DEVELOPMENT,8.3461e-06,-0.52176,-0.49654,0,0
1,GO SEROTONIN SECRETION,3.7287e-05,-0.52193,-0.51869,0,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,6.6813e-06,-0.52255,-0.51674,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,8.3461e-06,-0.52323,-0.54286,0,0
1,GO ENDOCRINE HORMONE SECRETION,7.7514e-06,-0.52338,-0.5096,0,0
1,GO SUBPALLIUM DEVELOPMENT,0.00048214,-0.52488,-0.5271,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,6.2007e-06,-0.52547,-0.58457,0,0
1,GO G2 DNA DAMAGE CHECKPOINT,1.6059e-05,-0.52632,-0.55319,0,0
1,GO MITOTIC DNA REPLICATION,2.8267e-05,-0.52678,-0.50732,0,0
1,GO LIMB BUD FORMATION,0.00042807,-0.52708,-0.53091,0,0
1,GO REGULATION OF EXCRETION,3.0304e-05,-0.52726,-0.51229,0,0
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,1.6059e-05,-0.52872,-0.57301,0,0
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00051151,-0.5295,-0.45802,0,0
1,GO AXONAL FASCICULATION,1.8524e-05,-0.53065,-0.62544,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,1.0403e-05,-0.53094,-0.5023,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,9.5377e-05,-0.5316,-0.51037,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,1.7249e-05,-0.53237,-0.53298,0,0
1,GO RENAL SODIUM EXCRETION,3.7287e-05,-0.53237,-0.53049,0,0
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,3.7287e-05,-0.5327,-0.57433,0,0
1,GO REGULATION OF HISTONE PHOSPHORYLATION,3.4805e-05,-0.53278,-0.51548,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,3.7287e-05,-0.53328,-0.47271,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,4.2539e-06,-0.53437,-0.55039,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00024771,-0.53451,-0.49719,0,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.00017019,-0.53457,-0.47884,0,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00014989,-0.53515,-0.72535,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,6.6813e-06,-0.53542,-0.50258,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,1.2939e-05,-0.53572,-0.50093,0,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,5.2428e-05,-0.53578,-0.5624,0,0
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,5.337e-06,-0.53623,-0.56393,0,0
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,2.1347e-05,-0.5365,-0.5321,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,4.2539e-06,-0.53653,-0.52896,0,0
1,GO MELANOCYTE DIFFERENTIATION,5.7533e-06,-0.53714,-0.54311,0,0
1,GO RESPONSE TO PAIN,6.6813e-06,-0.5373,-0.55658,0,0
1,GO AUTOPHAGY OF MITOCHONDRION,6.6813e-06,-0.53747,-0.54935,0,0
1,GO RESPONSE TO ESTRADIOL,7.1973e-06,-0.5379,-0.52886,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,8.3461e-06,-0.53836,-0.61776,0,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,6.2007e-06,-0.53839,-0.53057,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,4.2763e-05,-0.53869,-0.5239,0,0
1,GO RESPONSE TO TEMPERATURE STIMULUS,8.3461e-06,-0.53911,-0.51788,0,0
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,4.9495e-06,-0.53952,-0.55464,0,0
1,GO REGULATION OF HEAT GENERATION,0.00011593,-0.53956,-0.48251,0,0
1,GO GOLGI VESICLE TRANSPORT,6.6813e-06,-0.54058,-0.55259,0,0
1,GO BODY FLUID SECRETION,1.3909e-05,-0.54097,-0.4715,0,0
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,2.1347e-05,-0.54153,-0.52104,0,0
1,GO CELL AGING,6.2007e-06,-0.54179,-0.49695,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,6.2007e-06,-0.54183,-0.531,0,0
1,GO REGULATION OF HEART GROWTH,6.6813e-06,-0.54242,-0.52696,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,2.8267e-05,-0.54242,-0.55249,0,0
1,GO MESONEPHROS DEVELOPMENT,8.9843e-06,-0.54244,-0.53066,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.00026348,-0.54382,-0.50823,0,0
1,GO POSITIVE REGULATION OF CELL DIVISION,8.3461e-06,-0.54383,-0.50886,0,0
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,1.4947e-05,-0.5444,-0.58831,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,8.9843e-06,-0.54453,-0.57297,0,0
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,2.4576e-05,-0.54495,-0.55132,0,0
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,5.337e-06,-0.54516,-0.54553,0,0
1,GO RENAL TUBULE DEVELOPMENT,5.7533e-06,-0.54585,-0.57487,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,5.7533e-06,-0.54778,-0.54019,0,0
1,GO SEROTONIN TRANSPORT,1.3909e-05,-0.54811,-0.57176,0,0
1,GO LATERAL MESODERM DEVELOPMENT,5.9985e-05,-0.54851,-0.48219,0,0
1,GO RESPONSE TO HEAT,1.2035e-05,-0.54896,-0.50852,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,6.6813e-06,-0.54939,-0.53319,0,0
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00014989,-0.55016,-0.66654,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,7.1973e-06,-0.55035,-0.52488,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,7.1973e-06,-0.55131,-0.57645,0,0
1,GO REGULATION OF MACROAUTOPHAGY,5.7533e-06,-0.55173,-0.56902,0,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.9888e-05,-0.55208,-0.53707,0,0
1,GO RENAL VESICLE DEVELOPMENT,1.8524e-05,-0.55209,-0.57087,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.00013188,-0.55212,-0.4434,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,4.9495e-06,-0.55306,-0.54702,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,7.7514e-06,-0.55402,-0.54204,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,1.1191e-05,-0.55416,-0.49156,0,0
1,GO GLUCOSE IMPORT,4.9495e-06,-0.55445,-0.5239,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,5.7533e-06,-0.55452,-0.54902,0,0
1,GO PROSTATIC BUD FORMATION,8.9327e-05,-0.55547,-0.56247,0,0
1,GO REGULATION OF ERAD PATHWAY,1.0403e-05,-0.55552,-0.56012,0,0
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.00011593,-0.55622,-0.54199,0,0
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,5.7533e-06,-0.55623,-0.57532,0,0
1,GO SNARE COMPLEX ASSEMBLY,2.8267e-05,-0.5563,-0.56379,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,4.5891e-06,-0.55694,-0.60024,0,0
1,GO NATURAL KILLER CELL CHEMOTAXIS,0.21989,-0.55703,-0.40063,0,0
1,GO POSITIVE REGULATION OF MYELINATION,1.8524e-05,-0.55796,-0.60184,0,0
1,GO CARTILAGE MORPHOGENESIS,2.8267e-05,-0.55806,-0.6166,0,0
1,GO POSITIVE REGULATION OF HEART GROWTH,4.9495e-06,-0.55821,-0.54706,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.00057531,-0.56057,-0.48642,0,0
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,5.337e-06,-0.56166,-0.58808,0,0
1,GO MUSCLE ORGAN DEVELOPMENT,1.0403e-05,-0.5622,-0.53793,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,6.6813e-06,-0.56222,-0.53912,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.2939e-05,-0.56273,-0.5296,0,0
1,GO NEPHRON MORPHOGENESIS,8.3461e-06,-0.56305,-0.55933,0,0
1,GO PIGMENT CELL DIFFERENTIATION,8.3461e-06,-0.56427,-0.53233,0,0
1,GO CELLULAR RESPONSE TO VITAMIN,2.4576e-05,-0.56502,-0.5915,0,0
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,5.337e-06,-0.56513,-0.55864,0,0
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.4805e-05,-0.56529,-0.57349,0,0
1,GO MESODERM DEVELOPMENT,6.6813e-06,-0.56551,-0.52189,0,0
1,GO MIDGUT DEVELOPMENT,7.7514e-06,-0.56577,-0.6011,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,6.2007e-06,-0.56636,-0.55329,0,0
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,3.9422e-06,-0.56699,-0.58345,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.7249e-05,-0.56781,-0.5418,0,0
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,4.8997e-05,-0.56879,-0.55621,0,0
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00014989,-0.569,-0.5918,0,0
1,GO CELLULAR RESPONSE TO HEAT,1.7249e-05,-0.56921,-0.5168,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,7.1973e-06,-0.56965,-0.57786,0,0
1,GO KIDNEY MORPHOGENESIS,8.3461e-06,-0.5697,-0.56118,0,0
1,GO CARDIAC MUSCLE CELL PROLIFERATION,9.6689e-06,-0.56978,-0.56276,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.7514e-06,-0.57,-0.52755,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,7.1973e-06,-0.57053,-0.62073,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,3.7287e-05,-0.57187,-0.51519,0,0
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,4.9495e-06,-0.57322,-0.56316,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,4.9495e-06,-0.57353,-0.54987,0,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,5.337e-06,-0.5741,-0.65483,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,1.8524e-05,-0.57434,-0.51219,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,4.5891e-06,-0.5747,-0.59589,0,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,1.3909e-05,-0.57542,-0.53891,0,0
1,GO METANEPHROS DEVELOPMENT,5.7533e-06,-0.57604,-0.59824,0,0
1,GO MUSCLE TISSUE DEVELOPMENT,6.6813e-06,-0.57613,-0.54463,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,2.1347e-05,-0.57662,-0.55771,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,3.4805e-05,-0.57669,-0.50425,0,0
1,GO HEART GROWTH,5.7533e-06,-0.57682,-0.55623,0,0
1,GO CELLULAR RESPONSE TO NUTRIENT,1.2939e-05,-0.57684,-0.60987,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,1.4947e-05,-0.57775,-0.52588,0,0
1,GO GLIAL CELL DIFFERENTIATION,5.7533e-06,-0.57779,-0.56441,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,4.9495e-06,-0.57849,-0.60207,0,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,4.9495e-06,-0.57954,-0.58552,0,0
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,1.1191e-05,-0.58036,-0.607,0,0
1,GO RESPONSE TO HYPEROXIA,1.3909e-05,-0.58183,-0.56627,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00051151,-0.58207,-0.48987,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,5.337e-06,-0.58238,-0.57304,0,0
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,5.337e-06,-0.58286,-0.60314,0,0
1,GO OVULATION,4.8997e-05,-0.58431,-0.52417,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.00010181,-0.58464,-0.48628,0,0
1,GO PROSTATE GLAND MORPHOGENESIS,9.5377e-05,-0.58543,-0.54484,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.1347e-05,-0.58555,-0.57269,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,3.7287e-05,-0.58585,-0.54656,0,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,6.6813e-06,-0.5861,-0.58199,0,0
1,GO HINDLIMB MORPHOGENESIS,1.4947e-05,-0.58612,-0.55147,0,0
1,GO ENDOSOME TO LYSOSOME TRANSPORT,8.3461e-06,-0.58645,-0.5898,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,1.7249e-05,-0.58665,-0.63454,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.337e-06,-0.58687,-0.61337,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,3.9422e-06,-0.58691,-0.6311,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,6.2007e-06,-0.58809,-0.58554,0,0
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,6.2007e-06,-0.58814,-0.57959,0,0
1,GO GOLGI ORGANIZATION,7.7514e-06,-0.58836,-0.61489,0,0
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,1.4947e-05,-0.58863,-0.49446,0,0
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,8.3461e-06,-0.58869,-0.55175,0,0
1,GO REGULATION OF HISTONE METHYLATION,7.1973e-06,-0.58984,-0.61844,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,5.7533e-06,-0.59005,-0.54306,0,0
1,GO CELL FATE DETERMINATION,1.4947e-05,-0.59017,-0.54004,0,0
1,GO REGULATION OF TUBULIN DEACETYLATION,2.8267e-05,-0.5924,-0.60212,0,0
1,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00031664,-0.59257,-0.50145,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.1347e-05,-0.59274,-0.57737,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,7.7514e-06,-0.59317,-0.62126,0,0
1,GO POSITIVE REGULATION OF URINE VOLUME,1.6059e-05,-0.5934,-0.58338,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,1.0403e-05,-0.59401,-0.57647,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,7.1973e-06,-0.59432,-0.64539,0,0
1,GO ADIPOSE TISSUE DEVELOPMENT,1.2035e-05,-0.59481,-0.58766,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,8.9843e-06,-0.59496,-0.54583,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,1.2939e-05,-0.59552,-0.59168,0,0
1,GO RESPONSE TO TESTOSTERONE,5.7533e-06,-0.59684,-0.51954,0,0
1,GO MESENCHYME DEVELOPMENT,5.337e-06,-0.59702,-0.59726,0,0
1,GO POSITIVE REGULATION OF GROWTH,5.337e-06,-0.5972,-0.60031,0,0
1,GO REPLICATIVE SENESCENCE,0.00011593,-0.59799,-0.44546,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,5.7533e-06,-0.59877,-0.59124,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.0304e-05,-0.59941,-0.56164,0,0
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,5.7533e-06,-0.59962,-0.57291,0,0
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,2.4576e-05,-0.6012,-0.59063,0,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,2.4576e-05,-0.60181,-0.54868,0,0
1,GO POSITIVE REGULATION OF OSSIFICATION,9.6689e-06,-0.60202,-0.60707,0,0
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.08881,-0.6031,-0.50927,0,0
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,5.337e-06,-0.6044,-0.61632,0,0
1,GO MUSCLE STRUCTURE DEVELOPMENT,6.2007e-06,-0.60586,-0.56902,0,0
1,GO ORGAN GROWTH,5.337e-06,-0.60688,-0.57859,0,0
1,GO CARDIAC CELL DEVELOPMENT,5.337e-06,-0.6082,-0.55358,0,0
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,5.7533e-06,-0.60952,-0.56865,0,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,7.1973e-06,-0.61008,-0.57586,0,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,5.337e-06,-0.61075,-0.62745,0,0
1,GO OSSIFICATION,5.7533e-06,-0.61146,-0.59866,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,5.337e-06,-0.61163,-0.68276,0,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.00029789,-0.61172,-0.52724,0,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,7.1973e-06,-0.61404,-0.60842,0,0
1,GO ENDOSOMAL TRANSPORT,6.2007e-06,-0.61405,-0.57551,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00024771,-0.61587,-0.52319,0,0
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,8.9843e-06,-0.61685,-0.64275,0,0
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,3.0304e-05,-0.61716,-0.68145,0,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,6.6813e-06,-0.61735,-0.59391,0,0
1,GO UROGENITAL SYSTEM DEVELOPMENT,5.337e-06,-0.61927,-0.59248,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.00014062,-0.61934,-0.616,0,0
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,1.9888e-05,-0.61984,-0.60423,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,7.8298e-05,-0.62016,-0.52483,0,0
1,GO EMBRYONIC MORPHOGENESIS,7.7514e-06,-0.62034,-0.58899,0,0
1,GO CYTOPLASM ORGANIZATION,2.8267e-05,-0.62118,-0.63331,0,0
1,GO RESPONSE TO PROGESTERONE,1.7249e-05,-0.6221,-0.60191,0,0
1,GO MUSCLE CELL DIFFERENTIATION,5.337e-06,-0.62257,-0.57761,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.00018128,-0.62273,-0.55863,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,4.8997e-05,-0.62354,-0.57035,0,0
1,GO STRIATUM DEVELOPMENT,8.3461e-06,-0.62354,-0.59681,0,0
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,5.7533e-06,-0.62376,-0.61086,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.9936e-05,-0.62665,-0.56867,0,0
1,GO CARDIAC SEPTUM MORPHOGENESIS,5.337e-06,-0.62739,-0.65548,0,0
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,2.636e-05,-0.62773,-0.64486,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.4947e-05,-0.62813,-0.60703,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,4.5891e-06,-0.62888,-0.61292,0,0
1,GO MESENCHYMAL CELL PROLIFERATION,1.7249e-05,-0.62904,-0.63066,0,0
1,GO CARDIOCYTE DIFFERENTIATION,6.2007e-06,-0.6296,-0.58022,0,0
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,1.6059e-05,-0.63088,-0.58837,0,0
1,GO MESENCHYME MORPHOGENESIS,7.1973e-06,-0.63112,-0.65846,0,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,5.7533e-06,-0.63129,-0.57989,0,0
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,6.2007e-06,-0.63203,-0.57,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,1.1191e-05,-0.63223,-0.66824,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,3.9422e-06,-0.63349,-0.65688,0,0
1,GO EPITHELIAL TUBE FORMATION,5.7533e-06,-0.63411,-0.5703,0,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,3.9422e-06,-0.63417,-0.66632,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,3.7287e-05,-0.63776,-0.67216,0,0
1,GO APPENDAGE MORPHOGENESIS,1.0403e-05,-0.63821,-0.61092,0,0
1,GO EXOCRINE SYSTEM DEVELOPMENT,1.2035e-05,-0.63983,-0.64231,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,1.0403e-05,-0.6399,-0.67132,0,0
1,GO SMOOTH MUSCLE CONTRACTION,6.2007e-06,-0.64098,-0.56496,0,0
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,7.7514e-06,-0.64159,-0.62501,0,0
1,GO EPITHELIAL CELL FATE COMMITMENT,6.4139e-05,-0.64183,-0.57726,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,6.2007e-06,-0.6436,-0.61408,0,0
1,GO ENDOCARDIUM DEVELOPMENT,1.2939e-05,-0.6437,-0.58751,0,0
1,GO REGULATION OF NEURON PROJECTION REGENERATION,1.7249e-05,-0.64411,-0.62284,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,5.6086e-05,-0.64412,-0.60018,0,0
1,GO REGULATION OF VASOCONSTRICTION,1.9888e-05,-0.6469,-0.60359,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,3.9936e-05,-0.64704,-0.62853,0,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,1.1191e-05,-0.64718,-0.61357,0,0
1,GO MESENCHYMAL CELL DIFFERENTIATION,6.6813e-06,-0.64725,-0.62054,0,0
1,GO REGULATION OF GLOMERULAR FILTRATION,3.9936e-05,-0.64761,-0.71001,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00068502,-0.65021,-0.4927,0,0
1,GO MESODERM MORPHOGENESIS,7.7514e-06,-0.65025,-0.58089,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.2763e-05,-0.65191,-0.54522,0,0
1,GO KERATINOCYTE DEVELOPMENT,4.5779e-05,-0.65246,-0.60162,0,0
1,GO HAIR FOLLICLE MATURATION,1.6059e-05,-0.65287,-0.59663,0,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,8.9327e-05,-0.65302,-0.55135,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,5.2428e-05,-0.65367,-0.5725,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,2.2907e-05,-0.65377,-0.60784,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,1.8524e-05,-0.65529,-0.55986,0,0
1,GO MUSCLE ORGAN MORPHOGENESIS,7.1973e-06,-0.65571,-0.60511,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,7.7514e-06,-0.65572,-0.6445,0,0
1,GO MICROVILLUS ASSEMBLY,6.2007e-06,-0.65844,-0.62401,0,0
1,GO HEART DEVELOPMENT,5.337e-06,-0.65915,-0.61202,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,7.7514e-06,-0.65935,-0.58324,0,0
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,5.337e-06,-0.65961,-0.62179,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.6059e-05,-0.66002,-0.58874,0,0
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,8.3461e-06,-0.66018,-0.63035,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,1.1191e-05,-0.66028,-0.61658,0,0
1,GO ROOF OF MOUTH DEVELOPMENT,7.7514e-06,-0.66101,-0.62541,0,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,2.4576e-05,-0.66295,-0.6353,0,0
1,GO MUSCLE HYPERTROPHY,4.9495e-06,-0.66296,-0.62384,0,0
1,GO RESPONSE TO GROWTH FACTOR,5.337e-06,-0.66318,-0.62267,0,0
1,GO SKELETAL SYSTEM DEVELOPMENT,5.337e-06,-0.66428,-0.63388,0,0
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,8.3461e-06,-0.66533,-0.67772,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,4.5779e-05,-0.6674,-0.63301,0,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,7.1973e-06,-0.66803,-0.64314,0,0
1,GO NEPHRON DEVELOPMENT,4.5891e-06,-0.66924,-0.6585,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.2939e-05,-0.6699,-0.70113,0,0
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.67312,-0.64881,0,0
1,GO BONE MATURATION,2.636e-05,-0.67384,-0.59912,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,4.5891e-06,-0.67414,-0.6464,0,0
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,6.2007e-06,-0.67643,-0.71077,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0040644,-0.67724,-0.49713,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.6689e-06,-0.67795,-0.68938,0,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,9.6689e-06,-0.68051,-0.59433,0,0
1,GO ANIMAL ORGAN MATURATION,1.8524e-05,-0.68123,-0.60075,0,0
1,GO RESPIRATORY SYSTEM DEVELOPMENT,6.6813e-06,-0.68357,-0.64067,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,1.2939e-05,-0.68411,-0.6421,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,4.5891e-06,-0.68421,-0.66246,0,0
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.6059e-05,-0.68573,-0.72672,0,0
1,GO VASCULOGENESIS,7.7514e-06,-0.68683,-0.69869,0,0
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,7.7514e-06,-0.68733,-0.63843,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.0403e-05,-0.68824,-0.62279,0,0
1,GO HEART TRABECULA MORPHOGENESIS,5.337e-06,-0.68871,-0.6915,0,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,8.9843e-06,-0.68875,-0.66573,0,0
1,GO CARDIAC CHAMBER DEVELOPMENT,4.2539e-06,-0.69028,-0.67302,0,0
1,GO EPITHELIAL CELL DEVELOPMENT,5.7533e-06,-0.69175,-0.6592,0,0
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,8.9843e-06,-0.69266,-0.61652,0,0
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,5.7533e-06,-0.69391,-0.65055,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,5.6086e-05,-0.69409,-0.58774,0,0
1,GO CHONDROCYTE PROLIFERATION,6.6813e-06,-0.69435,-0.71863,0,0
1,GO SALIVARY GLAND DEVELOPMENT,8.9843e-06,-0.69467,-0.69411,0,0
1,GO SIALYLATION,2.8267e-05,-0.696,-0.61698,0,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,4.9495e-06,-0.69753,-0.66752,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,8.9843e-06,-0.69874,-0.65651,0,0
1,GO ACTIN FILAMENT NETWORK FORMATION,6.4139e-05,-0.6992,-0.62519,0,0
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,8.9843e-06,-0.70124,-0.69209,0,0
1,GO ENDOCARDIAL CUSHION FORMATION,7.7514e-06,-0.70131,-0.71273,0,0
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,7.7514e-06,-0.70367,-0.66148,0,0
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,6.6813e-06,-0.70487,-0.6759,0,0
1,GO ENERGY HOMEOSTASIS,8.3461e-06,-0.70562,-0.62612,0,0
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,8.9843e-06,-0.70597,-0.62652,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,9.6689e-06,-0.706,-0.64688,0,0
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,9.6689e-06,-0.70849,-0.67437,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,7.1973e-06,-0.70966,-0.64862,0,0
1,GO TRACHEA MORPHOGENESIS,6.6813e-06,-0.71048,-0.7329,0,0
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,2.636e-05,-0.71126,-0.73059,0,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,3.4805e-05,-0.71194,-0.77023,0,0
1,GO N GLYCAN PROCESSING,5.7533e-06,-0.71337,-0.71513,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,3.4805e-05,-0.71454,-0.64454,0,0
1,GO CONVERGENT EXTENSION,1.2939e-05,-0.71753,-0.65202,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,3.0304e-05,-0.7183,-0.69954,0,0
1,GO REGULATION OF HIPPO SIGNALING,7.7514e-06,-0.71893,-0.71096,0,0
1,GO RESPONSE TO BMP,6.2007e-06,-0.71925,-0.66641,0,0
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,8.9843e-06,-0.72024,-0.71669,0,0
1,GO CHONDROCYTE DIFFERENTIATION,6.6813e-06,-0.72163,-0.71302,0,0
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,1.2939e-05,-0.72302,-0.72361,0,0
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,3.248e-05,-0.72579,-0.64293,0,0
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,7.1973e-06,-0.72585,-0.67736,0,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,6.4139e-05,-0.72645,-0.73748,0,0
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.2035e-05,-0.7311,-0.65917,0,0
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,1.4947e-05,-0.73603,-0.6407,0,0
1,GO REGULATION OF BMP SIGNALING PATHWAY,6.6813e-06,-0.73675,-0.69345,0,0
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,7.7514e-06,-0.73693,-0.69843,0,0
1,GO ANOIKIS,7.1973e-06,-0.73805,-0.70717,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,3.4805e-05,-0.74462,-0.72744,0,0
1,GO APICAL JUNCTION ASSEMBLY,1.3909e-05,-0.74463,-0.58289,0,0
1,GO BONE GROWTH,5.7533e-06,-0.74557,-0.69662,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,6.2007e-06,-0.75096,-0.66822,0,0
1,GO SPROUTING ANGIOGENESIS,7.1973e-06,-0.75733,-0.71691,0,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.00012367,-0.7576,-0.71518,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,1.0403e-05,-0.75903,-0.7079,0,0
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,1.4947e-05,-0.76487,-0.7168,0,0
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,7.1973e-06,-0.76888,-0.78333,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,5.9985e-05,-0.77132,-0.70133,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,7.7514e-06,-0.77772,-0.71194,0,0
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,6.6813e-06,-0.7833,-0.7779,0,0
1,GO RENAL FILTRATION,1.2939e-05,-0.82191,-0.83322,0,0
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2035e-05,-0.82381,-0.75096,0,0
1,GO RESPONSE TO FLUID SHEAR STRESS,1.6059e-05,-0.84676,-0.79348,0,0
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.8524e-05,-0.85518,-0.82255,0,0
1,GO NUCLEAR MIGRATION,4.2539e-06,-0.86204,-0.85697,0,0
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.7249e-05,-0.87614,-0.93082,0,0
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,1.1191e-05,-0.88187,-0.82601,0,0
1,GO NUCLEUS LOCALIZATION,4.9495e-06,-0.88833,-0.8264,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,5.7533e-06,-0.89294,-0.82075,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.0403e-05,-0.94764,-0.86321,0,0
1,GO ENDOTHELIAL CELL MORPHOGENESIS,1.4947e-05,-0.97533,-0.9131,0,0
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,1.2035e-05,-1.0072,-1.0078,0,0
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,9.6689e-06,-1.0288,-0.99691,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,5.337e-06,-1.0345,-0.95198,0,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00031664,0.6788,0.58172,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,5.6086e-05,0.66771,0.69044,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0021907,0.66339,0.55448,1,1
2,GO RESPONSE TO POTASSIUM ION,0.00024771,0.64682,0.52154,1,1
2,GO OPTIC NERVE DEVELOPMENT,0.0016767,0.63923,0.5256,1,1
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0015882,0.63061,0.47872,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00042807,0.61198,0.53397,1,1
2,GO SYNAPTIC MEMBRANE ADHESION,8.3641e-05,0.60825,0.5794,1,1
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.00054254,0.59893,0.50405,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00014989,0.58419,0.50284,1,1
2,GO DISTAL TUBULE DEVELOPMENT,0.0028457,0.57009,0.4761,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.00012367,0.56853,0.60656,1,1
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.00014989,0.5636,0.52568,1,1
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00026348,0.55783,0.47928,1,1
2,GO PREPULSE INHIBITION,0.00024771,0.54593,0.54065,1,1
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00010866,0.53498,0.51352,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0017696,0.53317,0.42302,1,1
2,GO CENTRIOLE CENTRIOLE COHESION,4.2763e-05,0.53217,0.53708,1,1
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00091199,0.52928,0.52999,1,1
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.0016767,0.52575,0.49748,1,1
2,GO SYNAPTIC VESICLE DOCKING,0.0011418,0.52087,0.4563,1,1
2,GO MEIOTIC CHROMOSOME SEPARATION,7.3279e-05,0.51966,0.49679,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0017696,0.51712,0.40221,1,1
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00068502,0.51538,0.5059,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0011418,0.51534,0.52655,1,1
2,GO POSTSYNAPSE ASSEMBLY,0.00017019,0.50919,0.48901,1,1
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.00014989,0.50791,0.48134,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00076864,0.50494,0.456,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00013188,0.49886,0.57246,1,1
2,GO SYNAPSE MATURATION,0.00054254,0.49689,0.50741,1,1
2,GO DORSAL SPINAL CORD DEVELOPMENT,0.0003797,0.49622,0.44771,1,1
2,GO KINETOCHORE ASSEMBLY,0.00017019,0.49564,0.42935,1,1
2,GO KINETOCHORE ORGANIZATION,5.2428e-05,0.48985,0.46319,1,1
2,GO MICROTUBULE DEPOLYMERIZATION,0.00013188,0.47855,0.44907,1,1
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0044907,0.47555,0.42399,1,1
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0015882,0.47507,0.4253,1,1
2,GO TRIGEMINAL NERVE DEVELOPMENT,0.0042727,0.47279,0.45668,1,1
2,GO MRNA SPLICE SITE SELECTION,4.2763e-05,0.47064,0.45146,1,1
2,GO MALE SEX DETERMINATION,0.0042727,0.47058,0.36272,1,1
2,GO FOREBRAIN REGIONALIZATION,8.3641e-05,0.46744,0.52661,1,1
2,GO REPLICATION FORK PROCESSING,0.00024771,0.46568,0.42814,1,1
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.00031664,0.46354,0.42289,1,1
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00028019,0.456,0.43297,1,1
2,GO REGULATION OF NEURON MIGRATION,0.00015974,0.45598,0.50077,1,1
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00017019,0.45544,0.41983,1,1
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.00031664,0.45517,0.47759,1,1
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0038653,0.45182,0.40489,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.021265,0.44724,0.33177,1,1
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.012106,0.44595,0.33611,1,1
2,GO DENDRITIC TRANSPORT,0.0012071,0.44437,0.44426,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0020776,0.4401,0.3644,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00045436,0.43533,0.39455,1,1
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.031957,0.43274,0.30288,1,1
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0003797,0.43265,0.44015,1,1
2,GO HISTONE H3 K36 METHYLATION,0.0003797,0.42971,0.439,1,1
2,GO NEURONAL ION CHANNEL CLUSTERING,0.00010866,0.42886,0.46452,1,1
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0021907,0.42824,0.35412,1,1
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.00048214,0.42727,0.40279,1,1
2,GO SPINAL CORD PATTERNING,0.0013481,0.42597,0.44487,1,1
2,GO DENTATE GYRUS DEVELOPMENT,0.00015974,0.42533,0.53385,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.01266,0.42439,0.33803,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00033648,0.42171,0.33473,1,1
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00040321,0.42145,0.40513,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.0042727,0.42095,0.33113,1,1
2,GO CENTRIOLE ASSEMBLY,4.2763e-05,0.41747,0.40494,1,1
2,GO HOMOLOGOUS RECOMBINATION,0.00017019,0.41557,0.36197,1,1
2,GO SYNAPTIC VESICLE CLUSTERING,0.00068502,0.41548,0.46256,1,1
2,GO URETER DEVELOPMENT,0.020391,0.41407,0.41664,1,1
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.00014062,0.41273,0.4009,1,1
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00019306,0.41172,0.41191,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.0080134,0.41004,0.3208,1,1
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.0010209,0.40982,0.39879,1,1
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.00028019,0.40885,0.42811,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.0020776,0.40768,0.41078,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.00064645,0.40552,0.45485,1,1
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.00086166,0.40543,0.37191,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00045436,0.40495,0.3671,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0052065,0.40431,0.34059,1,1
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00024771,0.40355,0.42498,1,1
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00010866,0.4016,0.43114,1,1
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0003797,0.39842,0.41159,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,0.00017019,0.39725,0.41029,1,1
2,GO ANATOMICAL STRUCTURE REGRESSION,0.0011418,0.3972,0.41303,1,1
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,4.5779e-05,0.39613,0.41673,1,1
2,GO HISTONE H3 K27 METHYLATION,0.00033648,0.39479,0.40476,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,0.0027019,0.39394,0.35523,1,1
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00045436,0.39278,0.41001,1,1
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.00010866,0.39255,0.34969,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,6.4139e-05,0.38962,0.38812,1,1
2,GO CEREBELLAR CORTEX DEVELOPMENT,8.9327e-05,0.38898,0.36974,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0012758,0.38846,0.40758,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.0027019,0.38781,0.37924,1,1
2,GO NEURON CELL CELL ADHESION,0.0012071,0.38702,0.39507,1,1
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0024341,0.38679,0.31467,1,1
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00048214,0.38619,0.36427,1,1
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00091199,0.38615,0.35036,1,1
2,GO MATING BEHAVIOR,0.00031664,0.38559,0.38521,1,1
2,GO LOOP OF HENLE DEVELOPMENT,0.0036751,0.38482,0.45578,1,1
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00096503,0.38268,0.36978,1,1
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00018128,0.38113,0.46488,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.010101,0.37915,0.49282,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00042807,0.37884,0.35601,1,1
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00019306,0.37584,0.36406,1,1
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.0047188,0.37532,0.33625,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0060238,0.37466,0.4203,1,1
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00076864,0.37459,0.37076,1,1
2,GO GROWTH HORMONE SECRETION,0.0010209,0.37305,0.39767,1,1
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00035748,0.37057,0.38401,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0010798,0.36962,0.36445,1,1
2,GO NOSE DEVELOPMENT,0.0060238,0.36949,0.36235,1,1
2,GO ADULT BEHAVIOR,0.00010181,0.36922,0.34347,1,1
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.010572,0.3687,0.34712,1,1
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0027019,0.36837,0.3418,1,1
2,GO REGULATION OF COLLATERAL SPROUTING,0.0044907,0.36818,0.31704,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.00064645,0.36817,0.34874,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.010572,0.36681,0.30985,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0003797,0.36549,0.34864,1,1
2,GO STARTLE RESPONSE,0.00020554,0.36335,0.41447,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00028019,0.36227,0.36337,1,1
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.00096503,0.36169,0.31953,1,1
2,GO CEREBELLAR CORTEX MORPHOGENESIS,0.00029789,0.36006,0.37462,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0042727,0.35895,0.32107,1,1
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00096503,0.35867,0.31671,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.9888e-05,0.35813,0.52664,1,1
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00076864,0.35773,0.3516,1,1
2,GO NERVE DEVELOPMENT,0.0024341,0.35759,0.34488,1,1
2,GO REGULATION OF GROWTH HORMONE SECRETION,0.0010798,0.35705,0.46892,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0028457,0.35692,0.31959,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.3279e-05,0.35638,0.44521,1,1
2,GO ACROSOME ASSEMBLY,0.0020776,0.3563,0.31021,1,1
2,GO NEURAL TUBE PATTERNING,0.0011418,0.35628,0.30043,1,1
2,GO CENTROMERE COMPLEX ASSEMBLY,7.3279e-05,0.35407,0.40122,1,1
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.00028019,0.35349,0.29493,1,1
2,GO NEURON CELLULAR HOMEOSTASIS,0.008797,0.35341,0.30412,1,1
2,GO METENCEPHALON DEVELOPMENT,5.9985e-05,0.35324,0.35204,1,1
2,GO HISTONE H3 K9 METHYLATION,0.00086166,0.35306,0.3567,1,1
2,GO MEIOSIS I CELL CYCLE PROCESS,8.9327e-05,0.35157,0.31883,1,1
2,GO CENTROSOME DUPLICATION,0.00017019,0.35138,0.33631,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.010101,0.35114,0.31327,1,1
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.00045436,0.35072,0.33307,1,1
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00020554,0.35062,0.34212,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.0096484,0.35057,0.28303,1,1
2,GO PROTEIN LOCALIZATION TO CILIUM,0.00040321,0.34874,0.34708,1,1
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.00057531,0.34842,0.38761,1,1
2,GO RESPONSE TO COCAINE,6.8565e-05,0.34764,0.39024,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.00024771,0.34752,0.35287,1,1
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00086166,0.34699,0.32018,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0066311,0.34695,0.38183,1,1
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0028457,0.34685,0.33026,1,1
2,GO POSITIVE REGULATION OF BEHAVIOR,0.0021907,0.34658,0.29327,1,1
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00014062,0.34625,0.36809,1,1
2,GO REGULATION OF MICROTUBULE BINDING,0.00072571,0.34572,0.36602,1,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00045436,0.34509,0.31209,1,1
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,6.8565e-05,0.34434,0.37218,1,1
2,GO RESPONSE TO L GLUTAMATE,0.00029789,0.3439,0.33451,1,1
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.00081392,0.34373,0.41763,1,1
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.00026348,0.34364,0.52124,1,1
2,GO CHROMATIN REMODELING AT CENTROMERE,7.8298e-05,0.34332,0.39674,1,1
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,7.8298e-05,0.34331,0.36667,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0021907,0.342,0.35396,1,1
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00332,0.34172,0.30155,1,1
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00057531,0.34132,0.28913,1,1
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0011418,0.34037,0.38189,1,1
2,GO RETROGRADE AXONAL TRANSPORT,0.00057531,0.33901,0.40439,1,1
2,GO FOREBRAIN NEURON DEVELOPMENT,0.0019699,0.33825,0.31886,1,1
2,GO CARDIAC CHAMBER FORMATION,0.011063,0.33576,0.29779,1,1
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0019699,0.33571,0.34048,1,1
2,GO MICROTUBULE ANCHORING,0.00018128,0.33425,0.37307,1,1
2,GO REGULATION OF FEEDING BEHAVIOR,8.9327e-05,0.33319,0.31475,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.00091199,0.33316,0.30199,1,1
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0021907,0.33202,0.31704,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00091199,0.33186,0.39081,1,1
2,GO RESPONSE TO INSECTICIDE,0.0038653,0.33135,0.30009,1,1
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.00028019,0.33133,0.34859,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0013481,0.33131,0.34502,1,1
2,GO SEX DETERMINATION,0.0172,0.3312,0.23621,1,1
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.6086e-05,0.33115,0.35627,1,1
2,GO CEREBELLAR CORTEX FORMATION,0.00035748,0.33043,0.3534,1,1
2,GO CHROMOSOME SEPARATION,5.9985e-05,0.33018,0.34681,1,1
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.008797,0.33017,0.27895,1,1
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0015882,0.32911,0.27124,1,1
2,GO MITOTIC SISTER CHROMATID COHESION,0.00021879,0.32849,0.34653,1,1
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.0012071,0.32734,0.31596,1,1
2,GO MITOTIC RECOMBINATION,0.0010209,0.32694,0.31374,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.0010798,0.32692,0.3228,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0012071,0.32652,0.3373,1,1
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0052065,0.3265,0.42137,1,1
2,GO SYNAPSE ASSEMBLY,0.00051151,0.32648,0.33937,1,1
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.00081392,0.32638,0.28958,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,8.3641e-05,0.32566,0.34756,1,1
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0014241,0.32529,0.28074,1,1
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0010798,0.32472,0.3256,1,1
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,5.2428e-05,0.32451,0.35471,1,1
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00060992,0.32375,0.33757,1,1
2,GO PRO B CELL DIFFERENTIATION,0.0034935,0.32366,0.35184,1,1
2,GO INNERVATION,0.0028457,0.32308,0.45099,1,1
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0003797,0.32289,0.34388,1,1
2,GO LONG TERM SYNAPTIC DEPRESSION,0.008797,0.32228,0.27049,1,1
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.00020554,0.32195,0.34339,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0029965,0.32128,0.28928,1,1
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0028457,0.32127,0.2798,1,1
2,GO REGULATION OF RESPONSE TO FOOD,0.0003797,0.32106,0.3847,1,1
2,GO DENDRITE MORPHOGENESIS,0.00040321,0.32096,0.32902,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0019699,0.3206,0.38718,1,1
2,GO FEAR RESPONSE,0.0027019,0.31896,0.25685,1,1
2,GO HISTONE EXCHANGE,4.8997e-05,0.31856,0.34481,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,4.8997e-05,0.31798,0.36683,1,1
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0038653,0.31751,0.31044,1,1
2,GO NOREPINEPHRINE SECRETION,0.006955,0.31638,0.32744,1,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.00057531,0.31531,0.28258,1,1
2,GO PRESYNAPSE ORGANIZATION,0.00057531,0.3151,0.3316,1,1
2,GO CARNITINE SHUTTLE,0.00054254,0.31508,0.32655,1,1
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00064645,0.31421,0.36095,1,1
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.014457,0.31421,0.28498,1,1
2,GO DENDRITIC SPINE MORPHOGENESIS,0.00042807,0.31418,0.33337,1,1
2,GO REGULATION OF SISTER CHROMATID COHESION,0.00028019,0.31391,0.36418,1,1
2,GO MITOTIC CHROMOSOME CONDENSATION,0.00013188,0.31389,0.46232,1,1
2,GO SECRETORY GRANULE LOCALIZATION,0.0031545,0.31377,0.34152,1,1
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0015041,0.31361,0.33598,1,1
2,GO GLIAL CELL FATE COMMITMENT,0.0021907,0.31317,0.32952,1,1
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,5.2428e-05,0.31282,0.33231,1,1
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00057531,0.31265,0.32671,1,1
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00064645,0.31233,0.34753,1,1
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00091199,0.31058,0.31446,1,1
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,6.8565e-05,0.31055,0.38455,1,1
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,3.9936e-05,0.31032,0.33397,1,1
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,9.5377e-05,0.31025,0.32437,1,1
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.00010181,0.31003,0.30578,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.010572,0.30939,0.2574,1,1
2,GO MICROTUBULE BASED MOVEMENT,0.00024771,0.30913,0.30652,1,1
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00023283,0.30895,0.31022,1,1
2,GO RESPONSE TO AUDITORY STIMULUS,0.0028457,0.30891,0.35719,1,1
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00010866,0.30816,0.30452,1,1
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.00057531,0.30603,0.31975,1,1
2,GO CATECHOLAMINE UPTAKE,0.0011418,0.30568,0.3552,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.00076864,0.30566,0.34259,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0010798,0.3054,0.32024,1,1
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0011418,0.30538,0.31264,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0024341,0.30535,0.28676,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.020391,0.30522,0.23722,1,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00051151,0.30511,0.30967,1,1
2,GO BRAIN MORPHOGENESIS,0.00033648,0.30505,0.32843,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00020554,0.30409,0.34248,1,1
2,GO ANTEROGRADE AXONAL TRANSPORT,0.00042807,0.30407,0.30885,1,1
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,6.4139e-05,0.30404,0.33712,1,1
2,GO REGULATION OF CHROMOSOME SEGREGATION,5.2428e-05,0.30373,0.33289,1,1
2,GO UTERUS DEVELOPMENT,0.0034935,0.30333,0.35583,1,1
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00068502,0.3033,0.323,1,1
2,GO RETINAL ROD CELL DIFFERENTIATION,0.021265,0.30316,0.22177,1,1
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.00068502,0.30274,0.32653,1,1
2,GO UV DAMAGE EXCISION REPAIR,0.0018673,0.30273,0.26975,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0018673,0.3025,0.36865,1,1
2,GO RESPONSE TO FOOD,0.00017019,0.30195,0.32477,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0096484,0.30183,0.32297,1,1
2,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0024341,0.30107,0.28619,1,1
2,GO SYNAPTIC VESICLE PRIMING,0.0057394,0.30098,0.288,1,1
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0047188,0.30065,0.26914,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00051151,0.30039,0.3391,1,1
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00020554,0.3,0.32954,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0047188,0.29997,0.30958,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.0019699,0.29981,0.27834,1,1
2,GO G0 TO G1 TRANSITION,0.00018128,0.29974,0.35149,1,1
2,GO INOSITOL METABOLIC PROCESS,0.0080134,0.29904,0.26639,1,1
2,GO NEURON FATE SPECIFICATION,0.0031545,0.299,0.36581,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00060992,0.29879,0.30457,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00332,0.29783,0.2867,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0010798,0.29774,0.29946,1,1
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.00051151,0.29763,0.31015,1,1
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00019306,0.29727,0.34007,1,1
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00028019,0.29722,0.30507,1,1
2,GO NOREPINEPHRINE TRANSPORT,0.0049572,0.29714,0.35024,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,0.0015041,0.29683,0.32153,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.0012758,0.29658,0.3105,1,1
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0010209,0.29641,0.30898,1,1
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0076456,0.29613,0.27659,1,1
2,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.034576,0.29601,0.33967,1,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00014062,0.29592,0.34468,1,1
2,GO CHROMOSOME SEGREGATION,0.00013188,0.29586,0.30249,1,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.00040321,0.29582,0.36511,1,1
2,GO NEUROTRANSMITTER SECRETION,0.00040321,0.29435,0.32481,1,1
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0028457,0.29396,0.42045,1,1
2,GO NUCLEAR PORE ORGANIZATION,0.0020776,0.29374,0.32416,1,1
2,GO REGULATION OF CHROMOSOME SEPARATION,3.9936e-05,0.29344,0.31753,1,1
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00057531,0.29326,0.28197,1,1
2,GO CHROMOSOME CONDENSATION,0.00020554,0.29312,0.37852,1,1
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.0096484,0.29311,0.29588,1,1
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0040644,0.29255,0.30924,1,1
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0016767,0.29248,0.31333,1,1
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,5.2428e-05,0.29201,0.31181,1,1
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.0003797,0.29198,0.33154,1,1
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,6.4139e-05,0.29171,0.32196,1,1
2,GO REGULATION OF CHROMATIN BINDING,0.00035748,0.2916,0.34402,1,1
2,GO CRANIAL NERVE DEVELOPMENT,0.0060238,0.29093,0.31996,1,1
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.010572,0.28895,0.24482,1,1
2,GO P BODY ASSEMBLY,0.00086166,0.2889,0.3369,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00068502,0.28861,0.33055,1,1
2,GO GOLGI RIBBON FORMATION,0.00064645,0.28761,0.35091,1,1
2,GO NEURAL RETINA DEVELOPMENT,0.00057531,0.28741,0.31286,1,1
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00072571,0.28698,0.32411,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00051151,0.28693,0.32365,1,1
2,GO EPITHELIAL CELL MATURATION,0.043559,0.28639,0.20885,1,1
2,GO NEURON MIGRATION,0.00018128,0.28622,0.36605,1,1
2,GO MEIOTIC SPINDLE ORGANIZATION,0.0015882,0.28564,0.3537,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.015104,0.28558,0.24806,1,1
2,GO SPINDLE ORGANIZATION,0.00014062,0.28539,0.31322,1,1
2,GO STRESS GRANULE ASSEMBLY,0.00033648,0.2853,0.31091,1,1
2,GO MICROTUBULE BASED TRANSPORT,0.00048214,0.28512,0.2921,1,1
2,GO DENDRITE DEVELOPMENT,0.00060992,0.28488,0.30514,1,1
2,GO MICROTUBULE POLYMERIZATION,0.0003797,0.28464,0.32383,1,1
2,GO MICROTUBULE BASED PROCESS,9.5377e-05,0.28428,0.3024,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00057531,0.28406,0.31957,1,1
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00051151,0.28406,0.29786,1,1
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0015882,0.28377,0.30776,1,1
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0057394,0.28367,0.27355,1,1
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.015776,0.28343,0.30057,1,1
2,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00091199,0.2832,0.32422,1,1
2,GO THALAMUS DEVELOPMENT,0.007293,0.28279,0.27372,1,1
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0014241,0.28247,0.32794,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00064645,0.28216,0.3527,1,1
2,GO PEPTIDYL LYSINE METHYLATION,0.00060992,0.28139,0.31444,1,1
2,GO MYOBLAST MIGRATION,0.02951,0.28093,0.2314,1,1
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.014457,0.28012,0.27188,1,1
2,GO REGULATION OF APPETITE,0.0044907,0.28004,0.26982,1,1
2,GO REGULATION OF DENDRITE MORPHOGENESIS,9.5377e-05,0.27997,0.3343,1,1
2,GO ATP DEPENDENT CHROMATIN REMODELING,7.8298e-05,0.2796,0.33694,1,1
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0023095,0.27947,0.27852,1,1
2,GO REGULATION OF CENTROSOME CYCLE,0.00023283,0.27929,0.28117,1,1
2,GO SISTER CHROMATID SEGREGATION,0.00010866,0.27927,0.30304,1,1
2,GO TRANSPORT ALONG MICROTUBULE,0.00023283,0.27876,0.29093,1,1
2,GO SPINAL CORD DEVELOPMENT,0.00019306,0.27872,0.38,1,1
2,GO REGULATION OF AXONOGENESIS,0.0015882,0.27868,0.30675,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.015776,0.2786,0.28691,1,1
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00048214,0.27848,0.29924,1,1
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,7.8298e-05,0.2782,0.32438,1,1
2,GO RECOMBINATIONAL REPAIR,0.00035748,0.27811,0.31047,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.00042807,0.27768,0.30039,1,1
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.00010181,0.27755,0.29886,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00033648,0.27747,0.30809,1,1
2,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.006955,0.27744,0.26861,1,1
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00048214,0.27729,0.27425,1,1
2,GO RESPONSE TO HYDROXYUREA,0.0014241,0.27706,0.28225,1,1
2,GO FEEDING BEHAVIOR,0.0016767,0.27689,0.25341,1,1
2,GO HISTONE H2A UBIQUITINATION,0.0013481,0.27659,0.27933,1,1
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0028457,0.2761,0.28892,1,1
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.0092139,0.27573,0.29711,1,1
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.00028019,0.27547,0.30565,1,1
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0019699,0.27543,0.28692,1,1
2,GO SMOOTHENED SIGNALING PATHWAY,0.00020554,0.27539,0.29677,1,1
2,GO MITOTIC SPINDLE ORGANIZATION,0.00011593,0.27527,0.32199,1,1
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.008797,0.27523,0.27665,1,1
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00018128,0.27515,0.30603,1,1
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0013481,0.27503,0.31969,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00057531,0.27494,0.31091,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.0015882,0.27469,0.30466,1,1
2,GO HISTONE METHYLATION,0.00064645,0.27464,0.30417,1,1
2,GO MEMBRANE DISASSEMBLY,0.013235,0.27439,0.23965,1,1
2,GO HISTONE H3 K9 MODIFICATION,0.0015041,0.27395,0.30587,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0027019,0.27382,0.2604,1,1
2,GO SYNAPTIC VESICLE LOCALIZATION,0.0015882,0.2737,0.28496,1,1
2,GO MISMATCH REPAIR,0.00010866,0.27366,0.29834,1,1
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00096503,0.2735,0.29493,1,1
2,GO NEUROMUSCULAR PROCESS,0.0023095,0.2735,0.2588,1,1
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.00010866,0.27347,0.34121,1,1
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,8.3641e-05,0.27277,0.30252,1,1
2,GO MEIOTIC CELL CYCLE PROCESS,0.00011593,0.27235,0.29593,1,1
2,GO CILIUM ORGANIZATION,0.0003797,0.27231,0.30876,1,1
2,GO LEARNING,0.00029789,0.27227,0.30367,1,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.00072571,0.27197,0.32342,1,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.035953,0.27184,0.25279,1,1
2,GO SYNAPTIC SIGNALING,0.00057531,0.2718,0.2715,1,1
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00096503,0.27177,0.31047,1,1
2,GO POSTSYNAPSE ORGANIZATION,0.00045436,0.27167,0.30325,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00064645,0.27121,0.28879,1,1
2,GO PROTEIN METHYLATION,0.00054254,0.27071,0.29019,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0015882,0.26999,0.25106,1,1
2,GO DENDRITIC SPINE DEVELOPMENT,0.00033648,0.2697,0.31348,1,1
2,GO ASYMMETRIC CELL DIVISION,0.00332,0.26958,0.26242,1,1
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.00013188,0.26936,0.29704,1,1
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00072571,0.26913,0.2818,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00048214,0.26782,0.29544,1,1
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.00029789,0.26767,0.33155,1,1
2,GO METHIONINE METABOLIC PROCESS,0.0012758,0.26752,0.26489,1,1
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0044907,0.2674,0.37378,1,1
2,GO NEUROBLAST PROLIFERATION,0.0015882,0.2671,0.29482,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00096503,0.26708,0.30265,1,1
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0034935,0.26624,0.32991,1,1
2,GO OOCYTE MATURATION,0.0054671,0.2662,0.29452,1,1
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0010209,0.26567,0.28512,1,1
2,GO SYNAPSE ORGANIZATION,0.00086166,0.26551,0.27937,1,1
2,GO HISTONE H3 DEACETYLATION,0.0038653,0.26521,0.25516,1,1
2,GO REGULATION OF MRNA PROCESSING,0.00042807,0.26407,0.27321,1,1
2,GO SISTER CHROMATID COHESION,0.00031664,0.26353,0.32248,1,1
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0013481,0.26342,0.25223,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.046961,0.26341,0.23254,1,1
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.0021907,0.26301,0.29103,1,1
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00076864,0.26299,0.29483,1,1
2,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0047188,0.26288,0.23608,1,1
2,GO DNA GEOMETRIC CHANGE,0.00033648,0.26259,0.2951,1,1
2,GO PHOTORECEPTOR CELL MAINTENANCE,7.8298e-05,0.26248,0.27773,1,1
2,GO GENITALIA MORPHOGENESIS,0.019548,0.26242,0.28284,1,1
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00010866,0.26222,0.28759,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,0.0024341,0.26152,0.33077,1,1
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.0028457,0.26149,0.27222,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00048214,0.26144,0.28757,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00086166,0.26143,0.25721,1,1
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0025648,0.26133,0.29503,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.00042807,0.26081,0.28755,1,1
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0015882,0.25994,0.30745,1,1
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.031957,0.25973,0.19876,1,1
2,GO V D J RECOMBINATION,0.0018673,0.25967,0.28218,1,1
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00045436,0.25947,0.26091,1,1
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0023095,0.2593,0.2979,1,1
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0012758,0.25918,0.27133,1,1
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0015041,0.25909,0.29011,1,1
2,GO MEIOTIC CELL CYCLE,0.00010181,0.25864,0.2988,1,1
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00060992,0.25832,0.29375,1,1
2,GO SINGLE STRAND BREAK REPAIR,0.00026348,0.25819,0.30196,1,1
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0057394,0.25735,0.25654,1,1
2,GO MICROTUBULE NUCLEATION,0.0024341,0.25715,0.31322,1,1
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,5.2428e-05,0.25645,0.31714,1,1
2,GO HIPPO SIGNALING,0.0066311,0.25586,0.27704,1,1
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.00081392,0.25576,0.26335,1,1
2,GO RESPONSE TO LEUCINE,0.0027019,0.25573,0.31673,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,9.5377e-05,0.25512,0.29813,1,1
2,GO MITOCHONDRION LOCALIZATION,0.00064645,0.25497,0.28681,1,1
2,GO NEUROTRANSMITTER TRANSPORT,0.00076864,0.25466,0.29073,1,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0014241,0.25395,0.2825,1,1
2,GO LOCOMOTORY BEHAVIOR,0.00048214,0.25377,0.29449,1,1
2,GO DNA DEPENDENT DNA REPLICATION,0.00060992,0.2537,0.29404,1,1
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00064645,0.25317,0.35059,1,1
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00086166,0.25291,0.30872,1,1
2,GO REGULATION OF MEIOTIC CELL CYCLE,0.0036751,0.25285,0.22161,1,1
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.018736,0.25238,0.26344,1,1
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.015776,0.2522,0.26738,1,1
2,GO HISTONE H4 K16 ACETYLATION,0.00051151,0.25209,0.30462,1,1
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.048745,0.25176,0.20126,1,1
2,GO AXONAL TRANSPORT,0.00057531,0.25176,0.30824,1,1
2,GO SPINDLE ASSEMBLY,0.00040321,0.25155,0.29347,1,1
2,GO RECEPTOR CLUSTERING,0.0092139,0.25106,0.25923,1,1
2,GO MITOTIC SPINDLE ASSEMBLY,0.00076864,0.25101,0.27484,1,1
2,GO NEURON MATURATION,0.0028457,0.25095,0.27855,1,1
2,GO BEHAVIOR,0.0011418,0.2507,0.24715,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00012367,0.25045,0.28008,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0025648,0.2503,0.27714,1,1
2,GO NEURON PROJECTION ARBORIZATION,0.0057394,0.25015,0.30642,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.0044907,0.24995,0.28147,1,1
2,GO HISTONE H3 K4 METHYLATION,0.00057531,0.2498,0.29741,1,1
2,GO CEREBRAL CORTEX DEVELOPMENT,0.00064645,0.24962,0.28679,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00091199,0.24953,0.27737,1,1
2,GO SPINDLE LOCALIZATION,0.0010209,0.24952,0.26441,1,1
2,GO RESPONSE TO NERVE GROWTH FACTOR,0.0017696,0.2491,0.23943,1,1
2,GO DNA REPLICATION CHECKPOINT,0.0011418,0.24906,0.33389,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0076456,0.24889,0.26934,1,1
2,GO CHROMATIN REMODELING,0.00040321,0.24849,0.28641,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00024771,0.24836,0.30914,1,1
2,GO DNA RECOMBINATION,0.0010209,0.24783,0.245,1,1
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0010798,0.2476,0.30136,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00086166,0.24724,0.31801,1,1
2,GO CELL PART MORPHOGENESIS,0.0015041,0.24696,0.27832,1,1
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.011574,0.24663,0.25232,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,0.0028457,0.24636,0.25247,1,1
2,GO HINDBRAIN MORPHOGENESIS,0.00042807,0.24598,0.28089,1,1
2,GO LENS FIBER CELL DIFFERENTIATION,0.0036751,0.24547,0.24518,1,1
2,GO HINDBRAIN DEVELOPMENT,0.00023283,0.24539,0.28312,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.019548,0.24459,0.18542,1,1
2,GO EXTRACELLULAR TRANSPORT,0.018736,0.24444,0.27848,1,1
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00086166,0.24408,0.37059,1,1
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0060238,0.24398,0.26208,1,1
2,GO ORGANELLE FISSION,0.00015974,0.24378,0.25365,1,1
2,GO AXON DEVELOPMENT,0.0015041,0.24366,0.28283,1,1
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.010101,0.24343,0.31012,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0017696,0.24337,0.25402,1,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.00057531,0.24287,0.26547,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.00026348,0.24262,0.2809,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0083971,0.24256,0.24703,1,1
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00028019,0.24235,0.2767,1,1
2,GO REGULATION OF CYTOKINESIS,0.00054254,0.24095,0.27784,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00091199,0.24094,0.24501,1,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.0034935,0.24071,0.22344,1,1
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0172,0.24044,0.33328,1,1
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.035953,0.24027,0.23697,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0083971,0.24022,0.2521,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00033648,0.23993,0.23909,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0066311,0.23982,0.30433,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.037377,0.23978,0.1865,1,1
2,GO HISTONE H3 K9 TRIMETHYLATION,0.0015882,0.23967,0.30563,1,1
2,GO CHROMOSOME LOCALIZATION,0.0003797,0.23962,0.25098,1,1
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0010209,0.23908,0.25122,1,1
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00040321,0.23898,0.28458,1,1
2,GO APICAL PROTEIN LOCALIZATION,0.013235,0.2389,0.26967,1,1
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0049572,0.23883,0.22533,1,1
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.01266,0.23881,0.24873,1,1
2,GO POST ANAL TAIL MORPHOGENESIS,0.0044907,0.23859,0.2995,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.0054671,0.23846,0.22379,1,1
2,GO HISTONE H4 DEACETYLATION,0.0025648,0.23774,0.22382,1,1
2,GO DOPAMINE TRANSPORT,0.007293,0.23773,0.29661,1,1
2,GO REGULATION OF RNA SPLICING,0.00060992,0.23769,0.25698,1,1
2,GO AXON EXTENSION,0.0038653,0.23762,0.26338,1,1
2,GO AXO DENDRITIC TRANSPORT,0.0023095,0.23716,0.28026,1,1
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0021907,0.23677,0.28985,1,1
2,GO NUCLEOSOME ORGANIZATION,0.00020554,0.2366,0.28792,1,1
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.014457,0.23602,0.23572,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.00040321,0.23583,0.25322,1,1
2,GO CELL CYCLE DNA REPLICATION,0.0012071,0.2354,0.2979,1,1
2,GO REGULATION OF CIRCADIAN RHYTHM,0.00029789,0.23536,0.27098,1,1
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0010209,0.23523,0.28301,1,1
2,GO ADULT LOCOMOTORY BEHAVIOR,0.007293,0.23517,0.22749,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.0019699,0.23506,0.23728,1,1
2,GO DORSAL VENTRAL PATTERN FORMATION,0.0013481,0.23504,0.28592,1,1
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0047188,0.23484,0.30813,1,1
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.013235,0.23464,0.26866,1,1
2,GO DNA REPLICATION,0.00019306,0.23364,0.30122,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0019699,0.23339,0.31923,1,1
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0010209,0.23326,0.27779,1,1
2,GO POSITIVE REGULATION OF AXONOGENESIS,0.0029965,0.23324,0.2931,1,1
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0017696,0.23315,0.29018,1,1
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0076456,0.23287,0.2937,1,1
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.0020776,0.23276,0.26049,1,1
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0019699,0.23274,0.24854,1,1
2,GO NEURON PROJECTION EXTENSION,0.00332,0.23261,0.25396,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00045436,0.23238,0.32451,1,1
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.0052065,0.2321,0.28433,1,1
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0003797,0.23193,0.2908,1,1
2,GO ECTODERM DEVELOPMENT,0.0047188,0.23149,0.23002,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00332,0.23145,0.24809,1,1
2,GO POTASSIUM ION HOMEOSTASIS,0.015104,0.23141,0.18135,1,1
2,GO ESTROUS CYCLE,0.016475,0.23115,0.25914,1,1
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.00076864,0.23061,0.26974,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0013481,0.23009,0.25092,1,1
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.0047188,0.22998,0.28522,1,1
2,GO PALLIUM DEVELOPMENT,0.0003797,0.22971,0.26953,1,1
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.022172,0.22968,0.2142,1,1
2,GO SPERM MOTILITY,0.0040644,0.22929,0.23606,1,1
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00040321,0.22907,0.30069,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0040644,0.22881,0.23903,1,1
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0029965,0.22858,0.26478,1,1
2,GO METANEPHROS MORPHOGENESIS,0.010101,0.2285,0.24971,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.0036751,0.22845,0.27375,1,1
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0015041,0.22831,0.25457,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0028457,0.22814,0.2777,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.00042807,0.2281,0.27719,1,1
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00020554,0.22762,0.28129,1,1
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.00048214,0.22725,0.31902,1,1
2,GO MITOTIC NUCLEAR DIVISION,0.00014062,0.22679,0.27234,1,1
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0010209,0.2264,0.26811,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00012367,0.2264,0.24409,1,1
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.00332,0.22633,0.22301,1,1
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0012071,0.22599,0.26223,1,1
2,GO PANCREAS DEVELOPMENT,0.0013481,0.22567,0.30494,1,1
2,GO RNA INTERFERENCE,0.0031545,0.22566,0.22838,1,1
2,GO EMBRYONIC AXIS SPECIFICATION,0.00033648,0.22564,0.27255,1,1
2,GO MRNA 3 END PROCESSING,0.00040321,0.22543,0.25386,1,1
2,GO DNA CONFORMATION CHANGE,0.00026348,0.2254,0.30101,1,1
2,GO HISTONE UBIQUITINATION,0.0015041,0.22528,0.2518,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0029965,0.22449,0.22473,1,1
2,GO RNA POLYADENYLATION,0.0013481,0.22427,0.24741,1,1
2,GO METAPHASE PLATE CONGRESSION,0.00031664,0.22422,0.25232,1,1
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00029789,0.22375,0.20421,1,1
2,GO NEURON DEVELOPMENT,0.0011418,0.22336,0.25547,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.00072571,0.22324,0.26002,1,1
2,GO DNA REPLICATION INITIATION,0.0076456,0.22304,0.23853,1,1
2,GO MRNA METHYLATION,0.0029965,0.22273,0.26717,1,1
2,GO MAINTENANCE OF CELL POLARITY,0.010101,0.22225,0.23474,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.011063,0.2216,0.28486,1,1
2,GO REGULATION OF NEURON DIFFERENTIATION,0.0010798,0.22125,0.26425,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.008797,0.22086,0.24082,1,1
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.00045436,0.22038,0.25101,1,1
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0023095,0.22026,0.24625,1,1
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0040644,0.22012,0.22428,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.00064645,0.22009,0.25566,1,1
2,GO MALE MEIOSIS I,0.0047188,0.21989,0.27047,1,1
2,GO NUCLEOSOME ASSEMBLY,0.00019306,0.21977,0.32103,1,1
2,GO HISTONE MONOUBIQUITINATION,0.0042727,0.21953,0.25175,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00051151,0.21951,0.26374,1,1
2,GO REGULATION OF SYNAPTIC PLASTICITY,0.0028457,0.21834,0.249,1,1
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0052065,0.21829,0.2262,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0025648,0.21811,0.28031,1,1
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.008797,0.2181,0.23367,1,1
2,GO NEGATIVE REGULATION OF DNA BINDING,0.0010209,0.2177,0.23398,1,1
2,GO ORGANIC CATION TRANSPORT,0.019548,0.21747,0.20631,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.043559,0.21726,0.21172,1,1
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.045233,0.21713,0.28314,1,1
2,GO MEMBRANE DOCKING,0.00068502,0.21697,0.25174,1,1
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.0060238,0.21659,0.22943,1,1
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.0027019,0.21658,0.24104,1,1
2,GO NEURON DIFFERENTIATION,0.00091199,0.21644,0.25325,1,1
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0016767,0.2164,0.20182,1,1
2,GO PATTERN SPECIFICATION PROCESS,0.0029965,0.21631,0.22016,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0025648,0.21615,0.30813,1,1
2,GO POSITIVE REGULATION OF RNA SPLICING,0.0018673,0.21584,0.23655,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00086166,0.21584,0.24977,1,1
2,GO POSITIVE REGULATION OF DNA REPAIR,0.00040321,0.21561,0.25543,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0042727,0.21555,0.24188,1,1
2,GO NEGATIVE CHEMOTAXIS,0.025096,0.21508,0.24356,1,1
2,GO DNA PACKAGING,0.00018128,0.21483,0.3153,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.023112,0.2147,0.21024,1,1
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.018736,0.21438,0.24176,1,1
2,GO CENTROSOME SEPARATION,0.00064645,0.21376,0.27669,1,1
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0083971,0.21345,0.24521,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.00081392,0.21335,0.2756,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0054671,0.2131,0.20127,1,1
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.006955,0.2125,0.25176,1,1
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00332,0.21224,0.23152,1,1
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0080134,0.21122,0.26645,1,1
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0083971,0.21097,0.18531,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0034935,0.21083,0.25861,1,1
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.0013481,0.21062,0.24869,1,1
2,GO EATING BEHAVIOR,0.006955,0.2104,0.23219,1,1
2,GO PROTEIN AUTOUBIQUITINATION,0.00035748,0.21022,0.23587,1,1
2,GO MRNA CLEAVAGE,0.0025648,0.2102,0.24106,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.0024341,0.21019,0.23751,1,1
2,GO TORC1 SIGNALING,0.0015041,0.20995,0.27642,1,1
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00054254,0.20985,0.28116,1,1
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00021879,0.20954,0.25279,1,1
2,GO ADHERENS JUNCTION ORGANIZATION,0.011574,0.20895,0.23246,1,1
2,GO RRNA CATABOLIC PROCESS,0.0172,0.20844,0.17002,1,1
2,GO CALCIUM ION REGULATED EXOCYTOSIS,0.015776,0.20785,0.27767,1,1
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0024341,0.20724,0.26659,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0057394,0.20713,0.19035,1,1
2,GO MOTOR NEURON AXON GUIDANCE,0.015104,0.20712,0.24319,1,1
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.006955,0.20711,0.24862,1,1
2,GO TELENCEPHALON DEVELOPMENT,0.00045436,0.20703,0.26076,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.00054254,0.2069,0.27501,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.048745,0.20677,0.1837,1,1
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0038653,0.20674,0.31349,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0031545,0.20624,0.20585,1,1
2,GO HEAD DEVELOPMENT,0.00091199,0.20624,0.24269,1,1
2,GO CYTOKINESIS,0.00057531,0.20564,0.23512,1,1
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00020554,0.20549,0.22888,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.008797,0.20544,0.20772,1,1
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0019699,0.20521,0.23356,1,1
2,GO CELL DIVISION,0.00019306,0.20505,0.24589,1,1
2,GO PROTEIN MANNOSYLATION,0.010101,0.20456,0.2073,1,1
2,GO CELL PROJECTION ORGANIZATION,0.0012758,0.20412,0.23255,1,1
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.010101,0.20403,0.18722,1,1
2,GO REGULATION OF MITOPHAGY,0.011063,0.20402,0.22906,1,1
2,GO SPERMATID DIFFERENTIATION,0.00054254,0.20392,0.22371,1,1
2,GO UV PROTECTION,0.033245,0.20387,0.20908,1,1
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0011418,0.20369,0.25667,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.00086166,0.2036,0.28468,1,1
2,GO REGULATION OF LYASE ACTIVITY,0.0038653,0.20353,0.2157,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.00076864,0.20351,0.23384,1,1
2,GO CELL CYCLE CHECKPOINT,0.00076864,0.2034,0.28174,1,1
2,GO DEFINITIVE HEMOPOIESIS,0.038848,0.20326,0.25132,1,1
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0092139,0.20317,0.21347,1,1
2,GO REGULATION OF DOPAMINE SECRETION,0.022172,0.20289,0.26211,1,1
2,GO HISTONE H2A ACETYLATION,0.00060992,0.20256,0.24248,1,1
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.00072571,0.20219,0.25033,1,1
2,GO HISTONE DEACETYLATION,0.0083971,0.20185,0.22972,1,1
2,GO POSITIVE REGULATION OF FERTILIZATION,0.012106,0.20182,0.16704,1,1
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.00081392,0.20109,0.27243,1,1
2,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0017696,0.20091,0.23892,1,1
2,GO ASSOCIATIVE LEARNING,0.00042807,0.20046,0.2448,1,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0092139,0.20032,0.19187,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0057394,0.20014,0.17023,1,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00028019,0.19995,0.24786,1,1
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.015104,0.19959,0.24309,1,1
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0047188,0.19955,0.15142,1,1
2,GO FOREBRAIN DEVELOPMENT,0.00045436,0.19934,0.25818,1,1
2,GO METHYLATION,0.00086166,0.19933,0.21373,1,1
2,GO REGIONALIZATION,0.0054671,0.19931,0.21106,1,1
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00072571,0.19929,0.24214,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0011418,0.19922,0.24245,1,1
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00057531,0.1989,0.26814,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.022172,0.19856,0.1884,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.0020776,0.19853,0.28616,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0019699,0.19825,0.19051,1,1
2,GO ATP TRANSPORT,0.007293,0.1978,0.1966,1,1
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0036751,0.19769,0.22878,1,1
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0003797,0.19756,0.21484,1,1
2,GO HISTONE H2B UBIQUITINATION,0.018736,0.19675,0.17288,1,1
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.015104,0.19668,0.20864,1,1
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.010572,0.1965,0.2124,1,1
2,GO REGULATION OF DNA REPLICATION,0.00023283,0.1964,0.26739,1,1
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.011063,0.1963,0.22054,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0023095,0.19608,0.21124,1,1
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.021265,0.1956,0.2231,1,1
2,GO REGULATION OF NEURON MATURATION,0.0083971,0.1956,0.2724,1,1
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0027019,0.19486,0.24156,1,1
2,GO NEUROGENESIS,0.0016767,0.19482,0.22879,1,1
2,GO TRANSMISSION OF NERVE IMPULSE,0.0040644,0.19476,0.24093,1,1
2,GO ORGANELLE ASSEMBLY,0.00068502,0.19462,0.22267,1,1
2,GO MRNA PROCESSING,0.00048214,0.19447,0.23537,1,1
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0036751,0.19416,0.21524,1,1
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.0080134,0.19413,0.22078,1,1
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.010101,0.19373,0.23071,1,1
2,GO PROTEIN MONOUBIQUITINATION,0.0012758,0.19362,0.24964,1,1
2,GO DNA CATABOLIC PROCESS,0.0013481,0.19343,0.19554,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.0036751,0.19324,0.25768,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00332,0.19312,0.24146,1,1
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0019699,0.19279,0.23018,1,1
2,GO MITOPHAGY,0.010572,0.19274,0.20602,1,1
2,GO COGNITION,0.0023095,0.19273,0.20603,1,1
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0040644,0.19261,0.22112,1,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.00064645,0.19259,0.29323,1,1
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00081392,0.19242,0.21109,1,1
2,GO RNA SPLICING,0.0003797,0.19172,0.2316,1,1
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.013235,0.19165,0.27559,1,1
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0027019,0.19153,0.22611,1,1
2,GO REGULATION OF BEHAVIOR,0.0021907,0.1911,0.21612,1,1
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0047188,0.19079,0.24475,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00051151,0.19041,0.23462,1,1
2,GO GAMETE GENERATION,0.00031664,0.19006,0.22022,1,1
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.015104,0.18992,0.19042,1,1
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.007293,0.18952,0.2314,1,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.00026348,0.18934,0.22381,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.00086166,0.18887,0.24228,1,1
2,GO REGULATION OF NUCLEAR DIVISION,0.00020554,0.18845,0.23313,1,1
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0029965,0.18831,0.22213,1,1
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.00033648,0.18818,0.32467,1,1
2,GO RNA METHYLATION,0.0047188,0.18799,0.17762,1,1
2,GO PROTEIN TARGETING TO LYSOSOME,0.013235,0.18752,0.22406,1,1
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00028019,0.18743,0.24565,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.00086166,0.18742,0.24183,1,1
2,GO MALE GAMETE GENERATION,0.00024771,0.18713,0.21992,1,1
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.0011418,0.18684,0.26543,1,1
2,GO SEGMENTATION,0.0080134,0.18681,0.20856,1,1
2,GO CATECHOLAMINE SECRETION,0.0017696,0.18664,0.3055,1,1
2,GO INCLUSION BODY ASSEMBLY,0.0049572,0.18558,0.25419,1,1
2,GO SEXUAL REPRODUCTION,0.00042807,0.18557,0.20712,1,1
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.01266,0.18556,0.12304,1,1
2,GO MACROMOLECULE DEACYLATION,0.0083971,0.18551,0.20207,1,1
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.00091199,0.18524,0.21239,1,1
2,GO SOMITE DEVELOPMENT,0.0060238,0.18495,0.22178,1,1
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.011574,0.18464,0.19677,1,1
2,GO MANNOSYLATION,0.0049572,0.18413,0.19467,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0015041,0.18404,0.17623,1,1
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.018736,0.18374,0.23495,1,1
2,GO TRNA TRANSPORT,0.0063209,0.18365,0.20712,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0021907,0.18359,0.23176,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0063209,0.18342,0.18794,1,1
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.015776,0.18321,0.16201,1,1
2,GO ONE CARBON METABOLIC PROCESS,0.028348,0.18317,0.15497,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0083971,0.18312,0.21493,1,1
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00024771,0.18276,0.2362,1,1
2,GO ORGANELLE LOCALIZATION,0.0023095,0.18244,0.19948,1,1
2,GO CARNITINE METABOLIC PROCESS,0.023112,0.18226,0.16686,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0092139,0.18168,0.22432,1,1
2,GO FOREBRAIN NEURON DIFFERENTIATION,0.028348,0.18159,0.211,1,1
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.008797,0.1814,0.24892,1,1
2,GO OLIGODENDROCYTE DEVELOPMENT,0.0027019,0.18138,0.2403,1,1
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.1812,0.21584,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00091199,0.18058,0.18695,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0010209,0.17996,0.19012,1,1
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0172,0.17937,0.20942,1,1
2,GO DNA METABOLIC PROCESS,0.0010798,0.17884,0.19834,1,1
2,GO LIMBIC SYSTEM DEVELOPMENT,0.00051151,0.17789,0.23845,1,1
2,GO MITOTIC CYTOKINESIS,0.00096503,0.17787,0.22193,1,1
2,GO GERM CELL DEVELOPMENT,0.00040321,0.17737,0.23508,1,1
2,GO POST EMBRYONIC DEVELOPMENT,0.0092139,0.17723,0.21817,1,1
2,GO EMBRYONIC PATTERN SPECIFICATION,0.00033648,0.17706,0.23755,1,1
2,GO CAMERA TYPE EYE DEVELOPMENT,0.0038653,0.17705,0.22412,1,1
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0013481,0.17698,0.22348,1,1
2,GO REGULATION OF CELL DIVISION,0.0036751,0.17676,0.1931,1,1
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.006955,0.17643,0.227,1,1
2,GO CELLULAR RESPONSE TO STEROL,0.015104,0.17637,0.23997,1,1
2,GO TRNA METHYLATION,0.006955,0.17588,0.17146,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0028457,0.17582,0.15293,1,1
2,GO FATTY ACID BETA OXIDATION,0.015776,0.1753,0.14433,1,1
2,GO REGULATION OF SENSORY PERCEPTION,0.0083971,0.17445,0.21658,1,1
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.0023095,0.17443,0.2134,1,1
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.0031545,0.17401,0.20188,1,1
2,GO RESPONSE TO UV,0.0028457,0.174,0.20034,1,1
2,GO REGULATION OF DNA RECOMBINATION,0.0060238,0.17387,0.202,1,1
2,GO POSITIVE REGULATION OF ACROSOME REACTION,0.020391,0.17387,0.15517,1,1
2,GO SYNAPTIC VESICLE RECYCLING,0.0063209,0.1738,0.21156,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE,0.0012758,0.17372,0.20419,1,1
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0010798,0.17363,0.19812,1,1
2,GO MITOTIC CELL CYCLE,0.00033648,0.17357,0.22624,1,1
2,GO SOMITOGENESIS,0.010572,0.17338,0.20619,1,1
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.012106,0.17311,0.18118,1,1
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.0066311,0.17288,0.27942,1,1
2,GO NCRNA TRANSCRIPTION,0.00072571,0.17273,0.19565,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0012071,0.17263,0.2143,1,1
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011063,0.17212,0.17374,1,1
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.0042727,0.17205,0.21335,1,1
2,GO FEMALE GAMETE GENERATION,0.0040644,0.17184,0.18724,1,1
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011574,0.17169,0.1921,1,1
2,GO NUCLEAR BODY ORGANIZATION,0.0021907,0.17159,0.20775,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.031957,0.17142,0.18115,1,1
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.021265,0.17133,0.25295,1,1
2,GO ACIDIC AMINO ACID TRANSPORT,0.0063209,0.17026,0.22647,1,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.00024771,0.17014,0.23384,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0016767,0.17012,0.18094,1,1
2,GO TELOMERE ORGANIZATION,0.0025648,0.16975,0.19919,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.012106,0.16955,0.20975,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.018736,0.16952,0.15856,1,1
2,GO REGULATION OF MEMBRANE POTENTIAL,0.0049572,0.16909,0.19387,1,1
2,GO CELL CYCLE PROCESS,0.00021879,0.16908,0.2401,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.00057531,0.16821,0.23178,1,1
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0096484,0.16794,0.18811,1,1
2,GO NUCLEAR EXPORT,0.00064645,0.16788,0.21759,1,1
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.011063,0.16738,0.19839,1,1
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0063209,0.16721,0.17876,1,1
2,GO DETECTION OF VISIBLE LIGHT,0.00057531,0.16678,0.1682,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.034576,0.16677,0.15352,1,1
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016475,0.16656,0.22274,1,1
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0047188,0.16639,0.2143,1,1
2,GO RNA SURVEILLANCE,0.0066311,0.16629,0.13674,1,1
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.015776,0.16586,0.26333,1,1
2,GO ACROSOME REACTION,0.017954,0.16519,0.17838,1,1
2,GO PEPTIDE HORMONE SECRETION,0.0031545,0.16432,0.20541,1,1
2,GO REGULATION OF CELL CYCLE,0.00045436,0.16419,0.22065,1,1
2,GO RNA DESTABILIZATION,0.02951,0.16399,0.20246,1,1
2,GO CELL CYCLE,0.00045436,0.1637,0.22206,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0020776,0.16358,0.1954,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0063209,0.16331,0.20068,1,1
2,GO PROTEIN SUMOYLATION,0.0015882,0.16312,0.21782,1,1
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0036751,0.1631,0.17731,1,1
2,GO AXIS SPECIFICATION,0.0031545,0.16307,0.2009,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.00091199,0.16264,0.1987,1,1
2,GO CELL MORPHOGENESIS,0.010101,0.16261,0.20997,1,1
2,GO MECHANORECEPTOR DIFFERENTIATION,0.0023095,0.1626,0.20708,1,1
2,GO SNRNA TRANSCRIPTION,0.00068502,0.16253,0.19683,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0015882,0.16239,0.19237,1,1
2,GO DEMETHYLATION,0.0083971,0.16218,0.20403,1,1
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.010572,0.16143,0.17789,1,1
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.038848,0.16134,0.18518,1,1
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.035953,0.16045,0.15897,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.00010866,0.1604,0.24905,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.028348,0.16035,0.19383,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.006955,0.16019,0.16863,1,1
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00096503,0.16009,0.18395,1,1
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0066311,0.15976,0.12578,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.037377,0.15968,0.19882,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0015041,0.1596,0.24024,1,1
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.024086,0.15946,0.20258,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0083971,0.15909,0.15632,1,1
2,GO RESPONSE TO SALT,0.041938,0.15898,0.14333,1,1
2,GO NERVOUS SYSTEM PROCESS,0.010101,0.15891,0.16011,1,1
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.010101,0.15865,0.20628,1,1
2,GO MULTICELLULAR ORGANISM GROWTH,0.0027019,0.15847,0.22774,1,1
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.030713,0.15828,0.15959,1,1
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00019306,0.15824,0.18245,1,1
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0092139,0.15815,0.17322,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0038653,0.1576,0.21055,1,1
2,GO FERTILIZATION,0.0016767,0.15735,0.17489,1,1
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0019699,0.15724,0.19583,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.007293,0.15646,0.17775,1,1
2,GO NUCLEAR TRANSPORT,0.0010209,0.15614,0.19383,1,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011063,0.15543,0.18859,1,1
2,GO PHOTOTRANSDUCTION,0.0021907,0.15534,0.12707,1,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.013235,0.15528,0.16031,1,1
2,GO PROTEIN TARGETING TO VACUOLE,0.006955,0.15513,0.20825,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0025648,0.15501,0.18171,1,1
2,GO CELL CYCLE ARREST,0.00033648,0.155,0.22259,1,1
2,GO POSITIVE REGULATION OF MITOPHAGY,0.025096,0.15471,0.21872,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0023095,0.15424,0.1879,1,1
2,GO TRNA MODIFICATION,0.013834,0.15401,0.1426,1,1
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.0028457,0.1535,0.20313,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00033648,0.15328,0.21393,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0036751,0.15311,0.22475,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.00029789,0.15293,0.21573,1,1
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.035953,0.15282,0.12197,1,1
2,GO DETECTION OF LIGHT STIMULUS,0.0015041,0.15241,0.13845,1,1
2,GO CIRCADIAN RHYTHM,0.0027019,0.15238,0.21112,1,1
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.02951,0.15208,0.17286,1,1
2,GO ENAMEL MINERALIZATION,0.028348,0.152,0.19641,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.00045436,0.15197,0.20577,1,1
2,GO RNA STABILIZATION,0.012106,0.15189,0.19348,1,1
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.019548,0.15182,0.15838,1,1
2,GO SEX DIFFERENTIATION,0.0054671,0.15172,0.18752,1,1
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.010572,0.1516,0.1787,1,1
2,GO DNA METHYLATION,0.014457,0.15149,0.1693,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0023095,0.15145,0.22513,1,1
2,GO HISTONE H3 ACETYLATION,0.016475,0.1506,0.18143,1,1
2,GO FOREBRAIN GENERATION OF NEURONS,0.035953,0.15046,0.18667,1,1
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00091199,0.15042,0.17156,1,1
2,GO MRNA METABOLIC PROCESS,0.00076864,0.15034,0.17532,1,1
2,GO TOR SIGNALING,0.006955,0.15028,0.19224,1,1
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0036751,0.14953,0.20193,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0021907,0.14942,0.20111,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00096503,0.14941,0.15737,1,1
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.010572,0.14886,0.18918,1,1
2,GO RNA PROCESSING,0.0018673,0.14884,0.17564,1,1
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0047188,0.14729,0.20927,1,1
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.012106,0.14708,0.17557,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.00332,0.14683,0.16296,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.0019699,0.14679,0.18062,1,1
2,GO REGULATION OF MITOTIC CELL CYCLE,0.00045436,0.14643,0.20608,1,1
2,GO RNA LOCALIZATION,0.0024341,0.14633,0.17913,1,1
2,GO REGULATION OF GLUCONEOGENESIS,0.028348,0.14624,0.18234,1,1
2,GO RNA MODIFICATION,0.012106,0.14619,0.12662,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.0057394,0.14616,0.13469,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0027019,0.1456,0.16837,1,1
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0092139,0.1455,0.17136,1,1
2,GO AMINE TRANSPORT,0.006955,0.14523,0.24304,1,1
2,GO PROSTATE GLAND GROWTH,0.035953,0.14508,0.1598,1,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0016767,0.14476,0.15688,1,1
2,GO INTRACELLULAR LIPID TRANSPORT,0.0096484,0.14467,0.2032,1,1
2,GO IMPORT INTO NUCLEUS,0.0060238,0.14444,0.16533,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.028348,0.14418,0.14884,1,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.024086,0.14409,0.13822,1,1
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.010101,0.14403,0.17563,1,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.045233,0.14379,0.18279,1,1
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0063209,0.14353,0.20606,1,1
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.011574,0.14352,0.17209,1,1
2,GO PEPTIDYL THREONINE MODIFICATION,0.02951,0.14333,0.18387,1,1
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.027226,0.14248,0.20506,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0096484,0.14244,0.17302,1,1
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.041938,0.14233,0.12724,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.0060238,0.14229,0.18966,1,1
2,GO OVULATION CYCLE,0.035953,0.14198,0.19139,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.045233,0.14185,0.14183,1,1
2,GO COENZYME A METABOLIC PROCESS,0.014457,0.14163,0.17846,1,1
2,GO REGULATION OF CELL AGING,0.034576,0.14135,0.16733,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.014457,0.14104,0.16565,1,1
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.023112,0.14079,0.16772,1,1
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.010572,0.13946,0.17476,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.0010209,0.13946,0.19024,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.0015882,0.13926,0.14272,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.034576,0.13906,0.14971,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.034576,0.13866,0.14771,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0038653,0.13857,0.16141,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0029965,0.13847,0.17032,1,1
2,GO SENSORY PERCEPTION OF SMELL,0.0054671,0.13798,0.12886,1,1
2,GO CELLULAR RESPONSE TO UV,0.0060238,0.13797,0.17858,1,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.023112,0.13759,0.28722,1,1
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.011063,0.13735,0.24859,1,1
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.040368,0.13701,0.19939,1,1
2,GO APOPTOTIC DNA FRAGMENTATION,0.0076456,0.13699,0.17499,1,1
2,GO RESPONSE TO AMINO ACID STARVATION,0.00332,0.13685,0.19855,1,1
2,GO DEVELOPMENTAL GROWTH,0.015776,0.13683,0.18693,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.014457,0.13571,0.17311,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0028457,0.13567,0.16179,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0060238,0.13563,0.18147,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0066311,0.1354,0.17059,1,1
2,GO PEPTIDYL SERINE MODIFICATION,0.013834,0.13499,0.18126,1,1
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.02951,0.13491,0.1873,1,1
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0057394,0.13461,0.20743,1,1
2,GO TRNA PROCESSING,0.0172,0.13448,0.11955,1,1
2,GO SINGLE FERTILIZATION,0.0011418,0.13426,0.1777,1,1
2,GO CLATHRIN COAT ASSEMBLY,0.016475,0.13406,0.17693,1,1
2,GO REGULATION OF CELL MATURATION,0.0023095,0.13396,0.17962,1,1
2,GO GOLGI LOCALIZATION,0.023112,0.13367,0.13195,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.010572,0.1334,0.12038,1,1
2,GO FEMALE SEX DIFFERENTIATION,0.011063,0.13335,0.20006,1,1
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.0063209,0.13311,0.17185,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.014457,0.13305,0.16694,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0036751,0.13299,0.17605,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.0092139,0.13147,0.15314,1,1
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0083971,0.13094,0.18167,1,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.017954,0.13055,0.17199,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0021907,0.13054,0.20767,1,1
2,GO UBIQUINONE METABOLIC PROCESS,0.0083971,0.13053,0.13395,1,1
2,GO CELLULAR RESPONSE TO ALKALOID,0.028348,0.13003,0.15904,1,1
2,GO CELLULAR RESPONSE TO RADIATION,0.0096484,0.13,0.14629,1,1
2,GO RHYTHMIC PROCESS,0.0028457,0.12982,0.20592,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0096484,0.12959,0.14941,1,1
2,GO REGULATION OF DEPHOSPHORYLATION,0.035953,0.12938,0.15757,1,1
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.007293,0.1289,0.17369,1,1
2,GO TRNA METABOLIC PROCESS,0.022172,0.12872,0.11862,1,1
2,GO REGULATION OF PROTEIN ACETYLATION,0.020391,0.12798,0.15114,1,1
2,GO INSULIN SECRETION,0.008797,0.12779,0.1892,1,1
2,GO CELLULAR RESPONSE TO STARVATION,0.011574,0.12663,0.17486,1,1
2,GO MAGNESIUM ION TRANSPORT,0.0047188,0.12651,0.19961,1,1
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.026142,0.1265,0.20069,1,1
2,GO LIPID DROPLET ORGANIZATION,0.007293,0.12555,0.1757,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.025096,0.12539,0.12997,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0092139,0.12436,0.17965,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0092139,0.1243,0.15752,1,1
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.016475,0.12398,0.15457,1,1
2,GO SNRNA METABOLIC PROCESS,0.0063209,0.12342,0.13702,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.027226,0.12282,0.12102,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.010101,0.12263,0.1414,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.01266,0.12251,0.14705,1,1
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.035953,0.12207,0.1358,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.035953,0.12206,0.1209,1,1
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.040368,0.1219,0.14512,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0021907,0.12151,0.13975,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.01266,0.12122,0.12895,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0023095,0.12109,0.14079,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0063209,0.1209,0.18469,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0029965,0.1208,0.17659,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.037377,0.12076,0.13015,1,1
2,GO REGULATION OF INSULIN SECRETION,0.0096484,0.12046,0.18576,1,1
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.012106,0.12034,0.17442,1,1
2,GO CELL CELL SIGNALING,0.030713,0.12033,0.14223,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.041938,0.12008,0.13796,1,1
2,GO PHOTOPERIODISM,0.020391,0.12001,0.18142,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.014457,0.11941,0.19421,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.021265,0.11931,0.14073,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.046961,0.11879,0.12553,1,1
2,GO RESPONSE TO RADIATION,0.0076456,0.1186,0.15235,1,1
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.0018673,0.11843,0.13672,1,1
2,GO DNA MODIFICATION,0.020391,0.1181,0.13638,1,1
2,GO PROTEIN IMPORT,0.025096,0.11721,0.13082,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.035953,0.11717,0.19237,1,1
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.017954,0.11704,0.12837,1,1
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.034576,0.11618,0.1826,1,1
2,GO RESPONSE TO STARVATION,0.014457,0.11508,0.16516,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.033245,0.1149,0.14318,1,1
2,GO STRIATED MUSCLE ADAPTATION,0.028348,0.1146,0.18813,1,1
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.048745,0.11432,0.14181,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0080134,0.11415,0.14291,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.02951,0.11402,0.16014,1,1
2,GO TRANSPOSITION,0.033245,0.11346,0.15878,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.011574,0.11268,0.12279,1,1
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.034576,0.11177,0.11564,1,1
2,GO VESICLE LOCALIZATION,0.019548,0.11126,0.15319,1,1
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0076456,0.10993,0.2034,1,1
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.012106,0.1088,0.12191,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.014457,0.10762,0.13241,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.025096,0.10686,0.12774,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.027226,0.10637,0.13246,1,1
2,GO PROTEIN NEDDYLATION,0.016475,0.10634,0.11052,1,1
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0076456,0.10576,0.14726,1,1
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.031957,0.10503,0.18159,1,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.026142,0.10496,0.14472,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00332,0.10479,0.14452,1,1
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.013235,0.10409,0.15133,1,1
2,GO INTRACELLULAR MRNA LOCALIZATION,0.028348,0.10377,0.18142,1,1
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.043559,0.10372,0.16973,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.0029965,0.10324,0.14301,1,1
2,GO ESTABLISHMENT OF CELL POLARITY,0.015776,0.10322,0.19714,1,1
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.026142,0.10245,0.12871,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.017954,0.10115,0.18223,1,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.027226,0.10066,0.12515,1,1
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.030713,0.099341,0.13292,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.031957,0.09888,0.14412,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.037377,0.098835,0.12632,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.028348,0.097184,0.12203,1,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0063209,0.09469,0.11693,1,1
2,GO REGULATION OF ATPASE ACTIVITY,0.011574,0.094054,0.12771,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.048745,0.092442,0.12033,1,1
2,GO ORGANELLE DISASSEMBLY,0.027226,0.091837,0.13106,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.025096,0.091604,0.11727,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.018736,0.090437,0.10011,1,1
2,GO MACROAUTOPHAGY,0.048745,0.089653,0.1248,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.037377,0.089282,0.16457,1,1
2,GO PROTEIN DEPHOSPHORYLATION,0.015776,0.085337,0.14065,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.015104,0.084541,0.076801,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.023112,0.081228,0.071508,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.011063,0.079335,0.091809,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.035953,0.079033,0.095524,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.017954,0.075385,0.12411,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.020391,0.073013,0.10413,1,1
2,GO RNA CATABOLIC PROCESS,0.01266,0.067845,0.091944,1,1
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.028348,0.065361,0.075438,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.013235,0.057302,0.087028,1,1
2,GO PROTEIN TARGETING,0.008797,0.055792,0.069696,1,1
2,GO REGULATION OF SYNAPSE MATURATION,0.00042807,0.55798,0.54151,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0010798,0.4302,0.43104,1,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00086166,0.39611,0.42496,1,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00057531,0.37484,0.34743,1,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.0052065,0.36013,0.32995,1,0
2,GO VOCALIZATION BEHAVIOR,0.0031545,0.35188,0.37794,1,0
2,GO INTRACILIARY TRANSPORT,0.0003797,0.34979,0.34849,1,0
2,GO FORELIMB MORPHOGENESIS,0.0011418,0.33599,0.35748,1,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.00332,0.33432,0.28156,1,0
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.0027019,0.33202,0.33942,1,0
2,GO RETINA LAYER FORMATION,0.00091199,0.32733,0.39711,1,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.0080134,0.32094,0.27347,1,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.008797,0.31688,0.35687,1,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.00057531,0.31571,0.32833,1,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0029965,0.31271,0.31564,1,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0025648,0.3068,0.29978,1,0
2,GO MICROTUBULE SEVERING,0.0010798,0.30268,0.3247,1,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.00028019,0.29637,0.31883,1,0
2,GO DENSE CORE GRANULE TRANSPORT,0.0076456,0.29367,0.38763,1,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0049572,0.29142,0.35188,1,0
2,GO MICROTUBULE BUNDLE FORMATION,0.0029965,0.29058,0.31587,1,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.0029965,0.28577,0.29993,1,0
2,GO NEURON RECOGNITION,0.0092139,0.28467,0.26347,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0013481,0.28065,0.35324,1,0
2,GO CELL JUNCTION MAINTENANCE,0.014457,0.27864,0.26938,1,0
2,GO RESPONSE TO ACETYLCHOLINE,0.0021907,0.27851,0.34313,1,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.028348,0.27787,0.22438,1,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00332,0.2762,0.25817,1,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.00068502,0.2737,0.29251,1,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0012071,0.27179,0.28748,1,0
2,GO DOSAGE COMPENSATION,0.0057394,0.26741,0.28508,1,0
2,GO MECHANOSENSORY BEHAVIOR,0.012106,0.26707,0.40733,1,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0042727,0.26606,0.30392,1,0
2,GO COLLATERAL SPROUTING,0.011574,0.26342,0.26681,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0017696,0.26253,0.31293,1,0
2,GO MUSCLE FIBER DEVELOPMENT,0.0060238,0.25947,0.23912,1,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0042727,0.25889,0.2824,1,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00048214,0.25766,0.33857,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0013481,0.25237,0.32299,1,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.030713,0.25,0.23307,1,0
2,GO PROTEIN POLYGLUTAMYLATION,0.0092139,0.24936,0.29772,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0047188,0.24875,0.35101,1,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.0014241,0.24667,0.31712,1,0
2,GO PROTEIN PALMITOYLATION,0.0015041,0.24654,0.30331,1,0
2,GO CHROMATIN SILENCING,0.0012071,0.24317,0.27015,1,0
2,GO RESPONSE TO NICOTINE,0.00332,0.24092,0.26799,1,0
2,GO PROTEIN DEMETHYLATION,0.0029965,0.24084,0.29132,1,0
2,GO HISTONE H4 K5 ACETYLATION,0.0031545,0.2384,0.25487,1,0
2,GO NEURON PROJECTION GUIDANCE,0.0038653,0.23797,0.28582,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.019548,0.23714,0.32974,1,0
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.00332,0.23479,0.28921,1,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.019548,0.23368,0.25867,1,0
2,GO FOREBRAIN CELL MIGRATION,0.0012071,0.23263,0.28789,1,0
2,GO MYELIN MAINTENANCE,0.045233,0.23247,0.21173,1,0
2,GO RESPONSE TO GLUCAGON,0.023112,0.23156,0.20998,1,0
2,GO COLLECTING DUCT DEVELOPMENT,0.007293,0.23074,0.32119,1,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.043559,0.22883,0.21973,1,0
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0018673,0.2284,0.29068,1,0
2,GO TONGUE DEVELOPMENT,0.028348,0.2273,0.18871,1,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.0063209,0.22592,0.31709,1,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0172,0.22556,0.20387,1,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0027019,0.22551,0.27971,1,0
2,GO AXONEME ASSEMBLY,0.028348,0.22499,0.29829,1,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0076456,0.22322,0.2744,1,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0014241,0.22204,0.29361,1,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0066311,0.22106,0.25456,1,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.010101,0.22065,0.22379,1,0
2,GO SYNAPTIC VESICLE TRANSPORT,0.011063,0.21953,0.20346,1,0
2,GO MYOTUBE CELL DEVELOPMENT,0.016475,0.21891,0.18101,1,0
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0012758,0.21659,0.28398,1,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.012106,0.2154,0.23192,1,0
2,GO NEURAL TUBE DEVELOPMENT,0.014457,0.21464,0.21269,1,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0028457,0.21399,0.29669,1,0
2,GO HISTONE DEUBIQUITINATION,0.011574,0.21384,0.25927,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.043559,0.2138,0.26422,1,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.020391,0.21348,0.26553,1,0
2,GO CILIUM MOVEMENT,0.0096484,0.21319,0.26121,1,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0052065,0.21277,0.28563,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.024086,0.21254,0.35813,1,0
2,GO DEVELOPMENTAL CELL GROWTH,0.010101,0.21135,0.21959,1,0
2,GO REGULATION OF TORC1 SIGNALING,0.0015041,0.211,0.27497,1,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.018736,0.21044,0.23755,1,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.010101,0.20981,0.2661,1,0
2,GO CELL MIGRATION IN HINDBRAIN,0.041938,0.20779,0.23945,1,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0096484,0.20756,0.22359,1,0
2,GO CELL FATE SPECIFICATION,0.010572,0.20741,0.22516,1,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0172,0.20582,0.22939,1,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.010101,0.20564,0.28039,1,0
2,GO NEURON FATE COMMITMENT,0.007293,0.20545,0.26136,1,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0034935,0.20497,0.26321,1,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.00332,0.20258,0.24794,1,0
2,GO TUBULIN DEACETYLATION,0.035953,0.20097,0.21601,1,0
2,GO NEURON PROJECTION ORGANIZATION,0.0024341,0.20049,0.26513,1,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0044907,0.20028,0.24648,1,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.033245,0.19936,0.23475,1,0
2,GO HISTONE H4 ACETYLATION,0.0015041,0.19732,0.24365,1,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.0076456,0.19575,0.24042,1,0
2,GO HEART VALVE FORMATION,0.016475,0.19558,0.30109,1,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.048745,0.19347,0.3321,1,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.0092139,0.19294,0.23087,1,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.016475,0.19228,0.2079,1,0
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.030713,0.19214,0.22243,1,0
2,GO REGULATION OF ACTION POTENTIAL,0.011063,0.19207,0.19968,1,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.010572,0.19177,0.21288,1,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.00024771,0.19101,0.27288,1,0
2,GO PROTEIN ACYLATION,0.0013481,0.19058,0.24151,1,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.035953,0.19055,0.23272,1,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0063209,0.19014,0.2023,1,0
2,GO HETEROCHROMATIN ORGANIZATION,0.0031545,0.18905,0.25778,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,0.024086,0.18852,0.28077,1,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.040368,0.18635,0.20636,1,0
2,GO COVALENT CHROMATIN MODIFICATION,0.0013481,0.18576,0.25987,1,0
2,GO NEUROTRANSMITTER REUPTAKE,0.01266,0.18501,0.22653,1,0
2,GO MEMORY,0.0080134,0.18384,0.19283,1,0
2,GO SYNAPTIC VESICLE MATURATION,0.045233,0.18243,0.27099,1,0
2,GO ACTIN CROSSLINK FORMATION,0.006955,0.18173,0.29677,1,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.014457,0.18122,0.21568,1,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.026142,0.18116,0.26342,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.016475,0.18116,0.2238,1,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0052065,0.18086,0.20967,1,0
2,GO CHROMATIN ORGANIZATION,0.00096503,0.18018,0.2676,1,0
2,GO FUCOSYLATION,0.041938,0.18013,0.15915,1,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.031957,0.17972,0.17286,1,0
2,GO LYSINE METABOLIC PROCESS,0.038848,0.1794,0.21806,1,0
2,GO LACTATION,0.033245,0.17933,0.19365,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0066311,0.1789,0.23368,1,0
2,GO REGULATION OF AXON GUIDANCE,0.045233,0.17823,0.21786,1,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.028348,0.17791,0.17843,1,0
2,GO REGULATION OF CELL SIZE,0.0080134,0.17725,0.22842,1,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,0.010101,0.17674,0.16522,1,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.010101,0.17553,0.21585,1,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0092139,0.17534,0.23821,1,0
2,GO LONG TERM MEMORY,0.048745,0.17502,0.19035,1,0
2,GO SCHWANN CELL DEVELOPMENT,0.027226,0.17484,0.21395,1,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.015104,0.17481,0.21171,1,0
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00332,0.1747,0.19932,1,0
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.015104,0.17282,0.22741,1,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.022172,0.17248,0.16607,1,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.006955,0.17185,0.2059,1,0
2,GO PROTEIN ACETYLATION,0.0014241,0.17159,0.23189,1,0
2,GO NEUROTRANSMITTER UPTAKE,0.012106,0.17157,0.20094,1,0
2,GO SCHWANN CELL DIFFERENTIATION,0.017954,0.17072,0.22227,1,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0080134,0.17014,0.22698,1,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.006955,0.16987,0.20995,1,0
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.010101,0.16936,0.23835,1,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.011574,0.16901,0.17624,1,0
2,GO MRNA MODIFICATION,0.011574,0.16879,0.1763,1,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0096484,0.1678,0.21988,1,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.018736,0.16741,0.20635,1,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.027226,0.16706,0.20559,1,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.0015041,0.16687,0.23324,1,0
2,GO PROTEIN DEPOLYMERIZATION,0.0028457,0.16681,0.23687,1,0
2,GO TELOMERE CAPPING,0.018736,0.16612,0.19942,1,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.019548,0.165,0.21218,1,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.037377,0.16469,0.26305,1,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.040368,0.16467,0.25434,1,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.023112,0.16419,0.22302,1,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.0015882,0.16403,0.23675,1,0
2,GO REGULATION OF TOR SIGNALING,0.0063209,0.16384,0.20417,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.012106,0.16359,0.21904,1,0
2,GO TUBE FORMATION,0.020391,0.163,0.186,1,0
2,GO PRESYNAPTIC ENDOCYTOSIS,0.006955,0.16108,0.21717,1,0
2,GO OXIDATIVE DEMETHYLATION,0.031957,0.16061,0.1883,1,0
2,GO CELL PROJECTION ASSEMBLY,0.0044907,0.1597,0.20761,1,0
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0096484,0.15932,0.20127,1,0
2,GO REGULATION OF TELOMERE CAPPING,0.043559,0.15916,0.18537,1,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.013235,0.15901,0.20393,1,0
2,GO REGULATION OF TELOMERE MAINTENANCE,0.013834,0.15883,0.1917,1,0
2,GO FUCOSE METABOLIC PROCESS,0.013235,0.15876,0.17546,1,0
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.0019699,0.15822,0.22153,1,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.025096,0.15711,0.20928,1,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.045233,0.15564,0.29511,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.015776,0.15543,0.25748,1,0
2,GO CELL JUNCTION ORGANIZATION,0.0092139,0.15533,0.20769,1,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0020776,0.15479,0.18428,1,0
2,GO DENDRITE EXTENSION,0.013834,0.15446,0.23695,1,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.022172,0.15219,0.18892,1,0
2,GO REGULATION OF CELL DEVELOPMENT,0.0060238,0.15008,0.1994,1,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.033245,0.14957,0.17695,1,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.01266,0.14935,0.22414,1,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.037377,0.14903,0.12833,1,0
2,GO REGULATION OF HISTONE MODIFICATION,0.0042727,0.14856,0.20655,1,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0080134,0.14844,0.19794,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,0.015104,0.14737,0.22198,1,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0083971,0.14689,0.21745,1,0
2,GO STEM CELL PROLIFERATION,0.021265,0.14651,0.19928,1,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.033245,0.14591,0.18572,1,0
2,GO POLYOL CATABOLIC PROCESS,0.0044907,0.14395,0.20844,1,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0096484,0.14383,0.21325,1,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.014457,0.14346,0.20191,1,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.030713,0.1432,0.13467,1,0
2,GO LYSOSOMAL TRANSPORT,0.0172,0.14308,0.19095,1,0
2,GO EYE MORPHOGENESIS,0.034576,0.14274,0.18719,1,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.0063209,0.14266,0.22666,1,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0060238,0.14256,0.16312,1,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.011574,0.14255,0.22754,1,0
2,GO CELL JUNCTION ASSEMBLY,0.026142,0.14249,0.19862,1,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.030713,0.1423,0.17172,1,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.021265,0.14223,0.1465,1,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.048745,0.14199,0.17419,1,0
2,GO MONOAMINE TRANSPORT,0.0096484,0.14181,0.24359,1,0
2,GO REGULATION OF RNA BINDING,0.031957,0.14175,0.13437,1,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.007293,0.1409,0.1874,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.040368,0.14084,0.1803,1,0
2,GO RESPONSE TO DOPAMINE,0.015104,0.14053,0.16873,1,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.015104,0.1404,0.18591,1,0
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.02951,0.13986,0.17188,1,0
2,GO MEMBRANE HYPERPOLARIZATION,0.038848,0.13899,0.24397,1,0
2,GO CYTOSKELETON ORGANIZATION,0.0080134,0.13869,0.18914,1,0
2,GO HAIR CELL DIFFERENTIATION,0.015776,0.13846,0.19938,1,0
2,GO CARDIAC CONDUCTION,0.033245,0.13838,0.16068,1,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0083971,0.13822,0.2094,1,0
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.013235,0.13813,0.16532,1,0
2,GO VISUAL BEHAVIOR,0.0057394,0.13723,0.19425,1,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.026142,0.1372,0.20601,1,0
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0042727,0.13675,0.19734,1,0
2,GO NEUROBLAST DIVISION,0.046961,0.13675,0.19013,1,0
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0019699,0.13502,0.19252,1,0
2,GO SENSORY ORGAN DEVELOPMENT,0.010101,0.1345,0.18989,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.013235,0.13411,0.19529,1,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.012106,0.13384,0.1711,1,0
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.028348,0.1338,0.18612,1,0
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.013834,0.13334,0.18519,1,0
2,GO POTASSIUM ION TRANSPORT,0.020391,0.13262,0.17688,1,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.019548,0.13252,0.20577,1,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.027226,0.13245,0.18174,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.024086,0.13216,0.25334,1,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.017954,0.13198,0.19511,1,0
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0047188,0.13015,0.19507,1,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,0.02951,0.13015,0.14829,1,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.006955,0.12914,0.17948,1,0
2,GO APPENDAGE DEVELOPMENT,0.013834,0.12857,0.20496,1,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.030713,0.12811,0.17576,1,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.01266,0.12772,0.16491,1,0
2,GO MULTI ORGANISM PROCESS,0.0044907,0.12754,0.16446,1,0
2,GO REGULATION OF HORMONE SECRETION,0.031957,0.12749,0.1553,1,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.015776,0.12739,0.17906,1,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.027226,0.12721,0.17571,1,0
2,GO RESPONSE TO ALKALOID,0.01266,0.12666,0.16805,1,0
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.041938,0.12637,0.20069,1,0
2,GO SPECIFICATION OF SYMMETRY,0.007293,0.12576,0.19686,1,0
2,GO ACTION POTENTIAL,0.0172,0.12545,0.1588,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.046961,0.12509,0.1988,1,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.040368,0.12503,0.14931,1,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.045233,0.12492,0.14149,1,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0060238,0.12245,0.14664,1,0
2,GO CYTOSOLIC TRANSPORT,0.045233,0.12148,0.15514,1,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.028348,0.12125,0.16215,1,0
2,GO MEMBRANE FISSION,0.043559,0.12124,0.17529,1,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.030713,0.1209,0.15025,1,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.034576,0.12073,0.1906,1,0
2,GO VACUOLAR TRANSPORT,0.043559,0.12053,0.15027,1,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.023112,0.11799,0.20559,1,0
2,GO REGULATION OF DNA BINDING,0.013235,0.11776,0.17339,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.045233,0.11763,0.18168,1,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.046961,0.11737,0.16668,1,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.043559,0.11729,0.12577,1,0
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0172,0.11592,0.14994,1,0
2,GO REGULATION OF EXOCYTOSIS,0.043559,0.11454,0.15632,1,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.048745,0.11398,0.14657,1,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.048745,0.11383,0.15553,1,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.038848,0.1132,0.14886,1,0
2,GO HORMONE TRANSPORT,0.034576,0.11315,0.15084,1,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.034576,0.11302,0.17221,1,0
2,GO REGULATION OF HISTONE UBIQUITINATION,0.013834,0.11288,0.18667,1,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,0.021265,0.11259,0.174,1,0
2,GO DEVELOPMENTAL MATURATION,0.031957,0.11188,0.16967,1,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.014457,0.11167,0.12921,1,0
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.0092139,0.11031,0.1632,1,0
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.030713,0.11026,0.13126,1,0
2,GO RESPIRATORY SYSTEM PROCESS,0.046961,0.10892,0.17503,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.035953,0.10878,0.14769,1,0
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.011063,0.10849,0.1444,1,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.048745,0.10814,0.16403,1,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.038848,0.10778,0.16297,1,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.01266,0.10663,0.1539,1,0
2,GO SEGMENT SPECIFICATION,0.038848,0.10656,0.20431,1,0
2,GO DEPHOSPHORYLATION,0.038848,0.10518,0.13217,1,0
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.018736,0.10277,0.15886,1,0
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.045233,0.10156,0.16963,1,0
2,GO MITOCHONDRIAL TRANSPORT,0.015776,0.10043,0.11563,1,0
2,GO VESICLE DOCKING,0.023112,0.099975,0.17406,1,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.026142,0.099529,0.13193,1,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.040368,0.099081,0.14742,1,0
2,GO PROTEIN STABILIZATION,0.048745,0.098124,0.11704,1,0
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.021265,0.097591,0.11702,1,0
2,GO REGULATION OF ATP METABOLIC PROCESS,0.035953,0.097458,0.13061,1,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.048745,0.096609,0.13792,1,0
2,GO MIDBRAIN DEVELOPMENT,0.027226,0.096519,0.14014,1,0
2,GO REGULATION OF SYSTEM PROCESS,0.034576,0.096179,0.1497,1,0
2,GO EAR MORPHOGENESIS,0.043559,0.095927,0.18164,1,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.015776,0.09577,0.17015,1,0
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.035953,0.095028,0.1436,1,0
2,GO SENSORY PERCEPTION,0.040368,0.094391,0.11687,1,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.045233,0.092067,0.14014,1,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.037377,0.091963,0.13771,1,0
2,GO MACROMOLECULE CATABOLIC PROCESS,0.048745,0.090318,0.10914,1,0
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.045233,0.089463,0.13687,1,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0052065,0.089296,0.12347,1,0
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.041938,0.089022,0.15013,1,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.030713,0.086324,0.20288,1,0
2,GO EMBRYO DEVELOPMENT,0.046961,0.082821,0.15875,1,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.028348,0.081089,0.1443,1,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.043559,0.080469,0.1334,1,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.043559,0.079759,0.12479,1,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.040368,0.079463,0.12562,1,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.046961,0.078071,0.14167,1,0
2,GO NUCLEOTIDE PHOSPHORYLATION,0.048745,0.077857,0.13623,1,0
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.037377,0.077243,0.12138,1,0
2,GO SODIUM ION TRANSPORT,0.048745,0.077134,0.14836,1,0
2,GO REGULATION OF GENE SILENCING,0.046961,0.076491,0.14328,1,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.028348,0.073801,0.24158,1,0
2,GO CELL FATE COMMITMENT,0.037377,0.071319,0.16387,1,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.037377,0.070686,0.095559,1,0
2,GO RETINA HOMEOSTASIS,0.035953,0.069635,0.14556,1,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.030713,0.067638,0.089874,1,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.037377,0.062821,0.095331,1,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.033245,0.061765,0.10391,1,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.040368,0.050932,0.082163,1,0
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.035953,-0.06969,-0.074908,1,0
2,GO URONIC ACID METABOLIC PROCESS,0.043559,-0.079983,-0.077057,1,0
2,GO POLYAMINE METABOLIC PROCESS,0.02951,-0.11123,-0.064675,1,0
2,GO HEMOGLOBIN METABOLIC PROCESS,0.024086,-0.13761,-0.095112,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.038848,-0.15383,-0.12518,1,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.034576,-0.17163,-0.17282,1,0
2,GO CELL CELL RECOGNITION,0.046961,-0.17179,-0.11386,1,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.048745,-0.17235,-0.12104,1,0
2,GO B CELL APOPTOTIC PROCESS,0.028348,-0.17261,-0.15288,1,0
2,GO GALACTOSE METABOLIC PROCESS,0.0172,-0.1861,-0.17275,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.040368,-0.19618,-0.21088,1,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.019548,-0.19696,-0.18278,1,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.01266,-0.1997,-0.17643,1,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.017954,-0.20903,-0.14739,1,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.013834,-0.21188,-0.1696,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.034576,-0.2149,-0.24648,1,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.028348,-0.2169,-0.34868,1,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.022172,-0.21811,-0.16304,1,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.041938,-0.22184,-0.23363,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.025096,-0.22213,-0.19867,1,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.030713,-0.22303,-0.21244,1,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.021265,-0.22326,-0.22182,1,0
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.045233,-0.22394,-0.26485,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.034576,-0.22446,-0.17886,1,0
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.0083971,-0.22714,-0.21232,1,0
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.016475,-0.22867,-0.1971,1,0
2,GO TROPHOBLAST CELL MIGRATION,0.046961,-0.23157,-0.12426,1,0
2,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.038848,-0.2318,-0.24876,1,0
2,GO LEUKOCYTE CHEMOTAXIS,0.048745,-0.23276,-0.24841,1,0
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.046961,-0.23289,-0.23607,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.035953,-0.23739,-0.27079,1,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0092139,-0.23753,-0.17038,1,0
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.041938,-0.23783,-0.2898,1,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.035953,-0.23795,-0.20231,1,0
2,GO MYELOID LEUKOCYTE MIGRATION,0.024086,-0.2384,-0.26327,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.046961,-0.24119,-0.24009,1,0
2,GO SIGNAL PEPTIDE PROCESSING,0.043559,-0.24328,-0.17071,1,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.010101,-0.2453,-0.16641,1,0
2,GO T CELL MEDIATED IMMUNITY,0.037377,-0.24536,-0.27737,1,0
2,GO INTERLEUKIN 1 PRODUCTION,0.040368,-0.24561,-0.2676,1,0
2,GO ICOSANOID BIOSYNTHETIC PROCESS,0.027226,-0.24594,-0.23622,1,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.037377,-0.24844,-0.19319,1,0
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0076456,-0.24902,-0.24892,1,0
2,GO RESPONSE TO FUNGUS,0.028348,-0.25,-0.23874,1,0
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.041938,-0.25054,-0.14324,1,0
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.023112,-0.25135,-0.24533,1,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.033245,-0.2535,-0.17009,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.046961,-0.25826,-0.1675,1,0
2,GO CELL KILLING,0.034576,-0.25852,-0.26675,1,0
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.028348,-0.26225,-0.2653,1,0
2,GO PROTEIN TRIMERIZATION,0.037377,-0.26238,-0.20324,1,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.033245,-0.26312,-0.31286,1,0
2,GO EMBRYO IMPLANTATION,0.033245,-0.26324,-0.16965,1,0
2,GO SEQUESTERING OF METAL ION,0.021265,-0.26673,-0.22585,1,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.043559,-0.26904,-0.25201,1,0
2,GO RESPIRATORY BURST,0.033245,-0.27,-0.29274,1,0
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.035953,-0.27021,-0.25138,1,0
2,GO REGULATION OF COAGULATION,0.025096,-0.27276,-0.22731,1,0
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.040368,-0.27276,-0.2928,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.02951,-0.27324,-0.28362,1,0
2,GO PROSTANOID BIOSYNTHETIC PROCESS,0.015104,-0.27363,-0.31119,1,0
2,GO ZYMOGEN ACTIVATION,0.024086,-0.27448,-0.21259,1,0
2,GO REGULATION OF B CELL PROLIFERATION,0.041938,-0.27471,-0.3096,1,0
2,GO GRANULOCYTE CHEMOTAXIS,0.016475,-0.27517,-0.32823,1,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013834,-0.27582,-0.24015,1,0
2,GO RESPONSE TO INTERFERON BETA,0.035953,-0.27763,-0.28149,1,0
2,GO IMMUNOGLOBULIN SECRETION,0.041938,-0.27878,-0.25881,1,0
2,GO REGULATION OF CELL KILLING,0.048745,-0.28343,-0.28379,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.021265,-0.28373,-0.27493,1,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.027226,-0.28442,-0.1908,1,0
2,GO GRANULOCYTE MIGRATION,0.015776,-0.28746,-0.3215,1,0
2,GO PLASMINOGEN ACTIVATION,0.0066311,-0.29178,-0.31441,1,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.019548,-0.29188,-0.33046,1,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.031957,-0.29215,-0.32213,1,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.043559,-0.29339,-0.24714,1,0
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.017954,-0.29431,-0.30794,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.021265,-0.29496,-0.29372,1,0
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.023112,-0.29804,-0.28287,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.025096,-0.29951,-0.32095,1,0
2,GO REGULATION OF MACROPHAGE MIGRATION,0.026142,-0.2997,-0.27021,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.043559,-0.29976,-0.33409,1,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.045233,-0.30039,-0.26623,1,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.030713,-0.30227,-0.18987,1,0
2,GO COLLAGEN METABOLIC PROCESS,0.045233,-0.30374,-0.18045,1,0
2,GO REGULATION OF T CELL MIGRATION,0.021265,-0.30694,-0.31499,1,0
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.046961,-0.30721,-0.2134,1,0
2,GO NEUTROPHIL MIGRATION,0.025096,-0.30914,-0.32626,1,0
2,GO SUPEROXIDE ANION GENERATION,0.043559,-0.30963,-0.24712,1,0
2,GO RESPONSE TO CHEMOKINE,0.030713,-0.3098,-0.33135,1,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.046961,-0.31052,-0.27107,1,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.034576,-0.31136,-0.22097,1,0
2,GO DEFENSE RESPONSE TO FUNGUS,0.0044907,-0.31184,-0.31845,1,0
2,GO NEGATIVE REGULATION OF CELL KILLING,0.035953,-0.31198,-0.38334,1,0
2,GO MACROPHAGE CHEMOTAXIS,0.045233,-0.3121,-0.23169,1,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.048745,-0.31219,-0.27458,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.035953,-0.31486,-0.27539,1,0
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.020391,-0.31547,-0.22866,1,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.041938,-0.31555,-0.25062,1,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.041938,-0.31644,-0.20215,1,0
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.040368,-0.31804,-0.27658,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.041938,-0.31867,-0.28749,1,0
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.038848,-0.3187,-0.32235,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.0054671,-0.32,-0.37373,1,0
2,GO VITAMIN D METABOLIC PROCESS,0.031957,-0.3205,-0.2443,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.043559,-0.32096,-0.30855,1,0
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.041938,-0.3223,-0.28086,1,0
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.02951,-0.32307,-0.29242,1,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.041938,-0.32327,-0.26318,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.023112,-0.32333,-0.33286,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.024086,-0.32376,-0.29885,1,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.046961,-0.32716,-0.24641,1,0
2,GO CELL JUNCTION DISASSEMBLY,0.037377,-0.3272,-0.30332,1,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.041938,-0.32895,-0.33122,1,0
2,GO LYMPHOCYTE MIGRATION,0.048745,-0.32933,-0.29762,1,0
2,GO TYPE 2 IMMUNE RESPONSE,0.045233,-0.32948,-0.31562,1,0
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.023112,-0.33008,-0.30027,1,0
2,GO PEPTIDE CROSS LINKING,0.020391,-0.33131,-0.3019,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.037377,-0.33292,-0.34859,1,0
2,GO FIBRINOLYSIS,0.018736,-0.33361,-0.30506,1,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0036751,-0.33528,-0.29093,1,0
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.028348,-0.33564,-0.31648,1,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.033245,-0.33645,-0.27814,1,0
2,GO NEUTROPHIL CHEMOTAXIS,0.023112,-0.33758,-0.3447,1,0
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.021265,-0.3412,-0.30302,1,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.027226,-0.34163,-0.34261,1,0
2,GO REGULATION OF T CELL CHEMOTAXIS,0.011063,-0.34222,-0.4187,1,0
2,GO DECIDUALIZATION,0.037377,-0.34283,-0.2219,1,0
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.016475,-0.34499,-0.27472,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.027226,-0.34598,-0.36994,1,0
2,GO HUMORAL IMMUNE RESPONSE,0.026142,-0.34986,-0.27193,1,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.048745,-0.35015,-0.3374,1,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.035953,-0.3505,-0.41062,1,0
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.019548,-0.35239,-0.39037,1,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.048745,-0.3542,-0.27571,1,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.026142,-0.35461,-0.24621,1,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.043559,-0.3558,-0.33658,1,0
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.014457,-0.35616,-0.41241,1,0
2,GO DENDRITIC CELL DIFFERENTIATION,0.041938,-0.35755,-0.37031,1,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.027226,-0.35887,-0.32634,1,0
2,GO T CELL MEDIATED CYTOTOXICITY,0.016475,-0.36036,-0.40359,1,0
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.024086,-0.36089,-0.33904,1,0
2,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0040644,-0.36138,-0.37389,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.015776,-0.36158,-0.29056,1,0
2,GO T CELL CHEMOTAXIS,0.019548,-0.36426,-0.42333,1,0
2,GO DENDRITIC CELL MIGRATION,0.035953,-0.36624,-0.37529,1,0
2,GO T CELL MIGRATION,0.024086,-0.36811,-0.33774,1,0
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.026142,-0.37031,-0.31614,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.011574,-0.37663,-0.33867,1,0
2,GO INTERLEUKIN 10 PRODUCTION,0.013235,-0.37807,-0.38763,1,0
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.019548,-0.37843,-0.36039,1,0
2,GO APOPTOTIC CELL CLEARANCE,0.048745,-0.37946,-0.26549,1,0
2,GO RESPONSE TO LIPOTEICHOIC ACID,0.022172,-0.37949,-0.33997,1,0
2,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.014457,-0.38329,-0.36652,1,0
2,GO REGULATION OF FIBRINOLYSIS,0.010101,-0.3835,-0.316,1,0
2,GO LIPOXYGENASE PATHWAY,0.015104,-0.38533,-0.30949,1,0
2,GO HISTAMINE SECRETION,0.025096,-0.38571,-0.28037,1,0
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.048745,-0.38571,-0.31301,1,0
2,GO INTERLEUKIN 13 PRODUCTION,0.024086,-0.38651,-0.36446,1,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.01266,-0.38823,-0.40156,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.013834,-0.38825,-0.36918,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010572,-0.38863,-0.323,1,0
2,GO COLLAGEN CATABOLIC PROCESS,0.024086,-0.38875,-0.25634,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.013834,-0.38977,-0.37896,1,0
2,GO MUCUS SECRETION,0.0080134,-0.39575,-0.32513,1,0
2,GO REGULATION OF PLATELET ACTIVATION,0.015776,-0.39645,-0.32035,1,0
2,GO MONONUCLEAR CELL MIGRATION,0.0076456,-0.39677,-0.39445,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.037377,-0.39754,-0.3312,1,0
2,GO CHEMOKINE SECRETION,0.016475,-0.39775,-0.38271,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.043559,-0.39781,-0.30976,1,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0083971,-0.39814,-0.38106,1,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.041938,-0.40085,-0.27961,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.014457,-0.40662,-0.41981,1,0
2,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.035953,-0.40934,-0.46182,1,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.01266,-0.4094,-0.41325,1,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.031957,-0.40998,-0.37898,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.031957,-0.41171,-0.34984,1,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.013235,-0.41514,-0.34759,1,0
2,GO DENDRITIC CELL CHEMOTAXIS,0.024086,-0.42413,-0.41589,1,0
2,GO INTERLEUKIN 4 PRODUCTION,0.026142,-0.42687,-0.34472,1,0
2,GO HYPERSENSITIVITY,0.017954,-0.4282,-0.48058,1,0
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.007293,-0.42882,-0.40687,1,0
2,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.018736,-0.42888,-0.38181,1,0
2,GO CELLULAR DEFENSE RESPONSE,0.026142,-0.43046,-0.37712,1,0
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.028348,-0.43664,-0.32702,1,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.012106,-0.43788,-0.39322,1,0
2,GO LYMPHOCYTE CHEMOTAXIS,0.023112,-0.43994,-0.39808,1,0
2,GO CYCLOOXYGENASE PATHWAY,0.011063,-0.44091,-0.41591,1,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.041938,-0.45181,-0.31456,1,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.008797,-0.45254,-0.43487,1,0
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.017954,-0.46295,-0.416,1,0
2,GO CYTOLYSIS,0.045233,-0.46577,-0.38676,1,0
2,GO TOLERANCE INDUCTION,0.037377,-0.46605,-0.45988,1,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.030713,-0.47513,-0.43844,1,0
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.017954,-0.48399,-0.39472,1,0
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.012106,-0.48451,-0.45194,1,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.011574,-0.48785,-0.4523,1,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.027226,-0.49176,-0.49243,1,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.01266,-0.49265,-0.43253,1,0
2,GO COMPLEMENT ACTIVATION,0.01266,-0.49388,-0.39882,1,0
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0083971,-0.49421,-0.43845,1,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.013834,-0.49423,-0.46614,1,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.035953,-0.49633,-0.36501,1,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.022172,-0.49763,-0.49695,1,0
2,GO T CELL TOLERANCE INDUCTION,0.048745,-0.50523,-0.45378,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.011574,-0.50615,-0.50272,1,0
2,GO MONOCYTE CHEMOTAXIS,0.0034935,-0.50762,-0.48342,1,0
2,GO REGULATION OF TOLERANCE INDUCTION,0.046961,-0.51213,-0.44771,1,0
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.013235,-0.51418,-0.40382,1,0
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.013834,-0.52267,-0.40221,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0060238,-0.52319,-0.43014,1,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.02951,-0.52447,-0.36524,1,0
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.007293,-0.53538,-0.54382,1,0
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.020391,-0.53739,-0.4278,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0080134,-0.54311,-0.50555,1,0
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.0027019,-0.54444,-0.47925,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0015882,-0.5631,-0.49045,1,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.011574,-0.58005,-0.51549,1,0
2,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.041938,-0.58855,-0.52501,1,0
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0052065,-0.59041,-0.56231,1,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.018736,-0.59255,-0.51264,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.01266,-0.5977,-0.49638,1,0
2,GO SYNAPSE PRUNING,0.0063209,-0.61077,-0.62576,1,0
2,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.0047188,-0.6129,-0.52463,1,0
2,GO REGULATION OF NEUTROPHIL ACTIVATION,0.010572,-0.62389,-0.46431,1,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0036751,-0.69818,-0.68088,1,0
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0076456,-0.73532,-0.70881,1,0
2,GO EOSINOPHIL MIGRATION,0.0028457,-0.7354,-0.60917,1,0
2,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.0057394,-0.78295,-0.74754,1,0
2,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.02951,-0.78448,-0.61782,1,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.10811,0.27146,0.22893,0,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.26442,0.24797,0.11995,0,1
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.060677,0.24783,0.1582,0,1
2,GO AMMONIUM ION METABOLIC PROCESS,0.1475,0.24724,0.16616,0,1
2,GO PARTURITION,0.08588,0.23893,0.15135,0,1
2,GO MIDGUT DEVELOPMENT,0.056456,0.2373,0.1823,0,1
2,GO EXPLORATION BEHAVIOR,0.077559,0.22983,0.16509,0,1
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.1475,0.22649,0.20921,0,1
2,GO CYSTEINE METABOLIC PROCESS,0.054439,0.22597,0.2011,0,1
2,GO SKELETAL MUSCLE ADAPTATION,0.12273,0.21298,0.14134,0,1
2,GO CGMP METABOLIC PROCESS,0.12662,0.21006,0.15432,0,1
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.16123,0.20271,0.29796,0,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.094909,0.20146,0.18461,0,1
2,GO BICARBONATE TRANSPORT,0.13467,0.2005,0.14722,0,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.067497,0.19834,0.19216,0,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.11524,0.18789,0.14111,0,1
2,GO RESPONSE TO VITAMIN A,0.060677,0.18753,0.14146,0,1
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.069906,0.187,0.18525,0,1
2,GO CELLULAR RESPONSE TO PH,0.052482,0.18136,0.16984,0,1
2,GO RESPONSE TO ETHER,0.08881,0.18086,0.15377,0,1
2,GO DORSAL AORTA DEVELOPMENT,0.19156,0.17988,0.17222,0,1
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.056456,0.17923,0.15854,0,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.080256,0.17813,0.19114,0,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.080256,0.17548,0.16418,0,1
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.197,0.17517,0.10248,0,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.058535,0.17418,0.16854,0,1
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.1475,0.17171,0.15014,0,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.15655,0.17106,0.14236,0,1
2,GO BILE ACID METABOLIC PROCESS,0.074935,0.16998,0.12611,0,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.20256,0.1673,0.15909,0,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.17091,0.16295,0.15848,0,1
2,GO THYROID GLAND DEVELOPMENT,0.062884,0.1609,0.18771,0,1
2,GO REGULATION OF RECEPTOR RECYCLING,0.16123,0.15999,0.13266,0,1
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.21989,0.15797,0.11135,0,1
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.052482,0.15766,0.17357,0,1
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.058535,0.15687,0.1388,0,1
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.16602,0.15631,0.17918,0,1
2,GO OVULATION CYCLE PROCESS,0.054439,0.15351,0.16554,0,1
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.12662,0.15283,0.13693,0,1
2,GO MITOCHONDRIAL RNA PROCESSING,0.14312,0.15203,0.10295,0,1
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.16123,0.1517,0.17687,0,1
2,GO PORE COMPLEX ASSEMBLY,0.080256,0.14728,0.11333,0,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.056456,0.14612,0.14607,0,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.069906,0.14505,0.1502,0,1
2,GO RECEPTOR RECYCLING,0.15197,0.14314,0.13015,0,1
2,GO INTRACELLULAR STEROL TRANSPORT,0.067497,0.14297,0.17834,0,1
2,GO SELECTIVE AUTOPHAGY,0.10468,0.14147,0.13173,0,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.052482,0.14137,0.1796,0,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.077559,0.14104,0.1655,0,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,0.062884,0.14047,0.13488,0,1
2,GO PURINE NUCLEOTIDE TRANSPORT,0.08303,0.1391,0.12501,0,1
2,GO ACTIVATION OF MAPKK ACTIVITY,0.058535,0.13813,0.19076,0,1
2,GO WHITE FAT CELL DIFFERENTIATION,0.12273,0.13574,0.14514,0,1
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.062884,0.13574,0.11231,0,1
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.067497,0.13553,0.14624,0,1
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.056456,0.13525,0.16356,0,1
2,GO LEFT RIGHT PATTERN FORMATION,0.069906,0.1347,0.17888,0,1
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.050584,0.13374,0.15426,0,1
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.052482,0.13201,0.15047,0,1
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.16123,0.12956,0.14172,0,1
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.14312,0.12879,0.10518,0,1
2,GO PROTEIN REFOLDING,0.08588,0.12832,0.15134,0,1
2,GO TOXIN TRANSPORT,0.13467,0.12728,0.1163,0,1
2,GO MANGANESE ION TRANSPORT,0.214,0.12621,0.11337,0,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.08881,0.12583,0.21554,0,1
2,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.16602,0.12539,0.1512,0,1
2,GO PROSTATIC BUD FORMATION,0.18624,0.12376,0.12961,0,1
2,GO REGULATION OF PROTEIN DEACETYLATION,0.060677,0.12262,0.16095,0,1
2,GO RESPONSE TO CAFFEINE,0.08588,0.12218,0.1185,0,1
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.067497,0.12157,0.14551,0,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.12662,0.12125,0.14786,0,1
2,GO NCRNA CATABOLIC PROCESS,0.094909,0.12081,0.11032,0,1
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.41494,0.12059,0.071137,0,1
2,GO NUCLEOTIDE TRANSPORT,0.14312,0.12049,0.10894,0,1
2,GO IMP METABOLIC PROCESS,0.66333,0.11923,0.044198,0,1
2,GO REGULATION OF VASCULOGENESIS,0.42405,0.11909,0.099654,0,1
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.26442,0.11801,0.1318,0,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.08303,0.11662,0.12171,0,1
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.060677,0.11659,0.14036,0,1
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.27126,0.11557,0.10217,0,1
2,GO LIPOPROTEIN METABOLIC PROCESS,0.052482,0.11541,0.12457,0,1
2,GO KIDNEY MORPHOGENESIS,0.062884,0.1151,0.18086,0,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.14312,0.11462,0.11114,0,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.069906,0.1142,0.12296,0,1
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.052482,0.11338,0.19096,0,1
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.08881,0.11191,0.13002,0,1
2,GO PYRUVATE METABOLIC PROCESS,0.08881,0.11145,0.12803,0,1
2,GO RNA DECAPPING,0.10468,0.11122,0.14645,0,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.054439,0.10991,0.15311,0,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.067497,0.10833,0.1486,0,1
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.25111,0.10782,0.11104,0,1
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.065157,0.10747,0.12643,0,1
2,GO VESICLE CARGO LOADING,0.094909,0.10718,0.13789,0,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.26442,0.10715,0.10793,0,1
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.060677,0.10705,0.11471,0,1
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.077559,0.1069,0.17973,0,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.11163,0.1059,0.12252,0,1
2,GO AUTOPHAGY OF MITOCHONDRION,0.069906,0.10551,0.12935,0,1
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11524,0.10547,0.098957,0,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.19156,0.10533,0.11835,0,1
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.08881,0.10517,0.1255,0,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.11894,0.10399,0.069279,0,1
2,GO THIOESTER METABOLIC PROCESS,0.054439,0.10322,0.10067,0,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.18102,0.10161,0.13442,0,1
2,GO REGULATION OF PROTON TRANSPORT,0.060677,0.10099,0.14353,0,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.12662,0.10098,0.1113,0,1
2,GO GLUTAMATE METABOLIC PROCESS,0.056456,0.10023,0.17077,0,1
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.067497,0.099826,0.099589,0,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.056456,0.099463,0.13219,0,1
2,GO NEURON APOPTOTIC PROCESS,0.10811,0.099322,0.11661,0,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.10134,0.099243,0.11678,0,1
2,GO RHYTHMIC BEHAVIOR,0.056456,0.099042,0.14227,0,1
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.054439,0.098671,0.12278,0,1
2,GO VIRAL RNA GENOME REPLICATION,0.094909,0.098333,0.13935,0,1
2,GO NEPHRON MORPHOGENESIS,0.098083,0.097342,0.15965,0,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.077559,0.095891,0.092434,0,1
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.15655,0.094564,0.11055,0,1
2,GO POLYOL METABOLIC PROCESS,0.067497,0.09362,0.12469,0,1
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.08881,0.093574,0.14981,0,1
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.17091,0.093228,0.10068,0,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.2577,0.093199,0.081312,0,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.12273,0.091689,0.1204,0,1
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.098083,0.09042,0.07894,0,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.214,0.089882,0.098603,0,1
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.37964,0.086615,0.089293,0,1
2,GO CELLULAR SENESCENCE,0.1475,0.084212,0.1111,0,1
2,GO DENDRITIC SPINE MAINTENANCE,0.33821,0.084033,0.11906,0,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.054439,0.08403,0.08724,0,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.23827,0.083083,0.081157,0,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.32248,0.081368,0.061844,0,1
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.050584,0.080641,0.12776,0,1
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.13885,0.080256,0.11861,0,1
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.25111,0.080141,0.055237,0,1
2,GO ER OVERLOAD RESPONSE,0.16123,0.077722,0.11266,0,1
2,GO NEURON DEATH,0.19156,0.077251,0.11376,0,1
2,GO REGULATION OF PROTEIN LOCALIZATION,0.16602,0.077177,0.10843,0,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.1306,0.077004,0.11291,0,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.2577,0.076334,0.069944,0,1
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.53179,0.075259,0.044649,0,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.098083,0.074622,0.1172,0,1
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.17591,0.073336,0.10202,0,1
2,GO PROTEIN ADP RIBOSYLATION,0.67486,0.073292,0.049589,0,1
2,GO AUTOPHAGOSOME ORGANIZATION,0.18102,0.073172,0.1146,0,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.08881,0.072356,0.15154,0,1
2,GO REGULATION OF ERAD PATHWAY,0.20822,0.071513,0.087971,0,1
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.20256,0.071063,0.15745,0,1
2,GO FATTY ACYL COA METABOLIC PROCESS,0.08303,0.070872,0.11763,0,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.20822,0.070415,0.10876,0,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.18624,0.06949,0.10551,0,1
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.214,0.068828,0.10114,0,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.34626,0.068685,0.056566,0,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.27821,0.068504,0.049733,0,1
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.10468,0.067906,0.1333,0,1
2,GO ALDITOL METABOLIC PROCESS,0.38829,0.067796,0.093045,0,1
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.53179,0.067265,0.056952,0,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.28529,0.065203,0.06983,0,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.23827,0.062903,0.092543,0,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.27126,0.061438,0.085824,0,1
2,GO PEPTIDE METABOLIC PROCESS,0.08588,0.051893,0.057051,0,1
2,GO GOLGI VESICLE BUDDING,0.43329,0.050273,0.075023,0,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.54223,0.049223,0.041783,0,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.23203,0.048759,0.080726,0,1
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.1475,0.046955,0.074471,0,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.41494,0.046373,0.030901,0,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.25111,0.044943,0.069282,0,1
2,GO PROTEIN DESTABILIZATION,0.39705,0.043175,0.08368,0,1
2,GO HORMONE BIOSYNTHETIC PROCESS,0.53179,0.042224,0.06239,0,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.10468,0.033937,0.06,0,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.46168,0.027687,0.044045,0,1
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.028348,0.44699,0.39044,0,0
2,GO REGULATION OF CENTRIOLE REPLICATION,4.8997e-05,0.38369,0.39847,0,0
2,GO LIMB BUD FORMATION,0.007293,0.37938,0.35329,0,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.013235,0.36522,0.26783,0,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0044907,0.3565,0.33519,0,0
2,GO REPRODUCTIVE BEHAVIOR,0.00064645,0.3379,0.34714,0,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.028348,0.33572,0.27933,0,0
2,GO AXONAL FASCICULATION,0.0023095,0.33304,0.33085,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.0020776,0.33255,0.37301,0,0
2,GO SUCKLING BEHAVIOR,0.0036751,0.32122,0.33308,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.10468,0.31962,0.31765,0,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.077559,0.29186,0.20221,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0025648,0.29129,0.31704,0,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.065157,0.29049,0.24196,0,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.008797,0.28843,0.28309,0,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.0016767,0.2851,0.34063,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.0040644,0.28272,0.28541,0,0
2,GO NUCLEUS LOCALIZATION,0.00091199,0.28265,0.39119,0,0
2,GO DNA STRAND ELONGATION,0.0012758,0.27708,0.2788,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.00048214,0.27525,0.26907,0,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0057394,0.27489,0.26263,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.0021907,0.27307,0.28493,0,0
2,GO MAGNESIUM ION HOMEOSTASIS,0.0028457,0.26909,0.35184,0,0
2,GO GROOMING BEHAVIOR,0.020391,0.26756,0.27335,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0027019,0.26733,0.29546,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00048214,0.26485,0.30091,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.0017696,0.25479,0.29084,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.031957,0.25457,0.19473,0,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.065157,0.25284,0.18292,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.018736,0.25259,0.28305,0,0
2,GO PENILE ERECTION,0.045233,0.25094,0.32104,0,0
2,GO SIALYLATION,0.0028457,0.2494,0.30946,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.018736,0.24858,0.23457,0,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.013235,0.24719,0.22411,0,0
2,GO NUCLEAR MIGRATION,0.0017696,0.24505,0.38099,0,0
2,GO REGULATION OF GLUTAMATE SECRETION,0.065157,0.245,0.27598,0,0
2,GO PARENTAL BEHAVIOR,0.074935,0.24299,0.33785,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.16123,0.23923,0.15322,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.094909,0.23764,0.178,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.0057394,0.23733,0.223,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.072385,0.23513,0.23328,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.0012758,0.23222,0.26291,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.020391,0.23129,0.25251,0,0
2,GO TONGUE MORPHOGENESIS,0.1475,0.22523,0.1392,0,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,0.056456,0.22266,0.19948,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.065157,0.21944,0.22611,0,0
2,GO REGULATION OF EXIT FROM MITOSIS,0.0034935,0.21842,0.29108,0,0
2,GO RRNA 3 END PROCESSING,0.0025648,0.21796,0.17949,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.08881,0.21601,0.2064,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.012106,0.21584,0.21449,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.0034935,0.21386,0.28616,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.069906,0.21385,0.17664,0,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.050584,0.21346,0.25256,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.00076864,0.21248,0.29895,0,0
2,GO AZOLE TRANSMEMBRANE TRANSPORT,0.27821,0.2115,0.14197,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.02951,0.21001,0.25578,0,0
2,GO REGULATION OF HIPPO SIGNALING,0.023112,0.20959,0.2402,0,0
2,GO MATING,0.00332,0.20954,0.25515,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.00081392,0.20851,0.24001,0,0
2,GO REGULATION OF DNA REPAIR,0.00051151,0.20656,0.26274,0,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.00040321,0.20622,0.23915,0,0
2,GO MITOTIC DNA REPLICATION,0.02951,0.2045,0.21463,0,0
2,GO REGULATION OF HELICASE ACTIVITY,0.020391,0.20277,0.17488,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.12273,0.20218,0.17904,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.031957,0.20081,0.19909,0,0
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.00096503,0.1979,0.27969,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.040368,0.19638,0.18443,0,0
2,GO TRNA CATABOLIC PROCESS,0.011574,0.19602,0.23272,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0012071,0.19474,0.25348,0,0
2,GO HINDLIMB MORPHOGENESIS,0.030713,0.19415,0.20731,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.0172,0.19404,0.23833,0,0
2,GO STEM CELL DIVISION,0.11894,0.19366,0.18369,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.197,0.19228,0.17472,0,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.091819,0.19182,0.22664,0,0
2,GO HISTONE PHOSPHORYLATION,0.0027019,0.19137,0.21562,0,0
2,GO CHROMOSOME ORGANIZATION,0.00051151,0.19083,0.25761,0,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.10811,0.19053,0.19438,0,0
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.13467,0.18949,0.14081,0,0
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.080256,0.18943,0.21205,0,0
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.00332,0.18932,0.24514,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.10134,0.189,0.21652,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.050584,0.18831,0.18565,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.0080134,0.18709,0.23362,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.054439,0.18621,0.2113,0,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.027226,0.18618,0.22136,0,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.0096484,0.18578,0.23054,0,0
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.08588,0.18564,0.15065,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.013235,0.18506,0.25053,0,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0031545,0.18495,0.21433,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.050584,0.1849,0.22973,0,0
2,GO RNA 3 END PROCESSING,0.00096503,0.18456,0.20313,0,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.038848,0.18439,0.24328,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.080256,0.18435,0.21619,0,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.060677,0.18424,0.24108,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.091819,0.18355,0.23841,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.11163,0.18311,0.13448,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.0023095,0.18276,0.20599,0,0
2,GO MRNA EXPORT FROM NUCLEUS,0.00072571,0.18192,0.24352,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.08303,0.18177,0.18323,0,0
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.0066311,0.18159,0.21962,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.15197,0.18038,0.19019,0,0
2,GO DNA REPAIR,0.00042807,0.18031,0.24837,0,0
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.023112,0.17943,0.19596,0,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,0.10811,0.17869,0.23115,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.052482,0.17743,0.24035,0,0
2,GO REGULATION OF GTP BINDING,0.15655,0.17678,0.14622,0,0
2,GO FAT CELL PROLIFERATION,0.074935,0.1753,0.16922,0,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.056456,0.17466,0.25687,0,0
2,GO MRNA TRANSPORT,0.0012758,0.17428,0.21975,0,0
2,GO EXIT FROM MITOSIS,0.0020776,0.17209,0.23002,0,0
2,GO SOMATIC STEM CELL DIVISION,0.27126,0.17205,0.17564,0,0
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.016475,0.17133,0.20055,0,0
2,GO OXYGEN TRANSPORT,0.28529,0.17077,0.19941,0,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.069906,0.17034,0.23835,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.10134,0.17017,0.21414,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.16602,0.16992,0.13796,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0092139,0.16969,0.19104,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.054439,0.16956,0.16933,0,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.094909,0.16906,0.32154,0,0
2,GO ENERGY HOMEOSTASIS,0.043559,0.16729,0.18639,0,0
2,GO CELL AGGREGATION,0.074935,0.16717,0.18885,0,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.065157,0.16698,0.20924,0,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.13467,0.16696,0.14522,0,0
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.00068502,0.16654,0.23244,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.041938,0.16648,0.28135,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00096503,0.16576,0.22827,0,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.28529,0.16569,0.16027,0,0
2,GO DNA LIGATION,0.0020776,0.16509,0.19448,0,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.052482,0.16503,0.15297,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.040368,0.16444,0.18369,0,0
2,GO GANGLION DEVELOPMENT,0.19156,0.16365,0.13772,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.23203,0.16325,0.13178,0,0
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0010209,0.16317,0.20659,0,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.16602,0.16305,0.22239,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.20822,0.16287,0.36655,0,0
2,GO ERYTHROCYTE MATURATION,0.08881,0.16238,0.14702,0,0
2,GO REGULATION OF OOGENESIS,0.054439,0.16164,0.13697,0,0
2,GO DIVALENT METAL ION EXPORT,0.067497,0.16148,0.19455,0,0
2,GO SHORT TERM MEMORY,0.018736,0.16116,0.22345,0,0
2,GO SPERM AXONEME ASSEMBLY,0.018736,0.16084,0.23263,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.16602,0.16075,0.1773,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0028457,0.16064,0.233,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.00051151,0.16002,0.26293,0,0
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0017696,0.15989,0.2047,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.08303,0.1596,0.21087,0,0
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.0019699,0.15946,0.14917,0,0
2,GO WALKING BEHAVIOR,0.062884,0.15935,0.15328,0,0
2,GO DIENCEPHALON DEVELOPMENT,0.0096484,0.15884,0.24133,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.0092139,0.15883,0.21508,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.056456,0.15857,0.16036,0,0
2,GO C4 DICARBOXYLATE TRANSPORT,0.01266,0.15843,0.16859,0,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.2998,0.15786,0.14415,0,0
2,GO OOGENESIS,0.0012071,0.15778,0.22213,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.054439,0.15764,0.23433,0,0
2,GO COCHLEA DEVELOPMENT,0.017954,0.1573,0.22636,0,0
2,GO RESPONSE TO INACTIVITY,0.34626,0.15649,0.1074,0,0
2,GO NEURAL CREST FORMATION,0.058535,0.15633,0.25516,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.08303,0.15545,0.16562,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.14312,0.155,0.18812,0,0
2,GO EPITHELIAL TUBE FORMATION,0.033245,0.15458,0.17695,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.019548,0.15403,0.24875,0,0
2,GO NEURONAL ACTION POTENTIAL,0.08303,0.15354,0.14817,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.26442,0.15296,0.14035,0,0
2,GO GENE SILENCING,0.0044907,0.15295,0.1967,0,0
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.0019699,0.15163,0.21798,0,0
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.054439,0.15116,0.1865,0,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.035953,0.15005,0.16493,0,0
2,GO VIRAL LATENCY,0.015104,0.14981,0.17071,0,0
2,GO APPENDAGE MORPHOGENESIS,0.01266,0.14975,0.2247,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00057531,0.14936,0.19713,0,0
2,GO GLUTAMATE SECRETION,0.065157,0.14901,0.20299,0,0
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.034576,0.14881,0.17355,0,0
2,GO SALIVA SECRETION,0.20822,0.14849,0.13461,0,0
2,GO NEURAL TUBE FORMATION,0.074935,0.14839,0.1633,0,0
2,GO REGULATION OF CILIUM MOVEMENT,0.046961,0.14792,0.19304,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.0049572,0.14754,0.23948,0,0
2,GO RRNA TRANSCRIPTION,0.0092139,0.14707,0.16392,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00091199,0.147,0.22445,0,0
2,GO POSTREPLICATION REPAIR,0.0020776,0.14659,0.16793,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.2577,0.14613,0.13118,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.0038653,0.14492,0.19123,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0011418,0.1445,0.20823,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.08588,0.14442,0.20157,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.052482,0.14381,0.17174,0,0
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.10468,0.14373,0.15551,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.24463,0.14349,0.21821,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.08881,0.14344,0.20712,0,0
2,GO OOCYTE DIFFERENTIATION,0.023112,0.14321,0.15843,0,0
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00076864,0.14309,0.20888,0,0
2,GO NUCLEUS ORGANIZATION,0.0044907,0.14305,0.17737,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.016475,0.14286,0.20546,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.11524,0.14194,0.12938,0,0
2,GO BASE EXCISION REPAIR,0.0011418,0.1419,0.20905,0,0
2,GO NOTOCHORD DEVELOPMENT,0.10468,0.14159,0.19062,0,0
2,GO N GLYCAN PROCESSING,0.062884,0.14111,0.23316,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0066311,0.14094,0.17014,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.27821,0.14018,0.088415,0,0
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.08588,0.13958,0.21586,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.19156,0.13936,0.1777,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.011063,0.13889,0.25691,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.072385,0.13881,0.24662,0,0
2,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.19156,0.13869,0.15278,0,0
2,GO MULTICELLULAR ORGANISM AGING,0.28529,0.13848,0.098874,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0036751,0.13843,0.17575,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.074935,0.13833,0.21745,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.050584,0.13802,0.15075,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.006955,0.13791,0.19507,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.12662,0.13774,0.16343,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.214,0.13768,0.10057,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.17591,0.1375,0.11785,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.23827,0.137,0.12361,0,0
2,GO REFLEX,0.56341,0.13685,0.08074,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.11524,0.13613,0.15164,0,0
2,GO REGULATION OF GLUCOSE IMPORT,0.035953,0.1358,0.14144,0,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.34626,0.13555,0.11294,0,0
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.11894,0.13491,0.13988,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.014457,0.13488,0.1528,0,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.08881,0.13472,0.26595,0,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.074935,0.13461,0.11064,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.037377,0.1344,0.18831,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.08881,0.13432,0.1532,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.013834,0.13424,0.17561,0,0
2,GO MEMBRANE DEPOLARIZATION,0.23203,0.13325,0.12496,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.40594,0.13277,0.097017,0,0
2,GO GOLGI ORGANIZATION,0.030713,0.13257,0.15276,0,0
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.074935,0.13228,0.10263,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.15197,0.13223,0.12507,0,0
2,GO COCHLEA MORPHOGENESIS,0.14312,0.13205,0.16889,0,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.25111,0.13166,0.15663,0,0
2,GO INNER EAR MORPHOGENESIS,0.018736,0.13136,0.21942,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.065157,0.13025,0.24084,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.10468,0.13012,0.20077,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0042727,0.13002,0.18828,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.37964,0.13,0.12756,0,0
2,GO TRANSLESION SYNTHESIS,0.0052065,0.12978,0.15091,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.23827,0.12954,0.10221,0,0
2,GO RESPONSE TO AMINE,0.10468,0.12937,0.13554,0,0
2,GO NUCLEOTIDE EXCISION REPAIR,0.0017696,0.12882,0.16544,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0036751,0.12862,0.17953,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.86799,0.12848,0.068866,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.023112,0.12842,0.14147,0,0
2,GO MYELIN ASSEMBLY,0.074935,0.12791,0.19444,0,0
2,GO GENITALIA DEVELOPMENT,0.12662,0.12778,0.14448,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.012106,0.12746,0.14983,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.037377,0.12742,0.1623,0,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.069906,0.12732,0.20289,0,0
2,GO CHROMATIN DISASSEMBLY,0.20256,0.1272,0.13471,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.27821,0.12711,0.15131,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.054439,0.1263,0.13086,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.0060238,0.12618,0.14852,0,0
2,GO FIBROBLAST APOPTOTIC PROCESS,0.074935,0.12598,0.15593,0,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.27821,0.12586,0.10578,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.054439,0.1255,0.15885,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.016475,0.12548,0.22422,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.10468,0.12436,0.19946,0,0
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0023095,0.12429,0.16999,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.060677,0.12403,0.18098,0,0
2,GO INTRACELLULAR TRANSPORT,0.0063209,0.12397,0.13678,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.058535,0.12395,0.20809,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.15197,0.12387,0.070434,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.20256,0.12386,0.1468,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.011063,0.12356,0.20029,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.44264,0.12339,0.070612,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.13885,0.12317,0.18046,0,0
2,GO LATERAL MESODERM DEVELOPMENT,0.08303,0.1231,0.16936,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.36271,0.12208,0.13081,0,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.08588,0.12187,0.19656,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.017954,0.12168,0.13715,0,0
2,GO RRNA MODIFICATION,0.16602,0.1216,0.081288,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.014457,0.1215,0.17048,0,0
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0025648,0.12076,0.199,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.13885,0.12015,0.087626,0,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.080256,0.12004,0.20579,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.40594,0.11974,0.1965,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.214,0.11958,0.11095,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.14312,0.11947,0.13414,0,0
2,GO PIGMENT GRANULE LOCALIZATION,0.14312,0.11916,0.13167,0,0
2,GO REGULATION OF MRNA BINDING,0.12662,0.11889,0.093743,0,0
2,GO MEMBRANE BIOGENESIS,0.080256,0.11771,0.15307,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.12662,0.11763,0.19209,0,0
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.16602,0.11746,0.11321,0,0
2,GO DNA DEALKYLATION,0.08303,0.11738,0.12912,0,0
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.028348,0.11735,0.11755,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.84314,0.11696,0.002672,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.08881,0.11673,0.1775,0,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.08588,0.11655,0.13639,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.49108,0.11626,0.10805,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.14312,0.11597,0.13672,0,0
2,GO LACTATE METABOLIC PROCESS,0.024086,0.11597,0.14497,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.67486,0.11588,0.061772,0,0
2,GO ENDOCYTIC RECYCLING,0.11163,0.11583,0.16011,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.19156,0.11528,0.16807,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.10134,0.11505,0.23283,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.018736,0.11505,0.16913,0,0
2,GO RRNA METHYLATION,0.2259,0.11505,0.067117,0,0
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.15655,0.11492,0.070675,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.031957,0.11492,0.12802,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.052482,0.11488,0.15318,0,0
2,GO FATTY ACID CATABOLIC PROCESS,0.052482,0.11479,0.12241,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.2998,0.11452,0.13271,0,0
2,GO VITAMIN CATABOLIC PROCESS,0.25111,0.11447,0.1514,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.76963,0.11442,0.0046577,0,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.2577,0.11427,0.10778,0,0
2,GO SIGNAL RELEASE,0.067497,0.11426,0.1293,0,0
2,GO REPRODUCTION,0.0092139,0.1141,0.16598,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.08881,0.1138,0.11083,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.35442,0.11373,0.086438,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.11894,0.11364,0.21666,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.25111,0.11362,0.096196,0,0
2,GO DNA DEMETHYLATION,0.056456,0.11354,0.15165,0,0
2,GO NEPHRON TUBULE FORMATION,0.30724,0.11348,0.096542,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.041938,0.11334,0.16038,0,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.197,0.11323,0.30835,0,0
2,GO RENAL VESICLE DEVELOPMENT,0.16123,0.11297,0.1655,0,0
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.18102,0.11286,0.13664,0,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.17591,0.11266,0.085005,0,0
2,GO DRUG CATABOLIC PROCESS,0.17591,0.11228,0.11522,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.060677,0.11218,0.14295,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.021265,0.11204,0.13841,0,0
2,GO POSITIVE REGULATION OF CELL MATURATION,0.23203,0.11203,0.10284,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.062884,0.112,0.13081,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.197,0.11186,0.099878,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.2259,0.11141,0.080858,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.041938,0.11131,0.14747,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.16123,0.11128,0.12802,0,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.098083,0.11097,0.14246,0,0
2,GO PERICARDIUM DEVELOPMENT,0.1475,0.11067,0.15662,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.214,0.11064,0.15931,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.091819,0.11056,0.18954,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.0063209,0.11052,0.12645,0,0
2,GO REGULATION OF TRANSPOSITION,0.074935,0.11041,0.14996,0,0
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.16123,0.11004,0.10634,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.2577,0.10999,0.1306,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.072385,0.10998,0.19516,0,0
2,GO RESPONSE TO IRON ION,0.74555,0.10961,0.075141,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.072385,0.1095,0.17685,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.072385,0.10949,0.21257,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.30724,0.10945,0.1032,0,0
2,GO RESPONSE TO ACTIVITY,0.098083,0.10922,0.11188,0,0
2,GO LIPID PHOSPHORYLATION,0.10811,0.1092,0.15208,0,0
2,GO NEURAL CREST CELL MIGRATION,0.08303,0.10909,0.17002,0,0
2,GO ANIMAL ORGAN MATURATION,0.17091,0.10895,0.17356,0,0
2,GO OSTEOBLAST DEVELOPMENT,0.23203,0.1087,0.1078,0,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.08881,0.10866,0.12612,0,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.056456,0.10862,0.14084,0,0
2,GO PONS DEVELOPMENT,0.13467,0.10841,0.32297,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.20256,0.10835,0.13218,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.056456,0.10764,0.17668,0,0
2,GO HEART PROCESS,0.077559,0.10749,0.11766,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.11524,0.10747,0.13913,0,0
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.34626,0.10746,0.10646,0,0
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.08303,0.10737,0.11473,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.11163,0.10736,0.16585,0,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.39705,0.10702,0.10861,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,0.054439,0.10687,0.15924,0,0
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.1475,0.10647,0.14392,0,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.08881,0.1062,0.13255,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.045233,0.1062,0.16865,0,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.11163,0.10615,0.20986,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.062884,0.10601,0.13482,0,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.062884,0.106,0.157,0,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.14312,0.10594,0.15827,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.08588,0.10592,0.13102,0,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.49108,0.10581,0.10151,0,0
2,GO LIPID OXIDATION,0.1475,0.10568,0.10116,0,0
2,GO MIRNA METABOLIC PROCESS,0.10811,0.10557,0.13629,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.091819,0.10539,0.12674,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.28529,0.10538,0.087857,0,0
2,GO PITUITARY GLAND DEVELOPMENT,0.067497,0.10524,0.24024,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.08303,0.10522,0.13785,0,0
2,GO SECRETORY GRANULE ORGANIZATION,0.19156,0.10514,0.1278,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.056456,0.10502,0.17431,0,0
2,GO REGULATION OF PROTEIN SUMOYLATION,0.067497,0.10501,0.15113,0,0
2,GO TRACHEA DEVELOPMENT,0.33821,0.10481,0.13033,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.29248,0.10477,0.11027,0,0
2,GO HYPEROSMOTIC RESPONSE,0.10468,0.10467,0.20515,0,0
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.16602,0.10462,0.11942,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.091819,0.10411,0.16444,0,0
2,GO LIPID MODIFICATION,0.1475,0.10394,0.11207,0,0
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.19156,0.10363,0.13605,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.14312,0.1036,0.15698,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.13467,0.10333,0.14467,0,0
2,GO POSITIVE REGULATION OF BINDING,0.074935,0.10308,0.12196,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.050584,0.10297,0.15487,0,0
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.2998,0.10281,0.11932,0,0
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0042727,0.10276,0.17277,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.214,0.10268,0.14331,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.32248,0.10231,0.081484,0,0
2,GO GMP METABOLIC PROCESS,0.077559,0.10199,0.12244,0,0
2,GO GOLGI VESICLE TRANSPORT,0.048745,0.10192,0.12867,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.16123,0.10187,0.17269,0,0
2,GO SNRNA PROCESSING,0.056456,0.10165,0.092341,0,0
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.015776,0.10122,0.13822,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.17091,0.10121,0.10729,0,0
2,GO PROTEIN KINASE A SIGNALING,0.35442,0.10102,0.080616,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.13467,0.10101,0.15364,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.10134,0.10098,0.12426,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.23827,0.10084,0.14123,0,0
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.27821,0.10046,0.12861,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.074935,0.10038,0.11781,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.08881,0.1003,0.10895,0,0
2,GO GENETIC IMPRINTING,0.11163,0.1002,0.16959,0,0
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0023095,0.10014,0.14225,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.11894,0.10013,0.14093,0,0
2,GO NCRNA PROCESSING,0.030713,0.10012,0.10043,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.067497,0.099933,0.14769,0,0
2,GO MESONEPHROS DEVELOPMENT,0.11524,0.099912,0.14236,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.08303,0.099891,0.15175,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.1306,0.09958,0.12158,0,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.069906,0.099269,0.18867,0,0
2,GO NCRNA 3 END PROCESSING,0.054439,0.099161,0.091837,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.15197,0.098551,0.10312,0,0
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.28529,0.098374,0.15712,0,0
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.11163,0.09836,0.13806,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.10468,0.098315,0.13062,0,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,0.052482,0.098274,0.14944,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.065157,0.098263,0.20364,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.40594,0.098075,0.076916,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.12273,0.097986,0.13428,0,0
2,GO BLASTOCYST GROWTH,0.1475,0.097954,0.11009,0,0
2,GO MOLTING CYCLE,0.08881,0.097945,0.1599,0,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.30724,0.097752,0.14807,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.043559,0.097534,0.14763,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.08881,0.097451,0.12637,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.20256,0.09745,0.12578,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.040368,0.097367,0.16143,0,0
2,GO POSITIVE REGULATION OF HEART GROWTH,0.29248,0.097338,0.10712,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.11524,0.097187,0.10504,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.21989,0.097044,0.097892,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.41494,0.096961,0.055465,0,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.077559,0.096679,0.14692,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.2259,0.096246,0.095734,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.23827,0.096229,0.13459,0,0
2,GO CELL FATE DETERMINATION,0.23827,0.096157,0.11567,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.067497,0.095961,0.13787,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.44264,0.095915,0.072834,0,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.074935,0.095823,0.15657,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.058535,0.095531,0.13914,0,0
2,GO MYOBLAST PROLIFERATION,0.12273,0.095454,0.10201,0,0
2,GO STRIATUM DEVELOPMENT,0.1306,0.095377,0.16695,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.067497,0.095352,0.1107,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.2998,0.095331,0.097751,0,0
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.025096,0.095314,0.14285,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.16123,0.095232,0.17288,0,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.12662,0.094857,0.12972,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.060677,0.094794,0.18544,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.70989,0.094728,0.035772,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.08303,0.094705,0.13106,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.12273,0.094685,0.10121,0,0
2,GO DETECTION OF CALCIUM ION,0.17591,0.094676,0.13469,0,0
2,GO ENDOSOMAL TRANSPORT,0.074935,0.094588,0.12477,0,0
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.2577,0.094571,0.10429,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.098083,0.094516,0.13755,0,0
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.214,0.094405,0.098276,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.17091,0.094251,0.12785,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.11163,0.094057,0.12707,0,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.08303,0.093984,0.15737,0,0
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.53179,0.093934,0.12068,0,0
2,GO HISTONE H3 K9 ACETYLATION,0.045233,0.0939,0.14095,0,0
2,GO BLASTOCYST DEVELOPMENT,0.013235,0.093821,0.12376,0,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.1306,0.093787,0.12768,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.37111,0.093573,0.13116,0,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.052482,0.09353,0.14693,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.30724,0.093205,0.11725,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.16602,0.093122,0.13164,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.10468,0.093083,0.15402,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.11524,0.093025,0.11531,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.10811,0.092956,0.22837,0,0
2,GO CARTILAGE MORPHOGENESIS,0.067497,0.09294,0.22264,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.43329,0.092848,0.090087,0,0
2,GO REGULATION OF RELAXATION OF MUSCLE,0.49108,0.092726,0.052977,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.094909,0.092601,0.16043,0,0
2,GO GLIAL CELL DIFFERENTIATION,0.18102,0.092458,0.13956,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.43329,0.092356,0.12786,0,0
2,GO ENSHEATHMENT OF NEURONS,0.14312,0.092286,0.13768,0,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.67486,0.09215,0.06527,0,0
2,GO NCRNA METABOLIC PROCESS,0.026142,0.092075,0.10201,0,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.33029,0.092072,0.059834,0,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.034576,0.091917,0.15048,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.006955,0.091808,0.14894,0,0
2,GO LAMELLIPODIUM ASSEMBLY,0.47137,0.091761,0.093462,0,0
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.011063,0.091637,0.111,0,0
2,GO MALE GENITALIA DEVELOPMENT,0.38829,0.091635,0.067678,0,0
2,GO RESPONSE TO CATECHOLAMINE,0.074935,0.091604,0.12561,0,0
2,GO DNA BIOSYNTHETIC PROCESS,0.0063209,0.09159,0.14107,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.20256,0.091532,0.13185,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.018736,0.091095,0.20831,0,0
2,GO PROTEIN AUTOPHOSPHORYLATION,0.34626,0.091077,0.12552,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.16123,0.091013,0.12212,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.058535,0.09088,0.14798,0,0
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.27821,0.090745,0.089774,0,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.11894,0.090595,0.10681,0,0
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.37964,0.090249,0.091599,0,0
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.054439,0.090245,0.12084,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.19156,0.090231,0.13813,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.11894,0.090211,0.11926,0,0
2,GO MATURATION OF 5 8S RRNA,0.29248,0.090204,0.066173,0,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.052482,0.090198,0.1665,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.023112,0.090126,0.12719,0,0
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.074935,0.090067,0.085713,0,0
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.7336,0.089845,0.028236,0,0
2,GO RESPONSE TO UV C,0.17091,0.089756,0.12394,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.11894,0.089649,0.17344,0,0
2,GO SERTOLI CELL DEVELOPMENT,0.24463,0.089315,0.14755,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.12273,0.089168,0.13995,0,0
2,GO CELL CELL SIGNALING BY WNT,0.080256,0.089168,0.14675,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.16602,0.089149,0.16498,0,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.74555,0.089144,0.038156,0,0
2,GO PIRNA METABOLIC PROCESS,0.24463,0.089144,0.061506,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.077559,0.089039,0.12625,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.16602,0.088893,0.14534,0,0
2,GO DOPAMINE METABOLIC PROCESS,0.49108,0.088733,0.082641,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.11524,0.088126,0.13948,0,0
2,GO CRISTAE FORMATION,0.08588,0.088089,0.13094,0,0
2,GO RRNA METABOLIC PROCESS,0.056456,0.088031,0.08667,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.067497,0.087992,0.15838,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.23827,0.087991,0.11783,0,0
2,GO HEAT GENERATION,0.27821,0.087929,0.11024,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.16602,0.087804,0.11581,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.34626,0.087781,0.099165,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.27821,0.087534,0.099025,0,0
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.32248,0.087529,0.083485,0,0
2,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.47137,0.087293,0.074374,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.094909,0.087219,0.1122,0,0
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.11163,0.087168,0.12649,0,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.077559,0.08704,0.18185,0,0
2,GO REGULATION OF DNA METHYLATION,0.58498,0.08699,0.059887,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.050584,0.086881,0.15198,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.30724,0.086816,0.079931,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.34626,0.086606,0.1453,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.016475,0.086297,0.13316,0,0
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.18624,0.086219,0.12318,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.3148,0.086176,0.075926,0,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.20822,0.086085,0.11386,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.11524,0.08598,0.11686,0,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.18624,0.085703,0.078177,0,0
2,GO REGULATION OF MACROAUTOPHAGY,0.054439,0.085661,0.13311,0,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.16123,0.08558,0.11111,0,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.32248,0.085527,0.1642,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.15197,0.085511,0.1258,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.18624,0.085506,0.14374,0,0
2,GO POSITIVE REGULATION OF GROWTH,0.16123,0.08512,0.13703,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.48117,0.085042,0.077625,0,0
2,GO SULFATION,0.28529,0.084853,0.12628,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.072385,0.084677,0.14221,0,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.24463,0.084564,0.10989,0,0
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.045233,0.08443,0.14207,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.7336,0.084228,0.072819,0,0
2,GO REGULATION OF BINDING,0.197,0.084194,0.11917,0,0
2,GO RIBOSOME BIOGENESIS,0.056456,0.084068,0.080652,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.84314,0.084019,0.081694,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.2259,0.083982,0.11259,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.66333,0.08396,0.03605,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.020391,0.083904,0.12841,0,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.30724,0.0837,0.144,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.36271,0.083601,0.10297,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.10811,0.08345,0.12631,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.28529,0.083424,0.11492,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.13467,0.083404,0.11513,0,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,0.074935,0.083325,0.1286,0,0
2,GO RESPONSE TO OXYGEN RADICAL,0.20256,0.083299,0.090255,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.214,0.083244,0.1261,0,0
2,GO RESPONSE TO IONIZING RADIATION,0.13885,0.083181,0.11227,0,0
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.27821,0.083124,0.12241,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.08303,0.08311,0.12522,0,0
2,GO NUCLEOSIDE SALVAGE,0.067497,0.082967,0.12955,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.15655,0.082956,0.1305,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.16123,0.082898,0.10263,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.17091,0.082533,0.14455,0,0
2,GO SNORNA METABOLIC PROCESS,0.30724,0.082344,0.05692,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.42405,0.082218,0.11026,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.038848,0.082002,0.12851,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.27126,0.081958,0.1427,0,0
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.046961,0.08185,0.13335,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.40594,0.081602,0.084295,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.069906,0.081565,0.19956,0,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.66333,0.081555,0.063736,0,0
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.55277,0.081516,0.090921,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.27126,0.0813,0.10832,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.25111,0.081299,0.13188,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.61803,0.081105,0.051178,0,0
2,GO REGULATION OF BLOOD CIRCULATION,0.18624,0.08102,0.11191,0,0
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.11894,0.08088,0.14433,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.19156,0.080869,0.15718,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.35442,0.080832,0.098713,0,0
2,GO SEROTONIN TRANSPORT,0.27821,0.080828,0.11983,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.080256,0.080809,0.093047,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.030713,0.080779,0.1023,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.069906,0.080531,0.14818,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.75756,0.080522,0.034145,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.20822,0.080414,0.085326,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.2998,0.080119,0.1143,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.015776,0.080061,0.14303,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.18624,0.079907,0.099381,0,0
2,GO ERYTHROCYTE DEVELOPMENT,0.49108,0.079786,0.083411,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.11524,0.079582,0.15214,0,0
2,GO PROTEIN KINASE C SIGNALING,0.40594,0.079442,0.14023,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.33821,0.079434,0.13148,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.08303,0.079118,0.13525,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.20822,0.079013,0.088053,0,0
2,GO EAR DEVELOPMENT,0.026142,0.078751,0.17205,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.23827,0.078723,0.12181,0,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.077559,0.078602,0.12753,0,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.57414,0.078434,0.081633,0,0
2,GO PIGMENTATION,0.080256,0.078403,0.12795,0,0
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.10811,0.078234,0.10933,0,0
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.1306,0.078185,0.13335,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.28529,0.078173,0.12998,0,0
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.052482,0.07805,0.10757,0,0
2,GO L AMINO ACID TRANSPORT,0.43329,0.077947,0.077488,0,0
2,GO CHLORIDE TRANSPORT,0.080256,0.077775,0.12553,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.80618,0.077614,0.029442,0,0
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.11524,0.0776,0.15578,0,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.2998,0.077578,0.12572,0,0
2,GO REGULATION OF HEAT GENERATION,0.12662,0.077562,0.17636,0,0
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.15197,0.077491,0.14905,0,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.065157,0.077389,0.14276,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.48117,0.077343,0.058445,0,0
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.214,0.077239,0.0837,0,0
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.54223,0.077237,0.063761,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.072385,0.077231,0.12948,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.10811,0.077094,0.14417,0,0
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.20822,0.07709,0.11369,0,0
2,GO REGULATION OF HORMONE LEVELS,0.098083,0.077079,0.11321,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.28529,0.077058,0.13201,0,0
2,GO MYOBLAST DIFFERENTIATION,0.50109,0.076959,0.085378,0,0
2,GO ALANINE TRANSPORT,0.32248,0.076665,0.13159,0,0
2,GO EXCRETION,0.11163,0.076435,0.16281,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.10468,0.076234,0.14649,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.33821,0.076179,0.10358,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.21989,0.076123,0.16023,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.08588,0.076066,0.12998,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.1306,0.075998,0.11986,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.42405,0.075856,0.068234,0,0
2,GO NADH METABOLIC PROCESS,0.23203,0.075854,0.10591,0,0
2,GO DE NOVO PROTEIN FOLDING,0.15197,0.075648,0.11038,0,0
2,GO MALE SEX DIFFERENTIATION,0.065157,0.075562,0.15132,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.18624,0.075489,0.14525,0,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.25111,0.075477,0.11558,0,0
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.12273,0.075437,0.13402,0,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.10468,0.075334,0.11271,0,0
2,GO IMP BIOSYNTHETIC PROCESS,0.84314,0.07531,0.0094396,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.16602,0.075228,0.14608,0,0
2,GO MATURATION OF SSU RRNA,0.18624,0.075202,0.073516,0,0
2,GO REGULATION OF HEART GROWTH,0.23203,0.075187,0.10166,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.077559,0.07506,0.1378,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.10811,0.074969,0.11374,0,0
2,GO FATTY ACID HOMEOSTASIS,0.214,0.074956,0.12215,0,0
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.35442,0.074914,0.093277,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.12662,0.074812,0.13171,0,0
2,GO MAMMARY GLAND DEVELOPMENT,0.197,0.07478,0.1463,0,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.61803,0.074683,0.089625,0,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.062884,0.074507,0.14398,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.43329,0.074398,0.13983,0,0
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.197,0.074276,0.10353,0,0
2,GO INSEMINATION,0.51122,0.074157,0.081843,0,0
2,GO HEPATOCYTE DIFFERENTIATION,0.60692,0.074111,0.029761,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.065157,0.074089,0.13673,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.214,0.074012,0.1342,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.46168,0.073719,0.092781,0,0
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.23827,0.073694,0.092722,0,0
2,GO STEM CELL DIFFERENTIATION,0.39705,0.073654,0.093463,0,0
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.85555,0.073635,0.03549,0,0
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.16123,0.073429,0.11205,0,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.058535,0.073422,0.13416,0,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.36271,0.073339,0.11116,0,0
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.52145,0.073325,0.05021,0,0
2,GO LIVER REGENERATION,0.5959,0.073324,0.056978,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.1475,0.07332,0.1477,0,0
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.12662,0.073159,0.14801,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.15197,0.073143,0.11697,0,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17091,0.073086,0.14815,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.13467,0.072798,0.17633,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.18102,0.072388,0.15885,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.46168,0.072379,0.098791,0,0
2,GO GROWTH,0.062884,0.072318,0.14408,0,0
2,GO GABAERGIC NEURON DIFFERENTIATION,0.54223,0.072278,0.13478,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.47137,0.072234,0.11144,0,0
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.27126,0.072098,0.091934,0,0
2,GO REGULATION OF PROTEIN STABILITY,0.17591,0.072076,0.0944,0,0
2,GO IMPORT INTO CELL,0.19156,0.072051,0.10903,0,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.30724,0.071917,0.093732,0,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.29248,0.071878,0.14354,0,0
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.14312,0.071604,0.14284,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.2577,0.071485,0.14637,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.12662,0.07138,0.13363,0,0
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.050584,0.071312,0.18672,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.022172,0.071002,0.11953,0,0
2,GO PIGMENT ACCUMULATION,0.78176,0.070965,0.031807,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.18624,0.070614,0.12683,0,0
2,GO PROTEIN DEGLYCOSYLATION,0.90549,0.070427,0.023691,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.37111,0.070412,0.088199,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.11163,0.070326,0.13929,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.072385,0.070162,0.11027,0,0
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.35442,0.070116,0.087721,0,0
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.50109,0.070091,0.10947,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.069906,0.069957,0.073249,0,0
2,GO MICROVILLUS ASSEMBLY,0.42405,0.069931,0.085537,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.42405,0.06989,0.073362,0,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.1306,0.0698,0.10739,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.51122,0.069797,0.071412,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,0.26442,0.069746,0.16369,0,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,0.47137,0.069718,0.080856,0,0
2,GO LIPID TRANSLOCATION,0.37964,0.069659,0.11641,0,0
2,GO XENOBIOTIC TRANSPORT,0.214,0.069544,0.15432,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.2259,0.06952,0.12249,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.24463,0.069516,0.14956,0,0
2,GO GLIAL CELL DEVELOPMENT,0.33821,0.069434,0.11502,0,0
2,GO AMINO ACID TRANSPORT,0.069906,0.069425,0.14711,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.14312,0.069396,0.10374,0,0
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.30724,0.069369,0.085234,0,0
2,GO NEURON PROJECTION REGENERATION,0.16123,0.069203,0.16271,0,0
2,GO CALCIUM ION IMPORT,0.49108,0.069172,0.071233,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.38829,0.069109,0.10524,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.16602,0.069038,0.15076,0,0
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.1475,0.06899,0.080814,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.36271,0.068852,0.12384,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.214,0.068846,0.095279,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.12273,0.06851,0.10496,0,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,0.2577,0.06847,0.13109,0,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.08588,0.068441,0.16423,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.24463,0.068393,0.098884,0,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.33029,0.068355,0.12285,0,0
2,GO EXOCYTIC PROCESS,0.13467,0.068151,0.13873,0,0
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.1475,0.068118,0.12317,0,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.33029,0.068117,0.09214,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.060677,0.068106,0.13515,0,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.57414,0.06807,0.071062,0,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.23827,0.067961,0.16337,0,0
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.52145,0.067913,0.11021,0,0
2,GO ACTIVATION OF GTPASE ACTIVITY,0.23827,0.0677,0.13594,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.18102,0.067627,0.098193,0,0
2,GO REGULATION OF CATABOLIC PROCESS,0.10468,0.067522,0.11276,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.32248,0.067486,0.078482,0,0
2,GO PEROXISOME ORGANIZATION,0.25111,0.067384,0.061478,0,0
2,GO ORGANELLE FUSION,0.15197,0.067346,0.10496,0,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.57414,0.067253,0.024806,0,0
2,GO HEART FORMATION,0.49108,0.06723,0.075185,0,0
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.35442,0.06698,0.11877,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.55277,0.066955,0.090885,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.30724,0.066857,0.086207,0,0
2,GO RNA CAPPING,0.098083,0.066831,0.080552,0,0
2,GO REGULATION OF DENDRITE EXTENSION,0.069906,0.06675,0.20071,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.050584,0.066623,0.078246,0,0
2,GO RESPONSE TO AMPHETAMINE,0.24463,0.066589,0.118,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.077559,0.06653,0.18706,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.19156,0.066489,0.1173,0,0
2,GO LUNG CELL DIFFERENTIATION,0.14312,0.066428,0.18723,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.14312,0.066273,0.13357,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.28529,0.066229,0.097076,0,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.27126,0.06615,0.094227,0,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,0.2998,0.066107,0.12224,0,0
2,GO PROTEIN POLYMERIZATION,0.15197,0.06605,0.11488,0,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.08881,0.065871,0.11544,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.33821,0.06587,0.085362,0,0
2,GO ENDOSOME ORGANIZATION,0.18624,0.065843,0.083019,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.84314,0.065837,0.0011202,0,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.13467,0.065802,0.13031,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.54223,0.065702,0.088373,0,0
2,GO BONE MATURATION,0.17591,0.065696,0.17362,0,0
2,GO AXIS ELONGATION,0.47137,0.065581,0.095683,0,0
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.2577,0.065555,0.065669,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.43329,0.065528,0.067019,0,0
2,GO HEART GROWTH,0.48117,0.065518,0.088402,0,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.094909,0.065442,0.071971,0,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.20822,0.065435,0.11999,0,0
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.61803,0.065423,0.017121,0,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.11163,0.065385,0.11042,0,0
2,GO BODY FLUID SECRETION,0.40594,0.065272,0.08472,0,0
2,GO GLAND DEVELOPMENT,0.14312,0.065168,0.13201,0,0
2,GO REGULATION OF AUTOPHAGY,0.11163,0.065105,0.11733,0,0
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.3148,0.065078,0.095197,0,0
2,GO PSEUDOURIDINE SYNTHESIS,0.33821,0.065027,0.046025,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.16602,0.064969,0.11244,0,0
2,GO MATURATION OF LSU RRNA,0.34626,0.064921,0.052809,0,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.79394,0.06486,0.034463,0,0
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.62923,0.064838,0.058145,0,0
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.08588,0.064606,0.09315,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.074935,0.064557,0.11206,0,0
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.39705,0.064442,0.080715,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.21989,0.064378,0.23815,0,0
2,GO REGULATION OF PROTEIN IMPORT,0.41494,0.064311,0.085823,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.25111,0.064022,0.10116,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.61803,0.063981,0.027312,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.08881,0.063915,0.11546,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.43329,0.063899,0.076213,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.11524,0.063726,0.10788,0,0
2,GO DEVELOPMENTAL INDUCTION,0.49108,0.063695,0.073545,0,0
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.30724,0.063676,0.11032,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.14312,0.063489,0.11495,0,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.11894,0.063463,0.1164,0,0
2,GO REGULATION OF VESICLE FUSION,0.16602,0.063455,0.15846,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.33029,0.063404,0.091097,0,0
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.57414,0.06332,0.081801,0,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.16602,0.063231,0.16505,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.35442,0.06299,0.070635,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.57414,0.062976,0.086584,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.30724,0.062871,0.11587,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.41494,0.062599,0.098493,0,0
2,GO BLASTOCYST FORMATION,0.15655,0.062589,0.084449,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.49108,0.062524,0.056672,0,0
2,GO PROTEIN FOLDING,0.098083,0.062522,0.083089,0,0
2,GO MEMBRANE REPOLARIZATION,0.65188,0.062501,0.063326,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.18102,0.062466,0.097517,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.08881,0.062424,0.12957,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.10468,0.062424,0.10778,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.2577,0.062336,0.12826,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.51122,0.062223,0.12714,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.10811,0.062203,0.12786,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.88046,0.062099,0.029095,0,0
2,GO VIRAL TRANSLATION,0.10468,0.061989,0.090437,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.42405,0.061986,0.14116,0,0
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.17591,0.061946,0.12344,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.41494,0.061934,0.086273,0,0
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.25111,0.061882,0.09141,0,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.55277,0.061851,0.077934,0,0
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.51122,0.061795,0.0686,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.21989,0.061766,0.11596,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.75756,0.061766,0.057282,0,0
2,GO CELL AGING,0.17591,0.061689,0.099767,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.16123,0.061678,0.088506,0,0
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.08881,0.061556,0.13274,0,0
2,GO GLIOGENESIS,0.47137,0.061553,0.10673,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.10134,0.061537,0.10242,0,0
2,GO REGULATION OF TRANSPORT,0.36271,0.061531,0.089191,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.41494,0.061445,0.11681,0,0
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.054439,0.061276,0.11045,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.16123,0.061267,0.11376,0,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.17591,0.061242,0.093758,0,0
2,GO RESPONSE TO CARBOHYDRATE,0.23203,0.061239,0.10061,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.23203,0.061146,0.12366,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.074935,0.061133,0.14087,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.18624,0.060903,0.10802,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.20822,0.060814,0.11666,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.1475,0.060605,0.15078,0,0
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.36271,0.060594,0.071113,0,0
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.16602,0.060585,0.07705,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.2259,0.060544,0.11469,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.20256,0.060488,0.099034,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.069906,0.060398,0.11318,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.47137,0.060352,0.12559,0,0
2,GO REGULATION OF JUN KINASE ACTIVITY,0.49108,0.060282,0.11906,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.20822,0.060245,0.10488,0,0
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.13885,0.060219,0.11951,0,0
2,GO RESPONSE TO CALCIUM ION,0.27821,0.060201,0.10078,0,0
2,GO AUTOPHAGOSOME MATURATION,0.46168,0.060196,0.076719,0,0
2,GO REGULATION OF AMINO ACID TRANSPORT,0.15655,0.060156,0.16238,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.15655,0.060094,0.10478,0,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.1475,0.060089,0.10649,0,0
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.17591,0.060058,0.13426,0,0
2,GO AMINO ACID ACTIVATION,0.23203,0.059927,0.066423,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.10811,0.059899,0.10732,0,0
2,GO GLUCOSE IMPORT,0.27126,0.059886,0.088092,0,0
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.79394,0.059859,0.021526,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.48117,0.059853,0.076649,0,0
2,GO RESPONSE TO AXON INJURY,0.33029,0.059376,0.1188,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.49108,0.059326,0.066333,0,0
2,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.65188,0.059234,0.045394,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.60692,0.05913,0.03399,0,0
2,GO SENSORY PERCEPTION OF PAIN,0.20256,0.059078,0.11252,0,0
2,GO THYMUS DEVELOPMENT,0.080256,0.058967,0.14176,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.16602,0.058963,0.11669,0,0
2,GO ACID SECRETION,0.21989,0.058951,0.11146,0,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.47137,0.058914,0.096592,0,0
2,GO SPLEEN DEVELOPMENT,0.60692,0.058912,0.050962,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.62923,0.058771,0.089044,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.048745,0.058537,0.093708,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.10468,0.058499,0.11978,0,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.34626,0.058356,0.092812,0,0
2,GO LOCOMOTOR RHYTHM,0.27126,0.058307,0.12653,0,0
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.26442,0.058299,0.077529,0,0
2,GO NOTCH RECEPTOR PROCESSING,0.61803,0.05823,0.065982,0,0
2,GO RESPONSE TO MONOSACCHARIDE,0.15197,0.058214,0.11133,0,0
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.43329,0.058036,0.071005,0,0
2,GO RESPONSE TO BMP,0.35442,0.058031,0.1371,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.34626,0.0579,0.10416,0,0
2,GO REGULATION OF ORGAN GROWTH,0.36271,0.057895,0.10072,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.18102,0.057886,0.10943,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.08881,0.057728,0.11585,0,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.21989,0.057453,0.14569,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.57414,0.057451,0.11101,0,0
2,GO GLYCOSYLATION,0.25111,0.057441,0.097231,0,0
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.68646,0.057431,0.035635,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.58498,0.057123,0.05222,0,0
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.51122,0.057117,0.098108,0,0
2,GO CELL GROWTH,0.15655,0.056997,0.12799,0,0
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.14312,0.056913,0.10715,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.18624,0.05685,0.11681,0,0
2,GO MESODERM DEVELOPMENT,0.25111,0.056521,0.098818,0,0
2,GO VESICLE TARGETING,0.32248,0.056448,0.085814,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.37111,0.056392,0.089201,0,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.26442,0.05634,0.10635,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.18102,0.056299,0.12787,0,0
2,GO BLASTODERM SEGMENTATION,0.23203,0.056261,0.11286,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.2998,0.056209,0.083369,0,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.25111,0.056191,0.11001,0,0
2,GO SNORNA 3 END PROCESSING,0.42405,0.056145,0.056957,0,0
2,GO FIBROBLAST MIGRATION,0.50109,0.056072,0.1103,0,0
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.79394,0.055982,0.049789,0,0
2,GO PYROPTOSIS,0.26442,0.055918,0.11507,0,0
2,GO HEART DEVELOPMENT,0.214,0.055918,0.13828,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.33029,0.055884,0.088111,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.17591,0.055817,0.087972,0,0
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.32248,0.055622,0.10945,0,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.2259,0.055592,0.16904,0,0
2,GO NODAL SIGNALING PATHWAY,0.23827,0.055529,0.11656,0,0
2,GO RESPONSE TO ESTRADIOL,0.4521,0.055465,0.080111,0,0
2,GO REGULATION OF CELLULAR RESPIRATION,0.16123,0.055463,0.08872,0,0
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.074935,0.055337,0.11693,0,0
2,GO ERBB SIGNALING PATHWAY,0.75756,0.055253,0.073028,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.34626,0.05525,0.09073,0,0
2,GO REGULATION OF HAIR CYCLE,0.19156,0.055022,0.13452,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.17591,0.054982,0.15291,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.197,0.054973,0.034001,0,0
2,GO LAMELLIPODIUM ORGANIZATION,0.72171,0.054725,0.079697,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.79394,0.054721,0.013321,0,0
2,GO HEART MORPHOGENESIS,0.29248,0.054711,0.1342,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.15655,0.054654,0.14532,0,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.65188,0.054634,0.032568,0,0
2,GO REGULATION OF URINE VOLUME,0.58498,0.054508,0.080253,0,0
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.17591,0.054448,0.077307,0,0
2,GO ANOIKIS,0.29248,0.054437,0.12956,0,0
2,GO VESICLE ORGANIZATION,0.36271,0.054101,0.089527,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.23203,0.054041,0.079348,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.75756,0.054022,0.051662,0,0
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.70989,0.053955,0.1029,0,0
2,GO MITOCHONDRIAL FUSION,0.14312,0.053908,0.10439,0,0
2,GO ERBB2 SIGNALING PATHWAY,0.41494,0.053882,0.089552,0,0
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.39705,0.053853,0.10713,0,0
2,GO CARBOHYDRATE METABOLIC PROCESS,0.2998,0.053845,0.085036,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,0.2259,0.053744,0.14022,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.39705,0.05373,0.11756,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.2998,0.053524,0.082811,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.29248,0.053416,0.1019,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.57414,0.053346,0.12495,0,0
2,GO REGULATION OF ACROSOME REACTION,0.29248,0.053095,0.085788,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.16123,0.053084,0.11624,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.44264,0.05293,0.089806,0,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.23827,0.052826,0.13076,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.24463,0.0528,0.083412,0,0
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.2577,0.052721,0.071806,0,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.33029,0.0527,0.13464,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.35442,0.052652,0.11059,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.48117,0.052605,0.058677,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.65188,0.05221,0.052838,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.14312,0.052018,0.10412,0,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.65188,0.051963,0.078708,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.44264,0.051837,0.12932,0,0
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.51122,0.051832,0.041618,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.47137,0.051735,0.0747,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.2577,0.051725,0.12962,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.20822,0.051644,0.1202,0,0
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.054439,0.05164,0.075838,0,0
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.23203,0.051613,0.16197,0,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.2998,0.051593,0.1061,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.060677,0.051448,0.087924,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.098083,0.051368,0.12294,0,0
2,GO SPERM CAPACITATION,0.26442,0.051347,0.10397,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.99368,0.051208,0.025389,0,0
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.53179,0.051152,0.099417,0,0
2,GO TOOTH MINERALIZATION,0.21989,0.0511,0.17242,0,0
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.47137,0.051087,0.11228,0,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.52145,0.051046,0.055299,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.28529,0.051028,0.11305,0,0
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.17091,0.050962,0.069503,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.36271,0.050917,0.11726,0,0
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.46168,0.050703,0.12674,0,0
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.32248,0.050506,0.11283,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.38829,0.050497,0.10241,0,0
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.7336,0.050492,0.084974,0,0
2,GO LUNG MORPHOGENESIS,0.51122,0.050466,0.10339,0,0
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.56341,0.050361,0.065263,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.43329,0.050347,0.093249,0,0
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.79394,0.050328,0.079683,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.26442,0.050238,0.13149,0,0
2,GO CELLULAR RESPONSE TO ALCOHOL,0.65188,0.050221,0.096766,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.28529,0.050063,0.14299,0,0
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.27821,0.050018,0.13661,0,0
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.17091,0.049907,0.10786,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.4521,0.049785,0.093798,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.36271,0.049687,0.095056,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.25111,0.049686,0.10321,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.40594,0.049652,0.10611,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.43329,0.049611,0.096207,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.88046,0.04946,0.086758,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.019548,0.049414,0.065656,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.15655,0.049317,0.14308,0,0
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.66333,0.049142,0.038042,0,0
2,GO RESPONSE TO STEROL,0.34626,0.04907,0.13047,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.3148,0.048994,0.11078,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.4521,0.04898,0.082328,0,0
2,GO RESPONSE TO INSULIN,0.26442,0.048868,0.10363,0,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.49108,0.048706,0.091733,0,0
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.30724,0.04866,0.088173,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.214,0.048587,0.11656,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.72171,0.048311,0.050454,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.21989,0.048256,0.12551,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.16123,0.047941,0.086543,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.37111,0.047896,0.10222,0,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.93062,0.047813,0.047576,0,0
2,GO TISSUE MORPHOGENESIS,0.2998,0.047757,0.11781,0,0
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.41494,0.047629,0.15789,0,0
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.66333,0.047581,0.02636,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.57414,0.047432,0.11072,0,0
2,GO CELL MATURATION,0.1475,0.047415,0.12978,0,0
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.4521,0.047403,0.068539,0,0
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.44264,0.047308,0.091087,0,0
2,GO MEMBRANE ORGANIZATION,0.38829,0.047283,0.084206,0,0
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.2577,0.047282,0.065385,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.56341,0.04725,0.094059,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.21989,0.047219,0.12977,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.46168,0.047211,0.054177,0,0
2,GO PIGMENT GRANULE ORGANIZATION,0.56341,0.047174,0.06564,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.66333,0.047171,0.038164,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.24463,0.046982,0.13911,0,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.15655,0.046976,0.11936,0,0
2,GO RESPONSE TO STEROL DEPLETION,0.75756,0.046897,0.038435,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.58498,0.046878,0.059756,0,0
2,GO VIRAL RELEASE FROM HOST CELL,0.99368,0.046873,0.026119,0,0
2,GO AMELOGENESIS,0.4521,0.046645,0.094646,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.21989,0.046628,0.13825,0,0
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.70989,0.046528,0.091716,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.2577,0.046448,0.13211,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.33821,0.046283,0.077988,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.53179,0.046184,0.049405,0,0
2,GO REGULATION OF GROWTH,0.24463,0.04614,0.12227,0,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.69814,0.046088,0.073278,0,0
2,GO LIPID HOMEOSTASIS,0.64051,0.046006,0.062288,0,0
2,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.3148,0.045985,0.1025,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.51122,0.045969,0.10939,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.23827,0.045914,0.076713,0,0
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.86799,0.045814,0.044594,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.55277,0.045598,0.07724,0,0
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.57414,0.045594,0.049296,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.41494,0.04557,0.085046,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.29248,0.045565,0.11235,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.60692,0.045554,0.097437,0,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.23827,0.04554,0.1113,0,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.93062,0.045534,0.062885,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.47137,0.045508,0.093238,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.43329,0.045465,0.09454,0,0
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.60692,0.045379,0.083415,0,0
2,GO REGULATION OF SECRETION,0.53179,0.045326,0.087399,0,0
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.61803,0.045312,0.09021,0,0
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.25111,0.045247,0.060607,0,0
2,GO LYMPHANGIOGENESIS,0.81845,0.045216,0.060362,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.64051,0.045211,0.069957,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.30724,0.045157,0.0813,0,0
2,GO PROTEIN DEMANNOSYLATION,0.91805,0.044721,0.048168,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.36271,0.044575,0.13821,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.47137,0.04452,0.068897,0,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.48117,0.044268,0.14843,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.66333,0.044231,0.10105,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.11163,0.044003,0.093791,0,0
2,GO COPII COATED VESICLE BUDDING,0.39705,0.043842,0.072827,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.43329,0.043705,0.10674,0,0
2,GO RESPONSE TO FORSKOLIN,0.17091,0.043666,0.21774,0,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.75756,0.043654,0.049499,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.29248,0.043624,0.12481,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.53179,0.043531,0.10685,0,0
2,GO ORGANELLE MEMBRANE FUSION,0.28529,0.043463,0.097022,0,0
2,GO TRANSMEMBRANE TRANSPORT,0.19156,0.043453,0.091768,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.47137,0.043375,0.11955,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.41494,0.043274,0.12265,0,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.80618,0.043249,0.0066412,0,0
2,GO REGULATION OF PROTEIN BINDING,0.61803,0.043243,0.084265,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.26442,0.043176,0.10602,0,0
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.28529,0.043144,0.17098,0,0
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.30724,0.043109,0.11439,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.1475,0.0431,0.069002,0,0
2,GO PEROXISOMAL TRANSPORT,0.37964,0.043033,0.0505,0,0
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.75756,0.043004,0.033452,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13885,0.042997,0.12015,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.33029,0.04298,0.11088,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.44264,0.04286,0.05544,0,0
2,GO RECEPTOR INTERNALIZATION,0.37964,0.04274,0.10206,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.70989,0.042578,0.091765,0,0
2,GO MUSCLE HYPERTROPHY,0.41494,0.042541,0.10942,0,0
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.18102,0.04242,0.10992,0,0
2,GO DENDRITE SELF AVOIDANCE,0.33029,0.042389,0.10521,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.57414,0.042344,0.10676,0,0
2,GO STEROL HOMEOSTASIS,0.84314,0.042339,0.018486,0,0
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.37111,0.042328,0.077932,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.2577,0.042253,0.10927,0,0
2,GO HAIR FOLLICLE MATURATION,0.3148,0.042227,0.094927,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.08588,0.042225,0.13281,0,0
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.83078,0.042198,0.074566,0,0
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.88046,0.042127,0.071038,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.47137,0.042062,0.082765,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.91805,0.041676,0.069379,0,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.65188,0.041669,0.079308,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.26442,0.041617,0.076914,0,0
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.38829,0.0416,0.096787,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.2259,0.041553,0.089673,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.46168,0.041416,0.098753,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.35442,0.041373,0.097534,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.7336,0.041182,0.02649,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.36271,0.041165,0.11306,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.58498,0.041057,0.075913,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.56341,0.041052,0.074385,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.4521,0.040933,0.1081,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.28529,0.0408,0.1052,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS,0.2577,0.040775,0.19558,0,0
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.42405,0.040715,0.080227,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.24463,0.040609,0.091759,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.48117,0.040461,0.096478,0,0
2,GO PROTEIN TETRAMERIZATION,0.36271,0.040417,0.070827,0,0
2,GO COPULATION,0.39705,0.03998,0.17021,0,0
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.21989,0.03982,0.06583,0,0
2,GO CYTOKINETIC PROCESS,0.16602,0.039797,0.11013,0,0
2,GO UTP METABOLIC PROCESS,0.81845,0.039781,0.010261,0,0
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.24463,0.039767,0.080341,0,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.61803,0.039723,0.070486,0,0
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.39705,0.039598,0.11378,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.37964,0.039476,0.083563,0,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.5959,0.039346,0.07106,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.4521,0.039346,0.10267,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.43329,0.039293,0.10665,0,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,0.58498,0.039262,0.062181,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.37111,0.039164,0.06864,0,0
2,GO CATION TRANSPORT,0.25111,0.039078,0.093003,0,0
2,GO CELLULAR PIGMENTATION,0.32248,0.038834,0.068189,0,0
2,GO SECONDARY HEART FIELD SPECIFICATION,0.62923,0.038809,0.1074,0,0
2,GO SULFATE TRANSPORT,0.27126,0.038804,0.096729,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.48117,0.038801,0.087321,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.40594,0.038729,0.084972,0,0
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.91805,0.038716,0.00023811,0,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.40594,0.038383,0.06731,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.43329,0.038316,0.13271,0,0
2,GO PROSTATE GLAND DEVELOPMENT,0.44264,0.038214,0.093155,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.35442,0.038011,0.070111,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.66333,0.037983,0.065543,0,0
2,GO SLEEP,0.54223,0.037872,0.032258,0,0
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.54223,0.037843,0.089712,0,0
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.44264,0.037806,0.076539,0,0
2,GO EPITHELIUM DEVELOPMENT,0.32248,0.037802,0.10146,0,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.32248,0.037748,0.17067,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.61803,0.037595,0.090574,0,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.49108,0.037562,0.10102,0,0
2,GO FEVER GENERATION,0.62923,0.037458,0.060404,0,0
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.94321,0.037367,0.05778,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.52145,0.037268,0.098573,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.41494,0.037113,0.088806,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.48117,0.037076,0.096806,0,0
2,GO RESPONSE TO PH,0.53179,0.03688,0.099799,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.35442,0.036874,0.12847,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.42405,0.036847,0.091441,0,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.65188,0.036806,0.055522,0,0
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.65188,0.036776,0.065375,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.43329,0.036758,0.11096,0,0
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.40594,0.036756,0.099024,0,0
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.85555,0.036745,0.064616,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.58498,0.036632,0.064881,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.68646,0.036584,0.047183,0,0
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.18102,0.036514,0.12935,0,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.75756,0.03647,0.030245,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.25111,0.03642,0.10026,0,0
2,GO INORGANIC ANION TRANSPORT,0.37964,0.036355,0.09168,0,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.27821,0.036352,0.12185,0,0
2,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.65188,0.036348,0.081877,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.36271,0.036334,0.10074,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.58498,0.036239,0.089998,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.66333,0.036185,0.08658,0,0
2,GO ATP METABOLIC PROCESS,0.18102,0.036134,0.065259,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.98106,0.036078,0.024927,0,0
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.72171,0.035979,0.06427,0,0
2,GO RESPONSE TO UV B,0.78176,0.035916,0.021026,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.69814,0.035911,0.076914,0,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.26442,0.035908,0.1177,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.57414,0.035815,0.095853,0,0
2,GO REGULATION OF PEPTIDE SECRETION,0.91805,0.035763,0.056612,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.60692,0.035692,0.047051,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.58498,0.035646,0.086776,0,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.53179,0.035562,0.10089,0,0
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.49108,0.035522,0.049918,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.53179,0.035501,0.063654,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.75756,0.035478,0.084058,0,0
2,GO BIOLOGICAL PHASE,0.74555,0.035341,0.019935,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.48117,0.035106,0.1268,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.52145,0.035095,0.064576,0,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.58498,0.03488,0.050693,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.32248,0.034806,0.094949,0,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.58498,0.034768,0.096491,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.76963,0.034717,0.040943,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.36271,0.034622,0.10745,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.56341,0.034536,0.059877,0,0
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.81845,0.034516,0.052082,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.12273,0.034506,0.13324,0,0
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.26442,0.034452,0.09485,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.41494,0.034428,0.13369,0,0
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.37111,0.034247,0.077526,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.69814,0.034223,0.047691,0,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.91805,0.034191,0.028255,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.48117,0.03417,0.095819,0,0
2,GO NUCLEOSIDE METABOLIC PROCESS,0.41494,0.034159,0.044418,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.41494,0.034151,0.086415,0,0
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.3148,0.034135,0.053767,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.67486,0.034102,-0.010121,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.30724,0.034068,0.10527,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.3148,0.034057,0.085881,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.79394,0.033995,0.050658,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.32248,0.033995,0.10989,0,0
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.34626,0.033989,0.11307,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.62923,0.033955,0.072286,0,0
2,GO RESPONSE TO HEAT,0.17591,0.033846,0.10001,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.67486,0.033813,0.090116,0,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.57414,0.033792,0.083578,0,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.2998,0.033594,0.099164,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.38829,0.033572,0.07719,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.85555,0.033515,0.047826,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.58498,0.033511,0.057513,0,0
2,GO REGULATION OF ION TRANSPORT,0.37111,0.033403,0.083945,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.2259,0.033069,0.091423,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.69814,0.033062,0.056182,0,0
2,GO ION TRANSPORT,0.32248,0.033048,0.086419,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.33821,0.03297,0.085104,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.33821,0.032657,0.084245,0,0
2,GO CATECHOLAMINE METABOLIC PROCESS,0.53179,0.032617,0.073293,0,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.30724,0.03241,0.11905,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.35442,0.032384,0.079766,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.7336,0.03222,0.079875,0,0
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.68646,0.032106,0.062067,0,0
2,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.30724,0.032089,0.075747,0,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.33029,0.032082,0.077335,0,0
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.88046,0.032031,0.089132,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.40594,0.031976,0.088535,0,0
2,GO SODIUM ION HOMEOSTASIS,0.40594,0.031914,0.11053,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.7336,0.031722,0.088836,0,0
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.43329,0.031612,0.052243,0,0
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.50109,0.031585,0.068843,0,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.60692,0.031552,0.063926,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.55277,0.031548,0.039599,0,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.58498,0.031519,0.085174,0,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.42405,0.031497,0.079632,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.16123,0.031487,0.070899,0,0
2,GO BONE MORPHOGENESIS,0.40594,0.031479,0.11123,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.27126,0.031447,0.091369,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.78176,0.031379,0.02362,0,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.24463,0.031344,0.082132,0,0
2,GO ODONTOGENESIS,0.51122,0.031323,0.099576,0,0
2,GO MITRAL VALVE DEVELOPMENT,0.51122,0.031319,0.095683,0,0
2,GO STEROL METABOLIC PROCESS,0.81845,0.031143,0.044814,0,0
2,GO L GLUTAMATE IMPORT,0.23203,0.031091,0.1318,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.56341,0.031066,0.048638,0,0
2,GO MEMBRANE FUSION,0.88046,0.030746,0.053062,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.2998,0.030701,0.079087,0,0
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.94321,0.030674,0.047236,0,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.70989,0.030543,0.010773,0,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.47137,0.03045,0.077895,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.7336,0.030448,-0.0002517,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.41494,0.030434,0.079905,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.48117,0.03039,0.095267,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.62923,0.0303,0.10713,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.72171,0.030086,0.14464,0,0
2,GO ERAD PATHWAY,0.37964,0.030072,0.076238,0,0
2,GO SECONDARY METABOLIC PROCESS,0.3148,0.030006,0.11425,0,0
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.95582,0.029956,0.06525,0,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.80618,0.029914,0.047679,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.33029,0.029886,0.10633,0,0
2,GO METAL ION TRANSPORT,0.32248,0.029818,0.088106,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.21989,0.029703,0.097341,0,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.57414,0.029695,0.052173,0,0
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.37111,0.029527,0.10137,0,0
2,GO KERATINOCYTE PROLIFERATION,0.70989,0.029463,0.074176,0,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.55277,0.029455,0.066955,0,0
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.72171,0.029441,0.040282,0,0
2,GO VACUOLE ORGANIZATION,0.48117,0.029411,0.08591,0,0
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.70989,0.029403,0.079762,0,0
2,GO MITOCHONDRION ORGANIZATION,0.12273,0.02937,0.079928,0,0
2,GO SUBPALLIUM DEVELOPMENT,0.55277,0.029316,0.092894,0,0
2,GO ERYTHROCYTE HOMEOSTASIS,0.65188,0.029206,0.0756,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.7336,0.029176,0.072863,0,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.79394,0.029164,0.034793,0,0
2,GO STEROL BIOSYNTHETIC PROCESS,0.3148,0.029101,0.091882,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.5959,0.029095,0.081514,0,0
2,GO REPLACEMENT OSSIFICATION,0.85555,0.029067,0.027217,0,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.65188,0.029053,-0.017403,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.42405,0.029005,0.11203,0,0
2,GO CAMP METABOLIC PROCESS,0.28529,0.028933,0.15224,0,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.62923,0.028848,0.036825,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.35442,0.028792,0.075307,0,0
2,GO PEPTIDE SECRETION,0.76963,0.028695,0.06599,0,0
2,GO TOXIN METABOLIC PROCESS,0.65188,0.028663,0.071177,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.33821,0.028663,0.094627,0,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.7336,0.028641,0.017275,0,0
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.50109,0.028575,0.069631,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.60692,0.028493,0.09277,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.7336,0.028479,0.077902,0,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.69814,0.028468,0.04494,0,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.70989,0.028402,0.040394,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.48117,0.028252,0.071461,0,0
2,GO POSITIVE REGULATION OF TRANSLATION,0.66333,0.028219,0.037221,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.81845,0.028126,0.043714,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.78176,0.028091,0.051076,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.68646,0.028075,0.071761,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.33029,0.028044,0.14731,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.33029,0.027959,0.11626,0,0
2,GO MITOCHONDRIAL FISSION,0.55277,0.027931,0.065455,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.95582,0.027829,0.06871,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.96843,0.027743,0.070237,0,0
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.84314,0.027697,0.07033,0,0
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.49108,0.027561,0.075066,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.55277,0.027553,0.072917,0,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.5959,0.027504,0.095558,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.4521,0.027273,0.071553,0,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,0.41494,0.027174,0.081989,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.74555,0.027158,0.065725,0,0
2,GO RESPONSE TO SALT STRESS,0.52145,0.027118,0.092897,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.40594,0.02709,0.086656,0,0
2,GO REGULATION OF MYELINATION,0.41494,0.027032,0.08709,0,0
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.38829,0.026869,0.11495,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.89296,0.026802,0.038264,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.48117,0.026652,0.095714,0,0
2,GO APICAL JUNCTION ASSEMBLY,0.41494,0.026644,0.10557,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.85555,0.026644,0.022362,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.74555,0.026533,0.092758,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.62923,0.0264,0.046029,0,0
2,GO SARCOMERE ORGANIZATION,0.37111,0.026311,0.069445,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.72171,0.026302,0.071417,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.81845,0.026277,0.084492,0,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.67486,0.026269,-0.046464,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.64051,0.026207,0.096755,0,0
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.52145,0.026157,0.085088,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.85555,0.026133,-0.0017265,0,0
2,GO BONE GROWTH,0.50109,0.026115,0.11705,0,0
2,GO STRESS FIBER ASSEMBLY,0.5959,0.026035,0.11297,0,0
2,GO ACTIN FILAMENT BASED MOVEMENT,0.43329,0.025986,0.10281,0,0
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.40594,0.025952,0.067169,0,0
2,GO QUINONE METABOLIC PROCESS,0.214,0.025816,0.11716,0,0
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.93062,0.025699,0.044337,0,0
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.37964,0.025614,0.088609,0,0
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.56341,0.02554,0.11594,0,0
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.62923,0.025419,0.085047,0,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.24463,0.025181,0.1252,0,0
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.27126,0.025175,0.063347,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.98106,0.025171,0.035356,0,0
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.62923,0.0251,0.066934,0,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.42405,0.024969,0.075113,0,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.79394,0.024887,-0.01818,0,0
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.83078,0.024807,0.037341,0,0
2,GO DIOL METABOLIC PROCESS,0.44264,0.024688,0.093665,0,0
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.41494,0.024674,0.095298,0,0
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.41494,0.024557,0.13195,0,0
2,GO MESODERMAL CELL FATE COMMITMENT,0.75756,0.024514,0.021641,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.58498,0.024504,0.10011,0,0
2,GO MESENCHYME DEVELOPMENT,0.48117,0.024443,0.094878,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.23827,0.024426,0.11742,0,0
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.64051,0.024396,0.043544,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.48117,0.024383,0.074736,0,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.99368,0.024378,0.0018245,0,0
2,GO REGULATION OF CELL DEATH,0.84314,0.024373,0.046333,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.53179,0.024345,0.094589,0,0
2,GO FOCAL ADHESION ASSEMBLY,0.37111,0.024232,0.14202,0,0
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.84314,0.024222,0.023711,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.64051,0.024126,0.085491,0,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.66333,0.024075,0.079309,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.46168,0.023982,0.097631,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.89296,0.023808,0.0022453,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.68646,0.023678,0.029444,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.85555,0.023639,0.03915,0,0
2,GO RESPONSE TO TESTOSTERONE,0.74555,0.023535,0.050099,0,0
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.3148,0.023409,0.050242,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.37964,0.023295,0.071855,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.80618,0.023245,0.051693,0,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.53179,0.023017,0.068829,0,0
2,GO METANEPHROS DEVELOPMENT,0.48117,0.022969,0.098797,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.61803,0.022937,0.07511,0,0
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.86799,0.022921,0.064887,0,0
2,GO LIPID BIOSYNTHETIC PROCESS,0.67486,0.022862,0.056225,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.76963,0.022787,0.060934,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.3148,0.022701,0.051232,0,0
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.65188,0.022622,0.058053,0,0
2,GO FILOPODIUM ASSEMBLY,0.7336,0.02261,0.085146,0,0
2,GO MUSCLE CELL MIGRATION,0.89296,0.022592,0.044397,0,0
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.93062,0.022311,0.023242,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.78176,0.022281,0.060185,0,0
2,GO REGULATION OF HYDROLASE ACTIVITY,0.88046,0.022171,0.068918,0,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.58498,0.022102,0.069665,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.5959,0.02205,0.08186,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.57414,0.022049,0.083803,0,0
2,GO SECONDARY PALATE DEVELOPMENT,0.41494,0.022036,0.1236,0,0
2,GO MIDBODY ABSCISSION,0.76963,0.021957,0.015266,0,0
2,GO PIGMENT METABOLIC PROCESS,0.57414,0.021933,0.044748,0,0
2,GO CERAMIDE METABOLIC PROCESS,0.60692,0.02188,0.074058,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.5959,0.021686,0.083317,0,0
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.51122,0.021649,0.049308,0,0
2,GO ORGAN GROWTH,0.50109,0.021498,0.10203,0,0
2,GO HEPARIN METABOLIC PROCESS,0.34626,0.021281,0.092836,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.76963,0.021192,0.038836,0,0
2,GO ALCOHOL METABOLIC PROCESS,0.68646,0.02117,0.057231,0,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.94321,0.021095,0.01408,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.75756,0.021052,0.060546,0,0
2,GO RESPONSE TO ACIDIC PH,0.81845,0.020898,0.053602,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.34626,0.020763,0.12722,0,0
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.3148,0.020418,0.070487,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.58498,0.020381,0.036207,0,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.61803,0.020299,0.07405,0,0
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.56341,0.020175,0.066575,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.94321,0.02017,0.049096,0,0
2,GO CELLULAR KETONE METABOLIC PROCESS,0.38829,0.020142,0.062044,0,0
2,GO GLUTAMINE METABOLIC PROCESS,0.37964,0.020113,0.079729,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.58498,0.02009,0.059751,0,0
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.70989,0.019872,0.061999,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.99368,0.019863,0.057431,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.76963,0.01985,0.0546,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.7336,0.019823,0.06209,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.42405,0.019749,0.049865,0,0
2,GO GLYCEROLIPID METABOLIC PROCESS,0.85555,0.019682,0.048962,0,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.4521,0.019598,0.13666,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.37964,0.019561,0.070751,0,0
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.91805,0.019552,0.0010282,0,0
2,GO APOPTOTIC PROCESS,0.99368,0.019508,0.054638,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.62923,0.019394,0.069815,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.50109,0.019357,0.070868,0,0
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.93062,0.019248,0.033966,0,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.52145,0.019157,0.066584,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.80618,0.019122,0.018479,0,0
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.2998,0.019023,0.10233,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.49108,0.018997,0.080988,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.72171,0.018869,0.064239,0,0
2,GO RESPONSE TO ABIOTIC STIMULUS,0.46168,0.018786,0.078596,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.74555,0.018698,0.07852,0,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,0.89296,0.0186,0.041945,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.91805,0.018574,0.017561,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.51122,0.018513,0.13337,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.51122,0.018509,0.1226,0,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.40594,0.018445,0.09417,0,0
2,GO JNK CASCADE,0.89296,0.018444,0.066768,0,0
2,GO HOMEOSTATIC PROCESS,0.88046,0.018342,0.057977,0,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.88046,0.018302,0.041554,0,0
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.51122,0.018217,0.014313,0,0
2,GO DETECTION OF STIMULUS,0.30724,0.018143,0.065504,0,0
2,GO TELOMERASE RNA LOCALIZATION,0.48117,0.017953,0.042257,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.80618,0.017858,0.030269,0,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.51122,0.017848,0.08096,0,0
2,GO TRICARBOXYLIC ACID CYCLE,0.86799,0.017763,0.037638,0,0
2,GO FOREGUT MORPHOGENESIS,0.26442,0.017755,0.12918,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.66333,0.017709,0.098289,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.40594,0.01768,0.10849,0,0
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.96843,0.017632,0.06012,0,0
2,GO REGULATION OF RESPONSE TO STRESS,0.70989,0.017497,0.026358,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.42405,0.017439,0.08075,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.81845,0.017386,0.073719,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.68646,0.017335,0.07366,0,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.88046,0.017322,0.050855,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.55277,0.017197,0.10311,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.60692,0.017195,0.10581,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.99368,0.017141,0.024761,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.93062,0.01688,0.014844,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.84314,0.016859,0.07491,0,0
2,GO LIPID CATABOLIC PROCESS,0.96843,0.016822,0.030462,0,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.67486,0.016809,0.087988,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.66333,0.016799,0.068886,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.98106,0.016787,0.020111,0,0
2,GO FAT CELL DIFFERENTIATION,0.7336,0.016783,0.078361,0,0
2,GO CARDIOLIPIN METABOLIC PROCESS,0.94321,0.016753,0.0026588,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.91805,0.016751,0.058679,0,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.95582,0.016586,0.0066616,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.67486,0.016554,0.079256,0,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.94321,0.016534,0.052067,0,0
2,GO NOTCH SIGNALING PATHWAY,0.21989,0.016438,0.11569,0,0
2,GO RESPONSE TO WATER,0.85555,0.0162,0.0066891,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.39705,0.016146,0.093779,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.88046,0.015986,0.067651,0,0
2,GO ACTIN FILAMENT BASED PROCESS,0.65188,0.015929,0.099493,0,0
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.93062,0.015644,0.060229,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.42405,0.015582,0.10537,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.60692,0.015546,0.076807,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.62923,0.015374,0.092855,0,0
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.37111,0.014762,0.056231,0,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.69814,0.014743,0.051446,0,0
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.86799,0.014706,0.069596,0,0
2,GO VIRAL GENOME REPLICATION,0.96843,0.014562,0.027767,0,0
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.67486,0.014542,0.062158,0,0
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.80618,0.014541,0.060201,0,0
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.69814,0.01448,0.073115,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.79394,0.014421,0.031753,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.95582,0.014411,0.059216,0,0
2,GO REGULATION OF HEART RATE,0.33821,0.014297,0.083322,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.40594,0.014209,0.13688,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1,0.013932,0.047036,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.39705,0.013847,0.10444,0,0
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.65188,0.013566,0.077928,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.98106,0.013389,0.0016034,0,0
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.88046,0.013356,0.057121,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.98106,0.013254,0.016314,0,0
2,GO MUSCLE SYSTEM PROCESS,0.57414,0.013124,0.070837,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.57414,0.013094,0.06417,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.72171,0.013014,0.093901,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.55277,0.012743,0.11348,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.55277,0.012718,0.060958,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.94321,0.012517,0.026991,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.83078,0.012439,0.04539,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.7336,0.012122,0.09691,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.56341,0.012055,-0.025922,0,0
2,GO REGULATION OF CARDIAC CONDUCTION,0.37111,0.012011,0.07495,0,0
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.27126,0.011948,0.11183,0,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.90549,0.011895,0.034621,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.69814,0.01182,0.045539,0,0
2,GO ANION TRANSPORT,0.53179,0.011727,0.081409,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.64051,0.011636,0.061532,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.67486,0.0116,-0.018819,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.76963,0.011581,0.067722,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.84314,0.011551,0.074317,0,0
2,GO REGULATION OF FERTILIZATION,0.3148,0.011445,0.072557,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.43329,0.011373,0.10043,0,0
2,GO CELLULAR RESPONSE TO DRUG,1,0.011295,0.054719,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.38829,0.011246,0.073392,0,0
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.7336,0.011218,0.042284,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.4521,0.011207,0.08924,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.88046,0.011199,0.00037133,0,0
2,GO GASTRIC ACID SECRETION,0.33821,0.011161,0.11493,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.70989,0.011112,0.070057,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.48117,0.011098,0.092095,0,0
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.84314,0.010883,0.017569,0,0
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.25111,0.010743,0.11459,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.94321,0.010717,0.028819,0,0
2,GO ENDODERMAL CELL FATE COMMITMENT,0.94321,0.010639,0.025493,0,0
2,GO STEROID METABOLIC PROCESS,0.99368,0.010485,0.03038,0,0
2,GO ORGANELLE INHERITANCE,0.35442,0.01043,0.096983,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.83078,0.010168,0.0314,0,0
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.61803,0.010159,0.062092,0,0
2,GO SENSORY PERCEPTION OF BITTER TASTE,0.44264,0.010157,0.1071,0,0
2,GO TRACHEA MORPHOGENESIS,0.51122,0.010098,0.11767,0,0
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.83078,0.0099624,0.039957,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.80618,0.009862,0.03325,0,0
2,GO LYMPH VESSEL DEVELOPMENT,0.70989,0.0098215,0.098912,0,0
2,GO TRANSLATIONAL ELONGATION,0.65188,0.0097887,0.01864,0,0
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.49108,0.0097494,0.11326,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.66333,0.0097163,0.087492,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.7336,0.0096543,0.039597,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.35442,0.0095624,0.1155,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.66333,0.0095459,0.094307,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.83078,0.0095178,0.039472,0,0
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.83078,0.0094526,0.073143,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.84314,0.0093989,0.026285,0,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.88046,0.0093961,0.057258,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.42405,0.009145,0.067249,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.90549,0.0091445,0.05811,0,0
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.88046,0.0091068,0.042375,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.90549,0.0089538,0.051727,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.62923,0.0088279,0.089049,0,0
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.91805,0.0087538,0.018788,0,0
2,GO RESPONSE TO X RAY,0.55277,0.0087387,0.07263,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.99368,0.008711,0.020371,0,0
2,GO MITOCHONDRION MORPHOGENESIS,0.57414,0.0086844,0.061582,0,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.66333,0.0086522,0.050769,0,0
2,GO MAST CELL MIGRATION,0.40594,0.0085302,0.1011,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.96843,0.0085174,0.072693,0,0
2,GO ORGANIC ACID METABOLIC PROCESS,0.76963,0.0084223,0.047605,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.67486,0.0083519,0.10904,0,0
2,GO HEART FIELD SPECIFICATION,0.72171,0.0083509,0.086857,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.70989,0.0082038,0.077658,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.61803,0.0081352,0.083911,0,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.90549,0.0080346,0.035891,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.56341,0.0080329,0.06772,0,0
2,GO HORMONE METABOLIC PROCESS,0.65188,0.0080327,0.052425,0,0
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.84314,0.0080194,0.031937,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.58498,0.0079565,0.074123,0,0
2,GO HEART VALVE DEVELOPMENT,0.69814,0.007946,0.10469,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.98106,0.0077985,0.043066,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.95582,0.007787,0.043671,0,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.76963,0.0077709,0.049473,0,0
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.78176,0.0077478,0.052249,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.98106,0.0076544,0.054209,0,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.7336,0.0076529,0.072613,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.62923,0.0076184,0.12286,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.7336,0.0075232,0.058535,0,0
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.61803,0.0075231,0.061706,0,0
2,GO CELLULAR RESPIRATION,0.72171,0.0074216,0.015523,0,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.61803,0.0073184,0.068102,0,0
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.84314,0.0072539,0.042767,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.67486,0.0070318,0.047511,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.74555,0.0068264,0.073464,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.66333,0.0067769,0.091646,0,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.25111,0.0067607,0.15145,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.94321,0.0066966,0.043577,0,0
2,GO SKIN MORPHOGENESIS,0.96843,0.006672,0.067868,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.98106,0.0063897,0.031852,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.91805,0.0062855,0.0024219,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.78176,0.0062526,-0.0018722,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.83078,0.0061605,0.036064,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.46168,0.0060035,0.070769,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.67486,0.0059991,0.079593,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.88046,0.0059984,0.064719,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.74555,0.0059762,0.0026527,0,0
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.74555,0.0059753,0.062873,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.75756,0.0059392,0.057919,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.51122,0.0059379,0.097184,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.46168,0.0059221,0.090969,0,0
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1,0.0058366,0.040523,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.75756,0.0058334,0.064602,0,0
2,GO RESPONSE TO DRUG,0.79394,0.0058164,0.067572,0,0
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.58498,0.0058127,0.10653,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.48117,0.0057759,-0.050408,0,0
2,GO SYMBIOTIC PROCESS,0.95582,0.0057627,0.03343,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.93062,0.0057407,0.048196,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.96843,0.0055959,0.050871,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.93062,0.0055555,0.058923,0,0
2,GO MITOCHONDRIAL GENE EXPRESSION,0.78176,0.005494,0.015546,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.83078,0.0053842,0.028196,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.5959,0.0051054,0.066523,0,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.89296,0.0050644,-0.0016851,0,0
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.89296,0.0050088,0.064452,0,0
2,GO RESPONSE TO GAMMA RADIATION,0.99368,0.0049241,0.025861,0,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.76963,0.0048928,0.046347,0,0
2,GO RIBOSOME ASSEMBLY,0.75756,0.004765,0.011046,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.76963,0.0047081,0.063701,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.91805,0.0044598,0.043728,0,0
2,GO VASCULOGENESIS,0.46168,0.0043289,0.1171,0,0
2,GO RECEPTOR CATABOLIC PROCESS,0.78176,0.0042255,0.034861,0,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.3148,0.0039651,0.074903,0,0
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.81845,0.0039245,0.044816,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.81845,0.0038679,0.035387,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.80618,0.0038662,0.015432,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.7336,0.0038124,0.078004,0,0
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.98106,0.0037512,0.015116,0,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.88046,0.0037426,0.017277,0,0
2,GO EPIDERMIS DEVELOPMENT,0.62923,0.0036284,0.060161,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.93062,0.0036044,0.047789,0,0
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.98106,0.0035314,0.040229,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.49108,0.0033578,0.098721,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.41494,0.0032013,0.11579,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.2998,0.0031496,0.093326,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.95582,0.0030267,0.023576,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.93062,0.0029505,0.049052,0,0
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.96843,0.0029027,0.02815,0,0
2,GO LIPID GLYCOSYLATION,0.41494,0.002785,0.12995,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.58498,0.0027737,0.086903,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.89296,0.0026886,0.030185,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.85555,0.0026721,0.030916,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.88046,0.0024628,0.080966,0,0
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.99368,0.0023677,0.015212,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.66333,0.0023465,0.011853,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.80618,0.0022832,0.032162,0,0
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.88046,0.0022662,0.0051102,0,0
2,GO INTERMEMBRANE LIPID TRANSFER,0.98106,0.0022427,0.049678,0,0
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.88046,0.0020374,0.051412,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.47137,0.0019956,0.092941,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.56341,0.0018077,0.096633,0,0
2,GO ANION HOMEOSTASIS,0.74555,0.0016041,0.073067,0,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.89296,0.0015452,0.0031086,0,0
2,GO REGULATION OF ENDOCYTOSIS,1,0.0015426,0.060201,0,0
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.74555,0.0014801,0.057277,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.68646,0.0014094,-0.0078169,0,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.99368,0.0013896,0.033619,0,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.52145,0.0013673,0.081203,0,0
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.68646,0.001345,0.10089,0,0
2,GO GAS TRANSPORT,0.61803,0.0013265,0.098278,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.96843,0.001305,0.0072909,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.72171,0.0012015,0.079141,0,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.48117,0.0010277,0.13695,0,0
2,GO TRNA 5 LEADER REMOVAL,0.75756,0.00097085,-0.010289,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.86799,0.00096476,0.049562,0,0
2,GO TRANSLATIONAL INITIATION,0.74555,0.00094755,0.020307,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.91805,0.00091413,0.00017544,0,0
2,GO REGULATION OF TELOMERASE ACTIVITY,0.81845,0.00090402,0.055855,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.65188,0.0008305,0.07894,0,0
2,GO MYELOID CELL HOMEOSTASIS,0.93062,0.00082089,0.054123,0,0
2,GO RESPONSE TO LEAD ION,0.64051,0.00073144,0.065228,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.91805,0.00068519,0.020939,0,0
2,GO LIPID METABOLIC PROCESS,0.88046,0.00058115,0.04934,0,0
2,GO NEPHRON DEVELOPMENT,0.44264,0.00053228,0.10944,0,0
2,GO REGULATION OF GASTRIC ACID SECRETION,0.32248,0.00048317,0.16825,0,0
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.67486,0.0004234,0.051837,0,0
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.75756,0.00041036,0.015601,0,0
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.62923,0.00035755,-0.0013479,0,0
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.58498,0.00016526,0.028966,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.47137,-0.00012366,0.10148,0,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.58498,-0.00012698,0.072771,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.81845,-0.000274,0.057529,0,0
2,GO VIRAL BUDDING,0.72171,-0.00030374,-0.016321,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.69814,-0.00049632,0.027969,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.84314,-0.00071562,0.041169,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.80618,-0.00082709,0.0086405,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.76963,-0.00083135,0.049803,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.54223,-0.00087788,0.081408,0,0
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.88046,-0.00090349,0.06125,0,0
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.7336,-0.0009087,0.042747,0,0
2,GO VIRAL GENE EXPRESSION,0.67486,-0.00092902,0.01795,0,0
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.81845,-0.00095552,0.071657,0,0
2,GO ACTIN FILAMENT ORGANIZATION,0.91805,-0.0009692,0.073806,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.88046,-0.0010039,0.014957,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.5959,-0.0010176,0.14832,0,0
2,GO ACTIN MEDIATED CELL CONTRACTION,0.51122,-0.0010394,0.077015,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.74555,-0.0012024,0.083582,0,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.90549,-0.0012028,0.031369,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.80618,-0.0014752,0.033178,0,0
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.75756,-0.0014796,0.09242,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.70989,-0.0017639,0.089916,0,0
2,GO STEROL TRANSPORT,0.99368,-0.0020278,0.032526,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.81845,-0.0021409,0.027552,0,0
2,GO LYTIC VACUOLE ORGANIZATION,0.79394,-0.0023311,0.037536,0,0
2,GO PROTEOLYSIS,0.86799,-0.0023794,0.063328,0,0
2,GO RESPONSE TO CADMIUM ION,0.99368,-0.0025015,0.018192,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.84314,-0.0025081,0.024996,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.94321,-0.0026442,0.047624,0,0
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.81845,-0.0026671,0.052429,0,0
2,GO AORTA DEVELOPMENT,0.83078,-0.0029452,0.091453,0,0
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.68646,-0.0031173,0.043901,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.50109,-0.0031556,0.11616,0,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.89296,-0.0031685,0.068539,0,0
2,GO RESPONSE TO DIETARY EXCESS,0.93062,-0.0032382,0.015578,0,0
2,GO NEGATIVE REGULATION OF CELL DEATH,0.89296,-0.0032971,0.04233,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.91805,-0.0033738,0.059725,0,0
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.75756,-0.0034001,-0.0086444,0,0
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.85555,-0.0034415,0.064849,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.98106,-0.0034751,0.059291,0,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.74555,-0.003634,0.0047919,0,0
2,GO RESPONSE TO PEPTIDE,0.7336,-0.003689,0.08082,0,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.75756,-0.0037304,0.077912,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.98106,-0.0037641,0.051097,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.93062,-0.0039125,0.060992,0,0
2,GO MUSCLE CONTRACTION,0.54223,-0.0039311,0.071555,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.91805,-0.0039903,0.02876,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.83078,-0.0041416,0.055276,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.93062,-0.0041849,-0.0077047,0,0
2,GO CELLULAR HOMEOSTASIS,0.85555,-0.0042055,0.037471,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.70989,-0.0042889,0.080407,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.76963,-0.0043198,0.012307,0,0
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.98106,-0.0043305,0.019917,0,0
2,GO ORGANIC ANION TRANSPORT,0.60692,-0.0044281,0.071137,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.41494,-0.0044439,0.08188,0,0
2,GO REGULATION OF GLIOGENESIS,1,-0.0044473,0.044634,0,0
2,GO OXIDATION REDUCTION PROCESS,0.89296,-0.004473,0.034131,0,0
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.69814,-0.0045151,-0.030717,0,0
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.94321,-0.0045348,0.049541,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.4521,-0.0045731,-0.070805,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.96843,-0.0046804,0.023366,0,0
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.72171,-0.0047472,0.0081898,0,0
2,GO CYTOPLASM ORGANIZATION,0.58498,-0.0047848,0.087628,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.70989,-0.004864,0.078552,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.99368,-0.0049193,0.068673,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.70989,-0.0050907,0.056123,0,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,0.53179,-0.0050982,0.17952,0,0
2,GO CYTOPLASMIC TRANSLATION,0.41494,-0.0053569,0.03871,0,0
2,GO RNA 5 END PROCESSING,0.90549,-0.0054084,0.0064739,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.5959,-0.0054406,0.053848,0,0
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.62923,-0.0055496,0.067123,0,0
2,GO SPROUTING ANGIOGENESIS,0.88046,-0.0057413,0.0734,0,0
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.70989,-0.0057561,0.033121,0,0
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.42405,-0.005777,0.082177,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.84314,-0.0059646,0.043899,0,0
2,GO MESODERM MORPHOGENESIS,0.93062,-0.0061283,0.052005,0,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.86799,-0.0062831,0.093268,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.96843,-0.0064367,0.040341,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.86799,-0.0071457,0.047148,0,0
2,GO RESPONSE TO OSMOTIC STRESS,0.69814,-0.0071923,0.069628,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.49108,-0.0074009,0.11466,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.90549,-0.007454,0.049999,0,0
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.69814,-0.0074724,0.092047,0,0
2,GO CELLULAR RESPONSE TO VIRUS,0.61803,-0.0074838,-0.024971,0,0
2,GO PENTOSE METABOLIC PROCESS,0.89296,-0.0076142,0.031785,0,0
2,GO ADAPTIVE THERMOGENESIS,0.79394,-0.0078269,0.070484,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.75756,-0.0078491,0.064692,0,0
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.86799,-0.0080275,0.078245,0,0
2,GO SEROTONIN SECRETION,0.85555,-0.00804,0.017068,0,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.88046,-0.0081253,0.049027,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.93062,-0.0081808,0.064854,0,0
2,GO CIRCULATORY SYSTEM PROCESS,0.64051,-0.0081858,0.073867,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.85555,-0.0081875,0.063099,0,0
2,GO MYOFIBRIL ASSEMBLY,0.98106,-0.0082173,0.037035,0,0
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.79394,-0.0082845,0.028398,0,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.78176,-0.0084834,0.077518,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,0.79394,-0.0085396,0.01643,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.65188,-0.0085705,0.045102,0,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.95582,-0.0086658,0.04353,0,0
2,GO CELLULAR LIPID METABOLIC PROCESS,0.95582,-0.0086753,0.043778,0,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.49108,-0.0088838,-0.073092,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.85555,-0.008971,0.041987,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.83078,-0.0090632,0.040952,0,0
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.84314,-0.0090737,0.039026,0,0
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.81845,-0.0091848,0.018192,0,0
2,GO RESPONSE TO STEROID HORMONE,0.89296,-0.0091912,0.061194,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.84314,-0.0092297,0.042619,0,0
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.78176,-0.0092689,0.033887,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.72171,-0.0092982,-0.037767,0,0
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.69814,-0.0093702,-0.015749,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.78176,-0.009645,0.024962,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.99368,-0.0098584,0.033403,0,0
2,GO RELAXATION OF MUSCLE,0.96843,-0.0098738,0.0033593,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.84314,-0.010312,0.061215,0,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.85555,-0.010326,0.011307,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.78176,-0.010431,-0.024404,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.94321,-0.010444,0.034707,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.76963,-0.010733,0.02224,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.99368,-0.010834,0.027603,0,0
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.79394,-0.010898,0.036931,0,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.90549,-0.010914,0.042335,0,0
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.4521,-0.011344,-0.039653,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.89296,-0.011442,0.07474,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.93062,-0.011498,0.045655,0,0
2,GO RENAL SYSTEM PROCESS,0.69814,-0.011583,0.091064,0,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.83078,-0.011599,0.047994,0,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,0.49108,-0.011609,0.090033,0,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.98106,-0.011693,0.030449,0,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.7336,-0.011696,-0.013748,0,0
2,GO DNA DEAMINATION,0.42405,-0.011811,-0.083371,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.96843,-0.011834,0.042315,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.69814,-0.011869,-0.014401,0,0
2,GO PLACENTA DEVELOPMENT,0.94321,-0.011969,0.045923,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.66333,-0.011982,-0.012603,0,0
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.80618,-0.012009,0.012223,0,0
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.99368,-0.012019,0.02427,0,0
2,GO CONVERGENT EXTENSION,0.54223,-0.012042,0.10085,0,0
2,GO NEGATIVE REGULATION OF TRANSPORT,0.93062,-0.012093,0.056153,0,0
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.94321,-0.012106,0.033845,0,0
2,GO LUNG ALVEOLUS DEVELOPMENT,1,-0.012114,0.078366,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.98106,-0.012142,0.034991,0,0
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.56341,-0.012221,-0.0022643,0,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.60692,-0.012407,-0.011523,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.84314,-0.012427,0.032648,0,0
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.49108,-0.012475,-0.027518,0,0
2,GO HEXOSE CATABOLIC PROCESS,0.96843,-0.012499,0.033316,0,0
2,GO RESPONSE TO METAL ION,0.91805,-0.012536,0.048835,0,0
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.68646,-0.012752,0.0063459,0,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.69814,-0.012775,0.059782,0,0
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.50109,-0.012859,-0.029239,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.89296,-0.012904,0.076137,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.91805,-0.012969,0.048214,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.50109,-0.012992,0.10045,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.58498,-0.013033,-0.028952,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.69814,-0.013091,0.047823,0,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.91805,-0.013112,0.0055997,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.66333,-0.013228,0.0020879,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.51122,-0.013351,0.080978,0,0
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.76963,-0.013574,0.034443,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.39705,-0.013582,-0.061409,0,0
2,GO ZINC ION TRANSPORT,0.7336,-0.013594,0.0068894,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.53179,-0.013619,0.083188,0,0
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.95582,-0.013646,0.023685,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.78176,-0.013735,0.071186,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.64051,-0.013794,-0.0098716,0,0
2,GO PROTEIN AUTOPROCESSING,0.84314,-0.01382,0.02524,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.79394,-0.014035,0.027523,0,0
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94321,-0.014222,0.021681,0,0
2,GO REPLICATIVE SENESCENCE,0.78176,-0.014285,-0.0014716,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.52145,-0.014302,-0.018242,0,0
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.58498,-0.014328,0.060283,0,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.66333,-0.014519,0.082652,0,0
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.86799,-0.014709,0.012735,0,0
2,GO RESPONSE TO ETHANOL,0.96843,-0.014895,0.049908,0,0
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.96843,-0.014905,0.038117,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.90549,-0.014915,0.04684,0,0
2,GO EPIDERMAL CELL DIFFERENTIATION,0.88046,-0.014942,0.021928,0,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.94321,-0.015007,0.014327,0,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.60692,-0.015075,0.064386,0,0
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.86799,-0.015129,0.0030546,0,0
2,GO AMINE CATABOLIC PROCESS,0.91805,-0.015177,-0.0041391,0,0
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96843,-0.015178,0.053433,0,0
2,GO FATTY ACID METABOLIC PROCESS,0.95582,-0.015201,0.032673,0,0
2,GO CELLULAR RESPONSE TO DSRNA,0.70989,-0.015331,-0.0031339,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.67486,-0.015334,0.094676,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.88046,-0.015547,0.027595,0,0
2,GO ORGANIC ACID TRANSPORT,0.58498,-0.015631,0.066227,0,0
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.60692,-0.015647,0.0074998,0,0
2,GO AMYLOID BETA FORMATION,0.88046,-0.015945,0.062806,0,0
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.75756,-0.016107,0.007367,0,0
2,GO CHEMICAL HOMEOSTASIS,0.85555,-0.016316,0.039614,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.57414,-0.016426,-0.063098,0,0
2,GO TUBE DEVELOPMENT,0.95582,-0.016585,0.073313,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.76963,-0.016812,0.03906,0,0
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.81845,-0.01682,0.038057,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.86799,-0.01689,0.064134,0,0
2,GO GDP METABOLIC PROCESS,0.57414,-0.017002,0.078657,0,0
2,GO HEART TRABECULA FORMATION,0.49108,-0.01706,-0.068456,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.99368,-0.01708,0.065771,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.81845,-0.017138,0.00077661,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.57414,-0.017143,0.0027365,0,0
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.88046,-0.017166,0.052427,0,0
2,GO NUCLEOTIDE SALVAGE,0.37964,-0.017222,-0.035747,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.93062,-0.017327,0.027348,0,0
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.69814,-0.017343,0.051777,0,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.76963,-0.017589,0.054586,0,0
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.90549,-0.017701,0.033504,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.5959,-0.017805,-0.038108,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.89296,-0.018007,-0.01677,0,0
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.96843,-0.018205,0.040552,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.81845,-0.018306,0.074454,0,0
2,GO PODOSOME ASSEMBLY,0.95582,-0.018581,0.041947,0,0
2,GO RESPONSE TO HORMONE,0.90549,-0.018679,0.066143,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.99368,-0.019012,0.039372,0,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.65188,-0.01925,-0.0043211,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.7336,-0.019293,-0.012807,0,0
2,GO POSITIVE REGULATION OF SECRETION,0.70989,-0.019412,0.022105,0,0
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.86799,-0.019435,0.072599,0,0
2,GO REGULATION OF PH,0.89296,-0.019453,0.034678,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.64051,-0.019773,0.033857,0,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,1,-0.01989,0.04198,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.72171,-0.01991,0.033286,0,0
2,GO REGULATION OF GASTRULATION,0.5959,-0.019995,-0.0041954,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.89296,-0.020059,0.026461,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.44264,-0.020223,-0.043359,0,0
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.93062,-0.020361,0.054228,0,0
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.68646,-0.020462,-0.013924,0,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.4521,-0.020675,0.12005,0,0
2,GO AMINO SUGAR METABOLIC PROCESS,0.53179,-0.021015,-0.0014952,0,0
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.89296,-0.021086,0.0095646,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.74555,-0.021097,0.00013707,0,0
2,GO INTERFERON BETA PRODUCTION,0.75756,-0.02119,0.010657,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.99368,-0.021248,0.066328,0,0
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.78176,-0.021521,0.02075,0,0
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.65188,-0.021531,0.032392,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.93062,-0.021572,0.060176,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.83078,-0.021582,0.0089919,0,0
2,GO CELL MOTILITY,0.78176,-0.02177,0.04796,0,0
2,GO REGULATION OF WATER LOSS VIA SKIN,0.76963,-0.021783,-0.0076335,0,0
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.65188,-0.021827,-0.0011241,0,0
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.70989,-0.021834,-0.023883,0,0
2,GO RESPONSE TO DEXAMETHASONE,0.64051,-0.021837,0.0018973,0,0
2,GO DRUG METABOLIC PROCESS,0.90549,-0.022095,0.0023916,0,0
2,GO NAD METABOLIC PROCESS,0.96843,-0.022116,0.051334,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.78176,-0.022179,0.072066,0,0
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.79394,-0.02227,0.086842,0,0
2,GO MUSCLE FILAMENT SLIDING,0.74555,-0.022586,-0.013283,0,0
2,GO LIVER MORPHOGENESIS,0.61803,-0.022602,-0.019584,0,0
2,GO GLAND MORPHOGENESIS,0.86799,-0.02262,0.070699,0,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.55277,-0.022888,-0.01116,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.74555,-0.023033,0.052387,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.66333,-0.023192,-0.01155,0,0
2,GO MITOCHONDRIAL TRANSLATION,0.68646,-0.023252,-0.007626,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.99368,-0.023311,0.026238,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.58498,-0.023442,0.049889,0,0
2,GO SECRETION BY TISSUE,0.60692,-0.023719,-0.026375,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.81845,-0.023767,0.051828,0,0
2,GO AGING,0.91805,-0.024096,0.039524,0,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.69814,-0.02411,0.013141,0,0
2,GO RESPONSE TO PAIN,0.5959,-0.024257,0.068858,0,0
2,GO IMMUNE SYSTEM DEVELOPMENT,0.5959,-0.024465,-0.0014679,0,0
2,GO REGULATION OF LIPID STORAGE,0.81845,-0.02457,0.013703,0,0
2,GO RESPONSE TO INTERLEUKIN 12,0.54223,-0.024635,-0.029867,0,0
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.95582,-0.024689,0.05848,0,0
2,GO MYELOID CELL DIFFERENTIATION,0.56341,-0.024702,0.0089623,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.38829,-0.024772,-0.004687,0,0
2,GO REGULATION OF MAPK CASCADE,0.53179,-0.024933,0.020098,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.90549,-0.024949,0.043587,0,0
2,GO RESPONSE TO TOXIC SUBSTANCE,0.95582,-0.02518,0.039772,0,0
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.86799,-0.025224,0.033556,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.64051,-0.025302,-0.046464,0,0
2,GO REGENERATION,0.83078,-0.025432,0.036828,0,0
2,GO RESPONSE TO OXYGEN LEVELS,0.44264,-0.025547,0.009454,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.89296,-0.02561,0.032602,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.88046,-0.02569,0.040104,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.79394,-0.025907,0.025769,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.60692,-0.025939,0.0078258,0,0
2,GO TUBE MORPHOGENESIS,0.98106,-0.026023,0.069861,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.68646,-0.026041,0.021188,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.79394,-0.026041,0.010904,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.96843,-0.026057,0.070632,0,0
2,GO FOLIC ACID METABOLIC PROCESS,0.34626,-0.026067,-0.021149,0,0
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.93062,-0.026128,0.056687,0,0
2,GO POSITIVE REGULATION OF CELL DEATH,0.74555,-0.02613,0.045277,0,0
2,GO AORTA MORPHOGENESIS,0.90549,-0.026152,0.039206,0,0
2,GO CHOLESTEROL STORAGE,0.62923,-0.026234,-0.020746,0,0
2,GO REGULATION OF VIRAL TRANSCRIPTION,0.60692,-0.026239,0.0099945,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.72171,-0.026249,0.004082,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.83078,-0.026302,0.077118,0,0
2,GO MUSCLE ADAPTATION,1,-0.026321,0.065832,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.72171,-0.026329,0.074334,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.98106,-0.026332,0.059258,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.78176,-0.026597,0.044574,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65188,-0.026739,0.015542,0,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.99368,-0.026839,0.043724,0,0
2,GO WATER HOMEOSTASIS,0.7336,-0.026873,0.06587,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.83078,-0.026882,0.034739,0,0
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.90549,-0.026927,0.063731,0,0
2,GO HORMONE CATABOLIC PROCESS,0.78176,-0.026934,0.024823,0,0
2,GO AMINO ACID IMPORT,0.98106,-0.026949,0.029678,0,0
2,GO RESPONSE TO ALCOHOL,0.90549,-0.027218,0.046449,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.81845,-0.0273,-0.013316,0,0
2,GO HEART TRABECULA MORPHOGENESIS,0.93062,-0.027329,0.045984,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.78176,-0.027462,0.072326,0,0
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.94321,-0.027525,0.034773,0,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.42405,-0.027636,0.029433,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.75756,-0.027647,-0.00098788,0,0
2,GO RIG I SIGNALING PATHWAY,0.79394,-0.028114,-0.0033099,0,0
2,GO NK T CELL DIFFERENTIATION,0.55277,-0.02812,-0.080192,0,0
2,GO ALCOHOL CATABOLIC PROCESS,0.60692,-0.028166,0.065609,0,0
2,GO LIPID STORAGE,0.79394,-0.028266,0.026617,0,0
2,GO REGULATION OF CELLULAR PH,0.81845,-0.028482,0.033591,0,0
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.29248,-0.028591,-0.059264,0,0
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.27126,-0.028789,-0.037507,0,0
2,GO BODY MORPHOGENESIS,0.85555,-0.028799,0.073378,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.85555,-0.028819,0.045666,0,0
2,GO TISSUE HOMEOSTASIS,0.86799,-0.028864,0.037538,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.88046,-0.028864,0.051622,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.74555,-0.029005,0.029002,0,0
2,GO RESPONSE TO PROGESTERONE,0.68646,-0.029033,0.017233,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.70989,-0.029085,0.016379,0,0
2,GO SKIN DEVELOPMENT,0.81845,-0.029259,0.045415,0,0
2,GO RENAL WATER HOMEOSTASIS,0.49108,-0.029317,0.13191,0,0
2,GO NEGATIVE REGULATION OF SECRETION,0.86799,-0.029342,0.05249,0,0
2,GO SECRETION,0.52145,-0.029372,0.0086603,0,0
2,GO TRNA 5 END PROCESSING,0.56341,-0.029475,-0.0083104,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.79394,-0.029505,0.012049,0,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.7336,-0.029569,0.0099645,0,0
2,GO DIET INDUCED THERMOGENESIS,0.90549,-0.029665,-0.0034391,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.81845,-0.029685,-0.00096129,0,0
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.60692,-0.029896,0.0137,0,0
2,GO RESPONSE TO ANTIBIOTIC,0.70989,-0.029918,0.020976,0,0
2,GO BONE DEVELOPMENT,0.91805,-0.030039,0.072235,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.91805,-0.030067,0.024062,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.44264,-0.030137,-0.0075567,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.90549,-0.030285,0.059998,0,0
2,GO RESPONSE TO COLD,0.81845,-0.030412,0.026422,0,0
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.5959,-0.030499,0.026111,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.53179,-0.030511,-0.013741,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.79394,-0.030522,0.070727,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.95582,-0.030562,0.041572,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.68646,-0.030681,0.0078234,0,0
2,GO SPERM EGG RECOGNITION,0.80618,-0.030917,-0.0062768,0,0
2,GO PROTEIN MATURATION,0.52145,-0.031195,0.0069289,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.84314,-0.031224,0.065614,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.89296,-0.031263,0.0084657,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.62923,-0.031381,0.021008,0,0
2,GO ENDOCYTOSIS,0.61803,-0.031452,0.028282,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.69814,-0.031578,0.059398,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.76963,-0.031711,0.049056,0,0
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.79394,-0.031725,0.010223,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.41494,-0.031749,-0.1067,0,0
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.48117,-0.031782,-0.0058834,0,0
2,GO OPSONIZATION,0.70989,-0.031817,-0.10274,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.81845,-0.031903,-0.0051988,0,0
2,GO MYOTUBE DIFFERENTIATION,0.74555,-0.03194,0.012433,0,0
2,GO GASTRULATION,0.74555,-0.031955,0.034311,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.91805,-0.03204,0.014872,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.49108,-0.032048,-0.040242,0,0
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.43329,-0.032207,-0.014149,0,0
2,GO TETRAPYRROLE METABOLIC PROCESS,0.96843,-0.032222,0.015078,0,0
2,GO NADPH REGENERATION,0.98106,-0.032294,0.013513,0,0
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.99368,-0.032341,0.013781,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.61803,-0.032346,-0.0066328,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.68646,-0.032415,0.084896,0,0
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.76963,-0.032453,0.043793,0,0
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.69814,-0.032522,0.013591,0,0
2,GO VAGINA DEVELOPMENT,0.41494,-0.032536,0.12864,0,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.98106,-0.032555,0.040895,0,0
2,GO VIRAL LIFE CYCLE,0.47137,-0.032591,-0.0048054,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.50109,-0.032706,-0.015345,0,0
2,GO TRANSFERRIN TRANSPORT,0.98106,-0.032798,0.0426,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.95582,-0.032934,-0.0075241,0,0
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.76963,-0.033093,-0.036444,0,0
2,GO AEROBIC RESPIRATION,0.58498,-0.033128,-0.0033398,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.86799,-0.033264,0.036251,0,0
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.47137,-0.033275,-0.066319,0,0
2,GO LAMELLIPODIUM MORPHOGENESIS,0.91805,-0.033337,0.074733,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.43329,-0.033451,-0.050206,0,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.69814,-0.033467,0.0060936,0,0
2,GO CELLULAR OXIDANT DETOXIFICATION,0.76963,-0.033705,-0.0084292,0,0
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.46168,-0.034088,-0.043648,0,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.95582,-0.034156,0.0094555,0,0
2,GO SKELETAL MUSCLE TISSUE REGENERATION,0.81845,-0.034257,-0.0054863,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.83078,-0.034514,0.019622,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.69814,-0.034605,0.0045643,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.94321,-0.034686,0.062569,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.38829,-0.034787,0.014902,0,0
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.79394,-0.034815,-0.013202,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.66333,-0.034888,0.090644,0,0
2,GO CELLULAR RESPONSE TO ATP,0.49108,-0.035071,-0.030104,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.52145,-0.035532,0.005244,0,0
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.65188,-0.035705,-0.01368,0,0
2,GO BRONCHUS DEVELOPMENT,0.79394,-0.03617,0.11217,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.89296,-0.036242,0.019126,0,0
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.4521,-0.036337,0.021888,0,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.21989,-0.036429,-0.025669,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.66333,-0.036431,0.025453,0,0
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.74555,-0.036539,0.011958,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.80618,-0.036621,0.016612,0,0
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.44264,-0.03671,-0.040248,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.88046,-0.036788,0.04519,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.62923,-0.036811,0.038787,0,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.96843,-0.036969,0.029805,0,0
2,GO REGULATION OF CELL SHAPE,0.76963,-0.036978,0.04159,0,0
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.65188,-0.03699,0.016692,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.52145,-0.037032,0.08403,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.96843,-0.037034,0.014275,0,0
2,GO CELLULAR RESPONSE TO LIPID,0.57414,-0.037111,0.012006,0,0
2,GO MAINTENANCE OF LOCATION,0.57414,-0.037137,0.020345,0,0
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.99368,-0.03714,0.034236,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.30724,-0.037183,-0.066579,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.57414,-0.037804,0.014672,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.95582,-0.037821,0.068364,0,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.37111,-0.038215,-0.029841,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.61803,-0.038356,0.021057,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.46168,-0.03844,-0.02056,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.5959,-0.038573,0.024961,0,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.35442,-0.038781,-0.071794,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.96843,-0.038874,0.057759,0,0
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.53179,-0.038932,-0.0062399,0,0
2,GO OXIDATIVE PHOSPHORYLATION,0.27126,-0.039001,-0.035285,0,0
2,GO SENSORY PERCEPTION OF TASTE,0.74555,-0.039038,0.026153,0,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.36271,-0.039217,-0.038158,0,0
2,GO RENAL SODIUM EXCRETION,0.80618,-0.039331,0.092554,0,0
2,GO GONADOTROPIN SECRETION,0.5959,-0.039479,-0.005097,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.76963,-0.039638,0.0091028,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.81845,-0.039679,0.079487,0,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.69814,-0.039853,0.0050849,0,0
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.83078,-0.039863,0.019112,0,0
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.54223,-0.039884,0.016157,0,0
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.67486,-0.039905,-0.0034022,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.55277,-0.039915,0.00043636,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.88046,-0.039945,0.069755,0,0
2,GO NIK NF KAPPAB SIGNALING,0.4521,-0.039959,-0.038398,0,0
2,GO REGULATION OF SYMBIOTIC PROCESS,0.30724,-0.039987,-0.032583,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.47137,-0.040087,-0.022848,0,0
2,GO CYTIDINE TO URIDINE EDITING,0.40594,-0.040308,-0.097005,0,0
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.33821,-0.040334,-0.017824,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.90549,-0.040432,0.05159,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.62923,-0.040441,-0.018056,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.76963,-0.040534,0.010074,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.81845,-0.040609,0.030462,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.94321,-0.040618,0.054456,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.44264,-0.040673,0.1513,0,0
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.72171,-0.040785,-0.0077967,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.85555,-0.040868,0.014765,0,0
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.50109,-0.040912,-0.061616,0,0
2,GO REGULATION OF ANION TRANSPORT,0.81845,-0.04092,0.048523,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.96843,-0.040937,0.029769,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.75756,-0.040955,-0.0092248,0,0
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.88046,-0.040956,0.044531,0,0
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.67486,-0.040962,0.029468,0,0
2,GO RESPONSE TO ESTROGEN,0.47137,-0.041369,-0.009557,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.91805,-0.041421,0.060363,0,0
2,GO REGULATION OF PROTEOLYSIS,0.66333,-0.041504,0.024296,0,0
2,GO TRANSLATIONAL TERMINATION,0.38829,-0.041554,-0.02369,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.89296,-0.041623,0.047216,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.94321,-0.041872,0.058253,0,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.5959,-0.042331,0.0014534,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.40594,-0.042411,-0.026542,0,0
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.58498,-0.042475,-0.025876,0,0
2,GO REGULATION OF ICOSANOID SECRETION,0.75756,-0.042477,-0.0053259,0,0
2,GO REGULATION OF PODOSOME ASSEMBLY,0.94321,-0.04265,0.032953,0,0
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.55277,-0.042671,0.018602,0,0
2,GO ACTIN NUCLEATION,0.35442,-0.0428,-0.0057815,0,0
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.48117,-0.042863,-0.035404,0,0
2,GO CARTILAGE DEVELOPMENT,0.81845,-0.04292,0.04616,0,0
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.33821,-0.043429,-0.038191,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.98106,-0.04362,0.047272,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.56341,-0.043835,0.010376,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.70989,-0.043941,-0.011788,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.55277,-0.044272,0.034583,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.76963,-0.044353,0.047034,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.57414,-0.044549,0.10389,0,0
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.60692,-0.04461,-0.027038,0,0
2,GO CARBOHYDRATE TRANSPORT,0.66333,-0.044636,0.023322,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.99368,-0.044704,0.058496,0,0
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.66333,-0.044738,-0.0028231,0,0
2,GO REGULATION OF EXCRETION,0.85555,-0.044771,0.066051,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.78176,-0.044975,0.0066035,0,0
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.96843,-0.044989,0.027184,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.91805,-0.045066,0.045254,0,0
2,GO CELL CELL ADHESION,0.70989,-0.045135,0.029618,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.68646,-0.045244,-0.058316,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.2577,-0.045491,-0.06397,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.84314,-0.045505,0.076641,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.94321,-0.045731,0.070063,0,0
2,GO LIPID LOCALIZATION,0.75756,-0.045764,0.020524,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.90549,-0.045842,0.041146,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.60692,-0.045855,0.021722,0,0
2,GO VIRION ASSEMBLY,0.197,-0.045948,-0.027412,0,0
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.42405,-0.045995,-0.022715,0,0
2,GO ION HOMEOSTASIS,0.78176,-0.046059,0.02267,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.70989,-0.046141,0.0033409,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.96843,-0.046176,0.056156,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.55277,-0.046294,-0.017886,0,0
2,GO KERATINOCYTE MIGRATION,0.72171,-0.046324,0.026123,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.80618,-0.046384,-0.014273,0,0
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.64051,-0.046397,0.015243,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.80618,-0.046597,0.024588,0,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.57414,-0.046832,-0.0031277,0,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.88046,-0.046916,0.021328,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.5959,-0.047085,-0.008001,0,0
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.88046,-0.047092,0.010448,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.27126,-0.047231,-0.055126,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.66333,-0.047344,0.025599,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.84314,-0.047429,0.07161,0,0
2,GO REGULATION OF PINOCYTOSIS,0.7336,-0.047479,0.02112,0,0
2,GO CELL RECOGNITION,0.70989,-0.047544,0.022115,0,0
2,GO EPIBOLY,0.57414,-0.047648,0.037697,0,0
2,GO TYPE I INTERFERON PRODUCTION,0.55277,-0.047765,-0.021005,0,0
2,GO GTP METABOLIC PROCESS,0.65188,-0.047774,0.008494,0,0
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.54223,-0.047826,-0.018474,0,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.89296,-0.04786,0.044462,0,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.49108,-0.047963,-0.0152,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.98106,-0.047992,0.015655,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.69814,-0.048074,0.019164,0,0
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.81845,-0.04822,0.014318,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.1306,-0.048349,-0.077571,0,0
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.51122,-0.048353,-0.039417,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.44264,-0.048375,-0.070529,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.53179,-0.048616,0.012967,0,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.33821,-0.048662,-0.041234,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.2577,-0.048794,-0.048966,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.51122,-0.048972,-0.049954,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.46168,-0.049101,-0.072559,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.86799,-0.049182,0.044704,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.72171,-0.049258,-0.0099155,0,0
2,GO FC RECEPTOR SIGNALING PATHWAY,0.42405,-0.04939,-0.028728,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.69814,-0.049424,0.013995,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.21989,-0.049564,-0.024348,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.38829,-0.04965,0.0052245,0,0
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.27126,-0.049655,-0.078489,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.78176,-0.049655,-0.0018098,0,0
2,GO APOPTOTIC SIGNALING PATHWAY,0.33029,-0.049731,0.0023963,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.50109,-0.050078,-0.049347,0,0
2,GO TERPENOID METABOLIC PROCESS,0.85555,-0.050081,0.027187,0,0
2,GO REGULATION OF OSSIFICATION,0.88046,-0.050088,0.049838,0,0
2,GO BILE ACID AND BILE SALT TRANSPORT,0.32248,-0.050222,-0.079896,0,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.38829,-0.050278,-0.0016035,0,0
2,GO ISOPRENOID METABOLIC PROCESS,0.70989,-0.050282,0.034365,0,0
2,GO FATTY ACID TRANSPORT,0.55277,-0.050323,-0.0016137,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.69814,-0.050339,0.0091496,0,0
2,GO GLIAL CELL PROLIFERATION,0.88046,-0.050486,0.006985,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.55277,-0.050733,-0.004675,0,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.40594,-0.050859,-0.052856,0,0
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.49108,-0.050962,-0.057988,0,0
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.57414,-0.051608,-0.062082,0,0
2,GO T CELL HOMEOSTASIS,0.62923,-0.051752,-0.037589,0,0
2,GO CELL SUBSTRATE ADHESION,0.57414,-0.051812,0.030585,0,0
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.54223,-0.051822,-0.068961,0,0
2,GO TISSUE REGENERATION,0.98106,-0.051904,0.026782,0,0
2,GO BIOLOGICAL ADHESION,0.5959,-0.051907,0.027219,0,0
2,GO HYPOTONIC RESPONSE,0.91805,-0.051914,0.067644,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.49108,-0.052058,-0.026311,0,0
2,GO RESPONSE TO VIRUS,0.4521,-0.052148,-0.063216,0,0
2,GO ANIMAL ORGAN FORMATION,0.88046,-0.052294,0.044325,0,0
2,GO VITAMIN METABOLIC PROCESS,0.10134,-0.052412,-0.042603,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.90549,-0.052649,0.038635,0,0
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.37111,-0.052791,-0.069408,0,0
2,GO DETOXIFICATION,0.84314,-0.052914,0.00085457,0,0
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.84314,-0.053456,0.014648,0,0
2,GO RETINOL METABOLIC PROCESS,0.62923,-0.053622,-0.045328,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.48117,-0.053679,0.013135,0,0
2,GO ARGININE METABOLIC PROCESS,0.49108,-0.053789,-0.011676,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.39705,-0.053796,-0.017329,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.57414,-0.054078,-0.0023055,0,0
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.60692,-0.054229,-0.01336,0,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.81845,-0.054235,0.011783,0,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.55277,-0.054274,-0.021481,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.46168,-0.054461,0.0039343,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.94321,-0.054465,0.03237,0,0
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.67486,-0.054691,0.013205,0,0
2,GO PEPTIDYL ARGININE MODIFICATION,0.72171,-0.054706,-0.017652,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.68646,-0.054857,0.0043054,0,0
2,GO AMINE METABOLIC PROCESS,0.60692,-0.054878,0.0061815,0,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.99368,-0.054898,0.02562,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.72171,-0.054908,0.01651,0,0
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.27126,-0.054987,-0.05213,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.60692,-0.055102,0.013172,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.67486,-0.055204,-0.020309,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.75756,-0.055278,0.012994,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.33029,-0.05532,-0.12325,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.67486,-0.055354,0.0052963,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.42405,-0.055487,-0.010588,0,0
2,GO MRNA TRANSCRIPTION,0.75756,-0.055716,0.081395,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.67486,-0.05609,0.051542,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.64051,-0.056168,0.0082274,0,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.49108,-0.05628,-0.0015546,0,0
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.55277,-0.056372,0.0062493,0,0
2,GO STEROID ESTERIFICATION,0.33821,-0.056493,-0.07695,0,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.62923,-0.056494,-0.0020858,0,0
2,GO ANDROGEN METABOLIC PROCESS,0.41494,-0.056601,-0.011244,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.43329,-0.056646,-0.0038238,0,0
2,GO RESPONSE TO THYROID HORMONE,0.5959,-0.05671,-0.022185,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.35442,-0.056737,-0.010125,0,0
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.7336,-0.056761,-0.0019923,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.76963,-0.056773,0.012329,0,0
2,GO REGULATION OF TUBE SIZE,0.84314,-0.056818,0.023583,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.68646,-0.056898,0.035346,0,0
2,GO REGULATION OF VASOCONSTRICTION,0.76963,-0.057015,0.04602,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.33821,-0.057047,-0.024772,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.95582,-0.057119,0.026379,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.43329,-0.057195,-0.0023011,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.7336,-0.057418,0.033465,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.5959,-0.057438,0.0075145,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.56341,-0.057492,0.015091,0,0
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.47137,-0.05803,0.0151,0,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.47137,-0.058152,-0.023294,0,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.48117,-0.058197,-0.029598,0,0
2,GO BONE MINERALIZATION,0.46168,-0.058311,-0.0016896,0,0
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,1,-0.058331,0.050204,0,0
2,GO REGULATION OF ACTIN NUCLEATION,0.61803,-0.058437,0.00047265,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.91805,-0.058495,0.026579,0,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.35442,-0.058495,-0.0045497,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.7336,-0.058574,-0.018655,0,0
2,GO RESPONSE TO OXIDATIVE STRESS,0.46168,-0.058809,0.0085169,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.46168,-0.058855,0.0083842,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.3148,-0.058874,-0.067466,0,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.29248,-0.058912,-0.11205,0,0
2,GO AMINE BIOSYNTHETIC PROCESS,0.64051,-0.058977,-0.025359,0,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.99368,-0.059088,0.016928,0,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.60692,-0.059101,-0.04419,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.80618,-0.059144,0.052687,0,0
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.93062,-0.059169,0.01248,0,0
2,GO HEME METABOLIC PROCESS,0.40594,-0.059181,-0.018731,0,0
2,GO I KAPPAB PHOSPHORYLATION,0.34626,-0.059224,-0.075016,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.49108,-0.059257,-0.019272,0,0
2,GO O GLYCAN PROCESSING,0.43329,-0.059431,-0.039831,0,0
2,GO AMP METABOLIC PROCESS,0.29248,-0.059473,-0.049212,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.2998,-0.059544,-0.094543,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.49108,-0.059683,0.083168,0,0
2,GO CHOLESTEROL EFFLUX,0.55277,-0.059759,-0.033571,0,0
2,GO MICROVILLUS ORGANIZATION,0.57414,-0.05979,-0.013077,0,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.40594,-0.059948,-0.049224,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.44264,-0.060027,0.0069966,0,0
2,GO INTERACTION WITH HOST,0.34626,-0.060178,-0.02633,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.56341,-0.060312,-0.021707,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.39705,-0.060342,-0.024215,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.72171,-0.060551,0.0045529,0,0
2,GO AUTOPHAGIC CELL DEATH,0.36271,-0.060586,-0.023613,0,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.89296,-0.060609,0.02375,0,0
2,GO RESPONSE TO NUTRIENT,0.29248,-0.06061,-0.017978,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.4521,-0.060707,-0.023529,0,0
2,GO PROTEIN KINASE B SIGNALING,0.57414,-0.060737,0.0043995,0,0
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.21989,-0.06076,-0.059923,0,0
2,GO REGULATION OF ANOIKIS,0.7336,-0.0608,0.020609,0,0
2,GO TRABECULA MORPHOGENESIS,0.65188,-0.060844,-0.00030308,0,0
2,GO REGULATION OF HEMOPOIESIS,0.52145,-0.060889,-0.019142,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.37111,-0.060918,-0.020273,0,0
2,GO PSEUDOPODIUM ORGANIZATION,0.53179,-0.060971,-0.034709,0,0
2,GO METAL ION HOMEOSTASIS,0.65188,-0.061228,0.0070369,0,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.28529,-0.061261,-0.09232,0,0
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.54223,-0.061388,0.0033879,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.35442,-0.061402,0.18426,0,0
2,GO RESPONSE TO FATTY ACID,0.54223,-0.061465,0.0020337,0,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.40594,-0.061488,0.0060076,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.5959,-0.061547,0.012528,0,0
2,GO RESPONSE TO KETONE,0.60692,-0.061783,0.026439,0,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.80618,-0.0619,0.057097,0,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.56341,-0.061946,-0.01732,0,0
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.65188,-0.062191,-0.015606,0,0
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.91805,-0.062233,0.058185,0,0
2,GO DIGESTION,0.91805,-0.062379,0.028184,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.66333,-0.06245,0.013426,0,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.90549,-0.062488,-0.010842,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.46168,-0.062599,-0.012244,0,0
2,GO OSSIFICATION,0.74555,-0.062747,0.036678,0,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.32248,-0.062885,-0.033552,0,0
2,GO BEHAVIORAL RESPONSE TO PAIN,0.99368,-0.063071,0.050045,0,0
2,GO FIBROBLAST PROLIFERATION,0.7336,-0.063084,0.042552,0,0
2,GO RESPONSE TO WOUNDING,0.49108,-0.063132,0.0010898,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.62923,-0.063172,0.0058809,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.95582,-0.063366,0.059896,0,0
2,GO HEAD MORPHOGENESIS,0.68646,-0.063411,0.028395,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.37111,-0.063416,0.0095558,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.42405,-0.063541,-0.049122,0,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.68646,-0.063777,-0.038359,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.29248,-0.063922,-0.13301,0,0
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.51122,-0.063948,-0.021162,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.79394,-0.064036,0.014919,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.41494,-0.06408,-0.019193,0,0
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.26442,-0.064136,-0.070797,0,0
2,GO HEART INDUCTION,0.64051,-0.064176,-0.01682,0,0
2,GO TAXIS,0.5959,-0.064198,0.031906,0,0
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.48117,-0.064306,-0.030008,0,0
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.29248,-0.064334,0.0015042,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.24463,-0.064499,-0.061296,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.79394,-0.064617,-0.03421,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.78176,-0.064738,0.013793,0,0
2,GO CELL MATRIX ADHESION,0.54223,-0.064883,0.029476,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.43329,-0.064906,-0.03516,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.57414,-0.065166,-0.022312,0,0
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.55277,-0.065223,-0.0058151,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.53179,-0.06523,-0.042115,0,0
2,GO KERATINOCYTE DIFFERENTIATION,0.85555,-0.065435,-0.015432,0,0
2,GO RESPONSE TO DSRNA,0.43329,-0.065853,-0.033794,0,0
2,GO ANIMAL ORGAN REGENERATION,0.2998,-0.065961,-0.02529,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.70989,-0.066031,0.024609,0,0
2,GO RENAL FILTRATION,0.88046,-0.066125,0.098527,0,0
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.28529,-0.066151,-0.073019,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.83078,-0.066293,0.029979,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.40594,-0.066433,-0.065424,0,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.91805,-0.066595,0.045981,0,0
2,GO RESPONSE TO LIPID,0.4521,-0.066756,-0.0031604,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.40594,-0.066776,-0.039687,0,0
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.27126,-0.066876,-0.042421,0,0
2,GO GLUTATHIONE METABOLIC PROCESS,0.3148,-0.066907,-0.041277,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.72171,-0.067017,-0.013971,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.89296,-0.067075,0.076709,0,0
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.42405,-0.067112,-0.016579,0,0
2,GO MYELOID CELL DEVELOPMENT,0.39705,-0.067209,-0.019744,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.54223,-0.067394,0.0066323,0,0
2,GO TISSUE MIGRATION,0.55277,-0.067458,0.0036141,0,0
2,GO KERATINIZATION,0.36271,-0.067747,-0.069904,0,0
2,GO PROTEIN DENEDDYLATION,0.32248,-0.067929,-0.041507,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.52145,-0.068091,-0.063091,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.43329,-0.068113,0.0076968,0,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.72171,-0.068202,-0.0075643,0,0
2,GO MIDDLE EAR MORPHOGENESIS,0.90549,-0.068203,-0.017971,0,0
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.64051,-0.068281,-0.030787,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.39705,-0.068401,-0.03278,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.49108,-0.068532,-0.019205,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.49108,-0.068944,-0.035718,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.39705,-0.069058,-0.071672,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.49108,-0.06908,-0.038916,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.69814,-0.069169,-0.02904,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.44264,-0.069248,-0.042945,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.10811,-0.069472,-0.083696,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.2998,-0.069533,-0.10663,0,0
2,GO BIOMINERALIZATION,0.69814,-0.069572,0.02189,0,0
2,GO RESPONSE TO ATP,0.5959,-0.069756,-0.023666,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.83078,-0.069779,0.001758,0,0
2,GO PROTEIN OXIDATION,0.37964,-0.069898,-0.068002,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.42405,-0.070019,-0.022102,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.38829,-0.070031,-0.04267,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.43329,-0.070141,0.016288,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.24463,-0.070162,-0.013168,0,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15655,-0.070188,-0.046503,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.2577,-0.070204,-0.039321,0,0
2,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.57414,-0.070273,-0.079715,0,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.27126,-0.070317,-0.080682,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.53179,-0.070476,0.0072841,0,0
2,GO LINOLEIC ACID METABOLIC PROCESS,0.50109,-0.070483,-0.0078359,0,0
2,GO EXOCYTOSIS,0.29248,-0.070484,-0.032646,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.54223,-0.070626,-0.0064729,0,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.072385,-0.070778,-0.075541,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.93062,-0.070833,0.016295,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.81845,-0.070835,-0.0012251,0,0
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.4521,-0.071286,-0.032884,0,0
2,GO RESPONSE TO ANGIOTENSIN,0.30724,-0.071497,-0.054497,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.57414,-0.07156,0.012774,0,0
2,GO WOUND HEALING,0.46168,-0.071651,-0.013701,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.3148,-0.071668,-0.072227,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.47137,-0.071811,-0.019649,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.49108,-0.071847,-0.0049441,0,0
2,GO FIBROBLAST ACTIVATION,0.52145,-0.072212,-0.015611,0,0
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.37964,-0.072335,-0.092156,0,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.47137,-0.072493,-0.019668,0,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.42405,-0.07254,0.0044309,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.55277,-0.072663,-0.037383,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.36271,-0.072679,-0.11327,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.79394,-0.072865,0.037719,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.16123,-0.072994,-0.053056,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.33821,-0.073088,-0.044348,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.58498,-0.073407,-0.002171,0,0
2,GO PHAGOSOME ACIDIFICATION,0.41494,-0.073496,-0.020542,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.098083,-0.073699,-0.080223,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.27821,-0.073814,-0.036917,0,0
2,GO PH REDUCTION,0.46168,-0.074003,-0.010056,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.24463,-0.074006,0.010437,0,0
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.13467,-0.074035,-0.067931,0,0
2,GO PROTEASOME ASSEMBLY,0.16123,-0.074126,-0.05803,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.34626,-0.07423,-0.042505,0,0
2,GO VASCULATURE DEVELOPMENT,0.56341,-0.074335,0.020489,0,0
2,GO DEFENSE RESPONSE TO VIRUS,0.44264,-0.074441,-0.064697,0,0
2,GO GTP BIOSYNTHETIC PROCESS,0.37964,-0.074927,-0.082417,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.43329,-0.074976,-0.017556,0,0
2,GO IRON ION TRANSPORT,0.74555,-0.074977,0.022631,0,0
2,GO ELECTRON TRANSPORT CHAIN,0.067497,-0.075148,-0.068012,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.33029,-0.075276,-0.035586,0,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.90549,-0.075289,0.0083757,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.39705,-0.075516,-0.020074,0,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.40594,-0.075572,-0.020646,0,0
2,GO MESODERMAL CELL DIFFERENTIATION,0.79394,-0.075802,0.015267,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.50109,-0.075813,-0.053348,0,0
2,GO T CELL APOPTOTIC PROCESS,0.16602,-0.075928,-0.17743,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.70989,-0.076092,0.028044,0,0
2,GO PEPTIDYL TYROSINE MODIFICATION,0.43329,-0.076118,0.0022146,0,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.5959,-0.076207,-0.011274,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.75756,-0.076238,0.027435,0,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.27821,-0.076364,-0.0015674,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.38829,-0.076421,-0.042973,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.26442,-0.076838,-0.073303,0,0
2,GO B CELL DIFFERENTIATION,0.42405,-0.077116,-0.058472,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.38829,-0.077189,-0.05214,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.44264,-0.077324,-0.0023633,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.68646,-0.077402,-0.0070662,0,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.56341,-0.077526,-0.016155,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.29248,-0.077554,-0.0046556,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.49108,-0.077564,0.011185,0,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.23203,-0.077672,-0.069431,0,0
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.058535,-0.077986,-0.060284,0,0
2,GO ARTERY DEVELOPMENT,0.83078,-0.078116,0.072803,0,0
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.64051,-0.078142,0.008743,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.1475,-0.078189,-0.11728,0,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.15655,-0.078451,-0.083068,0,0
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.55277,-0.078454,-0.015256,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.33029,-0.078649,-0.024872,0,0
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.33821,-0.07882,-0.030873,0,0
2,GO RESPONSE TO GONADOTROPIN,0.3148,-0.078837,-0.054105,0,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.2259,-0.079019,-0.055283,0,0
2,GO LYSOSOME LOCALIZATION,0.48117,-0.079213,-0.029617,0,0
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.44264,-0.079315,-0.054158,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.58498,-0.079411,-0.0048832,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.48117,-0.079467,-0.011012,0,0
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.2998,-0.079522,-0.017093,0,0
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.39705,-0.079693,-0.013733,0,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.64051,-0.079699,-0.018565,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.50109,-0.079928,-0.0043446,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.16123,-0.079931,-0.026905,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.81845,-0.080126,-0.015842,0,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.60692,-0.080178,-0.055547,0,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.27126,-0.080242,-0.082335,0,0
2,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.96843,-0.080364,0.039078,0,0
2,GO GLIAL CELL MIGRATION,0.44264,-0.080538,-0.022741,0,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.2259,-0.080563,-0.10355,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.35442,-0.080987,-0.019515,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.37964,-0.081048,-0.031552,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1,-0.081383,0.024632,0,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.35442,-0.081395,-0.0072811,0,0
2,GO NADP METABOLIC PROCESS,0.70989,-0.081481,-0.0074385,0,0
2,GO SERTOLI CELL DIFFERENTIATION,0.75756,-0.082002,0.020433,0,0
2,GO MUSCLE CELL PROLIFERATION,0.33821,-0.082229,-0.013647,0,0
2,GO NEURON REMODELING,0.27126,-0.082248,-0.10552,0,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.53179,-0.082326,-0.028934,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.50109,-0.082657,-0.038291,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.27821,-0.08289,-0.025031,0,0
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.36271,-0.083203,-0.022026,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.53179,-0.083279,0.050529,0,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.95582,-0.083316,0.056914,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.66333,-0.083358,0.012417,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.90549,-0.083508,0.042463,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.25111,-0.08383,-0.024036,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.2998,-0.083987,-0.1065,0,0
2,GO RESPONSE TO REDOX STATE,0.70989,-0.084526,-0.033668,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.55277,-0.084538,-0.032556,0,0
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.37111,-0.084785,-0.055314,0,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.214,-0.084816,-0.050858,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.4521,-0.084836,-0.017608,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15197,-0.08486,-0.019965,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.40594,-0.085303,-0.11144,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.41494,-0.085393,-0.03422,0,0
2,GO P38MAPK CASCADE,0.55277,-0.085521,0.018158,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.40594,-0.085527,-0.053927,0,0
2,GO DIGESTIVE SYSTEM PROCESS,0.75756,-0.085551,0.015192,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.21989,-0.085751,-0.041218,0,0
2,GO MESENCHYME MORPHOGENESIS,0.49108,-0.086487,-0.0089269,0,0
2,GO RESPONSE TO CORTICOSTEROID,0.5959,-0.086628,0.0075778,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.33029,-0.086748,-0.041169,0,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.64051,-0.086807,-0.031453,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.21989,-0.086882,-0.046098,0,0
2,GO ZINC ION HOMEOSTASIS,0.28529,-0.086915,-0.098676,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.41494,-0.086996,-0.032023,0,0
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.21989,-0.08706,-0.063918,0,0
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.37964,-0.087116,-0.056968,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.42405,-0.087377,-0.029107,0,0
2,GO IRON ION HOMEOSTASIS,0.62923,-0.087705,-0.0047355,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.57414,-0.087706,0.0027079,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.50109,-0.087722,0.013927,0,0
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.78176,-0.087959,-0.0091558,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.10811,-0.087969,-0.05306,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.15197,-0.08804,-0.084857,0,0
2,GO GLYCINE METABOLIC PROCESS,0.21989,-0.088083,-0.077364,0,0
2,GO FACE DEVELOPMENT,0.56341,-0.088134,0.019602,0,0
2,GO REGULATION OF RUFFLE ASSEMBLY,0.37111,-0.088307,-0.016546,0,0
2,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.42405,-0.088475,-0.12263,0,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.18102,-0.088495,-0.099207,0,0
2,GO REGULATION OF LIPID LOCALIZATION,0.68646,-0.088498,-0.00057643,0,0
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.23203,-0.088501,-0.038739,0,0
2,GO TRANSCYTOSIS,0.47137,-0.088891,-0.059204,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.25111,-0.088948,-0.033255,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.44264,-0.089022,-0.041336,0,0
2,GO INTERFERON ALPHA PRODUCTION,0.57414,-0.089307,-0.067481,0,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.38829,-0.089319,-0.0038538,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.36271,-0.089388,-0.0079399,0,0
2,GO GRANULOCYTE DIFFERENTIATION,0.2577,-0.08953,-0.11052,0,0
2,GO PROTEIN PROCESSING,0.14312,-0.089612,-0.047079,0,0
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.60692,-0.089696,-0.00073103,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.28529,-0.08975,-0.061021,0,0
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.27126,-0.089761,-0.051124,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.44264,-0.089925,-0.0407,0,0
2,GO PROTEIN HYDROXYLATION,0.074935,-0.089951,-0.099917,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.25111,-0.090123,-0.055709,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.42405,-0.090335,-0.036772,0,0
2,GO LUTEINIZATION,0.79394,-0.090361,0.076572,0,0
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.38829,-0.090452,-0.050834,0,0
2,GO INTERACTION WITH SYMBIONT,0.28529,-0.09048,-0.054468,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.33029,-0.090822,-0.055391,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.28529,-0.090905,-0.036134,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.214,-0.091073,-0.099484,0,0
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.37964,-0.091078,-0.066561,0,0
2,GO OVULATION,0.28529,-0.091597,-0.067697,0,0
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.47137,-0.091742,-0.0042546,0,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.56341,-0.092025,-0.037001,0,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.60692,-0.092032,0.0033509,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.24463,-0.092054,-0.1391,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.62923,-0.092172,0.0040529,0,0
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.41494,-0.092192,-0.09063,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.85555,-0.092328,0.024897,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.58498,-0.0925,-0.030882,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.2259,-0.092554,-0.089924,0,0
2,GO REGULATION OF DEFENSE RESPONSE,0.2259,-0.092782,-0.086723,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.83078,-0.092782,0.036288,0,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.10468,-0.092871,-0.0478,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.17091,-0.093378,-0.14581,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.89296,-0.093691,0.034903,0,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.39705,-0.093902,-0.014377,0,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.60692,-0.093914,-0.033855,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.99368,-0.093978,0.04826,0,0
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.27126,-0.094182,-0.054193,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.38829,-0.094229,-0.080105,0,0
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.38829,-0.094713,-0.014521,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.12662,-0.094779,-0.035721,0,0
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.37111,-0.094829,-0.024837,0,0
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.16602,-0.094888,-0.066389,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.30724,-0.094954,-0.065506,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.29248,-0.095095,-0.020428,0,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.30724,-0.095186,-0.030702,0,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.28529,-0.095347,-0.093344,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.70989,-0.095454,0.024105,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.28529,-0.096047,-0.042946,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.4521,-0.096379,-0.016145,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.60692,-0.096395,-0.065987,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.44264,-0.096489,-0.051324,0,0
2,GO RESPONSE TO RETINOIC ACID,0.56341,-0.096989,-0.0016148,0,0
2,GO RESPONSE TO CYTOKINE,0.14312,-0.097694,-0.091496,0,0
2,GO RESPONSE TO VITAMIN D,0.42405,-0.097744,-0.041686,0,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.2577,-0.097762,-0.069694,0,0
2,GO COAGULATION,0.28529,-0.097802,-0.051217,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.21989,-0.097816,-0.057987,0,0
2,GO RESPONSE TO ISCHEMIA,0.44264,-0.097933,-0.017433,0,0
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.21989,-0.098088,-0.11099,0,0
2,GO PHAGOSOME MATURATION,0.32248,-0.098102,-0.021829,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.13885,-0.098117,-0.08851,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.34626,-0.098351,-0.019727,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.65188,-0.098389,-0.043889,0,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.28529,-0.098626,-0.049982,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.43329,-0.099027,-0.14493,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.54223,-0.099141,-0.026613,0,0
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.3148,-0.099254,-0.012974,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.37111,-0.099398,-0.029321,0,0
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.70989,-0.099408,0.0092475,0,0
2,GO LIPID EXPORT FROM CELL,0.37111,-0.09952,-0.048072,0,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.23203,-0.099653,-0.016893,0,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.4521,-0.09968,-0.010992,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.75756,-0.09972,-0.0026047,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.35442,-0.099769,-0.036356,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.57414,-0.10006,0.016305,0,0
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.30724,-0.10013,-0.052334,0,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.46168,-0.1002,-0.018781,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.3148,-0.10057,-0.068145,0,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.37964,-0.10057,-0.087022,0,0
2,GO RESPONSE TO VITAMIN,0.20822,-0.10063,-0.05015,0,0
2,GO STEROID HORMONE SECRETION,0.72171,-0.10077,-0.0015267,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.46168,-0.10097,-0.063221,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.54223,-0.10117,-0.0099881,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.42405,-0.10131,-0.033706,0,0
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.23827,-0.10132,-0.078495,0,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.25111,-0.10136,-0.036954,0,0
2,GO RESPONSE TO CAMP,0.52145,-0.10137,0.0079813,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.058535,-0.10139,-0.069191,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.21989,-0.10174,-0.058089,0,0
2,GO PINOCYTOSIS,0.41494,-0.10177,-0.043011,0,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.64051,-0.10191,0.0055419,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.20822,-0.10211,-0.077657,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.94321,-0.10212,0.0051858,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.33821,-0.10214,-0.037724,0,0
2,GO REGULATION OF BODY FLUID LEVELS,0.50109,-0.10215,-0.0030858,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.39705,-0.10246,-0.053624,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.89296,-0.10248,0.05866,0,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.27821,-0.10267,-0.033196,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.67486,-0.10269,-0.003807,0,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.42405,-0.10271,-0.02987,0,0
2,GO ENDOCRINE PROCESS,0.35442,-0.103,-0.045572,0,0
2,GO RUFFLE ASSEMBLY,0.49108,-0.10301,0.0055738,0,0
2,GO PROTEIN NITROSYLATION,0.24463,-0.10314,-0.1063,0,0
2,GO CORNIFICATION,0.39705,-0.10327,-0.075647,0,0
2,GO CHONDROCYTE PROLIFERATION,0.88046,-0.1033,0.050726,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.52145,-0.10336,-0.050174,0,0
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.53179,-0.10349,-0.04014,0,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.84314,-0.10382,0.057765,0,0
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.76963,-0.10393,0.05771,0,0
2,GO RESPONSE TO MUSCLE STRETCH,0.47137,-0.10404,-0.0445,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.51122,-0.10427,-0.021308,0,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.20822,-0.10429,-0.091903,0,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.42405,-0.10479,-0.059213,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.33821,-0.1049,-0.028587,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.36271,-0.10491,-0.038227,0,0
2,GO RESPONSE TO ZINC ION,0.80618,-0.10564,-0.022335,0,0
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.80618,-0.10567,0.008775,0,0
2,GO OSTEOBLAST PROLIFERATION,0.72171,-0.1058,0.034914,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.52145,-0.10581,-0.0032839,0,0
2,GO NECROTIC CELL DEATH,0.27821,-0.10607,-0.048364,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.58498,-0.10618,0.0036638,0,0
2,GO T CELL RECEPTOR SIGNALING PATHWAY,0.21989,-0.10628,-0.10785,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.69814,-0.10633,0.014388,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.69814,-0.10638,0.074443,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.12662,-0.10665,-0.096375,0,0
2,GO ORGAN INDUCTION,0.61803,-0.10672,-0.020154,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.33029,-0.10679,-0.10006,0,0
2,GO REGULATION OF ODONTOGENESIS,0.74555,-0.10689,-0.01812,0,0
2,GO VACUOLAR ACIDIFICATION,0.23827,-0.10693,-0.038061,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.20822,-0.1073,-0.10127,0,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.2998,-0.10731,-0.035685,0,0
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.48117,-0.10813,-0.038062,0,0
2,GO PLATELET MORPHOGENESIS,0.37964,-0.10825,-0.029668,0,0
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.30724,-0.1084,-0.078657,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.69814,-0.10842,0.048668,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.30724,-0.10879,-0.085251,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.83078,-0.10882,-0.015551,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.37111,-0.10883,-0.016273,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.16602,-0.10883,-0.081921,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.81845,-0.10939,-0.0072189,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.35442,-0.10949,-0.093696,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.40594,-0.10986,-0.024747,0,0
2,GO CERAMIDE TRANSPORT,0.37964,-0.10996,-0.072978,0,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.060677,-0.11011,-0.0773,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.58498,-0.11021,-0.03739,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.37111,-0.11039,-0.025648,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.29248,-0.1105,-0.041618,0,0
2,GO RETINAL METABOLIC PROCESS,0.70989,-0.11051,-0.037049,0,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.40594,-0.11073,-0.04142,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.38829,-0.11137,-0.023488,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.21989,-0.11159,-0.19111,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.35442,-0.11226,-0.07364,0,0
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.26442,-0.11237,-0.084537,0,0
2,GO ENDODERM DEVELOPMENT,0.51122,-0.11238,0.0086497,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.47137,-0.11277,-0.038503,0,0
2,GO MONONUCLEAR CELL DIFFERENTIATION,0.38829,-0.11295,-0.055559,0,0
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.26442,-0.11309,-0.063938,0,0
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.20822,-0.11313,-0.067711,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.90549,-0.11372,-0.0076919,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.15197,-0.11397,-0.10022,0,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.11524,-0.11406,-0.11438,0,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.20822,-0.11413,-0.095898,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.10134,-0.11418,-0.22463,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.16602,-0.11442,-0.078465,0,0
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.30724,-0.11469,-0.080764,0,0
2,GO LIPID IMPORT INTO CELL,0.17591,-0.11497,-0.040636,0,0
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.2998,-0.11517,-0.12733,0,0
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.24463,-0.11542,-0.14235,0,0
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.27126,-0.11564,-0.054543,0,0
2,GO RESPONSE TO MANGANESE ION,0.27821,-0.1159,-0.043527,0,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.26442,-0.11623,-0.089729,0,0
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.28529,-0.11723,-0.11685,0,0
2,GO POLYOL TRANSPORT,0.48117,-0.11753,-0.049707,0,0
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.3148,-0.11764,-0.026312,0,0
2,GO POSITIVE REGULATION OF MYELINATION,0.41494,-0.11764,-0.067509,0,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.33821,-0.11784,-0.093108,0,0
2,GO PHOSPHOLIPID CATABOLIC PROCESS,0.13885,-0.11786,-0.09825,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.15655,-0.11814,-0.11518,0,0
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.2998,-0.11845,-0.087319,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.32248,-0.11848,-0.043582,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.7336,-0.11855,0.0088238,0,0
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.13885,-0.11947,-0.096856,0,0
2,GO MYELOID CELL APOPTOTIC PROCESS,0.21989,-0.11948,-0.10301,0,0
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.36271,-0.11956,-0.041554,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.23827,-0.11959,-0.077106,0,0
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.37964,-0.1196,-0.059459,0,0
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.21989,-0.11977,-0.102,0,0
2,GO CYTOKINE PRODUCTION,0.19156,-0.11979,-0.11488,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.47137,-0.11989,-0.090151,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.66333,-0.11998,0.014559,0,0
2,GO POSITIVE REGULATION OF WOUND HEALING,0.30724,-0.12014,-0.067962,0,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.16602,-0.12015,-0.11151,0,0
2,GO ARTERY MORPHOGENESIS,0.83078,-0.12029,0.027399,0,0
2,GO ETHANOL CATABOLIC PROCESS,0.88046,-0.12032,0.0023798,0,0
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.37111,-0.1204,-0.057963,0,0
2,GO LYMPHOCYTE DIFFERENTIATION,0.46168,-0.12041,-0.076918,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.33821,-0.12062,-0.031238,0,0
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.4521,-0.12134,-0.061806,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.077559,-0.12142,-0.12736,0,0
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.50109,-0.12145,-0.036426,0,0
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.27126,-0.12163,-0.075723,0,0
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.27821,-0.12166,-0.11628,0,0
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.32248,-0.12194,-0.078101,0,0
2,GO CGMP MEDIATED SIGNALING,0.3148,-0.12197,-0.071896,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.23203,-0.12224,-0.099363,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.70989,-0.12239,-0.013202,0,0
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.27126,-0.12243,-0.089973,0,0
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.68646,-0.12257,-0.010161,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.17091,-0.12262,-0.077914,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.20256,-0.12263,-0.096685,0,0
2,GO RESPONSE TO TUMOR CELL,0.32248,-0.12271,-0.10661,0,0
2,GO RESPONSE TO LEPTIN,0.46168,-0.12317,-0.035178,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.56341,-0.12329,-0.053041,0,0
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.27821,-0.12337,-0.10566,0,0
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.30724,-0.12338,-0.072652,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.23203,-0.12377,-0.041649,0,0
2,GO GERMINAL CENTER FORMATION,0.069906,-0.12401,-0.28423,0,0
2,GO CELLULAR RESPONSE TO ZINC ION,0.98106,-0.12417,0.0020817,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.17091,-0.12423,-0.13337,0,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.23827,-0.12444,-0.11763,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.17091,-0.12453,-0.085212,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.38829,-0.12459,-0.074758,0,0
2,GO ARACHIDONIC ACID SECRETION,0.14312,-0.12468,-0.079084,0,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.18102,-0.1248,-0.065565,0,0
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.4521,-0.12503,-0.082399,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.35442,-0.12529,-0.052965,0,0
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.3148,-0.12547,-0.052862,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.197,-0.12554,-0.056455,0,0
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.38829,-0.12567,-0.047853,0,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.33821,-0.12613,-0.065658,0,0
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.27821,-0.12676,-0.061195,0,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.3148,-0.12696,-0.049058,0,0
2,GO B CELL HOMEOSTASIS,0.214,-0.12753,-0.10966,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.99368,-0.1276,0.077384,0,0
2,GO COPPER ION HOMEOSTASIS,0.08303,-0.12779,-0.078159,0,0
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.3148,-0.12793,-0.11422,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.062884,-0.12793,-0.096363,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.49108,-0.12818,-0.025978,0,0
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.3148,-0.12835,-0.02788,0,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.50109,-0.12851,-0.025931,0,0
2,GO REGULATION OF CELL ADHESION,0.26442,-0.12878,-0.055759,0,0
2,GO T CELL DIFFERENTIATION,0.43329,-0.12897,-0.092152,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.69814,-0.12903,-0.021824,0,0
2,GO ACUTE PHASE RESPONSE,0.12273,-0.1291,-0.15114,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.66333,-0.12914,0.014036,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.57414,-0.12917,-0.063311,0,0
2,GO RESPONSE TO INTERLEUKIN 1,0.17091,-0.12918,-0.10645,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.53179,-0.12922,-0.010725,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.12662,-0.12939,-0.10339,0,0
2,GO REGULATION OF WOUND HEALING,0.13885,-0.12963,-0.096596,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.72171,-0.12966,-0.017785,0,0
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.052482,-0.1297,-0.12616,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.11894,-0.12972,-0.067523,0,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.34626,-0.12975,-0.10218,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.098083,-0.13016,-0.12494,0,0
2,GO RESPONSE TO INTERLEUKIN 18,0.37964,-0.13029,-0.10266,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.2259,-0.13062,-0.067633,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.2259,-0.13078,-0.12054,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.2259,-0.13112,-0.17379,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.16123,-0.13113,-0.091607,0,0
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.20822,-0.13116,-0.10713,0,0
2,GO CELLULAR RESPONSE TO ETHANOL,0.28529,-0.13143,-0.10668,0,0
2,GO DEFENSE RESPONSE,0.20256,-0.13148,-0.11161,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.29248,-0.1315,-0.10835,0,0
2,GO RUFFLE ORGANIZATION,0.13885,-0.13159,-0.066671,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.30724,-0.13182,-0.076541,0,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.20822,-0.13235,-0.049812,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.72171,-0.13241,0.027583,0,0
2,GO REGULATION OF PROTEIN MATURATION,0.18102,-0.13254,-0.049122,0,0
2,GO MOVEMENT IN HOST ENVIRONMENT,0.18624,-0.13283,-0.080613,0,0
2,GO LEUKOCYTE HOMEOSTASIS,0.34626,-0.13321,-0.094689,0,0
2,GO CELL REDOX HOMEOSTASIS,0.08588,-0.13339,-0.11112,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.17091,-0.13342,-0.086009,0,0
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.12273,-0.13355,-0.20483,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.069906,-0.13359,-0.10867,0,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.27821,-0.13414,-0.054483,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.57414,-0.13419,-0.04061,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.23203,-0.13453,-0.092342,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.214,-0.13458,-0.060726,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.24463,-0.13464,-0.062903,0,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.24463,-0.13468,-0.09316,0,0
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.65188,-0.13523,0.021614,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.35442,-0.13585,-0.095678,0,0
2,GO LEUKOCYTE DIFFERENTIATION,0.39705,-0.13595,-0.079076,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.16123,-0.13613,-0.11708,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.067497,-0.13624,-0.14908,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.2259,-0.13664,-0.083524,0,0
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.35442,-0.13669,-0.10942,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.24463,-0.137,-0.081382,0,0
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.10134,-0.13704,-0.17131,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.42405,-0.1371,-0.072567,0,0
2,GO RESPONSE TO BIOTIC STIMULUS,0.17091,-0.13711,-0.11354,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.2259,-0.13718,-0.051305,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.48117,-0.13725,-0.012169,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.5959,-0.13748,-0.012172,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.47137,-0.13749,-0.058192,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.072385,-0.13764,-0.11872,0,0
2,GO RESPONSE TO COPPER ION,0.39705,-0.1377,-0.05334,0,0
2,GO ETHER BIOSYNTHETIC PROCESS,0.10468,-0.13778,-0.12373,0,0
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.37111,-0.13792,-0.053307,0,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.39705,-0.13793,-0.044251,0,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.35442,-0.13796,-0.18417,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.3148,-0.1381,-0.065554,0,0
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.197,-0.13854,-0.084214,0,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.18102,-0.13858,-0.087431,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.24463,-0.13863,-0.062356,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.29248,-0.13863,-0.073243,0,0
2,GO POSITIVE CHEMOTAXIS,0.25111,-0.13863,-0.068086,0,0
2,GO SUPEROXIDE METABOLIC PROCESS,0.18102,-0.13871,-0.076905,0,0
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.10811,-0.13874,-0.14592,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.39705,-0.13887,-0.031371,0,0
2,GO BONE CELL DEVELOPMENT,0.2577,-0.13914,-0.059346,0,0
2,GO RESPONSE TO EPINEPHRINE,0.1475,-0.13927,-0.099603,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.53179,-0.13942,-0.019427,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.23203,-0.13946,-0.095842,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.49108,-0.13959,-0.048512,0,0
2,GO CELL ACTIVATION,0.21989,-0.13973,-0.10371,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.48117,-0.13977,-0.057114,0,0
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.29248,-0.14013,-0.064491,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.38829,-0.1412,-0.073999,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.16602,-0.14152,-0.069888,0,0
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.38829,-0.14169,-0.051173,0,0
2,GO RENAL ABSORPTION,0.7336,-0.14185,-0.0079236,0,0
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.08303,-0.14196,-0.14211,0,0
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.18102,-0.142,-0.1102,0,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.091819,-0.14222,-0.12945,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.19156,-0.14255,-0.12824,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.23827,-0.14267,-0.13218,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.11163,-0.14304,-0.12888,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.19156,-0.1438,-0.13956,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.46168,-0.14385,-0.020762,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.28529,-0.14396,-0.091354,0,0
2,GO ETHER METABOLIC PROCESS,0.08588,-0.14402,-0.079297,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.28529,-0.14417,-0.059282,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.32248,-0.14445,-0.078662,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.43329,-0.14467,-0.015917,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18102,-0.14487,-0.11459,0,0
2,GO BONE REMODELING,0.21989,-0.14533,-0.056606,0,0
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.2259,-0.1454,-0.071274,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.4521,-0.14547,-0.055524,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.37111,-0.14571,-0.03119,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.21989,-0.14583,-0.071469,0,0
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.214,-0.14586,-0.1633,0,0
2,GO IMMUNE EFFECTOR PROCESS,0.16123,-0.14589,-0.12892,0,0
2,GO BARBED END ACTIN FILAMENT CAPPING,0.1475,-0.146,-0.081738,0,0
2,GO PROSTANOID METABOLIC PROCESS,0.058535,-0.14603,-0.18065,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.25111,-0.14603,-0.04892,0,0
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.3148,-0.14638,-0.049619,0,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.15655,-0.14642,-0.077923,0,0
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.17591,-0.14659,-0.12253,0,0
2,GO RESPONSE TO HYPEROXIA,0.17091,-0.14667,-0.059585,0,0
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.18624,-0.14684,-0.1349,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.197,-0.14713,-0.10557,0,0
2,GO RESPONSE TO HYDROPEROXIDE,0.38829,-0.14737,-0.07967,0,0
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.197,-0.14752,-0.18871,0,0
2,GO FLUID TRANSPORT,0.24463,-0.14753,-0.1013,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.36271,-0.14759,-0.02967,0,0
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.19156,-0.1476,-0.12062,0,0
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.12273,-0.14766,-0.18615,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.2259,-0.1477,-0.1626,0,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.41494,-0.14797,-0.050952,0,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.38829,-0.148,-0.086039,0,0
2,GO GLOMERULUS DEVELOPMENT,0.74555,-0.1482,0.015985,0,0
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.18102,-0.14822,-0.18675,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.17591,-0.14835,-0.11017,0,0
2,GO ASTROCYTE DEVELOPMENT,0.48117,-0.14861,-0.049447,0,0
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.11524,-0.14867,-0.18145,0,0
2,GO INNATE IMMUNE RESPONSE,0.11524,-0.14876,-0.15802,0,0
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.1306,-0.1489,-0.18855,0,0
2,GO REGULATION OF T CELL DIFFERENTIATION,0.33821,-0.14905,-0.10715,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.58498,-0.1493,-0.038139,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.20822,-0.14933,-0.07554,0,0
2,GO GLYCEROL ETHER METABOLIC PROCESS,0.037377,-0.14942,-0.11194,0,0
2,GO B CELL ACTIVATION,0.30724,-0.14948,-0.112,0,0
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.29248,-0.14958,-0.10273,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.18624,-0.14961,-0.05302,0,0
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.17091,-0.14967,-0.19997,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.28529,-0.14995,-0.024209,0,0
2,GO LYMPHOCYTE ACTIVATION,0.2998,-0.15049,-0.1108,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.3148,-0.15061,-0.15426,0,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.13885,-0.15112,-0.126,0,0
2,GO MUSCLE CELL FATE COMMITMENT,0.094909,-0.15123,-0.14996,0,0
2,GO AMYLOID FIBRIL FORMATION,0.29248,-0.15138,-0.075032,0,0
2,GO NAD BIOSYNTHETIC PROCESS,0.42405,-0.15138,-0.085121,0,0
2,GO HETEROTYPIC CELL CELL ADHESION,0.19156,-0.15167,-0.10476,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.28529,-0.15174,-0.14836,0,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.29248,-0.15186,-0.12791,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.27126,-0.15222,-0.077869,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.52145,-0.15245,-0.049273,0,0
2,GO PROSTAGLANDIN SECRETION,0.34626,-0.15249,-0.090195,0,0
2,GO PANCREATIC JUICE SECRETION,0.23827,-0.15249,-0.077635,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.13885,-0.1526,-0.095714,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.35442,-0.15289,-0.043004,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.12273,-0.15329,-0.11597,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.37964,-0.15353,-0.032139,0,0
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.38829,-0.15389,-0.10244,0,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.10811,-0.15417,-0.14696,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.08303,-0.1544,-0.15915,0,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.15655,-0.15444,-0.18523,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.24463,-0.15478,-0.082144,0,0
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.1306,-0.15491,-0.14731,0,0
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.214,-0.15491,-0.083416,0,0
2,GO ALPHA BETA T CELL ACTIVATION,0.26442,-0.15514,-0.16171,0,0
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.20822,-0.15539,-0.1367,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.214,-0.15551,-0.074433,0,0
2,GO L SERINE METABOLIC PROCESS,0.42405,-0.15554,-0.073196,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.1475,-0.1558,-0.16508,0,0
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.12662,-0.15601,-0.20258,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.33029,-0.15609,-0.12167,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.12273,-0.15612,-0.17629,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.12273,-0.15635,-0.15072,0,0
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.20256,-0.15637,-0.16016,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.1475,-0.1564,-0.097841,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.26442,-0.15677,-0.079975,0,0
2,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.53179,-0.157,-0.058265,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.13467,-0.15704,-0.078496,0,0
2,GO VASCULAR WOUND HEALING,0.18102,-0.15706,-0.079196,0,0
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.214,-0.15741,-0.1187,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.08303,-0.1576,-0.18432,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.23827,-0.15765,-0.048285,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.10134,-0.1583,-0.063897,0,0
2,GO INTERLEUKIN 6 PRODUCTION,0.094909,-0.15833,-0.17705,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.21989,-0.15846,-0.12645,0,0
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.95582,-0.1585,0.0070776,0,0
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.26442,-0.1587,-0.056436,0,0
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.24463,-0.15877,-0.14657,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.52145,-0.15887,-0.067128,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.16602,-0.15894,-0.070726,0,0
2,GO COPPER ION TRANSPORT,0.17591,-0.15895,-0.10827,0,0
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.077559,-0.15908,-0.24024,0,0
2,GO CD40 SIGNALING PATHWAY,0.072385,-0.15935,-0.23926,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.197,-0.15963,-0.099362,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.36271,-0.15984,-0.034027,0,0
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.197,-0.15994,-0.14808,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.08303,-0.16056,-0.073431,0,0
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.10134,-0.16057,-0.26493,0,0
2,GO RESPONSE TO MAGNESIUM ION,0.091819,-0.16064,-0.14045,0,0
2,GO REGULATORY T CELL DIFFERENTIATION,0.23827,-0.16069,-0.19139,0,0
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.13467,-0.16103,-0.24372,0,0
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.1306,-0.16117,-0.1486,0,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.21989,-0.16129,-0.11464,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.11894,-0.16138,-0.14872,0,0
2,GO ERK1 AND ERK2 CASCADE,0.26442,-0.16158,-0.077996,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.20822,-0.16219,-0.093346,0,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.55277,-0.16228,-0.014232,0,0
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.27126,-0.16258,-0.10505,0,0
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.24463,-0.16278,-0.16021,0,0
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.1306,-0.1628,-0.090196,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.15655,-0.16285,-0.13875,0,0
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.2259,-0.16288,-0.15277,0,0
2,GO PLATELET ACTIVATION,0.2259,-0.16288,-0.073109,0,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.69814,-0.16291,-0.027292,0,0
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.35442,-0.16299,-0.087744,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.96843,-0.16353,0.018882,0,0
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.197,-0.16359,-0.19676,0,0
2,GO INFLAMMATORY RESPONSE,0.13467,-0.16386,-0.14616,0,0
2,GO RESPONSE TO LITHIUM ION,0.27821,-0.1639,-0.033362,0,0
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.1306,-0.16394,-0.23058,0,0
2,GO NEUTROPHIL EXTRAVASATION,0.29248,-0.16396,-0.1389,0,0
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.11524,-0.16424,-0.13199,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.091819,-0.16474,-0.17255,0,0
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.19156,-0.16542,-0.16736,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.34626,-0.16559,-0.098478,0,0
2,GO T CELL ACTIVATION,0.28529,-0.16628,-0.13797,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.15655,-0.1664,-0.060282,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.08303,-0.16652,-0.14089,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.42405,-0.16661,-0.040007,0,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.17591,-0.16684,-0.17742,0,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.12662,-0.16686,-0.18608,0,0
2,GO ENTRY INTO HOST,0.19156,-0.1673,-0.099764,0,0
2,GO RESPONSE TO INTERLEUKIN 7,0.080256,-0.16762,-0.13458,0,0
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.24463,-0.16789,-0.11174,0,0
2,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.17091,-0.16816,-0.14022,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.32248,-0.16849,-0.075493,0,0
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.35442,-0.16858,-0.1401,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.062884,-0.16888,-0.069388,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.2577,-0.16912,-0.087136,0,0
2,GO PHOSPHATE ION TRANSPORT,0.11894,-0.16969,-0.096363,0,0
2,GO REGULATION OF CELL CELL ADHESION,0.24463,-0.17019,-0.12555,0,0
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.11894,-0.17049,-0.20009,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.067497,-0.17055,-0.13239,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.32248,-0.1722,-0.051923,0,0
2,GO NEUTROPHIL HOMEOSTASIS,0.25111,-0.17227,-0.10386,0,0
2,GO MAST CELL MEDIATED IMMUNITY,0.16602,-0.17236,-0.15111,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.39705,-0.17313,-0.11547,0,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.13467,-0.17315,-0.16424,0,0
2,GO FOAM CELL DIFFERENTIATION,0.15197,-0.17341,-0.1215,0,0
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.33821,-0.17365,-0.089542,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.20256,-0.17377,-0.069665,0,0
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.069906,-0.17381,-0.14992,0,0
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.3148,-0.17387,-0.084222,0,0
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.11894,-0.17453,-0.19293,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.26442,-0.17466,-0.1387,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.23203,-0.17468,-0.13587,0,0
2,GO REGULATION OF TISSUE REMODELING,0.13885,-0.17529,-0.093219,0,0
2,GO T CELL LINEAGE COMMITMENT,0.214,-0.1755,-0.14945,0,0
2,GO AMYLOID BETA CLEARANCE,0.11163,-0.17603,-0.16117,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.080256,-0.17625,-0.201,0,0
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.20256,-0.17632,-0.18998,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.214,-0.17728,-0.083476,0,0
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.16602,-0.1773,-0.13774,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.62923,-0.17733,-0.061035,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.12662,-0.17766,-0.12491,0,0
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.11524,-0.17794,-0.19225,0,0
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.26442,-0.17803,-0.13431,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.19156,-0.17821,-0.17998,0,0
2,GO GAP JUNCTION ASSEMBLY,0.054439,-0.1786,-0.24197,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.17091,-0.17904,-0.11068,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.098083,-0.17909,-0.13245,0,0
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.33029,-0.17931,-0.13833,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.3148,-0.17963,-0.073766,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.38829,-0.18024,-0.075505,0,0
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.20256,-0.18058,-0.19475,0,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.16123,-0.18164,-0.20508,0,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.197,-0.18164,-0.10644,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.20822,-0.1823,-0.1671,0,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.15197,-0.18254,-0.13865,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.2259,-0.18261,-0.10355,0,0
2,GO TISSUE REMODELING,0.17591,-0.18268,-0.080805,0,0
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.069906,-0.18293,-0.21222,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION,0.17591,-0.1831,-0.13422,0,0
2,GO ETHANOL METABOLIC PROCESS,0.26442,-0.18367,-0.10019,0,0
2,GO LEUKOTRIENE METABOLIC PROCESS,0.13885,-0.1847,-0.14206,0,0
2,GO MYELOID LEUKOCYTE ACTIVATION,0.08881,-0.18502,-0.1586,0,0
2,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.16602,-0.18521,-0.21099,0,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.08881,-0.18533,-0.14183,0,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.29248,-0.18544,-0.15169,0,0
2,GO REGULATION OF LIPASE ACTIVITY,0.15655,-0.18551,-0.10162,0,0
2,GO TRABECULA FORMATION,0.15655,-0.18563,-0.11595,0,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.1306,-0.18566,-0.084693,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.44264,-0.18585,-0.05352,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.23827,-0.18632,-0.12911,0,0
2,GO RESPONSE TO BACTERIUM,0.10134,-0.18637,-0.16163,0,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.19156,-0.18638,-0.12111,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.50109,-0.18643,-0.052328,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.10468,-0.18646,-0.085512,0,0
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.19156,-0.18649,-0.15406,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.16602,-0.187,-0.09826,0,0
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.067497,-0.18706,-0.18122,0,0
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.094909,-0.18729,-0.16637,0,0
2,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.21989,-0.18735,-0.13992,0,0
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.11894,-0.18758,-0.19181,0,0
2,GO RESPONSE TO INTERLEUKIN 6,0.15197,-0.18768,-0.10411,0,0
2,GO SYNCYTIUM FORMATION,0.17591,-0.18787,-0.10733,0,0
2,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.18624,-0.18829,-0.19431,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.15197,-0.18854,-0.17886,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.16602,-0.18862,-0.10955,0,0
2,GO T CELL CYTOKINE PRODUCTION,0.080256,-0.18893,-0.24619,0,0
2,GO RESPONSE TO AMYLOID BETA,0.29248,-0.18938,-0.039304,0,0
2,GO BONE RESORPTION,0.067497,-0.18985,-0.1474,0,0
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.16602,-0.19031,-0.21698,0,0
2,GO REGULATION OF CELL ACTIVATION,0.18102,-0.19041,-0.16348,0,0
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.062884,-0.19047,-0.14832,0,0
2,GO REGULATION OF IMMUNE RESPONSE,0.15655,-0.19068,-0.15403,0,0
2,GO REGULATION OF B CELL DIFFERENTIATION,0.19156,-0.19076,-0.19581,0,0
2,GO ICOSANOID METABOLIC PROCESS,0.1306,-0.19269,-0.11752,0,0
2,GO ACTIVATION OF IMMUNE RESPONSE,0.16123,-0.19283,-0.14066,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.054439,-0.19332,-0.19381,0,0
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.080256,-0.19396,-0.17282,0,0
2,GO CYTOKINE SECRETION,0.14312,-0.19464,-0.16028,0,0
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.40594,-0.19467,-0.088967,0,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.11524,-0.19511,-0.19362,0,0
2,GO REGULATION OF BONE REMODELING,0.098083,-0.19512,-0.12154,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.15197,-0.19515,-0.11059,0,0
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.067497,-0.19525,-0.18351,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.34626,-0.19591,-0.12508,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.3148,-0.19595,-0.066375,0,0
2,GO MAST CELL ACTIVATION,0.214,-0.19612,-0.14558,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.16602,-0.19646,-0.11395,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.056456,-0.19671,-0.1888,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.16602,-0.19674,-0.1096,0,0
2,GO REGULATION OF B CELL ACTIVATION,0.094909,-0.19751,-0.23011,0,0
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.13467,-0.19843,-0.15233,0,0
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.098083,-0.19853,-0.13298,0,0
2,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.44264,-0.19871,-0.060873,0,0
2,GO FRUCTOSE METABOLIC PROCESS,0.197,-0.19891,-0.064624,0,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.15197,-0.19923,-0.16822,0,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.28529,-0.19964,-0.12969,0,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.16602,-0.20005,-0.13353,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.23203,-0.20045,-0.1125,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.10811,-0.20046,-0.076935,0,0
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.23203,-0.20047,-0.15763,0,0
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.11163,-0.20051,-0.11889,0,0
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.1306,-0.20144,-0.15296,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.13467,-0.20192,-0.16539,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.1306,-0.20211,-0.22496,0,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.13467,-0.20256,-0.22837,0,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.094909,-0.20266,-0.11654,0,0
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.15655,-0.20313,-0.1813,0,0
2,GO CELL CHEMOTAXIS,0.077559,-0.20356,-0.1901,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.094909,-0.20413,-0.17605,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.10811,-0.20466,-0.21526,0,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.091819,-0.20521,-0.19322,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.13885,-0.20543,-0.13212,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.16123,-0.2055,-0.2078,0,0
2,GO LEUKOCYTE MIGRATION,0.08303,-0.20616,-0.18352,0,0
2,GO ACTIN FILAMENT SEVERING,0.060677,-0.20622,-0.17694,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.15655,-0.20631,-0.17685,0,0
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.094909,-0.20631,-0.20036,0,0
2,GO STEROID CATABOLIC PROCESS,0.08588,-0.20673,-0.16847,0,0
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.1306,-0.20707,-0.21752,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.13885,-0.20713,-0.22524,0,0
2,GO CELLULAR EXTRAVASATION,0.1475,-0.20718,-0.17595,0,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.12662,-0.20738,-0.1844,0,0
2,GO MYOBLAST FUSION,0.20256,-0.20827,-0.11844,0,0
2,GO POSITIVE REGULATION OF COAGULATION,0.060677,-0.20836,-0.1754,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.094909,-0.20855,-0.19093,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.17091,-0.20887,-0.13414,0,0
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.10811,-0.20921,-0.21221,0,0
2,GO REGULATION OF PHAGOCYTOSIS,0.08588,-0.20952,-0.20388,0,0
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.11524,-0.20967,-0.1932,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.214,-0.21024,-0.13559,0,0
2,GO T CELL SELECTION,0.23203,-0.21025,-0.20958,0,0
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.15197,-0.21029,-0.17319,0,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.11894,-0.21062,-0.19778,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.08881,-0.21066,-0.11334,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.2259,-0.21083,-0.076473,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.1475,-0.21098,-0.17319,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.4521,-0.21141,-0.13927,0,0
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.11524,-0.21229,-0.23663,0,0
2,GO REGULATION OF CHEMOTAXIS,0.11894,-0.2124,-0.13058,0,0
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.1306,-0.21264,-0.1677,0,0
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.054439,-0.21274,-0.20022,0,0
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.13467,-0.21298,-0.19665,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.28529,-0.21315,-0.16503,0,0
2,GO REGULATION OF T CELL ACTIVATION,0.214,-0.21331,-0.1703,0,0
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.12662,-0.21351,-0.14736,0,0
2,GO LEUKOCYTE AGGREGATION,0.17591,-0.21389,-0.25521,0,0
2,GO PLASMA MEMBRANE FUSION,0.058535,-0.21427,-0.21145,0,0
2,GO REGULATION OF MAST CELL ACTIVATION,0.08881,-0.21436,-0.20233,0,0
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.25111,-0.21472,-0.073569,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.094909,-0.21513,-0.14683,0,0
2,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.17591,-0.21568,-0.26219,0,0
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.054439,-0.21593,-0.21667,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.08303,-0.21598,-0.20973,0,0
2,GO LEYDIG CELL DIFFERENTIATION,0.58498,-0.21711,-0.045595,0,0
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.11163,-0.21792,-0.2991,0,0
2,GO ENDODERM FORMATION,0.2259,-0.21796,-0.080272,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.058535,-0.21812,-0.18849,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.214,-0.22003,-0.17333,0,0
2,GO PLATELET AGGREGATION,0.12662,-0.22033,-0.10404,0,0
2,GO CYTOKINE METABOLIC PROCESS,0.072385,-0.22048,-0.2262,0,0
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.094909,-0.22086,-0.24165,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.17091,-0.2209,-0.13044,0,0
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.197,-0.2211,-0.096433,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.069906,-0.22119,-0.17735,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.054439,-0.22127,-0.16535,0,0
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.060677,-0.22161,-0.19057,0,0
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.10811,-0.22176,-0.20116,0,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.072385,-0.22218,-0.18658,0,0
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.091819,-0.22355,-0.14427,0,0
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.098083,-0.22363,-0.23471,0,0
2,GO LEUKOCYTE CELL CELL ADHESION,0.16602,-0.22364,-0.19087,0,0
2,GO ADRENAL GLAND DEVELOPMENT,0.32248,-0.22397,-0.053558,0,0
2,GO LIPID DIGESTION,0.15655,-0.22418,-0.17424,0,0
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.10811,-0.22466,-0.16596,0,0
2,GO DETECTION OF BIOTIC STIMULUS,0.11163,-0.22491,-0.20552,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.11524,-0.22527,-0.13423,0,0
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.11163,-0.22593,-0.21783,0,0
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.08881,-0.22605,-0.22818,0,0
2,GO ASTROCYTE ACTIVATION,0.12273,-0.22639,-0.18029,0,0
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.094909,-0.22641,-0.2058,0,0
2,GO WATER TRANSPORT,0.23203,-0.22803,-0.14304,0,0
2,GO MEMBRANE INVAGINATION,0.10468,-0.22864,-0.1669,0,0
2,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.1475,-0.22944,-0.2065,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.054439,-0.22967,-0.21841,0,0
2,GO PHAGOCYTOSIS RECOGNITION,0.27126,-0.23016,-0.13858,0,0
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.11163,-0.23023,-0.13131,0,0
2,GO ZYMOGEN INHIBITION,0.077559,-0.23162,-0.19661,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.08588,-0.23167,-0.16078,0,0
2,GO PHAGOCYTOSIS,0.10811,-0.23187,-0.16013,0,0
2,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.052482,-0.2321,-0.22142,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.12273,-0.23212,-0.13936,0,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.10134,-0.23272,-0.2814,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.074935,-0.23284,-0.22885,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.30724,-0.23294,-0.19506,0,0
2,GO VITAMIN TRANSPORT,0.074935,-0.23463,-0.096386,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.060677,-0.23494,-0.17944,0,0
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.041938,-0.23497,-0.17234,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.18624,-0.23555,-0.19623,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.10468,-0.23583,-0.16441,0,0
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.11894,-0.23629,-0.2122,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.35442,-0.23692,-0.058742,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.35442,-0.23699,-0.12075,0,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.16123,-0.23741,-0.21774,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.12662,-0.23853,-0.20662,0,0
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.062884,-0.23892,-0.2497,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.094909,-0.23904,-0.1696,0,0
2,GO INTEGRIN ACTIVATION,0.056456,-0.2399,-0.25468,0,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.067497,-0.2404,-0.21836,0,0
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.052482,-0.2408,-0.19527,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.15197,-0.24134,-0.19687,0,0
2,GO INTESTINAL ABSORPTION,0.11163,-0.24208,-0.16326,0,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.26442,-0.24219,-0.10636,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.091819,-0.24262,-0.16644,0,0
2,GO GLYCINE TRANSPORT,0.20256,-0.24322,-0.10867,0,0
2,GO T CELL PROLIFERATION,0.10134,-0.24333,-0.22698,0,0
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.10811,-0.24418,-0.21746,0,0
2,GO EPOXYGENASE P450 PATHWAY,0.2998,-0.24479,-0.076915,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.054439,-0.24499,-0.30068,0,0
2,GO INTERLEUKIN 8 PRODUCTION,0.054439,-0.24564,-0.23191,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.058535,-0.2468,-0.26602,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.054439,-0.2469,-0.18709,0,0
2,GO BLOOD VESSEL REMODELING,0.18102,-0.24713,-0.11355,0,0
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.098083,-0.24714,-0.283,0,0
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.054439,-0.24759,-0.26592,0,0
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.1475,-0.2477,-0.12283,0,0
2,GO HISTAMINE TRANSPORT,0.11894,-0.24838,-0.17396,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.10468,-0.24891,-0.15441,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.1306,-0.24967,-0.22118,0,0
2,GO RESPONSE TO INTERFERON GAMMA,0.067497,-0.24981,-0.27713,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.091819,-0.25052,-0.21044,0,0
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.20256,-0.25061,-0.17795,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.10811,-0.25135,-0.17358,0,0
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.056456,-0.25172,-0.22415,0,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.091819,-0.2519,-0.22918,0,0
2,GO PLATELET DEGRANULATION,0.074935,-0.25199,-0.15807,0,0
2,GO CELL ADHESION MOLECULE PRODUCTION,0.19156,-0.2529,-0.12945,0,0
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.08881,-0.25294,-0.21268,0,0
2,GO MACROPHAGE APOPTOTIC PROCESS,0.197,-0.25299,-0.15758,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.10468,-0.25319,-0.18924,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.077559,-0.25322,-0.27501,0,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.13467,-0.25373,-0.12645,0,0
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.098083,-0.25389,-0.23863,0,0
2,GO INTERLEUKIN 2 PRODUCTION,0.052482,-0.25421,-0.27212,0,0
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.067497,-0.25543,-0.24998,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.1475,-0.25607,-0.19848,0,0
2,GO LEUKOCYTE PROLIFERATION,0.11163,-0.25644,-0.21493,0,0
2,GO BLEB ASSEMBLY,0.25111,-0.25699,-0.10144,0,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.067497,-0.25793,-0.22956,0,0
2,GO POSITIVE T CELL SELECTION,0.20256,-0.25895,-0.22623,0,0
2,GO ADAPTIVE IMMUNE RESPONSE,0.098083,-0.25902,-0.26237,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.16602,-0.25904,-0.13744,0,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.1306,-0.26056,-0.22116,0,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.077559,-0.26125,-0.3088,0,0
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.054439,-0.26174,-0.31458,0,0
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.10468,-0.26177,-0.2324,0,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.10134,-0.2621,-0.14353,0,0
2,GO VASODILATION,0.091819,-0.26224,-0.13763,0,0
2,GO MACROPHAGE MIGRATION,0.052482,-0.26252,-0.23986,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.067497,-0.26286,-0.25556,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.2998,-0.26301,-0.12315,0,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.060677,-0.26303,-0.22419,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.056456,-0.26318,-0.23797,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.037377,-0.2642,-0.26273,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.08588,-0.26503,-0.20317,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.060677,-0.26532,-0.22881,0,0
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.08303,-0.2658,-0.26933,0,0
2,GO T HELPER 1 CELL DIFFERENTIATION,0.080256,-0.26585,-0.28359,0,0
2,GO CHEMOKINE PRODUCTION,0.058535,-0.26659,-0.20167,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.091819,-0.26676,-0.20562,0,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.065157,-0.26684,-0.21979,0,0
2,GO B CELL MEDIATED IMMUNITY,0.074935,-0.26688,-0.24709,0,0
2,GO RESPONSE TO TYPE I INTERFERON,0.10468,-0.26741,-0.2143,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.069906,-0.2681,-0.25005,0,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.054439,-0.26859,-0.2953,0,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.050584,-0.26875,-0.24871,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.11163,-0.2688,-0.23542,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.077559,-0.27009,-0.22343,0,0
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.11524,-0.27037,-0.21383,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.098083,-0.27088,-0.18275,0,0
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.11163,-0.27119,-0.21107,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.077559,-0.27134,-0.22546,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.067497,-0.27173,-0.26016,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.29248,-0.27216,-0.21501,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.10811,-0.27365,-0.15168,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.30724,-0.27386,-0.18998,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.065157,-0.27455,-0.24739,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.61803,-0.27548,-0.068077,0,0
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.14312,-0.27639,-0.20698,0,0
2,GO MATURE B CELL DIFFERENTIATION,0.14312,-0.27683,-0.21077,0,0
2,GO LYMPHOCYTE COSTIMULATION,0.14312,-0.27736,-0.22489,0,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.060677,-0.27816,-0.33626,0,0
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.12662,-0.27819,-0.17181,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.056456,-0.2799,-0.23382,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.10811,-0.2804,-0.25067,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.13467,-0.28133,-0.22757,0,0
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.15197,-0.28166,-0.17005,0,0
2,GO MACROPHAGE ACTIVATION,0.074935,-0.28166,-0.2501,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.056456,-0.28175,-0.23561,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.052482,-0.28187,-0.25626,0,0
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.11163,-0.28234,-0.2763,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.11524,-0.28335,-0.22739,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.067497,-0.28343,-0.25219,0,0
2,GO INTERFERON GAMMA PRODUCTION,0.058535,-0.28412,-0.27731,0,0
2,GO T CELL EXTRAVASATION,0.11524,-0.28421,-0.21914,0,0
2,GO GLIAL CELL ACTIVATION,0.067497,-0.2843,-0.26325,0,0
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.14312,-0.28451,-0.24104,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.065157,-0.2849,-0.20614,0,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.11163,-0.28715,-0.26468,0,0
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.098083,-0.28788,-0.2441,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.067497,-0.2882,-0.25985,0,0
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.054439,-0.28876,-0.27295,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.043559,-0.28946,-0.29169,0,0
2,GO THYMIC T CELL SELECTION,0.20822,-0.28995,-0.23333,0,0
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.056456,-0.29113,-0.26402,0,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.08303,-0.29173,-0.15564,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.08303,-0.29248,-0.31946,0,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.1306,-0.29329,-0.21851,0,0
2,GO LYMPH NODE DEVELOPMENT,0.08881,-0.29439,-0.21482,0,0
2,GO RESPONSE TO PROTOZOAN,0.08588,-0.29553,-0.291,0,0
2,GO DETECTION OF OTHER ORGANISM,0.091819,-0.29574,-0.26168,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.058535,-0.2965,-0.26745,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.11894,-0.29705,-0.20436,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.13885,-0.29804,-0.22652,0,0
2,GO B CELL PROLIFERATION,0.072385,-0.29942,-0.28452,0,0
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.054439,-0.30093,-0.27949,0,0
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.060677,-0.30321,-0.27586,0,0
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.12662,-0.3051,-0.21584,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.050584,-0.30634,-0.27482,0,0
2,GO POSITIVE REGULATION OF CELL KILLING,0.065157,-0.30643,-0.28508,0,0
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.067497,-0.30713,-0.29507,0,0
2,GO REGULATION OF BONE DEVELOPMENT,0.054439,-0.30816,-0.2184,0,0
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.052482,-0.30894,-0.26043,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.050584,-0.31067,-0.27503,0,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.2577,-0.31152,-0.14849,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.054439,-0.31175,-0.26403,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.065157,-0.31205,-0.31897,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.060677,-0.31232,-0.28768,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.08303,-0.31382,-0.29014,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.060677,-0.31397,-0.23269,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.065157,-0.32009,-0.2515,0,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.077559,-0.32115,-0.27723,0,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.21989,-0.32358,-0.12784,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.094909,-0.32483,-0.21653,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.13467,-0.32559,-0.29261,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.054439,-0.3265,-0.28102,0,0
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.08588,-0.32681,-0.17771,0,0
2,GO RESPONSE TO INTERLEUKIN 15,0.10811,-0.32684,-0.28182,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.058535,-0.32722,-0.23224,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.060677,-0.33937,-0.20727,0,0
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.058535,-0.34527,-0.31399,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.18102,-0.34628,-0.2953,0,0
2,GO T HELPER 2 CELL DIFFERENTIATION,0.12273,-0.34792,-0.25123,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.16602,-0.34841,-0.18908,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.050584,-0.35177,-0.32326,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.08881,-0.35216,-0.29973,0,0
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.058535,-0.36229,-0.37681,0,0
2,GO INTERLEUKIN 12 PRODUCTION,0.060677,-0.36684,-0.31711,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.054439,-0.36789,-0.39441,0,0
2,GO INTERLEUKIN 5 PRODUCTION,0.054439,-0.37103,-0.2898,0,0
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.08881,-0.3713,-0.26283,0,0
2,GO ETHANOL OXIDATION,0.08588,-0.37277,-0.21986,0,0
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.056456,-0.38197,-0.21713,0,0
2,GO NEGATIVE T CELL SELECTION,0.18624,-0.39105,-0.29586,0,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.074935,-0.4117,-0.31454,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.060677,-0.42444,-0.19383,0,0
2,GO MACROPHAGE PROLIFERATION,0.098083,-0.42871,-0.27832,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0063209,-0.43688,-0.33873,0,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.052482,-0.47242,-0.41756,0,0
2,GO ADHESION OF SYMBIONT TO HOST,0.08303,-0.47737,-0.28665,0,0
2,GO NATURAL KILLER CELL CHEMOTAXIS,0.056456,-0.7335,-0.50642,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.0028457,-0.74584,-0.5898,0,0
3,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.027226,0.81585,0.62653,1,1
3,GO T CELL TOLERANCE INDUCTION,0.026142,0.80233,0.5658,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00014989,0.75503,0.61569,1,1
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.007293,0.75103,0.64269,1,1
3,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.037377,0.7416,0.41856,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,0.043559,0.65557,0.46477,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0012758,0.64165,0.54118,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0015041,0.62234,0.53192,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.037377,0.62094,0.46213,1,1
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00096503,0.60951,0.50831,1,1
3,GO POSITIVE T CELL SELECTION,0.030713,0.5698,0.42416,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00057531,0.56377,0.49539,1,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.007293,0.55075,0.40968,1,1
3,GO VOCALIZATION BEHAVIOR,0.00096503,0.53646,0.4594,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.026142,0.53359,0.37385,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.046961,0.53118,0.38903,1,1
3,GO SYNAPSE MATURATION,0.0015041,0.52541,0.46096,1,1
3,GO POSITIVE THYMIC T CELL SELECTION,0.035953,0.52242,0.45,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0015882,0.52212,0.43715,1,1
3,GO THYMIC T CELL SELECTION,0.026142,0.51904,0.42731,1,1
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0012071,0.51415,0.4376,1,1
3,GO PREPULSE INHIBITION,0.0063209,0.51155,0.44871,1,1
3,GO REGULATION OF SYNAPSE MATURATION,0.0034935,0.51128,0.44826,1,1
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.010572,0.50832,0.37823,1,1
3,GO REGULATION OF GLUTAMATE SECRETION,0.00057531,0.50221,0.4948,1,1
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.023112,0.49911,0.42237,1,1
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.027226,0.49785,0.45996,1,1
3,GO RESPONSE TO INTERLEUKIN 2,0.018736,0.4951,0.41796,1,1
3,GO INNER DYNEIN ARM ASSEMBLY,0.033245,0.49293,0.34548,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.010101,0.49257,0.46101,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,3.0304e-05,0.4905,0.47373,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.034576,0.48428,0.34372,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00068502,0.48313,0.42871,1,1
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.010572,0.48015,0.40191,1,1
3,GO MACROPHAGE PROLIFERATION,0.027226,0.47946,0.40457,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00018128,0.47283,0.47753,1,1
3,GO LONG TERM SYNAPTIC DEPRESSION,8.9327e-05,0.47222,0.42572,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00035748,0.47129,0.49432,1,1
3,GO T CELL SELECTION,0.030713,0.46968,0.40736,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0015041,0.46915,0.40725,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.034576,0.46805,0.43573,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.02951,0.46535,0.39582,1,1
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0018673,0.46468,0.44606,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0029965,0.46112,0.40727,1,1
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0013481,0.46107,0.43275,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.046961,0.45471,0.37581,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.035953,0.45424,0.33169,1,1
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00021879,0.45341,0.39932,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,0.045233,0.44505,0.37201,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00081392,0.44316,0.43016,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,1.8524e-05,0.44005,0.49279,1,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.033245,0.43904,0.35464,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0066311,0.43875,0.45095,1,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.00028019,0.43832,0.38124,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.046961,0.43831,0.35268,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,0.0012758,0.43767,0.39209,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00017019,0.4351,0.40781,1,1
3,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.0063209,0.43107,0.3897,1,1
3,GO MICROTUBULE DEPOLYMERIZATION,0.0012758,0.431,0.41682,1,1
3,GO POSTSYNAPSE ASSEMBLY,0.0021907,0.43022,0.42492,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0014241,0.43009,0.49362,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0015882,0.42708,0.37763,1,1
3,GO NEGATIVE T CELL SELECTION,0.045233,0.42701,0.47913,1,1
3,GO MEMBRANE HYPERPOLARIZATION,0.0024341,0.427,0.43055,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0021907,0.42585,0.58018,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00068502,0.42447,0.36647,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0016767,0.42421,0.39184,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.028348,0.42413,0.35418,1,1
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.033245,0.42372,0.29014,1,1
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.00045436,0.42255,0.40464,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,2.8267e-05,0.41979,0.43715,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0015041,0.4197,0.51677,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00010181,0.41896,0.46271,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00035748,0.41889,0.43294,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.00033648,0.41807,0.39887,1,1
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00023283,0.41481,0.46223,1,1
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.012106,0.41413,0.31146,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.046961,0.4118,0.40554,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,0.00060992,0.41159,0.37943,1,1
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.00020554,0.41094,0.41566,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00060992,0.41091,0.42187,1,1
3,GO SYNAPTIC VESICLE BUDDING,0.00018128,0.40977,0.3979,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.00026348,0.40791,0.35673,1,1
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.046961,0.40722,0.3647,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.041938,0.40349,0.32456,1,1
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.0049572,0.40245,0.36731,1,1
3,GO RESPONSE TO POTASSIUM ION,0.011574,0.40233,0.30948,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.0003797,0.39805,0.439,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0010209,0.3977,0.37416,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.011063,0.39706,0.31876,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.0047188,0.3958,0.35866,1,1
3,GO FOREBRAIN NEURON DEVELOPMENT,0.0047188,0.39387,0.30268,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.00014989,0.3931,0.50064,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00091199,0.39267,0.39593,1,1
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.025096,0.39237,0.41414,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.02951,0.39212,0.33655,1,1
3,GO NEURON CELLULAR HOMEOSTASIS,0.00054254,0.38937,0.39208,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0042727,0.38687,0.33511,1,1
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00076864,0.38633,0.35682,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00029789,0.38594,0.36551,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0015041,0.38568,0.33676,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,6.8565e-05,0.38554,0.42459,1,1
3,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.027226,0.3849,0.32119,1,1
3,GO DIVALENT METAL ION EXPORT,0.0018673,0.38417,0.39715,1,1
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.013834,0.38412,0.30994,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00020554,0.38317,0.3789,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.046961,0.38195,0.30431,1,1
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0023095,0.38189,0.3449,1,1
3,GO ALPHA BETA T CELL ACTIVATION,0.041938,0.3818,0.31443,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0017696,0.38133,0.32721,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,2.4576e-05,0.38043,0.37907,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.013235,0.37869,0.30025,1,1
3,GO COLLATERAL SPROUTING,0.0019699,0.37863,0.34168,1,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0052065,0.37719,0.40382,1,1
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.00081392,0.37648,0.45434,1,1
3,GO CARDIAC CHAMBER FORMATION,0.0012758,0.37629,0.43964,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0015882,0.37579,0.36481,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0015882,0.37126,0.35701,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.034576,0.37103,0.33085,1,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.020391,0.37008,0.36222,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.02951,0.37,0.307,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0060238,0.36999,0.33497,1,1
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0029965,0.3699,0.41024,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,0.045233,0.36983,0.38632,1,1
3,GO RECEPTOR CLUSTERING,0.006955,0.36977,0.31911,1,1
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0036751,0.36918,0.34325,1,1
3,GO NOREPINEPHRINE SECRETION,0.00091199,0.36733,0.39769,1,1
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0025648,0.36729,0.3205,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0028457,0.36619,0.33702,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00096503,0.3649,0.35037,1,1
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.00086166,0.36427,0.34322,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.041938,0.36388,0.29171,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0024341,0.36369,0.32277,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.028348,0.36212,0.29484,1,1
3,GO NEUROMUSCULAR PROCESS,0.00018128,0.36161,0.37355,1,1
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.038848,0.3616,0.26489,1,1
3,GO GRANULOCYTE DIFFERENTIATION,0.013235,0.36135,0.29413,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00035748,0.36062,0.39579,1,1
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.00051151,0.36032,0.35328,1,1
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.010101,0.35958,0.33324,1,1
3,GO T CELL LINEAGE COMMITMENT,0.041938,0.35951,0.30352,1,1
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00068502,0.35874,0.29127,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013834,0.35843,0.25763,1,1
3,GO REGULATION OF LYASE ACTIVITY,1.7249e-05,0.35754,0.36269,1,1
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0063209,0.3572,0.38502,1,1
3,GO ALANINE TRANSPORT,0.00086166,0.35551,0.38366,1,1
3,GO OLFACTORY LOBE DEVELOPMENT,0.018736,0.35496,0.2701,1,1
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0076456,0.35431,0.29183,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.022172,0.35261,0.27409,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0038653,0.35258,0.33815,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.010572,0.35226,0.34177,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.023112,0.35206,0.28163,1,1
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.00332,0.35126,0.32459,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00096503,0.34942,0.36855,1,1
3,GO LIPID GLYCOSYLATION,0.00054254,0.34927,0.34936,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0042727,0.34922,0.28972,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0060238,0.3492,0.30857,1,1
3,GO HISTONE H3 K27 METHYLATION,0.0042727,0.34774,0.33497,1,1
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00096503,0.34731,0.43444,1,1
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.0036751,0.3469,0.40585,1,1
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.006955,0.34639,0.3356,1,1
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0011418,0.34549,0.32695,1,1
3,GO REGULATION OF GLIAL CELL MIGRATION,0.027226,0.34521,0.34146,1,1
3,GO REGULATION OF COLLATERAL SPROUTING,0.0049572,0.34478,0.31639,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.028348,0.34439,0.37534,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.022172,0.34403,0.26374,1,1
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0021907,0.34356,0.34094,1,1
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.011574,0.34301,0.30264,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.035953,0.3422,0.31712,1,1
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.00010866,0.34215,0.41895,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00068502,0.34159,0.43292,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00060992,0.34085,0.35796,1,1
3,GO RESPONSE TO ACETYLCHOLINE,0.00072571,0.3404,0.39229,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0057394,0.34036,0.36125,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.030713,0.34035,0.27544,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.038848,0.34005,0.33815,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,9.5377e-05,0.33953,0.39415,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0052065,0.33952,0.41517,1,1
3,GO SPINAL CORD PATTERNING,0.0076456,0.33949,0.33422,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.00057531,0.33936,0.37209,1,1
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.00029789,0.3393,0.33382,1,1
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0034935,0.33873,0.35139,1,1
3,GO LOCALIZATION WITHIN MEMBRANE,0.0019699,0.33823,0.29352,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0036751,0.33785,0.31371,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.013235,0.33721,0.27581,1,1
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0029965,0.33717,0.318,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0057394,0.33693,0.31274,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,0.0012071,0.33687,0.35827,1,1
3,GO HEART VALVE FORMATION,0.0010798,0.33512,0.43739,1,1
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.026142,0.33502,0.38754,1,1
3,GO GLUTAMATE SECRETION,0.00042807,0.33461,0.36026,1,1
3,GO APOPTOTIC CELL CLEARANCE,0.041938,0.33446,0.30217,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0011418,0.3344,0.32423,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.00091199,0.33293,0.39832,1,1
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0012071,0.3329,0.34032,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.00040321,0.33259,0.31242,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.038848,0.33238,0.2851,1,1
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.00068502,0.33182,0.31692,1,1
3,GO NEUTROPHIL EXTRAVASATION,0.030713,0.33098,0.32038,1,1
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0019699,0.33084,0.35265,1,1
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0012071,0.33069,0.30282,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.018736,0.33045,0.25825,1,1
3,GO RETROGRADE AXONAL TRANSPORT,0.0054671,0.33038,0.34199,1,1
3,GO AZOLE TRANSMEMBRANE TRANSPORT,0.0012758,0.33021,0.36091,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.023112,0.33008,0.3565,1,1
3,GO PHAGOCYTOSIS RECOGNITION,0.020391,0.32992,0.29507,1,1
3,GO MAST CELL MIGRATION,0.027226,0.32972,0.27244,1,1
3,GO RETINA LAYER FORMATION,0.020391,0.32906,0.25711,1,1
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0013481,0.32901,0.31906,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,3.248e-05,0.32827,0.42887,1,1
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.0027019,0.32822,0.35941,1,1
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.0010798,0.32766,0.35219,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.006955,0.3272,0.29788,1,1
3,GO NATURAL KILLER CELL ACTIVATION,0.041938,0.32649,0.28076,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00091199,0.32589,0.32576,1,1
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.046961,0.32573,0.29906,1,1
3,GO RESPONSE TO INSECTICIDE,0.0028457,0.32369,0.31222,1,1
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0003797,0.3234,0.35299,1,1
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0017696,0.32265,0.41284,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.045233,0.32158,0.27456,1,1
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0021907,0.32098,0.33023,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.0003797,0.32065,0.36728,1,1
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.0034935,0.32064,0.27564,1,1
3,GO AORTIC VALVE DEVELOPMENT,0.021265,0.32063,0.25865,1,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00045436,0.32027,0.29682,1,1
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.00057531,0.31989,0.36685,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0016767,0.31966,0.39895,1,1
3,GO BASIC AMINO ACID TRANSPORT,0.00091199,0.31951,0.36525,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.0034935,0.31927,0.28118,1,1
3,GO REGULATION OF B CELL ACTIVATION,0.045233,0.31792,0.31336,1,1
3,GO MAST CELL ACTIVATION,0.028348,0.3178,0.29127,1,1
3,GO POSTSYNAPSE ORGANIZATION,0.0015041,0.31743,0.30424,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.00060992,0.3171,0.39362,1,1
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.00076864,0.31679,0.30582,1,1
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.012106,0.3164,0.32649,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.007293,0.31631,0.30296,1,1
3,GO RESPONSE TO LEUCINE,0.00031664,0.3161,0.40798,1,1
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.007293,0.31594,0.30005,1,1
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0040644,0.31558,0.30034,1,1
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.041938,0.31508,0.1508,1,1
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.00091199,0.31483,0.34798,1,1
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.020391,0.31305,0.25772,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.010572,0.31206,0.2812,1,1
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00045436,0.31198,0.34838,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.0024341,0.31156,0.3645,1,1
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0038653,0.31151,0.31891,1,1
3,GO PIGMENT ACCUMULATION,0.0060238,0.31138,0.32791,1,1
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00091199,0.3113,0.32448,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,7.8298e-05,0.31047,0.32663,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.011574,0.30974,0.3078,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00048214,0.30947,0.34706,1,1
3,GO REGULATION OF VESICLE FUSION,0.0034935,0.30914,0.30204,1,1
3,GO SYNAPTIC VESICLE MATURATION,0.0042727,0.3087,0.4084,1,1
3,GO NEURON MATURATION,0.010572,0.30852,0.24968,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.025096,0.30802,0.25212,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,8.3641e-05,0.30773,0.34147,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0010209,0.3076,0.3396,1,1
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0057394,0.3074,0.29114,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,0.0027019,0.30693,0.28333,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.0013481,0.30635,0.30502,1,1
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.013235,0.30624,0.29562,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.046961,0.30605,0.27037,1,1
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.023112,0.30587,0.28171,1,1
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0012071,0.30572,0.28938,1,1
3,GO SYNAPTIC VESICLE LOCALIZATION,0.0028457,0.30529,0.30294,1,1
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.0057394,0.30483,0.26248,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.040368,0.30457,0.27722,1,1
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.030713,0.30447,0.30796,1,1
3,GO MECHANOSENSORY BEHAVIOR,0.033245,0.30444,0.25875,1,1
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.00076864,0.30444,0.34019,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.00029789,0.30423,0.32363,1,1
3,GO CD40 SIGNALING PATHWAY,0.038848,0.30422,0.27723,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.017954,0.30411,0.34586,1,1
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,9.5377e-05,0.30379,0.34397,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.0015041,0.30337,0.39492,1,1
3,GO POST ANAL TAIL MORPHOGENESIS,0.023112,0.30314,0.27135,1,1
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.0003797,0.30314,0.36665,1,1
3,GO PROTEIN KINASE C SIGNALING,0.0054671,0.30286,0.30194,1,1
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00096503,0.30226,0.33532,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0010209,0.30202,0.37043,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.0036751,0.3019,0.2732,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,4.8997e-05,0.30179,0.36507,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,0.0040644,0.30115,0.32139,1,1
3,GO MAST CELL MEDIATED IMMUNITY,0.027226,0.30088,0.29383,1,1
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.015776,0.30056,0.2741,1,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0066311,0.30054,0.34065,1,1
3,GO LEARNING,0.0052065,0.30048,0.2775,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0012758,0.29973,0.33016,1,1
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0015041,0.29961,0.3074,1,1
3,GO T CELL DIFFERENTIATION,0.045233,0.29939,0.28531,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.007293,0.2991,0.30358,1,1
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.00091199,0.29904,0.35602,1,1
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.00072571,0.29897,0.33039,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.025096,0.29861,0.31383,1,1
3,GO STARTLE RESPONSE,0.010572,0.29849,0.33875,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.040368,0.2983,0.28845,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.023112,0.29825,0.22916,1,1
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00040321,0.29822,0.32696,1,1
3,GO REGULATION OF PODOSOME ASSEMBLY,0.0042727,0.29805,0.32516,1,1
3,GO B CELL HOMEOSTASIS,0.040368,0.29779,0.29471,1,1
3,GO LONG TERM SYNAPTIC POTENTIATION,0.00054254,0.29761,0.32522,1,1
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0014241,0.29759,0.31725,1,1
3,GO CELL JUNCTION MAINTENANCE,0.0040644,0.29625,0.31736,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00013188,0.29616,0.33487,1,1
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.031957,0.29504,0.23675,1,1
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0029965,0.29491,0.30974,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,0.045233,0.29456,0.28427,1,1
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00091199,0.29453,0.37482,1,1
3,GO CARDIOBLAST DIFFERENTIATION,0.033245,0.29447,0.21541,1,1
3,GO CEREBRAL CORTEX CELL MIGRATION,0.017954,0.29378,0.25858,1,1
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0052065,0.29368,0.24946,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00048214,0.29366,0.37218,1,1
3,GO NEURON PROJECTION GUIDANCE,0.0021907,0.29364,0.3104,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0024341,0.29315,0.3669,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.038848,0.29289,0.30806,1,1
3,GO LONG TERM MEMORY,0.00014989,0.2922,0.35011,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,0.00019306,0.29218,0.39127,1,1
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0027019,0.29194,0.2563,1,1
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.0049572,0.29155,0.29642,1,1
3,GO NEUROTRANSMITTER SECRETION,0.0023095,0.29145,0.30538,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.012106,0.29119,0.34131,1,1
3,GO NEURON FATE SPECIFICATION,0.024086,0.29115,0.26131,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0027019,0.2908,0.27071,1,1
3,GO AXON EXTENSION,0.00076864,0.29077,0.32546,1,1
3,GO NEURAL CREST FORMATION,0.025096,0.2907,0.30562,1,1
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00017019,0.29048,0.28953,1,1
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0047188,0.29017,0.32007,1,1
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0019699,0.28995,0.32447,1,1
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.0015041,0.28909,0.37208,1,1
3,GO REGULATION OF AXONOGENESIS,0.00081392,0.28902,0.34222,1,1
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.013235,0.28868,0.25361,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.041938,0.28833,0.24669,1,1
3,GO RESPONSE TO GLUCAGON,0.0014241,0.28792,0.30754,1,1
3,GO LYMPHOCYTE ACTIVATION,0.035953,0.28788,0.27094,1,1
3,GO PODOSOME ASSEMBLY,0.0049572,0.28711,0.32975,1,1
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0083971,0.28688,0.30094,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.012106,0.28665,0.29588,1,1
3,GO SYNAPTIC SIGNALING,0.0013481,0.28645,0.28645,1,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.0018673,0.28615,0.29912,1,1
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0172,0.28589,0.22807,1,1
3,GO CGMP METABOLIC PROCESS,0.0028457,0.28578,0.32266,1,1
3,GO MEIOTIC SPINDLE ORGANIZATION,0.01266,0.28574,0.29534,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0019699,0.2857,0.38605,1,1
3,GO NEURON PROJECTION ORGANIZATION,0.0010798,0.28517,0.32266,1,1
3,GO RESPONSE TO PROSTAGLANDIN,0.033245,0.28505,0.23603,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0044907,0.28505,0.25082,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00332,0.28491,0.25306,1,1
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.013235,0.28462,0.30864,1,1
3,GO CHROMATIN SILENCING AT TELOMERE,0.037377,0.28458,0.21458,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0028457,0.28439,0.30079,1,1
3,GO DENDRITE MORPHOGENESIS,0.0080134,0.2843,0.28039,1,1
3,GO TORC1 SIGNALING,0.00091199,0.28363,0.32333,1,1
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00014062,0.28346,0.32061,1,1
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0083971,0.28328,0.30308,1,1
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0036751,0.28267,0.29697,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0010209,0.28261,0.29943,1,1
3,GO NEURON MIGRATION,0.0057394,0.28226,0.28502,1,1
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0019699,0.28162,0.29247,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.027226,0.28147,0.2787,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.040368,0.28139,0.27393,1,1
3,GO REGULATION OF B CELL PROLIFERATION,0.043559,0.28088,0.34872,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00086166,0.28074,0.29437,1,1
3,GO FUCOSYLATION,0.0063209,0.28026,0.24065,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.025096,0.28003,0.2601,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.015104,0.28002,0.26024,1,1
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.048745,0.27989,0.23503,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,0.00076864,0.27944,0.31484,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0017696,0.2791,0.32323,1,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.035953,0.27909,0.24318,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0040644,0.27861,0.2829,1,1
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.010572,0.27821,0.27238,1,1
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0031545,0.27775,0.26236,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0066311,0.27715,0.29485,1,1
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.00086166,0.27709,0.32264,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.0172,0.27691,0.2385,1,1
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.048745,0.27685,0.20446,1,1
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.013834,0.27684,0.25434,1,1
3,GO SECRETORY GRANULE LOCALIZATION,0.021265,0.27671,0.26423,1,1
3,GO POTASSIUM ION HOMEOSTASIS,0.0031545,0.27657,0.25266,1,1
3,GO MICROTUBULE POLYMERIZATION,0.0042727,0.27649,0.28109,1,1
3,GO B CELL ACTIVATION,0.045233,0.27602,0.2849,1,1
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0054671,0.2755,0.31579,1,1
3,GO CELL FATE SPECIFICATION,0.007293,0.2752,0.22715,1,1
3,GO ACTIVATION OF JNKK ACTIVITY,0.0040644,0.27482,0.30109,1,1
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.01266,0.27482,0.27337,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0076456,0.2745,0.29788,1,1
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0027019,0.27407,0.25244,1,1
3,GO NEURON REMODELING,0.016475,0.27394,0.32543,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0049572,0.27388,0.28127,1,1
3,GO WALKING BEHAVIOR,0.00072571,0.27385,0.31065,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.043559,0.27364,0.21551,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.043559,0.27341,0.22522,1,1
3,GO REGULATION OF TORC1 SIGNALING,0.0014241,0.27308,0.29812,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.037377,0.27282,0.18845,1,1
3,GO DENDRITE DEVELOPMENT,0.0047188,0.2724,0.28071,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0060238,0.27198,0.26285,1,1
3,GO MYOTUBE CELL DEVELOPMENT,0.007293,0.27185,0.22984,1,1
3,GO STORE OPERATED CALCIUM ENTRY,0.011574,0.27159,0.26626,1,1
3,GO NEURON RECOGNITION,0.0066311,0.2707,0.27671,1,1
3,GO PROTEIN POLYGLUTAMYLATION,0.0054671,0.27011,0.31572,1,1
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.016475,0.2699,0.27791,1,1
3,GO T CELL HOMEOSTASIS,0.021265,0.26976,0.24673,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0010209,0.26925,0.28881,1,1
3,GO NEURON PROJECTION EXTENSION,0.0015041,0.2689,0.2939,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.021265,0.26888,0.35787,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.017954,0.26874,0.33227,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0028457,0.26866,0.28407,1,1
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00068502,0.26865,0.29925,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.01266,0.26854,0.23075,1,1
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00021879,0.26844,0.32628,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.025096,0.26835,0.23334,1,1
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0038653,0.26805,0.26602,1,1
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00076864,0.268,0.32306,1,1
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0023095,0.26771,0.26888,1,1
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0020776,0.26735,0.37363,1,1
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.023112,0.26731,0.28167,1,1
3,GO LYSOSOME LOCALIZATION,0.0063209,0.26669,0.27828,1,1
3,GO NEUROTRANSMITTER TRANSPORT,0.0016767,0.26666,0.29446,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.046961,0.26654,0.21187,1,1
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0010798,0.26653,0.27662,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.0080134,0.26647,0.30647,1,1
3,GO CGMP MEDIATED SIGNALING,0.006955,0.26639,0.24801,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00040321,0.26629,0.27925,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,0.040368,0.26607,0.26649,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.01266,0.26597,0.30905,1,1
3,GO REGULATION OF AXON GUIDANCE,0.0076456,0.26595,0.28625,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0016767,0.26589,0.24994,1,1
3,GO SPINAL CORD DEVELOPMENT,0.00332,0.26588,0.27766,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00057531,0.26559,0.33298,1,1
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.011063,0.26551,0.26504,1,1
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.033245,0.2655,0.20012,1,1
3,GO PINOCYTOSIS,0.035953,0.26518,0.23878,1,1
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0076456,0.2651,0.25149,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0063209,0.26505,0.27035,1,1
3,GO CELL CELL JUNCTION MAINTENANCE,0.010572,0.2648,0.2937,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0019699,0.26456,0.27771,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.017954,0.26429,0.27035,1,1
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.0047188,0.2641,0.26336,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0080134,0.26351,0.30558,1,1
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0038653,0.26334,0.27649,1,1
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00096503,0.2632,0.2989,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.030713,0.26312,0.21758,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.00086166,0.26257,0.26389,1,1
3,GO EATING BEHAVIOR,0.0003797,0.26246,0.32709,1,1
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0012758,0.26244,0.317,1,1
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.00072571,0.26129,0.30376,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.00054254,0.26124,0.26146,1,1
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.046961,0.26082,0.20844,1,1
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.0034935,0.26069,0.26102,1,1
3,GO ADULT BEHAVIOR,0.0052065,0.26054,0.2678,1,1
3,GO CELL PART MORPHOGENESIS,0.0036751,0.26045,0.27234,1,1
3,GO GLIAL CELL MIGRATION,0.0024341,0.26004,0.30021,1,1
3,GO RESPONSE TO NICOTINE,0.017954,0.25968,0.23429,1,1
3,GO EPITHELIAL CELL MATURATION,0.016475,0.25943,0.28053,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.008797,0.2593,0.26448,1,1
3,GO FILOPODIUM ASSEMBLY,0.0049572,0.25929,0.24893,1,1
3,GO NEURAL RETINA DEVELOPMENT,0.0017696,0.25924,0.3048,1,1
3,GO LEUKOCYTE DIFFERENTIATION,0.048745,0.25866,0.24485,1,1
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0076456,0.25858,0.24504,1,1
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0015882,0.2579,0.32409,1,1
3,GO SYNAPSE ORGANIZATION,0.0036751,0.25765,0.27724,1,1
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.017954,0.25719,0.2222,1,1
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.0036751,0.25714,0.23074,1,1
3,GO NEURON CELL CELL ADHESION,0.024086,0.25714,0.39953,1,1
3,GO DNA DEAMINATION,0.034576,0.25653,0.22056,1,1
3,GO CALCINEURIN MEDIATED SIGNALING,0.0052065,0.25645,0.23928,1,1
3,GO LIPID TRANSLOCATION,0.014457,0.25633,0.27152,1,1
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.0044907,0.25624,0.25523,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0052065,0.25497,0.21059,1,1
3,GO MUSCLE FIBER DEVELOPMENT,0.010572,0.2548,0.23296,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.041938,0.25473,0.22624,1,1
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.038848,0.25411,0.31773,1,1
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.0076456,0.25408,0.2316,1,1
3,GO EXPLORATION BEHAVIOR,0.030713,0.25399,0.22122,1,1
3,GO NEUROBLAST PROLIFERATION,0.0040644,0.2539,0.2629,1,1
3,GO MEMBRANE DEPOLARIZATION,0.021265,0.25388,0.20475,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.006955,0.25385,0.3063,1,1
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.01266,0.25381,0.27009,1,1
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00072571,0.25372,0.28608,1,1
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.016475,0.25368,0.21751,1,1
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.0012071,0.25351,0.27747,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.025096,0.25306,0.27766,1,1
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00057531,0.25229,0.27821,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.023112,0.25167,0.23719,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.0015882,0.25134,0.26175,1,1
3,GO CELL MIGRATION IN HINDBRAIN,0.0060238,0.2512,0.32885,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0028457,0.25098,0.27134,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0083971,0.25071,0.26124,1,1
3,GO BEHAVIOR,0.0044907,0.25025,0.24166,1,1
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.0038653,0.25011,0.23181,1,1
3,GO AXON DEVELOPMENT,0.0036751,0.25007,0.27762,1,1
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0020776,0.24986,0.30898,1,1
3,GO FEAR RESPONSE,0.048745,0.2496,0.16671,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.038848,0.24956,0.18029,1,1
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0014241,0.24939,0.26784,1,1
3,GO REGULATION OF RESPIRATORY BURST,0.034576,0.24894,0.23927,1,1
3,GO NERVE DEVELOPMENT,0.031957,0.24894,0.23168,1,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.010572,0.24881,0.2377,1,1
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.0027019,0.24877,0.30476,1,1
3,GO NEURON FATE COMMITMENT,0.018736,0.24819,0.22854,1,1
3,GO REGULATION OF MRNA BINDING,0.0066311,0.24811,0.21472,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.0092139,0.24805,0.28603,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.017954,0.24798,0.2022,1,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.02951,0.24758,0.20738,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.018736,0.24751,0.2732,1,1
3,GO FOREBRAIN CELL MIGRATION,0.010572,0.24741,0.2596,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.010101,0.24738,0.24284,1,1
3,GO GDP METABOLIC PROCESS,0.0019699,0.24731,0.28832,1,1
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.0027019,0.24729,0.27667,1,1
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.0044907,0.24724,0.22983,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0172,0.24712,0.22915,1,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.2763e-05,0.24705,0.28695,1,1
3,GO LOCOMOTORY BEHAVIOR,0.0054671,0.24645,0.26542,1,1
3,GO REGULATION OF GOLGI ORGANIZATION,0.0014241,0.24629,0.26022,1,1
3,GO MAINTENANCE OF CELL POLARITY,0.0038653,0.24615,0.29688,1,1
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0066311,0.24603,0.29938,1,1
3,GO RESPONSE TO ISCHEMIA,0.0083971,0.24589,0.24498,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0031545,0.2455,0.28033,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.006955,0.24549,0.25669,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00086166,0.24542,0.26531,1,1
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.0015041,0.24516,0.25858,1,1
3,GO REGULATION OF BEHAVIOR,0.008797,0.24509,0.20253,1,1
3,GO SPINDLE MIDZONE ASSEMBLY,0.0096484,0.24472,0.28833,1,1
3,GO RESPONSE TO VITAMIN A,0.0047188,0.24417,0.21528,1,1
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.027226,0.24417,0.22763,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.015104,0.24346,0.21052,1,1
3,GO ORGANIC CATION TRANSPORT,0.013834,0.24274,0.23612,1,1
3,GO CEREBELLAR CORTEX FORMATION,0.0042727,0.24269,0.26005,1,1
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.019548,0.24266,0.18432,1,1
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.028348,0.24261,0.21982,1,1
3,GO GROWTH HORMONE SECRETION,0.023112,0.24231,0.29313,1,1
3,GO FUCOSE METABOLIC PROCESS,0.037377,0.24229,0.17185,1,1
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0049572,0.24203,0.22426,1,1
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.011063,0.24201,0.27043,1,1
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.046961,0.24176,0.26093,1,1
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.020391,0.24173,0.24137,1,1
3,GO SYNAPTIC VESICLE RECYCLING,0.0023095,0.24162,0.27001,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.007293,0.24131,0.29578,1,1
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012106,0.24126,0.29319,1,1
3,GO TUBULIN DEACETYLATION,0.025096,0.24123,0.2352,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0040644,0.24099,0.29761,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.0049572,0.24098,0.2336,1,1
3,GO STEROID ESTERIFICATION,0.022172,0.2409,0.23015,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.008797,0.24071,0.19341,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.016475,0.24068,0.25692,1,1
3,GO AXO DENDRITIC TRANSPORT,0.015104,0.24045,0.23591,1,1
3,GO CHROMATIN DISASSEMBLY,0.0042727,0.24041,0.26638,1,1
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.02951,0.24009,0.21359,1,1
3,GO ASSOCIATIVE LEARNING,0.007293,0.23996,0.25636,1,1
3,GO PROTEIN DEPOLYMERIZATION,0.0014241,0.23987,0.28438,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.02951,0.23947,0.29735,1,1
3,GO NEURAL CREST CELL MIGRATION,0.011063,0.23919,0.24688,1,1
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.031957,0.23912,0.23004,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0029965,0.23904,0.23981,1,1
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.028348,0.23871,0.25815,1,1
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.0031545,0.23848,0.26268,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.010101,0.23846,0.25016,1,1
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.045233,0.23841,0.20621,1,1
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.046961,0.23817,0.19613,1,1
3,GO PROTEIN KINASE A SIGNALING,0.0021907,0.23815,0.25053,1,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.041938,0.23813,0.20735,1,1
3,GO REGULATION OF ISOTYPE SWITCHING,0.025096,0.23803,0.25111,1,1
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.00332,0.23791,0.31458,1,1
3,GO FEEDING BEHAVIOR,0.0012071,0.23786,0.25339,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.031957,0.23778,0.22063,1,1
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.00081392,0.23757,0.31719,1,1
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00072571,0.23733,0.24691,1,1
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.031957,0.23711,0.23606,1,1
3,GO RESPONSE TO PARATHYROID HORMONE,0.033245,0.23677,0.19511,1,1
3,GO NEURON DEVELOPMENT,0.0031545,0.23655,0.25571,1,1
3,GO SKELETAL MUSCLE CONTRACTION,0.0016767,0.23644,0.24538,1,1
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.00332,0.23626,0.22624,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.040368,0.23621,0.25539,1,1
3,GO METENCEPHALON DEVELOPMENT,0.00332,0.236,0.25175,1,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.011574,0.23598,0.23216,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0044907,0.23591,0.24024,1,1
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.024086,0.23547,0.21592,1,1
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.01266,0.23534,0.1792,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.030713,0.23461,0.19178,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.034576,0.23459,0.22142,1,1
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00068502,0.23424,0.25547,1,1
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0172,0.23404,0.27117,1,1
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.011574,0.23373,0.30319,1,1
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00011593,0.23371,0.27247,1,1
3,GO DEVELOPMENTAL CELL GROWTH,0.0034935,0.23337,0.26335,1,1
3,GO RHYTHMIC BEHAVIOR,0.0034935,0.23314,0.25928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.048745,0.23302,0.2105,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0092139,0.23277,0.20997,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.045233,0.23256,0.25045,1,1
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0034935,0.23235,0.25616,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0021907,0.23233,0.26487,1,1
3,GO CELLULAR RESPONSE TO PH,0.00045436,0.23231,0.32189,1,1
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0060238,0.2317,0.2608,1,1
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0010209,0.23159,0.26277,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.026142,0.23144,0.23633,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0015882,0.23125,0.25783,1,1
3,GO HEART VALVE DEVELOPMENT,0.015104,0.23124,0.25472,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.015776,0.23108,0.23293,1,1
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0031545,0.231,0.22629,1,1
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0031545,0.23092,0.31088,1,1
3,GO LEFT RIGHT PATTERN FORMATION,0.014457,0.23092,0.20749,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.030713,0.23065,0.25167,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.015104,0.23051,0.23579,1,1
3,GO EMBRYONIC HEMOPOIESIS,0.007293,0.23035,0.22468,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0083971,0.23031,0.25127,1,1
3,GO PLATELET MORPHOGENESIS,0.00054254,0.23027,0.33731,1,1
3,GO DEFINITIVE HEMOPOIESIS,0.027226,0.22967,0.25029,1,1
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.033245,0.22952,0.16948,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0021907,0.22907,0.27661,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,0.0042727,0.22907,0.28925,1,1
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00091199,0.22884,0.24931,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.0013481,0.22876,0.24553,1,1
3,GO REGULATION OF INSULIN SECRETION,0.0018673,0.22873,0.25453,1,1
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00054254,0.22872,0.2416,1,1
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0042727,0.22863,0.24587,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0012071,0.22818,0.2518,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0049572,0.22817,0.2755,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.030713,0.22805,0.20488,1,1
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0023095,0.22793,0.26627,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0010209,0.2279,0.34592,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0018673,0.22787,0.28571,1,1
3,GO NEURON DIFFERENTIATION,0.0028457,0.22786,0.2477,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.01266,0.22779,0.24074,1,1
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.010101,0.22774,0.20609,1,1
3,GO ENDOTHELIUM DEVELOPMENT,0.019548,0.2277,0.20471,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,0.0029965,0.22741,0.26697,1,1
3,GO INSULIN SECRETION,0.0024341,0.22725,0.25357,1,1
3,GO RESPONSE TO ATP,0.0049572,0.22724,0.23704,1,1
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0042727,0.22724,0.23718,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0063209,0.22707,0.21375,1,1
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.033245,0.22686,0.24584,1,1
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0003797,0.22641,0.2688,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.008797,0.22619,0.29479,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.010101,0.22614,0.20835,1,1
3,GO FORELIMB MORPHOGENESIS,0.0034935,0.22604,0.28275,1,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.0012071,0.226,0.27552,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.027226,0.22597,0.22533,1,1
3,GO REGULATION OF EXOCYTOSIS,0.0010798,0.22516,0.25233,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.010101,0.22436,0.30667,1,1
3,GO RESPONSE TO IRON ION,0.0172,0.22433,0.17939,1,1
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0017696,0.22415,0.29558,1,1
3,GO REGULATION OF CELL SIZE,0.0011418,0.2241,0.2825,1,1
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.011063,0.22404,0.25472,1,1
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00045436,0.22389,0.25473,1,1
3,GO REGULATION OF NEURON DIFFERENTIATION,0.00332,0.22376,0.2516,1,1
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0016767,0.22369,0.25024,1,1
3,GO NEURON APOPTOTIC PROCESS,0.0024341,0.2236,0.21171,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.041938,0.22328,0.24213,1,1
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.00020554,0.22327,0.25167,1,1
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.008797,0.22296,0.20075,1,1
3,GO CEREBRAL CORTEX DEVELOPMENT,0.0060238,0.22275,0.25761,1,1
3,GO PEPTIDE HORMONE SECRETION,0.0040644,0.22263,0.23172,1,1
3,GO CERAMIDE TRANSPORT,0.0027019,0.22212,0.27319,1,1
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0044907,0.22207,0.21912,1,1
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0036751,0.22206,0.26234,1,1
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.011063,0.22205,0.24319,1,1
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0054671,0.22197,0.23076,1,1
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.037377,0.22185,0.19786,1,1
3,GO SERTOLI CELL DIFFERENTIATION,0.040368,0.22173,0.19599,1,1
3,GO FOREGUT MORPHOGENESIS,0.013834,0.2214,0.23964,1,1
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0092139,0.22123,0.22732,1,1
3,GO NEURON DEATH,0.0019699,0.22071,0.21695,1,1
3,GO REGULATION OF TRANSPOSITION,0.028348,0.22054,0.19861,1,1
3,GO RESPONSE TO HYDROXYUREA,0.0060238,0.22053,0.24495,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.011063,0.22026,0.18981,1,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.0036751,0.21972,0.25905,1,1
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.021265,0.21947,0.2695,1,1
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0018673,0.21922,0.29267,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.012106,0.21922,0.2429,1,1
3,GO HINDBRAIN MORPHOGENESIS,0.0054671,0.21915,0.22231,1,1
3,GO CARDIAC CONDUCTION,0.0066311,0.21845,0.22025,1,1
3,GO ENDOCRINE SYSTEM DEVELOPMENT,0.008797,0.21843,0.17528,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.0019699,0.21818,0.24486,1,1
3,GO L AMINO ACID TRANSPORT,0.0013481,0.218,0.23531,1,1
3,GO POTASSIUM ION TRANSPORT,0.0023095,0.21797,0.25693,1,1
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.025096,0.21767,0.2267,1,1
3,GO MEMORY,0.0023095,0.21749,0.24595,1,1
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00332,0.21716,0.23949,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0036751,0.2169,0.28026,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0029965,0.21669,0.25084,1,1
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.010101,0.21635,0.21741,1,1
3,GO RESPONSE TO ACIDIC PH,0.00081392,0.2159,0.36857,1,1
3,GO RESPONSE TO DOPAMINE,0.00091199,0.21582,0.24855,1,1
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0054671,0.21559,0.23235,1,1
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.0019699,0.21532,0.23089,1,1
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.0018673,0.21531,0.26527,1,1
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0080134,0.21496,0.2182,1,1
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.006955,0.21466,0.22092,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.028348,0.21411,0.23185,1,1
3,GO ENDOCYTIC RECYCLING,0.015104,0.2141,0.22078,1,1
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0015041,0.21392,0.26389,1,1
3,GO XENOBIOTIC TRANSPORT,0.011574,0.21387,0.24006,1,1
3,GO FOREBRAIN GENERATION OF NEURONS,0.020391,0.21376,0.17664,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,0.011063,0.21363,0.17361,1,1
3,GO REGULATION OF ION TRANSPORT,0.0015882,0.21332,0.22821,1,1
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.020391,0.21263,0.22515,1,1
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.022172,0.21258,0.20452,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.014457,0.21238,0.18937,1,1
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0011418,0.21234,0.25855,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.0018673,0.2123,0.21402,1,1
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0083971,0.21193,0.23085,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.010101,0.21161,0.22004,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0083971,0.21137,0.23799,1,1
3,GO RECEPTOR INTERNALIZATION,0.00023283,0.21128,0.26199,1,1
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.0044907,0.21111,0.26239,1,1
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.013834,0.21092,0.26806,1,1
3,GO REGULATION OF PROTON TRANSPORT,0.00081392,0.21073,0.21993,1,1
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.020391,0.21057,0.20606,1,1
3,GO CALCIUM ION IMPORT,0.0015882,0.21029,0.2324,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.027226,0.2102,0.20373,1,1
3,GO RESPIRATORY SYSTEM PROCESS,0.0054671,0.2102,0.29352,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.0024341,0.21004,0.23633,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0049572,0.20999,0.27989,1,1
3,GO PROTEIN TRIMERIZATION,0.013235,0.20998,0.27594,1,1
3,GO THYROID GLAND DEVELOPMENT,0.023112,0.20981,0.20076,1,1
3,GO TRANSMISSION OF NERVE IMPULSE,0.0042727,0.20968,0.27817,1,1
3,GO REGULATION OF STEM CELL PROLIFERATION,0.0080134,0.20948,0.21393,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0049572,0.20941,0.24623,1,1
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.00072571,0.2093,0.2641,1,1
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.0034935,0.20921,0.28298,1,1
3,GO INTERMEMBRANE LIPID TRANSFER,0.0052065,0.20881,0.23183,1,1
3,GO ACTIN CROSSLINK FORMATION,0.038848,0.20848,0.21728,1,1
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.011063,0.20844,0.24325,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.20831,0.23387,1,1
3,GO REGULATION OF AMINO ACID TRANSPORT,0.011063,0.20827,0.2588,1,1
3,GO REGULATION OF RNA BINDING,0.012106,0.20807,0.1812,1,1
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0040644,0.20772,0.25793,1,1
3,GO ADHERENS JUNCTION ASSEMBLY,0.0063209,0.2077,0.29519,1,1
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0015041,0.20754,0.22133,1,1
3,GO LACTATION,0.017954,0.20748,0.18706,1,1
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.034576,0.20735,0.23065,1,1
3,GO NEUROGENESIS,0.0036751,0.20717,0.23911,1,1
3,GO MOTOR NEURON AXON GUIDANCE,0.008797,0.20704,0.25916,1,1
3,GO OUTFLOW TRACT MORPHOGENESIS,0.037377,0.20658,0.19794,1,1
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0044907,0.20656,0.23722,1,1
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0034935,0.20611,0.23756,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,0.012106,0.2057,0.21433,1,1
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.0018673,0.20569,0.23504,1,1
3,GO SCHWANN CELL DEVELOPMENT,0.015776,0.20568,0.24657,1,1
3,GO PHOSPHOLIPID TRANSPORT,0.021265,0.20563,0.19858,1,1
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.007293,0.2055,0.22648,1,1
3,GO CATECHOLAMINE UPTAKE,0.019548,0.20515,0.25822,1,1
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.013834,0.20502,0.23008,1,1
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.00035748,0.20495,0.24843,1,1
3,GO POSITIVE REGULATION OF JNK CASCADE,0.019548,0.20485,0.2424,1,1
3,GO REGULATION OF STEROL TRANSPORT,0.043559,0.20469,0.1774,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,0.033245,0.20459,0.19893,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.006955,0.20453,0.22419,1,1
3,GO RESPONSE TO PH,0.00042807,0.20448,0.34319,1,1
3,GO CELL FATE COMMITMENT,0.0040644,0.20442,0.20625,1,1
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.041938,0.2044,0.17309,1,1
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.014457,0.20431,0.2242,1,1
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.045233,0.20422,0.19484,1,1
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.023112,0.20414,0.26567,1,1
3,GO ADULT LOCOMOTORY BEHAVIOR,0.0083971,0.20412,0.23047,1,1
3,GO CELL MORPHOGENESIS,0.0044907,0.2036,0.24766,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.017954,0.20337,0.23185,1,1
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.013834,0.20323,0.21624,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.011063,0.20318,0.20867,1,1
3,GO REGULATION OF HORMONE SECRETION,0.0096484,0.20308,0.19706,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00054254,0.20295,0.24358,1,1
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.016475,0.20288,0.23873,1,1
3,GO SECONDARY PALATE DEVELOPMENT,0.02951,0.20288,0.24186,1,1
3,GO SIGNAL RELEASE,0.0052065,0.20283,0.21006,1,1
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.007293,0.20275,0.22012,1,1
3,GO HINDBRAIN DEVELOPMENT,0.011574,0.20262,0.21251,1,1
3,GO REGULATION OF CELL MORPHOGENESIS,0.0023095,0.2026,0.26456,1,1
3,GO DENDRITE SELF AVOIDANCE,0.045233,0.20243,0.22083,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.023112,0.20223,0.19834,1,1
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.026142,0.20194,0.23793,1,1
3,GO HEAD DEVELOPMENT,0.008797,0.20157,0.2159,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00040321,0.20117,0.25561,1,1
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00076864,0.20111,0.24204,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.010572,0.20094,0.23107,1,1
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.020391,0.2008,0.19167,1,1
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0049572,0.20072,0.219,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.015104,0.20067,0.23325,1,1
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0083971,0.20056,0.25567,1,1
3,GO CALCIUM MEDIATED SIGNALING,0.021265,0.20034,0.21129,1,1
3,GO MITOCHONDRION LOCALIZATION,0.015104,0.2003,0.21858,1,1
3,GO DEVELOPMENTAL MATURATION,0.0036751,0.20007,0.22623,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00031664,0.19999,0.24473,1,1
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.013834,0.19994,0.22067,1,1
3,GO CELLULAR COMPONENT MAINTENANCE,0.0036751,0.19962,0.28066,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.00051151,0.19931,0.23057,1,1
3,GO APICAL PROTEIN LOCALIZATION,0.031957,0.19926,0.20006,1,1
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0047188,0.19921,0.31701,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.014457,0.19911,0.21948,1,1
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0044907,0.1984,0.23157,1,1
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.02951,0.19836,0.20868,1,1
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0038653,0.19821,0.21789,1,1
3,GO SECRETORY GRANULE ORGANIZATION,0.033245,0.19814,0.18947,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.00048214,0.19812,0.29917,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0038653,0.1978,0.26661,1,1
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.011574,0.19753,0.21234,1,1
3,GO FOREBRAIN DEVELOPMENT,0.0040644,0.19721,0.23428,1,1
3,GO IMPORT INTO CELL,0.0020776,0.19721,0.22474,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.045233,0.19705,0.21094,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.021265,0.19688,0.2024,1,1
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.016475,0.19658,0.2287,1,1
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.031957,0.19654,0.24434,1,1
3,GO FATTY ACID HOMEOSTASIS,0.0027019,0.1965,0.25996,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.019548,0.1965,0.25003,1,1
3,GO REGULATION OF HEMOPOIESIS,0.045233,0.19637,0.19243,1,1
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.027226,0.19627,0.2696,1,1
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.015776,0.19623,0.22607,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.014457,0.19611,0.21391,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.007293,0.19596,0.22418,1,1
3,GO EMBRYONIC EYE MORPHOGENESIS,0.037377,0.19574,0.22894,1,1
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.030713,0.19562,0.21198,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.00051151,0.19554,0.27287,1,1
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.013834,0.19554,0.25718,1,1
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0092139,0.1955,0.20965,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.028348,0.19529,0.20645,1,1
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.025096,0.19528,0.26194,1,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.00076864,0.19496,0.26832,1,1
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.030713,0.1949,0.20515,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.015104,0.19482,0.18885,1,1
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.030713,0.19449,0.24776,1,1
3,GO COLLECTING DUCT DEVELOPMENT,0.041938,0.19439,0.32703,1,1
3,GO ACIDIC AMINO ACID TRANSPORT,0.00035748,0.19434,0.29392,1,1
3,GO REGULATION OF PROTEIN TARGETING,0.0014241,0.19406,0.20077,1,1
3,GO MONOAMINE TRANSPORT,0.0057394,0.19406,0.27877,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.0012758,0.19399,0.2033,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.0023095,0.19383,0.2158,1,1
3,GO REGULATION OF MEMBRANE POTENTIAL,0.0021907,0.19369,0.23998,1,1
3,GO TRANSPOSITION,0.020391,0.19339,0.19354,1,1
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.016475,0.19319,0.23348,1,1
3,GO INOSITOL METABOLIC PROCESS,0.037377,0.19318,0.23984,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.019548,0.19317,0.19307,1,1
3,GO NEURAL CREST CELL DIFFERENTIATION,0.028348,0.19316,0.20242,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.041938,0.19258,0.18493,1,1
3,GO COGNITION,0.0031545,0.19253,0.23258,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,0.010572,0.19249,0.20857,1,1
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0021907,0.19217,0.30995,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.030713,0.19192,0.18902,1,1
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033245,0.19182,0.16913,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.010572,0.19158,0.1783,1,1
3,GO AMINO ACID TRANSPORT,0.00033648,0.19142,0.2521,1,1
3,GO DNA DEMETHYLATION,0.0096484,0.19136,0.20368,1,1
3,GO POSITIVE REGULATION OF DNA REPAIR,0.0076456,0.19136,0.20646,1,1
3,GO ERYTHROCYTE MATURATION,0.015776,0.1912,0.23133,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.013834,0.19112,0.20754,1,1
3,GO SENSORY PERCEPTION OF PAIN,0.013235,0.19099,0.19823,1,1
3,GO STEM CELL PROLIFERATION,0.0066311,0.19087,0.22513,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.037377,0.19084,0.19533,1,1
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.048745,0.19082,0.18978,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0063209,0.19081,0.22181,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0019699,0.19078,0.20767,1,1
3,GO HORMONE TRANSPORT,0.0057394,0.19072,0.20708,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.019548,0.19052,0.24074,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.0172,0.19048,0.18825,1,1
3,GO SENSORY PERCEPTION,0.0014241,0.19028,0.18743,1,1
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.015104,0.19023,0.16975,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0044907,0.19013,0.25239,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.031957,0.1901,0.19427,1,1
3,GO LIPOPROTEIN LOCALIZATION,0.019548,0.18998,0.23156,1,1
3,GO POSITIVE REGULATION OF DNA BINDING,0.0096484,0.18959,0.1737,1,1
3,GO VISUAL BEHAVIOR,0.0042727,0.18956,0.22116,1,1
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0029965,0.18952,0.29984,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0019699,0.18946,0.22639,1,1
3,GO OVULATION CYCLE PROCESS,0.024086,0.18918,0.17841,1,1
3,GO SPLEEN DEVELOPMENT,0.0021907,0.189,0.23856,1,1
3,GO CELLULAR RESPONSE TO SALT STRESS,0.041938,0.18877,0.17893,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.025096,0.18874,0.21169,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0021907,0.1887,0.22936,1,1
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0010209,0.18781,0.2317,1,1
3,GO CRISTAE FORMATION,0.0092139,0.18772,0.20002,1,1
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0044907,0.18758,0.2272,1,1
3,GO DORSAL VENTRAL PATTERN FORMATION,0.019548,0.18754,0.18721,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.010101,0.18748,0.18944,1,1
3,GO CELLULAR RESPONSE TO ATP,0.0034935,0.18742,0.23643,1,1
3,GO ENDOTHELIAL CELL DEVELOPMENT,0.023112,0.18724,0.21776,1,1
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0021907,0.1871,0.26097,1,1
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.010101,0.18705,0.21584,1,1
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.023112,0.18695,0.18456,1,1
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.028348,0.18682,0.20768,1,1
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0076456,0.18679,0.19845,1,1
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.031957,0.18658,0.2027,1,1
3,GO RESPONSE TO CATECHOLAMINE,0.0031545,0.18652,0.22354,1,1
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.0031545,0.18638,0.2368,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0063209,0.18583,0.21487,1,1
3,GO REGULATION OF GLIOGENESIS,0.01266,0.18571,0.17567,1,1
3,GO CELL CELL SIGNALING,0.0034935,0.18543,0.21442,1,1
3,GO NERVOUS SYSTEM PROCESS,0.00068502,0.18535,0.2254,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0013481,0.18529,0.20662,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.0034935,0.18517,0.20175,1,1
3,GO CELL RECOGNITION,0.0060238,0.18512,0.21172,1,1
3,GO CELL JUNCTION ORGANIZATION,0.01266,0.18505,0.22441,1,1
3,GO GLYCINE METABOLIC PROCESS,0.015104,0.18491,0.21149,1,1
3,GO CELL PROJECTION ORGANIZATION,0.0066311,0.18487,0.21858,1,1
3,GO TYPE I INTERFERON PRODUCTION,0.031957,0.18477,0.21042,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0044907,0.18462,0.22271,1,1
3,GO NADH METABOLIC PROCESS,0.0076456,0.18456,0.20054,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0015041,0.18453,0.23152,1,1
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.007293,0.18436,0.21326,1,1
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.038848,0.18422,0.14786,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00051151,0.18419,0.23285,1,1
3,GO PALLIUM DEVELOPMENT,0.011574,0.18418,0.21264,1,1
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0047188,0.18396,0.19817,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.015776,0.18354,0.22198,1,1
3,GO DENDRITE EXTENSION,0.034576,0.18332,0.19711,1,1
3,GO MEGAKARYOCYTE DEVELOPMENT,0.01266,0.18331,0.2541,1,1
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.00040321,0.18329,0.23186,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0080134,0.18328,0.21411,1,1
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.0060238,0.18288,0.25318,1,1
3,GO SPECIFICATION OF SYMMETRY,0.018736,0.18272,0.18568,1,1
3,GO REGULATION OF METAL ION TRANSPORT,0.0017696,0.18259,0.22223,1,1
3,GO PEPTIDYL ARGININE MODIFICATION,0.0054671,0.18257,0.18168,1,1
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.011574,0.18252,0.21823,1,1
3,GO MEMBRANE FISSION,0.022172,0.18249,0.20431,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0018673,0.18245,0.25218,1,1
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0028457,0.18239,0.26767,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.0017696,0.18223,0.22168,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.022172,0.18214,0.29101,1,1
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0044907,0.18193,0.23175,1,1
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0040644,0.18169,0.21813,1,1
3,GO POSITIVE REGULATION OF MITOPHAGY,0.0092139,0.18163,0.31067,1,1
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0028457,0.18127,0.22916,1,1
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.0083971,0.18123,0.17122,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,0.0010798,0.18116,0.20908,1,1
3,GO REGULATION OF MITOPHAGY,0.010572,0.18101,0.26529,1,1
3,GO INCLUSION BODY ASSEMBLY,0.0049572,0.18098,0.24466,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.018736,0.18085,0.23225,1,1
3,GO PROTEIN DEMETHYLATION,0.034576,0.18071,0.2294,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.0027019,0.18036,0.28747,1,1
3,GO SMOOTHENED SIGNALING PATHWAY,0.020391,0.18036,0.20269,1,1
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.045233,0.18017,0.2082,1,1
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.0172,0.18009,0.19694,1,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.02951,0.1798,0.23381,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.00060992,0.17976,0.26734,1,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0092139,0.1796,0.22973,1,1
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.033245,0.17956,0.16477,1,1
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.013834,0.17941,0.24125,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0020776,0.1794,0.22889,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0096484,0.17934,0.21438,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.0076456,0.1793,0.23259,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.022172,0.17929,0.20926,1,1
3,GO NEUROTRANSMITTER UPTAKE,0.020391,0.17911,0.18693,1,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.016475,0.1789,0.15109,1,1
3,GO EXOCYTIC PROCESS,0.0042727,0.17868,0.22006,1,1
3,GO DETECTION OF ABIOTIC STIMULUS,0.00042807,0.17864,0.26522,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0038653,0.17861,0.25598,1,1
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.040368,0.17844,0.20911,1,1
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.030713,0.17839,0.20209,1,1
3,GO NEUROTRANSMITTER REUPTAKE,0.030713,0.17835,0.20028,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.048745,0.17834,0.19272,1,1
3,GO MEMBRANE REPOLARIZATION,0.020391,0.17819,0.18727,1,1
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0049572,0.17818,0.23239,1,1
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0018673,0.17813,0.28327,1,1
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0066311,0.17794,0.21861,1,1
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.015776,0.17745,0.23848,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0054671,0.17718,0.2091,1,1
3,GO REGULATION OF TOR SIGNALING,0.019548,0.17709,0.18864,1,1
3,GO RESPONSE TO MISFOLDED PROTEIN,0.0092139,0.17699,0.23668,1,1
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.030713,0.17698,0.19424,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.017954,0.17673,0.22831,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.017954,0.17656,0.20471,1,1
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.010572,0.17647,0.19778,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0049572,0.17643,0.22144,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.011063,0.17642,0.19572,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,0.0014241,0.17638,0.20148,1,1
3,GO REGULATION OF CIRCADIAN RHYTHM,0.028348,0.1763,0.18887,1,1
3,GO RECEPTOR METABOLIC PROCESS,0.0020776,0.17621,0.21445,1,1
3,GO REGULATION OF CELL DEVELOPMENT,0.0054671,0.17587,0.2176,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.0096484,0.17568,0.23498,1,1
3,GO REGULATION OF ENDOCYTOSIS,0.007293,0.17567,0.22363,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0021907,0.17564,0.18459,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0015882,0.17561,0.22276,1,1
3,GO REGULATION OF CARDIAC CONDUCTION,0.011574,0.17551,0.18903,1,1
3,GO CELL MATURATION,0.014457,0.17546,0.17219,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0044907,0.17514,0.19321,1,1
3,GO RECEPTOR RECYCLING,0.040368,0.17511,0.15532,1,1
3,GO TAXIS,0.037377,0.17508,0.19991,1,1
3,GO DICARBOXYLIC ACID TRANSPORT,0.00086166,0.175,0.24214,1,1
3,GO DNA DEALKYLATION,0.0038653,0.17499,0.19998,1,1
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.031957,0.17486,0.16226,1,1
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.030713,0.17484,0.20024,1,1
3,GO UV PROTECTION,0.008797,0.17479,0.25321,1,1
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.011063,0.17417,0.19042,1,1
3,GO SENSORY SYSTEM DEVELOPMENT,0.0060238,0.17399,0.2255,1,1
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0172,0.17396,0.21437,1,1
3,GO PATTERN SPECIFICATION PROCESS,0.01266,0.1736,0.18398,1,1
3,GO LIPID PHOSPHORYLATION,0.008797,0.1735,0.212,1,1
3,GO DETECTION OF VISIBLE LIGHT,0.0066311,0.17345,0.3041,1,1
3,GO NAD METABOLIC PROCESS,0.0012071,0.17337,0.21293,1,1
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00033648,0.17329,0.26591,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0019699,0.17325,0.19026,1,1
3,GO REGULATION OF HORMONE LEVELS,0.011063,0.17309,0.16998,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.030713,0.17309,0.22914,1,1
3,GO REGULATION OF GTPASE ACTIVITY,0.007293,0.17259,0.2351,1,1
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.010572,0.17249,0.21973,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.045233,0.17221,0.18102,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.012106,0.17218,0.22597,1,1
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0034935,0.17208,0.19704,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.01266,0.17189,0.16806,1,1
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.022172,0.17162,0.20082,1,1
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0023095,0.1714,0.26819,1,1
3,GO PLATELET AGGREGATION,0.031957,0.17139,0.24632,1,1
3,GO REGULATION OF ANION TRANSPORT,0.033245,0.1711,0.17511,1,1
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.031957,0.17107,0.1895,1,1
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.01266,0.17083,0.19535,1,1
3,GO PROTEIN POLYMERIZATION,0.00060992,0.17081,0.23336,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0027019,0.17065,0.19994,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.048745,0.17053,0.15445,1,1
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0049572,0.16992,0.20271,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.01266,0.16985,0.1934,1,1
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.008797,0.16955,0.20812,1,1
3,GO CELLULAR RESPONSE TO CAMP,0.025096,0.16954,0.17198,1,1
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0040644,0.16948,0.2886,1,1
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.010101,0.16946,0.22337,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.0042727,0.16935,0.19588,1,1
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.01266,0.16934,0.21626,1,1
3,GO MULTICELLULAR ORGANISM GROWTH,0.0038653,0.16934,0.24,1,1
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.026142,0.16932,0.2026,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.043559,0.16932,0.16241,1,1
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0036751,0.16931,0.26215,1,1
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0096484,0.16921,0.23078,1,1
3,GO CATION TRANSPORT,0.0017696,0.16904,0.206,1,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.013834,0.16895,0.17969,1,1
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.011574,0.16877,0.21721,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.031957,0.16876,0.16268,1,1
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.02951,0.16872,0.18312,1,1
3,GO SULFATE TRANSPORT,0.020391,0.16866,0.20217,1,1
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0042727,0.16861,0.1989,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.043559,0.16808,0.17952,1,1
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.0023095,0.16792,0.24327,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.0036751,0.16788,0.18369,1,1
3,GO FATTY ACID BETA OXIDATION,0.037377,0.16774,0.14407,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0052065,0.16756,0.19877,1,1
3,GO CAMERA TYPE EYE DEVELOPMENT,0.0049572,0.16719,0.22667,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.007293,0.16702,0.21601,1,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0029965,0.16694,0.20288,1,1
3,GO ACTIVATION OF MAPKK ACTIVITY,0.030713,0.16691,0.2239,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.0042727,0.16689,0.22471,1,1
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0063209,0.16689,0.24332,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.035953,0.16674,0.19072,1,1
3,GO VIRAL RNA GENOME REPLICATION,0.025096,0.16671,0.17667,1,1
3,GO HISTONE H4 ACETYLATION,0.0080134,0.16667,0.22112,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.021265,0.1666,0.19569,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0040644,0.16638,0.21687,1,1
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.010101,0.16635,0.2151,1,1
3,GO DETECTION OF LIGHT STIMULUS,0.0031545,0.16626,0.31945,1,1
3,GO REGULATION OF MYELINATION,0.0172,0.16625,0.21398,1,1
3,GO VESICLE DOCKING,0.020391,0.16612,0.17766,1,1
3,GO HISTONE H3 DEACETYLATION,0.024086,0.16612,0.19941,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.012106,0.16591,0.18705,1,1
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.013235,0.16587,0.18205,1,1
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0052065,0.16568,0.21722,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.045233,0.16567,0.2048,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.015776,0.16567,0.1755,1,1
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.030713,0.16546,0.16618,1,1
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.031957,0.16545,0.1943,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0076456,0.16533,0.19279,1,1
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.018736,0.16519,0.20278,1,1
3,GO RESPONSE TO WATER,0.0172,0.16491,0.16549,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.045233,0.16489,0.22794,1,1
3,GO ACID SECRETION,0.0024341,0.16467,0.20072,1,1
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0036751,0.16466,0.31052,1,1
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.021265,0.1646,0.18817,1,1
3,GO MIRNA METABOLIC PROCESS,0.0038653,0.16432,0.20639,1,1
3,GO CATECHOLAMINE SECRETION,0.007293,0.16426,0.28029,1,1
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0025648,0.16426,0.24584,1,1
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.033245,0.16417,0.19806,1,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0054671,0.16413,0.17952,1,1
3,GO NOTCH SIGNALING PATHWAY,0.031957,0.16392,0.16819,1,1
3,GO METAL ION TRANSPORT,0.0025648,0.1639,0.20243,1,1
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.046961,0.16367,0.16959,1,1
3,GO B CELL APOPTOTIC PROCESS,0.048745,0.16358,0.19582,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.026142,0.16357,0.18449,1,1
3,GO NEGATIVE REGULATION OF CELL AGING,0.030713,0.16288,0.15494,1,1
3,GO PHAGOSOME MATURATION,0.0036751,0.16258,0.21277,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.0038653,0.1624,0.18216,1,1
3,GO CELL CELL ADHESION,0.028348,0.16232,0.21757,1,1
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.030713,0.16213,0.14585,1,1
3,GO REGULATION OF TRANSPORT,0.0083971,0.16212,0.19134,1,1
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.023112,0.16175,0.17098,1,1
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.040368,0.1615,0.19473,1,1
3,GO EYE MORPHOGENESIS,0.0096484,0.16144,0.22021,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00076864,0.16143,0.21091,1,1
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0060238,0.16143,0.2184,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.014457,0.16136,0.2061,1,1
3,GO STRIATED MUSCLE CONTRACTION,0.0057394,0.16116,0.17807,1,1
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.017954,0.16113,0.17773,1,1
3,GO MUSCLE CONTRACTION,0.0096484,0.16104,0.18074,1,1
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.010572,0.16099,0.28384,1,1
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0052065,0.16075,0.18537,1,1
3,GO DENDRITIC SPINE MAINTENANCE,0.0052065,0.16074,0.28074,1,1
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0066311,0.16058,0.225,1,1
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.038848,0.16024,0.17899,1,1
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.018736,0.16015,0.19146,1,1
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.0066311,0.15984,0.19775,1,1
3,GO TOR SIGNALING,0.010572,0.15978,0.19296,1,1
3,GO ORGANELLE LOCALIZATION,0.018736,0.1597,0.16811,1,1
3,GO PH REDUCTION,0.008797,0.15953,0.15827,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.00057531,0.15887,0.21993,1,1
3,GO PEPTIDYL THREONINE MODIFICATION,0.019548,0.15846,0.19425,1,1
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.021265,0.15819,0.17898,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0083971,0.15807,0.20578,1,1
3,GO STRIATED MUSCLE ADAPTATION,0.023112,0.15796,0.19095,1,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0021907,0.15793,0.2133,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.008797,0.15792,0.16493,1,1
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.024086,0.15785,0.15639,1,1
3,GO RETINAL CONE CELL DIFFERENTIATION,0.015104,0.15772,0.36469,1,1
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0019699,0.15678,0.16707,1,1
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011574,0.15674,0.19215,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00081392,0.15657,0.1712,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0012071,0.15633,0.18264,1,1
3,GO DETECTION OF MECHANICAL STIMULUS,0.041938,0.15631,0.16543,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.013834,0.15617,0.26743,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.011574,0.15614,0.161,1,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0057394,0.15613,0.18731,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.018736,0.15608,0.19952,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.025096,0.15607,0.18774,1,1
3,GO ACTION POTENTIAL,0.0092139,0.15606,0.18989,1,1
3,GO SENSORY ORGAN DEVELOPMENT,0.011063,0.15604,0.20646,1,1
3,GO REGULATION OF CELL SHAPE,0.037377,0.15603,0.21668,1,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.013235,0.15564,0.21226,1,1
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0054671,0.15563,0.23686,1,1
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.006955,0.15556,0.23399,1,1
3,GO MEMBRANE DOCKING,0.035953,0.15512,0.172,1,1
3,GO MYOFIBRIL ASSEMBLY,0.040368,0.15494,0.17836,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.006955,0.1546,0.19079,1,1
3,GO REGULATION OF SYSTEM PROCESS,0.0040644,0.15429,0.21027,1,1
3,GO HETEROCHROMATIN ORGANIZATION,0.035953,0.15415,0.18571,1,1
3,GO CELL PROJECTION ASSEMBLY,0.027226,0.15411,0.17814,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00332,0.15358,0.2,1,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.031957,0.15353,0.23874,1,1
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.026142,0.15348,0.17605,1,1
3,GO REGULATION OF PEPTIDE SECRETION,0.018736,0.15345,0.19092,1,1
3,GO LIMBIC SYSTEM DEVELOPMENT,0.015104,0.15305,0.18306,1,1
3,GO PROTEIN O LINKED MANNOSYLATION,0.030713,0.15301,0.18044,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.02951,0.15272,0.15888,1,1
3,GO POLYAMINE METABOLIC PROCESS,0.0066311,0.1526,0.14396,1,1
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.011574,0.15245,0.20161,1,1
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.00054254,0.15245,0.26328,1,1
3,GO REGIONALIZATION,0.015776,0.15231,0.16804,1,1
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0047188,0.15164,0.22491,1,1
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.011574,0.1514,0.21072,1,1
3,GO ORGANIC ACID TRANSPORT,0.006955,0.15137,0.17042,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0092139,0.15123,0.19173,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.048745,0.15084,0.16643,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,0.014457,0.15077,0.20574,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.033245,0.15075,0.20159,1,1
3,GO REGULATION OF SECRETION,0.010101,0.15058,0.19739,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.037377,0.15056,0.18224,1,1
3,GO ENSHEATHMENT OF NEURONS,0.025096,0.15037,0.17132,1,1
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0047188,0.15021,0.23156,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.041938,0.15017,0.14598,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.006955,0.15014,0.1682,1,1
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.024086,0.14995,0.19278,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0096484,0.14995,0.20658,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.013235,0.14994,0.20384,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.007293,0.14994,0.17386,1,1
3,GO ENDOCYTOSIS,0.017954,0.14991,0.20009,1,1
3,GO ACTIN NUCLEATION,0.035953,0.14989,0.14732,1,1
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0014241,0.1495,0.22743,1,1
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.046961,0.14945,0.2065,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.018736,0.14935,0.18972,1,1
3,GO CIRCADIAN RHYTHM,0.01266,0.14927,0.17624,1,1
3,GO REGULATION OF CELLULAR LOCALIZATION,0.0040644,0.14923,0.19007,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.016475,0.14904,0.17626,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0014241,0.14903,0.21368,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.040368,0.149,0.19483,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,0.0034935,0.1488,0.1902,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.041938,0.14857,0.21193,1,1
3,GO GLIOGENESIS,0.0172,0.14838,0.19278,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00332,0.14836,0.19752,1,1
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.007293,0.1481,0.22111,1,1
3,GO HEART PROCESS,0.017954,0.14794,0.16607,1,1
3,GO RECEPTOR CATABOLIC PROCESS,0.043559,0.14773,0.17674,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.018736,0.14772,0.17836,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.033245,0.14732,0.16849,1,1
3,GO TRANSMEMBRANE TRANSPORT,0.00332,0.1473,0.17458,1,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0172,0.14717,0.19672,1,1
3,GO MUSCLE SYSTEM PROCESS,0.0172,0.14689,0.17215,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0172,0.14682,0.17593,1,1
3,GO REGULATION OF FIBROBLAST MIGRATION,0.020391,0.14663,0.20825,1,1
3,GO LIPID MODIFICATION,0.019548,0.14647,0.15506,1,1
3,GO POLYOL METABOLIC PROCESS,0.0025648,0.14631,0.19751,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.016475,0.14628,0.18474,1,1
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.026142,0.1462,0.30247,1,1
3,GO CELLULAR ION HOMEOSTASIS,0.019548,0.14609,0.18229,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0034935,0.14584,0.22985,1,1
3,GO PROTEIN KINASE B SIGNALING,0.028348,0.14567,0.19994,1,1
3,GO NUCLEAR BODY ORGANIZATION,0.0049572,0.14566,0.1985,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.014457,0.14565,0.19976,1,1
3,GO NEUTRAL AMINO ACID TRANSPORT,0.022172,0.14546,0.18011,1,1
3,GO LIPID IMPORT INTO CELL,0.046961,0.14529,0.1723,1,1
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.015776,0.14528,0.19601,1,1
3,GO AMINE TRANSPORT,0.007293,0.14477,0.2492,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.00332,0.14434,0.19176,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.011063,0.1439,0.15326,1,1
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.030713,0.14387,0.15913,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.0083971,0.14375,0.14569,1,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.022172,0.14373,0.19699,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.041938,0.14331,0.15333,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.038848,0.14303,0.19585,1,1
3,GO ION TRANSPORT,0.0040644,0.14271,0.18564,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.034576,0.14266,0.14574,1,1
3,GO SODIUM ION TRANSPORT,0.022172,0.14247,0.17179,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.011063,0.14222,0.1627,1,1
3,GO REGULATION OF PROTEIN BINDING,0.008797,0.14212,0.19457,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.045233,0.14201,0.17111,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012106,0.14153,0.18178,1,1
3,GO TRANSFERRIN TRANSPORT,0.013834,0.14149,0.15863,1,1
3,GO DEVELOPMENTAL GROWTH,0.015776,0.14109,0.1898,1,1
3,GO LYSOSOMAL TRANSPORT,0.025096,0.14087,0.20166,1,1
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.011063,0.14043,0.2206,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.034576,0.14033,0.14976,1,1
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.040368,0.14019,0.19456,1,1
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.021265,0.14007,0.1636,1,1
3,GO NUCLEOTIDE SALVAGE,0.01266,0.14,0.18438,1,1
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0096484,0.13995,0.32413,1,1
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.020391,0.13983,0.19679,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.040368,0.13981,0.1504,1,1
3,GO PORE COMPLEX ASSEMBLY,0.024086,0.13978,0.14365,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0054671,0.13976,0.17819,1,1
3,GO ADAPTIVE THERMOGENESIS,0.022172,0.13971,0.16283,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.012106,0.13966,0.18035,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.01266,0.13956,0.1657,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.024086,0.13954,0.18588,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.023112,0.1394,0.18444,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.043559,0.13928,0.1215,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.011574,0.13923,0.17842,1,1
3,GO EMBRYONIC ORGAN DEVELOPMENT,0.026142,0.13887,0.17849,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.034576,0.13884,0.15341,1,1
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.011063,0.13867,0.20464,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.010572,0.13819,0.18304,1,1
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.038848,0.13818,0.16466,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.006955,0.13816,0.17228,1,1
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.014457,0.13813,0.17517,1,1
3,GO DEMETHYLATION,0.0172,0.13807,0.19206,1,1
3,GO RESPONSE TO ALKALOID,0.040368,0.13785,0.13383,1,1
3,GO ATP TRANSPORT,0.015776,0.1378,0.15919,1,1
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.020391,0.13755,0.18895,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.027226,0.13702,0.1868,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.046961,0.13678,0.13419,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0066311,0.13666,0.19881,1,1
3,GO LAMELLIPODIUM ASSEMBLY,0.030713,0.13665,0.17798,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.012106,0.13648,0.17259,1,1
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.046961,0.13642,0.17943,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.010101,0.13638,0.15728,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.040368,0.13604,0.17521,1,1
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0066311,0.13583,0.16765,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.038848,0.13581,0.16455,1,1
3,GO CYTOSKELETON ORGANIZATION,0.0096484,0.13577,0.19473,1,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.010101,0.13574,0.2,1,1
3,GO REGULATION OF DEPHOSPHORYLATION,0.010101,0.13539,0.1761,1,1
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.028348,0.13534,0.15013,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0038653,0.13507,0.18214,1,1
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.014457,0.13504,0.19035,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.038848,0.13489,0.17664,1,1
3,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.034576,0.13475,0.18466,1,1
3,GO PEPTIDYL SERINE MODIFICATION,0.010101,0.13398,0.1856,1,1
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.011063,0.13376,0.20183,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.034576,0.13366,0.17468,1,1
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.027226,0.13364,0.18456,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.0038653,0.1335,0.19962,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.037377,0.13349,0.15965,1,1
3,GO CLATHRIN COAT ASSEMBLY,0.023112,0.13336,0.179,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.006955,0.13334,0.20756,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.020391,0.13333,0.20432,1,1
3,GO GLIAL CELL APOPTOTIC PROCESS,0.041938,0.13324,0.16385,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.048745,0.1332,0.15007,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.015776,0.13309,0.19702,1,1
3,GO CANONICAL WNT SIGNALING PATHWAY,0.027226,0.13307,0.16202,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.025096,0.13303,0.17709,1,1
3,GO SENSORY ORGAN MORPHOGENESIS,0.023112,0.13287,0.18845,1,1
3,GO APPENDAGE DEVELOPMENT,0.031957,0.13284,0.19103,1,1
3,GO EAR MORPHOGENESIS,0.043559,0.13251,0.15605,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.013834,0.13237,0.18477,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0052065,0.1323,0.15741,1,1
3,GO RHYTHMIC PROCESS,0.022172,0.13214,0.16716,1,1
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.046961,0.13211,0.13844,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.028348,0.13211,0.16719,1,1
3,GO MEMBRANE ORGANIZATION,0.011574,0.13188,0.16574,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0052065,0.13153,0.1956,1,1
3,GO CARDIAC MUSCLE CONTRACTION,0.021265,0.1315,0.15883,1,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.02951,0.13146,0.15169,1,1
3,GO CELL GROWTH,0.015776,0.13144,0.1916,1,1
3,GO PROTEIN HOMOTETRAMERIZATION,0.019548,0.13136,0.15245,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0054671,0.13127,0.16459,1,1
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.037377,0.1311,0.18881,1,1
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.026142,0.13102,0.17402,1,1
3,GO DNA CATABOLIC PROCESS,0.013235,0.1309,0.15697,1,1
3,GO RRNA CATABOLIC PROCESS,0.028348,0.13076,0.1534,1,1
3,GO GLIAL CELL DEVELOPMENT,0.027226,0.13075,0.18482,1,1
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0066311,0.13054,0.20512,1,1
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.01266,0.13034,0.13992,1,1
3,GO FIBROBLAST MIGRATION,0.024086,0.13022,0.20858,1,1
3,GO REGULATION OF CELL DIFFERENTIATION,0.015104,0.12994,0.19009,1,1
3,GO CIRCULATORY SYSTEM PROCESS,0.040368,0.12959,0.15614,1,1
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.014457,0.12933,0.19007,1,1
3,GO PHAGOSOME ACIDIFICATION,0.031957,0.12932,0.15,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.010572,0.12932,0.17605,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.034576,0.12912,0.17528,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.030713,0.12826,0.17388,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.033245,0.12802,0.17096,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.017954,0.128,0.14402,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.035953,0.12792,0.1832,1,1
3,GO REGULATION OF PH,0.031957,0.12767,0.1448,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.015776,0.12727,0.17028,1,1
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0021907,0.12721,0.19233,1,1
3,GO GLUCOSE METABOLIC PROCESS,0.0083971,0.12713,0.16926,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.012106,0.12689,0.15696,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0172,0.12667,0.1722,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.0063209,0.12664,0.13997,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.037377,0.12661,0.20805,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.021265,0.12654,0.17936,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.030713,0.12648,0.22166,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.041938,0.12642,0.18552,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,0.0172,0.12625,0.16493,1,1
3,GO REGULATION OF DNA BINDING,0.015776,0.12624,0.16207,1,1
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.037377,0.12614,0.18829,1,1
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.043559,0.1261,0.19673,1,1
3,GO PROTEIN INSERTION INTO MEMBRANE,0.020391,0.12605,0.11196,1,1
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.040368,0.12594,0.15583,1,1
3,GO RESPONSE TO AMINO ACID STARVATION,0.017954,0.12555,0.17492,1,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00332,0.12527,0.14003,1,1
3,GO GMP METABOLIC PROCESS,0.0096484,0.12506,0.17078,1,1
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.034576,0.12505,0.13398,1,1
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.023112,0.12476,0.14643,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.014457,0.1247,0.1324,1,1
3,GO RESPONSE TO ALCOHOL,0.040368,0.12462,0.15898,1,1
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.016475,0.12448,0.17496,1,1
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.010572,0.12427,0.1332,1,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.027226,0.12424,0.17716,1,1
3,GO REGULATION OF MEMBRANE PERMEABILITY,0.037377,0.12407,0.11538,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.035953,0.12405,0.17556,1,1
3,GO MEMBRANE FUSION,0.026142,0.12395,0.15605,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.037377,0.12394,0.15465,1,1
3,GO APOPTOTIC DNA FRAGMENTATION,0.0083971,0.12391,0.15037,1,1
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.015104,0.12384,0.18528,1,1
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.033245,0.12342,0.16161,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.022172,0.12333,0.14782,1,1
3,GO REGULATION OF HISTONE UBIQUITINATION,0.021265,0.12329,0.17099,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.026142,0.12323,0.12671,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.028348,0.12315,0.18372,1,1
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.021265,0.123,0.15128,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,0.013834,0.12249,0.16036,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.017954,0.12235,0.1663,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.025096,0.12222,0.12875,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.015776,0.12175,0.19417,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.021265,0.12171,0.16707,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.0057394,0.12163,0.15557,1,1
3,GO POSITIVE REGULATION OF SIGNALING,0.0172,0.12159,0.17457,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.031957,0.12099,0.16898,1,1
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.025096,0.12081,0.1511,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.033245,0.12076,0.18369,1,1
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.025096,0.12064,0.13708,1,1
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.0083971,0.12036,0.21817,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.023112,0.12034,0.16134,1,1
3,GO CELLULAR HOMEOSTASIS,0.008797,0.12019,0.17873,1,1
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0172,0.12002,0.19185,1,1
3,GO REGULATION OF VASCULAR PERMEABILITY,0.033245,0.11997,0.20508,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,0.015776,0.11997,0.16525,1,1
3,GO ESTABLISHMENT OF CELL POLARITY,0.007293,0.11975,0.21293,1,1
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.033245,0.11967,0.1767,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.035953,0.11966,0.15226,1,1
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0063209,0.11963,0.1547,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.020391,0.11959,0.17072,1,1
3,GO VITAMIN METABOLIC PROCESS,0.031957,0.11954,0.13499,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.030713,0.11953,0.19931,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.041938,0.11907,0.17817,1,1
3,GO CELL CELL SIGNALING BY WNT,0.019548,0.11886,0.16541,1,1
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.046961,0.11873,0.1147,1,1
3,GO ANION HOMEOSTASIS,0.016475,0.11873,0.18591,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.045233,0.11858,0.14617,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.015776,0.11842,0.17556,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.02951,0.11825,0.15295,1,1
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.024086,0.11821,0.15998,1,1
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.045233,0.11817,0.13331,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.018736,0.11793,0.17242,1,1
3,GO PHOTOTRANSDUCTION,0.0066311,0.1176,0.30488,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.026142,0.11758,0.16766,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.025096,0.11756,0.1737,1,1
3,GO MAMMARY GLAND DEVELOPMENT,0.037377,0.1174,0.18257,1,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.020391,0.11684,0.17491,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.01266,0.11667,0.18105,1,1
3,GO MALE GAMETE GENERATION,0.048745,0.11665,0.12643,1,1
3,GO VACUOLAR TRANSPORT,0.023112,0.11661,0.17432,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.048745,0.11661,0.14547,1,1
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.030713,0.1161,0.11803,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0066311,0.11593,0.13636,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.035953,0.11589,0.17318,1,1
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.013834,0.11586,0.16557,1,1
3,GO MAINTENANCE OF LOCATION,0.02951,0.11578,0.17455,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.025096,0.11546,0.15366,1,1
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.007293,0.11494,0.1757,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.027226,0.11488,0.16723,1,1
3,GO SCHWANN CELL DIFFERENTIATION,0.043559,0.11486,0.17774,1,1
3,GO DEPHOSPHORYLATION,0.020391,0.11439,0.14527,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.0172,0.11434,0.16046,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,0.0092139,0.11423,0.16346,1,1
3,GO RESPONSE TO STARVATION,0.025096,0.11416,0.14077,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.02951,0.1139,0.17402,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.048745,0.11375,0.095685,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.038848,0.11364,0.15101,1,1
3,GO CELL CYCLE ARREST,0.031957,0.11353,0.14514,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0092139,0.11344,0.17665,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.028348,0.11342,0.16463,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.031957,0.11338,0.1411,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.027226,0.11316,0.15828,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.028348,0.113,0.14249,1,1
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.01266,0.11279,0.16121,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.031957,0.11272,0.15947,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.025096,0.11256,0.13306,1,1
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.027226,0.1124,0.17551,1,1
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.022172,0.1122,0.12585,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.024086,0.11178,0.14638,1,1
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.021265,0.11161,0.11424,1,1
3,GO ANIMAL ORGAN MORPHOGENESIS,0.030713,0.11159,0.1688,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.030713,0.11126,0.15677,1,1
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.02951,0.11082,0.13335,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.031957,0.11058,0.13729,1,1
3,GO DETECTION OF STIMULUS,0.006955,0.11051,0.14357,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.013235,0.11049,0.17611,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.027226,0.11034,0.16742,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.025096,0.11008,0.1657,1,1
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.040368,0.10995,0.12652,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.038848,0.10981,0.15048,1,1
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.037377,0.10976,0.1698,1,1
3,GO POSITIVE REGULATION OF BINDING,0.0057394,0.10946,0.16656,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.016475,0.10929,0.15792,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.030713,0.1089,0.19229,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0040644,0.10874,0.19854,1,1
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.024086,0.10853,0.10244,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.020391,0.10837,0.17207,1,1
3,GO APOPTOTIC PROCESS,0.024086,0.10824,0.14964,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,0.011063,0.10788,0.15025,1,1
3,GO VESICLE LOCALIZATION,0.018736,0.10756,0.16513,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.043559,0.10746,0.15521,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.025096,0.10741,0.16362,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.019548,0.10732,0.1498,1,1
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.037377,0.10732,0.13561,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.022172,0.10685,0.16393,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.027226,0.10669,0.12897,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.026142,0.10661,0.16179,1,1
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.025096,0.10645,0.11079,1,1
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.035953,0.10636,0.15577,1,1
3,GO BIOLOGICAL ADHESION,0.048745,0.10601,0.20093,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.038848,0.10598,0.14877,1,1
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0172,0.10557,0.23054,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.033245,0.10491,0.13539,1,1
3,GO EMBRYO DEVELOPMENT,0.037377,0.10475,0.16182,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.011063,0.10474,0.18163,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,0.034576,0.10449,0.15528,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.030713,0.10441,0.15275,1,1
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.018736,0.10436,0.1631,1,1
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.035953,0.10434,0.13345,1,1
3,GO PROTEIN TETRAMERIZATION,0.017954,0.10427,0.15393,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.041938,0.10418,0.18678,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.018736,0.10415,0.11095,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.048745,0.10405,0.14353,1,1
3,GO RESPONSE TO PEPTIDE,0.034576,0.10384,0.16363,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.02951,0.10355,0.16303,1,1
3,GO GROWTH,0.026142,0.10343,0.16104,1,1
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.008797,0.10251,0.13587,1,1
3,GO CERAMIDE METABOLIC PROCESS,0.020391,0.10248,0.17275,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.015776,0.1021,0.14334,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0083971,0.10183,0.13059,1,1
3,GO MUSCLE CELL DEVELOPMENT,0.038848,0.10174,0.15295,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.017954,0.1017,0.12675,1,1
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.02951,0.10127,0.1745,1,1
3,GO MULTI ORGANISM PROCESS,0.048745,0.10105,0.12132,1,1
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.028348,0.10099,0.16146,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.026142,0.10087,0.14825,1,1
3,GO TEMPERATURE HOMEOSTASIS,0.030713,0.10063,0.14834,1,1
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.040368,0.10011,0.13531,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.008797,0.099913,0.11831,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.041938,0.099629,0.14041,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0172,0.099474,0.11067,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.040368,0.099414,0.12242,1,1
3,GO ORGANELLE ASSEMBLY,0.037377,0.09923,0.14567,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.031957,0.099002,0.151,1,1
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.013235,0.09813,0.17383,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.015104,0.097948,0.1497,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.022172,0.097822,0.18062,1,1
3,GO ACTIN FILAMENT BASED MOVEMENT,0.037377,0.097283,0.16915,1,1
3,GO GLAND DEVELOPMENT,0.046961,0.096884,0.14681,1,1
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.022172,0.096672,0.14756,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.023112,0.096397,0.13618,1,1
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.038848,0.096308,0.14054,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.033245,0.096254,0.17209,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.017954,0.096018,0.15077,1,1
3,GO RESPONSE TO LIGHT STIMULUS,0.011574,0.095936,0.16025,1,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.046961,0.095484,0.13251,1,1
3,GO RESPONSE TO INSULIN,0.034576,0.095453,0.14779,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,0.01266,0.095372,0.15992,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.038848,0.094463,0.15038,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.048745,0.094398,0.12402,1,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.020391,0.093251,0.11205,1,1
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0083971,0.093126,0.13469,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.046961,0.092802,0.16994,1,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.035953,0.092309,0.14936,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.040368,0.092224,0.13218,1,1
3,GO REGULATION OF AUTOPHAGY,0.028348,0.091474,0.14949,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.033245,0.091388,0.14892,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.027226,0.091286,0.17516,1,1
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.043559,0.091192,0.21177,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.027226,0.090799,0.1402,1,1
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.033245,0.090796,0.15573,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.028348,0.090624,0.18964,1,1
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.035953,0.0899,0.13756,1,1
3,GO VACUOLE ORGANIZATION,0.038848,0.089889,0.15197,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.038848,0.089312,0.12321,1,1
3,GO PROTEIN STABILIZATION,0.043559,0.089033,0.12032,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.046961,0.088435,0.13786,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.041938,0.088398,0.1458,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.010572,0.08792,0.12595,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.017954,0.087844,0.12119,1,1
3,GO CYTOSOLIC TRANSPORT,0.02951,0.087743,0.18454,1,1
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.048745,0.087565,0.092639,1,1
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.022172,0.087504,0.12794,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.011063,0.08654,0.11907,1,1
3,GO PIGMENT METABOLIC PROCESS,0.010101,0.085906,0.12991,1,1
3,GO ATP METABOLIC PROCESS,0.0052065,0.085258,0.10567,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.034576,0.083891,0.12145,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.048745,0.082749,0.11801,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0080134,0.082631,0.11637,1,1
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0092139,0.08257,0.13334,1,1
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.028348,0.082506,0.13114,1,1
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.040368,0.08248,0.13176,1,1
3,GO PROTEIN DEPHOSPHORYLATION,0.0172,0.080632,0.1482,1,1
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.043559,0.080328,0.088137,1,1
3,GO SULFUR COMPOUND TRANSPORT,0.030713,0.080181,0.18097,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.038848,0.080127,0.14416,1,1
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.023112,0.078573,0.14281,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0047188,0.078003,0.12478,1,1
3,GO VESICLE ORGANIZATION,0.021265,0.07717,0.15488,1,1
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.015104,0.076318,0.12233,1,1
3,GO REGULATION OF GROWTH,0.040368,0.073224,0.15679,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0092139,0.072641,0.11622,1,1
3,GO AMINE METABOLIC PROCESS,0.037377,0.070855,0.11261,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.041938,0.070784,0.1206,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY,0.013235,0.07042,0.1373,1,1
3,GO ERAD PATHWAY,0.025096,0.070051,0.14479,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.015776,0.069264,0.11961,1,1
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.012106,0.068512,0.12572,1,1
3,GO MITOCHONDRION ORGANIZATION,0.038848,0.050741,0.10291,1,1
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.015776,0.4081,0.38829,1,0
3,GO DENDRITIC TRANSPORT,0.0063209,0.40498,0.37648,1,0
3,GO NK T CELL DIFFERENTIATION,0.016475,0.40111,0.44291,1,0
3,GO CARDIAC VENTRICLE FORMATION,0.0020776,0.38969,0.44224,1,0
3,GO REGULATION OF NEURON MIGRATION,0.0080134,0.38846,0.34517,1,0
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0063209,0.38105,0.42701,1,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0047188,0.37526,0.50143,1,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.016475,0.36198,0.29738,1,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.046961,0.36137,0.49306,1,0
3,GO TRIGEMINAL NERVE DEVELOPMENT,0.020391,0.35998,0.38578,1,0
3,GO THALAMUS DEVELOPMENT,0.015776,0.3384,0.2975,1,0
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0080134,0.30515,0.30697,1,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.020391,0.3042,0.24837,1,0
3,GO SYNAPTIC VESICLE CLUSTERING,0.011063,0.29441,0.40563,1,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.02951,0.29439,0.26103,1,0
3,GO REGULATION OF MICROTUBULE BINDING,0.0038653,0.29304,0.35344,1,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.043559,0.28982,0.26957,1,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.019548,0.2872,0.30762,1,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.037377,0.28697,0.26733,1,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.0063209,0.28105,0.38315,1,0
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0015041,0.27968,0.28652,1,0
3,GO CELL PROLIFERATION IN FOREBRAIN,0.018736,0.27882,0.28853,1,0
3,GO NEURAL TUBE PATTERNING,0.013834,0.27423,0.2333,1,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.034576,0.26513,0.26046,1,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.018736,0.26072,0.27603,1,0
3,GO NEURON PROJECTION ARBORIZATION,0.020391,0.25989,0.28187,1,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.045233,0.25682,0.23638,1,0
3,GO INNERVATION,0.046961,0.25609,0.29172,1,0
3,GO MICROTUBULE NUCLEATION,0.013834,0.25425,0.25175,1,0
3,GO CELL PROLIFERATION IN HINDBRAIN,0.017954,0.2507,0.24655,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0028457,0.2499,0.39316,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0080134,0.2446,0.34677,1,0
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.041938,0.24172,0.26249,1,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.013834,0.23771,0.23931,1,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0012758,0.23653,0.31018,1,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0063209,0.2361,0.2412,1,0
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.021265,0.23562,0.24064,1,0
3,GO RESPONSE TO L GLUTAMATE,0.011063,0.23523,0.21813,1,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.006955,0.23508,0.28953,1,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0044907,0.23489,0.27267,1,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.041938,0.23489,0.24801,1,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.0060238,0.23455,0.253,1,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.02951,0.23241,0.23654,1,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.006955,0.23055,0.27036,1,0
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0052065,0.23047,0.21678,1,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0024341,0.23017,0.34023,1,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0083971,0.22767,0.24354,1,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.010101,0.22055,0.2043,1,0
3,GO CAMP METABOLIC PROCESS,0.024086,0.22005,0.23448,1,0
3,GO CHOLESTEROL EFFLUX,0.0096484,0.21896,0.24649,1,0
3,GO SYNAPTIC VESICLE PRIMING,0.019548,0.21802,0.28959,1,0
3,GO AXONAL TRANSPORT,0.020391,0.21796,0.23809,1,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.013834,0.21738,0.24045,1,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.045233,0.21502,0.20004,1,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0172,0.21315,0.25862,1,0
3,GO PLATELET ACTIVATION,0.022172,0.21067,0.26528,1,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.006955,0.20616,0.2615,1,0
3,GO SKELETAL MUSCLE ADAPTATION,0.0172,0.20544,0.21194,1,0
3,GO MICROTUBULE BUNDLE FORMATION,0.023112,0.20502,0.21833,1,0
3,GO HISTONE H4 K5 ACETYLATION,0.027226,0.20393,0.21266,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.035953,0.20265,0.19651,1,0
3,GO SYNAPSE ASSEMBLY,0.027226,0.20253,0.23775,1,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.046961,0.1959,0.20641,1,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0080134,0.19191,0.22474,1,0
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.045233,0.19159,0.20228,1,0
3,GO HISTONE H3 K9 METHYLATION,0.038848,0.19068,0.20606,1,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.038848,0.18971,0.20998,1,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.018736,0.18864,0.28828,1,0
3,GO MRNA TRANSCRIPTION,0.043559,0.1883,0.20669,1,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.015104,0.18815,0.21106,1,0
3,GO PANCREAS DEVELOPMENT,0.023112,0.18814,0.17025,1,0
3,GO HISTONE H3 K9 MODIFICATION,0.021265,0.18788,0.20139,1,0
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.015104,0.18665,0.25238,1,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.048745,0.18464,0.23163,1,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.010572,0.18457,0.2446,1,0
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.00332,0.18352,0.25001,1,0
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.018736,0.18316,0.17571,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.043559,0.18267,0.2242,1,0
3,GO HISTONE H3 K14 ACETYLATION,0.017954,0.18004,0.2089,1,0
3,GO ARGININE METABOLIC PROCESS,0.011063,0.17999,0.19225,1,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0060238,0.17932,0.21419,1,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.045233,0.17662,0.23682,1,0
3,GO TRANSPORT ALONG MICROTUBULE,0.031957,0.17655,0.18315,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.038848,0.17423,0.22465,1,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.030713,0.17391,0.20345,1,0
3,GO REGULATION OF MRNA PROCESSING,0.046961,0.17378,0.1543,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.015104,0.17337,0.18901,1,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.030713,0.17242,0.25469,1,0
3,GO HISTONE METHYLATION,0.018736,0.17223,0.209,1,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.048745,0.16864,0.18291,1,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.035953,0.16858,0.22622,1,0
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.020391,0.16637,0.18142,1,0
3,GO G0 TO G1 TRANSITION,0.033245,0.16631,0.17801,1,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.023112,0.16606,0.25232,1,0
3,GO RENAL WATER HOMEOSTASIS,0.038848,0.16455,0.23771,1,0
3,GO HISTONE H3 ACETYLATION,0.017954,0.16446,0.18003,1,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.048745,0.16225,0.14957,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0052065,0.16197,0.19474,1,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0052065,0.16077,0.22925,1,0
3,GO PEPTIDYL LYSINE METHYLATION,0.024086,0.15896,0.20147,1,0
3,GO GENETIC IMPRINTING,0.0172,0.15822,0.22795,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.045233,0.15786,0.19073,1,0
3,GO DEVELOPMENTAL PIGMENTATION,0.010101,0.15724,0.19452,1,0
3,GO MEMBRANE BIOGENESIS,0.031957,0.15297,0.1806,1,0
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.014457,0.15274,0.20696,1,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.038848,0.15249,0.19933,1,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.017954,0.15218,0.2076,1,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.030713,0.15208,0.17599,1,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.030713,0.15158,0.16197,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.025096,0.15103,0.17633,1,0
3,GO POST EMBRYONIC DEVELOPMENT,0.045233,0.15102,0.19218,1,0
3,GO MITOPHAGY,0.019548,0.15071,0.20966,1,0
3,GO COPPER ION HOMEOSTASIS,0.01266,0.1501,0.18748,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.040368,0.14934,0.21764,1,0
3,GO GENITALIA MORPHOGENESIS,0.040368,0.1489,0.22324,1,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.046961,0.1482,0.17482,1,0
3,GO METAL ION HOMEOSTASIS,0.026142,0.14647,0.1799,1,0
3,GO MACROMOLECULE DEACYLATION,0.043559,0.14593,0.162,1,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.020391,0.14546,0.17913,1,0
3,GO HYPEROSMOTIC RESPONSE,0.028348,0.14427,0.23377,1,0
3,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.031957,0.14277,0.21747,1,0
3,GO HISTONE DEACETYLATION,0.048745,0.14277,0.16991,1,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.030713,0.14244,0.20141,1,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.046961,0.14234,0.18363,1,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.041938,0.14228,0.23165,1,0
3,GO REGULATION OF BLOOD CIRCULATION,0.023112,0.14103,0.17447,1,0
3,GO PROTEIN ACYLATION,0.033245,0.13844,0.17654,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0080134,0.13811,0.13772,1,0
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.019548,0.13487,0.14417,1,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.035953,0.13467,0.15683,1,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.019548,0.13466,0.21885,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.045233,0.13346,0.18941,1,0
3,GO PROTEIN TARGETING TO VACUOLE,0.020391,0.13337,0.20117,1,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.045233,0.13329,0.19065,1,0
3,GO HISTONE H2A ACETYLATION,0.045233,0.13296,0.15669,1,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.035953,0.1322,0.1389,1,0
3,GO RESPONSE TO AXON INJURY,0.017954,0.13088,0.20818,1,0
3,GO PROTEIN METHYLATION,0.048745,0.13071,0.17282,1,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.007293,0.12979,0.19636,1,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.025096,0.12965,0.17818,1,0
3,GO ION HOMEOSTASIS,0.026142,0.12906,0.17202,1,0
3,GO REGULATION OF HISTONE MODIFICATION,0.021265,0.12835,0.17384,1,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.035953,0.12768,0.16669,1,0
3,GO PROTEIN ACETYLATION,0.017954,0.12696,0.17778,1,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.019548,0.12685,0.21856,1,0
3,GO COVALENT CHROMATIN MODIFICATION,0.038848,0.12635,0.18594,1,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.007293,0.12597,0.20196,1,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.048745,0.12571,0.117,1,0
3,GO CHROMATIN ORGANIZATION,0.041938,0.12464,0.17221,1,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.045233,0.12461,0.14301,1,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.031957,0.124,0.14582,1,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.013834,0.12357,0.18831,1,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.028348,0.12329,0.19199,1,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.035953,0.12266,0.17124,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.038848,0.12231,0.16479,1,0
3,GO PEPTIDE SECRETION,0.016475,0.1222,0.19329,1,0
3,GO LYTIC VACUOLE ORGANIZATION,0.0172,0.12204,0.18033,1,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.046961,0.12163,0.15889,1,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.045233,0.1215,0.17935,1,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.027226,0.12145,0.17673,1,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.046961,0.12058,0.14124,1,0
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.014457,0.11928,0.13446,1,0
3,GO REGULATION OF GLUCONEOGENESIS,0.020391,0.11924,0.17011,1,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.041938,0.11886,0.18793,1,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.027226,0.11874,0.22355,1,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.027226,0.11737,0.17812,1,0
3,GO MYOBLAST PROLIFERATION,0.031957,0.11602,0.1656,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.025096,0.1156,0.17218,1,0
3,GO REGULATION OF MAPK CASCADE,0.034576,0.11473,0.17916,1,0
3,GO REGULATION OF SENSORY PERCEPTION,0.028348,0.11383,0.20153,1,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.038848,0.11354,0.19052,1,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.030713,0.1124,0.1841,1,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.02951,0.11225,0.16348,1,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.028348,0.11207,0.18829,1,0
3,GO JNK CASCADE,0.025096,0.11204,0.1979,1,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.041938,0.11123,0.16409,1,0
3,GO SECRETION,0.045233,0.11104,0.15874,1,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.018736,0.11057,0.13468,1,0
3,GO ORGANIC ANION TRANSPORT,0.026142,0.10956,0.15137,1,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.038848,0.10754,0.15001,1,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.028348,0.10752,0.14952,1,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.034576,0.10691,0.15099,1,0
3,GO PROTEIN POLYUBIQUITINATION,0.046961,0.1064,0.13767,1,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.023112,0.10575,0.16961,1,0
3,GO CHEMICAL HOMEOSTASIS,0.021265,0.10166,0.16541,1,0
3,GO HOMEOSTATIC PROCESS,0.025096,0.099198,0.15548,1,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.045233,0.098559,0.1488,1,0
3,GO CHLORIDE TRANSPORT,0.041938,0.097369,0.13913,1,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.038848,0.096823,0.15392,1,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.046961,0.096736,0.15295,1,0
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.017954,0.095026,0.12733,1,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.02951,0.094405,0.1648,1,0
3,GO DNA MODIFICATION,0.028348,0.093456,0.13996,1,0
3,GO ANION TRANSPORT,0.027226,0.093451,0.14883,1,0
3,GO NUCLEOTIDE TRANSPORT,0.035953,0.092815,0.14675,1,0
3,GO LIPID HOMEOSTASIS,0.045233,0.092807,0.15035,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.038848,0.090022,0.16103,1,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.040368,0.088535,0.14688,1,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.028348,0.084132,0.12445,1,0
3,GO SECONDARY METABOLIC PROCESS,0.035953,0.083612,0.12058,1,0
3,GO PHOTOPERIODISM,0.046961,0.082781,0.14101,1,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.040368,0.08191,0.18943,1,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.030713,0.081904,0.16651,1,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.041938,0.079372,0.14526,1,0
3,GO RESPONSE TO RADIATION,0.038848,0.07821,0.13133,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.031957,0.076366,0.15655,1,0
3,GO ORGANELLE FUSION,0.022172,0.074174,0.15692,1,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.040368,0.062913,0.1291,1,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.02951,0.053281,0.14605,1,0
3,GO PROTEIN NEDDYLATION,0.041938,-0.098839,-0.095878,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.02951,-0.14753,-0.15599,1,0
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.045233,-0.14757,-0.081248,1,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0024341,-0.17588,-0.18537,1,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.046961,-0.20181,-0.22024,1,0
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00048214,-0.22586,-0.19593,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0012071,-0.25032,-0.24438,1,0
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0010798,-0.26178,-0.27863,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.016475,-0.28578,-0.33617,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,0.014457,-0.30568,-0.37305,1,0
3,GO OPSONIZATION,0.018736,-0.32036,-0.36851,1,0
3,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0014241,-0.4493,-0.47537,1,0
3,GO TOLERANCE INDUCTION,0.054439,0.60259,0.44374,0,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.060677,0.56243,0.4311,0,1
3,GO REGULATORY T CELL DIFFERENTIATION,0.052482,0.53271,0.35611,0,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.050584,0.51833,0.37541,0,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.060677,0.51572,0.38668,0,1
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.056456,0.51111,0.55122,0,1
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.13885,0.48618,0.31761,0,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.056456,0.47123,0.3552,0,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.080256,0.47008,0.27473,0,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.12662,0.44002,0.36374,0,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.077559,0.43851,0.32259,0,1
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.056456,0.43717,0.29132,0,1
3,GO NEGATIVE REGULATION OF CELL KILLING,0.08303,0.43486,0.33906,0,1
3,GO INTERLEUKIN 4 PRODUCTION,0.058535,0.4097,0.32277,0,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.091819,0.40881,0.28075,0,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.15655,0.40523,0.27861,0,1
3,GO FACIAL NERVE MORPHOGENESIS,0.052482,0.4018,0.28531,0,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.054439,0.39999,0.31037,0,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.08881,0.38998,0.28264,0,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.080256,0.38886,0.32665,0,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.08588,0.38663,0.3261,0,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.08881,0.38457,0.28446,0,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.056456,0.38054,0.34424,0,1
3,GO RESPONSE TO PROTOZOAN,0.11894,0.38029,0.27806,0,1
3,GO CELLULAR DEFENSE RESPONSE,0.12662,0.37981,0.27083,0,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.062884,0.37824,0.30332,0,1
3,GO ALPHA BETA T CELL PROLIFERATION,0.074935,0.37666,0.32638,0,1
3,GO RESPONSE TO TYPE I INTERFERON,0.11894,0.37282,0.24995,0,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.077559,0.37281,0.29133,0,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.08881,0.37193,0.32083,0,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.054439,0.37088,0.3144,0,1
3,GO DENDRITIC CELL MIGRATION,0.074935,0.36962,0.34127,0,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.050584,0.36904,0.31968,0,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.052482,0.36494,0.30334,0,1
3,GO T HELPER 2 CELL DIFFERENTIATION,0.26442,0.36446,0.20022,0,1
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.10468,0.36431,0.31896,0,1
3,GO RESPONSE TO INTERLEUKIN 15,0.11524,0.36228,0.29736,0,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.077559,0.36196,0.36186,0,1
3,GO INTERLEUKIN 12 PRODUCTION,0.065157,0.36013,0.3155,0,1
3,GO T CELL EXTRAVASATION,0.080256,0.3596,0.28389,0,1
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.15655,0.3593,0.19218,0,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.10134,0.35866,0.39447,0,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.067497,0.35638,0.30954,0,1
3,GO GERMINAL CENTER FORMATION,0.12273,0.35634,0.30103,0,1
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.065157,0.35242,0.27713,0,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.074935,0.35103,0.27075,0,1
3,GO LYMPH NODE DEVELOPMENT,0.052482,0.34774,0.31228,0,1
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.10811,0.3475,0.279,0,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.11894,0.34638,0.21784,0,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.050584,0.34579,0.28774,0,1
3,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.050584,0.34498,0.27717,0,1
3,GO MOTILE CILIUM ASSEMBLY,0.060677,0.34496,0.24488,0,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.08588,0.34433,0.26993,0,1
3,GO CYTIDINE TO URIDINE EDITING,0.062884,0.34415,0.27901,0,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.13885,0.34321,0.21995,0,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.077559,0.3411,0.28636,0,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.091819,0.33694,0.34057,0,1
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.094909,0.33641,0.2542,0,1
3,GO ADAPTIVE IMMUNE RESPONSE,0.080256,0.33575,0.29296,0,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.20256,0.33573,0.23143,0,1
3,GO CELLULAR EXTRAVASATION,0.052482,0.33567,0.29001,0,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.08881,0.33122,0.38192,0,1
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.060677,0.33073,0.30883,0,1
3,GO REGULATION OF NEUTROPHIL ACTIVATION,0.067497,0.32854,0.35557,0,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.08881,0.3275,0.25952,0,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.098083,0.32522,0.24605,0,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.08881,0.32453,0.30258,0,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.058535,0.32441,0.29339,0,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.062884,0.32435,0.26829,0,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.13467,0.3239,0.20861,0,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.094909,0.32383,0.29102,0,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.077559,0.32337,0.29719,0,1
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.062884,0.32331,0.35262,0,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.11894,0.32269,0.25551,0,1
3,GO PENILE ERECTION,0.10468,0.3208,0.23332,0,1
3,GO REGULATION OF RECEPTOR CLUSTERING,0.11894,0.32044,0.21081,0,1
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.062884,0.31994,0.20247,0,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.091819,0.31828,0.28581,0,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.15197,0.3161,0.2205,0,1
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.056456,0.31571,0.28045,0,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.08303,0.31532,0.2438,0,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.069906,0.31446,0.28324,0,1
3,GO B CELL PROLIFERATION,0.050584,0.31399,0.35556,0,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.10811,0.31343,0.21343,0,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.060677,0.31333,0.25422,0,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.10134,0.31286,0.24977,0,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.065157,0.31259,0.29507,0,1
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.054439,0.31255,0.22325,0,1
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.11524,0.30919,0.25333,0,1
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.20822,0.30911,0.23418,0,1
3,GO LIMB BUD FORMATION,0.056456,0.30869,0.26807,0,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.067497,0.30726,0.25744,0,1
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.08588,0.30682,0.20453,0,1
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.08303,0.30673,0.26193,0,1
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.12273,0.30569,0.25334,0,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.20256,0.30548,0.21381,0,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.10468,0.30538,0.21675,0,1
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.080256,0.3051,0.308,0,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.094909,0.30293,0.25656,0,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.18624,0.30287,0.20954,0,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.08881,0.30151,0.22339,0,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.058535,0.30088,0.27939,0,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.060677,0.30067,0.29229,0,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.060677,0.30004,0.28035,0,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.11894,0.2997,0.22692,0,1
3,GO T CELL DIFFERENTIATION IN THYMUS,0.050584,0.29821,0.25793,0,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.080256,0.29772,0.23228,0,1
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.091819,0.2975,0.25386,0,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.091819,0.29691,0.28748,0,1
3,GO T CELL ACTIVATION,0.050584,0.29585,0.2633,0,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.12273,0.29552,0.25385,0,1
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.074935,0.29364,0.20034,0,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.08303,0.29347,0.20933,0,1
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.43329,0.29222,0.15559,0,1
3,GO GLIAL CELL PROLIFERATION,0.072385,0.29161,0.17097,0,1
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.08881,0.29101,0.25165,0,1
3,GO LYMPHANGIOGENESIS,0.16602,0.29094,0.16275,0,1
3,GO CYTOLYSIS,0.214,0.29036,0.21725,0,1
3,GO LEUKOCYTE CELL CELL ADHESION,0.062884,0.29025,0.25302,0,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.050584,0.28959,0.2118,0,1
3,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.214,0.28879,0.18209,0,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.077559,0.28805,0.23709,0,1
3,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.16602,0.28551,0.27719,0,1
3,GO MALE SEX DETERMINATION,0.056456,0.28547,0.24865,0,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.050584,0.28543,0.26905,0,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.052482,0.28524,0.27037,0,1
3,GO RESPONSE TO INTERFERON GAMMA,0.20256,0.28451,0.19838,0,1
3,GO LYMPH VESSEL DEVELOPMENT,0.091819,0.28436,0.21882,0,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.13885,0.28412,0.23536,0,1
3,GO T CELL PROLIFERATION,0.060677,0.28233,0.26481,0,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.1306,0.28178,0.21258,0,1
3,GO INTEGRIN ACTIVATION,0.062884,0.28122,0.27243,0,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.091819,0.28108,0.22422,0,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.067497,0.28081,0.24612,0,1
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.060677,0.28005,0.26737,0,1
3,GO CARDIAC ATRIUM DEVELOPMENT,0.054439,0.27981,0.21724,0,1
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.091819,0.27933,0.23913,0,1
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.38829,0.27792,0.13183,0,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.10134,0.27746,0.22616,0,1
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.062884,0.27742,0.25098,0,1
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.060677,0.27694,0.26977,0,1
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.08303,0.27588,0.1638,0,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.072385,0.27566,0.26968,0,1
3,GO REGULATION OF CELL ACTIVATION,0.054439,0.27522,0.25813,0,1
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.060677,0.27507,0.21795,0,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.11524,0.27505,0.23172,0,1
3,GO DETECTION OF OTHER ORGANISM,0.36271,0.27375,0.17267,0,1
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.052482,0.27356,0.18512,0,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.16123,0.27341,0.19288,0,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.15655,0.27337,0.24767,0,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.13885,0.27284,0.23858,0,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.12662,0.27156,0.17838,0,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.08588,0.27151,0.20112,0,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.08588,0.27097,0.30115,0,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.10468,0.27048,0.25264,0,1
3,GO LYMPHOCYTE MIGRATION,0.11163,0.26976,0.2537,0,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.091819,0.26962,0.23708,0,1
3,GO B CELL MEDIATED IMMUNITY,0.10468,0.26898,0.26747,0,1
3,GO MULTI ORGANISM CELLULAR PROCESS,0.069906,0.26869,0.23191,0,1
3,GO PULMONARY VALVE DEVELOPMENT,0.065157,0.2679,0.23607,0,1
3,GO MITRAL VALVE DEVELOPMENT,0.1306,0.26788,0.18279,0,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.050584,0.26688,0.25365,0,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.052482,0.26646,0.24742,0,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.058535,0.26635,0.2713,0,1
3,GO AXONEME ASSEMBLY,0.060677,0.26617,0.19124,0,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.11524,0.26555,0.22552,0,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.062884,0.2649,0.19385,0,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.060677,0.26443,0.27341,0,1
3,GO LEUKOCYTE PROLIFERATION,0.060677,0.26398,0.2667,0,1
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.058535,0.2629,0.2307,0,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.10811,0.26243,0.22374,0,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.10468,0.26236,0.24254,0,1
3,GO ACTIVATED T CELL PROLIFERATION,0.072385,0.26119,0.22214,0,1
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.15655,0.26064,0.23085,0,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.098083,0.26039,0.23986,0,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.11163,0.26015,0.21594,0,1
3,GO REGULATION OF MYOBLAST FUSION,0.20256,0.25966,0.20399,0,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.1306,0.25955,0.23288,0,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.13885,0.25912,0.17299,0,1
3,GO COPULATION,0.11894,0.25883,0.16047,0,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.052482,0.25847,0.23893,0,1
3,GO MICROTUBULE SEVERING,0.080256,0.25831,0.16727,0,1
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.069906,0.25794,0.20791,0,1
3,GO INTERFERON GAMMA PRODUCTION,0.1306,0.25581,0.25507,0,1
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.11163,0.25562,0.213,0,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.056456,0.25545,0.20964,0,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.11163,0.25471,0.23472,0,1
3,GO FAT CELL PROLIFERATION,0.10134,0.25349,0.17271,0,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.11524,0.25313,0.17292,0,1
3,GO SPROUTING ANGIOGENESIS,0.062884,0.25294,0.17981,0,1
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.069906,0.25255,0.26414,0,1
3,GO IMMUNOGLOBULIN PRODUCTION,0.056456,0.25038,0.25105,0,1
3,GO T CELL MIGRATION,0.091819,0.25032,0.28923,0,1
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.18102,0.24854,0.22178,0,1
3,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.10134,0.2483,0.1865,0,1
3,GO REGULATION OF CELL CELL ADHESION,0.052482,0.24751,0.23656,0,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.18624,0.24715,0.19771,0,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.16123,0.24687,0.25698,0,1
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.052482,0.24511,0.2205,0,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.08881,0.24498,0.2003,0,1
3,GO INTERLEUKIN 17 PRODUCTION,0.25111,0.24479,0.17436,0,1
3,GO ACTIVATION OF IMMUNE RESPONSE,0.067497,0.24448,0.21561,0,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.10811,0.24443,0.20389,0,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.094909,0.2443,0.19184,0,1
3,GO REGULATION OF IMMUNE RESPONSE,0.08881,0.24427,0.20125,0,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.17091,0.24369,0.20899,0,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.077559,0.24355,0.17637,0,1
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.1306,0.24325,0.16467,0,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.091819,0.24312,0.21875,0,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.091819,0.24243,0.20567,0,1
3,GO T CELL APOPTOTIC PROCESS,0.19156,0.2423,0.16386,0,1
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.072385,0.24216,0.16882,0,1
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.058535,0.24189,0.28733,0,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.077559,0.24166,0.2134,0,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.080256,0.24073,0.17395,0,1
3,GO ACROSOME ASSEMBLY,0.054439,0.23924,0.17001,0,1
3,GO CELLULAR RESPONSE TO VITAMIN,0.214,0.2384,0.1573,0,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.094909,0.23804,0.20503,0,1
3,GO AMINO SUGAR CATABOLIC PROCESS,0.2259,0.23779,0.19345,0,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.27821,0.23777,0.13658,0,1
3,GO MACROPHAGE DIFFERENTIATION,0.08881,0.2369,0.22155,0,1
3,GO LYMPH VESSEL MORPHOGENESIS,0.16123,0.23588,0.16216,0,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.074935,0.23588,0.21661,0,1
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.080256,0.23565,0.2458,0,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.094909,0.23394,0.23191,0,1
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.050584,0.23369,0.19677,0,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.214,0.23353,0.18037,0,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.077559,0.23329,0.21378,0,1
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.12662,0.23324,0.20305,0,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.098083,0.23203,0.18532,0,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.11163,0.23191,0.22084,0,1
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.12662,0.23189,0.16042,0,1
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.069906,0.23189,0.21961,0,1
3,GO RESPONSE TO INACTIVITY,0.077559,0.23188,0.16689,0,1
3,GO LEUKOCYTE HOMEOSTASIS,0.08588,0.23143,0.22094,0,1
3,GO REGULATION OF PLATELET AGGREGATION,0.091819,0.23109,0.19082,0,1
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.080256,0.23099,0.19429,0,1
3,GO CARDIAC CELL FATE COMMITMENT,0.058535,0.22891,0.17453,0,1
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.1475,0.22826,0.22105,0,1
3,GO REGULATION OF EXCRETION,0.056456,0.22722,0.18333,0,1
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.17091,0.22707,0.20435,0,1
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.1475,0.22653,0.18409,0,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.058535,0.2262,0.24266,0,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.54223,0.22602,0.1204,0,1
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.18624,0.22598,0.11671,0,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.10811,0.22509,0.20649,0,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.074935,0.22501,0.18696,0,1
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.08303,0.22448,0.19641,0,1
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.26442,0.22417,0.15001,0,1
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.15197,0.22364,0.2113,0,1
3,GO AORTA MORPHOGENESIS,0.1306,0.22337,0.14897,0,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.14312,0.22272,0.16218,0,1
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.23203,0.22248,0.15182,0,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.13885,0.22195,0.22644,0,1
3,GO AMYLOID FIBRIL FORMATION,0.13885,0.22185,0.16737,0,1
3,GO NEURONAL ACTION POTENTIAL,0.10134,0.22168,0.14278,0,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.08303,0.22136,0.26081,0,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.074935,0.22082,0.15872,0,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.14312,0.21892,0.21693,0,1
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.077559,0.21883,0.23898,0,1
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.11163,0.21846,0.15216,0,1
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.24463,0.21791,0.2348,0,1
3,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.08881,0.21775,0.25523,0,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.08588,0.21737,0.19848,0,1
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.056456,0.21697,0.19986,0,1
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.056456,0.21681,0.22219,0,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.074935,0.21652,0.15225,0,1
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.074935,0.21632,0.21148,0,1
3,GO VASCULAR WOUND HEALING,0.1475,0.21619,0.18204,0,1
3,GO DEFENSE RESPONSE TO VIRUS,0.21989,0.21615,0.14317,0,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.20256,0.21574,0.14223,0,1
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.1475,0.2153,0.20892,0,1
3,GO METANEPHROS MORPHOGENESIS,0.067497,0.21496,0.16386,0,1
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.091819,0.21448,0.17803,0,1
3,GO ATRIAL SEPTUM DEVELOPMENT,0.052482,0.214,0.22913,0,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.098083,0.21278,0.17891,0,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.065157,0.21266,0.20201,0,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.10811,0.21228,0.14616,0,1
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.067497,0.21213,0.18488,0,1
3,GO PSEUDOPODIUM ORGANIZATION,0.21989,0.21144,0.13683,0,1
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.094909,0.21141,0.25264,0,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.072385,0.21128,0.16934,0,1
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.29248,0.21125,0.14101,0,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.18102,0.21109,0.13305,0,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.29248,0.21081,0.11356,0,1
3,GO INTERFERON BETA PRODUCTION,0.052482,0.21079,0.21393,0,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.1306,0.21051,0.15811,0,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.069906,0.20992,0.21638,0,1
3,GO CELLULAR RESPONSE TO VIRUS,0.094909,0.20912,0.17203,0,1
3,GO INTERFERON ALPHA PRODUCTION,0.1475,0.2086,0.17758,0,1
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.08881,0.20843,0.19426,0,1
3,GO CARNITINE SHUTTLE,0.072385,0.2075,0.183,0,1
3,GO REGULATION OF RECEPTOR BINDING,0.058535,0.20713,0.23522,0,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.1306,0.20698,0.22266,0,1
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.098083,0.20697,0.1688,0,1
3,GO MEMBRANE RAFT ORGANIZATION,0.13467,0.20692,0.19323,0,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.15655,0.20673,0.16193,0,1
3,GO TRABECULA MORPHOGENESIS,0.080256,0.20652,0.19831,0,1
3,GO CELL ADHESION MOLECULE PRODUCTION,0.15197,0.20572,0.17714,0,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.10811,0.20564,0.21884,0,1
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.08881,0.20514,0.18341,0,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.1306,0.20508,0.18686,0,1
3,GO INNATE IMMUNE RESPONSE,0.16123,0.20472,0.15036,0,1
3,GO AMINE CATABOLIC PROCESS,0.15655,0.20438,0.15551,0,1
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.062884,0.20426,0.15093,0,1
3,GO RESPONSE TO HYDROPEROXIDE,0.08303,0.20415,0.1998,0,1
3,GO ERK1 AND ERK2 CASCADE,0.060677,0.20382,0.20308,0,1
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.1475,0.20355,0.1927,0,1
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.050584,0.20337,0.18101,0,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.2259,0.20293,0.095397,0,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.17591,0.20259,0.17964,0,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.074935,0.2023,0.15148,0,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.1306,0.20209,0.2104,0,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.050584,0.20206,0.22916,0,1
3,GO RESPONSE TO FLUID SHEAR STRESS,0.1306,0.20129,0.18104,0,1
3,GO MYOTUBE DIFFERENTIATION,0.077559,0.20097,0.15491,0,1
3,GO DOSAGE COMPENSATION,0.091819,0.20094,0.18011,0,1
3,GO REGULATION OF RESPONSE TO FOOD,0.067497,0.20066,0.14761,0,1
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.060677,0.20066,0.20276,0,1
3,GO REGULATION OF TISSUE REMODELING,0.11524,0.20062,0.204,0,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.074935,0.20051,0.16204,0,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.060677,0.20047,0.22191,0,1
3,GO LOCOMOTOR RHYTHM,0.072385,0.20027,0.22584,0,1
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.052482,0.19976,0.15778,0,1
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.2577,0.19955,0.18666,0,1
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.072385,0.19895,0.21039,0,1
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.21989,0.19825,0.13858,0,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.077559,0.19805,0.21117,0,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.1306,0.19802,0.19844,0,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.062884,0.19796,0.24488,0,1
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.10468,0.19791,0.14815,0,1
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.08881,0.19786,0.16167,0,1
3,GO B CELL DIFFERENTIATION,0.052482,0.1978,0.26145,0,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.094909,0.1973,0.19187,0,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.062884,0.19724,0.18827,0,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.08588,0.19688,0.17031,0,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.17591,0.19686,0.19069,0,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.16602,0.19607,0.16117,0,1
3,GO REGULATION OF BONE REMODELING,0.091819,0.196,0.20912,0,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.2998,0.19598,0.081966,0,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.60692,0.1959,0.077054,0,1
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.054439,0.19539,0.19444,0,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.1475,0.19508,0.14076,0,1
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.069906,0.19506,0.15984,0,1
3,GO REGULATION OF ODONTOGENESIS,0.17591,0.19496,0.13595,0,1
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.16602,0.19471,0.1575,0,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.17091,0.19459,0.16419,0,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.077559,0.19455,0.19464,0,1
3,GO POSITIVE CHEMOTAXIS,0.20822,0.19451,0.11804,0,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.091819,0.19401,0.14391,0,1
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.1475,0.19344,0.16163,0,1
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11524,0.19321,0.12696,0,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.072385,0.1932,0.16342,0,1
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.091819,0.1931,0.18032,0,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.094909,0.1928,0.19975,0,1
3,GO RESPONSE TO VIRUS,0.18624,0.19278,0.13502,0,1
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.16123,0.19273,0.18398,0,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.11894,0.192,0.11712,0,1
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.058535,0.19193,0.20789,0,1
3,GO RESPONSE TO COCAINE,0.065157,0.19153,0.16779,0,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.072385,0.19117,0.20736,0,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.054439,0.19115,0.24281,0,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.058535,0.19087,0.21623,0,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.10468,0.19023,0.27748,0,1
3,GO SERTOLI CELL DEVELOPMENT,0.067497,0.18892,0.18204,0,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.065157,0.18869,0.22894,0,1
3,GO PRO B CELL DIFFERENTIATION,0.11524,0.18851,0.16824,0,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.28529,0.18843,0.093759,0,1
3,GO REPLACEMENT OSSIFICATION,0.16123,0.18826,0.118,0,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.1306,0.18826,0.19351,0,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.065157,0.18774,0.20203,0,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.080256,0.18733,0.17118,0,1
3,GO RESPONSE TO UV B,0.060677,0.18697,0.096063,0,1
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.08303,0.18681,0.13928,0,1
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.17591,0.18667,0.15694,0,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.067497,0.18645,0.15781,0,1
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.1475,0.18644,0.1892,0,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.08588,0.18604,0.18553,0,1
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.12273,0.18604,0.15229,0,1
3,GO REGULATION OF PINOCYTOSIS,0.11894,0.1855,0.17271,0,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.08588,0.18518,0.17343,0,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.11524,0.18462,0.13128,0,1
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.11524,0.18451,0.21626,0,1
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.32248,0.18426,0.12146,0,1
3,GO BLOOD VESSEL REMODELING,0.054439,0.1839,0.22085,0,1
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.072385,0.18387,0.22119,0,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.12662,0.18337,0.15866,0,1
3,GO REGULATION OF CHEMOTAXIS,0.14312,0.1832,0.16627,0,1
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.060677,0.1831,0.12391,0,1
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.16123,0.18279,0.16696,0,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.060677,0.18255,0.18531,0,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.21989,0.18243,0.14584,0,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.10811,0.18241,0.13758,0,1
3,GO OSTEOCLAST DIFFERENTIATION,0.16123,0.18211,0.16415,0,1
3,GO RESPONSE TO VITAMIN,0.11524,0.18209,0.14494,0,1
3,GO NOSE DEVELOPMENT,0.17091,0.1817,0.18594,0,1
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.10811,0.18154,0.15648,0,1
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.11894,0.18145,0.1456,0,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.21989,0.18113,0.1185,0,1
3,GO REGULATION OF LIPASE ACTIVITY,0.1475,0.18028,0.13285,0,1
3,GO ADRENAL GLAND DEVELOPMENT,0.18102,0.17997,0.15212,0,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.060677,0.17978,0.18061,0,1
3,GO BONE RESORPTION,0.08303,0.1797,0.21451,0,1
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.12273,0.17959,0.16934,0,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.058535,0.17955,0.21335,0,1
3,GO CELL ACTIVATION,0.074935,0.17882,0.19505,0,1
3,GO GLOMERULUS DEVELOPMENT,0.214,0.17836,0.15055,0,1
3,GO PITUITARY GLAND DEVELOPMENT,0.072385,0.17818,0.14007,0,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.08881,0.17811,0.2264,0,1
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.056456,0.17808,0.16142,0,1
3,GO CELLULAR RESPONSE TO NUTRIENT,0.16123,0.17778,0.14609,0,1
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.10811,0.17738,0.14608,0,1
3,GO CHONDROCYTE PROLIFERATION,0.27821,0.17679,0.1242,0,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.052482,0.17631,0.20151,0,1
3,GO RESPONSE TO VITAMIN D,0.16123,0.1763,0.14215,0,1
3,GO PANCREATIC JUICE SECRETION,0.080256,0.17539,0.19492,0,1
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.11163,0.17519,0.13249,0,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.2259,0.17497,0.15583,0,1
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.18624,0.17485,0.15966,0,1
3,GO MYELIN MAINTENANCE,0.098083,0.17393,0.20701,0,1
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.054439,0.17329,0.18981,0,1
3,GO REGULATION OF TELOMERE CAPPING,0.10134,0.17292,0.16685,0,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.050584,0.17281,0.23838,0,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.056456,0.17275,0.23877,0,1
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.15655,0.17262,0.13923,0,1
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.23203,0.17261,0.18705,0,1
3,GO ENDOCARDIUM DEVELOPMENT,0.11894,0.17216,0.10887,0,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.1475,0.17176,0.089359,0,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.074935,0.17173,0.31557,0,1
3,GO HEAD MORPHOGENESIS,0.2577,0.17146,0.15419,0,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.12662,0.17115,0.18339,0,1
3,GO IMMUNE EFFECTOR PROCESS,0.14312,0.17106,0.15671,0,1
3,GO REGULATION OF PLATELET ACTIVATION,0.18102,0.17103,0.20969,0,1
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.25111,0.17088,0.15271,0,1
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.18102,0.17067,0.16473,0,1
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.08881,0.17048,0.17179,0,1
3,GO PROGRAMMED NECROTIC CELL DEATH,0.15655,0.17015,0.14591,0,1
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.11524,0.16986,0.17576,0,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.10468,0.1698,0.29491,0,1
3,GO RESPONSE TO FOOD,0.065157,0.16956,0.13515,0,1
3,GO CELL JUNCTION ASSEMBLY,0.058535,0.16936,0.18015,0,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.08588,0.16927,0.1732,0,1
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.34626,0.16897,0.089874,0,1
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.056456,0.16893,0.14526,0,1
3,GO REGULATION OF DEFENSE RESPONSE,0.11894,0.1689,0.14558,0,1
3,GO CARDIAC SEPTUM DEVELOPMENT,0.067497,0.16879,0.19123,0,1
3,GO MYELOID CELL DIFFERENTIATION,0.050584,0.16879,0.18179,0,1
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.16602,0.16877,0.1638,0,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.072385,0.16863,0.17136,0,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.077559,0.16859,0.18805,0,1
3,GO TELOMERE CAPPING,0.080256,0.16853,0.15878,0,1
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.2259,0.16842,0.13692,0,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.28529,0.16838,0.14153,0,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.054439,0.16761,0.15668,0,1
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.38829,0.16747,0.095183,0,1
3,GO CYTOKINE PRODUCTION,0.12662,0.16745,0.1699,0,1
3,GO MYOBLAST DIFFERENTIATION,0.13467,0.16715,0.12032,0,1
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.13467,0.16662,0.11721,0,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.33029,0.1662,0.13978,0,1
3,GO TROPHOBLAST CELL MIGRATION,0.214,0.1662,0.12441,0,1
3,GO CHONDROCYTE DIFFERENTIATION,0.080256,0.16601,0.19192,0,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.15655,0.16599,0.16434,0,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.10811,0.16594,0.12763,0,1
3,GO AMINO ACID IMPORT,0.056456,0.16577,0.16262,0,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.1306,0.16533,0.17699,0,1
3,GO AORTA DEVELOPMENT,0.091819,0.16497,0.20292,0,1
3,GO DNA REPLICATION CHECKPOINT,0.214,0.16451,0.11373,0,1
3,GO REGULATION OF CELL ADHESION,0.056456,0.1645,0.22018,0,1
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.30724,0.16444,0.12344,0,1
3,GO CILIUM MOVEMENT,0.10811,0.16426,0.12108,0,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.16123,0.16392,0.11457,0,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.15655,0.16389,0.12156,0,1
3,GO REGULATION OF CALCIUM ION IMPORT,0.20256,0.16341,0.13837,0,1
3,GO CELL FATE DETERMINATION,0.056456,0.16312,0.14122,0,1
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.08303,0.16307,0.1691,0,1
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.23827,0.16293,0.10548,0,1
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.12662,0.16236,0.16284,0,1
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.13885,0.16221,0.13998,0,1
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.067497,0.16199,0.16353,0,1
3,GO RESPONSE TO FATTY ACID,0.10468,0.16135,0.13611,0,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.16123,0.16112,0.15014,0,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.060677,0.16101,0.19622,0,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.13885,0.16088,0.13985,0,1
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.056456,0.16052,0.18606,0,1
3,GO REGULATION OF ACTIN NUCLEATION,0.060677,0.16052,0.15598,0,1
3,GO REGULATION OF HAIR CYCLE,0.26442,0.16047,0.073926,0,1
3,GO SPINDLE LOCALIZATION,0.1475,0.15954,0.14009,0,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.21989,0.15936,0.11966,0,1
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.052482,0.15929,0.18118,0,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.077559,0.15925,0.13418,0,1
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.12273,0.15911,0.18394,0,1
3,GO CYTOKINE METABOLIC PROCESS,0.34626,0.159,0.13169,0,1
3,GO NIK NF KAPPAB SIGNALING,0.10134,0.15871,0.13547,0,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.2259,0.15813,0.13607,0,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10811,0.15801,0.19595,0,1
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.058535,0.15777,0.17138,0,1
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.10468,0.15768,0.1642,0,1
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.15655,0.1574,0.13015,0,1
3,GO REGULATION OF DENDRITE EXTENSION,0.060677,0.15738,0.18891,0,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.08303,0.15699,0.19937,0,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.11894,0.15681,0.13282,0,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.15197,0.15674,0.12251,0,1
3,GO COBALAMIN METABOLIC PROCESS,0.052482,0.1566,0.17381,0,1
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.098083,0.15605,0.1075,0,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.11894,0.15591,0.17932,0,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.51122,0.15559,0.068308,0,1
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.13467,0.1555,0.10135,0,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.058535,0.15549,0.14537,0,1
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.062884,0.15546,0.18282,0,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.067497,0.15545,0.18972,0,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.052482,0.15532,0.21411,0,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.062884,0.15519,0.22768,0,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.058535,0.15434,0.18717,0,1
3,GO RENAL SODIUM EXCRETION,0.12662,0.15419,0.16026,0,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.19156,0.15415,0.1436,0,1
3,GO REGULATION OF TUBULIN DEACETYLATION,0.08303,0.15406,0.15887,0,1
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.16602,0.15348,0.18099,0,1
3,GO DEFENSE RESPONSE,0.17591,0.15342,0.14387,0,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.056456,0.15279,0.16704,0,1
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.054439,0.15237,0.17383,0,1
3,GO MATERNAL PLACENTA DEVELOPMENT,0.19156,0.15202,0.15996,0,1
3,GO ENDOTHELIAL CELL PROLIFERATION,0.08303,0.15115,0.17246,0,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.11524,0.1509,0.17922,0,1
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.2259,0.15061,0.13343,0,1
3,GO REGULATION OF BIOMINERALIZATION,0.15197,0.1506,0.14177,0,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.054439,0.15049,0.19055,0,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.062884,0.1504,0.18046,0,1
3,GO OXIDATIVE DEMETHYLATION,0.11163,0.15021,0.11163,0,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.30724,0.14966,0.10318,0,1
3,GO REGULATION OF CELLULAR PH,0.056456,0.1496,0.13934,0,1
3,GO POSITIVE REGULATION OF CELL AGING,0.074935,0.14944,0.12609,0,1
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.098083,0.14943,0.14899,0,1
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.15655,0.14903,0.14533,0,1
3,GO RESPONSE TO LEPTIN,0.056456,0.14889,0.12731,0,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.050584,0.14847,0.18445,0,1
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.08588,0.14804,0.15221,0,1
3,GO MITOCHONDRIAL DEPOLARIZATION,0.11524,0.14782,0.17826,0,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.18102,0.14739,0.13788,0,1
3,GO FIBROBLAST ACTIVATION,0.33821,0.14703,0.10486,0,1
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.11524,0.14699,0.1474,0,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.094909,0.14682,0.17761,0,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.20256,0.14674,0.12827,0,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.12662,0.14663,0.1591,0,1
3,GO RESPONSE TO BMP,0.065157,0.14635,0.17957,0,1
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.11894,0.14606,0.16616,0,1
3,GO CELLULAR RESPONSE TO KETONE,0.08881,0.14573,0.1383,0,1
3,GO RESPONSE TO BIOTIC STIMULUS,0.214,0.14564,0.12528,0,1
3,GO DNA RECOMBINATION,0.11524,0.1446,0.12255,0,1
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.1306,0.14458,0.12674,0,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.51122,0.14454,0.08098,0,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.21989,0.14443,0.13815,0,1
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.062884,0.14431,0.16729,0,1
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.19156,0.14418,0.12356,0,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.10811,0.14398,0.16264,0,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.077559,0.14345,0.12441,0,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.098083,0.14339,0.1572,0,1
3,GO SPERM MOTILITY,0.14312,0.1425,0.10843,0,1
3,GO CELL CELL RECOGNITION,0.069906,0.14236,0.13014,0,1
3,GO RESPONSE TO CAMP,0.056456,0.14226,0.15473,0,1
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.2998,0.14216,0.10901,0,1
3,GO MUSCLE HYPERTROPHY,0.091819,0.14205,0.13421,0,1
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.067497,0.14159,0.16822,0,1
3,GO THYMUS DEVELOPMENT,0.050584,0.14144,0.13333,0,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.16602,0.14109,0.16433,0,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.15655,0.14087,0.16227,0,1
3,GO LIPID OXIDATION,0.098083,0.14075,0.1127,0,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.054439,0.1406,0.17538,0,1
3,GO MICROTUBULE BASED PROCESS,0.058535,0.14059,0.16345,0,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.15655,0.14057,0.12789,0,1
3,GO SYNCYTIUM FORMATION,0.08588,0.14056,0.20348,0,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.072385,0.14054,0.12196,0,1
3,GO INACTIVATION OF MAPK ACTIVITY,0.13885,0.14052,0.14243,0,1
3,GO MUSCLE CELL PROLIFERATION,0.2577,0.14008,0.10726,0,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.14312,0.13972,0.16076,0,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.15197,0.13968,0.13953,0,1
3,GO DIGESTION,0.069906,0.13966,0.13336,0,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.08588,0.13912,0.13252,0,1
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.35442,0.13818,0.11747,0,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.24463,0.13815,0.1246,0,1
3,GO RESPONSE TO CYTOKINE,0.15655,0.13813,0.14482,0,1
3,GO CRANIAL NERVE DEVELOPMENT,0.18624,0.13768,0.14473,0,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.25111,0.13747,0.1304,0,1
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.077559,0.13739,0.11912,0,1
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.091819,0.13735,0.25459,0,1
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.052482,0.13697,0.17352,0,1
3,GO HOMOTYPIC CELL CELL ADHESION,0.091819,0.13687,0.184,0,1
3,GO REGULATION OF CELL AGING,0.067497,0.13619,0.10271,0,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.15197,0.13618,0.16858,0,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.11524,0.13602,0.13998,0,1
3,GO GERM CELL DEVELOPMENT,0.062884,0.13551,0.12584,0,1
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.197,0.13539,0.099791,0,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.197,0.13534,0.12749,0,1
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.077559,0.13533,0.15147,0,1
3,GO DNA PACKAGING,0.08588,0.13518,0.1465,0,1
3,GO BLOOD VESSEL MORPHOGENESIS,0.14312,0.13486,0.1648,0,1
3,GO APPENDAGE MORPHOGENESIS,0.054439,0.13476,0.18576,0,1
3,GO REGULATION OF NECROTIC CELL DEATH,0.08588,0.13459,0.14218,0,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.072385,0.13451,0.18584,0,1
3,GO MUSCLE ADAPTATION,0.094909,0.13435,0.14082,0,1
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.16123,0.13422,0.14409,0,1
3,GO PEPTIDE CATABOLIC PROCESS,0.058535,0.13413,0.20302,0,1
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.08303,0.13349,0.19352,0,1
3,GO RESPONSE TO RETINOIC ACID,0.072385,0.13317,0.17074,0,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.11163,0.13309,0.12923,0,1
3,GO V D J RECOMBINATION,0.2577,0.1329,0.10551,0,1
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.091819,0.13275,0.14823,0,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.091819,0.13257,0.16131,0,1
3,GO RESPONSE TO AMINE,0.10468,0.13245,0.10513,0,1
3,GO TONGUE DEVELOPMENT,0.60692,0.1324,0.043036,0,1
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.18624,0.13231,0.091856,0,1
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.20822,0.1323,0.15846,0,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.067497,0.13203,0.17339,0,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.054439,0.13154,0.14419,0,1
3,GO CELL VOLUME HOMEOSTASIS,0.065157,0.13148,0.17801,0,1
3,GO MYELOID CELL HOMEOSTASIS,0.060677,0.13142,0.1356,0,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.069906,0.13137,0.12863,0,1
3,GO ARTERY MORPHOGENESIS,0.25111,0.13129,0.13318,0,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.069906,0.13121,0.17103,0,1
3,GO SOMITE DEVELOPMENT,0.08881,0.13118,0.14901,0,1
3,GO MESENCHYME MORPHOGENESIS,0.1306,0.13109,0.15908,0,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.060677,0.13102,0.19258,0,1
3,GO SPINDLE ORGANIZATION,0.12273,0.131,0.13025,0,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.16123,0.13096,0.15236,0,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.32248,0.13095,0.11662,0,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.14312,0.13088,0.13292,0,1
3,GO ENDOTHELIAL CELL MIGRATION,0.20822,0.13082,0.14336,0,1
3,GO ARTERY DEVELOPMENT,0.1475,0.13057,0.16976,0,1
3,GO EAR DEVELOPMENT,0.054439,0.13049,0.15962,0,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.1306,0.13039,0.15442,0,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.2259,0.13028,0.11967,0,1
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.072385,0.12999,0.16597,0,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.094909,0.12991,0.19279,0,1
3,GO RESPONSE TO NUTRIENT,0.077559,0.12984,0.14709,0,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.10134,0.12962,0.13555,0,1
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.2998,0.12923,0.098932,0,1
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.060677,0.12883,0.16067,0,1
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.1306,0.12868,0.13711,0,1
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.091819,0.12867,0.13395,0,1
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.060677,0.12828,0.20706,0,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.056456,0.12828,0.12351,0,1
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.067497,0.12811,0.20738,0,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.21989,0.12803,0.12637,0,1
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.197,0.12786,0.11831,0,1
3,GO RESPONSE TO LIPID,0.11894,0.12786,0.13537,0,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.050584,0.12775,0.17024,0,1
3,GO RUFFLE ORGANIZATION,0.1475,0.1272,0.15224,0,1
3,GO HEART MORPHOGENESIS,0.058535,0.1272,0.17321,0,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.33821,0.127,0.094502,0,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.26442,0.12631,0.097761,0,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.25111,0.12521,0.11014,0,1
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.1475,0.12502,0.16083,0,1
3,GO ROOF OF MOUTH DEVELOPMENT,0.12273,0.12493,0.14151,0,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.15655,0.12471,0.12318,0,1
3,GO HISTONE PHOSPHORYLATION,0.069906,0.12439,0.13625,0,1
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.058535,0.12381,0.16811,0,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.37111,0.12379,0.091918,0,1
3,GO NEPHRON TUBULE FORMATION,0.57414,0.12368,-0.013817,0,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.32248,0.12364,0.12531,0,1
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.072385,0.1235,0.13556,0,1
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.08588,0.1231,0.17294,0,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.37964,0.12302,0.048776,0,1
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.072385,0.12297,0.10652,0,1
3,GO CELL CELL JUNCTION ORGANIZATION,0.11163,0.12278,0.14177,0,1
3,GO RESPONSE TO HORMONE,0.054439,0.12271,0.14587,0,1
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.27126,0.12263,0.07371,0,1
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.050584,0.12261,0.17573,0,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.16123,0.1225,0.098243,0,1
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.094909,0.12232,0.13266,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.18102,0.12224,0.11917,0,1
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.091819,0.12211,0.12721,0,1
3,GO ODONTOGENESIS,0.16602,0.1221,0.14954,0,1
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.10134,0.12206,0.16598,0,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.28529,0.122,0.14639,0,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.2577,0.12188,0.19241,0,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.48117,0.12157,0.082104,0,1
3,GO ERYTHROCYTE DEVELOPMENT,0.054439,0.12119,0.16329,0,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.32248,0.12109,0.097731,0,1
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.42405,0.12091,0.078001,0,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.058535,0.12081,0.19787,0,1
3,GO HYALURONAN METABOLIC PROCESS,0.3148,0.12073,0.10492,0,1
3,GO REGULATION OF LIPID LOCALIZATION,0.08588,0.1207,0.15579,0,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.072385,0.12062,0.13179,0,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.054439,0.11998,0.16928,0,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.08881,0.11994,0.13812,0,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.065157,0.11967,0.14911,0,1
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.058535,0.11965,0.19967,0,1
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.2259,0.11961,0.097057,0,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.067497,0.11935,0.16324,0,1
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.15197,0.11924,0.18863,0,1
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.1306,0.11923,0.087263,0,1
3,GO SENSORY PERCEPTION OF SMELL,0.10811,0.11911,0.08465,0,1
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.46168,0.11902,0.02034,0,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.050584,0.11863,0.15429,0,1
3,GO ACTIN MEDIATED CELL CONTRACTION,0.10134,0.1185,0.12618,0,1
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.10811,0.11836,0.14178,0,1
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.094909,0.11821,0.15832,0,1
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.23203,0.11809,0.13192,0,1
3,GO VACUOLAR ACIDIFICATION,0.27126,0.11783,0.097711,0,1
3,GO REGULATION OF DNA RECOMBINATION,0.065157,0.11723,0.15683,0,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.12273,0.11721,0.15547,0,1
3,GO REGULATION OF GASTRULATION,0.37964,0.11713,0.098495,0,1
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.14312,0.11712,0.11083,0,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.058535,0.11696,0.18675,0,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.08303,0.11655,0.12702,0,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.08303,0.116,0.10381,0,1
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.18102,0.11552,0.14089,0,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.077559,0.11498,0.14432,0,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.20256,0.11469,0.13563,0,1
3,GO SPINDLE ASSEMBLY,0.13885,0.11468,0.11956,0,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.058535,0.11429,0.16075,0,1
3,GO CARDIAC CHAMBER DEVELOPMENT,0.10811,0.11411,0.15646,0,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.20256,0.11384,0.13803,0,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.27821,0.11373,0.077122,0,1
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.074935,0.11372,0.14159,0,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.20256,0.11327,0.093477,0,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.16602,0.1132,0.15061,0,1
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.20256,0.11318,0.17084,0,1
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.08303,0.11272,0.17846,0,1
3,GO RESPONSE TO STEROID HORMONE,0.16123,0.11267,0.1243,0,1
3,GO GAMETE GENERATION,0.077559,0.11264,0.12422,0,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.074935,0.11179,0.13271,0,1
3,GO RESPONSE TO KETONE,0.094909,0.11152,0.13824,0,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.067497,0.11117,0.1123,0,1
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.08303,0.11094,0.13454,0,1
3,GO REGULATION OF CELL CYCLE,0.077559,0.11094,0.13068,0,1
3,GO VASCULATURE DEVELOPMENT,0.1306,0.11089,0.16556,0,1
3,GO MUSCLE CELL DIFFERENTIATION,0.074935,0.11071,0.14116,0,1
3,GO STEM CELL DIFFERENTIATION,0.08303,0.11065,0.12551,0,1
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.065157,0.11054,0.14513,0,1
3,GO PLACENTA DEVELOPMENT,0.16602,0.11032,0.12435,0,1
3,GO ENDODERM DEVELOPMENT,0.11524,0.1101,0.19745,0,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.094909,0.10881,0.14298,0,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.077559,0.10875,0.11562,0,1
3,GO TISSUE REMODELING,0.15197,0.10855,0.1786,0,1
3,GO REGULATION OF HEART MORPHOGENESIS,0.16602,0.10846,0.13269,0,1
3,GO FOCAL ADHESION ASSEMBLY,0.1475,0.10836,0.17156,0,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.13467,0.10828,0.1618,0,1
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.077559,0.10819,0.14883,0,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.094909,0.10815,0.12193,0,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.2998,0.10812,0.089567,0,1
3,GO DNA INTEGRITY CHECKPOINT,0.18624,0.10802,0.11366,0,1
3,GO AMINO SUGAR METABOLIC PROCESS,0.074935,0.10791,0.16802,0,1
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.15655,0.10786,0.13097,0,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.14312,0.10783,0.13412,0,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.41494,0.10781,0.11584,0,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.08881,0.10769,0.12048,0,1
3,GO CELL MOTILITY,0.058535,0.10767,0.16836,0,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.050584,0.10763,0.14983,0,1
3,GO RESPONSE TO CALCIUM ION,0.077559,0.10738,0.12844,0,1
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.091819,0.10721,0.11619,0,1
3,GO TUBE DEVELOPMENT,0.11894,0.10712,0.15074,0,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.091819,0.10693,0.16454,0,1
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.065157,0.10683,0.16471,0,1
3,GO EMBRYONIC MORPHOGENESIS,0.054439,0.10674,0.16435,0,1
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.30724,0.10649,0.11715,0,1
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.08588,0.10639,0.11348,0,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.18624,0.10585,0.098177,0,1
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.08303,0.10537,0.11821,0,1
3,GO LAMELLIPODIUM ORGANIZATION,0.077559,0.10529,0.15977,0,1
3,GO BONE REMODELING,0.098083,0.10493,0.19926,0,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.072385,0.10468,0.12175,0,1
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.10811,0.10449,0.14765,0,1
3,GO REGULATION OF CELL CYCLE PROCESS,0.074935,0.10443,0.12718,0,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.197,0.10438,0.090818,0,1
3,GO NON RECOMBINATIONAL REPAIR,0.11894,0.10434,0.12976,0,1
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.08303,0.10403,0.11383,0,1
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.10468,0.10378,0.17612,0,1
3,GO SEXUAL REPRODUCTION,0.056456,0.10362,0.12186,0,1
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.13467,0.10361,0.12141,0,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.23827,0.1031,0.12325,0,1
3,GO SKELETAL SYSTEM DEVELOPMENT,0.10134,0.10288,0.1547,0,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.1306,0.10287,0.1285,0,1
3,GO CARDIOCYTE DIFFERENTIATION,0.13885,0.10284,0.11658,0,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.23203,0.10283,0.1154,0,1
3,GO CELL CELL JUNCTION ASSEMBLY,0.20822,0.10278,0.11613,0,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.15655,0.10259,0.11859,0,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.080256,0.10259,0.13212,0,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.050584,0.10227,0.12163,0,1
3,GO REGULATION OF CELL DEATH,0.058535,0.10158,0.13932,0,1
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.2998,0.10145,0.086928,0,1
3,GO CELL CYCLE PROCESS,0.091819,0.10111,0.12182,0,1
3,GO VIRAL GENOME REPLICATION,0.15655,0.10082,0.10467,0,1
3,GO CELL CYCLE,0.094909,0.10081,0.12314,0,1
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.11163,0.099875,0.17549,0,1
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.15655,0.099868,0.11934,0,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.054439,0.099373,0.1289,0,1
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.214,0.099182,0.058637,0,1
3,GO MUSCLE ORGAN DEVELOPMENT,0.08881,0.098101,0.13462,0,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.056456,0.09798,0.095144,0,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.20822,0.097807,0.092389,0,1
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.054439,0.097458,0.12709,0,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.20256,0.097441,0.11465,0,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.29248,0.097435,0.10347,0,1
3,GO REGULATION OF LIPID TRANSPORT,0.069906,0.096711,0.15553,0,1
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.214,0.09661,0.085983,0,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.18624,0.096369,0.10422,0,1
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.060677,0.096349,0.099885,0,1
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.17091,0.096334,0.21131,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.15655,0.096094,0.12461,0,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.080256,0.095981,0.088699,0,1
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.15655,0.095808,0.14548,0,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.23203,0.095581,0.092699,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.052482,0.095469,0.1334,0,1
3,GO REGULATION OF MITOTIC CELL CYCLE,0.098083,0.095321,0.12139,0,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.072385,0.095197,0.1357,0,1
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.074935,0.094934,0.12187,0,1
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.094909,0.094603,0.086821,0,1
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.13467,0.094439,0.11734,0,1
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.27126,0.094394,0.14292,0,1
3,GO POSITIVE REGULATION OF CELL CYCLE,0.10811,0.094189,0.12676,0,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.08303,0.093992,0.16233,0,1
3,GO SNORNA METABOLIC PROCESS,0.10811,0.093543,0.12173,0,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.069906,0.092715,0.13614,0,1
3,GO MITOTIC CELL CYCLE,0.10811,0.092687,0.11456,0,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.050584,0.091947,0.15485,0,1
3,GO REPRODUCTION,0.069906,0.091653,0.12459,0,1
3,GO ENDOSOMAL TRANSPORT,0.052482,0.091574,0.1461,0,1
3,GO CELL DIVISION,0.19156,0.091158,0.1049,0,1
3,GO LAMELLIPODIUM MORPHOGENESIS,0.197,0.090953,0.13736,0,1
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.10134,0.090604,0.11387,0,1
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.094909,0.090603,0.12247,0,1
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.33821,0.090325,0.067614,0,1
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.11894,0.089892,0.10478,0,1
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.13467,0.089727,0.12095,0,1
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13467,0.089675,0.1031,0,1
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.15655,0.089424,0.093062,0,1
3,GO NUCLEUS ORGANIZATION,0.23203,0.089396,0.094308,0,1
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.10134,0.08913,0.11353,0,1
3,GO AGING,0.10468,0.089045,0.12226,0,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.10134,0.088899,0.13538,0,1
3,GO EMBRYO IMPLANTATION,0.38829,0.08848,0.1064,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.08881,0.08832,0.098842,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.12273,0.088004,0.098123,0,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.14312,0.087696,0.13593,0,1
3,GO CELL CYCLE PHASE TRANSITION,0.1475,0.087448,0.099496,0,1
3,GO CELLULAR RESPONSE TO FATTY ACID,0.2577,0.086767,0.095076,0,1
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.08588,0.086632,0.096006,0,1
3,GO VIRAL LIFE CYCLE,0.21989,0.086487,0.10475,0,1
3,GO CELLULAR RESPONSE TO STARVATION,0.069906,0.086159,0.12429,0,1
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.062884,0.08608,0.099133,0,1
3,GO BLASTOCYST DEVELOPMENT,0.13885,0.085859,0.092518,0,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.21989,0.085729,0.10211,0,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.098083,0.085517,0.13251,0,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.14312,0.085367,0.11817,0,1
3,GO SPERMATID DIFFERENTIATION,0.1475,0.08532,0.088161,0,1
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.072385,0.085272,0.11242,0,1
3,GO APOPTOTIC SIGNALING PATHWAY,0.060677,0.084335,0.12795,0,1
3,GO RESPONSE TO OSMOTIC STRESS,0.23827,0.08256,0.10575,0,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.10468,0.082399,0.13566,0,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.050584,0.082155,0.13063,0,1
3,GO HAIR FOLLICLE MATURATION,0.30724,0.080759,0.10558,0,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.214,0.080736,0.099311,0,1
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.058535,0.080642,0.15775,0,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.33821,0.079962,0.094991,0,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.12662,0.079705,0.086489,0,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.14312,0.079658,0.11036,0,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.08588,0.079371,0.0829,0,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.12662,0.078958,0.12571,0,1
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.15655,0.078559,0.11592,0,1
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.16123,0.078392,0.087829,0,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.094909,0.078355,0.086488,0,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.08588,0.077512,0.12169,0,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.13467,0.076546,0.10803,0,1
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.091819,0.076248,0.1231,0,1
3,GO REGULATION OF PROTEIN FOLDING,0.11524,0.076199,0.11425,0,1
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.062884,0.076037,0.12602,0,1
3,GO REGULATION OF VIRAL LIFE CYCLE,0.23827,0.075651,0.10086,0,1
3,GO INTRACELLULAR TRANSPORT,0.060677,0.075305,0.10934,0,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.10134,0.075216,0.12286,0,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.17091,0.0751,0.095315,0,1
3,GO REGULATION OF MACROAUTOPHAGY,0.072385,0.074954,0.13013,0,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.13467,0.07484,0.082329,0,1
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.10811,0.074757,0.11671,0,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.11163,0.074561,0.10194,0,1
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.067497,0.074269,0.12843,0,1
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.23203,0.073578,0.066973,0,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.10134,0.073384,0.10331,0,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.10811,0.072913,0.1371,0,1
3,GO PROTEIN CATABOLIC PROCESS,0.058535,0.072198,0.13038,0,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.08303,0.072072,0.13594,0,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.060677,0.071399,0.10802,0,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.058535,0.070745,0.10435,0,1
3,GO EPITHELIUM DEVELOPMENT,0.16123,0.070659,0.10827,0,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.072385,0.07008,0.13572,0,1
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.16123,0.069999,0.085057,0,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.13885,0.069855,0.10482,0,1
3,GO DNA BIOSYNTHETIC PROCESS,0.11163,0.069303,0.10044,0,1
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.067497,0.06891,0.12824,0,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.11894,0.068855,0.1473,0,1
3,GO MACROAUTOPHAGY,0.1306,0.06872,0.11056,0,1
3,GO GASTRULATION,0.14312,0.06851,0.15404,0,1
3,GO AUTOPHAGOSOME ORGANIZATION,0.17091,0.068484,0.12297,0,1
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.20256,0.068483,0.10171,0,1
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.19156,0.068279,0.074602,0,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.10811,0.068206,0.13425,0,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.091819,0.066335,0.10962,0,1
3,GO CELLULAR SENESCENCE,0.15655,0.065943,0.081058,0,1
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.14312,0.064858,0.088676,0,1
3,GO OXIDATION REDUCTION PROCESS,0.11524,0.06458,0.076506,0,1
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.15655,0.06312,0.097643,0,1
3,GO REGULATION OF TELOMERASE ACTIVITY,0.23827,0.06295,0.087887,0,1
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.08881,0.061617,0.093626,0,1
3,GO REGENERATION,0.27821,0.061577,0.093985,0,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.16123,0.060454,0.16487,0,1
3,GO SLEEP,0.098083,0.05891,0.14708,0,1
3,GO PROTEOLYSIS,0.15197,0.058478,0.11227,0,1
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.098083,0.058324,0.12407,0,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.21989,0.058096,0.12296,0,1
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.094909,0.055005,0.14216,0,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.14312,0.053096,0.067547,0,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.1306,0.051206,0.11415,0,1
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.21989,0.048069,0.085432,0,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.25111,0.047594,0.069014,0,1
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.76963,0.046381,0.032591,0,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.080256,0.04599,0.13801,0,1
3,GO SNORNA 3 END PROCESSING,0.32248,0.045931,0.075735,0,1
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.43329,0.042382,0.055193,0,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.056456,0.45109,0.28538,0,0
3,GO NATURAL KILLER CELL CHEMOTAXIS,0.48117,0.41946,0.17927,0,0
3,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.091819,0.41409,0.48129,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.2998,0.3882,0.22731,0,0
3,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.16123,0.38776,0.38883,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.25111,0.37541,0.24167,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.27126,0.37166,0.23823,0,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.077559,0.36878,0.50636,0,0
3,GO PARENTAL BEHAVIOR,0.030713,0.3677,0.33961,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.072385,0.36015,0.30574,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.015104,0.3545,0.24159,0,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.017954,0.3499,0.36397,0,0
3,GO HYPERSENSITIVITY,0.13885,0.33629,0.33754,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.1306,0.33402,0.26492,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.014457,0.33265,0.35281,0,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.1475,0.32948,0.26563,0,0
3,GO POSITIVE REGULATION OF CELL KILLING,0.1306,0.32888,0.27869,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.067497,0.32303,0.32234,0,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.098083,0.32045,0.23841,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.11524,0.31897,0.22886,0,0
3,GO MACROPHAGE APOPTOTIC PROCESS,0.062884,0.31797,0.24842,0,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.11163,0.31611,0.23789,0,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.094909,0.3134,0.31449,0,0
3,GO DISTAL TUBULE DEVELOPMENT,0.060677,0.31243,0.29575,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.13885,0.31012,0.30645,0,0
3,GO LEUKOCYTE AGGREGATION,0.40594,0.30332,0.15915,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.08881,0.30059,0.36862,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.37111,0.29886,0.14903,0,0
3,GO FOREBRAIN REGIONALIZATION,0.098083,0.2981,0.17213,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.10811,0.29324,0.27179,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.12273,0.29118,0.1843,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.015104,0.28804,0.29461,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.15197,0.28135,0.30955,0,0
3,GO SYNAPTIC MEMBRANE ADHESION,0.098083,0.28067,0.22386,0,0
3,GO SYNAPSE PRUNING,0.17091,0.27866,0.30803,0,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.15197,0.27801,0.24876,0,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.2998,0.27739,0.20907,0,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.20822,0.27618,0.24081,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.098083,0.27566,0.16351,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.27821,0.27504,0.17457,0,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.16602,0.27109,0.22683,0,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.26442,0.26786,0.21105,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0172,0.26758,0.24934,0,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.11894,0.26757,0.31313,0,0
3,GO REGULATION OF CELL KILLING,0.16602,0.26481,0.21824,0,0
3,GO OTIC VESICLE DEVELOPMENT,0.2259,0.26472,0.058116,0,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.08881,0.26395,0.21797,0,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.08588,0.26303,0.26874,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.3148,0.26202,0.16354,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.30724,0.25989,0.14262,0,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.13467,0.25932,0.20155,0,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.098083,0.25892,0.21098,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.17591,0.25845,0.1867,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.052482,0.25698,0.29768,0,0
3,GO SEX DETERMINATION,0.052482,0.2566,0.18524,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.050584,0.25545,0.21521,0,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.16602,0.25461,0.19782,0,0
3,GO HISTONE H3 K36 METHYLATION,0.08881,0.25456,0.22513,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.16123,0.25343,0.21515,0,0
3,GO AXONAL FASCICULATION,0.017954,0.25327,0.28736,0,0
3,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.11163,0.25313,0.18614,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.13467,0.24916,0.32765,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.38829,0.24698,0.12922,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.060677,0.24552,0.27328,0,0
3,GO CELL KILLING,0.17591,0.24546,0.17929,0,0
3,GO CHEMOKINE SECRETION,0.41494,0.24413,0.11293,0,0
3,GO SEROTONIN SECRETION,0.045233,0.24411,0.24751,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.065157,0.24265,0.2236,0,0
3,GO MRNA SPLICE SITE SELECTION,0.12273,0.24197,0.1615,0,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.077559,0.24122,0.21374,0,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.214,0.24121,0.2274,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.197,0.24108,0.20741,0,0
3,GO REPRODUCTIVE BEHAVIOR,0.033245,0.2398,0.22619,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.19156,0.23729,0.20025,0,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.18102,0.23721,0.18247,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.20256,0.23674,0.15755,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.3148,0.23442,0.11634,0,0
3,GO TRABECULA FORMATION,0.17591,0.23323,0.1619,0,0
3,GO SULFATION,0.14312,0.23187,0.14085,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.0042727,0.23159,0.26871,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.12273,0.23155,0.17564,0,0
3,GO ELASTIC FIBER ASSEMBLY,0.27821,0.22944,0.2103,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.11894,0.22773,0.24455,0,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.1475,0.22645,0.19902,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.15655,0.22625,0.16599,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.4521,0.22383,0.10973,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.08588,0.22347,0.23537,0,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.23827,0.2221,0.23327,0,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.091819,0.22162,0.19228,0,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.058535,0.22154,0.16869,0,0
3,GO CELL JUNCTION DISASSEMBLY,0.08303,0.22108,0.27226,0,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.08588,0.22008,0.26034,0,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.054439,0.21905,0.19526,0,0
3,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.27821,0.21855,0.23373,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.17591,0.21816,0.21395,0,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.15655,0.21808,0.20343,0,0
3,GO T CELL MEDIATED IMMUNITY,0.18624,0.21799,0.17645,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.077559,0.21789,0.20354,0,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.23827,0.21732,0.18267,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.17091,0.21685,0.15972,0,0
3,GO T CELL CHEMOTAXIS,0.1306,0.21672,0.27936,0,0
3,GO STEM CELL DIVISION,0.20822,0.21665,0.15116,0,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.11163,0.21664,0.23739,0,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.1475,0.21633,0.27733,0,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.214,0.21619,0.1845,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.13885,0.21604,0.1871,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.050584,0.21554,0.17504,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.17091,0.21548,0.23672,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.054439,0.21492,0.27882,0,0
3,GO NUCLEUS LOCALIZATION,0.023112,0.21464,0.29469,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.24463,0.21323,0.17075,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.080256,0.2127,0.236,0,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.056456,0.21205,0.2315,0,0
3,GO GLIAL CELL ACTIVATION,0.18102,0.21077,0.20175,0,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.067497,0.21054,0.19585,0,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.08303,0.20991,0.22108,0,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.18624,0.20678,0.23563,0,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.080256,0.20657,0.23458,0,0
3,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.17091,0.20648,0.21615,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.056456,0.20647,0.21474,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.197,0.20643,0.16809,0,0
3,GO URETER DEVELOPMENT,0.20822,0.20564,0.078544,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.074935,0.20559,0.17277,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.022172,0.2043,0.21083,0,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.15197,0.20397,0.16571,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.1475,0.20359,0.12772,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.060677,0.20347,0.20189,0,0
3,GO REGULATION OF INTEGRIN ACTIVATION,0.10468,0.20296,0.22985,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.20256,0.20256,0.21122,0,0
3,GO RESPIRATORY BURST,0.13885,0.20227,0.24312,0,0
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.060677,0.2022,0.19714,0,0
3,GO SHORT TERM MEMORY,0.015776,0.20137,0.29936,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.2259,0.20135,0.13479,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.20822,0.20121,0.20079,0,0
3,GO DOPAMINE TRANSPORT,0.065157,0.20111,0.21269,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.20822,0.19966,0.20187,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.17591,0.19908,0.1761,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.15655,0.19907,0.2128,0,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.2577,0.19818,0.12908,0,0
3,GO RESPONSE TO PAIN,0.028348,0.19749,0.21224,0,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.069906,0.19739,0.24934,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.19156,0.197,0.21733,0,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.098083,0.19682,0.15588,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.010101,0.19646,0.19673,0,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.15655,0.19568,0.17672,0,0
3,GO LOOP OF HENLE DEVELOPMENT,0.33821,0.19535,0.11017,0,0
3,GO REGULATION OF T CELL MIGRATION,0.18102,0.19527,0.20463,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.058535,0.19466,0.2317,0,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.28529,0.19461,0.19269,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.1475,0.19451,0.15859,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.08881,0.19297,0.2099,0,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.17591,0.19291,0.17877,0,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.26442,0.19194,0.13498,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.13885,0.19035,0.15293,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.28529,0.19009,0.18137,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.1475,0.18991,0.16445,0,0
3,GO REGULATION OF DOPAMINE SECRETION,0.067497,0.18984,0.20212,0,0
3,GO LEFT RIGHT AXIS SPECIFICATION,0.16123,0.18964,0.1245,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.1306,0.18961,0.15451,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.18624,0.18942,0.16231,0,0
3,GO NUCLEAR MIGRATION,0.038848,0.18937,0.27353,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.50109,0.18936,0.098411,0,0
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.052482,0.1889,0.19772,0,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.13885,0.18823,0.14452,0,0
3,GO INTERLEUKIN 13 PRODUCTION,0.38829,0.1882,0.10773,0,0
3,GO SOMATIC STEM CELL DIVISION,0.3148,0.18777,0.12023,0,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0172,0.18726,0.18827,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.33029,0.18684,0.10425,0,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.1306,0.18662,0.13633,0,0
3,GO T CELL CYTOKINE PRODUCTION,0.26442,0.18643,0.16455,0,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.64051,0.18571,0.060144,0,0
3,GO P BODY ASSEMBLY,0.10811,0.18523,0.16491,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.08588,0.18523,0.18785,0,0
3,GO REGULATION OF NEURON MATURATION,0.065157,0.1851,0.19002,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.0080134,0.18494,0.22772,0,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.37964,0.18468,0.15251,0,0
3,GO EPITHELIAL CELL CELL ADHESION,0.17591,0.18468,0.18057,0,0
3,GO L SERINE METABOLIC PROCESS,0.02951,0.18463,0.27357,0,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.19156,0.18412,0.16472,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.47137,0.18385,0.090586,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.067497,0.18355,0.23243,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.056456,0.18221,0.18573,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.098083,0.18024,0.22636,0,0
3,GO TRANSEPITHELIAL TRANSPORT,0.10811,0.18014,0.1444,0,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.098083,0.18014,0.16222,0,0
3,GO REGULATION OF OOGENESIS,0.0060238,0.17994,0.19269,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.060677,0.17987,0.16916,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.050584,0.17964,0.19551,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.20256,0.17959,0.1863,0,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.18624,0.17948,0.20668,0,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.214,0.17918,0.14585,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.11894,0.17914,0.16285,0,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.069906,0.17879,0.23735,0,0
3,GO MATING BEHAVIOR,0.074935,0.17781,0.1779,0,0
3,GO PRESYNAPSE ORGANIZATION,0.080256,0.17779,0.17611,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.067497,0.17762,0.22339,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.4521,0.17741,0.1214,0,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.33029,0.17732,0.18774,0,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.214,0.1773,0.14769,0,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.26442,0.1773,0.13661,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.29248,0.17729,0.11418,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.53179,0.17695,0.093915,0,0
3,GO INTERLEUKIN 6 PRODUCTION,0.1475,0.17624,0.18593,0,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.19156,0.17592,0.19839,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.42405,0.17577,0.11715,0,0
3,GO GLIAL CELL FATE COMMITMENT,0.50109,0.17569,0.0097997,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.5959,0.17541,0.097509,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.21989,0.17528,0.16293,0,0
3,GO RESPONSE TO INTERFERON BETA,0.23203,0.17483,0.17335,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.077559,0.17451,0.23328,0,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.18624,0.17435,0.19241,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.074935,0.17428,0.23882,0,0
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.050584,0.17423,0.19497,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.052482,0.17394,0.18991,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.16602,0.17383,0.22171,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.058535,0.17373,0.17704,0,0
3,GO LEUKOCYTE MIGRATION,0.20256,0.17345,0.15618,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.094909,0.17211,0.24993,0,0
3,GO INTERLEUKIN 10 PRODUCTION,0.29248,0.17192,0.18018,0,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.3148,0.17191,0.16642,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.2998,0.17184,0.13195,0,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.074935,0.1718,0.16995,0,0
3,GO VASCULOGENESIS,0.14312,0.17143,0.17329,0,0
3,GO EPITHELIAL CELL MORPHOGENESIS,0.13467,0.17133,0.12201,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.17591,0.17123,0.19091,0,0
3,GO INTERLEUKIN 5 PRODUCTION,0.84314,0.17051,0.011589,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.15655,0.17045,0.17825,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.069906,0.17038,0.12403,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.20256,0.17035,0.1816,0,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,0.28529,0.17011,0.12077,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.15655,0.1696,0.10804,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.08588,0.16951,0.16957,0,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.2577,0.16945,0.13177,0,0
3,GO MACROPHAGE ACTIVATION,0.21989,0.1694,0.18596,0,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.2577,0.16923,0.23493,0,0
3,GO REPLICATION FORK PROCESSING,0.47137,0.16913,0.089584,0,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.5959,0.169,0.072439,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.08303,0.1689,0.2281,0,0
3,GO DENSE CORE GRANULE TRANSPORT,0.11894,0.1685,0.25336,0,0
3,GO PROTEIN PALMITOYLATION,0.050584,0.16834,0.18776,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.43329,0.16802,0.043632,0,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.016475,0.16793,0.18075,0,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.18624,0.16745,0.14523,0,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.21989,0.16735,0.095279,0,0
3,GO RIG I SIGNALING PATHWAY,0.098083,0.16714,0.14219,0,0
3,GO MATING,0.08303,0.167,0.15307,0,0
3,GO RESPONSE TO INTERFERON ALPHA,0.26442,0.16696,0.18916,0,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.19156,0.16695,0.12135,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.15197,0.16684,0.16,0,0
3,GO MATURE B CELL DIFFERENTIATION,0.091819,0.16665,0.2555,0,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.10811,0.16656,0.18137,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.1475,0.16647,0.18168,0,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.19156,0.16554,0.21333,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.072385,0.16541,0.16028,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.12273,0.16537,0.15535,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.23203,0.16469,0.15088,0,0
3,GO NEGATIVE CHEMOTAXIS,0.062884,0.1644,0.21091,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.197,0.16428,0.14355,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.052482,0.16412,0.23877,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.16602,0.1641,0.17823,0,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.077559,0.16403,0.19243,0,0
3,GO MYELOID CELL APOPTOTIC PROCESS,0.27821,0.16369,0.10728,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.15655,0.16362,0.16845,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0038653,0.16361,0.23095,0,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.53179,0.16332,0.069292,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.214,0.1633,0.17468,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.08588,0.16296,0.19287,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.074935,0.16288,0.20308,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.27126,0.16287,0.21754,0,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.3148,0.16226,0.13586,0,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.1475,0.16219,0.12948,0,0
3,GO PHAGOCYTOSIS,0.10468,0.16192,0.21373,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.077559,0.16143,0.20563,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0012758,0.16085,0.27503,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.050584,0.16037,0.17643,0,0
3,GO COMPLEMENT ACTIVATION,0.33029,0.16034,0.15309,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.074935,0.16024,0.16147,0,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.062884,0.16023,0.18764,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0063209,0.1597,0.21308,0,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.10134,0.15966,0.17296,0,0
3,GO BONE CELL DEVELOPMENT,0.091819,0.15928,0.20954,0,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.29248,0.15915,0.15717,0,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.052482,0.15893,0.18044,0,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.094909,0.15846,0.19513,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.33029,0.15819,0.13981,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.056456,0.15817,0.15939,0,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.074935,0.15733,0.15511,0,0
3,GO STEROL TRANSPORT,0.08303,0.15692,0.1509,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.27821,0.1565,0.096796,0,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.32248,0.1565,0.1643,0,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.2998,0.15635,0.1064,0,0
3,GO SEROTONIN TRANSPORT,0.023112,0.15627,0.23089,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.11894,0.15617,0.19817,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.23827,0.1559,0.12705,0,0
3,GO ENERGY HOMEOSTASIS,0.077559,0.15561,0.15143,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.02951,0.15546,0.27265,0,0
3,GO RENAL FILTRATION,0.11163,0.15499,0.23106,0,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.197,0.15475,0.17749,0,0
3,GO CYTOKINE SECRETION,0.23827,0.15455,0.14029,0,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.091819,0.15443,0.17225,0,0
3,GO PYROPTOSIS,0.38829,0.15347,0.11459,0,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.30724,0.15337,0.12632,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.18102,0.15326,0.20488,0,0
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.060677,0.15308,0.22182,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.19156,0.15286,0.12506,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.038848,0.15271,0.15805,0,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.080256,0.15263,0.24812,0,0
3,GO MYOBLAST FUSION,0.10134,0.15261,0.19941,0,0
3,GO PIGMENT CELL DIFFERENTIATION,0.017954,0.15247,0.2006,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.072385,0.15244,0.21477,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.043559,0.1524,0.14071,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.014457,0.15217,0.20597,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.17591,0.152,0.19981,0,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.48117,0.15184,0.077321,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.14312,0.15172,0.17005,0,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20822,0.15156,0.11364,0,0
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.50109,0.15152,0.080293,0,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.53179,0.15141,0.043996,0,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.57414,0.15136,0.064192,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.094909,0.15102,0.201,0,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.27821,0.15093,0.19128,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.20822,0.15091,0.10822,0,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.11163,0.1509,0.1636,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.098083,0.15064,0.21247,0,0
3,GO NEPHRON DEVELOPMENT,0.17591,0.15033,0.12991,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.17091,0.15012,0.12152,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.64051,0.15009,0.079042,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.14312,0.15003,0.14628,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.17091,0.14993,0.15284,0,0
3,GO GLYCINE TRANSPORT,0.20256,0.14988,0.14838,0,0
3,GO BRAIN MORPHOGENESIS,0.077559,0.14965,0.14422,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.24463,0.14934,0.13752,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.0076456,0.14929,0.22242,0,0
3,GO SIALYLATION,0.045233,0.14915,0.23818,0,0
3,GO MULTICELLULAR ORGANISM AGING,0.043559,0.14913,0.15571,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.062884,0.14858,0.24809,0,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.29248,0.14836,0.13042,0,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.23827,0.1483,0.12986,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.10468,0.14827,0.13674,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.61803,0.14821,0.061062,0,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.20822,0.14817,0.17111,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.2998,0.14814,0.10282,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.26442,0.14811,0.12419,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.29248,0.14804,0.14767,0,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.098083,0.14799,0.20166,0,0
3,GO REGULATION OF RNA SPLICING,0.058535,0.14795,0.13561,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.40594,0.14787,0.1589,0,0
3,GO MICROTUBULE ANCHORING,0.08881,0.14779,0.18188,0,0
3,GO DEVELOPMENTAL INDUCTION,0.091819,0.14769,0.10725,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.15197,0.14747,0.2231,0,0
3,GO RESPONSE TO AMYLOID BETA,0.050584,0.1472,0.24591,0,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.077559,0.14683,0.1843,0,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.074935,0.14665,0.17022,0,0
3,GO RESPONSE TO SALT,0.11163,0.14624,0.12133,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.24463,0.14618,0.15647,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.10811,0.14596,0.25208,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.046961,0.1457,0.15772,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.197,0.14566,0.14237,0,0
3,GO MEMBRANE INVAGINATION,0.067497,0.14564,0.24379,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.23827,0.14561,0.10557,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.197,0.14547,0.13751,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.1475,0.14522,0.17395,0,0
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.90549,0.14495,-0.0087511,0,0
3,GO PROSTATIC BUD FORMATION,0.197,0.14486,0.1636,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.26442,0.14482,0.1214,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.214,0.14463,0.10987,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.32248,0.14426,0.14586,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.20256,0.14422,0.13115,0,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.18624,0.14411,0.1478,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.08303,0.14409,0.17052,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.1306,0.14408,0.18286,0,0
3,GO METANEPHROS DEVELOPMENT,0.1475,0.14373,0.12584,0,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.26442,0.14373,0.098134,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.023112,0.1437,0.17997,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.016475,0.14366,0.25109,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.43329,0.14359,0.076586,0,0
3,GO COAGULATION,0.056456,0.14312,0.18407,0,0
3,GO RESPONSE TO TUMOR CELL,0.37111,0.14311,0.12199,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.069906,0.14307,0.16414,0,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.054439,0.14306,0.16252,0,0
3,GO COCHLEA DEVELOPMENT,0.045233,0.143,0.19117,0,0
3,GO RNA DESTABILIZATION,0.050584,0.14298,0.19052,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.069906,0.14285,0.22544,0,0
3,GO LEUKOCYTE CHEMOTAXIS,0.37964,0.14285,0.10838,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.054439,0.14284,0.19818,0,0
3,GO REGULATION OF DNA REPAIR,0.035953,0.14273,0.16192,0,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.44264,0.14268,0.091014,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.30724,0.14235,0.11568,0,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.074935,0.14225,0.15196,0,0
3,GO INFLAMMATORY RESPONSE,0.2259,0.14215,0.146,0,0
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.11524,0.14211,0.14736,0,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.18102,0.14203,0.1492,0,0
3,GO OOGENESIS,0.067497,0.14194,0.12104,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.33029,0.14194,0.19824,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.052482,0.1417,0.15096,0,0
3,GO CILIUM ORGANIZATION,0.067497,0.14169,0.17536,0,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.12662,0.14167,0.16446,0,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.12273,0.14159,0.16023,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.17591,0.14149,0.17233,0,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.16602,0.14138,0.14976,0,0
3,GO PONS DEVELOPMENT,0.1306,0.14114,0.27654,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.025096,0.14113,0.17248,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.28529,0.14112,0.14506,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.11894,0.1409,0.13276,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.44264,0.14089,0.16616,0,0
3,GO HIPPO SIGNALING,0.20256,0.14086,0.16198,0,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.18102,0.14077,0.21809,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.080256,0.14071,0.24953,0,0
3,GO RENAL SYSTEM PROCESS,0.056456,0.14042,0.19211,0,0
3,GO REGULATION OF SPINDLE ORGANIZATION,0.094909,0.1404,0.15988,0,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.094909,0.14036,0.19153,0,0
3,GO NEURAL TUBE DEVELOPMENT,0.074935,0.14025,0.17201,0,0
3,GO IMMUNOGLOBULIN SECRETION,0.1306,0.14014,0.19812,0,0
3,GO REGULATION OF TUBE SIZE,0.10134,0.13996,0.14252,0,0
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.10811,0.13971,0.11019,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.65188,0.13964,0.017383,0,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.062884,0.1396,0.11675,0,0
3,GO LIPOXYGENASE PATHWAY,0.78176,0.13956,-0.051798,0,0
3,GO N GLYCAN PROCESSING,0.041938,0.13953,0.23793,0,0
3,GO SALIVA SECRETION,0.094909,0.13951,0.18925,0,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.23827,0.13913,0.10735,0,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.035953,0.1389,0.20612,0,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.17091,0.13854,0.24345,0,0
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.2998,0.13853,0.14805,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.16123,0.13849,0.17242,0,0
3,GO MIDGUT DEVELOPMENT,0.15197,0.13843,0.16043,0,0
3,GO BROWN FAT CELL DIFFERENTIATION,0.1306,0.13842,0.098499,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.08881,0.1384,0.1481,0,0
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.08303,0.13811,0.17214,0,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.12662,0.13805,0.2086,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.23203,0.13801,0.16067,0,0
3,GO ZYMOGEN INHIBITION,0.51122,0.13782,0.098948,0,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.37964,0.13773,0.025729,0,0
3,GO FLUID TRANSPORT,0.55277,0.13733,0.054367,0,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.42405,0.13728,0.10333,0,0
3,GO HISTONE H3 K4 METHYLATION,0.065157,0.13695,0.17049,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.080256,0.13692,0.18739,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.056456,0.13682,0.19269,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.19156,0.13679,0.20088,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.52145,0.13663,0.087665,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.214,0.13645,0.13109,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.14312,0.1364,0.14173,0,0
3,GO CARNITINE METABOLIC PROCESS,0.050584,0.13638,0.1548,0,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.15197,0.13637,0.15732,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.037377,0.13612,0.14464,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.197,0.13608,0.14438,0,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.28529,0.13605,0.13568,0,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.24463,0.13577,0.083063,0,0
3,GO CELLULAR RESPONSE TO IRON ION,0.18624,0.13556,0.13517,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.072385,0.13556,0.16018,0,0
3,GO SUPEROXIDE ANION GENERATION,0.13885,0.13539,0.20286,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.26442,0.13537,0.14809,0,0
3,GO NEUTROPHIL MIGRATION,0.48117,0.13533,0.10915,0,0
3,GO DIENCEPHALON DEVELOPMENT,0.052482,0.13505,0.16842,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.27821,0.13488,0.12038,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.15655,0.13483,0.14879,0,0
3,GO STEROID HORMONE SECRETION,0.1306,0.1346,0.14662,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.1306,0.13458,0.16557,0,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.077559,0.13449,0.1759,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.13885,0.13429,0.12461,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.23203,0.13416,0.13321,0,0
3,GO COCHLEA MORPHOGENESIS,0.214,0.13393,0.14341,0,0
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.098083,0.13375,0.19911,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.052482,0.13348,0.16486,0,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.16602,0.13331,0.14478,0,0
3,GO REGULATION OF CHROMATIN BINDING,0.1306,0.13315,0.13626,0,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.33029,0.13282,0.082253,0,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.065157,0.13271,0.20183,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.08588,0.13262,0.12988,0,0
3,GO TISSUE MIGRATION,0.2259,0.13251,0.13962,0,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.1306,0.1325,0.15209,0,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.2259,0.13217,0.1161,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.060677,0.13202,0.15562,0,0
3,GO RESPONSE TO INTERLEUKIN 6,0.20822,0.13196,0.16597,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.026142,0.13193,0.17295,0,0
3,GO MESENCHYME DEVELOPMENT,0.08881,0.13186,0.15545,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.27821,0.13174,0.10922,0,0
3,GO SPERM AXONEME ASSEMBLY,0.39705,0.13148,0.031186,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.021265,0.13109,0.18188,0,0
3,GO RESPONSE TO AMPHETAMINE,0.14312,0.13066,0.10532,0,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.10811,0.13057,0.12506,0,0
3,GO CHROMATIN REMODELING,0.050584,0.13048,0.15988,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.067497,0.13039,0.15834,0,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.10134,0.13031,0.17349,0,0
3,GO INSEMINATION,0.28529,0.13024,0.12242,0,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.26442,0.13018,0.10773,0,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.27821,0.12999,0.16454,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.53179,0.12992,0.080415,0,0
3,GO MALE MEIOSIS I,0.060677,0.12981,0.16077,0,0
3,GO RELAXATION OF MUSCLE,0.33821,0.1298,0.080354,0,0
3,GO RECOMBINATIONAL REPAIR,0.23203,0.12979,0.11583,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.14312,0.12928,0.15275,0,0
3,GO MEMBRANE DISASSEMBLY,0.050584,0.12927,0.19977,0,0
3,GO RESPONSE TO INTERLEUKIN 18,0.52145,0.12894,0.09173,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.32248,0.12878,0.08413,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.054439,0.12851,0.20324,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.27821,0.12845,0.14895,0,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.17091,0.12838,0.14437,0,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.39705,0.12828,0.10564,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.197,0.12827,0.066421,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.74555,0.12817,0.053153,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.30724,0.12814,0.15225,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0076456,0.12804,0.22228,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.11163,0.12781,0.15511,0,0
3,GO GROOMING BEHAVIOR,0.10468,0.12768,0.15273,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.38829,0.1275,0.08274,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.49108,0.12746,0.070727,0,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.15655,0.12746,0.13195,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.12273,0.12737,0.15842,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.067497,0.12732,0.13769,0,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.23827,0.12731,0.098442,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.08881,0.1273,0.12135,0,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.33029,0.12726,0.096287,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.098083,0.12719,0.19864,0,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.56341,0.12711,0.06027,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.23203,0.12703,0.13808,0,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.20256,0.12692,0.11871,0,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.10811,0.12677,0.14446,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.11163,0.12654,0.13213,0,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,0.16123,0.12642,0.1144,0,0
3,GO REGULATION OF VASOCONSTRICTION,0.10468,0.12636,0.15289,0,0
3,GO PROTEIN AUTOUBIQUITINATION,0.11163,0.12636,0.11666,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.062884,0.12619,0.17248,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.2998,0.12612,0.10875,0,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.47137,0.12589,0.10795,0,0
3,GO BIOMINERALIZATION,0.33029,0.12582,0.10238,0,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.20256,0.12577,0.088058,0,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.074935,0.12557,0.13767,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.29248,0.12552,0.1747,0,0
3,GO NEUTROPHIL HOMEOSTASIS,0.53179,0.12551,0.10471,0,0
3,GO HINDLIMB MORPHOGENESIS,0.0172,0.12529,0.22227,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10811,0.1252,0.16626,0,0
3,GO GASTRIC ACID SECRETION,0.014457,0.12508,0.16399,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.14312,0.12494,0.16999,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.077559,0.1249,0.15242,0,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.214,0.12476,0.16398,0,0
3,GO RESPONSE TO CHEMOKINE,0.2998,0.12465,0.14806,0,0
3,GO STRESS FIBER ASSEMBLY,0.065157,0.1245,0.18539,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.2998,0.12442,0.16101,0,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.23203,0.12428,0.13604,0,0
3,GO PROTEIN DEGLYCOSYLATION,0.15197,0.12426,0.1447,0,0
3,GO PARAXIAL MESODERM DEVELOPMENT,0.78176,0.12424,0.035538,0,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,0.17591,0.12421,0.15473,0,0
3,GO CHROMATIN SILENCING,0.11894,0.12418,0.12785,0,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.16602,0.12393,0.1388,0,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,0.25111,0.12383,0.10575,0,0
3,GO RETINOL METABOLIC PROCESS,0.27821,0.12376,0.066285,0,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.17091,0.12369,0.15954,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.56341,0.12358,0.015697,0,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.56341,0.12355,0.069789,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.90549,0.12345,0.035653,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.30724,0.12329,0.1107,0,0
3,GO GONADOTROPIN SECRETION,0.27821,0.12289,0.065548,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.50109,0.12276,0.069186,0,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.53179,0.12275,0.074714,0,0
3,GO CHROMOSOME SEPARATION,0.34626,0.12266,0.087596,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.052482,0.12264,0.1556,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.29248,0.12254,0.078264,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.0040644,0.12239,0.20671,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.7336,0.1222,0.055546,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.197,0.12199,0.12179,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.16123,0.12197,0.18245,0,0
3,GO RESPONSE TO ESTRADIOL,0.040368,0.12194,0.15536,0,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,0.14312,0.12183,0.12733,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.054439,0.12168,0.15603,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.11163,0.12146,0.12901,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.41494,0.12144,0.12516,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.08881,0.12142,0.15,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.27821,0.1214,0.12485,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.37964,0.12112,0.11805,0,0
3,GO DIGESTIVE SYSTEM PROCESS,0.08881,0.12081,0.12654,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.55277,0.12076,0.079946,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.32248,0.12073,0.093414,0,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.10468,0.1207,0.17733,0,0
3,GO CELL CHEMOTAXIS,0.37111,0.12066,0.12312,0,0
3,GO TERPENOID METABOLIC PROCESS,0.16602,0.12057,0.099436,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.16602,0.12044,0.14464,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.077559,0.12014,0.1826,0,0
3,GO TRACHEA DEVELOPMENT,0.2259,0.12007,0.13001,0,0
3,GO CELLULAR RESPONSE TO LIPID,0.12662,0.12004,0.13845,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.037377,0.12003,0.24715,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.030713,0.11964,0.1802,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.16602,0.11944,0.15842,0,0
3,GO OOCYTE DIFFERENTIATION,0.1475,0.1193,0.10636,0,0
3,GO COLLAGEN METABOLIC PROCESS,0.3148,0.11928,0.16695,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.067497,0.11908,0.21161,0,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.28529,0.11885,0.14051,0,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.58498,0.11875,0.056733,0,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.42405,0.11871,0.084757,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.046961,0.11866,0.14031,0,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.08303,0.11857,0.11691,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.072385,0.11848,0.20645,0,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.062884,0.11842,0.12412,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.11524,0.11824,0.18632,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.32248,0.11814,0.10291,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.058535,0.11783,0.19846,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.38829,0.11776,0.14281,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.18102,0.1177,0.13237,0,0
3,GO CHROMOSOME ORGANIZATION,0.08303,0.11763,0.13902,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.077559,0.11753,0.1414,0,0
3,GO ACTIN FILAMENT SEVERING,0.37111,0.11745,0.12194,0,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.21989,0.11739,0.12636,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.12273,0.11735,0.19052,0,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.4521,0.11718,0.14476,0,0
3,GO INTERLEUKIN 1 PRODUCTION,0.39705,0.11714,0.12237,0,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.13467,0.11713,0.15094,0,0
3,GO GANGLION DEVELOPMENT,0.11163,0.11697,0.20173,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.18624,0.11685,0.13488,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.17591,0.11684,0.11447,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.10468,0.11678,0.17389,0,0
3,GO TUBE FORMATION,0.20822,0.11672,0.11386,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.050584,0.11657,0.16645,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.2259,0.11643,0.15741,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.16123,0.11635,0.19513,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.11524,0.11635,0.14175,0,0
3,GO MYELOID CELL DEVELOPMENT,0.11163,0.11631,0.17009,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.13467,0.11625,0.15611,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.13467,0.11621,0.1477,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.52145,0.11619,0.078785,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.4521,0.11615,0.088091,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12662,0.11607,0.16582,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.11524,0.11607,0.10476,0,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.17091,0.11589,0.12606,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.25111,0.11572,0.15831,0,0
3,GO NECROTIC CELL DEATH,0.214,0.11571,0.1125,0,0
3,GO EXTRACELLULAR TRANSPORT,0.23203,0.11568,0.13599,0,0
3,GO HEME METABOLIC PROCESS,0.12273,0.11564,0.095519,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.27126,0.11554,0.18508,0,0
3,GO KINETOCHORE ORGANIZATION,0.60692,0.11552,0.043875,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.020391,0.11545,0.15983,0,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.2577,0.11543,0.13526,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.18624,0.11539,0.14688,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.060677,0.11526,0.19223,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.53179,0.11526,0.062413,0,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.054439,0.11523,0.14601,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.41494,0.11522,0.13825,0,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,0.12273,0.11516,0.13723,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.56341,0.11514,0.094701,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.13885,0.11494,0.1337,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.060677,0.11494,0.16594,0,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.094909,0.11489,0.14244,0,0
3,GO MEIOTIC CELL CYCLE,0.2998,0.11481,0.094749,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.42405,0.11463,0.074665,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.065157,0.11457,0.14322,0,0
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.16123,0.11451,0.0957,0,0
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.20822,0.11416,0.090396,0,0
3,GO CELLULAR RESPONSE TO ALKALOID,0.067497,0.11416,0.1199,0,0
3,GO MUSCLE FILAMENT SLIDING,0.023112,0.11379,0.18211,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.08303,0.11371,0.21536,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.2259,0.11358,0.12341,0,0
3,GO NAD BIOSYNTHETIC PROCESS,0.54223,0.11353,0.05439,0,0
3,GO DENTATE GYRUS DEVELOPMENT,0.25111,0.11346,0.066204,0,0
3,GO SEGMENTATION,0.13467,0.11335,0.13522,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.27821,0.11335,0.12669,0,0
3,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.17091,0.11333,0.27655,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.3148,0.11325,0.15349,0,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.058535,0.11323,0.12252,0,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.47137,0.11318,0.10423,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.42405,0.11315,0.075602,0,0
3,GO PROTEIN ADP RIBOSYLATION,0.091819,0.11298,0.15211,0,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.26442,0.11297,0.12289,0,0
3,GO ECTODERM DEVELOPMENT,0.60692,0.11283,0.05673,0,0
3,GO AMYLOID BETA FORMATION,0.074935,0.11274,0.16886,0,0
3,GO VITAMIN D METABOLIC PROCESS,0.61803,0.1127,0.068949,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.080256,0.11268,0.18273,0,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.75756,0.11248,0.072241,0,0
3,GO MISMATCH REPAIR,0.08588,0.11244,0.13187,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.046961,0.11236,0.13348,0,0
3,GO RNA SPLICING,0.2259,0.11195,0.08766,0,0
3,GO HISTONE H4 DEACETYLATION,0.16123,0.11185,0.11929,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.023112,0.11184,0.16187,0,0
3,GO RESPONSE TO GONADOTROPIN,0.29248,0.11183,0.1065,0,0
3,GO REGULATION OF CELL DIVISION,0.074935,0.1118,0.13889,0,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.33821,0.11168,0.1301,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.12273,0.11145,0.15299,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.1475,0.11131,0.11331,0,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.23203,0.11128,0.13142,0,0
3,GO ANIMAL ORGAN FORMATION,0.34626,0.11105,0.087713,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.1306,0.11102,0.1256,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.214,0.11099,0.17417,0,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.2998,0.11087,0.14192,0,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.2577,0.11083,0.12423,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.2577,0.11081,0.12446,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.197,0.11077,0.16844,0,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.37111,0.11068,0.070905,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.32248,0.11068,0.14565,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.56341,0.11057,0.041676,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.33821,0.11052,0.10323,0,0
3,GO MRNA PROCESSING,0.2259,0.11049,0.095133,0,0
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.2259,0.11043,0.087361,0,0
3,GO CARTILAGE MORPHOGENESIS,0.069906,0.11042,0.17791,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.55277,0.11038,0.070574,0,0
3,GO RESPONSE TO GROWTH FACTOR,0.1306,0.11036,0.13769,0,0
3,GO RRNA MODIFICATION,0.43329,0.11034,0.059344,0,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.38829,0.11032,0.12419,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.060677,0.1103,0.11929,0,0
3,GO TELOMERE ORGANIZATION,0.20822,0.11027,0.097231,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.12273,0.11021,0.1189,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.21989,0.11017,0.08339,0,0
3,GO ORGANELLE FISSION,0.16602,0.10998,0.10601,0,0
3,GO HISTONE DEUBIQUITINATION,0.062884,0.10975,0.18859,0,0
3,GO LIPID CATABOLIC PROCESS,0.074935,0.10971,0.13245,0,0
3,GO STEROID CATABOLIC PROCESS,0.13885,0.10969,0.15925,0,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.098083,0.10967,0.19353,0,0
3,GO INNER EAR MORPHOGENESIS,0.062884,0.10961,0.14314,0,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.15655,0.1092,0.17286,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.08588,0.1091,0.15027,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.91805,0.10896,0.025666,0,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.19156,0.1089,0.13163,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.29248,0.10885,0.088404,0,0
3,GO DNA CONFORMATION CHANGE,0.1475,0.10884,0.11896,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.55277,0.10877,0.1132,0,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.32248,0.10874,0.10188,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.20256,0.10868,0.11225,0,0
3,GO CELL MATRIX ADHESION,0.15655,0.10866,0.17254,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.10811,0.10865,0.15791,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.36271,0.10864,0.062728,0,0
3,GO CENTRIOLE ASSEMBLY,0.42405,0.10857,0.080248,0,0
3,GO CELL SUBSTRATE ADHESION,0.12662,0.10841,0.18095,0,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.062884,0.10838,0.15839,0,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.016475,0.10837,0.15927,0,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.197,0.10832,0.14379,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.21989,0.10819,0.10515,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.11894,0.10816,0.11924,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.27126,0.10789,0.095512,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.33029,0.10788,0.084028,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.13885,0.10786,0.13726,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.25111,0.10784,0.13367,0,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.25111,0.10779,0.12958,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.39705,0.10773,0.065956,0,0
3,GO REGULATION OF CYTOKINESIS,0.060677,0.10769,0.16036,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.091819,0.10761,0.15074,0,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.091819,0.1076,0.16819,0,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.014457,0.1075,0.1636,0,0
3,GO RRNA TRANSCRIPTION,0.034576,0.1075,0.14347,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.13467,0.10749,0.18343,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.017954,0.10745,0.1614,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.069906,0.10745,0.13881,0,0
3,GO RESPONSE TO SALT STRESS,0.24463,0.10731,0.11246,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33029,0.10731,0.12537,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.1306,0.10727,0.11973,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.040368,0.10722,0.15718,0,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.11163,0.10717,0.15809,0,0
3,GO HYPOTONIC RESPONSE,0.20822,0.10707,0.11923,0,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.12662,0.10702,0.16487,0,0
3,GO CYTOKINESIS,0.080256,0.10702,0.13484,0,0
3,GO RESPONSE TO FORSKOLIN,0.24463,0.107,0.15926,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.23827,0.10699,0.14168,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.10468,0.10692,0.13415,0,0
3,GO MYELIN ASSEMBLY,0.13885,0.10691,0.16264,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.19156,0.10682,0.17172,0,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.18624,0.10678,0.16826,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.41494,0.10678,0.093721,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.10811,0.10677,0.19561,0,0
3,GO BONE GROWTH,0.17591,0.1067,0.15898,0,0
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.056456,0.10666,0.16494,0,0
3,GO NCRNA CATABOLIC PROCESS,0.094909,0.10658,0.10628,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.17091,0.10649,0.14731,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.2577,0.10648,0.11916,0,0
3,GO TUBE MORPHOGENESIS,0.1306,0.10642,0.15631,0,0
3,GO STEROL HOMEOSTASIS,0.27821,0.1064,0.10336,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.21989,0.10635,0.14116,0,0
3,GO INTRACILIARY TRANSPORT,0.23203,0.10629,0.12439,0,0
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.0080134,0.10622,0.20564,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.091819,0.10611,0.14232,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.46168,0.10607,0.086636,0,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.36271,0.10603,0.15261,0,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.15655,0.10581,0.16228,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.1475,0.10579,0.14785,0,0
3,GO EPITHELIAL TUBE FORMATION,0.21989,0.10579,0.11056,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.2259,0.10578,0.15629,0,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.23203,0.10563,0.096181,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.13467,0.10561,0.10648,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.54223,0.10553,0.046566,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.10811,0.10551,0.14015,0,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.40594,0.10551,0.11737,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.056456,0.10548,0.16518,0,0
3,GO GRANULOCYTE MIGRATION,0.51122,0.10547,0.088915,0,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.24463,0.10529,0.16114,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.15197,0.10529,0.13885,0,0
3,GO NEUROBLAST DIVISION,0.08303,0.1052,0.19014,0,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.12273,0.10514,0.10008,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.058535,0.10505,0.147,0,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.49108,0.10491,0.064813,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.11524,0.10479,0.13488,0,0
3,GO RRNA METHYLATION,0.23203,0.10425,0.065171,0,0
3,GO MITOTIC NUCLEAR DIVISION,0.11894,0.10394,0.12202,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.091819,0.10392,0.12526,0,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.050584,0.10391,0.13685,0,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.11894,0.10391,0.20423,0,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.19156,0.10386,0.10386,0,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.72171,0.10379,0.033504,0,0
3,GO INTERLEUKIN 8 PRODUCTION,0.50109,0.10374,0.098748,0,0
3,GO HISTONE UBIQUITINATION,0.19156,0.10372,0.11497,0,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.28529,0.10368,0.13816,0,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.75756,0.10367,0.060434,0,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.13885,0.10362,0.14104,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.66333,0.10361,0.072779,0,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.37964,0.10361,0.10762,0,0
3,GO ALDEHYDE CATABOLIC PROCESS,0.016475,0.10359,0.12766,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.080256,0.10354,0.1359,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.1475,0.10354,0.14894,0,0
3,GO REGULATION OF BINDING,0.019548,0.10349,0.16949,0,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.10811,0.10344,0.12744,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.12273,0.10338,0.20006,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.56341,0.1032,0.093514,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.12662,0.10313,0.17336,0,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.14312,0.10301,0.14541,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.20822,0.10286,0.14209,0,0
3,GO METHYLATION,0.080256,0.10276,0.12627,0,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.32248,0.10274,0.14832,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.48117,0.10268,0.063944,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.040368,0.10258,0.15125,0,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.1475,0.10253,0.1603,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.40594,0.10249,0.09096,0,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.060677,0.10245,0.14506,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.23203,0.10231,0.085992,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.1475,0.10227,0.095847,0,0
3,GO BONE MINERALIZATION,0.37111,0.10213,0.089389,0,0
3,GO FATTY ACID CATABOLIC PROCESS,0.12662,0.10202,0.10767,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.2577,0.10191,0.10723,0,0
3,GO MACROPHAGE MIGRATION,0.69814,0.10186,0.072822,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.51122,0.1018,0.064505,0,0
3,GO REGULATION OF RESPONSE TO STRESS,0.091819,0.10166,0.13456,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.11163,0.10163,0.16645,0,0
3,GO OSSIFICATION,0.2577,0.10157,0.11058,0,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.18624,0.10157,0.1117,0,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.29248,0.10138,0.084393,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.25111,0.10131,0.091781,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.098083,0.10127,0.10295,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.20256,0.10113,0.1037,0,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.16602,0.10112,0.12867,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.40594,0.10108,0.09451,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.25111,0.10101,0.16993,0,0
3,GO SOMITOGENESIS,0.074935,0.10099,0.14957,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.23827,0.10094,0.082054,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.16123,0.10093,0.1259,0,0
3,GO SEX DIFFERENTIATION,0.091819,0.10082,0.11858,0,0
3,GO MESONEPHROS DEVELOPMENT,0.17591,0.10075,0.10659,0,0
3,GO BODY MORPHOGENESIS,0.25111,0.10073,0.15434,0,0
3,GO RENAL TUBULE DEVELOPMENT,0.23203,0.10054,0.093158,0,0
3,GO NOTOCHORD DEVELOPMENT,0.46168,0.10054,0.086034,0,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.12273,0.10054,0.10297,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.16123,0.10051,0.10982,0,0
3,GO HEART GROWTH,0.17091,0.10034,0.11031,0,0
3,GO P38MAPK CASCADE,0.16602,0.10027,0.16138,0,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.68646,0.10026,0.059384,0,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.11524,0.10019,0.13341,0,0
3,GO MITOTIC DNA REPLICATION,0.3148,0.10019,0.11349,0,0
3,GO CELL CYCLE DNA REPLICATION,0.25111,0.10018,0.10257,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.15197,0.10017,0.13069,0,0
3,GO SUCKLING BEHAVIOR,0.10811,0.10017,0.1677,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.5959,0.10012,0.07685,0,0
3,GO OVULATION CYCLE,0.12662,0.10011,0.13941,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.53179,0.10008,0.12471,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.2259,0.099902,0.15217,0,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.27821,0.099894,0.12563,0,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.55277,0.099857,0.084321,0,0
3,GO RESPONSE TO MECHANICAL STIMULUS,0.11524,0.09981,0.14238,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.16123,0.099681,0.076965,0,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.077559,0.099653,0.13047,0,0
3,GO BRANCHING MORPHOGENESIS OF A NERVE,0.32248,0.099505,0.1198,0,0
3,GO EXOCYTOSIS,0.098083,0.099482,0.15154,0,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.74555,0.09946,0.024073,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.15655,0.099361,0.13279,0,0
3,GO RESPONSE TO METAL ION,0.098083,0.099175,0.11446,0,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.08588,0.099164,0.15975,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.15655,0.099135,0.12498,0,0
3,GO BLASTODERM SEGMENTATION,0.16123,0.098985,0.1222,0,0
3,GO CARTILAGE DEVELOPMENT,0.21989,0.098928,0.12539,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.36271,0.098913,0.15347,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.50109,0.098907,0.10141,0,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.08881,0.098825,0.11427,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.024086,0.098574,0.20062,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.25111,0.098542,0.11474,0,0
3,GO FACE DEVELOPMENT,0.34626,0.098502,0.12253,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.058535,0.098432,0.1315,0,0
3,GO GENE SILENCING,0.10468,0.098407,0.12732,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.54223,0.098313,0.051539,0,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.40594,0.098132,0.06823,0,0
3,GO RESPONSE TO WOUNDING,0.11524,0.098101,0.15933,0,0
3,GO BODY FLUID SECRETION,0.12273,0.098076,0.12338,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.056456,0.098049,0.11486,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.55277,0.098009,0.053162,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.17591,0.097989,0.094149,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.098083,0.097955,0.20648,0,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.16123,0.097913,0.091711,0,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.46168,0.09779,0.077874,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.25111,0.097713,0.11486,0,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,0.11894,0.097441,0.15152,0,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.94321,0.097432,-0.0296,0,0
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.15197,0.097424,0.14818,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.61803,0.097394,0.053904,0,0
3,GO POSITIVE REGULATION OF CELL MATURATION,0.037377,0.097376,0.23222,0,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.056456,0.097284,0.14479,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.20822,0.097269,0.092366,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.18624,0.097228,0.11862,0,0
3,GO REGULATION OF BODY FLUID LEVELS,0.067497,0.097144,0.16348,0,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.214,0.097091,0.091496,0,0
3,GO LIPID LOCALIZATION,0.12662,0.097034,0.13083,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.44264,0.096956,0.081915,0,0
3,GO NUCLEOSOME ORGANIZATION,0.091819,0.096925,0.13167,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.11524,0.096738,0.070237,0,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.2998,0.096723,0.11683,0,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.33029,0.096715,0.096608,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.20822,0.096705,0.11862,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.35442,0.09669,0.08881,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.44264,0.096608,0.086855,0,0
3,GO KIDNEY MORPHOGENESIS,0.24463,0.096565,0.09763,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.18624,0.096518,0.080403,0,0
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.21989,0.096506,0.11449,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.13467,0.096348,0.14488,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.40594,0.096326,0.080295,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.18624,0.096301,0.18999,0,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.47137,0.09628,0.10455,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.1475,0.096194,0.15474,0,0
3,GO AUTOPHAGOSOME MATURATION,0.16602,0.095999,0.12006,0,0
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.14312,0.095892,0.16737,0,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.01266,0.095866,0.18971,0,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.20822,0.095855,0.10833,0,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.18102,0.095735,0.16196,0,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.33029,0.095622,0.10211,0,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.50109,0.095566,0.052943,0,0
3,GO GLAND MORPHOGENESIS,0.23203,0.095551,0.13901,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.094909,0.09552,0.11855,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.094909,0.09541,0.12016,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.20256,0.095395,0.13545,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.19156,0.095384,0.12632,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.16602,0.095371,0.12282,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.44264,0.095294,0.11703,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.4521,0.09526,0.079132,0,0
3,GO EXIT FROM MITOSIS,0.13467,0.09512,0.11406,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.13885,0.095078,0.14847,0,0
3,GO ASTROCYTE ACTIVATION,0.23827,0.094928,0.1621,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.46168,0.094874,0.15066,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.072385,0.094843,0.14319,0,0
3,GO PLATELET DEGRANULATION,0.26442,0.094831,0.14735,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.214,0.09477,0.1385,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.23827,0.094518,0.10962,0,0
3,GO DNA REPAIR,0.11894,0.09437,0.11409,0,0
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.10134,0.094359,0.16505,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.091819,0.094324,0.12199,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION,0.041938,0.09425,0.13151,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.39705,0.094061,0.15225,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.098083,0.093999,0.13034,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.43329,0.093995,0.11178,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.2998,0.093985,0.087923,0,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.34626,0.093842,0.097933,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.20822,0.093736,0.13799,0,0
3,GO TONGUE MORPHOGENESIS,0.61803,0.093521,0.021758,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.41494,0.093512,0.085416,0,0
3,GO AXIS SPECIFICATION,0.10134,0.093476,0.1192,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.077559,0.093474,0.11992,0,0
3,GO CHROMOSOME CONDENSATION,0.20822,0.093466,0.1281,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.41494,0.093444,0.070174,0,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.2259,0.0934,0.10195,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.53179,0.093362,0.046965,0,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.27821,0.093244,0.10878,0,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.21989,0.093155,0.14377,0,0
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.33821,0.093123,0.094082,0,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.13467,0.093122,0.12558,0,0
3,GO DNA METABOLIC PROCESS,0.08303,0.092946,0.12002,0,0
3,GO HEPARIN METABOLIC PROCESS,0.36271,0.092914,0.07372,0,0
3,GO MRNA TRANSPORT,0.33821,0.092786,0.091344,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.197,0.092779,0.084618,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.3148,0.092734,0.10614,0,0
3,GO EOSINOPHIL CHEMOTAXIS,0.98106,0.092694,0.022158,0,0
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.056456,0.092671,0.1705,0,0
3,GO DNA REPLICATION INITIATION,0.20822,0.092631,0.11775,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.2998,0.092579,0.086491,0,0
3,GO REGULATION OF GENE SILENCING,0.054439,0.092472,0.13861,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.49108,0.092456,0.1105,0,0
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.065157,0.092377,0.10116,0,0
3,GO REGULATION OF RESPONSE TO WOUNDING,0.37964,0.092257,0.10544,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.11163,0.092238,0.16809,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.37964,0.092209,0.079453,0,0
3,GO AUTOPHAGIC CELL DEATH,0.197,0.09213,0.084863,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.056456,0.092084,0.14097,0,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.62923,0.092038,0.053465,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.24463,0.091945,0.11503,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.14312,0.091754,0.13984,0,0
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.072385,0.0917,0.12748,0,0
3,GO UTERUS DEVELOPMENT,0.072385,0.091598,0.21167,0,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.08881,0.091592,0.1604,0,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.39705,0.091542,0.068161,0,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.37111,0.091389,0.057561,0,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.20822,0.091363,0.12029,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.34626,0.09131,0.11331,0,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.5959,0.091167,0.042239,0,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.37964,0.091163,0.15719,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.17591,0.091009,0.12903,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.069906,0.090902,0.13653,0,0
3,GO RESPONSE TO COLD,0.091819,0.090878,0.11486,0,0
3,GO DNA REPLICATION,0.27821,0.090872,0.090285,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.2259,0.090868,0.11323,0,0
3,GO NEURAL TUBE FORMATION,0.23203,0.090807,0.13119,0,0
3,GO REGULATION OF OSSIFICATION,0.17091,0.090695,0.13801,0,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.2577,0.090464,0.11237,0,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.35442,0.090405,0.11371,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.15197,0.090376,0.13095,0,0
3,GO RESPONSE TO LITHIUM ION,0.54223,0.090267,0.060886,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.51122,0.090169,0.050674,0,0
3,GO L GLUTAMATE IMPORT,0.27126,0.090158,0.10016,0,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.08588,0.090016,0.12886,0,0
3,GO PROGESTERONE METABOLIC PROCESS,0.46168,0.089862,0.088058,0,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.26442,0.089772,0.15096,0,0
3,GO GRANULOCYTE CHEMOTAXIS,0.66333,0.089706,0.0675,0,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.52145,0.089703,0.054848,0,0
3,GO KINETOCHORE ASSEMBLY,0.66333,0.089657,0.039224,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.3148,0.089636,0.091853,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.067497,0.089634,0.11578,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.10134,0.089555,0.11805,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.35442,0.089311,0.083682,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.23203,0.089267,0.17464,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.41494,0.089062,0.099865,0,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.62923,0.088972,0.03728,0,0
3,GO INTERACTION WITH HOST,0.27821,0.088969,0.10939,0,0
3,GO PARTURITION,0.2259,0.088916,0.11863,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.091819,0.088906,0.16701,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.67486,0.088678,-0.002386,0,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.15655,0.088671,0.10697,0,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.022172,0.088667,0.15426,0,0
3,GO HORMONE METABOLIC PROCESS,0.13467,0.08864,0.10872,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.33821,0.0885,0.1795,0,0
3,GO CHROMOSOME SEGREGATION,0.33029,0.088448,0.082776,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.20256,0.088404,0.10427,0,0
3,GO RESPONSE TO ESTROGEN,0.23827,0.08832,0.11588,0,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.24463,0.088231,0.086326,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.41494,0.088108,0.093203,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2577,0.088063,0.13741,0,0
3,GO NUCLEAR EXPORT,0.24463,0.088052,0.094877,0,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.25111,0.088048,0.11734,0,0
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.19156,0.088015,0.080024,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.44264,0.087966,0.084561,0,0
3,GO RESPONSE TO ACTIVITY,0.197,0.087949,0.087891,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.23827,0.087899,0.13409,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.08881,0.087828,0.15627,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.045233,0.087796,0.15284,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.18624,0.08778,0.14029,0,0
3,GO BONE MORPHOGENESIS,0.27821,0.08761,0.1425,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.038848,0.087555,0.13798,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.28529,0.087522,0.092648,0,0
3,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.214,0.087478,0.1363,0,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.69814,0.087447,0.039309,0,0
3,GO POLYOL CATABOLIC PROCESS,0.4521,0.087374,0.062957,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.80618,0.08728,-0.02497,0,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.15197,0.087249,0.14272,0,0
3,GO NEPHRON MORPHOGENESIS,0.24463,0.087213,0.097695,0,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.50109,0.087161,0.071724,0,0
3,GO HEART FIELD SPECIFICATION,0.56341,0.087153,0.056954,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.27126,0.087148,0.079823,0,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.29248,0.087061,0.076273,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.13467,0.08704,0.10938,0,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.16123,0.086899,0.1284,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.37111,0.086888,0.12637,0,0
3,GO CHROMOSOME LOCALIZATION,0.29248,0.086837,0.085766,0,0
3,GO HEART DEVELOPMENT,0.15655,0.086756,0.13599,0,0
3,GO ENDOCRINE HORMONE SECRETION,0.18102,0.086457,0.098431,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.27126,0.086383,0.083913,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.12662,0.086274,0.15443,0,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.1306,0.0862,0.11592,0,0
3,GO CELLULAR RESPONSE TO DSRNA,0.62923,0.086183,0.060253,0,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.47137,0.086168,0.081162,0,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.28529,0.08616,0.12567,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.11524,0.086149,0.21241,0,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.17591,0.08605,0.1099,0,0
3,GO REGULATION OF COAGULATION,0.50109,0.08597,0.078023,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.69814,0.085895,0.0388,0,0
3,GO WOUND HEALING,0.1306,0.085813,0.15437,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.34626,0.085789,0.086743,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION,0.214,0.085721,0.087887,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.27821,0.085559,0.081735,0,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.058535,0.085456,0.16764,0,0
3,GO CONVERGENT EXTENSION,0.28529,0.085402,0.1345,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.47137,0.085316,0.046579,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.74555,0.085293,0.074013,0,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.2259,0.085287,0.12479,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.30724,0.085252,0.13325,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.17591,0.085164,0.12233,0,0
3,GO ANIMAL ORGAN MATURATION,0.20822,0.08514,0.13536,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.052482,0.085134,0.11136,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.35442,0.085112,0.090675,0,0
3,GO TOXIN TRANSPORT,0.17591,0.085088,0.11717,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.21989,0.085077,0.10671,0,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.20256,0.08502,0.1087,0,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.44264,0.084985,0.08031,0,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.041938,0.08477,0.14811,0,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.53179,0.084614,0.14331,0,0
3,GO DNA METHYLATION,0.069906,0.084535,0.13359,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.66333,0.084475,0.034573,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.49108,0.084354,0.11078,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.20256,0.084351,0.11568,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.17091,0.084345,0.094766,0,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.4521,0.084342,0.077019,0,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.16602,0.084293,0.11162,0,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.49108,0.084161,0.094424,0,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.091819,0.084086,0.15595,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.197,0.084063,0.10699,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.091819,0.084038,0.11924,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.15197,0.08402,0.12706,0,0
3,GO NOTCH RECEPTOR PROCESSING,0.65188,0.08398,0.061886,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.24463,0.08389,0.090281,0,0
3,GO ETHANOL METABOLIC PROCESS,0.76963,0.083884,-0.044784,0,0
3,GO BLASTOCYST FORMATION,0.067497,0.083846,0.09879,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.27821,0.083839,0.13652,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.56341,0.083796,0.05192,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.62923,0.083775,0.06126,0,0
3,GO UTP METABOLIC PROCESS,0.60692,0.083759,0.016098,0,0
3,GO REGULATION OF SPINDLE ASSEMBLY,0.40594,0.083742,0.092315,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.30724,0.08367,0.10156,0,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.08881,0.083564,0.12148,0,0
3,GO RESPONSE TO ANGIOTENSIN,0.39705,0.083523,0.11121,0,0
3,GO NADP METABOLIC PROCESS,0.25111,0.083508,0.087526,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.15655,0.08349,0.13111,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.36271,0.083387,0.095963,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.14312,0.083289,0.097553,0,0
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.021265,0.08326,0.19585,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.11894,0.083259,0.13351,0,0
3,GO REGULATION OF CILIUM MOVEMENT,0.67486,0.083225,0.013364,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.37111,0.083202,0.10404,0,0
3,GO GLUCOSE IMPORT,0.08303,0.083176,0.12475,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.077559,0.083077,0.14624,0,0
3,GO PROTEIN IMPORT,0.30724,0.083,0.082952,0,0
3,GO NUCLEOSIDE SALVAGE,0.024086,0.082876,0.11637,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.53179,0.082834,0.11362,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.034576,0.08276,0.13029,0,0
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.072385,0.082705,0.10283,0,0
3,GO RESPONSE TO EPINEPHRINE,0.43329,0.082687,0.07231,0,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.42405,0.082637,0.077659,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.28529,0.08247,0.08865,0,0
3,GO MOLTING CYCLE,0.35442,0.082459,0.07735,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.065157,0.082452,0.11882,0,0
3,GO VITAMIN TRANSPORT,0.091819,0.082441,0.16014,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.62923,0.08241,0.030902,0,0
3,GO MESODERM DEVELOPMENT,0.060677,0.082259,0.13786,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.20822,0.082148,0.12695,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.067497,0.082135,0.12636,0,0
3,GO NUCLEAR TRANSPORT,0.18624,0.082125,0.090521,0,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.17591,0.082065,0.12958,0,0
3,GO HEAT GENERATION,0.91805,0.08206,-0.052143,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.15197,0.082043,0.11405,0,0
3,GO ERBB SIGNALING PATHWAY,0.29248,0.082013,0.1146,0,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.36271,0.081848,0.093273,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.29248,0.081803,0.11245,0,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.61803,0.081799,0.067562,0,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.098083,0.081739,0.14689,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.78176,0.081632,0.039806,0,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.11894,0.081591,0.16427,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.26442,0.081561,0.10081,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.79394,0.081547,0.060283,0,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.20822,0.081534,0.13418,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.29248,0.081504,0.10397,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.30724,0.081501,0.10576,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.66333,0.081468,0.038716,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.2577,0.081461,0.12465,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.26442,0.081406,0.14331,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.197,0.081388,0.14519,0,0
3,GO RENAL ABSORPTION,0.66333,0.08138,0.067112,0,0
3,GO RESPONSE TO ETHANOL,0.10468,0.081152,0.11435,0,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.80618,0.08105,0.012292,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.197,0.080887,0.11118,0,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.2577,0.080751,0.12616,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.38829,0.080637,0.10622,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.010101,0.080627,0.10583,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.14312,0.080496,0.11395,0,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.17091,0.080488,0.12725,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.16602,0.080354,0.13749,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.44264,0.08033,0.098804,0,0
3,GO NCRNA TRANSCRIPTION,0.18102,0.080324,0.095149,0,0
3,GO HISTONE H2A UBIQUITINATION,0.2259,0.080241,0.11351,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.11524,0.080187,0.16399,0,0
3,GO EOSINOPHIL MIGRATION,0.70989,0.08003,0.10151,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.062884,0.079934,0.13582,0,0
3,GO TISSUE HOMEOSTASIS,0.1475,0.079915,0.13253,0,0
3,GO TISSUE REGENERATION,0.62923,0.079774,0.05208,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.1475,0.079591,0.17462,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.080256,0.079579,0.12915,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.16123,0.079564,0.13382,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.28529,0.079552,0.096434,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.19156,0.079535,0.1277,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.32248,0.079415,0.1257,0,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.36271,0.079377,0.087402,0,0
3,GO NEURON PROJECTION REGENERATION,0.062884,0.079354,0.2112,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.17591,0.079098,0.10699,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.13467,0.079082,0.10255,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.2577,0.079066,0.097874,0,0
3,GO ORGAN GROWTH,0.13467,0.079035,0.12715,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.35442,0.078913,0.070431,0,0
3,GO ONE CARBON METABOLIC PROCESS,0.11894,0.078888,0.099822,0,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.85555,0.078882,0.010055,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.23827,0.078804,0.12188,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.098083,0.078764,0.11792,0,0
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.14312,0.078747,0.13737,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.60692,0.078723,0.11184,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.33029,0.078655,0.08315,0,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.214,0.078599,0.14519,0,0
3,GO MIDBRAIN DEVELOPMENT,0.054439,0.078572,0.14139,0,0
3,GO PROTEIN DENEDDYLATION,0.35442,0.078441,0.056656,0,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.53179,0.078363,0.078296,0,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.38829,0.078311,0.10125,0,0
3,GO HUMORAL IMMUNE RESPONSE,0.66333,0.078283,0.036852,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.78176,0.078262,0.052352,0,0
3,GO RESPONSE TO DRUG,0.10468,0.078213,0.11933,0,0
3,GO NEGATIVE REGULATION OF GROWTH,0.14312,0.078161,0.12611,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.34626,0.07807,0.081212,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11163,0.078061,0.11886,0,0
3,GO REGULATION OF NUCLEAR DIVISION,0.197,0.078059,0.094656,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.11894,0.078001,0.1131,0,0
3,GO CELL CYCLE CHECKPOINT,0.19156,0.077889,0.10585,0,0
3,GO RESPONSE TO TESTOSTERONE,0.30724,0.077804,0.085741,0,0
3,GO SISTER CHROMATID SEGREGATION,0.29248,0.07778,0.086047,0,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.33029,0.077778,0.082101,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.094909,0.077463,0.10701,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.48117,0.077368,0.078032,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.29248,0.077355,0.10807,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.27126,0.077291,0.10155,0,0
3,GO HORMONE CATABOLIC PROCESS,0.54223,0.077224,0.056539,0,0
3,GO ENDODERMAL CELL FATE COMMITMENT,0.30724,0.07709,0.087627,0,0
3,GO RESPONSE TO INTERLEUKIN 1,0.54223,0.077074,0.056917,0,0
3,GO HAIR CELL DIFFERENTIATION,0.15197,0.07686,0.16084,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.12662,0.076811,0.12947,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.27821,0.076798,0.10304,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.13467,0.076714,0.095945,0,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.26442,0.076655,0.1192,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.94321,0.076618,0.023225,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.43329,0.076572,0.060608,0,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.10134,0.076539,0.12201,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.17091,0.076478,0.094389,0,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.026142,0.076388,0.15929,0,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.66333,0.076292,0.057417,0,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.10468,0.076288,0.12254,0,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.99368,0.076197,0.014426,0,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.12662,0.076194,0.12311,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.2577,0.076105,0.094096,0,0
3,GO SENSORY PERCEPTION OF TASTE,0.75756,0.076102,0.0043509,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.39705,0.076068,0.070217,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.13885,0.075953,0.095813,0,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.61803,0.075908,0.055969,0,0
3,GO CENTROSOME DUPLICATION,0.4521,0.075903,0.073267,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.29248,0.075831,0.1232,0,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.36271,0.075763,0.10595,0,0
3,GO SMOOTH MUSCLE CELL MIGRATION,0.197,0.075756,0.16161,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.83078,0.075741,0.022178,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.16602,0.075729,0.15146,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.12662,0.075687,0.10455,0,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.13467,0.075629,0.12774,0,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.76963,0.075554,0.034219,0,0
3,GO STRESS GRANULE ASSEMBLY,0.42405,0.075547,0.092451,0,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.08303,0.075509,0.11805,0,0
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.29248,0.075462,0.086804,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.47137,0.075248,0.041111,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.36271,0.075145,0.081041,0,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.26442,0.075058,0.12166,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.35442,0.075052,0.14593,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.26442,0.074885,0.10872,0,0
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.197,0.074879,0.07622,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.21989,0.074788,0.091049,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.060677,0.074779,0.11462,0,0
3,GO RNA MODIFICATION,0.24463,0.074778,0.073225,0,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.3148,0.07464,0.09089,0,0
3,GO CARBOHYDRATE TRANSPORT,0.19156,0.074626,0.11197,0,0
3,GO FIBROBLAST PROLIFERATION,0.25111,0.074625,0.12206,0,0
3,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.43329,0.074622,0.10433,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.1306,0.074535,0.12651,0,0
3,GO RNA POLYADENYLATION,0.26442,0.074479,0.10725,0,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.30724,0.074462,0.11659,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.19156,0.07446,0.098963,0,0
3,GO REGULATION OF SYMBIOTIC PROCESS,0.30724,0.074432,0.086474,0,0
3,GO BONE DEVELOPMENT,0.13885,0.074341,0.1564,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.15197,0.07434,0.13093,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.098083,0.074337,0.12597,0,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.2577,0.074215,0.090941,0,0
3,GO REGULATION OF CELL MATURATION,0.08881,0.074121,0.12523,0,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.18624,0.074093,0.10496,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.2259,0.073834,0.11509,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.28529,0.073816,0.076385,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.48117,0.07375,0.065972,0,0
3,GO FATTY ACID TRANSPORT,0.23203,0.073744,0.10239,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.214,0.073725,0.12433,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.47137,0.07372,0.078846,0,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.57414,0.073634,0.071331,0,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.18624,0.073558,0.13026,0,0
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.48117,0.073541,0.054877,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.18102,0.073435,0.098002,0,0
3,GO RNA DECAPPING,0.36271,0.073244,0.095191,0,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.36271,0.073157,0.087392,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.29248,0.073134,0.12221,0,0
3,GO PROTEIN MONOUBIQUITINATION,0.2998,0.073093,0.094633,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.12273,0.073081,0.15531,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.11524,0.072906,0.15235,0,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.51122,0.072891,0.084215,0,0
3,GO RESPONSE TO BACTERIUM,0.47137,0.072873,0.068136,0,0
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.2998,0.072866,0.065816,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.29248,0.072768,0.10276,0,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.20822,0.072741,0.13549,0,0
3,GO MRNA METHYLATION,0.64051,0.072729,0.05933,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.2998,0.072663,0.18799,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.2577,0.072572,0.086625,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.18102,0.072545,0.097261,0,0
3,GO FOAM CELL DIFFERENTIATION,0.27821,0.072345,0.12552,0,0
3,GO PIGMENTATION,0.11524,0.072325,0.11519,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.53179,0.07228,0.08288,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.34626,0.072223,0.086342,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.43329,0.072212,0.090787,0,0
3,GO DNA LIGATION,0.72171,0.072158,0.024581,0,0
3,GO REGULATION OF WOUND HEALING,0.48117,0.072132,0.080823,0,0
3,GO LIPID METABOLIC PROCESS,0.10134,0.072126,0.1176,0,0
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.58498,0.072112,0.041595,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.64051,0.072054,0.054974,0,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.2259,0.072037,0.11108,0,0
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.33821,0.071941,0.082474,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.2577,0.071837,0.10681,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.16602,0.07172,0.10167,0,0
3,GO REGULATION OF PROTEOLYSIS,0.197,0.071699,0.10584,0,0
3,GO ARACHIDONIC ACID SECRETION,0.24463,0.07166,0.08987,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.36271,0.071655,0.084348,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.11163,0.071655,0.094245,0,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.32248,0.071539,0.10703,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.21989,0.071394,0.1249,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.52145,0.071273,0.074695,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.1306,0.071228,0.11696,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.08881,0.071144,0.13292,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.33821,0.071069,0.075747,0,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.20822,0.071055,0.11322,0,0
3,GO MANNOSYLATION,0.2577,0.071023,0.092553,0,0
3,GO INORGANIC ANION TRANSPORT,0.197,0.07102,0.10602,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.54223,0.070926,0.045167,0,0
3,GO HISTONE MONOUBIQUITINATION,0.41494,0.070827,0.085614,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.23203,0.070492,0.12203,0,0
3,GO TOOTH MINERALIZATION,0.50109,0.070458,0.1306,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.2577,0.070402,0.089163,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.054439,0.07032,0.13753,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.4521,0.070266,0.049632,0,0
3,GO REGULATION OF DNA METHYLATION,0.32248,0.070222,0.082054,0,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.46168,0.070131,0.086753,0,0
3,GO FAT CELL DIFFERENTIATION,0.33821,0.070091,0.097741,0,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.42405,0.070026,0.084607,0,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.17591,0.069949,0.12521,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.48117,0.069871,0.06432,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11524,0.069867,0.097972,0,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.4521,0.069852,0.079321,0,0
3,GO FOLIC ACID METABOLIC PROCESS,0.072385,0.069811,0.13484,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.4521,0.069786,0.069273,0,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.51122,0.06976,0.11554,0,0
3,GO MRNA 3 END PROCESSING,0.39705,0.069717,0.077429,0,0
3,GO RESPONSE TO HEAT,0.17091,0.069694,0.10613,0,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.5959,0.069664,0.060514,0,0
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.10468,0.069524,0.11264,0,0
3,GO MAINTENANCE OF CELL NUMBER,0.12662,0.069469,0.13064,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.51122,0.069405,0.058452,0,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.33029,0.069317,0.10146,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.60692,0.069314,0.034032,0,0
3,GO GENITALIA DEVELOPMENT,0.58498,0.069239,0.076872,0,0
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.056456,0.068918,0.10098,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.08303,0.068918,0.11963,0,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.84314,0.068913,0.0068746,0,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.13467,0.068898,0.11761,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.098083,0.068838,0.10541,0,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.16123,0.068741,0.098055,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.16123,0.068639,0.11284,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.44264,0.068541,0.080551,0,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.23203,0.068529,0.10165,0,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.54223,0.068516,0.084658,0,0
3,GO NUCLEOSOME ASSEMBLY,0.33029,0.068448,0.088336,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.052482,0.068266,0.1221,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.37964,0.068251,0.0899,0,0
3,GO REGULATION OF VASCULOGENESIS,0.56341,0.068065,0.050846,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.18102,0.067989,0.10144,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.098083,0.067982,0.15398,0,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.28529,0.067956,0.086089,0,0
3,GO NCRNA 3 END PROCESSING,0.42405,0.067918,0.044278,0,0
3,GO PROTEIN HETEROOLIGOMERIZATION,0.32248,0.067888,0.071657,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.08881,0.067861,0.12101,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.050584,0.067776,0.12044,0,0
3,GO EXCRETION,0.11163,0.067771,0.15996,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.28529,0.067762,0.091539,0,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.094909,0.067749,0.11482,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.08881,0.067743,0.12099,0,0
3,GO REGULATION OF DNA REPLICATION,0.46168,0.067704,0.065353,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.12662,0.067696,0.10261,0,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.15655,0.06764,0.11075,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.2998,0.067607,0.11228,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.34626,0.067552,0.084528,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.41494,0.067531,0.084952,0,0
3,GO STRIATUM DEVELOPMENT,0.41494,0.067505,0.084293,0,0
3,GO FATTY ACID METABOLIC PROCESS,0.30724,0.067481,0.07685,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.091819,0.067454,0.17598,0,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.44264,0.067435,0.071431,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.5959,0.067432,0.042856,0,0
3,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.49108,0.067219,0.083114,0,0
3,GO MRNA CLEAVAGE,0.08303,0.067045,0.1244,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.79394,0.066952,0.046936,0,0
3,GO STEROL METABOLIC PROCESS,0.18624,0.066929,0.10053,0,0
3,GO BONE MATURATION,0.36271,0.066926,0.11528,0,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.35442,0.066926,0.076429,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.75756,0.066846,0.058344,0,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.25111,0.06674,0.10973,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.3148,0.066715,0.1009,0,0
3,GO REGULATION OF EXOSOMAL SECRETION,0.3148,0.066644,0.091465,0,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.27821,0.066639,0.11354,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.26442,0.066601,0.10244,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.72171,0.066529,0.049565,0,0
3,GO ACROSOME REACTION,0.16123,0.066512,0.14252,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.33821,0.066479,0.077095,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.42405,0.066468,0.063136,0,0
3,GO SELECTIVE AUTOPHAGY,0.10468,0.066418,0.14579,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.49108,0.06636,0.052312,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.52145,0.066325,0.03279,0,0
3,GO POSITIVE REGULATION OF ACROSOME REACTION,0.27126,0.066288,0.13102,0,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.5959,0.066277,0.075744,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.49108,0.066003,0.041351,0,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.20822,0.065999,0.10037,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.34626,0.065972,0.087167,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.17091,0.065922,0.13705,0,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.23827,0.06592,0.11162,0,0
3,GO REGULATION OF ORGAN GROWTH,0.25111,0.0658,0.10657,0,0
3,GO DNA GEOMETRIC CHANGE,0.3148,0.065771,0.088571,0,0
3,GO RNA 3 END PROCESSING,0.40594,0.065727,0.065913,0,0
3,GO THIOESTER METABOLIC PROCESS,0.26442,0.065618,0.067131,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.40594,0.065578,0.074685,0,0
3,GO RESPONSE TO STEROL,0.08881,0.06547,0.19361,0,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.93062,0.065458,-0.031805,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.16123,0.065303,0.098479,0,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.42405,0.065214,0.072155,0,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.54223,0.065131,0.064519,0,0
3,GO SKIN MORPHOGENESIS,0.76963,0.065116,0.091629,0,0
3,GO CELL REDOX HOMEOSTASIS,0.48117,0.065111,0.05495,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.08881,0.065093,0.14494,0,0
3,GO LIPID STORAGE,0.2259,0.065089,0.12818,0,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.57414,0.065046,0.053124,0,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.15197,0.065012,0.11231,0,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.46168,0.064963,0.077289,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.18624,0.064807,0.088071,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.86799,0.064786,0.02774,0,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.91805,0.064769,-0.022623,0,0
3,GO MITOTIC RECOMBINATION,0.48117,0.064697,0.055249,0,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.32248,0.064643,0.12219,0,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.12662,0.064591,0.1462,0,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.49108,0.064579,0.064686,0,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.62923,0.064531,0.07973,0,0
3,GO CELLULAR RESPONSE TO UV,0.5959,0.064369,0.054518,0,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.68646,0.064351,0.022581,0,0
3,GO MOVEMENT IN HOST ENVIRONMENT,0.34626,0.064263,0.09777,0,0
3,GO NODAL SIGNALING PATHWAY,0.28529,0.064236,0.087612,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.86799,0.064196,0.047889,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.11524,0.064046,0.15036,0,0
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.14312,0.064036,0.081442,0,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.25111,0.063808,0.09954,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.7336,0.063796,0.025469,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.79394,0.063787,0.021879,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.40594,0.063545,0.089857,0,0
3,GO ICOSANOID METABOLIC PROCESS,0.67486,0.063507,0.048354,0,0
3,GO RNA PROCESSING,0.38829,0.063349,0.061952,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.2259,0.063245,0.058854,0,0
3,GO TISSUE MORPHOGENESIS,0.19156,0.063124,0.13107,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.074935,0.063021,0.13894,0,0
3,GO MESODERM MORPHOGENESIS,0.15655,0.063007,0.1445,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.62923,0.062953,0.050446,0,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.35442,0.062934,0.095656,0,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.18102,0.062916,0.15395,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.19156,0.062864,0.11157,0,0
3,GO FEMALE GAMETE GENERATION,0.35442,0.062785,0.072652,0,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.88046,0.062769,0.010616,0,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.16602,0.062768,0.12336,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.76963,0.062725,0.054016,0,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.78176,0.062633,0.015085,0,0
3,GO VESICLE TARGETING,0.2259,0.062628,0.096241,0,0
3,GO MITOCHONDRIAL FISSION,0.15655,0.062535,0.10323,0,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.24463,0.06238,0.11819,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.13885,0.062329,0.11434,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.094909,0.062305,0.12039,0,0
3,GO APICAL JUNCTION ASSEMBLY,0.56341,0.062223,0.058883,0,0
3,GO GOLGI VESICLE TRANSPORT,0.10811,0.062158,0.11974,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.7336,0.062123,0.037377,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.23827,0.062081,0.098702,0,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.44264,0.062072,0.04728,0,0
3,GO MUSCLE CELL MIGRATION,0.23827,0.062058,0.13144,0,0
3,GO LYSINE METABOLIC PROCESS,0.65188,0.061914,0.036072,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.2259,0.061819,0.11969,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.29248,0.06163,0.079611,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.18624,0.061574,0.12387,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.214,0.061483,0.1969,0,0
3,GO TRANSLESION SYNTHESIS,0.2577,0.061457,0.079265,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11163,0.061409,0.092619,0,0
3,GO RESPONSE TO UV,0.38829,0.061399,0.073377,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.2577,0.061391,0.080527,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.074935,0.061295,0.11574,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.16602,0.061285,0.092379,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.18624,0.061125,0.10252,0,0
3,GO BARBED END ACTIN FILAMENT CAPPING,0.66333,0.061073,0.06885,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.39705,0.061004,0.077497,0,0
3,GO MATURATION OF 5 8S RRNA,0.7336,0.060994,0.029262,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.18102,0.06083,0.11558,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38829,0.060805,0.11176,0,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.12662,0.060797,0.12492,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.25111,0.060693,0.14889,0,0
3,GO REGULATION OF BLOOD PRESSURE,0.33821,0.060659,0.092188,0,0
3,GO KERATINOCYTE MIGRATION,0.42405,0.060649,0.099292,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.2577,0.060643,0.059619,0,0
3,GO GOLGI ORGANIZATION,0.37964,0.060487,0.09371,0,0
3,GO ASYMMETRIC CELL DIVISION,0.25111,0.060448,0.11385,0,0
3,GO ACETYL COA METABOLIC PROCESS,0.25111,0.060348,0.088982,0,0
3,GO CHEMOKINE PRODUCTION,0.54223,0.060319,0.075542,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.12662,0.060226,0.1363,0,0
3,GO REGULATION OF URINE VOLUME,0.25111,0.060149,0.12981,0,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.39705,0.060147,0.089116,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.2577,0.060113,0.10672,0,0
3,GO ZYMOGEN ACTIVATION,0.98106,0.060096,0.021332,0,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.76963,0.060028,0.04049,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.35442,0.060022,0.086977,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.65188,0.05997,-0.045251,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.55277,0.059944,0.086349,0,0
3,GO RESPONSE TO CAFFEINE,0.10468,0.059909,0.13502,0,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.84314,0.059854,0.049035,0,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.23203,0.059851,0.13959,0,0
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.20822,0.059833,0.07304,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.46168,0.059743,0.083144,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.3148,0.059705,0.055361,0,0
3,GO OLIGOPEPTIDE TRANSPORT,0.25111,0.059696,0.13023,0,0
3,GO TRNA TRANSPORT,0.32248,0.05968,0.087079,0,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.44264,0.05966,0.059025,0,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.23203,0.059599,0.10067,0,0
3,GO RESPONSE TO LEAD ION,0.53179,0.059585,0.074206,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.10811,0.059477,0.13627,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.098083,0.059393,0.11948,0,0
3,GO LUTEINIZATION,0.24463,0.059287,0.17207,0,0
3,GO EPITHELIAL CELL PROLIFERATION,0.34626,0.05922,0.098204,0,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.79394,0.059178,0.043773,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.40594,0.059058,0.068233,0,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.15197,0.058966,0.11078,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.47137,0.058956,0.077731,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.21989,0.058934,0.11055,0,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.84314,0.058846,-0.078437,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.1306,0.058816,0.097788,0,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.69814,0.058771,-0.076529,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.40594,0.058748,0.070726,0,0
3,GO ERBB2 SIGNALING PATHWAY,0.39705,0.058736,0.068627,0,0
3,GO PROTEIN PROCESSING,0.50109,0.058728,0.074559,0,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.20256,0.058702,0.14165,0,0
3,GO GLYCOSYLATION,0.16602,0.058686,0.099425,0,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.11524,0.05867,0.090682,0,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.27821,0.058581,0.1017,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.37111,0.058549,0.069809,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.96843,0.0585,-0.014129,0,0
3,GO RNA LOCALIZATION,0.34626,0.058446,0.07323,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.41494,0.058401,0.061683,0,0
3,GO STEROID METABOLIC PROCESS,0.37111,0.058237,0.066909,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.38829,0.058219,0.13511,0,0
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.3148,0.058204,0.063152,0,0
3,GO PEPTIDE CROSS LINKING,0.37111,0.058191,0.12025,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.94321,0.058113,0.0098759,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.48117,0.058068,0.11063,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.20256,0.057877,0.15688,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.85555,0.057785,0.021016,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.12662,0.057751,0.18473,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.37111,0.057721,0.086077,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.96843,0.057607,0.0146,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.14312,0.057495,0.098076,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.214,0.057271,0.088146,0,0
3,GO HEART TRABECULA FORMATION,0.20256,0.057262,0.13944,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.37111,0.057254,0.1229,0,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.56341,0.057251,0.061897,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.4521,0.057128,0.047345,0,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.60692,0.057121,0.054519,0,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.062884,0.057117,0.14208,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.30724,0.057095,0.078996,0,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.16123,0.057089,0.10147,0,0
3,GO SISTER CHROMATID COHESION,0.38829,0.056986,0.082868,0,0
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.18102,0.056964,0.074621,0,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.91805,0.056963,0.029288,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.52145,0.056929,0.073271,0,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.60692,0.056773,0.054286,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.214,0.056743,0.14619,0,0
3,GO VIRAL LATENCY,0.75756,0.056723,0.032731,0,0
3,GO SECRETION BY TISSUE,0.32248,0.05669,0.074945,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.10134,0.056637,0.12159,0,0
3,GO SKIN DEVELOPMENT,0.76963,0.056596,0.022749,0,0
3,GO RESPONSE TO FUNGUS,0.62923,0.056528,0.05524,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.43329,0.056509,0.097014,0,0
3,GO HEART FORMATION,0.56341,0.05642,0.068148,0,0
3,GO PROTEIN MATURATION,0.2998,0.056223,0.081875,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.49108,0.05619,0.095566,0,0
3,GO RESPONSE TO CORTICOSTEROID,0.34626,0.056144,0.088943,0,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.35442,0.056083,0.084486,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.16123,0.055927,0.09607,0,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.4521,0.055911,0.10742,0,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.197,0.055895,0.096924,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.60692,0.055786,0.073281,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.12273,0.055692,0.10507,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.67486,0.055574,0.014085,0,0
3,GO FERTILIZATION,0.098083,0.055497,0.10076,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.30724,0.055167,0.078426,0,0
3,GO ALDITOL METABOLIC PROCESS,0.36271,0.055154,0.080414,0,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.25111,0.055012,0.099174,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.1306,0.054951,0.081676,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.67486,0.054941,0.067187,0,0
3,GO HISTONE H2B UBIQUITINATION,0.91805,0.054799,0.018098,0,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.44264,0.054499,0.078282,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.38829,0.054465,0.10461,0,0
3,GO MITOTIC CYTOKINESIS,0.38829,0.054314,0.083016,0,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.46168,0.054291,0.089405,0,0
3,GO EPOXYGENASE P450 PATHWAY,0.86799,0.05415,0.001476,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.3148,0.054127,0.13562,0,0
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.16123,0.054124,0.13835,0,0
3,GO RETINA HOMEOSTASIS,0.20256,0.054118,0.063913,0,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.62923,0.054067,0.016577,0,0
3,GO CYTOPLASM ORGANIZATION,0.80618,0.053888,-0.034222,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.49108,0.05388,0.10507,0,0
3,GO ENTRY INTO HOST,0.33029,0.053754,0.10226,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.2998,0.053748,0.086799,0,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.47137,0.053648,0.067776,0,0
3,GO REGULATION OF LIPID STORAGE,0.27821,0.053619,0.13592,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.30724,0.053585,0.1285,0,0
3,GO IMPORT INTO NUCLEUS,0.32248,0.053527,0.076842,0,0
3,GO EPIBOLY,0.64051,0.053411,0.10587,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.60692,0.053388,0.024115,0,0
3,GO GOLGI RIBBON FORMATION,0.48117,0.053339,0.089429,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.50109,0.053297,0.060936,0,0
3,GO PROTEIN DEMANNOSYLATION,0.49108,0.053275,0.10295,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.36271,0.053209,0.088346,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.55277,0.05319,0.030493,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.18624,0.053061,0.10749,0,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.70989,0.053034,0.0041202,0,0
3,GO GTP BIOSYNTHETIC PROCESS,0.35442,0.052829,0.032751,0,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.37111,0.052801,0.10044,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.35442,0.05275,0.14424,0,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.34626,0.052743,0.10458,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.16602,0.052564,0.14485,0,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.21989,0.052555,0.096843,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.15197,0.052526,0.080131,0,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.25111,0.052482,0.10133,0,0
3,GO VIRAL TRANSLATION,0.3148,0.05242,0.056456,0,0
3,GO COPII COATED VESICLE BUDDING,0.23827,0.052336,0.097356,0,0
3,GO DIOL METABOLIC PROCESS,0.3148,0.052301,0.079362,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.5959,0.052199,0.085366,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.65188,0.052074,0.047417,0,0
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.052482,0.051946,0.075818,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.27821,0.051884,0.075602,0,0
3,GO TRACHEA MORPHOGENESIS,0.214,0.051825,0.14466,0,0
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.30724,0.051814,0.1099,0,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.98106,0.051812,-0.011849,0,0
3,GO VASODILATION,0.79394,0.051785,0.052405,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.13885,0.051741,0.099001,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.10811,0.051636,0.091459,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.56341,0.051583,0.047708,0,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.66333,0.051561,-0.046482,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.08303,0.051504,0.13176,0,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.49108,0.051499,0.10053,0,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.10811,0.051473,0.12343,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.57414,0.051461,0.070676,0,0
3,GO MALE SEX DIFFERENTIATION,0.35442,0.051397,0.086136,0,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.66333,0.051334,0.055623,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.1306,0.051298,0.10911,0,0
3,GO ZINC ION TRANSPORT,0.060677,0.051237,0.12596,0,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.32248,0.05122,0.063077,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.17591,0.051177,0.094652,0,0
3,GO AMYLOID BETA CLEARANCE,0.42405,0.051125,0.13695,0,0
3,GO RNA METHYLATION,0.52145,0.051058,0.048904,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.52145,0.050636,0.066197,0,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.54223,0.050456,0.057383,0,0
3,GO SNRNA TRANSCRIPTION,0.46168,0.050264,0.060017,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.38829,0.05021,0.10298,0,0
3,GO ORGANELLE DISASSEMBLY,0.12662,0.050179,0.10652,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.61803,0.050032,0.044,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.043559,0.049942,0.13885,0,0
3,GO PENTOSE METABOLIC PROCESS,0.28529,0.049755,0.097319,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.26442,0.049713,0.082895,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.1306,0.049704,0.12202,0,0
3,GO REGULATION OF RELAXATION OF MUSCLE,0.46168,0.049627,0.1125,0,0
3,GO VAGINA DEVELOPMENT,0.32248,0.049559,0.10754,0,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.52145,0.049495,0.10964,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.34626,0.04948,0.069573,0,0
3,GO RUFFLE ASSEMBLY,0.40594,0.049316,0.098998,0,0
3,GO REGULATION OF HEART RATE,0.48117,0.049287,0.058958,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.4521,0.049268,0.060986,0,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.25111,0.049236,0.099538,0,0
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.12273,0.04916,0.069939,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.67486,0.049136,0.060996,0,0
3,GO MATURATION OF SSU RRNA,0.89296,0.048969,0.016947,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.46168,0.048921,0.062693,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.27821,0.048895,0.091797,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.24463,0.048859,0.091622,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.4521,0.048735,0.078502,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.11524,0.0486,0.10294,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.84314,0.048542,0.035166,0,0
3,GO TRNA PROCESSING,0.90549,0.048529,0.013873,0,0
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.37964,0.048515,0.063922,0,0
3,GO ETHER METABOLIC PROCESS,0.47137,0.048433,0.062754,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.58498,0.048324,0.10119,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.79394,0.048309,-0.067115,0,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.23827,0.048298,0.13574,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.76963,0.048186,0.022784,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.65188,0.048159,0.056586,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.46168,0.048101,0.080197,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.11163,0.048097,0.11598,0,0
3,GO PROTEIN SUMOYLATION,0.19156,0.047968,0.11093,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.78176,0.047931,0.037895,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.34626,0.047899,0.073187,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.51122,0.047733,0.073472,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.99368,0.04772,0.027157,0,0
3,GO VIRAL RELEASE FROM HOST CELL,0.27821,0.047708,0.08004,0,0
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.58498,0.047703,0.056535,0,0
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.11163,0.047659,0.081122,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.29248,0.047649,0.054005,0,0
3,GO GOLGI VESICLE BUDDING,0.28529,0.04764,0.094164,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.40594,0.04762,0.090097,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.85555,0.047578,0.012654,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.214,0.047323,0.10518,0,0
3,GO OOCYTE MATURATION,0.197,0.047311,0.095883,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.80618,0.047178,-0.098037,0,0
3,GO MRNA MODIFICATION,0.94321,0.047162,0.011813,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.33029,0.047159,0.082911,0,0
3,GO CELLULAR PIGMENTATION,0.41494,0.047068,0.073273,0,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.18624,0.046849,0.11166,0,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.36271,0.046749,0.095613,0,0
3,GO CELLULAR RESPONSE TO HEAT,0.27821,0.046721,0.091134,0,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.21989,0.046592,0.10276,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.50109,0.046515,0.055194,0,0
3,GO DNA STRAND ELONGATION,0.50109,0.046417,0.062289,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.16602,0.046332,0.091537,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.88046,0.046208,0.051008,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.54223,0.046175,0.065535,0,0
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.66333,0.046165,0.049725,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.4521,0.046163,0.043058,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.78176,0.045997,0.036126,0,0
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.27821,0.045937,0.077096,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.4521,0.045917,0.071176,0,0
3,GO DIET INDUCED THERMOGENESIS,0.70989,0.045832,0.02828,0,0
3,GO BASE EXCISION REPAIR,0.1475,0.045695,0.11261,0,0
3,GO RNA SURVEILLANCE,0.61803,0.045373,0.047594,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.94321,0.045355,0.018395,0,0
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.43329,0.045279,0.042684,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.25111,0.045182,0.15645,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.34626,0.044965,0.11779,0,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.35442,0.04473,0.10817,0,0
3,GO NUCLEOBASE METABOLIC PROCESS,0.18102,0.044638,0.11289,0,0
3,GO RNA STABILIZATION,0.33821,0.044608,0.084691,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.33821,0.044564,0.097877,0,0
3,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.17091,0.044554,0.091996,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.27821,0.04453,0.098309,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.57414,0.044309,0.053234,0,0
3,GO RESPONSE TO ANTIBIOTIC,0.60692,0.044256,0.057018,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.43329,0.04422,0.080432,0,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.89296,0.04421,-0.012425,0,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.30724,0.044173,0.19156,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,0.80618,0.044162,-0.022533,0,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,0.56341,0.044047,0.056056,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.34626,0.044022,0.091598,0,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.96843,0.043936,0.0242,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.41494,0.04392,0.063923,0,0
3,GO REGULATION OF HEART GROWTH,0.60692,0.043696,0.063388,0,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.54223,0.043672,0.086399,0,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.37964,0.04366,0.073231,0,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.56341,0.043642,0.066623,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.26442,0.043566,0.12923,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.1475,0.04355,0.085701,0,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,0.29248,0.043526,0.079857,0,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.67486,0.043454,0.064575,0,0
3,GO RESPONSE TO HYPEROXIA,0.65188,0.043417,0.060973,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.26442,0.043385,0.075096,0,0
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.70989,0.04337,0.025419,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.34626,0.043347,0.078532,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.79394,0.043317,0.015739,0,0
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.2998,0.043162,0.077031,0,0
3,GO LUNG MORPHOGENESIS,0.67486,0.043121,0.0544,0,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.40594,0.043119,0.063544,0,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.13885,0.04311,0.18304,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.27821,0.043108,0.10953,0,0
3,GO MRNA METABOLIC PROCESS,0.42405,0.042967,0.050555,0,0
3,GO TRNA WOBBLE BASE MODIFICATION,0.20256,0.042951,0.078451,0,0
3,GO CELL AGING,0.17091,0.042904,0.084597,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.76963,0.042861,0.026764,0,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.36271,0.042696,0.088177,0,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.33029,0.042571,0.16191,0,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.91805,0.042553,-0.0010118,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.37964,0.042403,0.076578,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.42405,0.042401,0.074162,0,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.51122,0.042225,0.1073,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.11524,0.04219,0.098724,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.20822,0.042103,0.080421,0,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.17091,0.04193,0.1089,0,0
3,GO RESPONSE TO THYROID HORMONE,0.61803,0.041926,0.053385,0,0
3,GO REGULATION OF ERAD PATHWAY,0.15197,0.041908,0.11978,0,0
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.27821,0.041778,0.083201,0,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.55277,0.041719,0.063809,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.64051,0.041562,0.057793,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.48117,0.041502,0.047347,0,0
3,GO SUBPALLIUM DEVELOPMENT,0.64051,0.041422,0.086393,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.30724,0.041309,0.083148,0,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.33821,0.041297,0.082909,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.62923,0.041134,0.05504,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.14312,0.040978,0.11349,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.36271,0.040765,0.073306,0,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.29248,0.040747,0.099144,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.44264,0.040717,0.043994,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.41494,0.040706,0.049032,0,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.57414,0.040679,0.052173,0,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.27126,0.040389,0.144,0,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.64051,0.040337,0.052899,0,0
3,GO SYMBIOTIC PROCESS,0.20822,0.040335,0.079868,0,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.32248,0.040251,0.10014,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.33029,0.040239,0.15442,0,0
3,GO REGULATION OF HIPPO SIGNALING,0.29248,0.039982,0.13782,0,0
3,GO GAS TRANSPORT,0.79394,0.039778,0.036386,0,0
3,GO ELECTRON TRANSPORT CHAIN,0.10468,0.039586,0.05445,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.53179,0.039581,0.066774,0,0
3,GO NCRNA PROCESSING,0.99368,0.039422,0.013496,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.69814,0.039399,0.043448,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.17591,0.039359,0.096471,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.52145,0.039351,0.050232,0,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.50109,0.039246,0.073651,0,0
3,GO AXIS ELONGATION,0.70989,0.039236,0.053698,0,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.091819,0.039174,0.12306,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.95582,0.039083,0.0027475,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.3148,0.03902,0.076041,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.5959,0.038975,0.037465,0,0
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.2577,0.038935,0.14467,0,0
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.49108,0.038935,0.053376,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.70989,0.03881,0.057494,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.79394,0.038615,0.0086618,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.53179,0.038574,0.026624,0,0
3,GO RRNA METABOLIC PROCESS,0.99368,0.038485,0.012546,0,0
3,GO ENDOSOME ORGANIZATION,0.27821,0.03832,0.089575,0,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.13885,0.038293,0.14233,0,0
3,GO REGULATION OF HEAT GENERATION,0.94321,0.038137,-0.074546,0,0
3,GO GLUTAMINE METABOLIC PROCESS,0.4521,0.038002,0.066097,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.67486,0.037951,0.028716,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.23827,0.037884,0.14985,0,0
3,GO FEVER GENERATION,0.75756,0.037877,-0.075591,0,0
3,GO RESPONSE TO ZINC ION,0.35442,0.037859,0.082717,0,0
3,GO PERICARDIUM DEVELOPMENT,0.39705,0.037756,0.11073,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.84314,0.037703,0.0346,0,0
3,GO MICROVILLUS ASSEMBLY,0.32248,0.037695,0.092803,0,0
3,GO POSTREPLICATION REPAIR,0.57414,0.037664,0.047451,0,0
3,GO ASTROCYTE DEVELOPMENT,0.48117,0.037636,0.11595,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.68646,0.037535,0.021679,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.38829,0.037524,0.042587,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.17091,0.037421,0.13269,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.75756,0.03737,0.053841,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.43329,0.037285,0.073249,0,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.55277,0.037035,0.10197,0,0
3,GO ORGANELLE INHERITANCE,0.36271,0.036975,0.091754,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.86799,0.036929,0.027354,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.28529,0.036923,0.074944,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.80618,0.036921,0.034256,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.42405,0.03688,0.092333,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.23827,0.036769,0.098096,0,0
3,GO PROTEIN MANNOSYLATION,0.26442,0.036768,0.11208,0,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.58498,0.036703,0.076126,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.35442,0.036695,0.12363,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.25111,0.03669,0.17469,0,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.20822,0.036658,0.10731,0,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.33821,0.03661,0.12112,0,0
3,GO SARCOMERE ORGANIZATION,0.49108,0.036533,0.057069,0,0
3,GO PEROXISOME ORGANIZATION,0.40594,0.036504,0.052266,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.60692,0.036423,0.036964,0,0
3,GO BILE ACID AND BILE SALT TRANSPORT,0.48117,0.036372,0.085298,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.52145,0.036316,0.094127,0,0
3,GO POSITIVE REGULATION OF TRANSLATION,0.28529,0.036179,0.071855,0,0
3,GO RNA CAPPING,0.1475,0.036063,0.085347,0,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,0.40594,0.035736,0.11256,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.37964,0.035618,0.12321,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.197,0.035605,0.10057,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.16602,0.035567,0.097009,0,0
3,GO PROTEIN FOLDING,0.27126,0.035548,0.068815,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.34626,0.035546,0.10323,0,0
3,GO TRNA MODIFICATION,0.88046,0.035463,0.0018792,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.36271,0.035443,0.10208,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.72171,0.035436,0.049459,0,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.37964,0.03531,0.045723,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.5959,0.035228,0.057604,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.55277,0.035113,0.062664,0,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.58498,0.035036,0.067028,0,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.20822,0.034358,0.10528,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.57414,0.034336,0.065278,0,0
3,GO RESPONSE TO DSRNA,0.69814,0.034208,0.050501,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.38829,0.034078,0.17957,0,0
3,GO RESPONSE TO GAMMA RADIATION,0.2259,0.034057,0.091274,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.23827,0.034007,0.091067,0,0
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.33821,0.033982,0.088794,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.55277,0.033959,0.054834,0,0
3,GO METAPHASE PLATE CONGRESSION,0.44264,0.033928,0.071433,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.72171,0.033749,0.036448,0,0
3,GO REGULATION OF ACROSOME REACTION,0.43329,0.033688,0.07877,0,0
3,GO AMP METABOLIC PROCESS,0.60692,0.033455,0.05433,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.37111,0.0333,0.045555,0,0
3,GO PHOSPHATE ION TRANSPORT,0.67486,0.033285,0.064846,0,0
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.38829,0.033148,0.037108,0,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.68646,0.03309,0.062126,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.65188,0.032828,0.060573,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.36271,0.032587,0.10389,0,0
3,GO PLASMA MEMBRANE FUSION,0.56341,0.032504,0.043833,0,0
3,GO REGULATION OF PROTEIN IMPORT,0.83078,0.032498,0.055389,0,0
3,GO PROSTANOID METABOLIC PROCESS,0.85555,0.03228,0.0035742,0,0
3,GO WATER HOMEOSTASIS,0.7336,0.032116,0.05103,0,0
3,GO PEROXISOMAL TRANSPORT,0.4521,0.032003,0.051978,0,0
3,GO RESPONSE TO REDOX STATE,0.52145,0.031934,0.052058,0,0
3,GO RESPONSE TO ETHER,0.50109,0.031917,0.059975,0,0
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.95582,0.031835,0.010625,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.41494,0.031829,0.055955,0,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.41494,0.031822,0.12251,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.197,0.031687,0.091023,0,0
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.16123,0.031652,0.097698,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.53179,0.031611,0.094391,0,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.83078,0.031523,0.039035,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.94321,0.031508,0.0065266,0,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.62923,0.031465,-0.058262,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,1,0.03131,0.034277,0,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.90549,0.031283,0.0027026,0,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,1,0.03125,0.009915,0,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.69814,0.031231,0.052286,0,0
3,GO GOLGI LOCALIZATION,0.90549,0.030787,0.030503,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.214,0.030672,0.089671,0,0
3,GO NCRNA METABOLIC PROCESS,0.84314,0.030632,0.023788,0,0
3,GO PROTEIN DESTABILIZATION,0.20822,0.030628,0.11737,0,0
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.2259,0.030532,0.051858,0,0
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.90549,0.030519,0.0044669,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.61803,0.030425,0.06322,0,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.89296,0.030404,0.021385,0,0
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.44264,0.030354,-0.047065,0,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.28529,0.030116,0.12542,0,0
3,GO SNRNA PROCESSING,0.64051,0.030045,0.037065,0,0
3,GO MITOCHONDRIAL RNA PROCESSING,0.78176,0.030003,-0.033301,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.34626,0.029799,0.096243,0,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.60692,0.029758,0.064595,0,0
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.40594,0.029634,0.055226,0,0
3,GO ENDOCRINE PROCESS,0.72171,0.029309,0.055245,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.14312,0.029291,0.081759,0,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.1306,0.029025,0.12522,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.35442,0.028932,0.1182,0,0
3,GO REGULATION OF FERTILIZATION,0.57414,0.028664,0.041833,0,0
3,GO REGULATION OF SPINDLE CHECKPOINT,0.68646,0.028354,0.044832,0,0
3,GO VIRION ASSEMBLY,0.197,0.028271,0.064568,0,0
3,GO NADPH REGENERATION,0.25111,0.028235,0.067762,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.48117,0.028021,0.087617,0,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.75756,0.02775,-0.060215,0,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.69814,0.027724,0.068131,0,0
3,GO TRICARBOXYLIC ACID CYCLE,0.50109,0.027629,0.057056,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.23203,0.027568,0.10797,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.55277,0.027506,0.056602,0,0
3,GO RNA INTERFERENCE,0.88046,0.02748,-0.0078296,0,0
3,GO MACROPHAGE CHEMOTAXIS,0.91805,0.027466,0.039361,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.80618,0.027397,0.056719,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.55277,0.027306,0.060796,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.61803,0.027094,0.041015,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.55277,0.027091,0.061438,0,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.56341,0.02707,0.054825,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.72171,0.027053,0.057137,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.99368,0.026972,0.013024,0,0
3,GO REGULATION OF APPETITE,0.88046,0.026715,0.0014478,0,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.54223,0.02657,0.041131,0,0
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.24463,0.026506,0.076118,0,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.88046,0.026362,0.036626,0,0
3,GO HISTONE EXCHANGE,0.84314,0.026086,0.0099613,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.64051,0.026077,0.073059,0,0
3,GO HISTONE SERINE PHOSPHORYLATION,0.86799,0.026014,0.013157,0,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.61803,0.025955,0.07048,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.44264,0.025854,0.079051,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.4521,0.025413,0.13275,0,0
3,GO HISTAMINE TRANSPORT,0.70989,0.025394,0.050427,0,0
3,GO POSITIVE REGULATION OF WOUND HEALING,0.79394,0.025348,0.05424,0,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.48117,0.025294,0.073094,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.69814,0.025054,0.074503,0,0
3,GO SNRNA METABOLIC PROCESS,0.86799,0.024977,0.02641,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.21989,0.024893,0.1201,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.85555,0.024723,-0.006308,0,0
3,GO LUNG EPITHELIUM DEVELOPMENT,0.62923,0.024671,0.025052,0,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.32248,0.024453,0.060383,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.20822,0.024327,0.083472,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.54223,0.02417,0.070097,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.21989,0.024129,0.090808,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.75756,0.024015,0.027009,0,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.65188,0.023947,0.045789,0,0
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.4521,0.023922,0.078913,0,0
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.81845,0.023874,0.022137,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.36271,0.023756,0.11195,0,0
3,GO PROTEIN OXIDATION,0.55277,0.023655,0.058592,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.17091,0.023547,0.043722,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.41494,0.023453,0.11756,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.76963,0.023294,0.043463,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.93062,0.023279,0.0032097,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.68646,0.0232,0.02668,0,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.76963,0.023142,0.04807,0,0
3,GO SINGLE FERTILIZATION,0.17591,0.022903,0.099787,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.25111,0.022855,0.067182,0,0
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.42405,0.022738,0.063842,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.79394,0.022688,0.015621,0,0
3,GO PROSTATE GLAND GROWTH,0.89296,0.022623,0.0082929,0,0
3,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.95582,0.022524,0.00043806,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.86799,0.022463,0.018181,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.29248,0.022322,0.13461,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.33029,0.022206,0.11018,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.64051,0.022006,0.069014,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.55277,0.021934,0.048525,0,0
3,GO COENZYME A METABOLIC PROCESS,0.20256,0.021781,0.098213,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.11894,0.021723,0.12091,0,0
3,GO SEGMENT SPECIFICATION,0.74555,0.021378,0.037277,0,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.48117,0.021268,0.059688,0,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.17591,0.021206,0.056271,0,0
3,GO RESPONSE TO UV C,0.83078,0.020671,0.019398,0,0
3,GO INTERACTION WITH SYMBIONT,0.96843,0.02064,0.0011,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.91805,0.020499,-0.039072,0,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.52145,0.020442,0.077454,0,0
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.57414,0.020406,0.028866,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.86799,0.019974,0.026062,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.83078,0.019897,0.043686,0,0
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.83078,0.019826,0.0114,0,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.50109,0.01981,0.092449,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.42405,0.019668,0.048712,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.56341,0.019566,0.076367,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.47137,0.019191,0.08172,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.54223,0.019103,0.036864,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.51122,0.019101,0.087755,0,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,0.75756,0.018692,0.03011,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.52145,0.018651,0.092736,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.5959,0.0186,0.049535,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.84314,0.018393,0.029535,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.37111,0.018182,0.097277,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.74555,0.018002,0.033268,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.89296,0.017897,0.025126,0,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.91805,0.017772,0.0083844,0,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.51122,0.017595,0.090418,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.47137,0.017548,0.12889,0,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.27126,0.017527,0.084181,0,0
3,GO BLASTOCYST GROWTH,0.81845,0.017509,0.032933,0,0
3,GO TRNA METABOLIC PROCESS,1,0.017375,0.0053431,0,0
3,GO AMIDE BIOSYNTHETIC PROCESS,1,0.017362,0.021691,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.94321,0.017328,0.027416,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.88046,0.017222,0.028832,0,0
3,GO SODIUM ION HOMEOSTASIS,0.24463,0.017206,0.11398,0,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.48117,0.016888,0.071918,0,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.69814,0.016761,-0.11438,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,1,0.016694,0.023109,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.33029,0.016649,0.1154,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.81845,0.016647,0.035831,0,0
3,GO RIBOSOME BIOGENESIS,0.65188,0.016474,-0.021245,0,0
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.4521,0.016397,0.1416,0,0
3,GO DECIDUALIZATION,0.56341,0.016163,0.081766,0,0
3,GO REGULATION OF CENTROSOME DUPLICATION,0.84314,0.015908,0.035683,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.65188,0.015754,0.078103,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.43329,0.01569,0.08471,0,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.81845,0.015479,-0.020704,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.70989,0.015172,-0.035466,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.83078,0.01514,0.0023366,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.95582,0.014966,0.0035152,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.86799,0.014796,0.051268,0,0
3,GO ENDODERM FORMATION,0.34626,0.014795,0.16868,0,0
3,GO PROTEIN TARGETING,0.53179,0.01476,0.029298,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.38829,0.014684,0.070073,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.83078,0.014593,0.034265,0,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.64051,0.014119,0.050552,0,0
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.37964,0.014104,0.04804,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.98106,0.014094,0.00020333,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.90549,0.014008,0.019271,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.26442,0.013802,0.12099,0,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1,0.013468,-0.010053,0,0
3,GO TELOMERASE RNA LOCALIZATION,0.91805,0.013464,0.014343,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.96843,0.013327,0.033076,0,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.93062,0.013109,0.029334,0,0
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.94321,0.013034,-0.019582,0,0
3,GO URONIC ACID METABOLIC PROCESS,0.85555,0.01281,0.015045,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.83078,0.01257,0.060963,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.83078,0.012481,0.054103,0,0
3,GO QUINONE METABOLIC PROCESS,0.58498,0.01219,0.083215,0,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.62923,0.011907,0.067603,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.76963,0.011883,0.056575,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.76963,0.011639,0.042739,0,0
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.47137,0.011362,0.046993,0,0
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.49108,0.011346,0.065805,0,0
3,GO MONONUCLEAR CELL MIGRATION,0.85555,0.011323,0.036467,0,0
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.65188,0.0113,0.02619,0,0
3,GO EPIDERMIS DEVELOPMENT,0.74555,0.01123,0.029221,0,0
3,GO LIPID DROPLET ORGANIZATION,0.42405,0.011223,0.081966,0,0
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.69814,0.011076,0.070437,0,0
3,GO TRNA METHYLATION,0.83078,0.010835,-0.0044911,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.86799,0.010834,0.0239,0,0
3,GO REGULATION OF ICOSANOID SECRETION,0.58498,0.010716,0.073912,0,0
3,GO WATER TRANSPORT,0.52145,0.010635,0.10399,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.68646,0.010477,0.081513,0,0
3,GO LUNG CELL DIFFERENTIATION,0.72171,0.010022,-0.0029041,0,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.89296,0.0099854,0.046989,0,0
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.46168,0.0098395,0.060162,0,0
3,GO METHIONINE METABOLIC PROCESS,0.62923,0.0097839,0.061315,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.93062,0.0096811,-0.0062786,0,0
3,GO PIRNA METABOLIC PROCESS,0.61803,0.0093213,0.039855,0,0
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.7336,0.0092187,0.031652,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.93062,0.0090322,-0.0069864,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.94321,0.0089448,0.020942,0,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.89296,0.0089089,0.042693,0,0
3,GO MYOBLAST MIGRATION,0.95582,0.0088743,-0.019378,0,0
3,GO PRIMARY MIRNA PROCESSING,0.98106,0.0088013,-0.017988,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.214,0.008315,0.070531,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.37964,0.0082392,0.072951,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.94321,0.00821,0.005371,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.84314,0.008129,0.0096103,0,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.80618,0.0079533,0.040472,0,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.90549,0.0077796,0.050344,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.60692,0.0076009,0.0090262,0,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.42405,0.0075034,0.098329,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.53179,0.0073226,0.051608,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.42405,0.0072889,0.067399,0,0
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.66333,0.0072058,0.036454,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.79394,0.0070447,0.04218,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.56341,0.0064793,0.11723,0,0
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.88046,0.0062706,0.032574,0,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.66333,0.0060228,0.07126,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.89296,0.0059068,0.041948,0,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.81845,0.0057747,0.0051848,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.67486,0.0057021,0.071078,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.41494,0.0056656,0.10685,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.42405,0.0055486,0.098265,0,0
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.69814,0.0053908,-0.011004,0,0
3,GO IMP BIOSYNTHETIC PROCESS,0.99368,0.004655,0.023888,0,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.83078,0.004532,-0.0028075,0,0
3,GO AEROBIC RESPIRATION,0.86799,0.0044846,0.034866,0,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.86799,0.0044743,0.047401,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.7336,0.0043554,0.066464,0,0
3,GO MULTIVESICULAR BODY ORGANIZATION,0.69814,0.0040898,0.0027705,0,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.75756,0.0040433,-0.027318,0,0
3,GO DE NOVO PROTEIN FOLDING,0.95582,0.0040321,0.033714,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.99368,0.0039522,0.034253,0,0
3,GO RESPONSE TO X RAY,0.94321,0.0038828,0.028908,0,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.78176,0.0036344,0.032723,0,0
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.67486,0.0036259,-0.0075825,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.69814,0.003622,0.03004,0,0
3,GO CHOLESTEROL STORAGE,0.53179,0.003521,0.11148,0,0
3,GO MITOTIC CYTOKINETIC PROCESS,0.81845,0.0035025,0.0082767,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.30724,0.0029641,0.085802,0,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.56341,0.0028827,0.056395,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.81845,0.0027247,0.036453,0,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.98106,0.0027231,0.03051,0,0
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.46168,0.0026419,0.046473,0,0
3,GO DEFENSE RESPONSE TO BACTERIUM,0.84314,0.0025844,0.015529,0,0
3,GO ENAMEL MINERALIZATION,0.65188,0.0023519,0.09324,0,0
3,GO PROTEIN HYDROXYLATION,0.99368,0.0022577,0.030088,0,0
3,GO AMELOGENESIS,0.76963,0.0022328,0.067809,0,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.94321,0.0020011,0.014212,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.79394,0.0018871,0.045562,0,0
3,GO VIRAL BUDDING,0.68646,0.0018747,0.03233,0,0
3,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,1,0.0018663,0.020954,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.86799,0.0017433,0.044883,0,0
3,GO REGULATION OF CENTROSOME CYCLE,0.78176,0.0016945,0.03575,0,0
3,GO TOXIN METABOLIC PROCESS,0.74555,0.0016796,0.040296,0,0
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.67486,0.0016311,0.067564,0,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.89296,0.0014684,0.012365,0,0
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.33029,0.0012327,-0.038819,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.50109,0.0011699,0.07952,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.4521,0.00090133,0.11621,0,0
3,GO CELLULAR RESPIRATION,0.39705,0.00073815,0.045501,0,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.48117,0.00073763,0.091373,0,0
3,GO REGULATION OF CELLULAR RESPIRATION,0.86799,0.00072287,0.020275,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.72171,0.00070267,0.071809,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.65188,0.00043069,0.053263,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.85555,0.00021839,0.026247,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.88046,-0.0003088,0.0075213,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.69814,-0.0003643,0.0039776,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.75756,-0.00045259,0.038605,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.75756,-0.00046197,0.035623,0,0
3,GO MITOCHONDRIAL FUSION,0.57414,-0.00052322,0.07268,0,0
3,GO RESPONSE TO PROGESTERONE,0.95582,-0.00054394,0.024827,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.37964,-0.00061393,0.10179,0,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.70989,-0.00073287,0.045849,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.57414,-0.00085594,0.054329,0,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.46168,-0.00088058,0.10452,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.83078,-0.00095802,0.0008944,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.69814,-0.0010767,0.073928,0,0
3,GO OXIDATIVE PHOSPHORYLATION,0.75756,-0.0013588,0.023534,0,0
3,GO MESODERMAL CELL FATE SPECIFICATION,0.3148,-0.0015842,0.15365,0,0
3,GO LIPID EXPORT FROM CELL,0.55277,-0.0017346,0.067297,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.44264,-0.0019801,0.14077,0,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.76963,-0.0021297,0.014441,0,0
3,GO PSEUDOURIDINE SYNTHESIS,0.84314,-0.002431,0.020217,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.7336,-0.0025811,0.016402,0,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.7336,-0.0027723,-0.0069062,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.94321,-0.0028425,0.011974,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.80618,-0.0028556,-0.020868,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.66333,-0.0028613,-0.029923,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.98106,-0.0030854,0.011193,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.69814,-0.0031592,0.075208,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.43329,-0.0037295,0.15866,0,0
3,GO VESICLE CARGO LOADING,0.86799,-0.0039282,0.037878,0,0
3,GO KERATINOCYTE PROLIFERATION,0.94321,-0.0039897,0.0053612,0,0
3,GO TRNA CATABOLIC PROCESS,0.67486,-0.0043819,0.034206,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.67486,-0.0044087,0.11092,0,0
3,GO MICROVILLUS ORGANIZATION,0.84314,-0.0046292,0.0053117,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.50109,-0.0047318,0.085588,0,0
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.40594,-0.0048726,0.090574,0,0
3,GO HISTONE MRNA METABOLIC PROCESS,0.68646,-0.0055381,0.024263,0,0
3,GO RNA 5 END PROCESSING,0.90549,-0.0057243,0.0086589,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.91805,-0.0059203,0.0044647,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.91805,-0.0059575,0.022922,0,0
3,GO EPIDERMAL CELL DIFFERENTIATION,0.75756,-0.0059589,-0.017859,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.88046,-0.0060298,0.00045419,0,0
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.56341,-0.0060322,-0.030635,0,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.3148,-0.0061105,0.11691,0,0
3,GO CENTROSOME SEPARATION,0.76963,-0.0061526,0.046597,0,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.80618,-0.0064218,0.033296,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.60692,-0.0064676,0.069175,0,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.95582,-0.0064679,0.020671,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.75756,-0.006506,0.020311,0,0
3,GO ORGAN INDUCTION,0.99368,-0.0072984,-0.014633,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.98106,-0.0075924,0.0022645,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.54223,-0.0076379,-0.020336,0,0
3,GO PEPTIDE METABOLIC PROCESS,0.90549,-0.0076697,0.023575,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.64051,-0.0079967,0.052577,0,0
3,GO LEYDIG CELL DIFFERENTIATION,0.90549,-0.0080006,-0.027933,0,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.83078,-0.0081394,0.017722,0,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.90549,-0.0082476,0.031547,0,0
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.88046,-0.0084476,0.019612,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.99368,-0.0085405,0.021403,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.74555,-0.0086261,0.01656,0,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.49108,-0.008821,0.069682,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.84314,-0.0088873,0.025985,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.78176,-0.0088884,0.049798,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.66333,-0.0088887,0.069676,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.79394,-0.0089418,0.058891,0,0
3,GO IMP METABOLIC PROCESS,0.80618,-0.009351,0.019984,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.85555,-0.0095432,0.030572,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.74555,-0.0099823,0.072514,0,0
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.76963,-0.010044,-0.010032,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.89296,-0.01019,0.01912,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.74555,-0.010382,-0.0834,0,0
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.65188,-0.010405,0.00065464,0,0
3,GO RNA CATABOLIC PROCESS,0.72171,-0.010849,-0.00049416,0,0
3,GO NUCLEAR PORE ORGANIZATION,0.86799,-0.011004,-0.0026934,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.85555,-0.011297,0.045066,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.84314,-0.011657,-0.022542,0,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.89296,-0.011814,0.01611,0,0
3,GO REGULATION OF WATER LOSS VIA SKIN,0.40594,-0.011853,-0.063466,0,0
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.3148,-0.012101,-0.038495,0,0
3,GO REGULATION OF RUFFLE ASSEMBLY,1,-0.012135,0.038672,0,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.78176,-0.012513,0.020791,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,1,-0.012555,0.01236,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.53179,-0.012627,0.04999,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.85555,-0.012695,-0.010167,0,0
3,GO SPERM CAPACITATION,1,-0.0127,0.014398,0,0
3,GO ANIMAL ORGAN REGENERATION,0.84314,-0.012735,0.044349,0,0
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.75756,-0.013211,-0.0078611,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.67486,-0.013547,0.010491,0,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.83078,-0.013746,-0.043235,0,0
3,GO DETOXIFICATION,0.68646,-0.013987,-0.00029814,0,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.33821,-0.014144,0.097077,0,0
3,GO ANOIKIS,0.89296,-0.014176,0.033082,0,0
3,GO TRANSLATIONAL ELONGATION,0.53179,-0.014234,-0.017799,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.81845,-0.01429,0.0038541,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.80618,-0.014618,0.0025309,0,0
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.61803,-0.014648,-0.020205,0,0
3,GO MANGANESE ION TRANSPORT,0.78176,-0.015359,-0.001743,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.85555,-0.015453,-0.027414,0,0
3,GO RESPONSE TO CADMIUM ION,0.88046,-0.015678,0.040162,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.68646,-0.0157,-0.015037,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.98106,-0.016078,0.029074,0,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.98106,-0.016748,0.034828,0,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.74555,-0.017196,0.0078594,0,0
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.79394,-0.017204,-0.0063593,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.89296,-0.017354,0.052669,0,0
3,GO KERATINOCYTE DIFFERENTIATION,0.56341,-0.017579,-0.061235,0,0
3,GO BIOLOGICAL PHASE,0.5959,-0.017615,-0.058288,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.72171,-0.017708,0.059164,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.99368,-0.017762,0.016823,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.66333,-0.017858,-0.0031272,0,0
3,GO CYTOKINETIC PROCESS,0.99368,-0.01786,0.040791,0,0
3,GO IRON ION TRANSPORT,0.80618,-0.018403,0.057331,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.84314,-0.018975,0.0024472,0,0
3,GO RETINAL METABOLIC PROCESS,0.86799,-0.019504,-0.010285,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.61803,-0.019507,-0.088161,0,0
3,GO FRUCTOSE METABOLIC PROCESS,0.49108,-0.019522,0.082549,0,0
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.83078,-0.019591,0.00049415,0,0
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.89296,-0.020044,0.0052085,0,0
3,GO TRNA 5 END PROCESSING,0.5959,-0.020716,-0.021184,0,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.66333,-0.020835,0.024545,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.50109,-0.021563,-0.022548,0,0
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.28529,-0.022068,-0.054949,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.78176,-0.022624,-0.011872,0,0
3,GO TRANSCYTOSIS,0.66333,-0.022696,-0.020966,0,0
3,GO SPERM EGG RECOGNITION,0.72171,-0.023315,-0.012013,0,0
3,GO GAP JUNCTION ASSEMBLY,0.76963,-0.023885,0.040371,0,0
3,GO MAGNESIUM ION TRANSPORT,0.65188,-0.024256,0.0085354,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.94321,-0.024325,0.033747,0,0
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.99368,-0.024589,0.031395,0,0
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.60692,-0.025277,-0.0093716,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.37111,-0.025432,-0.037438,0,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.99368,-0.025554,0.033053,0,0
3,GO LIVER MORPHOGENESIS,0.57414,-0.025651,-0.029141,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.96843,-0.025732,0.014864,0,0
3,GO MITOCHONDRIAL TRANSCRIPTION,0.43329,-0.026361,-0.035455,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.5959,-0.026408,-0.023339,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.48117,-0.02641,-0.024837,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.95582,-0.02664,0.023099,0,0
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.42405,-0.02697,-0.029179,0,0
3,GO INTESTINAL ABSORPTION,0.88046,-0.027598,0.014431,0,0
3,GO HEPATOCYTE DIFFERENTIATION,0.28529,-0.027814,-0.089946,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.69814,-0.02784,-0.0022234,0,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.80618,-0.027898,0.040222,0,0
3,GO MIDBODY ABSCISSION,0.2998,-0.028232,-0.052395,0,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.86799,-0.028472,-0.038174,0,0
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.64051,-0.029149,-0.010471,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.93062,-0.029344,-0.013958,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.69814,-0.030474,-0.0017891,0,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.95582,-0.030655,0.010782,0,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.55277,-0.030708,-0.0012364,0,0
3,GO OSTEOBLAST PROLIFERATION,0.86799,-0.030732,0.0024184,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.89296,-0.031304,0.019245,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.95582,-0.031528,0.017234,0,0
3,GO REGULATION OF GTP BINDING,0.95582,-0.032061,0.012465,0,0
3,GO PIGMENT GRANULE LOCALIZATION,0.54223,-0.032279,-0.019258,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.66333,-0.032428,-0.021807,0,0
3,GO REGULATION OF ANOIKIS,0.4521,-0.032583,-0.072207,0,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.69814,-0.032951,0.015465,0,0
3,GO MONOCYTE CHEMOTAXIS,0.90549,-0.033217,-0.003555,0,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.72171,-0.033461,0.058874,0,0
3,GO IRON ION HOMEOSTASIS,0.62923,-0.033638,-0.0045997,0,0
3,GO RESPONSE TO LIPOTEICHOIC ACID,0.54223,-0.034138,0.11535,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.76963,-0.034164,-0.01445,0,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.52145,-0.034387,-0.036208,0,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.88046,-0.036187,0.016699,0,0
3,GO INTESTINAL LIPID ABSORPTION,0.81845,-0.036681,-0.015861,0,0
3,GO OVULATION,0.51122,-0.036792,-0.068075,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.57414,-0.036914,0.013621,0,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.85555,-0.037857,-0.0052606,0,0
3,GO POLYOL TRANSPORT,0.66333,-0.038157,-0.022527,0,0
3,GO AMINO ACID ACTIVATION,0.44264,-0.038419,-0.020932,0,0
3,GO MITOCHONDRIAL GENE EXPRESSION,0.15197,-0.03849,-0.049273,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.99368,-0.039604,0.054814,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.35442,-0.041081,-0.027643,0,0
3,GO ZINC ION HOMEOSTASIS,0.94321,-0.041507,0.03563,0,0
3,GO REGULATION OF CELL FATE SPECIFICATION,0.67486,-0.041679,-0.029064,0,0
3,GO BILE ACID METABOLIC PROCESS,0.70989,-0.041953,-0.012323,0,0
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.75756,-0.043971,-0.015285,0,0
3,GO CYTOPLASMIC TRANSLATION,0.20256,-0.044194,-0.053032,0,0
3,GO MATURATION OF LSU RRNA,0.18624,-0.044529,-0.094146,0,0
3,GO POSITIVE REGULATION OF COAGULATION,0.98106,-0.045011,0.028584,0,0
3,GO PROTEIN TARGETING TO MEMBRANE,0.098083,-0.045093,-0.044747,0,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,0.58498,-0.045603,-0.059641,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.96843,-0.046199,0.034301,0,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.54223,-0.046588,-0.014896,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.34626,-0.047126,-0.014098,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.91805,-0.047408,-0.0011368,0,0
3,GO TRNA 5 LEADER REMOVAL,0.11163,-0.047468,-0.089093,0,0
3,GO MITOCHONDRIAL TRANSLATION,0.17091,-0.047918,-0.050355,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.99368,-0.048576,0.034999,0,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.29248,-0.04872,-0.024181,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.75756,-0.048883,-0.046055,0,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.95582,-0.04966,0.026761,0,0
3,GO PROTEIN REFOLDING,0.78176,-0.049944,0.0026315,0,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.61803,-0.050166,-0.010332,0,0
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.60692,-0.050851,-0.0077153,0,0
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.94321,-0.051375,0.046886,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.86799,-0.051455,0.014105,0,0
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.077559,-0.05256,-0.11295,0,0
3,GO TRANSLATIONAL TERMINATION,0.16602,-0.05265,-0.053276,0,0
3,GO TONIC SMOOTH MUSCLE CONTRACTION,0.51122,-0.053046,-0.081161,0,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.95582,-0.053637,0.0095087,0,0
3,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.69814,-0.053674,-0.080195,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.26442,-0.053715,-0.088846,0,0
3,GO NEGATIVE REGULATION OF ANOIKIS,0.33821,-0.053795,-0.1139,0,0
3,GO OXYGEN TRANSPORT,0.66333,-0.053929,-0.064199,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.93062,-0.053945,0.055338,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.67486,-0.054163,-0.024941,0,0
3,GO BLEB ASSEMBLY,0.67486,-0.055449,-0.050382,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.98106,-0.055801,0.0037515,0,0
3,GO MALE GENITALIA DEVELOPMENT,0.39705,-0.055929,-0.084887,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.60692,-0.056031,-0.027544,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.89296,-0.056611,0.029673,0,0
3,GO REFLEX,0.62923,-0.056745,-0.025154,0,0
3,GO LIVER REGENERATION,0.60692,-0.056982,-0.0021743,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.33029,-0.057097,-0.056031,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.78176,-0.057609,-0.014238,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.83078,-0.058012,0.01303,0,0
3,GO ER OVERLOAD RESPONSE,0.64051,-0.058272,0.018839,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.2998,-0.058647,-0.079873,0,0
3,GO VIRAL GENE EXPRESSION,0.058535,-0.059631,-0.067336,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.2998,-0.059722,-0.059328,0,0
3,GO BRONCHUS DEVELOPMENT,0.79394,-0.060825,0.016498,0,0
3,GO RESPONSE TO MANGANESE ION,0.66333,-0.061046,-0.0019966,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.27821,-0.061251,-0.042909,0,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.79394,-0.062155,-0.00040019,0,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.68646,-0.062532,-0.0044749,0,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.33821,-0.06345,-0.037398,0,0
3,GO O GLYCAN PROCESSING,0.78176,-0.064267,-0.028049,0,0
3,GO BICARBONATE TRANSPORT,0.41494,-0.064451,-0.050789,0,0
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.76963,-0.064484,-0.045482,0,0
3,GO ACUTE PHASE RESPONSE,0.52145,-0.064542,-0.072098,0,0
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.15197,-0.064786,-0.064081,0,0
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.44264,-0.065012,-0.051661,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.70989,-0.065663,0.013059,0,0
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.36271,-0.066366,-0.046068,0,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.28529,-0.066736,-0.057257,0,0
3,GO IRON COORDINATION ENTITY TRANSPORT,0.81845,-0.066808,0.024321,0,0
3,GO ETHANOL OXIDATION,0.78176,-0.067051,-0.073263,0,0
3,GO HISTAMINE SECRETION,0.98106,-0.067499,0.0010286,0,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.86799,-0.067964,0.023827,0,0
3,GO RIBOSOME ASSEMBLY,0.17591,-0.06887,-0.059027,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.68646,-0.06892,-0.049209,0,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.11894,-0.069104,-0.065913,0,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.27821,-0.070003,-0.090267,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.95582,-0.070004,0.042498,0,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.36271,-0.070541,0.0007038,0,0
3,GO RESPONSE TO COPPER ION,0.81845,-0.070726,0.011695,0,0
3,GO REPLICATIVE SENESCENCE,0.83078,-0.070887,0.0041371,0,0
3,GO PROTEASOME ASSEMBLY,0.20256,-0.071027,-0.063284,0,0
3,GO GTP METABOLIC PROCESS,0.70989,-0.072091,-0.0060781,0,0
3,GO LIPID DIGESTION,0.75756,-0.072764,-0.052661,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.80618,-0.073609,-0.0050112,0,0
3,GO DETECTION OF CALCIUM ION,0.90549,-0.073693,0.013395,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.68646,-0.073918,-0.026565,0,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.61803,-0.073954,-0.093614,0,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.33029,-0.074574,-0.12513,0,0
3,GO FIBRINOLYSIS,0.56341,-0.074734,-0.07109,0,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.69814,-0.074842,-0.077971,0,0
3,GO PROTEIN AUTOPROCESSING,0.35442,-0.075088,-0.07174,0,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.28529,-0.076327,-0.067052,0,0
3,GO RRNA 3 END PROCESSING,0.74555,-0.076641,-0.022608,0,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.96843,-0.077076,0.024372,0,0
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.74555,-0.077488,0.019625,0,0
3,GO LACTATE METABOLIC PROCESS,0.83078,-0.077709,0.0051407,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.65188,-0.077842,0.009525,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.37964,-0.078058,-0.058894,0,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.72171,-0.078976,0.04423,0,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.35442,-0.079905,-0.057224,0,0
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.23203,-0.080454,-0.076307,0,0
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.36271,-0.082129,-0.058265,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.2577,-0.083046,-0.05513,0,0
3,GO DRUG METABOLIC PROCESS,0.28529,-0.083137,-0.071997,0,0
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0172,-0.083157,-0.13178,0,0
3,GO ESTROUS CYCLE,0.57414,-0.083164,-0.051918,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.93062,-0.085166,0.023529,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.68646,-0.086707,-0.027493,0,0
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.27821,-0.086997,-0.062844,0,0
3,GO PROTEIN NITROSYLATION,0.40594,-0.087283,-0.064905,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.27821,-0.087298,-0.031926,0,0
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.08303,-0.087422,-0.078317,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.027226,-0.088417,-0.083595,0,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.28529,-0.088646,-0.046127,0,0
3,GO PLASMINOGEN ACTIVATION,0.25111,-0.08908,-0.1217,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.25111,-0.089537,-0.07565,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.37964,-0.089787,-0.027638,0,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.80618,-0.091156,-0.0025434,0,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.4521,-0.092474,-0.019223,0,0
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.037377,-0.095271,-0.11407,0,0
3,GO SIGNAL PEPTIDE PROCESSING,0.3148,-0.095574,-0.069486,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.57414,-0.09582,-0.017074,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.49108,-0.096178,-0.044246,0,0
3,GO MUCUS SECRETION,0.18102,-0.096287,-0.16658,0,0
3,GO CELL AGGREGATION,0.54223,-0.096583,-0.084097,0,0
3,GO HEART INDUCTION,0.84314,-0.097352,-0.014359,0,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.20822,-0.097683,-0.061798,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.16123,-0.097887,-0.12804,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.28529,-0.098685,-0.036562,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.12273,-0.10181,-0.079941,0,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.49108,-0.10297,-0.083502,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.14312,-0.10346,-0.068817,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.2259,-0.10376,-0.10892,0,0
3,GO RESPONSE TO NITROSATIVE STRESS,0.058535,-0.10529,-0.097981,0,0
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.08588,-0.10686,-0.11457,0,0
3,GO COPPER ION TRANSPORT,0.27126,-0.10696,-0.08233,0,0
3,GO KERATINIZATION,0.33821,-0.11159,-0.10055,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.2998,-0.1128,-0.074398,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.67486,-0.11532,-0.025556,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.81845,-0.11843,-0.039644,0,0
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.39705,-0.12024,-0.057101,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.7336,-0.12082,-0.015644,0,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.27821,-0.12171,-0.11904,0,0
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.10468,-0.12251,-0.096418,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.5959,-0.12365,-0.054153,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.15655,-0.12451,-0.13676,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.069906,-0.12468,-0.13265,0,0
3,GO PROSTAGLANDIN SECRETION,0.81845,-0.12513,0.033619,0,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.37111,-0.12572,-0.095306,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.90549,-0.12872,0.013963,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.33029,-0.13002,-0.062901,0,0
3,GO TRANSLATIONAL INITIATION,0.0018673,-0.13072,-0.1272,0,0
3,GO SEQUESTERING OF METAL ION,0.34626,-0.13281,-0.10741,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.37111,-0.13697,-0.052004,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.12662,-0.14034,-0.095893,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.64051,-0.14069,0.0035943,0,0
3,GO DRUG CATABOLIC PROCESS,0.091819,-0.14653,-0.13588,0,0
3,GO CORNIFICATION,0.1306,-0.15078,-0.16969,0,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.067497,-0.15216,-0.11557,0,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.18102,-0.18297,-0.16866,0,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.077559,-0.19035,-0.14403,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.052482,-0.20461,-0.31813,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.35442,-0.22109,-0.15516,0,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.067497,-0.26104,-0.21451,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.30724,-0.2674,-0.17221,0,0
4,GO OUTER DYNEIN ARM ASSEMBLY,0.0063209,0.67074,0.51237,1,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0010209,0.62543,0.61713,1,1
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0012071,0.62205,0.68183,1,1
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.0054671,0.59026,0.44668,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0049572,0.57552,0.47969,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0027019,0.56075,0.48804,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,7.8298e-05,0.54966,0.75607,1,1
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0013481,0.54355,0.44643,1,1
4,GO LOOP OF HENLE DEVELOPMENT,0.00023283,0.54282,0.55236,1,1
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00086166,0.53949,0.49087,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00026348,0.53284,0.65768,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00332,0.5278,0.49814,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00010181,0.52556,0.62763,1,1
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00051151,0.5246,0.5198,1,1
4,GO PONS DEVELOPMENT,0.00014062,0.51956,0.6068,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0021907,0.50342,0.52035,1,1
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00021879,0.50325,0.54217,1,1
4,GO SYNAPTIC VESICLE DOCKING,0.00033648,0.4991,0.66821,1,1
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0083971,0.48659,0.36675,1,1
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00014989,0.48406,0.49094,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00048214,0.47665,0.48389,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0042727,0.47615,0.41386,1,1
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00332,0.47317,0.43356,1,1
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.00013188,0.47179,0.62988,1,1
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0023095,0.46652,0.48021,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,8.9327e-05,0.45689,0.62103,1,1
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00042807,0.45677,0.67834,1,1
4,GO DENSE CORE GRANULE TRANSPORT,0.00068502,0.44643,0.56444,1,1
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0015041,0.44424,0.37859,1,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00028019,0.44381,0.49743,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,7.8298e-05,0.44301,0.597,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0021907,0.44081,0.44581,1,1
4,GO CELL JUNCTION MAINTENANCE,0.00019306,0.44008,0.40795,1,1
4,GO AXONEME ASSEMBLY,0.0029965,0.43844,0.3801,1,1
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0076456,0.43807,0.47816,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0040644,0.43755,0.39703,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00013188,0.43717,0.65224,1,1
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.0021907,0.43122,0.42033,1,1
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0054671,0.43039,0.36751,1,1
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0031545,0.42977,0.35789,1,1
4,GO DENDRITIC TRANSPORT,0.0076456,0.4285,0.35113,1,1
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0076456,0.42661,0.45751,1,1
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0010209,0.42585,0.46655,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00014062,0.41552,0.53888,1,1
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00051151,0.4148,0.42274,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00054254,0.41325,0.47152,1,1
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,5.9985e-05,0.4125,0.42286,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0027019,0.41244,0.45802,1,1
4,GO LIPID DIGESTION,0.0010209,0.40648,0.43956,1,1
4,GO PREPULSE INHIBITION,0.0054671,0.40379,0.42828,1,1
4,GO RESPONSE TO FORSKOLIN,0.0015882,0.40074,0.421,1,1
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0024341,0.3961,0.39019,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00045436,0.39596,0.38552,1,1
4,GO NEURON REMODELING,0.007293,0.39567,0.36652,1,1
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00076864,0.3952,0.49052,1,1
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0018673,0.39098,0.48144,1,1
4,GO SYNAPTIC VESICLE CLUSTERING,0.00081392,0.39092,0.50124,1,1
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0027019,0.38974,0.62491,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0010209,0.38969,0.39991,1,1
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.0023095,0.38863,0.38673,1,1
4,GO VOCALIZATION BEHAVIOR,0.0060238,0.38723,0.35745,1,1
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.0028457,0.38711,0.40221,1,1
4,GO REFLEX,0.0023095,0.38421,0.38683,1,1
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00051151,0.38295,0.44356,1,1
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0012758,0.38082,0.37694,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.0029965,0.37897,0.3,1,1
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0019699,0.37796,0.39869,1,1
4,GO POSTSYNAPSE ASSEMBLY,0.0066311,0.37788,0.40449,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00081392,0.37665,0.31837,1,1
4,GO MEMBRANE DEPOLARIZATION,0.00017019,0.37604,0.3977,1,1
4,GO IRON COORDINATION ENTITY TRANSPORT,0.0025648,0.37252,0.34863,1,1
4,GO EXTRACELLULAR TRANSPORT,0.0018673,0.37087,0.35355,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00019306,0.37063,0.55426,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.00086166,0.3696,0.36416,1,1
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00072571,0.36938,0.43044,1,1
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0042727,0.36937,0.31266,1,1
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.00035748,0.36923,0.48169,1,1
4,GO REGULATION OF CILIUM ASSEMBLY,0.0015041,0.36902,0.31921,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00014989,0.3689,0.53641,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00086166,0.36792,0.36009,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.0054671,0.36528,0.30362,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0034935,0.36334,0.4684,1,1
4,GO ADRENAL GLAND DEVELOPMENT,0.0012071,0.36316,0.36521,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.0015882,0.36267,0.4446,1,1
4,GO INTESTINAL LIPID ABSORPTION,0.00076864,0.36199,0.45502,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00081392,0.36168,0.4078,1,1
4,GO SECRETORY GRANULE LOCALIZATION,0.0044907,0.35989,0.39039,1,1
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0011418,0.35986,0.34862,1,1
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0023095,0.35952,0.35171,1,1
4,GO GLUTAMATE SECRETION,0.00064645,0.35757,0.36777,1,1
4,GO NEURONAL ACTION POTENTIAL,0.0016767,0.35697,0.3869,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.045233,0.3564,0.26348,1,1
4,GO MICROTUBULE BUNDLE FORMATION,0.0014241,0.35586,0.35448,1,1
4,GO SYNAPTIC VESICLE BUDDING,0.0021907,0.35576,0.32837,1,1
4,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.043559,0.35476,0.28937,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0016767,0.35423,0.38463,1,1
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0011418,0.35303,0.36413,1,1
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00040321,0.35179,0.44272,1,1
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0036751,0.35153,0.37576,1,1
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0010798,0.35132,0.3857,1,1
4,GO SYNAPTIC VESICLE MATURATION,0.00042807,0.35107,0.51246,1,1
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0014241,0.34935,0.3573,1,1
4,GO DOSAGE COMPENSATION,0.0040644,0.34774,0.30121,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0020776,0.34736,0.39116,1,1
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.0040644,0.34725,0.3814,1,1
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.0040644,0.3463,0.37583,1,1
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0024341,0.34558,0.42141,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00096503,0.34439,0.33628,1,1
4,GO REGULATION OF DOPAMINE SECRETION,0.00019306,0.3425,0.49076,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0040644,0.34164,0.31374,1,1
4,GO MRNA SPLICE SITE SELECTION,0.012106,0.3405,0.28228,1,1
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0052065,0.33979,0.27748,1,1
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0036751,0.33946,0.55451,1,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.01266,0.33908,0.27546,1,1
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.00051151,0.33904,0.39475,1,1
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0029965,0.33879,0.3735,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0016767,0.33702,0.35776,1,1
4,GO SYNAPTIC VESICLE LOCALIZATION,0.00033648,0.33698,0.37777,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.011574,0.33572,0.28282,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.046961,0.33445,0.2393,1,1
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.025096,0.33286,0.31694,1,1
4,GO NEURON MATURATION,0.0024341,0.33152,0.31724,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.024086,0.33106,0.26704,1,1
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0020776,0.33042,0.31589,1,1
4,GO NEUROTRANSMITTER SECRETION,0.00054254,0.3304,0.4086,1,1
4,GO HISTONE H3 K9 DEMETHYLATION,0.00332,0.32995,0.32885,1,1
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.00081392,0.32931,0.4197,1,1
4,GO CHROMATIN SILENCING AT TELOMERE,0.010101,0.32785,0.24308,1,1
4,GO PROTEIN POLYGLUTAMYLATION,0.00042807,0.32588,0.36113,1,1
4,GO COLLECTING DUCT DEVELOPMENT,0.0012758,0.32556,0.40725,1,1
4,GO STARTLE RESPONSE,0.0016767,0.32553,0.35323,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0016767,0.32535,0.38174,1,1
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0034935,0.32533,0.29141,1,1
4,GO RETROGRADE AXONAL TRANSPORT,0.0076456,0.32525,0.33376,1,1
4,GO CHEMOSENSORY BEHAVIOR,0.00018128,0.32481,0.40855,1,1
4,GO SYNAPSE ASSEMBLY,0.00096503,0.32469,0.37653,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0021907,0.32439,0.35424,1,1
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.013834,0.32426,0.27261,1,1
4,GO REGULATION OF VESICLE FUSION,0.00081392,0.32416,0.38178,1,1
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.00072571,0.3234,0.39095,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0096484,0.32332,0.33999,1,1
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0049572,0.32323,0.38434,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0025648,0.32277,0.31692,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.023112,0.32274,0.30575,1,1
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0025648,0.32224,0.3172,1,1
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0014241,0.32043,0.30489,1,1
4,GO LOCOMOTOR RHYTHM,0.00054254,0.3204,0.40197,1,1
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.011574,0.32016,0.29343,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0024341,0.31948,0.37323,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0017696,0.31939,0.35775,1,1
4,GO COLLATERAL SPROUTING,0.0038653,0.31917,0.35053,1,1
4,GO MICROTUBULE POLYMERIZATION,0.0015041,0.31907,0.30601,1,1
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0020776,0.31762,0.43678,1,1
4,GO NEUROTRANSMITTER TRANSPORT,0.00057531,0.31656,0.37778,1,1
4,GO PANCREATIC JUICE SECRETION,0.015776,0.31646,0.24779,1,1
4,GO FOREBRAIN NEURON DEVELOPMENT,0.0019699,0.31599,0.32282,1,1
4,GO MICROTUBULE SEVERING,0.010572,0.31592,0.25994,1,1
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0017696,0.31585,0.28042,1,1
4,GO REGULATION OF COLLATERAL SPROUTING,0.011063,0.31463,0.32534,1,1
4,GO SYNAPTIC VESICLE PRIMING,0.00048214,0.31365,0.52409,1,1
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0015041,0.31182,0.38057,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0018673,0.31181,0.26996,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0063209,0.31043,0.3879,1,1
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.010101,0.31021,0.3451,1,1
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0063209,0.31017,0.29416,1,1
4,GO HISTONE H3 K4 TRIMETHYLATION,0.0080134,0.31012,0.33843,1,1
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0057394,0.31005,0.32694,1,1
4,GO ADULT BEHAVIOR,0.0042727,0.30948,0.28426,1,1
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0010798,0.30936,0.39511,1,1
4,GO NODAL SIGNALING PATHWAY,0.0016767,0.30921,0.31791,1,1
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.0025648,0.30879,0.44018,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.00081392,0.30864,0.38979,1,1
4,GO SECONDARY HEART FIELD SPECIFICATION,0.0063209,0.30837,0.3602,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0096484,0.30835,0.26873,1,1
4,GO NEURON PROJECTION EXTENSION,0.00068502,0.30835,0.33252,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0012071,0.3082,0.41382,1,1
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0057394,0.30782,0.27396,1,1
4,GO REGULATION OF GOLGI ORGANIZATION,0.00076864,0.30702,0.34924,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,4.5779e-05,0.30629,0.37766,1,1
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00017019,0.30618,0.33529,1,1
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.0017696,0.3061,0.36353,1,1
4,GO ANTEROGRADE AXONAL TRANSPORT,0.0027019,0.30582,0.30434,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0010798,0.30565,0.35921,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.023112,0.30537,0.27329,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00081392,0.30513,0.32986,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0010798,0.30258,0.2798,1,1
4,GO PEPTIDYL ARGININE METHYLATION,1.7249e-05,0.30197,0.34315,1,1
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.0076456,0.30111,0.28667,1,1
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.0042727,0.30055,0.39228,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0044907,0.3001,0.36373,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0018673,0.29977,0.3421,1,1
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0024341,0.29951,0.32387,1,1
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0025648,0.29889,0.29282,1,1
4,GO DENDRITE MORPHOGENESIS,0.0044907,0.29872,0.2951,1,1
4,GO PROTEIN PALMITOYLATION,0.00013188,0.2987,0.35201,1,1
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00045436,0.29857,0.37432,1,1
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.008797,0.29824,0.27431,1,1
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.0052065,0.29756,0.34056,1,1
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.015104,0.29728,0.32737,1,1
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00045436,0.29649,0.32322,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.008797,0.296,0.33974,1,1
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0049572,0.29577,0.29987,1,1
4,GO INTRACILIARY TRANSPORT,0.006955,0.29539,0.24888,1,1
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00054254,0.29473,0.48956,1,1
4,GO AXON EXTENSION,0.0015041,0.29437,0.32297,1,1
4,GO PROTEIN DEMETHYLATION,0.0018673,0.29411,0.35322,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0016767,0.2939,0.30637,1,1
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.0057394,0.29345,0.29733,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.0012758,0.29318,0.34917,1,1
4,GO CILIUM MOVEMENT,0.0018673,0.29307,0.31126,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00023283,0.29264,0.34489,1,1
4,GO SYNAPTIC VESICLE TRANSPORT,0.00029789,0.29257,0.34212,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0080134,0.29209,0.34418,1,1
4,GO PIGMENT ACCUMULATION,0.015776,0.29166,0.25977,1,1
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0025648,0.29151,0.33289,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.00040321,0.29131,0.35474,1,1
4,GO ACROSOME REACTION,0.00035748,0.29127,0.27183,1,1
4,GO AXO DENDRITIC TRANSPORT,0.00068502,0.29095,0.32302,1,1
4,GO DETECTION OF CALCIUM ION,0.0020776,0.29093,0.37192,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0013481,0.28993,0.28786,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.013834,0.28992,0.27433,1,1
4,GO REGULATION OF MICROTUBULE BINDING,0.0036751,0.28861,0.30435,1,1
4,GO POTASSIUM ION HOMEOSTASIS,0.00048214,0.28753,0.31284,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00051151,0.28698,0.31961,1,1
4,GO WATER HOMEOSTASIS,0.0023095,0.28668,0.27395,1,1
4,GO CELLULAR COMPONENT MAINTENANCE,0.00045436,0.28641,0.31159,1,1
4,GO LYSINE METABOLIC PROCESS,0.0010798,0.28608,0.31363,1,1
4,GO DOPAMINE TRANSPORT,0.00035748,0.286,0.43498,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.0029965,0.28584,0.31043,1,1
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00048214,0.28539,0.29319,1,1
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00068502,0.28519,0.33601,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0042727,0.28372,0.28115,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.008797,0.28286,0.2973,1,1
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0016767,0.28279,0.34148,1,1
4,GO REGULATION OF MITOPHAGY,0.00028019,0.28263,0.38881,1,1
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.015104,0.2817,0.23152,1,1
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.0019699,0.28124,0.31958,1,1
4,GO SYNAPTIC SIGNALING,0.00076864,0.28108,0.33114,1,1
4,GO OXIDATIVE DEMETHYLATION,0.00045436,0.28092,0.35746,1,1
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.019548,0.28075,0.23363,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.015776,0.28055,0.25699,1,1
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.00086166,0.28032,0.38269,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0038653,0.27957,0.35254,1,1
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.00076864,0.27952,0.30083,1,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.0012758,0.27928,0.30964,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0057394,0.27917,0.24568,1,1
4,GO POSITIVE REGULATION OF BEHAVIOR,0.008797,0.27916,0.24153,1,1
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.007293,0.27855,0.29322,1,1
4,GO REGULATION OF TELOMERE CAPPING,0.0038653,0.27832,0.26299,1,1
4,GO UV DAMAGE EXCISION REPAIR,0.007293,0.27817,0.25766,1,1
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0012071,0.27815,0.33818,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0172,0.27814,0.27116,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0020776,0.27782,0.34731,1,1
4,GO HISTONE H3 K9 TRIMETHYLATION,0.0042727,0.27775,0.29539,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.0020776,0.27639,0.31173,1,1
4,GO LONG TERM SYNAPTIC DEPRESSION,0.0027019,0.27635,0.33584,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0023095,0.27631,0.31909,1,1
4,GO FUCOSYLATION,0.0019699,0.27593,0.29634,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00011593,0.27565,0.34952,1,1
4,GO CHROMATIN DISASSEMBLY,0.0080134,0.27525,0.25235,1,1
4,GO POSITIVE REGULATION OF ACROSOME REACTION,0.00045436,0.27484,0.2768,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.0016767,0.27445,0.30742,1,1
4,GO DEVELOPMENTAL CELL GROWTH,0.00096503,0.27404,0.29703,1,1
4,GO POTASSIUM ION TRANSPORT,0.00042807,0.274,0.31467,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0017696,0.27359,0.30921,1,1
4,GO ADHERENS JUNCTION ASSEMBLY,0.0011418,0.273,0.34154,1,1
4,GO RESPONSE TO GLUCAGON,0.022172,0.27279,0.21468,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0024341,0.27203,0.2894,1,1
4,GO CGMP MEDIATED SIGNALING,0.0044907,0.2718,0.31901,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.00057531,0.27166,0.4179,1,1
4,GO AXONAL TRANSPORT,0.0015041,0.27146,0.30598,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.008797,0.27139,0.29899,1,1
4,GO MITOCHONDRION LOCALIZATION,0.0014241,0.27108,0.28815,1,1
4,GO MICROTUBULE BASED MOVEMENT,0.00076864,0.27099,0.28671,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.016475,0.27088,0.32247,1,1
4,GO REGULATION OF AXON GUIDANCE,0.0042727,0.27075,0.34193,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0016767,0.27071,0.34581,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.00026348,0.27035,0.50889,1,1
4,GO GENETIC IMPRINTING,0.0012071,0.27012,0.32365,1,1
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0014241,0.26986,0.33277,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.0027019,0.26976,0.2719,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.007293,0.26935,0.26348,1,1
4,GO BRAIN MORPHOGENESIS,0.0020776,0.26884,0.29534,1,1
4,GO CELL MIGRATION IN HINDBRAIN,0.008797,0.26877,0.29034,1,1
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0063209,0.26842,0.34808,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.0049572,0.2681,0.34991,1,1
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.008797,0.2678,0.25182,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00068502,0.26729,0.32022,1,1
4,GO SYNAPTIC VESICLE RECYCLING,0.00019306,0.2672,0.38697,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.011063,0.26691,0.30037,1,1
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.007293,0.2666,0.23461,1,1
4,GO NEGATIVE CHEMOTAXIS,0.0038653,0.26659,0.33692,1,1
4,GO NEURON PROJECTION ARBORIZATION,0.015776,0.26617,0.27326,1,1
4,GO MICROTUBULE NUCLEATION,0.0049572,0.26601,0.28802,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.00014989,0.266,0.35948,1,1
4,GO ACIDIC AMINO ACID TRANSPORT,0.00064645,0.2653,0.30617,1,1
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0054671,0.26525,0.28505,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.0052065,0.26479,0.31738,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.023112,0.26448,0.30697,1,1
4,GO MICROTUBULE ANCHORING,0.00332,0.26424,0.33332,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.020391,0.26384,0.23495,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0031545,0.26368,0.32329,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.0020776,0.26355,0.34577,1,1
4,GO CATECHOLAMINE SECRETION,0.00029789,0.26354,0.39608,1,1
4,GO CILIUM ORGANIZATION,0.0019699,0.26345,0.27103,1,1
4,GO NON MOTILE CILIUM ASSEMBLY,0.0042727,0.26295,0.24012,1,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.0029965,0.26286,0.32026,1,1
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.007293,0.26272,0.29245,1,1
4,GO BASEMENT MEMBRANE ASSEMBLY,0.0034935,0.26267,0.40651,1,1
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0083971,0.26224,0.30427,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00051151,0.26175,0.37455,1,1
4,GO CELL PART MORPHOGENESIS,0.0024341,0.26172,0.27353,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.0080134,0.26148,0.23239,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.00042807,0.2611,0.29602,1,1
4,GO DENDRITIC SPINE MORPHOGENESIS,0.0038653,0.26086,0.31856,1,1
4,GO NEURON PROJECTION ORGANIZATION,0.0040644,0.26079,0.29069,1,1
4,GO DIOL METABOLIC PROCESS,0.0023095,0.26066,0.26683,1,1
4,GO O GLYCAN PROCESSING,0.0076456,0.26066,0.26428,1,1
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.0057394,0.26039,0.25407,1,1
4,GO DENDRITE EXTENSION,0.00023283,0.26024,0.43094,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.0012758,0.2602,0.28445,1,1
4,GO MICROTUBULE BASED TRANSPORT,0.0010798,0.25979,0.27567,1,1
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00028019,0.25946,0.31582,1,1
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0080134,0.25928,0.30565,1,1
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.0036751,0.25882,0.27664,1,1
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0031545,0.25864,0.27723,1,1
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0083971,0.2585,0.38433,1,1
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0018673,0.25799,0.28633,1,1
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.0029965,0.25773,0.29967,1,1
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.0034935,0.25728,0.2712,1,1
4,GO DENDRITE DEVELOPMENT,0.0042727,0.25694,0.26948,1,1
4,GO TELOMERE CAPPING,0.0017696,0.25692,0.25346,1,1
4,GO POSTSYNAPSE ORGANIZATION,0.0038653,0.25692,0.28132,1,1
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0060238,0.25683,0.30855,1,1
4,GO TRANSPORT ALONG MICROTUBULE,0.0014241,0.2568,0.26296,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0038653,0.25672,0.24698,1,1
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.014457,0.25658,0.23384,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.0042727,0.25655,0.30345,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0020776,0.2565,0.26117,1,1
4,GO CAMP METABOLIC PROCESS,0.0015882,0.25646,0.33787,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0044907,0.25589,0.28728,1,1
4,GO HISTONE H4 K5 ACETYLATION,0.0014241,0.25579,0.28428,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.00011593,0.25567,0.33353,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.043559,0.25551,0.21648,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.0042727,0.25515,0.26815,1,1
4,GO SYNAPSE ORGANIZATION,0.0029965,0.25502,0.31066,1,1
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0014241,0.25492,0.32897,1,1
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0015041,0.25472,0.28895,1,1
4,GO NEURON PROJECTION GUIDANCE,0.0049572,0.25455,0.28182,1,1
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0028457,0.25404,0.27877,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.013834,0.25385,0.30324,1,1
4,GO FIBROBLAST ACTIVATION,0.022172,0.25356,0.21568,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00091199,0.25315,0.29186,1,1
4,GO MECHANOSENSORY BEHAVIOR,0.034576,0.25307,0.27048,1,1
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0080134,0.25295,0.23289,1,1
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.0023095,0.2527,0.26885,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00096503,0.25219,0.28822,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00040321,0.25187,0.30723,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0023095,0.25155,0.29254,1,1
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0025648,0.25154,0.28118,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0052065,0.25153,0.28308,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0017696,0.25128,0.2758,1,1
4,GO SKELETAL MUSCLE ADAPTATION,0.0028457,0.25088,0.32509,1,1
4,GO FEAR RESPONSE,0.0096484,0.25051,0.21965,1,1
4,GO AXON DEVELOPMENT,0.0042727,0.25033,0.2643,1,1
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0027019,0.24944,0.34011,1,1
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.037377,0.24925,0.26916,1,1
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.00081392,0.24921,0.3222,1,1
4,GO REGULATION OF RESPONSE TO FOOD,0.0038653,0.24919,0.318,1,1
4,GO RESPONSE TO REDOX STATE,0.0066311,0.24844,0.28527,1,1
4,GO BODY MORPHOGENESIS,0.0076456,0.24785,0.27711,1,1
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.011574,0.24747,0.21638,1,1
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.020391,0.24743,0.26831,1,1
4,GO TRANSCYTOSIS,0.014457,0.2473,0.2613,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0029965,0.24709,0.34416,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0012758,0.24701,0.34547,1,1
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.012106,0.24596,0.35137,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0019699,0.24529,0.31287,1,1
4,GO LEARNING,0.0038653,0.24521,0.28673,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.007293,0.24485,0.28287,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.0018673,0.24469,0.24828,1,1
4,GO HISTONE DEUBIQUITINATION,0.0052065,0.24467,0.2688,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.00035748,0.24442,0.37667,1,1
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.007293,0.24414,0.27337,1,1
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0014241,0.24396,0.2827,1,1
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.026142,0.24368,0.31514,1,1
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0012071,0.24364,0.31385,1,1
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.0066311,0.24348,0.29042,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0042727,0.24287,0.2504,1,1
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.00096503,0.24274,0.2689,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.0044907,0.24268,0.26239,1,1
4,GO SEGMENT SPECIFICATION,0.010572,0.24266,0.2969,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.012106,0.24191,0.21439,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0020776,0.24179,0.25402,1,1
4,GO HISTONE H3 K9 MODIFICATION,0.013235,0.24124,0.26042,1,1
4,GO NEURAL NUCLEUS DEVELOPMENT,0.00023283,0.24121,0.29713,1,1
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0047188,0.24117,0.34725,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00068502,0.24117,0.2382,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.014457,0.24084,0.32451,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0057394,0.24036,0.25503,1,1
4,GO REGULATION OF APPETITE,0.006955,0.23994,0.31532,1,1
4,GO REGULATION OF AXONOGENESIS,0.0066311,0.23991,0.28914,1,1
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.026142,0.23988,0.28935,1,1
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.00332,0.2398,0.27717,1,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.017954,0.23907,0.29358,1,1
4,GO HISTONE H3 K9 METHYLATION,0.01266,0.23855,0.28022,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.01266,0.23825,0.26853,1,1
4,GO LONG TERM SYNAPTIC POTENTIATION,0.0092139,0.23809,0.29374,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.010572,0.23763,0.25516,1,1
4,GO RESPONSE TO DOPAMINE,0.0010798,0.23708,0.2396,1,1
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.00076864,0.23683,0.31224,1,1
4,GO HISTONE H2A MONOUBIQUITINATION,0.0016767,0.23676,0.29738,1,1
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.034576,0.23672,0.3093,1,1
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0028457,0.2359,0.36074,1,1
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.006955,0.23571,0.27167,1,1
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0010209,0.23528,0.2825,1,1
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0040644,0.2341,0.29521,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,0.011574,0.23344,0.20743,1,1
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.0047188,0.23311,0.32559,1,1
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00026348,0.23301,0.39418,1,1
4,GO TORC1 SIGNALING,0.0023095,0.23277,0.28959,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.0011418,0.23276,0.26137,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.024086,0.23273,0.2106,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.0014241,0.23247,0.27497,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.00035748,0.2321,0.2806,1,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0172,0.23154,0.21486,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0040644,0.23125,0.32962,1,1
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.018736,0.23091,0.19134,1,1
4,GO MYOTUBE CELL DEVELOPMENT,0.027226,0.23088,0.1743,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00035748,0.23072,0.31989,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0052065,0.23043,0.32265,1,1
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.0015041,0.23039,0.26135,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.0052065,0.23009,0.31883,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.011063,0.23002,0.34893,1,1
4,GO VISUAL BEHAVIOR,0.00015974,0.22982,0.31884,1,1
4,GO CELL VOLUME HOMEOSTASIS,0.00096503,0.22978,0.29181,1,1
4,GO CORNIFICATION,0.040368,0.22911,0.15945,1,1
4,GO CARDIAC CONDUCTION,0.0042727,0.22897,0.29321,1,1
4,GO MONOAMINE TRANSPORT,0.0014241,0.22887,0.32107,1,1
4,GO ACTION POTENTIAL,0.0028457,0.22842,0.31776,1,1
4,GO AMINE TRANSPORT,0.0027019,0.2284,0.29736,1,1
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.022172,0.22807,0.22842,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.0021907,0.22783,0.28929,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.034576,0.22777,0.20428,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.031957,0.2277,0.25752,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.043559,0.22769,0.21592,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.0019699,0.22725,0.24171,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0092139,0.22685,0.23443,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.045233,0.2268,0.26009,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.0010209,0.2267,0.27399,1,1
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046961,0.22654,0.23059,1,1
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.0014241,0.22626,0.33992,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.025096,0.2262,0.19397,1,1
4,GO REGULATION OF TORC1 SIGNALING,0.00332,0.22613,0.27175,1,1
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.011574,0.22595,0.29448,1,1
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.00035748,0.2258,0.21278,1,1
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.010101,0.22577,0.25324,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,0.00060992,0.22547,0.23014,1,1
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0034935,0.22525,0.28691,1,1
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0040644,0.22515,0.29692,1,1
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.00072571,0.22503,0.35136,1,1
4,GO LUTEINIZATION,0.023112,0.22466,0.33648,1,1
4,GO CELLULAR RESPONSE TO PH,0.0076456,0.22455,0.24373,1,1
4,GO CELL JUNCTION ASSEMBLY,0.0019699,0.22447,0.27811,1,1
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0019699,0.22433,0.36178,1,1
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0028457,0.22432,0.27943,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0003797,0.22407,0.31225,1,1
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.048745,0.22381,0.24928,1,1
4,GO LATERAL VENTRICLE DEVELOPMENT,0.013834,0.22361,0.30153,1,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.035953,0.22336,0.2872,1,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.011574,0.2232,0.30191,1,1
4,GO HEART FIELD SPECIFICATION,0.012106,0.22317,0.27276,1,1
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0096484,0.22312,0.28467,1,1
4,GO DETECTION OF VISIBLE LIGHT,0.00081392,0.2231,0.20204,1,1
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.0080134,0.22303,0.23949,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.008797,0.22294,0.20234,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.00064645,0.22287,0.26697,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.015776,0.22255,0.24867,1,1
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0012071,0.2223,0.2807,1,1
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.00072571,0.22174,0.32665,1,1
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00026348,0.2217,0.22272,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0015882,0.22123,0.25954,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.031957,0.22103,0.27144,1,1
4,GO NEURON DEVELOPMENT,0.0029965,0.22103,0.26342,1,1
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.043559,0.22101,0.19825,1,1
4,GO MICROTUBULE BASED PROCESS,0.0034935,0.22088,0.23003,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0044907,0.22087,0.30191,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.017954,0.22076,0.23687,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0036751,0.22008,0.27191,1,1
4,GO SODIUM ION TRANSPORT,0.00054254,0.21986,0.30944,1,1
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0063209,0.21981,0.27721,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.011574,0.21972,0.23214,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00332,0.21965,0.2795,1,1
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.018736,0.21962,0.2306,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00042807,0.21954,0.27749,1,1
4,GO RENAL WATER HOMEOSTASIS,0.0052065,0.21925,0.27042,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0049572,0.2191,0.27773,1,1
4,GO PROTEIN METHYLATION,0.0057394,0.21906,0.24089,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0015041,0.21856,0.23123,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.017954,0.21846,0.20831,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.023112,0.21813,0.23018,1,1
4,GO POLYOL CATABOLIC PROCESS,0.0060238,0.21726,0.26372,1,1
4,GO REGULATION OF MEMBRANE POTENTIAL,0.00096503,0.21686,0.29684,1,1
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0092139,0.2166,0.28187,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.006955,0.21655,0.2338,1,1
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.00081392,0.21618,0.20775,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00060992,0.21603,0.30337,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.017954,0.21583,0.22254,1,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0015041,0.21582,0.20842,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.013834,0.21569,0.29079,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0019699,0.21565,0.29476,1,1
4,GO DETECTION OF LIGHT STIMULUS,0.00086166,0.21546,0.19937,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.011574,0.21522,0.18441,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00076864,0.21494,0.29707,1,1
4,GO MIRNA METABOLIC PROCESS,0.00091199,0.21488,0.26672,1,1
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.00332,0.2148,0.3218,1,1
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0018673,0.21462,0.26149,1,1
4,GO PRESYNAPSE ORGANIZATION,0.0042727,0.21458,0.31855,1,1
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0049572,0.21445,0.32666,1,1
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0027019,0.21444,0.26144,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.037377,0.21413,0.17658,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0060238,0.21411,0.26782,1,1
4,GO REGULATION OF MRNA PROCESSING,0.021265,0.21411,0.19128,1,1
4,GO LOCOMOTORY BEHAVIOR,0.008797,0.2141,0.2522,1,1
4,GO MEMORY,0.0034935,0.21407,0.28415,1,1
4,GO CELL CELL JUNCTION MAINTENANCE,0.017954,0.21402,0.27717,1,1
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.038848,0.21395,0.24955,1,1
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.0092139,0.2139,0.24654,1,1
4,GO HISTONE H3 DEACETYLATION,0.00332,0.21386,0.27586,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0052065,0.21377,0.2992,1,1
4,GO MEMBRANE DOCKING,0.0011418,0.21357,0.24879,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.010101,0.21322,0.27439,1,1
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.017954,0.21281,0.20746,1,1
4,GO BONE CELL DEVELOPMENT,0.040368,0.21255,0.21603,1,1
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.0021907,0.21222,0.28738,1,1
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.006955,0.2122,0.2594,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0020776,0.2121,0.23677,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0049572,0.21206,0.2741,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0040644,0.21201,0.28105,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.0036751,0.21198,0.30747,1,1
4,GO ADAPTATION OF SIGNALING PATHWAY,0.017954,0.21179,0.29024,1,1
4,GO THYROID GLAND DEVELOPMENT,0.0172,0.21177,0.21208,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.011063,0.2117,0.28979,1,1
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.038848,0.21162,0.16493,1,1
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.012106,0.21156,0.36015,1,1
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0013481,0.21137,0.30085,1,1
4,GO REGULATION OF MRNA POLYADENYLATION,0.0047188,0.21105,0.27937,1,1
4,GO RESPONSE TO CATECHOLAMINE,0.0016767,0.21077,0.24533,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.035953,0.21076,0.18869,1,1
4,GO HINDBRAIN DEVELOPMENT,0.014457,0.21066,0.20769,1,1
4,GO HEAD MORPHOGENESIS,0.019548,0.21039,0.28514,1,1
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.0021907,0.21037,0.2933,1,1
4,GO REGULATION OF RNA SPLICING,0.011574,0.21025,0.1977,1,1
4,GO PARTURITION,0.010101,0.21004,0.2312,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.0083971,0.21004,0.21441,1,1
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.033245,0.21001,0.2019,1,1
4,GO LONG TERM MEMORY,0.017954,0.20991,0.26835,1,1
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.033245,0.20988,0.18793,1,1
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.046961,0.2097,0.24904,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.035953,0.20964,0.20199,1,1
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.007293,0.20961,0.20219,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.028348,0.20939,0.21765,1,1
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0080134,0.20933,0.25488,1,1
4,GO EXOCYTIC PROCESS,0.0013481,0.20879,0.30124,1,1
4,GO CELL PROJECTION ORGANIZATION,0.0028457,0.20875,0.2458,1,1
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0015041,0.20841,0.26311,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0040644,0.20827,0.28667,1,1
4,GO PROTEIN HETEROOLIGOMERIZATION,0.0016767,0.20804,0.25393,1,1
4,GO REGULATION OF ACROSOME REACTION,0.0063209,0.20802,0.21422,1,1
4,GO PHOSPHATE ION TRANSPORT,0.043559,0.20793,0.19732,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0038653,0.20779,0.30822,1,1
4,GO NEURON DIFFERENTIATION,0.0038653,0.20767,0.24492,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.00086166,0.20761,0.3147,1,1
4,GO BEHAVIOR,0.010101,0.20749,0.22721,1,1
4,GO SPERM MOTILITY,0.0027019,0.20713,0.26011,1,1
4,GO ASSOCIATIVE LEARNING,0.0060238,0.207,0.27922,1,1
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0054671,0.20697,0.26463,1,1
4,GO PHOTOTRANSDUCTION,0.0010798,0.20675,0.17381,1,1
4,GO MITOPHAGY,0.00091199,0.2067,0.29474,1,1
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.025096,0.20638,0.21919,1,1
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0060238,0.20635,0.17002,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.031957,0.20625,0.20794,1,1
4,GO NEUROTRANSMITTER REUPTAKE,0.0027019,0.20624,0.29542,1,1
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0023095,0.20603,0.28464,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0023095,0.2059,0.27249,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.02951,0.2058,0.1898,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0029965,0.2058,0.40535,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0036751,0.20549,0.26446,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0096484,0.20543,0.27915,1,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.030713,0.20531,0.18154,1,1
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0040644,0.20498,0.3096,1,1
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.0047188,0.20496,0.26323,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0044907,0.20494,0.26056,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0063209,0.2047,0.31761,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.013235,0.20468,0.23161,1,1
4,GO REGULATION OF NEURON DIFFERENTIATION,0.0076456,0.20433,0.23558,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.007293,0.20352,0.29709,1,1
4,GO MITOCHONDRION DISTRIBUTION,0.0096484,0.20348,0.26104,1,1
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.011574,0.20288,0.21902,1,1
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.030713,0.20288,0.19918,1,1
4,GO CRISTAE FORMATION,0.00054254,0.20247,0.23623,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0034935,0.2016,0.2734,1,1
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.006955,0.20117,0.19788,1,1
4,GO REGULATION OF HORMONE SECRETION,0.0028457,0.20097,0.22592,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0044907,0.20066,0.21641,1,1
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.046961,0.20057,0.17593,1,1
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.020391,0.20024,0.20397,1,1
4,GO RNA POLYADENYLATION,0.0057394,0.20012,0.23701,1,1
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0031545,0.19935,0.31177,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0083971,0.19919,0.21114,1,1
4,GO HISTONE MONOUBIQUITINATION,0.0066311,0.19905,0.23223,1,1
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0049572,0.19899,0.24952,1,1
4,GO MEMBRANE BIOGENESIS,0.0042727,0.19873,0.30811,1,1
4,GO AROMATIC AMINO ACID TRANSPORT,0.048745,0.19865,0.23499,1,1
4,GO SINGLE STRAND BREAK REPAIR,0.0066311,0.19849,0.26,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.00013188,0.19837,0.29824,1,1
4,GO SMOOTHENED SIGNALING PATHWAY,0.015104,0.19822,0.21301,1,1
4,GO RESPIRATORY SYSTEM PROCESS,0.007293,0.1982,0.29009,1,1
4,GO NOTCH SIGNALING PATHWAY,0.0014241,0.19809,0.26241,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.023112,0.19795,0.27326,1,1
4,GO RESPONSE TO LEAD ION,0.0025648,0.19707,0.25647,1,1
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.018736,0.19687,0.24635,1,1
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0012758,0.19613,0.26581,1,1
4,GO PROTEIN ACYLATION,0.0029965,0.19607,0.2271,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0016767,0.19601,0.23656,1,1
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0049572,0.19599,0.31208,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0172,0.1959,0.28802,1,1
4,GO ATP TRANSPORT,0.0017696,0.19565,0.2089,1,1
4,GO TRANSFERRIN TRANSPORT,0.00020554,0.19539,0.26967,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.013235,0.19531,0.17604,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.015776,0.19523,0.21485,1,1
4,GO PHOTOPERIODISM,0.0024341,0.19522,0.22481,1,1
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00332,0.1952,0.25671,1,1
4,GO REGULATION OF TOR SIGNALING,0.0015882,0.1952,0.22526,1,1
4,GO MEMBRANE REPOLARIZATION,0.0044907,0.19495,0.31544,1,1
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.031957,0.19475,0.25277,1,1
4,GO DICARBOXYLIC ACID TRANSPORT,0.00051151,0.1947,0.26312,1,1
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.011063,0.19462,0.26224,1,1
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.0049572,0.19459,0.2401,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.008797,0.1945,0.21215,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.007293,0.19433,0.23107,1,1
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.018736,0.1943,0.23887,1,1
4,GO DEVELOPMENTAL MATURATION,0.0054671,0.19428,0.2362,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.0012071,0.19403,0.237,1,1
4,GO SPERMATID DIFFERENTIATION,0.0040644,0.19402,0.19572,1,1
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0063209,0.194,0.2067,1,1
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.035953,0.19376,0.23034,1,1
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.011574,0.19369,0.35051,1,1
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0016767,0.19355,0.27408,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0066311,0.19353,0.22781,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.024086,0.19342,0.24183,1,1
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.033245,0.19321,0.21203,1,1
4,GO NUCLEOTIDE TRANSPORT,0.0017696,0.19297,0.20346,1,1
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0080134,0.19224,0.21775,1,1
4,GO GOLGI RIBBON FORMATION,0.030713,0.19206,0.27231,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.014457,0.19196,0.19943,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.034576,0.19191,0.16661,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.021265,0.19188,0.20559,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.0052065,0.19154,0.22112,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.02951,0.19138,0.21251,1,1
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0076456,0.19118,0.22222,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.0060238,0.19115,0.19529,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.012106,0.19109,0.22735,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0063209,0.19099,0.23667,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0016767,0.19093,0.30465,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.034576,0.19093,0.17816,1,1
4,GO CELL MATURATION,0.0066311,0.19017,0.19619,1,1
4,GO INSULIN SECRETION,0.0010798,0.18997,0.26234,1,1
4,GO P BODY ASSEMBLY,0.024086,0.18993,0.22509,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,0.0017696,0.18991,0.20041,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0057394,0.1898,0.29699,1,1
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.01266,0.18968,0.29046,1,1
4,GO HISTONE H3 K14 ACETYLATION,0.0040644,0.1895,0.29615,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.022172,0.18942,0.19028,1,1
4,GO CELL PROJECTION ASSEMBLY,0.0031545,0.18936,0.22779,1,1
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.023112,0.1891,0.20764,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0021907,0.18893,0.21622,1,1
4,GO SPECIFICATION OF SYMMETRY,0.00332,0.18862,0.24366,1,1
4,GO SECONDARY PALATE DEVELOPMENT,0.007293,0.18861,0.34395,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0052065,0.18848,0.23986,1,1
4,GO PEPTIDE HORMONE SECRETION,0.0010209,0.18839,0.26515,1,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0054671,0.18831,0.25844,1,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0066311,0.18822,0.23277,1,1
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0057394,0.18788,0.26565,1,1
4,GO PLASMA MEMBRANE TUBULATION,0.013834,0.18767,0.25,1,1
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.010572,0.18743,0.22732,1,1
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0092139,0.18735,0.2629,1,1
4,GO NEURON PROJECTION REGENERATION,0.006955,0.1872,0.23444,1,1
4,GO CHROMATIN SILENCING,0.038848,0.18701,0.18394,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0038653,0.18646,0.21858,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0080134,0.18642,0.23039,1,1
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.0049572,0.18637,0.26014,1,1
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0017696,0.18633,0.26097,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.00033648,0.18621,0.22287,1,1
4,GO KERATINIZATION,0.018736,0.18592,0.17834,1,1
4,GO HEART PROCESS,0.013834,0.18592,0.22242,1,1
4,GO HISTONE H2A UBIQUITINATION,0.0063209,0.18582,0.22619,1,1
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.00064645,0.18561,0.26865,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0038653,0.18551,0.21049,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0057394,0.18551,0.22732,1,1
4,GO TOOTH MINERALIZATION,0.01266,0.18486,0.28316,1,1
4,GO NUCLEAR BODY ORGANIZATION,0.0042727,0.18485,0.23172,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0172,0.18472,0.17837,1,1
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.035953,0.18467,0.16958,1,1
4,GO PHOSPHOLIPID TRANSPORT,0.046961,0.18465,0.16807,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0040644,0.18459,0.20742,1,1
4,GO REGULATION OF CELL SIZE,0.0047188,0.18452,0.26159,1,1
4,GO AMINO ACID TRANSPORT,0.0016767,0.18442,0.24163,1,1
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0066311,0.18432,0.26866,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.030713,0.18401,0.19927,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0063209,0.18393,0.27807,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.021265,0.18389,0.21608,1,1
4,GO CHLORIDE TRANSPORT,0.0066311,0.18351,0.25401,1,1
4,GO REGULATION OF INSULIN SECRETION,0.0010798,0.18349,0.26435,1,1
4,GO HISTONE UBIQUITINATION,0.008797,0.1833,0.21715,1,1
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0036751,0.18321,0.31081,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.013235,0.18285,0.22612,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.019548,0.18267,0.20309,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.043559,0.18239,0.22004,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.0036751,0.18239,0.22638,1,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0083971,0.18238,0.245,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0080134,0.18232,0.21172,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0054671,0.18217,0.22416,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.0060238,0.18202,0.21098,1,1
4,GO MRNA PROCESSING,0.021265,0.18198,0.15706,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0049572,0.18147,0.21224,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0010209,0.18075,0.20522,1,1
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0015041,0.18074,0.22982,1,1
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.012106,0.18057,0.21069,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0047188,0.18002,0.20864,1,1
4,GO METHYLATION,0.011063,0.17994,0.18109,1,1
4,GO RESPONSE TO LITHIUM ION,0.0092139,0.17979,0.23027,1,1
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.0025648,0.17961,0.22618,1,1
4,GO PANCREAS DEVELOPMENT,0.015104,0.17942,0.22862,1,1
4,GO AORTA MORPHOGENESIS,0.017954,0.17929,0.29166,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.020391,0.17928,0.20307,1,1
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0047188,0.17927,0.21482,1,1
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.016475,0.17926,0.17009,1,1
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.0028457,0.17915,0.26111,1,1
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.021265,0.17907,0.25119,1,1
4,GO HISTONE DEACETYLATION,0.0083971,0.17886,0.24159,1,1
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0054671,0.17848,0.22143,1,1
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0063209,0.17841,0.29548,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.023112,0.17834,0.22132,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0036751,0.17829,0.24977,1,1
4,GO PEPTIDYL ARGININE MODIFICATION,0.0083971,0.17828,0.14557,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0092139,0.17808,0.2371,1,1
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.01266,0.17804,0.2389,1,1
4,GO COVALENT CHROMATIN MODIFICATION,0.0096484,0.17788,0.22445,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0015882,0.1777,0.21602,1,1
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.01266,0.17729,0.22582,1,1
4,GO SKELETAL MUSCLE CONTRACTION,0.0092139,0.17722,0.28987,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0018673,0.17715,0.28156,1,1
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0052065,0.17678,0.24676,1,1
4,GO NEUROTRANSMITTER UPTAKE,0.007293,0.17654,0.22775,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.030713,0.17654,0.2348,1,1
4,GO CHROMATIN REMODELING,0.021265,0.17607,0.19443,1,1
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0060238,0.17569,0.2714,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0023095,0.17566,0.23602,1,1
4,GO ORGANELLE LOCALIZATION,0.0012071,0.17545,0.21886,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.041938,0.17512,0.14412,1,1
4,GO FACE DEVELOPMENT,0.031957,0.1748,0.24094,1,1
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.013235,0.17479,0.23858,1,1
4,GO CELL JUNCTION ORGANIZATION,0.0027019,0.17468,0.27159,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.00086166,0.17467,0.23665,1,1
4,GO POLYOL METABOLIC PROCESS,0.0020776,0.17461,0.21057,1,1
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.022172,0.17453,0.17862,1,1
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.037377,0.17451,0.2169,1,1
4,GO PROTEIN ACETYLATION,0.006955,0.17435,0.20561,1,1
4,GO AXIS SPECIFICATION,0.0047188,0.17425,0.19026,1,1
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.0044907,0.17419,0.23143,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.016475,0.17412,0.24338,1,1
4,GO REGULATION OF CYCLASE ACTIVITY,0.018736,0.17392,0.19507,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0031545,0.1737,0.25353,1,1
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.021265,0.17367,0.18262,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0063209,0.17362,0.20803,1,1
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.0054671,0.1736,0.28264,1,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.0096484,0.17353,0.23973,1,1
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.012106,0.17352,0.26329,1,1
4,GO DIET INDUCED THERMOGENESIS,0.041938,0.17341,0.20704,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.030713,0.1734,0.22091,1,1
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0172,0.17315,0.22043,1,1
4,GO REGULATION OF TELOMERE MAINTENANCE,0.028348,0.17304,0.17516,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0015041,0.17262,0.22108,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0031545,0.17255,0.20687,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00072571,0.17253,0.20845,1,1
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0014241,0.17242,0.28931,1,1
4,GO RESPONSE TO LEPTIN,0.0057394,0.1724,0.24852,1,1
4,GO EXCRETION,0.037377,0.17226,0.19706,1,1
4,GO TOR SIGNALING,0.0016767,0.17214,0.21161,1,1
4,GO ACID SECRETION,0.0021907,0.17167,0.21679,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0031545,0.17129,0.26517,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,0.00332,0.17126,0.22062,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.0023095,0.17115,0.19346,1,1
4,GO VASODILATION,0.038848,0.1711,0.18198,1,1
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0060238,0.17104,0.23861,1,1
4,GO INORGANIC ANION TRANSPORT,0.0063209,0.17088,0.22101,1,1
4,GO NEURAL TUBE DEVELOPMENT,0.038848,0.17086,0.18886,1,1
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.006955,0.17082,0.29329,1,1
4,GO REGULATION OF EXOCYTOSIS,0.0031545,0.17081,0.27055,1,1
4,GO MANNOSYLATION,0.019548,0.17074,0.15807,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0047188,0.17074,0.20302,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0092139,0.17038,0.23321,1,1
4,GO RESPONSE TO CALCIUM ION,0.0034935,0.17029,0.25065,1,1
4,GO UV PROTECTION,0.024086,0.17012,0.21749,1,1
4,GO RESPONSE TO PH,0.024086,0.16997,0.20903,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.01266,0.16978,0.19111,1,1
4,GO HORMONE TRANSPORT,0.0023095,0.16975,0.22932,1,1
4,GO RNA SPLICING,0.034576,0.16951,0.14209,1,1
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.0096484,0.1694,0.20329,1,1
4,GO REGULATION OF PROTEIN TARGETING,0.0031545,0.16933,0.21233,1,1
4,GO REGULATION OF HISTONE MODIFICATION,0.015104,0.16932,0.19902,1,1
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.01266,0.16931,0.24811,1,1
4,GO DEMETHYLATION,0.0015041,0.16923,0.25632,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0092139,0.16874,0.18802,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.0013481,0.16872,0.26508,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.034576,0.1687,0.18764,1,1
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.015104,0.16862,0.1967,1,1
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0092139,0.16859,0.22566,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.0020776,0.1685,0.21635,1,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.027226,0.16816,0.27115,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.015776,0.16808,0.25549,1,1
4,GO CELLULAR RESPONSE TO SALT STRESS,0.028348,0.16804,0.20921,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.0025648,0.16782,0.24164,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.037377,0.16761,0.16557,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0018673,0.16756,0.21467,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.033245,0.16713,0.19263,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0020776,0.16691,0.2578,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.010101,0.16691,0.22515,1,1
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.043559,0.16661,0.19418,1,1
4,GO NERVOUS SYSTEM PROCESS,0.0019699,0.16642,0.23117,1,1
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.0021907,0.16634,0.19903,1,1
4,GO RESPONSE TO WATER,0.011063,0.1658,0.21472,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.0066311,0.16561,0.19849,1,1
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.010101,0.16552,0.19785,1,1
4,GO REGULATION OF LYASE ACTIVITY,0.019548,0.16552,0.183,1,1
4,GO GERM CELL DEVELOPMENT,0.006955,0.16548,0.18495,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.019548,0.16541,0.16489,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.010101,0.16539,0.23245,1,1
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0172,0.16526,0.23684,1,1
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0080134,0.16513,0.20498,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.0034935,0.16503,0.21958,1,1
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.006955,0.16473,0.18498,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,0.00057531,0.16468,0.20115,1,1
4,GO RENAL SYSTEM PROCESS,0.045233,0.16452,0.19149,1,1
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.01266,0.16444,0.25525,1,1
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.0015041,0.16439,0.20969,1,1
4,GO VESICLE DOCKING,0.00076864,0.16428,0.29962,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0017696,0.16409,0.24368,1,1
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.033245,0.16388,0.17649,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.019548,0.16369,0.19976,1,1
4,GO REGULATION OF FERTILIZATION,0.0044907,0.16329,0.17638,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0023095,0.16316,0.21784,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.011574,0.16313,0.20999,1,1
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.048745,0.1631,0.17171,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.0014241,0.16282,0.27831,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.007293,0.16279,0.2428,1,1
4,GO STRIATED MUSCLE CONTRACTION,0.012106,0.16266,0.25568,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.0076456,0.16264,0.18989,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00332,0.16256,0.18231,1,1
4,GO CHROMATIN ORGANIZATION,0.01266,0.16225,0.21412,1,1
4,GO SECONDARY METABOLIC PROCESS,0.0023095,0.16218,0.20842,1,1
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0036751,0.16192,0.17672,1,1
4,GO REGULATION OF HORMONE LEVELS,0.0049572,0.16183,0.19703,1,1
4,GO MRNA 3 END PROCESSING,0.041938,0.16182,0.15475,1,1
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.015776,0.16155,0.15902,1,1
4,GO VESICLE LOCALIZATION,0.00064645,0.16122,0.25714,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.007293,0.16028,0.23299,1,1
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.011063,0.1599,0.24946,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.020391,0.15977,0.17111,1,1
4,GO CYTOSKELETON ORGANIZATION,0.0096484,0.15972,0.20301,1,1
4,GO INACTIVATION OF MAPK ACTIVITY,0.034576,0.15971,0.20405,1,1
4,GO ENDOCYTIC RECYCLING,0.0042727,0.15964,0.26736,1,1
4,GO PLATELET MORPHOGENESIS,0.011063,0.1595,0.26693,1,1
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.010101,0.15924,0.2399,1,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.0092139,0.15853,0.20173,1,1
4,GO ORGANELLE ASSEMBLY,0.0025648,0.15844,0.19462,1,1
4,GO MACROMOLECULE DEACYLATION,0.007293,0.1584,0.22717,1,1
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.012106,0.1584,0.2384,1,1
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0083971,0.15756,0.21943,1,1
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.014457,0.15735,0.21064,1,1
4,GO IMPORT INTO CELL,0.0049572,0.15712,0.22669,1,1
4,GO RESPONSE TO LIGHT STIMULUS,0.00332,0.15707,0.19761,1,1
4,GO ORGANIC ACID TRANSPORT,0.0060238,0.15689,0.18703,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.021265,0.15664,0.25465,1,1
4,GO MYELIN ASSEMBLY,0.013834,0.15651,0.27934,1,1
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.027226,0.15634,0.17681,1,1
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.0054671,0.15625,0.24625,1,1
4,GO CIRCADIAN RHYTHM,0.0076456,0.15606,0.19097,1,1
4,GO SPLEEN DEVELOPMENT,0.018736,0.15605,0.21129,1,1
4,GO MIDBRAIN DEVELOPMENT,0.0063209,0.15592,0.16094,1,1
4,GO ESCRT COMPLEX DISASSEMBLY,0.018736,0.1553,0.14859,1,1
4,GO GLYCOSYLATION,0.0047188,0.1552,0.19485,1,1
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.027226,0.1551,0.23932,1,1
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0083971,0.15504,0.20327,1,1
4,GO MRNA METHYLATION,0.033245,0.15495,0.17297,1,1
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.015776,0.15495,0.19373,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.030713,0.15486,0.17637,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.023112,0.15463,0.18629,1,1
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.019548,0.15458,0.21711,1,1
4,GO SEXUAL REPRODUCTION,0.011063,0.15427,0.17594,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.010101,0.15419,0.22264,1,1
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.0172,0.15417,0.19508,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0036751,0.15416,0.21251,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.0063209,0.15411,0.18995,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.040368,0.1539,0.22165,1,1
4,GO COPII COATED VESICLE BUDDING,0.0044907,0.1538,0.20907,1,1
4,GO REGULATION OF SODIUM ION TRANSPORT,0.0036751,0.15374,0.25784,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.011063,0.15363,0.20811,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.0028457,0.15351,0.25664,1,1
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.024086,0.15289,0.17245,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.025096,0.15287,0.15629,1,1
4,GO RESPONSE TO AXON INJURY,0.0076456,0.15283,0.19472,1,1
4,GO MYOFIBRIL ASSEMBLY,0.015104,0.1525,0.2181,1,1
4,GO ARTERY DEVELOPMENT,0.045233,0.15237,0.2163,1,1
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.035953,0.15219,0.26534,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0052065,0.15212,0.19076,1,1
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0063209,0.15186,0.25799,1,1
4,GO STRESS GRANULE ASSEMBLY,0.017954,0.15148,0.20142,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.017954,0.15148,0.20075,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0060238,0.15114,0.2295,1,1
4,GO CELLULAR PIGMENTATION,0.0042727,0.15086,0.2072,1,1
4,GO SKIN DEVELOPMENT,0.038848,0.15064,0.15532,1,1
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.034576,0.15058,0.17257,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.012106,0.15056,0.21447,1,1
4,GO SIGNAL RELEASE,0.0066311,0.15038,0.21787,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.0044907,0.15026,0.18928,1,1
4,GO ORGANELLE FUSION,0.0016767,0.15015,0.23696,1,1
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.015776,0.1501,0.23257,1,1
4,GO ARTERY MORPHOGENESIS,0.034576,0.15002,0.22386,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.026142,0.15001,0.22547,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.011574,0.14994,0.21246,1,1
4,GO MRNA CLEAVAGE,0.0015882,0.1499,0.20781,1,1
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.0096484,0.14978,0.21496,1,1
4,GO FEMALE GAMETE GENERATION,0.017954,0.14965,0.16966,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0080134,0.14964,0.24572,1,1
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0047188,0.1494,0.25313,1,1
4,GO PIGMENTATION,0.0040644,0.14939,0.22783,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.030713,0.14925,0.16262,1,1
4,GO REGULATION OF CELL MORPHOGENESIS,0.015104,0.14862,0.21383,1,1
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.045233,0.14848,0.21853,1,1
4,GO REGULATION OF FEEDING BEHAVIOR,0.011574,0.14834,0.1965,1,1
4,GO GAMETE GENERATION,0.0096484,0.14813,0.1787,1,1
4,GO SENSORY PERCEPTION,0.0027019,0.14774,0.19867,1,1
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.020391,0.14701,0.19325,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.00332,0.14687,0.19762,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.0047188,0.14686,0.23789,1,1
4,GO NEURAL TUBE FORMATION,0.02951,0.1467,0.19064,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0021907,0.14645,0.20364,1,1
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00081392,0.14642,0.20346,1,1
4,GO GLUCOSE METABOLIC PROCESS,0.006955,0.14641,0.1831,1,1
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.031957,0.14624,0.17408,1,1
4,GO HYPEROSMOTIC RESPONSE,0.046961,0.14623,0.19674,1,1
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0049572,0.14623,0.24248,1,1
4,GO MEMBRANE FUSION,0.0038653,0.14623,0.22132,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.0014241,0.1462,0.19372,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.027226,0.14611,0.14082,1,1
4,GO PROTEIN HOMOOLIGOMERIZATION,0.0063209,0.14593,0.20535,1,1
4,GO CLATHRIN COAT ASSEMBLY,0.013834,0.14573,0.29374,1,1
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0052065,0.14563,0.17337,1,1
4,GO REGULATION OF ION TRANSPORT,0.0080134,0.14541,0.22299,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.014457,0.14528,0.19596,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0092139,0.14514,0.29272,1,1
4,GO PROTEIN POLYMERIZATION,0.0063209,0.14496,0.19831,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.021265,0.14492,0.2277,1,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.0021907,0.1449,0.2177,1,1
4,GO STRESS FIBER ASSEMBLY,0.010572,0.14433,0.22695,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0034935,0.14426,0.17691,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0076456,0.14403,0.32769,1,1
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0034935,0.14393,0.25166,1,1
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.027226,0.14373,0.19688,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.035953,0.1435,0.22675,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.014457,0.14313,0.18468,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.0044907,0.14273,0.24442,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.010572,0.14271,0.23181,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0020776,0.14249,0.20201,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.011574,0.14233,0.2145,1,1
4,GO MALE GAMETE GENERATION,0.010101,0.14225,0.17376,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0096484,0.14217,0.19306,1,1
4,GO KETONE BODY METABOLIC PROCESS,0.020391,0.14213,0.15648,1,1
4,GO DEVELOPMENTAL INDUCTION,0.043559,0.14194,0.17714,1,1
4,GO SOMITOGENESIS,0.048745,0.14169,0.18661,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0038653,0.14154,0.17594,1,1
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.034576,0.14144,0.16189,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.0044907,0.14126,0.17373,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.023112,0.14122,0.16648,1,1
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0038653,0.14027,0.21596,1,1
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.0054671,0.14027,0.21092,1,1
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.010101,0.14012,0.21046,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0025648,0.13994,0.16605,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0020776,0.13913,0.24021,1,1
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.0036751,0.13898,0.19776,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0060238,0.13895,0.19389,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.015104,0.13875,0.20136,1,1
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.017954,0.13869,0.17699,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0172,0.13866,0.21008,1,1
4,GO ACTIN NUCLEATION,0.013235,0.13825,0.16283,1,1
4,GO ERYTHROCYTE DEVELOPMENT,0.046961,0.13808,0.18681,1,1
4,GO REGULATION OF PROTEIN ACETYLATION,0.012106,0.13803,0.17829,1,1
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.034576,0.13796,0.1801,1,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.02951,0.13756,0.18248,1,1
4,GO FATTY ACID BETA OXIDATION,0.010572,0.13731,0.19535,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.015776,0.13724,0.30352,1,1
4,GO RETINA HOMEOSTASIS,0.0060238,0.13717,0.18381,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0038653,0.13695,0.32427,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.010101,0.13676,0.17207,1,1
4,GO HISTONE H2A ACETYLATION,0.013834,0.13662,0.21666,1,1
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.043559,0.13646,0.15973,1,1
4,GO GOLGI VESICLE BUDDING,0.0042727,0.13611,0.20971,1,1
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.0057394,0.13601,0.15205,1,1
4,GO LIPID OXIDATION,0.040368,0.1359,0.16184,1,1
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.020391,0.13587,0.20931,1,1
4,GO CARBOHYDRATE TRANSPORT,0.018736,0.13584,0.17564,1,1
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.046961,0.13529,0.18244,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.011063,0.13453,0.24871,1,1
4,GO NUCLEOTIDE PHOSPHORYLATION,0.02951,0.13445,0.14969,1,1
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.019548,0.13437,0.1787,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.00332,0.13425,0.27102,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0054671,0.13425,0.23197,1,1
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.020391,0.13424,0.21246,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0036751,0.13418,0.20364,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0076456,0.13416,0.16995,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00332,0.13415,0.19697,1,1
4,GO MOLTING CYCLE,0.048745,0.13414,0.1692,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0083971,0.13403,0.1707,1,1
4,GO DEPHOSPHORYLATION,0.007293,0.13374,0.20279,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.043559,0.13333,0.10915,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0025648,0.13332,0.23079,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0096484,0.13322,0.15479,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.0080134,0.1332,0.22144,1,1
4,GO COPII COATED VESICLE CARGO LOADING,0.041938,0.13284,0.20866,1,1
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.038848,0.13275,0.12171,1,1
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.012106,0.13273,0.2481,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.015776,0.1324,0.19216,1,1
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.02951,0.1324,0.16632,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0028457,0.13227,0.2317,1,1
4,GO CELL CELL SIGNALING,0.0066311,0.13198,0.21171,1,1
4,GO RESPONSE TO METAL ION,0.013834,0.13192,0.16232,1,1
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.0063209,0.13186,0.19714,1,1
4,GO ORGANIC ANION TRANSPORT,0.007293,0.13167,0.17553,1,1
4,GO EPIDERMIS DEVELOPMENT,0.048745,0.1316,0.14384,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0057394,0.1312,0.17936,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0044907,0.1308,0.17499,1,1
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.034576,0.13077,0.11349,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.045233,0.13055,0.19501,1,1
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.026142,0.13019,0.1988,1,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0096484,0.1301,0.17254,1,1
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.0025648,0.13003,0.144,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.013834,0.12993,0.26049,1,1
4,GO IRON ION TRANSPORT,0.019548,0.12992,0.16292,1,1
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.046961,0.12973,0.15679,1,1
4,GO ESTABLISHMENT OF CELL POLARITY,0.018736,0.12958,0.20821,1,1
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.038848,0.12953,0.26197,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.031957,0.12944,0.15459,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.020391,0.12921,0.15475,1,1
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.022172,0.129,0.15552,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0049572,0.12899,0.1442,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.038848,0.12887,0.24724,1,1
4,GO CALCINEURIN MEDIATED SIGNALING,0.021265,0.12871,0.20684,1,1
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.034576,0.12863,0.21221,1,1
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0024341,0.12862,0.15813,1,1
4,GO NCRNA TRANSCRIPTION,0.035953,0.12853,0.13851,1,1
4,GO RHYTHMIC PROCESS,0.015776,0.12837,0.1826,1,1
4,GO HEART FORMATION,0.031957,0.1283,0.19645,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,0.024086,0.12787,0.15389,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.013235,0.12762,0.13749,1,1
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.016475,0.12695,0.17932,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.013235,0.12673,0.17462,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.017954,0.12645,0.16676,1,1
4,GO MITOCHONDRIAL FUSION,0.00332,0.12643,0.19121,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0096484,0.12635,0.20971,1,1
4,GO PHAGOSOME ACIDIFICATION,0.0092139,0.12612,0.18426,1,1
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.013235,0.1256,0.19961,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0057394,0.12507,0.14433,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.008797,0.12493,0.19026,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.025096,0.12492,0.15113,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.025096,0.12461,0.17296,1,1
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.025096,0.12461,0.19655,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.0036751,0.1246,0.20859,1,1
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.028348,0.12413,0.18773,1,1
4,GO MULTI ORGANISM PROCESS,0.017954,0.12384,0.15829,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0042727,0.12362,0.17003,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014457,0.12356,0.13442,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.006955,0.1235,0.16282,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.011063,0.12348,0.166,1,1
4,GO SPERM EGG RECOGNITION,0.0012758,0.12338,0.14644,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0038653,0.12277,0.20158,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0083971,0.12276,0.17582,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.0052065,0.12272,0.21312,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.034576,0.12267,0.15239,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.010101,0.12265,0.18008,1,1
4,GO NEGATIVE REGULATION OF GROWTH,0.040368,0.12236,0.15451,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0025648,0.12196,0.19409,1,1
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.026142,0.12177,0.17819,1,1
4,GO LIPID MODIFICATION,0.018736,0.12173,0.1927,1,1
4,GO ANION TRANSPORT,0.0040644,0.12155,0.19406,1,1
4,GO LIPID PHOSPHORYLATION,0.041938,0.12111,0.18824,1,1
4,GO RETINAL CONE CELL DIFFERENTIATION,0.026142,0.12105,0.17491,1,1
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.019548,0.12081,0.16494,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.0036751,0.12074,0.20741,1,1
4,GO DETECTION OF STIMULUS,0.0052065,0.12052,0.1577,1,1
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.015104,0.12,0.11172,1,1
4,GO MITOCHONDRION MORPHOGENESIS,0.0049572,0.11986,0.16857,1,1
4,GO ORGANELLE INHERITANCE,0.0076456,0.11977,0.16768,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.022172,0.11963,0.12957,1,1
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.017954,0.11938,0.15066,1,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.026142,0.11935,0.17272,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0096484,0.11922,0.16035,1,1
4,GO CATION TRANSPORT,0.0042727,0.11796,0.21076,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,0.013235,0.1175,0.15401,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0042727,0.11745,0.16478,1,1
4,GO METAL ION TRANSPORT,0.006955,0.11724,0.21283,1,1
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.043559,0.11706,0.23218,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.018736,0.11651,0.14849,1,1
4,GO ION TRANSPORT,0.0049572,0.11649,0.20365,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.027226,0.11587,0.21163,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.0096484,0.11575,0.15863,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.015776,0.11532,0.19451,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0080134,0.1147,0.16943,1,1
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.043559,0.11381,0.19499,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.0044907,0.11377,0.17787,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0076456,0.11371,0.15936,1,1
4,GO REGULATION OF ATPASE ACTIVITY,0.014457,0.11323,0.12215,1,1
4,GO EPITHELIUM DEVELOPMENT,0.025096,0.11279,0.16318,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.040368,0.1127,0.14809,1,1
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.028348,0.11211,0.22612,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0042727,0.11171,0.1804,1,1
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011063,0.1116,0.18746,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.026142,0.11144,0.15168,1,1
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.021265,0.11059,0.16005,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.013235,0.11016,0.16529,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.023112,0.10992,0.1664,1,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.013235,0.10983,0.17019,1,1
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.040368,0.10933,0.14945,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.015104,0.1091,0.14613,1,1
4,GO NEURON APOPTOTIC PROCESS,0.046961,0.10869,0.14319,1,1
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.045233,0.10842,0.14284,1,1
4,GO PEROXISOME ORGANIZATION,0.035953,0.10813,0.13186,1,1
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.016475,0.10798,0.15976,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.021265,0.10786,0.13096,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.016475,0.10765,0.12668,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.022172,0.1076,0.18343,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.010572,0.10711,0.15691,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00332,0.10649,0.1951,1,1
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.021265,0.10631,0.1706,1,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.024086,0.1062,0.23326,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.037377,0.10577,0.13247,1,1
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.027226,0.10567,0.12756,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.041938,0.10538,0.14848,1,1
4,GO PROTEIN DEPHOSPHORYLATION,0.008797,0.10532,0.1901,1,1
4,GO ERAD PATHWAY,0.011574,0.10508,0.19293,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.017954,0.10499,0.17607,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.025096,0.10463,0.14002,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.015776,0.10414,0.19737,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0076456,0.10353,0.12207,1,1
4,GO LIPID LOCALIZATION,0.048745,0.10343,0.15171,1,1
4,GO STEROID METABOLIC PROCESS,0.048745,0.10297,0.13566,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.037377,0.10261,0.15341,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.027226,0.10232,0.19749,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.030713,0.10221,0.13349,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.020391,0.10172,0.15895,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.0092139,0.10134,0.15038,1,1
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0172,0.10129,0.21856,1,1
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.033245,0.10056,0.11887,1,1
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.038848,0.099668,0.21526,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.019548,0.098679,0.095058,1,1
4,GO RNA CAPPING,0.027226,0.098554,0.10786,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.046961,0.098415,0.10341,1,1
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.013235,0.097561,0.10731,1,1
4,GO REGULATION OF ENDOCYTOSIS,0.048745,0.097473,0.1884,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.013834,0.09729,0.16011,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0063209,0.096634,0.18206,1,1
4,GO LYTIC VACUOLE ORGANIZATION,0.031957,0.096632,0.17288,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.018736,0.096624,0.14695,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.017954,0.096054,0.15042,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.043559,0.096052,0.15213,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,0.030713,0.096017,0.12552,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.040368,0.095286,0.13629,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.048745,0.094507,0.13706,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.028348,0.093213,0.1472,1,1
4,GO PEROXISOMAL TRANSPORT,0.02951,0.092812,0.11676,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.021265,0.09273,0.22341,1,1
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.028348,0.091875,0.11652,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.026142,0.091874,0.1265,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.011574,0.091702,0.22459,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0083971,0.091457,0.15277,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.037377,0.091413,0.17386,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.033245,0.09076,0.1223,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.025096,0.090551,0.19283,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,0.027226,0.089769,0.11075,1,1
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.046961,0.088498,0.1522,1,1
4,GO MITOCHONDRIAL FISSION,0.018736,0.087284,0.16839,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.016475,0.086449,0.11691,1,1
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.015104,0.086255,0.13155,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.012106,0.086168,0.17801,1,1
4,GO REGULATION OF AUTOPHAGY,0.010572,0.08564,0.18918,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.028348,0.085037,0.18773,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.020391,0.083579,0.14141,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.018736,0.082219,0.12511,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.017954,0.082103,0.19058,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.013235,0.081831,0.15813,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.028348,0.078152,0.11307,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.030713,0.076407,0.12575,1,1
4,GO MITOCHONDRION ORGANIZATION,0.0028457,0.074203,0.12085,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.011574,0.074064,0.10703,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.046961,0.072046,0.22116,1,1
4,GO MITOTIC CYTOKINETIC PROCESS,0.035953,0.071951,0.10861,1,1
4,GO OXIDATION REDUCTION PROCESS,0.034576,0.070797,0.10732,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.043559,0.069408,0.13702,1,1
4,GO PIGMENT METABOLIC PROCESS,0.016475,0.068857,0.12449,1,1
4,GO PROTEIN FOLDING,0.031957,0.068181,0.10967,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.041938,0.067478,0.10112,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.026142,0.066629,0.10069,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.01266,0.059084,0.12986,1,1
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.015104,0.4552,0.37454,1,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.015776,0.42738,0.38517,1,0
4,GO RESPONSE TO POTASSIUM ION,0.0031545,0.40842,0.44511,1,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.019548,0.38203,0.37195,1,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0080134,0.37543,0.41134,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,0.025096,0.37218,0.31136,1,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.018736,0.36254,0.33039,1,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00072571,0.35445,0.60204,1,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.02951,0.33987,0.30048,1,0
4,GO REGULATION OF SYNAPSE MATURATION,0.043559,0.32634,0.24711,1,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.010572,0.31488,0.33836,1,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0044907,0.30888,0.32903,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.016475,0.30844,0.26911,1,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.011574,0.30499,0.30222,1,0
4,GO SEX DETERMINATION,0.0080134,0.30328,0.27752,1,0
4,GO HISTONE H3 K27 METHYLATION,0.0036751,0.30173,0.36361,1,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.012106,0.3012,0.34598,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.0057394,0.29142,0.31125,1,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.025096,0.29012,0.24539,1,0
4,GO SYNAPSE MATURATION,0.041938,0.28456,0.27727,1,0
4,GO RESPONSE TO ACETYLCHOLINE,0.01266,0.28331,0.28369,1,0
4,GO NEURON CELL CELL ADHESION,0.0060238,0.2822,0.41569,1,0
4,GO RETINA LAYER FORMATION,0.027226,0.27793,0.34044,1,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.0060238,0.27602,0.44032,1,0
4,GO REGULATION OF NEURON MIGRATION,0.022172,0.27567,0.29516,1,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.031957,0.27551,0.24204,1,0
4,GO MEMBRANE HYPERPOLARIZATION,0.010572,0.27324,0.26862,1,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.012106,0.27311,0.33482,1,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.019548,0.26851,0.29801,1,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.0054671,0.26071,0.29098,1,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.026142,0.25948,0.28204,1,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.0060238,0.25612,0.27269,1,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.046961,0.25501,0.31944,1,0
4,GO HISTONE METHYLATION,0.0028457,0.25013,0.26941,1,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.0080134,0.24346,0.24547,1,0
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.038848,0.24232,0.27299,1,0
4,GO EXPLORATION BEHAVIOR,0.015776,0.24228,0.26523,1,0
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0011418,0.24183,0.31392,1,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0028457,0.24048,0.28754,1,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.008797,0.24019,0.25716,1,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0096484,0.24008,0.33416,1,0
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.014457,0.23988,0.31198,1,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.016475,0.23819,0.27757,1,0
4,GO NEUROMUSCULAR PROCESS,0.0066311,0.23797,0.26761,1,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00091199,0.2373,0.30016,1,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0023095,0.23526,0.32185,1,0
4,GO RESPONSE TO AUDITORY STIMULUS,0.026142,0.23362,0.25658,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.024086,0.23239,0.24453,1,0
4,GO TUBULIN DEACETYLATION,0.0066311,0.23174,0.31332,1,0
4,GO HISTONE H3 K36 METHYLATION,0.018736,0.2297,0.29688,1,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0018673,0.22968,0.29085,1,0
4,GO PEPTIDYL LYSINE METHYLATION,0.0044907,0.22732,0.26398,1,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.007293,0.22722,0.27146,1,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.008797,0.22714,0.26634,1,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.026142,0.22686,0.17262,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.021265,0.22677,0.21804,1,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.046961,0.22637,0.23871,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.025096,0.22596,0.23204,1,0
4,GO RECEPTOR CLUSTERING,0.01266,0.22415,0.28401,1,0
4,GO DIVALENT METAL ION EXPORT,0.015104,0.22281,0.26278,1,0
4,GO SPINDLE LOCALIZATION,0.0034935,0.22228,0.23937,1,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.043559,0.22211,0.18314,1,0
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.011063,0.22204,0.3375,1,0
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.013235,0.22137,0.28179,1,0
4,GO THALAMUS DEVELOPMENT,0.048745,0.22065,0.21354,1,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.020391,0.21954,0.25017,1,0
4,GO NEURON RECOGNITION,0.020391,0.21919,0.28272,1,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.022172,0.21861,0.22633,1,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0054671,0.21819,0.25751,1,0
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.019548,0.21707,0.24054,1,0
4,GO NEURON MIGRATION,0.0172,0.21338,0.23699,1,0
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.011574,0.21224,0.21152,1,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.045233,0.2122,0.18756,1,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.014457,0.2122,0.32124,1,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.012106,0.21219,0.28883,1,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0060238,0.21197,0.3064,1,0
4,GO MAINTENANCE OF CELL POLARITY,0.016475,0.21137,0.23989,1,0
4,GO LIPID TRANSLOCATION,0.0083971,0.20921,0.26601,1,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.038848,0.20825,0.17531,1,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0038653,0.20762,0.32037,1,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.020391,0.20741,0.23471,1,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.034576,0.20558,0.2047,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.046961,0.20499,0.165,1,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.015104,0.20435,0.25417,1,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.013834,0.20362,0.28384,1,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.031957,0.20269,0.20402,1,0
4,GO RESPONSE TO COCAINE,0.0066311,0.2019,0.25641,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.016475,0.20162,0.23306,1,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.0029965,0.20068,0.24766,1,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.0172,0.20043,0.24935,1,0
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.007293,0.20024,0.21243,1,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0092139,0.19797,0.31174,1,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0027019,0.19708,0.26779,1,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0047188,0.19585,0.31337,1,0
4,GO CGMP METABOLIC PROCESS,0.012106,0.19573,0.30117,1,0
4,GO GROWTH HORMONE SECRETION,0.027226,0.19514,0.29588,1,0
4,GO COBALAMIN METABOLIC PROCESS,0.0031545,0.19442,0.23266,1,0
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.040368,0.19415,0.19132,1,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.017954,0.19317,0.28886,1,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.030713,0.19241,0.2361,1,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0027019,0.19216,0.30355,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.013834,0.19198,0.20326,1,0
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0076456,0.19124,0.26376,1,0
4,GO MITOTIC RECOMBINATION,0.040368,0.18931,0.19282,1,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.013235,0.1881,0.22676,1,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0044907,0.18691,0.25507,1,0
4,GO REGULATION OF TUBE SIZE,0.030713,0.18691,0.17526,1,0
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0019699,0.18688,0.25569,1,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.037377,0.18672,0.22754,1,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.0076456,0.18661,0.23309,1,0
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.011574,0.18656,0.22786,1,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.016475,0.18638,0.22495,1,0
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0172,0.18629,0.29015,1,0
4,GO HETEROCHROMATIN ORGANIZATION,0.0083971,0.18623,0.24163,1,0
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.011574,0.18614,0.23249,1,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.0063209,0.18588,0.21615,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.031957,0.18579,0.18553,1,0
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.015776,0.18563,0.26713,1,0
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.026142,0.18425,0.28289,1,0
4,GO METENCEPHALON DEVELOPMENT,0.016475,0.18318,0.22148,1,0
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0015041,0.1829,0.28124,1,0
4,GO HEAD DEVELOPMENT,0.0044907,0.18238,0.21797,1,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.020391,0.18117,0.20882,1,0
4,GO HISTONE H3 K4 METHYLATION,0.011574,0.1805,0.22719,1,0
4,GO FOREBRAIN CELL MIGRATION,0.026142,0.18039,0.21023,1,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0080134,0.17997,0.25226,1,0
4,GO CATECHOLAMINE UPTAKE,0.013235,0.17912,0.31082,1,0
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.0083971,0.17842,0.21701,1,0
4,GO NEUROGENESIS,0.0047188,0.17814,0.23041,1,0
4,GO HISTONE H4 ACETYLATION,0.0036751,0.17797,0.24045,1,0
4,GO COGNITION,0.010101,0.17769,0.23452,1,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.025096,0.17726,0.23904,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.033245,0.17489,0.1958,1,0
4,GO PROTEIN MANNOSYLATION,0.007293,0.17425,0.21177,1,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.007293,0.17367,0.33596,1,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.010572,0.17296,0.18699,1,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.019548,0.17181,0.17336,1,0
4,GO PALLIUM DEVELOPMENT,0.025096,0.17168,0.18365,1,0
4,GO HISTONE H4 K16 ACETYLATION,0.026142,0.17168,0.20616,1,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0040644,0.17134,0.24966,1,0
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.026142,0.17044,0.18607,1,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.022172,0.17019,0.20833,1,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.038848,0.16971,0.2011,1,0
4,GO FEEDING BEHAVIOR,0.041938,0.16954,0.17663,1,0
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.00332,0.16932,0.23472,1,0
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.019548,0.16909,0.28815,1,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.022172,0.16906,0.18856,1,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0042727,0.16904,0.33582,1,0
4,GO CEREBELLAR CORTEX FORMATION,0.0042727,0.16885,0.27949,1,0
4,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.0044907,0.16854,0.31261,1,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.010101,0.16834,0.21488,1,0
4,GO INOSITOL METABOLIC PROCESS,0.043559,0.16829,0.20373,1,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.027226,0.16733,0.31646,1,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.02951,0.16712,0.21651,1,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00332,0.16689,0.25033,1,0
4,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.030713,0.16667,0.24588,1,0
4,GO OOCYTE MATURATION,0.01266,0.16616,0.19857,1,0
4,GO RESPONSE TO FOOD,0.026142,0.16586,0.17979,1,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.028348,0.1654,0.22719,1,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.035953,0.16534,0.18795,1,0
4,GO DEFINITIVE HEMOPOIESIS,0.048745,0.16532,0.24495,1,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.0096484,0.16524,0.26487,1,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.0092139,0.16491,0.2305,1,0
4,GO CELL MORPHOGENESIS,0.007293,0.16479,0.23696,1,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.030713,0.16472,0.21845,1,0
4,GO LYSOSOMAL TRANSPORT,0.0040644,0.16331,0.25307,1,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.025096,0.16253,0.291,1,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.015104,0.16249,0.25523,1,0
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.02951,0.16239,0.17661,1,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.0096484,0.16205,0.24573,1,0
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.048745,0.16205,0.16414,1,0
4,GO HISTONE H4 DEACETYLATION,0.038848,0.16146,0.15667,1,0
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.028348,0.16117,0.17449,1,0
4,GO HISTONE H3 ACETYLATION,0.019548,0.16116,0.18385,1,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.017954,0.16113,0.2122,1,0
4,GO PROTEIN DEPOLYMERIZATION,0.0060238,0.16075,0.24856,1,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037377,0.16074,0.18658,1,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.033245,0.16052,0.21175,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.025096,0.16003,0.21316,1,0
4,GO REGULATION OF RUFFLE ASSEMBLY,0.048745,0.16001,0.16768,1,0
4,GO NADH METABOLIC PROCESS,0.041938,0.15979,0.16458,1,0
4,GO POST EMBRYONIC DEVELOPMENT,0.007293,0.15939,0.23301,1,0
4,GO SPINAL CORD DEVELOPMENT,0.038848,0.15876,0.21746,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.037377,0.15861,0.13966,1,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.007293,0.15826,0.22394,1,0
4,GO RESPONSE TO DIETARY EXCESS,0.015776,0.15819,0.26703,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.021265,0.15786,0.17468,1,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.031957,0.15783,0.20802,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.043559,0.1574,0.18686,1,0
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.011063,0.15727,0.20972,1,0
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.011574,0.15685,0.24596,1,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0029965,0.15658,0.21734,1,0
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.0092139,0.1551,0.21676,1,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.037377,0.15497,0.27361,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.027226,0.15494,0.20417,1,0
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0044907,0.15474,0.24373,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.026142,0.15466,0.20217,1,0
4,GO CYTOSOLIC TRANSPORT,0.0018673,0.15465,0.25619,1,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.011574,0.15454,0.21323,1,0
4,GO ERYTHROCYTE MATURATION,0.045233,0.15412,0.23715,1,0
4,GO LEFT RIGHT PATTERN FORMATION,0.01266,0.15296,0.23522,1,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.014457,0.15274,0.202,1,0
4,GO AORTA DEVELOPMENT,0.040368,0.15229,0.2399,1,0
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0080134,0.15221,0.22568,1,0
4,GO EATING BEHAVIOR,0.02951,0.15205,0.18226,1,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.011574,0.15202,0.18854,1,0
4,GO SULFATE TRANSPORT,0.031957,0.15104,0.19208,1,0
4,GO RESPONSE TO ALKALOID,0.0076456,0.15071,0.19736,1,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.017954,0.15055,0.20538,1,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0092139,0.15045,0.20902,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.038848,0.14996,0.14687,1,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.011574,0.14989,0.2079,1,0
4,GO REGULATION OF GLUCONEOGENESIS,0.0066311,0.14957,0.26203,1,0
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.0080134,0.14948,0.1999,1,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.038848,0.1494,0.16935,1,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.037377,0.14922,0.20153,1,0
4,GO SENSORY PERCEPTION OF PAIN,0.0172,0.14921,0.18212,1,0
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0096484,0.1492,0.1613,1,0
4,GO FILOPODIUM ASSEMBLY,0.031957,0.14915,0.19538,1,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.011063,0.14845,0.21656,1,0
4,GO DNA METHYLATION,0.021265,0.14844,0.18548,1,0
4,GO METHIONINE METABOLIC PROCESS,0.046961,0.14824,0.15142,1,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.0172,0.14817,0.2,1,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0060238,0.14809,0.26,1,0
4,GO FOCAL ADHESION ASSEMBLY,0.045233,0.14804,0.22605,1,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.013834,0.148,0.21048,1,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.010572,0.14719,0.23385,1,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0172,0.14711,0.16396,1,0
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.035953,0.14683,0.20574,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.027226,0.14677,0.22418,1,0
4,GO FOREBRAIN DEVELOPMENT,0.022172,0.14652,0.19088,1,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.048745,0.14588,0.18977,1,0
4,GO SOMITE DEVELOPMENT,0.022172,0.14576,0.19342,1,0
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.010572,0.14572,0.21177,1,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.046961,0.14557,0.22973,1,0
4,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.0038653,0.14548,0.20373,1,0
4,GO MEIOTIC CELL CYCLE,0.023112,0.14495,0.17378,1,0
4,GO CELL GROWTH,0.0036751,0.14482,0.21705,1,0
4,GO REGULATION OF CELL DEVELOPMENT,0.011574,0.14449,0.2012,1,0
4,GO TELENCEPHALON DEVELOPMENT,0.043559,0.14438,0.1745,1,0
4,GO PROTEIN KINASE A SIGNALING,0.048745,0.14437,0.17246,1,0
4,GO PEPTIDE CATABOLIC PROCESS,0.038848,0.14413,0.1971,1,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.022172,0.14393,0.2629,1,0
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.022172,0.14354,0.26142,1,0
4,GO CARDIAC MUSCLE CONTRACTION,0.015776,0.14276,0.2444,1,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.015104,0.14274,0.1844,1,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.0060238,0.14254,0.18542,1,0
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0080134,0.14149,0.21706,1,0
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0080134,0.14053,0.23497,1,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0080134,0.13979,0.20429,1,0
4,GO CIRCULATORY SYSTEM PROCESS,0.025096,0.13954,0.19264,1,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.021265,0.13909,0.23794,1,0
4,GO HINDBRAIN MORPHOGENESIS,0.025096,0.13856,0.21919,1,0
4,GO MUSCLE FIBER DEVELOPMENT,0.024086,0.13823,0.19898,1,0
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0054671,0.13806,0.22645,1,0
4,GO STEROL METABOLIC PROCESS,0.037377,0.13783,0.15208,1,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.041938,0.13671,0.23196,1,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.045233,0.13659,0.19211,1,0
4,GO DEVELOPMENTAL GROWTH,0.0092139,0.13652,0.21067,1,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.007293,0.13615,0.17956,1,0
4,GO ERBB SIGNALING PATHWAY,0.046961,0.13607,0.17781,1,0
4,GO PROTEIN MONOUBIQUITINATION,0.013834,0.13583,0.1875,1,0
4,GO ACTIN FILAMENT BASED PROCESS,0.021265,0.13566,0.20519,1,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0083971,0.13554,0.22179,1,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.038848,0.13548,0.22418,1,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.0040644,0.13535,0.201,1,0
4,GO PEPTIDYL SERINE MODIFICATION,0.006955,0.13519,0.21622,1,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0052065,0.13511,0.19646,1,0
4,GO CALCIUM ION IMPORT,0.0092139,0.13372,0.27295,1,0
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.015104,0.1337,0.22561,1,0
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.02951,0.13334,0.22832,1,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.021265,0.1332,0.18424,1,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.017954,0.13299,0.21677,1,0
4,GO ACTIN FILAMENT BASED MOVEMENT,0.019548,0.13297,0.21939,1,0
4,GO VACUOLAR TRANSPORT,0.0023095,0.13295,0.2347,1,0
4,GO SECRETORY GRANULE ORGANIZATION,0.037377,0.13289,0.20248,1,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.018736,0.13275,0.13988,1,0
4,GO MEMBRANE FISSION,0.038848,0.13273,0.21856,1,0
4,GO PATTERN SPECIFICATION PROCESS,0.041938,0.13219,0.16247,1,0
4,GO AMYLOID BETA METABOLIC PROCESS,0.033245,0.132,0.18973,1,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.0042727,0.13112,0.18614,1,0
4,GO DNA MODIFICATION,0.011574,0.1311,0.1622,1,0
4,GO ACTIN FILAMENT ORGANIZATION,0.027226,0.13095,0.18563,1,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.010572,0.13083,0.18504,1,0
4,GO CYTOKINESIS,0.0096484,0.13067,0.18822,1,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.010101,0.13028,0.22685,1,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.012106,0.13014,0.19447,1,0
4,GO EYE MORPHOGENESIS,0.011063,0.13,0.22812,1,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.034576,0.12975,0.16135,1,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.035953,0.12973,0.17326,1,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.043559,0.12904,0.19467,1,0
4,GO REGULATION OF SYSTEM PROCESS,0.007293,0.12893,0.21244,1,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.011574,0.12888,0.18739,1,0
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0060238,0.12826,0.21448,1,0
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.045233,0.12808,0.15878,1,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.040368,0.12803,0.16669,1,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.043559,0.1277,0.1606,1,0
4,GO MUSCLE CONTRACTION,0.024086,0.12743,0.19708,1,0
4,GO DNA DEALKYLATION,0.043559,0.12717,0.13841,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.013834,0.12685,0.19318,1,0
4,GO VESICLE TARGETING,0.0023095,0.12635,0.2161,1,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.045233,0.12559,0.16386,1,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.048745,0.12544,0.17631,1,0
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0054671,0.12494,0.22391,1,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.010101,0.12489,0.17163,1,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.02951,0.12475,0.20376,1,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.010572,0.12456,0.21106,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.015776,0.12441,0.20476,1,0
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.035953,0.12416,0.15902,1,0
4,GO SENSORY ORGAN DEVELOPMENT,0.033245,0.12406,0.17495,1,0
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0057394,0.12349,0.1541,1,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.033245,0.12258,0.1753,1,0
4,GO SARCOMERE ORGANIZATION,0.017954,0.12257,0.16765,1,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.034576,0.12244,0.16713,1,0
4,GO LIPID DROPLET ORGANIZATION,0.0019699,0.12215,0.19908,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.011574,0.12206,0.19583,1,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.021265,0.12195,0.19985,1,0
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.035953,0.12195,0.18026,1,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.043559,0.1217,0.22923,1,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.0096484,0.1208,0.2238,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.013834,0.12014,0.16358,1,0
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.006955,0.12001,0.20173,1,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.043559,0.11966,0.17724,1,0
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.016475,0.1188,0.20385,1,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.024086,0.11845,0.15374,1,0
4,GO REGULATION OF CELLULAR LOCALIZATION,0.0096484,0.11829,0.195,1,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.038848,0.11821,0.31522,1,0
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.020391,0.11774,0.15719,1,0
4,GO LIPID CATABOLIC PROCESS,0.038848,0.1176,0.13607,1,0
4,GO SELECTIVE AUTOPHAGY,0.0096484,0.11732,0.21664,1,0
4,GO REGULATION OF CYTOKINESIS,0.027226,0.117,0.17443,1,0
4,GO REGULATION OF PROTEIN BINDING,0.023112,0.11699,0.17911,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.019548,0.11683,0.14388,1,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.025096,0.11657,0.19556,1,0
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0172,0.11595,0.23014,1,0
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.015776,0.11553,0.19176,1,0
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.035953,0.11503,0.17441,1,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0080134,0.11467,0.18291,1,0
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.026142,0.11433,0.17565,1,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.030713,0.11392,0.1496,1,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.035953,0.11372,0.15055,1,0
4,GO TRANSMEMBRANE TRANSPORT,0.0034935,0.11359,0.20067,1,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.019548,0.11247,0.14072,1,0
4,GO ORGANELLE DISASSEMBLY,0.0044907,0.11244,0.19304,1,0
4,GO REGULATION OF TRANSPORT,0.019548,0.11233,0.18092,1,0
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0172,0.11232,0.1602,1,0
4,GO AUTOPHAGOSOME MATURATION,0.013834,0.11205,0.22418,1,0
4,GO PHAGOSOME MATURATION,0.015776,0.11184,0.20551,1,0
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.021265,0.1117,0.18125,1,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.024086,0.11109,0.1791,1,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.016475,0.11105,0.1711,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.021265,0.11101,0.29549,1,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.033245,0.11091,0.17577,1,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.017954,0.11019,0.1755,1,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.034576,0.11018,0.13173,1,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.028348,0.11009,0.16775,1,0
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.01266,0.1098,0.16329,1,0
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.013834,0.10967,0.16021,1,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.048745,0.10964,0.17248,1,0
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0076456,0.10936,0.21101,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.02951,0.10927,0.2202,1,0
4,GO SINGLE FERTILIZATION,0.01266,0.10891,0.13915,1,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.024086,0.10874,0.14282,1,0
4,GO MUSCLE CELL DEVELOPMENT,0.026142,0.10847,0.18009,1,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.046961,0.10786,0.1868,1,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.035953,0.10739,0.16521,1,0
4,GO POSITIVE REGULATION OF SECRETION,0.041938,0.10728,0.16663,1,0
4,GO REGULATION OF SECRETION,0.025096,0.10701,0.17938,1,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.037377,0.10642,0.13807,1,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.0057394,0.10633,0.18947,1,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.041938,0.10616,0.19701,1,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.006955,0.10596,0.1812,1,0
4,GO REGULATION OF GROWTH,0.0080134,0.10553,0.18193,1,0
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.031957,0.10509,0.15734,1,0
4,GO MEMBRANE ORGANIZATION,0.0172,0.10498,0.16904,1,0
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.020391,0.10448,0.16791,1,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.034576,0.10435,0.14913,1,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.017954,0.1043,0.22405,1,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.011574,0.10392,0.13934,1,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.020391,0.10344,0.15032,1,0
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00060992,0.10344,0.2263,1,0
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.030713,0.10288,0.19483,1,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0047188,0.10287,0.16317,1,0
4,GO EMBRYO DEVELOPMENT,0.020391,0.10271,0.17566,1,0
4,GO NON RECOMBINATIONAL REPAIR,0.046961,0.10231,0.14754,1,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.024086,0.10213,0.18187,1,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.026142,0.10186,0.24453,1,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.027226,0.10129,0.15933,1,0
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.013834,0.10129,0.16488,1,0
4,GO VESICLE ORGANIZATION,0.0036751,0.10103,0.207,1,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.013834,0.10088,0.14236,1,0
4,GO PROTEIN CATABOLIC PROCESS,0.0083971,0.10074,0.16129,1,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.030713,0.10069,0.20801,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.040368,0.10046,0.15516,1,0
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.026142,0.10034,0.15246,1,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0083971,0.099988,0.13953,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.019548,0.099786,0.16201,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.031957,0.099639,0.14636,1,0
4,GO MACROAUTOPHAGY,0.0057394,0.09938,0.18681,1,0
4,GO CHEMICAL HOMEOSTASIS,0.045233,0.099345,0.1545,1,0
4,GO MUSCLE SYSTEM PROCESS,0.037377,0.099196,0.17971,1,0
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0034935,0.099157,0.1996,1,0
4,GO ERBB2 SIGNALING PATHWAY,0.040368,0.099063,0.20619,1,0
4,GO REGULATION OF PROTEIN STABILITY,0.025096,0.099006,0.13044,1,0
4,GO TOXIN TRANSPORT,0.025096,0.09805,0.19897,1,0
4,GO ENDOSOME ORGANIZATION,0.028348,0.097854,0.14473,1,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.015104,0.097748,0.30071,1,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.021265,0.097539,0.18082,1,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.041938,0.097093,0.23782,1,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.0172,0.096965,0.19417,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.028348,0.09694,0.15692,1,0
4,GO FATTY ACID METABOLIC PROCESS,0.038848,0.096747,0.13352,1,0
4,GO VIRAL RELEASE FROM HOST CELL,0.013235,0.096484,0.14512,1,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.030713,0.096483,0.14718,1,0
4,GO UBIQUINONE METABOLIC PROCESS,0.0172,0.095824,0.12764,1,0
4,GO MAINTENANCE OF CELL NUMBER,0.048745,0.095397,0.15272,1,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.046961,0.094916,0.15685,1,0
4,GO GROWTH,0.010101,0.094787,0.18246,1,0
4,GO RESPONSE TO RADIATION,0.016475,0.094668,0.15557,1,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.026142,0.094555,0.13766,1,0
4,GO REGULATION OF CELLULAR PH,0.015776,0.094378,0.17388,1,0
4,GO CARNITINE SHUTTLE,0.046961,0.094199,0.2007,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.033245,0.093922,0.14896,1,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.026142,0.093768,0.18904,1,0
4,GO CELL CELL SIGNALING BY WNT,0.012106,0.093666,0.17994,1,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.037377,0.093658,0.16797,1,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.0017696,0.092961,0.16093,1,0
4,GO POLYAMINE METABOLIC PROCESS,0.028348,0.092131,0.12103,1,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.034576,0.091946,0.1306,1,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.021265,0.091915,0.20415,1,0
4,GO FERTILIZATION,0.0054671,0.091582,0.15535,1,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.027226,0.091231,0.15032,1,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.021265,0.091151,0.18331,1,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.038848,0.09066,0.16677,1,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.024086,0.090297,0.10194,1,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.033245,0.090093,0.15904,1,0
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.025096,0.090017,0.14801,1,0
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.028348,0.089992,0.11945,1,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.024086,0.08945,0.16705,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.027226,0.089132,0.17339,1,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.028348,0.088763,0.16655,1,0
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.040368,0.087414,0.16173,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION,0.020391,0.086571,0.15688,1,0
4,GO VACUOLE ORGANIZATION,0.008797,0.086347,0.19692,1,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.027226,0.086247,0.23943,1,0
4,GO REGULATION OF PEPTIDE TRANSPORT,0.046961,0.086083,0.14792,1,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.040368,0.085915,0.14753,1,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.045233,0.085904,0.10902,1,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0047188,0.085643,0.1469,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.045233,0.085221,0.16947,1,0
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0052065,0.085032,0.13797,1,0
4,GO REGULATION OF PH,0.018736,0.085019,0.16731,1,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.030713,0.084633,0.17103,1,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.040368,0.084278,0.18858,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.046961,0.083882,0.13626,1,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011574,0.083748,0.13072,1,0
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.02951,0.083479,0.18299,1,0
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.028348,0.082796,0.16169,1,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.023112,0.082593,0.12508,1,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.023112,0.082042,0.14506,1,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.028348,0.081752,0.11349,1,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.02951,0.080866,0.11892,1,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.019548,0.080707,0.16556,1,0
4,GO CELLULAR LIPID METABOLIC PROCESS,0.034576,0.08064,0.14961,1,0
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.031957,0.080462,0.18582,1,0
4,GO RESPONSE TO NITROGEN COMPOUND,0.041938,0.080164,0.15066,1,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.021265,0.080129,0.17345,1,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.033245,0.080095,0.10777,1,0
4,GO REGULATION OF CELL CYCLE,0.031957,0.079789,0.14753,1,0
4,GO PROTEIN SUMOYLATION,0.024086,0.079495,0.16465,1,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.015104,0.078653,0.15791,1,0
4,GO CELLULAR RESPONSE TO STARVATION,0.024086,0.077315,0.15725,1,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.041938,0.077303,0.14229,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.043559,0.077276,0.16893,1,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.034576,0.07726,0.10747,1,0
4,GO ORGANIC ACID METABOLIC PROCESS,0.024086,0.077159,0.12439,1,0
4,GO PROTEOLYSIS,0.031957,0.075505,0.14643,1,0
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.035953,0.07535,0.19957,1,0
4,GO PROTEIN DESTABILIZATION,0.017954,0.074832,0.16076,1,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.040368,0.07482,0.13587,1,0
4,GO RESPONSE TO STARVATION,0.027226,0.074601,0.14987,1,0
4,GO REGULATION OF GENE SILENCING,0.034576,0.072931,0.15708,1,0
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.028348,0.072879,0.16355,1,0
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.045233,0.071413,0.14465,1,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.033245,0.07,0.16067,1,0
4,GO LIPID METABOLIC PROCESS,0.030713,0.069466,0.14898,1,0
4,GO CELL CYCLE PROCESS,0.046961,0.066958,0.14107,1,0
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.043559,0.065882,0.23307,1,0
4,GO NEGATIVE REGULATION OF SIGNALING,0.040368,0.064727,0.16478,1,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.023112,0.062343,0.11544,1,0
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.016475,0.061539,0.2052,1,0
4,GO CELL CYCLE,0.028348,0.061341,0.15057,1,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.018736,0.060677,0.12741,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.040368,0.058298,0.19377,1,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.02951,0.057775,0.10591,1,0
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0096484,0.057716,0.20291,1,0
4,GO VIRION ASSEMBLY,0.033245,0.056516,0.092306,1,0
4,GO ATP METABOLIC PROCESS,0.024086,0.055203,0.092016,1,0
4,GO GOLGI TO ENDOSOME TRANSPORT,0.035953,0.048927,0.27214,1,0
4,GO PROTEIN TARGETING,0.026142,0.034003,0.061629,1,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.030713,-0.18518,-0.16748,1,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.022172,-0.18656,-0.13994,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.015776,-0.20926,-0.17763,1,0
4,GO REGULATION OF NUCLEASE ACTIVITY,0.020391,-0.21981,-0.16791,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.006955,-0.27466,-0.23085,1,0
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.034576,-0.30583,-0.28329,1,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0080134,-0.31192,-0.27359,1,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.035953,-0.47802,-0.30244,1,0
4,GO NATURAL KILLER CELL CHEMOTAXIS,0.048745,-0.76758,-0.53432,1,0
4,GO ADHESION OF SYMBIONT TO HOST,0.067497,0.43803,0.33558,0,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.069906,0.39935,0.27095,0,1
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.2577,0.36177,0.22356,0,1
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.065157,0.35783,0.27766,0,1
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.11163,0.35493,0.24956,0,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.15197,0.35137,0.21921,0,1
4,GO HEMIDESMOSOME ASSEMBLY,0.1306,0.34047,0.23013,0,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.077559,0.31235,0.23145,0,1
4,GO CELL AGGREGATION,0.074935,0.30569,0.22922,0,1
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.1306,0.28857,0.21571,0,1
4,GO INTERLEUKIN 5 PRODUCTION,0.12273,0.2842,0.22326,0,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.10468,0.28343,0.23137,0,1
4,GO ELASTIC FIBER ASSEMBLY,0.098083,0.25915,0.31757,0,1
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.058535,0.25839,0.21269,0,1
4,GO LIPOXYGENASE PATHWAY,0.26442,0.25137,0.11838,0,1
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.077559,0.2493,0.21259,0,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.077559,0.24661,0.18017,0,1
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.052482,0.24081,0.21138,0,1
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.056456,0.23705,0.22039,0,1
4,GO OSTEOCLAST DEVELOPMENT,0.21989,0.2315,0.14565,0,1
4,GO SKIN MORPHOGENESIS,0.37111,0.23031,0.13888,0,1
4,GO ACTIVATION OF JNKK ACTIVITY,0.094909,0.22844,0.21188,0,1
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.2998,0.22452,0.18878,0,1
4,GO RESPONSE TO CORTICOSTERONE,0.074935,0.22371,0.19247,0,1
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.11524,0.21741,0.19439,0,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.1475,0.21473,0.17277,0,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.080256,0.21155,0.18292,0,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.056456,0.21152,0.20253,0,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.054439,0.21091,0.19471,0,1
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.052482,0.21071,0.2191,0,1
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.077559,0.20585,0.22188,0,1
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.16602,0.20512,0.18447,0,1
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.1306,0.20404,0.15276,0,1
4,GO GLIAL CELL FATE COMMITMENT,0.058535,0.20349,0.2364,0,1
4,GO WALKING BEHAVIOR,0.069906,0.20343,0.19645,0,1
4,GO RESPONSE TO MAGNESIUM ION,0.067497,0.20261,0.23653,0,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.062884,0.20166,0.18724,0,1
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.060677,0.19999,0.19054,0,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.056456,0.19916,0.19679,0,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.091819,0.19784,0.21586,0,1
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.067497,0.19651,0.19075,0,1
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.27126,0.19644,0.1269,0,1
4,GO ACTIN CROSSLINK FORMATION,0.1306,0.19533,0.17241,0,1
4,GO SHORT TERM MEMORY,0.1475,0.19507,0.18459,0,1
4,GO LENS FIBER CELL DIFFERENTIATION,0.056456,0.1947,0.16194,0,1
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.16123,0.19208,0.16175,0,1
4,GO ORGANIC CATION TRANSPORT,0.11524,0.18761,0.14958,0,1
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.050584,0.18579,0.24572,0,1
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.050584,0.18487,0.20436,0,1
4,GO METANEPHROS MORPHOGENESIS,0.054439,0.18483,0.19198,0,1
4,GO DORSAL AORTA DEVELOPMENT,0.23827,0.18403,0.16929,0,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.20822,0.18375,0.18346,0,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.058535,0.18079,0.18798,0,1
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.062884,0.18051,0.16124,0,1
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.067497,0.18026,0.14982,0,1
4,GO MYOTUBE DIFFERENTIATION,0.11163,0.17922,0.15283,0,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.077559,0.17886,0.16466,0,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.080256,0.17808,0.19879,0,1
4,GO CARDIOBLAST DIFFERENTIATION,0.33029,0.17745,0.11972,0,1
4,GO SODIUM ION HOMEOSTASIS,0.050584,0.17494,0.20662,0,1
4,GO REGULATION OF NEURON MATURATION,0.1306,0.17224,0.15148,0,1
4,GO DRUG CATABOLIC PROCESS,0.060677,0.17208,0.19567,0,1
4,GO XENOBIOTIC TRANSPORT,0.094909,0.17188,0.1675,0,1
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.072385,0.17165,0.2047,0,1
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.052482,0.17111,0.23606,0,1
4,GO ENDODERM DEVELOPMENT,0.091819,0.17028,0.19563,0,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.077559,0.16981,0.17492,0,1
4,GO CELL SUBSTRATE ADHESION,0.10811,0.16911,0.18218,0,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.26442,0.16872,0.1522,0,1
4,GO COCHLEA DEVELOPMENT,0.098083,0.16839,0.13557,0,1
4,GO CARBOHYDRATE PHOSPHORYLATION,0.050584,0.16803,0.17513,0,1
4,GO CELL MATRIX ADHESION,0.10811,0.16653,0.18773,0,1
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.08881,0.16601,0.17664,0,1
4,GO GANGLION DEVELOPMENT,0.050584,0.16574,0.22044,0,1
4,GO RESPONSE TO GONADOTROPIN,0.08303,0.16458,0.13829,0,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.3148,0.16241,0.12674,0,1
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.10811,0.16133,0.22657,0,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.28529,0.16114,0.13308,0,1
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.08303,0.16045,0.20487,0,1
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.12273,0.15989,0.18263,0,1
4,GO SALIVARY GLAND DEVELOPMENT,0.098083,0.15966,0.19099,0,1
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.056456,0.15957,0.2234,0,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.072385,0.15803,0.13719,0,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.08881,0.15706,0.16911,0,1
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.067497,0.15615,0.14758,0,1
4,GO RESPONSE TO IRON ION,0.12273,0.15516,0.13782,0,1
4,GO REGULATION OF HAIR CYCLE,0.094909,0.15504,0.16013,0,1
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.27821,0.15472,0.13831,0,1
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.074935,0.15425,0.11377,0,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.08588,0.15398,0.16783,0,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.069906,0.15284,0.1431,0,1
4,GO NEPHRON DEVELOPMENT,0.094909,0.15235,0.17925,0,1
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.21989,0.15156,0.098292,0,1
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.18624,0.15119,0.13454,0,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.094909,0.14985,0.16312,0,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.1306,0.14957,0.14997,0,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.056456,0.14954,0.13335,0,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.080256,0.14875,0.22614,0,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.11163,0.14855,0.19627,0,1
4,GO REGULATION OF CILIUM MOVEMENT,0.074935,0.14836,0.12261,0,1
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.065157,0.14791,0.18492,0,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.060677,0.14715,0.18572,0,1
4,GO RESPONSE TO BMP,0.060677,0.14481,0.18802,0,1
4,GO MAMMARY GLAND MORPHOGENESIS,0.18102,0.14432,0.16744,0,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.44264,0.14176,0.083791,0,1
4,GO RESPONSE TO AMINE,0.098083,0.14137,0.15103,0,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.08881,0.14079,0.17177,0,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.080256,0.14055,0.20119,0,1
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.054439,0.13901,0.14976,0,1
4,GO RNA PROCESSING,0.065157,0.136,0.11201,0,1
4,GO PLASMA MEMBRANE FUSION,0.067497,0.13522,0.19306,0,1
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.1306,0.13501,0.14577,0,1
4,GO CELLULAR RESPONSE TO ALKALOID,0.12273,0.1338,0.13306,0,1
4,GO FORMATION OF PRIMARY GERM LAYER,0.08588,0.13373,0.17842,0,1
4,GO MUSCLE HYPERTROPHY,0.056456,0.13352,0.17668,0,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.24463,0.13298,0.14606,0,1
4,GO LIPID HOMEOSTASIS,0.10811,0.13271,0.13579,0,1
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.13885,0.13144,0.18485,0,1
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.10811,0.13126,0.18018,0,1
4,GO DIGESTION,0.069906,0.13116,0.13038,0,1
4,GO HORMONE METABOLIC PROCESS,0.050584,0.13115,0.12634,0,1
4,GO RESPONSE TO CAMP,0.10134,0.13113,0.13001,0,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.1306,0.13102,0.17661,0,1
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.16602,0.13071,0.15709,0,1
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.16602,0.13055,0.11228,0,1
4,GO AMELOGENESIS,0.050584,0.13009,0.15011,0,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.23203,0.13005,0.1277,0,1
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.050584,0.12932,0.18088,0,1
4,GO RESPONSE TO ACIDIC PH,0.091819,0.12792,0.19442,0,1
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.1306,0.12755,0.10684,0,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.1306,0.12706,0.13135,0,1
4,GO RESPONSE TO ISCHEMIA,0.21989,0.1255,0.13694,0,1
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.16602,0.12409,0.1032,0,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.197,0.12112,0.1275,0,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.27126,0.12081,0.090162,0,1
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.060677,0.1206,0.14453,0,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.072385,0.12053,0.13094,0,1
4,GO AMINO ACID IMPORT,0.16602,0.12012,0.11696,0,1
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.15655,0.11988,0.10925,0,1
4,GO MAGNESIUM ION TRANSPORT,0.054439,0.11979,0.2374,0,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.1306,0.11829,0.15364,0,1
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.23203,0.11685,0.11217,0,1
4,GO MESODERM MORPHOGENESIS,0.050584,0.11681,0.16218,0,1
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.1475,0.11663,0.19393,0,1
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.1475,0.11604,0.075305,0,1
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.050584,0.11565,0.19377,0,1
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.091819,0.1156,0.12367,0,1
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.11163,0.11464,0.094064,0,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.12273,0.11451,0.16015,0,1
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.13467,0.11416,0.13317,0,1
4,GO KERATINOCYTE DIFFERENTIATION,0.065157,0.11416,0.12853,0,1
4,GO PIRNA METABOLIC PROCESS,0.27821,0.11371,0.083284,0,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.11894,0.11329,0.1505,0,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.11163,0.11287,0.10577,0,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.067497,0.11283,0.12929,0,1
4,GO NADP METABOLIC PROCESS,0.17091,0.11279,0.090726,0,1
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.074935,0.11237,0.1491,0,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.13885,0.11125,0.14213,0,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.080256,0.10893,0.13238,0,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.08588,0.10831,0.16766,0,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.15655,0.10776,0.13167,0,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.08881,0.10755,0.20282,0,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.14312,0.10729,0.14541,0,1
4,GO SKIN EPIDERMIS DEVELOPMENT,0.11163,0.10656,0.14549,0,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.065157,0.10652,0.11027,0,1
4,GO SNRNA PROCESSING,0.11894,0.10538,0.083261,0,1
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.10811,0.10522,0.13448,0,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.27126,0.10516,0.10739,0,1
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.10134,0.10439,0.089977,0,1
4,GO JNK CASCADE,0.074935,0.10358,0.16949,0,1
4,GO RESPONSE TO NUTRIENT,0.32248,0.10253,0.10225,0,1
4,GO NEURON DEATH,0.065157,0.10098,0.14952,0,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.29248,0.10069,0.099788,0,1
4,GO RHYTHMIC BEHAVIOR,0.091819,0.10056,0.13525,0,1
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.065157,0.10053,0.16609,0,1
4,GO RESPONSE TO MUSCLE STRETCH,0.12662,0.10015,0.2584,0,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.14312,0.09976,0.12731,0,1
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.10468,0.099654,0.11304,0,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.056456,0.099586,0.14776,0,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.17591,0.098844,0.089891,0,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.16602,0.095873,0.10454,0,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.065157,0.095727,0.24573,0,1
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.197,0.095576,0.10013,0,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.054439,0.095562,0.15673,0,1
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.080256,0.095185,0.13498,0,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.054439,0.095143,0.15279,0,1
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.10468,0.095076,0.14525,0,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.27821,0.094529,0.13554,0,1
4,GO LINOLEIC ACID METABOLIC PROCESS,0.10134,0.092638,0.16458,0,1
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.052482,0.092266,0.18583,0,1
4,GO CELL RECOGNITION,0.16123,0.091351,0.12105,0,1
4,GO GASTRULATION,0.056456,0.090417,0.17685,0,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.060677,0.089823,0.10892,0,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.23203,0.089563,0.090459,0,1
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.077559,0.088737,0.25295,0,1
4,GO SLEEP,0.24463,0.084885,0.092099,0,1
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.08588,0.08101,0.12637,0,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.12662,0.08084,0.09607,0,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.054439,0.07882,0.13959,0,1
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.34626,0.078518,0.11465,0,1
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.058535,0.076945,0.15344,0,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.050584,0.076608,0.12903,0,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.080256,0.075651,0.1422,0,1
4,GO CARDIOLIPIN METABOLIC PROCESS,0.2259,0.07274,0.090474,0,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.11524,0.062249,0.10821,0,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.056456,0.061339,0.11308,0,1
4,GO DISTAL TUBULE DEVELOPMENT,0.056456,0.42488,0.30762,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.0076456,0.37005,0.31395,0,0
4,GO PARENTAL BEHAVIOR,0.077559,0.34714,0.215,0,0
4,GO LIMB BUD FORMATION,0.052482,0.34295,0.25846,0,0
4,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0040644,0.29641,0.33845,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.0066311,0.29039,0.30653,0,0
4,GO CARDIAC CHAMBER FORMATION,0.10468,0.28934,0.17281,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0044907,0.28268,0.26001,0,0
4,GO OPSONIZATION,0.48117,0.28104,0.088689,0,0
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.012106,0.27907,0.24964,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.091819,0.252,0.28014,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.067497,0.25139,0.25293,0,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.058535,0.24992,0.20692,0,0
4,GO GLYCINE TRANSPORT,0.15197,0.24772,0.18913,0,0
4,GO NUCLEUS LOCALIZATION,0.0016767,0.24453,0.39717,0,0
4,GO FAT CELL PROLIFERATION,0.0066311,0.23941,0.24493,0,0
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0060238,0.23586,0.26857,0,0
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.29248,0.23574,0.15103,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.016475,0.2351,0.29204,0,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.094909,0.23462,0.20332,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.01266,0.23333,0.29969,0,0
4,GO REGULATION OF CELL PROJECTION SIZE,0.098083,0.23327,0.16995,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.050584,0.23279,0.27947,0,0
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.019548,0.23155,0.24966,0,0
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.13467,0.22954,0.15099,0,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.052482,0.22928,0.20249,0,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.098083,0.22452,0.25026,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.072385,0.22438,0.17333,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.021265,0.22306,0.29537,0,0
4,GO SPINAL CORD PATTERNING,0.11163,0.22211,0.19907,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.050584,0.22168,0.27021,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.043559,0.21951,0.22724,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.037377,0.21686,0.23189,0,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.28529,0.21654,0.18855,0,0
4,GO NUCLEAR MIGRATION,0.0019699,0.21588,0.39083,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.024086,0.21554,0.21253,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.20256,0.21542,0.17008,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.041938,0.21474,0.2398,0,0
4,GO CATECHOLAMINE METABOLIC PROCESS,0.0024341,0.21357,0.26248,0,0
4,GO FOREGUT MORPHOGENESIS,0.12662,0.21298,0.16439,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.0040644,0.21201,0.21743,0,0
4,GO REGULATION OF HIPPO SIGNALING,0.012106,0.21069,0.27754,0,0
4,GO RESPONSE TO PAIN,0.01266,0.21043,0.26733,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.074935,0.20899,0.22243,0,0
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.010572,0.20629,0.24685,0,0
4,GO THYROID HORMONE METABOLIC PROCESS,0.18624,0.20605,0.12146,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.098083,0.20582,0.19249,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.11524,0.20546,0.18206,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.12273,0.2054,0.16816,0,0
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.50109,0.20506,0.095565,0,0
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.15655,0.20048,0.12768,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.39705,0.20027,0.11796,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.01266,0.20005,0.30303,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.046961,0.20001,0.2282,0,0
4,GO CARDIAC VENTRICLE FORMATION,0.16602,0.2,0.13702,0,0
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.067497,0.19965,0.25113,0,0
4,GO HISTONE H3 K9 ACETYLATION,0.035953,0.19677,0.19546,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.030713,0.19474,0.30469,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.08588,0.19217,0.14928,0,0
4,GO OOCYTE DIFFERENTIATION,0.00086166,0.19194,0.24279,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.197,0.1919,0.17497,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.072385,0.19179,0.20444,0,0
4,GO SPERM AXONEME ASSEMBLY,0.011063,0.19178,0.21976,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.065157,0.19143,0.15586,0,0
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.17591,0.19132,0.17591,0,0
4,GO REGULATION OF HEART RATE,0.01266,0.19127,0.25266,0,0
4,GO CHOLESTEROL EFFLUX,0.069906,0.19037,0.18048,0,0
4,GO REPRODUCTIVE BEHAVIOR,0.08303,0.18922,0.17225,0,0
4,GO INTERLEUKIN 13 PRODUCTION,0.72171,0.18842,0.054438,0,0
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.025096,0.18834,0.17811,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.013235,0.188,0.19979,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.045233,0.18618,0.23564,0,0
4,GO CYTOPLASM ORGANIZATION,0.013235,0.186,0.27136,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.41494,0.1858,0.10065,0,0
4,GO PROTEIN ACTIVATION CASCADE,0.55277,0.18488,0.05499,0,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.27126,0.18467,0.12257,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.15197,0.18396,0.22932,0,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.08588,0.18375,0.19301,0,0
4,GO ENERGY HOMEOSTASIS,0.0054671,0.1836,0.25213,0,0
4,GO OOGENESIS,0.0040644,0.18325,0.1894,0,0
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.056456,0.18215,0.24535,0,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.011063,0.1821,0.21843,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.040368,0.18187,0.28537,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.062884,0.18185,0.18701,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.050584,0.18126,0.18128,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.052482,0.18051,0.17025,0,0
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.44264,0.18018,0.12678,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.041938,0.17906,0.24922,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.0060238,0.17812,0.24051,0,0
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.007293,0.17789,0.22871,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.0038653,0.1775,0.3053,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.13467,0.17746,0.18148,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.10811,0.17643,0.15295,0,0
4,GO MRNA TRANSCRIPTION,0.23203,0.1764,0.13763,0,0
4,GO REVERSE CHOLESTEROL TRANSPORT,0.3148,0.17614,0.17206,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.20822,0.17611,0.17076,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.094909,0.17592,0.20678,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.020391,0.17534,0.20714,0,0
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.11894,0.17466,0.15442,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.08588,0.17359,0.21793,0,0
4,GO AXONAL FASCICULATION,0.052482,0.17356,0.28201,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.13467,0.1735,0.20593,0,0
4,GO MYOBLAST FUSION,0.18102,0.1735,0.15731,0,0
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.2998,0.1735,0.13867,0,0
4,GO ARACHIDONIC ACID SECRETION,0.091819,0.17312,0.12936,0,0
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.16123,0.17264,0.1475,0,0
4,GO AMYLOID FIBRIL FORMATION,0.2998,0.17237,0.12212,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0016767,0.17182,0.28442,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.13467,0.17137,0.19344,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.1306,0.17081,0.14199,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40594,0.17062,0.11206,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.033245,0.1706,0.21986,0,0
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0076456,0.1703,0.28269,0,0
4,GO RESPONSE TO INACTIVITY,0.098083,0.16935,0.17689,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.077559,0.16932,0.17687,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.024086,0.16917,0.21742,0,0
4,GO APICAL JUNCTION ASSEMBLY,0.008797,0.1689,0.20828,0,0
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.02951,0.16883,0.21632,0,0
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.21989,0.16802,0.12542,0,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.023112,0.16722,0.22319,0,0
4,GO MACROPHAGE PROLIFERATION,0.58498,0.16709,0.095644,0,0
4,GO AZOLE TRANSMEMBRANE TRANSPORT,0.074935,0.1669,0.21553,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.44264,0.16676,0.15591,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.010101,0.16669,0.29841,0,0
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.29248,0.16646,0.095922,0,0
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.013235,0.16614,0.21432,0,0
4,GO BRONCHUS DEVELOPMENT,0.12273,0.16543,0.20313,0,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.020391,0.1653,0.3043,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.060677,0.1653,0.16736,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.017954,0.16501,0.21056,0,0
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.072385,0.16492,0.20543,0,0
4,GO EPITHELIAL CELL CELL ADHESION,0.21989,0.16488,0.16992,0,0
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.069906,0.16473,0.26052,0,0
4,GO GONADOTROPIN SECRETION,0.014457,0.16472,0.20092,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.098083,0.1647,0.14153,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.11894,0.16398,0.18829,0,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.080256,0.16367,0.21363,0,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.16123,0.16364,0.1336,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.094909,0.16286,0.21384,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.16602,0.16229,0.15366,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.25111,0.16206,0.15368,0,0
4,GO RELAXATION OF CARDIAC MUSCLE,0.1306,0.16181,0.24529,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.058535,0.16172,0.18124,0,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.11894,0.16165,0.16101,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.0083971,0.1614,0.29179,0,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.37111,0.16132,0.12181,0,0
4,GO ALANINE TRANSPORT,0.062884,0.1613,0.24738,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.026142,0.16086,0.20549,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.214,0.16073,0.18963,0,0
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0027019,0.16064,0.21219,0,0
4,GO REPLICATION FORK PROCESSING,0.23827,0.16049,0.161,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.08881,0.1604,0.15595,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.11894,0.16011,0.18318,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.008797,0.15926,0.19467,0,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.2259,0.15867,0.099575,0,0
4,GO REGULATION OF WOUND HEALING,0.24463,0.15845,0.11776,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.067497,0.15797,0.28679,0,0
4,GO RESPONSE TO LEUCINE,0.15655,0.15742,0.17614,0,0
4,GO CELLULAR RESPONSE TO STEROL,0.08303,0.15732,0.21323,0,0
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.13467,0.15686,0.14696,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.065157,0.1564,0.21728,0,0
4,GO LIPID GLYCOSYLATION,0.058535,0.15633,0.20098,0,0
4,GO STORE OPERATED CALCIUM ENTRY,0.4521,0.15624,0.096731,0,0
4,GO HEPARIN METABOLIC PROCESS,0.214,0.15602,0.22183,0,0
4,GO STRIATUM DEVELOPMENT,0.037377,0.15569,0.20328,0,0
4,GO ACROSOME ASSEMBLY,0.10811,0.15529,0.14484,0,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.098083,0.15513,0.15047,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0080134,0.15509,0.27112,0,0
4,GO EPIDERMIS MORPHOGENESIS,0.43329,0.15502,0.10643,0,0
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.30724,0.15483,0.12092,0,0
4,GO MALE SEX DETERMINATION,0.1306,0.15469,0.2016,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.29248,0.15432,0.12378,0,0
4,GO PROGESTERONE METABOLIC PROCESS,0.072385,0.15421,0.16146,0,0
4,GO RESPONSE TO AMPHETAMINE,0.060677,0.15419,0.17028,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.060677,0.15399,0.098729,0,0
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.074935,0.15341,0.16629,0,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.058535,0.15339,0.18506,0,0
4,GO SPERM CAPACITATION,0.014457,0.1529,0.19575,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.045233,0.1526,0.1934,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.014457,0.15224,0.15646,0,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.24463,0.15167,0.16355,0,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.18624,0.15095,0.19367,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.058535,0.15091,0.14606,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.13467,0.15073,0.19745,0,0
4,GO REGULATION OF RESPIRATORY BURST,0.11894,0.15029,0.1571,0,0
4,GO REGULATION OF DNA REPAIR,0.014457,0.1499,0.18916,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.060677,0.14902,0.17176,0,0
4,GO ENDODERM FORMATION,0.20256,0.14893,0.17768,0,0
4,GO HINDLIMB MORPHOGENESIS,0.062884,0.14879,0.18658,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.060677,0.14839,0.21214,0,0
4,GO HEART INDUCTION,0.056456,0.14743,0.21745,0,0
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.18102,0.1473,0.17669,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.10134,0.14694,0.11557,0,0
4,GO PROTEIN KINASE C SIGNALING,0.050584,0.14675,0.24451,0,0
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.08588,0.14637,0.17492,0,0
4,GO RENAL FILTRATION,0.23203,0.14635,0.20936,0,0
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.077559,0.14614,0.19613,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0092139,0.14604,0.27242,0,0
4,GO RESPONSE TO MINERALOCORTICOID,0.16123,0.14599,0.11188,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.20256,0.14596,0.12866,0,0
4,GO REGULATION OF BODY FLUID LEVELS,0.10468,0.14574,0.15141,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.0096484,0.14572,0.17172,0,0
4,GO INTESTINAL ABSORPTION,0.18624,0.14568,0.14395,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.11524,0.14554,0.19029,0,0
4,GO PROTEIN DEMANNOSYLATION,0.18102,0.1454,0.1541,0,0
4,GO POSITIVE REGULATION OF HEART RATE,0.10811,0.14527,0.1621,0,0
4,GO MACROMOLECULE DEPALMITOYLATION,0.017954,0.14503,0.11419,0,0
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.074935,0.14491,0.16453,0,0
4,GO ESTROUS CYCLE,0.17091,0.14486,0.15185,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.1475,0.1446,0.12618,0,0
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.214,0.14446,0.16708,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.21989,0.14444,0.11029,0,0
4,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.11163,0.14428,0.15121,0,0
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.060677,0.14422,0.22578,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.48117,0.14408,0.064198,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,0.011063,0.14402,0.27205,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.027226,0.14377,0.18049,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.29248,0.14368,0.065626,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.74555,0.14368,0.083826,0,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.023112,0.14361,0.18928,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.11524,0.14357,0.23182,0,0
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.065157,0.14333,0.18841,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.065157,0.14272,0.20239,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.041938,0.14254,0.20256,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.2259,0.14237,0.065045,0,0
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.27126,0.14225,0.10536,0,0
4,GO BARBED END ACTIN FILAMENT CAPPING,0.19156,0.14209,0.13653,0,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.08303,0.14197,0.15812,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.20256,0.1419,0.19475,0,0
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.0172,0.14184,0.17135,0,0
4,GO SOMATIC STEM CELL DIVISION,0.36271,0.14183,0.13839,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.16602,0.14177,0.18,0,0
4,GO KERATINOCYTE MIGRATION,0.10811,0.14151,0.16946,0,0
4,GO CELLULAR RESPONSE TO ALCOHOL,0.080256,0.14137,0.17329,0,0
4,GO NERVE DEVELOPMENT,0.1306,0.14136,0.16256,0,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.37964,0.14125,0.12102,0,0
4,GO INNERVATION,0.17591,0.14113,0.21164,0,0
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.2998,0.14103,0.11078,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.197,0.14102,0.1557,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.02951,0.14098,0.15024,0,0
4,GO RNA 3 END PROCESSING,0.067497,0.14097,0.1321,0,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.08588,0.14096,0.20102,0,0
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.37111,0.14093,0.10914,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.074935,0.1409,0.26061,0,0
4,GO GOLGI ORGANIZATION,0.0080134,0.14088,0.24068,0,0
4,GO ECTODERM DEVELOPMENT,0.067497,0.14049,0.15388,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.017954,0.14042,0.2206,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.074935,0.14028,0.16967,0,0
4,GO GENE SILENCING,0.018736,0.14024,0.17279,0,0
4,GO XENOBIOTIC CATABOLIC PROCESS,0.49108,0.13991,0.094947,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.10811,0.13982,0.15533,0,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.017954,0.13978,0.15373,0,0
4,GO PLATELET DEGRANULATION,0.5959,0.1397,0.070068,0,0
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.10468,0.1393,0.26106,0,0
4,GO RECEPTOR RECYCLING,0.15655,0.13922,0.14577,0,0
4,GO VITAMIN D METABOLIC PROCESS,0.98106,0.13902,0.015232,0,0
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.2259,0.13877,0.10857,0,0
4,GO SEROTONIN TRANSPORT,0.18624,0.13872,0.1475,0,0
4,GO POLYOL TRANSPORT,0.34626,0.1385,0.10431,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.13467,0.13839,0.17543,0,0
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.1306,0.13805,0.15627,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.21989,0.13805,0.16355,0,0
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.16123,0.138,0.15877,0,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.065157,0.13793,0.17768,0,0
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.02951,0.13768,0.27435,0,0
4,GO G0 TO G1 TRANSITION,0.067497,0.13757,0.18159,0,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.2259,0.13743,0.15087,0,0
4,GO REGULATION OF OOGENESIS,0.048745,0.13737,0.14111,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.38829,0.13737,0.13746,0,0
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.40594,0.13721,0.10039,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.15197,0.1368,0.11208,0,0
4,GO NEGATIVE REGULATION OF ANOIKIS,0.52145,0.13659,0.091953,0,0
4,GO REGULATION OF ANION TRANSPORT,0.077559,0.13653,0.14392,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.080256,0.1364,0.19229,0,0
4,GO CELL FATE DETERMINATION,0.01266,0.13627,0.21149,0,0
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.23827,0.13615,0.17961,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.024086,0.13612,0.2699,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.15197,0.13586,0.14335,0,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.20822,0.13535,0.14486,0,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.10134,0.1353,0.19701,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.08588,0.13527,0.19009,0,0
4,GO REGULATION OF LIPID STORAGE,0.214,0.13522,0.12332,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.062884,0.13488,0.18765,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.66333,0.13468,0.073014,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.11894,0.13458,0.14014,0,0
4,GO WOUND HEALING,0.23203,0.13433,0.1422,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.050584,0.13428,0.1857,0,0
4,GO EPITHELIAL TUBE FORMATION,0.041938,0.13425,0.17099,0,0
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.015104,0.1342,0.23329,0,0
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.067497,0.13415,0.14642,0,0
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.27821,0.13397,0.12591,0,0
4,GO TERPENOID METABOLIC PROCESS,0.197,0.13379,0.091272,0,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.94321,0.13378,0.00086793,0,0
4,GO COLLAGEN CATABOLIC PROCESS,0.2998,0.13358,0.15857,0,0
4,GO AMMONIUM ION METABOLIC PROCESS,0.041938,0.13352,0.23524,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.76963,0.13323,0.061562,0,0
4,GO ALDEHYDE CATABOLIC PROCESS,0.11163,0.13319,0.090093,0,0
4,GO ENDOSOMAL TRANSPORT,0.00332,0.13314,0.21499,0,0
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.038848,0.13297,0.18066,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.86799,0.13295,0.017373,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.10468,0.13288,0.1879,0,0
4,GO SNARE COMPLEX ASSEMBLY,0.01266,0.13262,0.28325,0,0
4,GO REGULATION OF GASTRULATION,0.1475,0.13261,0.14359,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.15197,0.13244,0.14427,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.17091,0.1323,0.20025,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.060677,0.13224,0.16523,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.10134,0.1322,0.20689,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.0066311,0.13194,0.22509,0,0
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.16602,0.13194,0.15779,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.098083,0.13179,0.13851,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.062884,0.13173,0.17635,0,0
4,GO PARAXIAL MESODERM DEVELOPMENT,0.12662,0.13169,0.15322,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.054439,0.13165,0.17776,0,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.008797,0.13163,0.17074,0,0
4,GO TRNA PROCESSING,0.18624,0.13158,0.085796,0,0
4,GO ENAMEL MINERALIZATION,0.08881,0.13135,0.20402,0,0
4,GO RENAL ABSORPTION,0.33821,0.13128,0.11841,0,0
4,GO SULFATION,0.26442,0.13119,0.10628,0,0
4,GO PROTEIN PROCESSING,0.197,0.13119,0.1078,0,0
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.062884,0.13105,0.17601,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.12662,0.13102,0.14998,0,0
4,GO TUBE FORMATION,0.058535,0.1306,0.16349,0,0
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.21989,0.13026,0.10369,0,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.16602,0.13018,0.1478,0,0
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.056456,0.13016,0.19938,0,0
4,GO AUTOPHAGY OF MITOCHONDRION,0.0047188,0.12984,0.20847,0,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.84314,0.1297,-0.0013768,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.37964,0.12962,0.10229,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.11524,0.12958,0.17956,0,0
4,GO NEURAL TUBE PATTERNING,0.08303,0.12949,0.1672,0,0
4,GO REGULATION OF GTP BINDING,0.08303,0.12945,0.16357,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.18102,0.12934,0.17376,0,0
4,GO MRNA EXPORT FROM NUCLEUS,0.025096,0.12927,0.17352,0,0
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.035953,0.12926,0.18239,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.13885,0.12923,0.17291,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.062884,0.12919,0.16521,0,0
4,GO ISOPRENOID METABOLIC PROCESS,0.11894,0.12918,0.095431,0,0
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.10468,0.12901,0.12172,0,0
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.38829,0.12891,0.13553,0,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.52145,0.12886,0.071812,0,0
4,GO STEROL BIOSYNTHETIC PROCESS,0.011574,0.1288,0.15292,0,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.40594,0.12879,0.060342,0,0
4,GO REGULATION OF ENDOCRINE PROCESS,0.21989,0.12864,0.11303,0,0
4,GO HEXOSE CATABOLIC PROCESS,0.080256,0.12861,0.13057,0,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.13467,0.12828,0.19317,0,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.17591,0.12783,0.10769,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.1306,0.12778,0.15519,0,0
4,GO CERAMIDE CATABOLIC PROCESS,0.25111,0.12778,0.12251,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.065157,0.12769,0.20898,0,0
4,GO NUCLEUS ORGANIZATION,0.006955,0.12768,0.17746,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.1475,0.12767,0.19551,0,0
4,GO SISTER CHROMATID COHESION,0.12273,0.12748,0.14744,0,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.067497,0.1274,0.20639,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.01266,0.1273,0.16825,0,0
4,GO MICROVILLUS ORGANIZATION,0.08881,0.12723,0.15308,0,0
4,GO GOLGI VESICLE TRANSPORT,0.0024341,0.12721,0.21806,0,0
4,GO BONE MATURATION,0.18102,0.127,0.1472,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.16602,0.12671,0.13262,0,0
4,GO FUCOSE METABOLIC PROCESS,0.065157,0.12648,0.15772,0,0
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.214,0.12586,0.19774,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.25111,0.12579,0.11526,0,0
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.19156,0.12562,0.16989,0,0
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.077559,0.12554,0.16228,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.035953,0.12551,0.17132,0,0
4,GO ER NUCLEUS SIGNALING PATHWAY,0.10134,0.12543,0.1192,0,0
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.10811,0.12537,0.24954,0,0
4,GO LATERAL MESODERM DEVELOPMENT,0.098083,0.12533,0.14554,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.0096484,0.12526,0.19677,0,0
4,GO BLOOD VESSEL REMODELING,0.094909,0.1251,0.22342,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.17591,0.12504,0.17438,0,0
4,GO TISSUE REGENERATION,0.197,0.12496,0.11807,0,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.33821,0.12496,0.13262,0,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.028348,0.12494,0.1937,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.091819,0.12485,0.145,0,0
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.35442,0.12485,0.11338,0,0
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.072385,0.12478,0.12156,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.62923,0.1247,0.096796,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.060677,0.12442,0.31492,0,0
4,GO SIGNAL PEPTIDE PROCESSING,0.12662,0.12433,0.15057,0,0
4,GO REGULATION OF RESPONSE TO WOUNDING,0.23203,0.12396,0.1244,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.056456,0.12391,0.18953,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.052482,0.12347,0.2965,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.077559,0.12328,0.1523,0,0
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.10468,0.12313,0.18874,0,0
4,GO REGULATION OF STEROL TRANSPORT,0.29248,0.12302,0.1016,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.12662,0.12289,0.18244,0,0
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.054439,0.12287,0.21438,0,0
4,GO HIPPO SIGNALING,0.12273,0.12253,0.18423,0,0
4,GO GAS TRANSPORT,0.39705,0.12253,0.10109,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.074935,0.12224,0.245,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.34626,0.12216,0.1074,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.24463,0.12216,0.13299,0,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.050584,0.12215,0.20267,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.13467,0.12197,0.17433,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.15655,0.12177,0.16128,0,0
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.3148,0.12172,0.12745,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.12273,0.1217,0.15983,0,0
4,GO NEGATIVE REGULATION OF COAGULATION,0.41494,0.12166,0.10435,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.052482,0.12166,0.21486,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.08303,0.12159,0.1962,0,0
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.30724,0.12157,0.13368,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.021265,0.12139,0.27035,0,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.060677,0.1212,0.16522,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.024086,0.12107,0.15029,0,0
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.32248,0.12104,0.070305,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.12662,0.12101,0.18426,0,0
4,GO MRNA MODIFICATION,0.21989,0.12098,0.10074,0,0
4,GO APICAL PROTEIN LOCALIZATION,0.08881,0.12098,0.20898,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.16123,0.12087,0.13435,0,0
4,GO TRNA MODIFICATION,0.19156,0.12084,0.085922,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20822,0.12072,0.16643,0,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.056456,0.12069,0.14846,0,0
4,GO RNA DESTABILIZATION,0.056456,0.1205,0.20868,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.40594,0.12037,0.03619,0,0
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.18624,0.12021,0.19391,0,0
4,GO MUSCLE ADAPTATION,0.091819,0.12012,0.15508,0,0
4,GO LYMPHANGIOGENESIS,0.13885,0.1201,0.19771,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.23827,0.12001,0.17341,0,0
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.10468,0.11986,0.18751,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.052482,0.11985,0.17651,0,0
4,GO BIOMINERALIZATION,0.24463,0.11962,0.11773,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10468,0.11951,0.13274,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.10134,0.11943,0.15945,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.48117,0.11915,0.09695,0,0
4,GO CARNITINE METABOLIC PROCESS,0.11163,0.11886,0.15536,0,0
4,GO N GLYCAN PROCESSING,0.16123,0.11885,0.16935,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.025096,0.11883,0.20561,0,0
4,GO ANIMAL ORGAN MATURATION,0.28529,0.11876,0.126,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.08303,0.11867,0.14348,0,0
4,GO OXYGEN TRANSPORT,0.3148,0.11863,0.12192,0,0
4,GO ADIPOSE TISSUE DEVELOPMENT,0.065157,0.11861,0.1615,0,0
4,GO ACTIN FILAMENT SEVERING,0.2577,0.11844,0.1567,0,0
4,GO BASE EXCISION REPAIR,0.0172,0.11842,0.16903,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.10468,0.1183,0.15663,0,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.19156,0.11828,0.18842,0,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.074935,0.11826,0.20925,0,0
4,GO MESENCHYME DEVELOPMENT,0.043559,0.11823,0.17319,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.067497,0.11815,0.17151,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.11163,0.11792,0.2005,0,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.28529,0.11791,0.12861,0,0
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.072385,0.11774,0.2433,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.33029,0.11761,0.12374,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.13885,0.11756,0.12752,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.062884,0.11754,0.15055,0,0
4,GO NOREPINEPHRINE SECRETION,0.11524,0.11752,0.18547,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.074935,0.11749,0.182,0,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.3148,0.11746,0.11512,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.29248,0.11722,0.15879,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.11894,0.11697,0.12064,0,0
4,GO CHROMOSOME ORGANIZATION,0.025096,0.11693,0.17588,0,0
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.077559,0.11692,0.1588,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.12273,0.1169,0.13015,0,0
4,GO OSSIFICATION,0.17091,0.11689,0.12811,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.37111,0.11676,0.11754,0,0
4,GO RESPONSE TO WOUNDING,0.20256,0.11673,0.14071,0,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.10811,0.11669,0.17416,0,0
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.050584,0.11667,0.22102,0,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.24463,0.11658,0.14465,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.36271,0.11654,0.083095,0,0
4,GO CONVERGENT EXTENSION,0.054439,0.11648,0.23484,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.10811,0.11639,0.14853,0,0
4,GO RESPONSE TO AMYLOID BETA,0.25111,0.11631,0.15858,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.072385,0.11628,0.13721,0,0
4,GO LUNG CELL DIFFERENTIATION,0.074935,0.11622,0.21508,0,0
4,GO MULTICELLULAR ORGANISM AGING,0.2577,0.11616,0.10581,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.11894,0.11606,0.12461,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.013834,0.11605,0.14333,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.052482,0.11595,0.19378,0,0
4,GO BEHAVIORAL RESPONSE TO PAIN,0.26442,0.11584,0.12969,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.18624,0.11574,0.15832,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0076456,0.11557,0.16648,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.35442,0.11547,0.12819,0,0
4,GO REGULATION OF CELL MATRIX ADHESION,0.27821,0.11541,0.15031,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.33821,0.11537,0.13082,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.14312,0.11532,0.13407,0,0
4,GO RESPONSE TO HYDROXYUREA,0.091819,0.11527,0.16893,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.13467,0.11513,0.21294,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.041938,0.11495,0.17177,0,0
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.17591,0.11456,0.16413,0,0
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.23827,0.11442,0.17179,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.19156,0.11433,0.12898,0,0
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.040368,0.11431,0.12669,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.080256,0.11426,0.16668,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.12273,0.11422,0.13728,0,0
4,GO PULMONARY VALVE DEVELOPMENT,0.23827,0.11419,0.17766,0,0
4,GO HEART TRABECULA FORMATION,0.37111,0.11391,0.074095,0,0
4,GO INTRACELLULAR STEROL TRANSPORT,0.2259,0.11388,0.12833,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.20256,0.11382,0.12047,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.11524,0.11377,0.18759,0,0
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.069906,0.11373,0.12256,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.08881,0.11365,0.17771,0,0
4,GO MICROVILLUS ASSEMBLY,0.19156,0.11344,0.11091,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.054439,0.11344,0.16243,0,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.4521,0.11343,0.085575,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.62923,0.11333,0.060843,0,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.13467,0.11331,0.14879,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.035953,0.1132,0.135,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.016475,0.11317,0.15628,0,0
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.074935,0.11308,0.16536,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.46168,0.11302,0.08483,0,0
4,GO REGULATION OF MACROAUTOPHAGY,0.0036751,0.11283,0.20608,0,0
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.054439,0.11282,0.15492,0,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.24463,0.11279,0.11582,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.44264,0.11279,0.11389,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.050584,0.11256,0.19334,0,0
4,GO GLIAL CELL MIGRATION,0.32248,0.11248,0.13093,0,0
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.072385,0.11245,0.14949,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.11163,0.11224,0.19431,0,0
4,GO ENDOCRINE HORMONE SECRETION,0.25111,0.11216,0.10157,0,0
4,GO MOVEMENT IN HOST ENVIRONMENT,0.55277,0.1121,0.075224,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.11524,0.11207,0.07885,0,0
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.13467,0.11202,0.1185,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.034576,0.11199,0.21986,0,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.23827,0.11194,0.14496,0,0
4,GO SEGMENTATION,0.060677,0.11193,0.15773,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.098083,0.1119,0.11643,0,0
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.067497,0.11178,0.1107,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.2998,0.11153,0.087169,0,0
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.091819,0.11152,0.15164,0,0
4,GO VESICLE CARGO LOADING,0.11163,0.11147,0.16578,0,0
4,GO GASTRIC ACID SECRETION,0.15197,0.11126,0.08516,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.091819,0.11125,0.14002,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.37964,0.11114,0.11303,0,0
4,GO INTRACELLULAR TRANSPORT,0.00332,0.11112,0.16144,0,0
4,GO SCHWANN CELL DEVELOPMENT,0.072385,0.11105,0.20154,0,0
4,GO DRUG METABOLIC PROCESS,0.14312,0.11086,0.1339,0,0
4,GO FAT CELL DIFFERENTIATION,0.10468,0.11067,0.14178,0,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.11524,0.1104,0.15018,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.13467,0.11032,0.1586,0,0
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.2259,0.11031,0.14032,0,0
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.52145,0.11028,0.12251,0,0
4,GO RESPONSE TO ESTROGEN,0.13885,0.11026,0.13967,0,0
4,GO REGULATION OF AMYLOID BETA FORMATION,0.23827,0.1102,0.1168,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.072385,0.11013,0.19037,0,0
4,GO DOUBLE STRAND BREAK REPAIR,0.060677,0.11013,0.15722,0,0
4,GO REPRODUCTION,0.019548,0.11008,0.15746,0,0
4,GO PROTEIN LOCALIZATION TO AXON,0.37964,0.11007,0.15301,0,0
4,GO KETONE BIOSYNTHETIC PROCESS,0.060677,0.10992,0.16356,0,0
4,GO PYRUVATE METABOLIC PROCESS,0.060677,0.10989,0.13203,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.35442,0.10989,0.098645,0,0
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.38829,0.10982,0.097133,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.23203,0.10948,0.13073,0,0
4,GO PROTEIN MATURATION,0.11524,0.10933,0.10504,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.27821,0.10928,0.1298,0,0
4,GO VIRAL BUDDING,0.0096484,0.10912,0.12651,0,0
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12273,0.10908,0.17165,0,0
4,GO UTP METABOLIC PROCESS,0.091819,0.10901,0.1371,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.018736,0.10897,0.19011,0,0
4,GO LACTATION,0.08881,0.10888,0.16771,0,0
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.011574,0.10886,0.24912,0,0
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.10134,0.10884,0.16394,0,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.20256,0.10882,0.092585,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.054439,0.10869,0.19686,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.53179,0.1086,0.086103,0,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.12662,0.1085,0.15368,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.060677,0.10842,0.15626,0,0
4,GO RESPONSE TO GROWTH HORMONE,0.25111,0.10839,0.10507,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.40594,0.10825,0.12055,0,0
4,GO LYMPH NODE DEVELOPMENT,0.37964,0.10812,0.12173,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.08881,0.10806,0.14575,0,0
4,GO MEMBRANE DISASSEMBLY,0.13885,0.10804,0.16349,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.27821,0.10794,0.18266,0,0
4,GO REGULATION OF MAP KINASE ACTIVITY,0.08881,0.10788,0.15773,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.60692,0.10779,0.063364,0,0
4,GO LUNG EPITHELIUM DEVELOPMENT,0.027226,0.10758,0.20894,0,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.054439,0.10754,0.14204,0,0
4,GO HEART MORPHOGENESIS,0.056456,0.1073,0.17613,0,0
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.35442,0.10717,0.1218,0,0
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.18102,0.10711,0.1144,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.50109,0.1071,0.072919,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.030713,0.107,0.20054,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.050584,0.107,0.17616,0,0
4,GO LYSOSOME LOCALIZATION,0.15197,0.10697,0.14343,0,0
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.1306,0.10683,0.16169,0,0
4,GO TUBE DEVELOPMENT,0.15197,0.10666,0.14752,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.3148,0.10664,0.13782,0,0
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0036751,0.10618,0.17918,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.060677,0.10607,0.1397,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.16602,0.10604,0.13314,0,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.052482,0.10598,0.12684,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.094909,0.10591,0.1705,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.11524,0.1059,0.14313,0,0
4,GO HEART GROWTH,0.048745,0.10589,0.16209,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.23203,0.10589,0.12137,0,0
4,GO REGULATION OF COAGULATION,0.68646,0.10563,0.063743,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.041938,0.1056,0.1617,0,0
4,GO HEART VALVE DEVELOPMENT,0.17091,0.10547,0.18537,0,0
4,GO METANEPHROS DEVELOPMENT,0.27126,0.10545,0.11654,0,0
4,GO TRIGEMINAL NERVE DEVELOPMENT,0.78176,0.10542,0.062605,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.031957,0.10535,0.15355,0,0
4,GO HEART VALVE FORMATION,0.28529,0.10516,0.14323,0,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.50109,0.10513,0.10776,0,0
4,GO ICOSANOID METABOLIC PROCESS,0.20256,0.10504,0.11165,0,0
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.3148,0.10502,0.093504,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.16123,0.10501,0.11836,0,0
4,GO BODY FLUID SECRETION,0.054439,0.10499,0.14671,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.067497,0.10492,0.15284,0,0
4,GO COAGULATION,0.26442,0.10483,0.12599,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.26442,0.1048,0.17236,0,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.08588,0.10478,0.15928,0,0
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.30724,0.10477,0.095073,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.16123,0.10476,0.093705,0,0
4,GO GLIAL CELL DEVELOPMENT,0.13885,0.10473,0.12858,0,0
4,GO DIGESTIVE SYSTEM PROCESS,0.197,0.10471,0.10175,0,0
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.17591,0.10469,0.14404,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.098083,0.10466,0.1967,0,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.54223,0.10451,0.080939,0,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.098083,0.10448,0.1376,0,0
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.197,0.10441,0.10702,0,0
4,GO REGULATION OF MUSCLE ADAPTATION,0.11524,0.10421,0.14138,0,0
4,GO CELL FATE SPECIFICATION,0.2998,0.10415,0.10824,0,0
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.23203,0.10406,0.12715,0,0
4,GO PROTEIN OXIDATION,0.27126,0.10404,0.10012,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.062884,0.10398,0.13594,0,0
4,GO DIENCEPHALON DEVELOPMENT,0.058535,0.10393,0.17502,0,0
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.007293,0.1039,0.22025,0,0
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.10811,0.10389,0.11047,0,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.056456,0.10388,0.17333,0,0
4,GO MIDGUT DEVELOPMENT,0.34626,0.10381,0.15738,0,0
4,GO REGULATION OF PLATELET ACTIVATION,0.98106,0.10379,0.0042211,0,0
4,GO EXECUTION PHASE OF APOPTOSIS,0.060677,0.10368,0.13673,0,0
4,GO MUSCLE CELL FATE COMMITMENT,0.10134,0.10365,0.18926,0,0
4,GO REGULATION OF VASCULOGENESIS,0.53179,0.10364,0.090847,0,0
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.072385,0.10364,0.14736,0,0
4,GO RNA METHYLATION,0.25111,0.10351,0.084417,0,0
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.010572,0.10342,0.18077,0,0
4,GO PLATELET ACTIVATION,0.35442,0.10341,0.11864,0,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.052482,0.10333,0.12687,0,0
4,GO L GLUTAMATE IMPORT,0.20822,0.10324,0.10816,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.069906,0.10324,0.13071,0,0
4,GO HAIR FOLLICLE MATURATION,0.11894,0.10323,0.17877,0,0
4,GO RNA STABILIZATION,0.060677,0.10323,0.14537,0,0
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.17591,0.10301,0.094771,0,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.067497,0.10297,0.17291,0,0
4,GO TRNA METABOLIC PROCESS,0.20822,0.10292,0.080018,0,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.21989,0.10281,0.10486,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.034576,0.1028,0.13548,0,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.18102,0.10267,0.17817,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.091819,0.10264,0.15443,0,0
4,GO RRNA TRANSCRIPTION,0.056456,0.10261,0.14742,0,0
4,GO RUFFLE ASSEMBLY,0.067497,0.10255,0.16618,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.028348,0.10243,0.15063,0,0
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.072385,0.10243,0.16715,0,0
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.13467,0.10241,0.12852,0,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.08588,0.1024,0.12262,0,0
4,GO SECRETION BY TISSUE,0.19156,0.10226,0.09951,0,0
4,GO MYELOID CELL DEVELOPMENT,0.098083,0.10213,0.1741,0,0
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.12662,0.10202,0.15526,0,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.031957,0.10194,0.14162,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.28529,0.10187,0.099154,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.32248,0.10149,0.069855,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.1475,0.10145,0.14646,0,0
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.27821,0.1013,0.14543,0,0
4,GO TISSUE MIGRATION,0.15655,0.10126,0.15581,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.027226,0.10121,0.12726,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.44264,0.10112,0.10543,0,0
4,GO INNER EAR MORPHOGENESIS,0.069906,0.10109,0.15265,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.12273,0.10105,0.14054,0,0
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.11894,0.10096,0.10334,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.11894,0.1008,0.14953,0,0
4,GO REGULATION OF ANOIKIS,0.47137,0.1008,0.092817,0,0
4,GO SYNCYTIUM FORMATION,0.33029,0.10079,0.1162,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.43329,0.10069,0.10503,0,0
4,GO ENTRY INTO HOST,0.62923,0.10067,0.064475,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.048745,0.10067,0.15962,0,0
4,GO FIBROBLAST MIGRATION,0.214,0.10056,0.13707,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.16123,0.10055,0.13997,0,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.072385,0.10044,0.1253,0,0
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.067497,0.10043,0.16792,0,0
4,GO BICARBONATE TRANSPORT,0.28529,0.10039,0.084548,0,0
4,GO BONE MINERALIZATION,0.35442,0.10018,0.10296,0,0
4,GO MUSCLE CELL DIFFERENTIATION,0.030713,0.10018,0.18795,0,0
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.18102,0.10013,0.11711,0,0
4,GO REGULATION OF FATTY ACID TRANSPORT,0.51122,0.10011,0.073289,0,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.25111,0.10002,0.095836,0,0
4,GO REGULATION OF URINE VOLUME,0.14312,0.099926,0.15758,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.3148,0.099865,0.14948,0,0
4,GO ORGANELLE FISSION,0.074935,0.099861,0.13777,0,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.2998,0.099839,0.10267,0,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.052482,0.09976,0.17572,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.56341,0.099743,0.088052,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.098083,0.099742,0.14622,0,0
4,GO DNA DEMETHYLATION,0.13467,0.099693,0.11725,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.5959,0.099664,0.075629,0,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.072385,0.099627,0.13961,0,0
4,GO PEPTIDE CROSS LINKING,0.54223,0.099565,0.087398,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.08588,0.099525,0.25148,0,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.08588,0.099469,0.15745,0,0
4,GO RESPONSE TO MANGANESE ION,0.20256,0.099335,0.11091,0,0
4,GO RESPONSE TO UV C,0.32248,0.099334,0.095251,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.33029,0.099233,0.094406,0,0
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.035953,0.099188,0.21654,0,0
4,GO REGULATION OF PEPTIDE SECRETION,0.077559,0.099187,0.14942,0,0
4,GO RESPONSE TO TYPE I INTERFERON,0.70989,0.099138,-0.042246,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.023112,0.099055,0.14555,0,0
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.20256,0.099009,0.10098,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.034576,0.098887,0.16107,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.15197,0.098843,0.15263,0,0
4,GO PRO B CELL DIFFERENTIATION,0.13467,0.098834,0.18301,0,0
4,GO CERAMIDE TRANSPORT,0.10811,0.098799,0.22477,0,0
4,GO THYMUS DEVELOPMENT,0.056456,0.098765,0.11916,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.5959,0.098756,0.054973,0,0
4,GO NCRNA CATABOLIC PROCESS,0.050584,0.098692,0.12797,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.058535,0.098536,0.27659,0,0
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.013235,0.098486,0.15597,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.054439,0.098472,0.16262,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.098083,0.098371,0.11597,0,0
4,GO HEART TRABECULA MORPHOGENESIS,0.17091,0.09833,0.1458,0,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,0.27126,0.098325,0.1132,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.02951,0.098325,0.2865,0,0
4,GO RESPONSE TO UV,0.054439,0.098079,0.13926,0,0
4,GO VIRAL RNA GENOME REPLICATION,0.1475,0.097965,0.12307,0,0
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.041938,0.097749,0.1683,0,0
4,GO EPITHELIAL CELL DEVELOPMENT,0.031957,0.09761,0.19429,0,0
4,GO SMOOTH MUSCLE CELL MIGRATION,0.15197,0.097608,0.15925,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.16123,0.097514,0.1647,0,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.067497,0.097354,0.20185,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.15197,0.097327,0.20764,0,0
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.15197,0.097319,0.088428,0,0
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.61803,0.097305,0.052278,0,0
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.42405,0.097247,0.061241,0,0
4,GO REGULATION OF CELL DIVISION,0.074935,0.097202,0.14077,0,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.098083,0.09711,0.1629,0,0
4,GO GLUCOSE IMPORT,0.045233,0.097029,0.15401,0,0
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.5959,0.096817,0.039832,0,0
4,GO TONGUE MORPHOGENESIS,0.51122,0.096792,0.064099,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.050584,0.096783,0.13708,0,0
4,GO REGULATION OF BONE DEVELOPMENT,0.51122,0.096765,0.092047,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.10134,0.096736,0.16788,0,0
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.23203,0.096584,0.10358,0,0
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.067497,0.096545,0.14824,0,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.37964,0.096462,0.1195,0,0
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.60692,0.096441,0.069492,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.11163,0.096425,0.17323,0,0
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.013834,0.096092,0.17594,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.10468,0.096027,0.15455,0,0
4,GO ENDOCARDIUM DEVELOPMENT,0.23203,0.09595,0.12102,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.49108,0.095853,0.085675,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.27126,0.09569,0.14336,0,0
4,GO ENDOTHELIAL CELL MIGRATION,0.21989,0.095351,0.14726,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.35442,0.095308,0.085023,0,0
4,GO KERATINOCYTE PROLIFERATION,0.36271,0.09529,0.09089,0,0
4,GO CHONDROCYTE PROLIFERATION,0.3148,0.095184,0.1392,0,0
4,GO RESPONSE TO MECHANICAL STIMULUS,0.14312,0.095144,0.14346,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.062884,0.095089,0.13184,0,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.069906,0.095073,0.19533,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.2259,0.095064,0.12733,0,0
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.24463,0.095036,0.10592,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.17091,0.095036,0.14202,0,0
4,GO STEROL TRANSPORT,0.065157,0.095002,0.17347,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.12273,0.094986,0.11735,0,0
4,GO MISMATCH REPAIR,0.060677,0.094879,0.15628,0,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.098083,0.094869,0.14711,0,0
4,GO GPI ANCHOR METABOLIC PROCESS,0.010572,0.094777,0.1623,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.060677,0.094774,0.13607,0,0
4,GO VASCULAR WOUND HEALING,0.78176,0.09467,0.078628,0,0
4,GO MRNA TRANSPORT,0.058535,0.094469,0.14352,0,0
4,GO DNA REPLICATION CHECKPOINT,0.35442,0.094464,0.14297,0,0
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.13885,0.094402,0.16518,0,0
4,GO FATTY ACID TRANSPORT,0.27821,0.094377,0.095524,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.16123,0.094201,0.17566,0,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.33029,0.094135,0.12405,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.08881,0.094135,0.12938,0,0
4,GO NOSE DEVELOPMENT,0.51122,0.094073,0.1439,0,0
4,GO DNA REPAIR,0.034576,0.094061,0.15129,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.13467,0.093976,0.15035,0,0
4,GO PROTEIN TARGETING TO LYSOSOME,0.66333,0.09394,0.097061,0,0
4,GO QUINONE METABOLIC PROCESS,0.08588,0.09392,0.074957,0,0
4,GO NUCLEOSOME ORGANIZATION,0.067497,0.093909,0.15019,0,0
4,GO DNA METABOLIC PROCESS,0.054439,0.093816,0.1312,0,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.025096,0.093751,0.15387,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.050584,0.093715,0.16253,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.11524,0.09367,0.13979,0,0
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.197,0.093635,0.14216,0,0
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.14312,0.093623,0.23304,0,0
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.58498,0.093553,0.045402,0,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.08303,0.093309,0.10878,0,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.11524,0.093215,0.12189,0,0
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.2259,0.093026,0.11517,0,0
4,GO RESPONSE TO PEPTIDE HORMONE,0.060677,0.092989,0.14759,0,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.021265,0.092956,0.18433,0,0
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.08588,0.092929,0.15867,0,0
4,GO SNRNA TRANSCRIPTION,0.094909,0.09292,0.11696,0,0
4,GO ANION HOMEOSTASIS,0.058535,0.09288,0.15861,0,0
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.42405,0.092814,0.10515,0,0
4,GO SUCKLING BEHAVIOR,0.36271,0.092685,0.11582,0,0
4,GO RESPONSE TO STEROL,0.12662,0.092595,0.1795,0,0
4,GO ENDOCRINE PROCESS,0.33029,0.092556,0.086194,0,0
4,GO TISSUE HOMEOSTASIS,0.11524,0.092463,0.15173,0,0
4,GO DNA CONFORMATION CHANGE,0.13885,0.092461,0.1358,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.94321,0.092331,0.010298,0,0
4,GO REGULATION OF PINOCYTOSIS,0.10468,0.092209,0.2121,0,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.1306,0.092064,0.17101,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.023112,0.092022,0.16008,0,0
4,GO STEROL HOMEOSTASIS,0.4521,0.092017,0.064912,0,0
4,GO MAMMARY GLAND DEVELOPMENT,0.065157,0.092001,0.18159,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.072385,0.091961,0.18677,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.30724,0.091916,0.1037,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.12662,0.091913,0.087762,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.214,0.091906,0.13968,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23827,0.091737,0.18775,0,0
4,GO MANGANESE ION TRANSPORT,0.27821,0.091632,0.095827,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.069906,0.091598,0.11907,0,0
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.062884,0.091593,0.15546,0,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.058535,0.091562,0.13827,0,0
4,GO RESPONSE TO INSULIN,0.054439,0.091541,0.15061,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.24463,0.091492,0.12916,0,0
4,GO BONE GROWTH,0.32248,0.091482,0.13029,0,0
4,GO LAMELLIPODIUM ORGANIZATION,0.11163,0.091467,0.15212,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.37111,0.091402,0.11466,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.214,0.091328,0.15001,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.098083,0.091321,0.14258,0,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.058535,0.09126,0.13931,0,0
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.13467,0.09114,0.10997,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.79394,0.091093,0.082066,0,0
4,GO LIPID IMPORT INTO CELL,0.13885,0.091084,0.14433,0,0
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.0044907,0.091069,0.14154,0,0
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.13885,0.091062,0.16399,0,0
4,GO EXIT FROM MITOSIS,0.08588,0.091016,0.13816,0,0
4,GO PEPTIDE SECRETION,0.065157,0.090893,0.16178,0,0
4,GO REGULATION OF RECEPTOR RECYCLING,0.35442,0.090854,0.11658,0,0
4,GO RESPONSE TO ALCOHOL,0.16123,0.090831,0.1226,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.08303,0.090665,0.092684,0,0
4,GO PINOCYTOSIS,0.4521,0.090581,0.10199,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.33821,0.09054,0.087217,0,0
4,GO GLOMERULUS DEVELOPMENT,0.1306,0.090513,0.21088,0,0
4,GO MATURE B CELL DIFFERENTIATION,0.98106,0.090504,-0.0077724,0,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.61803,0.090463,0.067155,0,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.15197,0.090404,0.16809,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.25111,0.090337,0.11053,0,0
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.091819,0.090248,0.17557,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.197,0.090213,0.12771,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.7336,0.090173,0.036699,0,0
4,GO REGULATION OF NECROTIC CELL DEATH,0.2577,0.090038,0.10662,0,0
4,GO RECOMBINATIONAL REPAIR,0.12662,0.089976,0.15271,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.080256,0.08994,0.16143,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.24463,0.089849,0.10148,0,0
4,GO RESPONSE TO PEPTIDE,0.077559,0.089816,0.14353,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.048745,0.089803,0.13631,0,0
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.7336,0.089799,0.028285,0,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.045233,0.089738,0.17323,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.33029,0.089694,0.15802,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.24463,0.089609,0.12608,0,0
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.094909,0.089609,0.12577,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.51122,0.089522,0.082378,0,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.7336,0.089403,0.065577,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.17591,0.089312,0.2797,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.27821,0.089278,0.11761,0,0
4,GO L AMINO ACID TRANSPORT,0.15197,0.089225,0.12682,0,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.11163,0.089182,0.11698,0,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.10134,0.089113,0.11448,0,0
4,GO EPIBOLY,0.28529,0.089092,0.14273,0,0
4,GO RESPONSE TO INSECTICIDE,0.094909,0.089087,0.19852,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.40594,0.089074,0.049445,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.10134,0.089044,0.14114,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.18624,0.089014,0.17811,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.15655,0.08893,0.16967,0,0
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.17591,0.088923,0.11971,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.046961,0.088878,0.17019,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.08881,0.088842,0.10144,0,0
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.12662,0.088816,0.12292,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.045233,0.088754,0.15004,0,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.052482,0.088649,0.22986,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.091819,0.088635,0.15371,0,0
4,GO BIOLOGICAL ADHESION,0.12273,0.08858,0.15803,0,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.2259,0.088465,0.11436,0,0
4,GO ENDOCYTOSIS,0.069906,0.088433,0.16921,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.060677,0.088429,0.15937,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.10468,0.088408,0.10839,0,0
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.80618,0.088357,-0.018372,0,0
4,GO REGULATION OF PROTEOLYSIS,0.23827,0.088355,0.10033,0,0
4,GO CENTRIOLE ASSEMBLY,0.20256,0.088071,0.13237,0,0
4,GO SEQUESTERING OF TRIGLYCERIDE,0.46168,0.088048,0.087232,0,0
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.052482,0.087864,0.15989,0,0
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.13885,0.087856,0.16061,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.39705,0.087822,0.10938,0,0
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.08303,0.087751,0.14706,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.40594,0.087734,0.043542,0,0
4,GO HEART DEVELOPMENT,0.027226,0.087704,0.18188,0,0
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.065157,0.087634,0.1158,0,0
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.094909,0.087553,0.1744,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.53179,0.087517,0.086458,0,0
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.098083,0.087514,0.14242,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.12273,0.087503,0.16261,0,0
4,GO DNA PACKAGING,0.11163,0.087489,0.14749,0,0
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.20822,0.087457,0.097422,0,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.050584,0.087278,0.13187,0,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.35442,0.087252,0.10244,0,0
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.1306,0.087146,0.13392,0,0
4,GO CENTROSOME DUPLICATION,0.18102,0.086993,0.12628,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13467,0.086914,0.11835,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.68646,0.086885,0.047149,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.197,0.086866,0.12365,0,0
4,GO REGULATION OF BEHAVIOR,0.065157,0.086844,0.13441,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.034576,0.086814,0.10877,0,0
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.077559,0.086795,0.12843,0,0
4,GO AMYLOID BETA FORMATION,0.214,0.086708,0.12314,0,0
4,GO RNA MODIFICATION,0.15197,0.086614,0.087779,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.006955,0.086538,0.20829,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.069906,0.086471,0.14561,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.16602,0.08641,0.11053,0,0
4,GO BLASTOCYST DEVELOPMENT,0.026142,0.086386,0.11629,0,0
4,GO THIOESTER METABOLIC PROCESS,0.11894,0.086262,0.094209,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.2577,0.086065,0.13625,0,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.69814,0.086003,0.073878,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.53179,0.085858,0.080138,0,0
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.197,0.085827,0.12728,0,0
4,GO FLUID TRANSPORT,0.62923,0.085787,0.055159,0,0
4,GO REGULATION OF GLUCOSE IMPORT,0.094909,0.085722,0.13588,0,0
4,GO RESPONSE TO VITAMIN,0.37964,0.085666,0.10233,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.37964,0.085651,0.15498,0,0
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.072385,0.085526,0.15912,0,0
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.43329,0.085405,0.1035,0,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.24463,0.085366,0.088276,0,0
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.038848,0.085365,0.15077,0,0
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.2577,0.085342,0.1277,0,0
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.13885,0.085332,0.14954,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.15197,0.085329,0.14534,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.48117,0.085184,0.10717,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.028348,0.085086,0.14381,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.08881,0.085043,0.18424,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.08303,0.084931,0.15525,0,0
4,GO ADAPTIVE THERMOGENESIS,0.10468,0.084921,0.13928,0,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.080256,0.084703,0.11414,0,0
4,GO CELLULAR RESPONSE TO PEPTIDE,0.062884,0.084675,0.15226,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.2577,0.084662,0.1128,0,0
4,GO P38MAPK CASCADE,0.48117,0.084648,0.093532,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.2998,0.084566,0.12671,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.74555,0.084513,0.065884,0,0
4,GO MALE MEIOSIS I,0.15655,0.084473,0.15549,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.19156,0.084433,0.12733,0,0
4,GO PROTEIN DEGLYCOSYLATION,0.27126,0.084416,0.13802,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.094909,0.084388,0.1522,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.15655,0.084335,0.16995,0,0
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.91805,0.084314,-0.0058476,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.072385,0.084142,0.10611,0,0
4,GO EAR MORPHOGENESIS,0.098083,0.084077,0.13087,0,0
4,GO RENAL SODIUM EXCRETION,0.197,0.084031,0.14313,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.074935,0.084024,0.15913,0,0
4,GO PROTEIN KINASE B SIGNALING,0.28529,0.084005,0.11624,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.08588,0.083898,0.16021,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.27126,0.083859,0.08195,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.065157,0.083843,0.16094,0,0
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.16602,0.083767,0.10988,0,0
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.2259,0.083749,0.077226,0,0
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.26442,0.083732,0.10842,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.40594,0.083686,0.033834,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.17591,0.083652,0.23917,0,0
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.072385,0.083644,0.11364,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.21989,0.08355,0.1383,0,0
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.080256,0.083499,0.080902,0,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.4521,0.083478,0.099859,0,0
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.026142,0.083431,0.11583,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.35442,0.083422,0.090426,0,0
4,GO REGULATION OF CELL MATURATION,0.10811,0.083395,0.11935,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.53179,0.083365,0.074053,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.26442,0.083335,0.080413,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.27126,0.083334,0.12632,0,0
4,GO HOMEOSTATIC PROCESS,0.058535,0.083305,0.14079,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.197,0.083225,0.092103,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.16123,0.083171,0.085166,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.2577,0.083059,0.12604,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.094909,0.08305,0.15879,0,0
4,GO RESPONSE TO NICOTINE,0.25111,0.082985,0.10006,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.81845,0.082917,0.0018641,0,0
4,GO NCRNA METABOLIC PROCESS,0.33029,0.082856,0.058419,0,0
4,GO OSTEOBLAST PROLIFERATION,0.78176,0.082795,0.067071,0,0
4,GO GLIOGENESIS,0.18102,0.082763,0.12854,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.72171,0.082751,0.054789,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.25111,0.082679,0.11239,0,0
4,GO GLAND DEVELOPMENT,0.10811,0.082671,0.1446,0,0
4,GO ETHANOL METABOLIC PROCESS,0.72171,0.082626,-0.038287,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.56341,0.082624,0.066645,0,0
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.20256,0.082475,0.093953,0,0
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.214,0.082469,0.18324,0,0
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.197,0.082382,0.115,0,0
4,GO POSITIVE REGULATION OF MYELINATION,0.19156,0.082376,0.15708,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.091819,0.082267,0.16539,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.16602,0.082212,0.12875,0,0
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.074935,0.082135,0.17329,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.062884,0.082028,0.15844,0,0
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.36271,0.081993,0.15957,0,0
4,GO NEUTROPHIL EXTRAVASATION,0.90549,0.081971,0.048312,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.53179,0.081949,0.074845,0,0
4,GO ENDOTHELIUM DEVELOPMENT,0.197,0.081902,0.16208,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.23203,0.081861,0.14714,0,0
4,GO PROTEIN STABILIZATION,0.1306,0.081701,0.10336,0,0
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.08881,0.081578,0.15676,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.10468,0.081566,0.10125,0,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.80618,0.081526,-0.022484,0,0
4,GO APPENDAGE DEVELOPMENT,0.197,0.081435,0.13936,0,0
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.28529,0.081325,0.10429,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.10134,0.081236,0.09918,0,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.13885,0.081234,0.18217,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.074935,0.081213,0.15513,0,0
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.067497,0.081187,0.16174,0,0
4,GO GDP METABOLIC PROCESS,0.21989,0.081137,0.13618,0,0
4,GO FEVER GENERATION,0.49108,0.081118,0.065178,0,0
4,GO DNA CATABOLIC PROCESS,0.13467,0.08106,0.099082,0,0
4,GO CELLULAR RESPONSE TO UV,0.11163,0.081006,0.1108,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11894,0.08097,0.098954,0,0
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.098083,0.080942,0.17662,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.93062,0.080898,0.022243,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.94321,0.080831,0.0095508,0,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.5959,0.080795,0.059875,0,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.13885,0.080738,0.0981,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.11163,0.080706,0.19014,0,0
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.072385,0.08057,0.15489,0,0
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.16123,0.080565,0.16174,0,0
4,GO TUBE MORPHOGENESIS,0.23827,0.08056,0.13585,0,0
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.11894,0.08052,0.12597,0,0
4,GO RESPONSE TO HORMONE,0.08881,0.080465,0.13993,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.1306,0.080373,0.20751,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.056456,0.080328,0.14829,0,0
4,GO CRANIAL NERVE DEVELOPMENT,0.2577,0.080325,0.14145,0,0
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.08881,0.080254,0.19095,0,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.35442,0.08018,0.047925,0,0
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.17591,0.080146,0.099582,0,0
4,GO RETINOL METABOLIC PROCESS,0.52145,0.080059,0.038338,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.052482,0.080023,0.14308,0,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.046961,0.07997,0.15015,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.14312,0.079926,0.14148,0,0
4,GO CENTROSOME SEPARATION,0.15655,0.079923,0.14389,0,0
4,GO DNA RECOMBINATION,0.20822,0.079744,0.10993,0,0
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.16602,0.079727,0.14578,0,0
4,GO RESPONSE TO ESTRADIOL,0.1475,0.079688,0.12205,0,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.1475,0.079658,0.1712,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.16123,0.079349,0.15358,0,0
4,GO AMYLOID BETA CLEARANCE,0.90549,0.079345,-0.0087541,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.44264,0.079138,0.13344,0,0
4,GO REGULATION OF GLOMERULAR FILTRATION,0.29248,0.079107,0.16277,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.056456,0.079085,0.17737,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.3148,0.079084,0.09122,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.39705,0.079079,0.11028,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.41494,0.079046,0.099275,0,0
4,GO REGULATION OF CELLULAR RESPIRATION,0.0092139,0.078893,0.13189,0,0
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.11163,0.07883,0.14369,0,0
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.056456,0.078822,0.13776,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.65188,0.078757,0.084105,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.12273,0.078736,0.11844,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.074935,0.078617,0.14031,0,0
4,GO SPROUTING ANGIOGENESIS,0.37964,0.078523,0.13187,0,0
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.10468,0.078522,0.13657,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.098083,0.078515,0.15309,0,0
4,GO PHOSPHOLIPID HOMEOSTASIS,0.33029,0.078512,0.1082,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.25111,0.078355,0.091381,0,0
4,GO HOMOTYPIC CELL CELL ADHESION,0.62923,0.078233,0.064822,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.08881,0.078148,0.12953,0,0
4,GO RNA EXPORT FROM NUCLEUS,0.069906,0.078075,0.13918,0,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.4521,0.078037,0.08018,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.44264,0.078011,0.12415,0,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.12662,0.077981,0.14045,0,0
4,GO RESPONSE TO TOXIC SUBSTANCE,0.10811,0.077942,0.091182,0,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.077559,0.077887,0.15494,0,0
4,GO RESPONSE TO STEROID HORMONE,0.12662,0.077701,0.13313,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.27126,0.077672,0.11384,0,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.17091,0.077548,0.14506,0,0
4,GO POSITIVE REGULATION OF TRANSPORT,0.077559,0.077478,0.14577,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.44264,0.077465,0.079217,0,0
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.094909,0.07745,0.151,0,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.1306,0.077365,0.17575,0,0
4,GO TISSUE MORPHOGENESIS,0.065157,0.077211,0.15022,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.1306,0.07706,0.13624,0,0
4,GO MATING,0.23203,0.077057,0.10693,0,0
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.077559,0.07705,0.1173,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.30724,0.076976,0.10884,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.094909,0.076955,0.14354,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.27821,0.076931,0.11898,0,0
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.54223,0.076926,0.074224,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.15197,0.076844,0.10893,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.18624,0.076843,0.15968,0,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.17091,0.076761,0.11336,0,0
4,GO INTRACELLULAR LIPID TRANSPORT,0.197,0.07666,0.13442,0,0
4,GO DNA GEOMETRIC CHANGE,0.25111,0.076651,0.11137,0,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.13885,0.07658,0.087781,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.23827,0.076464,0.13466,0,0
4,GO BLASTOCYST FORMATION,0.10468,0.076266,0.092941,0,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.37111,0.076257,0.063537,0,0
4,GO REGULATION OF BINDING,0.15655,0.076224,0.12008,0,0
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.050584,0.076186,0.14658,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.077559,0.076166,0.14628,0,0
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.028348,0.076159,0.1439,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.34626,0.075999,0.11762,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.197,0.075971,0.1094,0,0
4,GO STEM CELL PROLIFERATION,0.15197,0.07593,0.16046,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.17591,0.075856,0.10106,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.18624,0.075814,0.085571,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.37111,0.075656,0.041738,0,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.054439,0.075652,0.16628,0,0
4,GO RNA SURVEILLANCE,0.42405,0.075472,0.056698,0,0
4,GO EPOXYGENASE P450 PATHWAY,0.37111,0.07541,0.11149,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.48117,0.075392,0.083548,0,0
4,GO RESPONSE TO ETHANOL,0.12273,0.075361,0.11097,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.067497,0.075324,0.17226,0,0
4,GO COPPER ION TRANSPORT,0.64051,0.075273,0.032761,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.13467,0.075266,0.13989,0,0
4,GO HYALURONAN METABOLIC PROCESS,0.18624,0.075226,0.1723,0,0
4,GO RUFFLE ORGANIZATION,0.33029,0.075052,0.12123,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.17091,0.075007,0.10772,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.025096,0.074965,0.19479,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.1475,0.074762,0.1195,0,0
4,GO INTERACTION WITH HOST,0.48117,0.074728,0.085137,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.65188,0.074719,0.07881,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.39705,0.074702,0.11577,0,0
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.35442,0.074701,0.10139,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.16123,0.074652,0.11392,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.2259,0.074618,0.087242,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.214,0.074607,0.092528,0,0
4,GO VITAMIN TRANSPORT,0.18624,0.074605,0.12616,0,0
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.16123,0.074584,0.13646,0,0
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.13467,0.074535,0.14145,0,0
4,GO NEURAL CREST CELL MIGRATION,0.11894,0.074457,0.16307,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.052482,0.07441,0.16283,0,0
4,GO REGULATION OF METAL ION TRANSPORT,0.058535,0.074402,0.18077,0,0
4,GO NUCLEAR EXPORT,0.072385,0.074398,0.13353,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.26442,0.074372,0.09927,0,0
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.038848,0.074371,0.091986,0,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.38829,0.07437,0.083792,0,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.44264,0.074207,0.10543,0,0
4,GO MITOTIC CYTOKINESIS,0.08881,0.074196,0.1416,0,0
4,GO RESPONSE TO UV B,0.4521,0.074156,0.088186,0,0
4,GO PHAGOLYSOSOME ASSEMBLY,0.11524,0.07412,0.21417,0,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.61803,0.074072,0.061521,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.1306,0.073994,0.13512,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.28529,0.073984,0.09592,0,0
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.091819,0.073964,0.12802,0,0
4,GO RECEPTOR INTERNALIZATION,0.12273,0.073958,0.15427,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.08303,0.073934,0.13761,0,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.3148,0.073833,0.071165,0,0
4,GO MESODERM DEVELOPMENT,0.10811,0.073784,0.13074,0,0
4,GO OPTIC NERVE DEVELOPMENT,0.2577,0.07367,0.16159,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.95582,0.073624,0.0016832,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.20822,0.073571,0.074862,0,0
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.3148,0.073487,0.10983,0,0
4,GO RELAXATION OF MUSCLE,0.214,0.073487,0.18057,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.048745,0.073462,0.16348,0,0
4,GO POSITIVE REGULATION OF WOUND HEALING,0.50109,0.073341,0.084393,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.2259,0.073268,0.13746,0,0
4,GO PROTEIN TETRAMERIZATION,0.098083,0.073175,0.12316,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.39705,0.073054,0.10178,0,0
4,GO RETINAL METABOLIC PROCESS,0.65188,0.073004,0.046121,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.4521,0.072993,0.11616,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.70989,0.07295,0.068964,0,0
4,GO BILE ACID METABOLIC PROCESS,0.33821,0.072887,0.098799,0,0
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.14312,0.072874,0.12063,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.2998,0.07286,0.1223,0,0
4,GO CELL MOTILITY,0.16602,0.072842,0.13737,0,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.20822,0.072833,0.14417,0,0
4,GO GLYCOLIPID CATABOLIC PROCESS,0.99368,0.072777,0.007403,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.18624,0.072767,0.072162,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.25111,0.072764,0.072959,0,0
4,GO BIOLOGICAL PHASE,0.42405,0.072729,0.10685,0,0
4,GO NCRNA PROCESSING,0.49108,0.072656,0.046215,0,0
4,GO VACUOLAR ACIDIFICATION,0.32248,0.072638,0.084763,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.27821,0.072623,0.10458,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.1475,0.072557,0.16892,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.34626,0.072516,0.10761,0,0
4,GO REGULATION OF OSSIFICATION,0.48117,0.072415,0.10035,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.045233,0.072409,0.12306,0,0
4,GO ODONTOGENESIS,0.33821,0.072399,0.10433,0,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.10811,0.072366,0.11604,0,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.13467,0.072361,0.10258,0,0
4,GO MITOCHONDRIAL DEPOLARIZATION,0.2259,0.072358,0.13746,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.30724,0.072314,0.11983,0,0
4,GO LIPID STORAGE,0.32248,0.072292,0.095341,0,0
4,GO EPITHELIAL CELL FATE COMMITMENT,0.2577,0.07229,0.14203,0,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.056456,0.072289,0.13772,0,0
4,GO POSITIVE REGULATION OF JNK CASCADE,0.32248,0.072258,0.13239,0,0
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.19156,0.072248,0.11092,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.23203,0.072138,0.077423,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.20256,0.072114,0.13844,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.25111,0.072102,0.10885,0,0
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.1475,0.072075,0.17368,0,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.20822,0.072071,0.11425,0,0
4,GO EAR DEVELOPMENT,0.069906,0.072019,0.14005,0,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.36271,0.071981,0.085631,0,0
4,GO STEM CELL DIFFERENTIATION,0.2577,0.071786,0.099988,0,0
4,GO RESPONSE TO INTERFERON ALPHA,0.99368,0.071769,0.0054238,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.33821,0.071757,0.080721,0,0
4,GO RESPONSE TO OXIDATIVE STRESS,0.11894,0.071732,0.11359,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.68646,0.071712,0.02354,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.4521,0.071689,0.076036,0,0
4,GO RESPONSE TO DRUG,0.10811,0.071633,0.12033,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.35442,0.071574,0.089835,0,0
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.26442,0.07146,0.079249,0,0
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.29248,0.071455,0.12349,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.40594,0.071426,0.10662,0,0
4,GO SNRNA METABOLIC PROCESS,0.20822,0.071252,0.069791,0,0
4,GO APPENDAGE MORPHOGENESIS,0.23827,0.071237,0.14301,0,0
4,GO PLACENTA DEVELOPMENT,0.23203,0.071107,0.11571,0,0
4,GO GLAND MORPHOGENESIS,0.50109,0.071012,0.10155,0,0
4,GO RESPONSE TO INTERLEUKIN 2,1,0.070962,0.03585,0,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.23203,0.070955,0.13671,0,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.16123,0.070796,0.16257,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.11894,0.070667,0.11119,0,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.2577,0.070666,0.12479,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.72171,0.070619,0.053181,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.1475,0.070596,0.085738,0,0
4,GO ZINC ION TRANSPORT,0.069906,0.070591,0.10395,0,0
4,GO RESPONSE TO RETINOIC ACID,0.39705,0.070591,0.10028,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.098083,0.070529,0.17983,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.44264,0.070503,0.10832,0,0
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.33821,0.070467,0.087593,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.33821,0.070431,0.080121,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.091819,0.070429,0.14082,0,0
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.11524,0.070295,0.14238,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.37111,0.070189,0.089482,0,0
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.38829,0.070147,0.060118,0,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.20256,0.07014,0.11375,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.51122,0.070075,0.069696,0,0
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.13467,0.070045,0.14,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.14312,0.070014,0.10977,0,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.077559,0.070012,0.14606,0,0
4,GO REGULATION OF PROTON TRANSPORT,0.098083,0.070003,0.12615,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.10811,0.069955,0.14489,0,0
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.75756,0.069929,-0.0027644,0,0
4,GO RESPONSE TO OSMOTIC STRESS,0.11524,0.069894,0.14027,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.13467,0.069833,0.16201,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.80618,0.069828,0.062817,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.10134,0.069805,0.12637,0,0
4,GO PH REDUCTION,0.10134,0.069802,0.12219,0,0
4,GO RESPONSE TO ABIOTIC STIMULUS,0.035953,0.069757,0.12814,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.2998,0.069752,0.083138,0,0
4,GO CHROMOSOME SEGREGATION,0.33821,0.069699,0.099721,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.25111,0.069626,0.13169,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.08881,0.069563,0.14029,0,0
4,GO EXOCYTOSIS,0.32248,0.069427,0.099902,0,0
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.17091,0.069414,0.179,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.66333,0.069347,0.051337,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.49108,0.069334,0.087006,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.46168,0.069279,0.088798,0,0
4,GO CELL CELL ADHESION,0.27126,0.069259,0.1221,0,0
4,GO REGULATION OF ODONTOGENESIS,0.32248,0.06925,0.089949,0,0
4,GO RESPONSE TO PROGESTERONE,0.40594,0.069181,0.1031,0,0
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.2259,0.069158,0.12504,0,0
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.098083,0.069101,0.14331,0,0
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.56341,0.06905,0.072117,0,0
4,GO ANIMAL ORGAN FORMATION,0.32248,0.068958,0.096897,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.12273,0.068762,0.19859,0,0
4,GO OVULATION CYCLE,0.15655,0.068691,0.18217,0,0
4,GO MUSCLE CELL PROLIFERATION,0.40594,0.068624,0.10087,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.2998,0.068493,0.09955,0,0
4,GO PROTEIN AUTOPROCESSING,0.25111,0.068487,0.1055,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.10134,0.068448,0.15355,0,0
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.10468,0.068439,0.11264,0,0
4,GO SECRETION,0.13467,0.068439,0.12222,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.080256,0.068349,0.14925,0,0
4,GO TRANSLESION SYNTHESIS,0.24463,0.068289,0.072774,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.39705,0.068288,0.096,0,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.43329,0.068243,0.077023,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.197,0.068165,0.072474,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.51122,0.068164,0.080828,0,0
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.017954,0.068112,0.092421,0,0
4,GO REGIONALIZATION,0.13467,0.068054,0.13653,0,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.098083,0.067989,0.14382,0,0
4,GO ENSHEATHMENT OF NEURONS,0.11163,0.067876,0.1321,0,0
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.08881,0.067829,0.14075,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.36271,0.067653,0.069577,0,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.28529,0.067641,0.12765,0,0
4,GO MRNA METABOLIC PROCESS,0.11894,0.067581,0.088464,0,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.098083,0.06746,0.15855,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.12662,0.067451,0.12706,0,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.38829,0.067448,0.12841,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.077559,0.067422,0.10453,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.08588,0.067274,0.16325,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.10811,0.067225,0.086798,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.39705,0.067017,0.10645,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.27126,0.067007,0.12815,0,0
4,GO PROTEIN N LINKED GLYCOSYLATION,0.094909,0.066937,0.094736,0,0
4,GO REGULATION OF ORGAN GROWTH,0.11163,0.06692,0.13919,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.19156,0.066899,0.11458,0,0
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.61803,0.066841,0.046737,0,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.1475,0.066751,0.16648,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.32248,0.066726,0.079215,0,0
4,GO REGULATION OF DNA REPLICATION,0.25111,0.066712,0.10348,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.12662,0.066697,0.13191,0,0
4,GO NCRNA 3 END PROCESSING,0.20256,0.066679,0.064935,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.43329,0.066555,0.096086,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.10134,0.066464,0.22453,0,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.55277,0.066398,0.068438,0,0
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.51122,0.066309,0.079837,0,0
4,GO CELLULAR RESPONSE TO KETONE,0.17591,0.066302,0.1129,0,0
4,GO MALE GENITALIA DEVELOPMENT,0.61803,0.066302,0.038464,0,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.062884,0.066267,0.18304,0,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.10134,0.066264,0.12979,0,0
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.56341,0.066251,0.13744,0,0
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.66333,0.066171,0.085616,0,0
4,GO CELL FATE COMMITMENT,0.29248,0.066153,0.11738,0,0
4,GO MUSCLE CELL MIGRATION,0.47137,0.066129,0.10558,0,0
4,GO VASCULATURE DEVELOPMENT,0.34626,0.06606,0.12445,0,0
4,GO MATING BEHAVIOR,0.30724,0.066012,0.098664,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.197,0.065999,0.10403,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.34626,0.065933,0.10071,0,0
4,GO REGULATION OF HEART GROWTH,0.1475,0.065872,0.12204,0,0
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.25111,0.065852,0.13858,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.10811,0.065795,0.17932,0,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.11524,0.065561,0.12543,0,0
4,GO SPINDLE ASSEMBLY,0.29248,0.065384,0.1167,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.1306,0.065378,0.17142,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.20256,0.065326,0.15523,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.17091,0.065276,0.14274,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.57414,0.065244,0.072086,0,0
4,GO TISSUE REMODELING,0.43329,0.065217,0.12173,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.077559,0.065185,0.16223,0,0
4,GO ION HOMEOSTASIS,0.12273,0.065148,0.13531,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.08881,0.06508,0.23781,0,0
4,GO TRABECULA MORPHOGENESIS,0.35442,0.06502,0.12437,0,0
4,GO SPINDLE ORGANIZATION,0.24463,0.06498,0.13516,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.54223,0.064978,0.078079,0,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.08881,0.064781,0.1276,0,0
4,GO TRNA METHYLATION,0.33029,0.064767,0.073573,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.53179,0.064705,0.07366,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.28529,0.064692,0.05822,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.08881,0.064643,0.14085,0,0
4,GO METAL ION HOMEOSTASIS,0.16602,0.064591,0.12442,0,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.37111,0.064568,0.10801,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.44264,0.064544,0.098171,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.08881,0.064537,0.1551,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.11163,0.06453,0.1511,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.43329,0.064505,0.057409,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.44264,0.064471,0.078451,0,0
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.080256,0.064455,0.16401,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.17591,0.064439,0.13549,0,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.23203,0.064412,0.11373,0,0
4,GO RIG I SIGNALING PATHWAY,0.25111,0.064401,0.10655,0,0
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.29248,0.064311,0.095831,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.15197,0.064217,0.1221,0,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.52145,0.064209,0.1073,0,0
4,GO COENZYME A METABOLIC PROCESS,0.074935,0.064184,0.11392,0,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.052482,0.064165,0.11866,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.13885,0.064114,0.12861,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.65188,0.064106,0.078146,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.12662,0.063923,0.17593,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.37964,0.063876,0.098187,0,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.17591,0.063849,0.098685,0,0
4,GO CELLULAR ION HOMEOSTASIS,0.15655,0.063728,0.12209,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.18624,0.063593,0.093955,0,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.41494,0.063427,0.083256,0,0
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.36271,0.063355,0.072436,0,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.81845,0.063346,0.0043602,0,0
4,GO CYTOKINETIC PROCESS,0.019548,0.063286,0.15248,0,0
4,GO REGULATION OF CELL AGING,0.21989,0.063238,0.088169,0,0
4,GO REGULATION OF PHOSPHORYLATION,0.11163,0.063218,0.14084,0,0
4,GO PROTEIN DENEDDYLATION,0.197,0.063202,0.077389,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.65188,0.06311,0.029318,0,0
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.60692,0.063034,0.072419,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.197,0.062965,0.14645,0,0
4,GO CELLULAR HOMEOSTASIS,0.10811,0.062963,0.12338,0,0
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.33029,0.062949,0.12328,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.56341,0.06292,0.084176,0,0
4,GO TEMPERATURE HOMEOSTASIS,0.10811,0.062713,0.13245,0,0
4,GO GLIAL CELL APOPTOTIC PROCESS,0.33029,0.062648,0.10783,0,0
4,GO ANDROGEN METABOLIC PROCESS,0.75756,0.062416,0.015589,0,0
4,GO MYOBLAST PROLIFERATION,0.25111,0.062403,0.17802,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.53179,0.062304,0.12081,0,0
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.4521,0.062303,0.056097,0,0
4,GO MAINTENANCE OF LOCATION,0.18624,0.062282,0.11816,0,0
4,GO BONE RESORPTION,0.57414,0.062282,0.086158,0,0
4,GO REGULATION OF ICOSANOID SECRETION,0.40594,0.062176,0.084393,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.24463,0.062172,0.14385,0,0
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.29248,0.06211,0.14124,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.2259,0.062019,0.13279,0,0
4,GO RESPONSE TO OXYGEN LEVELS,0.27821,0.06201,0.086669,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.60692,0.06199,0.090995,0,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.89296,0.061878,0.041826,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.062884,0.061871,0.1303,0,0
4,GO DENDRITIC SPINE MAINTENANCE,0.33029,0.061802,0.14425,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.79394,0.061774,0.060567,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.19156,0.061764,0.1206,0,0
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.68646,0.06172,0.066027,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.10811,0.061561,0.12672,0,0
4,GO MESENCHYME MORPHOGENESIS,0.2259,0.061558,0.13837,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.17091,0.061438,0.1277,0,0
4,GO RESPONSE TO ZINC ION,0.85555,0.061313,-0.013801,0,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.25111,0.061301,0.1066,0,0
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.61803,0.061218,0.050995,0,0
4,GO PROTEIN HYDROXYLATION,0.2998,0.061205,0.11831,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.40594,0.061103,0.11044,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.16123,0.061033,0.11493,0,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.1475,0.060961,0.16854,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.10134,0.060733,0.12319,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.37964,0.060711,0.098884,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.28529,0.06063,0.080861,0,0
4,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.95582,0.060616,0.033534,0,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.86799,0.060586,0.020248,0,0
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.16602,0.060477,0.11739,0,0
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.17091,0.060439,0.11597,0,0
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.060677,0.060385,0.15494,0,0
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.15655,0.060314,0.16296,0,0
4,GO POSITIVE REGULATION OF CELL MATURATION,0.53179,0.060313,0.067787,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.74555,0.060247,0.069751,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.14312,0.060173,0.1024,0,0
4,GO AEROBIC RESPIRATION,0.10134,0.060153,0.05499,0,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.35442,0.060097,0.13449,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.51122,0.060033,0.080922,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.4521,0.060032,0.094918,0,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.17091,0.060031,0.13506,0,0
4,GO SEQUESTERING OF CALCIUM ION,0.214,0.059999,0.13558,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.37111,0.059796,0.11045,0,0
4,GO CELL CELL RECOGNITION,0.41494,0.059782,0.068776,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.50109,0.059756,0.11514,0,0
4,GO EPITHELIAL CELL PROLIFERATION,0.37964,0.059622,0.10588,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.56341,0.059585,0.045502,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.1306,0.059558,0.13665,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.36271,0.059456,0.10454,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.058535,0.059327,0.11622,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.18102,0.0593,0.10847,0,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.69814,0.0593,0.03586,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.16123,0.059159,0.10149,0,0
4,GO SEQUESTERING OF METAL ION,0.72171,0.059116,-0.051295,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.21989,0.059069,0.12369,0,0
4,GO PLATELET AGGREGATION,0.58498,0.058913,0.077272,0,0
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.39705,0.058895,0.10518,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.95582,0.058744,-0.0025271,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.15197,0.058641,0.13993,0,0
4,GO TRACHEA DEVELOPMENT,0.4521,0.058603,0.10384,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.27821,0.058583,0.10312,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.077559,0.058519,0.11107,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.20256,0.058394,0.11654,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.14312,0.058342,0.11349,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.33821,0.058258,0.15558,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.12273,0.058194,0.086335,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.080256,0.058174,0.18948,0,0
4,GO ASYMMETRIC CELL DIVISION,0.33029,0.058085,0.09866,0,0
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.44264,0.058038,0.092451,0,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.091819,0.058011,0.1273,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.2259,0.057921,0.13701,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.2259,0.057914,0.13059,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.2259,0.05791,0.10725,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.2577,0.057858,0.10063,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.13885,0.057795,0.19404,0,0
4,GO ACETYL COA METABOLIC PROCESS,0.14312,0.057755,0.10586,0,0
4,GO MAINTENANCE OF LOCATION IN CELL,0.20256,0.057747,0.11612,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.17591,0.057739,0.1399,0,0
4,GO REGENERATION,0.16602,0.057678,0.12096,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.64051,0.057615,-0.067019,0,0
4,GO ESTROGEN METABOLIC PROCESS,0.25111,0.057557,0.12776,0,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.27126,0.057504,0.087505,0,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.68646,0.057501,0.051201,0,0
4,GO CELL AGING,0.1475,0.057444,0.1024,0,0
4,GO RESPONSE TO LIPID,0.47137,0.057369,0.086287,0,0
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.4521,0.057359,0.061692,0,0
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.86799,0.057296,0.048371,0,0
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.89296,0.057202,0.044815,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.24463,0.057155,0.16549,0,0
4,GO RESPONSE TO CAFFEINE,0.19156,0.057142,0.15069,0,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.060677,0.057052,0.12478,0,0
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.12662,0.05703,0.12329,0,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.21989,0.056865,0.14712,0,0
4,GO CELL DIVISION,0.08303,0.056858,0.13343,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.37111,0.056688,0.079648,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.12662,0.056588,0.12092,0,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.1306,0.056424,0.11111,0,0
4,GO KIDNEY MORPHOGENESIS,0.21989,0.056407,0.12316,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.12662,0.056393,0.081285,0,0
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.34626,0.056324,0.072256,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.197,0.056272,0.10966,0,0
4,GO POSITIVE REGULATION OF SIGNALING,0.12662,0.056232,0.12855,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.17091,0.056152,0.16955,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.11163,0.056113,0.10045,0,0
4,GO ENERGY RESERVE METABOLIC PROCESS,0.028348,0.055915,0.17343,0,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.56341,0.055815,0.075067,0,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.50109,0.05576,0.059456,0,0
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.1306,0.055643,0.14959,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.36271,0.055637,0.12257,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.25111,0.055593,0.13267,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.46168,0.055435,0.058689,0,0
4,GO NEUROBLAST DIVISION,0.33029,0.055401,0.11444,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.28529,0.055391,0.17624,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.034576,0.055384,0.094845,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.18102,0.055372,0.12114,0,0
4,GO TOXIN METABOLIC PROCESS,0.2577,0.055289,0.12005,0,0
4,GO REGULATION OF HYDROLASE ACTIVITY,0.13467,0.055194,0.13287,0,0
4,GO GTP BIOSYNTHETIC PROCESS,0.55277,0.055141,0.063434,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.11894,0.055073,0.14453,0,0
4,GO MUSCLE FILAMENT SLIDING,0.24463,0.055042,0.11779,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.78176,0.055041,0.079291,0,0
4,GO RESPONSE TO OXYGEN RADICAL,0.57414,0.054977,0.061733,0,0
4,GO ORGAN GROWTH,0.077559,0.054881,0.15662,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.70989,0.054861,0.068092,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.49108,0.054667,0.060077,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.33029,0.054665,0.090056,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.55277,0.054665,0.093401,0,0
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.35442,0.054531,0.16741,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.94321,0.054517,0.034744,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.32248,0.054495,0.15824,0,0
4,GO MAST CELL MEDIATED IMMUNITY,0.86799,0.054482,0.049269,0,0
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.29248,0.054444,0.13036,0,0
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.79394,0.054368,0.060443,0,0
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.78176,0.054366,0.040493,0,0
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.86799,0.054356,0.03804,0,0
4,GO REGULATION OF RESPONSE TO STRESS,0.33029,0.054154,0.09193,0,0
4,GO GLYCINE METABOLIC PROCESS,0.85555,0.054085,-0.069411,0,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.20256,0.054011,0.12781,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.46168,0.053837,0.10433,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.20256,0.053792,0.10335,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.1475,0.053752,0.13713,0,0
4,GO CELL CYCLE CHECKPOINT,0.20256,0.053728,0.13901,0,0
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.38829,0.05369,0.086862,0,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.197,0.053497,0.091051,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.26442,0.053448,0.13975,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.20256,0.053444,0.12344,0,0
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.5959,0.053439,0.071608,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.37964,0.053394,0.11098,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.20822,0.053265,0.13742,0,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.35442,0.053141,0.12118,0,0
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.90549,0.053002,-0.044588,0,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.58498,0.052996,0.060283,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.53179,0.052842,0.075312,0,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.94321,0.052658,0.021463,0,0
4,GO IRON ION HOMEOSTASIS,0.33029,0.052629,0.088355,0,0
4,GO CHROMOSOME CONDENSATION,0.27126,0.052597,0.13563,0,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.68646,0.052372,-0.050431,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.28529,0.052371,0.10347,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.17591,0.052348,0.12595,0,0
4,GO TELOMERE ORGANIZATION,0.15197,0.052252,0.12033,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.037377,0.052095,0.12414,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.28529,0.051941,0.13744,0,0
4,GO ATP BIOSYNTHETIC PROCESS,0.44264,0.051913,0.064028,0,0
4,GO CARTILAGE DEVELOPMENT,0.2577,0.051876,0.12807,0,0
4,GO REGULATION OF DNA RECOMBINATION,0.17591,0.051722,0.12644,0,0
4,GO INSEMINATION,0.57414,0.051709,0.071334,0,0
4,GO AMINO ACID ACTIVATION,0.15197,0.05168,0.088716,0,0
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.2259,0.051632,0.12233,0,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.23203,0.051613,0.1122,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.17091,0.051574,0.11497,0,0
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.37964,0.05153,0.12668,0,0
4,GO MITOTIC CELL CYCLE,0.080256,0.051421,0.12728,0,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.30724,0.051397,0.10363,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.18102,0.051381,0.099855,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.81845,0.051174,0.059256,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.11524,0.051147,0.09896,0,0
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.80618,0.051106,0.059779,0,0
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.23203,0.051105,0.10382,0,0
4,GO AUTOPHAGY OF NUCLEUS,0.11163,0.051044,0.13592,0,0
4,GO RNA INTERFERENCE,0.12273,0.051012,0.1377,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.95582,0.050688,0.017085,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.46168,0.050653,0.079036,0,0
4,GO MUCUS SECRETION,0.62923,0.050605,0.061493,0,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.62923,0.050596,0.045091,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.43329,0.050576,0.092243,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.25111,0.050532,0.10016,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.23827,0.050346,0.093969,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2998,0.050291,0.13048,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.033245,0.050232,0.12008,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.20822,0.050198,0.10516,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.2998,0.050059,0.094262,0,0
4,GO POSITIVE REGULATION OF BINDING,0.23827,0.049961,0.098031,0,0
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.16602,0.049957,0.11987,0,0
4,GO NEUROBLAST PROLIFERATION,0.28529,0.049926,0.13894,0,0
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.64051,0.049825,0.05222,0,0
4,GO SIALYLATION,0.48117,0.049804,0.10098,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.10811,0.049754,0.15229,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.080256,0.049677,0.12263,0,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.39705,0.049576,0.097071,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.2998,0.049511,0.099167,0,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.23827,0.049472,0.04861,0,0
4,GO REGULATION OF MAPK CASCADE,0.3148,0.0494,0.11495,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.50109,0.049378,0.055101,0,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.3148,0.049324,0.099711,0,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.74555,0.049255,0.024122,0,0
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.4521,0.04924,0.07285,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.98106,0.049204,0.039358,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.23203,0.049169,0.12237,0,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.16123,0.049049,0.14986,0,0
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.67486,0.049007,0.07543,0,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.43329,0.048795,0.081985,0,0
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.23827,0.048721,0.13348,0,0
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.70989,0.048715,0.050455,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.11894,0.048681,0.10559,0,0
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.80618,0.04855,0.033459,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.62923,0.048447,0.089308,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.44264,0.048421,0.10973,0,0
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.55277,0.048258,0.079633,0,0
4,GO TRANSPOSITION,0.50109,0.048235,0.054526,0,0
4,GO CHROMOSOME SEPARATION,0.38829,0.048213,0.093711,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.052482,0.048186,0.10927,0,0
4,GO RNA LOCALIZATION,0.15655,0.048182,0.10259,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.41494,0.048034,0.10672,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.76963,0.047969,0.051536,0,0
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.1475,0.047908,0.095315,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.16602,0.047737,0.079509,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.79394,0.047724,0.065809,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.38829,0.047712,0.0755,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.1306,0.047524,0.10541,0,0
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.27126,0.047487,0.10727,0,0
4,GO HEME METABOLIC PROCESS,0.2998,0.047435,0.078286,0,0
4,GO NEURON FATE COMMITMENT,0.49108,0.047408,0.098075,0,0
4,GO RNA DECAPPING,0.39705,0.047348,0.11579,0,0
4,GO CELL CYCLE ARREST,0.12662,0.047256,0.11915,0,0
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.18102,0.047146,0.11685,0,0
4,GO DEFENSE RESPONSE TO VIRUS,0.74555,0.047142,-0.022521,0,0
4,GO TAXIS,0.32248,0.047124,0.11851,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.40594,0.04707,0.11209,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.51122,0.046919,0.032056,0,0
4,GO NUCLEAR TRANSPORT,0.1306,0.046833,0.11244,0,0
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.46168,0.046739,0.12286,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.55277,0.046704,0.078012,0,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.70989,0.046637,0.027234,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.35442,0.046593,0.08348,0,0
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.37111,0.046537,0.079876,0,0
4,GO ERYTHROCYTE HOMEOSTASIS,0.37964,0.046407,0.095922,0,0
4,GO GENITALIA DEVELOPMENT,0.85555,0.046343,0.040595,0,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.18102,0.046333,0.10912,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.32248,0.046294,0.10186,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.94321,0.046268,0.0337,0,0
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.48117,0.046247,0.10486,0,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.68646,0.046201,-0.063385,0,0
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.58498,0.046201,0.078201,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.091819,0.04612,0.12898,0,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.94321,0.046021,0.016088,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.32248,0.046001,0.093788,0,0
4,GO VASCULOGENESIS,0.50109,0.045989,0.1116,0,0
4,GO DETECTION OF OTHER ORGANISM,0.7336,0.045969,-0.057798,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.20256,0.04588,0.10157,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.42405,0.04569,0.11124,0,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.20822,0.045619,0.10863,0,0
4,GO SEX DIFFERENTIATION,0.21989,0.045597,0.10897,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.37111,0.045479,0.078474,0,0
4,GO REGULATION OF ERAD PATHWAY,0.11163,0.045437,0.12256,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.30724,0.045406,0.096442,0,0
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.19156,0.045347,0.10266,0,0
4,GO RESPONSE TO DEXAMETHASONE,0.90549,0.045318,0.032968,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.49108,0.045306,0.048344,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.78176,0.044954,0.0042652,0,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.23827,0.04495,0.1349,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.20256,0.044926,0.11107,0,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.54223,0.044625,0.056426,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.55277,0.044617,0.27379,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.20256,0.04459,0.1342,0,0
4,GO VITAMIN METABOLIC PROCESS,0.49108,0.044569,0.053644,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.91805,0.044353,0.0066229,0,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.74555,0.044284,0.058359,0,0
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.27126,0.04428,0.090596,0,0
4,GO PROSTANOID METABOLIC PROCESS,0.83078,0.043881,0.020164,0,0
4,GO LUNG MORPHOGENESIS,0.43329,0.043867,0.11737,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.61803,0.043638,0.10233,0,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.2577,0.043513,0.094669,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.19156,0.043372,0.13089,0,0
4,GO RESPONSE TO KETONE,0.50109,0.043341,0.085231,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.10134,0.043339,0.14307,0,0
4,GO AGING,0.29248,0.043256,0.10532,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.93062,0.043251,0.080719,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.10468,0.043159,0.18063,0,0
4,GO REGULATION OF CELL DEATH,0.33821,0.043103,0.095,0,0
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.23827,0.043076,0.09866,0,0
4,GO CELL ADHESION MOLECULE PRODUCTION,0.75756,0.043006,0.070608,0,0
4,GO NEGATIVE REGULATION OF SECRETION,0.33821,0.042987,0.090993,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.68646,0.042963,0.074041,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.47137,0.042875,0.097681,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.10468,0.042609,0.12643,0,0
4,GO POSTREPLICATION REPAIR,0.46168,0.042594,0.05321,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.94321,0.042578,0.035018,0,0
4,GO REGULATION OF BONE REMODELING,0.65188,0.042535,0.082098,0,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.21989,0.042444,0.13259,0,0
4,GO REGULATION OF LIPID LOCALIZATION,0.48117,0.042416,0.06949,0,0
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.67486,0.042285,-0.079711,0,0
4,GO HYPOTONIC RESPONSE,0.67486,0.042194,0.06409,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.20822,0.042171,0.08863,0,0
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.3148,0.042098,0.097342,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.49108,0.042093,0.087971,0,0
4,GO BONE DEVELOPMENT,0.30724,0.041897,0.12479,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.15197,0.041782,0.10441,0,0
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.11163,0.041779,0.13359,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.81845,0.041778,0.063786,0,0
4,GO HISTONE H2B UBIQUITINATION,0.197,0.041775,0.10769,0,0
4,GO BLASTOCYST GROWTH,0.5959,0.041746,0.05793,0,0
4,GO PROSTAGLANDIN TRANSPORT,0.4521,0.04168,0.094883,0,0
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.1475,0.041642,0.10141,0,0
4,GO GMP METABOLIC PROCESS,0.7336,0.041553,0.039624,0,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.10811,0.041483,0.11844,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.64051,0.041304,0.086752,0,0
4,GO REGULATION OF CELL SHAPE,0.66333,0.04128,0.097941,0,0
4,GO RRNA CATABOLIC PROCESS,0.30724,0.041272,0.10032,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.39705,0.041265,0.12189,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.28529,0.041249,0.11435,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.43329,0.041248,0.084419,0,0
4,GO REGULATION OF LIPID TRANSPORT,0.7336,0.041234,0.048485,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67486,0.041156,0.058476,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.056456,0.041052,0.10756,0,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.4521,0.040911,0.073503,0,0
4,GO SISTER CHROMATID SEGREGATION,0.40594,0.040879,0.092901,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.38829,0.04082,0.095651,0,0
4,GO MALE SEX DIFFERENTIATION,0.21989,0.04075,0.11881,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.098083,0.040719,0.14738,0,0
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.24463,0.040614,0.11986,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.42405,0.040591,0.081037,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.58498,0.040583,0.084388,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.13885,0.040581,0.1485,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.88046,0.040518,-0.034115,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.62923,0.040516,0.061056,0,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.17591,0.040437,0.09324,0,0
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.052482,0.040394,0.17178,0,0
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.10811,0.040214,0.12583,0,0
4,GO T CELL CYTOKINE PRODUCTION,0.66333,0.040108,-0.063209,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.2577,0.040063,0.12535,0,0
4,GO APOPTOTIC PROCESS,0.27821,0.039858,0.10049,0,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.76963,0.039827,0.019381,0,0
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.40594,0.039756,0.094285,0,0
4,GO ETHER METABOLIC PROCESS,0.33029,0.03971,0.096393,0,0
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.17091,0.039664,0.12427,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.90549,0.039651,0.029537,0,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.81845,0.0396,-0.010658,0,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.23827,0.03957,0.10498,0,0
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.37111,0.039497,0.14151,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.21989,0.039442,0.11146,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.4521,0.039247,0.11975,0,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.61803,0.039247,0.055125,0,0
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.47137,0.039044,0.087534,0,0
4,GO TRACHEA MORPHOGENESIS,0.37111,0.039044,0.11702,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.51122,0.039011,0.078258,0,0
4,GO REGULATION OF MYELINATION,0.2259,0.038954,0.12478,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.83078,0.038952,0.035775,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1,0.038915,0.024746,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.65188,0.038824,0.07898,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.60692,0.038819,0.061559,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.21989,0.038738,0.11923,0,0
4,GO OVULATION,0.68646,0.038632,0.064295,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.98106,0.038585,0.012995,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.35442,0.038553,0.10038,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.33821,0.03836,0.10357,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.19156,0.038258,0.15458,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.85555,0.038142,0.016159,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.60692,0.038075,0.077662,0,0
4,GO BROWN FAT CELL DIFFERENTIATION,0.43329,0.038015,0.076022,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.72171,0.037941,0.044325,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.074935,0.037929,0.071818,0,0
4,GO POSITIVE REGULATION OF CELL DEATH,0.2998,0.037881,0.10319,0,0
4,GO REGULATION OF TRANSPOSITION,0.58498,0.037861,0.045974,0,0
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.35442,0.037858,0.098308,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.17591,0.037851,0.18673,0,0
4,GO NAD METABOLIC PROCESS,0.60692,0.037831,0.068928,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.49108,0.037663,0.035274,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.25111,0.037591,0.088525,0,0
4,GO PEPTIDYL TYROSINE MODIFICATION,0.43329,0.037569,0.10665,0,0
4,GO PERICARDIUM DEVELOPMENT,0.81845,0.037538,0.054239,0,0
4,GO IMP METABOLIC PROCESS,0.69814,0.037524,0.042881,0,0
4,GO TRANSITION METAL ION HOMEOSTASIS,0.84314,0.037387,0.0285,0,0
4,GO VIRAL LIFE CYCLE,0.68646,0.037349,0.054913,0,0
4,GO PROTEIN IMPORT,0.214,0.037334,0.090429,0,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.60692,0.037237,0.045835,0,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.78176,0.037142,-0.02617,0,0
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.16123,0.037124,0.087522,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.90549,0.037105,8.3198e-05,0,0
4,GO APOPTOTIC SIGNALING PATHWAY,0.33029,0.037057,0.088292,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.11524,0.037019,0.11808,0,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.214,0.036915,0.15112,0,0
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.86799,0.036889,0.0034408,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.38829,0.036809,0.12452,0,0
4,GO RNA 5 END PROCESSING,0.32248,0.036767,0.050124,0,0
4,GO REGULATION OF CELL ADHESION,0.64051,0.036753,0.077976,0,0
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.62923,0.036705,0.051441,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.74555,0.036662,0.060701,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.4521,0.036654,0.082911,0,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.23827,0.036574,0.09268,0,0
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.33821,0.036565,0.097203,0,0
4,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.33029,0.036535,0.11041,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.2577,0.036505,0.27681,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.55277,0.036385,0.076048,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.44264,0.036301,0.065141,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.27821,0.036023,0.075783,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.37964,0.035987,0.12118,0,0
4,GO CELLULAR RESPONSE TO ATP,0.16123,0.035965,0.1387,0,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.17591,0.035931,0.14169,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.23203,0.035901,0.12984,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.20822,0.035894,0.12677,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.2998,0.035763,0.10347,0,0
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.89296,0.035727,0.0205,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.55277,0.035727,0.039324,0,0
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.35442,0.035571,0.084957,0,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.46168,0.035559,0.079343,0,0
4,GO REGULATION OF MRNA BINDING,0.53179,0.03555,0.054669,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.54223,0.035461,-0.069718,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.08881,0.035411,0.17333,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.55277,0.035259,0.062055,0,0
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.74555,0.034943,0.049251,0,0
4,GO MACROPHAGE CHEMOTAXIS,0.66333,0.034907,-0.031658,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.84314,0.034766,-0.020343,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.20256,0.034291,0.065528,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.55277,0.034239,0.077787,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.52145,0.034196,0.082697,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.26442,0.033986,0.061307,0,0
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.89296,0.033977,0.0055409,0,0
4,GO BONE REMODELING,0.60692,0.033954,0.097529,0,0
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.88046,0.033911,-0.011852,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.16602,0.033887,0.073136,0,0
4,GO MITOTIC DNA REPLICATION,0.93062,0.033771,-0.02193,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.20256,0.033746,0.051709,0,0
4,GO PROTEIN ADP RIBOSYLATION,0.46168,0.033642,0.063183,0,0
4,GO AMP METABOLIC PROCESS,0.75756,0.033355,0.034249,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.37964,0.03334,0.084886,0,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.27821,0.032948,0.12432,0,0
4,GO TRNA TRANSPORT,0.27126,0.032876,0.12,0,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.32248,0.032567,0.11219,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.58498,0.032513,-0.086007,0,0
4,GO ANOIKIS,0.39705,0.032383,0.11796,0,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.66333,0.032325,0.049555,0,0
4,GO NUCLEAR PORE ORGANIZATION,0.37964,0.032295,0.10628,0,0
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.25111,0.032176,0.10515,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.86799,0.032117,0.019967,0,0
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.83078,0.031998,0.04032,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.61803,0.031952,-0.045227,0,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.25111,0.031883,0.11563,0,0
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.16123,0.031861,0.083907,0,0
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.94321,0.031717,0.035199,0,0
4,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.48117,0.031708,0.075269,0,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.18102,0.031551,0.13812,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.96843,0.031446,0.031321,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.64051,0.03141,0.022559,0,0
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.21989,0.03121,0.10572,0,0
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.28529,0.031141,0.097024,0,0
4,GO CYTOKINE PRODUCTION,0.99368,0.030996,0.014491,0,0
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.76963,0.030831,-0.048628,0,0
4,GO CELLULAR KETONE METABOLIC PROCESS,0.53179,0.030677,0.050303,0,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.34626,0.030627,0.068763,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.99368,0.030468,0.019934,0,0
4,GO REPLACEMENT OSSIFICATION,0.57414,0.030423,0.092569,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.39705,0.030265,0.12602,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.2577,0.030222,0.11155,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.76963,0.030143,0.038678,0,0
4,GO REGULATION OF EXCRETION,0.48117,0.030088,0.088267,0,0
4,GO CALCIUM MEDIATED SIGNALING,0.29248,0.030029,0.11126,0,0
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.90549,0.029952,-0.014881,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.95582,0.029655,-0.0022729,0,0
4,GO MYELOID CELL HOMEOSTASIS,0.57414,0.029561,0.075914,0,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.40594,0.029439,0.083645,0,0
4,GO RESPONSE TO HYPEROXIA,0.84314,0.029439,0.057452,0,0
4,GO REGULATION OF RNA BINDING,0.40594,0.029287,0.062637,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.2259,0.029275,0.098904,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.18102,0.029213,0.056538,0,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.34626,0.02916,0.11145,0,0
4,GO DNA REPLICATION,0.27821,0.029125,0.10782,0,0
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.84314,0.029046,-0.017866,0,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.79394,0.028802,0.040877,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.4521,0.028783,0.088386,0,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.2577,0.028661,0.084186,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.96843,0.028652,0.063825,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.69814,0.028621,0.050427,0,0
4,GO DNA STRAND ELONGATION,0.60692,0.028604,0.060155,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.54223,0.028469,0.073573,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.7336,0.028376,0.077556,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.85555,0.028353,0.0025276,0,0
4,GO SNORNA METABOLIC PROCESS,0.7336,0.028168,0.048501,0,0
4,GO REGULATION OF GLIOGENESIS,0.66333,0.02815,0.057626,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.46168,0.028092,0.093167,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.96843,0.027942,0.020915,0,0
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.76963,0.027917,0.063498,0,0
4,GO CELLULAR RESPIRATION,0.091819,0.027899,0.056287,0,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.32248,0.027829,0.10282,0,0
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.62923,0.027662,0.082513,0,0
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.52145,0.02758,0.066541,0,0
4,GO UTERUS DEVELOPMENT,0.62923,0.027544,0.040814,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.12662,0.02752,0.055415,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.5959,0.027507,0.067301,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.94321,0.027428,0.019676,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.2577,0.027319,0.086797,0,0
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.67486,0.027256,0.061377,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.93062,0.027253,0.025215,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.60692,0.027188,0.068509,0,0
4,GO RESPONSE TO HEAT,0.19156,0.02718,0.098687,0,0
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.90549,0.027162,0.053906,0,0
4,GO MIDBODY ABSCISSION,0.36271,0.027162,0.059835,0,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.60692,0.027124,0.077477,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.78176,0.026983,0.051858,0,0
4,GO RESPONSE TO CYTOKINE,0.95582,0.026838,0.02263,0,0
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.67486,0.026781,0.075999,0,0
4,GO HEAT GENERATION,0.55277,0.026776,0.071733,0,0
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.66333,0.02676,0.056716,0,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.84314,0.026645,0.061473,0,0
4,GO RESPONSE TO SALT STRESS,0.7336,0.026478,0.053113,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.43329,0.026468,0.072629,0,0
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.74555,0.026404,0.060576,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.84314,0.026341,0.039252,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.85555,0.026309,0.015494,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.76963,0.026221,0.017151,0,0
4,GO RESPONSE TO VIRUS,0.78176,0.026013,-0.025206,0,0
4,GO REGULATION OF EXOSOMAL SECRETION,0.3148,0.026004,0.09557,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.86799,0.025995,0.046843,0,0
4,GO CELL ADHESION MEDIATED BY INTEGRIN,1,0.025942,0.02459,0,0
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.86799,0.025908,-0.016653,0,0
4,GO RESPONSE TO CORTICOSTEROID,0.54223,0.025803,0.06669,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.27821,0.025769,0.097144,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.51122,0.025707,0.099671,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.15655,0.025627,0.042008,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.88046,0.025615,-0.019433,0,0
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.72171,0.025595,0.061403,0,0
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.65188,0.025555,-0.047036,0,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.36271,0.025431,0.13325,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.80618,0.025403,0.030386,0,0
4,GO DNA REPLICATION INITIATION,0.76963,0.02538,0.022239,0,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.30724,0.025309,0.11308,0,0
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.67486,0.025218,-0.043105,0,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.46168,0.02504,-0.016098,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.32248,0.02503,0.092275,0,0
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.91805,0.024827,0.025874,0,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.214,0.024785,0.078651,0,0
4,GO ASTROCYTE ACTIVATION,0.76963,0.02477,0.051908,0,0
4,GO MESONEPHROS DEVELOPMENT,0.41494,0.024754,0.091351,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.23827,0.024749,0.13174,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.66333,0.024677,0.058089,0,0
4,GO OVULATION CYCLE PROCESS,0.13467,0.024612,0.19899,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.50109,0.024423,0.069639,0,0
4,GO ACUTE PHASE RESPONSE,0.93062,0.024366,-0.022352,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.14312,0.024362,0.1089,0,0
4,GO DEFENSE RESPONSE TO BACTERIUM,0.79394,0.024298,-0.026369,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.72171,0.024272,0.062914,0,0
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.61803,0.024219,0.092818,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.41494,0.024131,0.074403,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.99368,0.024013,0.024061,0,0
4,GO INCLUSION BODY ASSEMBLY,0.37964,0.023973,0.13505,0,0
4,GO MATURATION OF SSU RRNA,0.84314,0.023856,0.016895,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.69814,0.02385,0.050037,0,0
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.78176,0.023838,0.06946,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.54223,0.02379,0.087754,0,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.56341,0.023737,0.076216,0,0
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.70989,0.023563,0.064016,0,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.7336,0.02346,0.062171,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.95582,0.023396,0.032911,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.69814,0.023388,0.075076,0,0
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.66333,0.023289,-0.078143,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.93062,0.023285,0.016158,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.23203,0.023129,0.098,0,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.85555,0.023124,0.052774,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.49108,0.023102,0.091082,0,0
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.47137,0.022908,0.048502,0,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.78176,0.022758,0.03658,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.83078,0.022727,-0.0040127,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.3148,0.022603,0.099474,0,0
4,GO RESPONSE TO BACTERIUM,0.94321,0.022496,-0.0084401,0,0
4,GO NK T CELL DIFFERENTIATION,0.80618,0.022478,-0.021148,0,0
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.46168,0.022418,0.063447,0,0
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.90549,0.022401,0.042452,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.53179,0.022246,0.083881,0,0
4,GO HYPOTHALAMUS DEVELOPMENT,0.2998,0.022241,0.10821,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.81845,0.022233,0.037211,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.68646,0.022216,0.055038,0,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.27126,0.02207,0.09241,0,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.43329,0.022069,0.10897,0,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.52145,0.022015,0.064264,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.58498,0.022006,0.046181,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.4521,0.021975,0.07242,0,0
4,GO T CELL HOMEOSTASIS,0.91805,0.021967,0.030708,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.72171,0.02196,0.052686,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.20822,0.021802,0.087341,0,0
4,GO SNORNA 3 END PROCESSING,0.52145,0.021787,0.053422,0,0
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.76963,0.02169,0.031682,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.69814,0.021544,0.052888,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.091819,0.021398,0.098807,0,0
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.74555,0.02133,0.051263,0,0
4,GO FIBRINOLYSIS,0.85555,0.021255,0.022496,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.35442,0.021218,0.056196,0,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.89296,0.021194,0.056025,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.60692,0.021147,0.093123,0,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.84314,0.021126,0.058082,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.75756,0.020938,0.03367,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.89296,0.020753,-0.0030646,0,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.66333,0.020645,0.093049,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26442,0.020639,0.097201,0,0
4,GO COCHLEA MORPHOGENESIS,0.86799,0.020525,0.0074506,0,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.81845,0.020486,0.042586,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.51122,0.020432,0.061396,0,0
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.36271,0.02036,0.089101,0,0
4,GO NEPHRON MORPHOGENESIS,0.38829,0.020289,0.10239,0,0
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.93062,0.020209,0.013434,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.95582,0.020123,0.0016548,0,0
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.83078,0.02,-0.02451,0,0
4,GO COPPER ION HOMEOSTASIS,0.67486,0.019956,0.044921,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.42405,0.019925,0.050052,0,0
4,GO HETEROTYPIC CELL CELL ADHESION,0.88046,0.019811,-0.0045557,0,0
4,GO COPULATION,0.62923,0.019713,0.052448,0,0
4,GO LEUKOTRIENE METABOLIC PROCESS,0.75756,0.019675,0.034177,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.2259,0.019584,0.10304,0,0
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.24463,0.019536,0.10923,0,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.58498,0.019492,0.068499,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.37111,0.019475,0.14169,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.58498,0.019269,-0.11832,0,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.7336,0.019108,0.092527,0,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.91805,0.019105,0.022688,0,0
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.86799,0.019084,0.036453,0,0
4,GO DETERMINATION OF ADULT LIFESPAN,0.60692,0.019042,0.070701,0,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.78176,0.018802,0.037743,0,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.33821,0.018565,0.11444,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.75756,0.018423,0.045885,0,0
4,GO RESPONSE TO L GLUTAMATE,0.46168,0.018381,0.068745,0,0
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.52145,0.01829,0.058132,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.47137,0.018279,0.032891,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.78176,0.01817,0.016161,0,0
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.91805,0.018098,-0.011585,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.43329,0.01785,0.069761,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.60692,0.017773,0.051099,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.60692,0.017744,0.075999,0,0
4,GO RESPONSE TO COLD,0.24463,0.017454,0.14156,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.197,0.017396,0.20069,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.56341,0.01734,0.071486,0,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.55277,0.017275,0.053788,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.37111,0.017263,0.080471,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.67486,0.017207,-0.025759,0,0
4,GO DETOXIFICATION,0.76963,0.017181,-0.0256,0,0
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.84314,0.017094,-0.021651,0,0
4,GO VIRAL GENOME REPLICATION,0.76963,0.017065,-0.0012325,0,0
4,GO CHOLESTEROL STORAGE,0.78176,0.016959,-0.023761,0,0
4,GO TYPE I INTERFERON PRODUCTION,0.90549,0.01683,0.038351,0,0
4,GO MYELOID CELL DIFFERENTIATION,0.67486,0.016797,0.064635,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.84314,0.016554,0.053681,0,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.55277,0.016546,0.077394,0,0
4,GO FIBROBLAST PROLIFERATION,0.84314,0.016455,0.06444,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.67486,0.016428,0.023109,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.25111,0.016305,0.11469,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.75756,0.016282,0.054285,0,0
4,GO REGULATION OF RECEPTOR BINDING,0.90549,0.016199,0.033959,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.83078,0.016051,0.043346,0,0
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.41494,0.016028,0.080486,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.61803,0.015983,0.03205,0,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.70989,0.015971,0.066933,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.52145,0.015956,0.055263,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.7336,0.015826,0.063405,0,0
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.99368,0.01579,0.015192,0,0
4,GO KINETOCHORE ASSEMBLY,0.44264,0.015441,0.10896,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.47137,0.015389,0.049123,0,0
4,GO REGULATION OF DNA METHYLATION,0.81845,0.01537,0.043575,0,0
4,GO AMINE METABOLIC PROCESS,0.3148,0.015329,0.085873,0,0
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.88046,0.015324,0.038232,0,0
4,GO FRUCTOSE METABOLIC PROCESS,0.48117,0.015295,0.074837,0,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.83078,0.015195,0.056624,0,0
4,GO BONE MORPHOGENESIS,0.69814,0.015147,0.076211,0,0
4,GO CELLULAR SENESCENCE,0.25111,0.014938,0.090485,0,0
4,GO WATER TRANSPORT,0.76963,0.014752,0.043317,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.98106,0.014724,0.0096659,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.58498,0.014699,0.060302,0,0
4,GO RESPONSE TO ACID CHEMICAL,0.18624,0.014644,0.13028,0,0
4,GO MACROPHAGE MIGRATION,0.72171,0.014609,-0.060377,0,0
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.34626,0.014605,0.084838,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.57414,0.014604,0.064353,0,0
4,GO CELLULAR RESPONSE TO VIRUS,0.79394,0.014544,0.025683,0,0
4,GO RESPONSE TO EPINEPHRINE,0.30724,0.01453,0.17068,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.23203,0.014428,0.06635,0,0
4,GO INTERFERON BETA PRODUCTION,0.88046,0.01438,0.044583,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION,1,0.014347,0.020404,0,0
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.94321,0.014132,0.033692,0,0
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.95582,0.014011,0.029452,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.32248,0.013959,0.10057,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.90549,0.013944,0.022239,0,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.74555,0.013927,0.043767,0,0
4,GO NUCLEOTIDE SALVAGE,0.96843,0.013921,0.0062862,0,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.61803,0.013794,0.071942,0,0
4,GO RESPONSE TO VITAMIN A,0.84314,0.013657,0.019072,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.7336,0.013653,0.06835,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.72171,0.013608,0.031374,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.25111,0.013558,0.087707,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.41494,0.013545,0.065651,0,0
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.58498,0.013406,0.066556,0,0
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.86799,0.013308,0.0070688,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.61803,0.013292,0.071572,0,0
4,GO IMP BIOSYNTHETIC PROCESS,0.89296,0.013191,-0.0014326,0,0
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.52145,0.013108,0.085901,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.57414,0.012962,0.18209,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.81845,0.012948,0.042792,0,0
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.72171,0.012891,0.051953,0,0
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.75756,0.012835,-0.027045,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.2259,0.012777,0.13827,0,0
4,GO ER OVERLOAD RESPONSE,0.68646,0.012763,0.060023,0,0
4,GO REGULATION OF VIRAL LIFE CYCLE,0.89296,0.012339,-0.0046886,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.21989,0.012331,0.13737,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.20256,0.012326,0.14964,0,0
4,GO CELLULAR RESPONSE TO LIPID,0.58498,0.01232,0.072087,0,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.76963,0.012159,0.041028,0,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.75756,0.012132,0.056913,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.60692,0.012122,0.059081,0,0
4,GO MEMBRANE RAFT ORGANIZATION,0.88046,0.012111,0.048286,0,0
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.5959,0.012104,0.11389,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.89296,0.011766,0.045873,0,0
4,GO T CELL MEDIATED IMMUNITY,0.55277,0.011657,-0.079801,0,0
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.96843,0.011608,0.0012305,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.93062,0.011568,0.040913,0,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.3148,0.01155,0.11305,0,0
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.84314,0.011542,-0.0077131,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.99368,0.011359,0.027996,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.57414,0.011355,0.065132,0,0
4,GO RESPONSE TO ATP,0.28529,0.011275,0.1066,0,0
4,GO PENTOSE METABOLIC PROCESS,0.91805,0.011229,-0.0039458,0,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.52145,0.010985,0.04572,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.79394,0.010924,0.031407,0,0
4,GO IMMUNE SYSTEM DEVELOPMENT,0.80618,0.010817,0.047663,0,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.57414,0.0107,0.083047,0,0
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.68646,0.010457,-0.051297,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.46168,0.010435,0.059453,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.39705,0.010101,0.09173,0,0
4,GO REGULATION OF FATTY ACID OXIDATION,0.17091,0.01009,0.14574,0,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.75756,0.010027,0.051979,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.80618,0.0099944,0.016806,0,0
4,GO IMPORT INTO NUCLEUS,0.2998,0.00996,0.089495,0,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.93062,0.009821,0.03096,0,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.52145,0.0097505,0.086472,0,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.91805,0.0097352,0.037139,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.96843,0.0097348,0.034007,0,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.35442,0.009606,0.073428,0,0
4,GO BLASTODERM SEGMENTATION,0.64051,0.0094713,0.077025,0,0
4,GO DEFENSE RESPONSE,0.98106,0.0094606,0.0075662,0,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.81845,0.0094112,0.056568,0,0
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.70989,0.0093953,-0.03521,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.56341,0.0093721,0.057018,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.33029,0.0093719,0.11604,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.53179,0.0093227,0.054807,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.48117,0.0092935,0.14464,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.86799,0.0092228,0.025009,0,0
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.7336,0.0090409,-0.027251,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.79394,0.0089985,0.015828,0,0
4,GO REGULATION OF TISSUE REMODELING,0.58498,0.008965,0.083579,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.86799,0.0089092,0.035828,0,0
4,GO RESPONSE TO BIOTIC STIMULUS,0.89296,0.0088165,-0.0045026,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.85555,0.0088025,-0.010921,0,0
4,GO INDOLALKYLAMINE METABOLIC PROCESS,0.50109,0.0087815,0.090263,0,0
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.67486,0.0087207,0.025435,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.54223,0.0086793,0.076353,0,0
4,GO NUCLEOSOME ASSEMBLY,0.39705,0.0086528,0.075048,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.66333,0.0082285,-0.041238,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.78176,0.008215,0.052117,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.50109,0.0081819,0.087196,0,0
4,GO INTERLEUKIN 6 PRODUCTION,0.78176,0.0081493,-0.025548,0,0
4,GO EMBRYO IMPLANTATION,0.44264,0.0080224,0.10745,0,0
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.52145,0.0079991,0.098033,0,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.78176,0.0078634,0.071172,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.94321,0.0078405,0.045218,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.94321,0.0078352,0.026024,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.33821,0.0077675,0.1399,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.50109,0.0076297,0.03923,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.74555,0.0075175,0.040502,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.62923,0.007516,0.044452,0,0
4,GO RESPONSE TO FATTY ACID,0.84314,0.0075075,0.041926,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.40594,0.0074934,0.10225,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.99368,0.0074318,0.031367,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.27126,0.0073645,0.11341,0,0
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.93062,0.007064,-0.0081731,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.93062,0.0070184,0.033092,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.75756,0.0067552,0.058419,0,0
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.76963,0.0066924,-0.020925,0,0
4,GO DENDRITE SELF AVOIDANCE,0.27821,0.006552,0.18201,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.55277,0.0064678,0.056499,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.80618,0.0062655,0.046265,0,0
4,GO EPITHELIAL CELL MATURATION,0.69814,0.0062499,0.07267,0,0
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.88046,0.0062324,0.047374,0,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.80618,0.0060337,0.083636,0,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.44264,0.006008,0.068587,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.89296,0.0058101,0.034694,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.2577,0.0057486,0.15896,0,0
4,GO STEROID HORMONE SECRETION,0.68646,0.0056236,0.026912,0,0
4,GO LAMELLIPODIUM MORPHOGENESIS,0.43329,0.0055736,0.12359,0,0
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.75756,0.0054065,0.050001,0,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.78176,0.0053372,0.0071277,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.37964,0.005291,0.1183,0,0
4,GO RRNA METHYLATION,0.66333,0.0052075,0.04935,0,0
4,GO OXIDATIVE PHOSPHORYLATION,0.96843,0.0051607,0.0059302,0,0
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.90549,0.0050035,0.020757,0,0
4,GO TONGUE DEVELOPMENT,0.61803,0.0049834,0.034652,0,0
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,1,0.0049263,0.0099631,0,0
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.80618,0.0048578,-0.018267,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.52145,0.0048531,0.085112,0,0
4,GO RRNA METABOLIC PROCESS,0.96843,0.0048314,0.018638,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.99368,0.0047922,0.044322,0,0
4,GO DNA LIGATION,0.94321,0.00451,0.029949,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.74555,0.0043504,0.067366,0,0
4,GO STEROID CATABOLIC PROCESS,0.91805,0.0043175,-0.0056836,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.54223,0.0042528,-0.083796,0,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.52145,0.0041935,0.07654,0,0
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.66333,0.0041431,-0.072892,0,0
4,GO REGULATION OF PLATELET AGGREGATION,0.91805,0.0041197,0.019341,0,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.76963,0.0039728,0.08633,0,0
4,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.74555,0.003881,0.082023,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.40594,0.003764,0.074931,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.81845,0.0037314,0.059485,0,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.84314,0.0035921,0.026686,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.90549,0.0030698,-0.010031,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.95582,0.0030552,0.016822,0,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.49108,0.0030084,0.081032,0,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.37964,0.002974,0.052602,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.79394,0.0029733,0.017029,0,0
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.84314,0.0029371,-0.0033572,0,0
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.79394,0.0029158,-0.0091039,0,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.36271,0.0027963,0.14053,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.90549,0.0027819,0.026869,0,0
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.75756,0.0027613,0.05936,0,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.83078,0.0026336,0.054345,0,0
4,GO ENGULFMENT OF APOPTOTIC CELL,0.39705,0.0025781,0.13247,0,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.47137,0.0025015,0.10613,0,0
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.90549,0.0024366,0.013312,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.75756,0.0022855,0.066447,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.86799,0.0022717,0.0063916,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.96843,0.0021492,0.010027,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.95582,0.0021334,0.0021102,0,0
4,GO HISTONE EXCHANGE,0.80618,0.001993,0.027707,0,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.88046,0.0018073,0.029612,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.69814,0.0018062,0.069577,0,0
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.83078,0.0017571,-0.023109,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.91805,0.001705,0.054098,0,0
4,GO VIRAL TRANSLATION,0.60692,0.0016498,0.049101,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.47137,0.001628,0.085444,0,0
4,GO GERMINAL CENTER FORMATION,0.90549,0.001527,-0.018739,0,0
4,GO POSITIVE CHEMOTAXIS,0.91805,0.0012931,0.031918,0,0
4,GO NADPH REGENERATION,0.90549,0.0011875,0.030847,0,0
4,GO PRIMARY MIRNA PROCESSING,0.66333,0.0011049,0.07764,0,0
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.5959,0.00095836,0.12674,0,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.37964,0.00092214,0.1053,0,0
4,GO ELECTRON TRANSPORT CHAIN,0.83078,0.00081613,0.0065272,0,0
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.75756,0.00080046,0.057773,0,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.93062,0.00079501,0.0043613,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.89296,0.00071738,0.04223,0,0
4,GO REGULATION OF SYMBIOTIC PROCESS,0.95582,0.00066838,0.02129,0,0
4,GO MEMBRANE INVAGINATION,0.84314,0.0005683,-0.01035,0,0
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.65188,0.00056511,0.073179,0,0
4,GO DNA DEAMINATION,0.54223,0.0005316,-0.078485,0,0
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.91805,0.00023266,0.048791,0,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.72171,0.00013716,0.012459,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.42405,0.00012416,0.10055,0,0
4,GO POSITIVE REGULATION OF COAGULATION,0.66333,8.8702e-05,-0.025127,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.80618,-1.5567e-05,0.044011,0,0
4,GO REGULATION OF DEFENSE RESPONSE,1,-2.754e-05,0.019272,0,0
4,GO GALACTOSE METABOLIC PROCESS,0.76963,-0.00010272,0.044516,0,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.98106,-0.00013007,0.026953,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.91805,-0.00019002,0.022431,0,0
4,GO DNA DEPENDENT DNA REPLICATION,0.5959,-0.00022187,0.071472,0,0
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.76963,-0.00024401,-0.028559,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.74555,-0.00033272,-0.021314,0,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.95582,-0.00039181,0.016219,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.69814,-0.00042879,0.06599,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.38829,-0.00054078,0.098775,0,0
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.68646,-0.00056355,0.090361,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.90549,-0.00071125,0.04245,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.40594,-0.00075463,0.1041,0,0
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.89296,-0.00077072,0.057961,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.55277,-0.00085672,0.091309,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.57414,-0.00089492,0.088334,0,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.64051,-0.00093441,-0.018631,0,0
4,GO REGULATION OF MYOBLAST FUSION,0.99368,-0.00094241,0.012663,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.46168,-0.00099595,0.076581,0,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.64051,-0.0012573,0.04254,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.78176,-0.0012586,0.052905,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.70989,-0.0012865,-0.053149,0,0
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.98106,-0.0013207,0.037721,0,0
4,GO IMMUNE EFFECTOR PROCESS,0.81845,-0.0013301,-0.011253,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.65188,-0.0013847,-0.040875,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.57414,-0.0016853,0.1051,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.95582,-0.0017712,0.020846,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.66333,-0.001984,-0.0024438,0,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.96843,-0.0020414,0.038436,0,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.90549,-0.0020482,0.031856,0,0
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.78176,-0.0020577,0.038456,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.83078,-0.0021897,0.044935,0,0
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.83078,-0.0022987,0.010398,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.56341,-0.002484,0.098055,0,0
4,GO MATURATION OF 5 8S RRNA,0.74555,-0.0024938,0.024141,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.83078,-0.0025059,0.038059,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.53179,-0.0026895,0.093367,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.98106,-0.0028477,0.05223,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.79394,-0.0029431,0.042324,0,0
4,GO MAST CELL ACTIVATION,1,-0.0030241,-0.0019842,0,0
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.78176,-0.0031288,-0.044082,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.94321,-0.0031688,0.034929,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,1,-0.0032521,0.013398,0,0
4,GO GROOMING BEHAVIOR,0.64051,-0.0033666,0.067686,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.41494,-0.0034327,0.079436,0,0
4,GO PROGRAMMED NECROTIC CELL DEATH,0.99368,-0.0034871,0.019447,0,0
4,GO RNA CATABOLIC PROCESS,0.99368,-0.0036301,0.0061154,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.51122,-0.0036747,0.091479,0,0
4,GO STEM CELL DIVISION,0.37111,-0.0037786,0.10529,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.99368,-0.0039199,0.045127,0,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.76963,-0.0040159,0.031008,0,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.68646,-0.004029,-0.047342,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.51122,-0.0041263,0.051242,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.94321,-0.0042351,0.038646,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.43329,-0.0043188,0.090883,0,0
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.99368,-0.0043432,0.031231,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.25111,-0.0046042,0.10395,0,0
4,GO MYOBLAST DIFFERENTIATION,0.79394,-0.0046155,0.046159,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.49108,-0.004743,0.071756,0,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.95582,-0.0049722,0.036431,0,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.61803,-0.0052586,0.080351,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.40594,-0.0052896,0.04589,0,0
4,GO INFLAMMATORY RESPONSE,0.80618,-0.0055312,-0.014714,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.94321,-0.0055403,0.025925,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.67486,-0.0055439,0.071607,0,0
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.51122,-0.0056604,0.085178,0,0
4,GO SYMBIOTIC PROCESS,0.69814,-0.005728,0.050769,0,0
4,GO ANIMAL ORGAN REGENERATION,0.79394,-0.0057595,0.054665,0,0
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.65188,-0.0058446,0.095073,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.84314,-0.0058777,0.053811,0,0
4,GO LEUKOCYTE MEDIATED IMMUNITY,0.83078,-0.0059061,-0.020146,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.56341,-0.0059637,0.07091,0,0
4,GO STEROID ESTERIFICATION,0.61803,-0.0061456,-0.01906,0,0
4,GO RESPONSE TO ETHER,0.98106,-0.0062312,0.013054,0,0
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.61803,-0.0063313,-0.038333,0,0
4,GO MYELOID LEUKOCYTE ACTIVATION,0.66333,-0.006495,-0.034624,0,0
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.91805,-0.0065002,0.0073657,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.95582,-0.0065035,0.0093549,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.64051,-0.006535,0.064019,0,0
4,GO REGULATION OF INTEGRIN ACTIVATION,0.84314,-0.0065993,-0.014374,0,0
4,GO RESPONSE TO NITROSATIVE STRESS,0.93062,-0.006623,0.0081813,0,0
4,GO INNATE IMMUNE RESPONSE,0.66333,-0.0067145,-0.041451,0,0
4,GO GAP JUNCTION ASSEMBLY,0.96843,-0.0068278,0.032103,0,0
4,GO PLASMINOGEN ACTIVATION,0.81845,-0.0068316,0.0061401,0,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.55277,-0.007219,0.081724,0,0
4,GO PROTEIN REFOLDING,0.72171,-0.007278,0.026363,0,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.43329,-0.0073552,-0.039414,0,0
4,GO PROSTAGLANDIN SECRETION,0.90549,-0.0075904,0.031852,0,0
4,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.93062,-0.0078315,0.021836,0,0
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.56341,-0.0078951,-0.029962,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.84314,-0.0080099,0.03895,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.99368,-0.0080387,0.0382,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.93062,-0.0081384,0.016933,0,0
4,GO PORE COMPLEX ASSEMBLY,0.83078,-0.0082367,0.021686,0,0
4,GO RESPONSE TO X RAY,0.94321,-0.0082473,0.018137,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.43329,-0.008375,0.085516,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.91805,-0.0084885,0.048294,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.83078,-0.008638,-0.012718,0,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.88046,-0.0087199,0.035095,0,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.85555,-0.0087295,0.029943,0,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.61803,-0.0087908,0.054623,0,0
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.88046,-0.0088963,0.026239,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.75756,-0.0091013,0.056751,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.40594,-0.0091409,-0.040593,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.90549,-0.0091656,-0.021031,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.3148,-0.0092444,0.16583,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.66333,-0.0094053,-0.025912,0,0
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.84314,-0.0096976,-0.010511,0,0
4,GO B CELL APOPTOTIC PROCESS,0.74555,-0.0097129,0.047075,0,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.88046,-0.0097911,-0.03057,0,0
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.60692,-0.0098028,0.077034,0,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.7336,-0.010043,0.037865,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.60692,-0.010068,-0.059134,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.96843,-0.010157,0.043295,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.84314,-0.010158,0.0045286,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.80618,-0.010173,0.0052516,0,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.88046,-0.010185,-0.015321,0,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.78176,-0.01023,0.03519,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.57414,-0.010418,-0.015584,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.78176,-0.010461,-0.01222,0,0
4,GO L SERINE METABOLIC PROCESS,0.83078,-0.010814,0.015641,0,0
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.94321,-0.011099,0.040317,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.60692,-0.01118,-0.0098411,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.53179,-0.011221,0.084399,0,0
4,GO ZYMOGEN ACTIVATION,0.80618,-0.011317,0.038306,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,1,-0.011376,0.0068836,0,0
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.79394,-0.011401,0.052982,0,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.89296,-0.011431,-0.0020976,0,0
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.89296,-0.011448,-0.0047335,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.94321,-0.011653,0.038235,0,0
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.95582,-0.011973,0.0081669,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.99368,-0.012074,0.023304,0,0
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.88046,-0.012267,-0.014507,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.41494,-0.012287,-0.097175,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.42405,-0.012689,0.076253,0,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.70989,-0.012945,0.080214,0,0
4,GO TRANSLATIONAL ELONGATION,0.95582,-0.012971,0.0059878,0,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.94321,-0.013089,0.048405,0,0
4,GO FATTY ACID HOMEOSTASIS,0.90549,-0.013169,0.039099,0,0
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.79394,-0.01336,-0.014333,0,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.99368,-0.013371,0.046475,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.75756,-0.013505,-0.021192,0,0
4,GO FOAM CELL DIFFERENTIATION,0.84314,-0.013819,-0.010853,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.52145,-0.013894,0.079656,0,0
4,GO REGULATION OF T CELL MIGRATION,0.84314,-0.013925,-0.03394,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.83078,-0.014079,-0.00036645,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.53179,-0.014239,0.1042,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.90549,-0.014299,0.04113,0,0
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.24463,-0.01436,0.12785,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.34626,-0.014545,0.1069,0,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.72171,-0.014636,-0.026077,0,0
4,GO RESPONSE TO INTERLEUKIN 6,0.94321,-0.014767,0.044451,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.78176,-0.01516,0.011581,0,0
4,GO FORELIMB MORPHOGENESIS,0.76963,-0.015285,0.051505,0,0
4,GO B CELL DIFFERENTIATION,0.91805,-0.015324,0.0067012,0,0
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.94321,-0.015351,0.0091748,0,0
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.58498,-0.015467,-0.040016,0,0
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.52145,-0.01553,-0.027265,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.91805,-0.015722,0.031397,0,0
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.7336,-0.015731,-0.0086411,0,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.70989,-0.015799,-0.012215,0,0
4,GO NOTOCHORD DEVELOPMENT,0.96843,-0.016143,0.028189,0,0
4,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.85555,-0.016173,-0.029866,0,0
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.32248,-0.01625,-0.18753,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.96843,-0.016304,0.02387,0,0
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.80618,-0.016387,0.0018247,0,0
4,GO CHROMOSOME LOCALIZATION,0.5959,-0.016467,0.074346,0,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.42405,-0.016514,0.10467,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.89296,-0.01653,-0.033641,0,0
4,GO TELOMERASE RNA LOCALIZATION,0.69814,-0.01653,0.006887,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.60692,-0.016974,0.011017,0,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.83078,-0.01699,0.031829,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.70989,-0.017071,0.10592,0,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.83078,-0.017109,0.057061,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.98106,-0.017141,-0.015024,0,0
4,GO RESPONSE TO ANGIOTENSIN,0.56341,-0.017147,-0.0010936,0,0
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.90549,-0.017364,0.044192,0,0
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.60692,-0.017657,0.064566,0,0
4,GO ARGININE METABOLIC PROCESS,0.93062,-0.017697,0.02135,0,0
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.80618,-0.017706,-0.018409,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.99368,-0.017789,0.020821,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.85555,-0.017982,0.016219,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.95582,-0.018203,-0.014954,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.32248,-0.018209,-0.035089,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.62923,-0.018213,0.079997,0,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.51122,-0.01845,-0.041412,0,0
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.90549,-0.018452,0.023588,0,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.67486,-0.018528,0.097106,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.84314,-0.018533,0.036154,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.86799,-0.018596,0.040163,0,0
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.52145,-0.018646,0.098793,0,0
4,GO PROTEIN TRIMERIZATION,0.69814,-0.018826,0.058107,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.79394,-0.018886,0.051445,0,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.90549,-0.019047,0.056082,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.43329,-0.019088,-0.028832,0,0
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.4521,-0.01912,-0.098744,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.94321,-0.019147,0.015126,0,0
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.68646,-0.019337,-0.043756,0,0
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.7336,-0.019364,-0.027781,0,0
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,1,-0.019413,0.032889,0,0
4,GO DE NOVO PROTEIN FOLDING,0.91805,-0.01959,0.032926,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.72171,-0.019666,-0.08073,0,0
4,GO ERK1 AND ERK2 CASCADE,0.94321,-0.019711,0.026005,0,0
4,GO HISTONE PHOSPHORYLATION,0.80618,-0.020118,0.045339,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.64051,-0.020213,0.0013152,0,0
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.89296,-0.020518,0.01918,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.90549,-0.020543,-0.015674,0,0
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.88046,-0.020777,0.016192,0,0
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.57414,-0.021053,0.076373,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.66333,-0.021119,-0.004887,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.70989,-0.02116,-0.012417,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.80618,-0.021196,-0.032061,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.90549,-0.021215,0.053407,0,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.84314,-0.021282,0.063039,0,0
4,GO GOLGI LOCALIZATION,0.76963,-0.02138,0.038186,0,0
4,GO REGULATION OF MAST CELL ACTIVATION,0.96843,-0.02141,-0.0035904,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.70989,-0.021436,0.074448,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,1,-0.021581,0.022568,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.67486,-0.021605,0.063056,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.93062,-0.021964,0.033903,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.93062,-0.021979,0.018565,0,0
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.88046,-0.022061,0.013203,0,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.53179,-0.022136,0.084098,0,0
4,GO LACTATE METABOLIC PROCESS,0.76963,-0.022261,-0.0034399,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.95582,-0.022269,0.015725,0,0
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.93062,-0.022305,0.016512,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.86799,-0.022323,0.064127,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.5959,-0.022461,-0.0097003,0,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.84314,-0.022567,-0.0026149,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.80618,-0.022578,-0.026481,0,0
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.53179,-0.022591,-0.046979,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.86799,-0.022597,0.0096228,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.62923,-0.022694,0.075924,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.80618,-0.0227,0.04346,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.72171,-0.022878,-0.044074,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.86799,-0.023039,0.027083,0,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.44264,-0.023048,0.080035,0,0
4,GO RIBOSOME BIOGENESIS,0.70989,-0.023278,-0.0037528,0,0
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.89296,-0.023414,0.023636,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.81845,-0.023629,-0.041388,0,0
4,GO FC RECEPTOR SIGNALING PATHWAY,0.89296,-0.023657,0.028881,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.55277,-0.023747,-0.021075,0,0
4,GO TYPE 2 IMMUNE RESPONSE,0.43329,-0.02388,-0.1245,0,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.66333,-0.024002,-0.0036341,0,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.65188,-0.024168,-0.0075795,0,0
4,GO BLEB ASSEMBLY,0.72171,-0.024178,-0.029259,0,0
4,GO ACTIVATED T CELL PROLIFERATION,1,-0.024236,0.01047,0,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.89296,-0.024368,0.020673,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.83078,-0.024372,0.075307,0,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.94321,-0.024399,0.047878,0,0
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.54223,-0.024418,-0.04609,0,0
4,GO RRNA MODIFICATION,0.66333,-0.024509,0.037389,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.94321,-0.024586,-0.0006229,0,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.7336,-0.024675,0.055195,0,0
4,GO RRNA 3 END PROCESSING,0.69814,-0.024721,0.032975,0,0
4,GO CELL ACTIVATION,0.95582,-0.024977,0.0051375,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.89296,-0.025247,0.01572,0,0
4,GO NECROTIC CELL DEATH,0.89296,-0.025277,0.0036608,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.50109,-0.025385,0.13935,0,0
4,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.85555,-0.025517,-0.012964,0,0
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.76963,-0.025648,-0.036159,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.85555,-0.025725,0.03424,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.49108,-0.025766,-0.023002,0,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.66333,-0.025862,-0.066028,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.90549,-0.025905,0.022036,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.85555,-0.025916,0.012779,0,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.88046,-0.025961,0.0069349,0,0
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.93062,-0.026005,0.012666,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.98106,-0.026266,0.020346,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.79394,-0.026367,0.046596,0,0
4,GO MAST CELL MIGRATION,0.94321,-0.026408,0.042833,0,0
4,GO PROSTATIC BUD FORMATION,0.91805,-0.026475,-0.020864,0,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.52145,-0.026543,0.092052,0,0
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.41494,-0.02661,-0.1497,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.7336,-0.026662,-0.061555,0,0
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.84314,-0.026679,0.025274,0,0
4,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.61803,-0.026731,-0.089712,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.91805,-0.026948,0.046629,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.75756,-0.027026,0.041203,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.75756,-0.027032,-0.011863,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.20256,-0.027083,-0.036012,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.88046,-0.027135,-0.011292,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.99368,-0.027255,0.029748,0,0
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.53179,-0.027257,-0.085872,0,0
4,GO HISTAMINE TRANSPORT,0.84314,-0.027268,-0.012882,0,0
4,GO NUCLEOSIDE SALVAGE,0.90549,-0.02747,0.0083085,0,0
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.90549,-0.027545,0.011725,0,0
4,GO RESPONSE TO TESTOSTERONE,0.68646,-0.027659,0.0045666,0,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.65188,-0.027663,0.056277,0,0
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.7336,-0.02768,-0.01516,0,0
4,GO B CELL HOMEOSTASIS,0.89296,-0.028009,0.026219,0,0
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.98106,-0.028074,0.037881,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.99368,-0.028125,0.025672,0,0
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.98106,-0.028132,0.0024486,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.58498,-0.02814,0.12946,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.93062,-0.028163,0.049178,0,0
4,GO INTERACTION WITH SYMBIONT,0.70989,-0.028276,-0.013589,0,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.84314,-0.028301,0.041832,0,0
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.91805,-0.028322,0.0094726,0,0
4,GO RESPONSE TO ACTIVITY,0.93062,-0.028334,0.048696,0,0
4,GO FOREBRAIN REGIONALIZATION,0.85555,-0.028381,0.019894,0,0
4,GO REGULATION OF PROSTAGLANDIN SECRETION,1,-0.028454,0.016073,0,0
4,GO PODOSOME ASSEMBLY,0.74555,-0.028585,0.002056,0,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.94321,-0.028733,0.016197,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.99368,-0.028844,0.055441,0,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.47137,-0.028869,-0.016037,0,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.61803,-0.029038,-0.065068,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.56341,-0.02935,-0.039268,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.91805,-0.029447,0.040347,0,0
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.48117,-0.029725,-0.080448,0,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.91805,-0.029782,-0.0038689,0,0
4,GO MYELIN MAINTENANCE,0.80618,-0.029844,0.07182,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.7336,-0.029962,0.049091,0,0
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.91805,-0.030125,0.0013789,0,0
4,GO CELLULAR RESPONSE TO FATTY ACID,0.98106,-0.030173,0.028218,0,0
4,GO RESPONSE TO SALT,0.53179,-0.030404,-0.035294,0,0
4,GO CORTICOSTEROID HORMONE SECRETION,0.89296,-0.030432,0.017599,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.75756,-0.0305,-0.020309,0,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.76963,-0.030537,-0.0011064,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.83078,-0.03055,-0.033915,0,0
4,GO AMINO SUGAR CATABOLIC PROCESS,0.72171,-0.030572,-0.084893,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.58498,-0.0306,-0.015361,0,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.94321,-0.030769,0.01741,0,0
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.99368,-0.030816,0.0051907,0,0
4,GO REGULATION OF CHEMOTAXIS,0.96843,-0.030868,0.03569,0,0
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.91805,-0.031032,-0.018234,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.76963,-0.031268,-0.0035668,0,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.5959,-0.031573,0.067146,0,0
4,GO SUPEROXIDE METABOLIC PROCESS,0.95582,-0.031685,-0.0014873,0,0
4,GO HORMONE CATABOLIC PROCESS,0.79394,-0.031693,-0.016415,0,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.90549,-0.031809,-0.0090894,0,0
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.81845,-0.03194,0.0073262,0,0
4,GO DECIDUALIZATION,0.91805,-0.032481,0.025965,0,0
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.50109,-0.032537,-0.057926,0,0
4,GO SEQUESTERING OF ACTIN MONOMERS,0.65188,-0.032691,-0.07551,0,0
4,GO PHAGOCYTOSIS,0.95582,-0.032761,-0.0020441,0,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.84314,-0.032805,0.047778,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.52145,-0.033105,-0.056095,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.1475,-0.033126,-0.061923,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.91805,-0.033264,0.047167,0,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.89296,-0.033457,-0.011904,0,0
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.81845,-0.033472,0.051841,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.86799,-0.033483,0.037705,0,0
4,GO TRNA 5 LEADER REMOVAL,0.42405,-0.033524,-0.027165,0,0
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.47137,-0.033564,-0.079165,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.42405,-0.033598,0.10459,0,0
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.90549,-0.033602,-0.029986,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.84314,-0.033698,0.018365,0,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.79394,-0.033722,0.013124,0,0
4,GO FEMALE GENITALIA DEVELOPMENT,0.88046,-0.034174,0.019599,0,0
4,GO AXIS ELONGATION,0.76963,-0.034312,0.06476,0,0
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.90549,-0.034369,0.0032341,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.98106,-0.034507,0.04514,0,0
4,GO METAPHASE PLATE CONGRESSION,0.62923,-0.034756,0.062355,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.93062,-0.034955,0.013684,0,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.96843,-0.035233,0.018027,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.55277,-0.035457,0.058648,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.66333,-0.035528,-0.054458,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.74555,-0.035685,-0.005081,0,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.67486,-0.035763,-0.015278,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.86799,-0.035803,0.0078231,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.72171,-0.036542,0.00077282,0,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.85555,-0.036595,0.043188,0,0
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.60692,-0.036614,-0.054254,0,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.93062,-0.036634,-0.0065287,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.75756,-0.036807,0.077286,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.62923,-0.03695,0.087115,0,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.41494,-0.037041,-0.13289,0,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1,-0.037307,0.032222,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.85555,-0.03732,0.0010318,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.58498,-0.037333,-0.01272,0,0
4,GO TRANSLATIONAL TERMINATION,0.37111,-0.037399,-0.024134,0,0
4,GO REGULATION OF HEAT GENERATION,0.84314,-0.037648,0.022834,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.62923,-0.038071,0.1054,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.90549,-0.038072,0.024135,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.69814,-0.038201,0.037123,0,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.93062,-0.038218,0.051953,0,0
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.56341,-0.038497,-0.0769,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.7336,-0.038894,-0.039091,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.69814,-0.038917,0.013132,0,0
4,GO REGULATION OF DNA BINDING,1,-0.038981,0.052098,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.75756,-0.03923,0.016859,0,0
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.56341,-0.039595,-0.0084619,0,0
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.89296,-0.040153,0.00020188,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.93062,-0.040264,0.017026,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.64051,-0.040272,-0.017917,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.55277,-0.040372,-0.015313,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.65188,-0.040516,-0.04995,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.89296,-0.040566,-0.011718,0,0
4,GO REGULATION OF HEMOPOIESIS,0.79394,-0.040953,0.0055463,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.86799,-0.041098,0.029264,0,0
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.70989,-0.041101,-0.046297,0,0
4,GO REGULATION OF FIBRINOLYSIS,0.86799,-0.041192,0.027293,0,0
4,GO PROTEIN NEDDYLATION,0.51122,-0.04122,-0.019881,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.7336,-0.041242,-0.045529,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.58498,-0.041299,-0.01869,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.88046,-0.041404,0.0087637,0,0
4,GO HUMORAL IMMUNE RESPONSE,0.53179,-0.041613,-0.075856,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.67486,-0.041699,-0.027161,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.91805,-0.041924,0.0050826,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.39705,-0.041975,-0.058985,0,0
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.81845,-0.042025,-0.016182,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.81845,-0.042263,-0.012315,0,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.85555,-0.042368,0.041694,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.62923,-0.04247,0.063779,0,0
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.56341,-0.042619,-0.13377,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.94321,-0.042718,0.042956,0,0
4,GO RESPONSE TO THYROID HORMONE,0.27821,-0.042768,-0.071832,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.79394,-0.042897,-0.011852,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.79394,-0.043037,0.070831,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.89296,-0.043165,0.0071494,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.47137,-0.043193,-0.022153,0,0
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.98106,-0.043575,0.0053641,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.80618,-0.04359,-0.017877,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.78176,-0.043933,0.030366,0,0
4,GO RESPONSE TO DSRNA,0.57414,-0.044143,-0.010755,0,0
4,GO PROSTATE GLAND GROWTH,0.86799,-0.044475,0.022714,0,0
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.43329,-0.044476,-0.090506,0,0
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.46168,-0.044572,-0.1454,0,0
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.37111,-0.044623,-0.10054,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.96843,-0.04467,0.062947,0,0
4,GO RESPONSE TO INTERFERON BETA,0.51122,-0.044679,-0.10027,0,0
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.88046,-0.04499,0.0043695,0,0
4,GO LIVER REGENERATION,0.85555,-0.045012,0.048976,0,0
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.84314,-0.045057,-0.006651,0,0
4,GO PENILE ERECTION,0.7336,-0.045064,-0.057127,0,0
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.64051,-0.045132,-0.051858,0,0
4,GO TRABECULA FORMATION,0.93062,-0.04523,0.032856,0,0
4,GO GLIAL CELL PROLIFERATION,0.94321,-0.045399,0.025694,0,0
4,GO SUPEROXIDE ANION GENERATION,0.62923,-0.045459,-0.042616,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.70989,-0.045582,0.10282,0,0
4,GO VIRAL LATENCY,0.88046,-0.046018,0.015427,0,0
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.86799,-0.046301,-0.016505,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.7336,-0.046332,0.0075406,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.2259,-0.046426,-0.040168,0,0
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.79394,-0.047364,-0.018897,0,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.27126,-0.047404,-0.10901,0,0
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.57414,-0.04746,-0.092814,0,0
4,GO CELL CYCLE DNA REPLICATION,0.93062,-0.047471,0.030339,0,0
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.76963,-0.047487,-0.020653,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.56341,-0.047667,-0.02376,0,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.84314,-0.04776,-0.015403,0,0
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.7336,-0.04777,-0.0027909,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.89296,-0.048264,0.049326,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.4521,-0.048405,-0.010606,0,0
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.65188,-0.048526,-0.060155,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.79394,-0.048655,0.018841,0,0
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.51122,-0.048655,-0.11455,0,0
4,GO LEUKOCYTE MIGRATION,0.66333,-0.048924,-0.028315,0,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.60692,-0.049031,0.10049,0,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.93062,-0.049146,0.034448,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.52145,-0.049331,-0.058547,0,0
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.81845,-0.049478,-0.021245,0,0
4,GO PYROPTOSIS,0.75756,-0.049538,-0.042025,0,0
4,GO NIK NF KAPPAB SIGNALING,0.69814,-0.049571,-0.015729,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.94321,-0.04974,0.035008,0,0
4,GO TRNA 5 END PROCESSING,0.28529,-0.050253,-0.031757,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.89296,-0.050302,0.095803,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.49108,-0.050541,-0.088584,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.60692,-0.050631,-0.021331,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.33821,-0.050674,-0.088165,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.91805,-0.050724,-0.00078607,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.99368,-0.05073,0.00095303,0,0
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.78176,-0.050803,-0.011076,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.79394,-0.050947,-0.02064,0,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.84314,-0.051226,0.040768,0,0
4,GO REGULATION OF CELL CELL ADHESION,0.84314,-0.051376,-0.0087524,0,0
4,GO AMINE CATABOLIC PROCESS,0.95582,-0.051568,0.0060167,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.54223,-0.051613,-0.062184,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.90549,-0.051621,0.0042693,0,0
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.53179,-0.051689,-0.065782,0,0
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.99368,-0.051732,-0.0011754,0,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.49108,-0.052108,-0.024517,0,0
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.70989,-0.052145,-0.010117,0,0
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.83078,-0.052209,-0.001481,0,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.88046,-0.052425,-0.011001,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.2577,-0.052582,-0.047926,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.30724,-0.052603,-0.043639,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.78176,-0.052717,-0.020318,0,0
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.51122,-0.052735,-0.10587,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1,-0.052801,0.03215,0,0
4,GO RESPONSE TO INTERLEUKIN 1,0.39705,-0.053012,-0.060078,0,0
4,GO LIVER MORPHOGENESIS,0.51122,-0.053111,-0.024885,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.20822,-0.053318,-0.085138,0,0
4,GO CELL CHEMOTAXIS,0.61803,-0.053562,-0.036557,0,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.53179,-0.053617,0.090524,0,0
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.48117,-0.053664,-0.049803,0,0
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.54223,-0.053814,-0.074178,0,0
4,GO REGULATION OF NEUTROPHIL ACTIVATION,0.69814,-0.053817,-0.07483,0,0
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.88046,-0.054043,-0.010341,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.79394,-0.054158,-0.0099947,0,0
4,GO CELLULAR RESPONSE TO X RAY,0.53179,-0.054541,-0.029124,0,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.95582,-0.054662,-0.00956,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.72171,-0.054767,0.064637,0,0
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.23827,-0.055285,-0.064556,0,0
4,GO MULTI ORGANISM CELLULAR PROCESS,1,-0.05531,0.031282,0,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.95582,-0.055322,0.01375,0,0
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.72171,-0.055394,-0.015204,0,0
4,GO LEUKOCYTE DIFFERENTIATION,0.80618,-0.055571,-0.0088542,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.57414,-0.055588,-0.068405,0,0
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.69814,-0.055639,-0.0074986,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.60692,-0.055699,-0.1083,0,0
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.67486,-0.05575,-0.067803,0,0
4,GO GTP METABOLIC PROCESS,0.43329,-0.055795,-0.020991,0,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.98106,-0.055971,0.016803,0,0
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.52145,-0.055975,-0.033443,0,0
4,GO ALDITOL METABOLIC PROCESS,0.19156,-0.056249,-0.067764,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.78176,-0.056458,-0.0342,0,0
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.84314,-0.056606,-0.022244,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.72171,-0.056612,0.00092112,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.84314,-0.056951,-0.0044132,0,0
4,GO ASTROCYTE DEVELOPMENT,0.52145,-0.056998,-0.034368,0,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.34626,-0.05715,-0.12811,0,0
4,GO NEURON FATE SPECIFICATION,0.88046,-0.057162,0.05311,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.52145,-0.057406,-0.10112,0,0
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.80618,-0.057558,-0.011521,0,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.72171,-0.057797,-0.023916,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.40594,-0.057815,-0.038195,0,0
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.56341,-0.057829,-0.04295,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.64051,-0.058098,-0.017101,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.65188,-0.058232,-0.0025901,0,0
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.61803,-0.058434,-0.036089,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.80618,-0.058724,-0.00023502,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.55277,-0.058829,-0.065737,0,0
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.28529,-0.058854,-0.035105,0,0
4,GO SEROTONIN SECRETION,0.89296,-0.05896,0.010278,0,0
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.80618,-0.059084,-0.013884,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.39705,-0.059256,-0.06492,0,0
4,GO CYTIDINE TO URIDINE EDITING,0.47137,-0.059493,-0.11828,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.3148,-0.059768,-0.035049,0,0
4,GO T CELL DIFFERENTIATION,0.75756,-0.059808,-0.03309,0,0
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.64051,-0.059972,-0.056525,0,0
4,GO URETER DEVELOPMENT,0.40594,-0.060002,-0.11051,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.65188,-0.06013,-0.033711,0,0
4,GO CELLULAR RESPONSE TO DSRNA,0.7336,-0.060351,-0.023456,0,0
4,GO CELLULAR EXTRAVASATION,0.80618,-0.060494,-0.020964,0,0
4,GO TRNA CATABOLIC PROCESS,0.99368,-0.060584,0.015621,0,0
4,GO INTERFERON ALPHA PRODUCTION,0.78176,-0.060732,-0.022902,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.86799,-0.060748,-0.015172,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.67486,-0.060895,-0.068543,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.64051,-0.061162,-0.029868,0,0
4,GO CYTOKINE METABOLIC PROCESS,0.83078,-0.061464,-0.049466,0,0
4,GO ACUTE INFLAMMATORY RESPONSE,0.64051,-0.061472,-0.046306,0,0
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.57414,-0.061681,-0.084607,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.96843,-0.061774,-0.01519,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.33821,-0.061966,-0.044749,0,0
4,GO ORGAN INDUCTION,0.5959,-0.06204,0.049421,0,0
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.36271,-0.062092,-0.065884,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.49108,-0.062226,-0.042007,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.78176,-0.062346,0.0014233,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.48117,-0.062381,-0.0066448,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.36271,-0.062432,-0.024979,0,0
4,GO T CELL APOPTOTIC PROCESS,0.41494,-0.062566,-0.10186,0,0
4,GO PSEUDOPODIUM ORGANIZATION,0.67486,-0.062702,-0.0086636,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.79394,-0.06327,-0.004332,0,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.94321,-0.06331,0.031709,0,0
4,GO LIPID EXPORT FROM CELL,0.94321,-0.063476,-6.8752e-05,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.67486,-0.063503,-0.053602,0,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.66333,-0.064036,-0.020195,0,0
4,GO DETECTION OF BIOTIC STIMULUS,0.42405,-0.064561,-0.10833,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.30724,-0.06457,-0.03968,0,0
4,GO VIRAL GENE EXPRESSION,0.065157,-0.064805,-0.086527,0,0
4,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.81845,-0.064841,0.048656,0,0
4,GO LEUKOCYTE TETHERING OR ROLLING,0.62923,-0.065091,-0.073657,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.61803,-0.065145,-0.060766,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.53179,-0.065156,-0.094771,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.11894,-0.06537,-0.050197,0,0
4,GO INTERLEUKIN 1 PRODUCTION,0.35442,-0.066046,-0.13766,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.49108,-0.066203,-0.10528,0,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.61803,-0.066393,-0.043841,0,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,1,-0.066449,0.019129,0,0
4,GO LYMPHOCYTE DIFFERENTIATION,0.83078,-0.066493,-0.0159,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.55277,-0.067037,-0.08669,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.69814,-0.067236,-0.063169,0,0
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.90549,-0.067238,-0.019536,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.70989,-0.067535,-0.015595,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.60692,-0.067612,-0.034398,0,0
4,GO RESPONSE TO LIPOTEICHOIC ACID,0.33029,-0.06798,-0.12135,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.74555,-0.068064,-0.013821,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.83078,-0.068208,0.021797,0,0
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.83078,-0.068255,-0.050137,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.51122,-0.068401,-0.11435,0,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.23827,-0.068571,-0.052284,0,0
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.75756,-0.06863,-0.0015308,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.27821,-0.068666,-0.066377,0,0
4,GO CARTILAGE MORPHOGENESIS,0.41494,-0.068768,-0.04056,0,0
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.65188,-0.069046,-0.0046066,0,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.61803,-0.069113,0.0026282,0,0
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.54223,-0.069482,-0.12136,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.21989,-0.069495,-0.061888,0,0
4,GO REGULATION OF RELAXATION OF MUSCLE,0.84314,-0.069899,0.12315,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.57414,-0.070038,-0.076866,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.53179,-0.07018,-0.066325,0,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.7336,-0.070596,-0.037293,0,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.80618,-0.070657,-0.0060848,0,0
4,GO REGULATION OF LIGASE ACTIVITY,0.35442,-0.070795,-0.047087,0,0
4,GO REGULATION OF IMMUNE RESPONSE,0.76963,-0.071196,-0.029505,0,0
4,GO INTEGRIN ACTIVATION,0.72171,-0.071255,-0.045504,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.62923,-0.071257,-0.064188,0,0
4,GO SYNAPSE PRUNING,0.60692,-0.071305,-0.11601,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.70989,-0.071498,-0.045991,0,0
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.67486,-0.071532,-0.0034537,0,0
4,GO CYTOPLASMIC TRANSLATION,0.031957,-0.071588,-0.090936,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.64051,-0.072578,-0.062612,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.43329,-0.072923,-0.11357,0,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.33029,-0.073173,-0.070912,0,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.37111,-0.07332,-0.14616,0,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.94321,-0.073384,0.020112,0,0
4,GO ACTIVATION OF IMMUNE RESPONSE,0.79394,-0.073395,-0.021732,0,0
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.76963,-0.073496,-0.022651,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.40594,-0.073907,-0.077375,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.27126,-0.073959,-0.044302,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.74555,-0.074062,0.010072,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.36271,-0.074091,-0.12446,0,0
4,GO VAGINA DEVELOPMENT,0.56341,-0.074203,-0.06788,0,0
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.76963,-0.074253,-0.025766,0,0
4,GO REGULATION OF CELL ACTIVATION,0.80618,-0.074915,-0.030777,0,0
4,GO COMPLEMENT ACTIVATION,0.67486,-0.074991,-0.066184,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.51122,-0.075002,-0.045539,0,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.65188,-0.075345,-0.063797,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.81845,-0.075354,0.024978,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.75756,-0.075644,-0.010792,0,0
4,GO NEPHRON TUBULE FORMATION,0.78176,-0.075831,-0.038942,0,0
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.48117,-0.075856,-0.083252,0,0
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.64051,-0.076062,-0.016058,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.2998,-0.07622,-0.057648,0,0
4,GO RESPONSE TO CADMIUM ION,0.21989,-0.076341,-0.062731,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.83078,-0.076427,-0.055769,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.75756,-0.076746,0.014561,0,0
4,GO ETHANOL OXIDATION,0.40594,-0.076793,-0.14243,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.46168,-0.078093,-0.011741,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.1306,-0.078311,-0.10186,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.75756,-0.078583,-0.038986,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.33821,-0.078872,-0.071358,0,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.61803,-0.079828,-0.046639,0,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.56341,-0.080076,-0.055644,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.55277,-0.08051,-0.029304,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.68646,-0.080921,-0.023356,0,0
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.56341,-0.081574,-0.058966,0,0
4,GO LYMPHOCYTE ACTIVATION,0.70989,-0.08191,-0.030634,0,0
4,GO CHEMOKINE PRODUCTION,0.52145,-0.08199,-0.063823,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.48117,-0.08217,-0.083931,0,0
4,GO MATURATION OF LSU RRNA,0.098083,-0.082447,-0.088795,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.37964,-0.082554,-0.12405,0,0
4,GO RESPONSE TO INTERFERON GAMMA,0.39705,-0.082687,-0.1248,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.23203,-0.082775,-0.040599,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.51122,-0.083506,-0.011947,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.52145,-0.083664,-0.091403,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.49108,-0.083819,-0.12381,0,0
4,GO CELL REDOX HOMEOSTASIS,0.14312,-0.083893,-0.0873,0,0
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.66333,-0.084086,-0.026411,0,0
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.44264,-0.084315,-0.10517,0,0
4,GO POSITIVE REGULATION OF CELL AGING,0.85555,-0.084383,-0.0063205,0,0
4,GO REGULATION OF B CELL DIFFERENTIATION,0.65188,-0.084519,-0.064729,0,0
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.53179,-0.084562,-0.063433,0,0
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.49108,-0.084704,-0.068353,0,0
4,GO T CELL ACTIVATION,0.67486,-0.084907,-0.050317,0,0
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.47137,-0.085089,-0.10938,0,0
4,GO KINETOCHORE ORGANIZATION,0.75756,-0.085262,0.068959,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.61803,-0.085347,0.00036398,0,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.46168,-0.0854,-0.097563,0,0
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.69814,-0.086114,-0.06271,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.54223,-0.086187,-0.038038,0,0
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.49108,-0.08648,-0.059112,0,0
4,GO RESPONSE TO VITAMIN D,0.88046,-0.086699,0.0082027,0,0
4,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.51122,-0.086894,-0.10228,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.072385,-0.087171,-0.092002,0,0
4,GO CELLULAR RESPONSE TO ZINC ION,0.42405,-0.087426,-0.15024,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.88046,-0.087876,0.01697,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.69814,-0.08788,-0.017571,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.75756,-0.088134,-0.055326,0,0
4,GO T CELL PROLIFERATION,0.53179,-0.088673,-0.076674,0,0
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.37111,-0.088696,-0.13361,0,0
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.57414,-0.089297,-0.033396,0,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.054439,-0.089337,-0.078829,0,0
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.80618,-0.08959,-0.033715,0,0
4,GO REGULATION OF PODOSOME ASSEMBLY,0.36271,-0.090141,-0.072586,0,0
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.79394,-0.091714,-0.046221,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.37111,-0.091864,-0.081019,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.56341,-0.091891,-0.045048,0,0
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.40594,-0.091906,-0.079782,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.46168,-0.092137,-0.092123,0,0
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.30724,-0.092497,-0.13129,0,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.058535,-0.092704,-0.10112,0,0
4,GO B CELL MEDIATED IMMUNITY,0.78176,-0.092802,-0.03681,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.79394,-0.09299,-0.018454,0,0
4,GO REPLICATIVE SENESCENCE,0.62923,-0.093236,-0.026269,0,0
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.53179,-0.093531,-0.060792,0,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.27821,-0.093743,-0.061936,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.64051,-0.093756,-0.036229,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.93062,-0.093817,0.011126,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.42405,-0.094235,-0.11401,0,0
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.65188,-0.094711,-0.032383,0,0
4,GO RESPONSE TO TUMOR CELL,0.28529,-0.094774,-0.12193,0,0
4,GO GENITALIA MORPHOGENESIS,0.55277,-0.095612,-0.054905,0,0
4,GO ANTIMICROBIAL HUMORAL RESPONSE,0.68646,-0.095857,-0.050728,0,0
4,GO RESPONSE TO COPPER ION,0.23203,-0.096698,-0.10807,0,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.069906,-0.097,-0.12229,0,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.38829,-0.097826,-0.087992,0,0
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.75756,-0.097939,0.017168,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.072385,-0.098283,-0.10671,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.50109,-0.09832,-0.089662,0,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.37964,-0.098827,-0.019505,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.69814,-0.098955,-0.032411,0,0
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.27821,-0.098971,-0.15119,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.46168,-0.099008,-0.089136,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.33821,-0.099071,-0.027135,0,0
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.18624,-0.099526,-0.1097,0,0
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.51122,-0.09968,-0.071894,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.80618,-0.099793,0.057113,0,0
4,GO NEUROINFLAMMATORY RESPONSE,0.65188,-0.099796,-0.0679,0,0
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.54223,-0.09983,-0.084098,0,0
4,GO RESPONSE TO INTERLEUKIN 15,0.61803,-0.10011,-0.080988,0,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.35442,-0.10025,-0.13032,0,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.65188,-0.10027,-0.069256,0,0
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.80618,-0.1004,-0.034112,0,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.30724,-0.10049,-0.072625,0,0
4,GO ALPHA BETA T CELL ACTIVATION,0.47137,-0.10074,-0.095089,0,0
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.67486,-0.10088,-0.032699,0,0
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.57414,-0.10091,-0.034396,0,0
4,GO MACROPHAGE ACTIVATION,0.51122,-0.10098,-0.080557,0,0
4,GO B CELL ACTIVATION,0.81845,-0.10103,-0.023867,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.21989,-0.10149,-0.043766,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.53179,-0.10223,-0.082078,0,0
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.27126,-0.10241,-0.1101,0,0
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.62923,-0.10259,-0.06589,0,0
4,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.72171,-0.10269,-0.073521,0,0
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.24463,-0.10281,-0.1778,0,0
4,GO LEUKOCYTE CHEMOTAXIS,0.46168,-0.10301,-0.084549,0,0
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.44264,-0.10306,-0.088375,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.62923,-0.10357,-0.068339,0,0
4,GO CYSTEINE METABOLIC PROCESS,0.78176,-0.10366,0.0047834,0,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.072385,-0.10412,-0.096189,0,0
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.60692,-0.10449,-0.055894,0,0
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.54223,-0.10457,-0.049998,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.43329,-0.10573,-0.14328,0,0
4,GO LYMPHOCYTE MIGRATION,0.48117,-0.10679,-0.11364,0,0
4,GO ZINC ION HOMEOSTASIS,0.21989,-0.10747,-0.12589,0,0
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.64051,-0.10754,-0.035347,0,0
4,GO T CELL EXTRAVASATION,0.60692,-0.10787,-0.059953,0,0
4,GO NEURAL CREST FORMATION,0.69814,-0.10825,-0.03596,0,0
4,GO CELLULAR RESPONSE TO COPPER ION,0.38829,-0.10831,-0.13452,0,0
4,GO PHAGOCYTOSIS RECOGNITION,0.34626,-0.10847,-0.12065,0,0
4,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.13885,-0.10959,-0.17061,0,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.42405,-0.11038,-0.091901,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.016475,-0.11044,-0.12282,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.42405,-0.1115,-0.10383,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.60692,-0.11157,-0.071324,0,0
4,GO LEUKOCYTE HOMEOSTASIS,0.74555,-0.11157,-0.028236,0,0
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.78176,-0.11175,-0.038044,0,0
4,GO INTERLEUKIN 8 PRODUCTION,0.46168,-0.11192,-0.093371,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.86799,-0.11267,-0.028501,0,0
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.50109,-0.11328,-0.073829,0,0
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.55277,-0.11353,-0.11107,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.37111,-0.11361,-0.11047,0,0
4,GO GLIAL CELL ACTIVATION,0.62923,-0.11403,-0.086741,0,0
4,GO MYELOID LEUKOCYTE MIGRATION,0.46168,-0.11419,-0.089032,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.50109,-0.11462,-0.073978,0,0
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.43329,-0.11465,-0.096812,0,0
4,GO IMMUNOGLOBULIN SECRETION,0.46168,-0.11468,-0.093246,0,0
4,GO CYTOKINE SECRETION,0.42405,-0.11474,-0.088003,0,0
4,GO RESPONSE TO INTERLEUKIN 18,0.61803,-0.11541,-0.052547,0,0
4,GO SALIVA SECRETION,0.25111,-0.11558,-0.11476,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.40594,-0.11574,-0.072726,0,0
4,GO ADAPTIVE IMMUNE RESPONSE,0.52145,-0.11596,-0.10552,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.75756,-0.11608,0.050733,0,0
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.98106,-0.1165,0.0099937,0,0
4,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.3148,-0.11697,-0.19474,0,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0080134,-0.11824,-0.12661,0,0
4,GO PROTEIN NITROSYLATION,0.51122,-0.11826,-0.053661,0,0
4,GO TELENCEPHALON REGIONALIZATION,0.55277,-0.11839,-0.092842,0,0
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.35442,-0.11904,-0.11449,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.022172,-0.11911,-0.11263,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.27821,-0.11922,-0.091452,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.54223,-0.1193,-0.076082,0,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.33029,-0.11942,-0.081792,0,0
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.62923,-0.12013,-0.070686,0,0
4,GO RESPONSE TO FUNGUS,0.25111,-0.12069,-0.1353,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.79394,-0.12098,-0.015065,0,0
4,GO AUTOPHAGIC CELL DEATH,0.16602,-0.12106,-0.06434,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.38829,-0.12111,-0.085847,0,0
4,GO LEUKOCYTE PROLIFERATION,0.50109,-0.1223,-0.088407,0,0
4,GO PROTEASOME ASSEMBLY,0.072385,-0.12252,-0.084466,0,0
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.37111,-0.12347,-0.11535,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.57414,-0.12396,-0.062225,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.98106,-0.12431,0.031507,0,0
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.5959,-0.12446,-0.050946,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.11524,-0.12489,-0.068332,0,0
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.67486,-0.12523,-0.052482,0,0
4,GO TRANSLATIONAL INITIATION,0.011063,-0.12528,-0.13732,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.49108,-0.12529,-0.1106,0,0
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.42405,-0.1264,-0.13265,0,0
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.4521,-0.12673,-0.10041,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.5959,-0.12767,-0.044945,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.4521,-0.12777,-0.10678,0,0
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.42405,-0.12785,-0.12529,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.78176,-0.12794,-0.039834,0,0
4,GO HISTAMINE SECRETION,0.38829,-0.12844,-0.088118,0,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.99368,-0.12867,0.0022231,0,0
4,GO MYOBLAST MIGRATION,0.18102,-0.1288,-0.16275,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.1475,-0.12909,-0.14287,0,0
4,GO CHEMOKINE SECRETION,0.34626,-0.12959,-0.13594,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.88046,-0.12968,-0.0030413,0,0
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.33821,-0.13003,-0.094267,0,0
4,GO RIBOSOME ASSEMBLY,0.014457,-0.13049,-0.11646,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.37964,-0.13207,-0.13909,0,0
4,GO REGULATION OF CELL KILLING,0.43329,-0.13248,-0.10779,0,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.23827,-0.13281,-0.17594,0,0
4,GO REGULATION OF B CELL ACTIVATION,0.58498,-0.13364,-0.069653,0,0
4,GO ZYMOGEN INHIBITION,0.26442,-0.13453,-0.14389,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.89296,-0.13475,0.068425,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.197,-0.13533,-0.19127,0,0
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.4521,-0.1354,-0.09304,0,0
4,GO CELL KILLING,0.37964,-0.1358,-0.12161,0,0
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.17091,-0.13615,-0.11841,0,0
4,GO REGULATION OF NEUTROPHIL MIGRATION,0.79394,-0.13707,-0.04255,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.52145,-0.13753,-0.021906,0,0
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.21989,-0.1378,-0.15837,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.50109,-0.13812,-0.072534,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.48117,-0.13852,-0.088366,0,0
4,GO GRANULOCYTE CHEMOTAXIS,0.33029,-0.13858,-0.13264,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.95582,-0.13881,0.014574,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.54223,-0.13985,-0.078039,0,0
4,GO REGULATORY T CELL DIFFERENTIATION,0.57414,-0.13987,-0.075711,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.49108,-0.14057,-0.027894,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.56341,-0.14064,-0.044463,0,0
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.098083,-0.1411,-0.16169,0,0
4,GO T CELL MIGRATION,0.55277,-0.14121,-0.1197,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.32248,-0.14124,-0.086387,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.50109,-0.14181,-0.09386,0,0
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.50109,-0.14254,-0.11177,0,0
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.85555,-0.14386,-0.0094897,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.074935,-0.14396,-0.18473,0,0
4,GO GRANULOCYTE MIGRATION,0.36271,-0.14483,-0.12047,0,0
4,GO NATURAL KILLER CELL ACTIVATION,0.55277,-0.14543,-0.070647,0,0
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.7336,-0.14574,-0.041917,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.48117,-0.14576,-0.063229,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.197,-0.14628,-0.11961,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.58498,-0.14631,-0.070232,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.42405,-0.14633,-0.14285,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.67486,-0.14655,-0.005709,0,0
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.49108,-0.14692,-0.072557,0,0
4,GO T CELL LINEAGE COMMITMENT,0.66333,-0.14693,-0.030856,0,0
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.46168,-0.1481,-0.10362,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.35442,-0.14827,-0.12527,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.37111,-0.1485,-0.16177,0,0
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.57414,-0.14882,-0.073825,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.49108,-0.14893,-0.095491,0,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.49108,-0.15012,-0.13293,0,0
4,GO HYPERSENSITIVITY,0.44264,-0.15084,-0.17456,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION,0.5959,-0.15088,-0.060895,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.33821,-0.15115,-0.15527,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.58498,-0.15181,-0.13145,0,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.094909,-0.15181,-0.16964,0,0
4,GO REGULATION OF T CELL ACTIVATION,0.56341,-0.15283,-0.069665,0,0
4,GO RESPONSE TO PROTOZOAN,0.37111,-0.15319,-0.13433,0,0
4,GO POSITIVE REGULATION OF CELL KILLING,0.36271,-0.15443,-0.13874,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.37964,-0.15463,-0.10271,0,0
4,GO LYMPHOCYTE COSTIMULATION,0.78176,-0.15515,-0.055991,0,0
4,GO LEUKOCYTE CELL CELL ADHESION,0.53179,-0.15574,-0.08155,0,0
4,GO RESPIRATORY BURST,0.66333,-0.15624,-0.076237,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.36271,-0.1567,-0.11317,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.49108,-0.15674,-0.1089,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.3148,-0.15685,-0.14919,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.30724,-0.157,-0.1101,0,0
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.75756,-0.15911,-0.055889,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.08588,-0.15919,-0.18995,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.25111,-0.15994,-0.10593,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.46168,-0.16013,-0.031396,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.55277,-0.16021,-0.075522,0,0
4,GO LEUKOCYTE AGGREGATION,0.12662,-0.16053,-0.27667,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.28529,-0.16144,-0.17657,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.27126,-0.16173,-0.1705,0,0
4,GO V D J RECOMBINATION,0.46168,-0.16219,-0.072849,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.50109,-0.16241,-0.10713,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.39705,-0.16364,-0.1043,0,0
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.30724,-0.16413,-0.16048,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.86799,-0.16422,-0.022864,0,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.30724,-0.16465,-0.13712,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.46168,-0.16479,-0.17082,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.23827,-0.16507,-0.12313,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.42405,-0.16688,-0.063358,0,0
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.48117,-0.16737,-0.1236,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.197,-0.1675,-0.20034,0,0
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.3148,-0.16818,-0.14194,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.36271,-0.17074,-0.15894,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.44264,-0.17087,-0.13307,0,0
4,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.040368,-0.17255,-0.18918,0,0
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.28529,-0.17256,-0.12774,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.08303,-0.17391,-0.15217,0,0
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.37964,-0.17403,-0.11749,0,0
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.55277,-0.1745,-0.087798,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.13467,-0.17463,-0.1262,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.17591,-0.17516,-0.22716,0,0
4,GO REGULATION OF B CELL PROLIFERATION,0.56341,-0.17614,-0.11918,0,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.34626,-0.17615,-0.12856,0,0
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.4521,-0.17744,-0.10441,0,0
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.2259,-0.17744,-0.24224,0,0
4,GO DENDRITIC CELL DIFFERENTIATION,0.27821,-0.17878,-0.16781,0,0
4,GO CD40 SIGNALING PATHWAY,0.33029,-0.18027,-0.098388,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.44264,-0.18092,-0.16302,0,0
4,GO NEUTROPHIL MIGRATION,0.25111,-0.18171,-0.16389,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.16602,-0.18297,-0.13936,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.23203,-0.18343,-0.20183,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.34626,-0.18376,-0.12848,0,0
4,GO NEUTROPHIL CHEMOTAXIS,0.21989,-0.18502,-0.18628,0,0
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.35442,-0.18523,-0.15706,0,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.40594,-0.18534,-0.1032,0,0
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.30724,-0.18535,-0.12613,0,0
4,GO TONIC SMOOTH MUSCLE CONTRACTION,0.12662,-0.18674,-0.13429,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.017954,-0.18752,-0.15558,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.38829,-0.18761,-0.15554,0,0
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.28529,-0.18777,-0.14678,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.11524,-0.18889,-0.12152,0,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.64051,-0.18952,-0.094577,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.3148,-0.19136,-0.099961,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.44264,-0.19168,-0.11937,0,0
4,GO T CELL SELECTION,0.56341,-0.19332,-0.087536,0,0
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.72171,-0.19408,-0.085309,0,0
4,GO MONONUCLEAR CELL MIGRATION,0.197,-0.19408,-0.20648,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.27126,-0.19508,-0.16789,0,0
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.47137,-0.19566,-0.13934,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.44264,-0.19651,-0.10734,0,0
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.37111,-0.19833,-0.13389,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.44264,-0.1994,-0.12756,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.34626,-0.20026,-0.079557,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.62923,-0.20119,-0.072105,0,0
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.28529,-0.20135,-0.11112,0,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.30724,-0.20445,-0.1423,0,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.2577,-0.20664,-0.16802,0,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.023112,-0.20672,-0.17691,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.08588,-0.20674,-0.18303,0,0
4,GO THYMIC T CELL SELECTION,0.46168,-0.20852,-0.11002,0,0
4,GO T CELL MEDIATED CYTOTOXICITY,0.34626,-0.20906,-0.16828,0,0
4,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.37111,-0.20925,-0.15697,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.23827,-0.21025,-0.2329,0,0
4,GO INTERLEUKIN 10 PRODUCTION,0.47137,-0.21107,-0.14029,0,0
4,GO CELLULAR DEFENSE RESPONSE,0.25111,-0.21447,-0.19501,0,0
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.29248,-0.21468,-0.18813,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.26442,-0.21602,-0.14792,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.11894,-0.21622,-0.1561,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.080256,-0.21734,-0.21807,0,0
4,GO ALPHA BETA T CELL PROLIFERATION,0.37111,-0.21968,-0.13139,0,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.23203,-0.22189,-0.17829,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.36271,-0.22314,-0.16659,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.10468,-0.22385,-0.11328,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.33029,-0.22427,-0.14228,0,0
4,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.40594,-0.22518,-0.15162,0,0
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.41494,-0.22665,-0.12306,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.214,-0.22724,-0.21184,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.42405,-0.22747,-0.10441,0,0
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.38829,-0.23042,-0.12281,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.24463,-0.23044,-0.19334,0,0
4,GO B CELL PROLIFERATION,0.37111,-0.23195,-0.16248,0,0
4,GO RESPONSE TO CHEMOKINE,0.28529,-0.23243,-0.17428,0,0
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.3148,-0.23253,-0.17079,0,0
4,GO T HELPER CELL LINEAGE COMMITMENT,0.56341,-0.23288,-0.086204,0,0
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.2577,-0.23315,-0.23059,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.38829,-0.23751,-0.16081,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.54223,-0.23789,-0.072093,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.36271,-0.23857,-0.16219,0,0
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.53179,-0.23984,-0.088735,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.21989,-0.24025,-0.20399,0,0
4,GO MACROPHAGE APOPTOTIC PROCESS,0.18102,-0.24098,-0.16064,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.048745,-0.24174,-0.21524,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.48117,-0.24182,-0.13477,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.32248,-0.24643,-0.22617,0,0
4,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.17091,-0.24842,-0.18091,0,0
4,GO POSITIVE T CELL SELECTION,0.48117,-0.25169,-0.10037,0,0
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.48117,-0.2526,-0.12223,0,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.11894,-0.25285,-0.15939,0,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.20822,-0.2535,-0.22882,0,0
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.27821,-0.25603,-0.19906,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.28529,-0.25665,-0.17475,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.20822,-0.25848,-0.18812,0,0
4,GO CYCLOOXYGENASE PATHWAY,0.18102,-0.25882,-0.20703,0,0
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.2259,-0.26223,-0.17407,0,0
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.51122,-0.26409,-0.13828,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.23827,-0.27292,-0.13249,0,0
4,GO MONOCYTE CHEMOTAXIS,0.13467,-0.27366,-0.27322,0,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.16123,-0.27444,-0.27514,0,0
4,GO DENDRITIC CELL MIGRATION,0.13885,-0.27847,-0.26484,0,0
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.35442,-0.28212,-0.16909,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.54223,-0.28251,-0.080673,0,0
4,GO T CELL CHEMOTAXIS,0.20822,-0.28919,-0.23663,0,0
4,GO INTERLEUKIN 12 PRODUCTION,0.29248,-0.29136,-0.17082,0,0
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.17591,-0.29528,-0.24796,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.2998,-0.30723,-0.19464,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.30724,-0.31114,-0.16209,0,0
4,GO RESPONSE TO PEPTIDOGLYCAN,0.214,-0.31164,-0.23918,0,0
4,GO TOLERANCE INDUCTION,0.2259,-0.31203,-0.26558,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.41494,-0.31448,-0.17142,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.25111,-0.31573,-0.19652,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.14312,-0.31985,-0.17472,0,0
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.20256,-0.32228,-0.25694,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.197,-0.32889,-0.21571,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.32248,-0.33162,-0.14694,0,0
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.30724,-0.33297,-0.26649,0,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.20256,-0.33789,-0.32272,0,0
4,GO REGULATION OF TOLERANCE INDUCTION,0.28529,-0.3466,-0.22661,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.11524,-0.34911,-0.19985,0,0
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.38829,-0.35884,-0.19547,0,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.29248,-0.35901,-0.1838,0,0
4,GO T CELL TOLERANCE INDUCTION,0.32248,-0.36633,-0.23025,0,0
4,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.15655,-0.37062,-0.37874,0,0
4,GO NEGATIVE T CELL SELECTION,0.27126,-0.37495,-0.22344,0,0
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.074935,-0.37825,-0.28075,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.38829,-0.38782,-0.17324,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.060677,-0.41049,-0.2609,0,0
4,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.34626,-0.41579,-0.22668,0,0
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.077559,-0.41811,-0.40644,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.10811,-0.41821,-0.27485,0,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.048745,-0.42229,-0.42997,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.52145,-0.42457,-0.17157,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.18624,-0.43648,-0.29385,0,0
4,GO CYTOLYSIS,0.11524,-0.449,-0.31355,0,0
4,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.14312,-0.48633,-0.40482,0,0
4,GO EOSINOPHIL MIGRATION,0.065157,-0.49679,-0.3544,0,0
4,GO EOSINOPHIL CHEMOTAXIS,0.045233,-0.51324,-0.39188,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.062884,-0.53626,-0.3972,0,0
5,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.00024771,1.3009,1.1349,1,1
5,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.00048214,1.2291,1.0301,1,1
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00031664,1.1883,1.0172,1,1
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00042807,1.1765,0.99978,1,1
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00024771,1.0674,0.93336,1,1
5,GO CHRONIC INFLAMMATORY RESPONSE,4.5779e-05,1.0497,0.9186,1,1
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00054254,1.049,0.78867,1,1
5,GO NATURAL KILLER CELL CHEMOTAXIS,0.00096503,1.0422,0.94012,1,1
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010181,1.016,0.90428,1,1
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.4805e-05,1.0138,0.96191,1,1
5,GO TOLERANCE INDUCTION,0.00023283,1.0037,0.88068,1,1
5,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.00013188,0.98571,1.0232,1,1
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00048214,0.97908,0.83883,1,1
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.9888e-05,0.97026,0.96694,1,1
5,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.00057531,0.95327,0.7186,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,0.00033648,0.95134,0.84388,1,1
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,4.2763e-05,0.94918,0.80952,1,1
5,GO T CELL TOLERANCE INDUCTION,0.00014062,0.94674,0.92787,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,4.5779e-05,0.94272,0.92302,1,1
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00015974,0.94146,0.81221,1,1
5,GO HYPERSENSITIVITY,0.00028019,0.94002,0.84275,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00017019,0.93508,0.85707,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,3.0304e-05,0.93346,0.83287,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00015974,0.93178,0.86573,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00028019,0.93037,0.77835,1,1
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.2939e-05,0.91974,0.80347,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00013188,0.91928,0.84876,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00012367,0.91016,0.81894,1,1
5,GO T CELL CHEMOTAXIS,6.8565e-05,0.90146,0.79379,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00028019,0.89706,0.81671,1,1
5,GO LYMPHOCYTE CHEMOTAXIS,5.9985e-05,0.89535,0.79062,1,1
5,GO T HELPER 1 CELL DIFFERENTIATION,2.1347e-05,0.89161,0.83499,1,1
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.00031664,0.88717,0.79154,1,1
5,GO NEGATIVE T CELL SELECTION,0.00026348,0.88464,0.83696,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00029789,0.88211,0.68702,1,1
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,8.3641e-05,0.88164,0.84156,1,1
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00029789,0.87696,0.78717,1,1
5,GO DENDRITIC CELL MIGRATION,0.00017019,0.87431,0.7788,1,1
5,GO DENDRITIC CELL CHEMOTAXIS,0.00023283,0.87034,0.78332,1,1
5,GO DETECTION OF OTHER ORGANISM,0.00024771,0.86494,0.70947,1,1
5,GO INTERLEUKIN 10 PRODUCTION,0.00011593,0.86308,0.68972,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00028019,0.86034,0.78164,1,1
5,GO SYNAPSE PRUNING,0.00028019,0.85822,0.90533,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.636e-05,0.85721,0.79172,1,1
5,GO RESPONSE TO PROTOZOAN,5.2428e-05,0.8531,0.75232,1,1
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00023283,0.84866,0.71063,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.248e-05,0.84644,0.80699,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.4576e-05,0.84421,0.76817,1,1
5,GO T CELL MEDIATED CYTOTOXICITY,3.4805e-05,0.83775,0.75652,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.00014062,0.83281,0.76107,1,1
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00020554,0.82739,0.7207,1,1
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010181,0.82737,0.76827,1,1
5,GO T HELPER 2 CELL DIFFERENTIATION,2.8267e-05,0.82689,0.7744,1,1
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00042807,0.82552,0.6785,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00060992,0.82298,0.68716,1,1
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,4.8997e-05,0.8221,0.78898,1,1
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,2.4576e-05,0.82061,0.69872,1,1
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.8997e-05,0.81459,0.7094,1,1
5,GO POSITIVE THYMIC T CELL SELECTION,0.0014241,0.81335,0.6696,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,9.5377e-05,0.80976,0.65721,1,1
5,GO NEGATIVE REGULATION OF CELL KILLING,7.3279e-05,0.80686,0.82576,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,6.8565e-05,0.80677,0.73758,1,1
5,GO CYTOLYSIS,0.00024771,0.80082,0.79559,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,0.00019306,0.80074,0.72315,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.0012758,0.79535,0.6169,1,1
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00021879,0.79531,0.6606,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00020554,0.7939,0.68098,1,1
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,7.8298e-05,0.79218,0.8214,1,1
5,GO RESPONSE TO INTERLEUKIN 18,2.4576e-05,0.79218,0.72801,1,1
5,GO INTERLEUKIN 2 PRODUCTION,2.636e-05,0.78939,0.70784,1,1
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.00332,0.78553,0.64199,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00033648,0.78425,0.7127,1,1
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00045436,0.78321,0.71788,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00018128,0.78252,0.66864,1,1
5,GO DETECTION OF BIOTIC STIMULUS,0.00010866,0.78214,0.63784,1,1
5,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.00091199,0.78121,0.84217,1,1
5,GO POSITIVE T CELL SELECTION,0.00051151,0.78111,0.64842,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.4805e-05,0.77915,0.76199,1,1
5,GO T HELPER CELL LINEAGE COMMITMENT,0.00028019,0.77876,0.68925,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00013188,0.77595,0.69876,1,1
5,GO MONOCYTE CHEMOTAXIS,9.5377e-05,0.7753,0.73632,1,1
5,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.00064645,0.775,0.70096,1,1
5,GO POSITIVE REGULATION OF T CELL MIGRATION,4.2763e-05,0.77482,0.69693,1,1
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,3.4805e-05,0.77356,0.69139,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00020554,0.77253,0.67632,1,1
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.248e-05,0.77151,0.77123,1,1
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.5779e-05,0.77139,0.68192,1,1
5,GO INFLAMMATORY RESPONSE TO WOUNDING,0.00018128,0.76988,0.65047,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0003797,0.76914,0.6674,1,1
5,GO THYMIC T CELL SELECTION,0.0012071,0.76795,0.59895,1,1
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4576e-05,0.76616,0.75957,1,1
5,GO T CELL MIGRATION,0.00020554,0.7645,0.6831,1,1
5,GO CELLULAR DEFENSE RESPONSE,0.00021879,0.76434,0.67867,1,1
5,GO INTERLEUKIN 13 PRODUCTION,0.00014062,0.76378,0.70708,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.1347e-05,0.76364,0.76708,1,1
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00033648,0.76341,0.61213,1,1
5,GO ADAPTIVE IMMUNE RESPONSE,0.00020554,0.76263,0.64639,1,1
5,GO REGULATION OF T CELL CHEMOTAXIS,2.1347e-05,0.76106,0.74015,1,1
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,5.2428e-05,0.75938,0.70564,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.9936e-05,0.75901,0.70323,1,1
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00051151,0.75836,0.67253,1,1
5,GO RESPONSE TO CHEMOKINE,6.8565e-05,0.75816,0.69891,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00014062,0.75752,0.69688,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00014062,0.75679,0.66737,1,1
5,GO RESPONSE TO PEPTIDOGLYCAN,0.00015974,0.75648,0.69474,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,8.9327e-05,0.7533,0.72359,1,1
5,GO INTERLEUKIN 4 PRODUCTION,0.00048214,0.75161,0.61435,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00010181,0.75104,0.73252,1,1
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00042807,0.74938,0.65528,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,5.9985e-05,0.74799,0.69169,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,4.8997e-05,0.7477,0.69312,1,1
5,GO LEUKOCYTE AGGREGATION,0.00026348,0.7466,0.73461,1,1
5,GO RESPONSE TO INTERLEUKIN 15,0.00011593,0.74655,0.70712,1,1
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0003797,0.74591,0.62019,1,1
5,GO T CELL EXTRAVASATION,0.00012367,0.74508,0.64895,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,7.8298e-05,0.74167,0.70471,1,1
5,GO T CELL CYTOKINE PRODUCTION,3.0304e-05,0.73949,0.66784,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00012367,0.73901,0.66917,1,1
5,GO INTERLEUKIN 12 PRODUCTION,0.00035748,0.7387,0.63796,1,1
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00040321,0.73601,0.68172,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2428e-05,0.73368,0.69845,1,1
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.00042807,0.73256,0.69875,1,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.00013188,0.73249,0.70757,1,1
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,7.8298e-05,0.73193,0.63269,1,1
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00018128,0.73166,0.74469,1,1
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.7249e-05,0.7313,0.76368,1,1
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,3.4805e-05,0.72914,0.69462,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00021879,0.72817,0.63526,1,1
5,GO HEMIDESMOSOME ASSEMBLY,0.0028457,0.72743,0.59697,1,1
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00014062,0.72721,0.64531,1,1
5,GO LYMPHOCYTE MIGRATION,0.00024771,0.72683,0.65241,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00011593,0.72588,0.66771,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.00068502,0.72447,0.7145,1,1
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,5.2428e-05,0.72309,0.72124,1,1
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.00018128,0.72274,0.62133,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,7.8298e-05,0.72237,0.63685,1,1
5,GO T CELL MEDIATED IMMUNITY,3.4805e-05,0.71945,0.63212,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.00013188,0.71889,0.64307,1,1
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,8.3641e-05,0.71835,0.64746,1,1
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.248e-05,0.71784,0.65742,1,1
5,GO TYPE 2 IMMUNE RESPONSE,4.8997e-05,0.71754,0.70791,1,1
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,2.4576e-05,0.71699,0.72879,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.8267e-05,0.71686,0.66417,1,1
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00048214,0.71632,0.60398,1,1
5,GO CHEMOKINE SECRETION,0.00048214,0.7162,0.67957,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.2007e-06,0.71534,0.80315,1,1
5,GO REGULATION OF GLIAL CELL MIGRATION,0.00068502,0.71401,0.57522,1,1
5,GO NEUTROPHIL MIGRATION,0.00011593,0.71387,0.63742,1,1
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00010866,0.71269,0.61307,1,1
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00013188,0.71197,0.62154,1,1
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00064645,0.71192,0.59628,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00012367,0.7113,0.58561,1,1
5,GO RESPONSE TO INTERFERON GAMMA,7.3279e-05,0.71121,0.64951,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,9.5377e-05,0.71046,0.64857,1,1
5,GO MONONUCLEAR CELL MIGRATION,8.9327e-05,0.70982,0.67273,1,1
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,8.9327e-05,0.70973,0.67376,1,1
5,GO T CELL SELECTION,0.00051151,0.70952,0.60625,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00012367,0.70929,0.62287,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,0.00023283,0.70791,0.63586,1,1
5,GO INTERFERON GAMMA PRODUCTION,0.00020554,0.70787,0.63638,1,1
5,GO INTERLEUKIN 8 PRODUCTION,2.4576e-05,0.70617,0.62146,1,1
5,GO GLIAL CELL ACTIVATION,0.00024771,0.70601,0.65681,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,0.0013481,0.70599,0.53206,1,1
5,GO CYCLOOXYGENASE PATHWAY,0.00020554,0.70528,0.70722,1,1
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00010866,0.70503,0.62507,1,1
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0003797,0.70489,0.65295,1,1
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.9936e-05,0.70483,0.61797,1,1
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00015974,0.70278,0.67873,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.00045436,0.70194,0.56016,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.00023283,0.70101,0.63761,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.00020554,0.69947,0.65667,1,1
5,GO GERMINAL CENTER FORMATION,0.00057531,0.69922,0.63994,1,1
5,GO B CELL PROLIFERATION,0.00031664,0.6991,0.63154,1,1
5,GO AMINO SUGAR CATABOLIC PROCESS,0.00057531,0.69717,0.58458,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00014062,0.697,0.59832,1,1
5,GO REGULATION OF NEUTROPHIL ACTIVATION,0.0003797,0.6968,0.66737,1,1
5,GO REGULATION OF B CELL PROLIFERATION,0.0003797,0.69358,0.60605,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,8.3641e-05,0.6927,0.65488,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.9888e-05,0.6906,0.64917,1,1
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,3.4805e-05,0.68967,0.70493,1,1
5,GO INTERLEUKIN 1 PRODUCTION,9.5377e-05,0.68926,0.63972,1,1
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00029789,0.68882,0.67345,1,1
5,GO REGULATION OF CELL KILLING,8.3641e-05,0.68822,0.64886,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014062,0.68728,0.6505,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.4139e-05,0.68624,0.61561,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00010866,0.68532,0.64416,1,1
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00010181,0.68497,0.60677,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.8997e-05,0.68372,0.64397,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00029789,0.68259,0.63096,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00015974,0.67899,0.58893,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00021879,0.6787,0.63591,1,1
5,GO IMMUNOGLOBULIN SECRETION,0.00042807,0.67491,0.53356,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,6.8565e-05,0.67432,0.58373,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.8997e-05,0.67388,0.64806,1,1
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.3279e-05,0.67353,0.59837,1,1
5,GO GRANULOCYTE MIGRATION,0.00010181,0.67295,0.60447,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,9.5377e-05,0.67213,0.61134,1,1
5,GO ALPHA BETA T CELL ACTIVATION,0.00015974,0.67127,0.60277,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00028019,0.67077,0.57233,1,1
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00096503,0.67041,0.66413,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,5.9985e-05,0.66708,0.64454,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,6.8565e-05,0.66668,0.59299,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00042807,0.66665,0.70063,1,1
5,GO INTERLEUKIN 17 PRODUCTION,0.00014989,0.66408,0.60178,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00011593,0.66306,0.61196,1,1
5,GO B CELL MEDIATED IMMUNITY,0.00017019,0.66279,0.60211,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,5.9985e-05,0.66169,0.59631,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00048214,0.66044,0.58584,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,0.00015974,0.66009,0.60224,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,4.2763e-05,0.65938,0.65565,1,1
5,GO INTERLEUKIN 5 PRODUCTION,0.0031545,0.65937,0.53502,1,1
5,GO ETHANOL OXIDATION,2.2907e-05,0.65936,0.75367,1,1
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00057531,0.65914,0.71826,1,1
5,GO CELLULAR RESPONSE TO ETHANOL,0.00010866,0.6588,0.56227,1,1
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0012071,0.65812,0.57086,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00014062,0.65791,0.57928,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00045436,0.65738,0.59038,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,7.8298e-05,0.65639,0.60234,1,1
5,GO COMPLEMENT ACTIVATION,0.00040321,0.65556,0.71745,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,8.9327e-05,0.65532,0.59574,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.00010866,0.65487,0.61839,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00013188,0.65423,0.56715,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0014241,0.65352,0.5564,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0011418,0.65276,0.51552,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00040321,0.65186,0.56642,1,1
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.4139e-05,0.65166,0.57624,1,1
5,GO RESPONSE TO INTERFERON BETA,6.8565e-05,0.65095,0.59762,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00051151,0.65089,0.5921,1,1
5,GO RESPONSE TO LIPOTEICHOIC ACID,0.00035748,0.64947,0.60326,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00060992,0.64907,0.56514,1,1
5,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00010181,0.64789,0.58261,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00060992,0.64731,0.59982,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00028019,0.64711,0.58607,1,1
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00011593,0.6469,0.61838,1,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0011418,0.64651,0.52669,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00019306,0.64611,0.57093,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00031664,0.64574,0.55756,1,1
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0011418,0.64543,0.61276,1,1
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,9.5377e-05,0.64478,0.64755,1,1
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00010181,0.64411,0.59502,1,1
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00026348,0.64344,0.58714,1,1
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00026348,0.64125,0.61418,1,1
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00042807,0.64053,0.70316,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.00029789,0.64046,0.61197,1,1
5,GO NEUROINFLAMMATORY RESPONSE,0.00042807,0.64033,0.57964,1,1
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.2428e-05,0.63901,0.62689,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,0.00017019,0.63596,0.55341,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.00014062,0.63344,0.60824,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.00033648,0.63142,0.57692,1,1
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00096503,0.63054,0.50344,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00010866,0.62849,0.5657,1,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00024771,0.62753,0.59052,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,6.8565e-05,0.62699,0.57806,1,1
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00018128,0.62676,0.57891,1,1
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00026348,0.6259,0.67654,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.00048214,0.62559,0.5589,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00013188,0.6251,0.56383,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0010209,0.62406,0.648,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.8298e-05,0.62328,0.5626,1,1
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.8298e-05,0.62247,0.54026,1,1
5,GO CYTOKINE METABOLIC PROCESS,0.00011593,0.61983,0.55823,1,1
5,GO REGULATION OF PHAGOCYTOSIS,0.00021879,0.61914,0.55972,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00015974,0.6184,0.52684,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00015974,0.61836,0.55113,1,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00023283,0.61682,0.54107,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,7.8298e-05,0.61663,0.55228,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00010866,0.61505,0.53748,1,1
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.5779e-05,0.61407,0.64769,1,1
5,GO RESPONSE TO TYPE I INTERFERON,0.00010181,0.61285,0.56972,1,1
5,GO REGULATION OF MEMBRANE INVAGINATION,0.00081392,0.61282,0.59126,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00014989,0.61252,0.58699,1,1
5,GO REGULATION OF MYOBLAST FUSION,0.0012758,0.61248,0.56517,1,1
5,GO MACROPHAGE MIGRATION,0.00020554,0.61161,0.55347,1,1
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00014062,0.611,0.53955,1,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0003797,0.61069,0.58318,1,1
5,GO T CELL APOPTOTIC PROCESS,1.8524e-05,0.60975,0.58722,1,1
5,GO AMYLOID BETA CLEARANCE,0.00017019,0.608,0.53732,1,1
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00011593,0.60736,0.52291,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00011593,0.60636,0.55234,1,1
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00023283,0.60578,0.52699,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00013188,0.60572,0.63878,1,1
5,GO T CELL PROLIFERATION,0.00014989,0.60554,0.567,1,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.00011593,0.60425,0.54484,1,1
5,GO REGULATION OF T CELL MIGRATION,9.5377e-05,0.60421,0.58438,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00020554,0.60359,0.54092,1,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.00024771,0.60346,0.56375,1,1
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,3.248e-05,0.60323,0.66142,1,1
5,GO LEUKOCYTE APOPTOTIC PROCESS,7.8298e-05,0.60308,0.55252,1,1
5,GO I KAPPAB PHOSPHORYLATION,2.4576e-05,0.60299,0.5696,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00014062,0.60277,0.51978,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.2763e-05,0.60239,0.60126,1,1
5,GO ASTROCYTE ACTIVATION,0.00029789,0.60233,0.50525,1,1
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.6059e-05,0.60133,0.61487,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00015974,0.60093,0.55079,1,1
5,GO MACROPHAGE ACTIVATION,0.00028019,0.59976,0.57228,1,1
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00015974,0.59973,0.56922,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00081392,0.59945,0.49551,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00021879,0.59926,0.57245,1,1
5,GO REGULATION OF T CELL ACTIVATION,0.00021879,0.5986,0.52934,1,1
5,GO NEUTROPHIL EXTRAVASATION,4.2763e-05,0.59815,0.63668,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00011593,0.59766,0.5396,1,1
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00011593,0.59709,0.58047,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00021879,0.597,0.52467,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00040321,0.59683,0.60952,1,1
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.00040321,0.59664,0.57575,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0003797,0.59648,0.5499,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.8267e-05,0.596,0.58093,1,1
5,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0014241,0.59331,0.61045,1,1
5,GO REGULATION OF MACROPHAGE MIGRATION,0.00026348,0.59212,0.53454,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.8565e-05,0.59196,0.58085,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,0.00014062,0.59084,0.52956,1,1
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00042807,0.59005,0.55786,1,1
5,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.6086e-05,0.5891,0.55557,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00010866,0.58884,0.5437,1,1
5,GO LEUKOCYTE PROLIFERATION,0.00020554,0.58708,0.54592,1,1
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.3641e-05,0.58705,0.54953,1,1
5,GO MACROPHAGE CHEMOTAXIS,0.00026348,0.58676,0.525,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00017019,0.5856,0.51813,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0017696,0.58516,0.51447,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.248e-05,0.58501,0.54883,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00021879,0.58457,0.53605,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,7.1973e-06,0.58386,0.59123,1,1
5,GO APOPTOTIC CELL CLEARANCE,0.00072571,0.58385,0.52807,1,1
5,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,3.0304e-05,0.58293,0.62366,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00014062,0.58261,0.51779,1,1
5,GO BLEB ASSEMBLY,0.00019306,0.58221,0.58625,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010181,0.58165,0.55435,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0054671,0.58066,0.48266,1,1
5,GO CELLULAR EXTRAVASATION,0.00035748,0.58055,0.55282,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00018128,0.58043,0.52025,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,3.248e-05,0.57804,0.52207,1,1
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,7.3279e-05,0.57804,0.62912,1,1
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,7.3279e-05,0.5777,0.53471,1,1
5,GO LEUKOCYTE TETHERING OR ROLLING,0.00096503,0.57734,0.51711,1,1
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,6.8565e-05,0.57561,0.60734,1,1
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,8.9327e-05,0.57523,0.51682,1,1
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,9.6689e-06,0.57491,0.60104,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00014062,0.57462,0.51277,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00013188,0.57423,0.52304,1,1
5,GO REGULATION OF CELLULAR EXTRAVASATION,0.00068502,0.57358,0.55967,1,1
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.00010866,0.57269,0.57931,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00035748,0.57191,0.48373,1,1
5,GO BONE TRABECULA MORPHOGENESIS,0.0010798,0.57175,0.51618,1,1
5,GO CELL KILLING,0.00014989,0.57121,0.53053,1,1
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00048214,0.5711,0.57095,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.011063,0.56993,0.45124,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,1.8524e-05,0.56982,0.59658,1,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.00045436,0.56842,0.5033,1,1
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0015882,0.56815,0.49338,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00018128,0.56719,0.54036,1,1
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00045436,0.56605,0.48459,1,1
5,GO ETHANOL METABOLIC PROCESS,7.3279e-05,0.56559,0.592,1,1
5,GO T CELL DIFFERENTIATION,0.00019306,0.5651,0.5113,1,1
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00072571,0.56499,0.58579,1,1
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0003797,0.56493,0.46975,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00014989,0.56483,0.53612,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00081392,0.56355,0.51723,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,1.7249e-05,0.56336,0.56812,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00023283,0.56289,0.52753,1,1
5,GO T CELL ACTIVATION,0.00020554,0.56184,0.51405,1,1
5,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.0021907,0.5613,0.58908,1,1
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.00013188,0.55916,0.58886,1,1
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00017019,0.55882,0.56674,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00072571,0.55858,0.53352,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00023283,0.5585,0.50461,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00020554,0.55815,0.51921,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00035748,0.55776,0.54206,1,1
5,GO REGULATION OF CELL ACTIVATION,0.00026348,0.55727,0.48736,1,1
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00010181,0.55665,0.59283,1,1
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,5.2428e-05,0.55649,0.61324,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00014989,0.5564,0.51238,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.2763e-05,0.55601,0.60202,1,1
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00014062,0.55559,0.52735,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,4.5779e-05,0.55518,0.52553,1,1
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0003797,0.55483,0.61401,1,1
5,GO CD40 SIGNALING PATHWAY,0.00024771,0.55458,0.48901,1,1
5,GO MACROPHAGE DIFFERENTIATION,0.00033648,0.55342,0.48694,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,7.3279e-05,0.55324,0.51155,1,1
5,GO MACROPHAGE PROLIFERATION,0.0031545,0.55304,0.60019,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0003797,0.55302,0.48803,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00014062,0.55301,0.55056,1,1
5,GO NEUTROPHIL HOMEOSTASIS,4.5779e-05,0.55299,0.56035,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00023283,0.54961,0.49944,1,1
5,GO INTEGRIN ACTIVATION,0.00072571,0.54824,0.54308,1,1
5,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.0011418,0.54799,0.47376,1,1
5,GO INTERLEUKIN 6 PRODUCTION,0.00026348,0.5477,0.48649,1,1
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.9936e-05,0.54677,0.54393,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00064645,0.54659,0.49618,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.00040321,0.54573,0.54784,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0010209,0.54435,0.52661,1,1
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00010866,0.54391,0.57298,1,1
5,GO REGULATION OF AMYLOID BETA CLEARANCE,0.00035748,0.54272,0.48898,1,1
5,GO IMMUNE RESPONSE TO TUMOR CELL,5.9985e-05,0.54199,0.55515,1,1
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,9.5377e-05,0.54184,0.53639,1,1
5,GO LEUKOCYTE CHEMOTAXIS,0.00020554,0.54162,0.53458,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.7287e-05,0.54133,0.51349,1,1
5,GO REGULATION OF B CELL ACTIVATION,0.0003797,0.54064,0.54041,1,1
5,GO CYTOKINE SECRETION,0.00011593,0.53883,0.49396,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00019306,0.53815,0.55645,1,1
5,GO NATURAL KILLER CELL ACTIVATION,0.00024771,0.53777,0.50422,1,1
5,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00019306,0.53623,0.49692,1,1
5,GO PHAGOCYTOSIS RECOGNITION,0.0013481,0.53519,0.53121,1,1
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.00051151,0.53496,0.45754,1,1
5,GO RESPONSE TO INTERFERON ALPHA,0.00013188,0.53459,0.61529,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.00012367,0.53391,0.46769,1,1
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00013188,0.53324,0.58542,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00017019,0.53312,0.4916,1,1
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.00029789,0.53121,0.55322,1,1
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00013188,0.5306,0.43611,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00015974,0.52945,0.53197,1,1
5,GO RESPIRATORY BURST,0.00091199,0.52929,0.47675,1,1
5,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.0029965,0.52863,0.53459,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,4.8997e-05,0.52851,0.49456,1,1
5,GO RESPONSE TO MURAMYL DIPEPTIDE,6.4139e-05,0.52787,0.52186,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.9327e-05,0.52709,0.5634,1,1
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.8524e-05,0.52688,0.55105,1,1
5,GO PHAGOCYTOSIS,0.00021879,0.52662,0.47751,1,1
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,1.4947e-05,0.5265,0.54824,1,1
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0029965,0.52179,0.47613,1,1
5,GO ACUTE PHASE RESPONSE,0.00010866,0.52157,0.50809,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.5779e-05,0.52056,0.49305,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.00010181,0.52005,0.45472,1,1
5,GO NAD BIOSYNTHETIC PROCESS,6.8565e-05,0.51974,0.4646,1,1
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.00033648,0.51935,0.45626,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00013188,0.51928,0.43456,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,0.00018128,0.51879,0.48448,1,1
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00076864,0.51822,0.5245,1,1
5,GO MEMBRANE RAFT ORGANIZATION,0.00076864,0.5181,0.47973,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00054254,0.51752,0.50808,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00018128,0.51687,0.46183,1,1
5,GO INNATE IMMUNE RESPONSE,6.8565e-05,0.51676,0.47816,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0304e-05,0.51662,0.53567,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.00020554,0.51467,0.44521,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00018128,0.51355,0.48917,1,1
5,GO LYMPH NODE DEVELOPMENT,0.0063209,0.5135,0.40013,1,1
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0019699,0.5124,0.46589,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00023283,0.51205,0.52865,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,0.00023283,0.51181,0.50743,1,1
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00017019,0.51158,0.5074,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00035748,0.51151,0.41772,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00019306,0.51137,0.47482,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00019306,0.5106,0.47102,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00015974,0.51013,0.48102,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00026348,0.50982,0.48302,1,1
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00029789,0.50977,0.54692,1,1
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.9327e-05,0.50968,0.5808,1,1
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00033648,0.50907,0.47535,1,1
5,GO HUMORAL IMMUNE RESPONSE,0.00023283,0.50903,0.55992,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00031664,0.50762,0.47285,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00010866,0.50734,0.46176,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,9.5377e-05,0.50662,0.47142,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00020554,0.50593,0.52162,1,1
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00042807,0.50566,0.45659,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00068502,0.50515,0.58284,1,1
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0012071,0.50512,0.43809,1,1
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00048214,0.50389,0.4834,1,1
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,9.5377e-05,0.50383,0.54756,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,9.5377e-05,0.50374,0.45978,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00060992,0.50315,0.41383,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,5.6086e-05,0.50298,0.49867,1,1
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,9.5377e-05,0.50266,0.49539,1,1
5,GO REGULATION OF BONE DEVELOPMENT,7.3279e-05,0.50195,0.55854,1,1
5,GO ZYMOGEN INHIBITION,0.00033648,0.50123,0.48489,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00013188,0.50068,0.43483,1,1
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00023283,0.50038,0.51394,1,1
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00048214,0.50017,0.45049,1,1
5,GO REGULATION OF CELL CELL ADHESION,0.00021879,0.4995,0.45851,1,1
5,GO PEPTIDE CROSS LINKING,0.00026348,0.49936,0.51351,1,1
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.7249e-05,0.49869,0.54416,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,5.6086e-05,0.49841,0.46098,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00013188,0.49769,0.4434,1,1
5,GO B CELL HOMEOSTASIS,0.00045436,0.49723,0.43577,1,1
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,3.4805e-05,0.49631,0.59354,1,1
5,GO LYMPHOCYTE ACTIVATION,0.00020554,0.49619,0.4706,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0025648,0.49519,0.46383,1,1
5,GO CHEMOKINE PRODUCTION,9.5377e-05,0.49475,0.50273,1,1
5,GO INTERFERON ALPHA PRODUCTION,0.00010181,0.49438,0.49268,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,9.5377e-05,0.49369,0.46048,1,1
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,8.9327e-05,0.49343,0.47493,1,1
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.00042807,0.49307,0.41884,1,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00064645,0.493,0.49137,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0034935,0.49262,0.49564,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00014062,0.49156,0.4955,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00018128,0.48994,0.47005,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00023283,0.4897,0.46525,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,0.00012367,0.48837,0.57332,1,1
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00024771,0.48797,0.57903,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00023283,0.48777,0.41921,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00096503,0.48758,0.55043,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00013188,0.48748,0.44876,1,1
5,GO LEUKOCYTE DIFFERENTIATION,0.00020554,0.48575,0.45376,1,1
5,GO RESPONSE TO HYDROPEROXIDE,0.00011593,0.48534,0.51343,1,1
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0054671,0.48533,0.46658,1,1
5,GO CYTIDINE TO URIDINE EDITING,0.00054254,0.48504,0.48251,1,1
5,GO THYMOCYTE APOPTOTIC PROCESS,1.2939e-05,0.48473,0.50098,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0017696,0.48471,0.41025,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0044907,0.48421,0.40901,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,0.00020554,0.48417,0.46459,1,1
5,GO TUMOR NECROSIS FACTOR SECRETION,1.2035e-05,0.48379,0.5005,1,1
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0018673,0.48369,0.39952,1,1
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00019306,0.48179,0.55805,1,1
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,8.9327e-05,0.48154,0.44459,1,1
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00014062,0.48143,0.52517,1,1
5,GO CELL CHEMOTAXIS,0.00024771,0.48087,0.47844,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,9.5377e-05,0.48031,0.43624,1,1
5,GO REGULATION OF PLATELET ACTIVATION,0.0023095,0.47964,0.48793,1,1
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00014062,0.47933,0.50243,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.0047188,0.47916,0.42815,1,1
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0010798,0.47893,0.4672,1,1
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00091199,0.4775,0.46309,1,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00045436,0.47674,0.44422,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0036751,0.47659,0.42171,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00011593,0.47596,0.43925,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.5377e-05,0.47587,0.43003,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00096503,0.47557,0.43352,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.4805e-05,0.47525,0.48342,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00045436,0.47383,0.43694,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,8.3641e-05,0.47363,0.49189,1,1
5,GO IRON ION TRANSMEMBRANE TRANSPORT,3.0304e-05,0.47238,0.45636,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.00040321,0.47219,0.41998,1,1
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.4805e-05,0.47205,0.48085,1,1
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00011593,0.47196,0.47546,1,1
5,GO IMMUNE EFFECTOR PROCESS,8.3641e-05,0.47134,0.43519,1,1
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00023283,0.46996,0.44488,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00026348,0.46807,0.45498,1,1
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00020554,0.46797,0.47797,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00015974,0.46775,0.48115,1,1
5,GO MULTI ORGANISM CELLULAR PROCESS,0.00064645,0.46761,0.48639,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,0.00057531,0.46759,0.42185,1,1
5,GO CYTOKINE PRODUCTION,7.8298e-05,0.46663,0.44158,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00010181,0.46561,0.44454,1,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00033648,0.46372,0.48757,1,1
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00012367,0.46312,0.40887,1,1
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0018673,0.46273,0.46236,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,5.9985e-05,0.46224,0.49966,1,1
5,GO MITRAL VALVE DEVELOPMENT,0.00091199,0.46206,0.41833,1,1
5,GO VITAMIN D METABOLIC PROCESS,0.00035748,0.46189,0.44185,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00010866,0.4612,0.41365,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0014241,0.46094,0.42388,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,3.0304e-05,0.4608,0.48286,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,0.00013188,0.46044,0.4698,1,1
5,GO INFLAMMATORY RESPONSE,0.00020554,0.45986,0.45275,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0010209,0.45792,0.4846,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.8565e-05,0.45752,0.4602,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.0015041,0.45702,0.49812,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00024771,0.45683,0.47468,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,8.3641e-05,0.45675,0.44529,1,1
5,GO MYELOID CELL APOPTOTIC PROCESS,1.9888e-05,0.45658,0.45363,1,1
5,GO T CELL LINEAGE COMMITMENT,0.00096503,0.45555,0.45543,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.00013188,0.45539,0.4265,1,1
5,GO IMMUNOGLOBULIN PRODUCTION,0.00020554,0.45536,0.4552,1,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,7.3279e-05,0.45527,0.50581,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00060992,0.45474,0.42198,1,1
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00021879,0.45414,0.47133,1,1
5,GO MEMBRANE INVAGINATION,0.00096503,0.45401,0.41567,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.00029789,0.45391,0.3917,1,1
5,GO CELL JUNCTION DISASSEMBLY,0.00051151,0.45379,0.58983,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.7249e-05,0.45366,0.48855,1,1
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.00023283,0.45297,0.51039,1,1
5,GO MONONUCLEAR CELL DIFFERENTIATION,5.9985e-05,0.45277,0.53194,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0080134,0.45257,0.47577,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00081392,0.45245,0.44083,1,1
5,GO DEFENSE RESPONSE TO VIRUS,3.9936e-05,0.45216,0.45825,1,1
5,GO OSTEOCLAST DIFFERENTIATION,0.00024771,0.45194,0.41013,1,1
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.00064645,0.45165,0.4126,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,8.3641e-05,0.45138,0.46292,1,1
5,GO OSTEOCLAST DEVELOPMENT,0.00020554,0.45102,0.5541,1,1
5,GO LEUKOCYTE MIGRATION,0.00035748,0.45057,0.4542,1,1
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00035748,0.45042,0.52142,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,0.00024771,0.44951,0.42995,1,1
5,GO LIPOPROTEIN LOCALIZATION,0.00029789,0.44937,0.40613,1,1
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00018128,0.44899,0.45356,1,1
5,GO FEVER GENERATION,0.0015882,0.44863,0.36379,1,1
5,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00057531,0.44831,0.41296,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00013188,0.44806,0.43961,1,1
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00026348,0.4473,0.46099,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00020554,0.44606,0.3747,1,1
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00033648,0.445,0.44915,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00021879,0.44395,0.42285,1,1
5,GO AMINE CATABOLIC PROCESS,4.2763e-05,0.44274,0.43039,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0018673,0.44233,0.38691,1,1
5,GO B CELL ACTIVATION,0.00023283,0.44232,0.46853,1,1
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0012758,0.44206,0.40311,1,1
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00012367,0.44182,0.43394,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0012758,0.4418,0.49074,1,1
5,GO RESPONSE TO INTERLEUKIN 2,0.0012071,0.44113,0.51123,1,1
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00019306,0.43965,0.42451,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,5.2428e-05,0.43943,0.49105,1,1
5,GO SOMATIC STEM CELL DIVISION,0.00060992,0.43881,0.49427,1,1
5,GO RESPONSE TO BACTERIUM,9.5377e-05,0.4384,0.46766,1,1
5,GO OSTEOBLAST DEVELOPMENT,0.00054254,0.4378,0.36881,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,6.4139e-05,0.43771,0.41775,1,1
5,GO ACTIVATED T CELL PROLIFERATION,0.00026348,0.43769,0.41499,1,1
5,GO GRANULOCYTE DIFFERENTIATION,0.00060992,0.43724,0.42082,1,1
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,8.3641e-05,0.43612,0.48964,1,1
5,GO DEFENSE RESPONSE,8.3641e-05,0.43559,0.41292,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00026348,0.43511,0.41792,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.00023283,0.43317,0.46895,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00021879,0.43299,0.46699,1,1
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.9843e-06,0.43107,0.46203,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00010866,0.43045,0.38169,1,1
5,GO FLUID TRANSPORT,0.00015974,0.42994,0.46892,1,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00021879,0.42872,0.43865,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0015882,0.42773,0.3703,1,1
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00018128,0.4275,0.40221,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00014989,0.42692,0.45743,1,1
5,GO RETINAL METABOLIC PROCESS,0.00020554,0.42681,0.47283,1,1
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.6086e-05,0.42672,0.41127,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011593,0.42655,0.39474,1,1
5,GO RESPONSE TO TUMOR CELL,0.00026348,0.42621,0.45412,1,1
5,GO CHOLESTEROL STORAGE,0.00042807,0.42593,0.45051,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.00081392,0.42574,0.40859,1,1
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00023283,0.4254,0.47517,1,1
5,GO MYOBLAST FUSION,0.00028019,0.42525,0.44972,1,1
5,GO CELL ACTIVATION,0.00018128,0.4252,0.39886,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.00060992,0.42492,0.48964,1,1
5,GO HYPOTONIC RESPONSE,0.00020554,0.42405,0.40681,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.0023095,0.42358,0.40476,1,1
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.1191e-05,0.42302,0.44446,1,1
5,GO SKIN MORPHOGENESIS,0.0047188,0.42246,0.39058,1,1
5,GO ENTRY INTO HOST,0.00014062,0.42232,0.41537,1,1
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.4576e-05,0.42194,0.48036,1,1
5,GO PROSTANOID METABOLIC PROCESS,0.00021879,0.42193,0.39546,1,1
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00029789,0.42192,0.41325,1,1
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,4.8997e-05,0.42174,0.46801,1,1
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00015974,0.42102,0.47416,1,1
5,GO PINOCYTOSIS,0.00014989,0.42079,0.42585,1,1
5,GO WATER TRANSPORT,0.00091199,0.42075,0.4452,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00017019,0.42065,0.50217,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,8.3641e-05,0.41955,0.38926,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,4.8997e-05,0.41883,0.44074,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.5377e-05,0.41869,0.42559,1,1
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.00031664,0.41862,0.45937,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0023095,0.41789,0.38054,1,1
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.0010209,0.41779,0.37796,1,1
5,GO REGULATION OF INTEGRIN ACTIVATION,0.0019699,0.41706,0.4062,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00064645,0.41656,0.53066,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,7.8298e-05,0.41617,0.43179,1,1
5,GO RESPONSE TO VIRUS,4.5779e-05,0.41608,0.4308,1,1
5,GO RESPONSE TO PROSTAGLANDIN,0.00072571,0.41556,0.40775,1,1
5,GO FOAM CELL DIFFERENTIATION,0.0010209,0.41534,0.41619,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0024341,0.41531,0.41925,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,3.9936e-05,0.41485,0.45561,1,1
5,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.00021879,0.41369,0.3677,1,1
5,GO ASTROCYTE DEVELOPMENT,0.00013188,0.41297,0.45119,1,1
5,GO BONE RESORPTION,0.0024341,0.41212,0.37453,1,1
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,5.6086e-05,0.41146,0.55196,1,1
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00060992,0.41143,0.36456,1,1
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.00029789,0.41134,0.45754,1,1
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.00068502,0.41101,0.46991,1,1
5,GO MACROPHAGE APOPTOTIC PROCESS,0.0010209,0.41083,0.44324,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00031664,0.41003,0.46344,1,1
5,GO PODOSOME ASSEMBLY,0.00010866,0.40984,0.46315,1,1
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0013481,0.40913,0.37709,1,1
5,GO RESPONSE TO INTERLEUKIN 1,1.4947e-05,0.40885,0.38562,1,1
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,2.4576e-05,0.40813,0.42658,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025648,0.40715,0.40951,1,1
5,GO BONE CELL DEVELOPMENT,0.00021879,0.4069,0.43531,1,1
5,GO REGULATION OF DEFENSE RESPONSE,7.8298e-05,0.40659,0.38257,1,1
5,GO RESPONSE TO INTERLEUKIN 4,0.00018128,0.40637,0.39457,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.8565e-05,0.40475,0.38555,1,1
5,GO TRANSCYTOSIS,0.0034935,0.40449,0.39199,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00019306,0.40281,0.4055,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00010181,0.40244,0.38923,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.5779e-05,0.40179,0.4009,1,1
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00035748,0.40165,0.43982,1,1
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00021879,0.40153,0.48991,1,1
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0020776,0.40128,0.3443,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0012758,0.39995,0.47628,1,1
5,GO HETEROTYPIC CELL CELL ADHESION,0.00018128,0.39994,0.43289,1,1
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00048214,0.39978,0.37749,1,1
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026348,0.39929,0.37509,1,1
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00018128,0.39899,0.40182,1,1
5,GO ETHANOL CATABOLIC PROCESS,0.00051151,0.39894,0.38941,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.00072571,0.39838,0.39076,1,1
5,GO SYNCYTIUM FORMATION,0.00028019,0.39817,0.42669,1,1
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013188,0.3973,0.4564,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00054254,0.39702,0.34343,1,1
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00010181,0.3968,0.40384,1,1
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.00064645,0.3967,0.50559,1,1
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00020554,0.39625,0.46095,1,1
5,GO ERK1 AND ERK2 CASCADE,0.00076864,0.39586,0.36479,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,4.2763e-05,0.39529,0.40903,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,6.4139e-05,0.39527,0.38423,1,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00064645,0.39454,0.375,1,1
5,GO SEQUESTERING OF METAL ION,0.00014989,0.39418,0.456,1,1
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00024771,0.39404,0.44228,1,1
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00028019,0.39368,0.41842,1,1
5,GO MUCUS SECRETION,0.00012367,0.39365,0.44589,1,1
5,GO NK T CELL DIFFERENTIATION,0.026142,0.39358,0.35592,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00015974,0.39336,0.44938,1,1
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.00010181,0.39323,0.33412,1,1
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,4.8997e-05,0.39289,0.46143,1,1
5,GO REGULATION OF FIBRINOLYSIS,0.0034935,0.39247,0.42798,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,0.008797,0.39131,0.36996,1,1
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00045436,0.39121,0.38789,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.00076864,0.39108,0.49045,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.00014989,0.39091,0.43265,1,1
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00035748,0.39033,0.46104,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,6.8565e-05,0.39015,0.36635,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00015974,0.38993,0.39696,1,1
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.00045436,0.38943,0.42365,1,1
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0015882,0.38926,0.40159,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.9327e-05,0.3891,0.38624,1,1
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.0010209,0.38807,0.40753,1,1
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0066311,0.38801,0.37972,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00051151,0.38768,0.39402,1,1
5,GO REGULATION OF PODOSOME ASSEMBLY,0.00012367,0.38695,0.45807,1,1
5,GO ETHER BIOSYNTHETIC PROCESS,0.00026348,0.38694,0.37971,1,1
5,GO B CELL DIFFERENTIATION,0.00012367,0.3864,0.46659,1,1
5,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0012071,0.3862,0.34103,1,1
5,GO RESPONSE TO CYTOKINE,6.8565e-05,0.38489,0.37771,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00068502,0.38465,0.41345,1,1
5,GO COLLAGEN CATABOLIC PROCESS,0.0020776,0.38452,0.40625,1,1
5,GO HYALURONAN CATABOLIC PROCESS,0.00064645,0.3842,0.43518,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,6.8565e-05,0.38404,0.40468,1,1
5,GO PROGRAMMED NECROTIC CELL DEATH,0.00064645,0.38372,0.35408,1,1
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00031664,0.38303,0.3346,1,1
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00033648,0.38204,0.65519,1,1
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.00031664,0.38093,0.40458,1,1
5,GO STORE OPERATED CALCIUM ENTRY,0.00035748,0.38056,0.37519,1,1
5,GO STEROL HOMEOSTASIS,0.00024771,0.3805,0.35988,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00048214,0.38022,0.44228,1,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00012367,0.38002,0.32854,1,1
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00020554,0.37975,0.34446,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0031545,0.37938,0.30005,1,1
5,GO CELL ADHESION MOLECULE PRODUCTION,0.00081392,0.37903,0.45277,1,1
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.00018128,0.37901,0.42236,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00086166,0.37879,0.36315,1,1
5,GO COLLAGEN BIOSYNTHETIC PROCESS,0.0016767,0.37869,0.41934,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.2763e-05,0.37863,0.41731,1,1
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00029789,0.37841,0.4028,1,1
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00048214,0.3783,0.3514,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00010866,0.37829,0.48338,1,1
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0013481,0.37766,0.42989,1,1
5,GO MYOBLAST MIGRATION,0.0044907,0.37736,0.31376,1,1
5,GO SKELETAL MUSCLE TISSUE REGENERATION,8.9843e-06,0.37676,0.40872,1,1
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.00045436,0.37619,0.38268,1,1
5,GO ACTIN FILAMENT SEVERING,0.0013481,0.37599,0.42551,1,1
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0042727,0.37571,0.45068,1,1
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00010866,0.37545,0.40287,1,1
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0047188,0.37495,0.34797,1,1
5,GO T CELL HOMEOSTASIS,0.00054254,0.37484,0.34929,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.008797,0.37454,0.31265,1,1
5,GO NIK NF KAPPAB SIGNALING,2.4576e-05,0.37439,0.35695,1,1
5,GO REGULATION OF STEROL TRANSPORT,0.00091199,0.37426,0.34991,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00010181,0.37422,0.38882,1,1
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0012758,0.37381,0.40651,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.0012758,0.37372,0.31653,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00028019,0.37344,0.35291,1,1
5,GO REGULATION OF LIPID KINASE ACTIVITY,0.0014241,0.37328,0.36274,1,1
5,GO PSEUDOPODIUM ORGANIZATION,0.00040321,0.37315,0.38768,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00015974,0.3728,0.34179,1,1
5,GO REGULATION OF LIPASE ACTIVITY,0.00013188,0.37253,0.37998,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.636e-05,0.37237,0.40062,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0013481,0.37217,0.37483,1,1
5,GO REGULATION OF HEMOPOIESIS,0.00010181,0.37198,0.36919,1,1
5,GO RETINOL METABOLIC PROCESS,1.9888e-05,0.37165,0.39101,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00021879,0.37002,0.39799,1,1
5,GO PROTEIN NITROSYLATION,0.00013188,0.36994,0.37585,1,1
5,GO VAGINA DEVELOPMENT,0.0044907,0.36992,0.33797,1,1
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0044907,0.36978,0.36275,1,1
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00072571,0.3693,0.35699,1,1
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,6.4139e-05,0.36913,0.35064,1,1
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.00051151,0.36909,0.35211,1,1
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00048214,0.36891,0.41984,1,1
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00029789,0.36829,0.38062,1,1
5,GO DIET INDUCED THERMOGENESIS,0.0011418,0.36805,0.34593,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0020776,0.36804,0.33879,1,1
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00012367,0.36804,0.39235,1,1
5,GO RESPONSE TO INTERLEUKIN 7,0.00064645,0.36725,0.36024,1,1
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,3.7287e-05,0.36706,0.51387,1,1
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0040644,0.36594,0.34309,1,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.0304e-05,0.36523,0.40416,1,1
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,7.8298e-05,0.36514,0.39572,1,1
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,7.8298e-05,0.36477,0.38338,1,1
5,GO PYROPTOSIS,0.00086166,0.36451,0.40789,1,1
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,8.9843e-06,0.3645,0.39308,1,1
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,8.9327e-05,0.36379,0.40074,1,1
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00019306,0.36369,0.37403,1,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00019306,0.36329,0.44755,1,1
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.00060992,0.36273,0.36943,1,1
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.0047188,0.36266,0.35785,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0016767,0.3625,0.37595,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0010798,0.36249,0.39176,1,1
5,GO COLLAGEN METABOLIC PROCESS,0.0027019,0.36174,0.38093,1,1
5,GO REGULATION OF CHEMOTAXIS,0.00040321,0.36171,0.38537,1,1
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0019699,0.36089,0.37753,1,1
5,GO INTERFERON BETA PRODUCTION,9.5377e-05,0.36085,0.39826,1,1
5,GO MOVEMENT IN HOST ENVIRONMENT,8.9327e-05,0.35982,0.36483,1,1
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.00068502,0.35955,0.39496,1,1
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0025648,0.35922,0.34185,1,1
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,7.3279e-05,0.35903,0.42469,1,1
5,GO MAST CELL ACTIVATION,0.0083971,0.35893,0.34092,1,1
5,GO RESPONSE TO FUNGUS,0.0024341,0.35837,0.37142,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0021907,0.35789,0.39818,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0052065,0.35748,0.34525,1,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00086166,0.35628,0.31729,1,1
5,GO PROSTATE GLAND GROWTH,0.00035748,0.3561,0.39392,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.00081392,0.35583,0.33202,1,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00029789,0.35578,0.39006,1,1
5,GO MAST CELL MEDIATED IMMUNITY,0.010572,0.35537,0.32367,1,1
5,GO INTERACTION WITH SYMBIONT,8.9843e-06,0.35537,0.38143,1,1
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0021907,0.35371,0.40379,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00021879,0.3533,0.36353,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00068502,0.35325,0.4295,1,1
5,GO ZYMOGEN ACTIVATION,0.0016767,0.35312,0.37112,1,1
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.00057531,0.35308,0.43191,1,1
5,GO TRABECULA FORMATION,0.0063209,0.35272,0.3273,1,1
5,GO LYMPHANGIOGENESIS,0.00091199,0.35256,0.43366,1,1
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0031545,0.35213,0.39584,1,1
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.0028457,0.35159,0.43711,1,1
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.0013481,0.35147,0.38357,1,1
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00045436,0.35067,0.42572,1,1
5,GO GLYCOLIPID CATABOLIC PROCESS,0.00086166,0.35055,0.42596,1,1
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0010209,0.35036,0.37839,1,1
5,GO POSITIVE REGULATION OF LIPID STORAGE,0.00086166,0.35001,0.38746,1,1
5,GO MYELOID CELL DEVELOPMENT,7.3279e-05,0.34956,0.38845,1,1
5,GO COLLAGEN FIBRIL ORGANIZATION,0.012106,0.3481,0.43171,1,1
5,GO REGULATION OF BONE REMODELING,0.0083971,0.34799,0.30233,1,1
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00020554,0.34769,0.3358,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0024341,0.34766,0.42604,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,7.8298e-05,0.34737,0.38445,1,1
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,4.2763e-05,0.34728,0.38395,1,1
5,GO GAP JUNCTION ASSEMBLY,0.010101,0.34563,0.39516,1,1
5,GO PROTEIN TRIMERIZATION,0.0015882,0.34538,0.41212,1,1
5,GO RESPONSE TO ANGIOTENSIN,0.00081392,0.34408,0.32,1,1
5,GO RENAL ABSORPTION,0.0021907,0.34367,0.42817,1,1
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0066311,0.34356,0.37697,1,1
5,GO ENDODERMAL CELL DIFFERENTIATION,0.0021907,0.34286,0.42034,1,1
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0023095,0.34275,0.34683,1,1
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0015041,0.34268,0.398,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,5.6086e-05,0.34237,0.39047,1,1
5,GO BONE REMODELING,0.0025648,0.34227,0.33118,1,1
5,GO REGULATION OF RECEPTOR BINDING,0.00035748,0.34186,0.38703,1,1
5,GO REGULATION OF CELL ADHESION,0.0003797,0.34156,0.3809,1,1
5,GO TONIC SMOOTH MUSCLE CONTRACTION,0.00033648,0.34151,0.38105,1,1
5,GO RESPONSE TO PROSTAGLANDIN E,0.00332,0.34034,0.37066,1,1
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.00081392,0.33999,0.36898,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.006955,0.33998,0.30226,1,1
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0014241,0.3393,0.36557,1,1
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00026348,0.33911,0.35896,1,1
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.00031664,0.33896,0.38154,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00019306,0.33869,0.33402,1,1
5,GO LIPOXYGENASE PATHWAY,0.041938,0.33859,0.3021,1,1
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.00018128,0.33842,0.32645,1,1
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0028457,0.33814,0.30158,1,1
5,GO RESPONSE TO MANGANESE ION,0.00024771,0.33755,0.33523,1,1
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0020776,0.33743,0.38062,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0003797,0.33674,0.39815,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00045436,0.33662,0.35585,1,1
5,GO MODULATION BY HOST OF VIRAL PROCESS,3.0304e-05,0.33639,0.35733,1,1
5,GO LAMELLIPODIUM MORPHOGENESIS,0.0003797,0.33593,0.34589,1,1
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00024771,0.3359,0.39922,1,1
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00057531,0.33566,0.40232,1,1
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00076864,0.33536,0.34029,1,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.00033648,0.33515,0.38667,1,1
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00060992,0.33482,0.34269,1,1
5,GO DRUG CATABOLIC PROCESS,0.0016767,0.33475,0.27974,1,1
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0012758,0.33464,0.40737,1,1
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00081392,0.33447,0.39859,1,1
5,GO TYPE I INTERFERON PRODUCTION,0.00013188,0.33412,0.35029,1,1
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,7.3279e-05,0.33402,0.40841,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00035748,0.33371,0.38246,1,1
5,GO LIVER MORPHOGENESIS,0.00035748,0.33333,0.35516,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00081392,0.33201,0.38541,1,1
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.0020776,0.3317,0.34213,1,1
5,GO NOTOCHORD DEVELOPMENT,0.0018673,0.33149,0.32237,1,1
5,GO EPIDERMIS MORPHOGENESIS,0.0010798,0.33125,0.35813,1,1
5,GO DETERMINATION OF ADULT LIFESPAN,0.0042727,0.33112,0.2657,1,1
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0015882,0.33107,0.35521,1,1
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00017019,0.33097,0.3197,1,1
5,GO SERTOLI CELL DEVELOPMENT,0.00014989,0.33071,0.36796,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0031545,0.33027,0.35131,1,1
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00018128,0.32945,0.37048,1,1
5,GO CORNIFICATION,0.0018673,0.32874,0.31114,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00029789,0.32864,0.36331,1,1
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00054254,0.32864,0.30669,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.0015041,0.32848,0.33885,1,1
5,GO TRANSEPITHELIAL TRANSPORT,0.0027019,0.32791,0.32073,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.006955,0.32743,0.38907,1,1
5,GO POSITIVE REGULATION OF HAIR CYCLE,0.0018673,0.32732,0.32979,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00086166,0.32724,0.32453,1,1
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00040321,0.32706,0.38806,1,1
5,GO CELLULAR RESPONSE TO SALT STRESS,9.5377e-05,0.32699,0.40704,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.007293,0.32678,0.31469,1,1
5,GO REGULATION OF LIPID STORAGE,0.00048214,0.32669,0.32966,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0023095,0.32665,0.35317,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.00015974,0.32632,0.31988,1,1
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.0049572,0.32572,0.49681,1,1
5,GO LYMPH VESSEL DEVELOPMENT,0.0018673,0.32567,0.41592,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.00033648,0.32516,0.34526,1,1
5,GO REGULATION OF PLATELET AGGREGATION,0.0057394,0.32504,0.34434,1,1
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00014062,0.32388,0.34822,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00051151,0.3232,0.30144,1,1
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.0025648,0.32311,0.27226,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.0012758,0.32307,0.34233,1,1
5,GO REGULATION OF VIRAL LIFE CYCLE,5.9985e-05,0.32252,0.36929,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00060992,0.32224,0.31541,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00096503,0.32199,0.31606,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00028019,0.32181,0.4012,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0015882,0.32173,0.35746,1,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00014062,0.32153,0.4005,1,1
5,GO SUPEROXIDE METABOLIC PROCESS,0.00057531,0.3213,0.32502,1,1
5,GO LUNG MORPHOGENESIS,0.00096503,0.32117,0.34831,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0017696,0.32065,0.37676,1,1
5,GO RECEPTOR BIOSYNTHETIC PROCESS,7.3279e-05,0.32049,0.32879,1,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00051151,0.32016,0.40623,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,6.8565e-05,0.32011,0.34064,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.00040321,0.31984,0.3164,1,1
5,GO CHOLESTEROL EFFLUX,0.0044907,0.31977,0.28003,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00023283,0.31905,0.42583,1,1
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00012367,0.31884,0.40751,1,1
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0034935,0.31783,0.33582,1,1
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0034935,0.31691,0.28565,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0018673,0.31687,0.34529,1,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00029789,0.31678,0.38189,1,1
5,GO P38MAPK CASCADE,0.00048214,0.31666,0.3614,1,1
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,6.4139e-05,0.31658,0.31436,1,1
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00051151,0.31576,0.39647,1,1
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00014062,0.31553,0.42449,1,1
5,GO CELL AGGREGATION,0.013235,0.31516,0.27143,1,1
5,GO RESPONSE TO THYROID HORMONE,0.0023095,0.31484,0.28892,1,1
5,GO RESPONSE TO DSRNA,0.00033648,0.31472,0.3039,1,1
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0036751,0.31462,0.35774,1,1
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00010181,0.31456,0.36642,1,1
5,GO BRONCHUS DEVELOPMENT,0.00072571,0.31425,0.43012,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00051151,0.31411,0.41053,1,1
5,GO CELLULAR RESPONSE TO VIRUS,0.00018128,0.31399,0.37994,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0010209,0.31392,0.31568,1,1
5,GO STEROID ESTERIFICATION,0.0066311,0.31356,0.24762,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00031664,0.31338,0.31993,1,1
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.0044907,0.31299,0.30438,1,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0057394,0.31258,0.37301,1,1
5,GO REGULATION OF CALCIUM ION IMPORT,0.0025648,0.31143,0.32064,1,1
5,GO RIG I SIGNALING PATHWAY,7.3279e-05,0.31131,0.32567,1,1
5,GO O GLYCAN PROCESSING,0.0015041,0.31106,0.27905,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00057531,0.31106,0.33599,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.00064645,0.31095,0.35902,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00033648,0.31027,0.34952,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0040644,0.31013,0.33807,1,1
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0015041,0.30962,0.30114,1,1
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0018673,0.30944,0.27085,1,1
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.013235,0.30924,0.34249,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0066311,0.30909,0.34744,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,0.00045436,0.30887,0.38018,1,1
5,GO REGULATION OF TISSUE REMODELING,0.0057394,0.30872,0.30846,1,1
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.015776,0.3086,0.28174,1,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,8.9327e-05,0.30837,0.28748,1,1
5,GO PRIMARY MIRNA PROCESSING,0.0017696,0.30819,0.37954,1,1
5,GO AMYLOID FIBRIL FORMATION,0.0025648,0.30797,0.33504,1,1
5,GO REGULATION OF ISOTYPE SWITCHING,0.00042807,0.30779,0.37014,1,1
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00048214,0.30733,0.33841,1,1
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.00060992,0.30664,0.40905,1,1
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0080134,0.30662,0.29995,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00020554,0.30629,0.32114,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,0.00014989,0.30624,0.35001,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,0.00051151,0.30619,0.35637,1,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.2428e-05,0.30614,0.40599,1,1
5,GO MUSCLE CELL FATE COMMITMENT,0.00028019,0.30552,0.35865,1,1
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0010798,0.30546,0.35917,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00029789,0.30477,0.27936,1,1
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.0015882,0.30468,0.34837,1,1
5,GO MEMBRANE PROTEIN PROTEOLYSIS,0.00054254,0.3046,0.35879,1,1
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.00072571,0.30454,0.33758,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0040644,0.30421,0.35382,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00040321,0.30384,0.31561,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.0013481,0.3029,0.30219,1,1
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.010572,0.30276,0.35056,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00028019,0.30268,0.3182,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00060992,0.3024,0.35284,1,1
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.0016767,0.30231,0.32629,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0011418,0.30206,0.29304,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.030713,0.30194,0.32143,1,1
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0054671,0.30142,0.36005,1,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00010181,0.30084,0.26938,1,1
5,GO CERAMIDE TRANSPORT,0.019548,0.30061,0.2363,1,1
5,GO REGULATION OF PINOCYTOSIS,0.0016767,0.30037,0.32327,1,1
5,GO PLATELET DEGRANULATION,0.0034935,0.29996,0.37291,1,1
5,GO FC RECEPTOR SIGNALING PATHWAY,0.00012367,0.29936,0.30488,1,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0044907,0.29932,0.44179,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00018128,0.29896,0.32339,1,1
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0029965,0.29862,0.36038,1,1
5,GO REGULATION OF SYMBIOTIC PROCESS,4.2763e-05,0.29858,0.32875,1,1
5,GO TONGUE DEVELOPMENT,0.0034935,0.29848,0.2558,1,1
5,GO RESPONSE TO DEXAMETHASONE,0.00012367,0.29841,0.28758,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0012071,0.29798,0.3797,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00096503,0.29763,0.37639,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,0.00015974,0.29759,0.33342,1,1
5,GO RESPONSE TO MINERALOCORTICOID,0.02951,0.29747,0.22619,1,1
5,GO CELLULAR RESPONSE TO X RAY,0.00081392,0.29728,0.35418,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0029965,0.297,0.34218,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.0024341,0.29692,0.3869,1,1
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00042807,0.29666,0.37656,1,1
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0083971,0.29632,0.26211,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.2428e-05,0.29631,0.36096,1,1
5,GO RESPONSE TO INACTIVITY,0.0044907,0.29562,0.26542,1,1
5,GO NECROTIC CELL DEATH,0.00091199,0.29506,0.29348,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00026348,0.29499,0.3378,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.00013188,0.2949,0.32657,1,1
5,GO TISSUE REMODELING,0.0018673,0.29487,0.35463,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0012758,0.29427,0.33992,1,1
5,GO INTERACTION WITH HOST,5.6086e-05,0.29417,0.30811,1,1
5,GO CALCIUM MEDIATED SIGNALING,0.0015041,0.29415,0.30289,1,1
5,GO KERATINOCYTE PROLIFERATION,0.0018673,0.29407,0.30466,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00023283,0.29389,0.30496,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00031664,0.29377,0.35046,1,1
5,GO STEM CELL DIVISION,0.0014241,0.29374,0.32422,1,1
5,GO REGULATION OF ODONTOGENESIS,0.0049572,0.29374,0.32334,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00068502,0.29369,0.32908,1,1
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0040644,0.29335,0.34027,1,1
5,GO DECIDUALIZATION,0.0080134,0.29291,0.30178,1,1
5,GO EPITHELIAL CELL CELL ADHESION,0.0092139,0.29274,0.30654,1,1
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00045436,0.29253,0.28746,1,1
5,GO CELLULAR RESPONSE TO DSRNA,0.00081392,0.29226,0.35268,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00086166,0.29175,0.32879,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,0.0054671,0.29124,0.26182,1,1
5,GO NEGATIVE REGULATION OF GENE SILENCING,0.00010866,0.29091,0.34748,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.0014241,0.28977,0.33151,1,1
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00076864,0.28977,0.36669,1,1
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0038653,0.2897,0.35944,1,1
5,GO ARTERY MORPHOGENESIS,0.0003797,0.28959,0.37238,1,1
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.00051151,0.28933,0.3541,1,1
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00026348,0.28905,0.35188,1,1
5,GO MANGANESE ION TRANSPORT,0.00026348,0.28901,0.29256,1,1
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.016475,0.28896,0.2735,1,1
5,GO ARGININE METABOLIC PROCESS,0.00076864,0.28889,0.295,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.0083971,0.28869,0.31673,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0011418,0.28795,0.36548,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.8267e-05,0.28742,0.33039,1,1
5,GO URETER DEVELOPMENT,0.024086,0.28734,0.21688,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.00064645,0.28612,0.32685,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.0028457,0.28602,0.37264,1,1
5,GO REGULATION OF CELL FATE COMMITMENT,0.00033648,0.28567,0.34495,1,1
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0012758,0.28516,0.33832,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,9.5377e-05,0.28515,0.34116,1,1
5,GO BARBED END ACTIN FILAMENT CAPPING,0.0010798,0.28504,0.29885,1,1
5,GO TERPENOID METABOLIC PROCESS,8.9327e-05,0.28499,0.28117,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.00054254,0.28465,0.32152,1,1
5,GO ICOSANOID METABOLIC PROCESS,0.00091199,0.28446,0.31273,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0049572,0.28408,0.34154,1,1
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0083971,0.28398,0.25449,1,1
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,1.1191e-05,0.28383,0.33022,1,1
5,GO COPPER ION TRANSPORT,0.00064645,0.28383,0.31424,1,1
5,GO RUFFLE ORGANIZATION,0.00033648,0.28348,0.32293,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.00040321,0.28342,0.27035,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0042727,0.28317,0.30829,1,1
5,GO PLATELET ACTIVATION,0.010572,0.28316,0.30413,1,1
5,GO RESPONSE TO GROWTH HORMONE,9.5377e-05,0.28301,0.30215,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0012758,0.28297,0.36086,1,1
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.00024771,0.28291,0.36569,1,1
5,GO PULMONARY VALVE DEVELOPMENT,0.0054671,0.28264,0.37834,1,1
5,GO SEQUESTERING OF CALCIUM ION,0.0040644,0.28258,0.28253,1,1
5,GO GLIAL CELL PROLIFERATION,0.00076864,0.28227,0.32869,1,1
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.0020776,0.2822,0.29822,1,1
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0010209,0.28207,0.31059,1,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.021265,0.28163,0.27911,1,1
5,GO RESPONSE TO NITRIC OXIDE,0.0027019,0.2816,0.25594,1,1
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.0024341,0.28101,0.40516,1,1
5,GO RESPONSE TO STEROL,0.0003797,0.28094,0.31807,1,1
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.0013481,0.28092,0.28586,1,1
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00045436,0.28082,0.34175,1,1
5,GO ACTIN FILAMENT BASED TRANSPORT,0.0018673,0.28067,0.33047,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0013481,0.28064,0.29133,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0028457,0.2804,0.30095,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0015041,0.28038,0.24127,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,0.00051151,0.27988,0.3243,1,1
5,GO B CELL APOPTOTIC PROCESS,0.00042807,0.27924,0.32948,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.024086,0.27912,0.26705,1,1
5,GO ENDODERM DEVELOPMENT,0.0027019,0.27899,0.31788,1,1
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0010209,0.27893,0.30156,1,1
5,GO BEHAVIORAL RESPONSE TO PAIN,0.0047188,0.27871,0.28848,1,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.0013481,0.27868,0.29769,1,1
5,GO RESPONSE TO INTERLEUKIN 12,0.00024771,0.27853,0.28685,1,1
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0024341,0.27839,0.24036,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0016767,0.27826,0.29623,1,1
5,GO PEPTIDYL TYROSINE MODIFICATION,0.00040321,0.27807,0.3151,1,1
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00076864,0.27797,0.35527,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0015882,0.27758,0.36076,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0024341,0.2775,0.31596,1,1
5,GO INTRACELLULAR STEROL TRANSPORT,0.0003797,0.27748,0.30639,1,1
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,7.8298e-05,0.27732,0.32282,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00029789,0.27722,0.28082,1,1
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0096484,0.27668,0.30917,1,1
5,GO HEPATOCYTE DIFFERENTIATION,0.035953,0.27655,0.20581,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0015041,0.27637,0.3181,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,0.0017696,0.27617,0.32574,1,1
5,GO REGULATION OF AMYLOID BETA FORMATION,0.00035748,0.27589,0.32862,1,1
5,GO SALIVA SECRETION,0.0025648,0.27499,0.32787,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00072571,0.27485,0.33428,1,1
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0010209,0.27458,0.3153,1,1
5,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0060238,0.27416,0.31899,1,1
5,GO GLOMERULUS DEVELOPMENT,0.0054671,0.27405,0.34851,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0057394,0.27401,0.32284,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00026348,0.27398,0.30062,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.006955,0.27395,0.25645,1,1
5,GO ENDODERM FORMATION,0.0014241,0.27352,0.39361,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.045233,0.27335,0.19603,1,1
5,GO ARACHIDONIC ACID SECRETION,0.0052065,0.27327,0.23947,1,1
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0057394,0.27318,0.27625,1,1
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00024771,0.27287,0.25803,1,1
5,GO TRACHEA DEVELOPMENT,0.0014241,0.27272,0.3541,1,1
5,GO DRUG METABOLIC PROCESS,0.00064645,0.27238,0.29836,1,1
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00010866,0.27191,0.33902,1,1
5,GO TRABECULA MORPHOGENESIS,0.010572,0.27155,0.29166,1,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.00096503,0.27126,0.3001,1,1
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.0027019,0.27116,0.27166,1,1
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0042727,0.2707,0.30403,1,1
5,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0012758,0.2701,0.31385,1,1
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00018128,0.26945,0.32013,1,1
5,GO REGULATION OF PROTEIN MATURATION,0.00018128,0.26938,0.32459,1,1
5,GO COAGULATION,0.0057394,0.26875,0.28402,1,1
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0044907,0.26857,0.26536,1,1
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.00051151,0.26834,0.37237,1,1
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0027019,0.26831,0.32096,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.0028457,0.26825,0.29781,1,1
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.00020554,0.26818,0.26708,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00029789,0.26795,0.33911,1,1
5,GO SKELETAL MUSCLE CELL PROLIFERATION,0.0040644,0.26771,0.30053,1,1
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0080134,0.2677,0.22927,1,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.0018673,0.26766,0.34529,1,1
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.0092139,0.26752,0.39537,1,1
5,GO LYMPH VESSEL MORPHOGENESIS,0.0025648,0.26728,0.38779,1,1
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00060992,0.26728,0.29421,1,1
5,GO REGULATION OF DNA METHYLATION,0.0012758,0.26728,0.25064,1,1
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.006955,0.26682,0.36148,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00028019,0.26637,0.30541,1,1
5,GO ISOPRENOID METABOLIC PROCESS,6.8565e-05,0.26631,0.25002,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.00035748,0.26619,0.35767,1,1
5,GO HEAD MORPHOGENESIS,0.033245,0.26618,0.23897,1,1
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0044907,0.26596,0.27675,1,1
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0096484,0.26586,0.28861,1,1
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00015974,0.26586,0.2929,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0038653,0.26536,0.24878,1,1
5,GO REGULATION OF CELL SHAPE,0.00040321,0.26534,0.32528,1,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0019699,0.26515,0.28923,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.008797,0.26481,0.24979,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0172,0.26457,0.24739,1,1
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.248e-05,0.26449,0.29978,1,1
5,GO WOUND HEALING,0.0021907,0.26422,0.30143,1,1
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00042807,0.26382,0.32452,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.5377e-05,0.26375,0.29887,1,1
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.0054671,0.26358,0.32057,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,0.0049572,0.26313,0.21247,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.008797,0.26289,0.25577,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.0003797,0.26285,0.27957,1,1
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0023095,0.26235,0.26127,1,1
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.0052065,0.26222,0.37812,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0054671,0.26208,0.26099,1,1
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0017696,0.26207,0.37673,1,1
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00015974,0.26159,0.32074,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1347e-05,0.26151,0.30684,1,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.0012071,0.26133,0.28721,1,1
5,GO REPLACEMENT OSSIFICATION,0.00332,0.26099,0.3246,1,1
5,GO ARTERY DEVELOPMENT,0.0003797,0.2608,0.37109,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.0013481,0.26034,0.33998,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0016767,0.26018,0.28109,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.030713,0.25919,0.27271,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,0.0049572,0.25915,0.24407,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00081392,0.25906,0.28248,1,1
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0014241,0.25889,0.26786,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0040644,0.25869,0.26251,1,1
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.00051151,0.25844,0.347,1,1
5,GO HIPPO SIGNALING,0.0054671,0.25837,0.29328,1,1
5,GO FOREGUT MORPHOGENESIS,0.0020776,0.25804,0.34463,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.00040321,0.2577,0.31083,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0013481,0.25769,0.30455,1,1
5,GO REGULATION OF WOUND HEALING,0.0031545,0.25762,0.32132,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0172,0.25751,0.25702,1,1
5,GO SULFATION,0.013834,0.25742,0.25299,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00035748,0.25732,0.28764,1,1
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0029965,0.25705,0.31959,1,1
5,GO AMINO SUGAR METABOLIC PROCESS,0.0011418,0.25699,0.30697,1,1
5,GO CELL CELL RECOGNITION,7.3279e-05,0.25656,0.29326,1,1
5,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.0092139,0.25653,0.24606,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0025648,0.25633,0.32519,1,1
5,GO RESPONSE TO AMYLOID BETA,0.02951,0.25601,0.24922,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00042807,0.25555,0.29955,1,1
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0014241,0.25524,0.33613,1,1
5,GO VIRAL GENOME REPLICATION,0.00018128,0.25515,0.31729,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.007293,0.25505,0.26545,1,1
5,GO AMELOGENESIS,0.0010798,0.255,0.32005,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00026348,0.25477,0.2628,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0042727,0.25474,0.30626,1,1
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0018673,0.25468,0.32582,1,1
5,GO VIRAL LIFE CYCLE,5.6086e-05,0.25462,0.30163,1,1
5,GO PEPTIDE CATABOLIC PROCESS,0.0042727,0.25451,0.31409,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.00045436,0.25407,0.30022,1,1
5,GO PROSTAGLANDIN TRANSPORT,0.0066311,0.25381,0.31101,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0080134,0.25337,0.29915,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00072571,0.25337,0.30061,1,1
5,GO GLAND MORPHOGENESIS,0.0017696,0.2528,0.32774,1,1
5,GO CELLULAR OXIDANT DETOXIFICATION,0.00026348,0.25257,0.25869,1,1
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0014241,0.25222,0.29995,1,1
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.00081392,0.25188,0.33174,1,1
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00064645,0.25184,0.31118,1,1
5,GO MATERNAL PLACENTA DEVELOPMENT,0.0042727,0.25153,0.2658,1,1
5,GO PLATELET AGGREGATION,0.006955,0.25144,0.33785,1,1
5,GO EPIBOLY,0.00064645,0.25133,0.32935,1,1
5,GO PROSTATE GLAND DEVELOPMENT,0.0010798,0.25106,0.32245,1,1
5,GO MRNA TRANSCRIPTION,0.0024341,0.251,0.29848,1,1
5,GO TISSUE MIGRATION,0.0020776,0.251,0.30431,1,1
5,GO GLYCOPROTEIN CATABOLIC PROCESS,0.010101,0.25089,0.24803,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,0.0042727,0.2508,0.28723,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.021265,0.25044,0.26042,1,1
5,GO FACE DEVELOPMENT,0.008797,0.25035,0.27803,1,1
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.00042807,0.25024,0.26495,1,1
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.006955,0.2502,0.31974,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0021907,0.24999,0.281,1,1
5,GO RESPONSE TO X RAY,0.0015882,0.24993,0.26632,1,1
5,GO HEAT GENERATION,0.015776,0.24975,0.23933,1,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0038653,0.24966,0.31719,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.013235,0.2496,0.26909,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.018736,0.24955,0.3239,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.00018128,0.24954,0.28405,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.019548,0.24936,0.22877,1,1
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.0020776,0.24893,0.25027,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0010209,0.24864,0.31709,1,1
5,GO FEMALE GENITALIA DEVELOPMENT,0.0038653,0.24862,0.22371,1,1
5,GO ODONTOGENESIS,0.0015882,0.24837,0.27198,1,1
5,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0012071,0.24832,0.24984,1,1
5,GO REGULATION OF MIRNA METABOLIC PROCESS,0.011063,0.24818,0.25194,1,1
5,GO RESPONSE TO RETINOIC ACID,0.00068502,0.24809,0.28786,1,1
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.0057394,0.24793,0.28963,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.0015882,0.24746,0.34159,1,1
5,GO FIBROBLAST APOPTOTIC PROCESS,0.00064645,0.24739,0.28458,1,1
5,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00081392,0.24715,0.27793,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00014062,0.24707,0.30341,1,1
5,GO ENAMEL MINERALIZATION,0.0038653,0.24706,0.35564,1,1
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00086166,0.24691,0.30213,1,1
5,GO PROTEIN KINASE B SIGNALING,0.00086166,0.24689,0.29266,1,1
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0012071,0.24688,0.26788,1,1
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.018736,0.24687,0.22185,1,1
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.0013481,0.24673,0.27375,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.012106,0.2466,0.22678,1,1
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.010572,0.2466,0.34037,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.025096,0.24637,0.21354,1,1
5,GO INOSITOL LIPID MEDIATED SIGNALING,0.00060992,0.24635,0.31089,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.008797,0.24605,0.24193,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.021265,0.2458,0.29457,1,1
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0047188,0.24576,0.35179,1,1
5,GO MUSCLE CELL PROLIFERATION,0.00091199,0.24556,0.30738,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0010209,0.24522,0.2491,1,1
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,8.9327e-05,0.24509,0.27495,1,1
5,GO PROTEIN DEGLYCOSYLATION,0.00091199,0.24469,0.32709,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0021907,0.24424,0.26403,1,1
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00051151,0.24422,0.28238,1,1
5,GO AMYLOID BETA FORMATION,0.00042807,0.24418,0.28927,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00012367,0.24416,0.26225,1,1
5,GO RESPONSE TO FATTY ACID,0.00054254,0.24388,0.25967,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00018128,0.24373,0.30233,1,1
5,GO CELL MATRIX ADHESION,0.0066311,0.24367,0.31058,1,1
5,GO CELL SUBSTRATE ADHESION,0.0066311,0.24362,0.31502,1,1
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0019699,0.24359,0.25025,1,1
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.0014241,0.24325,0.37835,1,1
5,GO REGULATION OF TRANSPOSITION,0.043559,0.24316,0.18357,1,1
5,GO REGULATION OF GASTRULATION,0.00054254,0.24288,0.3085,1,1
5,GO FIBROBLAST ACTIVATION,0.010101,0.24284,0.26658,1,1
5,GO CELL REDOX HOMEOSTASIS,0.00048214,0.24258,0.27675,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,0.0017696,0.24252,0.29912,1,1
5,GO ENDODERMAL CELL FATE COMMITMENT,0.011574,0.2425,0.2398,1,1
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00081392,0.24238,0.30165,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,6.4139e-05,0.24201,0.2835,1,1
5,GO ERBB2 SIGNALING PATHWAY,0.00035748,0.24192,0.27144,1,1
5,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00015974,0.24186,0.23445,1,1
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.006955,0.24175,0.24157,1,1
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.012106,0.2417,0.27197,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0025648,0.24167,0.28115,1,1
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0042727,0.24155,0.23453,1,1
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0172,0.24144,0.27712,1,1
5,GO CELL CELL JUNCTION MAINTENANCE,0.0034935,0.24121,0.30835,1,1
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.022172,0.2405,0.22609,1,1
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.011574,0.23997,0.23165,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00072571,0.23975,0.26222,1,1
5,GO PANCREATIC JUICE SECRETION,0.0083971,0.23952,0.26266,1,1
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0172,0.23936,0.1885,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0015041,0.23929,0.34745,1,1
5,GO TISSUE REGENERATION,0.00054254,0.23919,0.24905,1,1
5,GO PROTEIN DEMANNOSYLATION,0.0016767,0.23908,0.3031,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.0014241,0.23876,0.25862,1,1
5,GO RESPONSE TO LIPID,0.00068502,0.23873,0.26221,1,1
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.00018128,0.23847,0.30667,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.006955,0.23835,0.25068,1,1
5,GO BLOOD VESSEL MORPHOGENESIS,0.0014241,0.23794,0.33962,1,1
5,GO RESPONSE TO ANTIBIOTIC,0.00015974,0.23791,0.25511,1,1
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0076456,0.2379,0.31817,1,1
5,GO KERATINOCYTE MIGRATION,0.0066311,0.23728,0.27757,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0019699,0.23717,0.2714,1,1
5,GO MEGAKARYOCYTE DEVELOPMENT,0.0023095,0.23711,0.30168,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.021265,0.23691,0.23858,1,1
5,GO MESODERMAL CELL DIFFERENTIATION,0.0015041,0.23655,0.29686,1,1
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.045233,0.23655,0.26653,1,1
5,GO NEPHRON TUBULE FORMATION,0.0012758,0.2363,0.34234,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0029965,0.23623,0.32562,1,1
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.028348,0.23606,0.30014,1,1
5,GO TOOTH MINERALIZATION,0.015776,0.23586,0.28585,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00011593,0.23567,0.29468,1,1
5,GO SECRETION BY TISSUE,0.00091199,0.23563,0.24141,1,1
5,GO RESPONSE TO UV C,0.0044907,0.23559,0.24614,1,1
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.0017696,0.23502,0.25446,1,1
5,GO AORTA DEVELOPMENT,0.00068502,0.23499,0.34206,1,1
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.0036751,0.23484,0.28965,1,1
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00051151,0.23447,0.28793,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0019699,0.23438,0.26468,1,1
5,GO VASCULATURE DEVELOPMENT,0.00096503,0.23435,0.33268,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00013188,0.23407,0.33261,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00035748,0.23407,0.3187,1,1
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0054671,0.23369,0.22247,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,0.00045436,0.23354,0.26041,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,8.3641e-05,0.23352,0.26828,1,1
5,GO REGULATION OF BONE MINERALIZATION,0.010572,0.23302,0.28141,1,1
5,GO GENITALIA DEVELOPMENT,0.0063209,0.2328,0.23161,1,1
5,GO HYALURONAN METABOLIC PROCESS,0.0076456,0.23244,0.30283,1,1
5,GO CELL CELL ADHESION,0.0027019,0.23219,0.26801,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.043559,0.23219,0.24583,1,1
5,GO PROSTAGLANDIN SECRETION,0.037377,0.23186,0.24704,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0010798,0.23149,0.28561,1,1
5,GO GLIAL CELL MIGRATION,0.033245,0.23113,0.22362,1,1
5,GO KERATINIZATION,0.013834,0.23095,0.1926,1,1
5,GO STEROL TRANSPORT,0.0013481,0.23077,0.26735,1,1
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0019699,0.23072,0.34537,1,1
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0049572,0.23037,0.30018,1,1
5,GO PIGMENT ACCUMULATION,0.037377,0.23001,0.27801,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0031545,0.22992,0.29858,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.028348,0.22945,0.18737,1,1
5,GO ACTIN CYTOSKELETON REORGANIZATION,0.00031664,0.22941,0.30162,1,1
5,GO ASTROCYTE DIFFERENTIATION,0.0034935,0.22933,0.27211,1,1
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00042807,0.22863,0.24518,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.0052065,0.22819,0.30313,1,1
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00017019,0.22782,0.27611,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00086166,0.22781,0.25521,1,1
5,GO MALE GENITALIA DEVELOPMENT,0.0047188,0.22779,0.26849,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00091199,0.22777,0.24601,1,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0020776,0.22772,0.26728,1,1
5,GO EXOCYTOSIS,0.00332,0.22751,0.23406,1,1
5,GO BONE DEVELOPMENT,0.00086166,0.22746,0.30106,1,1
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00031664,0.22727,0.25536,1,1
5,GO ERBB SIGNALING PATHWAY,0.00068502,0.22719,0.2587,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0054671,0.22701,0.20957,1,1
5,GO TRANSITION METAL ION HOMEOSTASIS,0.00023283,0.227,0.2415,1,1
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0015882,0.22646,0.27284,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0042727,0.22643,0.29227,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0010209,0.22633,0.2671,1,1
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0013481,0.22612,0.25358,1,1
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.010101,0.22592,0.29204,1,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.0076456,0.22579,0.2396,1,1
5,GO REGULATION OF RECEPTOR RECYCLING,0.00076864,0.22577,0.25867,1,1
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00054254,0.22552,0.29294,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.02951,0.22486,0.23673,1,1
5,GO RESPONSE TO WOUNDING,0.0042727,0.22485,0.2711,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.00054254,0.2247,0.27314,1,1
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.0003797,0.22459,0.2698,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.008797,0.22455,0.29629,1,1
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.0020776,0.22448,0.25768,1,1
5,GO RESPONSE TO SALT STRESS,0.013235,0.22441,0.21003,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0031545,0.22388,0.2698,1,1
5,GO AORTA MORPHOGENESIS,0.0054671,0.22378,0.32229,1,1
5,GO REGULATION OF NUCLEASE ACTIVITY,0.0057394,0.22363,0.21628,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00060992,0.2235,0.26453,1,1
5,GO DETOXIFICATION,0.00076864,0.22331,0.21521,1,1
5,GO RESPONSE TO ATP,0.0015041,0.22328,0.28111,1,1
5,GO FATTY ACID TRANSPORT,0.00068502,0.22311,0.25383,1,1
5,GO RESPONSE TO ISCHEMIA,0.0092139,0.22302,0.25218,1,1
5,GO TRANSPOSITION,0.031957,0.22296,0.17507,1,1
5,GO PARAXIAL MESODERM DEVELOPMENT,0.021265,0.22283,0.21555,1,1
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.013235,0.22269,0.30293,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.048745,0.22253,0.15666,1,1
5,GO EMBRYO IMPLANTATION,0.0015041,0.22215,0.30611,1,1
5,GO PIGMENT GRANULE LOCALIZATION,0.00051151,0.22206,0.24255,1,1
5,GO ESTROUS CYCLE,0.026142,0.22202,0.24656,1,1
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0044907,0.22201,0.25944,1,1
5,GO CELLULAR COPPER ION HOMEOSTASIS,0.0014241,0.22194,0.26081,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00091199,0.22155,0.2494,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00017019,0.22125,0.25498,1,1
5,GO RESPONSE TO GAMMA RADIATION,0.00042807,0.22101,0.26061,1,1
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0010798,0.22095,0.24274,1,1
5,GO PLASMA MEMBRANE FUSION,0.030713,0.22081,0.22248,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0012758,0.22077,0.26521,1,1
5,GO TROPHOBLAST CELL MIGRATION,0.0019699,0.22064,0.28013,1,1
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.048745,0.22049,0.16468,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0014241,0.22042,0.2795,1,1
5,GO BLASTODERM SEGMENTATION,0.0011418,0.22037,0.2758,1,1
5,GO TRIPARTITE REGIONAL SUBDIVISION,0.0034935,0.22031,0.23245,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0014241,0.22001,0.22673,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00068502,0.2198,0.26849,1,1
5,GO RESPONSE TO ESTROGEN,0.0014241,0.21959,0.2667,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0031545,0.21926,0.25546,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.008797,0.21916,0.2596,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00040321,0.21913,0.24327,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0023095,0.21902,0.31734,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.0017696,0.21879,0.22164,1,1
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.013834,0.21814,0.2527,1,1
5,GO COPPER ION HOMEOSTASIS,0.0015882,0.21742,0.22557,1,1
5,GO HEMOGLOBIN METABOLIC PROCESS,6.4139e-05,0.21704,0.29804,1,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,7.8298e-05,0.21691,0.25949,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0016767,0.21686,0.33021,1,1
5,GO LIVER REGENERATION,0.00021879,0.21683,0.25598,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0066311,0.21662,0.25621,1,1
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.018736,0.21649,0.22847,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00096503,0.21643,0.23192,1,1
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00068502,0.21631,0.25829,1,1
5,GO REGULATION OF BIOMINERALIZATION,0.0172,0.21615,0.25652,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0019699,0.21615,0.25242,1,1
5,GO LIPID STORAGE,0.0036751,0.21606,0.24286,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0012071,0.21606,0.24779,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.015776,0.21604,0.23989,1,1
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0020776,0.21594,0.23543,1,1
5,GO PULMONARY VALVE MORPHOGENESIS,0.0172,0.21591,0.34328,1,1
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0054671,0.2158,0.23663,1,1
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00017019,0.21576,0.23607,1,1
5,GO LEFT RIGHT AXIS SPECIFICATION,0.011574,0.21553,0.26997,1,1
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0010798,0.21526,0.27513,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0014241,0.21523,0.23546,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00086166,0.21475,0.24503,1,1
5,GO EPIDERMIS DEVELOPMENT,0.0023095,0.21463,0.22084,1,1
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0025648,0.21458,0.28559,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00014989,0.21453,0.26133,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00023283,0.21435,0.2529,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0021907,0.21383,0.28237,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.0092139,0.21351,0.23754,1,1
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0040644,0.21318,0.33636,1,1
5,GO REGULATION OF MAPK CASCADE,0.0021907,0.21308,0.25039,1,1
5,GO HEPARIN METABOLIC PROCESS,0.01266,0.21292,0.27098,1,1
5,GO PHOSPHOLIPID HOMEOSTASIS,0.0015041,0.21284,0.31093,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.0044907,0.21276,0.33243,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.012106,0.21249,0.22548,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0017696,0.21198,0.24317,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.0010798,0.21192,0.26682,1,1
5,GO BICARBONATE TRANSPORT,0.048745,0.21173,0.17459,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0015882,0.21173,0.24882,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0038653,0.21154,0.26636,1,1
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00076864,0.21147,0.27265,1,1
5,GO LIPID HOMEOSTASIS,0.00096503,0.21147,0.24443,1,1
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.011063,0.21118,0.24103,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0063209,0.211,0.28366,1,1
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00332,0.21083,0.34274,1,1
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.00068502,0.21059,0.23734,1,1
5,GO INTERMEDIATE FILAMENT ORGANIZATION,0.013235,0.21047,0.19437,1,1
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.014457,0.21033,0.28376,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.015104,0.2103,0.23976,1,1
5,GO TISSUE HOMEOSTASIS,0.00051151,0.21017,0.25271,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0080134,0.21008,0.21868,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,0.0096484,0.2099,0.20401,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.0080134,0.20989,0.25544,1,1
5,GO CELLULAR RESPONSE TO ATP,0.0031545,0.20953,0.25365,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.00096503,0.20915,0.23537,1,1
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.011574,0.20913,0.27765,1,1
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00024771,0.20897,0.24635,1,1
5,GO MYELOID CELL HOMEOSTASIS,0.00014989,0.20892,0.26434,1,1
5,GO REGULATION OF CELL MATRIX ADHESION,0.0060238,0.20887,0.28814,1,1
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.010572,0.20853,0.28769,1,1
5,GO REGULATION OF LIPID LOCALIZATION,0.0020776,0.20852,0.24526,1,1
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0025648,0.20843,0.25057,1,1
5,GO MRNA MODIFICATION,0.031957,0.20821,0.16323,1,1
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00018128,0.20786,0.29617,1,1
5,GO RNA DECAPPING,0.00091199,0.2078,0.25368,1,1
5,GO PERICARDIUM DEVELOPMENT,0.0015041,0.20767,0.31558,1,1
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00012367,0.20747,0.21038,1,1
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.02951,0.20725,0.22806,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0027019,0.20714,0.24143,1,1
5,GO INTRACELLULAR LIPID TRANSPORT,0.00091199,0.20675,0.24628,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0021907,0.20635,0.19855,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.0054671,0.20633,0.23302,1,1
5,GO RECEPTOR RECYCLING,0.0063209,0.20633,0.20792,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00072571,0.20586,0.31186,1,1
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.023112,0.20584,0.21049,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00048214,0.20576,0.22533,1,1
5,GO PLATELET MORPHOGENESIS,0.0047188,0.20573,0.28631,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.019548,0.20573,0.19371,1,1
5,GO POSITIVE REGULATION OF CELL AGING,0.016475,0.20547,0.15987,1,1
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.041938,0.20537,0.20778,1,1
5,GO BIOLOGICAL ADHESION,0.0054671,0.20525,0.26656,1,1
5,GO MYOTUBE DIFFERENTIATION,0.0057394,0.2051,0.24332,1,1
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0025648,0.20491,0.24105,1,1
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0024341,0.20477,0.24636,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00040321,0.2046,0.23034,1,1
5,GO INTERMEMBRANE LIPID TRANSFER,0.0012758,0.20456,0.26963,1,1
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0017696,0.20445,0.24353,1,1
5,GO ERYTHROCYTE DEVELOPMENT,0.00029789,0.20444,0.27477,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.0023095,0.20438,0.20947,1,1
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.00031664,0.20416,0.29257,1,1
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0034935,0.20349,0.28759,1,1
5,GO CELLULAR RESPONSE TO CAMP,0.00042807,0.20323,0.25757,1,1
5,GO CELLULAR IRON ION HOMEOSTASIS,0.0010798,0.20307,0.23103,1,1
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.045233,0.20281,0.15127,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.014457,0.20279,0.24287,1,1
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.027226,0.20274,0.26469,1,1
5,GO ERYTHROCYTE MATURATION,0.0038653,0.20234,0.27593,1,1
5,GO LAMELLIPODIUM ORGANIZATION,0.00086166,0.20229,0.25066,1,1
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.021265,0.20216,0.25689,1,1
5,GO SEQUESTERING OF TRIGLYCERIDE,0.0049572,0.20216,0.28738,1,1
5,GO RESPONSE TO VITAMIN,0.008797,0.20209,0.22278,1,1
5,GO OSTEOBLAST PROLIFERATION,0.0083971,0.20205,0.28396,1,1
5,GO TUBE MORPHOGENESIS,0.0021907,0.20199,0.27791,1,1
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0096484,0.20195,0.25163,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.023112,0.20183,0.28463,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0066311,0.20152,0.2493,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0063209,0.20145,0.264,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0027019,0.20138,0.26465,1,1
5,GO IRON ION HOMEOSTASIS,0.00029789,0.20122,0.27438,1,1
5,GO BILE ACID METABOLIC PROCESS,0.00332,0.20075,0.19557,1,1
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0042727,0.20073,0.29931,1,1
5,GO GENITALIA MORPHOGENESIS,0.012106,0.20073,0.28559,1,1
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.015104,0.20053,0.15143,1,1
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.012106,0.20042,0.27551,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.020391,0.20016,0.1905,1,1
5,GO REGULATION OF PROTEIN IMPORT,7.8298e-05,0.20011,0.24963,1,1
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0010209,0.19999,0.19804,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0044907,0.19997,0.224,1,1
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.015776,0.19977,0.23832,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0024341,0.19953,0.30074,1,1
5,GO FIBROBLAST PROLIFERATION,0.00045436,0.1994,0.27601,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.0025648,0.19902,0.20538,1,1
5,GO BIOMINERALIZATION,0.020391,0.19901,0.21773,1,1
5,GO PROTEIN HOMOTETRAMERIZATION,0.00017019,0.19896,0.25961,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.015776,0.1989,0.26675,1,1
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.034576,0.19889,0.22838,1,1
5,GO REGULATION OF TRANSLATIONAL TERMINATION,0.016475,0.19885,0.16921,1,1
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0029965,0.19881,0.21497,1,1
5,GO REGULATION OF HAIR CYCLE,0.0028457,0.19848,0.26706,1,1
5,GO ETHER METABOLIC PROCESS,0.0012758,0.19825,0.22677,1,1
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.013834,0.19825,0.1981,1,1
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0052065,0.19808,0.23648,1,1
5,GO MAINTENANCE OF LOCATION IN CELL,0.0034935,0.19806,0.22119,1,1
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0172,0.19799,0.23702,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.011574,0.19791,0.20744,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.0066311,0.19776,0.22624,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0016767,0.1972,0.27732,1,1
5,GO EMBRYONIC HEMOPOIESIS,0.0031545,0.19699,0.29015,1,1
5,GO PROTEIN AUTO ADP RIBOSYLATION,0.028348,0.19684,0.22657,1,1
5,GO MUSCLE CELL MIGRATION,0.0019699,0.19676,0.27737,1,1
5,GO XENOBIOTIC TRANSPORT,0.024086,0.19673,0.21275,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.021265,0.19667,0.21271,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0023095,0.19644,0.24614,1,1
5,GO ANIMAL ORGAN REGENERATION,0.0012758,0.1963,0.22784,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.0031545,0.19622,0.23547,1,1
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0015882,0.19603,0.28839,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0096484,0.19599,0.25268,1,1
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0092139,0.1959,0.1845,1,1
5,GO TAXIS,0.0066311,0.19573,0.24653,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.011574,0.19572,0.23422,1,1
5,GO PSEUDOURIDINE SYNTHESIS,0.026142,0.19555,0.11531,1,1
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.0083971,0.19527,0.28374,1,1
5,GO TOXIN TRANSPORT,0.0031545,0.19482,0.20795,1,1
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00013188,0.1948,0.26483,1,1
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.025096,0.19463,0.20619,1,1
5,GO SEGMENT SPECIFICATION,0.020391,0.19457,0.22854,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0012071,0.19434,0.23219,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0015041,0.19427,0.24808,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0015041,0.19425,0.24847,1,1
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0080134,0.19387,0.24186,1,1
5,GO RESPONSE TO IONIZING RADIATION,0.0012758,0.19378,0.21143,1,1
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0042727,0.19374,0.22914,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.0011418,0.19367,0.31676,1,1
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0018673,0.19363,0.20483,1,1
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0042727,0.19358,0.2638,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0036751,0.19353,0.20889,1,1
5,GO PLACENTA DEVELOPMENT,0.0027019,0.19292,0.22642,1,1
5,GO POSITIVE REGULATION OF AUTOPHAGY,0.0015041,0.19261,0.24309,1,1
5,GO SKIN DEVELOPMENT,0.0017696,0.1925,0.23645,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.00054254,0.19246,0.23249,1,1
5,GO ESTROGEN METABOLIC PROCESS,0.00068502,0.19239,0.19454,1,1
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.012106,0.19204,0.17575,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.040368,0.19184,0.19235,1,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0029965,0.1916,0.22024,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.00081392,0.19126,0.23571,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0054671,0.1912,0.24895,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.00021879,0.19118,0.2217,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00051151,0.19111,0.25222,1,1
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0021907,0.19098,0.20572,1,1
5,GO HEART VALVE DEVELOPMENT,0.025096,0.19075,0.28295,1,1
5,GO METAL ION HOMEOSTASIS,0.019548,0.1907,0.1899,1,1
5,GO RESPONSE TO NUTRIENT,0.0025648,0.19033,0.22623,1,1
5,GO NCRNA CATABOLIC PROCESS,0.037377,0.19032,0.1374,1,1
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.007293,0.19002,0.23083,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.035953,0.1896,0.18439,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.00060992,0.18941,0.19908,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0013481,0.18916,0.21325,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00054254,0.18889,0.24037,1,1
5,GO RNA DESTABILIZATION,0.011063,0.18863,0.24012,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0066311,0.18856,0.28401,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00015974,0.18818,0.24053,1,1
5,GO STEROL METABOLIC PROCESS,0.0010798,0.18792,0.21659,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0024341,0.18788,0.2241,1,1
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0010798,0.18773,0.21802,1,1
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.026142,0.18762,0.20317,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.038848,0.18756,0.21481,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.008797,0.18756,0.22138,1,1
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.0015041,0.18741,0.18584,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.015104,0.1872,0.27013,1,1
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.013235,0.18704,0.21021,1,1
5,GO LIPID EXPORT FROM CELL,0.017954,0.18697,0.18885,1,1
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.014457,0.18676,0.24658,1,1
5,GO FORMATION OF PRIMARY GERM LAYER,0.0031545,0.18656,0.2857,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.010572,0.18649,0.24964,1,1
5,GO ZINC ION HOMEOSTASIS,0.031957,0.18634,0.2016,1,1
5,GO GTP METABOLIC PROCESS,0.0010798,0.18617,0.18532,1,1
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0054671,0.18614,0.22274,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0044907,0.18559,0.19392,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.00332,0.18555,0.19532,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,0.0092139,0.18548,0.21137,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0092139,0.18539,0.20604,1,1
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.0014241,0.18533,0.32029,1,1
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.006955,0.18524,0.22239,1,1
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0042727,0.18519,0.23298,1,1
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0003797,0.18512,0.28384,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.015104,0.18488,0.1997,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.00332,0.18482,0.24653,1,1
5,GO AUTOPHAGOSOME MATURATION,0.00012367,0.1848,0.2386,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0049572,0.18477,0.23259,1,1
5,GO PHOSPHOLIPID TRANSPORT,0.019548,0.18472,0.1974,1,1
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0013481,0.1845,0.22466,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.0020776,0.18438,0.19158,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0044907,0.18436,0.2315,1,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.00024771,0.18386,0.23909,1,1
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.015776,0.18368,0.23526,1,1
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00081392,0.18367,0.20275,1,1
5,GO MYOBLAST PROLIFERATION,0.0038653,0.18345,0.29596,1,1
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.043559,0.18296,0.16801,1,1
5,GO RESPONSE TO CAMP,0.012106,0.18293,0.21078,1,1
5,GO CARDIOLIPIN METABOLIC PROCESS,0.0015041,0.18292,0.19894,1,1
5,GO HEME METABOLIC PROCESS,8.3641e-05,0.18278,0.22313,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0031545,0.18275,0.27255,1,1
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.019548,0.18267,0.13922,1,1
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.0011418,0.18263,0.21324,1,1
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.00026348,0.18221,0.25065,1,1
5,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.027226,0.1819,0.2607,1,1
5,GO PROTEIN PROCESSING,0.0036751,0.18152,0.23001,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,0.021265,0.18144,0.16921,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0066311,0.18091,0.26743,1,1
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.018736,0.18085,0.19766,1,1
5,GO DNA METHYLATION,0.022172,0.18073,0.1456,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.0003797,0.18059,0.24223,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.010101,0.18045,0.21776,1,1
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.012106,0.18035,0.22745,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.023112,0.1803,0.21055,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0076456,0.18019,0.18458,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.00076864,0.17994,0.22883,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0038653,0.17982,0.21967,1,1
5,GO NEUROBLAST DIVISION,0.015776,0.17973,0.22173,1,1
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,6.8565e-05,0.17957,0.25874,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0018673,0.17941,0.23598,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.017954,0.17925,0.22264,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.015104,0.17924,0.27022,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,0.0076456,0.17882,0.21849,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0028457,0.17875,0.20433,1,1
5,GO REGULATION OF ANOIKIS,0.048745,0.17872,0.21299,1,1
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0028457,0.17819,0.19451,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,0.00086166,0.17802,0.19488,1,1
5,GO RESPONSE TO UV B,0.0080134,0.17801,0.20689,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014457,0.17778,0.26392,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.011063,0.17777,0.18554,1,1
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00023283,0.17776,0.22709,1,1
5,GO AXIS ELONGATION,0.013235,0.17769,0.25619,1,1
5,GO MAINTENANCE OF LOCATION,0.0047188,0.17768,0.21001,1,1
5,GO PORE COMPLEX ASSEMBLY,0.0052065,0.17763,0.19174,1,1
5,GO CELL MOTILITY,0.007293,0.1776,0.23297,1,1
5,GO POSITIVE REGULATION OF ERAD PATHWAY,0.011574,0.17708,0.20572,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0010209,0.17708,0.25009,1,1
5,GO REGULATION OF VIRAL TRANSCRIPTION,0.00057531,0.17688,0.2144,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.0010798,0.17687,0.21293,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0013481,0.17673,0.22799,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,0.0047188,0.17665,0.25475,1,1
5,GO ENDOCYTOSIS,0.011574,0.1766,0.21227,1,1
5,GO RESPONSE TO KETONE,0.007293,0.17654,0.19948,1,1
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.021265,0.17651,0.23231,1,1
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.038848,0.17607,0.21796,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00081392,0.17601,0.22202,1,1
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.0080134,0.17601,0.23308,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.011063,0.17596,0.21058,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0066311,0.17559,0.22024,1,1
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.023112,0.17553,0.20286,1,1
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.017954,0.17539,0.2252,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,0.0063209,0.17535,0.21633,1,1
5,GO LAMELLIPODIUM ASSEMBLY,0.0044907,0.17508,0.21587,1,1
5,GO LIPID CATABOLIC PROCESS,0.00332,0.17472,0.19165,1,1
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00096503,0.17471,0.24352,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00091199,0.1745,0.21814,1,1
5,GO LIPID OXIDATION,0.011063,0.17438,0.15671,1,1
5,GO REGULATION OF OSSIFICATION,0.011063,0.1739,0.24216,1,1
5,GO SYMBIOTIC PROCESS,8.9327e-05,0.17382,0.20712,1,1
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.02951,0.17376,0.22984,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0063209,0.17353,0.22427,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0014241,0.17326,0.22709,1,1
5,GO REGULATION OF PROTEOLYSIS,0.00042807,0.17326,0.22548,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00332,0.17301,0.20452,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.020391,0.17257,0.17745,1,1
5,GO BONE MORPHOGENESIS,0.0060238,0.17233,0.26588,1,1
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0044907,0.17223,0.14653,1,1
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.025096,0.17206,0.16796,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.015104,0.17166,0.2327,1,1
5,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0083971,0.17163,0.22846,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.0080134,0.1714,0.21831,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0012758,0.17124,0.20213,1,1
5,GO RUFFLE ASSEMBLY,0.0028457,0.17118,0.23285,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0027019,0.17103,0.19389,1,1
5,GO DNA METHYLATION OR DEMETHYLATION,0.012106,0.17046,0.14777,1,1
5,GO NEGATIVE REGULATION OF CELL DEATH,0.00029789,0.17046,0.21548,1,1
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0063209,0.17037,0.22965,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0083971,0.17029,0.24074,1,1
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0031545,0.17027,0.17697,1,1
5,GO MESODERMAL CELL FATE COMMITMENT,0.013235,0.1699,0.16706,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,0.028348,0.16981,0.18148,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00091199,0.1697,0.24312,1,1
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0047188,0.16923,0.2548,1,1
5,GO ION HOMEOSTASIS,0.020391,0.16912,0.17579,1,1
5,GO REGULATION OF LIPID TRANSPORT,0.0044907,0.16906,0.21684,1,1
5,GO OLIGOPEPTIDE TRANSPORT,0.0096484,0.1689,0.23721,1,1
5,GO JNK CASCADE,0.0017696,0.16879,0.24493,1,1
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.011063,0.16875,0.22401,1,1
5,GO NADPH REGENERATION,0.015776,0.16872,0.15464,1,1
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.006955,0.16871,0.17592,1,1
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0023095,0.1684,0.1815,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0038653,0.16816,0.20694,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0025648,0.16812,0.2023,1,1
5,GO STEROID METABOLIC PROCESS,0.0017696,0.16802,0.18471,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.0052065,0.16796,0.21242,1,1
5,GO CORONARY VASCULATURE DEVELOPMENT,0.007293,0.16784,0.28856,1,1
5,GO REGULATION OF RIBOSOME BIOGENESIS,0.013834,0.16767,0.17513,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0092139,0.16755,0.20084,1,1
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0054671,0.16735,0.23037,1,1
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.045233,0.1671,0.12782,1,1
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0031545,0.16698,0.22055,1,1
5,GO BLASTOCYST FORMATION,0.00021879,0.16644,0.20753,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023095,0.16578,0.19454,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.045233,0.16562,0.15141,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0014241,0.16553,0.21246,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0057394,0.16518,0.24976,1,1
5,GO GALACTOSE METABOLIC PROCESS,0.018736,0.16503,0.20979,1,1
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0036751,0.16494,0.17059,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00332,0.16492,0.20457,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0054671,0.16468,0.24044,1,1
5,GO REGENERATION,0.0028457,0.1644,0.20751,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0080134,0.1643,0.22369,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0021907,0.1642,0.22632,1,1
5,GO LIPID LOCALIZATION,0.0044907,0.16416,0.21542,1,1
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.010572,0.16415,0.19622,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0038653,0.16379,0.18946,1,1
5,GO RRNA MODIFICATION,0.014457,0.16378,0.10921,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0044907,0.16333,0.18459,1,1
5,GO CELLULAR RESPONSE TO MANGANESE ION,0.013834,0.16328,0.17542,1,1
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0015041,0.16313,0.22238,1,1
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.031957,0.16307,0.17491,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0012071,0.16288,0.23197,1,1
5,GO FAT CELL DIFFERENTIATION,0.0063209,0.16285,0.22829,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0047188,0.16281,0.21635,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.017954,0.1626,0.21403,1,1
5,GO RESPONSE TO STEROID HORMONE,0.008797,0.1624,0.19249,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0066311,0.16214,0.23866,1,1
5,GO TETRAPYRROLE METABOLIC PROCESS,0.0010209,0.16185,0.1846,1,1
5,GO VESICLE CARGO LOADING,0.0020776,0.16183,0.218,1,1
5,GO VITAMIN METABOLIC PROCESS,0.00068502,0.16167,0.19432,1,1
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0066311,0.16105,0.18208,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.040368,0.1609,0.17275,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0092139,0.16081,0.18728,1,1
5,GO RRNA METHYLATION,0.018736,0.16066,0.12592,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.021265,0.16048,0.16136,1,1
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.013235,0.16037,0.24801,1,1
5,GO ANION HOMEOSTASIS,0.007293,0.15981,0.21614,1,1
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.0083971,0.15966,0.14141,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,0.011574,0.15918,0.24592,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.0016767,0.15916,0.2149,1,1
5,GO ACETYL COA METABOLIC PROCESS,0.0066311,0.15906,0.2224,1,1
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0034935,0.1589,0.18799,1,1
5,GO OSTEOBLAST DIFFERENTIATION,0.0066311,0.15886,0.216,1,1
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.033245,0.15862,0.20877,1,1
5,GO GASTRULATION,0.0025648,0.15835,0.25267,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.0092139,0.15815,0.18441,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0020776,0.15795,0.15008,1,1
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.019548,0.15793,0.20768,1,1
5,GO THIOESTER METABOLIC PROCESS,0.0031545,0.15781,0.17753,1,1
5,GO SECRETION,0.017954,0.1577,0.18287,1,1
5,GO PIGMENT GRANULE ORGANIZATION,0.0063209,0.15704,0.24563,1,1
5,GO ER NUCLEUS SIGNALING PATHWAY,0.0060238,0.15692,0.18863,1,1
5,GO REGULATION OF URINE VOLUME,0.043559,0.15686,0.2214,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.0027019,0.15674,0.1935,1,1
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0052065,0.15648,0.17559,1,1
5,GO TUBE DEVELOPMENT,0.008797,0.15635,0.23495,1,1
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.006955,0.15627,0.18452,1,1
5,GO EPITHELIAL CELL PROLIFERATION,0.013235,0.15601,0.21891,1,1
5,GO MYOFIBRIL ASSEMBLY,0.033245,0.15591,0.1967,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.037377,0.15575,0.15213,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0083971,0.15563,0.19534,1,1
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0003797,0.15563,0.19747,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.008797,0.1555,0.18283,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.035953,0.15548,0.16957,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.01266,0.15542,0.19521,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.015104,0.15537,0.16738,1,1
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0016767,0.15535,0.1761,1,1
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.007293,0.15516,0.19781,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0076456,0.15479,0.2041,1,1
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0047188,0.15478,0.22279,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.027226,0.15472,0.18459,1,1
5,GO STRIATED MUSCLE CELL PROLIFERATION,0.027226,0.15447,0.19277,1,1
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.048745,0.15441,0.18731,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0076456,0.1544,0.22829,1,1
5,GO RESPONSE TO VITAMIN A,0.016475,0.15436,0.20083,1,1
5,GO REGULATION OF CELLULAR PH,0.045233,0.1543,0.13518,1,1
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.033245,0.15419,0.20225,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.046961,0.15405,0.15436,1,1
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0096484,0.15367,0.1583,1,1
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.021265,0.15362,0.19049,1,1
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0025648,0.15357,0.20571,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0029965,0.15355,0.32489,1,1
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00332,0.15352,0.24798,1,1
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.013235,0.15327,0.16213,1,1
5,GO ENDOCYTIC RECYCLING,0.040368,0.15298,0.19122,1,1
5,GO PROTEIN MATURATION,0.0036751,0.15277,0.1858,1,1
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00091199,0.15265,0.20515,1,1
5,GO DEFINITIVE HEMOPOIESIS,0.048745,0.15239,0.24557,1,1
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00014989,0.15189,0.22288,1,1
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042727,0.15188,0.16281,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.010101,0.15172,0.22018,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0049572,0.15168,0.15864,1,1
5,GO VACUOLAR ACIDIFICATION,0.008797,0.15157,0.18455,1,1
5,GO NADP METABOLIC PROCESS,0.0054671,0.15147,0.17645,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00072571,0.15131,0.23404,1,1
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0019699,0.15128,0.18083,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.011574,0.15093,0.14584,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.016475,0.1509,0.21852,1,1
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.010572,0.15083,0.22829,1,1
5,GO PROTEIN TARGETING TO LYSOSOME,0.043559,0.15083,0.19738,1,1
5,GO LIPID METABOLIC PROCESS,0.0017696,0.15052,0.18407,1,1
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0023095,0.15008,0.21126,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.038848,0.15008,0.12185,1,1
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0044907,0.14977,0.18174,1,1
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0076456,0.14947,0.18688,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0013481,0.14935,0.20507,1,1
5,GO VITAMIN TRANSPORT,0.0172,0.14924,0.18173,1,1
5,GO REGULATION OF CELL DEATH,0.00076864,0.14922,0.20551,1,1
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00086166,0.14915,0.22479,1,1
5,GO CELLULAR PIGMENTATION,0.0018673,0.14885,0.20609,1,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0038653,0.14874,0.19151,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.037377,0.1485,0.2502,1,1
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00031664,0.14841,0.19534,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.046961,0.14826,0.20587,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0096484,0.14821,0.18564,1,1
5,GO DNA MODIFICATION,0.024086,0.14818,0.1253,1,1
5,GO CARTILAGE DEVELOPMENT,0.012106,0.14805,0.23364,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.013235,0.1477,0.21353,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014457,0.14764,0.25094,1,1
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0029965,0.1474,0.18825,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00072571,0.14733,0.21653,1,1
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0015041,0.14723,0.21081,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036751,0.14706,0.20538,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.038848,0.14695,0.21341,1,1
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.011063,0.14695,0.1685,1,1
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.008797,0.14634,0.22185,1,1
5,GO CARDIAC SEPTUM DEVELOPMENT,0.016475,0.14623,0.23496,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.013834,0.14615,0.18958,1,1
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.011063,0.14611,0.29527,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0012071,0.14603,0.21441,1,1
5,GO RECEPTOR CATABOLIC PROCESS,0.0066311,0.146,0.23402,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.011574,0.14597,0.18723,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0023095,0.14596,0.19193,1,1
5,GO RNA MODIFICATION,0.019548,0.14591,0.12541,1,1
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.01266,0.14584,0.20583,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0096484,0.14584,0.17994,1,1
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0012071,0.14564,0.18079,1,1
5,GO SELECTIVE AUTOPHAGY,0.0036751,0.14563,0.20382,1,1
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00026348,0.14562,0.18536,1,1
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.030713,0.14558,0.27315,1,1
5,GO SEGMENTATION,0.031957,0.14556,0.17633,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0011418,0.14549,0.2083,1,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0172,0.14504,0.13216,1,1
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.02951,0.14504,0.17012,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0057394,0.14491,0.21564,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.013235,0.14479,0.20826,1,1
5,GO DIGESTIVE SYSTEM PROCESS,0.028348,0.14406,0.15965,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.019548,0.14379,0.19535,1,1
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0066311,0.14366,0.17211,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011063,0.14358,0.15593,1,1
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.022172,0.14353,0.10778,1,1
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.025096,0.14342,0.25172,1,1
5,GO VIRAL RELEASE FROM HOST CELL,0.0031545,0.14339,0.16447,1,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.025096,0.14303,0.12715,1,1
5,GO REGULATION OF TELOMERASE ACTIVITY,0.0083971,0.14296,0.13987,1,1
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.011574,0.14271,0.19248,1,1
5,GO COBALAMIN METABOLIC PROCESS,0.034576,0.14266,0.18308,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0052065,0.14218,0.21379,1,1
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.040368,0.14204,0.16592,1,1
5,GO POSITIVE REGULATION OF SIGNALING,0.013834,0.14201,0.18041,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0027019,0.14195,0.18993,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0083971,0.14134,0.19911,1,1
5,GO STEM CELL DIFFERENTIATION,0.0052065,0.14111,0.18429,1,1
5,GO GLYCOSIDE METABOLIC PROCESS,0.0019699,0.14098,0.1701,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.0096484,0.14077,0.17012,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.016475,0.1407,0.2332,1,1
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.0049572,0.14046,0.19264,1,1
5,GO RESPONSE TO ALCOHOL,0.017954,0.14042,0.17713,1,1
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.0003797,0.14002,0.22784,1,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.011063,0.13995,0.21001,1,1
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0060238,0.13979,0.25366,1,1
5,GO MUSCLE ADAPTATION,0.012106,0.1395,0.19949,1,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.026142,0.1392,0.17177,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0025648,0.13913,0.1967,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0172,0.13911,0.19735,1,1
5,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.018736,0.13898,0.15771,1,1
5,GO FIBROBLAST MIGRATION,0.013834,0.13881,0.22817,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0054671,0.13874,0.18107,1,1
5,GO FOLIC ACID METABOLIC PROCESS,0.028348,0.13856,0.14192,1,1
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0019699,0.13848,0.14746,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0080134,0.13847,0.17806,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.015776,0.13839,0.17303,1,1
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.011574,0.13807,0.15018,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0019699,0.13784,0.16521,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.00096503,0.13784,0.19468,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.037377,0.13772,0.16179,1,1
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0052065,0.13751,0.17123,1,1
5,GO POSITIVE REGULATION OF TRANSLATION,0.0015882,0.13733,0.16112,1,1
5,GO AUTOPHAGY OF NUCLEUS,0.015776,0.137,0.18741,1,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0057394,0.13672,0.23915,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.021265,0.13672,0.14487,1,1
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.011574,0.13607,0.21849,1,1
5,GO CELLULAR RESPONSE TO UV,0.0172,0.13604,0.15442,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0034935,0.13556,0.20269,1,1
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0019699,0.13545,0.18428,1,1
5,GO SULFUR COMPOUND METABOLIC PROCESS,0.0021907,0.13544,0.16532,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.037377,0.13509,0.10834,1,1
5,GO SARCOMERE ORGANIZATION,0.02951,0.13464,0.16524,1,1
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.014457,0.13392,0.13849,1,1
5,GO CHEMICAL HOMEOSTASIS,0.038848,0.13388,0.15562,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.035953,0.13378,0.26345,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.030713,0.13377,0.15882,1,1
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.0044907,0.13355,0.1469,1,1
5,GO URONIC ACID METABOLIC PROCESS,0.015776,0.13346,0.1284,1,1
5,GO KETONE BODY METABOLIC PROCESS,0.031957,0.13339,0.13375,1,1
5,GO NUCLEOTIDE SALVAGE,0.028348,0.13337,0.16606,1,1
5,GO ACTIN FILAMENT DEPOLYMERIZATION,0.034576,0.13322,0.19733,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.013235,0.13302,0.2011,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0014241,0.13284,0.18288,1,1
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0027019,0.13215,0.18676,1,1
5,GO RESPONSE TO WATER,0.025096,0.13209,0.19662,1,1
5,GO CELLULAR KETONE METABOLIC PROCESS,0.00051151,0.13208,0.1586,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.018736,0.13203,0.16092,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035953,0.13174,0.18259,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,0.0024341,0.13172,0.16635,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.011574,0.13153,0.14683,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.045233,0.13139,0.17609,1,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.034576,0.13134,0.15503,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.014457,0.13106,0.20508,1,1
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.013834,0.13099,0.21825,1,1
5,GO PROTEIN TETRAMERIZATION,0.0028457,0.13097,0.19154,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0083971,0.13076,0.17352,1,1
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.023112,0.13049,0.22544,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.011574,0.13049,0.18369,1,1
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0060238,0.13044,0.22239,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.038848,0.13035,0.1802,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.02951,0.1303,0.15894,1,1
5,GO COPII COATED VESICLE CARGO LOADING,0.016475,0.13026,0.19528,1,1
5,GO SKELETAL SYSTEM MORPHOGENESIS,0.023112,0.13,0.20358,1,1
5,GO MICROVILLUS ORGANIZATION,0.02951,0.12989,0.15836,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0031545,0.12972,0.19795,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0047188,0.1296,0.18923,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0076456,0.12942,0.16644,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.0042727,0.12925,0.20131,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0019699,0.12923,0.20009,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,0.035953,0.12916,0.15457,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.037377,0.12862,0.18873,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0052065,0.12856,0.19057,1,1
5,GO HEART MORPHOGENESIS,0.038848,0.12853,0.20156,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.011063,0.12853,0.24525,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00068502,0.12849,0.17633,1,1
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0025648,0.12773,0.14313,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0031545,0.12769,0.1783,1,1
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.046961,0.12767,0.16728,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00096503,0.12761,0.20487,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.01266,0.12759,0.19971,1,1
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.015104,0.12735,0.16937,1,1
5,GO CELLULAR HOMEOSTASIS,0.023112,0.12728,0.14544,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.021265,0.12702,0.14542,1,1
5,GO RESPONSE TO HORMONE,0.015776,0.12641,0.17412,1,1
5,GO REGULATION OF GENE SILENCING,0.028348,0.12611,0.14444,1,1
5,GO REGULATION OF MRNA CATABOLIC PROCESS,0.0092139,0.12591,0.12733,1,1
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0083971,0.12567,0.2293,1,1
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0013481,0.12551,0.16968,1,1
5,GO NEURAL TUBE FORMATION,0.048745,0.12439,0.17605,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.038848,0.12429,0.12196,1,1
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.008797,0.12409,0.20562,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.016475,0.12405,0.15846,1,1
5,GO NEGATIVE REGULATION OF JNK CASCADE,0.008797,0.12375,0.18692,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.011574,0.12375,0.17767,1,1
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0010209,0.12333,0.17637,1,1
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.048745,0.12297,0.083935,1,1
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.01266,0.12284,0.18691,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.007293,0.12282,0.16464,1,1
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.018736,0.12213,0.13766,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.037377,0.12198,0.15158,1,1
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0034935,0.12154,0.14436,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.046961,0.12138,0.18507,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,0.041938,0.12124,0.15277,1,1
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.015776,0.12094,0.18431,1,1
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0028457,0.1209,0.18585,1,1
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00045436,0.1205,0.16858,1,1
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0023095,0.12036,0.17098,1,1
5,GO GOLGI VESICLE BUDDING,0.01266,0.12002,0.16282,1,1
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0042727,0.11984,0.14498,1,1
5,GO CELLULAR RESPONSE TO RADIATION,0.025096,0.1198,0.13506,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.02951,0.11977,0.15939,1,1
5,GO LIPID MODIFICATION,0.0172,0.11934,0.15865,1,1
5,GO NUCLEOSIDE METABOLIC PROCESS,0.0036751,0.11921,0.14129,1,1
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.021265,0.11918,0.11721,1,1
5,GO AUTOPHAGOSOME ORGANIZATION,0.0047188,0.11889,0.19645,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.010101,0.11863,0.18575,1,1
5,GO PROTEIN K63 LINKED UBIQUITINATION,0.035953,0.1186,0.13782,1,1
5,GO REGULATION OF PROTEIN SUMOYLATION,0.045233,0.1185,0.16803,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.010572,0.11834,0.16449,1,1
5,GO APOPTOTIC PROCESS,0.0029965,0.11829,0.18324,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0038653,0.11827,0.20318,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0057394,0.11824,0.1937,1,1
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.016475,0.11726,0.1647,1,1
5,GO CELL RECOGNITION,0.037377,0.11695,0.16742,1,1
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0172,0.11691,0.16584,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.0066311,0.11654,0.14411,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,0.031957,0.1154,0.17684,1,1
5,GO SPERM EGG RECOGNITION,0.020391,0.11519,0.13339,1,1
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0066311,0.11507,0.21155,1,1
5,GO ACETYL COA BIOSYNTHETIC PROCESS,0.027226,0.11479,0.16674,1,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.034576,0.11471,0.1194,1,1
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0040644,0.11471,0.18363,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.027226,0.11454,0.18627,1,1
5,GO IRON ION TRANSPORT,0.0076456,0.1144,0.18837,1,1
5,GO MULTI ORGANISM LOCALIZATION,0.011063,0.11427,0.1311,1,1
5,GO GOLGI TO ENDOSOME TRANSPORT,0.023112,0.11394,0.19635,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.0044907,0.1139,0.17118,1,1
5,GO HOMEOSTATIC PROCESS,0.013235,0.11363,0.16587,1,1
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0027019,0.11361,0.15702,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.046961,0.11321,0.17066,1,1
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.015104,0.11307,0.12332,1,1
5,GO HORMONE METABOLIC PROCESS,0.037377,0.1129,0.14501,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.028348,0.11255,0.17128,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.023112,0.11157,0.16699,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.037377,0.11137,0.19991,1,1
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.023112,0.1112,0.15535,1,1
5,GO PROTEIN LOCALIZATION TO NUCLEUS,0.02951,0.1111,0.14451,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.015104,0.11097,0.18794,1,1
5,GO REGULATION OF ORGAN GROWTH,0.0057394,0.11058,0.20979,1,1
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.038848,0.11005,0.11271,1,1
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.045233,0.10988,0.1897,1,1
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.015776,0.10981,0.15312,1,1
5,GO PROTEIN IMPORT,0.034576,0.10978,0.13119,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.020391,0.10941,0.21277,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.035953,0.10935,0.15473,1,1
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.038848,0.10824,0.11481,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.023112,0.10813,0.14475,1,1
5,GO RESPONSE TO PEPTIDE,0.034576,0.10793,0.15824,1,1
5,GO REGULATION OF TRANSLATIONAL INITIATION,0.019548,0.10764,0.12921,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.048745,0.10668,0.19999,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.021265,0.10661,0.16674,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.006955,0.10656,0.18645,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.013235,0.10642,0.17467,1,1
5,GO NUCLEOBASE METABOLIC PROCESS,0.018736,0.10627,0.11797,1,1
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0063209,0.1061,0.15483,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.041938,0.10564,0.15217,1,1
5,GO ORGANIC ACID METABOLIC PROCESS,0.0052065,0.10531,0.14871,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.038848,0.10531,0.20657,1,1
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0021907,0.10472,0.14371,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.021265,0.10452,0.16704,1,1
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.034576,0.10437,0.13233,1,1
5,GO TUBE FORMATION,0.035953,0.10427,0.1741,1,1
5,GO MALE SEX DIFFERENTIATION,0.038848,0.10397,0.16954,1,1
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.014457,0.10393,0.12349,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.0025648,0.10376,0.16865,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.027226,0.10341,0.15898,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0066311,0.10247,0.15251,1,1
5,GO COPII COATED VESICLE BUDDING,0.012106,0.1023,0.16002,1,1
5,GO PROTEOLYSIS,0.0060238,0.10184,0.16809,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,0.019548,0.10082,0.16845,1,1
5,GO AGING,0.0096484,0.10045,0.17523,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.043559,0.10044,0.15781,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.033245,0.10016,0.13428,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.030713,0.098971,0.15352,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.024086,0.098637,0.16043,1,1
5,GO MOLTING CYCLE,0.048745,0.098031,0.17849,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.016475,0.097685,0.16406,1,1
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.038848,0.097663,0.12597,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.035953,0.09715,0.15904,1,1
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.013235,0.097036,0.15075,1,1
5,GO RNA CATABOLIC PROCESS,0.020391,0.096524,0.079588,1,1
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.031957,0.09637,0.13196,1,1
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.038848,0.096062,0.20523,1,1
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.010101,0.095865,0.091395,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.026142,0.095815,0.17203,1,1
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.024086,0.095469,0.12963,1,1
5,GO PROTEIN DESTABILIZATION,0.0172,0.094451,0.16473,1,1
5,GO TISSUE MORPHOGENESIS,0.024086,0.094081,0.17668,1,1
5,GO CELLULAR RESPONSE TO DRUG,0.027226,0.092781,0.15258,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.020391,0.092777,0.16599,1,1
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.020391,0.092265,0.13,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.033245,0.092142,0.12828,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.037377,0.091883,0.1544,1,1
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.040368,0.091417,0.10238,1,1
5,GO VIRION ASSEMBLY,0.015104,0.09134,0.11468,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.037377,0.091116,0.12009,1,1
5,GO THYMUS DEVELOPMENT,0.017954,0.090892,0.15814,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.016475,0.090703,0.16839,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.019548,0.089789,0.13735,1,1
5,GO REGULATION OF MULTI ORGANISM PROCESS,0.014457,0.089033,0.14003,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.030713,0.088968,0.16256,1,1
5,GO HORMONE BIOSYNTHETIC PROCESS,0.024086,0.088537,0.13527,1,1
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.020391,0.088152,0.15193,1,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.014457,0.087931,0.13447,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.030713,0.087546,0.1928,1,1
5,GO RESPONSE TO DRUG,0.028348,0.087432,0.15461,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.027226,0.08741,0.13092,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.010572,0.085219,0.1509,1,1
5,GO REGULATION OF CATABOLIC PROCESS,0.017954,0.084932,0.14509,1,1
5,GO REGULATION OF VACUOLE ORGANIZATION,0.0038653,0.084817,0.18151,1,1
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.041938,0.084006,0.12084,1,1
5,GO OXIDATION REDUCTION PROCESS,0.008797,0.08107,0.11821,1,1
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.013235,0.080952,0.087553,1,1
5,GO VACUOLE ORGANIZATION,0.016475,0.080916,0.16604,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.021265,0.080567,0.12787,1,1
5,GO PEROXISOME ORGANIZATION,0.020391,0.079527,0.10599,1,1
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.026142,0.07932,0.13773,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0172,0.078516,0.143,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.045233,0.077561,0.172,1,1
5,GO ENDOSOME ORGANIZATION,0.033245,0.077163,0.13521,1,1
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.031957,0.076016,0.15982,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.033245,0.074572,0.14618,1,1
5,GO MACROMOLECULE CATABOLIC PROCESS,0.041938,0.073332,0.11576,1,1
5,GO CELLULAR COMPONENT DISASSEMBLY,0.048745,0.072151,0.11048,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.033245,0.071672,0.14423,1,1
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0172,0.070498,0.16254,1,1
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.030713,0.069177,0.11954,1,1
5,GO PIGMENT METABOLIC PROCESS,0.046961,0.068242,0.10938,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.046961,0.066016,0.14775,1,1
5,GO PEPTIDE METABOLIC PROCESS,0.045233,0.06307,0.069228,1,1
5,GO CELLULAR AMIDE METABOLIC PROCESS,0.017954,0.062496,0.086708,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.037377,0.04782,0.12539,1,1
5,GO EOSINOPHIL MIGRATION,0.0019699,0.77242,0.69089,1,0
5,GO OPSONIZATION,0.0060238,0.6288,0.5096,1,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0010798,0.61763,0.60771,1,0
5,GO PROTEIN ACTIVATION CASCADE,0.0016767,0.4668,0.52513,1,0
5,GO FIBRINOLYSIS,0.0017696,0.46359,0.49464,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0029965,0.44741,0.41137,1,0
5,GO PLASMINOGEN ACTIVATION,0.0063209,0.44077,0.4045,1,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0063209,0.41994,0.35775,1,0
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.014457,0.40564,0.38281,1,0
5,GO ELASTIC FIBER ASSEMBLY,0.0049572,0.3763,0.64106,1,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.0096484,0.37604,0.472,1,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.0060238,0.33777,0.39788,1,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0076456,0.32415,0.4145,1,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.0092139,0.30902,0.36733,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0092139,0.30292,0.42192,1,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,0.0016767,0.29398,0.38785,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,0.0080134,0.29121,0.3836,1,0
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.031957,0.28014,0.33189,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,0.0057394,0.27981,0.49529,1,0
5,GO VASCULAR WOUND HEALING,0.013834,0.27518,0.34371,1,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0038653,0.27446,0.30324,1,0
5,GO DNA DEAMINATION,0.0057394,0.27319,0.31498,1,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.014457,0.2725,0.28637,1,0
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.035953,0.26354,0.26071,1,0
5,GO ENDOTHELIAL CELL MIGRATION,0.0036751,0.26203,0.3153,1,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.043559,0.25876,0.25297,1,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,0.034576,0.25828,0.34235,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.0042727,0.2557,0.33161,1,0
5,GO REGULATION OF COAGULATION,0.0049572,0.25502,0.36692,1,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,0.0096484,0.25354,0.35327,1,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0172,0.24728,0.24915,1,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0036751,0.24664,0.33831,1,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.015104,0.24633,0.29637,1,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0024341,0.24534,0.27688,1,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.008797,0.24532,0.3484,1,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0042727,0.24363,0.28063,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.015776,0.24305,0.22572,1,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.030713,0.23274,0.26929,1,0
5,GO AORTIC VALVE DEVELOPMENT,0.023112,0.23145,0.3325,1,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.027226,0.22678,0.22888,1,0
5,GO BLOOD VESSEL REMODELING,0.0076456,0.21954,0.36368,1,0
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0066311,0.21232,0.32819,1,0
5,GO SENSORY PERCEPTION OF TASTE,0.041938,0.21155,0.16037,1,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.048745,0.20561,0.25413,1,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0036751,0.20265,0.23534,1,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.019548,0.20012,0.26695,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0054671,0.19828,0.28994,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.011574,0.19774,0.2796,1,0
5,GO GDP METABOLIC PROCESS,0.014457,0.19101,0.22008,1,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,0.008797,0.19035,0.28054,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.014457,0.18644,0.20926,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.010572,0.18359,0.20596,1,0
5,GO PHOSPHATE ION TRANSPORT,0.0057394,0.1796,0.27366,1,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.0172,0.17594,0.17073,1,0
5,GO NEURON REMODELING,0.041938,0.17504,0.2423,1,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.034576,0.17449,0.20541,1,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.008797,0.17386,0.31,1,0
5,GO CHONDROCYTE DEVELOPMENT,0.020391,0.17275,0.2718,1,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.018736,0.17186,0.23884,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0076456,0.16438,0.29515,1,0
5,GO REGULATION OF ENDOCYTIC RECYCLING,0.045233,0.16289,0.20409,1,0
5,GO RESPONSE TO SALT,0.028348,0.16105,0.14055,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.015104,0.15759,0.24953,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.048745,0.15591,0.26696,1,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.015104,0.15556,0.16205,1,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0096484,0.15488,0.21272,1,0
5,GO ENDOTHELIAL CELL PROLIFERATION,0.017954,0.15123,0.25004,1,0
5,GO BASEMENT MEMBRANE ORGANIZATION,0.038848,0.14933,0.25764,1,0
5,GO GLIAL CELL APOPTOTIC PROCESS,0.028348,0.14906,0.19783,1,0
5,GO ENDOTHELIUM DEVELOPMENT,0.043559,0.14882,0.24752,1,0
5,GO SMOOTH MUSCLE CELL MIGRATION,0.010101,0.14856,0.27009,1,0
5,GO REGULATION OF ACTIN NUCLEATION,0.041938,0.14749,0.14555,1,0
5,GO FILOPODIUM ASSEMBLY,0.028348,0.14725,0.19177,1,0
5,GO REGULATION OF MYELINATION,0.048745,0.14549,0.1869,1,0
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.026142,0.14496,0.19983,1,0
5,GO REGULATION OF GTPASE ACTIVITY,0.013834,0.14182,0.21524,1,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.040368,0.14137,0.2081,1,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.019548,0.13997,0.20261,1,0
5,GO ENDOCRINE PROCESS,0.015104,0.1362,0.22637,1,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.017954,0.13409,0.27509,1,0
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.025096,0.13376,0.17598,1,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.016475,0.12938,0.18103,1,0
5,GO VESICLE BUDDING FROM MEMBRANE,0.015776,0.12534,0.15594,1,0
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.011574,0.12387,0.17567,1,0
5,GO RETINA HOMEOSTASIS,0.027226,0.12372,0.1175,1,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.024086,0.12308,0.16209,1,0
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.027226,0.1204,0.18552,1,0
5,GO POSITIVE REGULATION OF NEURON DEATH,0.0172,0.11683,0.18913,1,0
5,GO ACTIN FILAMENT BASED MOVEMENT,0.027226,0.11654,0.18297,1,0
5,GO ACTIN NUCLEATION,0.021265,0.11631,0.15502,1,0
5,GO RESPONSE TO CADMIUM ION,0.028348,0.11515,0.16962,1,0
5,GO STRESS FIBER ASSEMBLY,0.043559,0.11293,0.21768,1,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.033245,0.11058,0.1815,1,0
5,GO ASYMMETRIC CELL DIVISION,0.025096,0.1094,0.17974,1,0
5,GO NEGATIVE REGULATION OF TRANSPORT,0.041938,0.10571,0.14467,1,0
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.025096,0.10534,0.2269,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.024086,0.10511,0.21186,1,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.046961,0.10071,0.16592,1,0
5,GO TEMPERATURE HOMEOSTASIS,0.046961,0.10048,0.15353,1,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.038848,0.095292,0.16134,1,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.019548,0.091921,0.16825,1,0
5,GO ACTIVATION OF GTPASE ACTIVITY,0.037377,0.090988,0.20807,1,0
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.037377,0.090176,0.16361,1,0
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.024086,0.088825,0.16301,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.033245,0.088468,0.22124,1,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.019548,0.087727,0.18883,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.022172,0.08634,0.18337,1,0
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.019548,0.084614,0.159,1,0
5,GO ORGANIC ACID CATABOLIC PROCESS,0.045233,0.083064,0.12057,1,0
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.048745,0.078747,0.14024,1,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.045233,0.077933,0.15186,1,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.034576,0.077089,0.14662,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.040368,0.07072,0.15124,1,0
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.031957,0.068864,0.14575,1,0
5,GO RESPONSE TO ACID CHEMICAL,0.041938,0.062246,0.13535,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.048745,0.061028,0.13701,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.035953,0.056659,0.13588,1,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.012106,-0.088829,-0.12014,1,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.038848,-0.10118,-0.13209,1,0
5,GO DETECTION OF ABIOTIC STIMULUS,0.046961,-0.10183,-0.072827,1,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.040368,-0.11558,-0.13579,1,0
5,GO RESPONSE TO CATECHOLAMINE,0.024086,-0.12539,-0.10471,1,0
5,GO ACROSOME REACTION,0.046961,-0.12678,-0.11706,1,0
5,GO FEAR RESPONSE,0.040368,-0.13424,-0.12612,1,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.020391,-0.13445,-0.13312,1,0
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.02951,-0.13645,-0.10579,1,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.041938,-0.13853,-0.1321,1,0
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.022172,-0.14668,-0.17698,1,0
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.02951,-0.15096,-0.12009,1,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.023112,-0.15414,-0.18203,1,0
5,GO RESPONSE TO DOPAMINE,0.0172,-0.155,-0.1209,1,0
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.046961,-0.15529,-0.11913,1,0
5,GO AXO DENDRITIC TRANSPORT,0.034576,-0.16278,-0.15353,1,0
5,GO POTASSIUM ION TRANSPORT,0.046961,-0.16297,-0.1157,1,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,0.026142,-0.16403,-0.17414,1,0
5,GO SYNAPSE ORGANIZATION,0.043559,-0.16431,-0.12102,1,0
5,GO AXONAL TRANSPORT,0.034576,-0.1654,-0.15186,1,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0172,-0.16933,-0.13531,1,0
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.023112,-0.17128,-0.17936,1,0
5,GO MICROTUBULE POLYMERIZATION,0.022172,-0.17198,-0.16134,1,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.038848,-0.17274,-0.095904,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.033245,-0.17327,-0.15628,1,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.046961,-0.17383,-0.28452,1,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.048745,-0.17499,-0.1521,1,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,0.046961,-0.17624,-0.14519,1,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0080134,-0.18065,-0.21321,1,0
5,GO RESPONSE TO COCAINE,0.026142,-0.18357,-0.16935,1,0
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.046961,-0.18395,-0.10246,1,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.024086,-0.18517,-0.13987,1,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,0.040368,-0.18639,-0.18115,1,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.027226,-0.18695,-0.19757,1,0
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.013834,-0.18859,-0.20018,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.035953,-0.18894,-0.15598,1,0
5,GO REGULATION OF SYNAPSE MATURATION,0.038848,-0.18902,-0.27076,1,0
5,GO FEEDING BEHAVIOR,0.0036751,-0.19106,-0.18567,1,0
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.030713,-0.19162,-0.12333,1,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.011063,-0.19238,-0.22125,1,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.043559,-0.19248,-0.1821,1,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0054671,-0.19263,-0.2283,1,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.046961,-0.19498,-0.18283,1,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.020391,-0.1959,-0.18664,1,0
5,GO PEPTIDE HORMONE SECRETION,0.021265,-0.19804,-0.12443,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.021265,-0.19823,-0.18002,1,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.015104,-0.19937,-0.20342,1,0
5,GO INSULIN SECRETION,0.048745,-0.20103,-0.10103,1,0
5,GO VESICLE DOCKING,0.023112,-0.20121,-0.1185,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.020391,-0.2031,-0.15505,1,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.030713,-0.20347,-0.17938,1,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.0057394,-0.20439,-0.18478,1,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.043559,-0.20533,-0.1525,1,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.041938,-0.20586,-0.23088,1,0
5,GO REGULATION OF MEMBRANE POTENTIAL,0.012106,-0.20644,-0.14675,1,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0042727,-0.20679,-0.21419,1,0
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.011063,-0.20818,-0.15427,1,0
5,GO NOTCH RECEPTOR PROCESSING,0.031957,-0.20853,-0.17603,1,0
5,GO PRESYNAPSE ORGANIZATION,0.011574,-0.21244,-0.21061,1,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.010101,-0.21272,-0.18423,1,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,0.01266,-0.21341,-0.18464,1,0
5,GO DICARBOXYLIC ACID TRANSPORT,0.016475,-0.21574,-0.14748,1,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.015776,-0.21732,-0.17945,1,0
5,GO REGULATION OF RESPONSE TO FOOD,0.040368,-0.21762,-0.21118,1,0
5,GO MICROTUBULE DEPOLYMERIZATION,0.015104,-0.21884,-0.27455,1,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.007293,-0.22103,-0.25296,1,0
5,GO LOCOMOTORY BEHAVIOR,0.028348,-0.22119,-0.15434,1,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.033245,-0.22202,-0.19352,1,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,0.026142,-0.22283,-0.2245,1,0
5,GO SYNAPTIC SIGNALING,0.0096484,-0.22333,-0.18531,1,0
5,GO NEUROMUSCULAR PROCESS,0.015776,-0.22388,-0.18468,1,0
5,GO SYNAPTIC VESICLE RECYCLING,0.007293,-0.22828,-0.15956,1,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.0049572,-0.22845,-0.21756,1,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.010572,-0.22896,-0.17401,1,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.006955,-0.23099,-0.23015,1,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0038653,-0.23188,-0.21783,1,0
5,GO RESPONSE TO POTASSIUM ION,0.022172,-0.23225,-0.2846,1,0
5,GO ADULT LOCOMOTORY BEHAVIOR,0.00332,-0.24006,-0.20924,1,0
5,GO NEURAL NUCLEUS DEVELOPMENT,0.0052065,-0.24023,-0.22464,1,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0083971,-0.24297,-0.24086,1,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.040368,-0.24407,-0.15077,1,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0015882,-0.2448,-0.29469,1,0
5,GO MATING BEHAVIOR,0.043559,-0.24659,-0.18223,1,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.0044907,-0.24877,-0.23695,1,0
5,GO SECRETORY GRANULE LOCALIZATION,0.011063,-0.24952,-0.23585,1,0
5,GO DETECTION OF CALCIUM ION,0.020391,-0.25055,-0.18241,1,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.013235,-0.25094,-0.24594,1,0
5,GO ACIDIC AMINO ACID TRANSPORT,0.0080134,-0.25156,-0.187,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0016767,-0.25201,-0.24514,1,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0076456,-0.25232,-0.24265,1,0
5,GO PROTEIN PALMITOYLATION,0.023112,-0.25266,-0.1708,1,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0034935,-0.25275,-0.30701,1,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.035953,-0.25506,-0.25098,1,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0063209,-0.25779,-0.24943,1,0
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.016475,-0.25821,-0.2669,1,0
5,GO PRESYNAPTIC ENDOCYTOSIS,0.0063209,-0.26124,-0.1843,1,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.046961,-0.26263,-0.15076,1,0
5,GO DOPAMINE METABOLIC PROCESS,0.014457,-0.26414,-0.1981,1,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.033245,-0.26498,-0.19504,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.02951,-0.26682,-0.20441,1,0
5,GO EXOCYTIC PROCESS,0.011574,-0.26714,-0.17598,1,0
5,GO SYNAPSE ASSEMBLY,0.019548,-0.26798,-0.21125,1,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.02951,-0.26999,-0.17486,1,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.010572,-0.27318,-0.2433,1,0
5,GO NEURONAL ACTION POTENTIAL,0.0040644,-0.27679,-0.24795,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.022172,-0.2771,-0.21464,1,0
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.046961,-0.27772,-0.24568,1,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.020391,-0.27904,-0.21138,1,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.0040644,-0.28165,-0.24434,1,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0018673,-0.28234,-0.2646,1,0
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.013834,-0.29103,-0.28332,1,0
5,GO EATING BEHAVIOR,0.0025648,-0.29174,-0.23806,1,0
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.033245,-0.29223,-0.18096,1,0
5,GO PROTEIN POLYGLUTAMYLATION,0.013834,-0.29885,-0.23861,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.025096,-0.30204,-0.21821,1,0
5,GO REGULATION OF AMINO ACID TRANSPORT,0.0028457,-0.30268,-0.24835,1,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.0040644,-0.30363,-0.25,1,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.0038653,-0.30378,-0.26853,1,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0016767,-0.3044,-0.26311,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.0066311,-0.30543,-0.29218,1,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.010572,-0.3094,-0.31018,1,0
5,GO ADULT BEHAVIOR,0.0017696,-0.31116,-0.26052,1,0
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.014457,-0.31189,-0.23972,1,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.0063209,-0.3121,-0.20508,1,0
5,GO SYNAPTIC MEMBRANE ADHESION,0.021265,-0.31746,-0.30412,1,0
5,GO REFLEX,0.013834,-0.32211,-0.26197,1,0
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.007293,-0.32256,-0.26567,1,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0017696,-0.323,-0.2894,1,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0042727,-0.32339,-0.36788,1,0
5,GO SYNAPTIC VESICLE LOCALIZATION,0.0012758,-0.32406,-0.28154,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.0024341,-0.32464,-0.29377,1,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0096484,-0.32496,-0.31588,1,0
5,GO THALAMUS DEVELOPMENT,0.0080134,-0.32604,-0.29438,1,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.006955,-0.32636,-0.31614,1,0
5,GO FOREBRAIN REGIONALIZATION,0.010101,-0.32817,-0.26912,1,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.00332,-0.32895,-0.29805,1,0
5,GO RESPONSE TO AUDITORY STIMULUS,0.016475,-0.32909,-0.25564,1,0
5,GO TELENCEPHALON REGIONALIZATION,0.0096484,-0.33351,-0.32002,1,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.0012758,-0.33429,-0.2994,1,0
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.006955,-0.33472,-0.23893,1,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.0036751,-0.33561,-0.37095,1,0
5,GO REGULATION OF VESICLE FUSION,0.00076864,-0.33653,-0.32622,1,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0066311,-0.33773,-0.37279,1,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00064645,-0.33897,-0.33661,1,0
5,GO RESPONSE TO ACETYLCHOLINE,0.0054671,-0.34574,-0.30063,1,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.027226,-0.34586,-0.36512,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0014241,-0.35138,-0.29217,1,0
5,GO DENDRITIC TRANSPORT,0.0027019,-0.35262,-0.37901,1,0
5,GO NEURON FATE COMMITMENT,0.0042727,-0.35368,-0.28238,1,0
5,GO VOCALIZATION BEHAVIOR,0.037377,-0.35982,-0.25614,1,0
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00081392,-0.36284,-0.28387,1,0
5,GO RESPONSE TO FORSKOLIN,0.040368,-0.36494,-0.22225,1,0
5,GO NOSE DEVELOPMENT,0.016475,-0.36509,-0.37024,1,0
5,GO SYNAPSE MATURATION,0.015776,-0.36655,-0.32815,1,0
5,GO SPINAL CORD PATTERNING,0.015104,-0.36664,-0.27683,1,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.016475,-0.36665,-0.27777,1,0
5,GO CGMP METABOLIC PROCESS,0.0063209,-0.36907,-0.30721,1,0
5,GO TRANSMISSION OF NERVE IMPULSE,0.0015041,-0.37218,-0.30697,1,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.006955,-0.37629,-0.31376,1,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00086166,-0.37673,-0.32357,1,0
5,GO DENDRITE EXTENSION,0.0012758,-0.38201,-0.34615,1,0
5,GO GLUTAMATE SECRETION,0.00081392,-0.38437,-0.3337,1,0
5,GO REGULATION OF MICROTUBULE BINDING,0.0014241,-0.38777,-0.31773,1,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0024341,-0.38817,-0.27389,1,0
5,GO POSTSYNAPSE ASSEMBLY,0.0021907,-0.3899,-0.36497,1,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0011418,-0.39034,-0.3628,1,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.0012758,-0.39158,-0.34686,1,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0049572,-0.39602,-0.29952,1,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.028348,-0.39654,-0.26473,1,0
5,GO NOREPINEPHRINE TRANSPORT,0.024086,-0.40152,-0.25561,1,0
5,GO NEUROTRANSMITTER TRANSPORT,0.00086166,-0.40177,-0.31382,1,0
5,GO GLIAL CELL FATE COMMITMENT,0.010101,-0.40471,-0.29663,1,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00076864,-0.41298,-0.37923,1,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00064645,-0.41411,-0.32846,1,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.00051151,-0.4145,-0.3678,1,0
5,GO NEURONAL ION CHANNEL CLUSTERING,0.0031545,-0.41825,-0.36752,1,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00072571,-0.423,-0.39043,1,0
5,GO CATECHOLAMINE UPTAKE,0.0038653,-0.42375,-0.32833,1,0
5,GO MONOAMINE TRANSPORT,0.0029965,-0.42616,-0.29822,1,0
5,GO AMINE TRANSPORT,0.00045436,-0.42779,-0.34345,1,0
5,GO NEUROTRANSMITTER SECRETION,0.00040321,-0.43182,-0.36351,1,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0010209,-0.43627,-0.38959,1,0
5,GO RESPONSE TO INSECTICIDE,0.00010181,-0.43762,-0.40757,1,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00045436,-0.44419,-0.38182,1,0
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.0063209,-0.44545,-0.36724,1,0
5,GO MECHANOSENSORY BEHAVIOR,0.0057394,-0.44619,-0.36111,1,0
5,GO PROTEIN LOCALIZATION TO AXON,0.0047188,-0.45636,-0.36372,1,0
5,GO GROWTH HORMONE SECRETION,0.0040644,-0.458,-0.34267,1,0
5,GO REGULATION OF DENDRITE EXTENSION,0.00072571,-0.46168,-0.41644,1,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00096503,-0.46203,-0.43211,1,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.0023095,-0.46317,-0.45157,1,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00040321,-0.46906,-0.40699,1,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.010101,-0.47635,-0.32818,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00042807,-0.48293,-0.51582,1,0
5,GO DOPAMINE TRANSPORT,0.00029789,-0.48584,-0.42044,1,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.0047188,-0.4874,-0.34043,1,0
5,GO INNERVATION,0.0025648,-0.49289,-0.42029,1,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0012758,-0.49481,-0.462,1,0
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00064645,-0.50428,-0.43285,1,0
5,GO REGULATION OF DOPAMINE SECRETION,0.00020554,-0.51401,-0.47121,1,0
5,GO SYNAPTIC VESICLE PRIMING,0.00031664,-0.51616,-0.42999,1,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00332,-0.51967,-0.4284,1,0
5,GO STARTLE RESPONSE,0.00026348,-0.52469,-0.46048,1,0
5,GO NEURON CELL CELL ADHESION,0.00031664,-0.53295,-0.49827,1,0
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.00086166,-0.53414,-0.42102,1,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00096503,-0.55162,-0.50795,1,0
5,GO DENSE CORE GRANULE TRANSPORT,0.00045436,-0.55399,-0.54887,1,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.0040644,-0.55628,-0.39444,1,0
5,GO NEURON FATE SPECIFICATION,0.00091199,-0.55706,-0.47627,1,0
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00023283,-0.55732,-0.45779,1,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.0021907,-0.55994,-0.48372,1,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00054254,-0.56048,-0.47497,1,0
5,GO CATECHOLAMINE SECRETION,0.00021879,-0.56055,-0.43652,1,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.00031664,-0.56756,-0.5024,1,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00091199,-0.56964,-0.46683,1,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.00045436,-0.57075,-0.51358,1,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.00035748,-0.57641,-0.47397,1,0
5,GO PREPULSE INHIBITION,0.00096503,-0.57649,-0.47463,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.0017696,-0.5801,-0.50783,1,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00033648,-0.59413,-0.50563,1,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00045436,-0.59876,-0.4835,1,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.0019699,-0.6056,-0.51349,1,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.00081392,-0.61133,-0.54203,1,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00020554,-0.61689,-0.4792,1,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.00018128,-0.62821,-0.64836,1,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.00020554,-0.65772,-0.57838,1,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.00035748,-0.66247,-0.5863,1,0
5,GO SYNAPTIC VESICLE MATURATION,9.5377e-05,-0.67194,-0.60198,1,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00015974,-0.67662,-0.57904,1,0
5,GO SYNAPTIC VESICLE DOCKING,0.00013188,-0.68803,-0.63475,1,0
5,GO PONS DEVELOPMENT,0.0019699,-0.72331,-0.67298,1,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.00031664,-0.75168,-0.64066,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,4.8997e-05,-0.85744,-0.79361,1,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,2.636e-05,-0.87588,-0.82983,1,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.00010866,-1.057,-0.90815,1,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.060677,0.31884,0.2855,0,1
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.054439,0.29711,0.25854,0,1
5,GO CYTOPLASM ORGANIZATION,0.074935,0.27449,0.26214,0,1
5,GO POLYOL TRANSPORT,0.054439,0.26509,0.22111,0,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.098083,0.26419,0.19469,0,1
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.050584,0.25642,0.27357,0,1
5,GO TRNA CATABOLIC PROCESS,0.10811,0.24939,0.16082,0,1
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.058535,0.24302,0.1844,0,1
5,GO CHROMATIN DISASSEMBLY,0.11163,0.23673,0.13276,0,1
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.058535,0.2294,0.20847,0,1
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.08588,0.22891,0.24243,0,1
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.15197,0.22815,0.1595,0,1
5,GO RESPONSE TO CORTICOSTERONE,0.32248,0.22712,0.1423,0,1
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.35442,0.21438,0.10421,0,1
5,GO HISTONE H3 K4 TRIMETHYLATION,0.077559,0.21272,0.23141,0,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.052482,0.20573,0.20011,0,1
5,GO ECTODERM DEVELOPMENT,0.067497,0.20478,0.15233,0,1
5,GO BODY MORPHOGENESIS,0.058535,0.20396,0.20252,0,1
5,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.13467,0.20365,0.10426,0,1
5,GO LYSOSOME LOCALIZATION,0.067497,0.20231,0.18119,0,1
5,GO TONGUE MORPHOGENESIS,0.18624,0.20158,0.12549,0,1
5,GO CORONARY VASCULATURE MORPHOGENESIS,0.077559,0.20123,0.22431,0,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.13467,0.20103,0.12776,0,1
5,GO REGULATION OF HIPPO SIGNALING,0.062884,0.19979,0.20857,0,1
5,GO NEGATIVE REGULATION OF ANOIKIS,0.12662,0.1991,0.21046,0,1
5,GO L SERINE METABOLIC PROCESS,0.3148,0.19654,0.049353,0,1
5,GO COCHLEA MORPHOGENESIS,0.050584,0.19471,0.17049,0,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.052482,0.1934,0.24948,0,1
5,GO ENDOCARDIUM DEVELOPMENT,0.094909,0.18961,0.18012,0,1
5,GO TRIGLYCERIDE CATABOLIC PROCESS,0.08881,0.18716,0.14667,0,1
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.27821,0.18561,0.11672,0,1
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.18102,0.18497,0.020001,0,1
5,GO PEPTIDYL PROLINE HYDROXYLATION,0.10134,0.18284,0.12881,0,1
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.10468,0.1813,0.1617,0,1
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.080256,0.17807,0.25863,0,1
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.1306,0.17682,0.10582,0,1
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.21989,0.17441,0.10015,0,1
5,GO SPINDLE MIDZONE ASSEMBLY,0.16602,0.17434,0.058457,0,1
5,GO BASEMENT MEMBRANE ASSEMBLY,0.11163,0.17149,0.24021,0,1
5,GO PRO B CELL DIFFERENTIATION,0.11163,0.1703,0.16982,0,1
5,GO LIPID IMPORT INTO CELL,0.058535,0.16955,0.17088,0,1
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.080256,0.16803,0.16987,0,1
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.050584,0.16752,0.11783,0,1
5,GO CELL PROLIFERATION IN HINDBRAIN,0.24463,0.16627,0.10387,0,1
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.072385,0.16624,0.1684,0,1
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.23827,0.16474,0.030756,0,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.14312,0.16434,0.13448,0,1
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.050584,0.15991,0.15381,0,1
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.20822,0.15951,0.15622,0,1
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.15197,0.15949,0.12954,0,1
5,GO MIDGUT DEVELOPMENT,0.054439,0.15911,0.22609,0,1
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.056456,0.1588,0.11768,0,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.11524,0.15876,0.20996,0,1
5,GO PEPTIDYL ARGININE MODIFICATION,0.1475,0.15856,0.12145,0,1
5,GO V D J RECOMBINATION,0.067497,0.15763,0.16119,0,1
5,GO P BODY ASSEMBLY,0.1306,0.15535,0.15701,0,1
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.15655,0.15529,0.17572,0,1
5,GO HISTONE H2B UBIQUITINATION,0.069906,0.15477,0.12843,0,1
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.069906,0.15429,0.14888,0,1
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.060677,0.15305,0.10585,0,1
5,GO GLUTAMINE METABOLIC PROCESS,0.060677,0.15264,0.11438,0,1
5,GO SIGNAL PEPTIDE PROCESSING,0.10468,0.15239,0.14183,0,1
5,GO TRNA PROCESSING,0.08881,0.15163,0.087131,0,1
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.11163,0.1513,0.080226,0,1
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.10134,0.15035,0.1372,0,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.056456,0.14855,0.16427,0,1
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.1306,0.14781,0.11506,0,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.054439,0.14688,0.18947,0,1
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.19156,0.14683,0.10827,0,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.050584,0.1466,0.16305,0,1
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.24463,0.14649,0.13837,0,1
5,GO IMP BIOSYNTHETIC PROCESS,0.10134,0.14647,0.094105,0,1
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.10468,0.14621,0.13437,0,1
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.27821,0.1462,0.12579,0,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.065157,0.14591,0.1732,0,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.069906,0.14535,0.15747,0,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.091819,0.14457,0.11288,0,1
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.12273,0.14304,0.10991,0,1
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.11524,0.14299,0.14996,0,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.094909,0.14281,0.1554,0,1
5,GO STEROL BIOSYNTHETIC PROCESS,0.094909,0.14205,0.12782,0,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.080256,0.14162,0.18642,0,1
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.058535,0.14046,0.08181,0,1
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.16602,0.14041,0.12972,0,1
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.16123,0.14031,0.16023,0,1
5,GO MIRNA METABOLIC PROCESS,0.11894,0.14027,0.1299,0,1
5,GO HISTONE SERINE PHOSPHORYLATION,0.26442,0.14006,0.013948,0,1
5,GO TRNA MODIFICATION,0.08303,0.13888,0.10242,0,1
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.15197,0.137,0.11102,0,1
5,GO RNA METHYLATION,0.056456,0.13697,0.11802,0,1
5,GO CHONDROCYTE DIFFERENTIATION,0.052482,0.13653,0.21615,0,1
5,GO DNA DEMETHYLATION,0.056456,0.13569,0.15285,0,1
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.052482,0.13563,0.18296,0,1
5,GO RESPONSE TO MECHANICAL STIMULUS,0.069906,0.13551,0.16852,0,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.062884,0.13519,0.12796,0,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.077559,0.13502,0.19249,0,1
5,GO RESPONSE TO OXYGEN RADICAL,0.054439,0.13453,0.12949,0,1
5,GO BLASTOCYST GROWTH,0.060677,0.13429,0.13014,0,1
5,GO TRNA METABOLIC PROCESS,0.094909,0.13228,0.078383,0,1
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.35442,0.13203,0.11283,0,1
5,GO REGULATION OF AXON GUIDANCE,0.14312,0.13185,0.17206,0,1
5,GO REGULATION OF VASCULOGENESIS,0.080256,0.13177,0.24268,0,1
5,GO REGULATION OF CHROMATIN ASSEMBLY,0.21989,0.13166,0.11279,0,1
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.091819,0.1297,0.092061,0,1
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.29248,0.12856,0.10054,0,1
5,GO NCRNA PROCESSING,0.062884,0.12734,0.084772,0,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.094909,0.12714,0.17309,0,1
5,GO NEGATIVE REGULATION OF SECRETION,0.054439,0.12609,0.14902,0,1
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.065157,0.12589,0.1643,0,1
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.19156,0.12507,0.1921,0,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.067497,0.12476,0.1471,0,1
5,GO RNA 5 END PROCESSING,0.069906,0.12444,0.075638,0,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.20256,0.12398,0.13513,0,1
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.08303,0.12361,0.19469,0,1
5,GO VIRAL RNA GENOME REPLICATION,0.058535,0.12351,0.13539,0,1
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.10134,0.12322,0.092679,0,1
5,GO WATER HOMEOSTASIS,0.091819,0.12248,0.15657,0,1
5,GO NEURAL TUBE DEVELOPMENT,0.08881,0.12182,0.16087,0,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.17091,0.12154,0.10231,0,1
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.27126,0.12101,0.071167,0,1
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.074935,0.12101,0.11214,0,1
5,GO HISTONE H4 DEACETYLATION,0.14312,0.12068,0.11289,0,1
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.069906,0.12032,0.13389,0,1
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.08303,0.12018,0.12798,0,1
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.060677,0.1194,0.16388,0,1
5,GO SNRNA PROCESSING,0.15655,0.11888,0.057921,0,1
5,GO TRNA 5 LEADER REMOVAL,0.29248,0.11864,0.033722,0,1
5,GO DENDRITIC SPINE MAINTENANCE,0.080256,0.11838,0.18263,0,1
5,GO REGULATION OF ENDOCYTOSIS,0.050584,0.1173,0.16535,0,1
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.14312,0.11682,0.11644,0,1
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.20822,0.11597,0.040111,0,1
5,GO NCRNA METABOLIC PROCESS,0.08303,0.11486,0.078036,0,1
5,GO LYTIC VACUOLE ORGANIZATION,0.08881,0.11382,0.15019,0,1
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.052482,0.11372,0.12938,0,1
5,GO MRNA METHYLATION,0.17091,0.11347,0.12018,0,1
5,GO RESPONSE TO GONADOTROPIN,0.08303,0.11329,0.15122,0,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.069906,0.11293,0.18783,0,1
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.098083,0.11292,0.11199,0,1
5,GO INNER CELL MASS CELL PROLIFERATION,0.13467,0.11221,0.071125,0,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.050584,0.1118,0.14806,0,1
5,GO G0 TO G1 TRANSITION,0.47137,0.11086,0.038822,0,1
5,GO ALDITOL METABOLIC PROCESS,0.2259,0.11069,0.048089,0,1
5,GO REGULATION OF PH,0.077559,0.11058,0.12075,0,1
5,GO PROTEIN POLYUBIQUITINATION,0.080256,0.11056,0.11305,0,1
5,GO NUCLEAR PORE ORGANIZATION,0.197,0.11039,0.089988,0,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.065157,0.10964,0.1348,0,1
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.13467,0.10961,0.12228,0,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.077559,0.10915,0.15995,0,1
5,GO APICAL JUNCTION ASSEMBLY,0.098083,0.10906,0.15017,0,1
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.050584,0.10892,0.17543,0,1
5,GO L GLUTAMATE IMPORT,0.12662,0.10872,0.14415,0,1
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.214,0.1087,0.072406,0,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.10811,0.10838,0.13356,0,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.050584,0.10775,0.16656,0,1
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.091819,0.10772,0.12397,0,1
5,GO HISTONE DEACETYLATION,0.197,0.10753,0.11202,0,1
5,GO AMINO ACID ACTIVATION,0.16123,0.10706,0.062426,0,1
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.08588,0.10699,0.15628,0,1
5,GO FATTY ACID BETA OXIDATION,0.13885,0.10689,0.10868,0,1
5,GO DEMETHYLATION,0.14312,0.10671,0.12014,0,1
5,GO SNRNA METABOLIC PROCESS,0.29248,0.10656,0.037308,0,1
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.052482,0.10654,0.16558,0,1
5,GO LIPID PHOSPHORYLATION,0.054439,0.10643,0.17302,0,1
5,GO ER OVERLOAD RESPONSE,0.067497,0.10626,0.15179,0,1
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.20256,0.10624,0.066232,0,1
5,GO GOLGI LOCALIZATION,0.10468,0.10595,0.1078,0,1
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.16602,0.10578,0.062527,0,1
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.11894,0.10551,0.13992,0,1
5,GO RESPONSE TO TESTOSTERONE,0.25111,0.10543,0.08859,0,1
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.08881,0.10531,0.11,0,1
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.57414,0.10526,0.1051,0,1
5,GO MRNA CLEAVAGE,0.11163,0.10518,0.10205,0,1
5,GO GOLGI RIBBON FORMATION,0.067497,0.10466,0.18497,0,1
5,GO METHYLATION,0.19156,0.10455,0.08108,0,1
5,GO MAMMARY GLAND DEVELOPMENT,0.052482,0.10394,0.19492,0,1
5,GO GENE SILENCING,0.08881,0.10383,0.11248,0,1
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.054439,0.1035,0.15406,0,1
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.094909,0.1032,0.12737,0,1
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.21989,0.10302,0.079062,0,1
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.08303,0.10228,0.19012,0,1
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.069906,0.10087,0.089027,0,1
5,GO RIBOSOME BIOGENESIS,0.098083,0.10069,0.063074,0,1
5,GO IMPORT INTO NUCLEUS,0.054439,0.10003,0.12281,0,1
5,GO DNA DEALKYLATION,0.11163,0.099914,0.13137,0,1
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.098083,0.099691,0.1646,0,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.13885,0.09869,0.099608,0,1
5,GO RNA INTERFERENCE,0.10468,0.098555,0.12338,0,1
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.08881,0.097377,0.10357,0,1
5,GO CARNITINE SHUTTLE,0.12662,0.097058,0.13947,0,1
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.13885,0.097049,0.21424,0,1
5,GO ANDROGEN METABOLIC PROCESS,0.050584,0.096714,0.1149,0,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.20822,0.096616,0.11542,0,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.091819,0.096517,0.12229,0,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.052482,0.09645,0.17574,0,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.13885,0.096361,0.067435,0,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.25111,0.096328,0.080147,0,1
5,GO PROTEASOME ASSEMBLY,0.18624,0.096239,0.042838,0,1
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.12662,0.095997,0.068424,0,1
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.056456,0.095467,0.11814,0,1
5,GO MODIFIED AMINO ACID TRANSPORT,0.094909,0.095201,0.14015,0,1
5,GO MATURATION OF 5 8S RRNA,0.214,0.094673,0.054416,0,1
5,GO SENSORY PERCEPTION OF SMELL,0.33029,0.09465,0.060496,0,1
5,GO MULTIVESICULAR BODY ORGANIZATION,0.08881,0.094346,0.088528,0,1
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.2577,0.094137,0.055466,0,1
5,GO REGULATION OF CELL AGING,0.14312,0.093982,0.074368,0,1
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.077559,0.093837,0.085736,0,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,0.10134,0.09378,0.12414,0,1
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.15197,0.093748,0.14313,0,1
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.080256,0.093046,0.13903,0,1
5,GO RESPONSE TO HEAT,0.08881,0.092941,0.1082,0,1
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.25111,0.092509,0.044873,0,1
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.1306,0.092049,0.13208,0,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.080256,0.091531,0.13746,0,1
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.11894,0.091487,0.12182,0,1
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.39705,0.091349,0.043134,0,1
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.11163,0.091303,0.13416,0,1
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.30724,0.091153,0.089725,0,1
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.050584,0.090526,0.12855,0,1
5,GO MATURATION OF SSU RRNA,0.091819,0.089709,0.067952,0,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.054439,0.089673,0.14426,0,1
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.1475,0.089566,0.062911,0,1
5,GO RRNA METABOLIC PROCESS,0.11894,0.089127,0.061218,0,1
5,GO INTRACELLULAR MRNA LOCALIZATION,0.054439,0.089007,0.15942,0,1
5,GO NCRNA EXPORT FROM NUCLEUS,0.15655,0.088668,0.076699,0,1
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.11894,0.088361,0.10728,0,1
5,GO PROTEIN STABILIZATION,0.072385,0.08803,0.11826,0,1
5,GO RNA STABILIZATION,0.062884,0.087826,0.11059,0,1
5,GO FATTY ACID CATABOLIC PROCESS,0.18624,0.087762,0.099463,0,1
5,GO NCRNA 3 END PROCESSING,0.33821,0.087564,0.016224,0,1
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.065157,0.087493,0.089234,0,1
5,GO PROTEIN HYDROXYLATION,0.17091,0.086546,0.12091,0,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.20256,0.086493,0.089931,0,1
5,GO RESPONSE TO ACTIVITY,0.13885,0.086259,0.11391,0,1
5,GO REGULATION OF GLUCOSE IMPORT,0.37111,0.086218,0.071131,0,1
5,GO REGULATION OF DNA RECOMBINATION,0.11524,0.086008,0.1158,0,1
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.080256,0.085648,0.096511,0,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.067497,0.085644,0.14415,0,1
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.17091,0.085443,0.070766,0,1
5,GO RESPONSE TO NITROSATIVE STRESS,0.067497,0.084626,0.10573,0,1
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.34626,0.084307,0.064043,0,1
5,GO MATURATION OF LSU RRNA,0.2577,0.084094,0.055785,0,1
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.077559,0.083348,0.074643,0,1
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.3148,0.082561,0.10087,0,1
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.25111,0.081506,0.039252,0,1
5,GO TRNA WOBBLE BASE MODIFICATION,0.20256,0.080984,0.073951,0,1
5,GO PROTEIN AUTOUBIQUITINATION,0.44264,0.080897,0.062218,0,1
5,GO SULFUR COMPOUND TRANSPORT,0.08881,0.080844,0.13748,0,1
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.20822,0.080424,0.13719,0,1
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.33821,0.080374,-0.002457,0,1
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.16123,0.080212,0.022893,0,1
5,GO PEPTIDE BIOSYNTHETIC PROCESS,0.091819,0.079382,0.053653,0,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.08588,0.079086,0.12834,0,1
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.18102,0.07894,0.13458,0,1
5,GO QUINONE METABOLIC PROCESS,0.098083,0.078924,0.072076,0,1
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.17091,0.078799,0.092764,0,1
5,GO CARBOHYDRATE CATABOLIC PROCESS,0.11894,0.078634,0.11492,0,1
5,GO CELL AGING,0.065157,0.078602,0.12909,0,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,0.7336,0.078352,0.055445,0,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.12662,0.077128,0.1093,0,1
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.16123,0.076899,0.083176,0,1
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.2259,0.076777,0.10162,0,1
5,GO RESPONSE TO RADIATION,0.17591,0.076611,0.095666,0,1
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.11524,0.07645,0.12027,0,1
5,GO EMBRYONIC DIGIT MORPHOGENESIS,0.15197,0.076138,0.13742,0,1
5,GO REGULATION OF CELL MATURATION,0.30724,0.075953,0.063669,0,1
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.1306,0.075942,0.06868,0,1
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.08588,0.075503,0.067159,0,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.12662,0.07466,0.11772,0,1
5,GO RESPONSE TO INSULIN,0.074935,0.074209,0.14107,0,1
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.16602,0.074132,0.08511,0,1
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.1306,0.074033,0.15285,0,1
5,GO GOLGI VESICLE TRANSPORT,0.11894,0.073543,0.11313,0,1
5,GO ENDOSOME TO LYSOSOME TRANSPORT,0.1306,0.073543,0.11615,0,1
5,GO GLUCOSE IMPORT,0.30724,0.073365,0.081711,0,1
5,GO DE NOVO PROTEIN FOLDING,0.35442,0.073251,0.058435,0,1
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.12662,0.073247,0.075912,0,1
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.34626,0.071832,0.058119,0,1
5,GO MACROAUTOPHAGY,0.050584,0.071684,0.12496,0,1
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.11894,0.07163,0.10438,0,1
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.32248,0.070317,0.099273,0,1
5,GO MACROMOLECULE DEACYLATION,0.32248,0.070211,0.09036,0,1
5,GO AMIDE BIOSYNTHETIC PROCESS,0.077559,0.070135,0.057058,0,1
5,GO KETONE BIOSYNTHETIC PROCESS,0.10134,0.07013,0.11614,0,1
5,GO TRNA TRANSPORT,0.17591,0.069825,0.061974,0,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.13467,0.06953,0.11279,0,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.067497,0.069458,0.10187,0,1
5,GO CELLULAR SENESCENCE,0.12273,0.069108,0.10478,0,1
5,GO PROTEIN SUMOYLATION,0.13467,0.068815,0.099888,0,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.1475,0.068514,0.079742,0,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.12273,0.06818,0.1385,0,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.51122,0.067436,0.082602,0,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.32248,0.067363,0.067122,0,1
5,GO TRNA 5 END PROCESSING,0.4521,0.067047,0.0058177,0,1
5,GO PROTEIN CATABOLIC PROCESS,0.10468,0.066103,0.11607,0,1
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.51122,0.066073,0.032599,0,1
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.16602,0.066047,0.084614,0,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.094909,0.065874,0.13558,0,1
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.10468,0.065721,0.071132,0,1
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.47137,0.065334,0.065582,0,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.062884,0.065241,0.1505,0,1
5,GO VESICLE TARGETING,0.072385,0.063944,0.13386,0,1
5,GO PEROXISOMAL TRANSPORT,0.052482,0.063753,0.096059,0,1
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.81845,0.063695,-0.0069408,0,1
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.094909,0.063579,0.10541,0,1
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.40594,0.063565,0.095508,0,1
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.11524,0.063367,0.11977,0,1
5,GO MAGNESIUM ION TRANSPORT,0.2259,0.063243,0.096432,0,1
5,GO CELLULAR RESPONSE TO HEAT,0.11163,0.063143,0.099176,0,1
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.067497,0.062755,0.1502,0,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.2577,0.062166,0.097486,0,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.14312,0.061789,0.15044,0,1
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.34626,0.06146,0.04137,0,1
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.11524,0.059857,0.12379,0,1
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.18102,0.057224,0.066218,0,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.2259,0.056861,0.10455,0,1
5,GO VIRAL GENE EXPRESSION,0.21989,0.055555,0.050206,0,1
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.47137,0.05502,0.053437,0,1
5,GO REGULATION OF DNA METABOLIC PROCESS,0.20256,0.053954,0.081571,0,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.41494,0.053318,0.087143,0,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.23827,0.052979,0.091946,0,1
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.060677,0.052248,0.086235,0,1
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.33029,0.052162,0.070142,0,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.32248,0.048846,0.079994,0,1
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.42405,0.047432,0.056204,0,1
5,GO REGULATION OF ERAD PATHWAY,0.10468,0.047398,0.13754,0,1
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.29248,0.04707,0.032389,0,1
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.37111,0.042719,0.064222,0,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.21989,0.030147,0.095346,0,1
5,GO TRANSLATIONAL INITIATION,0.70989,0.023847,0.015384,0,1
5,GO EOSINOPHIL CHEMOTAXIS,0.0016767,0.72974,0.66563,0,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0014241,0.61267,0.54583,0,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0052065,0.58256,0.51706,0,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0027019,0.49122,0.49251,0,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00072571,0.41067,0.60841,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.017954,0.36244,0.2861,0,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00029789,0.3355,0.45537,0,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.0080134,0.31379,0.32851,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.010572,0.29421,0.34365,0,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0092139,0.29267,0.36264,0,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0038653,0.29224,0.35888,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0031545,0.29208,0.35132,0,0
5,GO CHONDROCYTE PROLIFERATION,0.0083971,0.28542,0.3267,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.02951,0.27938,0.22206,0,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0076456,0.2753,0.29253,0,0
5,GO BIOLOGICAL PHASE,0.0020776,0.27324,0.39475,0,0
5,GO REGULATION OF CELL FATE SPECIFICATION,0.021265,0.26664,0.27883,0,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.00096503,0.26561,0.32847,0,0
5,GO RESPONSE TO VITAMIN D,0.0076456,0.26528,0.27217,0,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.023112,0.26307,0.27996,0,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0042727,0.25399,0.42134,0,0
5,GO GAS TRANSPORT,0.024086,0.25208,0.31426,0,0
5,GO VASCULOGENESIS,0.0038653,0.25189,0.33017,0,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0024341,0.24954,0.40981,0,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.019548,0.24573,0.21467,0,0
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.067497,0.24493,0.13489,0,0
5,GO POSITIVE REGULATION OF URINE VOLUME,0.0060238,0.24045,0.32379,0,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0025648,0.24042,0.30644,0,0
5,GO REGULATION OF RESPIRATORY BURST,0.14312,0.23975,0.15076,0,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.13885,0.23822,0.25068,0,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.030713,0.23535,0.30191,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.010101,0.2333,0.37164,0,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.019548,0.2324,0.349,0,0
5,GO MYOBLAST DIFFERENTIATION,0.0012758,0.23169,0.27208,0,0
5,GO RESPONSE TO PROGESTERONE,0.0096484,0.23166,0.25092,0,0
5,GO RESPONSE TO FLUID SHEAR STRESS,0.0047188,0.22981,0.3727,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.060677,0.22976,0.27429,0,0
5,GO POSITIVE CHEMOTAXIS,0.0031545,0.2289,0.32559,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.080256,0.22835,0.26315,0,0
5,GO OVULATION,0.0092139,0.22599,0.27777,0,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.019548,0.22465,0.2396,0,0
5,GO SPROUTING ANGIOGENESIS,0.0040644,0.22389,0.32151,0,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0038653,0.22208,0.36613,0,0
5,GO PROSTATIC BUD FORMATION,0.018736,0.22179,0.3203,0,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.072385,0.21632,0.13206,0,0
5,GO BONE MATURATION,0.015104,0.21575,0.26255,0,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.0034935,0.21322,0.29257,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.10134,0.21046,0.20138,0,0
5,GO SALIVARY GLAND DEVELOPMENT,0.0096484,0.21001,0.31183,0,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.010101,0.20782,0.26074,0,0
5,GO CELLULAR RESPONSE TO VITAMIN,0.069906,0.2065,0.21052,0,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,0.08588,0.20589,0.23497,0,0
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.062884,0.20291,0.13306,0,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.013235,0.20235,0.23048,0,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0021907,0.20001,0.29271,0,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.080256,0.19964,0.1903,0,0
5,GO REGULATION OF NECROTIC CELL DEATH,0.01266,0.19814,0.20868,0,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.067497,0.19728,0.22352,0,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.080256,0.19485,0.25011,0,0
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.013834,0.19351,0.20968,0,0
5,GO POSITIVE REGULATION OF MYELINATION,0.050584,0.19169,0.22304,0,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.030713,0.19147,0.19586,0,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.013834,0.19037,0.22467,0,0
5,GO RESPONSE TO HYPEROXIA,0.0023095,0.18734,0.27778,0,0
5,GO AUTOPHAGIC CELL DEATH,0.0042727,0.18669,0.20198,0,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.1306,0.18638,0.16562,0,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.038848,0.18595,0.2669,0,0
5,GO HISTAMINE SECRETION,0.197,0.18294,0.17048,0,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.040368,0.18257,0.23958,0,0
5,GO ANIMAL ORGAN MATURATION,0.024086,0.18024,0.22568,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.034576,0.17959,0.19894,0,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.098083,0.17808,0.18546,0,0
5,GO STEROID CATABOLIC PROCESS,0.098083,0.17719,0.165,0,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.10811,0.17718,0.29257,0,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.11163,0.17652,0.2477,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.067497,0.17641,0.16615,0,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.12273,0.17572,0.2113,0,0
5,GO POSITIVE REGULATION OF OSSIFICATION,0.016475,0.17566,0.24303,0,0
5,GO SEROTONIN SECRETION,0.11524,0.17546,0.23975,0,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.11894,0.17397,0.19596,0,0
5,GO PROSTATE GLAND MORPHOGENESIS,0.080256,0.17186,0.21648,0,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.074935,0.1702,0.26561,0,0
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.23203,0.17019,0.18768,0,0
5,GO CARDIOBLAST DIFFERENTIATION,0.11524,0.16982,0.17382,0,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.058535,0.16853,0.17264,0,0
5,GO RENAL VESICLE DEVELOPMENT,0.067497,0.16796,0.19239,0,0
5,GO TRACHEA MORPHOGENESIS,0.024086,0.16771,0.31415,0,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.08881,0.16616,0.23645,0,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.15655,0.16552,0.18506,0,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.3148,0.164,0.12782,0,0
5,GO ENGULFMENT OF APOPTOTIC CELL,0.16602,0.16375,0.15122,0,0
5,GO REGULATION OF HEAT GENERATION,0.11163,0.16374,0.16561,0,0
5,GO BONE MINERALIZATION,0.052482,0.16312,0.21549,0,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.026142,0.16265,0.24512,0,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.16602,0.16099,0.15787,0,0
5,GO LATERAL VENTRICLE DEVELOPMENT,0.14312,0.16067,0.20701,0,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.072385,0.16063,0.22633,0,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.067497,0.16012,0.23091,0,0
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.11163,0.1595,0.17011,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,0.11524,0.15927,0.26612,0,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.094909,0.15888,0.1966,0,0
5,GO IMP METABOLIC PROCESS,0.077559,0.15854,0.10793,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.062884,0.15599,0.17704,0,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.11163,0.15434,0.14449,0,0
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.18102,0.15428,0.14625,0,0
5,GO METANEPHROS DEVELOPMENT,0.013834,0.1532,0.22783,0,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.015104,0.15284,0.16848,0,0
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.037377,0.15262,0.23419,0,0
5,GO LATERAL MESODERM DEVELOPMENT,0.043559,0.15253,0.19888,0,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.043559,0.15233,0.16997,0,0
5,GO PHAGOLYSOSOME ASSEMBLY,0.18102,0.15178,0.16111,0,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.043559,0.15064,0.24796,0,0
5,GO PARTURITION,0.098083,0.1502,0.16358,0,0
5,GO MITOTIC CELL CYCLE ARREST,0.013235,0.15019,0.20655,0,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.041938,0.14945,0.16801,0,0
5,GO BODY FLUID SECRETION,0.0172,0.14922,0.16736,0,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.091819,0.14841,0.19199,0,0
5,GO RESPONSE TO PARATHYROID HORMONE,0.15655,0.14762,0.14109,0,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.062884,0.14587,0.1959,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.24463,0.14538,0.13695,0,0
5,GO AZOLE TRANSMEMBRANE TRANSPORT,0.30724,0.14503,0.12932,0,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.10468,0.14467,0.13599,0,0
5,GO GOLGI TO VACUOLE TRANSPORT,0.13467,0.14439,0.16891,0,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.033245,0.143,0.24129,0,0
5,GO GLUTATHIONE METABOLIC PROCESS,0.0057394,0.14295,0.16691,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.10468,0.14251,0.21938,0,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.056456,0.1422,0.25404,0,0
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.050584,0.14053,0.19505,0,0
5,GO ENDOCARDIAL CUSHION FORMATION,0.11524,0.1403,0.2285,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.094909,0.14015,0.1277,0,0
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.16602,0.14008,0.14635,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.18102,0.13977,0.1414,0,0
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.058535,0.1387,0.20143,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.040368,0.13854,0.16518,0,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,0.011574,0.13837,0.18458,0,0
5,GO CELLULAR RESPONSE TO VITAMIN D,0.24463,0.1383,0.13533,0,0
5,GO GLYCINE METABOLIC PROCESS,0.2577,0.13822,0.080092,0,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.046961,0.13813,0.18258,0,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.074935,0.13777,0.24603,0,0
5,GO REPLICATION FORK PROCESSING,0.5959,0.13771,0.0237,0,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.060677,0.13764,0.20116,0,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.10811,0.13763,0.14133,0,0
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.20822,0.13759,0.097295,0,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,0.052482,0.13738,0.20481,0,0
5,GO OUTFLOW TRACT MORPHOGENESIS,0.062884,0.137,0.22966,0,0
5,GO REGULATION OF FATTY ACID TRANSPORT,0.077559,0.13692,0.17561,0,0
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.020391,0.1369,0.23996,0,0
5,GO MESENCHYME MORPHOGENESIS,0.054439,0.13645,0.23367,0,0
5,GO OSSIFICATION,0.021265,0.13619,0.2099,0,0
5,GO REGULATION OF PROTEIN BINDING,0.056456,0.13601,0.16086,0,0
5,GO REPLICATIVE SENESCENCE,0.1475,0.1359,0.12699,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.29248,0.13587,0.0029915,0,0
5,GO SKELETAL SYSTEM DEVELOPMENT,0.0096484,0.13531,0.21773,0,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.13467,0.13459,0.096864,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.11524,0.13454,0.15176,0,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.031957,0.13427,0.23389,0,0
5,GO POSITIVE REGULATION OF HEART GROWTH,0.016475,0.1342,0.20274,0,0
5,GO ANIMAL ORGAN FORMATION,0.043559,0.13348,0.19079,0,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.214,0.13316,0.086367,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.018736,0.13282,0.23666,0,0
5,GO FACIAL NERVE MORPHOGENESIS,0.214,0.1327,0.16436,0,0
5,GO CARDIAC CHAMBER DEVELOPMENT,0.037377,0.13262,0.20274,0,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.094909,0.13261,0.21198,0,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.019548,0.13176,0.22522,0,0
5,GO RNA SURVEILLANCE,0.1475,0.13144,0.05715,0,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.1475,0.13139,0.16376,0,0
5,GO CELLULAR RESPONSE TO NUTRIENT,0.10134,0.13084,0.18634,0,0
5,GO REGULATION OF CILIUM MOVEMENT,0.2998,0.13061,0.060724,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.091819,0.13022,0.19862,0,0
5,GO REGULATION OF GTP BINDING,0.23203,0.13003,0.11628,0,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.1475,0.12993,0.14891,0,0
5,GO OXIDATIVE DEMETHYLATION,0.24463,0.1296,0.10296,0,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.23203,0.12957,0.087312,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.022172,0.12888,0.18081,0,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.28529,0.12877,0.047919,0,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.17091,0.12776,0.18355,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.050584,0.12678,0.1554,0,0
5,GO HAIR FOLLICLE MATURATION,0.030713,0.1264,0.20715,0,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.61803,0.12596,0.065912,0,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.054439,0.12577,0.16396,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.13885,0.12548,0.14671,0,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.11894,0.12505,0.094059,0,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.062884,0.12502,0.19191,0,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.067497,0.12494,0.1052,0,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.054439,0.1244,0.21576,0,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.16123,0.12402,0.050567,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.16602,0.12396,0.14619,0,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.037377,0.12389,0.21136,0,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,0.052482,0.12373,0.17492,0,0
5,GO TRNA METHYLATION,0.091819,0.12299,0.11439,0,0
5,GO HISTONE H3 ACETYLATION,0.098083,0.12277,0.13166,0,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2259,0.12262,0.15557,0,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0012758,0.12237,0.21263,0,0
5,GO DIGESTION,0.065157,0.12237,0.14302,0,0
5,GO MANNOSYLATION,0.2998,0.12194,0.072584,0,0
5,GO CONVERGENT EXTENSION,0.08588,0.12147,0.20135,0,0
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.031957,0.12066,0.16998,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.091819,0.11972,0.21573,0,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.36271,0.11939,0.045806,0,0
5,GO INACTIVATION OF MAPK ACTIVITY,0.10468,0.11887,0.16056,0,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.098083,0.11878,0.18496,0,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.034576,0.11836,0.1496,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.027226,0.1182,0.16889,0,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.12273,0.11814,0.17514,0,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.197,0.11775,0.092627,0,0
5,GO NEPHRIC DUCT MORPHOGENESIS,0.10468,0.11774,0.19129,0,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.20822,0.11767,0.12073,0,0
5,GO MICROVILLUS ASSEMBLY,0.035953,0.11753,0.16342,0,0
5,GO NEURAL CREST CELL DIFFERENTIATION,0.08881,0.1175,0.17118,0,0
5,GO MIDDLE EAR MORPHOGENESIS,0.067497,0.11714,0.115,0,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.15197,0.11678,0.17875,0,0
5,GO CYSTEINE METABOLIC PROCESS,0.214,0.11669,0.10617,0,0
5,GO LIPID DIGESTION,0.18624,0.11665,0.14998,0,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.17091,0.11641,0.18022,0,0
5,GO INTESTINAL ABSORPTION,0.077559,0.11639,0.22172,0,0
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.15197,0.11626,0.12733,0,0
5,GO PROTEIN AUTOPROCESSING,0.25111,0.11624,0.095477,0,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,0.060677,0.1157,0.2103,0,0
5,GO NEPHRON DEVELOPMENT,0.031957,0.11559,0.21198,0,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.015776,0.11546,0.14621,0,0
5,GO MESENCHYMAL CELL PROLIFERATION,0.17591,0.11532,0.16258,0,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.17591,0.11528,0.18044,0,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.098083,0.11494,0.18378,0,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,0.098083,0.11476,0.17646,0,0
5,GO BONE GROWTH,0.091819,0.11392,0.20464,0,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.022172,0.11391,0.23218,0,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.11163,0.11384,0.17665,0,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,0.041938,0.11379,0.21428,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.052482,0.11357,0.13616,0,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.197,0.11322,0.14027,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.12662,0.11303,0.13525,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.11894,0.11285,0.14388,0,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.40594,0.11284,0.11223,0,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.14312,0.11263,0.12261,0,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.069906,0.11252,0.18249,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.23203,0.11249,0.17692,0,0
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.08303,0.11241,0.18161,0,0
5,GO MUSCLE HYPERTROPHY,0.13467,0.11141,0.14865,0,0
5,GO KIDNEY EPITHELIUM DEVELOPMENT,0.069906,0.11117,0.1762,0,0
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.027226,0.11062,0.2161,0,0
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.1306,0.11058,0.1278,0,0
5,GO ADAPTIVE THERMOGENESIS,0.067497,0.11049,0.14889,0,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.015776,0.11047,0.16498,0,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.44264,0.11014,0.088413,0,0
5,GO MITOCHONDRIAL DEPOLARIZATION,0.067497,0.11009,0.18339,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.025096,0.10964,0.11968,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.060677,0.10945,0.16603,0,0
5,GO MOTOR NEURON AXON GUIDANCE,0.35442,0.10941,0.1343,0,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.16123,0.10925,0.11842,0,0
5,GO SNORNA METABOLIC PROCESS,0.214,0.10847,0.032823,0,0
5,GO PHAGOSOME MATURATION,0.12273,0.10828,0.13983,0,0
5,GO IRON COORDINATION ENTITY TRANSPORT,0.11894,0.10807,0.19724,0,0
5,GO LUNG ALVEOLUS DEVELOPMENT,0.12662,0.10779,0.20252,0,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.11163,0.10741,0.13176,0,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.1475,0.10741,0.18779,0,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.19156,0.10737,0.16574,0,0
5,GO HORMONE CATABOLIC PROCESS,0.16123,0.10732,0.12512,0,0
5,GO PROGESTERONE METABOLIC PROCESS,0.072385,0.10725,0.20453,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.21989,0.10701,0.16869,0,0
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.050584,0.10673,0.15935,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.24463,0.10665,0.068418,0,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.35442,0.10647,0.08032,0,0
5,GO AMINO ACID IMPORT,0.18624,0.10635,0.13957,0,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.11163,0.10627,0.20084,0,0
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.13885,0.10565,0.19496,0,0
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.056456,0.10484,0.17114,0,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.065157,0.10465,0.2015,0,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.83078,0.10437,0.049459,0,0
5,GO NEURAL CREST FORMATION,0.40594,0.10431,0.12811,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.52145,0.10389,0.010706,0,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.15655,0.10387,0.16948,0,0
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.060677,0.10385,0.20821,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.16602,0.10361,0.19998,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.13885,0.10345,0.097719,0,0
5,GO PROTEIN KINASE A SIGNALING,0.098083,0.10295,0.13212,0,0
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.13467,0.10276,0.15156,0,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,0.2998,0.10265,0.086118,0,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.40594,0.10248,0.095235,0,0
5,GO REGULATION OF PEPTIDE SECRETION,0.14312,0.10234,0.13094,0,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.12273,0.10234,0.14376,0,0
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.072385,0.10216,0.21271,0,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.36271,0.1021,0.10488,0,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.046961,0.1017,0.22665,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.214,0.10136,0.097411,0,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.10468,0.10089,0.060926,0,0
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.11524,0.10082,0.11125,0,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.26442,0.10056,0.10772,0,0
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.048745,0.10053,0.18606,0,0
5,GO ORGAN INDUCTION,0.214,0.10012,0.13444,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.89296,0.10009,0.016211,0,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.045233,0.10002,0.17899,0,0
5,GO CELLULAR RESPONSE TO PEPTIDE,0.062884,0.099965,0.1513,0,0
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.24463,0.099803,0.11579,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,0.197,0.099709,0.13102,0,0
5,GO EPITHELIAL TUBE FORMATION,0.054439,0.099708,0.16818,0,0
5,GO DNA RECOMBINATION,0.27821,0.099609,0.041277,0,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.18102,0.099478,0.14207,0,0
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.35442,0.098872,0.074227,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.043559,0.098625,0.19623,0,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.2998,0.098615,0.1314,0,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.058535,0.098615,0.15384,0,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.12662,0.09861,0.1423,0,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.20822,0.098605,0.1677,0,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.08303,0.098374,0.24178,0,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.35442,0.098248,0.057449,0,0
5,GO SNRNA TRANSCRIPTION,0.27821,0.097771,0.061514,0,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,0.11524,0.097627,0.17452,0,0
5,GO POSITIVE REGULATION OF HEART RATE,0.25111,0.097601,0.09449,0,0
5,GO OVULATION CYCLE,0.17591,0.097392,0.14495,0,0
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.065157,0.097222,0.23902,0,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.43329,0.097216,0.079471,0,0
5,GO GMP METABOLIC PROCESS,0.10811,0.09719,0.11719,0,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.7336,0.097182,0.012376,0,0
5,GO HISTONE H3 K14 ACETYLATION,0.30724,0.097009,0.10358,0,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.077559,0.096908,0.24032,0,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.20822,0.096845,0.077318,0,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.23203,0.096792,0.18464,0,0
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.030713,0.096755,0.19355,0,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.27126,0.096703,0.10739,0,0
5,GO MESODERM MORPHOGENESIS,0.017954,0.096613,0.19679,0,0
5,GO DISACCHARIDE METABOLIC PROCESS,0.098083,0.096376,0.18767,0,0
5,GO REGULATION OF ICOSANOID SECRETION,0.16123,0.096302,0.1398,0,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.32248,0.096278,0.099273,0,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.10811,0.096198,0.13607,0,0
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.11894,0.09598,0.15893,0,0
5,GO MESENCHYME DEVELOPMENT,0.08881,0.095625,0.16948,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE,0.18102,0.095494,0.080843,0,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,0.1475,0.094833,0.083344,0,0
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.072385,0.094789,0.15925,0,0
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.060677,0.094692,0.16478,0,0
5,GO GASTRIC ACID SECRETION,0.2259,0.094668,0.10126,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.13885,0.094326,0.2183,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.76963,0.094021,0.02322,0,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.11524,0.094014,0.16801,0,0
5,GO HINDLIMB MORPHOGENESIS,0.29248,0.093934,0.12605,0,0
5,GO CARBOHYDRATE TRANSPORT,0.10468,0.093841,0.12659,0,0
5,GO CELL CELL JUNCTION ORGANIZATION,0.24463,0.092836,0.14155,0,0
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.27821,0.09274,0.080651,0,0
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.12273,0.092683,0.1798,0,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,0.08303,0.092385,0.24267,0,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.17091,0.092312,0.13754,0,0
5,GO LYSINE METABOLIC PROCESS,0.33029,0.091991,0.094237,0,0
5,GO REGULATION OF LIGASE ACTIVITY,0.041938,0.091941,0.12479,0,0
5,GO HEART TRABECULA MORPHOGENESIS,0.17591,0.091893,0.18383,0,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.37964,0.091765,0.16075,0,0
5,GO HISTONE H3 K4 METHYLATION,0.30724,0.091729,0.080483,0,0
5,GO MESONEPHROS DEVELOPMENT,0.1306,0.091486,0.13105,0,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.041938,0.09146,0.13849,0,0
5,GO PIGMENT CELL DIFFERENTIATION,0.20256,0.091312,0.12275,0,0
5,GO REGULATION OF VASOCONSTRICTION,0.065157,0.091257,0.22216,0,0
5,GO PROTEIN OXIDATION,0.25111,0.091182,0.086772,0,0
5,GO N GLYCAN PROCESSING,0.34626,0.090959,0.13282,0,0
5,GO RESPONSE TO EPINEPHRINE,0.10811,0.090805,0.16842,0,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.065157,0.090416,0.13955,0,0
5,GO RESPONSE TO MUSCLE STRETCH,0.098083,0.090382,0.21527,0,0
5,GO CELL CELL JUNCTION ASSEMBLY,0.20256,0.090156,0.13537,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.197,0.090087,0.091023,0,0
5,GO SPHINGOID METABOLIC PROCESS,0.32248,0.089971,0.11947,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.2577,0.089601,0.072022,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.16123,0.089529,0.13746,0,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.14312,0.089449,0.15123,0,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.37964,0.089339,0.021853,0,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.29248,0.089186,0.17174,0,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.1306,0.089083,0.2176,0,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.40594,0.088903,0.13427,0,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.2259,0.08864,0.10156,0,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.214,0.088487,0.1089,0,0
5,GO MAINTENANCE OF CELL NUMBER,0.060677,0.088296,0.15841,0,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.24463,0.088279,0.16873,0,0
5,GO RESPONSE TO UV,0.13467,0.088138,0.11096,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.091819,0.088009,0.19426,0,0
5,GO HISTONE DEUBIQUITINATION,0.27126,0.087859,0.11291,0,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.072385,0.087792,0.12025,0,0
5,GO ACTIN MEDIATED CELL CONTRACTION,0.13467,0.087632,0.13138,0,0
5,GO OVULATION CYCLE PROCESS,0.2998,0.087586,0.1161,0,0
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.18102,0.087391,0.18338,0,0
5,GO RRNA CATABOLIC PROCESS,0.38829,0.087154,0.049323,0,0
5,GO SNORNA 3 END PROCESSING,0.35442,0.087094,0.011369,0,0
5,GO HISTONE H3 K9 MODIFICATION,0.35442,0.086907,0.080119,0,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.034576,0.086747,0.15065,0,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.56341,0.086628,0.014031,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.214,0.086482,0.13118,0,0
5,GO NEPHRON MORPHOGENESIS,0.037377,0.086281,0.17148,0,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.056456,0.086206,0.15719,0,0
5,GO EXTRACELLULAR TRANSPORT,0.29248,0.0861,0.094836,0,0
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.11163,0.086001,0.1335,0,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.069906,0.085848,0.16081,0,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.17591,0.085774,0.2019,0,0
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.058535,0.085696,0.14688,0,0
5,GO REGULATION OF DEACETYLASE ACTIVITY,0.197,0.085674,0.14497,0,0
5,GO LIPOSACCHARIDE METABOLIC PROCESS,0.1475,0.085611,0.10549,0,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.2998,0.085584,0.057679,0,0
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.035953,0.085572,0.15288,0,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.197,0.085444,0.083238,0,0
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.15197,0.085324,0.1228,0,0
5,GO PIRNA METABOLIC PROCESS,0.44264,0.085194,0.066433,0,0
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.067497,0.085051,0.1484,0,0
5,GO ENDOSOMAL TRANSPORT,0.091819,0.085042,0.13182,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.37964,0.08487,0.066315,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.12273,0.084599,0.17272,0,0
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.077559,0.084325,0.1525,0,0
5,GO ANOIKIS,0.098083,0.084287,0.17353,0,0
5,GO REGULATION OF HEART GROWTH,0.038848,0.084221,0.16664,0,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.10811,0.084007,0.13208,0,0
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.069906,0.083926,0.14655,0,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.08881,0.083911,0.10286,0,0
5,GO SPLEEN DEVELOPMENT,0.060677,0.083877,0.14341,0,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.37111,0.083686,0.087393,0,0
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.1475,0.083455,0.17901,0,0
5,GO STEROID HORMONE SECRETION,0.48117,0.083419,0.086125,0,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.35442,0.083397,0.081436,0,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.052482,0.083335,0.19713,0,0
5,GO RESPONSE TO ESTRADIOL,0.08303,0.08324,0.14244,0,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.16123,0.083138,0.18552,0,0
5,GO EPITHELIUM DEVELOPMENT,0.054439,0.082581,0.14931,0,0
5,GO AMP METABOLIC PROCESS,0.037377,0.082522,0.11645,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.36271,0.082367,0.08305,0,0
5,GO CARDIOCYTE DIFFERENTIATION,0.074935,0.082255,0.15608,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.10134,0.082014,0.11411,0,0
5,GO MAGNESIUM ION HOMEOSTASIS,0.26442,0.081957,0.13943,0,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.077559,0.081817,0.18152,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.16123,0.081277,0.15068,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.41494,0.081228,-0.02284,0,0
5,GO ALCOHOL CATABOLIC PROCESS,0.11894,0.081202,0.10777,0,0
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.16602,0.081116,0.11585,0,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.48117,0.081097,0.052977,0,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.065157,0.080722,0.12438,0,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.29248,0.080717,0.097343,0,0
5,GO PLASMA MEMBRANE TUBULATION,0.197,0.080709,0.15825,0,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.12662,0.080104,0.10381,0,0
5,GO ENDOTHELIAL CELL CHEMOTAXIS,0.1475,0.079866,0.20502,0,0
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.054439,0.079787,0.1595,0,0
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.14312,0.079684,0.10905,0,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.35442,0.079596,0.063668,0,0
5,GO REGULATION OF CELL DIFFERENTIATION,0.10811,0.079463,0.14527,0,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.3148,0.079378,0.14508,0,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.33821,0.079208,0.10565,0,0
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.16123,0.079161,0.13425,0,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.37964,0.078987,0.075196,0,0
5,GO REGULATION OF EXOSOMAL SECRETION,0.1475,0.078932,0.1332,0,0
5,GO RESPONSE TO NITROGEN COMPOUND,0.094909,0.078538,0.12492,0,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.08303,0.07841,0.15351,0,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.36271,0.078102,0.068323,0,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.12662,0.078069,0.096161,0,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.062884,0.07781,0.15007,0,0
5,GO HISTONE MONOUBIQUITINATION,0.50109,0.077603,0.050529,0,0
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.060677,0.077297,0.15933,0,0
5,GO MUSCLE TISSUE DEVELOPMENT,0.080256,0.077232,0.14302,0,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.018736,0.077141,0.14826,0,0
5,GO UV PROTECTION,0.197,0.077138,0.14466,0,0
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.20256,0.077134,0.11029,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.058535,0.077119,0.1413,0,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.12273,0.077119,0.11124,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.42405,0.07711,0.13252,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.65188,0.076855,-0.040578,0,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.20822,0.076774,0.14367,0,0
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.12662,0.076756,0.10245,0,0
5,GO DISTAL TUBULE DEVELOPMENT,0.2577,0.076657,0.14636,0,0
5,GO RNA 3 END PROCESSING,0.49108,0.076581,0.021827,0,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.16123,0.076492,0.063207,0,0
5,GO POSITIVE REGULATION OF CELL MATURATION,0.24463,0.07645,0.14225,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.15655,0.076352,0.15875,0,0
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.23827,0.076183,0.10993,0,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.58498,0.076123,0.060166,0,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.27821,0.076077,0.099851,0,0
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.10811,0.076063,0.11341,0,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.50109,0.075918,0.042017,0,0
5,GO GOLGI ORGANIZATION,0.13467,0.075888,0.13319,0,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.13467,0.075832,0.095002,0,0
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.13467,0.075817,0.18305,0,0
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.060677,0.075688,0.15304,0,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.50109,0.075687,0.087688,0,0
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.067497,0.075588,0.17306,0,0
5,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.37964,0.075455,0.13231,0,0
5,GO REGULATION OF AUTOPHAGY,0.050584,0.07541,0.14529,0,0
5,GO KIDNEY MORPHOGENESIS,0.072385,0.075403,0.15458,0,0
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.1475,0.075353,0.12529,0,0
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.40594,0.07529,0.088035,0,0
5,GO GLYCOSYLATION,0.19156,0.075251,0.10927,0,0
5,GO RESPONSE TO PEPTIDE HORMONE,0.058535,0.074924,0.1399,0,0
5,GO NUCLEAR TRANSPORT,0.1475,0.074897,0.084214,0,0
5,GO RNA PROCESSING,0.34626,0.074605,0.053463,0,0
5,GO FRUCTOSE METABOLIC PROCESS,0.214,0.074582,0.11531,0,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.14312,0.07447,0.10757,0,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.25111,0.074337,0.078018,0,0
5,GO GLIAL CELL DEVELOPMENT,0.21989,0.074328,0.12582,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.15655,0.074249,0.10767,0,0
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.037377,0.074136,0.21755,0,0
5,GO RESPONSE TO ETHANOL,0.16123,0.074087,0.10351,0,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,0.29248,0.074069,0.066377,0,0
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.11163,0.0739,0.13006,0,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.10134,0.073725,0.10195,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.33821,0.073695,0.072899,0,0
5,GO PH REDUCTION,0.51122,0.073632,0.052806,0,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.094909,0.073327,0.11177,0,0
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.18102,0.073247,0.11773,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.074935,0.073213,0.13826,0,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.1475,0.073189,0.1471,0,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.28529,0.073157,0.062856,0,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.40594,0.073044,0.041516,0,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.2998,0.072966,0.05462,0,0
5,GO MYELIN MAINTENANCE,0.35442,0.072947,0.13024,0,0
5,GO HISTONE PHOSPHORYLATION,0.43329,0.072836,0.036614,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.29248,0.072664,0.06282,0,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.062884,0.072626,0.15673,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.33029,0.072503,0.066711,0,0
5,GO NCRNA TRANSCRIPTION,0.4521,0.072465,0.04437,0,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.13467,0.072356,0.1873,0,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.53179,0.072308,0.094453,0,0
5,GO HISTAMINE TRANSPORT,0.34626,0.072209,0.12085,0,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.40594,0.071971,0.09164,0,0
5,GO LACTATION,0.50109,0.071922,0.094509,0,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.12273,0.071817,0.079972,0,0
5,GO REGULATION OF CELL DIVISION,0.48117,0.071744,0.077863,0,0
5,GO GLIOGENESIS,0.37111,0.071683,0.10487,0,0
5,GO CRANIAL NERVE MORPHOGENESIS,0.41494,0.071642,0.10989,0,0
5,GO NAD METABOLIC PROCESS,0.214,0.071544,0.10523,0,0
5,GO INTESTINAL LIPID ABSORPTION,0.32248,0.071459,0.12097,0,0
5,GO PYRUVATE METABOLIC PROCESS,0.38829,0.071349,0.077622,0,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.197,0.071321,0.11881,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.17591,0.071277,0.11038,0,0
5,GO ORGAN GROWTH,0.037377,0.071251,0.18371,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.17091,0.071203,0.13456,0,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.197,0.071182,0.14606,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.68646,0.071101,0.080838,0,0
5,GO HISTONE H3 K9 ACETYLATION,0.16123,0.071013,0.1056,0,0
5,GO RESPONSE TO ZINC ION,0.23827,0.070999,0.09366,0,0
5,GO MELANOCYTE DIFFERENTIATION,0.4521,0.070914,0.075365,0,0
5,GO PIGMENTATION,0.091819,0.07091,0.12451,0,0
5,GO REGULATION OF GLIOGENESIS,0.067497,0.070882,0.14339,0,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.52145,0.070852,0.052607,0,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.62923,0.070835,0.077244,0,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.1475,0.070827,0.13518,0,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,0.15655,0.070793,0.14609,0,0
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.18624,0.070772,0.10002,0,0
5,GO AUTOPHAGY OF MITOCHONDRION,0.197,0.070699,0.10699,0,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.67486,0.070686,0.024138,0,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.48117,0.070668,0.053419,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.18102,0.070613,0.1774,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.13467,0.070613,0.12016,0,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.32248,0.070502,0.091169,0,0
5,GO POSITIVE REGULATION OF CELL DIVISION,0.33029,0.070358,0.088973,0,0
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.091819,0.070351,0.14154,0,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.41494,0.070307,0.056621,0,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.1475,0.070228,0.10212,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.15655,0.070187,0.11548,0,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.067497,0.070097,0.15047,0,0
5,GO MUSCLE CELL DIFFERENTIATION,0.072385,0.070008,0.14921,0,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.88046,0.069946,0.046096,0,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.39705,0.069931,0.013142,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.12662,0.0699,0.083035,0,0
5,GO PEPTIDYL PROLINE MODIFICATION,0.23827,0.069846,0.071078,0,0
5,GO NEGATIVE REGULATION OF GROWTH,0.08303,0.069393,0.14458,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.56341,0.06939,0.051387,0,0
5,GO LACTATE METABOLIC PROCESS,0.23203,0.068683,0.086993,0,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.42405,0.068504,0.085753,0,0
5,GO HETEROCHROMATIN ORGANIZATION,0.53179,0.068215,0.058166,0,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.34626,0.068066,0.048222,0,0
5,GO REGULATION OF PEPTIDE TRANSPORT,0.15655,0.06799,0.12233,0,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.21989,0.067985,0.14345,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,0.197,0.067945,0.14442,0,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.78176,0.067815,0.044835,0,0
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.25111,0.06777,0.10239,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.2998,0.067726,0.1141,0,0
5,GO RENAL SYSTEM PROCESS,0.14312,0.067657,0.16059,0,0
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.17091,0.067503,0.12828,0,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.39705,0.067448,0.097755,0,0
5,GO PENTOSE METABOLIC PROCESS,0.11894,0.06741,0.12991,0,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.069906,0.067405,0.15106,0,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.062884,0.067383,0.11569,0,0
5,GO CANONICAL WNT SIGNALING PATHWAY,0.197,0.067382,0.13687,0,0
5,GO NODAL SIGNALING PATHWAY,0.15197,0.067363,0.098666,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.197,0.067227,0.10982,0,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.33029,0.067207,0.079362,0,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.5959,0.067197,0.058974,0,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.2259,0.067091,0.094926,0,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.27126,0.067088,0.1513,0,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,0.28529,0.067032,0.09409,0,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.20256,0.067001,0.1006,0,0
5,GO TELOMERE ORGANIZATION,0.34626,0.066992,0.027288,0,0
5,GO MITOCHONDRIAL DNA REPLICATION,0.23827,0.066408,0.05021,0,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.19156,0.066309,0.16317,0,0
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.13885,0.066291,0.12152,0,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.20256,0.066218,0.12235,0,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,0.1475,0.066142,0.15837,0,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,0.57414,0.066126,0.075634,0,0
5,GO REGULATION OF ENDOCRINE PROCESS,0.27126,0.06602,0.1217,0,0
5,GO RENAL FILTRATION,0.34626,0.065949,0.1976,0,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.37111,0.065874,0.096488,0,0
5,GO MUSCLE ORGAN DEVELOPMENT,0.080256,0.065849,0.13941,0,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.38829,0.065806,0.10661,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.2259,0.065374,0.1002,0,0
5,GO REGULATION OF TRANSPORT,0.48117,0.065256,0.088623,0,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,0.29248,0.065212,0.1315,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.11894,0.065075,0.12112,0,0
5,GO RENAL TUBULE DEVELOPMENT,0.072385,0.064769,0.17389,0,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.065157,0.06468,0.11052,0,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.23827,0.064643,0.095258,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.15197,0.06458,0.12429,0,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.49108,0.064531,0.13105,0,0
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.15655,0.064496,0.13451,0,0
5,GO RESPONSE TO COPPER ION,0.43329,0.064439,0.080274,0,0
5,GO UV DAMAGE EXCISION REPAIR,0.49108,0.064288,0.068153,0,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.19156,0.064255,0.11335,0,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,0.12662,0.064157,0.10275,0,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.072385,0.063921,0.17742,0,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.058535,0.063793,0.15456,0,0
5,GO REGULATION OF BLOOD PRESSURE,0.1306,0.063691,0.13645,0,0
5,GO REGULATION OF BINDING,0.20822,0.063663,0.11986,0,0
5,GO UTERUS DEVELOPMENT,0.26442,0.063654,0.10456,0,0
5,GO MULTICELLULAR ORGANISM AGING,0.49108,0.063642,0.078311,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.15197,0.063632,0.17596,0,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.20256,0.06357,0.10349,0,0
5,GO RRNA TRANSCRIPTION,0.30724,0.063539,0.067741,0,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.57414,0.063532,0.065459,0,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.28529,0.063519,0.051121,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.41494,0.063474,0.074523,0,0
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.19156,0.063468,0.11579,0,0
5,GO NEURON PROJECTION ARBORIZATION,0.94321,0.06346,0.067866,0,0
5,GO REGULATION OF MACROAUTOPHAGY,0.10134,0.063449,0.12283,0,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.27821,0.063432,0.078132,0,0
5,GO POLYOL BIOSYNTHETIC PROCESS,0.13467,0.06336,0.1168,0,0
5,GO RESPONSE TO GROWTH FACTOR,0.11163,0.063274,0.15594,0,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.2577,0.063266,0.052077,0,0
5,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.32248,0.063257,0.09268,0,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.2998,0.063231,0.13796,0,0
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.11524,0.06323,0.18595,0,0
5,GO POSITIVE REGULATION OF BINDING,0.47137,0.063153,0.09129,0,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.34626,0.063112,0.051187,0,0
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.35442,0.063105,0.10248,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.36271,0.063077,0.10961,0,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.08881,0.062931,0.11314,0,0
5,GO FUCOSE METABOLIC PROCESS,0.61803,0.062926,0.044177,0,0
5,GO MESODERM DEVELOPMENT,0.10811,0.062741,0.12753,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.10811,0.062675,0.12607,0,0
5,GO MUSCLE ORGAN MORPHOGENESIS,0.20256,0.062583,0.12896,0,0
5,GO REGULATION OF PROTEIN DEACETYLATION,0.2577,0.06251,0.1136,0,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.36271,0.062484,0.083984,0,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.49108,0.062457,0.055482,0,0
5,GO PROTEIN N LINKED GLYCOSYLATION,0.067497,0.062229,0.13828,0,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.098083,0.062155,0.11117,0,0
5,GO NEURAL CREST CELL MIGRATION,0.24463,0.061842,0.1218,0,0
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.098083,0.061825,0.12127,0,0
5,GO REGULATION OF CARTILAGE DEVELOPMENT,0.17091,0.06179,0.1636,0,0
5,GO ANIMAL ORGAN MORPHOGENESIS,0.17591,0.061457,0.14137,0,0
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.23827,0.061435,0.10921,0,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.33821,0.061207,0.13583,0,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,0.3148,0.061177,0.061603,0,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.94321,0.06112,-0.0090884,0,0
5,GO RESPONSE TO IRON ION,0.7336,0.061076,0.067604,0,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.065157,0.061064,0.1326,0,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,0.48117,0.060985,0.038746,0,0
5,GO SLEEP,0.23827,0.060983,0.092958,0,0
5,GO SPHINGOLIPID METABOLIC PROCESS,0.24463,0.060917,0.10737,0,0
5,GO RECEPTOR INTERNALIZATION,0.47137,0.060874,0.094669,0,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.29248,0.06087,0.068813,0,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.2577,0.060767,0.12211,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.23827,0.060744,0.11402,0,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.46168,0.060623,0.11449,0,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.12273,0.060601,0.11381,0,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,0.16123,0.060587,0.10867,0,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.57414,0.06052,0.043528,0,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.89296,0.060387,-0.069933,0,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.25111,0.059955,0.18109,0,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.49108,0.05987,0.04965,0,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.19156,0.059741,0.10353,0,0
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.197,0.059677,0.11106,0,0
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.78176,0.059631,0.043736,0,0
5,GO RESPONSE TO ABIOTIC STIMULUS,0.077559,0.059623,0.11867,0,0
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.1475,0.059621,0.11493,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.56341,0.059607,0.069075,0,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.67486,0.059557,0.04712,0,0
5,GO BRAIN MORPHOGENESIS,0.93062,0.059509,-0.0042777,0,0
5,GO ORGANELLE DISASSEMBLY,0.2998,0.059423,0.081411,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.39705,0.059393,0.052692,0,0
5,GO VIRAL TRANSLATION,0.17091,0.059302,0.092792,0,0
5,GO OTIC VESICLE DEVELOPMENT,0.49108,0.059255,0.16015,0,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.89296,0.059102,0.032913,0,0
5,GO EYE MORPHOGENESIS,0.50109,0.059031,0.10738,0,0
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.18624,0.058932,0.13941,0,0
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.067497,0.058897,0.125,0,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.28529,0.058774,0.11036,0,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.49108,0.058661,0.08274,0,0
5,GO DENTATE GYRUS DEVELOPMENT,0.55277,0.058584,0.00977,0,0
5,GO RESPONSE TO BMP,0.25111,0.058542,0.15016,0,0
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.197,0.058485,0.086084,0,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.4521,0.058452,0.11858,0,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,0.2577,0.058192,0.11018,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.62923,0.058147,-0.0019213,0,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.56341,0.058145,0.030836,0,0
5,GO ENDOCRINE HORMONE SECRETION,0.2259,0.058144,0.11034,0,0
5,GO MRNA TRANSPORT,0.41494,0.058129,0.049119,0,0
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.37964,0.058023,0.084432,0,0
5,GO NEGATIVE REGULATION OF BINDING,0.15197,0.057996,0.12346,0,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.25111,0.057967,0.12036,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.1475,0.057704,0.12785,0,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.88046,0.057701,-0.043848,0,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.43329,0.057649,0.096724,0,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.197,0.057517,0.11293,0,0
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.2259,0.05748,0.12455,0,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.28529,0.057433,0.1105,0,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.37111,0.05741,0.04157,0,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.84314,0.05738,-0.038411,0,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.16123,0.057336,0.13407,0,0
5,GO HEART DEVELOPMENT,0.074935,0.057311,0.16695,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.16602,0.057229,0.11132,0,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.35442,0.057128,0.11229,0,0
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.16123,0.057121,0.11435,0,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.70989,0.056869,0.042091,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.28529,0.056858,0.10034,0,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.15197,0.056655,0.088223,0,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.11894,0.056654,0.094549,0,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.37964,0.056359,0.08877,0,0
5,GO MITOPHAGY,0.2577,0.056331,0.1198,0,0
5,GO INORGANIC ANION TRANSPORT,0.27821,0.056259,0.092145,0,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,0.1306,0.056225,0.11761,0,0
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.19156,0.056124,0.1528,0,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.18102,0.05596,0.10042,0,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.43329,0.055925,0.10338,0,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.23827,0.055793,0.097395,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,0.35442,0.05573,0.076024,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.47137,0.055725,0.021398,0,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.55277,0.055591,0.029136,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.29248,0.055512,0.1565,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.20822,0.055423,0.1161,0,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.214,0.055401,0.11201,0,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.54223,0.055398,0.17066,0,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.50109,0.055214,-0.038497,0,0
5,GO LYSOSOMAL TRANSPORT,0.18102,0.05518,0.14113,0,0
5,GO VACUOLAR TRANSPORT,0.14312,0.055149,0.12586,0,0
5,GO GTP BIOSYNTHETIC PROCESS,0.43329,0.055136,0.044744,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,0.47137,0.05509,0.034909,0,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,0.41494,0.055073,0.11303,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.30724,0.055026,0.047719,0,0
5,GO LIPID DROPLET ORGANIZATION,0.4521,0.054892,0.060023,0,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,0.75756,0.054835,0.027554,0,0
5,GO SOMITOGENESIS,0.27126,0.054776,0.10854,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.077559,0.054607,0.047517,0,0
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.1306,0.054554,0.13499,0,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.58498,0.054451,0.077584,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.7336,0.054246,0.015142,0,0
5,GO RESPONSE TO CAFFEINE,0.60692,0.054057,0.042688,0,0
5,GO PEPTIDYL THREONINE MODIFICATION,0.57414,0.054019,0.086043,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.55277,0.053996,0.068983,0,0
5,GO ORGANIC ANION TRANSPORT,0.24463,0.053752,0.10222,0,0
5,GO GPI ANCHOR METABOLIC PROCESS,0.37964,0.053739,0.051,0,0
5,GO MITOCHONDRIAL TRANSLATION,0.58498,0.053315,0.002342,0,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.62923,0.053168,0.030134,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.16602,0.053149,0.068601,0,0
5,GO MUSCLE FILAMENT SLIDING,0.2259,0.053094,0.12088,0,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,0.16602,0.053047,0.080058,0,0
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.20822,0.053019,0.15311,0,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.2998,0.052845,0.080656,0,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.29248,0.05269,0.081173,0,0
5,GO PROTEIN MONOUBIQUITINATION,0.5959,0.052677,0.038625,0,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.54223,0.052674,0.028927,0,0
5,GO LEFT RIGHT PATTERN FORMATION,0.4521,0.05265,0.09279,0,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.52145,0.052596,0.0437,0,0
5,GO NUCLEAR EXPORT,0.2998,0.052499,0.066022,0,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.49108,0.052478,0.099973,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.54223,0.052359,0.055103,0,0
5,GO ROOF OF MOUTH DEVELOPMENT,0.34626,0.05228,0.10612,0,0
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.60692,0.052157,0.059868,0,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.33821,0.052117,0.076334,0,0
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13467,0.052016,0.13728,0,0
5,GO CERAMIDE METABOLIC PROCESS,0.20256,0.051851,0.10551,0,0
5,GO BLASTOCYST DEVELOPMENT,0.24463,0.051734,0.060481,0,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.41494,0.051672,0.081785,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.79394,0.05161,-0.028242,0,0
5,GO RESPONSE TO ETHER,0.13885,0.051603,0.13254,0,0
5,GO OXYGEN TRANSPORT,0.4521,0.051597,0.081241,0,0
5,GO MEMBRANE LIPID METABOLIC PROCESS,0.1475,0.051576,0.10857,0,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.2259,0.051548,0.057392,0,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,0.30724,0.051513,0.059453,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.47137,0.05144,0.13084,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.35442,0.051161,0.11537,0,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.33821,0.051114,0.090388,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.08588,0.050833,0.12213,0,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.26442,0.050784,0.1821,0,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.42405,0.050727,0.058763,0,0
5,GO PEPTIDE SECRETION,0.33029,0.050716,0.097576,0,0
5,GO HISTONE UBIQUITINATION,0.66333,0.050647,0.028345,0,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.27821,0.050588,0.057757,0,0
5,GO REGULATION OF TELOMERE CAPPING,0.62923,0.050356,0.045766,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.57414,0.050253,0.040729,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.90549,0.05009,-0.051709,0,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.62923,0.05007,0.042765,0,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.19156,0.049978,0.11026,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.38829,0.049857,0.080889,0,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.61803,0.049854,0.04229,0,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,0.67486,0.049825,0.087829,0,0
5,GO CILIUM MOVEMENT,0.86799,0.049806,-0.0012669,0,0
5,GO RENAL WATER HOMEOSTASIS,0.2998,0.049709,0.15252,0,0
5,GO CYTOKINETIC PROCESS,0.42405,0.049708,0.031684,0,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.214,0.049708,0.15747,0,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.49108,0.049703,0.024907,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.33821,0.049531,0.046969,0,0
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.36271,0.049281,0.13651,0,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,0.51122,0.049047,0.092298,0,0
5,GO DEVELOPMENTAL PIGMENTATION,0.2577,0.048957,0.10755,0,0
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.27821,0.048944,0.1006,0,0
5,GO RNA EXPORT FROM NUCLEUS,0.47137,0.048929,0.038106,0,0
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.32248,0.048632,0.095622,0,0
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.197,0.048436,0.099106,0,0
5,GO SPERM MOTILITY,0.70989,0.048301,0.024112,0,0
5,GO NEURAL TUBE PATTERNING,0.16602,0.04827,0.14226,0,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.61803,0.048246,-0.12109,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.48117,0.048239,0.035858,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,0.44264,0.047959,0.073444,0,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.27821,0.047904,0.18975,0,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.58498,0.047795,0.08177,0,0
5,GO POSITIVE REGULATION OF SECRETION,0.28529,0.047753,0.099141,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.60692,0.047611,0.052424,0,0
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.18102,0.047611,0.13591,0,0
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.08303,0.047606,0.11342,0,0
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.34626,0.047506,0.11302,0,0
5,GO RNA LOCALIZATION,0.2998,0.04748,0.052504,0,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.18624,0.047438,0.11548,0,0
5,GO ANION TRANSPORT,0.25111,0.047435,0.095584,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.33029,0.047355,0.10254,0,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.24463,0.047011,0.059391,0,0
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.52145,0.046931,0.091646,0,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.84314,0.046868,0.022755,0,0
5,GO APPENDAGE MORPHOGENESIS,0.34626,0.046854,0.13104,0,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.27126,0.046792,0.074856,0,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.10811,0.04679,0.20348,0,0
5,GO PEPTIDYL LYSINE MODIFICATION,0.62923,0.046725,0.052153,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.5959,0.046399,0.01476,0,0
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.15197,0.046275,0.12498,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.15197,0.046167,0.13346,0,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.61803,0.04611,0.031239,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION,0.214,0.046075,0.11967,0,0
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.15197,0.045953,0.13361,0,0
5,GO NEGATIVE REGULATION OF ION TRANSPORT,0.20822,0.045872,0.10711,0,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,0.79394,0.04585,0.062162,0,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.39705,0.045778,0.058462,0,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.49108,0.045659,0.059347,0,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.4521,0.045635,0.033588,0,0
5,GO REGULATION OF FERTILIZATION,0.30724,0.04563,0.05685,0,0
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.58498,0.045533,0.073331,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.27126,0.045523,0.08626,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.29248,0.045438,0.16129,0,0
5,GO SPECIFICATION OF SYMMETRY,0.42405,0.045297,0.093422,0,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.32248,0.045187,0.067682,0,0
5,GO CELL CYCLE ARREST,0.57414,0.045027,0.053749,0,0
5,GO ALANINE TRANSPORT,0.74555,0.045,0.076733,0,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,0.14312,0.04491,0.084885,0,0
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.62923,0.044846,0.075541,0,0
5,GO ATP BIOSYNTHETIC PROCESS,0.38829,0.044759,0.077648,0,0
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.2998,0.044672,0.10482,0,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.76963,0.044561,0.0073337,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.40594,0.044479,0.066144,0,0
5,GO DNA INTEGRITY CHECKPOINT,0.60692,0.044392,0.01795,0,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.65188,0.044245,0.082298,0,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.40594,0.044223,0.0909,0,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.17091,0.044163,0.098667,0,0
5,GO HISTONE H3 K9 METHYLATION,0.65188,0.044161,0.056645,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.85555,0.04415,0.011732,0,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,0.46168,0.044134,0.074279,0,0
5,GO EMBRYONIC BODY MORPHOGENESIS,0.38829,0.044121,0.10152,0,0
5,GO RESPONSE TO METAL ION,0.48117,0.044097,0.078979,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.16602,0.044063,0.11664,0,0
5,GO VITAMIN CATABOLIC PROCESS,0.75756,0.043895,0.040826,0,0
5,GO COLLECTING DUCT DEVELOPMENT,0.5959,0.043714,0.059714,0,0
5,GO HEART GROWTH,0.14312,0.043694,0.13757,0,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.15197,0.043566,0.15279,0,0
5,GO LOCOMOTOR RHYTHM,0.46168,0.043439,0.09787,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.32248,0.043418,-0.0059907,0,0
5,GO RNA POLYADENYLATION,0.58498,0.043346,0.052987,0,0
5,GO MITOCHONDRIAL TRANSPORT,0.58498,0.043294,0.031234,0,0
5,GO MEMBRANE DISASSEMBLY,0.94321,0.04323,-0.024334,0,0
5,GO FATTY ACYL COA METABOLIC PROCESS,0.42405,0.043036,0.078148,0,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,0.33029,0.042909,0.11581,0,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.1475,0.042693,0.12427,0,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.52145,0.042679,0.062449,0,0
5,GO PHOTOPERIODISM,0.72171,0.042529,0.020069,0,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.42405,0.042521,0.079224,0,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.34626,0.042511,0.044517,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.91805,0.042343,-0.019621,0,0
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.29248,0.042334,0.11528,0,0
5,GO CARBOHYDRATE METABOLIC PROCESS,0.10134,0.042293,0.11675,0,0
5,GO EMBRYONIC MORPHOGENESIS,0.17091,0.042245,0.14096,0,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.35442,0.042147,0.098595,0,0
5,GO POSITIVE REGULATION OF MITOPHAGY,0.2998,0.042055,0.13188,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.72171,0.041946,0.073299,0,0
5,GO EPITHELIAL CELL DEVELOPMENT,0.15197,0.041811,0.16348,0,0
5,GO CIRCULATORY SYSTEM PROCESS,0.29248,0.04176,0.11458,0,0
5,GO UBIQUINONE METABOLIC PROCESS,0.64051,0.041595,0.016755,0,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.84314,0.041436,-0.0078627,0,0
5,GO MAST CELL MIGRATION,0.60692,0.04132,0.08337,0,0
5,GO CELL CELL SIGNALING BY WNT,0.35442,0.041311,0.11509,0,0
5,GO CELL CYCLE PHASE TRANSITION,0.44264,0.041281,0.026426,0,0
5,GO HYPEROSMOTIC RESPONSE,0.64051,0.041244,0.079535,0,0
5,GO POST EMBRYONIC DEVELOPMENT,0.2577,0.041163,0.12845,0,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.37964,0.041055,0.088492,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.42405,0.040995,0.12487,0,0
5,GO PROTEIN TARGETING TO VACUOLE,0.25111,0.040767,0.13917,0,0
5,GO GENETIC IMPRINTING,0.49108,0.040607,0.073804,0,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.50109,0.040523,0.069576,0,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.56341,0.0402,0.01324,0,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.20822,0.039927,0.15114,0,0
5,GO PROTEIN DEMETHYLATION,0.58498,0.039762,0.097169,0,0
5,GO NON RECOMBINATIONAL REPAIR,0.64051,0.039432,0.031542,0,0
5,GO PROTEIN MANNOSYLATION,0.89296,0.039325,0.014227,0,0
5,GO DNA BIOSYNTHETIC PROCESS,0.40594,0.039265,0.055688,0,0
5,GO MRNA 3 END PROCESSING,0.62923,0.038845,0.021899,0,0
5,GO MRNA METABOLIC PROCESS,0.37964,0.038715,0.039531,0,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.95582,0.038713,0.032631,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.48117,0.038639,0.016573,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.15655,0.038454,0.122,0,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.214,0.038308,0.11511,0,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.50109,0.0382,0.067341,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.48117,0.038022,0.019111,0,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.84314,0.037721,0.027934,0,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.62923,0.037707,0.10807,0,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.41494,0.037551,0.061533,0,0
5,GO DNA METABOLIC PROCESS,0.51122,0.03738,0.028405,0,0
5,GO NEGATIVE CHEMOTAXIS,0.33029,0.037332,0.1368,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.23203,0.036961,0.024733,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.12662,0.03692,0.11417,0,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.26442,0.03677,0.090499,0,0
5,GO SECONDARY METABOLIC PROCESS,0.56341,0.036569,0.041472,0,0
5,GO REGULATION OF LYASE ACTIVITY,0.61803,0.036554,0.02682,0,0
5,GO VIRAL BUDDING,0.49108,0.036533,0.045036,0,0
5,GO CALCIUM ION IMPORT,0.40594,0.036525,0.079788,0,0
5,GO CERAMIDE BIOSYNTHETIC PROCESS,0.52145,0.036513,0.070268,0,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.36271,0.036341,0.044955,0,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.74555,0.036315,0.092025,0,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.51122,0.036309,0.020024,0,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.54223,0.036306,-0.11844,0,0
5,GO TRICARBOXYLIC ACID CYCLE,0.55277,0.036273,0.032574,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.74555,0.03627,-0.042112,0,0
5,GO LIPOPROTEIN METABOLIC PROCESS,0.197,0.036216,0.10034,0,0
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.37964,0.036183,0.07819,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.99368,0.036149,0.0063288,0,0
5,GO HISTONE H4 K16 ACETYLATION,0.74555,0.035948,0.030961,0,0
5,GO REGULATION OF SENSORY PERCEPTION,0.40594,0.035736,0.062028,0,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.4521,0.035601,0.096708,0,0
5,GO MEMBRANE ORGANIZATION,0.2998,0.035533,0.098903,0,0
5,GO VIRAL LATENCY,0.52145,0.035396,-0.00026149,0,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.1475,0.035366,0.10754,0,0
5,GO UTP METABOLIC PROCESS,0.80618,0.035321,0.021195,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.99368,0.035311,-0.012847,0,0
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.28529,0.035032,0.11873,0,0
5,GO REGULATION OF NEURON MATURATION,0.90549,0.034964,0.078705,0,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.57414,0.034938,0.060304,0,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.76963,0.034934,0.041004,0,0
5,GO RESPONSE TO CALCIUM ION,0.39705,0.03482,0.078163,0,0
5,GO GONADOTROPIN SECRETION,0.94321,0.034591,0.036686,0,0
5,GO REGULATION OF CELL CYCLE,0.74555,0.034564,0.033368,0,0
5,GO PHAGOSOME ACIDIFICATION,0.52145,0.034541,0.050712,0,0
5,GO PROTEIN HOMOOLIGOMERIZATION,0.2577,0.034521,0.086585,0,0
5,GO EMBRYONIC PATTERN SPECIFICATION,0.5959,0.034438,0.060617,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.42405,0.034425,0.018289,0,0
5,GO METAL ION TRANSPORT,0.57414,0.034227,0.067965,0,0
5,GO DETECTION OF STIMULUS,0.52145,0.034223,0.052987,0,0
5,GO SPERMATID DIFFERENTIATION,0.86799,0.03422,-0.0020228,0,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.15655,0.034105,0.11375,0,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.81845,0.034037,-0.026826,0,0
5,GO ONE CARBON METABOLIC PROCESS,0.37111,0.033918,0.045434,0,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.74555,0.033798,0.024779,0,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.37111,0.033792,0.16079,0,0
5,GO MRNA EXPORT FROM NUCLEUS,0.5959,0.033538,0.028994,0,0
5,GO CELL CYCLE CHECKPOINT,0.68646,0.033408,0.00050195,0,0
5,GO HEXOSE CATABOLIC PROCESS,0.80618,0.033332,0.049257,0,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.93062,0.033306,0.035068,0,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.61803,0.033291,0.043319,0,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.69814,0.033253,0.051025,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.56341,0.033144,0.085035,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.69814,0.033126,0.018791,0,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.4521,0.033097,0.061451,0,0
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.48117,0.033038,0.087663,0,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.51122,0.032975,0.054202,0,0
5,GO PROTEIN REFOLDING,0.69814,0.032965,0.016462,0,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.20822,0.032959,0.15743,0,0
5,GO REGULATION OF RNA SPLICING,0.88046,0.032955,0.0068346,0,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,1,0.032849,0.013979,0,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.70989,0.032827,0.022365,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.68646,0.032785,-0.025005,0,0
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.33821,0.03267,0.10975,0,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.37964,0.03263,0.049465,0,0
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.91805,0.032511,0.051069,0,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.72171,0.032411,0.024166,0,0
5,GO DEPHOSPHORYLATION,0.27126,0.032336,0.096598,0,0
5,GO NUCLEUS LOCALIZATION,0.96843,0.032223,0.051867,0,0
5,GO COVALENT CHROMATIN MODIFICATION,0.72171,0.032201,0.045494,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.93062,0.032146,0.033842,0,0
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.214,0.032068,0.18777,0,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.40594,0.032023,0.071653,0,0
5,GO SMOOTH MUSCLE CONTRACTION,0.37111,0.03199,0.1143,0,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,0.55277,0.031849,0.046437,0,0
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.37111,0.031793,0.11846,0,0
5,GO PROTEIN POLYMERIZATION,0.47137,0.031737,0.088831,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.81845,0.031731,0.084373,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.69814,0.031728,-0.068375,0,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.39705,0.031708,0.094361,0,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.2998,0.031614,0.090422,0,0
5,GO REGULATION OF DNA BINDING,0.61803,0.031575,0.051183,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.33029,0.031211,0.10453,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,0.48117,0.031206,0.060219,0,0
5,GO GLUCOSE METABOLIC PROCESS,0.66333,0.030996,0.063403,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.23203,0.030983,0.13274,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.61803,0.030926,0.036941,0,0
5,GO PEPTIDYL SERINE MODIFICATION,0.5959,0.030803,0.083869,0,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.98106,0.030792,-0.080512,0,0
5,GO REGULATION OF HISTONE MODIFICATION,0.56341,0.030728,0.070205,0,0
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.47137,0.030677,0.080068,0,0
5,GO BASE EXCISION REPAIR,0.88046,0.030632,-0.040612,0,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.96843,0.030451,0.036249,0,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.61803,0.030367,-0.029446,0,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.5959,0.03036,0.093099,0,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,0.81845,0.030118,0.042012,0,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.5959,0.030051,0.061373,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.86799,0.030042,-0.049804,0,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,0.75756,0.02981,0.052795,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.2259,0.029788,0.078275,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.27126,0.029754,0.12119,0,0
5,GO SENSORY ORGAN MORPHOGENESIS,0.49108,0.029746,0.082686,0,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.75756,0.029734,-0.030182,0,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.49108,0.029594,0.050809,0,0
5,GO STRIATED MUSCLE ADAPTATION,0.4521,0.0295,0.10633,0,0
5,GO MUSCLE SYSTEM PROCESS,0.34626,0.029333,0.10254,0,0
5,GO ENERGY RESERVE METABOLIC PROCESS,0.83078,0.029324,0.041768,0,0
5,GO REGULATION OF TOR SIGNALING,0.54223,0.029207,0.084817,0,0
5,GO EPITHELIAL CELL MORPHOGENESIS,0.83078,0.029164,0.10064,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.58498,0.029123,0.0041592,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.78176,0.029031,-0.044265,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.36271,0.028917,0.12804,0,0
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.75756,0.028847,0.048814,0,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.32248,0.028786,0.10463,0,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.40594,0.028754,0.063074,0,0
5,GO CELLULAR RESPONSE TO PH,0.60692,0.028582,0.067484,0,0
5,GO INTRACELLULAR TRANSPORT,0.54223,0.028525,0.061457,0,0
5,GO REGULATION OF CHROMATIN BINDING,0.75756,0.028466,0.037813,0,0
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.37111,0.028368,0.10736,0,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.98106,0.028359,-0.014131,0,0
5,GO CHROMATIN REMODELING,0.83078,0.028358,0.0018143,0,0
5,GO ESTABLISHMENT OF CELL POLARITY,0.2259,0.028349,0.13763,0,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.79394,0.028338,0.048749,0,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.46168,0.028309,0.11136,0,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.93062,0.028302,0.027654,0,0
5,GO SEX DIFFERENTIATION,0.35442,0.02826,0.10209,0,0
5,GO MITOCHONDRION ORGANIZATION,0.57414,0.028217,0.037642,0,0
5,GO REGULATION OF DEPHOSPHORYLATION,0.4521,0.028185,0.096198,0,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.81845,0.028161,-0.098933,0,0
5,GO OOCYTE MATURATION,0.74555,0.028064,-0.050712,0,0
5,GO ENSHEATHMENT OF NEURONS,0.41494,0.027962,0.10183,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.65188,0.027834,0.041013,0,0
5,GO CENTROSOME SEPARATION,0.99368,0.027781,-0.063209,0,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.81845,0.027764,0.043074,0,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.67486,0.027749,0.047887,0,0
5,GO REGULATION OF CELLULAR RESPIRATION,0.79394,0.027733,0.035613,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.52145,0.027618,-0.0087615,0,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.7336,0.027593,0.0047357,0,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.29248,0.027545,0.097866,0,0
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.43329,0.027492,0.11625,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.2577,0.02746,0.0447,0,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.99368,0.027457,-0.01845,0,0
5,GO REGULATION OF ORGANELLE ORGANIZATION,0.74555,0.027347,0.062693,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.44264,0.027168,-0.0061021,0,0
5,GO CELLULAR RESPONSE TO STARVATION,0.35442,0.027135,0.095699,0,0
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.46168,0.027069,0.071014,0,0
5,GO REGULATION OF MITOTIC CELL CYCLE,0.66333,0.026921,0.028831,0,0
5,GO REGULATION OF TUBE SIZE,0.40594,0.026898,0.11558,0,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.84314,0.026795,0.041845,0,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,0.75756,0.026678,0.04955,0,0
5,GO DENDRITE SELF AVOIDANCE,0.27126,0.026645,0.11489,0,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.32248,0.026611,0.14179,0,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,0.72171,0.026591,0.026413,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.61803,0.026474,0.024376,0,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.69814,0.026359,0.074773,0,0
5,GO CYTOSKELETON ORGANIZATION,0.5959,0.026296,0.088947,0,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,0.60692,0.026271,0.050916,0,0
5,GO ERAD PATHWAY,0.13885,0.026197,0.12331,0,0
5,GO GROWTH,0.62923,0.026184,0.094196,0,0
5,GO CHROMATIN SILENCING,0.86799,0.02612,-0.017867,0,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.49108,0.026098,0.023265,0,0
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.79394,0.026021,0.043102,0,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.32248,0.02577,0.096376,0,0
5,GO VESICLE LOCALIZATION,0.79394,0.025661,0.063502,0,0
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.37111,0.02561,0.11282,0,0
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.58498,0.02555,0.072492,0,0
5,GO EMBRYO DEVELOPMENT,0.23827,0.025505,0.11865,0,0
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.33821,0.025482,0.092486,0,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.99368,0.025439,-0.014954,0,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.72171,0.025414,0.045495,0,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,0.67486,0.025379,0.0058341,0,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.62923,0.025374,0.061584,0,0
5,GO TOR SIGNALING,0.42405,0.025295,0.090441,0,0
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.64051,0.025203,0.030114,0,0
5,GO SYNAPTIC VESICLE BUDDING,0.74555,0.025182,0.059855,0,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.94321,0.025124,-0.020219,0,0
5,GO RESPONSE TO LIGHT STIMULUS,0.70989,0.0251,0.045273,0,0
5,GO SIALYLATION,0.4521,0.025007,0.097544,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.5959,0.024913,0.13582,0,0
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.56341,0.024869,0.075848,0,0
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.3148,0.024768,0.10514,0,0
5,GO MITOTIC CYTOKINESIS,0.95582,0.024715,-0.0041546,0,0
5,GO MITOTIC RECOMBINATION,0.90549,0.024665,0.01002,0,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.27821,0.024505,0.11038,0,0
5,GO RIBOSOME ASSEMBLY,0.85555,0.024462,-0.0040222,0,0
5,GO GLUCOSE CATABOLIC PROCESS,0.78176,0.024254,-0.0034334,0,0
5,GO FEMALE GAMETE GENERATION,0.75756,0.024185,0.021305,0,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,1,0.024006,0.0070117,0,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.68646,0.023914,0.03452,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.89296,0.023911,-0.032187,0,0
5,GO MAINTENANCE OF PROTEIN LOCATION,0.2998,0.023849,0.0995,0,0
5,GO EMBRYONIC EYE MORPHOGENESIS,0.29248,0.023788,0.15623,0,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.90549,0.023661,-0.0096798,0,0
5,GO CHEMOSENSORY BEHAVIOR,0.84314,0.023536,0.015283,0,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.49108,0.02335,0.085173,0,0
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.26442,0.023326,0.15148,0,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.88046,0.023245,-0.008144,0,0
5,GO INSEMINATION,0.94321,0.023194,0.0057614,0,0
5,GO EXCRETION,0.85555,0.023141,0.044973,0,0
5,GO ANION TRANSMEMBRANE TRANSPORT,0.64051,0.023047,0.068483,0,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.54223,0.022833,0.058995,0,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.56341,0.022774,0.084413,0,0
5,GO AMINE METABOLIC PROCESS,0.2998,0.022767,0.071598,0,0
5,GO RESPONSE TO MUSCLE ACTIVITY,0.56341,0.022677,0.049229,0,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.28529,0.022675,0.082334,0,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,0.69814,0.022632,0.05788,0,0
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.38829,0.022597,0.091229,0,0
5,GO REPRODUCTION,0.66333,0.022585,0.064104,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.90549,0.022335,0.022054,0,0
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.42405,0.022332,0.082931,0,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.67486,0.022311,0.034244,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.72171,0.022282,0.039812,0,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.70989,0.022276,0.077012,0,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.76963,0.022259,0.052167,0,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.95582,0.022232,-0.031957,0,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,0.60692,0.021942,0.086481,0,0
5,GO HAIR CELL DIFFERENTIATION,0.74555,0.021746,0.0014087,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.84314,0.021668,0.028316,0,0
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.33821,0.021485,0.097893,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.67486,0.02128,0.059336,0,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.40594,0.021264,0.098032,0,0
5,GO NUCLEAR MIGRATION,0.93062,0.021183,0.047614,0,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,0.76963,0.02114,-0.0030205,0,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.4521,0.021037,0.055332,0,0
5,GO REGULATION OF GLUCONEOGENESIS,0.51122,0.020923,0.074427,0,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.86799,0.02091,-0.029266,0,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.81845,0.020866,0.026042,0,0
5,GO NEURON DEATH,0.34626,0.020709,0.10156,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.35442,0.020669,0.14471,0,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.96843,0.020558,0.020666,0,0
5,GO HISTONE H3 K9 DEMETHYLATION,0.86799,0.020385,0.025589,0,0
5,GO CELLULAR RESPONSE TO IRON ION,0.35442,0.020317,0.13115,0,0
5,GO PLASMA MEMBRANE ORGANIZATION,0.41494,0.020294,0.10746,0,0
5,GO REGULATION OF CYCLASE ACTIVITY,0.81845,0.020281,0.019967,0,0
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.55277,0.020238,0.091616,0,0
5,GO NOTCH SIGNALING PATHWAY,0.83078,0.020066,0.056572,0,0
5,GO RESPONSE TO ACIDIC PH,0.53179,0.019791,0.099253,0,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.98106,0.019781,-0.0033915,0,0
5,GO LENS FIBER CELL DIFFERENTIATION,0.7336,0.019614,0.056679,0,0
5,GO REGULATION OF RNA BINDING,0.99368,0.019542,-0.010927,0,0
5,GO CARDIAC CELL DEVELOPMENT,0.32248,0.019523,0.093809,0,0
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.75756,0.019387,0.053961,0,0
5,GO DIGESTIVE SYSTEM DEVELOPMENT,0.66333,0.019297,0.089827,0,0
5,GO INNER EAR MORPHOGENESIS,0.72171,0.019203,0.041095,0,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.39705,0.019078,0.066576,0,0
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.47137,0.019016,0.070891,0,0
5,GO ION TRANSPORT,0.69814,0.019014,0.062554,0,0
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.37964,0.018642,0.10224,0,0
5,GO SISTER CHROMATID COHESION,0.61803,0.018579,-0.092001,0,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.67486,0.018289,0.02843,0,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.37111,0.018249,0.18834,0,0
5,GO EAR MORPHOGENESIS,0.72171,0.018198,0.043037,0,0
5,GO REGULATION OF SECRETION,0.75756,0.018178,0.059102,0,0
5,GO POLYOL METABOLIC PROCESS,0.50109,0.018036,0.070281,0,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.57414,0.017913,0.039361,0,0
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.54223,0.017894,0.10442,0,0
5,GO NEGATIVE REGULATION OF CELL AGING,0.83078,0.017842,0.01879,0,0
5,GO REGULATION OF CELLULAR LOCALIZATION,0.43329,0.017841,0.087113,0,0
5,GO CYTOSOLIC TRANSPORT,0.48117,0.017585,0.094732,0,0
5,GO POLYSACCHARIDE METABOLIC PROCESS,0.89296,0.017574,0.05485,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.86799,0.017508,-0.0069927,0,0
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.27821,0.017477,0.1443,0,0
5,GO ADAPTATION OF SIGNALING PATHWAY,0.89296,0.017458,0.024233,0,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.55277,0.017296,0.13186,0,0
5,GO HISTONE H2A UBIQUITINATION,0.7336,0.017226,0.034925,0,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.89296,0.017029,-0.011779,0,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.95582,0.016968,-0.025648,0,0
5,GO REGULATION OF PROTEIN TARGETING,0.34626,0.016965,0.091298,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.66333,0.016962,0.068768,0,0
5,GO MIDBODY ABSCISSION,0.55277,0.016475,0.026643,0,0
5,GO REGULATION OF CELL CYCLE PROCESS,0.7336,0.016439,0.018569,0,0
5,GO MITOCHONDRION MORPHOGENESIS,0.62923,0.01629,0.033185,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING,1,0.0161,0.0052855,0,0
5,GO G2 DNA DAMAGE CHECKPOINT,0.99368,0.016033,-0.024192,0,0
5,GO REGULATION OF STEM CELL PROLIFERATION,0.69814,0.01588,0.067759,0,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.34626,0.015854,0.094331,0,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.2998,0.015702,-0.16235,0,0
5,GO PROTEIN DEPHOSPHORYLATION,0.36271,0.015663,0.091207,0,0
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.80618,0.015644,0.017636,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.94321,0.015626,-0.040822,0,0
5,GO GLIAL CELL DIFFERENTIATION,0.88046,0.01552,0.068211,0,0
5,GO PEPTIDYL LYSINE METHYLATION,0.81845,0.015467,0.025348,0,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.23827,0.015465,0.068651,0,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.74555,0.015417,0.023662,0,0
5,GO NUCLEOSIDE SALVAGE,0.52145,0.015369,0.038279,0,0
5,GO GANGLIOSIDE METABOLIC PROCESS,0.55277,0.015198,0.088048,0,0
5,GO SODIUM ION HOMEOSTASIS,0.69814,0.015193,0.053563,0,0
5,GO AEROBIC RESPIRATION,0.65188,0.015088,-0.019507,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.89296,0.015078,0.0058091,0,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.33821,0.015006,0.14805,0,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.57414,0.014867,0.041583,0,0
5,GO HISTONE H4 K5 ACETYLATION,0.86799,0.014755,-0.0088218,0,0
5,GO REGULATION OF MITOPHAGY,0.60692,0.014737,0.094741,0,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.80618,0.014591,-0.046517,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.85555,0.014577,0.045887,0,0
5,GO RNA CAPPING,0.7336,0.014555,-0.02428,0,0
5,GO REGULATION OF MRNA 3 END PROCESSING,0.89296,0.014412,0.021581,0,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.74555,0.014368,0.054124,0,0
5,GO LIPID GLYCOSYLATION,0.90549,0.014101,0.012531,0,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.78176,0.013884,0.088557,0,0
5,GO NUCLEUS ORGANIZATION,0.84314,0.013798,0.027202,0,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.36271,0.013743,0.094291,0,0
5,GO ELECTRON TRANSPORT CHAIN,0.76963,0.013736,0.017691,0,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.42405,0.013726,0.065118,0,0
5,GO LIPID TRANSLOCATION,0.70989,0.01371,0.086665,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,0.69814,0.013679,0.074792,0,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.52145,0.013669,0.037382,0,0
5,GO PROTEIN METHYLATION,0.96843,0.01351,0.015686,0,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.66333,0.01346,-0.020506,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.60692,0.013366,0.093297,0,0
5,GO ORGANIC ACID TRANSPORT,0.5959,0.013301,0.072356,0,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.57414,0.013106,0.027445,0,0
5,GO REGULATION OF GROWTH,0.5959,0.012997,0.093456,0,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.93062,0.012905,0.0021635,0,0
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.75756,0.012863,0.013505,0,0
5,GO PROTEIN TARGETING,0.84314,0.012786,0.018412,0,0
5,GO FATTY ACID HOMEOSTASIS,0.46168,0.012752,0.070112,0,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.96843,0.012705,0.021099,0,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.80618,0.012446,0.016312,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.3148,0.012401,0.080957,0,0
5,GO KERATINOCYTE DEVELOPMENT,0.39705,0.012193,0.15539,0,0
5,GO HISTONE H3 K27 METHYLATION,0.81845,0.01199,-0.014759,0,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.96843,0.011799,0.04828,0,0
5,GO CYTOPLASMIC TRANSLATION,0.83078,0.011777,-0.018873,0,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.70989,0.011668,0.040637,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.55277,0.011399,-0.02155,0,0
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.65188,0.011376,0.080476,0,0
5,GO REGULATION OF ION TRANSPORT,0.84314,0.011304,0.04401,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.7336,0.011048,0.026045,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.86799,0.011019,0.015662,0,0
5,GO NUCLEOTIDE PHOSPHORYLATION,0.5959,0.011019,0.055166,0,0
5,GO REGULATION OF BEHAVIOR,0.91805,0.011012,0.0073742,0,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.84314,0.010914,0.013048,0,0
5,GO DNA GEOMETRIC CHANGE,0.89296,0.010858,-0.026107,0,0
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.55277,0.010727,-0.0030724,0,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.66333,0.010688,-0.0049431,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.94321,0.010687,0.03863,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.68646,0.010579,0.075191,0,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.61803,0.010497,0.062202,0,0
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.81845,0.010366,0.05447,0,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.72171,0.01036,-0.0020042,0,0
5,GO MULTI ORGANISM PROCESS,0.85555,0.010323,0.045889,0,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.76963,0.010219,0.018347,0,0
5,GO TRANSMEMBRANE TRANSPORT,0.65188,0.010127,0.059684,0,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.80618,0.010125,-0.026012,0,0
5,GO REGULATION OF CELL MORPHOGENESIS,0.88046,0.010094,0.083325,0,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.89296,0.0095911,0.033382,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.7336,0.0095132,0.050141,0,0
5,GO MUSCLE CELL DEVELOPMENT,0.47137,0.0094441,0.090231,0,0
5,GO HEART TRABECULA FORMATION,0.5959,0.0094327,0.096635,0,0
5,GO FORELIMB MORPHOGENESIS,0.89296,0.009363,0.0070837,0,0
5,GO CARDIAC MUSCLE CONTRACTION,0.58498,0.0093146,0.057674,0,0
5,GO EXIT FROM MITOSIS,0.60692,0.0093017,-0.059048,0,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.42405,0.0092863,0.098992,0,0
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.75756,0.0090133,0.050104,0,0
5,GO GLAND DEVELOPMENT,0.3148,0.0087407,0.12991,0,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.52145,0.0087198,0.10168,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.62923,0.0086127,0.055575,0,0
5,GO CHROMATIN ORGANIZATION,0.93062,0.0084851,0.020339,0,0
5,GO REGULATION OF CELL CYCLE ARREST,0.64051,0.0084655,-0.019915,0,0
5,GO RESPONSE TO COLD,0.61803,0.0084381,0.074511,0,0
5,GO OOGENESIS,0.66333,0.0083473,-0.035429,0,0
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,1,0.0081166,0.032845,0,0
5,GO REGULATION OF HISTONE METHYLATION,0.72171,0.0080984,0.055865,0,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.4521,0.0080904,0.038212,0,0
5,GO SENSORY PERCEPTION,0.88046,0.0080891,0.021602,0,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.95582,0.0080686,0.014415,0,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.33029,0.0079036,0.13989,0,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.81845,0.0078718,0.049727,0,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.5959,0.0078167,0.060074,0,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.89296,0.0078037,-0.01641,0,0
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.68646,0.0077682,-0.003057,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.83078,0.0077631,0.011595,0,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.51122,0.0077359,0.082704,0,0
5,GO REGULATION OF CENTROSOME CYCLE,0.98106,0.0076584,-0.03457,0,0
5,GO EAR DEVELOPMENT,0.76963,0.0076241,0.048092,0,0
5,GO APPENDAGE DEVELOPMENT,0.41494,0.0075953,0.11889,0,0
5,GO REGULATION OF GONAD DEVELOPMENT,0.36271,0.0075067,0.086365,0,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.57414,0.0073374,0.037971,0,0
5,GO RESPONSE TO HYDROXYUREA,0.90549,0.0072439,-0.01812,0,0
5,GO LUNG EPITHELIUM DEVELOPMENT,0.57414,0.007129,0.10887,0,0
5,GO SKELETAL MUSCLE CONTRACTION,0.68646,0.0071104,0.049853,0,0
5,GO VESICLE ORGANIZATION,0.51122,0.007099,0.085319,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.7336,0.0069448,-0.019509,0,0
5,GO CORPUS CALLOSUM DEVELOPMENT,0.4521,0.0069164,0.12725,0,0
5,GO CHROMOSOME ORGANIZATION,0.98106,0.0068611,-0.0027534,0,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.53179,0.0066853,0.088535,0,0
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.33029,0.0066852,0.095493,0,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.70989,0.0064713,-0.018212,0,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.83078,0.0063361,-0.025855,0,0
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.80618,0.0062992,0.050805,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.96843,0.0062806,-0.0086411,0,0
5,GO ANATOMICAL STRUCTURE MATURATION,0.52145,0.0062702,0.086251,0,0
5,GO REGULATION OF MUSCLE CONTRACTION,0.52145,0.006206,0.075147,0,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.90549,0.0061018,-0.048991,0,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,0.49108,0.0059972,0.10244,0,0
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.51122,0.0058715,0.073075,0,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.49108,0.0058034,0.13888,0,0
5,GO HISTONE H3 DEACETYLATION,0.79394,0.0057957,0.045,0,0
5,GO RECOMBINATIONAL REPAIR,1,0.0056695,-0.036359,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.75756,0.0056449,-0.038273,0,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.85555,0.005469,0.062093,0,0
5,GO MRNA PROCESSING,0.90549,0.0052396,0.007703,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.85555,0.0051402,0.028632,0,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.94321,0.0051377,-0.010156,0,0
5,GO NEPHRIC DUCT DEVELOPMENT,0.64051,0.0050821,0.075035,0,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.84314,0.0050734,-0.038165,0,0
5,GO CATION TRANSPORT,0.94321,0.0050694,0.043793,0,0
5,GO BASIC AMINO ACID TRANSPORT,0.93062,0.0050361,0.041874,0,0
5,GO RNA SPLICING,0.89296,0.0049095,0.0066614,0,0
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.91805,0.004881,0.043488,0,0
5,GO FEMALE SEX DIFFERENTIATION,0.51122,0.0048736,0.093778,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,0.81845,0.0046658,0.060702,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.93062,0.0046118,0.025429,0,0
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.86799,0.0044424,0.016407,0,0
5,GO PEPTIDYL ARGININE METHYLATION,0.54223,0.0044397,-0.053098,0,0
5,GO CARDIAC ATRIUM DEVELOPMENT,0.81845,0.0041496,0.076819,0,0
5,GO PEPTIDYL LYSINE ACETYLATION,0.83078,0.0040916,0.026338,0,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.74555,0.0040478,-0.016185,0,0
5,GO SOMITE DEVELOPMENT,0.62923,0.0040352,0.076517,0,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.46168,0.0040198,0.08068,0,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.65188,0.0038802,0.073161,0,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.60692,0.0038584,0.029499,0,0
5,GO NEUTRAL AMINO ACID TRANSPORT,0.56341,0.0036781,0.08446,0,0
5,GO REGULATION OF MRNA BINDING,0.88046,0.0036377,-0.0043649,0,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.57414,0.0036348,0.083665,0,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.64051,0.0036215,0.092423,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.70989,0.0036193,0.049958,0,0
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.55277,0.0033415,0.089616,0,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.49108,0.0032593,0.073415,0,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.40594,0.0031982,0.070689,0,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.94321,0.003168,0.053302,0,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.90549,0.0031403,0.016251,0,0
5,GO REGULATION OF FEEDING BEHAVIOR,0.80618,0.0030599,0.011787,0,0
5,GO ADIPOSE TISSUE DEVELOPMENT,0.85555,0.0028002,0.062456,0,0
5,GO PROTEIN HETEROOLIGOMERIZATION,0.61803,0.0027886,-0.017828,0,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.99368,0.0027593,0.033368,0,0
5,GO FUCOSYLATION,0.93062,0.0026979,0.014226,0,0
5,GO REGULATION OF SODIUM ION TRANSPORT,0.75756,0.0026155,0.062412,0,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.83078,0.0025932,-0.052997,0,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.46168,0.0024915,0.10993,0,0
5,GO TRANSLATIONAL TERMINATION,0.90549,0.002345,-0.019172,0,0
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.70989,0.0023272,0.083322,0,0
5,GO TELOMERE CAPPING,0.80618,0.0022173,0.030142,0,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.50109,0.0021931,0.10499,0,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.75756,0.0021515,-0.027049,0,0
5,GO HISTONE H2A MONOUBIQUITINATION,0.7336,0.0019201,-0.0032757,0,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.76963,0.0019159,0.0046535,0,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.81845,0.0016031,0.02817,0,0
5,GO CELL CYCLE,0.89296,0.0015802,0.019415,0,0
5,GO APICAL PROTEIN LOCALIZATION,1,0.001557,0.039401,0,0
5,GO HISTONE H4 ACETYLATION,0.65188,0.0013217,0.0038065,0,0
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.39705,0.0012332,0.10472,0,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.93062,0.0010993,-0.010741,0,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.80618,0.00092957,0.0065326,0,0
5,GO DNA REPAIR,0.98106,0.00085916,-0.02011,0,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.38829,0.00081676,0.16944,0,0
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.89296,0.00064618,0.045524,0,0
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.93062,0.00063687,0.035222,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.94321,0.00052807,-0.0096888,0,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.33821,0.00048886,0.089978,0,0
5,GO CELL CYCLE PROCESS,0.96843,0.00038873,0.0081403,0,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.75756,0.00026935,-0.049524,0,0
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.58498,0.00019469,0.070765,0,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,0.50109,0.00010713,0.13243,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.96843,6.384e-05,0.020764,0,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,0.7336,-5.9268e-05,-0.03902,0,0
5,GO REGIONALIZATION,0.93062,-7.8497e-05,0.040022,0,0
5,GO DOUBLE STRAND BREAK REPAIR,0.90549,-0.00013,-0.021272,0,0
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.54223,-0.00037557,-0.03862,0,0
5,GO DIOL METABOLIC PROCESS,0.51122,-0.0003983,-0.030427,0,0
5,GO REGULATION OF ANION TRANSPORT,0.54223,-0.00056186,0.069327,0,0
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.49108,-0.00059604,0.082872,0,0
5,GO MITOTIC CELL CYCLE,0.96843,-0.00066558,0.0053015,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.91805,-0.00075809,-0.049604,0,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.98106,-0.00089194,0.050701,0,0
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.67486,-0.00089923,-0.034889,0,0
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.61803,-0.0011043,-0.0086009,0,0
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.81845,-0.0013141,0.03176,0,0
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.99368,-0.0014114,0.058374,0,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.93062,-0.0014175,-0.0067289,0,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.34626,-0.0014551,0.10283,0,0
5,GO ACTIN CROSSLINK FORMATION,0.86799,-0.0019956,0.02003,0,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.65188,-0.002007,0.075549,0,0
5,GO NEURON APOPTOTIC PROCESS,0.61803,-0.0020509,0.067132,0,0
5,GO LOOP OF HENLE DEVELOPMENT,0.42405,-0.0022569,0.10666,0,0
5,GO SCHWANN CELL DIFFERENTIATION,0.72171,-0.0023426,0.062569,0,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.49108,-0.0024418,0.093073,0,0
5,GO REGULATION OF TORC1 SIGNALING,0.98106,-0.002587,0.04246,0,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.76963,-0.0026635,0.045355,0,0
5,GO MIDBRAIN DEVELOPMENT,0.68646,-0.0028463,0.063738,0,0
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.86799,-0.0029634,0.013685,0,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,0.98106,-0.0030848,0.024747,0,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.54223,-0.0030981,0.10016,0,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.75756,-0.0031884,-0.035565,0,0
5,GO STRIATED MUSCLE CONTRACTION,0.84314,-0.0031967,0.035917,0,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.89296,-0.0032317,0.0067151,0,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.5959,-0.0032428,-0.090037,0,0
5,GO TRANSLATIONAL ELONGATION,0.49108,-0.0033852,-0.042547,0,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.98106,-0.0034357,-0.015147,0,0
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.88046,-0.0034729,0.016883,0,0
5,GO RESPONSE TO PH,0.42405,-0.0037753,0.11004,0,0
5,GO HEART VALVE FORMATION,0.5959,-0.0038639,0.086378,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.96843,-0.0039412,0.016315,0,0
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.91805,-0.0039544,0.023761,0,0
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.74555,-0.0040686,-0.010167,0,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.80618,-0.0043985,0.061338,0,0
5,GO SPERM CAPACITATION,0.96843,-0.0045132,0.015992,0,0
5,GO PROTEIN ACETYLATION,0.84314,-0.0045622,0.021559,0,0
5,GO POSITIVE REGULATION OF CELL GROWTH,0.83078,-0.004563,0.072524,0,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.98106,-0.0047082,0.010356,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.86799,-0.0047246,-0.031873,0,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.91805,-0.0047848,0.042755,0,0
5,GO STEM CELL PROLIFERATION,1,-0.0048779,0.066975,0,0
5,GO EXECUTION PHASE OF APOPTOSIS,0.98106,-0.0050215,0.03438,0,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.96843,-0.0050557,0.032898,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.91805,-0.0050563,0.020802,0,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.54223,-0.0050583,-0.02695,0,0
5,GO LONG TERM MEMORY,0.62923,-0.0053941,-0.023426,0,0
5,GO TORC1 SIGNALING,0.79394,-0.0054722,0.06709,0,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.89296,-0.005596,0.035279,0,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.96843,-0.0056075,0.022749,0,0
5,GO DNA CONFORMATION CHANGE,0.78176,-0.0058896,-0.050544,0,0
5,GO DNA DEPENDENT DNA REPLICATION,0.96843,-0.0060372,-0.058551,0,0
5,GO MULTICELLULAR ORGANISM REPRODUCTION,1,-0.006064,0.034303,0,0
5,GO CHROMOSOME SEPARATION,0.66333,-0.0060743,-0.094549,0,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,0.83078,-0.0061401,0.034372,0,0
5,GO GAMETE GENERATION,0.67486,-0.0063045,-0.00038424,0,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.48117,-0.0063578,-0.0076422,0,0
5,GO PATTERN SPECIFICATION PROCESS,0.86799,-0.006424,0.035871,0,0
5,GO TRANSLESION SYNTHESIS,0.93062,-0.0065447,-0.0092871,0,0
5,GO CELL FATE COMMITMENT,0.90549,-0.0069095,0.06949,0,0
5,GO PROTEIN FOLDING,0.40594,-0.0070236,-0.0049787,0,0
5,GO METANEPHROS MORPHOGENESIS,0.88046,-0.0072068,0.048246,0,0
5,GO REGULATION OF MRNA POLYADENYLATION,0.68646,-0.007266,-0.0092404,0,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.95582,-0.0073348,0.03027,0,0
5,GO RESPIRATORY SYSTEM PROCESS,0.66333,-0.007366,0.072032,0,0
5,GO RESPONSE TO AXON INJURY,1,-0.0074385,0.054503,0,0
5,GO MEMBRANE FUSION,0.85555,-0.0078121,0.057064,0,0
5,GO CORTICOSTEROID HORMONE SECRETION,0.54223,-0.0078938,-0.065613,0,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.72171,-0.0079724,-0.036393,0,0
5,GO MISMATCH REPAIR,0.58498,-0.0081207,-0.047744,0,0
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.85555,-0.0085339,0.025836,0,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.7336,-0.0088002,-0.10216,0,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.78176,-0.0088265,-0.0078836,0,0
5,GO LIMB BUD FORMATION,0.23827,-0.008852,0.21686,0,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,0.94321,-0.0088792,0.022624,0,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.88046,-0.0091295,-0.062865,0,0
5,GO MALE GAMETE GENERATION,0.69814,-0.0091602,-0.0088599,0,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.95582,-0.0092298,-0.015838,0,0
5,GO REGULATION OF PROTEIN ACETYLATION,0.75756,-0.0098063,0.059275,0,0
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.58498,-0.0098195,0.095999,0,0
5,GO CLATHRIN COAT ASSEMBLY,0.75756,-0.0099918,0.029879,0,0
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.94321,-0.010193,0.060948,0,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.80618,-0.010256,0.052195,0,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,0.88046,-0.010354,0.035926,0,0
5,GO GERM CELL DEVELOPMENT,0.69814,-0.010422,-0.019549,0,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.49108,-0.010703,0.090053,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,0.75756,-0.010711,-0.026877,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.65188,-0.010834,-0.0061262,0,0
5,GO HISTONE METHYLATION,1,-0.010892,0.015602,0,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.72171,-0.010906,-0.026779,0,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.86799,-0.010912,0.0031412,0,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.61803,-0.010914,-0.098718,0,0
5,GO RESPONSE TO STARVATION,0.83078,-0.010918,0.061359,0,0
5,GO MULTICELLULAR ORGANISM GROWTH,0.52145,-0.01093,0.02091,0,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.7336,-0.010988,-0.094758,0,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.86799,-0.011,0.030685,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.76963,-0.011001,0.02838,0,0
5,GO LUNG CELL DIFFERENTIATION,0.96843,-0.011248,0.061851,0,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.90549,-0.011484,-0.096552,0,0
5,GO REGULATION OF DNA REPLICATION,0.88046,-0.011768,-0.021135,0,0
5,GO DNA REPLICATION,0.99368,-0.012071,-0.0366,0,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.88046,-0.012196,-0.028152,0,0
5,GO POSITIVE REGULATION OF GROWTH,0.81845,-0.012316,0.08124,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,0.85555,-0.012339,-0.009093,0,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.78176,-0.012358,-0.043506,0,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.91805,-0.012431,-0.015667,0,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.62923,-0.012546,-0.1337,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.94321,-0.01325,0.0014463,0,0
5,GO CELL PROJECTION ASSEMBLY,0.85555,-0.013261,0.054333,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.60692,-0.013343,0.066171,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.74555,-0.013511,-0.09492,0,0
5,GO RESPONSE TO LEAD ION,0.95582,-0.013586,0.023444,0,0
5,GO FERTILIZATION,0.64051,-0.0136,-0.0096458,0,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.94321,-0.013682,0.055006,0,0
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.85555,-0.01377,0.0026118,0,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.51122,-0.013837,-0.027551,0,0
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.90549,-0.01403,0.026146,0,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.85555,-0.014145,-0.012178,0,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.91805,-0.014207,-0.034308,0,0
5,GO REGULATION OF HORMONE LEVELS,0.7336,-0.014221,0.016197,0,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.66333,-0.014226,0.0061952,0,0
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.95582,-0.014293,0.0055577,0,0
5,GO ATP METABOLIC PROCESS,0.76963,-0.014576,-0.0031678,0,0
5,GO ADHERENS JUNCTION ORGANIZATION,0.98106,-0.015086,0.056505,0,0
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.94321,-0.015188,0.052099,0,0
5,GO RENAL SODIUM EXCRETION,0.83078,-0.01525,0.02854,0,0
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.88046,-0.015266,0.030312,0,0
5,GO ORGANELLE ASSEMBLY,0.7336,-0.015352,0.007753,0,0
5,GO METHIONINE METABOLIC PROCESS,0.53179,-0.015527,0.053832,0,0
5,GO OOCYTE DIFFERENTIATION,0.47137,-0.01561,-0.046266,0,0
5,GO DETECTION OF LIGHT STIMULUS,0.54223,-0.015848,-0.034979,0,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.86799,-0.015886,0.060375,0,0
5,GO DNA PACKAGING,0.49108,-0.01594,-0.097186,0,0
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.55277,-0.016013,-0.012328,0,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.5959,-0.016038,-0.07144,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.78176,-0.016092,-0.012261,0,0
5,GO EXPLORATION BEHAVIOR,0.91805,-0.0162,0.004412,0,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.42405,-0.016304,-0.070449,0,0
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.94321,-0.016316,0.055173,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.44264,-0.016338,-0.087518,0,0
5,GO POSITIVE REGULATION OF FERTILIZATION,0.89296,-0.01635,0.023801,0,0
5,GO CELLULAR RESPONSE TO ALKALOID,1,-0.016378,0.02716,0,0
5,GO PHOTOTRANSDUCTION,0.7336,-0.016397,0.015222,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.57414,-0.016463,-0.21231,0,0
5,GO NON MOTILE CILIUM ASSEMBLY,0.94321,-0.016477,0.0040464,0,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.68646,-0.016491,-0.020098,0,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.64051,-0.016568,-0.027474,0,0
5,GO ADHERENS JUNCTION ASSEMBLY,0.78176,-0.016785,0.05294,0,0
5,GO DEVELOPMENTAL GROWTH,0.96843,-0.017019,0.066651,0,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.60692,-0.017167,0.083784,0,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,0.85555,-0.017185,-0.026142,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.79394,-0.01734,0.10215,0,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.95582,-0.017362,0.022512,0,0
5,GO REGULATION OF EXCRETION,0.79394,-0.017369,0.030428,0,0
5,GO REGULATION OF HISTONE UBIQUITINATION,0.96843,-0.017421,0.0061623,0,0
5,GO VASODILATION,0.62923,-0.01746,0.053648,0,0
5,GO CAMERA TYPE EYE DEVELOPMENT,0.94321,-0.017593,0.063957,0,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.69814,-0.017751,-0.091241,0,0
5,GO POSTREPLICATION REPAIR,0.90549,-0.017788,-0.010431,0,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.62923,-0.017798,-0.030626,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.79394,-0.017836,-0.025,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.58498,-0.018215,-0.054237,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.81845,-0.018276,0.065974,0,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.85555,-0.018399,-0.011004,0,0
5,GO RELAXATION OF CARDIAC MUSCLE,0.95582,-0.018456,0.022907,0,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.50109,-0.018485,0.068751,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.90549,-0.018487,0.002861,0,0
5,GO CELL MATURATION,0.98106,-0.018553,0.056364,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.99368,-0.018697,0.012982,0,0
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.78176,-0.018731,0.072219,0,0
5,GO CELL GROWTH,0.96843,-0.019076,0.066424,0,0
5,GO POSITIVE REGULATION OF CELL CYCLE,0.84314,-0.019398,0.0048629,0,0
5,GO ION TRANSMEMBRANE TRANSPORT,0.86799,-0.019587,0.027796,0,0
5,GO SENSORY ORGAN DEVELOPMENT,0.85555,-0.019735,0.066027,0,0
5,GO CATION TRANSMEMBRANE TRANSPORT,0.79394,-0.019864,0.023254,0,0
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.7336,-0.020025,0.04235,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.89296,-0.020347,-0.024208,0,0
5,GO SINGLE STRAND BREAK REPAIR,0.66333,-0.020398,-0.022376,0,0
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.76963,-0.020537,0.037599,0,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.94321,-0.020588,0.066919,0,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.75756,-0.020629,-0.023823,0,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.28529,-0.020918,-0.030485,0,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.68646,-0.021011,0.03663,0,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.50109,-0.021116,-0.052627,0,0
5,GO THYROID GLAND DEVELOPMENT,0.54223,-0.021138,-0.016924,0,0
5,GO PROTEIN NEDDYLATION,0.67486,-0.021368,-0.022451,0,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.75756,-0.021608,-0.0076324,0,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.91805,-0.021889,0.042015,0,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.95582,-0.021963,0.029857,0,0
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.99368,-0.022148,0.046323,0,0
5,GO RESPONSE TO MISFOLDED PROTEIN,0.65188,-0.022197,0.026777,0,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.68646,-0.022252,0.069811,0,0
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.75756,-0.022364,0.019525,0,0
5,GO RRNA 3 END PROCESSING,0.89296,-0.022488,-0.037967,0,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.65188,-0.022939,0.011982,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.88046,-0.022996,-0.035906,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,0.56341,-0.023158,0.014941,0,0
5,GO POLYAMINE METABOLIC PROCESS,0.90549,-0.023371,0.015509,0,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.94321,-0.023452,0.0077579,0,0
5,GO ORGANELLE LOCALIZATION,0.49108,-0.023596,-0.0055986,0,0
5,GO MITOCHONDRIAL FISSION,0.98106,-0.023604,0.055509,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.76963,-0.023662,-0.013249,0,0
5,GO NEURON PROJECTION REGENERATION,0.86799,-0.02378,0.075511,0,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.78176,-0.023851,0.00072848,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.52145,-0.023856,-0.076374,0,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.85555,-0.023951,-0.0045161,0,0
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.52145,-0.024007,0.084905,0,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.85555,-0.024107,0.033808,0,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,0.85555,-0.024462,0.0073337,0,0
5,GO RESPONSE TO CARBOHYDRATE,0.89296,-0.024547,0.041031,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.91805,-0.02461,0.0013889,0,0
5,GO CARBOHYDRATE PHOSPHORYLATION,0.95582,-0.024718,0.047943,0,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.99368,-0.024728,-0.056179,0,0
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.67486,-0.025174,0.0090889,0,0
5,GO DIOL BIOSYNTHETIC PROCESS,0.57414,-0.02529,-0.014586,0,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.61803,-0.025615,-0.0025051,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.53179,-0.025651,-0.029678,0,0
5,GO REGULATION OF NEURON MIGRATION,0.55277,-0.025667,-0.048994,0,0
5,GO REGULATION OF ATPASE ACTIVITY,0.41494,-0.02581,-0.00057168,0,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.67486,-0.026316,0.020411,0,0
5,GO CHROMOSOME SEGREGATION,0.65188,-0.02636,-0.089775,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.4521,-0.026626,-0.074468,0,0
5,GO MITOTIC DNA REPLICATION,0.72171,-0.026794,-0.13117,0,0
5,GO MUSCLE CONTRACTION,0.68646,-0.026799,0.069466,0,0
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.86799,-0.026896,0.026748,0,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.89296,-0.027211,0.12563,0,0
5,GO HISTONE H3 K36 METHYLATION,0.90549,-0.027292,0.0091628,0,0
5,GO SENSORY SYSTEM DEVELOPMENT,0.99368,-0.027343,0.066045,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.83078,-0.027499,0.050648,0,0
5,GO CELL DIVISION,0.89296,-0.02751,-0.015199,0,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.47137,-0.027571,-0.068217,0,0
5,GO POSITIVE REGULATION OF DNA REPAIR,0.67486,-0.027706,-0.022976,0,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.69814,-0.027924,-0.098539,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.64051,-0.028251,-0.04339,0,0
5,GO CELLULAR COMPONENT MAINTENANCE,0.52145,-0.028442,-0.0021439,0,0
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.5959,-0.028723,-0.030614,0,0
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.96843,-0.028752,0.025493,0,0
5,GO DNA LIGATION,0.91805,-0.028768,-0.040163,0,0
5,GO CARBOHYDRATE HOMEOSTASIS,0.67486,-0.028924,0.023527,0,0
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.55277,-0.028989,-0.020818,0,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.75756,-0.029075,0.0097773,0,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.60692,-0.029206,-0.032375,0,0
5,GO MITOCHONDRIAL FUSION,0.38829,-0.029241,-0.020738,0,0
5,GO POSITIVE REGULATION OF RNA SPLICING,0.43329,-0.029302,-0.034277,0,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,0.61803,-0.029403,0.12173,0,0
5,GO REGULATION OF HEART RATE,0.86799,-0.029628,0.02465,0,0
5,GO LENS FIBER CELL DEVELOPMENT,0.88046,-0.029662,0.039174,0,0
5,GO RHYTHMIC BEHAVIOR,0.89296,-0.029846,0.016897,0,0
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.96843,-0.029917,0.012402,0,0
5,GO STRESS GRANULE ASSEMBLY,0.98106,-0.029948,0.033012,0,0
5,GO PENILE ERECTION,0.70989,-0.029986,-0.090526,0,0
5,GO SEXUAL REPRODUCTION,0.54223,-0.030038,-0.004517,0,0
5,GO DNA CATABOLIC PROCESS,0.74555,-0.030077,0.020119,0,0
5,GO ORGANIC CATION TRANSPORT,0.85555,-0.030134,0.015097,0,0
5,GO CHLORIDE TRANSPORT,0.98106,-0.03023,0.021715,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.5959,-0.030261,0.04658,0,0
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.99368,-0.030319,0.034775,0,0
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.99368,-0.030699,0.037975,0,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,0.98106,-0.030809,0.024537,0,0
5,GO CAMP METABOLIC PROCESS,0.94321,-0.030883,0.055991,0,0
5,GO NADH METABOLIC PROCESS,0.58498,-0.031063,-0.021505,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.81845,-0.031064,-0.014883,0,0
5,GO CELLULAR RESPIRATION,0.20256,-0.031145,-0.038461,0,0
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.78176,-0.031311,-0.013043,0,0
5,GO LUTEINIZATION,0.78176,-0.031809,0.05746,0,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,0.57414,-0.031868,0.021294,0,0
5,GO REGULATION OF DNA REPAIR,0.68646,-0.03192,-0.024916,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.69814,-0.031955,-0.031211,0,0
5,GO ZINC ION TRANSPORT,0.91805,-0.032069,0.035969,0,0
5,GO SKELETAL MUSCLE ADAPTATION,0.99368,-0.032117,0.041869,0,0
5,GO RHYTHMIC PROCESS,0.93062,-0.032251,0.042847,0,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.85555,-0.032324,0.013117,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.51122,-0.032554,-0.032313,0,0
5,GO RELAXATION OF MUSCLE,0.96843,-0.032956,0.032931,0,0
5,GO SINGLE FERTILIZATION,0.34626,-0.033128,-0.025691,0,0
5,GO POSITIVE REGULATION OF HORMONE SECRETION,0.29248,-0.033141,-0.021856,0,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.3148,-0.033253,-0.041221,0,0
5,GO MYELIN ASSEMBLY,0.48117,-0.033713,0.010065,0,0
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.88046,-0.033739,0.044184,0,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.69814,-0.034097,0.024557,0,0
5,GO HEART FORMATION,0.83078,-0.034303,0.021498,0,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.80618,-0.034389,0.043885,0,0
5,GO MEIOTIC CELL CYCLE,0.32248,-0.034393,-0.10531,0,0
5,GO GLYCINE TRANSPORT,1,-0.034627,-0.0011193,0,0
5,GO CELL JUNCTION ASSEMBLY,0.84314,-0.034769,0.048403,0,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.48117,-0.034795,0.12209,0,0
5,GO NUCLEOSOME ORGANIZATION,0.47137,-0.035009,-0.083913,0,0
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.67486,-0.035011,-0.034178,0,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.53179,-0.035201,0.017831,0,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.89296,-0.035284,0.047508,0,0
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.85555,-0.03534,0.057445,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.27821,-0.035479,-0.0036659,0,0
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.62923,-0.035574,-0.0041274,0,0
5,GO ENERGY HOMEOSTASIS,0.68646,-0.03571,0.026779,0,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.83078,-0.035837,0.049924,0,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.56341,-0.035883,-0.16017,0,0
5,GO CELL PROLIFERATION IN FOREBRAIN,0.80618,-0.036041,-0.010552,0,0
5,GO REGULATION OF MRNA PROCESSING,0.51122,-0.036109,-0.032707,0,0
5,GO MYOTUBE CELL DEVELOPMENT,0.95582,-0.036162,0.0021217,0,0
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.5959,-0.036245,0.011365,0,0
5,GO REGULATION OF CELL SIZE,0.93062,-0.036271,0.075811,0,0
5,GO TRANSFERRIN TRANSPORT,0.69814,-0.036299,0.00071672,0,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.51122,-0.036523,-0.066195,0,0
5,GO ACID SECRETION,0.75756,-0.036726,-0.0046746,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.66333,-0.03677,-0.049193,0,0
5,GO REGULATION OF NUCLEAR DIVISION,0.54223,-0.036823,-0.045951,0,0
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.76963,-0.03688,0.0452,0,0
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.86799,-0.037068,0.064233,0,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.54223,-0.037282,-0.025133,0,0
5,GO REGULATION OF CYTOKINESIS,0.53179,-0.037435,-0.049588,0,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.88046,-0.037536,0.032316,0,0
5,GO ATP TRANSPORT,0.46168,-0.037581,-0.01498,0,0
5,GO CELL CELL SIGNALING,0.55277,-0.037639,0.019654,0,0
5,GO DOSAGE COMPENSATION,0.81845,-0.037725,-0.006305,0,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.93062,-0.037764,0.028165,0,0
5,GO SMOOTHENED SIGNALING PATHWAY,0.93062,-0.037969,0.044091,0,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.5959,-0.038199,-0.0014956,0,0
5,GO ORGANELLE INHERITANCE,0.99368,-0.038314,0.013107,0,0
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.38829,-0.038703,-0.033795,0,0
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.56341,-0.039,0.0083133,0,0
5,GO CELL MORPHOGENESIS,0.76963,-0.03904,0.050446,0,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.66333,-0.03918,-0.039139,0,0
5,GO SCHWANN CELL DEVELOPMENT,0.90549,-0.039259,0.01247,0,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.53179,-0.039342,-0.021045,0,0
5,GO AXONAL FASCICULATION,0.54223,-0.039648,-0.064607,0,0
5,GO POLYOL CATABOLIC PROCESS,0.30724,-0.039649,-0.059238,0,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.41494,-0.039702,-0.059749,0,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.44264,-0.040277,-0.044447,0,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.44264,-0.040654,0.0046984,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.7336,-0.040762,-0.12657,0,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.42405,-0.040949,-0.026835,0,0
5,GO POTASSIUM ION HOMEOSTASIS,0.79394,-0.041071,-0.0027237,0,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.23203,-0.041073,-0.10128,0,0
5,GO IMPORT INTO CELL,0.81845,-0.041108,0.023052,0,0
5,GO COGNITION,0.47137,-0.041305,-0.023179,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.44264,-0.041592,-0.081876,0,0
5,GO MEMBRANE REPOLARIZATION,0.84314,-0.041657,0.02949,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.85555,-0.041684,0.037946,0,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,0.68646,-0.041835,0.047331,0,0
5,GO SULFATE TRANSPORT,0.44264,-0.042233,-0.042958,0,0
5,GO FAT CELL PROLIFERATION,0.50109,-0.04251,-0.032105,0,0
5,GO REGULATION OF CELL DEVELOPMENT,0.74555,-0.042565,0.045568,0,0
5,GO CENTRIOLE ASSEMBLY,0.83078,-0.042659,-0.032251,0,0
5,GO SEROTONIN TRANSPORT,0.88046,-0.042783,0.046005,0,0
5,GO PROTEIN ACYLATION,0.57414,-0.042968,-0.0024875,0,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.39705,-0.043194,-0.1045,0,0
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.53179,-0.043337,0.012878,0,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.42405,-0.043373,-0.048994,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.27126,-0.043462,-0.030268,0,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.66333,-0.043583,-0.0094125,0,0
5,GO CHROMOSOME LOCALIZATION,0.37111,-0.043679,-0.099354,0,0
5,GO ATRIAL SEPTUM DEVELOPMENT,0.48117,-0.044329,-0.0060505,0,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.62923,-0.044404,0.023393,0,0
5,GO CARTILAGE MORPHOGENESIS,0.96843,-0.044494,0.045902,0,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.68646,-0.044683,-0.001842,0,0
5,GO REGULATION OF CILIUM ASSEMBLY,0.51122,-0.044804,-0.048183,0,0
5,GO MUSCLE FIBER DEVELOPMENT,0.56341,-0.044889,-0.01024,0,0
5,GO SECONDARY PALATE DEVELOPMENT,1,-0.045012,0.031123,0,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.60692,-0.045034,-0.047025,0,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.33821,-0.045238,-0.097405,0,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.214,-0.045273,-0.067995,0,0
5,GO ASTRAL MICROTUBULE ORGANIZATION,0.60692,-0.045298,-0.0068273,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.90549,-0.045316,0.0545,0,0
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.60692,-0.045454,0.0048929,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.95582,-0.045636,0.0087604,0,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.20256,-0.046006,-0.037604,0,0
5,GO COPULATION,0.94321,-0.046054,-0.0053222,0,0
5,GO HISTONE H2A ACETYLATION,0.7336,-0.046122,-0.042053,0,0
5,GO REGULATION OF ACTION POTENTIAL,0.72171,-0.046196,-0.00060226,0,0
5,GO PURINE NUCLEOTIDE TRANSPORT,0.2998,-0.046504,-0.028786,0,0
5,GO DNA REPLICATION INITIATION,0.49108,-0.046564,-0.16751,0,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.36271,-0.046631,-0.040326,0,0
5,GO DENDRITIC SPINE DEVELOPMENT,0.53179,-0.046841,-0.015795,0,0
5,GO ORGANELLE MEMBRANE FUSION,0.27821,-0.046902,-0.00042575,0,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,0.89296,-0.047235,0.014192,0,0
5,GO RESPONSE TO LITHIUM ION,1,-0.047453,0.046098,0,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.2577,-0.047471,-0.14593,0,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.17591,-0.047496,-0.035342,0,0
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.54223,-0.047652,-0.01054,0,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.91805,-0.047693,0.065061,0,0
5,GO CYTOKINESIS,0.35442,-0.047715,-0.045103,0,0
5,GO SODIUM ION TRANSPORT,0.54223,-0.04774,-0.0052319,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.34626,-0.048219,-0.038875,0,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.53179,-0.048456,-0.056066,0,0
5,GO CELL CYCLE DNA REPLICATION,0.75756,-0.048456,-0.10731,0,0
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.50109,-0.048824,-0.043838,0,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.64051,-0.048907,-0.035057,0,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.43329,-0.049095,-0.047631,0,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.2998,-0.049466,-0.057206,0,0
5,GO MEMORY,0.27821,-0.049923,-0.052284,0,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.91805,-0.049944,0.039985,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.214,-0.049972,-0.13181,0,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.47137,-0.050335,-0.019682,0,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,0.5959,-0.050372,-0.0066845,0,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.56341,-0.050579,-0.067052,0,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.84314,-0.050831,-0.0033564,0,0
5,GO SPINDLE ASSEMBLY,0.60692,-0.05097,-0.071114,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.20256,-0.051096,-0.093822,0,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.58498,-0.05118,-0.023136,0,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.57414,-0.051229,0.00015491,0,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.98106,-0.051234,0.022047,0,0
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.19156,-0.051235,-0.061191,0,0
5,GO CELL JUNCTION ORGANIZATION,0.5959,-0.051509,0.016396,0,0
5,GO REGULATION OF ACROSOME REACTION,0.53179,-0.051784,-0.025968,0,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.95582,-0.051889,0.022523,0,0
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.96843,-0.052054,0.038659,0,0
5,GO COENZYME A METABOLIC PROCESS,0.24463,-0.052186,-0.048628,0,0
5,GO MECHANORECEPTOR DIFFERENTIATION,0.40594,-0.052299,-0.021558,0,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.38829,-0.052348,-0.16228,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.33029,-0.052431,-0.12064,0,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.79394,-0.052572,0.051102,0,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.5959,-0.052736,-0.036134,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.5959,-0.052976,-0.052123,0,0
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.51122,-0.053003,-0.029481,0,0
5,GO DNA REPLICATION CHECKPOINT,0.55277,-0.053067,-0.144,0,0
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.64051,-0.053152,0.0075187,0,0
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.40594,-0.053333,-0.0048065,0,0
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.5959,-0.053426,-0.029097,0,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.57414,-0.053692,-0.019684,0,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.40594,-0.053943,-0.037724,0,0
5,GO REGULATION OF VASCULAR PERMEABILITY,0.7336,-0.053967,0.10101,0,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.7336,-0.054041,0.030758,0,0
5,GO ORGANELLE FISSION,0.43329,-0.054112,-0.068354,0,0
5,GO CARNITINE METABOLIC PROCESS,0.99368,-0.054415,0.04458,0,0
5,GO CENTRIOLE CENTRIOLE COHESION,0.72171,-0.054668,-0.030851,0,0
5,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.66333,-0.055026,0.0096905,0,0
5,GO DEVELOPMENTAL INDUCTION,0.75756,-0.055706,0.021561,0,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,0.55277,-0.055824,9.8896e-05,0,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.60692,-0.055906,-0.0067784,0,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.91805,-0.05593,-0.11979,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.53179,-0.056042,-0.018177,0,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.61803,-0.056095,-0.085935,0,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.49108,-0.056103,-0.055458,0,0
5,GO SHORT TERM MEMORY,0.25111,-0.056415,-0.10012,0,0
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.66333,-0.056441,-0.012641,0,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.2577,-0.05649,-0.1655,0,0
5,GO RESPONSE TO MONOSACCHARIDE,0.55277,-0.056557,0.015028,0,0
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.30724,-0.056908,-0.014196,0,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,0.57414,-0.056968,-0.017068,0,0
5,GO CRISTAE FORMATION,0.32248,-0.057032,-0.038698,0,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.66333,-0.057707,-0.022133,0,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.84314,-0.057718,-0.0069848,0,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.54223,-0.057779,-0.10141,0,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.88046,-0.057861,0.040715,0,0
5,GO NUCLEOTIDE TRANSPORT,0.65188,-0.057995,0.0019029,0,0
5,GO MRNA SPLICE SITE SELECTION,0.20822,-0.058177,-0.14496,0,0
5,GO CENTROSOME DUPLICATION,0.68646,-0.058195,-0.048557,0,0
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.60692,-0.058373,0.028808,0,0
5,GO RESPONSE TO MAGNESIUM ION,0.70989,-0.058436,-0.013039,0,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.83078,-0.058469,0.035596,0,0
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.50109,-0.058637,-0.0082793,0,0
5,GO REGULATION OF BLOOD CIRCULATION,0.85555,-0.058844,0.027538,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.34626,-0.058976,-0.10313,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.43329,-0.059198,-0.039635,0,0
5,GO ORGANELLE FUSION,0.16602,-0.059335,-0.015692,0,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.7336,-0.059484,0.020571,0,0
5,GO CIRCADIAN RHYTHM,0.52145,-0.059543,0.0063293,0,0
5,GO AROMATIC AMINO ACID TRANSPORT,0.48117,-0.059643,-0.03662,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.197,-0.059711,-0.07093,0,0
5,GO REGULATION OF APPETITE,0.20822,-0.059769,-0.10586,0,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.76963,-0.059971,0.05138,0,0
5,GO AXON EXTENSION,0.52145,-0.060098,0.0075328,0,0
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.5959,-0.060131,-0.021112,0,0
5,GO METAPHASE PLATE CONGRESSION,0.48117,-0.060708,-0.1061,0,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.89296,-0.060878,-0.088388,0,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.37111,-0.060989,-0.10782,0,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.43329,-0.061283,-0.054893,0,0
5,GO DETECTION OF VISIBLE LIGHT,0.214,-0.061349,-0.066777,0,0
5,GO SECRETORY GRANULE ORGANIZATION,0.30724,-0.061632,-0.050198,0,0
5,GO DNA STRAND ELONGATION,0.60692,-0.06165,-0.14897,0,0
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.50109,-0.061752,0.011718,0,0
5,GO LONG TERM SYNAPTIC POTENTIATION,0.3148,-0.062406,-0.061448,0,0
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.36271,-0.062675,-0.024868,0,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.76963,-0.063215,0.016303,0,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,0.47137,-0.063486,0.0078756,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.072385,-0.063538,-0.10108,0,0
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.64051,-0.063565,0.02706,0,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,0.33821,-0.063598,-0.031484,0,0
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.64051,-0.063921,0.025578,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.32248,-0.064084,-0.047952,0,0
5,GO SISTER CHROMATID SEGREGATION,0.56341,-0.064275,-0.10513,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.2998,-0.064386,-0.086936,0,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.98106,-0.06479,0.043875,0,0
5,GO REGULATION OF SYSTEM PROCESS,0.64051,-0.064967,0.012805,0,0
5,GO NEURON PROJECTION GUIDANCE,0.39705,-0.065118,0.00034755,0,0
5,GO MICROTUBULE ANCHORING,0.61803,-0.065419,-0.013431,0,0
5,GO MITOTIC NUCLEAR DIVISION,0.42405,-0.065442,-0.079897,0,0
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.78176,-0.065632,0.054493,0,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.78176,-0.065879,0.049734,0,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.67486,-0.065984,0.01002,0,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.7336,-0.066032,0.014216,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.1306,-0.066158,-0.18646,0,0
5,GO HEART PROCESS,0.79394,-0.066551,0.014842,0,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.89296,-0.066663,-0.018314,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.46168,-0.06681,-0.020706,0,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.13885,-0.066974,-0.051956,0,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.38829,-0.067137,-0.052375,0,0
5,GO WALKING BEHAVIOR,0.13885,-0.067273,-0.11525,0,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.35442,-0.067329,-0.039661,0,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.214,-0.067351,-0.18089,0,0
5,GO MICROTUBULE NUCLEATION,0.2577,-0.0674,-0.053996,0,0
5,GO KINETOCHORE ASSEMBLY,0.47137,-0.067441,-0.18252,0,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,0.42405,-0.067583,-0.075745,0,0
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.50109,-0.067706,-0.055021,0,0
5,GO NEUROBLAST PROLIFERATION,0.23827,-0.067955,-0.049321,0,0
5,GO SPERM AXONEME ASSEMBLY,0.58498,-0.068291,-0.040069,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.44264,-0.068432,0.013843,0,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.47137,-0.068435,-0.11719,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.30724,-0.068837,-0.10067,0,0
5,GO LOCALIZATION WITHIN MEMBRANE,0.52145,-0.068866,-0.0016117,0,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.42405,-0.068872,-0.071513,0,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,0.29248,-0.069225,-0.045998,0,0
5,GO APOPTOTIC DNA FRAGMENTATION,0.4521,-0.069292,-0.017433,0,0
5,GO SEX DETERMINATION,0.70989,-0.06981,-0.022616,0,0
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.69814,-0.070238,-0.014952,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.61803,-0.07035,0.0073094,0,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.37111,-0.070551,-0.046356,0,0
5,GO HINDBRAIN MORPHOGENESIS,0.33821,-0.070674,-0.036944,0,0
5,GO CARDIAC CHAMBER FORMATION,0.49108,-0.071392,-0.082509,0,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.197,-0.071433,-0.043616,0,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.79394,-0.071786,0.029517,0,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.70989,-0.072006,-0.010551,0,0
5,GO RESPONSE TO ALKALOID,0.17591,-0.072035,-0.026001,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.66333,-0.072662,0.023805,0,0
5,GO L AMINO ACID TRANSPORT,0.88046,-0.07286,0.052091,0,0
5,GO VISUAL BEHAVIOR,0.37111,-0.072888,-0.022074,0,0
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.38829,-0.073264,-0.039974,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.56341,-0.073728,0.11333,0,0
5,GO REGULATION OF RECEPTOR CLUSTERING,0.72171,-0.073758,-0.0073143,0,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.23827,-0.073905,-0.043993,0,0
5,GO HOMOLOGOUS RECOMBINATION,0.39705,-0.07413,-0.12418,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.86799,-0.074216,0.013117,0,0
5,GO RESPONSE TO AMINE,0.30724,-0.074454,-0.045077,0,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.37111,-0.074635,-0.038196,0,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.54223,-0.074842,-0.038239,0,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.32248,-0.075037,-0.10745,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.50109,-0.075046,-0.14839,0,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.23827,-0.075286,-0.22058,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.29248,-0.075573,-0.085142,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.069906,-0.075958,-0.14063,0,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.30724,-0.075994,-0.085207,0,0
5,GO MICROTUBULE BASED PROCESS,0.2577,-0.076198,-0.0703,0,0
5,GO DETECTION OF MECHANICAL STIMULUS,0.56341,-0.076341,0.012171,0,0
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.26442,-0.076618,-0.043734,0,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.72171,-0.076713,-0.024304,0,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.5959,-0.076795,0.0028698,0,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.2259,-0.077022,-0.13599,0,0
5,GO SPINDLE LOCALIZATION,0.41494,-0.077079,-0.050046,0,0
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.42405,-0.077296,-0.0037633,0,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.40594,-0.07788,-0.029979,0,0
5,GO MICROTUBULE BASED MOVEMENT,0.25111,-0.077978,-0.079974,0,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.68646,-0.077994,0.017567,0,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.37964,-0.078272,-0.04721,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.37964,-0.078405,-0.043749,0,0
5,GO DENDRITIC SPINE MORPHOGENESIS,0.30724,-0.078478,-0.069427,0,0
5,GO HEART INDUCTION,0.5959,-0.078506,0.0012525,0,0
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.47137,-0.078645,0.0027393,0,0
5,GO AXIS SPECIFICATION,0.90549,-0.078727,0.016986,0,0
5,GO OXIDATIVE PHOSPHORYLATION,0.018736,-0.078822,-0.093621,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.98106,-0.078826,0.041389,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.98106,-0.078951,0.0087797,0,0
5,GO RESPONSE TO PAIN,0.47137,-0.079402,-0.044106,0,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.58498,-0.079421,-0.012262,0,0
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.49108,-0.079585,-0.0093915,0,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.54223,-0.07985,-0.026369,0,0
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.75756,-0.080026,0.04061,0,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.40594,-0.080202,-0.026241,0,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.37964,-0.080425,-0.031043,0,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.28529,-0.080642,-0.036118,0,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,0.69814,-0.080689,-0.0024597,0,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.3148,-0.080696,-0.1031,0,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.069906,-0.081377,-0.20438,0,0
5,GO RESPONSE TO DIETARY EXCESS,0.49108,-0.081396,-0.022099,0,0
5,GO NERVOUS SYSTEM PROCESS,0.27126,-0.08145,-0.023225,0,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.40594,-0.081474,-0.073371,0,0
5,GO REGULATION OF CIRCADIAN RHYTHM,0.28529,-0.081482,-0.043767,0,0
5,GO REGULATION OF PROTEIN FOLDING,0.10811,-0.081665,-0.047269,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,0.197,-0.08198,-0.088388,0,0
5,GO CELL PROJECTION ORGANIZATION,0.52145,-0.082048,0.0066067,0,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.80618,-0.082334,0.051528,0,0
5,GO SPINDLE ORGANIZATION,0.28529,-0.082499,-0.098195,0,0
5,GO ASSOCIATIVE LEARNING,0.16602,-0.08258,-0.065804,0,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.33029,-0.082886,-0.035785,0,0
5,GO PROTEIN LOCALIZATION TO CILIUM,0.46168,-0.083242,-0.056464,0,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.74555,-0.083619,0.051767,0,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.93062,-0.083849,0.054488,0,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.62923,-0.083885,0.016959,0,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.23827,-0.084427,-0.089206,0,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.29248,-0.084761,-0.072618,0,0
5,GO RETINA LAYER FORMATION,0.18102,-0.08489,-0.14517,0,0
5,GO STRIATUM DEVELOPMENT,0.93062,-0.086244,0.017412,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.2577,-0.086265,-0.04562,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.58498,-0.086492,-0.076399,0,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.008797,-0.086558,-0.098897,0,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.69814,-0.086942,-0.017185,0,0
5,GO CARDIAC VENTRICLE FORMATION,0.39705,-0.08772,-0.11773,0,0
5,GO NUCLEAR BODY ORGANIZATION,0.23827,-0.088034,-0.032415,0,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.14312,-0.08808,-0.085221,0,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.20256,-0.088319,-0.11199,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.54223,-0.088721,0.013165,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.2577,-0.088748,-0.084941,0,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.091819,-0.088888,-0.1056,0,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.56341,-0.089143,-0.10012,0,0
5,GO MEMBRANE FISSION,0.214,-0.089352,-0.04652,0,0
5,GO CRANIAL NERVE DEVELOPMENT,0.48117,-0.089371,-0.045094,0,0
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.214,-0.089453,-0.10165,0,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.16123,-0.089524,-0.089376,0,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.50109,-0.089531,-0.049875,0,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.56341,-0.089811,0.031262,0,0
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.54223,-0.090029,-0.055398,0,0
5,GO RESPONSE TO REDOX STATE,0.2577,-0.090221,-0.065026,0,0
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.19156,-0.090334,-0.072507,0,0
5,GO INCLUSION BODY ASSEMBLY,0.16123,-0.090373,-0.023429,0,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.83078,-0.090598,0.0096342,0,0
5,GO MEMBRANE DEPOLARIZATION,0.197,-0.09071,-0.077462,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.08303,-0.090722,-0.15303,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.18624,-0.091055,-0.1913,0,0
5,GO CELL FATE DETERMINATION,0.74555,-0.091056,0.013868,0,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.2998,-0.091231,-0.10898,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.44264,-0.091615,-0.022961,0,0
5,GO NEUROGENESIS,0.33821,-0.091649,-0.0020995,0,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.37964,-0.091945,-0.056473,0,0
5,GO NUCLEOSOME ASSEMBLY,0.20256,-0.092069,-0.15162,0,0
5,GO PROTEIN DEPOLYMERIZATION,0.11894,-0.092428,-0.046497,0,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.50109,-0.092467,0.0052836,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.21989,-0.092668,-0.11974,0,0
5,GO CILIUM ORGANIZATION,0.33029,-0.09268,-0.065562,0,0
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.1306,-0.093341,-0.056314,0,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.12662,-0.093465,-0.067682,0,0
5,GO MALE SEX DETERMINATION,0.46168,-0.09347,-0.078251,0,0
5,GO NEURON PROJECTION ORGANIZATION,0.34626,-0.093716,-0.028046,0,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.15655,-0.093861,-0.057882,0,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.33029,-0.093952,-0.071073,0,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.16602,-0.093993,-0.11717,0,0
5,GO AXON DEVELOPMENT,0.33821,-0.094,-0.022415,0,0
5,GO OLIGODENDROCYTE DIFFERENTIATION,0.47137,-0.094007,-0.0089872,0,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.18624,-0.094065,-0.13732,0,0
5,GO SIGNAL RELEASE,0.24463,-0.094107,-0.024713,0,0
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.2577,-0.094398,-0.071687,0,0
5,GO MICROTUBULE SEVERING,0.27821,-0.094465,-0.083979,0,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.12273,-0.094569,-0.054849,0,0
5,GO RESPONSE TO L GLUTAMATE,0.43329,-0.094614,-0.060278,0,0
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.50109,-0.094825,-0.0049428,0,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,0.67486,-0.094854,0.016625,0,0
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.25111,-0.094863,-0.085052,0,0
5,GO MEMBRANE HYPERPOLARIZATION,0.60692,-0.094901,-0.053484,0,0
5,GO EPITHELIAL CELL FATE COMMITMENT,0.52145,-0.094929,-0.017223,0,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.44264,-0.095028,-0.077249,0,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.27126,-0.095135,-0.12983,0,0
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.13885,-0.095753,-0.061209,0,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.83078,-0.095872,0.032708,0,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.27126,-0.096094,-0.10886,0,0
5,GO SENSORY PERCEPTION OF PAIN,0.27821,-0.096127,-0.032751,0,0
5,GO MOTILE CILIUM ASSEMBLY,0.42405,-0.096438,-0.073009,0,0
5,GO RESPONSE TO GLUCAGON,0.18624,-0.096565,-0.07726,0,0
5,GO MALE MEIOSIS I,0.18624,-0.096891,-0.11772,0,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.29248,-0.097282,-0.039003,0,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.197,-0.0973,-0.086379,0,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.2259,-0.097538,-0.028709,0,0
5,GO MICROTUBULE BASED TRANSPORT,0.27126,-0.097949,-0.066765,0,0
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.18102,-0.097966,-0.048337,0,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.10811,-0.098177,-0.087154,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.18102,-0.099349,-0.099979,0,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.30724,-0.099818,-0.042474,0,0
5,GO INOSITOL METABOLIC PROCESS,0.08881,-0.1001,-0.13955,0,0
5,GO RESPONSE TO AMPHETAMINE,0.35442,-0.10013,-0.046079,0,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.54223,-0.10024,-0.043513,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.18624,-0.10064,-0.209,0,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.32248,-0.10089,-0.065938,0,0
5,GO POSTSYNAPSE ORGANIZATION,0.098083,-0.10107,-0.095911,0,0
5,GO ACTION POTENTIAL,0.13885,-0.10114,-0.061447,0,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.78176,-0.10128,0.0048927,0,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.043559,-0.10145,-0.087895,0,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.11894,-0.10146,-0.084746,0,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.36271,-0.10149,-0.02984,0,0
5,GO MATING,0.34626,-0.10157,-0.052438,0,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.2577,-0.10176,-0.029037,0,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.20256,-0.10182,-0.071765,0,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,0.36271,-0.1021,-0.069343,0,0
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.23203,-0.10242,-0.055928,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.08881,-0.10254,-0.081534,0,0
5,GO POSITIVE REGULATION OF ACROSOME REACTION,0.52145,-0.10254,-0.046714,0,0
5,GO TELENCEPHALON DEVELOPMENT,0.26442,-0.10268,-0.039884,0,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.20822,-0.10269,-0.2222,0,0
5,GO NEUROTRANSMITTER REUPTAKE,0.2998,-0.10273,-0.071044,0,0
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.2577,-0.10284,-0.055925,0,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.17591,-0.1037,-0.091694,0,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.90549,-0.10439,0.025575,0,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.51122,-0.10447,0.002479,0,0
5,GO RESPONSE TO LEPTIN,0.58498,-0.10451,0.0080786,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.27126,-0.1046,-0.063188,0,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.16602,-0.10486,-0.09188,0,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.1306,-0.10488,-0.10866,0,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,0.13467,-0.1049,-0.097456,0,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.96843,-0.10552,-0.045489,0,0
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.2577,-0.10572,-0.08711,0,0
5,GO RESPONSE TO LEUCINE,0.20256,-0.106,-0.086268,0,0
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.214,-0.10608,-0.055728,0,0
5,GO DEVELOPMENTAL MATURATION,0.33029,-0.10611,-0.012743,0,0
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.13467,-0.10644,-0.090729,0,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.3148,-0.10656,-0.045165,0,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0040644,-0.10693,-0.1357,0,0
5,GO MEMBRANE DOCKING,0.098083,-0.10734,-0.080661,0,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,0.35442,-0.10763,-0.021323,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.069906,-0.10797,-0.10107,0,0
5,GO HISTONE EXCHANGE,0.16123,-0.10851,-0.1902,0,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.33029,-0.10927,-0.059683,0,0
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.016475,-0.10975,-0.13478,0,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,0.15655,-0.10999,-0.08231,0,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.21989,-0.10999,-0.046608,0,0
5,GO REGULATION OF NEURON DIFFERENTIATION,0.25111,-0.11023,-0.027617,0,0
5,GO TRANSPORT ALONG MICROTUBULE,0.13467,-0.11051,-0.092052,0,0
5,GO DIVALENT METAL ION EXPORT,0.2259,-0.1107,-0.10098,0,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,0.16602,-0.11094,-0.067279,0,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.61803,-0.11165,-0.013771,0,0
5,GO REGULATION OF AXONOGENESIS,0.37111,-0.1118,-0.03554,0,0
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.23203,-0.11186,-0.079871,0,0
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.28529,-0.11199,-0.054425,0,0
5,GO LEARNING,0.074935,-0.11218,-0.12499,0,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.17591,-0.11221,-0.12428,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.48117,-0.1125,-0.032782,0,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.060677,-0.11293,-0.20222,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.29248,-0.11344,-0.090881,0,0
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.21989,-0.11348,-0.030846,0,0
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.2998,-0.11375,-0.077145,0,0
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.20256,-0.11397,-0.031368,0,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.197,-0.11456,-0.080037,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.13467,-0.11461,-0.12761,0,0
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.23827,-0.11477,-0.029942,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.37111,-0.11486,-0.03126,0,0
5,GO RECEPTOR CLUSTERING,0.2577,-0.11499,-0.064363,0,0
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.2577,-0.11502,-0.04609,0,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.08881,-0.11512,-0.13137,0,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.42405,-0.11516,-0.055388,0,0
5,GO DENDRITE DEVELOPMENT,0.16123,-0.11527,-0.069558,0,0
5,GO BEHAVIOR,0.10811,-0.1159,-0.079906,0,0
5,GO NEURON DIFFERENTIATION,0.2577,-0.1163,-0.029565,0,0
5,GO HIPPOCAMPUS DEVELOPMENT,0.24463,-0.11646,-0.057876,0,0
5,GO MEMBRANE BIOGENESIS,0.27821,-0.11647,-0.05474,0,0
5,GO SNARE COMPLEX ASSEMBLY,0.11524,-0.11664,-0.067081,0,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,0.23203,-0.11666,-0.032018,0,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.27821,-0.11689,-0.12776,0,0
5,GO CHROMOSOME CONDENSATION,0.14312,-0.11699,-0.20455,0,0
5,GO CEREBRAL CORTEX DEVELOPMENT,0.12273,-0.11743,-0.10177,0,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,0.28529,-0.11751,-0.078652,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.34626,-0.11777,-0.068448,0,0
5,GO REGULATION OF HORMONE SECRETION,0.15197,-0.11794,-0.048561,0,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.080256,-0.1181,-0.10391,0,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.32248,-0.11868,-0.073095,0,0
5,GO CELL PART MORPHOGENESIS,0.17091,-0.11877,-0.049774,0,0
5,GO LEYDIG CELL DIFFERENTIATION,0.70989,-0.11888,-0.023069,0,0
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.23203,-0.119,-0.11612,0,0
5,GO DORSAL VENTRAL PATTERN FORMATION,0.065157,-0.11904,-0.10032,0,0
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.25111,-0.11946,-0.060199,0,0
5,GO HEAD DEVELOPMENT,0.20256,-0.11958,-0.036104,0,0
5,GO REGULATION OF OOGENESIS,0.15197,-0.11968,-0.085898,0,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.067497,-0.11998,-0.11803,0,0
5,GO REGULATION OF EXOCYTOSIS,0.13885,-0.12032,-0.057869,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0063209,-0.12043,-0.1678,0,0
5,GO EPITHELIAL CELL MATURATION,0.1306,-0.12112,-0.11678,0,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.74555,-0.12212,0.0041217,0,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.12273,-0.1223,-0.12981,0,0
5,GO FOREBRAIN CELL MIGRATION,0.30724,-0.12271,-0.053844,0,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.08881,-0.12275,-0.12046,0,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,0.12273,-0.12278,-0.1535,0,0
5,GO COCHLEA DEVELOPMENT,0.21989,-0.12282,-0.070578,0,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.074935,-0.12304,-0.14194,0,0
5,GO TUBULIN DEACETYLATION,0.11524,-0.12337,-0.075799,0,0
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.030713,-0.12338,-0.13263,0,0
5,GO ANATOMICAL STRUCTURE REGRESSION,0.27126,-0.12346,-0.089855,0,0
5,GO CELL FATE SPECIFICATION,0.16602,-0.12386,-0.088747,0,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.065157,-0.12481,-0.11167,0,0
5,GO MITOCHONDRION LOCALIZATION,0.080256,-0.12502,-0.1028,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.12662,-0.12535,-0.078685,0,0
5,GO NEURON DEVELOPMENT,0.17091,-0.12541,-0.041353,0,0
5,GO DEVELOPMENTAL CELL GROWTH,0.25111,-0.12551,-0.041257,0,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.16602,-0.12622,-0.13543,0,0
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.23827,-0.12679,-0.080082,0,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.1475,-0.12731,-0.11688,0,0
5,GO NEUROTRANSMITTER UPTAKE,0.214,-0.12789,-0.062528,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,0.20256,-0.12797,-0.095229,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.080256,-0.1282,-0.097534,0,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.53179,-0.12845,-0.02388,0,0
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.062884,-0.129,-0.10862,0,0
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.21989,-0.12903,-0.039715,0,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.26442,-0.12914,-0.051754,0,0
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.052482,-0.12929,-0.13313,0,0
5,GO RESPONSE TO NERVE GROWTH FACTOR,0.074935,-0.12963,-0.070971,0,0
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.094909,-0.12963,-0.07281,0,0
5,GO REGULATION OF ORGANIC ACID TRANSPORT,0.42405,-0.13059,-0.04326,0,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.074935,-0.13075,-0.14756,0,0
5,GO RETROGRADE AXONAL TRANSPORT,0.23203,-0.13084,-0.10662,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.094909,-0.13092,-0.12784,0,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.15655,-0.1312,-0.15754,0,0
5,GO DENDRITE MORPHOGENESIS,0.11894,-0.13175,-0.096963,0,0
5,GO METENCEPHALON DEVELOPMENT,0.080256,-0.13219,-0.11563,0,0
5,GO KINETOCHORE ORGANIZATION,0.15655,-0.13253,-0.27721,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.13467,-0.13255,-0.074153,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0038653,-0.13272,-0.14346,0,0
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.1475,-0.13278,-0.14348,0,0
5,GO ANTEROGRADE AXONAL TRANSPORT,0.060677,-0.13285,-0.14779,0,0
5,GO LIMBIC SYSTEM DEVELOPMENT,0.14312,-0.13296,-0.058669,0,0
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.17591,-0.13329,-0.07514,0,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.10134,-0.13343,-0.098297,0,0
5,GO TOXIN METABOLIC PROCESS,0.70989,-0.13363,-0.023406,0,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.27126,-0.13366,-0.086088,0,0
5,GO PROTEIN DENEDDYLATION,0.10811,-0.13389,-0.074108,0,0
5,GO REGULATION OF TUBULIN DEACETYLATION,0.077559,-0.13436,-0.11015,0,0
5,GO PALLIUM DEVELOPMENT,0.10134,-0.13491,-0.08644,0,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.33029,-0.13491,-0.093598,0,0
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.14312,-0.13522,-0.062889,0,0
5,GO REGULATION OF INSULIN SECRETION,0.13885,-0.13554,-0.060071,0,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.16123,-0.13574,-0.092499,0,0
5,GO ACROSOME ASSEMBLY,0.30724,-0.13833,-0.057752,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.08881,-0.13855,-0.22434,0,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.062884,-0.13955,-0.15145,0,0
5,GO HORMONE TRANSPORT,0.08303,-0.13983,-0.066576,0,0
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.19156,-0.14032,-0.037141,0,0
5,GO HINDBRAIN DEVELOPMENT,0.21989,-0.14046,-0.055901,0,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.1306,-0.14101,-0.19134,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,0.33821,-0.14111,-0.1542,0,0
5,GO RESPONSE TO FOOD,0.058535,-0.14125,-0.14142,0,0
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.26442,-0.14251,-0.10912,0,0
5,GO PROTEIN KINASE C SIGNALING,0.47137,-0.14256,-0.0060068,0,0
5,GO PANCREAS DEVELOPMENT,0.17091,-0.14269,-0.057388,0,0
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.10811,-0.14288,-0.10066,0,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.10811,-0.14309,-0.075976,0,0
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.16602,-0.14355,-0.083006,0,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.15197,-0.14363,-0.12304,0,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.091819,-0.14481,-0.15857,0,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.08881,-0.14487,-0.10774,0,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,0.1475,-0.1455,-0.095663,0,0
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.10468,-0.14591,-0.14142,0,0
5,GO REGULATION OF CARDIAC CONDUCTION,0.27126,-0.14668,-0.043651,0,0
5,GO REGULATION OF CAMP MEDIATED SIGNALING,0.094909,-0.1469,-0.091597,0,0
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.25111,-0.14837,-0.068451,0,0
5,GO MICROTUBULE BUNDLE FORMATION,0.067497,-0.14961,-0.15671,0,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.13885,-0.14965,-0.091196,0,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.37964,-0.14967,-0.051397,0,0
5,GO NEURON RECOGNITION,0.10811,-0.15145,-0.12461,0,0
5,GO NEURON PROJECTION EXTENSION,0.18102,-0.15187,-0.059085,0,0
5,GO INTRACILIARY TRANSPORT,0.15655,-0.15188,-0.13832,0,0
5,GO REGULATION OF COLLATERAL SPROUTING,0.37111,-0.15198,-0.079811,0,0
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.24463,-0.15273,-0.062713,0,0
5,GO AXONEME ASSEMBLY,0.11524,-0.15326,-0.16877,0,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,0.10468,-0.1539,-0.096324,0,0
5,GO CARDIAC CONDUCTION,0.15655,-0.15497,-0.070346,0,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.197,-0.15519,-0.073001,0,0
5,GO FOREBRAIN DEVELOPMENT,0.12662,-0.15579,-0.064155,0,0
5,GO CEREBELLAR CORTEX FORMATION,0.10468,-0.15612,-0.12613,0,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.37111,-0.15623,-0.089054,0,0
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.08588,-0.15642,-0.11649,0,0
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.10811,-0.15674,-0.06521,0,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.214,-0.1569,-0.10326,0,0
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.052482,-0.15716,-0.17555,0,0
5,GO SUBPALLIUM DEVELOPMENT,0.12662,-0.15728,-0.12554,0,0
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.72171,-0.15888,-0.044032,0,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.10811,-0.15919,-0.15734,0,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.23827,-0.15953,-0.10734,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.02951,-0.15969,-0.17961,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.24463,-0.15999,-0.086776,0,0
5,GO MAINTENANCE OF CELL POLARITY,0.10811,-0.16478,-0.098207,0,0
5,GO NERVE DEVELOPMENT,0.08588,-0.16557,-0.13638,0,0
5,GO CELL JUNCTION MAINTENANCE,0.11524,-0.16621,-0.12574,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.49108,-0.16761,0.0069369,0,0
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.10811,-0.16802,-0.099069,0,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.077559,-0.16855,-0.20017,0,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.052482,-0.16864,-0.14599,0,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,0.18624,-0.16883,-0.080482,0,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.08303,-0.16955,-0.10094,0,0
5,GO NEURON MIGRATION,0.10134,-0.17039,-0.11959,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.25111,-0.17089,-0.094929,0,0
5,GO LONG TERM SYNAPTIC DEPRESSION,0.2259,-0.17099,-0.11421,0,0
5,GO NEURAL RETINA DEVELOPMENT,0.058535,-0.17231,-0.15315,0,0
5,GO HEART FIELD SPECIFICATION,0.25111,-0.17319,-0.1127,0,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.18624,-0.17385,-0.10361,0,0
5,GO COLLATERAL SPROUTING,0.3148,-0.17499,-0.071337,0,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.10811,-0.17651,-0.10686,0,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.091819,-0.17673,-0.079464,0,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.12662,-0.17753,-0.31222,0,0
5,GO AMINO ACID TRANSPORT,0.052482,-0.17883,-0.090066,0,0
5,GO CGMP MEDIATED SIGNALING,0.25111,-0.17933,-0.078364,0,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.19156,-0.1796,-0.12481,0,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.17091,-0.18008,-0.11774,0,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.052482,-0.18075,-0.21082,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.08881,-0.18225,-0.092268,0,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.11894,-0.18242,-0.14004,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.18624,-0.18323,-0.14291,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.39705,-0.18388,-0.038101,0,0
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.060677,-0.18441,-0.19954,0,0
5,GO SPINAL CORD DEVELOPMENT,0.11524,-0.18495,-0.12847,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.20822,-0.1858,-0.13316,0,0
5,GO CATECHOLAMINE METABOLIC PROCESS,0.043559,-0.18631,-0.14043,0,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.10811,-0.18838,-0.1338,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.080256,-0.18838,-0.18312,0,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.072385,-0.18922,-0.12356,0,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.08588,-0.18963,-0.16316,0,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,0.080256,-0.18987,-0.15423,0,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.050584,-0.19025,-0.11909,0,0
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.21989,-0.19048,-0.1048,0,0
5,GO RESPONSE TO NICOTINE,0.091819,-0.19121,-0.13386,0,0
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.15655,-0.19306,-0.14397,0,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.15197,-0.19376,-0.21005,0,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.098083,-0.1964,-0.15154,0,0
5,GO NEURON MATURATION,0.065157,-0.1979,-0.12822,0,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.098083,-0.1994,-0.14108,0,0
5,GO ADRENAL GLAND DEVELOPMENT,0.19156,-0.20104,-0.080866,0,0
5,GO MITOCHONDRION DISTRIBUTION,0.1306,-0.20126,-0.062286,0,0
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.27821,-0.20137,-0.073659,0,0
5,GO GLUTAMATE METABOLIC PROCESS,0.052482,-0.20289,-0.10997,0,0
5,GO NEURON CELLULAR HOMEOSTASIS,0.12662,-0.20389,-0.16365,0,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.12273,-0.20462,-0.23243,0,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.067497,-0.20552,-0.19971,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.034576,-0.20592,-0.13439,0,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.056456,-0.20822,-0.14484,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.84314,-0.20961,0.0042664,0,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.025096,-0.21243,-0.19362,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.10811,-0.21268,-0.12369,0,0
5,GO OLIGODENDROCYTE DEVELOPMENT,0.052482,-0.21288,-0.095715,0,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.30724,-0.21705,-0.074538,0,0
5,GO HYPOTHALAMUS DEVELOPMENT,0.11524,-0.22126,-0.11186,0,0
5,GO DETECTION OF TEMPERATURE STIMULUS,0.0034935,-0.22341,-0.23753,0,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.18102,-0.22369,-0.07838,0,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.080256,-0.22605,-0.13364,0,0
5,GO CELL MIGRATION IN HINDBRAIN,0.1306,-0.22916,-0.10376,0,0
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.13885,-0.23094,-0.11309,0,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.052482,-0.2312,-0.12394,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.13885,-0.23668,-0.16201,0,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.056456,-0.23897,-0.13959,0,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.050584,-0.23992,-0.22552,0,0
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.067497,-0.24138,-0.14727,0,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.067497,-0.24309,-0.20648,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.074935,-0.24332,-0.15778,0,0
5,GO OPTIC NERVE DEVELOPMENT,0.054439,-0.24432,-0.2505,0,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.058535,-0.25286,-0.16952,0,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.080256,-0.25407,-0.19525,0,0
5,GO REPRODUCTIVE BEHAVIOR,0.027226,-0.25522,-0.19962,0,0
5,GO GROOMING BEHAVIOR,0.00096503,-0.25869,-0.3359,0,0
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.074935,-0.26163,-0.15608,0,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.36271,-0.26181,-0.093368,0,0
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0080134,-0.26416,-0.21858,0,0
5,GO SUCKLING BEHAVIOR,0.0063209,-0.27202,-0.24614,0,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.13467,-0.27911,-0.21607,0,0
5,GO TRIGEMINAL NERVE DEVELOPMENT,0.065157,-0.28597,-0.25555,0,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.12273,-0.28968,-0.18433,0,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.11163,-0.29033,-0.17506,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.08588,-0.29783,-0.20647,0,0
5,GO DIENCEPHALON DEVELOPMENT,0.01266,-0.30655,-0.19696,0,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,0.077559,-0.31345,-0.22291,0,0
5,GO NOREPINEPHRINE SECRETION,0.054439,-0.31913,-0.21369,0,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.12662,-0.32019,-0.15715,0,0
5,GO PARENTAL BEHAVIOR,0.010572,-0.32448,-0.36113,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.062884,-0.32647,-0.24281,0,0
5,GO GANGLION DEVELOPMENT,0.0172,-0.33287,-0.3012,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.008797,-0.33631,-0.28684,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.1306,-0.34424,-0.16162,0,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.0017696,-0.40185,-0.34933,0,0
5,GO REGULATION OF RELAXATION OF MUSCLE,0.050584,-0.40794,-0.25767,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.0054671,-0.42442,-0.27059,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.050584,-0.42915,-0.24972,0,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.012106,-0.48842,-0.39948,0,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00096503,-0.61102,-0.5019,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.0015041,-0.69161,-0.5144,0,0
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.023112,-0.74283,-0.40958,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.00076864,-0.82073,-0.70493,0,0
6,GO NATURAL KILLER CELL CHEMOTAXIS,0.00086166,1.1928,0.95197,1,1
6,GO REGULATION OF T CELL TOLERANCE INDUCTION,0.0017696,0.93552,0.80544,1,1
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0011418,0.93216,0.9212,1,1
6,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00054254,0.91742,0.92058,1,1
6,GO T CELL TOLERANCE INDUCTION,0.0028457,0.85507,0.72141,1,1
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00054254,0.83541,0.79509,1,1
6,GO EOSINOPHIL MIGRATION,0.00026348,0.83429,0.73977,1,1
6,GO TOLERANCE INDUCTION,0.0014241,0.81154,0.75442,1,1
6,GO REGULATION OF TOLERANCE INDUCTION,0.0014241,0.80737,0.74338,1,1
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0019699,0.79525,0.7033,1,1
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,8.9327e-05,0.79175,0.7796,1,1
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00045436,0.76134,0.79569,1,1
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0010209,0.74979,0.7088,1,1
6,GO LYMPHOCYTE CHEMOTAXIS,0.0011418,0.74852,0.6213,1,1
6,GO CHRONIC INFLAMMATORY RESPONSE,0.0019699,0.74687,0.6721,1,1
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00068502,0.72649,0.75018,1,1
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00035748,0.72267,0.67419,1,1
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00015974,0.69823,0.72311,1,1
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.4947e-05,0.69313,0.73708,1,1
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00023283,0.6923,0.64299,1,1
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0017696,0.69056,0.59799,1,1
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0010209,0.68945,0.63681,1,1
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00033648,0.68923,0.68657,1,1
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020554,0.68655,0.62972,1,1
6,GO MONOCYTE CHEMOTAXIS,0.00081392,0.68296,0.61321,1,1
6,GO CYTOLYSIS,0.0015041,0.68099,0.62353,1,1
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00091199,0.67066,0.5656,1,1
6,GO OPSONIZATION,0.0023095,0.67009,0.49287,1,1
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.00031664,0.66251,0.61201,1,1
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.0019699,0.66062,0.61891,1,1
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00060992,0.65572,0.59886,1,1
6,GO NEUTROPHIL CHEMOTAXIS,0.00081392,0.65519,0.55555,1,1
6,GO INTERLEUKIN 10 PRODUCTION,0.00086166,0.64899,0.55994,1,1
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.00332,0.64854,0.5396,1,1
6,GO DENDRITIC CELL CHEMOTAXIS,0.0010209,0.64849,0.65556,1,1
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00020554,0.64752,0.6259,1,1
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0025648,0.64361,0.63696,1,1
6,GO CELLULAR DEFENSE RESPONSE,0.00051151,0.64349,0.62444,1,1
6,GO NEUTROPHIL MIGRATION,0.00091199,0.63646,0.53397,1,1
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00020554,0.63587,0.64594,1,1
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.0040644,0.63323,0.60973,1,1
6,GO ADHESION OF SYMBIONT TO HOST,0.0015882,0.6221,0.60019,1,1
6,GO DENDRITIC CELL MIGRATION,0.00091199,0.61191,0.62269,1,1
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00048214,0.61174,0.54283,1,1
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0011418,0.6112,0.59546,1,1
6,GO POSITIVE REGULATION OF T CELL MIGRATION,0.00051151,0.60904,0.5801,1,1
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00042807,0.60836,0.53132,1,1
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0013481,0.59287,0.55213,1,1
6,GO PLASMINOGEN ACTIVATION,0.00026348,0.59221,0.51744,1,1
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0010209,0.59126,0.58065,1,1
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00031664,0.59071,0.53659,1,1
6,GO LYMPHOCYTE MIGRATION,0.0010209,0.59008,0.54757,1,1
6,GO REGULATION OF T CELL CHEMOTAXIS,0.00076864,0.59008,0.58142,1,1
6,GO INFLAMMATORY RESPONSE TO WOUNDING,0.0012758,0.58851,0.53342,1,1
6,GO RESPONSE TO CHEMOKINE,0.0021907,0.58701,0.52736,1,1
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00048214,0.58697,0.53829,1,1
6,GO CYCLOOXYGENASE PATHWAY,0.00026348,0.58601,0.60198,1,1
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00040321,0.58472,0.60245,1,1
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00086166,0.58317,0.58943,1,1
6,GO INTERLEUKIN 12 PRODUCTION,0.00072571,0.58264,0.56744,1,1
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.00048214,0.58207,0.54711,1,1
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00026348,0.57952,0.56116,1,1
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00035748,0.57852,0.53969,1,1
6,GO MONONUCLEAR CELL MIGRATION,0.00096503,0.5744,0.5382,1,1
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.00054254,0.57408,0.5391,1,1
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00064645,0.57239,0.49395,1,1
6,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00040321,0.57116,0.58353,1,1
6,GO GRANULOCYTE MIGRATION,0.00060992,0.56816,0.51555,1,1
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0029965,0.56524,0.48254,1,1
6,GO GRANULOCYTE CHEMOTAXIS,0.00081392,0.5648,0.52692,1,1
6,GO REGULATION OF MYOBLAST FUSION,0.00048214,0.56397,0.54736,1,1
6,GO NK T CELL DIFFERENTIATION,0.0011418,0.56371,0.52046,1,1
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0018673,0.56307,0.51939,1,1
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00072571,0.56008,0.51803,1,1
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0024341,0.55634,0.46234,1,1
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.9985e-05,0.55629,0.55928,1,1
6,GO T CELL MIGRATION,0.00091199,0.5525,0.57338,1,1
6,GO FIBRINOLYSIS,0.00051151,0.55065,0.49333,1,1
6,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00011593,0.54997,0.62158,1,1
6,GO RESPONSE TO INTERLEUKIN 15,0.0010798,0.54315,0.58213,1,1
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00045436,0.54306,0.47062,1,1
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00051151,0.54293,0.56016,1,1
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00072571,0.54269,0.51719,1,1
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.0027019,0.54189,0.48288,1,1
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0016767,0.53366,0.53717,1,1
6,GO REGULATION OF B CELL PROLIFERATION,0.00086166,0.53326,0.54982,1,1
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00064645,0.53268,0.50435,1,1
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00068502,0.53129,0.54055,1,1
6,GO T CELL CYTOKINE PRODUCTION,0.0015041,0.53013,0.47667,1,1
6,GO REGULATION OF PLATELET ACTIVATION,0.00019306,0.52938,0.53396,1,1
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00096503,0.52785,0.55301,1,1
6,GO CELL ADHESION MEDIATED BY INTEGRIN,8.9327e-05,0.52754,0.56491,1,1
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0023095,0.526,0.5229,1,1
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00040321,0.52567,0.51493,1,1
6,GO POSITIVE REGULATION OF CELL KILLING,0.0010798,0.52378,0.50131,1,1
6,GO GLYCINE TRANSPORT,0.0047188,0.52275,0.38788,1,1
6,GO NAD BIOSYNTHETIC PROCESS,0.00035748,0.52233,0.42167,1,1
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0034935,0.51537,0.50386,1,1
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00026348,0.51165,0.51258,1,1
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00096503,0.50978,0.58763,1,1
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0015882,0.50886,0.4951,1,1
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00024771,0.50885,0.50852,1,1
6,GO RESPIRATORY BURST,0.00086166,0.50863,0.48826,1,1
6,GO MAST CELL ACTIVATION,0.00057531,0.50554,0.44107,1,1
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00057531,0.50425,0.51382,1,1
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.0012758,0.50143,0.48515,1,1
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,6.8565e-05,0.50121,0.56666,1,1
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0020776,0.50101,0.41785,1,1
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0013481,0.49909,0.49409,1,1
6,GO REGULATION OF T CELL MIGRATION,0.00031664,0.49795,0.50873,1,1
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00081392,0.49159,0.46977,1,1
6,GO B CELL PROLIFERATION,0.00072571,0.49016,0.56532,1,1
6,GO HISTAMINE SECRETION,0.00057531,0.48776,0.44018,1,1
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00081392,0.48726,0.50247,1,1
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00021879,0.48666,0.56876,1,1
6,GO MATURE B CELL DIFFERENTIATION,0.0012071,0.48559,0.53757,1,1
6,GO MYELOID LEUKOCYTE MIGRATION,0.00051151,0.48449,0.46996,1,1
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00086166,0.48357,0.49245,1,1
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.00076864,0.48333,0.48532,1,1
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0010798,0.48314,0.46835,1,1
6,GO VASCULAR WOUND HEALING,0.00018128,0.48203,0.44515,1,1
6,GO DEFENSE RESPONSE TO FUNGUS,0.00017019,0.4811,0.45634,1,1
6,GO REGULATION OF LEUKOCYTE TETHERING OR ROLLING,0.0010209,0.47913,0.54662,1,1
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0023095,0.47835,0.49374,1,1
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0023095,0.47094,0.41898,1,1
6,GO MAST CELL MEDIATED IMMUNITY,0.00081392,0.47046,0.43254,1,1
6,GO T CELL LINEAGE COMMITMENT,0.0012758,0.46922,0.43303,1,1
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0021907,0.46843,0.44179,1,1
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00072571,0.46801,0.43075,1,1
6,GO LEUKOCYTE TETHERING OR ROLLING,0.0003797,0.46704,0.51061,1,1
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00076864,0.4661,0.44394,1,1
6,GO HUMORAL IMMUNE RESPONSE,0.00042807,0.46598,0.49301,1,1
6,GO LEUKOCYTE CHEMOTAXIS,0.00054254,0.46592,0.48296,1,1
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00010866,0.46491,0.4882,1,1
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00068502,0.4644,0.44717,1,1
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0019699,0.46425,0.46258,1,1
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0038653,0.46356,0.37801,1,1
6,GO RESPONSE TO FUNGUS,0.00012367,0.45682,0.44236,1,1
6,GO LYMPH NODE DEVELOPMENT,0.0010798,0.45606,0.46073,1,1
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00064645,0.45338,0.5656,1,1
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0017696,0.45321,0.37741,1,1
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0012758,0.45255,0.41625,1,1
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00045436,0.45165,0.51423,1,1
6,GO INTERLEUKIN 8 PRODUCTION,0.0010798,0.4512,0.43914,1,1
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00076864,0.45119,0.45219,1,1
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00068502,0.44763,0.4261,1,1
6,GO NEGATIVE REGULATION OF COAGULATION,0.00040321,0.44709,0.42212,1,1
6,GO INTEGRIN ACTIVATION,0.0010798,0.44676,0.51254,1,1
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.011063,0.44424,0.40161,1,1
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012758,0.44187,0.42343,1,1
6,GO REGULATION OF MAST CELL ACTIVATION,0.0015882,0.44178,0.40301,1,1
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00054254,0.43834,0.45408,1,1
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.00020554,0.43805,0.46196,1,1
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00064645,0.43715,0.48579,1,1
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00054254,0.43684,0.50987,1,1
6,GO ELASTIC FIBER ASSEMBLY,0.011574,0.43651,0.45987,1,1
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0020776,0.4332,0.42028,1,1
6,GO CYTIDINE TO URIDINE EDITING,0.0096484,0.43144,0.35901,1,1
6,GO ACUTE INFLAMMATORY RESPONSE,0.00051151,0.42941,0.42124,1,1
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00091199,0.42807,0.4526,1,1
6,GO BLEB ASSEMBLY,0.0047188,0.42641,0.37874,1,1
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0016767,0.42184,0.42527,1,1
6,GO REGULATION OF COAGULATION,0.00021879,0.42044,0.40984,1,1
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00091199,0.41745,0.43115,1,1
6,GO LABYRINTHINE LAYER MORPHOGENESIS,0.00054254,0.41649,0.41919,1,1
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00064645,0.41646,0.40349,1,1
6,GO NEGATIVE REGULATION OF ANOIKIS,0.0018673,0.41619,0.39835,1,1
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0040644,0.41472,0.4135,1,1
6,GO REGULATION OF PLATELET AGGREGATION,0.00031664,0.4127,0.43089,1,1
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00068502,0.41236,0.4343,1,1
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00057531,0.41041,0.39984,1,1
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.00011593,0.41023,0.46433,1,1
6,GO POSITIVE REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00045436,0.40807,0.42734,1,1
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,6.4139e-05,0.40797,0.42383,1,1
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0014241,0.40777,0.37662,1,1
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00054254,0.40769,0.42105,1,1
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0010798,0.40716,0.43949,1,1
6,GO CELL CHEMOTAXIS,0.00035748,0.40555,0.44224,1,1
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.022172,0.4023,0.26035,1,1
6,GO DEFENSE RESPONSE TO BACTERIUM,0.0003797,0.40198,0.40356,1,1
6,GO ACUTE PHASE RESPONSE,0.0011418,0.40154,0.4095,1,1
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0028457,0.40089,0.4318,1,1
6,GO ZYMOGEN INHIBITION,0.00068502,0.39954,0.44619,1,1
6,GO PROTEIN ACTIVATION CASCADE,0.0016767,0.39885,0.43765,1,1
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00035748,0.39711,0.42394,1,1
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00091199,0.39701,0.38076,1,1
6,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00033648,0.39667,0.41942,1,1
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00048214,0.39356,0.36253,1,1
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.00072571,0.39343,0.36384,1,1
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0010798,0.39323,0.37689,1,1
6,GO LIVER MORPHOGENESIS,0.0011418,0.39064,0.35624,1,1
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0016767,0.38737,0.45028,1,1
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00028019,0.38723,0.38214,1,1
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0015882,0.3868,0.42512,1,1
6,GO HISTAMINE TRANSPORT,0.00076864,0.38275,0.40466,1,1
6,GO INTESTINAL ABSORPTION,0.00035748,0.38236,0.4161,1,1
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00081392,0.38159,0.45916,1,1
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00057531,0.37963,0.35057,1,1
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0015041,0.37946,0.39222,1,1
6,GO PLATELET DEGRANULATION,0.00010866,0.37808,0.41347,1,1
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.033245,0.37773,0.33723,1,1
6,GO REGULATION OF INTEGRIN ACTIVATION,0.0012758,0.3763,0.43271,1,1
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.00072571,0.37403,0.41778,1,1
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0023095,0.37038,0.38773,1,1
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0021907,0.37016,0.37156,1,1
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.00021879,0.36934,0.35272,1,1
6,GO KERATAN SULFATE CATABOLIC PROCESS,0.0011418,0.36927,0.49087,1,1
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0083971,0.36802,0.30392,1,1
6,GO REGULATION OF STEM CELL DIVISION,0.0038653,0.36707,0.36633,1,1
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0011418,0.3664,0.38523,1,1
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00057531,0.36611,0.34737,1,1
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00060992,0.36059,0.37621,1,1
6,GO REGULATION OF BONE DEVELOPMENT,0.00054254,0.36055,0.45355,1,1
6,GO REGULATION OF BONE REMODELING,0.0003797,0.35694,0.39305,1,1
6,GO HETEROTYPIC CELL CELL ADHESION,0.00042807,0.35568,0.39438,1,1
6,GO REGULATION OF TISSUE REMODELING,0.00040321,0.35478,0.38245,1,1
6,GO RESPONSE TO INTERLEUKIN 6,0.00072571,0.35444,0.40678,1,1
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0023095,0.35389,0.36691,1,1
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0010798,0.35165,0.34103,1,1
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0010798,0.3503,0.35853,1,1
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0031545,0.34964,0.3496,1,1
6,GO RESPONSE TO THYROID HORMONE,0.00029789,0.34949,0.33665,1,1
6,GO REGULATION OF WOUND HEALING,0.00051151,0.34947,0.3282,1,1
6,GO VITAMIN BIOSYNTHETIC PROCESS,0.00023283,0.34899,0.41251,1,1
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0012758,0.34868,0.40958,1,1
6,GO POSITIVE REGULATION OF WOUND HEALING,0.00035748,0.34723,0.34276,1,1
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0080134,0.34584,0.34255,1,1
6,GO MYELOID LEUKOCYTE ACTIVATION,0.00064645,0.34577,0.37571,1,1
6,GO LIPOXYGENASE PATHWAY,0.0027019,0.34471,0.37913,1,1
6,GO CHOLESTEROL STORAGE,0.0027019,0.34403,0.34966,1,1
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0057394,0.3435,0.32547,1,1
6,GO IMMUNOLOGICAL MEMORY PROCESS,0.0015882,0.34296,0.34968,1,1
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0018673,0.34283,0.35657,1,1
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0019699,0.34249,0.3451,1,1
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00035748,0.34215,0.40941,1,1
6,GO PLATELET ACTIVATION,0.0016767,0.34213,0.32767,1,1
6,GO PROSTANOID METABOLIC PROCESS,0.0017696,0.34095,0.29646,1,1
6,GO NEGATIVE REGULATION OF WOUND HEALING,0.0020776,0.34074,0.31357,1,1
6,GO REGULATION OF INFLAMMATORY RESPONSE,0.00076864,0.34024,0.37557,1,1
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0016767,0.33985,0.36049,1,1
6,GO STEROID CATABOLIC PROCESS,0.00021879,0.33971,0.35696,1,1
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.0034935,0.33719,0.346,1,1
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00035748,0.33697,0.35145,1,1
6,GO POSITIVE REGULATION OF COAGULATION,0.00048214,0.33667,0.36196,1,1
6,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0020776,0.33647,0.36874,1,1
6,GO TRABECULA FORMATION,0.0047188,0.33407,0.30459,1,1
6,GO RELAXATION OF CARDIAC MUSCLE,0.0013481,0.33388,0.32531,1,1
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00081392,0.33367,0.35345,1,1
6,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0010209,0.33353,0.32798,1,1
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.011574,0.33254,0.32776,1,1
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0054671,0.33103,0.32753,1,1
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00023283,0.33079,0.35718,1,1
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0018673,0.32897,0.32086,1,1
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.0024341,0.32867,0.32996,1,1
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0010209,0.32846,0.33934,1,1
6,GO GLYCOLIPID CATABOLIC PROCESS,0.00060992,0.32817,0.39566,1,1
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0031545,0.3277,0.3683,1,1
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00068502,0.32493,0.28251,1,1
6,GO LUTEINIZATION,0.0060238,0.32459,0.30865,1,1
6,GO PLATELET AGGREGATION,0.0015882,0.32413,0.34168,1,1
6,GO BLOOD VESSEL REMODELING,0.0031545,0.32385,0.35034,1,1
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00054254,0.32352,0.34731,1,1
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0020776,0.32346,0.3272,1,1
6,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00015974,0.32218,0.35133,1,1
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.019548,0.32208,0.28853,1,1
6,GO B CELL HOMEOSTASIS,0.0034935,0.32183,0.33392,1,1
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.017954,0.32134,0.31905,1,1
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.006955,0.32127,0.39407,1,1
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00029789,0.31788,0.30735,1,1
6,GO HYALURONAN CATABOLIC PROCESS,0.00096503,0.31753,0.33528,1,1
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0027019,0.3172,0.29857,1,1
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.046961,0.3172,0.27929,1,1
6,GO HOMOTYPIC CELL CELL ADHESION,0.00081392,0.31697,0.33444,1,1
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00060992,0.3163,0.39486,1,1
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00086166,0.31609,0.33645,1,1
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00048214,0.31576,0.36584,1,1
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0013481,0.3157,0.27595,1,1
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00072571,0.31547,0.39829,1,1
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00081392,0.31468,0.36583,1,1
6,GO PHAGOLYSOSOME ASSEMBLY,0.00031664,0.31309,0.35762,1,1
6,GO REGULATION OF RESPIRATORY BURST,0.00057531,0.31255,0.33107,1,1
6,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0042727,0.31153,0.31102,1,1
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.0042727,0.30986,0.31699,1,1
6,GO POSITIVE REGULATION OF BONE RESORPTION,0.0016767,0.30939,0.32283,1,1
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00026348,0.30919,0.37099,1,1
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0003797,0.30889,0.30473,1,1
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0012071,0.3086,0.4175,1,1
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0028457,0.30675,0.29408,1,1
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.0066311,0.30611,0.31921,1,1
6,GO MYOBLAST FUSION,0.0011418,0.30534,0.37935,1,1
6,GO MAST CELL MIGRATION,0.0012071,0.3044,0.3399,1,1
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00057531,0.30416,0.37057,1,1
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00072571,0.3041,0.35082,1,1
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0023095,0.30409,0.33211,1,1
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00096503,0.30316,0.32309,1,1
6,GO DNA DEAMINATION,0.015776,0.30316,0.23924,1,1
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0036751,0.30285,0.30968,1,1
6,GO LYSOSOME LOCALIZATION,0.0031545,0.30202,0.26894,1,1
6,GO GALACTOSE METABOLIC PROCESS,0.00029789,0.30155,0.39901,1,1
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0017696,0.30153,0.38468,1,1
6,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0021907,0.30144,0.38839,1,1
6,GO ADRENAL GLAND DEVELOPMENT,0.0052065,0.30043,0.32808,1,1
6,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0003797,0.29905,0.34311,1,1
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0010798,0.29888,0.29893,1,1
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0042727,0.2988,0.36722,1,1
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00035748,0.29849,0.4328,1,1
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0172,0.29835,0.29126,1,1
6,GO CELL ADHESION MOLECULE PRODUCTION,0.010572,0.29624,0.32009,1,1
6,GO BONE RESORPTION,0.00060992,0.29613,0.37516,1,1
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0049572,0.29441,0.25341,1,1
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0042727,0.29402,0.26897,1,1
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.023112,0.29349,0.27003,1,1
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0015882,0.29268,0.3377,1,1
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00060992,0.29241,0.3069,1,1
6,GO COPPER ION TRANSPORT,0.00011593,0.29238,0.35765,1,1
6,GO INTESTINAL LIPID ABSORPTION,0.008797,0.29235,0.29509,1,1
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00023283,0.29173,0.33953,1,1
6,GO REGULATION OF VASCULOGENESIS,0.008797,0.29156,0.27608,1,1
6,GO STORE OPERATED CALCIUM ENTRY,0.01266,0.29113,0.26493,1,1
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.0010209,0.29081,0.35006,1,1
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0016767,0.29072,0.36358,1,1
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.006955,0.2906,0.24409,1,1
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00064645,0.2898,0.32443,1,1
6,GO REGULATION OF LIPASE ACTIVITY,0.0060238,0.28958,0.24489,1,1
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.023112,0.28844,0.30361,1,1
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0025648,0.28841,0.25576,1,1
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00072571,0.28827,0.28256,1,1
6,GO COLLAGEN BIOSYNTHETIC PROCESS,0.01266,0.28687,0.34105,1,1
6,GO TISSUE REMODELING,0.00072571,0.28674,0.36478,1,1
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0016767,0.28673,0.33421,1,1
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0029965,0.28658,0.30446,1,1
6,GO OSTEOBLAST PROLIFERATION,0.00091199,0.28583,0.33874,1,1
6,GO FATTY ACID DERIVATIVE TRANSPORT,0.00091199,0.28496,0.31066,1,1
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.007293,0.28433,0.26475,1,1
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.008797,0.28409,0.30029,1,1
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.00068502,0.2839,0.32991,1,1
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0042727,0.28214,0.30431,1,1
6,GO PROSTAGLANDIN SECRETION,0.0013481,0.28171,0.35268,1,1
6,GO TONIC SMOOTH MUSCLE CONTRACTION,0.027226,0.28069,0.23098,1,1
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0036751,0.28036,0.3184,1,1
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.037377,0.27965,0.25847,1,1
6,GO REGULATION OF ANOIKIS,0.0044907,0.27869,0.31164,1,1
6,GO RESPONSE TO MAGNESIUM ION,0.00332,0.27849,0.33909,1,1
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0014241,0.27828,0.28383,1,1
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.024086,0.278,0.24328,1,1
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0044907,0.2777,0.31411,1,1
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00031664,0.2775,0.31385,1,1
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00064645,0.27678,0.3167,1,1
6,GO P38MAPK CASCADE,0.0057394,0.27621,0.28447,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0020776,0.27607,0.24769,1,1
6,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00091199,0.27604,0.3683,1,1
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.0066311,0.27168,0.24923,1,1
6,GO HEPATOCYTE APOPTOTIC PROCESS,0.0011418,0.27153,0.26729,1,1
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00045436,0.27125,0.32906,1,1
6,GO PHOSPHATE ION TRANSPORT,0.0024341,0.27055,0.28829,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0047188,0.27022,0.29585,1,1
6,GO REGULATION OF RESPONSE TO WOUNDING,0.0016767,0.26982,0.27361,1,1
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0060238,0.26971,0.26154,1,1
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00332,0.26953,0.32443,1,1
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0054671,0.26946,0.31391,1,1
6,GO SIGNAL PEPTIDE PROCESSING,0.00035748,0.26781,0.31018,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.010572,0.26776,0.31836,1,1
6,GO GLYCOPROTEIN CATABOLIC PROCESS,0.0017696,0.2671,0.29656,1,1
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.015104,0.26639,0.22643,1,1
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0052065,0.26608,0.31202,1,1
6,GO HORMONE CATABOLIC PROCESS,0.0052065,0.26604,0.23891,1,1
6,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0040644,0.2643,0.28394,1,1
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.010101,0.26427,0.25624,1,1
6,GO PEPTIDYL PROLINE HYDROXYLATION,0.0054671,0.26364,0.2901,1,1
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.0036751,0.26357,0.24814,1,1
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0057394,0.26351,0.3221,1,1
6,GO PULMONARY VALVE DEVELOPMENT,0.031957,0.26059,0.24456,1,1
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0066311,0.26017,0.30923,1,1
6,GO PYROPTOSIS,0.011574,0.25997,0.28281,1,1
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0031545,0.25945,0.27748,1,1
6,GO REGULATION OF CELL ADHESION,0.0012071,0.2594,0.32786,1,1
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00060992,0.25909,0.32049,1,1
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0019699,0.25883,0.32093,1,1
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0049572,0.25877,0.24679,1,1
6,GO TRABECULA MORPHOGENESIS,0.019548,0.2586,0.24696,1,1
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.0092139,0.25847,0.26887,1,1
6,GO PROTEIN HYDROXYLATION,0.0044907,0.25815,0.27325,1,1
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.011574,0.25797,0.2889,1,1
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0024341,0.25742,0.28402,1,1
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.016475,0.25629,0.2773,1,1
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.011063,0.25577,0.27686,1,1
6,GO CELLULAR RESPONSE TO DSRNA,0.0052065,0.25557,0.27524,1,1
6,GO RESPONSE TO ANGIOTENSIN,0.0042727,0.25482,0.27033,1,1
6,GO REGULATION OF METANEPHROS DEVELOPMENT,0.022172,0.2543,0.27447,1,1
6,GO COLLAGEN FIBRIL ORGANIZATION,0.016475,0.25423,0.39354,1,1
6,GO PROTEIN DEGLYCOSYLATION,0.007293,0.25405,0.26714,1,1
6,GO TRIGLYCERIDE CATABOLIC PROCESS,0.01266,0.25153,0.20371,1,1
6,GO ARACHIDONIC ACID SECRETION,0.0012071,0.25101,0.26807,1,1
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0076456,0.25095,0.24189,1,1
6,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0016767,0.25029,0.26572,1,1
6,GO CELL REDOX HOMEOSTASIS,0.00021879,0.24895,0.27718,1,1
6,GO HEART INDUCTION,0.02951,0.24846,0.24771,1,1
6,GO RESPONSE TO IRON ION,0.0044907,0.24801,0.23138,1,1
6,GO SEMI LUNAR VALVE DEVELOPMENT,0.028348,0.24695,0.26356,1,1
6,GO STEROID HORMONE SECRETION,0.027226,0.24663,0.1954,1,1
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00048214,0.24644,0.32381,1,1
6,GO RESPONSE TO DIETARY EXCESS,0.0042727,0.24643,0.24183,1,1
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0012758,0.24624,0.26654,1,1
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014241,0.24495,0.27534,1,1
6,GO AMINE BIOSYNTHETIC PROCESS,0.00033648,0.24469,0.27995,1,1
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0054671,0.24419,0.28913,1,1
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0044907,0.24375,0.23223,1,1
6,GO BONE TRABECULA MORPHOGENESIS,0.034576,0.24272,0.33094,1,1
6,GO CELL CELL RECOGNITION,0.00031664,0.24257,0.25295,1,1
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0012758,0.24189,0.24264,1,1
6,GO KERATAN SULFATE METABOLIC PROCESS,0.0038653,0.2418,0.30337,1,1
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.01266,0.24148,0.24222,1,1
6,GO ANDROGEN METABOLIC PROCESS,0.0066311,0.24082,0.21411,1,1
6,GO RESPONSE TO MANGANESE ION,0.0017696,0.24046,0.26166,1,1
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0023095,0.24018,0.29439,1,1
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.015776,0.24005,0.34745,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00018128,0.23906,0.29082,1,1
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0063209,0.23886,0.27274,1,1
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.010101,0.23861,0.24339,1,1
6,GO MYELIN MAINTENANCE,0.0060238,0.23839,0.28673,1,1
6,GO ENDOTHELIAL CELL MIGRATION,0.0083971,0.23838,0.24349,1,1
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0054671,0.23827,0.24517,1,1
6,GO PANCREATIC JUICE SECRETION,0.0092139,0.23804,0.2422,1,1
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0057394,0.23801,0.23216,1,1
6,GO SEQUESTERING OF CALCIUM ION,0.0011418,0.23786,0.29915,1,1
6,GO REGULATION OF BONE MINERALIZATION,0.0047188,0.2375,0.29065,1,1
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0021907,0.23702,0.27564,1,1
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.0010798,0.2366,0.33324,1,1
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0080134,0.23607,0.24683,1,1
6,GO RESPONSE TO LITHIUM ION,0.00081392,0.23584,0.27057,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0092139,0.23502,0.24886,1,1
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0066311,0.23437,0.20672,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0049572,0.23409,0.23974,1,1
6,GO CELL MATRIX ADHESION,0.011063,0.23331,0.26705,1,1
6,GO LUNG ALVEOLUS DEVELOPMENT,0.0025648,0.23322,0.29256,1,1
6,GO RESPONSE TO EPINEPHRINE,0.017954,0.2322,0.21916,1,1
6,GO BONE CELL DEVELOPMENT,0.0083971,0.23151,0.30094,1,1
6,GO REGULATION OF ICOSANOID SECRETION,0.00064645,0.23102,0.28409,1,1
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0042727,0.23099,0.25046,1,1
6,GO O GLYCAN PROCESSING,0.013235,0.23073,0.21711,1,1
6,GO PROTEIN NITROSYLATION,0.0029965,0.22972,0.25023,1,1
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.019548,0.22937,0.23201,1,1
6,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0052065,0.22925,0.2412,1,1
6,GO BONE MINERALIZATION,0.0027019,0.2287,0.26827,1,1
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.011063,0.22832,0.23877,1,1
6,GO REGULATION OF NUCLEASE ACTIVITY,0.0096484,0.2281,0.19974,1,1
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0083971,0.22778,0.24022,1,1
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.030713,0.22774,0.22124,1,1
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.025096,0.22766,0.25964,1,1
6,GO RUFFLE ORGANIZATION,0.00332,0.22747,0.26417,1,1
6,GO CELLULAR RESPONSE TO X RAY,0.026142,0.22711,0.22728,1,1
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.013834,0.22672,0.21862,1,1
6,GO AMINO ACID IMPORT,0.0010798,0.22647,0.25549,1,1
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0017696,0.22597,0.30043,1,1
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0052065,0.22582,0.25542,1,1
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.041938,0.22563,0.22891,1,1
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.018736,0.22524,0.24409,1,1
6,GO RELAXATION OF MUSCLE,0.0066311,0.22415,0.21046,1,1
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0018673,0.2235,0.24955,1,1
6,GO PROTEIN DEMANNOSYLATION,0.007293,0.22316,0.27269,1,1
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00057531,0.22301,0.29809,1,1
6,GO LIPID EXPORT FROM CELL,0.0020776,0.22279,0.24236,1,1
6,GO ENDOCRINE PROCESS,0.0052065,0.2221,0.22487,1,1
6,GO PEPTIDYL TYROSINE MODIFICATION,0.0047188,0.22205,0.25961,1,1
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0010798,0.2218,0.25737,1,1
6,GO EXOCYTOSIS,0.00048214,0.22147,0.26696,1,1
6,GO REGULATION OF FATTY ACID TRANSPORT,0.00096503,0.2214,0.27938,1,1
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.016475,0.22139,0.25629,1,1
6,GO BARBED END ACTIN FILAMENT CAPPING,0.010572,0.22083,0.25725,1,1
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0015041,0.2208,0.30926,1,1
6,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00024771,0.21932,0.2323,1,1
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.015776,0.21887,0.19384,1,1
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0080134,0.21862,0.27621,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.019548,0.21862,0.2439,1,1
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0024341,0.21848,0.27004,1,1
6,GO LABYRINTHINE LAYER DEVELOPMENT,0.0044907,0.21846,0.23445,1,1
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00332,0.21844,0.23011,1,1
6,GO REGULATION OF CELL MATRIX ADHESION,0.007293,0.21834,0.26636,1,1
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0172,0.21832,0.21823,1,1
6,GO TISSUE MIGRATION,0.013235,0.21792,0.22577,1,1
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00019306,0.21774,0.24063,1,1
6,GO RESPONSE TO MUSCLE STRETCH,0.013834,0.2173,0.24867,1,1
6,GO RETINAL METABOLIC PROCESS,0.025096,0.21664,0.25784,1,1
6,GO PHOSPHOLIPID TRANSPORT,0.013834,0.21647,0.20862,1,1
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.018736,0.21587,0.22474,1,1
6,GO RESPONSE TO DEXAMETHASONE,0.0027019,0.21549,0.22732,1,1
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0021907,0.21488,0.25216,1,1
6,GO TOXIN METABOLIC PROCESS,0.0025648,0.21447,0.24958,1,1
6,GO DOPAMINE METABOLIC PROCESS,0.018736,0.2138,0.21297,1,1
6,GO EPIBOLY,0.00332,0.21298,0.28629,1,1
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0044907,0.21272,0.21454,1,1
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00024771,0.2127,0.29033,1,1
6,GO GLOMERULUS DEVELOPMENT,0.026142,0.21222,0.26382,1,1
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.010101,0.21215,0.22984,1,1
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0044907,0.21136,0.25514,1,1
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.033245,0.21116,0.22254,1,1
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00013188,0.21003,0.2725,1,1
6,GO RESPONSE TO MECHANICAL STIMULUS,0.0015882,0.20963,0.26193,1,1
6,GO VASODILATION,0.00064645,0.20803,0.25738,1,1
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.018736,0.208,0.19164,1,1
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00096503,0.20728,0.23015,1,1
6,GO INTRACELLULAR STEROL TRANSPORT,0.010101,0.20697,0.23159,1,1
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0054671,0.20692,0.23882,1,1
6,GO REGULATION OF RECEPTOR RECYCLING,0.018736,0.20421,0.19585,1,1
6,GO PLASMA MEMBRANE FUSION,0.0060238,0.20337,0.25437,1,1
6,GO REGULATION OF BIOMINERALIZATION,0.0063209,0.20232,0.26115,1,1
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0040644,0.20219,0.21072,1,1
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0042727,0.20202,0.2756,1,1
6,GO INSEMINATION,0.046961,0.2019,0.2255,1,1
6,GO POSITIVE REGULATION OF ANION TRANSPORT,0.0052065,0.20139,0.22025,1,1
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.022172,0.19974,0.20913,1,1
6,GO ENDOTHELIAL CELL PROLIFERATION,0.015776,0.19933,0.22745,1,1
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.022172,0.19922,0.22674,1,1
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0054671,0.19878,0.24173,1,1
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.0016767,0.19869,0.23861,1,1
6,GO CERAMIDE CATABOLIC PROCESS,0.0047188,0.19836,0.29786,1,1
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0038653,0.19825,0.25258,1,1
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0029965,0.19772,0.23447,1,1
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.012106,0.1977,0.30506,1,1
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.015104,0.19765,0.25949,1,1
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.026142,0.19715,0.25471,1,1
6,GO DIGESTIVE SYSTEM PROCESS,0.0047188,0.19681,0.197,1,1
6,GO REGULATION OF ENDOCRINE PROCESS,0.018736,0.19588,0.20213,1,1
6,GO POSITIVE REGULATION OF SECRETION,0.0027019,0.19566,0.20113,1,1
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0015882,0.19532,0.28492,1,1
6,GO REGULATION OF RELAXATION OF MUSCLE,0.048745,0.19472,0.27229,1,1
6,GO CERAMIDE TRANSPORT,0.012106,0.1943,0.23308,1,1
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0044907,0.19391,0.22663,1,1
6,GO LUNG CELL DIFFERENTIATION,0.0063209,0.19347,0.27905,1,1
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0057394,0.19306,0.2,1,1
6,GO ZINC ION HOMEOSTASIS,0.020391,0.19251,0.20717,1,1
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0011418,0.19244,0.20951,1,1
6,GO SMOOTH MUSCLE CELL MIGRATION,0.013834,0.19238,0.2659,1,1
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.020391,0.19217,0.22293,1,1
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.007293,0.19176,0.22111,1,1
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.015776,0.19055,0.20231,1,1
6,GO REGULATION OF EXOSOMAL SECRETION,0.00035748,0.19035,0.2631,1,1
6,GO PROTEIN OXIDATION,0.0060238,0.19007,0.24794,1,1
6,GO ER NUCLEUS SIGNALING PATHWAY,0.0016767,0.18948,0.20771,1,1
6,GO REGULATION OF HORMONE METABOLIC PROCESS,0.018736,0.18913,0.24695,1,1
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0040644,0.18905,0.22336,1,1
6,GO HEAT GENERATION,0.048745,0.18871,0.18736,1,1
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.00086166,0.18851,0.21734,1,1
6,GO MANGANESE ION TRANSPORT,0.023112,0.18772,0.18778,1,1
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.013834,0.18749,0.17704,1,1
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.025096,0.18748,0.20099,1,1
6,GO COPPER ION HOMEOSTASIS,0.0024341,0.1873,0.21024,1,1
6,GO RESPONSE TO HYDROGEN PEROXIDE,0.00096503,0.18698,0.22235,1,1
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.0029965,0.18686,0.21478,1,1
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.013834,0.18665,0.20922,1,1
6,GO RESPONSE TO COLD,0.0066311,0.18662,0.19996,1,1
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00045436,0.18659,0.24107,1,1
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.016475,0.18544,0.22291,1,1
6,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0096484,0.18514,0.264,1,1
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.0052065,0.18392,0.22566,1,1
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.013235,0.18352,0.20931,1,1
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.007293,0.18346,0.24613,1,1
6,GO GLYCEROLIPID CATABOLIC PROCESS,0.011574,0.18312,0.18858,1,1
6,GO LIPID LOCALIZATION,0.0063209,0.18311,0.20331,1,1
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.016475,0.18291,0.21445,1,1
6,GO SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY,0.035953,0.18249,0.24195,1,1
6,GO RESPONSE TO INTERLEUKIN 12,0.0023095,0.18244,0.21069,1,1
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014241,0.1824,0.21814,1,1
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.010101,0.18127,0.18991,1,1
6,GO REGULATION OF PEPTIDE SECRETION,0.0040644,0.18076,0.20692,1,1
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0060238,0.18075,0.18745,1,1
6,GO NEUTRAL LIPID CATABOLIC PROCESS,0.021265,0.18012,0.16574,1,1
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.037377,0.18001,0.16078,1,1
6,GO RESPONSE TO STEROL,0.021265,0.17966,0.23645,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.026142,0.17933,0.15434,1,1
6,GO PHAGOSOME MATURATION,0.0012758,0.17924,0.22662,1,1
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0066311,0.1786,0.2012,1,1
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.028348,0.17832,0.21601,1,1
6,GO MODULATION BY HOST OF VIRAL PROCESS,0.010572,0.17793,0.21048,1,1
6,GO REGULATION OF AMYLOID BETA FORMATION,0.023112,0.17789,0.20505,1,1
6,GO TRIGLYCERIDE METABOLIC PROCESS,0.0083971,0.17783,0.1982,1,1
6,GO SPHINGOMYELIN METABOLIC PROCESS,0.007293,0.17697,0.23608,1,1
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.018736,0.17633,0.19066,1,1
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.008797,0.17607,0.18544,1,1
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.014457,0.17567,0.18051,1,1
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.028348,0.17456,0.21188,1,1
6,GO CORTICAL CYTOSKELETON ORGANIZATION,0.008797,0.17433,0.20527,1,1
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.020391,0.17416,0.20147,1,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00091199,0.17339,0.22275,1,1
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.011063,0.16983,0.1914,1,1
6,GO TROPHOBLAST CELL MIGRATION,0.033245,0.16963,0.21908,1,1
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0014241,0.1696,0.21627,1,1
6,GO RESPONSE TO CORTICOSTEROID,0.0042727,0.16932,0.22456,1,1
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0015041,0.1692,0.22053,1,1
6,GO RESPONSE TO GROWTH HORMONE,0.0049572,0.16891,0.20687,1,1
6,GO RESPONSE TO CAMP,0.0040644,0.16827,0.22771,1,1
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.040368,0.16716,0.15897,1,1
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012106,0.16632,0.24806,1,1
6,GO MAINTENANCE OF LOCATION IN CELL,0.0018673,0.16541,0.22806,1,1
6,GO RESPONSE TO STEROL DEPLETION,0.02951,0.1653,0.20336,1,1
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.021265,0.16464,0.17538,1,1
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.026142,0.16441,0.27138,1,1
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0060238,0.16431,0.21464,1,1
6,GO DIGESTION,0.0063209,0.16405,0.1797,1,1
6,GO REGULATION OF MAP KINASE ACTIVITY,0.021265,0.16367,0.1914,1,1
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.017954,0.16367,0.19621,1,1
6,GO PHAGOSOME ACIDIFICATION,0.0034935,0.1632,0.19828,1,1
6,GO RESPONSE TO NUTRIENT,0.0076456,0.16308,0.2144,1,1
6,GO PEPTIDE SECRETION,0.0057394,0.16167,0.19759,1,1
6,GO PLASMA MEMBRANE ORGANIZATION,0.015776,0.1614,0.20987,1,1
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.020391,0.16107,0.22679,1,1
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0096484,0.16033,0.18725,1,1
6,GO LYTIC VACUOLE ORGANIZATION,0.0023095,0.16026,0.21295,1,1
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00033648,0.15985,0.21072,1,1
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.041938,0.15928,0.19002,1,1
6,GO REGULATION OF MUSCLE CONTRACTION,0.0092139,0.15924,0.17917,1,1
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.038848,0.15895,0.17947,1,1
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0031545,0.15878,0.25445,1,1
6,GO ACTIN MEDIATED CELL CONTRACTION,0.026142,0.15862,0.15776,1,1
6,GO REGULATION OF STEROID METABOLIC PROCESS,0.0025648,0.15842,0.20255,1,1
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0018673,0.1581,0.19651,1,1
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.034576,0.15799,0.227,1,1
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.045233,0.15792,0.19506,1,1
6,GO REGULATION OF BLOOD PRESSURE,0.010572,0.15542,0.19006,1,1
6,GO RESPONSE TO OXIDATIVE STRESS,0.0066311,0.15507,0.17791,1,1
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0057394,0.1546,0.17728,1,1
6,GO STEROL METABOLIC PROCESS,0.011063,0.15418,0.16856,1,1
6,GO MUSCLE CELL MIGRATION,0.022172,0.15417,0.22726,1,1
6,GO NEGATIVE REGULATION OF SECRETION,0.0063209,0.15311,0.19675,1,1
6,GO RESPONSE TO ORGANOPHOSPHORUS,0.0076456,0.15305,0.22116,1,1
6,GO VITAMIN METABOLIC PROCESS,0.0027019,0.15292,0.17576,1,1
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.010572,0.15282,0.18166,1,1
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0047188,0.15236,0.21141,1,1
6,GO REGULATION OF TUBE SIZE,0.0172,0.15221,0.18662,1,1
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.034576,0.15216,0.18061,1,1
6,GO PROTEIN N LINKED GLYCOSYLATION,0.0011418,0.15187,0.19387,1,1
6,GO HORMONE METABOLIC PROCESS,0.015104,0.15114,0.15444,1,1
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0083971,0.15079,0.23224,1,1
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.013834,0.15058,0.17498,1,1
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.006955,0.15037,0.20823,1,1
6,GO RESPONSE TO CADMIUM ION,0.017954,0.14939,0.15877,1,1
6,GO CIRCULATORY SYSTEM PROCESS,0.035953,0.14927,0.1647,1,1
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00332,0.14917,0.14087,1,1
6,GO CELL RECOGNITION,0.011574,0.14896,0.18894,1,1
6,GO CARBOHYDRATE TRANSPORT,0.017954,0.14895,0.15713,1,1
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0018673,0.14855,0.25596,1,1
6,GO POSITIVE REGULATION OF TRANSPORT,0.0096484,0.14804,0.17911,1,1
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.030713,0.148,0.17963,1,1
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.00076864,0.14798,0.24195,1,1
6,GO AMYLOID BETA METABOLIC PROCESS,0.035953,0.14752,0.18083,1,1
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.010101,0.14751,0.18299,1,1
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0076456,0.14724,0.20629,1,1
6,GO RESPONSE TO ETHER,0.041938,0.14704,0.16927,1,1
6,GO IRON ION TRANSPORT,0.0014241,0.14701,0.2019,1,1
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0080134,0.14699,0.18094,1,1
6,GO MUSCLE ADAPTATION,0.026142,0.1466,0.17863,1,1
6,GO LIPID IMPORT INTO CELL,0.021265,0.14636,0.184,1,1
6,GO REGULATION OF VASCULAR PERMEABILITY,0.013834,0.14586,0.23077,1,1
6,GO REGULATION OF LIPID METABOLIC PROCESS,0.0076456,0.14571,0.19303,1,1
6,GO ER OVERLOAD RESPONSE,0.013235,0.14566,0.19362,1,1
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0060238,0.14543,0.2151,1,1
6,GO RESPONSE TO INORGANIC SUBSTANCE,0.0060238,0.14538,0.16705,1,1
6,GO POSITIVE REGULATION OF ION TRANSPORT,0.011574,0.14496,0.174,1,1
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.015104,0.14492,0.16581,1,1
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0023095,0.14469,0.19377,1,1
6,GO NEUTRAL AMINO ACID TRANSPORT,0.0096484,0.14457,0.20663,1,1
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00091199,0.14437,0.23046,1,1
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0027019,0.14435,0.18666,1,1
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.043559,0.14419,0.19192,1,1
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.022172,0.14414,0.19024,1,1
6,GO EMBRYONIC PLACENTA DEVELOPMENT,0.020391,0.14368,0.19224,1,1
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0031545,0.14353,0.18904,1,1
6,GO RESPONSE TO METAL ION,0.00332,0.14337,0.16894,1,1
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.027226,0.14299,0.18819,1,1
6,GO MITOCHONDRIAL DEPOLARIZATION,0.013834,0.14276,0.20979,1,1
6,GO CELLULAR LIPID CATABOLIC PROCESS,0.015776,0.14202,0.16176,1,1
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.037377,0.14186,0.14613,1,1
6,GO CHONDROCYTE DEVELOPMENT,0.024086,0.14182,0.29276,1,1
6,GO CELLULAR RESPONSE TO KETONE,0.027226,0.1416,0.16776,1,1
6,GO NEGATIVE REGULATION OF MAPK CASCADE,0.026142,0.14118,0.1842,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.045233,0.14097,0.15051,1,1
6,GO RESPONSE TO GONADOTROPIN,0.034576,0.14091,0.19006,1,1
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.011063,0.14082,0.17761,1,1
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.006955,0.14026,0.20974,1,1
6,GO STEROID METABOLIC PROCESS,0.0047188,0.14025,0.16918,1,1
6,GO RESPONSE TO KETONE,0.0083971,0.13989,0.19483,1,1
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0083971,0.13949,0.14336,1,1
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.046961,0.13897,0.15968,1,1
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.007293,0.13885,0.17141,1,1
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.015776,0.13884,0.15302,1,1
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0054671,0.13839,0.17894,1,1
6,GO MIDBODY ABSCISSION,0.006955,0.1377,0.14708,1,1
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.014457,0.13679,0.20198,1,1
6,GO RESPONSE TO CALCIUM ION,0.031957,0.13635,0.14985,1,1
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.008797,0.13602,0.26168,1,1
6,GO EXTRACELLULAR VESICLE BIOGENESIS,0.00040321,0.13581,0.23062,1,1
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.028348,0.13567,0.2395,1,1
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0012758,0.13552,0.22595,1,1
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.010101,0.13539,0.17529,1,1
6,GO BILE ACID METABOLIC PROCESS,0.02951,0.13532,0.15113,1,1
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.037377,0.13518,0.19862,1,1
6,GO RESPONSE TO ALCOHOL,0.011574,0.13479,0.18871,1,1
6,GO AMYLOID BETA FORMATION,0.034576,0.13478,0.18982,1,1
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.015776,0.13433,0.17616,1,1
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0096484,0.13421,0.23142,1,1
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.020391,0.13379,0.14908,1,1
6,GO STRIATED MUSCLE CONTRACTION,0.030713,0.13346,0.14336,1,1
6,GO GLYCOPROTEIN METABOLIC PROCESS,0.021265,0.13328,0.1662,1,1
6,GO AMINE METABOLIC PROCESS,0.00045436,0.13298,0.1682,1,1
6,GO NEUTRAL LIPID METABOLIC PROCESS,0.023112,0.13132,0.16053,1,1
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.045233,0.1308,0.13523,1,1
6,GO RESPONSE TO STEROID HORMONE,0.033245,0.13049,0.16833,1,1
6,GO REGULATION OF METAL ION TRANSPORT,0.018736,0.12945,0.16022,1,1
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.045233,0.12904,0.17112,1,1
6,GO REGULATION OF ORGANIC ACID TRANSPORT,0.0096484,0.12897,0.19069,1,1
6,GO VESICLE BUDDING FROM MEMBRANE,0.013834,0.12874,0.15936,1,1
6,GO MEMBRANE FUSION,0.0042727,0.12829,0.17869,1,1
6,GO TRANSITION METAL ION TRANSPORT,0.0011418,0.12829,0.18317,1,1
6,GO REGULATION OF SECRETION,0.014457,0.12819,0.16287,1,1
6,GO PHOSPHOLIPID METABOLIC PROCESS,0.030713,0.12752,0.14613,1,1
6,GO NADP METABOLIC PROCESS,0.0054671,0.12747,0.18116,1,1
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0027019,0.12745,0.1492,1,1
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.045233,0.12677,0.1563,1,1
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.011574,0.12661,0.17377,1,1
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00072571,0.12634,0.17086,1,1
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.027226,0.1247,0.1162,1,1
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.025096,0.12468,0.16118,1,1
6,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0047188,0.12464,0.15157,1,1
6,GO STEROID BIOSYNTHETIC PROCESS,0.0076456,0.12451,0.14867,1,1
6,GO RESPONSE TO ETHANOL,0.0034935,0.12354,0.16613,1,1
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.041938,0.12336,0.16071,1,1
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015041,0.123,0.17319,1,1
6,GO ORGANELLE MEMBRANE FUSION,0.006955,0.1227,0.18029,1,1
6,GO FATTY ACID METABOLIC PROCESS,0.016475,0.12244,0.14608,1,1
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.0083971,0.12221,0.19471,1,1
6,GO REGULATION OF MUSCLE ADAPTATION,0.022172,0.12091,0.18133,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0054671,0.12047,0.18469,1,1
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.010101,0.12021,0.15774,1,1
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.022172,0.11933,0.15976,1,1
6,GO APOPTOTIC SIGNALING PATHWAY,0.0044907,0.11865,0.17492,1,1
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.046961,0.11807,0.16339,1,1
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.027226,0.1178,0.12759,1,1
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.017954,0.1175,0.17897,1,1
6,GO ANION HOMEOSTASIS,0.040368,0.11732,0.17718,1,1
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.034576,0.11708,0.17577,1,1
6,GO ALCOHOL METABOLIC PROCESS,0.028348,0.11698,0.1482,1,1
6,GO PEPTIDYL PROLINE MODIFICATION,0.034576,0.11695,0.11809,1,1
6,GO NEGATIVE REGULATION OF TRANSPORT,0.011574,0.11687,0.1653,1,1
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.006955,0.11629,0.16054,1,1
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.037377,0.11601,0.16859,1,1
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.015104,0.11525,0.17091,1,1
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.018736,0.11479,0.15481,1,1
6,GO SPLEEN DEVELOPMENT,0.038848,0.11442,0.13412,1,1
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00332,0.11302,0.16696,1,1
6,GO COPII COATED VESICLE BUDDING,0.014457,0.11283,0.15371,1,1
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.021265,0.11241,0.15753,1,1
6,GO TEMPERATURE HOMEOSTASIS,0.035953,0.11218,0.15438,1,1
6,GO REGULATION OF PEPTIDE TRANSPORT,0.022172,0.11186,0.15465,1,1
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.043559,0.11184,0.17666,1,1
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.024086,0.11158,0.12483,1,1
6,GO NAD METABOLIC PROCESS,0.017954,0.11125,0.17558,1,1
6,GO KETONE BIOSYNTHETIC PROCESS,0.030713,0.11063,0.14665,1,1
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0044907,0.11057,0.16714,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0080134,0.11015,0.17952,1,1
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.01266,0.10944,0.14427,1,1
6,GO FAT CELL DIFFERENTIATION,0.038848,0.10902,0.17875,1,1
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.028348,0.10887,0.1468,1,1
6,GO RESPONSE TO HORMONE,0.035953,0.1084,0.15641,1,1
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.037377,0.10835,0.12909,1,1
6,GO CELLULAR LIPID METABOLIC PROCESS,0.031957,0.10818,0.14095,1,1
6,GO GOLGI VESICLE BUDDING,0.013834,0.10762,0.15635,1,1
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0057394,0.10654,0.19347,1,1
6,GO SKELETAL MUSCLE CONTRACTION,0.021265,0.10621,0.15862,1,1
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.037377,0.10572,0.13682,1,1
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.024086,0.10526,0.15198,1,1
6,GO PEROXISOMAL TRANSPORT,0.011063,0.10487,0.12041,1,1
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.019548,0.10439,0.13541,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.034576,0.10284,0.13981,1,1
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.019548,0.10278,0.16377,1,1
6,GO CELLULAR RESPONSE TO DRUG,0.0063209,0.10248,0.1659,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.015104,0.10172,0.13942,1,1
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.028348,0.10159,0.14669,1,1
6,GO ERAD PATHWAY,0.043559,0.10152,0.13631,1,1
6,GO LIPID METABOLIC PROCESS,0.033245,0.10058,0.14357,1,1
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.040368,0.1,0.15475,1,1
6,GO MEMBRANE ORGANIZATION,0.031957,0.099109,0.14377,1,1
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0054671,0.098781,0.15821,1,1
6,GO RESPONSE TO TOXIC SUBSTANCE,0.023112,0.097885,0.13483,1,1
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.019548,0.097838,0.15294,1,1
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.030713,0.096641,0.15688,1,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.011574,0.095505,0.1491,1,1
6,GO ALCOHOL BIOSYNTHETIC PROCESS,0.014457,0.094559,0.1485,1,1
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.033245,0.094439,0.15339,1,1
6,GO VESICLE TARGETING,0.017954,0.094208,0.15235,1,1
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.048745,0.093856,0.11545,1,1
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.041938,0.093843,0.14985,1,1
6,GO LIPID BIOSYNTHETIC PROCESS,0.028348,0.093413,0.13385,1,1
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.048745,0.092584,0.16888,1,1
6,GO NADPH REGENERATION,0.031957,0.089984,0.12768,1,1
6,GO MITOTIC CYTOKINETIC PROCESS,0.033245,0.089209,0.11386,1,1
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.013834,0.088045,0.13543,1,1
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.043559,0.087803,0.14036,1,1
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.02951,0.08764,0.17799,1,1
6,GO PEROXISOME ORGANIZATION,0.015776,0.086133,0.10605,1,1
6,GO VESICLE ORGANIZATION,0.016475,0.085974,0.15073,1,1
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.043559,0.085957,0.13154,1,1
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.027226,0.085601,0.10895,1,1
6,GO MEMBRANE LIPID METABOLIC PROCESS,0.037377,0.084494,0.12957,1,1
6,GO FRUCTOSE METABOLIC PROCESS,0.046961,0.084441,0.17018,1,1
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.038848,0.083789,0.12388,1,1
6,GO VIRION ASSEMBLY,0.0080134,0.083657,0.11189,1,1
6,GO ZINC ION TRANSPORT,0.030713,0.079939,0.10416,1,1
6,GO ORGANIC ACID METABOLIC PROCESS,0.028348,0.078887,0.12486,1,1
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.027226,0.078408,0.13454,1,1
6,GO PROTEOLYSIS,0.040368,0.078303,0.142,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.038848,0.075993,0.15498,1,1
6,GO MITOCHONDRIAL FISSION,0.017954,0.073754,0.15469,1,1
6,GO CELLULAR KETONE METABOLIC PROCESS,0.041938,0.07145,0.11067,1,1
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.018736,0.067508,0.12596,1,1
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.034576,0.0662,0.11964,1,1
6,GO OXIDATION REDUCTION PROCESS,0.021265,0.065826,0.11011,1,1
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.043559,0.065803,0.126,1,1
6,GO DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION,0.0012071,0.98211,0.94969,1,0
6,GO T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL,0.0024341,0.96709,0.90297,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0012758,0.81894,0.67574,1,0
6,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0076456,0.81682,0.62709,1,0
6,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.0014241,0.7312,0.62941,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0010798,0.72255,0.66201,1,0
6,GO HYPERSENSITIVITY,0.0010798,0.69442,0.70486,1,0
6,GO T CELL CHEMOTAXIS,0.0016767,0.6823,0.61839,1,0
6,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00086166,0.68144,0.68828,1,0
6,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0034935,0.67628,0.58469,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.010101,0.6696,0.5556,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0031545,0.65692,0.61903,1,0
6,GO POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION,0.0025648,0.64671,0.55974,1,0
6,GO SYNAPSE PRUNING,0.0047188,0.63256,0.6019,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.006955,0.62103,0.52288,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00057531,0.61707,0.64346,1,0
6,GO POSITIVE THYMIC T CELL SELECTION,0.0031545,0.61534,0.62362,1,0
6,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0019699,0.61503,0.53374,1,0
6,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0018673,0.61444,0.65399,1,0
6,GO DENDRITIC CELL DIFFERENTIATION,0.0013481,0.61378,0.58761,1,0
6,GO POSITIVE T CELL SELECTION,0.0025648,0.61362,0.54798,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0017696,0.60733,0.64736,1,0
6,GO REGULATION OF NEUTROPHIL ACTIVATION,0.00064645,0.60669,0.61054,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.0016767,0.59016,0.54869,1,0
6,GO COMPLEMENT ACTIVATION,0.00081392,0.5874,0.58421,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0012758,0.58626,0.5829,1,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0015041,0.58614,0.6161,1,0
6,GO T HELPER CELL LINEAGE COMMITMENT,0.0021907,0.582,0.56528,1,0
6,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0023095,0.57997,0.53135,1,0
6,GO ALPHA BETA T CELL PROLIFERATION,0.0015041,0.57843,0.54447,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00072571,0.57801,0.61553,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00081392,0.57758,0.56509,1,0
6,GO GERMINAL CENTER FORMATION,0.00060992,0.5758,0.64441,1,0
6,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0019699,0.57494,0.57158,1,0
6,GO NEGATIVE T CELL SELECTION,0.0027019,0.57373,0.64142,1,0
6,GO T CELL MEDIATED CYTOTOXICITY,0.0017696,0.57281,0.54485,1,0
6,GO COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY,0.0015882,0.57169,0.58099,1,0
6,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0015041,0.56959,0.5558,1,0
6,GO LEUKOCYTE AGGREGATION,0.0025648,0.56781,0.61646,1,0
6,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0016767,0.56558,0.61925,1,0
6,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.0019699,0.5633,0.51109,1,0
6,GO DETECTION OF OTHER ORGANISM,0.0010209,0.56204,0.55477,1,0
6,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0017696,0.55572,0.54046,1,0
6,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0019699,0.55203,0.55181,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0047188,0.55188,0.47027,1,0
6,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0027019,0.55176,0.55001,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0029965,0.54855,0.53182,1,0
6,GO NEGATIVE REGULATION OF CELL KILLING,0.0049572,0.54598,0.53919,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0034935,0.54189,0.53472,1,0
6,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0014241,0.54056,0.57547,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0015882,0.5381,0.55147,1,0
6,GO REGULATORY T CELL DIFFERENTIATION,0.0012071,0.5377,0.50737,1,0
6,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0015882,0.53557,0.53038,1,0
6,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0021907,0.53555,0.51906,1,0
6,GO T CELL SELECTION,0.0017696,0.5315,0.52369,1,0
6,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0015041,0.53093,0.45702,1,0
6,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0024341,0.53056,0.541,1,0
6,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00072571,0.5297,0.53275,1,0
6,GO RESPONSE TO PROTOZOAN,0.0034935,0.52329,0.53843,1,0
6,GO TYPE 2 IMMUNE RESPONSE,0.0015882,0.52179,0.52144,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0012758,0.52057,0.53488,1,0
6,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0013481,0.51895,0.55985,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0023095,0.51822,0.46898,1,0
6,GO THYMIC T CELL SELECTION,0.0027019,0.51742,0.52068,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0019699,0.51633,0.54909,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00081392,0.51529,0.49822,1,0
6,GO CHEMOKINE SECRETION,0.0015882,0.51309,0.53481,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0017696,0.51208,0.51872,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE SECRETION,0.0014241,0.51142,0.55894,1,0
6,GO MYELOID DENDRITIC CELL ACTIVATION,0.0023095,0.50953,0.54339,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0083971,0.50944,0.44697,1,0
6,GO RESPONSE TO INTERFERON GAMMA,0.0015882,0.50832,0.50414,1,0
6,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0047188,0.5069,0.4751,1,0
6,GO MACROPHAGE CYTOKINE PRODUCTION,0.0021907,0.50643,0.46006,1,0
6,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0017696,0.50612,0.46674,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0024341,0.50524,0.48542,1,0
6,GO RESPONSE TO INTERFERON BETA,0.0012758,0.50499,0.48569,1,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0021907,0.50481,0.49163,1,0
6,GO IMMUNOGLOBULIN SECRETION,0.00051151,0.50349,0.51164,1,0
6,GO REGULATION OF CELL KILLING,0.0015041,0.5031,0.48505,1,0
6,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0040644,0.50188,0.48665,1,0
6,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0013481,0.50098,0.48479,1,0
6,GO CELL KILLING,0.0012071,0.50057,0.44547,1,0
6,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0020776,0.50021,0.5032,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0012758,0.49963,0.51771,1,0
6,GO RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE,0.006955,0.49941,0.36263,1,0
6,GO DETECTION OF BIOTIC STIMULUS,0.00081392,0.49872,0.48335,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0012758,0.49819,0.50851,1,0
6,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00054254,0.49794,0.53561,1,0
6,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0020776,0.4967,0.47575,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.0019699,0.49597,0.49053,1,0
6,GO AMINO SUGAR CATABOLIC PROCESS,0.0020776,0.49521,0.47835,1,0
6,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0020776,0.49196,0.50039,1,0
6,GO INTERLEUKIN 17 PRODUCTION,0.0016767,0.49184,0.49274,1,0
6,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0011418,0.49095,0.49037,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0027019,0.4907,0.49201,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0018673,0.4901,0.52579,1,0
6,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00091199,0.48925,0.52632,1,0
6,GO RESPONSE TO PEPTIDOGLYCAN,0.0060238,0.48915,0.4596,1,0
6,GO ADAPTIVE IMMUNE RESPONSE,0.0020776,0.48791,0.5153,1,0
6,GO INTERLEUKIN 4 PRODUCTION,0.00091199,0.4855,0.5505,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00054254,0.48499,0.49493,1,0
6,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00033648,0.48356,0.53403,1,0
6,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0021907,0.48163,0.46501,1,0
6,GO GLIAL CELL ACTIVATION,0.0025648,0.48099,0.51092,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00096503,0.4807,0.49963,1,0
6,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0012758,0.47897,0.46511,1,0
6,GO T HELPER 2 CELL DIFFERENTIATION,0.0036751,0.47612,0.47213,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0014241,0.47337,0.46461,1,0
6,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0019699,0.47244,0.46367,1,0
6,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0044907,0.47149,0.4452,1,0
6,GO NEUROINFLAMMATORY RESPONSE,0.0021907,0.46884,0.48587,1,0
6,GO MACROPHAGE PROLIFERATION,0.0034935,0.46804,0.50783,1,0
6,GO REGULATION OF MACROPHAGE ACTIVATION,0.0014241,0.4677,0.47136,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0013481,0.46608,0.44648,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0025648,0.46495,0.48442,1,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0016767,0.46481,0.41591,1,0
6,GO INTERLEUKIN 2 PRODUCTION,0.0031545,0.4643,0.44951,1,0
6,GO INTERLEUKIN 1 BETA PRODUCTION,0.0016767,0.46371,0.48009,1,0
6,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0028457,0.4635,0.45475,1,0
6,GO RESPONSE TO TYPE I INTERFERON,0.0034935,0.46284,0.44631,1,0
6,GO CD40 SIGNALING PATHWAY,0.00091199,0.4613,0.44022,1,0
6,GO T CELL MEDIATED IMMUNITY,0.0017696,0.45957,0.44964,1,0
6,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0021907,0.45819,0.52102,1,0
6,GO INTERLEUKIN 13 PRODUCTION,0.0014241,0.45781,0.51769,1,0
6,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0014241,0.45685,0.50847,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0025648,0.45614,0.51494,1,0
6,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0028457,0.45551,0.46845,1,0
6,GO T CELL EXTRAVASATION,0.0031545,0.45435,0.46277,1,0
6,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00060992,0.45393,0.49338,1,0
6,GO LYMPHOCYTE COSTIMULATION,0.00332,0.45376,0.43396,1,0
6,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0031545,0.45309,0.49375,1,0
6,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0013481,0.45251,0.44466,1,0
6,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0028457,0.45229,0.46558,1,0
6,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00054254,0.45215,0.46088,1,0
6,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00028019,0.45132,0.47688,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00068502,0.44933,0.4685,1,0
6,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00045436,0.44795,0.49094,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0012758,0.44741,0.45694,1,0
6,GO INTERFERON GAMMA PRODUCTION,0.0018673,0.4454,0.5036,1,0
6,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0019699,0.44413,0.48387,1,0
6,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0019699,0.44353,0.44228,1,0
6,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0013481,0.44285,0.47898,1,0
6,GO INTERLEUKIN 5 PRODUCTION,0.0054671,0.44077,0.36882,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0013481,0.44075,0.43728,1,0
6,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.0036751,0.44035,0.44472,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0019699,0.43987,0.46152,1,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0028457,0.43794,0.4679,1,0
6,GO REGULATION OF B CELL DIFFERENTIATION,0.0015041,0.43793,0.48426,1,0
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0017696,0.43733,0.44395,1,0
6,GO MACROPHAGE CHEMOTAXIS,0.00091199,0.43546,0.44238,1,0
6,GO RESPONSE TO LIPOTEICHOIC ACID,0.0014241,0.43529,0.46031,1,0
6,GO ALPHA BETA T CELL DIFFERENTIATION,0.0016767,0.43469,0.44635,1,0
6,GO ASTROCYTE ACTIVATION,0.0028457,0.43431,0.39463,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0011418,0.43397,0.46976,1,0
6,GO ALPHA BETA T CELL ACTIVATION,0.0024341,0.43209,0.44809,1,0
6,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0028457,0.4318,0.4358,1,0
6,GO REGULATION OF PHAGOCYTOSIS,0.0010798,0.43061,0.45858,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0023095,0.43036,0.47858,1,0
6,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0003797,0.42984,0.47474,1,0
6,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0017696,0.42829,0.45423,1,0
6,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0012071,0.42813,0.45443,1,0
6,GO INTERLEUKIN 1 PRODUCTION,0.0019699,0.42709,0.47123,1,0
6,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.006955,0.42652,0.43423,1,0
6,GO MACROPHAGE ACTIVATION,0.0012071,0.42584,0.47735,1,0
6,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0024341,0.42539,0.49299,1,0
6,GO MACROPHAGE MIGRATION,0.0012071,0.42276,0.44414,1,0
6,GO POSITIVE REGULATION OF GLIAL CELL MIGRATION,0.0060238,0.42214,0.42294,1,0
6,GO AMYLOID BETA CLEARANCE,0.0017696,0.42171,0.41959,1,0
6,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0047188,0.42094,0.55433,1,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00081392,0.4205,0.42746,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0020776,0.42021,0.45812,1,0
6,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0014241,0.41999,0.40391,1,0
6,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0013481,0.41858,0.45266,1,0
6,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.0031545,0.41812,0.48223,1,0
6,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0031545,0.41711,0.4237,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0023095,0.41569,0.41424,1,0
6,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0024341,0.41536,0.39182,1,0
6,GO REGULATION OF B CELL ACTIVATION,0.00068502,0.41516,0.48166,1,0
6,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0014241,0.41507,0.44815,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0025648,0.4145,0.43978,1,0
6,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0021907,0.41438,0.53217,1,0
6,GO T CELL PROLIFERATION,0.0014241,0.41385,0.46028,1,0
6,GO APOPTOTIC CELL CLEARANCE,0.00332,0.41353,0.43807,1,0
6,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0021907,0.4135,0.45859,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0012071,0.41308,0.43642,1,0
6,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0019699,0.41293,0.47178,1,0
6,GO CYTOKINE METABOLIC PROCESS,0.0016767,0.41277,0.424,1,0
6,GO VITAMIN D METABOLIC PROCESS,0.00033648,0.41233,0.44101,1,0
6,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00096503,0.41055,0.43131,1,0
6,GO T HELPER 1 CELL DIFFERENTIATION,0.0060238,0.41022,0.46324,1,0
6,GO REGULATION OF ANGIOTENSIN LEVELS IN BLOOD,0.0011418,0.40838,0.51466,1,0
6,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0016767,0.40727,0.46395,1,0
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0024341,0.40674,0.45409,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0015041,0.40656,0.43659,1,0
6,GO NEGATIVE REGULATION OF MAST CELL ACTIVATION,0.0023095,0.40537,0.44331,1,0
6,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.0025648,0.40485,0.40115,1,0
6,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0025648,0.4048,0.38071,1,0
6,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0020776,0.4044,0.43687,1,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0054671,0.40438,0.41041,1,0
6,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0024341,0.40393,0.40857,1,0
6,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0083971,0.4035,0.38815,1,0
6,GO CELLULAR EXTRAVASATION,0.00057531,0.40201,0.46442,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00086166,0.40127,0.43569,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0018673,0.4008,0.50552,1,0
6,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0015882,0.40057,0.4071,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0047188,0.40032,0.42115,1,0
6,GO REGULATION OF LEUKOCYTE MIGRATION,0.00064645,0.40016,0.45255,1,0
6,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0015882,0.39988,0.41459,1,0
6,GO IMMUNE RESPONSE TO TUMOR CELL,0.0016767,0.39959,0.41208,1,0
6,GO REGULATION OF CELLULAR EXTRAVASATION,0.00076864,0.39935,0.47227,1,0
6,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0015882,0.39895,0.45321,1,0
6,GO CYTOKINE SECRETION,0.0015041,0.39874,0.39454,1,0
6,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0023095,0.39835,0.41756,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.0024341,0.39829,0.48663,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0040644,0.3982,0.44821,1,0
6,GO T CELL APOPTOTIC PROCESS,0.0027019,0.398,0.41029,1,0
6,GO LEUKOCYTE CELL CELL ADHESION,0.0014241,0.39794,0.44495,1,0
6,GO RESPONSE TO INTERLEUKIN 18,0.0018673,0.39783,0.49313,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0031545,0.39542,0.42534,1,0
6,GO LEUKOCYTE PROLIFERATION,0.0012071,0.3953,0.45519,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0042727,0.39421,0.37101,1,0
6,GO NEUTROPHIL EXTRAVASATION,0.0040644,0.39411,0.39696,1,0
6,GO B CELL MEDIATED IMMUNITY,0.0015041,0.39321,0.47627,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0021907,0.3927,0.37483,1,0
6,GO LEUKOCYTE APOPTOTIC PROCESS,0.00091199,0.39142,0.42974,1,0
6,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0020776,0.39115,0.40458,1,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0014241,0.39058,0.4422,1,0
6,GO RESPONSE TO INTERLEUKIN 2,0.0017696,0.39019,0.48677,1,0
6,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00054254,0.38998,0.40413,1,0
6,GO REGULATION OF T CELL ACTIVATION,0.0015041,0.38998,0.42255,1,0
6,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.00072571,0.38979,0.4335,1,0
6,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0011418,0.389,0.39645,1,0
6,GO REGULATION OF MACROPHAGE MIGRATION,0.0019699,0.38886,0.43085,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0012758,0.38854,0.42712,1,0
6,GO INTERLEUKIN 6 PRODUCTION,0.0012071,0.38817,0.41155,1,0
6,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0027019,0.38647,0.43244,1,0
6,GO PHAGOCYTOSIS RECOGNITION,0.0038653,0.38613,0.37825,1,0
6,GO GAP JUNCTION ASSEMBLY,0.0049572,0.38463,0.40484,1,0
6,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0010798,0.38448,0.37341,1,0
6,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0024341,0.38447,0.38432,1,0
6,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0015882,0.3838,0.42267,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0018673,0.38378,0.40098,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0018673,0.38372,0.42205,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION,0.0029965,0.38363,0.39313,1,0
6,GO FOAM CELL DIFFERENTIATION,0.0010209,0.3824,0.3525,1,0
6,GO T CELL DIFFERENTIATION,0.0025648,0.38171,0.3905,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0021907,0.38155,0.43194,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0024341,0.38134,0.4105,1,0
6,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0018673,0.37945,0.39256,1,0
6,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0010209,0.37878,0.40663,1,0
6,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0020776,0.37793,0.4278,1,0
6,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0013481,0.37742,0.39463,1,0
6,GO MACROPHAGE APOPTOTIC PROCESS,0.0021907,0.37525,0.39402,1,0
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0036751,0.37515,0.4211,1,0
6,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00091199,0.37487,0.40579,1,0
6,GO RESPONSE TO INTERFERON ALPHA,0.0023095,0.37486,0.45037,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0027019,0.37476,0.38784,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0034935,0.37403,0.36018,1,0
6,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.0029965,0.37402,0.44673,1,0
6,GO ACTIVATED T CELL PROLIFERATION,0.0012071,0.37391,0.36997,1,0
6,GO NATURAL KILLER CELL ACTIVATION,0.0019699,0.37371,0.40327,1,0
6,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0020776,0.37333,0.42201,1,0
6,GO PHAGOCYTOSIS,0.00096503,0.37293,0.39917,1,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0017696,0.37243,0.40754,1,0
6,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.025096,0.37215,0.29837,1,0
6,GO CELL JUNCTION DISASSEMBLY,0.0044907,0.37206,0.42243,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00096503,0.37125,0.41282,1,0
6,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00021879,0.36952,0.42955,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0018673,0.36934,0.38516,1,0
6,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0023095,0.36933,0.4139,1,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0029965,0.36917,0.36082,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0010798,0.36903,0.45266,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0036751,0.3681,0.38405,1,0
6,GO MEMBRANE RAFT ORGANIZATION,0.00091199,0.36727,0.42701,1,0
6,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.011574,0.36703,0.33302,1,0
6,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0034935,0.36683,0.36854,1,0
6,GO REVERSE CHOLESTEROL TRANSPORT,0.0063209,0.36658,0.3698,1,0
6,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0027019,0.366,0.41906,1,0
6,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015882,0.36534,0.41351,1,0
6,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0016767,0.36488,0.41583,1,0
6,GO MACROPHAGE DIFFERENTIATION,0.0036751,0.36479,0.37435,1,0
6,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.013235,0.36352,0.34641,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0018673,0.36343,0.42063,1,0
6,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0016767,0.36289,0.36671,1,0
6,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00040321,0.36199,0.42235,1,0
6,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0019699,0.36088,0.40026,1,0
6,GO REGULATION OF MEMBRANE INVAGINATION,0.0054671,0.36025,0.40449,1,0
6,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0036751,0.3601,0.42032,1,0
6,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0036751,0.36,0.33117,1,0
6,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0013481,0.35981,0.43007,1,0
6,GO LEUKOCYTE MIGRATION,0.00040321,0.35933,0.44163,1,0
6,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0031545,0.35916,0.32538,1,0
6,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00086166,0.3576,0.35172,1,0
6,GO CHEMOKINE PRODUCTION,0.00091199,0.35725,0.39329,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0015041,0.35714,0.39068,1,0
6,GO LYMPHOCYTE HOMEOSTASIS,0.0014241,0.35706,0.3498,1,0
6,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0054671,0.35493,0.36015,1,0
6,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.0011418,0.35435,0.44154,1,0
6,GO T CELL ACTIVATION,0.0015041,0.35293,0.40115,1,0
6,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0015882,0.35289,0.41307,1,0
6,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0029965,0.35253,0.36841,1,0
6,GO SUPEROXIDE ANION GENERATION,0.00086166,0.35208,0.40022,1,0
6,GO REGULATION OF CELL ACTIVATION,0.0015882,0.35151,0.39403,1,0
6,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0010798,0.35118,0.355,1,0
6,GO LEUKOCYTE HOMEOSTASIS,0.0011418,0.35099,0.36972,1,0
6,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0018673,0.34992,0.41314,1,0
6,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0019699,0.34842,0.34973,1,0
6,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0024341,0.34782,0.37953,1,0
6,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0036751,0.34515,0.38542,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.007293,0.34497,0.37966,1,0
6,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0020776,0.34308,0.34965,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0013481,0.34223,0.30919,1,0
6,GO LEUKOCYTE MEDIATED IMMUNITY,0.00072571,0.34164,0.37273,1,0
6,GO ZYMOGEN ACTIVATION,0.00010866,0.34154,0.41617,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0012758,0.34136,0.39902,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0015882,0.34121,0.3885,1,0
6,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.01266,0.34107,0.36516,1,0
6,GO RESPONSE TO PROSTAGLANDIN,0.0052065,0.33996,0.30656,1,0
6,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00086166,0.33958,0.39198,1,0
6,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0025648,0.33877,0.37695,1,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0025648,0.33868,0.34426,1,0
6,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0024341,0.33847,0.34177,1,0
6,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.0066311,0.33838,0.35169,1,0
6,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0014241,0.33736,0.35834,1,0
6,GO MEMBRANE INVAGINATION,0.0029965,0.33508,0.36779,1,0
6,GO REGULATION OF FIBRINOLYSIS,0.0025648,0.33392,0.39919,1,0
6,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0020776,0.33364,0.32234,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0042727,0.33358,0.38184,1,0
6,GO RESPONSE TO PROSTAGLANDIN E,0.0024341,0.33349,0.3474,1,0
6,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00076864,0.33342,0.36331,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION,0.00081392,0.33316,0.39202,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0012071,0.33145,0.37253,1,0
6,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0040644,0.3309,0.3671,1,0
6,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0017696,0.33048,0.33739,1,0
6,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012071,0.33038,0.36228,1,0
6,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0012758,0.33001,0.38071,1,0
6,GO INFLAMMATORY RESPONSE,0.00068502,0.32981,0.39135,1,0
6,GO REGULATION OF IMMUNE RESPONSE,0.0017696,0.32913,0.36298,1,0
6,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0047188,0.32699,0.29438,1,0
6,GO REGULATION OF CELL CELL ADHESION,0.00081392,0.32664,0.38489,1,0
6,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0028457,0.32664,0.38648,1,0
6,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0020776,0.32589,0.35133,1,0
6,GO ACTIVATION OF IMMUNE RESPONSE,0.0019699,0.32572,0.34465,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.011574,0.32373,0.32239,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0021907,0.3229,0.38394,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0028457,0.3222,0.3682,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0025648,0.3215,0.39638,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0010798,0.32109,0.36258,1,0
6,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.0029965,0.32068,0.36227,1,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0015041,0.32052,0.41469,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00332,0.32039,0.35165,1,0
6,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0031545,0.31925,0.36011,1,0
6,GO LYMPHOCYTE DIFFERENTIATION,0.0020776,0.31853,0.36437,1,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.013235,0.31803,0.33325,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0010209,0.31784,0.36935,1,0
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0015882,0.31686,0.41342,1,0
6,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0021907,0.31621,0.34304,1,0
6,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0172,0.31606,0.2996,1,0
6,GO INNATE IMMUNE RESPONSE,0.0015882,0.31555,0.36091,1,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0018673,0.3154,0.35039,1,0
6,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0014241,0.31507,0.34861,1,0
6,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.00086166,0.31425,0.34729,1,0
6,GO RESPONSE TO TUMOR CELL,0.0016767,0.31368,0.37592,1,0
6,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0027019,0.3133,0.34647,1,0
6,GO PEPTIDE CROSS LINKING,0.006955,0.3123,0.35164,1,0
6,GO INTERFERON ALPHA PRODUCTION,0.0060238,0.31163,0.34595,1,0
6,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00332,0.31146,0.37149,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0014241,0.31073,0.36054,1,0
6,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00096503,0.31044,0.36867,1,0
6,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00054254,0.31028,0.37224,1,0
6,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00332,0.30946,0.37397,1,0
6,GO RESPONSE TO BACTERIUM,0.00057531,0.30898,0.38067,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.024086,0.30892,0.26104,1,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.013235,0.30812,0.32622,1,0
6,GO LYMPHOCYTE ACTIVATION,0.0024341,0.30755,0.36931,1,0
6,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.0010798,0.30709,0.35513,1,0
6,GO IMMUNE EFFECTOR PROCESS,0.00096503,0.30709,0.35387,1,0
6,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.0057394,0.30693,0.3416,1,0
6,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0024341,0.30687,0.36109,1,0
6,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0016767,0.30554,0.34394,1,0
6,GO B CELL ACTIVATION,0.0011418,0.30547,0.3918,1,0
6,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.015776,0.30541,0.25441,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00091199,0.30489,0.32504,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0015041,0.30467,0.33843,1,0
6,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0025648,0.30348,0.35608,1,0
6,GO GAMMA DELTA T CELL ACTIVATION,0.0047188,0.30273,0.40279,1,0
6,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0027019,0.3021,0.35013,1,0
6,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0054671,0.30201,0.3255,1,0
6,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0015882,0.29968,0.3735,1,0
6,GO TUMOR NECROSIS FACTOR SECRETION,0.0060238,0.29965,0.2884,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00081392,0.29895,0.30297,1,0
6,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0017696,0.29891,0.36276,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0024341,0.29655,0.32844,1,0
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.014457,0.29634,0.35804,1,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.015776,0.29608,0.27792,1,0
6,GO POSITIVE REGULATION OF LIPID STORAGE,0.0172,0.29608,0.28765,1,0
6,GO DEFENSE RESPONSE TO VIRUS,0.0028457,0.29602,0.32633,1,0
6,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0019699,0.29576,0.3514,1,0
6,GO REGULATION OF CHEMOTAXIS,0.00081392,0.29559,0.35691,1,0
6,GO ETHANOL OXIDATION,0.015104,0.29525,0.31217,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0060238,0.29467,0.29068,1,0
6,GO SEQUESTERING OF METAL ION,0.007293,0.29433,0.22215,1,0
6,GO ENTRY INTO HOST,0.00096503,0.29376,0.31069,1,0
6,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0083971,0.2934,0.3584,1,0
6,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.011063,0.29316,0.2912,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0052065,0.2917,0.30929,1,0
6,GO CELLULAR RESPONSE TO ETHANOL,0.0080134,0.29082,0.33831,1,0
6,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0015882,0.29077,0.3493,1,0
6,GO STEROID ESTERIFICATION,0.0028457,0.29061,0.27824,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0015882,0.29058,0.3735,1,0
6,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0042727,0.29044,0.29114,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.0012758,0.2904,0.37658,1,0
6,GO ETHANOL METABOLIC PROCESS,0.031957,0.28823,0.24226,1,0
6,GO REGULATION OF GLIAL CELL MIGRATION,0.0083971,0.28784,0.3704,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0076456,0.28707,0.31087,1,0
6,GO NEUTROPHIL HOMEOSTASIS,0.0023095,0.287,0.414,1,0
6,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0057394,0.28696,0.32316,1,0
6,GO IMMUNOGLOBULIN PRODUCTION,0.0018673,0.28625,0.35364,1,0
6,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0042727,0.28571,0.32433,1,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0015041,0.28518,0.3031,1,0
6,GO MYELOID CELL APOPTOTIC PROCESS,0.0015041,0.28451,0.33002,1,0
6,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00051151,0.28435,0.30389,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION,0.0024341,0.28397,0.29311,1,0
6,GO PSEUDOPODIUM ORGANIZATION,0.01266,0.28258,0.26329,1,0
6,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0019699,0.28243,0.36531,1,0
6,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.0014241,0.28052,0.2984,1,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0023095,0.28009,0.35613,1,0
6,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00076864,0.27884,0.31562,1,0
6,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0076456,0.2788,0.32929,1,0
6,GO LEYDIG CELL DIFFERENTIATION,0.011063,0.27791,0.32629,1,0
6,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0019699,0.27772,0.35404,1,0
6,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0034935,0.27756,0.33069,1,0
6,GO REFLEX,0.013235,0.27705,0.29512,1,0
6,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.014457,0.27638,0.26517,1,0
6,GO ASTROCYTE DEVELOPMENT,0.0066311,0.27615,0.31398,1,0
6,GO GAMMA DELTA T CELL DIFFERENTIATION,0.0066311,0.27584,0.3841,1,0
6,GO NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.008797,0.27507,0.37752,1,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0057394,0.27507,0.3141,1,0
6,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.031957,0.27489,0.24502,1,0
6,GO DEFENSE RESPONSE,0.0010209,0.27445,0.33653,1,0
6,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00068502,0.27396,0.32061,1,0
6,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0047188,0.27365,0.35159,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0015882,0.2736,0.28403,1,0
6,GO CELL ACTIVATION,0.00096503,0.27342,0.33852,1,0
6,GO T CELL HOMEOSTASIS,0.0038653,0.27338,0.28171,1,0
6,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.0025648,0.27325,0.31775,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00076864,0.27316,0.33128,1,0
6,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0063209,0.27232,0.27754,1,0
6,GO ERK1 AND ERK2 CASCADE,0.00332,0.27225,0.2988,1,0
6,GO CYTOKINE PRODUCTION,0.0013481,0.27076,0.34068,1,0
6,GO T CELL DIFFERENTIATION IN THYMUS,0.0024341,0.26887,0.33408,1,0
6,GO RESPONSE TO BIOTIC STIMULUS,0.00096503,0.26852,0.32649,1,0
6,GO REGULATION OF DEFENSE RESPONSE,0.0012758,0.26848,0.30348,1,0
6,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.030713,0.26803,0.193,1,0
6,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0012758,0.26706,0.31364,1,0
6,GO SYNCYTIUM FORMATION,0.0017696,0.26701,0.33114,1,0
6,GO RESPONSE TO INTERLEUKIN 7,0.0016767,0.26498,0.32077,1,0
6,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0096484,0.2646,0.33112,1,0
6,GO LEUKOTRIENE METABOLIC PROCESS,0.0057394,0.2633,0.28155,1,0
6,GO BONE REMODELING,0.00060992,0.26323,0.35704,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00048214,0.26304,0.28853,1,0
6,GO MULTI ORGANISM CELLULAR PROCESS,0.0060238,0.26281,0.33227,1,0
6,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0016767,0.26142,0.30271,1,0
6,GO MUCUS SECRETION,0.0018673,0.26141,0.31469,1,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0011418,0.26,0.34925,1,0
6,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00332,0.25989,0.28127,1,0
6,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0018673,0.25968,0.3191,1,0
6,GO CHOLESTEROL EFFLUX,0.011574,0.25924,0.23432,1,0
6,GO STEROL HOMEOSTASIS,0.0028457,0.25881,0.25616,1,0
6,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.021265,0.25829,0.27879,1,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.015104,0.25824,0.28959,1,0
6,GO AMYLOID FIBRIL FORMATION,0.0047188,0.25802,0.2963,1,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0066311,0.25724,0.25965,1,0
6,GO OSTEOCLAST DEVELOPMENT,0.0021907,0.25721,0.43638,1,0
6,GO RESPONSE TO VIRUS,0.0038653,0.25615,0.30563,1,0
6,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0076456,0.25561,0.27692,1,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.011063,0.25503,0.30132,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0076456,0.255,0.26722,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0012071,0.255,0.29675,1,0
6,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0018673,0.25397,0.30427,1,0
6,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00332,0.2539,0.28426,1,0
6,GO LEUKOCYTE DIFFERENTIATION,0.0019699,0.25388,0.3408,1,0
6,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.022172,0.25369,0.3126,1,0
6,GO RENAL ABSORPTION,0.0057394,0.25361,0.30996,1,0
6,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.0060238,0.25359,0.28994,1,0
6,GO COLLAGEN METABOLIC PROCESS,0.012106,0.2533,0.35415,1,0
6,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0036751,0.25297,0.24887,1,0
6,GO PINOCYTOSIS,0.020391,0.25275,0.25751,1,0
6,GO FEVER GENERATION,0.035953,0.25255,0.20697,1,0
6,GO RESPONSE TO INTERLEUKIN 1,0.0016767,0.25186,0.27981,1,0
6,GO SECONDARY HEART FIELD SPECIFICATION,0.035953,0.25031,0.24715,1,0
6,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0015041,0.2498,0.28541,1,0
6,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0019699,0.24936,0.36164,1,0
6,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0028457,0.24925,0.25343,1,0
6,GO PROSTAGLANDIN TRANSPORT,0.0010209,0.24804,0.35522,1,0
6,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.033245,0.24804,0.23162,1,0
6,GO RESPONSE TO INTERLEUKIN 4,0.0054671,0.24785,0.28417,1,0
6,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.008797,0.24618,0.23654,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0052065,0.24617,0.25708,1,0
6,GO PARAXIAL MESODERM MORPHOGENESIS,0.024086,0.24559,0.24817,1,0
6,GO COAGULATION,0.0027019,0.24522,0.27279,1,0
6,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0096484,0.2452,0.30119,1,0
6,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.018736,0.24502,0.23991,1,0
6,GO PROTEIN TRIMERIZATION,0.0060238,0.2444,0.29146,1,0
6,GO ICOSANOID METABOLIC PROCESS,0.0011418,0.24433,0.25638,1,0
6,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0083971,0.24395,0.27699,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0049572,0.24391,0.35484,1,0
6,GO COLLAGEN CATABOLIC PROCESS,0.010101,0.24168,0.38335,1,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0031545,0.24151,0.28588,1,0
6,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00332,0.24148,0.29857,1,0
6,GO REGULATION OF CALCIUM ION IMPORT,0.0044907,0.24101,0.26953,1,0
6,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0044907,0.24066,0.27187,1,0
6,GO MOVEMENT IN HOST ENVIRONMENT,0.0010209,0.24054,0.27741,1,0
6,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0024341,0.24051,0.2583,1,0
6,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0096484,0.23951,0.2449,1,0
6,GO TRANSCYTOSIS,0.0080134,0.23921,0.31216,1,0
6,GO RESPONSE TO CYTOKINE,0.0015041,0.23866,0.29834,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.015104,0.23847,0.23988,1,0
6,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0028457,0.23836,0.38247,1,0
6,GO CELLULAR RESPONSE TO AMYLOID BETA,0.025096,0.23803,0.24642,1,0
6,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.0040644,0.23749,0.31087,1,0
6,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0052065,0.2373,0.23917,1,0
6,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0066311,0.23727,0.2602,1,0
6,GO AMINOGLYCAN CATABOLIC PROCESS,0.0042727,0.23656,0.29908,1,0
6,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0020776,0.23654,0.26483,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.033245,0.23648,0.22082,1,0
6,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0063209,0.23606,0.22752,1,0
6,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0020776,0.23599,0.30354,1,0
6,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0027019,0.23532,0.25942,1,0
6,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.010572,0.23457,0.25459,1,0
6,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0066311,0.23432,0.24227,1,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.041938,0.23401,0.22991,1,0
6,GO WOUND HEALING,0.0047188,0.23386,0.26437,1,0
6,GO NEGATIVE REGULATION OF CELL ADHESION,0.0024341,0.23366,0.30978,1,0
6,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0042727,0.2336,0.30506,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0025648,0.2336,0.3072,1,0
6,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.028348,0.23355,0.20385,1,0
6,GO THYMOCYTE APOPTOTIC PROCESS,0.014457,0.23304,0.23877,1,0
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0057394,0.23292,0.29182,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0040644,0.23281,0.27981,1,0
6,GO OSTEOCLAST DIFFERENTIATION,0.0025648,0.23219,0.32549,1,0
6,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.023112,0.23203,0.2391,1,0
6,GO I KAPPAB PHOSPHORYLATION,0.01266,0.23137,0.29315,1,0
6,GO DECIDUALIZATION,0.0076456,0.23125,0.32415,1,0
6,GO ACTIN FILAMENT SEVERING,0.0092139,0.23063,0.30495,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0024341,0.23049,0.27667,1,0
6,GO DRUG METABOLIC PROCESS,0.015776,0.22948,0.16973,1,0
6,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00332,0.22942,0.30614,1,0
6,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0044907,0.22872,0.23719,1,0
6,GO THYROID HORMONE METABOLIC PROCESS,0.023112,0.22812,0.25409,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0025648,0.22768,0.26904,1,0
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.035953,0.2275,0.21728,1,0
6,GO REGULATION OF LIPID KINASE ACTIVITY,0.0096484,0.22733,0.27551,1,0
6,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0015882,0.22679,0.2793,1,0
6,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.012106,0.22677,0.25631,1,0
6,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.01266,0.22671,0.27356,1,0
6,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0010798,0.22659,0.24455,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.023112,0.22657,0.29921,1,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0092139,0.22635,0.29578,1,0
6,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.043559,0.22496,0.23685,1,0
6,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0036751,0.2249,0.28542,1,0
6,GO REGULATION OF CHOLESTEROL EFFLUX,0.040368,0.22473,0.22064,1,0
6,GO REGULATION OF BODY FLUID LEVELS,0.010101,0.22456,0.23133,1,0
6,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.040368,0.22429,0.30845,1,0
6,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0016767,0.2242,0.34253,1,0
6,GO B CELL DIFFERENTIATION,0.0014241,0.22414,0.36415,1,0
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0049572,0.2234,0.27631,1,0
6,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0025648,0.22305,0.31729,1,0
6,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0052065,0.22201,0.25713,1,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.025096,0.22141,0.2122,1,0
6,GO REGULATION OF RUFFLE ASSEMBLY,0.0092139,0.22086,0.20886,1,0
6,GO B CELL APOPTOTIC PROCESS,0.0016767,0.2206,0.26256,1,0
6,GO RESPONSE TO NITRIC OXIDE,0.0042727,0.22042,0.2361,1,0
6,GO REGULATION OF LIPID STORAGE,0.0083971,0.22033,0.25468,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.014457,0.21875,0.22843,1,0
6,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0023095,0.21778,0.2816,1,0
6,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.015776,0.21715,0.26476,1,0
6,GO AMINE CATABOLIC PROCESS,0.020391,0.21704,0.22548,1,0
6,GO REGULATION OF STEROL TRANSPORT,0.0096484,0.21665,0.23535,1,0
6,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0057394,0.21639,0.32988,1,0
6,GO REGULATION OF ISOTYPE SWITCHING,0.012106,0.21634,0.25749,1,0
6,GO LIPID DIGESTION,0.046961,0.21624,0.24454,1,0
6,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.0019699,0.21595,0.28125,1,0
6,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.011063,0.2157,0.27891,1,0
6,GO REGULATION OF RECEPTOR BINDING,0.010572,0.21517,0.28712,1,0
6,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0066311,0.21507,0.24351,1,0
6,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0047188,0.21485,0.28054,1,0
6,GO NECROTIC CELL DEATH,0.0015041,0.21455,0.26473,1,0
6,GO LIPOPROTEIN CATABOLIC PROCESS,0.012106,0.2145,0.22478,1,0
6,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0092139,0.21403,0.26184,1,0
6,GO RESPONSE TO HYDROPEROXIDE,0.0092139,0.21402,0.3382,1,0
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.033245,0.21304,0.18837,1,0
6,GO RESPONSE TO FATTY ACID,0.0049572,0.21265,0.2105,1,0
6,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.031957,0.21262,0.24256,1,0
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.031957,0.21248,0.22197,1,0
6,GO STEROL TRANSPORT,0.006955,0.21234,0.22783,1,0
6,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0172,0.21216,0.22024,1,0
6,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0031545,0.21,0.2556,1,0
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.040368,0.20988,0.25958,1,0
6,GO SEQUESTERING OF TRIGLYCERIDE,0.034576,0.20968,0.21927,1,0
6,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0042727,0.209,0.29388,1,0
6,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0028457,0.20875,0.32048,1,0
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.010572,0.20852,0.2411,1,0
6,GO BLOOD VESSEL MORPHOGENESIS,0.013235,0.20839,0.25766,1,0
6,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00086166,0.20824,0.2877,1,0
6,GO CGMP MEDIATED SIGNALING,0.041938,0.20676,0.18654,1,0
6,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.022172,0.20567,0.2386,1,0
6,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.030713,0.20468,0.27656,1,0
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.023112,0.20452,0.21744,1,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.015104,0.20449,0.25759,1,0
6,GO RESPONSE TO DSRNA,0.0031545,0.20433,0.24039,1,0
6,GO SECRETION BY TISSUE,0.013235,0.20422,0.19473,1,0
6,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0054671,0.204,0.28677,1,0
6,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.019548,0.20334,0.26949,1,0
6,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.0036751,0.20325,0.26172,1,0
6,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0036751,0.20313,0.2891,1,0
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.018736,0.20294,0.20537,1,0
6,GO NIK NF KAPPAB SIGNALING,0.0047188,0.20257,0.22727,1,0
6,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.040368,0.20244,0.21839,1,0
6,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.021265,0.20219,0.21243,1,0
6,GO EMBRYO IMPLANTATION,0.0025648,0.20115,0.28857,1,0
6,GO RESPONSE TO WOUNDING,0.008797,0.20115,0.23996,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.021265,0.20095,0.29186,1,0
6,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.0038653,0.20077,0.21044,1,0
6,GO RESPONSE TO AMYLOID BETA,0.030713,0.20064,0.25823,1,0
6,GO POSITIVE REGULATION OF JNK CASCADE,0.0092139,0.20039,0.25329,1,0
6,GO GRANULOCYTE DIFFERENTIATION,0.016475,0.1998,0.25554,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.033245,0.19979,0.17938,1,0
6,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.010101,0.1997,0.22684,1,0
6,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00051151,0.19963,0.23742,1,0
6,GO REGULATION OF CELL FATE COMMITMENT,0.0066311,0.19963,0.22576,1,0
6,GO POSITIVE REGULATION OF MAPK CASCADE,0.0066311,0.19892,0.23877,1,0
6,GO CELL SUBSTRATE ADHESION,0.018736,0.19819,0.25329,1,0
6,GO BIOMINERALIZATION,0.0076456,0.19789,0.24018,1,0
6,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.015776,0.1976,0.29304,1,0
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.010572,0.19756,0.24717,1,0
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.024086,0.19733,0.23251,1,0
6,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0049572,0.19702,0.2716,1,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.010101,0.1964,0.25726,1,0
6,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.040368,0.19627,0.22116,1,0
6,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0054671,0.19603,0.2174,1,0
6,GO PROGRAMMED NECROTIC CELL DEATH,0.0019699,0.19592,0.29431,1,0
6,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0034935,0.1959,0.29393,1,0
6,GO TYPE I INTERFERON PRODUCTION,0.010572,0.19567,0.23604,1,0
6,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0038653,0.19564,0.22595,1,0
6,GO REGULATION OF VIRAL LIFE CYCLE,0.0042727,0.19555,0.25068,1,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.016475,0.19517,0.22766,1,0
6,GO REGULATION OF KERATINOCYTE MIGRATION,0.0172,0.19497,0.30061,1,0
6,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.00332,0.19463,0.27484,1,0
6,GO MUSCLE CELL PROLIFERATION,0.010572,0.1945,0.22329,1,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0036751,0.19442,0.23115,1,0
6,GO SUPEROXIDE METABOLIC PROCESS,0.0010798,0.19422,0.27244,1,0
6,GO FC RECEPTOR SIGNALING PATHWAY,0.0042727,0.19393,0.21956,1,0
6,GO RESPONSE TO ISCHEMIA,0.0096484,0.19391,0.2298,1,0
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.008797,0.19387,0.29671,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.041938,0.19309,0.20609,1,0
6,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0029965,0.19287,0.23923,1,0
6,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.006955,0.19283,0.24917,1,0
6,GO REGULATION OF PEPTIDASE ACTIVITY,0.0013481,0.19237,0.24275,1,0
6,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.011574,0.19235,0.25394,1,0
6,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.027226,0.19203,0.23982,1,0
6,GO DIET INDUCED THERMOGENESIS,0.010572,0.19171,0.24074,1,0
6,GO PROTEIN KINASE B SIGNALING,0.0096484,0.19145,0.22889,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00332,0.19143,0.26563,1,0
6,GO RESPONSE TO LIPID,0.0057394,0.19121,0.22303,1,0
6,GO CELLULAR COPPER ION HOMEOSTASIS,0.0015041,0.19101,0.24351,1,0
6,GO RECEPTOR BIOSYNTHETIC PROCESS,0.02951,0.19035,0.17969,1,0
6,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.033245,0.19033,0.2401,1,0
6,GO CELLULAR IRON ION HOMEOSTASIS,0.00033648,0.19006,0.23508,1,0
6,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.010572,0.19004,0.20582,1,0
6,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.014457,0.18982,0.24946,1,0
6,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.022172,0.18926,0.24333,1,0
6,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0040644,0.189,0.25354,1,0
6,GO PROTEIN PROCESSING,0.00068502,0.18842,0.25535,1,0
6,GO ENGULFMENT OF APOPTOTIC CELL,0.041938,0.18829,0.21196,1,0
6,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.023112,0.18793,0.23511,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.031957,0.18785,0.18416,1,0
6,GO BILE ACID AND BILE SALT TRANSPORT,0.018736,0.18783,0.22562,1,0
6,GO PROTEIN KINASE C SIGNALING,0.034576,0.1876,0.22901,1,0
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.019548,0.18713,0.20659,1,0
6,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.015776,0.18709,0.23975,1,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.025096,0.18701,0.20894,1,0
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.016475,0.18693,0.25638,1,0
6,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0083971,0.18665,0.19835,1,0
6,GO INTERFERON BETA PRODUCTION,0.01266,0.18529,0.25634,1,0
6,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.011063,0.18513,0.33617,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0027019,0.18499,0.23737,1,0
6,GO CELLULAR RESPONSE TO VIRUS,0.013834,0.18483,0.23774,1,0
6,GO IMMUNE SYSTEM DEVELOPMENT,0.0044907,0.18468,0.23954,1,0
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0057394,0.18443,0.24508,1,0
6,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.035953,0.18441,0.24537,1,0
6,GO CELL CELL ADHESION,0.0054671,0.18425,0.24931,1,0
6,GO RESPONSE TO RETINOIC ACID,0.021265,0.1837,0.20144,1,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.043559,0.18278,0.20583,1,0
6,GO POSITIVE REGULATION OF GLIOGENESIS,0.048745,0.18274,0.18637,1,0
6,GO MYOTUBE DIFFERENTIATION,0.0172,0.18193,0.21773,1,0
6,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0020776,0.18185,0.23672,1,0
6,GO ACYLGLYCEROL HOMEOSTASIS,0.025096,0.18177,0.19929,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.033245,0.18159,0.20153,1,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.034576,0.18148,0.18532,1,0
6,GO LIPID STORAGE,0.0038653,0.18128,0.23451,1,0
6,GO REGULATION OF HEMOPOIESIS,0.0038653,0.18021,0.25054,1,0
6,GO SECRETION,0.0024341,0.18005,0.22156,1,0
6,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0096484,0.17995,0.23585,1,0
6,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.011063,0.17984,0.25796,1,0
6,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.008797,0.17964,0.21202,1,0
6,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.015104,0.17927,0.21963,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.006955,0.17925,0.21589,1,0
6,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0057394,0.17909,0.22082,1,0
6,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0015041,0.1779,0.2082,1,0
6,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0052065,0.17789,0.24893,1,0
6,GO CALCIUM MEDIATED SIGNALING,0.0047188,0.17786,0.24161,1,0
6,GO PARAXIAL MESODERM DEVELOPMENT,0.045233,0.17779,0.18517,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.010572,0.17752,0.20202,1,0
6,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.030713,0.17709,0.14278,1,0
6,GO ENDODERMAL CELL DIFFERENTIATION,0.019548,0.17705,0.33651,1,0
6,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0020776,0.1764,0.23326,1,0
6,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0096484,0.17612,0.24558,1,0
6,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.018736,0.17606,0.22237,1,0
6,GO PHOSPHOLIPID HOMEOSTASIS,0.021265,0.17495,0.20953,1,0
6,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0052065,0.1749,0.20369,1,0
6,GO INTERACTION WITH SYMBIONT,0.0025648,0.17445,0.21004,1,0
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.033245,0.17422,0.18659,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.022172,0.17422,0.22241,1,0
6,GO BIOLOGICAL ADHESION,0.0092139,0.17395,0.24312,1,0
6,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.041938,0.17377,0.22831,1,0
6,GO CELLULAR ION HOMEOSTASIS,0.0031545,0.1737,0.21216,1,0
6,GO FATTY ACID TRANSPORT,0.0038653,0.17336,0.21298,1,0
6,GO TRANSITION METAL ION HOMEOSTASIS,0.00064645,0.17301,0.21782,1,0
6,GO AMEBOIDAL TYPE CELL MIGRATION,0.045233,0.17276,0.19038,1,0
6,GO METAL ION HOMEOSTASIS,0.0021907,0.17263,0.22532,1,0
6,GO RESPONSE TO REDOX STATE,0.0096484,0.1721,0.24705,1,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.048745,0.17182,0.17946,1,0
6,GO HYALURONAN METABOLIC PROCESS,0.0063209,0.17168,0.27881,1,0
6,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.030713,0.17157,0.21336,1,0
6,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0044907,0.17131,0.23503,1,0
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0080134,0.1711,0.28907,1,0
6,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0027019,0.17059,0.24928,1,0
6,GO MYELOID CELL DIFFERENTIATION,0.0080134,0.17036,0.22311,1,0
6,GO SERTOLI CELL DIFFERENTIATION,0.045233,0.17034,0.19174,1,0
6,GO CELLULAR OXIDANT DETOXIFICATION,0.0057394,0.17032,0.17715,1,0
6,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.028348,0.17002,0.16948,1,0
6,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.011574,0.16992,0.32422,1,0
6,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.012106,0.16987,0.1716,1,0
6,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.041938,0.16977,0.16467,1,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.008797,0.16963,0.24918,1,0
6,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.028348,0.16951,0.14522,1,0
6,GO IRON ION HOMEOSTASIS,0.00091199,0.16762,0.23775,1,0
6,GO REGULATION OF SYMBIOTIC PROCESS,0.0044907,0.16727,0.22305,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0080134,0.16725,0.20409,1,0
6,GO INTERACTION WITH HOST,0.0052065,0.16716,0.2185,1,0
6,GO RESPONSE TO VITAMIN,0.012106,0.16711,0.21945,1,0
6,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0040644,0.16691,0.19432,1,0
6,GO REGULATION OF ANION TRANSPORT,0.006955,0.1665,0.21237,1,0
6,GO MYELOID CELL DEVELOPMENT,0.016475,0.16609,0.23973,1,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0047188,0.16503,0.34671,1,0
6,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0054671,0.16447,0.25119,1,0
6,GO LIPID CATABOLIC PROCESS,0.0060238,0.16447,0.18587,1,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.033245,0.16381,0.19784,1,0
6,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.02951,0.16359,0.26013,1,0
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.037377,0.16344,0.17836,1,0
6,GO REGULATION OF MAPK CASCADE,0.0080134,0.16342,0.21635,1,0
6,GO VASCULATURE DEVELOPMENT,0.020391,0.16307,0.23867,1,0
6,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0092139,0.16256,0.22537,1,0
6,GO ENDODERM FORMATION,0.022172,0.1625,0.31033,1,0
6,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.040368,0.16209,0.18642,1,0
6,GO CELLULAR RESPONSE TO LIPID,0.006955,0.162,0.21863,1,0
6,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.014457,0.16173,0.23049,1,0
6,GO RIG I SIGNALING PATHWAY,0.040368,0.16132,0.1668,1,0
6,GO ASTROCYTE DIFFERENTIATION,0.041938,0.16128,0.19059,1,0
6,GO GLAND MORPHOGENESIS,0.037377,0.16108,0.23153,1,0
6,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.020391,0.1608,0.20507,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.033245,0.1608,0.19059,1,0
6,GO AMINOGLYCAN METABOLIC PROCESS,0.019548,0.15957,0.23263,1,0
6,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.011574,0.15939,0.22434,1,0
6,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.017954,0.15931,0.20524,1,0
6,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.027226,0.15923,0.23533,1,0
6,GO REGULATION OF CELL SHAPE,0.022172,0.15814,0.22401,1,0
6,GO REGULATION OF VIRAL GENOME REPLICATION,0.0096484,0.15806,0.22842,1,0
6,GO TAXIS,0.022172,0.15793,0.21694,1,0
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.010572,0.15787,0.18289,1,0
6,GO ION HOMEOSTASIS,0.0034935,0.15784,0.20716,1,0
6,GO REGULATION OF LIPID LOCALIZATION,0.0054671,0.15736,0.21803,1,0
6,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.034576,0.15721,0.24658,1,0
6,GO DETOXIFICATION,0.0047188,0.15714,0.17019,1,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0060238,0.15677,0.2178,1,0
6,GO REGULATION OF ERBB SIGNALING PATHWAY,0.013834,0.15664,0.21388,1,0
6,GO LIPID TRANSLOCATION,0.038848,0.15607,0.20892,1,0
6,GO PROTEIN O LINKED GLYCOSYLATION,0.045233,0.15576,0.14967,1,0
6,GO REGULATION OF PROTEIN MATURATION,0.0036751,0.15512,0.25173,1,0
6,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.007293,0.1546,0.21157,1,0
6,GO IMPORT ACROSS PLASMA MEMBRANE,0.041938,0.15426,0.15232,1,0
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0018673,0.15381,0.23983,1,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0023095,0.15372,0.20943,1,0
6,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0063209,0.15341,0.22498,1,0
6,GO KERATINOCYTE MIGRATION,0.034576,0.15333,0.22893,1,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.030713,0.15329,0.21725,1,0
6,GO NUCLEOSIDE CATABOLIC PROCESS,0.010572,0.15328,0.1912,1,0
6,GO REGULATION OF LIPID TRANSPORT,0.0040644,0.15252,0.21356,1,0
6,GO ANIMAL ORGAN REGENERATION,0.0019699,0.15248,0.21005,1,0
6,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.034576,0.15244,0.198,1,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0049572,0.15209,0.22474,1,0
6,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.023112,0.15198,0.22119,1,0
6,GO RESPONSE TO XENOBIOTIC STIMULUS,0.011574,0.15197,0.13023,1,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.007293,0.15174,0.21029,1,0
6,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.037377,0.15165,0.18665,1,0
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.035953,0.15132,0.16731,1,0
6,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.031957,0.15114,0.1968,1,0
6,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.034576,0.15099,0.13788,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.023112,0.15079,0.2043,1,0
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.024086,0.15064,0.20231,1,0
6,GO VITAMIN TRANSPORT,0.012106,0.15036,0.19479,1,0
6,GO ARGININE METABOLIC PROCESS,0.0172,0.15028,0.19523,1,0
6,GO MYELOID CELL HOMEOSTASIS,0.012106,0.15008,0.18615,1,0
6,GO PROTEIN MATURATION,0.0021907,0.14888,0.20182,1,0
6,GO CELLULAR HORMONE METABOLIC PROCESS,0.016475,0.14885,0.14452,1,0
6,GO LIPID HOMEOSTASIS,0.031957,0.14861,0.17245,1,0
6,GO CELLULAR RESPONSE TO LITHIUM ION,0.016475,0.14833,0.18391,1,0
6,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0066311,0.14817,0.18625,1,0
6,GO RESPONSE TO ANTIBIOTIC,0.015776,0.14801,0.17127,1,0
6,GO REGULATION OF RESPONSE TO STRESS,0.0057394,0.14794,0.19955,1,0
6,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0020776,0.14754,0.18876,1,0
6,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.024086,0.14753,0.24987,1,0
6,GO TISSUE HOMEOSTASIS,0.017954,0.14726,0.19337,1,0
6,GO TUBE MORPHOGENESIS,0.043559,0.14702,0.19793,1,0
6,GO REGULATION OF OSSIFICATION,0.010101,0.14701,0.23405,1,0
6,GO VIRAL GENOME REPLICATION,0.011574,0.14665,0.2098,1,0
6,GO ENDOCYTOSIS,0.026142,0.14662,0.19088,1,0
6,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.027226,0.14594,0.25181,1,0
6,GO CELLULAR RESPONSE TO CAMP,0.018736,0.14578,0.17907,1,0
6,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.01266,0.14479,0.20121,1,0
6,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.038848,0.1443,0.21296,1,0
6,GO JNK CASCADE,0.027226,0.14414,0.1908,1,0
6,GO VIRAL LIFE CYCLE,0.0054671,0.14402,0.21085,1,0
6,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.022172,0.14374,0.21469,1,0
6,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.010572,0.14365,0.16366,1,0
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.033245,0.14312,0.2027,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.037377,0.14307,0.20802,1,0
6,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.020391,0.14212,0.19529,1,0
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.038848,0.14193,0.20851,1,0
6,GO ACTIVATION OF MAPK ACTIVITY,0.020391,0.1418,0.18448,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.025096,0.14168,0.19317,1,0
6,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.013235,0.14067,0.2329,1,0
6,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.022172,0.14033,0.19491,1,0
6,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.008797,0.14029,0.19457,1,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.023112,0.13923,0.1858,1,0
6,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.018736,0.13861,0.18271,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.046961,0.13842,0.19868,1,0
6,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.040368,0.13833,0.18913,1,0
6,GO REGULATION OF CALCIUM ION TRANSPORT,0.0066311,0.1383,0.20614,1,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.008797,0.13814,0.18134,1,0
6,GO POSITIVE REGULATION OF NEURON DEATH,0.023112,0.13808,0.17891,1,0
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.013235,0.13793,0.19219,1,0
6,GO VACUOLAR ACIDIFICATION,0.006955,0.13686,0.18464,1,0
6,GO EPITHELIAL CELL PROLIFERATION,0.018736,0.13663,0.19991,1,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0052065,0.13539,0.20371,1,0
6,GO ERYTHROCYTE HOMEOSTASIS,0.038848,0.13533,0.15709,1,0
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.048745,0.13516,0.18257,1,0
6,GO FORMATION OF PRIMARY GERM LAYER,0.024086,0.13475,0.24113,1,0
6,GO CELL MOTILITY,0.022172,0.13455,0.20418,1,0
6,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.040368,0.1344,0.18606,1,0
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.030713,0.13439,0.16295,1,0
6,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.010572,0.1343,0.1961,1,0
6,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.022172,0.13411,0.19231,1,0
6,GO INACTIVATION OF MAPK ACTIVITY,0.02951,0.13364,0.21014,1,0
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.031957,0.13347,0.19807,1,0
6,GO DIVALENT INORGANIC CATION TRANSPORT,0.01266,0.13315,0.17412,1,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.031957,0.13275,0.17076,1,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.030713,0.13255,0.15054,1,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.027226,0.13253,0.17621,1,0
6,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.033245,0.13221,0.15434,1,0
6,GO FACE DEVELOPMENT,0.040368,0.13216,0.22721,1,0
6,GO TRANSEPITHELIAL TRANSPORT,0.046961,0.13211,0.19361,1,0
6,GO CHEMICAL HOMEOSTASIS,0.006955,0.13185,0.18828,1,0
6,GO MAINTENANCE OF LOCATION,0.0042727,0.13181,0.20522,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.020391,0.1317,0.2118,1,0
6,GO ADAPTIVE THERMOGENESIS,0.048745,0.13096,0.15103,1,0
6,GO POLYSACCHARIDE CATABOLIC PROCESS,0.037377,0.13057,0.16443,1,0
6,GO RUFFLE ASSEMBLY,0.023112,0.13055,0.17493,1,0
6,GO LINOLEIC ACID METABOLIC PROCESS,0.041938,0.13011,0.1553,1,0
6,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.014457,0.12979,0.15237,1,0
6,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.041938,0.12953,0.17576,1,0
6,GO LONG CHAIN FATTY ACID TRANSPORT,0.01266,0.12946,0.17617,1,0
6,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.013235,0.12933,0.18594,1,0
6,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.007293,0.12919,0.18991,1,0
6,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.043559,0.12874,0.16608,1,0
6,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.040368,0.12858,0.18138,1,0
6,GO RESPONSE TO ATP,0.018736,0.12813,0.22147,1,0
6,GO REGULATION OF PROTEOLYSIS,0.006955,0.12798,0.18514,1,0
6,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.030713,0.12741,0.15406,1,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.008797,0.12701,0.16874,1,0
6,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.013834,0.12681,0.18008,1,0
6,GO FIBROBLAST PROLIFERATION,0.045233,0.12678,0.17921,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.02951,0.12629,0.1512,1,0
6,GO CELLULAR RESPONSE TO FATTY ACID,0.037377,0.12586,0.16497,1,0
6,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.031957,0.12559,0.18918,1,0
6,GO ETHER METABOLIC PROCESS,0.02951,0.12442,0.14777,1,0
6,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.008797,0.12431,0.17199,1,0
6,GO CARDIAC MUSCLE CONTRACTION,0.037377,0.12333,0.14228,1,0
6,GO AMINO SUGAR METABOLIC PROCESS,0.011574,0.12234,0.2332,1,0
6,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.020391,0.12176,0.20124,1,0
6,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.012106,0.12134,0.17649,1,0
6,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.027226,0.12075,0.17357,1,0
6,GO POSITIVE REGULATION OF SIGNALING,0.018736,0.12042,0.17237,1,0
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.024086,0.11984,0.18062,1,0
6,GO ACTIVATION OF JUN KINASE ACTIVITY,0.048745,0.11982,0.20617,1,0
6,GO CARTILAGE DEVELOPMENT,0.035953,0.11919,0.20498,1,0
6,GO L AMINO ACID TRANSPORT,0.048745,0.11826,0.15177,1,0
6,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.038848,0.11798,0.15968,1,0
6,GO REGULATION OF CELL POPULATION PROLIFERATION,0.016475,0.11768,0.1896,1,0
6,GO POSITIVE REGULATION OF CELL DEATH,0.015104,0.11752,0.18152,1,0
6,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.010572,0.11699,0.17192,1,0
6,GO ORGANIC ACID TRANSPORT,0.02951,0.11644,0.14857,1,0
6,GO ORGANIC ANION TRANSPORT,0.022172,0.11615,0.15251,1,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL PROCESS,0.033245,0.11615,0.20523,1,0
6,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.033245,0.11614,0.29347,1,0
6,GO REGULATION OF HYDROLASE ACTIVITY,0.035953,0.1145,0.16061,1,0
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.046961,0.11375,0.2109,1,0
6,GO NEGATIVE REGULATION OF OSSIFICATION,0.024086,0.11322,0.2204,1,0
6,GO CELLULAR HOMEOSTASIS,0.006955,0.11264,0.17594,1,0
6,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.019548,0.11195,0.16879,1,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.028348,0.11184,0.15828,1,0
6,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.027226,0.11138,0.15235,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.045233,0.11132,0.18042,1,0
6,GO REGULATION OF ACTIN FILAMENT LENGTH,0.046961,0.11085,0.16641,1,0
6,GO POSITIVE REGULATION OF VIRAL PROCESS,0.024086,0.10956,0.14415,1,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.011574,0.1094,0.16392,1,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.038848,0.10933,0.17619,1,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.037377,0.10899,0.16134,1,0
6,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.028348,0.10778,0.16631,1,0
6,GO HOMEOSTATIC PROCESS,0.028348,0.10753,0.15949,1,0
6,GO REGULATION OF CELL DEATH,0.017954,0.10557,0.1628,1,0
6,GO NEGATIVE REGULATION OF CELL DEATH,0.019548,0.10552,0.16357,1,0
6,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0096484,0.1053,0.17713,1,0
6,GO RESPONSE TO OXYGEN LEVELS,0.010572,0.10477,0.15732,1,0
6,GO ESTROGEN METABOLIC PROCESS,0.040368,0.10464,0.11852,1,0
6,GO RECEPTOR CATABOLIC PROCESS,0.048745,0.10438,0.16913,1,0
6,GO CONNECTIVE TISSUE DEVELOPMENT,0.046961,0.10417,0.1925,1,0
6,GO ION TRANSPORT,0.037377,0.10394,0.13068,1,0
6,GO MONOCARBOXYLIC ACID TRANSPORT,0.019548,0.10292,0.18353,1,0
6,GO REGULATION OF TRANSPORT,0.040368,0.10234,0.13389,1,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.045233,0.10186,0.16409,1,0
6,GO POSITIVE REGULATION OF EXOCYTOSIS,0.02951,0.10097,0.17136,1,0
6,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.030713,0.1007,0.20391,1,0
6,GO PH REDUCTION,0.024086,0.10065,0.13917,1,0
6,GO ANION TRANSPORT,0.045233,0.10035,0.13756,1,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS,0.020391,0.099539,0.16249,1,0
6,GO POSITIVE REGULATION OF ERAD PATHWAY,0.033245,0.099396,0.17291,1,0
6,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.035953,0.09933,0.16959,1,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.008797,0.098676,0.18671,1,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0060238,0.097354,0.17666,1,0
6,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.048745,0.097311,0.13978,1,0
6,GO REGULATION OF CELLULAR PH,0.030713,0.096567,0.13578,1,0
6,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.043559,0.095438,0.15351,1,0
6,GO GLYCOSYLATION,0.045233,0.095366,0.13691,1,0
6,GO APOPTOTIC PROCESS,0.026142,0.095209,0.15395,1,0
6,GO MICROVILLUS ORGANIZATION,0.038848,0.094744,0.1851,1,0
6,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.01266,0.094143,0.16101,1,0
6,GO RESPONSE TO GAMMA RADIATION,0.027226,0.093731,0.14152,1,0
6,GO OSTEOBLAST DIFFERENTIATION,0.041938,0.092051,0.18585,1,0
6,GO GLIAL CELL APOPTOTIC PROCESS,0.048745,0.09078,0.19475,1,0
6,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.023112,0.089898,0.11708,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.037377,0.089804,0.165,1,0
6,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.038848,0.089771,0.13535,1,0
6,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.028348,0.089446,0.20488,1,0
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.045233,0.089417,0.14009,1,0
6,GO AGING,0.027226,0.089334,0.16028,1,0
6,GO RESPONSE TO DRUG,0.038848,0.088533,0.15049,1,0
6,GO INTERMEMBRANE LIPID TRANSFER,0.038848,0.086145,0.18624,1,0
6,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.043559,0.085578,0.14184,1,0
6,GO SYMBIOTIC PROCESS,0.019548,0.085431,0.12837,1,0
6,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.037377,0.084769,0.14436,1,0
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.035953,0.082521,0.14344,1,0
6,GO CATION TRANSPORT,0.046961,0.081178,0.12352,1,0
6,GO REGULATION OF PH,0.040368,0.080695,0.12689,1,0
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.045233,0.079412,0.16301,1,0
6,GO METAL ION TRANSPORT,0.043559,0.078778,0.13293,1,0
6,GO PROTEIN DESTABILIZATION,0.046961,0.077761,0.15018,1,0
6,GO REGULATION OF MULTI ORGANISM PROCESS,0.037377,0.07604,0.12504,1,0
6,GO REGULATION OF VIRAL TRANSCRIPTION,0.048745,0.076023,0.11204,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.031957,0.076021,0.098978,1,0
6,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.027226,0.075343,0.16349,1,0
6,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.048745,0.074719,0.11922,1,0
6,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.041938,0.073697,0.097261,1,0
6,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.046961,0.073406,0.1198,1,0
6,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.046961,0.072999,0.15364,1,0
6,GO PLACENTA DEVELOPMENT,0.048745,0.071991,0.16729,1,0
6,GO ENDOSOME ORGANIZATION,0.048745,0.068176,0.13176,1,0
6,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.027226,0.061273,0.12938,1,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.045233,0.061186,0.1435,1,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.045233,0.05095,0.10657,1,0
6,GO ACTIN NUCLEATION,0.02951,0.044076,0.15468,1,0
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.025096,-0.10464,-0.084175,1,0
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.048745,-0.10789,-0.10512,1,0
6,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.028348,-0.11284,-0.083333,1,0
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.031957,-0.12965,-0.11638,1,0
6,GO CELL CYCLE DNA REPLICATION,0.043559,-0.13398,-0.12803,1,0
6,GO MEIOSIS I CELL CYCLE PROCESS,0.040368,-0.1369,-0.11858,1,0
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.027226,-0.13735,-0.10632,1,0
6,GO POSITIVE REGULATION OF MRNA PROCESSING,0.013235,-0.14119,-0.13079,1,0
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.030713,-0.14383,-0.13126,1,0
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.022172,-0.14679,-0.11553,1,0
6,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.037377,-0.14896,-0.12093,1,0
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.026142,-0.15214,-0.14189,1,0
6,GO REGULATION OF MRNA PROCESSING,0.035953,-0.15718,-0.11122,1,0
6,GO POSITIVE REGULATION OF RNA SPLICING,0.038848,-0.15767,-0.10979,1,0
6,GO SPERMATID NUCLEUS DIFFERENTIATION,0.045233,-0.15851,-0.1185,1,0
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.025096,-0.15903,-0.11966,1,0
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.026142,-0.15997,-0.1293,1,0
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.041938,-0.16007,-0.10657,1,0
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.035953,-0.16093,-0.16275,1,0
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0020776,-0.16239,-0.13609,1,0
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.046961,-0.16604,-0.14217,1,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.019548,-0.16863,-0.12873,1,0
6,GO CELL DIFFERENTIATION IN HINDBRAIN,0.030713,-0.17226,-0.17668,1,0
6,GO G0 TO G1 TRANSITION,0.046961,-0.17243,-0.1288,1,0
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.048745,-0.17395,-0.10982,1,0
6,GO DNA REPLICATION INITIATION,0.022172,-0.17636,-0.13894,1,0
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.027226,-0.17874,-0.14334,1,0
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.046961,-0.17939,-0.1493,1,0
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.048745,-0.17986,-0.11832,1,0
6,GO INTERSTRAND CROSS LINK REPAIR,0.018736,-0.17986,-0.16316,1,0
6,GO CHROMATIN DISASSEMBLY,0.031957,-0.18077,-0.13952,1,0
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.046961,-0.182,-0.14151,1,0
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.017954,-0.18229,-0.16056,1,0
6,GO HISTONE H3 K9 TRIMETHYLATION,0.031957,-0.18573,-0.14289,1,0
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0047188,-0.18957,-0.17493,1,0
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.048745,-0.1937,-0.12472,1,0
6,GO NUCLEOSOME ORGANIZATION,0.027226,-0.1961,-0.12732,1,0
6,GO DNA PACKAGING,0.037377,-0.19672,-0.12239,1,0
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.033245,-0.19683,-0.14097,1,0
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.011574,-0.19804,-0.1922,1,0
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.007293,-0.19977,-0.19426,1,0
6,GO NUCLEOSOME ASSEMBLY,0.045233,-0.20119,-0.1271,1,0
6,GO CHROMATIN SILENCING,0.037377,-0.20316,-0.1324,1,0
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.035953,-0.20365,-0.20625,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.013235,-0.20451,-0.14793,1,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.015776,-0.20673,-0.16799,1,0
6,GO ATP DEPENDENT CHROMATIN REMODELING,0.038848,-0.20943,-0.13224,1,0
6,GO VENTRAL SPINAL CORD DEVELOPMENT,0.02951,-0.21036,-0.15275,1,0
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.027226,-0.21402,-0.12944,1,0
6,GO CEREBELLAR CORTEX FORMATION,0.043559,-0.21503,-0.15545,1,0
6,GO OTIC VESICLE DEVELOPMENT,0.013235,-0.2167,-0.22221,1,0
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.035953,-0.21816,-0.13532,1,0
6,GO MRNA SPLICE SITE SELECTION,0.02951,-0.21821,-0.21186,1,0
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.030713,-0.22545,-0.21998,1,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.041938,-0.23064,-0.11684,1,0
6,GO CHROMATIN SILENCING AT TELOMERE,0.00332,-0.23764,-0.22257,1,0
6,GO PROTEIN POLYGLUTAMYLATION,0.019548,-0.23916,-0.19579,1,0
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0076456,-0.24127,-0.20706,1,0
6,GO CENTROMERE COMPLEX ASSEMBLY,0.013834,-0.24324,-0.1844,1,0
6,GO HISTONE H3 K27 METHYLATION,0.037377,-0.24757,-0.18539,1,0
6,GO RETROGRADE AXONAL TRANSPORT,0.037377,-0.24948,-0.20764,1,0
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.013235,-0.25262,-0.17809,1,0
6,GO HISTONE EXCHANGE,0.01266,-0.25317,-0.18198,1,0
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.025096,-0.25329,-0.26195,1,0
6,GO DNA REPLICATION CHECKPOINT,0.015776,-0.25349,-0.1998,1,0
6,GO EMBRYONIC BRAIN DEVELOPMENT,0.0063209,-0.25418,-0.21872,1,0
6,GO CARDIAC VENTRICLE FORMATION,0.034576,-0.25603,-0.28071,1,0
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.0172,-0.26062,-0.29955,1,0
6,GO KINETOCHORE ASSEMBLY,0.019548,-0.26244,-0.19098,1,0
6,GO REGULATION OF RESPONSE TO FOOD,0.015776,-0.26248,-0.22947,1,0
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.014457,-0.26769,-0.28002,1,0
6,GO CHROMATIN REMODELING AT CENTROMERE,0.0049572,-0.27451,-0.2287,1,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.045233,-0.2768,-0.18865,1,0
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.0092139,-0.29886,-0.24946,1,0
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.041938,-0.30275,-0.27202,1,0
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.030713,-0.30362,-0.24247,1,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.01266,-0.30613,-0.24457,1,0
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.031957,-0.31056,-0.25567,1,0
6,GO KINETOCHORE ORGANIZATION,0.014457,-0.32638,-0.21314,1,0
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.041938,-0.35273,-0.26876,1,0
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.016475,-0.40494,-0.37244,1,0
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0049572,-0.48019,-0.44974,1,0
6,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.074935,0.29746,0.24123,0,1
6,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.077559,0.26889,0.22669,0,1
6,GO SKIN MORPHOGENESIS,0.054439,0.26684,0.27319,0,1
6,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.054439,0.26035,0.24256,0,1
6,GO EXTRACELLULAR MATRIX ASSEMBLY,0.067497,0.26019,0.26601,0,1
6,GO AORTIC VALVE DEVELOPMENT,0.054439,0.23153,0.23327,0,1
6,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.11163,0.23087,0.2127,0,1
6,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.20822,0.22141,0.12989,0,1
6,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.08881,0.21925,0.28739,0,1
6,GO DOPAMINE BIOSYNTHETIC PROCESS,0.10811,0.21902,0.18889,0,1
6,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.10134,0.21856,0.20501,0,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.12273,0.21437,0.16131,0,1
6,GO AMMONIUM ION METABOLIC PROCESS,0.062884,0.20321,0.19253,0,1
6,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.11163,0.20187,0.16091,0,1
6,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.056456,0.20165,0.20349,0,1
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.077559,0.19831,0.238,0,1
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.054439,0.19799,0.21423,0,1
6,GO CELLULAR RESPONSE TO ZINC ION,0.18624,0.19466,0.15286,0,1
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.065157,0.19425,0.19932,0,1
6,GO RESPONSE TO IMMOBILIZATION STRESS,0.058535,0.19312,0.16028,0,1
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.12662,0.1919,0.21355,0,1
6,GO BASEMENT MEMBRANE ORGANIZATION,0.050584,0.18873,0.2333,0,1
6,GO REPLICATIVE SENESCENCE,0.050584,0.18831,0.19616,0,1
6,GO VITAMIN CATABOLIC PROCESS,0.25111,0.18326,0.091336,0,1
6,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.072385,0.17967,0.1951,0,1
6,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.056456,0.1748,0.20979,0,1
6,GO NOREPINEPHRINE METABOLIC PROCESS,0.13885,0.17451,0.17156,0,1
6,GO INNERVATION,0.23827,0.17332,0.21867,0,1
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.29248,0.17187,0.12085,0,1
6,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.060677,0.17187,0.21536,0,1
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.060677,0.17097,0.2054,0,1
6,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.058535,0.16776,0.19005,0,1
6,GO ENDODERMAL CELL FATE COMMITMENT,0.10134,0.16605,0.15743,0,1
6,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.065157,0.16166,0.19219,0,1
6,GO MATERNAL PLACENTA DEVELOPMENT,0.058535,0.16113,0.21314,0,1
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.052482,0.15856,0.1675,0,1
6,GO ENAMEL MINERALIZATION,0.11524,0.15556,0.17093,0,1
6,GO RETINOL METABOLIC PROCESS,0.11524,0.15447,0.12824,0,1
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.058535,0.154,0.21289,0,1
6,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.052482,0.1529,0.19191,0,1
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.23827,0.15257,0.075777,0,1
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.065157,0.15233,0.15736,0,1
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.48117,0.15192,0.076404,0,1
6,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.10468,0.15171,0.16287,0,1
6,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.13467,0.14887,0.16469,0,1
6,GO AMELOGENESIS,0.10468,0.14761,0.14701,0,1
6,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.13885,0.14689,0.12955,0,1
6,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.19156,0.14533,0.11776,0,1
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.37111,0.14428,0.080902,0,1
6,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.14312,0.14421,0.096572,0,1
6,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.10134,0.14158,0.11655,0,1
6,GO REGULATION OF MICROVILLUS ORGANIZATION,0.074935,0.14091,0.17133,0,1
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.10134,0.14075,0.16126,0,1
6,GO RECEPTOR RECYCLING,0.08588,0.14074,0.14999,0,1
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.074935,0.13971,0.12599,0,1
6,GO RESPONSE TO CAFFEINE,0.13467,0.13665,0.1217,0,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.11163,0.13654,0.14159,0,1
6,GO LIPID OXIDATION,0.15655,0.13577,0.10252,0,1
6,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.091819,0.13565,0.13848,0,1
6,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.056456,0.13484,0.18377,0,1
6,GO RESPONSE TO AMPHETAMINE,0.077559,0.13448,0.12589,0,1
6,GO POSITIVE REGULATION OF HORMONE SECRETION,0.10811,0.13372,0.11486,0,1
6,GO CELLULAR RESPONSE TO ALKALOID,0.08303,0.13259,0.11234,0,1
6,GO TOOTH MINERALIZATION,0.17091,0.13247,0.14482,0,1
6,GO ACTIN FILAMENT DEPOLYMERIZATION,0.08588,0.13199,0.17349,0,1
6,GO EMBRYONIC HEMOPOIESIS,0.080256,0.13158,0.18631,0,1
6,GO MUSCLE SYSTEM PROCESS,0.052482,0.13054,0.14598,0,1
6,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.10468,0.13016,0.16671,0,1
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.197,0.12946,0.11704,0,1
6,GO N GLYCAN PROCESSING,0.072385,0.12879,0.22623,0,1
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.091819,0.1266,0.19749,0,1
6,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.069906,0.12613,0.14179,0,1
6,GO ACTIN FILAMENT BASED MOVEMENT,0.080256,0.12484,0.14742,0,1
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.054439,0.12413,0.17269,0,1
6,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.050584,0.12258,0.18427,0,1
6,GO RESPONSE TO ZINC ION,0.091819,0.12201,0.12962,0,1
6,GO MUSCLE HYPERTROPHY,0.10468,0.122,0.14029,0,1
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.069906,0.12155,0.17357,0,1
6,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.054439,0.12126,0.16666,0,1
6,GO NUCLEOTIDE TRANSPORT,0.069906,0.12104,0.12148,0,1
6,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.10468,0.12072,0.1365,0,1
6,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.056456,0.1189,0.15444,0,1
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.13467,0.11757,0.12662,0,1
6,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.065157,0.11695,0.14714,0,1
6,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.065157,0.11602,0.12673,0,1
6,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.050584,0.11498,0.14419,0,1
6,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.060677,0.11458,0.14833,0,1
6,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.065157,0.11411,0.12389,0,1
6,GO SMOOTH MUSCLE CONTRACTION,0.08303,0.11379,0.14744,0,1
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.062884,0.11297,0.17484,0,1
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.16123,0.11172,0.1227,0,1
6,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.050584,0.11062,0.14988,0,1
6,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.08588,0.10911,0.12505,0,1
6,GO ENDOCRINE HORMONE SECRETION,0.062884,0.10811,0.14991,0,1
6,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.2998,0.10788,0.13289,0,1
6,GO RESPONSE TO X RAY,0.18624,0.10759,0.11208,0,1
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.091819,0.10754,0.11832,0,1
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.12273,0.10589,0.12982,0,1
6,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.11894,0.10332,0.14628,0,1
6,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.08588,0.10182,0.12437,0,1
6,GO MAGNESIUM ION TRANSPORT,0.1306,0.10159,0.13256,0,1
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.12662,0.10054,0.11905,0,1
6,GO PEROXISOMAL MEMBRANE TRANSPORT,0.065157,0.099819,0.11421,0,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.067497,0.098447,0.15172,0,1
6,GO POSITIVE REGULATION OF CELL MATURATION,0.18102,0.095513,0.12598,0,1
6,GO CIRCADIAN SLEEP WAKE CYCLE,0.37111,0.094747,0.071124,0,1
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.38829,0.094245,0.10739,0,1
6,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.12273,0.093684,0.13232,0,1
6,GO GLYCEROLIPID METABOLIC PROCESS,0.065157,0.093515,0.12451,0,1
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.080256,0.093477,0.14238,0,1
6,GO SPHINGOLIPID METABOLIC PROCESS,0.050584,0.090801,0.14395,0,1
6,GO RESPONSE TO CARBOHYDRATE,0.1306,0.090059,0.11634,0,1
6,GO REGULATION OF TRANSFERASE ACTIVITY,0.08588,0.089918,0.13138,0,1
6,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.08881,0.089372,0.17003,0,1
6,GO LIPOPROTEIN METABOLIC PROCESS,0.091819,0.088982,0.11685,0,1
6,GO SMALL MOLECULE CATABOLIC PROCESS,0.050584,0.087485,0.11379,0,1
6,GO REGULATION OF FATTY ACID OXIDATION,0.36271,0.085961,0.093775,0,1
6,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.098083,0.085641,0.12959,0,1
6,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.065157,0.084433,0.1335,0,1
6,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.062884,0.084288,0.11734,0,1
6,GO PURINE CONTAINING COMPOUND SALVAGE,0.17091,0.083388,0.076146,0,1
6,GO RESPONSE TO ENDOGENOUS STIMULUS,0.067497,0.082889,0.14526,0,1
6,GO INTRACELLULAR LIPID TRANSPORT,0.197,0.082581,0.12751,0,1
6,GO LIPID MODIFICATION,0.21989,0.081898,0.10458,0,1
6,GO MULTIVESICULAR BODY ORGANIZATION,0.10468,0.081894,0.087659,0,1
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.11163,0.08157,0.09537,0,1
6,GO NEGATIVE REGULATION OF BINDING,0.39705,0.081275,0.088542,0,1
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.13885,0.080853,0.12255,0,1
6,GO RESPONSE TO NITROGEN COMPOUND,0.060677,0.080163,0.13788,0,1
6,GO HORMONE BIOSYNTHETIC PROCESS,0.10134,0.079195,0.11228,0,1
6,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.062884,0.077138,0.14318,0,1
6,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.098083,0.07528,0.11403,0,1
6,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.18102,0.075004,0.11159,0,1
6,GO RESPONSE TO MONOSACCHARIDE,0.2259,0.073657,0.10023,0,1
6,GO REGULATION OF PROTEIN LOCALIZATION,0.12662,0.073484,0.12568,0,1
6,GO THIOESTER BIOSYNTHETIC PROCESS,0.2259,0.073216,0.11067,0,1
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.18624,0.072526,0.11568,0,1
6,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.214,0.071505,0.091065,0,1
6,GO CARBOHYDRATE CATABOLIC PROCESS,0.19156,0.071319,0.10505,0,1
6,GO FATTY ACID CATABOLIC PROCESS,0.23827,0.06999,0.089394,0,1
6,GO ORGANIC ACID CATABOLIC PROCESS,0.08303,0.069693,0.10673,0,1
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.49108,0.069156,0.077589,0,1
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.23827,0.068797,0.10813,0,1
6,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.062884,0.067977,0.11528,0,1
6,GO RESPONSE TO INSULIN,0.11894,0.060683,0.12221,0,1
6,GO RESPONSE TO NITROSATIVE STRESS,0.13885,0.058346,0.083632,0,1
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.15197,0.053689,0.12945,0,1
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.13885,0.051643,0.072905,0,1
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.12662,0.046561,0.093354,0,1
6,GO EOSINOPHIL CHEMOTAXIS,0.00045436,0.79187,0.72111,0,0
6,GO NEGATIVE REGULATION OF BONE REMODELING,0.0015041,0.60078,0.54194,0,0
6,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.00048214,0.5135,0.52444,0,0
6,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0010798,0.49975,0.51051,0,0
6,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00051151,0.3457,0.41102,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00091199,0.34117,0.43493,0,0
6,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.026142,0.30736,0.25801,0,0
6,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0015041,0.30384,0.39639,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.011063,0.30301,0.28598,0,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0021907,0.29224,0.26837,0,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0092139,0.28445,0.266,0,0
6,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0054671,0.27951,0.28042,0,0
6,GO SEROTONIN SECRETION,0.019548,0.27801,0.29207,0,0
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.052482,0.27493,0.25304,0,0
6,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.023112,0.27032,0.35572,0,0
6,GO REGULATION OF CELL FATE SPECIFICATION,0.0023095,0.27012,0.30768,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0063209,0.26737,0.26719,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.041938,0.26009,0.25192,0,0
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.0066311,0.25865,0.26923,0,0
6,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.08588,0.25797,0.19855,0,0
6,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.0049572,0.25675,0.26464,0,0
6,GO REGULATION OF GLOMERULAR FILTRATION,0.031957,0.25563,0.28334,0,0
6,GO POSITIVE CHEMOTAXIS,0.00064645,0.25489,0.31492,0,0
6,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.060677,0.25214,0.21094,0,0
6,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.094909,0.2516,0.21663,0,0
6,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.25111,0.25156,0.11669,0,0
6,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.013834,0.2514,0.26963,0,0
6,GO POSITIVE REGULATION OF MYELINATION,0.011063,0.24921,0.27048,0,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.041938,0.24711,0.19582,0,0
6,GO POLYOL TRANSPORT,0.016475,0.24326,0.28325,0,0
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.056456,0.23832,0.27533,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.006955,0.23721,0.31704,0,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.027226,0.23555,0.26489,0,0
6,GO POSITIVE REGULATION OF URINE VOLUME,0.038848,0.23302,0.21556,0,0
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.027226,0.23275,0.23209,0,0
6,GO CELLULAR RESPONSE TO IRON ION,0.030713,0.2325,0.23215,0,0
6,GO RESPONSE TO FLUID SHEAR STRESS,0.0172,0.23212,0.28056,0,0
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.069906,0.2278,0.22257,0,0
6,GO CELLULAR RESPONSE TO COPPER ION,0.23203,0.22542,0.14458,0,0
6,GO DETOXIFICATION OF INORGANIC COMPOUND,0.4521,0.22423,0.1353,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.17591,0.22044,0.15513,0,0
6,GO RESPONSE TO PROGESTERONE,0.013235,0.2201,0.26222,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.017954,0.21979,0.21136,0,0
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.12662,0.21958,0.19111,0,0
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0020776,0.2193,0.24836,0,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.08303,0.21797,0.1917,0,0
6,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.048745,0.21779,0.26173,0,0
6,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0047188,0.21686,0.25647,0,0
6,GO OVULATION,0.015776,0.21684,0.2457,0,0
6,GO BICARBONATE TRANSPORT,0.058535,0.21642,0.15915,0,0
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.011574,0.21277,0.25375,0,0
6,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.080256,0.21202,0.19882,0,0
6,GO PULMONARY VALVE MORPHOGENESIS,0.11163,0.2114,0.1849,0,0
6,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.0076456,0.21064,0.277,0,0
6,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.11163,0.21059,0.17976,0,0
6,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.0083971,0.21037,0.24349,0,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.050584,0.20907,0.2412,0,0
6,GO VAGINA DEVELOPMENT,0.072385,0.2081,0.18028,0,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.026142,0.20737,0.2019,0,0
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.08881,0.20681,0.21686,0,0
6,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0066311,0.20659,0.25077,0,0
6,GO CORTICOSTEROID HORMONE SECRETION,0.067497,0.20593,0.16703,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.094909,0.20375,0.1994,0,0
6,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0083971,0.20359,0.23189,0,0
6,GO RENAL FILTRATION,0.038848,0.20348,0.27724,0,0
6,GO HEART TRABECULA FORMATION,0.052482,0.20259,0.2005,0,0
6,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.062884,0.20244,0.27024,0,0
6,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.069906,0.20048,0.21541,0,0
6,GO BRANCH ELONGATION OF AN EPITHELIUM,0.054439,0.20023,0.17791,0,0
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.058535,0.19769,0.20412,0,0
6,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.067497,0.19556,0.27528,0,0
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.040368,0.19524,0.20236,0,0
6,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.016475,0.19495,0.25269,0,0
6,GO REGULATION OF PINOCYTOSIS,0.065157,0.19314,0.20328,0,0
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.050584,0.19231,0.18684,0,0
6,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.072385,0.19159,0.20263,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.045233,0.19139,0.18243,0,0
6,GO REGULATION OF VASOCONSTRICTION,0.015104,0.1904,0.245,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.054439,0.18907,0.24055,0,0
6,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.098083,0.18889,0.19531,0,0
6,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.08303,0.18828,0.19069,0,0
6,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.030713,0.18825,0.22126,0,0
6,GO REGULATION OF RENAL SYSTEM PROCESS,0.0172,0.18791,0.23086,0,0
6,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.045233,0.18787,0.21002,0,0
6,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.091819,0.18724,0.20719,0,0
6,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.17091,0.18631,0.16352,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.040368,0.18617,0.29464,0,0
6,GO HEART TRABECULA MORPHOGENESIS,0.048745,0.18567,0.19996,0,0
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.067497,0.18484,0.21182,0,0
6,GO DERMATAN SULFATE METABOLIC PROCESS,0.077559,0.18447,0.2505,0,0
6,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.12662,0.18392,0.2079,0,0
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0021907,0.18286,0.26262,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.098083,0.18228,0.20676,0,0
6,GO CARDIOBLAST DIFFERENTIATION,0.072385,0.1816,0.19338,0,0
6,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.18624,0.18052,0.15632,0,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.020391,0.18043,0.22295,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.021265,0.1802,0.30961,0,0
6,GO POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION,0.058535,0.17856,0.18059,0,0
6,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.16602,0.1784,0.16779,0,0
6,GO GENITALIA DEVELOPMENT,0.091819,0.17837,0.15156,0,0
6,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.062884,0.17718,0.23063,0,0
6,GO POSITIVE REGULATION OF OSSIFICATION,0.0076456,0.17611,0.25157,0,0
6,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.098083,0.17603,0.18891,0,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0024341,0.17555,0.25421,0,0
6,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.0083971,0.175,0.24707,0,0
6,GO L GLUTAMATE IMPORT,0.038848,0.17459,0.18412,0,0
6,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.010572,0.1725,0.25411,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.017954,0.17243,0.20339,0,0
6,GO LUNG EPITHELIUM DEVELOPMENT,0.0034935,0.17122,0.25869,0,0
6,GO HEART FIELD SPECIFICATION,0.069906,0.17017,0.19693,0,0
6,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.035953,0.16985,0.24827,0,0
6,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.3148,0.16957,0.1322,0,0
6,GO EPITHELIAL CELL CELL ADHESION,0.16123,0.16937,0.18505,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.062884,0.16922,0.17935,0,0
6,GO REGULATION OF SPROUTING ANGIOGENESIS,0.1306,0.16857,0.1667,0,0
6,GO SPROUTING ANGIOGENESIS,0.08881,0.16827,0.17223,0,0
6,GO RESPONSE TO COPPER ION,0.045233,0.16798,0.16941,0,0
6,GO TRACHEA MORPHOGENESIS,0.054439,0.16717,0.20839,0,0
6,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.11163,0.167,0.16874,0,0
6,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.067497,0.16641,0.20405,0,0
6,GO ORGAN INDUCTION,0.021265,0.16589,0.18348,0,0
6,GO REGULATION OF HEAT GENERATION,0.045233,0.16477,0.21231,0,0
6,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.056456,0.16472,0.27096,0,0
6,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.031957,0.16417,0.17696,0,0
6,GO ETHER BIOSYNTHETIC PROCESS,0.098083,0.16398,0.1308,0,0
6,GO PROTEIN AUTOPROCESSING,0.024086,0.16272,0.16782,0,0
6,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.080256,0.16258,0.16002,0,0
6,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.094909,0.162,0.14836,0,0
6,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.10134,0.1614,0.27092,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.050584,0.16138,0.16563,0,0
6,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.072385,0.16061,0.15787,0,0
6,GO REGULATION OF ACTION POTENTIAL,0.11524,0.16014,0.13945,0,0
6,GO CATECHOLAMINE METABOLIC PROCESS,0.026142,0.1599,0.16975,0,0
6,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.094909,0.15983,0.20232,0,0
6,GO RESPONSE TO INACTIVITY,0.1475,0.15964,0.15362,0,0
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.12662,0.15939,0.15728,0,0
6,GO FEMALE GENITALIA DEVELOPMENT,0.15197,0.15855,0.11634,0,0
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.15197,0.1584,0.19208,0,0
6,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.015104,0.15824,0.24514,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.072385,0.15792,0.15513,0,0
6,GO PROSTATIC BUD FORMATION,0.10134,0.15732,0.21137,0,0
6,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.13467,0.15715,0.18836,0,0
6,GO ETHANOL CATABOLIC PROCESS,0.18624,0.15652,0.16915,0,0
6,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.16602,0.15577,0.17031,0,0
6,GO DETERMINATION OF ADULT LIFESPAN,0.1306,0.15547,0.15578,0,0
6,GO BRONCHUS DEVELOPMENT,0.1475,0.15532,0.2082,0,0
6,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.048745,0.15529,0.2777,0,0
6,GO MALE GENITALIA DEVELOPMENT,0.11894,0.15513,0.16686,0,0
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.040368,0.15511,0.20457,0,0
6,GO RESPONSE TO MURAMYL DIPEPTIDE,0.091819,0.15493,0.22934,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.069906,0.15475,0.24686,0,0
6,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.16602,0.15466,0.15472,0,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.11163,0.15448,0.16883,0,0
6,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.1306,0.15392,0.1768,0,0
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.20256,0.15316,0.13873,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.060677,0.15314,0.16935,0,0
6,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.10468,0.15291,0.14929,0,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.050584,0.15271,0.17721,0,0
6,GO RENAL SYSTEM PROCESS,0.067497,0.15262,0.18431,0,0
6,GO STRIATUM DEVELOPMENT,0.050584,0.15245,0.18172,0,0
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.067497,0.15215,0.16907,0,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.031957,0.15203,0.16699,0,0
6,GO CHONDROCYTE DIFFERENTIATION,0.034576,0.1516,0.22574,0,0
6,GO AUTOPHAGIC CELL DEATH,0.0049572,0.15129,0.20617,0,0
6,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.10134,0.15107,0.1605,0,0
6,GO PROGESTERONE METABOLIC PROCESS,0.065157,0.15096,0.16419,0,0
6,GO MONONUCLEAR CELL DIFFERENTIATION,0.050584,0.15084,0.23818,0,0
6,GO RESPONSE TO ESTROGEN,0.062884,0.1504,0.15926,0,0
6,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.080256,0.15037,0.21125,0,0
6,GO SECRETORY GRANULE ORGANIZATION,0.065157,0.14995,0.17397,0,0
6,GO RESPONSE TO VITAMIN D,0.020391,0.14979,0.24758,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.11524,0.14979,0.14963,0,0
6,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.2998,0.14978,0.11939,0,0
6,GO NEURON REMODELING,0.12273,0.1493,0.19887,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.050584,0.1491,0.19813,0,0
6,GO ENDOTHELIUM DEVELOPMENT,0.050584,0.14869,0.21398,0,0
6,GO BROWN FAT CELL DIFFERENTIATION,0.052482,0.14841,0.1534,0,0
6,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.14312,0.14815,0.10428,0,0
6,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.15655,0.14813,0.14805,0,0
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.0057394,0.1478,0.16887,0,0
6,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.018736,0.14753,0.21096,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.12662,0.14723,0.16047,0,0
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.065157,0.14714,0.19197,0,0
6,GO ENTRY OF BACTERIUM INTO HOST CELL,0.1475,0.14712,0.1685,0,0
6,GO ALANINE TRANSPORT,0.11894,0.14694,0.19856,0,0
6,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.038848,0.14689,0.17473,0,0
6,GO MUSCLE FILAMENT SLIDING,0.028348,0.14578,0.11402,0,0
6,GO C21 STEROID HORMONE METABOLIC PROCESS,0.046961,0.14574,0.13674,0,0
6,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.094909,0.1454,0.18647,0,0
6,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.21989,0.14526,0.12988,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.214,0.14518,0.10173,0,0
6,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.15655,0.14507,0.13256,0,0
6,GO OSSIFICATION,0.014457,0.14493,0.21228,0,0
6,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.072385,0.14481,0.23922,0,0
6,GO PROTEIN LOCALIZATION TO AXON,0.36271,0.14479,0.15298,0,0
6,GO WATER TRANSPORT,0.065157,0.14474,0.25168,0,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.091819,0.14459,0.22572,0,0
6,GO CELLULAR RESPONSE TO ALCOHOL,0.054439,0.14443,0.17911,0,0
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.052482,0.14398,0.16518,0,0
6,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.067497,0.14392,0.14939,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.091819,0.14365,0.13086,0,0
6,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.028348,0.14351,0.16796,0,0
6,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.052482,0.14335,0.16588,0,0
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.35442,0.14318,0.087351,0,0
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.18102,0.14293,0.15435,0,0
6,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.1475,0.14264,0.15134,0,0
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.26442,0.14261,0.12368,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.34626,0.14225,0.065983,0,0
6,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.060677,0.14224,0.24701,0,0
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.062884,0.14219,0.17902,0,0
6,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.028348,0.14219,0.18353,0,0
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.067497,0.14212,0.14967,0,0
6,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.098083,0.14206,0.16694,0,0
6,GO LAMELLIPODIUM MORPHOGENESIS,0.065157,0.14189,0.2073,0,0
6,GO ACTIN FILAMENT NETWORK FORMATION,0.037377,0.1416,0.21364,0,0
6,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.060677,0.14157,0.21415,0,0
6,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.214,0.1415,0.15807,0,0
6,GO MESENCHYME MORPHOGENESIS,0.056456,0.14029,0.20819,0,0
6,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.074935,0.14027,0.367,0,0
6,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.094909,0.14013,0.14678,0,0
6,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.10134,0.14,0.27428,0,0
6,GO PROTEIN AUTO ADP RIBOSYLATION,0.32248,0.13968,0.12571,0,0
6,GO STEM CELL DIVISION,0.28529,0.13929,0.13354,0,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.080256,0.13928,0.18586,0,0
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.16602,0.13924,0.19384,0,0
6,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.091819,0.13915,0.23234,0,0
6,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.080256,0.13891,0.19368,0,0
6,GO PROTEIN ADP RIBOSYLATION,0.074935,0.13865,0.13781,0,0
6,GO RESPONSE TO UV B,0.074935,0.13864,0.15963,0,0
6,GO HEMIDESMOSOME ASSEMBLY,0.91805,0.13859,-0.025858,0,0
6,GO REGULATION OF VESICLE FUSION,0.18102,0.13855,0.18081,0,0
6,GO REGULATION OF JUN KINASE ACTIVITY,0.072385,0.13847,0.18045,0,0
6,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.065157,0.13832,0.20241,0,0
6,GO XENOBIOTIC CATABOLIC PROCESS,0.2998,0.13815,0.12886,0,0
6,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0063209,0.13773,0.19108,0,0
6,GO CELLULAR RESPONSE TO RETINOIC ACID,0.15197,0.13767,0.15553,0,0
6,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.080256,0.13751,0.16797,0,0
6,GO FLUID TRANSPORT,0.067497,0.13732,0.22283,0,0
6,GO NEURONAL ACTION POTENTIAL,0.11163,0.1373,0.14093,0,0
6,GO HYPOTONIC RESPONSE,0.13885,0.13713,0.12405,0,0
6,GO CARDIAC CHAMBER MORPHOGENESIS,0.074935,0.13678,0.18382,0,0
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.10134,0.13675,0.16871,0,0
6,GO NEPHRIC DUCT DEVELOPMENT,0.18624,0.13656,0.13903,0,0
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.17091,0.1361,0.15469,0,0
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.08588,0.13577,0.18925,0,0
6,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.1306,0.13552,0.096165,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.094909,0.13547,0.15155,0,0
6,GO DORSAL AORTA DEVELOPMENT,0.37964,0.13538,0.11957,0,0
6,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.074935,0.13532,0.16119,0,0
6,GO SALIVARY GLAND DEVELOPMENT,0.058535,0.13524,0.22873,0,0
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.098083,0.13513,0.12773,0,0
6,GO REGULATION OF MUSCLE HYPERTROPHY,0.060677,0.13502,0.15851,0,0
6,GO MULTICELLULAR ORGANISM AGING,0.14312,0.13475,0.12231,0,0
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.10468,0.13446,0.23803,0,0
6,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.069906,0.13439,0.18115,0,0
6,GO MYOBLAST DIFFERENTIATION,0.062884,0.13438,0.16668,0,0
6,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.23203,0.13435,0.098583,0,0
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.28529,0.13425,0.11818,0,0
6,GO KERATINOCYTE DEVELOPMENT,0.12662,0.13422,0.20285,0,0
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.53179,0.13398,0.060918,0,0
6,GO REGULATION OF RECEPTOR CLUSTERING,0.36271,0.1339,0.1515,0,0
6,GO NEPHRIC DUCT MORPHOGENESIS,0.30724,0.13383,0.089686,0,0
6,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.15655,0.1338,0.11924,0,0
6,GO KERATINOCYTE PROLIFERATION,0.050584,0.13364,0.19584,0,0
6,GO AXIS ELONGATION,0.11894,0.13354,0.14918,0,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.098083,0.13353,0.19935,0,0
6,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0044907,0.13346,0.19218,0,0
6,GO MUSCLE CONTRACTION,0.050584,0.13339,0.14584,0,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.038848,0.13315,0.20448,0,0
6,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.080256,0.13247,0.16063,0,0
6,GO REGULATION OF GASTRULATION,0.067497,0.1324,0.17554,0,0
6,GO RESPONSE TO PAIN,0.069906,0.13219,0.14617,0,0
6,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.056456,0.13204,0.17833,0,0
6,GO SUBPALLIUM DEVELOPMENT,0.12273,0.13174,0.17533,0,0
6,GO POSITIVE REGULATION OF HEART RATE,0.13885,0.13153,0.14281,0,0
6,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.062884,0.13151,0.15673,0,0
6,GO EPITHELIAL CELL MORPHOGENESIS,0.10468,0.13121,0.21323,0,0
6,GO ANOIKIS,0.056456,0.13119,0.19572,0,0
6,GO MIDGUT DEVELOPMENT,0.2998,0.13117,0.12656,0,0
6,GO GLUCOCORTICOID METABOLIC PROCESS,0.11524,0.13108,0.13696,0,0
6,GO MESODERMAL CELL DIFFERENTIATION,0.16123,0.13108,0.15192,0,0
6,GO REGULATION OF ODONTOGENESIS,0.15655,0.13104,0.14995,0,0
6,GO POSITIVE REGULATION OF AUTOPHAGY,0.062884,0.13084,0.16461,0,0
6,GO SEROTONIN TRANSPORT,0.19156,0.13072,0.1505,0,0
6,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.1475,0.12999,0.12278,0,0
6,GO RESPONSE TO HYPEROXIA,0.0092139,0.12984,0.22586,0,0
6,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.058535,0.12977,0.17805,0,0
6,GO EXPLORATION BEHAVIOR,0.2998,0.1297,0.08774,0,0
6,GO ANIMAL ORGAN FORMATION,0.08303,0.1296,0.14101,0,0
6,GO FIBROBLAST APOPTOTIC PROCESS,0.098083,0.12909,0.14186,0,0
6,GO OPTIC NERVE DEVELOPMENT,0.18624,0.12883,0.13925,0,0
6,GO LENS FIBER CELL DEVELOPMENT,0.30724,0.12827,0.10274,0,0
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.11894,0.12812,0.11571,0,0
6,GO CELLULAR RESPONSE TO ATP,0.091819,0.12812,0.17211,0,0
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.15197,0.12775,0.14194,0,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.12273,0.12772,0.16668,0,0
6,GO TRIGEMINAL NERVE DEVELOPMENT,0.68646,0.12753,0.082973,0,0
6,GO REGULATION OF WATER LOSS VIA SKIN,0.15197,0.12752,0.11088,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.0096484,0.12655,0.1409,0,0
6,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.098083,0.12654,0.14118,0,0
6,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.031957,0.12652,0.16939,0,0
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.08303,0.12651,0.16062,0,0
6,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.098083,0.12644,0.14242,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.39705,0.12644,0.13575,0,0
6,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.069906,0.12641,0.18583,0,0
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.10468,0.1261,0.18411,0,0
6,GO REGULATION OF EXCRETION,0.08881,0.12556,0.15471,0,0
6,GO PEPTIDE CATABOLIC PROCESS,0.056456,0.12555,0.19243,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.08303,0.12528,0.10841,0,0
6,GO REPLACEMENT OSSIFICATION,0.10811,0.12524,0.19748,0,0
6,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.080256,0.12504,0.19139,0,0
6,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.054439,0.12501,0.18248,0,0
6,GO GLUTATHIONE METABOLIC PROCESS,0.12273,0.12477,0.097158,0,0
6,GO MESENCHYMAL CELL DIFFERENTIATION,0.10468,0.12476,0.16713,0,0
6,GO WHITE FAT CELL DIFFERENTIATION,0.23203,0.12434,0.10445,0,0
6,GO ALCOHOL CATABOLIC PROCESS,0.062884,0.12432,0.13236,0,0
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.091819,0.12428,0.16511,0,0
6,GO CIRCULATORY SYSTEM DEVELOPMENT,0.050584,0.12423,0.18276,0,0
6,GO POSITIVE REGULATION OF HEART CONTRACTION,0.098083,0.124,0.13658,0,0
6,GO REGULATION OF BLOOD CIRCULATION,0.11524,0.12394,0.12007,0,0
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.16602,0.12392,0.18527,0,0
6,GO NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.052482,0.12389,0.13129,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.094909,0.12382,0.13755,0,0
6,GO GLIAL CELL PROLIFERATION,0.197,0.12363,0.14394,0,0
6,GO ERBB SIGNALING PATHWAY,0.069906,0.12338,0.16608,0,0
6,GO PROTEIN AUTOPHOSPHORYLATION,0.10134,0.12333,0.15472,0,0
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.056456,0.12332,0.13501,0,0
6,GO HYPOTHALAMUS DEVELOPMENT,0.098083,0.12331,0.13506,0,0
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.23203,0.12324,0.13086,0,0
6,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.18102,0.12236,0.14283,0,0
6,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.11894,0.12215,0.16443,0,0
6,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.38829,0.12213,0.090075,0,0
6,GO KERATINOCYTE DIFFERENTIATION,0.17091,0.12202,0.099527,0,0
6,GO DRUG CATABOLIC PROCESS,0.098083,0.12202,0.10151,0,0
6,GO TERPENOID METABOLIC PROCESS,0.11163,0.12195,0.12273,0,0
6,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.098083,0.12188,0.097858,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS,0.42405,0.12125,0.085365,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0047188,0.12123,0.14932,0,0
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.067497,0.12108,0.17478,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.08588,0.12107,0.14221,0,0
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.10468,0.12095,0.19286,0,0
6,GO CARDIAC MUSCLE CELL CONTRACTION,0.052482,0.1209,0.15189,0,0
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.080256,0.12001,0.12101,0,0
6,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.067497,0.11985,0.14127,0,0
6,GO DISACCHARIDE METABOLIC PROCESS,0.074935,0.11979,0.18501,0,0
6,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.052482,0.11979,0.16219,0,0
6,GO WATER HOMEOSTASIS,0.1306,0.11942,0.13709,0,0
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.094909,0.11935,0.1642,0,0
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.15655,0.11881,0.15641,0,0
6,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.12662,0.11862,0.1411,0,0
6,GO PLATELET MORPHOGENESIS,0.11524,0.11849,0.16963,0,0
6,GO METANEPHROS MORPHOGENESIS,0.12662,0.11846,0.16204,0,0
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.08303,0.11844,0.20318,0,0
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.33029,0.11836,0.10292,0,0
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.10811,0.11824,0.15073,0,0
6,GO RESPONSE TO TESTOSTERONE,0.065157,0.11816,0.1356,0,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.046961,0.11811,0.17796,0,0
6,GO RESPONSE TO LEPTIN,0.17091,0.11809,0.1237,0,0
6,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.065157,0.11804,0.12815,0,0
6,GO NERVE DEVELOPMENT,0.20256,0.118,0.1469,0,0
6,GO SPHINGOID METABOLIC PROCESS,0.058535,0.11799,0.19652,0,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.19156,0.1175,0.11732,0,0
6,GO DETECTION OF MECHANICAL STIMULUS,0.062884,0.11746,0.18589,0,0
6,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.052482,0.11736,0.15154,0,0
6,GO MEMBRANE REPOLARIZATION,0.16602,0.11714,0.11877,0,0
6,GO RESPONSE TO MUSCLE ACTIVITY,0.18102,0.11712,0.13039,0,0
6,GO RESPONSE TO AUDITORY STIMULUS,0.2998,0.1171,0.1298,0,0
6,GO TUBE DEVELOPMENT,0.050584,0.11695,0.18656,0,0
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.14312,0.11692,0.15968,0,0
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.15655,0.11691,0.13378,0,0
6,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.18624,0.11685,0.15547,0,0
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.080256,0.11663,0.21275,0,0
6,GO PROSTATE GLAND DEVELOPMENT,0.077559,0.11658,0.17685,0,0
6,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.058535,0.11653,0.16554,0,0
6,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.28529,0.11641,0.17546,0,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.28529,0.11641,0.1221,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.16123,0.11624,0.17691,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.10468,0.1162,0.18007,0,0
6,GO ENDOCARDIAL CUSHION FORMATION,0.077559,0.11592,0.21134,0,0
6,GO ANIMAL ORGAN MATURATION,0.1475,0.11583,0.16533,0,0
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.08588,0.1158,0.15211,0,0
6,GO RESPONSE TO AMINE,0.094909,0.1155,0.11472,0,0
6,GO CELLULAR RESPONSE TO MANGANESE ION,0.056456,0.11539,0.14137,0,0
6,GO HEART VALVE DEVELOPMENT,0.1306,0.11532,0.18074,0,0
6,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.08303,0.11495,0.13458,0,0
6,GO URETER DEVELOPMENT,0.50109,0.11489,0.067049,0,0
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.08588,0.11488,0.19173,0,0
6,GO REGULATION OF MEMBRANE REPOLARIZATION,0.20822,0.11486,0.12344,0,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.30724,0.11479,0.12441,0,0
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.069906,0.11479,0.18526,0,0
6,GO CRANIAL NERVE DEVELOPMENT,0.17591,0.11436,0.1499,0,0
6,GO KIDNEY MESENCHYME DEVELOPMENT,0.08881,0.11417,0.17054,0,0
6,GO ISOPRENOID METABOLIC PROCESS,0.10811,0.11374,0.10848,0,0
6,GO CALCIUM ION IMPORT,0.12273,0.11355,0.11752,0,0
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.12662,0.1133,0.17566,0,0
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.16123,0.11324,0.16998,0,0
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.33029,0.11311,0.1097,0,0
6,GO REGULATION OF NECROTIC CELL DEATH,0.035953,0.11278,0.17676,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.43329,0.11263,0.078377,0,0
6,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.20822,0.11263,0.12978,0,0
6,GO COPULATION,0.14312,0.11252,0.18049,0,0
6,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.10134,0.11239,0.16655,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.23203,0.11234,0.12201,0,0
6,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.060677,0.11213,0.14799,0,0
6,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.10468,0.11205,0.14071,0,0
6,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.2998,0.11187,0.15981,0,0
6,GO SENSORY PERCEPTION OF PAIN,0.10134,0.11186,0.13218,0,0
6,GO REGULATION OF ION TRANSPORT,0.062884,0.11173,0.13147,0,0
6,GO REGULATION OF HEART RATE,0.11524,0.11162,0.10311,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.12273,0.11158,0.17244,0,0
6,GO ESTROUS CYCLE,0.36271,0.11146,0.13051,0,0
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.08303,0.11139,0.12434,0,0
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.25111,0.11124,0.13709,0,0
6,GO POLYSACCHARIDE METABOLIC PROCESS,0.069906,0.11115,0.13849,0,0
6,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.077559,0.11108,0.16766,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.080256,0.11108,0.19719,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.18102,0.11102,0.14478,0,0
6,GO MESONEPHROS DEVELOPMENT,0.11163,0.11094,0.13452,0,0
6,GO LIVER REGENERATION,0.060677,0.1108,0.14313,0,0
6,GO EXOCRINE SYSTEM DEVELOPMENT,0.094909,0.11069,0.18884,0,0
6,GO CELLULAR RESPONSE TO VITAMIN,0.12662,0.11062,0.19115,0,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.060677,0.11061,0.19603,0,0
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.52145,0.11024,0.083828,0,0
6,GO DEVELOPMENTAL INDUCTION,0.17091,0.11001,0.13286,0,0
6,GO CAMP METABOLIC PROCESS,0.33029,0.1097,0.12707,0,0
6,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.3148,0.10968,0.096065,0,0
6,GO CELLULAR RESPONSE TO STEROL,0.20256,0.10957,0.15083,0,0
6,GO MITOTIC CELL CYCLE ARREST,0.14312,0.10939,0.13411,0,0
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.2998,0.10931,0.11608,0,0
6,GO HEMOGLOBIN METABOLIC PROCESS,0.12662,0.10893,0.12011,0,0
6,GO MAMMARY GLAND MORPHOGENESIS,0.12273,0.10883,0.19015,0,0
6,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.27126,0.10855,0.11838,0,0
6,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.10468,0.10854,0.15192,0,0
6,GO VIRAL BUDDING,0.045233,0.10843,0.097762,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.080256,0.10841,0.12775,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.08303,0.10836,0.16428,0,0
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.052482,0.10824,0.15835,0,0
6,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.060677,0.10813,0.12884,0,0
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.78176,0.10771,0.025322,0,0
6,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.12662,0.10769,0.12659,0,0
6,GO REGULATION OF ACTIN NUCLEATION,0.052482,0.10759,0.15386,0,0
6,GO REGULATION OF HORMONE LEVELS,0.098083,0.10747,0.11308,0,0
6,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.2259,0.10718,0.13156,0,0
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.51122,0.10692,0.10146,0,0
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.056456,0.10683,0.15826,0,0
6,GO BODY FLUID SECRETION,0.052482,0.10675,0.14638,0,0
6,GO DIOL BIOSYNTHETIC PROCESS,0.26442,0.10655,0.091467,0,0
6,GO POSITIVE REGULATION OF VESICLE FUSION,0.2998,0.10628,0.12423,0,0
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.25111,0.10613,0.089148,0,0
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.33029,0.10607,0.10769,0,0
6,GO NEGATIVE REGULATION OF AUTOPHAGY,0.1306,0.1059,0.13699,0,0
6,GO CARTILAGE MORPHOGENESIS,0.15655,0.10578,0.14441,0,0
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.1306,0.10577,0.18816,0,0
6,GO REGULATION OF ENDOCYTOSIS,0.056456,0.10565,0.15261,0,0
6,GO IMPORT INTO CELL,0.10811,0.10547,0.12259,0,0
6,GO REGULATION OF ANIMAL ORGAN FORMATION,0.094909,0.10544,0.1389,0,0
6,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.060677,0.10543,0.17095,0,0
6,GO MAINTENANCE OF CELL POLARITY,0.12273,0.10533,0.16352,0,0
6,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.26442,0.10516,0.090036,0,0
6,GO ENDODERM DEVELOPMENT,0.08588,0.10488,0.22716,0,0
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.043559,0.10447,0.1165,0,0
6,GO HEART PROCESS,0.21989,0.10431,0.094227,0,0
6,GO BEHAVIORAL RESPONSE TO PAIN,0.25111,0.1043,0.13468,0,0
6,GO SIGNAL RELEASE,0.11524,0.10417,0.12825,0,0
6,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.069906,0.10402,0.14278,0,0
6,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.058535,0.10396,0.1736,0,0
6,GO URONIC ACID METABOLIC PROCESS,0.077559,0.10382,0.12034,0,0
6,GO REGULATION OF URINE VOLUME,0.12662,0.10378,0.16178,0,0
6,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.10811,0.10376,0.12885,0,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.19156,0.10353,0.10343,0,0
6,GO SULFUR COMPOUND CATABOLIC PROCESS,0.056456,0.10333,0.16229,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.2998,0.1033,0.11439,0,0
6,GO POSITIVE REGULATION OF HEART GROWTH,0.27821,0.10324,0.096492,0,0
6,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.069906,0.10322,0.15007,0,0
6,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.098083,0.10311,0.12457,0,0
6,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.038848,0.10309,0.14381,0,0
6,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.038848,0.10302,0.15451,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.037377,0.10295,0.14549,0,0
6,GO INOSITOL LIPID MEDIATED SIGNALING,0.080256,0.10272,0.18278,0,0
6,GO ACTIN CYTOSKELETON REORGANIZATION,0.1306,0.10271,0.1572,0,0
6,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.15197,0.10271,0.13909,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.16123,0.10265,0.13358,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.062884,0.10265,0.15519,0,0
6,GO POSITIVE REGULATION OF HAIR CYCLE,0.42405,0.10245,0.086151,0,0
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.17591,0.10236,0.15359,0,0
6,GO FUCOSYLATION,0.2259,0.1022,0.090108,0,0
6,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.214,0.10198,0.16905,0,0
6,GO REGULATION OF MITOCHONDRIAL FISSION,0.030713,0.10177,0.17215,0,0
6,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.12273,0.10161,0.14238,0,0
6,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.024086,0.10149,0.21017,0,0
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.32248,0.10142,0.12065,0,0
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.060677,0.101,0.14479,0,0
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.077559,0.10089,0.17085,0,0
6,GO CELL CELL JUNCTION MAINTENANCE,0.27126,0.1008,0.1634,0,0
6,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.052482,0.10072,0.15639,0,0
6,GO DIGESTIVE SYSTEM DEVELOPMENT,0.10811,0.10053,0.16584,0,0
6,GO NEURON DEATH,0.11163,0.10049,0.12915,0,0
6,GO ACTIN FILAMENT ORGANIZATION,0.10468,0.10047,0.15016,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.21989,0.10044,0.12131,0,0
6,GO LUNG MORPHOGENESIS,0.1475,0.10019,0.18008,0,0
6,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.32248,0.099848,0.10517,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT,0.058535,0.099544,0.14055,0,0
6,GO REGULATION OF PHOSPHORYLATION,0.050584,0.09952,0.1551,0,0
6,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.11163,0.099359,0.1547,0,0
6,GO NEGATIVE REGULATION OF NEURON DEATH,0.17091,0.099347,0.11746,0,0
6,GO PROSTATE GLAND MORPHOGENESIS,0.20256,0.099257,0.17118,0,0
6,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.2259,0.099052,0.08527,0,0
6,GO ORGANIC CATION TRANSPORT,0.19156,0.098994,0.12927,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.098083,0.09886,0.085464,0,0
6,GO REGULATION OF DEOXYRIBONUCLEASE ACTIVITY,0.065157,0.098847,0.12944,0,0
6,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.23827,0.098354,0.1583,0,0
6,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.10134,0.098315,0.13701,0,0
6,GO GLIAL CELL MIGRATION,0.10134,0.098262,0.17903,0,0
6,GO ACTION POTENTIAL,0.1475,0.098245,0.10036,0,0
6,GO DEFINITIVE HEMOPOIESIS,0.44264,0.098188,0.1113,0,0
6,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.045233,0.097847,0.1318,0,0
6,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.060677,0.097795,0.17649,0,0
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.27821,0.097658,0.10754,0,0
6,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.077559,0.09751,0.14644,0,0
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.048745,0.097241,0.22523,0,0
6,GO LAMELLIPODIUM ORGANIZATION,0.18102,0.097164,0.13367,0,0
6,GO FIBROBLAST MIGRATION,0.15655,0.096914,0.14462,0,0
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.2577,0.096796,0.12654,0,0
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.08881,0.096733,0.14261,0,0
6,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.11894,0.096713,0.10885,0,0
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.37111,0.096374,0.076536,0,0
6,GO RESPONSE TO UV C,0.29248,0.096037,0.096672,0,0
6,GO ION TRANSMEMBRANE TRANSPORT,0.13885,0.096008,0.10272,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.19156,0.095963,0.12163,0,0
6,GO REGULATION OF DOPAMINE SECRETION,0.53179,0.095942,0.089794,0,0
6,GO DETECTION OF CALCIUM ION,0.39705,0.095895,0.07711,0,0
6,GO REGULATION OF PROTEIN BINDING,0.17591,0.095807,0.12794,0,0
6,GO CARDIAC VENTRICLE MORPHOGENESIS,0.23203,0.095798,0.1419,0,0
6,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.074935,0.095726,0.14647,0,0
6,GO TERPENOID BIOSYNTHETIC PROCESS,0.12662,0.095526,0.09132,0,0
6,GO ARTERY MORPHOGENESIS,0.13885,0.095179,0.18961,0,0
6,GO MESODERMAL CELL FATE COMMITMENT,0.3148,0.095095,0.07052,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.14312,0.095069,0.1737,0,0
6,GO UROGENITAL SYSTEM DEVELOPMENT,0.12273,0.095061,0.14374,0,0
6,GO MESODERMAL CELL FATE SPECIFICATION,0.38829,0.095057,0.045251,0,0
6,GO FUCOSE METABOLIC PROCESS,0.17591,0.095052,0.10104,0,0
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.050584,0.094505,0.12785,0,0
6,GO FEAR RESPONSE,0.25111,0.094459,0.055155,0,0
6,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.08303,0.094402,0.16377,0,0
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.34626,0.094391,0.10743,0,0
6,GO CARDIAC SEPTUM MORPHOGENESIS,0.2259,0.094057,0.15845,0,0
6,GO RESPONSE TO ESTRADIOL,0.080256,0.093936,0.14323,0,0
6,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.13885,0.093896,0.1021,0,0
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.40594,0.093844,0.10814,0,0
6,GO GANGLION DEVELOPMENT,0.53179,0.093788,0.11559,0,0
6,GO ADIPOSE TISSUE DEVELOPMENT,0.29248,0.093667,0.1022,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.067497,0.093601,0.14073,0,0
6,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.1306,0.093561,0.13768,0,0
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.33029,0.093252,0.091256,0,0
6,GO HEAD MORPHOGENESIS,0.077559,0.093149,0.2075,0,0
6,GO RENAL VESICLE DEVELOPMENT,0.197,0.093008,0.13156,0,0
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.23827,0.092999,0.07789,0,0
6,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.26442,0.092961,0.096835,0,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.12273,0.092952,0.19316,0,0
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.38829,0.092907,0.12269,0,0
6,GO CARDIAC VENTRICLE DEVELOPMENT,0.2259,0.092887,0.13646,0,0
6,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.17091,0.092759,0.14468,0,0
6,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.197,0.092724,0.27828,0,0
6,GO GDP METABOLIC PROCESS,0.23203,0.09264,0.12127,0,0
6,GO ATRIAL SEPTUM DEVELOPMENT,0.23827,0.092561,0.14512,0,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.08588,0.092542,0.12294,0,0
6,GO IRON COORDINATION ENTITY TRANSPORT,0.3148,0.092538,0.13703,0,0
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.1306,0.092373,0.13052,0,0
6,GO REGULATION OF CELLULAR RESPIRATION,0.10134,0.092348,0.10491,0,0
6,GO GLYCEROL ETHER METABOLIC PROCESS,0.098083,0.092294,0.12289,0,0
6,GO VASCULOGENESIS,0.16123,0.092129,0.15898,0,0
6,GO RADIAL GLIAL CELL DIFFERENTIATION,0.40594,0.092106,0.099141,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.080256,0.092022,0.14093,0,0
6,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.17591,0.092014,0.16664,0,0
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.2998,0.091937,0.11552,0,0
6,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.15655,0.091774,0.1518,0,0
6,GO POSITIVE REGULATION OF PROTEIN BINDING,0.054439,0.091757,0.15469,0,0
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.49108,0.091713,0.10863,0,0
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.25111,0.091701,0.13814,0,0
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.091819,0.091377,0.13401,0,0
6,GO POSITIVE REGULATION OF CELL DIVISION,0.23203,0.091263,0.10897,0,0
6,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.16602,0.091166,0.094466,0,0
6,GO RESPONSE TO PEPTIDE,0.069906,0.091058,0.14154,0,0
6,GO POSITIVE REGULATION OF CELL GROWTH,0.16123,0.090709,0.12996,0,0
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.20256,0.090676,0.1869,0,0
6,GO STRIATED MUSCLE CELL PROLIFERATION,0.197,0.090591,0.11907,0,0
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.23827,0.090548,0.099069,0,0
6,GO TRACHEA DEVELOPMENT,0.23203,0.09054,0.1371,0,0
6,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.098083,0.090532,0.15381,0,0
6,GO LAMELLIPODIUM ASSEMBLY,0.29248,0.090464,0.11,0,0
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.37964,0.090463,0.098088,0,0
6,GO REGULATION OF AMINO ACID TRANSPORT,0.23827,0.090317,0.10727,0,0
6,GO FOCAL ADHESION ASSEMBLY,0.16602,0.090074,0.15847,0,0
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.13467,0.089914,0.11767,0,0
6,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.17591,0.089855,0.19586,0,0
6,GO CATION TRANSMEMBRANE TRANSPORT,0.13885,0.089488,0.10419,0,0
6,GO GLYCOSIDE METABOLIC PROCESS,0.062884,0.089483,0.10939,0,0
6,GO ACTIVATION OF MAPKK ACTIVITY,0.20822,0.089358,0.14452,0,0
6,GO POSITIVE REGULATION OF CELL AGING,0.14312,0.08924,0.10478,0,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.20256,0.089104,0.11643,0,0
6,GO REGULATION OF HISTONE DEACETYLATION,0.16123,0.089075,0.14556,0,0
6,GO MUSCLE ORGAN MORPHOGENESIS,0.15197,0.088871,0.14089,0,0
6,GO BONE MATURATION,0.33821,0.08883,0.12172,0,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.18102,0.088802,0.081898,0,0
6,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.15655,0.088519,0.14281,0,0
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.27126,0.088412,0.065838,0,0
6,GO ANATOMICAL STRUCTURE REGRESSION,0.41494,0.088344,0.11285,0,0
6,GO EPIDERMAL CELL DIFFERENTIATION,0.24463,0.088296,0.086213,0,0
6,GO CELLULAR RESPONSE TO CALCIUM ION,0.094909,0.088244,0.13405,0,0
6,GO MUSCLE CELL FATE COMMITMENT,0.43329,0.088174,0.023399,0,0
6,GO HEPARIN METABOLIC PROCESS,0.1475,0.088164,0.15493,0,0
6,GO CELLULAR RESPONSE TO NUTRIENT,0.048745,0.088163,0.20771,0,0
6,GO FACIAL NERVE MORPHOGENESIS,0.23203,0.088112,0.17339,0,0
6,GO MICROVILLUS ASSEMBLY,0.15197,0.087992,0.14569,0,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.32248,0.087918,0.093478,0,0
6,GO SKIN DEVELOPMENT,0.23203,0.087877,0.10287,0,0
6,GO OLIGOPEPTIDE TRANSPORT,0.13467,0.087779,0.17084,0,0
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.16602,0.087661,0.11289,0,0
6,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.16123,0.087579,0.18823,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.091819,0.087275,0.10596,0,0
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.57414,0.087037,0.05956,0,0
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.23827,0.087018,0.089771,0,0
6,GO MODIFIED AMINO ACID TRANSPORT,0.08588,0.086934,0.14718,0,0
6,GO PURINE NUCLEOTIDE TRANSPORT,0.26442,0.086893,0.097449,0,0
6,GO PERICARDIUM DEVELOPMENT,0.25111,0.086699,0.13534,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.10468,0.086628,0.12722,0,0
6,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.21989,0.086585,0.12022,0,0
6,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.062884,0.086553,0.14315,0,0
6,GO RNA DECAPPING,0.214,0.086527,0.1263,0,0
6,GO CARDIAC CHAMBER DEVELOPMENT,0.17591,0.086428,0.15515,0,0
6,GO SALIVA SECRETION,0.37964,0.0864,0.10775,0,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.13885,0.086228,0.20868,0,0
6,GO SLEEP,0.10468,0.086116,0.1078,0,0
6,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.13467,0.085856,0.17024,0,0
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.27126,0.085725,0.047552,0,0
6,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.33821,0.085629,0.067791,0,0
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.12662,0.085586,0.10041,0,0
6,GO FOREGUT MORPHOGENESIS,0.57414,0.08553,0.073266,0,0
6,GO INORGANIC ANION TRANSPORT,0.12662,0.085468,0.10896,0,0
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.44264,0.085464,0.10377,0,0
6,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.13885,0.085405,0.23188,0,0
6,GO MECHANOSENSORY BEHAVIOR,0.58498,0.085341,0.10851,0,0
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.42405,0.08526,0.079559,0,0
6,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.33821,0.08522,0.084093,0,0
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.08303,0.084975,0.13679,0,0
6,GO MEMBRANE DEPOLARIZATION,0.32248,0.08492,0.073886,0,0
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.25111,0.084878,0.11206,0,0
6,GO REGULATION OF LIGASE ACTIVITY,0.094909,0.084744,0.1046,0,0
6,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.34626,0.084709,0.12093,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.12273,0.084491,0.16805,0,0
6,GO RESPONSE TO ACIDIC PH,0.20256,0.084304,0.1516,0,0
6,GO REGULATION OF CARDIAC CONDUCTION,0.23827,0.084218,0.085921,0,0
6,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.08588,0.084142,0.089593,0,0
6,GO STRESS FIBER ASSEMBLY,0.19156,0.084041,0.14958,0,0
6,GO EPITHELIAL CELL DIFFERENTIATION,0.17091,0.084019,0.12426,0,0
6,GO CARDIAC ATRIUM DEVELOPMENT,0.25111,0.084009,0.14835,0,0
6,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.24463,0.083969,0.10952,0,0
6,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.19156,0.083924,0.10203,0,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.069906,0.083815,0.13264,0,0
6,GO REGULATION OF FAT CELL DIFFERENTIATION,0.054439,0.083811,0.19339,0,0
6,GO DIGESTIVE TRACT MORPHOGENESIS,0.27821,0.083685,0.13111,0,0
6,GO PROTEIN TARGETING TO LYSOSOME,0.13885,0.08362,0.16852,0,0
6,GO GASTRULATION,0.08588,0.083569,0.17756,0,0
6,GO REGULATION OF GTPASE ACTIVITY,0.26442,0.083461,0.14093,0,0
6,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.17091,0.083445,0.095049,0,0
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.38829,0.083351,0.12364,0,0
6,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.80618,0.083292,-0.027426,0,0
6,GO RESPONSE TO PH,0.27821,0.083255,0.14721,0,0
6,GO FOLIC ACID METABOLIC PROCESS,0.21989,0.083101,0.098671,0,0
6,GO PODOSOME ASSEMBLY,0.16602,0.083042,0.17335,0,0
6,GO GENITALIA MORPHOGENESIS,0.37964,0.082897,0.095313,0,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.33821,0.082675,0.10774,0,0
6,GO TRANSMEMBRANE TRANSPORT,0.094909,0.082592,0.1035,0,0
6,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.52145,0.082587,0.064337,0,0
6,GO HEART GROWTH,0.36271,0.082584,0.098049,0,0
6,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.33029,0.082535,0.11854,0,0
6,GO LYMPHANGIOGENESIS,0.56341,0.082466,0.097618,0,0
6,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.074935,0.082421,0.12475,0,0
6,GO REGULATION OF PROTEIN DEACETYLATION,0.1306,0.082387,0.13254,0,0
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.10468,0.082347,0.1066,0,0
6,GO REGULATION OF HEART GROWTH,0.18624,0.082255,0.10804,0,0
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.17091,0.082227,0.11746,0,0
6,GO POSITIVE REGULATION OF BINDING,0.2259,0.082223,0.10577,0,0
6,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.18624,0.082169,0.14719,0,0
6,GO GTP METABOLIC PROCESS,0.20256,0.082154,0.08551,0,0
6,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.1306,0.082072,0.11669,0,0
6,GO ATP BIOSYNTHETIC PROCESS,0.046961,0.081962,0.15113,0,0
6,GO ACTIN FILAMENT BASED PROCESS,0.16602,0.081893,0.13447,0,0
6,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.17091,0.081828,0.076484,0,0
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.50109,0.081824,0.076335,0,0
6,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.062884,0.08177,0.16678,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.060677,0.081692,0.14472,0,0
6,GO REGULATION OF FIBROBLAST MIGRATION,0.2259,0.0815,0.14175,0,0
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.60692,0.081292,0.10295,0,0
6,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.077559,0.081161,0.18835,0,0
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.66333,0.08091,0.058166,0,0
6,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.27126,0.080879,0.16299,0,0
6,GO CELLULAR HYPEROSMOTIC RESPONSE,0.58498,0.080871,0.063404,0,0
6,GO PROTON TRANSMEMBRANE TRANSPORT,0.12273,0.080715,0.078175,0,0
6,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.36271,0.080585,0.040067,0,0
6,GO BASIC AMINO ACID TRANSPORT,0.24463,0.080582,0.12781,0,0
6,GO REGULATION OF SYSTEM PROCESS,0.28529,0.080535,0.10153,0,0
6,GO GLIAL CELL DEVELOPMENT,0.19156,0.080529,0.1312,0,0
6,GO SKELETAL MUSCLE ADAPTATION,0.197,0.080515,0.13131,0,0
6,GO KIDNEY EPITHELIUM DEVELOPMENT,0.24463,0.080505,0.12315,0,0
6,GO REGULATION OF NEURON MATURATION,0.33821,0.080375,0.13567,0,0
6,GO REGULATION OF EXOCYTOSIS,0.11524,0.080355,0.13361,0,0
6,GO NEURON APOPTOTIC PROCESS,0.28529,0.080341,0.10229,0,0
6,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.062884,0.080287,0.1291,0,0
6,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.15197,0.08026,0.11883,0,0
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.43329,0.080233,0.078136,0,0
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.53179,0.080228,0.083434,0,0
6,GO APICAL JUNCTION ASSEMBLY,0.1306,0.080228,0.14653,0,0
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.069906,0.080196,0.14576,0,0
6,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.29248,0.080096,0.12176,0,0
6,GO REGULATION OF FILOPODIUM ASSEMBLY,0.29248,0.080035,0.10893,0,0
6,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.094909,0.079893,0.11958,0,0
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.19156,0.079817,0.1005,0,0
6,GO NEGATIVE REGULATION OF GENE SILENCING,0.197,0.079807,0.094985,0,0
6,GO REGULATION OF KIDNEY DEVELOPMENT,0.11163,0.079768,0.17621,0,0
6,GO BONE DEVELOPMENT,0.08303,0.07976,0.19311,0,0
6,GO TISSUE REGENERATION,0.17091,0.079528,0.10747,0,0
6,GO NEPHRON DEVELOPMENT,0.2259,0.079246,0.14077,0,0
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.33821,0.079216,0.097565,0,0
6,GO BODY MORPHOGENESIS,0.16123,0.079202,0.17148,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.21989,0.079128,0.1175,0,0
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.214,0.078946,0.16731,0,0
6,GO SODIUM ION HOMEOSTASIS,0.20256,0.078912,0.10045,0,0
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.26442,0.078515,0.1302,0,0
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.36271,0.078483,0.12749,0,0
6,GO AUTOPHAGOSOME MATURATION,0.35442,0.078482,0.10581,0,0
6,GO REGULATION OF DEACETYLASE ACTIVITY,0.16123,0.078481,0.16438,0,0
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.25111,0.078431,0.13683,0,0
6,GO CELL MATURATION,0.12662,0.078355,0.12309,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.33029,0.078192,0.068798,0,0
6,GO REGULATION OF SODIUM ION TRANSPORT,0.29248,0.078171,0.091897,0,0
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.76963,0.078084,0.007206,0,0
6,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.10811,0.077962,0.13897,0,0
6,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.21989,0.077954,0.080864,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.11524,0.077946,0.12135,0,0
6,GO METANEPHRIC NEPHRON DEVELOPMENT,0.20822,0.077922,0.17198,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12662,0.077852,0.11852,0,0
6,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.1306,0.077837,0.1234,0,0
6,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.10811,0.077784,0.10279,0,0
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.88046,0.077706,0.040809,0,0
6,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.072385,0.07753,0.1581,0,0
6,GO RESPONSE TO GROWTH FACTOR,0.13885,0.077477,0.14606,0,0
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.27126,0.077402,0.12169,0,0
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.42405,0.077266,0.12408,0,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.094909,0.077213,0.10943,0,0
6,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.067497,0.0771,0.16475,0,0
6,GO FATTY ACID BETA OXIDATION,0.50109,0.076984,0.062119,0,0
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.25111,0.076935,0.1181,0,0
6,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.14312,0.076826,0.10481,0,0
6,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.21989,0.076811,0.15454,0,0
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.10468,0.076774,0.17021,0,0
6,GO RECEPTOR METABOLIC PROCESS,0.12273,0.076747,0.12775,0,0
6,GO SPERM CAPACITATION,0.045233,0.076613,0.16553,0,0
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.40594,0.076552,0.093651,0,0
6,GO REGULATION OF PROTEIN IMPORT,0.16602,0.076186,0.11451,0,0
6,GO CONVERGENT EXTENSION,0.23827,0.075937,0.16728,0,0
6,GO EXECUTION PHASE OF APOPTOSIS,0.3148,0.075811,0.074627,0,0
6,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.060677,0.075778,0.115,0,0
6,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.34626,0.075697,0.11126,0,0
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.61803,0.075512,0.074407,0,0
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.36271,0.075507,0.091811,0,0
6,GO POSITIVE REGULATION OF GROWTH,0.27126,0.075472,0.12056,0,0
6,GO VESICLE CARGO LOADING,0.2259,0.075397,0.11733,0,0
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.10134,0.075305,0.15625,0,0
6,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.08588,0.075142,0.21713,0,0
6,GO RESPONSE TO BMP,0.26442,0.0751,0.14913,0,0
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.27126,0.074981,0.16452,0,0
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.214,0.074913,0.10712,0,0
6,GO MESODERM MORPHOGENESIS,0.08588,0.074731,0.15621,0,0
6,GO MUSCLE TISSUE DEVELOPMENT,0.23827,0.074558,0.10654,0,0
6,GO REGULATION OF REPRODUCTIVE PROCESS,0.14312,0.074557,0.1076,0,0
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.28529,0.07448,0.11784,0,0
6,GO REGULATION OF PROTON TRANSPORT,0.08881,0.07441,0.096264,0,0
6,GO LOCOMOTOR RHYTHM,0.29248,0.0744,0.12267,0,0
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.2998,0.074386,0.14696,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.2577,0.07432,0.081432,0,0
6,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.080256,0.074076,0.13254,0,0
6,GO NEUROTRANSMITTER UPTAKE,0.34626,0.074071,0.093128,0,0
6,GO CHLORIDE TRANSPORT,0.25111,0.073966,0.086701,0,0
6,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.36271,0.073868,0.10418,0,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.17591,0.073848,0.078827,0,0
6,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.27821,0.073824,0.085503,0,0
6,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.08588,0.073804,0.1386,0,0
6,GO L ASCORBIC ACID METABOLIC PROCESS,0.17091,0.073626,0.085832,0,0
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.18102,0.073572,0.13465,0,0
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.54223,0.073565,0.11434,0,0
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.50109,0.073354,0.079411,0,0
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.11524,0.073149,0.17079,0,0
6,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.33029,0.073091,0.1339,0,0
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.52145,0.072981,0.081166,0,0
6,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.57414,0.072979,0.043127,0,0
6,GO EPITHELIAL CELL DEVELOPMENT,0.12662,0.072958,0.15842,0,0
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.79394,0.072668,0.080441,0,0
6,GO CARBOHYDRATE HOMEOSTASIS,0.17091,0.072613,0.10353,0,0
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.34626,0.072609,0.11088,0,0
6,GO XENOBIOTIC TRANSPORT,0.25111,0.07259,0.13901,0,0
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.20822,0.072537,0.1332,0,0
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.32248,0.072469,0.10362,0,0
6,GO MONOSACCHARIDE METABOLIC PROCESS,0.12273,0.072403,0.11023,0,0
6,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.214,0.072309,0.10457,0,0
6,GO POLYAMINE METABOLIC PROCESS,0.214,0.072241,0.066709,0,0
6,GO MYOBLAST MIGRATION,0.62923,0.07211,0.034083,0,0
6,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.050584,0.072076,0.16145,0,0
6,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.18102,0.072055,0.12457,0,0
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.14312,0.071968,0.12267,0,0
6,GO MESENCHYME DEVELOPMENT,0.18624,0.071955,0.12949,0,0
6,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.14312,0.07195,0.10732,0,0
6,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.13885,0.071863,0.0866,0,0
6,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.098083,0.071839,0.11399,0,0
6,GO REGULATION OF TRANSPOSITION,0.214,0.071791,0.11411,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.38829,0.071786,0.11866,0,0
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.42405,0.071759,0.051755,0,0
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.3148,0.071749,0.097445,0,0
6,GO GLAND DEVELOPMENT,0.11894,0.071731,0.14326,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.072385,0.071673,0.13634,0,0
6,GO MUSCLE STRUCTURE DEVELOPMENT,0.16602,0.071581,0.12519,0,0
6,GO POSITIVE REGULATION OF DNA BINDING,0.20256,0.071526,0.091809,0,0
6,GO REGULATION OF MYELINATION,0.20256,0.071446,0.13726,0,0
6,GO MUSCLE CELL DIFFERENTIATION,0.16123,0.071354,0.12129,0,0
6,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.074935,0.071343,0.1369,0,0
6,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.1306,0.071251,0.12345,0,0
6,GO RESPONSE TO PEPTIDE HORMONE,0.13467,0.071128,0.12273,0,0
6,GO RESPONSE TO FORSKOLIN,0.28529,0.071107,0.16067,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.25111,0.070994,0.17131,0,0
6,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.33821,0.070973,0.1196,0,0
6,GO EPOXYGENASE P450 PATHWAY,0.077559,0.070903,0.16461,0,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.16602,0.070902,0.14373,0,0
6,GO CHLORIDE ION HOMEOSTASIS,0.41494,0.070888,0.08077,0,0
6,GO BASEMENT MEMBRANE ASSEMBLY,0.48117,0.070881,0.11622,0,0
6,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.2577,0.070733,0.13749,0,0
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.17591,0.070633,0.14243,0,0
6,GO REGULATION OF PODOSOME ASSEMBLY,0.3148,0.070371,0.12907,0,0
6,GO AMP METABOLIC PROCESS,0.14312,0.070346,0.06186,0,0
6,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.20256,0.070322,0.10473,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.27821,0.07023,0.080161,0,0
6,GO EPIDERMIS MORPHOGENESIS,0.214,0.070185,0.12293,0,0
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.08303,0.070164,0.22717,0,0
6,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.16602,0.070143,0.1214,0,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17091,0.070082,0.14494,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.16123,0.070063,0.1775,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.49108,0.070005,0.061748,0,0
6,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.13467,0.069968,0.11621,0,0
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.18102,0.069886,0.10722,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.10468,0.069834,0.12679,0,0
6,GO LACTATION,0.29248,0.06981,0.11242,0,0
6,GO MELANOCYTE DIFFERENTIATION,0.39705,0.069765,0.079522,0,0
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.2259,0.069685,0.12124,0,0
6,GO CELL CELL SIGNALING,0.2998,0.069655,0.097138,0,0
6,GO REGULATION OF BINDING,0.2577,0.069604,0.10456,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.61803,0.069578,0.063278,0,0
6,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.15655,0.069364,0.14907,0,0
6,GO OVULATION CYCLE PROCESS,0.52145,0.069335,0.087364,0,0
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.12662,0.069215,0.17082,0,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION,0.21989,0.069165,0.097273,0,0
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.214,0.068977,0.1206,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.25111,0.068946,0.086189,0,0
6,GO RESPONSE TO LEAD ION,0.16602,0.068883,0.11324,0,0
6,GO MIDDLE EAR MORPHOGENESIS,0.27821,0.068871,0.078828,0,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.10811,0.068836,0.15335,0,0
6,GO EXPORT ACROSS PLASMA MEMBRANE,0.30724,0.068806,0.09902,0,0
6,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.49108,0.06879,0.066195,0,0
6,GO ORGANELLE FUSION,0.062884,0.068649,0.12898,0,0
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.13885,0.068606,0.1287,0,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.3148,0.068602,0.07462,0,0
6,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.08588,0.068565,0.14274,0,0
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.14312,0.068415,0.1087,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.37964,0.068323,0.12895,0,0
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.11163,0.068267,0.12881,0,0
6,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.17591,0.068183,0.11983,0,0
6,GO HORMONE TRANSPORT,0.24463,0.068172,0.094426,0,0
6,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.11894,0.068168,0.10144,0,0
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.067497,0.06814,0.19646,0,0
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.78176,0.068044,0.016074,0,0
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.17591,0.067995,0.14879,0,0
6,GO ENDOTHELIAL CELL MORPHOGENESIS,0.47137,0.067944,0.18039,0,0
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.33029,0.067938,0.076266,0,0
6,GO CERAMIDE BIOSYNTHETIC PROCESS,0.12273,0.067881,0.12073,0,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.197,0.067838,0.11212,0,0
6,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.19156,0.067757,0.12633,0,0
6,GO CERAMIDE METABOLIC PROCESS,0.12662,0.067621,0.12144,0,0
6,GO LIPOSACCHARIDE METABOLIC PROCESS,0.19156,0.067615,0.10987,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.57414,0.067578,0.069574,0,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.15655,0.067543,0.14468,0,0
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.214,0.067352,0.15153,0,0
6,GO RETINOIC ACID METABOLIC PROCESS,0.17591,0.06734,0.12428,0,0
6,GO CELLULAR PIGMENTATION,0.58498,0.066968,0.054372,0,0
6,GO POLYOL BIOSYNTHETIC PROCESS,0.056456,0.066869,0.13667,0,0
6,GO CELLULAR GLUCAN METABOLIC PROCESS,0.41494,0.066838,0.082174,0,0
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.098083,0.066705,0.17251,0,0
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.20822,0.066596,0.09826,0,0
6,GO NUCLEOTIDE SALVAGE,0.23827,0.066484,0.071882,0,0
6,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.17591,0.066454,0.10364,0,0
6,GO TRANSFERRIN TRANSPORT,0.20256,0.066291,0.10865,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.37111,0.066245,0.11181,0,0
6,GO METANEPHROS DEVELOPMENT,0.17591,0.066155,0.14906,0,0
6,GO RESPONSE TO OXYGEN RADICAL,0.55277,0.066144,0.057503,0,0
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.35442,0.066106,0.12993,0,0
6,GO LENS FIBER CELL DIFFERENTIATION,0.52145,0.066095,0.075978,0,0
6,GO SNARE COMPLEX ASSEMBLY,0.33029,0.066075,0.12383,0,0
6,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.21989,0.065955,0.19237,0,0
6,GO DOPAMINE TRANSPORT,0.5959,0.065869,0.091233,0,0
6,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.197,0.065468,0.11023,0,0
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.17091,0.065445,0.14604,0,0
6,GO REGULATION OF CELLULAR LOCALIZATION,0.23827,0.065311,0.10435,0,0
6,GO ENSHEATHMENT OF NEURONS,0.27821,0.065106,0.12024,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.50109,0.065074,0.11086,0,0
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.28529,0.065056,0.15383,0,0
6,GO CARDIAC SEPTUM DEVELOPMENT,0.28529,0.065002,0.13673,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.197,0.064893,0.10789,0,0
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.4521,0.064868,0.080276,0,0
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.41494,0.06485,0.10409,0,0
6,GO BONE MORPHOGENESIS,0.11524,0.064819,0.18309,0,0
6,GO ENDOCARDIUM DEVELOPMENT,0.34626,0.064814,0.10486,0,0
6,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.18102,0.064699,0.10414,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.62923,0.06455,0.082922,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.33821,0.064522,0.11002,0,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.14312,0.064521,0.11549,0,0
6,GO RENAL SODIUM EXCRETION,0.26442,0.06451,0.11518,0,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.35442,0.064396,0.10125,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.40594,0.064348,0.087092,0,0
6,GO HEART FORMATION,0.28529,0.064248,0.10929,0,0
6,GO REGULATION OF DNA CATABOLIC PROCESS,0.11894,0.064199,0.097961,0,0
6,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.3148,0.064087,0.13823,0,0
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.18102,0.064084,0.11356,0,0
6,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.098083,0.064064,0.12061,0,0
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.42405,0.064047,0.085208,0,0
6,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.08881,0.063975,0.13305,0,0
6,GO DNA DEMETHYLATION,0.43329,0.063859,0.081459,0,0
6,GO REGULATION OF MESODERM DEVELOPMENT,0.47137,0.063791,0.058338,0,0
6,GO AMINO ACID TRANSPORT,0.27126,0.063696,0.098874,0,0
6,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.12662,0.063655,0.13365,0,0
6,GO SKELETAL MUSCLE TISSUE REGENERATION,0.26442,0.063634,0.072955,0,0
6,GO NEGATIVE REGULATION OF CELL GROWTH,0.214,0.063631,0.12352,0,0
6,GO DEVELOPMENTAL MATURATION,0.26442,0.063627,0.10566,0,0
6,GO CELL GROWTH,0.44264,0.063623,0.09864,0,0
6,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.13885,0.06362,0.083319,0,0
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.81845,0.063545,0.085988,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.35442,0.063532,0.080531,0,0
6,GO ARTERY DEVELOPMENT,0.27126,0.063382,0.1481,0,0
6,GO CELLULAR RESPONSE TO PEPTIDE,0.1306,0.063356,0.13101,0,0
6,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.51122,0.063332,0.057193,0,0
6,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.214,0.063327,0.062122,0,0
6,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.11894,0.063308,0.095863,0,0
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.25111,0.063304,0.1364,0,0
6,GO RESPONSE TO IONIZING RADIATION,0.38829,0.062841,0.075344,0,0
6,GO RESPONSE TO ALKALOID,0.36271,0.062517,0.062678,0,0
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.27126,0.062453,0.11308,0,0
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.27821,0.062322,0.081299,0,0
6,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.27821,0.062168,0.053578,0,0
6,GO RESPONSE TO STARVATION,0.17091,0.062168,0.10157,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.1475,0.062153,0.15943,0,0
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.17591,0.062035,0.12395,0,0
6,GO RECEPTOR CLUSTERING,0.43329,0.061917,0.10518,0,0
6,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.098083,0.06185,0.078611,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.2259,0.061823,0.15109,0,0
6,GO ANATOMICAL STRUCTURE MATURATION,0.13467,0.06178,0.12467,0,0
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.54223,0.061779,0.077341,0,0
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.74555,0.061655,0.021801,0,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.15655,0.061567,0.15481,0,0
6,GO CARBOHYDRATE METABOLIC PROCESS,0.12662,0.061457,0.11061,0,0
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.21989,0.061264,0.11036,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.080256,0.061218,0.15139,0,0
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.30724,0.061163,0.12057,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.2577,0.06098,0.07998,0,0
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.39705,0.060837,0.10482,0,0
6,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.16602,0.060705,0.12112,0,0
6,GO MYOBLAST PROLIFERATION,0.66333,0.060439,0.022655,0,0
6,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.48117,0.060269,0.1236,0,0
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.20822,0.060247,0.10811,0,0
6,GO HEME METABOLIC PROCESS,0.077559,0.060161,0.10923,0,0
6,GO ACTIVATION OF JNKK ACTIVITY,0.33821,0.060147,0.11825,0,0
6,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.23827,0.060132,0.080418,0,0
6,GO CATECHOLAMINE UPTAKE,0.51122,0.060102,0.12125,0,0
6,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.42405,0.06005,0.1092,0,0
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.17591,0.059994,0.12539,0,0
6,GO EXOCYTIC PROCESS,0.197,0.059963,0.13494,0,0
6,GO SOMATIC STEM CELL DIVISION,0.29248,0.059853,0.15821,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.64051,0.059829,0.080975,0,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.20822,0.059772,0.078294,0,0
6,GO COPII COATED VESICLE CARGO LOADING,0.37964,0.059528,0.10988,0,0
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.10811,0.059499,0.15377,0,0
6,GO GLUCOSE METABOLIC PROCESS,0.25111,0.059293,0.095107,0,0
6,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.33029,0.059205,0.036945,0,0
6,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.21989,0.059101,0.11041,0,0
6,GO SENSORY PERCEPTION OF BITTER TASTE,0.58498,0.059016,0.0044716,0,0
6,GO POLYOL METABOLIC PROCESS,0.3148,0.058978,0.094699,0,0
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.32248,0.058973,0.083035,0,0
6,GO OVULATION CYCLE,0.39705,0.05881,0.10612,0,0
6,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.57414,0.05874,0.08946,0,0
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.4521,0.058676,0.074589,0,0
6,GO ACTIVATION OF GTPASE ACTIVITY,0.27126,0.058518,0.13754,0,0
6,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.197,0.058443,0.089296,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.065157,0.058435,0.12789,0,0
6,GO SKELETAL SYSTEM DEVELOPMENT,0.1475,0.058299,0.15316,0,0
6,GO REGULATION OF TRANSPORTER ACTIVITY,0.44264,0.058254,0.061705,0,0
6,GO BASE EXCISION REPAIR AP SITE FORMATION,0.32248,0.058187,0.050167,0,0
6,GO NEGATIVE REGULATION OF GROWTH,0.11894,0.058178,0.1344,0,0
6,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.12662,0.058131,0.11318,0,0
6,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.33821,0.058126,0.075206,0,0
6,GO SECONDARY PALATE DEVELOPMENT,0.3148,0.058064,0.13767,0,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.43329,0.058058,0.047911,0,0
6,GO CYTOCHROME COMPLEX ASSEMBLY,0.14312,0.05799,0.066067,0,0
6,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.17091,0.057892,0.12631,0,0
6,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.27126,0.057757,0.06918,0,0
6,GO LOCALIZATION WITHIN MEMBRANE,0.44264,0.057662,0.099446,0,0
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.35442,0.057657,0.10491,0,0
6,GO FILOPODIUM ASSEMBLY,0.41494,0.05758,0.10057,0,0
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.17591,0.057548,0.12053,0,0
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.20256,0.05754,0.10192,0,0
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.23827,0.057396,0.1194,0,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.40594,0.057226,0.072897,0,0
6,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.33821,0.057202,0.087217,0,0
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.18624,0.057028,0.1395,0,0
6,GO FIBROBLAST ACTIVATION,0.36271,0.05702,0.114,0,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.72171,0.056981,0.067122,0,0
6,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.15655,0.056953,0.08073,0,0
6,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.39705,0.056919,0.090266,0,0
6,GO CARDIAC CELL FATE COMMITMENT,0.88046,0.056878,-0.0077776,0,0
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.36271,0.056713,0.080659,0,0
6,GO FATTY ACYL COA METABOLIC PROCESS,0.19156,0.056709,0.11687,0,0
6,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.27126,0.056698,0.088099,0,0
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.37111,0.056683,0.15536,0,0
6,GO LIPID DROPLET ORGANIZATION,0.21989,0.056633,0.09248,0,0
6,GO CANONICAL WNT SIGNALING PATHWAY,0.3148,0.056389,0.1121,0,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.16602,0.056348,0.14908,0,0
6,GO MEGAKARYOCYTE DIFFERENTIATION,0.27126,0.056237,0.10354,0,0
6,GO STEROL BIOSYNTHETIC PROCESS,0.30724,0.056207,0.088121,0,0
6,GO PROTEIN HOMOTETRAMERIZATION,0.23203,0.056171,0.087626,0,0
6,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.214,0.056136,0.095689,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.21989,0.056025,0.11338,0,0
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.3148,0.055955,0.13667,0,0
6,GO UV PROTECTION,0.78176,0.055923,0.054696,0,0
6,GO LONG TERM SYNAPTIC POTENTIATION,0.88046,0.055894,0.045354,0,0
6,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.077559,0.05582,0.14245,0,0
6,GO RECEPTOR INTERNALIZATION,0.42405,0.055805,0.091499,0,0
6,GO ERBB2 SIGNALING PATHWAY,0.57414,0.055742,0.069554,0,0
6,GO DICARBOXYLIC ACID TRANSPORT,0.46168,0.055598,0.081079,0,0
6,GO CELLULAR RESPONSE TO SALT STRESS,0.54223,0.055596,0.080231,0,0
6,GO CARDIAC CONDUCTION,0.52145,0.055077,0.055878,0,0
6,GO RESPONSE TO SALT STRESS,0.27821,0.055046,0.13101,0,0
6,GO REGULATION OF HORMONE SECRETION,0.30724,0.054611,0.08569,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.3148,0.054579,0.070301,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.3148,0.054523,0.081483,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.41494,0.054508,0.074011,0,0
6,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.29248,0.054429,0.056342,0,0
6,GO ENERGY HOMEOSTASIS,0.66333,0.05439,0.07943,0,0
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.17591,0.0542,0.1717,0,0
6,GO PARTURITION,0.53179,0.054193,0.082508,0,0
6,GO CARDIOCYTE DIFFERENTIATION,0.24463,0.054078,0.10571,0,0
6,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.1306,0.054035,0.15656,0,0
6,GO RESPONSE TO OSMOTIC STRESS,0.067497,0.053927,0.15078,0,0
6,GO REGENERATION,0.13885,0.053925,0.13086,0,0
6,GO REGULATION OF ERAD PATHWAY,0.12662,0.053777,0.1336,0,0
6,GO NEGATIVE REGULATION OF JNK CASCADE,0.30724,0.053705,0.12102,0,0
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.13467,0.053657,0.1273,0,0
6,GO MULTICELLULAR ORGANISMAL SIGNALING,0.4521,0.053585,0.060373,0,0
6,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.76963,0.053576,0.053168,0,0
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.44264,0.053569,0.102,0,0
6,GO COLLATERAL SPROUTING,0.56341,0.053329,-0.028591,0,0
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.37964,0.053312,0.097562,0,0
6,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.33029,0.053229,0.092948,0,0
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.18102,0.053158,0.11383,0,0
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.61803,0.053157,0.071226,0,0
6,GO REGULATION OF HISTONE PHOSPHORYLATION,0.68646,0.053088,0.07849,0,0
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.29248,0.053039,0.11996,0,0
6,GO CARDIAC MUSCLE CELL PROLIFERATION,0.34626,0.052983,0.097809,0,0
6,GO GLUCOSE IMPORT,0.52145,0.052981,0.064215,0,0
6,GO RESPONSE TO PARATHYROID HORMONE,0.41494,0.052962,0.082489,0,0
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.41494,0.052921,0.097319,0,0
6,GO AORTA MORPHOGENESIS,0.60692,0.052841,0.091417,0,0
6,GO NON CANONICAL WNT SIGNALING PATHWAY,0.197,0.052747,0.099561,0,0
6,GO GOLGI TO ENDOSOME TRANSPORT,0.36271,0.052591,0.10154,0,0
6,GO CARBOHYDRATE PHOSPHORYLATION,0.15655,0.052491,0.1196,0,0
6,GO NEGATIVE CHEMOTAXIS,0.67486,0.052362,0.083197,0,0
6,GO KETONE BODY METABOLIC PROCESS,0.23203,0.052359,0.087417,0,0
6,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.13467,0.052347,0.11074,0,0
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.27126,0.052332,0.062872,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.44264,0.052323,0.071131,0,0
6,GO NOTCH SIGNALING PATHWAY,0.39705,0.052257,0.092703,0,0
6,GO ERYTHROCYTE DEVELOPMENT,0.56341,0.052202,0.088135,0,0
6,GO PONS DEVELOPMENT,0.66333,0.052196,0.12657,0,0
6,GO PLASMA MEMBRANE TUBULATION,0.50109,0.052195,0.11951,0,0
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.23827,0.052176,0.11416,0,0
6,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.23827,0.052169,0.13568,0,0
6,GO THIOESTER METABOLIC PROCESS,0.098083,0.052019,0.10794,0,0
6,GO SODIUM ION TRANSPORT,0.47137,0.052006,0.054688,0,0
6,GO MATING,0.48117,0.051929,0.076177,0,0
6,GO MESENCHYMAL CELL PROLIFERATION,0.2577,0.051919,0.15236,0,0
6,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.33821,0.051763,0.1127,0,0
6,GO ENDOCYTIC RECYCLING,0.47137,0.051696,0.10295,0,0
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.11894,0.051596,0.12324,0,0
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.24463,0.051565,0.10891,0,0
6,GO CELL CELL JUNCTION ASSEMBLY,0.33821,0.051517,0.11868,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.43329,0.051494,0.068244,0,0
6,GO DETECTION OF STIMULUS,0.11894,0.051412,0.086428,0,0
6,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.56341,0.051305,0.074932,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.1306,0.051294,0.12579,0,0
6,GO REGULATION OF SULFUR METABOLIC PROCESS,0.33821,0.051271,0.12418,0,0
6,GO MONOVALENT INORGANIC CATION TRANSPORT,0.30724,0.051189,0.069303,0,0
6,GO REGULATION OF STEM CELL DIFFERENTIATION,0.32248,0.051154,0.073983,0,0
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.30724,0.051141,0.071909,0,0
6,GO OLFACTORY LOBE DEVELOPMENT,0.57414,0.051008,0.05736,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION,0.18102,0.050766,0.10802,0,0
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.33821,0.050737,0.095249,0,0
6,GO VIRAL RELEASE FROM HOST CELL,0.17091,0.050622,0.09545,0,0
6,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.11524,0.050608,0.078218,0,0
6,GO REGULATION OF TRANSLATIONAL TERMINATION,0.54223,0.050561,0.052944,0,0
6,GO RESPONSE TO ABIOTIC STIMULUS,0.12662,0.050413,0.11116,0,0
6,GO DIOL METABOLIC PROCESS,0.18102,0.050264,0.10877,0,0
6,GO SULFUR COMPOUND TRANSPORT,0.35442,0.050125,0.10117,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.18102,0.050115,0.10871,0,0
6,GO TOXIN TRANSPORT,0.43329,0.050033,0.08445,0,0
6,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.46168,0.049808,0.089349,0,0
6,GO RETINAL CONE CELL DIFFERENTIATION,0.23827,0.049764,0.063828,0,0
6,GO ELECTRON TRANSPORT CHAIN,0.0076456,0.04971,0.090358,0,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.29248,0.049572,0.10236,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.11524,0.049559,0.11009,0,0
6,GO SULFUR COMPOUND METABOLIC PROCESS,0.098083,0.049527,0.11138,0,0
6,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.2998,0.049452,0.10021,0,0
6,GO NEGATIVE REGULATION OF SIGNALING,0.08588,0.049315,0.13968,0,0
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.39705,0.049313,0.13437,0,0
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.11163,0.049288,0.17448,0,0
6,GO OUTER DYNEIN ARM ASSEMBLY,1,0.049266,-0.067,0,0
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.67486,0.049067,0.072346,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.10468,0.049007,0.15575,0,0
6,GO MEGAKARYOCYTE DEVELOPMENT,0.2259,0.048783,0.14856,0,0
6,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.67486,0.048766,0.069128,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.27821,0.048761,0.069541,0,0
6,GO DNA CATABOLIC PROCESS,0.32248,0.048718,0.073945,0,0
6,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.64051,0.048715,0.076133,0,0
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.78176,0.048578,0.045853,0,0
6,GO TETRAPYRROLE METABOLIC PROCESS,0.18624,0.048528,0.10362,0,0
6,GO MUSCLE CELL APOPTOTIC PROCESS,0.16123,0.048504,0.12749,0,0
6,GO ANION TRANSMEMBRANE TRANSPORT,0.28529,0.048488,0.094437,0,0
6,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.88046,0.048389,0.01132,0,0
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.93062,0.04823,0.035529,0,0
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.42405,0.048157,0.088484,0,0
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.23203,0.048102,0.11841,0,0
6,GO TRANSPOSITION,0.2998,0.048048,0.098555,0,0
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.53179,0.048041,0.067425,0,0
6,GO LIPID PHOSPHORYLATION,0.26442,0.047957,0.13161,0,0
6,GO ORGAN GROWTH,0.37111,0.047939,0.096211,0,0
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.79394,0.047937,0.054253,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.43329,0.047832,0.082662,0,0
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.68646,0.047671,0.049338,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.86799,0.047654,0.080366,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.11163,0.047651,0.082646,0,0
6,GO MAMMARY GLAND DEVELOPMENT,0.214,0.047623,0.15139,0,0
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.58498,0.047559,0.074302,0,0
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.47137,0.047472,0.07608,0,0
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.47137,0.04744,0.096965,0,0
6,GO REGULATION OF GLIOGENESIS,0.49108,0.047078,0.082932,0,0
6,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.24463,0.04705,0.078923,0,0
6,GO DORSAL SPINAL CORD DEVELOPMENT,0.85555,0.047001,0.023952,0,0
6,GO GLIOGENESIS,0.44264,0.046858,0.10305,0,0
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.86799,0.046615,0.043816,0,0
6,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.29248,0.046575,0.12233,0,0
6,GO NOREPINEPHRINE SECRETION,0.72171,0.046567,0.046815,0,0
6,GO RESPONSE TO CATECHOLAMINE,0.67486,0.046411,0.05656,0,0
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.64051,0.046393,0.089051,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.61803,0.046311,0.05407,0,0
6,GO SKELETAL SYSTEM MORPHOGENESIS,0.36271,0.046193,0.11009,0,0
6,GO CELLULAR RESPONSE TO STARVATION,0.29248,0.046155,0.097776,0,0
6,GO PROTEIN HOMOOLIGOMERIZATION,0.37111,0.046122,0.076264,0,0
6,GO PARENTAL BEHAVIOR,0.47137,0.045939,0.086499,0,0
6,GO CARDIOLIPIN METABOLIC PROCESS,0.40594,0.045891,0.040896,0,0
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.42405,0.045818,0.068468,0,0
6,GO LATERAL MESODERM DEVELOPMENT,0.62923,0.045726,-0.025786,0,0
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.88046,0.045664,-0.02231,0,0
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.5959,0.045417,0.068029,0,0
6,GO MONOAMINE TRANSPORT,0.39705,0.045317,0.10695,0,0
6,GO SENSORY PERCEPTION OF TASTE,0.50109,0.045301,0.023607,0,0
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.23827,0.045198,0.1039,0,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.17591,0.045141,0.1173,0,0
6,GO CRANIAL NERVE MORPHOGENESIS,0.40594,0.045026,0.10759,0,0
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.21989,0.044784,0.10973,0,0
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.60692,0.044703,0.083302,0,0
6,GO NEURON CELLULAR HOMEOSTASIS,0.72171,0.044591,0.039217,0,0
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.25111,0.044579,0.11881,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.56341,0.044539,0.066756,0,0
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.214,0.044472,0.12253,0,0
6,GO MAGNESIUM ION HOMEOSTASIS,0.74555,0.044469,-0.032347,0,0
6,GO HOMOCYSTEINE METABOLIC PROCESS,0.94321,0.044428,-0.0034746,0,0
6,GO GMP METABOLIC PROCESS,0.43329,0.044359,0.067651,0,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.75756,0.044183,0.074456,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.57414,0.044095,0.072737,0,0
6,GO BRANCHING MORPHOGENESIS OF A NERVE,1,0.044044,0.021841,0,0
6,GO PROTEIN POLYMERIZATION,0.41494,0.04384,0.090589,0,0
6,GO GLYCINE METABOLIC PROCESS,0.91805,0.04383,0.0098918,0,0
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.42405,0.043786,0.080908,0,0
6,GO CELL FATE DETERMINATION,0.3148,0.043493,0.10973,0,0
6,GO EPIDERMIS DEVELOPMENT,0.2998,0.043412,0.08692,0,0
6,GO HYPEROSMOTIC RESPONSE,0.44264,0.043336,0.095225,0,0
6,GO ESCRT COMPLEX DISASSEMBLY,0.35442,0.043245,0.071185,0,0
6,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.56341,0.043191,0.080785,0,0
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.99368,0.043182,-0.0031797,0,0
6,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.50109,0.04317,0.097966,0,0
6,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.60692,0.043109,0.040471,0,0
6,GO EPITHELIUM DEVELOPMENT,0.2577,0.042942,0.10892,0,0
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.57414,0.042711,0.05791,0,0
6,GO PROTEIN COMPLEX OLIGOMERIZATION,0.32248,0.042706,0.085085,0,0
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.23203,0.042656,0.093708,0,0
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.2577,0.042642,0.096843,0,0
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.51122,0.042569,0.057378,0,0
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.37111,0.042503,0.13673,0,0
6,GO RHYTHMIC BEHAVIOR,0.29248,0.042059,0.10013,0,0
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.36271,0.041952,0.10024,0,0
6,GO CALCINEURIN MEDIATED SIGNALING,0.69814,0.041922,0.047144,0,0
6,GO VACUOLE ORGANIZATION,0.08588,0.041892,0.13879,0,0
6,GO CELL CELL SIGNALING BY WNT,0.35442,0.041808,0.099312,0,0
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.53179,0.041671,0.095573,0,0
6,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.214,0.041573,0.10172,0,0
6,GO LIPID GLYCOSYLATION,0.47137,0.041552,0.085615,0,0
6,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.42405,0.041507,0.10014,0,0
6,GO SYNAPTIC VESICLE BUDDING,0.76963,0.04138,0.033003,0,0
6,GO PIGMENT CELL DIFFERENTIATION,0.43329,0.041303,0.10349,0,0
6,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.48117,0.041294,0.049573,0,0
6,GO PROTEIN IMPORT,0.39705,0.041201,0.07062,0,0
6,GO NOTOCHORD DEVELOPMENT,0.47137,0.040856,0.091072,0,0
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.35442,0.040856,0.08465,0,0
6,GO RESPONSE TO TEMPERATURE STIMULUS,0.23203,0.040792,0.096746,0,0
6,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.35442,0.04077,0.068477,0,0
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.81845,0.04064,0.052084,0,0
6,GO OUTFLOW TRACT MORPHOGENESIS,0.21989,0.040535,0.14505,0,0
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.66333,0.040256,0.078437,0,0
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.67486,0.040254,0.099182,0,0
6,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.16602,0.040187,0.09081,0,0
6,GO ROOF OF MOUTH DEVELOPMENT,0.2998,0.039986,0.1225,0,0
6,GO APOPTOTIC DNA FRAGMENTATION,0.43329,0.039969,0.065455,0,0
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.60692,0.039944,0.047228,0,0
6,GO MACROMOLECULE DEPALMITOYLATION,0.50109,0.039808,0.031774,0,0
6,GO SULFATION,0.37111,0.039801,0.13393,0,0
6,GO HEART DEVELOPMENT,0.34626,0.03972,0.10949,0,0
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.64051,0.039628,0.069423,0,0
6,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.27821,0.039544,0.11115,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.99368,0.039524,-0.0086661,0,0
6,GO MESODERM DEVELOPMENT,0.3148,0.039437,0.10735,0,0
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.74555,0.039307,0.037754,0,0
6,GO EAR MORPHOGENESIS,0.67486,0.039258,0.049839,0,0
6,GO FATTY ACID HOMEOSTASIS,0.24463,0.039252,0.11324,0,0
6,GO SPERM EGG RECOGNITION,0.23827,0.039219,0.047775,0,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.33821,0.039163,0.057455,0,0
6,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.38829,0.039083,0.072602,0,0
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.30724,0.038976,0.073163,0,0
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.68646,0.038812,0.058951,0,0
6,GO REGULATION OF HAIR CYCLE,0.85555,0.03876,0.04188,0,0
6,GO INOSITOL METABOLIC PROCESS,0.68646,0.038718,0.0706,0,0
6,GO CORONARY VASCULATURE DEVELOPMENT,0.61803,0.038651,0.10294,0,0
6,GO REGULATION OF CELL DIFFERENTIATION,0.25111,0.038632,0.12472,0,0
6,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.51122,0.038575,0.071997,0,0
6,GO SELECTIVE AUTOPHAGY,0.38829,0.038283,0.099188,0,0
6,GO REGULATION OF CILIUM MOVEMENT,0.54223,0.038243,0.034455,0,0
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.60692,0.038183,0.082768,0,0
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.98106,0.038089,0.0099946,0,0
6,GO MOTILE CILIUM ASSEMBLY,0.88046,0.038018,-0.024918,0,0
6,GO CELLULAR RESPONSE TO VITAMIN D,0.34626,0.037882,0.10182,0,0
6,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.1475,0.037809,0.087654,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.33029,0.037749,0.072827,0,0
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.51122,0.037709,0.074112,0,0
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.62923,0.037491,0.10535,0,0
6,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.18102,0.037484,0.070163,0,0
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.48117,0.037383,0.083185,0,0
6,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.69814,0.037378,0.021992,0,0
6,GO CELL JUNCTION ASSEMBLY,0.72171,0.037238,0.073575,0,0
6,GO REGULATION OF GLUTAMATE SECRETION,0.69814,0.037231,0.050599,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.4521,0.037204,0.082096,0,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.23827,0.037116,0.14537,0,0
6,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.17591,0.037103,0.090782,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.29248,0.036998,0.098109,0,0
6,GO MUSCLE CELL DEVELOPMENT,0.52145,0.036968,0.080171,0,0
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.2577,0.036806,0.068614,0,0
6,GO GROWTH,0.60692,0.036643,0.088594,0,0
6,GO SECONDARY METABOLIC PROCESS,0.28529,0.03658,0.070376,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.52145,0.036496,0.10768,0,0
6,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.25111,0.036452,0.10331,0,0
6,GO SERTOLI CELL DEVELOPMENT,0.40594,0.036426,0.11745,0,0
6,GO CHONDROCYTE PROLIFERATION,0.50109,0.036296,0.11901,0,0
6,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.67486,0.036288,0.050938,0,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.44264,0.036083,0.11014,0,0
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.37964,0.036066,0.12522,0,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.50109,0.036027,0.086336,0,0
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.40594,0.035961,0.097959,0,0
6,GO CELLULAR GLUCOSE HOMEOSTASIS,0.53179,0.035863,0.073656,0,0
6,GO CELL JUNCTION ORGANIZATION,0.93062,0.035614,0.063398,0,0
6,GO ENERGY RESERVE METABOLIC PROCESS,0.51122,0.035561,0.067456,0,0
6,GO RENAL WATER HOMEOSTASIS,0.58498,0.035552,0.10546,0,0
6,GO CELL VOLUME HOMEOSTASIS,0.44264,0.035551,0.11343,0,0
6,GO NUCLEOBASE METABOLIC PROCESS,0.2259,0.035457,0.092679,0,0
6,GO AORTA DEVELOPMENT,0.57414,0.035368,0.1019,0,0
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.89296,0.035284,-0.061377,0,0
6,GO AROMATIC AMINO ACID TRANSPORT,0.76963,0.035077,0.07516,0,0
6,GO HORMONE MEDIATED SIGNALING PATHWAY,0.72171,0.034855,0.06008,0,0
6,GO CELL CELL JUNCTION ORGANIZATION,0.33029,0.034828,0.12324,0,0
6,GO DIENCEPHALON DEVELOPMENT,0.70989,0.034806,0.087411,0,0
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.66333,0.034803,0.064684,0,0
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.52145,0.034743,0.073453,0,0
6,GO HEPATOCYTE DIFFERENTIATION,0.51122,0.03469,0.052993,0,0
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.4521,0.034684,0.083293,0,0
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.64051,0.03468,0.065458,0,0
6,GO REGULATION OF PHOSPHATASE ACTIVITY,0.66333,0.034508,0.064927,0,0
6,GO REGULATION OF FERTILIZATION,0.2259,0.03447,0.074496,0,0
6,GO PIGMENT METABOLIC PROCESS,0.36271,0.034459,0.06871,0,0
6,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.29248,0.034182,0.12557,0,0
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.44264,0.034163,0.07933,0,0
6,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.70989,0.034077,0.041829,0,0
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.5959,0.034069,0.092013,0,0
6,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.32248,0.034055,0.074656,0,0
6,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.47137,0.034052,0.069528,0,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.29248,0.033978,0.099454,0,0
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.61803,0.033945,0.061949,0,0
6,GO SARCOMERE ORGANIZATION,0.72171,0.033894,0.030065,0,0
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.30724,0.033876,0.073577,0,0
6,GO ACTIN FILAMENT BASED TRANSPORT,0.64051,0.033845,0.10137,0,0
6,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.41494,0.033573,0.053714,0,0
6,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.35442,0.033515,0.068648,0,0
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.72171,0.033424,0.050447,0,0
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.53179,0.033374,0.068905,0,0
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.57414,0.033299,0.048102,0,0
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.27126,0.033289,0.13036,0,0
6,GO MEMBRANE BIOGENESIS,0.57414,0.033182,0.080443,0,0
6,GO MYOFIBRIL ASSEMBLY,0.43329,0.03311,0.086103,0,0
6,GO ATP TRANSPORT,0.53179,0.03308,0.055259,0,0
6,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.11894,0.03305,0.099005,0,0
6,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.53179,0.032947,0.058635,0,0
6,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.62923,0.032908,0.066979,0,0
6,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.79394,0.032801,0.01999,0,0
6,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.99368,0.032626,0.023001,0,0
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.50109,0.032615,0.094968,0,0
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.90549,0.032591,0.040394,0,0
6,GO REGULATION OF ORGAN GROWTH,0.33821,0.032513,0.097882,0,0
6,GO GROOMING BEHAVIOR,0.56341,0.032473,0.055929,0,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.37964,0.03234,0.10612,0,0
6,GO NUCLEOSIDE METABOLIC PROCESS,0.23203,0.032278,0.068023,0,0
6,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.29248,0.032273,0.087061,0,0
6,GO BIOLOGICAL PHASE,0.74555,0.032252,0.022818,0,0
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.72171,0.03216,0.087607,0,0
6,GO AUTOPHAGY OF NUCLEUS,0.46168,0.032147,0.10026,0,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS,0.197,0.03211,0.1241,0,0
6,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.33029,0.032068,0.083316,0,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.29248,0.032056,0.079444,0,0
6,GO REGULATION OF VACUOLE ORGANIZATION,0.16123,0.031955,0.13013,0,0
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.53179,0.031925,0.079384,0,0
6,GO PENTOSE METABOLIC PROCESS,0.44264,0.031887,0.030411,0,0
6,GO COCHLEA DEVELOPMENT,0.81845,0.031817,0.036818,0,0
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.37111,0.031817,0.11045,0,0
6,GO CARDIAC ATRIUM MORPHOGENESIS,0.33821,0.031803,0.14283,0,0
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.76963,0.031798,0.036223,0,0
6,GO DNA DEALKYLATION,0.39705,0.031618,0.075401,0,0
6,GO REGULATION OF CATION CHANNEL ACTIVITY,0.83078,0.031487,0.034705,0,0
6,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.29248,0.031127,0.13852,0,0
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.70989,0.031106,0.070478,0,0
6,GO STEM CELL DIFFERENTIATION,0.3148,0.031104,0.086641,0,0
6,GO ENDOSOMAL TRANSPORT,0.49108,0.031052,0.084232,0,0
6,GO CGMP METABOLIC PROCESS,0.99368,0.031043,0.019076,0,0
6,GO CELLULAR RESPONSE TO RADIATION,0.95582,0.031026,0.039277,0,0
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.66333,0.030953,0.075724,0,0
6,GO REGULATION OF PROTEIN POLYMERIZATION,0.42405,0.030926,0.092817,0,0
6,GO PREPULSE INHIBITION,0.69814,0.030905,-0.067809,0,0
6,GO REGULATION OF GLUCOSE IMPORT,0.61803,0.03077,0.048729,0,0
6,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.15655,0.030741,0.089706,0,0
6,GO C4 DICARBOXYLATE TRANSPORT,0.47137,0.030675,0.06545,0,0
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.38829,0.030599,0.093331,0,0
6,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.50109,0.030475,0.07233,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1,0.030303,0.026245,0,0
6,GO LYMPH VESSEL DEVELOPMENT,0.57414,0.030138,0.10705,0,0
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.58498,0.030011,0.064058,0,0
6,GO RESPONSE TO ACID CHEMICAL,0.20822,0.029982,0.10783,0,0
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.43329,0.029955,0.11017,0,0
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.7336,0.029895,0.056294,0,0
6,GO CORNIFICATION,0.57414,0.029874,0.033959,0,0
6,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.32248,0.029704,0.07788,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.37111,0.029695,0.1129,0,0
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.72171,0.029622,-0.018227,0,0
6,GO PIGMENTATION,0.72171,0.029376,0.046426,0,0
6,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.62923,0.029198,0.053457,0,0
6,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.51122,0.0291,0.03554,0,0
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.49108,0.029091,0.073573,0,0
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.64051,0.028973,0.09164,0,0
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.57414,0.028968,0.093927,0,0
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.44264,0.02894,0.071486,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.56341,0.028923,0.055904,0,0
6,GO ORGANELLE INHERITANCE,0.66333,0.028921,0.067927,0,0
6,GO MITOCHONDRION DISTRIBUTION,1,0.028904,0.034801,0,0
6,GO COBALAMIN METABOLIC PROCESS,0.2259,0.028903,0.11285,0,0
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.29248,0.028742,0.078591,0,0
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.40594,0.028739,0.11785,0,0
6,GO REGULATION OF COLLATERAL SPROUTING,0.52145,0.028643,-0.068414,0,0
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.99368,0.028599,0.045426,0,0
6,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.214,0.028558,0.093766,0,0
6,GO AMINE TRANSPORT,0.99368,0.028553,0.055784,0,0
6,GO VIRAL RNA GENOME REPLICATION,0.54223,0.028506,0.074166,0,0
6,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.37964,0.028498,0.062583,0,0
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.60692,0.028496,0.057978,0,0
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.79394,0.028491,0.05231,0,0
6,GO EAR DEVELOPMENT,0.52145,0.028459,0.073549,0,0
6,GO CLATHRIN COAT ASSEMBLY,0.58498,0.028438,0.051639,0,0
6,GO NEURON MATURATION,0.70989,0.028403,0.067281,0,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.57414,0.028295,0.048793,0,0
6,GO POSITIVE REGULATION OF TRANSLATION,0.34626,0.028283,0.067656,0,0
6,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.49108,0.028267,0.11519,0,0
6,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.78176,0.02821,0.07045,0,0
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.29248,0.028176,0.097046,0,0
6,GO CELLULAR RESPONSE TO UV,0.99368,0.028004,0.020196,0,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.11524,0.02797,0.20377,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.25111,0.027966,0.10638,0,0
6,GO ADAPTATION OF SIGNALING PATHWAY,0.81845,0.027912,0.018171,0,0
6,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.24463,0.027766,0.095138,0,0
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.68646,0.027484,0.084503,0,0
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.49108,0.027331,0.089817,0,0
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.56341,0.027144,0.069081,0,0
6,GO EMBRYONIC ORGAN DEVELOPMENT,0.5959,0.027142,0.079986,0,0
6,GO MANNOSYLATION,0.80618,0.027134,0.051816,0,0
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.1306,0.027121,0.075126,0,0
6,GO REGULATION OF PROTEIN TARGETING,0.3148,0.027114,0.092207,0,0
6,GO REGULATION OF GROWTH,0.34626,0.027051,0.10687,0,0
6,GO POTASSIUM ION TRANSPORT,0.57414,0.027044,0.054106,0,0
6,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.68646,0.026999,0.085634,0,0
6,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.41494,0.026985,0.10621,0,0
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.88046,0.026736,0.0417,0,0
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.90549,0.026731,0.056632,0,0
6,GO POSITIVE REGULATION OF TOR SIGNALING,0.93062,0.02649,0.027916,0,0
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.43329,0.026464,0.09459,0,0
6,GO STRIATED MUSCLE ADAPTATION,0.34626,0.026445,0.1202,0,0
6,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.3148,0.026437,0.075892,0,0
6,GO REGULATION OF DNA BINDING,0.52145,0.026399,0.065554,0,0
6,GO SEQUESTERING OF ACTIN MONOMERS,0.70989,0.026363,0.065287,0,0
6,GO REGULATION OF AUTOPHAGY,0.20822,0.026178,0.11329,0,0
6,GO INNER DYNEIN ARM ASSEMBLY,0.64051,0.026146,-0.099907,0,0
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.70989,0.026111,0.041342,0,0
6,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.27821,0.026091,0.065534,0,0
6,GO PROTEIN TETRAMERIZATION,0.38829,0.026022,0.081376,0,0
6,GO RENAL TUBULE DEVELOPMENT,0.51122,0.025911,0.089687,0,0
6,GO KIDNEY MORPHOGENESIS,0.37111,0.025891,0.10655,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.43329,0.025835,0.12169,0,0
6,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.98106,0.025834,0.041742,0,0
6,GO ALPHA AMINO ACID METABOLIC PROCESS,0.34626,0.025819,0.069337,0,0
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.34626,0.025747,0.086834,0,0
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.75756,0.025664,0.04457,0,0
6,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.81845,0.025633,0.063762,0,0
6,GO TISSUE MORPHOGENESIS,0.2577,0.025295,0.11852,0,0
6,GO RESPONSE TO MINERALOCORTICOID,0.18624,0.025263,0.10952,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.46168,0.02521,0.063738,0,0
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.55277,0.025153,0.089582,0,0
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.2998,0.025146,0.11421,0,0
6,GO HYPEROSMOTIC SALINITY RESPONSE,0.58498,0.025033,0.064689,0,0
6,GO NOTCH RECEPTOR PROCESSING,0.56341,0.024947,0.077248,0,0
6,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.16602,0.024944,0.10585,0,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.48117,0.024918,0.092214,0,0
6,GO MUSCLE ORGAN DEVELOPMENT,0.33821,0.024802,0.098296,0,0
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.74555,0.024753,0.067888,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.48117,0.02473,0.088528,0,0
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.35442,0.024706,0.10062,0,0
6,GO TRNA CATABOLIC PROCESS,0.90549,0.024508,0.0051968,0,0
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.28529,0.024478,0.093467,0,0
6,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.17091,0.024449,0.14422,0,0
6,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.5959,0.024428,0.095098,0,0
6,GO RHYTHMIC PROCESS,0.66333,0.02442,0.066334,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.95582,0.024391,0.026279,0,0
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.72171,0.024374,0.077969,0,0
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.39705,0.024326,0.083867,0,0
6,GO REGULATION OF DENDRITE EXTENSION,0.34626,0.0243,0.13203,0,0
6,GO SECRETORY GRANULE LOCALIZATION,0.83078,0.02422,0.062487,0,0
6,GO HEART MORPHOGENESIS,0.50109,0.024139,0.10132,0,0
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.69814,0.024056,0.042374,0,0
6,GO PYRUVATE METABOLIC PROCESS,0.75756,0.024035,0.062807,0,0
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.70989,0.024035,0.046998,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.7336,0.023888,0.052621,0,0
6,GO NEURON CELL CELL ADHESION,0.85555,0.023674,0.027302,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.76963,0.02365,0.063186,0,0
6,GO EMBRYONIC MORPHOGENESIS,0.49108,0.02351,0.092173,0,0
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.90549,0.023464,0.042452,0,0
6,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.50109,0.023361,0.051571,0,0
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.66333,0.023342,0.053713,0,0
6,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.43329,0.023174,0.11228,0,0
6,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.32248,0.022884,0.086909,0,0
6,GO RESPONSE TO ACTIVITY,0.18624,0.022858,0.1031,0,0
6,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.41494,0.02273,0.087231,0,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.2998,0.022625,0.12784,0,0
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.69814,0.022569,0.076609,0,0
6,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.48117,0.022524,0.058895,0,0
6,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.85555,0.022447,0.07759,0,0
6,GO ACID SECRETION,0.52145,0.022344,0.04187,0,0
6,GO EMBRYONIC BODY MORPHOGENESIS,0.84314,0.022339,0.03527,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.95582,0.022312,0.042708,0,0
6,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.80618,0.022261,0.060573,0,0
6,GO CORONARY VASCULATURE MORPHOGENESIS,0.88046,0.022254,0.051053,0,0
6,GO PROTEIN PALMITOYLATION,0.98106,0.022146,0.04918,0,0
6,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.80618,0.022095,0.037659,0,0
6,GO TRANSMISSION OF NERVE IMPULSE,0.90549,0.022041,0.043166,0,0
6,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.3148,0.022034,0.072835,0,0
6,GO DEPHOSPHORYLATION,0.52145,0.022004,0.073606,0,0
6,GO RESPONSE TO NICOTINE,0.65188,0.021727,0.044033,0,0
6,GO BLASTOCYST FORMATION,0.58498,0.021642,0.053424,0,0
6,GO BLASTODERM SEGMENTATION,0.74555,0.02161,0.059084,0,0
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.58498,0.021609,-0.036205,0,0
6,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.13885,0.021596,0.14234,0,0
6,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.58498,0.021577,0.055599,0,0
6,GO CELLULAR RESPONSE TO HEAT,0.58498,0.021557,0.075962,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.70989,0.021517,0.016084,0,0
6,GO DEVELOPMENTAL PIGMENTATION,0.61803,0.021453,0.073902,0,0
6,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.5959,0.021444,0.077746,0,0
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.99368,0.021437,0.041409,0,0
6,GO NADH METABOLIC PROCESS,0.74555,0.021429,0.060733,0,0
6,GO EXCRETION,0.50109,0.021417,0.093571,0,0
6,GO DEVELOPMENTAL GROWTH,0.95582,0.021367,0.059417,0,0
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.60692,0.021331,0.054078,0,0
6,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.38829,0.021114,0.057782,0,0
6,GO NEPHRON TUBULE FORMATION,0.69814,0.021079,0.058745,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.28529,0.021033,0.14915,0,0
6,GO VESICLE LOCALIZATION,0.62923,0.020942,0.069556,0,0
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.37964,0.02088,0.1298,0,0
6,GO NOSE DEVELOPMENT,0.78176,0.020759,0.09355,0,0
6,GO POST ANAL TAIL MORPHOGENESIS,0.98106,0.02061,0.042058,0,0
6,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.38829,0.020602,0.094211,0,0
6,GO APPENDAGE MORPHOGENESIS,1,0.020584,0.047063,0,0
6,GO ENDOCRINE SYSTEM DEVELOPMENT,0.53179,0.020527,0.099681,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.43329,0.020174,0.08918,0,0
6,GO LACTATE METABOLIC PROCESS,0.56341,0.020123,0.047872,0,0
6,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.39705,0.020119,0.083143,0,0
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.23203,0.020114,0.10123,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.46168,0.020086,0.083434,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.74555,0.020047,0.047144,0,0
6,GO PEPTIDYL SERINE MODIFICATION,0.65188,0.02004,0.084534,0,0
6,GO CARDIAC CELL DEVELOPMENT,0.74555,0.019889,0.052738,0,0
6,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.43329,0.019875,0.060994,0,0
6,GO EPITHELIAL CELL FATE COMMITMENT,0.78176,0.019826,0.064735,0,0
6,GO NUCLEOSIDE SALVAGE,0.60692,0.019792,0.043056,0,0
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.78176,0.019556,0.051377,0,0
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.40594,0.019553,0.057143,0,0
6,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.214,0.019509,0.11218,0,0
6,GO INNER EAR MORPHOGENESIS,0.76963,0.019365,0.041142,0,0
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.32248,0.019349,0.099173,0,0
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.69814,0.019323,0.048292,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.53179,0.01927,0.094017,0,0
6,GO LYMPH VESSEL MORPHOGENESIS,0.57414,0.019243,0.096278,0,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.44264,0.019243,0.094466,0,0
6,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.33029,0.019124,0.049078,0,0
6,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.39705,0.018927,0.057633,0,0
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.80618,0.018907,0.054625,0,0
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.44264,0.018706,0.087211,0,0
6,GO SENSORY PERCEPTION OF SMELL,0.7336,0.018673,0.019707,0,0
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.41494,0.018602,0.086337,0,0
6,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.23203,0.018459,0.10913,0,0
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.99368,0.018335,0.056581,0,0
6,GO PROTEIN LOCALIZATION TO MEMBRANE,0.39705,0.018311,0.061754,0,0
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.83078,0.018288,0.066671,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.5959,0.018202,0.061677,0,0
6,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.80618,0.01818,0.026537,0,0
6,GO HEXOSE CATABOLIC PROCESS,0.18624,0.018119,0.11769,0,0
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.68646,0.018055,0.06894,0,0
6,GO CYTOKINETIC PROCESS,0.32248,0.018009,0.08107,0,0
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.61803,0.017919,0.059068,0,0
6,GO NERVOUS SYSTEM PROCESS,0.88046,0.017862,0.035459,0,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.56341,0.017857,0.083991,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.36271,0.017843,0.08741,0,0
6,GO REGULATION OF GLUCONEOGENESIS,0.65188,0.017816,0.065869,0,0
6,GO REPRODUCTION,0.83078,0.01777,0.053276,0,0
6,GO APICAL PROTEIN LOCALIZATION,0.60692,0.017701,0.076564,0,0
6,GO REGULATION OF DEPHOSPHORYLATION,0.72171,0.017508,0.064922,0,0
6,GO PROTEIN TARGETING TO VACUOLE,0.50109,0.017366,0.10488,0,0
6,GO REGULATION OF ACROSOME REACTION,0.40594,0.017354,0.076597,0,0
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.89296,0.01733,0.069292,0,0
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.30724,0.01725,0.15042,0,0
6,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.4521,0.017209,0.047864,0,0
6,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.61803,0.017141,0.047071,0,0
6,GO REGULATION OF PROTEIN STABILITY,0.2998,0.017113,0.084525,0,0
6,GO SEX DIFFERENTIATION,0.84314,0.017112,0.057709,0,0
6,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.69814,0.016711,0.015748,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.46168,0.016642,0.095197,0,0
6,GO REGULATION OF CELL MORPHOGENESIS,0.89296,0.016113,0.075572,0,0
6,GO PROTEIN FOLDING,0.37111,0.016051,0.074025,0,0
6,GO PROTEIN DEPHOSPHORYLATION,0.7336,0.016005,0.062032,0,0
6,GO HAIR FOLLICLE MATURATION,0.61803,0.015962,0.074987,0,0
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.30724,0.01595,0.088274,0,0
6,GO RESPONSE TO GLUCAGON,0.7336,0.015894,0.025587,0,0
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.50109,0.01574,0.05955,0,0
6,GO EPITHELIAL TUBE FORMATION,0.91805,0.015441,0.052482,0,0
6,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.37111,0.01544,0.049405,0,0
6,GO GLUTAMATE SECRETION,0.96843,0.015435,0.044936,0,0
6,GO ONE CARBON METABOLIC PROCESS,0.61803,0.015422,0.051042,0,0
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.99368,0.015413,0.017427,0,0
6,GO RESPONSE TO MISFOLDED PROTEIN,0.51122,0.015412,0.081618,0,0
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.93062,0.015243,0.056466,0,0
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.60692,0.015229,0.076525,0,0
6,GO PIGMENT ACCUMULATION,0.62923,0.0152,0.099295,0,0
6,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.18624,0.015198,0.07685,0,0
6,GO ECTODERM DEVELOPMENT,0.58498,0.015099,-0.006463,0,0
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.75756,0.014752,0.045936,0,0
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.7336,0.014752,0.049404,0,0
6,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.60692,0.014668,0.025373,0,0
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.60692,0.014651,0.063019,0,0
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,1,0.014609,0.049108,0,0
6,GO DE NOVO PROTEIN FOLDING,0.51122,0.014492,0.059428,0,0
6,GO MUSCLE FIBER DEVELOPMENT,0.90549,0.014438,0.024267,0,0
6,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.46168,0.014225,0.067715,0,0
6,GO REGULATION OF DEVELOPMENTAL GROWTH,0.95582,0.014196,0.054871,0,0
6,GO REGULATION OF BMP SIGNALING PATHWAY,0.42405,0.014145,0.14943,0,0
6,GO CYTOPLASM ORGANIZATION,0.62923,0.014144,0.058455,0,0
6,GO SENSORY PERCEPTION,0.78176,0.014051,0.04412,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.4521,0.014026,0.087028,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.95582,0.013998,-0.0059559,0,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.99368,0.013991,0.050784,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.72171,0.013895,0.065438,0,0
6,GO REGULATION OF INSULIN SECRETION,0.56341,0.013868,0.068507,0,0
6,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.74555,0.013848,0.061401,0,0
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.72171,0.013809,0.060833,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.90549,0.013755,0.02406,0,0
6,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.34626,0.01374,0.051717,0,0
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.68646,0.013686,0.060303,0,0
6,GO CELL AGING,0.2577,0.013632,0.094826,0,0
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.85555,0.013599,0.035071,0,0
6,GO REGULATION OF CELLULAR COMPONENT SIZE,0.5959,0.013516,0.095824,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.72171,0.013498,0.048846,0,0
6,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.74555,0.013497,0.029414,0,0
6,GO REGULATION OF TOR SIGNALING,0.83078,0.013487,0.036534,0,0
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.51122,0.013424,0.069571,0,0
6,GO REGULATION OF SENSORY PERCEPTION,0.74555,0.013347,0.048516,0,0
6,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.43329,0.013196,0.086742,0,0
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.51122,0.013134,0.058988,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.80618,0.013111,0.042932,0,0
6,GO REGULATION OF GASTRIC ACID SECRETION,0.81845,0.013058,-0.0043534,0,0
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.81845,0.012994,0.059025,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.89296,0.012726,0.053761,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.81845,0.012645,0.049465,0,0
6,GO CATECHOLAMINE SECRETION,0.91805,0.012624,0.0688,0,0
6,GO CIRCADIAN RHYTHM,0.74555,0.012602,0.064341,0,0
6,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.41494,0.012565,0.077291,0,0
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.93062,0.012462,-0.012742,0,0
6,GO REGULATION OF CATABOLIC PROCESS,0.29248,0.012423,0.093214,0,0
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.81845,0.012398,0.10007,0,0
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.41494,0.012261,0.098928,0,0
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.98106,0.012253,0.026587,0,0
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.80618,0.012245,0.047788,0,0
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.58498,0.012236,0.08207,0,0
6,GO ODONTOGENESIS,0.37111,0.012218,0.11431,0,0
6,GO RESPONSE TO CORTICOSTERONE,0.70989,0.01211,0.054965,0,0
6,GO IN UTERO EMBRYONIC DEVELOPMENT,0.60692,0.012088,0.075633,0,0
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.46168,0.012063,0.093352,0,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.79394,0.011937,0.063331,0,0
6,GO ESTABLISHMENT OF CELL POLARITY,0.79394,0.011907,0.085106,0,0
6,GO ACIDIC AMINO ACID TRANSPORT,0.81845,0.011886,0.062908,0,0
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.60692,0.011534,0.07212,0,0
6,GO REGULATION OF ATP METABOLIC PROCESS,0.57414,0.011461,0.065547,0,0
6,GO ANIMAL ORGAN MORPHOGENESIS,0.4521,0.011448,0.10033,0,0
6,GO GOLGI TO VACUOLE TRANSPORT,0.94321,0.011295,0.047964,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.19156,0.011288,0.11009,0,0
6,GO INCLUSION BODY ASSEMBLY,0.5959,0.011288,0.10058,0,0
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.64051,0.011273,-0.018646,0,0
6,GO REGULATION OF PROTEIN ACETYLATION,0.72171,0.01125,0.055612,0,0
6,GO ESTABLISHMENT OF TISSUE POLARITY,0.42405,0.011138,0.072436,0,0
6,GO REGULATION OF CELL DIVISION,0.90549,0.011062,0.04499,0,0
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.93062,0.011061,-0.00047302,0,0
6,GO ENDOCRINE PANCREAS DEVELOPMENT,0.99368,0.011005,0.047535,0,0
6,GO FEMALE SEX DIFFERENTIATION,0.83078,0.011,0.060436,0,0
6,GO SULFATE TRANSPORT,0.80618,0.010893,0.053522,0,0
6,GO TUBE FORMATION,0.88046,0.010873,0.053161,0,0
6,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.99368,0.010831,0.065729,0,0
6,GO REGULATION OF POTASSIUM ION TRANSPORT,0.93062,0.010702,0.026279,0,0
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.78176,0.0107,0.064208,0,0
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.62923,0.010601,0.071616,0,0
6,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.52145,0.010546,0.06959,0,0
6,GO MYELIN ASSEMBLY,0.4521,0.010478,0.13702,0,0
6,GO HISTONE H2B UBIQUITINATION,0.38829,0.010467,0.079988,0,0
6,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.89296,0.010434,-0.0050451,0,0
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.39705,0.010364,0.094368,0,0
6,GO MODULATION BY VIRUS OF HOST PROCESS,0.54223,0.010344,0.070096,0,0
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.80618,0.010197,0.035262,0,0
6,GO QUINONE METABOLIC PROCESS,0.93062,0.010151,0.0092545,0,0
6,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.84314,0.010121,0.0035723,0,0
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.69814,0.0099832,0.062566,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY,0.32248,0.0099684,0.08321,0,0
6,GO PROTEIN TARGETING,0.23203,0.0094971,0.041259,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.79394,0.0094962,0.062872,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.81845,0.0094735,0.017842,0,0
6,GO DENTATE GYRUS DEVELOPMENT,0.60692,0.0094223,-0.082603,0,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.214,0.0091282,0.10755,0,0
6,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.52145,0.0088832,0.078481,0,0
6,GO GOLGI VESICLE TRANSPORT,0.36271,0.0088187,0.088624,0,0
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1,0.008768,0.01337,0,0
6,GO ATRIAL SEPTUM MORPHOGENESIS,0.62923,0.0082513,0.10095,0,0
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.83078,0.0082074,0.065194,0,0
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.44264,0.0081815,0.10479,0,0
6,GO CELLULAR SENESCENCE,0.28529,0.0081804,0.089246,0,0
6,GO PEPTIDE HORMONE SECRETION,0.70989,0.0081372,0.069874,0,0
6,GO GOLGI LOCALIZATION,0.58498,0.0081296,0.049272,0,0
6,GO GOLGI ORGANIZATION,0.19156,0.0081278,0.1153,0,0
6,GO APPENDAGE DEVELOPMENT,0.91805,0.0081059,0.058541,0,0
6,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.58498,0.0079985,0.027947,0,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.75756,0.0078345,0.078552,0,0
6,GO GLUCOSE CATABOLIC PROCESS,0.50109,0.0078158,0.088351,0,0
6,GO BEHAVIOR,0.93062,0.0077354,0.024266,0,0
6,GO MALE SEX DIFFERENTIATION,0.46168,0.0075924,0.092121,0,0
6,GO THYROID GLAND DEVELOPMENT,0.99368,0.0075552,0.024807,0,0
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.79394,0.0075227,0.065996,0,0
6,GO EMBRYONIC DIGIT MORPHOGENESIS,0.75756,0.0074869,0.067707,0,0
6,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.86799,0.007352,0.0099822,0,0
6,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.65188,0.0071034,0.06283,0,0
6,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.27126,0.0069938,0.096197,0,0
6,GO REGULATION OF HEART MORPHOGENESIS,0.26442,0.0069755,0.14678,0,0
6,GO MONOSACCHARIDE CATABOLIC PROCESS,0.27821,0.0067863,0.099423,0,0
6,GO REGULATION OF MEMBRANE PERMEABILITY,0.72171,0.0066552,0.053961,0,0
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.4521,0.006623,0.07275,0,0
6,GO REGULATION OF TELOMERASE ACTIVITY,0.95582,0.0065851,0.040768,0,0
6,GO PRIMARY MIRNA PROCESSING,0.85555,0.0065264,0.032596,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.95582,0.0065078,0.017887,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.75756,0.0065064,0.047099,0,0
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.66333,0.0063699,0.061354,0,0
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.52145,0.0062941,0.088998,0,0
6,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.40594,0.0061948,0.076427,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,1,0.0060497,0.008252,0,0
6,GO OXIDATIVE PHOSPHORYLATION,0.93062,0.0059872,0.0062568,0,0
6,GO CYTOSOLIC TRANSPORT,0.57414,0.005905,0.087667,0,0
6,GO POLYOL CATABOLIC PROCESS,0.94321,0.0058568,0.03341,0,0
6,GO RETINA HOMEOSTASIS,0.94321,0.0058306,0.012774,0,0
6,GO IMPORT INTO NUCLEUS,0.88046,0.0058015,0.043847,0,0
6,GO EPITHELIAL CELL MATURATION,0.68646,0.0057475,0.063618,0,0
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.57414,0.0055173,-0.031172,0,0
6,GO VACUOLAR TRANSPORT,0.54223,0.005491,0.08507,0,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.64051,0.0054651,-0.025592,0,0
6,GO NCRNA CATABOLIC PROCESS,1,0.0054095,0.030142,0,0
6,GO OVARIAN FOLLICLE DEVELOPMENT,0.93062,0.0053284,0.045519,0,0
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.66333,0.0053119,0.07608,0,0
6,GO REGULATION OF CELL PROJECTION SIZE,0.93062,0.005163,-0.011527,0,0
6,GO PROTEIN KINASE A SIGNALING,0.78176,0.0050962,0.046278,0,0
6,GO REGULATION OF PROTEIN FOLDING,0.49108,0.0050913,0.06628,0,0
6,GO REGULATION OF DNA RECOMBINATION,0.93062,0.0049646,0.043725,0,0
6,GO MIDBRAIN DEVELOPMENT,1,0.0048934,0.040141,0,0
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.62923,0.0047656,0.007016,0,0
6,GO PENILE ERECTION,0.88046,0.0047477,0.015229,0,0
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.93062,0.0047316,0.016647,0,0
6,GO PIGMENT GRANULE ORGANIZATION,0.80618,0.0046687,0.047088,0,0
6,GO RETINAL GANGLION CELL AXON GUIDANCE,0.72171,0.0045765,0.05517,0,0
6,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.36271,0.0045259,0.063566,0,0
6,GO REGULATION OF CELL SIZE,0.75756,0.0044967,0.043829,0,0
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.50109,0.0044899,0.079864,0,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.37111,0.0044768,0.062349,0,0
6,GO GLIAL CELL DIFFERENTIATION,0.7336,0.0044184,0.083148,0,0
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.93062,0.0043931,0.0010832,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.81845,0.0043896,0.072482,0,0
6,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.96843,0.0043808,0.016225,0,0
6,GO RESPONSE TO INSECTICIDE,0.7336,0.0043071,-0.022188,0,0
6,GO SPERM AXONEME ASSEMBLY,0.48117,0.0042571,-0.047008,0,0
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.68646,0.0041668,0.0769,0,0
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.75756,0.004155,0.054368,0,0
6,GO MULTICELLULAR ORGANISM GROWTH,0.94321,0.0040827,0.070429,0,0
6,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.89296,0.0039981,0.034024,0,0
6,GO PROTEIN K63 LINKED UBIQUITINATION,0.38829,0.0039053,0.084263,0,0
6,GO GLUTAMINE METABOLIC PROCESS,0.60692,0.0037173,0.066126,0,0
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.89296,0.0036591,0.027435,0,0
6,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.41494,0.0036368,0.074444,0,0
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.84314,0.0035727,-0.0046027,0,0
6,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.61803,0.0033487,0.057212,0,0
6,GO INSULIN SECRETION,0.60692,0.0033415,0.069467,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.83078,0.0032934,0.016462,0,0
6,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.51122,0.0030733,0.068471,0,0
6,GO POST EMBRYONIC DEVELOPMENT,0.94321,0.0029939,0.073523,0,0
6,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.89296,0.0029099,0.033067,0,0
6,GO OXYGEN TRANSPORT,0.57414,0.0028233,0.096266,0,0
6,GO REGULATION OF MEMBRANE POTENTIAL,0.96843,0.0026457,0.036185,0,0
6,GO ASSOCIATIVE LEARNING,0.84314,0.0026193,0.0099681,0,0
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.40594,0.0024387,0.10303,0,0
6,GO PROTEASOME ASSEMBLY,0.98106,0.002412,0.0012948,0,0
6,GO SNORNA METABOLIC PROCESS,0.84314,0.0023975,0.0059308,0,0
6,GO DETECTION OF ABIOTIC STIMULUS,0.78176,0.0022332,0.037412,0,0
6,GO REGULATION OF BEHAVIOR,0.83078,0.0021409,0.025526,0,0
6,GO MEMORY,0.93062,0.0020946,0.033506,0,0
6,GO SEGMENT SPECIFICATION,0.94321,0.0020865,-0.0030928,0,0
6,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.68646,0.0018971,0.051243,0,0
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.7336,0.0017041,0.065555,0,0
6,GO NEPHRON MORPHOGENESIS,0.55277,0.0016077,0.082602,0,0
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.65188,0.0015485,0.073559,0,0
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.90549,0.0015446,0.014973,0,0
6,GO LEFT RIGHT PATTERN FORMATION,0.90549,0.0013776,0.026005,0,0
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.67486,0.0013549,0.045037,0,0
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.95582,0.00135,0.020443,0,0
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.93062,0.0012933,0.021788,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.54223,0.0012345,0.042199,0,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.99368,0.0012119,0.025363,0,0
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.74555,0.00099554,0.019495,0,0
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.78176,0.0007281,-0.0015685,0,0
6,GO RESPONSE TO WATER,0.83078,0.00050784,0.04011,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.51122,0.00049422,0.084365,0,0
6,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.70989,0.00047839,-0.012187,0,0
6,GO MULTI ORGANISM PROCESS,0.98106,0.00043393,0.040292,0,0
6,GO DENDRITIC SPINE MAINTENANCE,0.58498,0.00036884,0.09903,0,0
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.86799,0.00032171,0.071025,0,0
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.65188,0.0003198,0.070411,0,0
6,GO SENSORY ORGAN DEVELOPMENT,0.96843,0.00023136,0.048017,0,0
6,GO RESPONSE TO AMINO ACID STARVATION,0.76963,7.6263e-05,0.057896,0,0
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.68646,1.6568e-05,0.072279,0,0
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.72171,-4.4053e-06,0.061955,0,0
6,GO REGULATION OF HISTONE H4 ACETYLATION,0.76963,-3.156e-05,0.042373,0,0
6,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.62923,-0.00021061,-0.036101,0,0
6,GO PROTEIN STABILIZATION,0.5959,-0.00024824,0.0677,0,0
6,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.69814,-0.00039154,0.061305,0,0
6,GO MITOCHONDRIAL TRANSCRIPTION,0.98106,-0.00046933,0.0092767,0,0
6,GO MOTOR NEURON AXON GUIDANCE,0.93062,-0.00047307,0.037058,0,0
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.75756,-0.00063017,0.058465,0,0
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.81845,-0.00068175,0.10257,0,0
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.68646,-0.00086501,0.067209,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION,0.53179,-0.0011349,0.058666,0,0
6,GO V D J RECOMBINATION,0.67486,-0.0011532,0.037795,0,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.95582,-0.0012713,0.035794,0,0
6,GO CELLULAR AMIDE METABOLIC PROCESS,0.37111,-0.0014008,0.055601,0,0
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.96843,-0.0014412,0.050073,0,0
6,GO TOR SIGNALING,0.98106,-0.0014838,0.04416,0,0
6,GO PEPTIDE METABOLIC PROCESS,0.49108,-0.0014978,0.035398,0,0
6,GO SPERMATID DIFFERENTIATION,0.64051,-0.0017876,-0.014031,0,0
6,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.79394,-0.0018078,0.027913,0,0
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.83078,-0.001886,-0.024384,0,0
6,GO CELL FATE COMMITMENT,0.89296,-0.0021211,0.064964,0,0
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.60692,-0.0022231,0.065875,0,0
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.78176,-0.0022751,-0.014993,0,0
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.95582,-0.0025922,0.045681,0,0
6,GO AUTOPHAGOSOME ORGANIZATION,0.2998,-0.0026263,0.11416,0,0
6,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.88046,-0.002674,0.03402,0,0
6,GO COGNITION,1,-0.002773,0.030288,0,0
6,GO PROTEIN INSERTION INTO MEMBRANE,0.99368,-0.0031493,0.026929,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.7336,-0.0031805,0.041457,0,0
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.74555,-0.0032237,0.019811,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.40594,-0.0032424,0.09162,0,0
6,GO VISUAL BEHAVIOR,0.89296,-0.0033052,0.04304,0,0
6,GO VESICLE DOCKING,0.64051,-0.0033161,0.082246,0,0
6,GO RESPONSE TO AXON INJURY,0.91805,-0.003332,0.068566,0,0
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.99368,-0.0033564,0.0021687,0,0
6,GO FOREBRAIN GENERATION OF NEURONS,0.75756,-0.0034022,0.04741,0,0
6,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.93062,-0.0035359,0.043627,0,0
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.95582,-0.0035529,0.038352,0,0
6,GO GONADOTROPIN SECRETION,0.95582,-0.0035707,0.045008,0,0
6,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.79394,-0.0036113,0.014128,0,0
6,GO REGULATION OF CELL MATURATION,0.96843,-0.0036416,0.026354,0,0
6,GO MALE SEX DETERMINATION,0.95582,-0.003647,-0.0089014,0,0
6,GO DEVELOPMENTAL CELL GROWTH,0.74555,-0.0036585,0.02289,0,0
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.91805,-0.0036691,-0.011967,0,0
6,GO RESPONSE TO DOPAMINE,0.83078,-0.0037332,0.022862,0,0
6,GO PROTEIN TARGETING TO MITOCHONDRION,0.74555,-0.0041499,0.03621,0,0
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.93062,-0.004301,0.048846,0,0
6,GO PIGMENT GRANULE LOCALIZATION,0.57414,-0.0043153,-0.036365,0,0
6,GO REGULATION OF CELL AGING,0.61803,-0.0044448,0.055434,0,0
6,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.98106,-0.0044493,0.01851,0,0
6,GO LYSOSOMAL TRANSPORT,0.72171,-0.0044605,0.083703,0,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.90549,-0.0044873,0.053868,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.78176,-0.004551,0.013852,0,0
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.95582,-0.004551,0.046985,0,0
6,GO REGULATION OF MIRNA METABOLIC PROCESS,0.95582,-0.0045525,0.033128,0,0
6,GO REGULATION OF RIBOSOME BIOGENESIS,0.76963,-0.0047078,0.04345,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.67486,-0.0047456,0.03731,0,0
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.85555,-0.0048195,-0.023393,0,0
6,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.56341,-0.0048573,0.12014,0,0
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.94321,-0.0049451,0.02998,0,0
6,GO GANGLIOSIDE METABOLIC PROCESS,0.84314,-0.0050058,0.064905,0,0
6,GO PROTEIN POLYUBIQUITINATION,0.7336,-0.0050195,0.052132,0,0
6,GO MITOCHONDRIAL FUSION,0.51122,-0.0050352,-0.0036112,0,0
6,GO PEPTIDYL THREONINE MODIFICATION,0.81845,-0.0051377,0.069362,0,0
6,GO DNA BIOSYNTHETIC PROCESS,0.55277,-0.0052132,0.024451,0,0
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.95582,-0.0053139,0.023611,0,0
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.54223,-0.0053394,0.045226,0,0
6,GO RNA DESTABILIZATION,0.74555,-0.005345,0.081177,0,0
6,GO TRANSLATIONAL TERMINATION,0.62923,-0.0055143,-0.017089,0,0
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.65188,-0.0055995,0.078101,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.85555,-0.0056083,0.013331,0,0
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.66333,-0.0056106,0.061744,0,0
6,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.98106,-0.0056107,0.042205,0,0
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.81845,-0.0057045,0.047078,0,0
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.81845,-0.0057588,0.029462,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.72171,-0.005778,-0.010534,0,0
6,GO CELLULAR MACROMOLECULE LOCALIZATION,0.72171,-0.0058203,0.057419,0,0
6,GO RESPONSE TO UV,0.69814,-0.0063389,0.0069484,0,0
6,GO MOLTING CYCLE,0.88046,-0.0063956,0.054586,0,0
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.83078,-0.0066048,0.047867,0,0
6,GO REGULATION OF GTP BINDING,0.70989,-0.0066825,-0.02143,0,0
6,GO PROTEIN HETEROOLIGOMERIZATION,0.80618,-0.0067576,0.0055225,0,0
6,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.84314,-0.0069312,0.0087163,0,0
6,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.91805,-0.007136,0.028163,0,0
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.86799,-0.0071654,0.0017061,0,0
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.98106,-0.0074808,0.037139,0,0
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.89296,-0.007522,0.037035,0,0
6,GO EMBRYONIC ORGAN MORPHOGENESIS,0.86799,-0.0075484,0.048024,0,0
6,GO MEMBRANE FISSION,0.68646,-0.0076457,0.071378,0,0
6,GO EMBRYO DEVELOPMENT,0.91805,-0.007673,0.060968,0,0
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.56341,-0.0077051,0.075015,0,0
6,GO GAS TRANSPORT,0.70989,-0.0078765,0.064019,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.69814,-0.0079684,0.065916,0,0
6,GO GPI ANCHOR METABOLIC PROCESS,0.89296,-0.0079869,0.020167,0,0
6,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.95582,-0.008074,0.037644,0,0
6,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.72171,-0.0080873,0.070934,0,0
6,GO INTRACELLULAR MRNA LOCALIZATION,0.94321,-0.0081363,0.061238,0,0
6,GO RESPONSE TO NERVE GROWTH FACTOR,0.96843,-0.0081672,0.022301,0,0
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.72171,-0.00836,0.0061384,0,0
6,GO ALDEHYDE CATABOLIC PROCESS,0.95582,-0.0084953,-0.015665,0,0
6,GO PROTEIN LOCALIZATION TO VACUOLE,0.70989,-0.0085281,0.078399,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.86799,-0.0085426,0.036784,0,0
6,GO NEURON PROJECTION EXTENSION,0.5959,-0.0086049,0.0087992,0,0
6,GO STEM CELL PROLIFERATION,0.86799,-0.0086378,0.044915,0,0
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.67486,-0.0086844,0.020569,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.64051,-0.0087109,0.079362,0,0
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.49108,-0.0091033,-0.030088,0,0
6,GO HISTONE SERINE PHOSPHORYLATION,0.74555,-0.0091116,-0.016399,0,0
6,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.72171,-0.0091739,0.076329,0,0
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.98106,-0.0094162,0.061051,0,0
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.95582,-0.0094854,0.0092735,0,0
6,GO MITOCHONDRION ORGANIZATION,0.76963,-0.0096803,0.04234,0,0
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.7336,-0.0099109,0.048866,0,0
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,1,-0.0099142,0.010458,0,0
6,GO EPITHELIAL TUBE MORPHOGENESIS,0.52145,-0.0099437,0.097777,0,0
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.54223,-0.010004,0.077506,0,0
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.66333,-0.010111,0.038142,0,0
6,GO SYNAPSE ORGANIZATION,0.68646,-0.010216,0.0019498,0,0
6,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.90549,-0.010229,0.038122,0,0
6,GO REGULATION OF RECEPTOR INTERNALIZATION,0.55277,-0.010251,0.016413,0,0
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.7336,-0.010256,0.054229,0,0
6,GO MITOCHONDRIAL TRANSLATION,0.32248,-0.010332,-0.030522,0,0
6,GO REGULATION OF CENTROSOME DUPLICATION,0.78176,-0.010428,-0.0037075,0,0
6,GO REGULATION OF STEM CELL PROLIFERATION,0.88046,-0.010465,0.02047,0,0
6,GO PROTEIN DEPOLYMERIZATION,0.78176,-0.010545,0.028991,0,0
6,GO NEUROTRANSMITTER REUPTAKE,0.89296,-0.010611,0.030466,0,0
6,GO PRO B CELL DIFFERENTIATION,0.88046,-0.01085,0.0058675,0,0
6,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.84314,-0.01089,0.046642,0,0
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.98106,-0.010925,0.046995,0,0
6,GO POSITIVE REGULATION OF CYTOKINESIS,0.83078,-0.011013,0.01007,0,0
6,GO RESPIRATORY SYSTEM PROCESS,0.85555,-0.01116,0.020115,0,0
6,GO REGULATION OF DNA METHYLATION,0.83078,-0.01122,0.043975,0,0
6,GO VIRAL GENE EXPRESSION,0.66333,-0.011303,-0.0053327,0,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.85555,-0.01135,-0.0014933,0,0
6,GO BLASTOCYST DEVELOPMENT,0.93062,-0.011366,0.028135,0,0
6,GO CRISTAE FORMATION,0.48117,-0.011405,-0.01542,0,0
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.81845,-0.01142,0.06172,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.94321,-0.011505,-0.00079588,0,0
6,GO LIPOPROTEIN LOCALIZATION,0.72171,-0.011574,0.078323,0,0
6,GO PITUITARY GLAND DEVELOPMENT,0.78176,-0.011639,0.098515,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.86799,-0.012036,0.016458,0,0
6,GO ACETYL COA METABOLIC PROCESS,0.56341,-0.012214,0.079367,0,0
6,GO REGULATION OF ATPASE ACTIVITY,0.99368,-0.012365,0.026513,0,0
6,GO BLASTOCYST GROWTH,0.89296,-0.012496,0.017165,0,0
6,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.84314,-0.012612,0.042708,0,0
6,GO SKIN EPIDERMIS DEVELOPMENT,0.85555,-0.012795,0.061792,0,0
6,GO RESPONSE TO HEAT,0.54223,-0.012852,0.074881,0,0
6,GO LOCOMOTORY BEHAVIOR,0.90549,-0.012938,0.032003,0,0
6,GO MYOTUBE CELL DEVELOPMENT,0.96843,-0.01307,0.0080867,0,0
6,GO HINDLIMB MORPHOGENESIS,0.67486,-0.013106,-0.0044201,0,0
6,GO REGULATION OF CELL DEVELOPMENT,0.83078,-0.013148,0.048901,0,0
6,GO MRNA TRANSCRIPTION,0.51122,-0.013288,0.10192,0,0
6,GO THYMUS DEVELOPMENT,0.99368,-0.01329,0.032807,0,0
6,GO COCHLEA MORPHOGENESIS,0.58498,-0.013349,0.062204,0,0
6,GO MULTICELLULAR ORGANISM REPRODUCTION,0.91805,-0.013398,0.02082,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.79394,-0.013419,0.036039,0,0
6,GO AUTOPHAGY OF MITOCHONDRION,0.62923,-0.013499,0.068831,0,0
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.86799,-0.013574,0.038992,0,0
6,GO PHOTOTRANSDUCTION,0.66333,-0.013588,-0.0199,0,0
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.94321,-0.013657,0.053646,0,0
6,GO CELL CYCLE ARREST,0.91805,-0.013749,0.037984,0,0
6,GO SINGLE FERTILIZATION,0.76963,-0.013767,0.0051616,0,0
6,GO PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS,0.56341,-0.013906,-0.018739,0,0
6,GO ADHERENS JUNCTION ASSEMBLY,0.99368,-0.013925,0.077662,0,0
6,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.99368,-0.014314,0.014111,0,0
6,GO SENSORY ORGAN MORPHOGENESIS,0.94321,-0.014653,0.042014,0,0
6,GO CARNITINE METABOLIC PROCESS,0.74555,-0.014673,0.015558,0,0
6,GO CELL MORPHOGENESIS,0.90549,-0.014674,0.055725,0,0
6,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.86799,-0.014878,0.0073637,0,0
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.83078,-0.014928,0.039663,0,0
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.5959,-0.014951,0.026679,0,0
6,GO REGULATION OF MACROAUTOPHAGY,0.58498,-0.014972,0.081839,0,0
6,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.86799,-0.015019,0.036778,0,0
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.81845,-0.015403,0.027197,0,0
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.79394,-0.015463,0.051368,0,0
6,GO PRESYNAPTIC ENDOCYTOSIS,0.79394,-0.015548,0.033325,0,0
6,GO NEURAL NUCLEUS DEVELOPMENT,0.89296,-0.015575,0.054508,0,0
6,GO PROTEIN O LINKED MANNOSYLATION,0.88046,-0.01558,0.034977,0,0
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.68646,-0.015704,-0.018817,0,0
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.98106,-0.015711,0.04671,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.86799,-0.015736,0.045634,0,0
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.90549,-0.015763,0.0094191,0,0
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.60692,-0.016096,-0.029372,0,0
6,GO SYNAPSE ASSEMBLY,0.70989,-0.016129,-0.018491,0,0
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.70989,-0.016173,0.093388,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.83078,-0.016239,0.059978,0,0
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.96843,-0.016403,0.013175,0,0
6,GO DETECTION OF LIGHT STIMULUS,0.5959,-0.016417,-0.029089,0,0
6,GO MITOCHONDRIAL TRANSPORT,0.84314,-0.016536,0.024843,0,0
6,GO RESPONSE TO VITAMIN A,0.85555,-0.016594,0.013691,0,0
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.99368,-0.016615,0.0009984,0,0
6,GO RESPONSE TO RADIATION,0.98106,-0.016644,0.038078,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.79394,-0.016998,0.021435,0,0
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.85555,-0.017239,-0.011465,0,0
6,GO INTRACELLULAR PROTEIN TRANSPORT,0.85555,-0.017315,0.042958,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.84314,-0.01747,0.025873,0,0
6,GO INTRACELLULAR TRANSPORT,0.81845,-0.017485,0.049447,0,0
6,GO VOCALIZATION BEHAVIOR,0.78176,-0.017489,-0.025105,0,0
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.75756,-0.017577,0.087623,0,0
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.70989,-0.017587,0.0020949,0,0
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.66333,-0.017589,0.024818,0,0
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.99368,-0.017622,0.056562,0,0
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.83078,-0.017662,0.021757,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.81845,-0.01772,0.028485,0,0
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.62923,-0.017751,0.016932,0,0
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.70989,-0.018168,0.015215,0,0
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.81845,-0.018223,0.041964,0,0
6,GO SOMITOGENESIS,0.65188,-0.018266,0.070133,0,0
6,GO RRNA MODIFICATION,0.96843,-0.018401,0.017531,0,0
6,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.68646,-0.018405,0.059102,0,0
6,GO SYNAPTIC VESICLE MATURATION,0.75756,-0.018448,0.01797,0,0
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.94321,-0.018461,0.044131,0,0
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.4521,-0.018588,-0.033992,0,0
6,GO REGULATION OF SYNAPTIC PLASTICITY,0.80618,-0.018613,0.0078666,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.86799,-0.018952,0.059939,0,0
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.64051,-0.019019,0.016448,0,0
6,GO REGULATION OF GLIAL CELL PROLIFERATION,0.76963,-0.019054,0.050464,0,0
6,GO SYNAPTIC SIGNALING,0.69814,-0.019097,-0.0016009,0,0
6,GO PROTEIN CATABOLIC PROCESS,0.3148,-0.019294,0.087889,0,0
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.93062,-0.019408,0.049224,0,0
6,GO ORGANELLE LOCALIZATION,0.65188,-0.019441,0.022837,0,0
6,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.95582,-0.019446,0.02647,0,0
6,GO PIGMENT BIOSYNTHETIC PROCESS,0.86799,-0.019666,0.031053,0,0
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.64051,-0.019739,-0.0076002,0,0
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.84314,-0.019745,-0.063857,0,0
6,GO SHORT TERM MEMORY,0.93062,-0.019779,0.0071332,0,0
6,GO ACROSOME REACTION,0.70989,-0.019958,0.045593,0,0
6,GO SYNAPTIC VESICLE DOCKING,0.74555,-0.020008,-0.014765,0,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.88046,-0.020064,0.036498,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.94321,-0.020099,0.037307,0,0
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.98106,-0.020147,0.016861,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,1,-0.020228,0.023975,0,0
6,GO MACROAUTOPHAGY,0.54223,-0.020329,0.07776,0,0
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.48117,-0.02041,-0.011382,0,0
6,GO SEGMENTATION,0.83078,-0.020413,0.053597,0,0
6,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.34626,-0.020457,0.12153,0,0
6,GO FORELIMB MORPHOGENESIS,0.5959,-0.020494,-0.038978,0,0
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.99368,-0.020531,0.061213,0,0
6,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.58498,-0.020594,-0.018184,0,0
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.99368,-0.020673,0.027557,0,0
6,GO OSTEOBLAST DEVELOPMENT,0.69814,-0.020757,0.040558,0,0
6,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.76963,-0.020947,0.052497,0,0
6,GO TRANSLATIONAL INITIATION,0.49108,-0.021009,-0.016096,0,0
6,GO REGULATION OF MEIOTIC CELL CYCLE,0.61803,-0.021221,0.0034727,0,0
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.99368,-0.021358,0.0037048,0,0
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.61803,-0.021382,-0.025279,0,0
6,GO MACROMOLECULE CATABOLIC PROCESS,0.40594,-0.021501,0.072719,0,0
6,GO ORGANELLE DISASSEMBLY,0.51122,-0.02163,0.067484,0,0
6,GO INNER CELL MASS CELL PROLIFERATION,0.7336,-0.021678,0.00094276,0,0
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.69814,-0.021792,-0.0072988,0,0
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.91805,-0.021811,0.011117,0,0
6,GO PEPTIDE BIOSYNTHETIC PROCESS,0.57414,-0.021829,-0.00086826,0,0
6,GO NEUROBLAST DIVISION,0.46168,-0.021972,-0.021431,0,0
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.85555,-0.022088,0.033046,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.76963,-0.022099,0.055024,0,0
6,GO RNA MODIFICATION,0.61803,-0.022123,-0.0088584,0,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.93062,-0.02229,0.021988,0,0
6,GO SCHWANN CELL DEVELOPMENT,0.67486,-0.022331,-0.013447,0,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.91805,-0.022349,0.033929,0,0
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.91805,-0.022455,0.06239,0,0
6,GO KERATINIZATION,0.67486,-0.022595,0.031443,0,0
6,GO PANCREAS DEVELOPMENT,0.99368,-0.022645,0.056852,0,0
6,GO NEURAL CREST CELL DIFFERENTIATION,0.72171,-0.02276,0.070081,0,0
6,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.75756,-0.022926,0.053761,0,0
6,GO NEGATIVE REGULATION OF CELL AGING,0.67486,-0.02303,0.0056198,0,0
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.94321,-0.023084,0.053903,0,0
6,GO 3 UTR MEDIATED MRNA STABILIZATION,0.4521,-0.023192,-0.024452,0,0
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.84314,-0.023405,-0.0095538,0,0
6,GO ECTODERMAL PLACODE DEVELOPMENT,0.84314,-0.023426,0.0011614,0,0
6,GO TRICARBOXYLIC ACID CYCLE,0.75756,-0.023451,0.045796,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.79394,-0.023513,0.056648,0,0
6,GO DNA RECOMBINATION,0.48117,-0.023524,-0.02095,0,0
6,GO CHAPERONE MEDIATED AUTOPHAGY,0.62923,-0.023588,0.063644,0,0
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.99368,-0.023786,0.035087,0,0
6,GO AXONEME ASSEMBLY,0.60692,-0.023792,-0.066249,0,0
6,GO REGULATION OF DNA METABOLIC PROCESS,0.7336,-0.023806,0.024452,0,0
6,GO METHIONINE METABOLIC PROCESS,0.64051,-0.023836,-0.025289,0,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.90549,-0.024248,0.035495,0,0
6,GO PROTEIN TARGETING TO MEMBRANE,0.70989,-0.024347,-0.0035032,0,0
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.83078,-0.024388,0.045639,0,0
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.89296,-0.02443,0.046584,0,0
6,GO SOMITE DEVELOPMENT,0.84314,-0.02453,0.059193,0,0
6,GO ASYMMETRIC CELL DIVISION,0.48117,-0.02455,-0.043567,0,0
6,GO FOREBRAIN CELL MIGRATION,0.64051,-0.02457,-0.00418,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.53179,-0.024711,-0.034831,0,0
6,GO PROTEIN LOCALIZATION TO ORGANELLE,0.84314,-0.024741,0.034759,0,0
6,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.74555,-0.024747,0.0074455,0,0
6,GO HISTONE H3 K9 ACETYLATION,0.43329,-0.024771,-0.038018,0,0
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.79394,-0.024873,0.022714,0,0
6,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.58498,-0.024886,0.061818,0,0
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.88046,-0.025034,0.019095,0,0
6,GO SNRNA METABOLIC PROCESS,0.33821,-0.025428,-0.023208,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.55277,-0.025436,-0.013965,0,0
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.81845,-0.02544,0.036549,0,0
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.2259,-0.025497,-0.055614,0,0
6,GO MECHANORECEPTOR DIFFERENTIATION,0.93062,-0.025634,0.012501,0,0
6,GO AMINO ACID BETAINE METABOLIC PROCESS,0.53179,-0.025884,-0.029057,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.2577,-0.026033,-0.033528,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.57414,-0.02635,-0.016824,0,0
6,GO AMIDE BIOSYNTHETIC PROCESS,0.70989,-0.026397,0.016195,0,0
6,GO CELLULAR RESPIRATION,0.83078,-0.026421,0.022539,0,0
6,GO REGULATION OF TUBULIN DEACETYLATION,0.72171,-0.026518,0.081306,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.93062,-0.026607,0.061109,0,0
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.67486,-0.026706,0.058704,0,0
6,GO EXTRACELLULAR TRANSPORT,0.57414,-0.026724,-0.045803,0,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.47137,-0.02674,0.019998,0,0
6,GO MITOCHONDRIAL GENE EXPRESSION,0.27126,-0.026757,-0.033362,0,0
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.91805,-0.026817,0.058528,0,0
6,GO REGULATION OF SPINDLE ASSEMBLY,0.84314,-0.026872,0.013004,0,0
6,GO AZOLE TRANSMEMBRANE TRANSPORT,0.75756,-0.026961,0.069009,0,0
6,GO NEUROGENESIS,0.57414,-0.027152,0.018763,0,0
6,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.79394,-0.027236,0.0069136,0,0
6,GO NOREPINEPHRINE TRANSPORT,0.54223,-0.02731,0.088354,0,0
6,GO GOLGI RIBBON FORMATION,0.69814,-0.027466,0.088733,0,0
6,GO HISTONE PHOSPHORYLATION,0.93062,-0.027516,0.02902,0,0
6,GO NUCLEOTIDE PHOSPHORYLATION,0.85555,-0.027544,0.053494,0,0
6,GO NEUROBLAST PROLIFERATION,0.4521,-0.027584,-0.012804,0,0
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.98106,-0.0276,0.046237,0,0
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.64051,-0.027731,0.023,0,0
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.95582,-0.027798,0.026712,0,0
6,GO MITRAL VALVE DEVELOPMENT,0.80618,-0.028068,0.056946,0,0
6,GO PORE COMPLEX ASSEMBLY,0.95582,-0.028141,0.03287,0,0
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.99368,-0.028297,0.058897,0,0
6,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.96843,-0.028323,0.05682,0,0
6,GO POSITIVE REGULATION OF AXON EXTENSION,0.79394,-0.028359,0.040835,0,0
6,GO PSEUDOURIDINE SYNTHESIS,0.84314,-0.028363,0.0029344,0,0
6,GO FEEDING BEHAVIOR,0.54223,-0.028371,-0.034469,0,0
6,GO SYNAPTIC VESICLE RECYCLING,0.78176,-0.028396,0.028606,0,0
6,GO NEGATIVE REGULATION OF TOR SIGNALING,0.75756,-0.028491,0.023681,0,0
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.85555,-0.028603,0.021097,0,0
6,GO REGULATION OF HISTONE MODIFICATION,0.84314,-0.028692,0.04364,0,0
6,GO RRNA METHYLATION,0.80618,-0.028765,0.02423,0,0
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.95582,-0.028858,0.048563,0,0
6,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.32248,-0.029125,-0.020352,0,0
6,GO RIBOSOME ASSEMBLY,0.39705,-0.029423,-0.029026,0,0
6,GO NEUROMUSCULAR PROCESS,0.89296,-0.029797,0.00598,0,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.84314,-0.029922,0.061953,0,0
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.65188,-0.029926,-0.074337,0,0
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.44264,-0.029927,-0.030904,0,0
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.42405,-0.029934,0.076703,0,0
6,GO EMBRYONIC AXIS SPECIFICATION,0.39705,-0.030248,-0.038369,0,0
6,GO REGULATION OF TELOMERE CAPPING,0.70989,-0.03037,0.0074839,0,0
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.39705,-0.030426,-0.046028,0,0
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.61803,-0.030526,-0.012364,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.69814,-0.030548,0.010764,0,0
6,GO DORSAL VENTRAL PATTERN FORMATION,0.50109,-0.030869,0.0015052,0,0
6,GO ADULT LOCOMOTORY BEHAVIOR,0.96843,-0.030935,0.042537,0,0
6,GO NEURAL CREST CELL MIGRATION,0.88046,-0.031002,0.059301,0,0
6,GO HISTONE H3 ACETYLATION,0.7336,-0.031075,0.018266,0,0
6,GO REGULATION OF ORGANELLE ORGANIZATION,0.99368,-0.031089,0.051225,0,0
6,GO REGIONALIZATION,0.69814,-0.031134,0.027093,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.7336,-0.031262,-0.034552,0,0
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.83078,-0.031421,0.042241,0,0
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.72171,-0.031511,-0.0078725,0,0
6,GO AEROBIC RESPIRATION,0.88046,-0.031738,0.02194,0,0
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.25111,-0.031758,-0.072063,0,0
6,GO POSITIVE REGULATION OF FERTILIZATION,0.65188,-0.0318,-0.015466,0,0
6,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.58498,-0.031976,0.032693,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.83078,-0.032093,0.01877,0,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.60692,-0.032244,0.016175,0,0
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.89296,-0.032366,0.04655,0,0
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.5959,-0.032469,-0.02449,0,0
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.94321,-0.032778,0.038554,0,0
6,GO REGULATION OF EXTENT OF CELL GROWTH,0.42405,-0.032836,-0.024566,0,0
6,GO SNORNA 3 END PROCESSING,0.57414,-0.032915,-0.01166,0,0
6,GO MATURATION OF 5 8S RRNA,0.42405,-0.032975,-0.021537,0,0
6,GO UTERUS DEVELOPMENT,0.93062,-0.033052,0.0016124,0,0
6,GO RESPONSE TO LEUCINE,1,-0.033064,0.051192,0,0
6,GO UBIQUINONE METABOLIC PROCESS,0.85555,-0.033156,0.01535,0,0
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.79394,-0.033224,0.0052491,0,0
6,GO CYTOPLASMIC TRANSLATION,0.16602,-0.033234,-0.046691,0,0
6,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.93062,-0.033263,0.051608,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.75756,-0.033296,0.0089805,0,0
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.68646,-0.033578,-0.04043,0,0
6,GO CELLULAR COMPONENT MAINTENANCE,0.37111,-0.033656,-0.0099414,0,0
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.69814,-0.033664,-0.016927,0,0
6,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.94321,-0.033689,0.033946,0,0
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.4521,-0.033693,-0.019835,0,0
6,GO REGULATION OF FEEDING BEHAVIOR,0.25111,-0.033718,-0.0584,0,0
6,GO POSITIVE REGULATION OF AXONOGENESIS,0.44264,-0.033732,-0.011979,0,0
6,GO TONGUE DEVELOPMENT,0.81845,-0.033743,-0.012978,0,0
6,GO BONE GROWTH,0.44264,-0.034357,0.1311,0,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.76963,-0.034383,0.045864,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.84314,-0.03462,0.025982,0,0
6,GO FERTILIZATION,0.67486,-0.034632,0.0046964,0,0
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.94321,-0.034773,0.042381,0,0
6,GO NEURON DEVELOPMENT,0.60692,-0.035002,0.010633,0,0
6,GO TRNA 5 LEADER REMOVAL,0.43329,-0.035068,-0.046173,0,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.72171,-0.035085,0.03197,0,0
6,GO RRNA CATABOLIC PROCESS,0.60692,-0.035112,-0.0041365,0,0
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.98106,-0.035117,0.030556,0,0
6,GO PROTEIN K11 LINKED UBIQUITINATION,0.98106,-0.035121,0.023041,0,0
6,GO REGULATION OF NEURON DIFFERENTIATION,0.58498,-0.035173,0.0080719,0,0
6,GO SENSORY SYSTEM DEVELOPMENT,0.79394,-0.035192,0.046694,0,0
6,GO SYNAPTIC TRANSMISSION GABAERGIC,0.66333,-0.035275,-0.0087443,0,0
6,GO ERYTHROCYTE MATURATION,0.41494,-0.035326,-0.044455,0,0
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.91805,-0.035358,0.047252,0,0
6,GO WALKING BEHAVIOR,0.36271,-0.035435,-0.044581,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.69814,-0.035452,0.01989,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.46168,-0.035461,-0.014213,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.75756,-0.035924,0.014309,0,0
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.81845,-0.036099,0.0082372,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.43329,-0.036232,-0.0079744,0,0
6,GO RNA SURVEILLANCE,0.55277,-0.036306,-0.011222,0,0
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.62923,-0.036341,-0.020153,0,0
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.61803,-0.03672,0.0096091,0,0
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.98106,-0.036745,0.045308,0,0
6,GO LEARNING,0.48117,-0.036837,-0.049226,0,0
6,GO INTERMEDIATE FILAMENT ORGANIZATION,0.93062,-0.036877,-0.02086,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.16602,-0.037089,-0.077856,0,0
6,GO REGULATION OF CIRCADIAN RHYTHM,0.85555,-0.037168,0.028107,0,0
6,GO IMP BIOSYNTHETIC PROCESS,0.94321,-0.037205,0.027097,0,0
6,GO SYNAPTIC VESICLE TRANSPORT,0.66333,-0.037253,-0.012013,0,0
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.68646,-0.037351,-0.0021286,0,0
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.94321,-0.037397,0.051401,0,0
6,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.58498,-0.037609,-0.0051358,0,0
6,GO GROWTH HORMONE SECRETION,0.64051,-0.037706,0.0028985,0,0
6,GO REGULATION OF PROTEIN SUMOYLATION,0.62923,-0.037718,0.005646,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.72171,-0.03799,-0.0178,0,0
6,GO RNA CATABOLIC PROCESS,0.49108,-0.038152,-0.0026787,0,0
6,GO SIALYLATION,0.72171,-0.03834,0.086006,0,0
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.70989,-0.038387,0.019396,0,0
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.96843,-0.038454,0.034188,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.74555,-0.03856,0.019784,0,0
6,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.89296,-0.038616,0.015125,0,0
6,GO AXONAL FASCICULATION,0.48117,-0.038692,-0.052493,0,0
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.70989,-0.039073,0.0018778,0,0
6,GO ATP METABOLIC PROCESS,0.85555,-0.039179,0.037603,0,0
6,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.50109,-0.039343,0.0032407,0,0
6,GO PHOTOPERIODISM,0.70989,-0.039378,0.020142,0,0
6,GO NEURON DIFFERENTIATION,0.49108,-0.039401,0.0024519,0,0
6,GO HEAD DEVELOPMENT,0.53179,-0.039455,0.0095476,0,0
6,GO RIBOSOME BIOGENESIS,0.2998,-0.039694,-0.028467,0,0
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.86799,-0.039763,0.00086396,0,0
6,GO PROSTATE GLAND GROWTH,0.72171,-0.039789,-0.036334,0,0
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.52145,-0.039803,0.0072228,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.62923,-0.039865,0.058573,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.81845,-0.039917,0.027597,0,0
6,GO NEURON PROJECTION REGENERATION,0.75756,-0.039928,0.047655,0,0
6,GO RESPONSE TO SALT,0.67486,-0.040085,-0.011185,0,0
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.72171,-0.040306,-0.0050812,0,0
6,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.76963,-0.040314,0.020969,0,0
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.98106,-0.040405,0.020634,0,0
6,GO TRANSLATIONAL ELONGATION,0.20256,-0.040423,-0.035713,0,0
6,GO MULTI ORGANISM LOCALIZATION,0.64051,-0.040586,0.026644,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.28529,-0.040648,-0.035368,0,0
6,GO REGULATION OF LYASE ACTIVITY,0.7336,-0.040849,-0.0061716,0,0
6,GO VESICLE FUSION TO PLASMA MEMBRANE,0.99368,-0.041035,0.074675,0,0
6,GO GENETIC IMPRINTING,0.48117,-0.041151,-0.030561,0,0
6,GO FEMALE GAMETE GENERATION,0.42405,-0.041157,-0.015147,0,0
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.62923,-0.041226,0.020709,0,0
6,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.41494,-0.041276,-0.067596,0,0
6,GO PROTEIN MANNOSYLATION,0.90549,-0.041396,0.0070294,0,0
6,GO PRESYNAPSE ORGANIZATION,0.66333,-0.04149,-0.025549,0,0
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.67486,-0.04153,0.083365,0,0
6,GO SPERM MOTILITY,0.48117,-0.041709,-0.043777,0,0
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.68646,-0.041878,-0.0073893,0,0
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.54223,-0.042008,0.018704,0,0
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.70989,-0.04226,0.022435,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE,0.67486,-0.042349,0.019142,0,0
6,GO MITOTIC SISTER CHROMATID COHESION,0.41494,-0.042364,-0.029476,0,0
6,GO TORC1 SIGNALING,0.48117,-0.042469,0.0007531,0,0
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.83078,-0.042494,-0.017623,0,0
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.94321,-0.042546,-0.0047089,0,0
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.41494,-0.042557,0.0022597,0,0
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.84314,-0.042559,0.018355,0,0
6,GO PROTEIN REFOLDING,0.80618,-0.042849,-0.016431,0,0
6,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.7336,-0.042889,0.051853,0,0
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.95582,-0.042905,0.043837,0,0
6,GO CELL PROJECTION ORGANIZATION,0.66333,-0.042905,0.021359,0,0
6,GO NEURON PROJECTION ARBORIZATION,0.75756,-0.042969,0.040669,0,0
6,GO SNRNA PROCESSING,0.34626,-0.043025,-0.032142,0,0
6,GO SEXUAL REPRODUCTION,0.52145,-0.043331,-0.0042525,0,0
6,GO SCHWANN CELL DIFFERENTIATION,0.74555,-0.043411,0.0062471,0,0
6,GO CYTOSKELETON ORGANIZATION,0.78176,-0.043459,0.040235,0,0
6,GO NEGATIVE REGULATION OF DNA BINDING,0.76963,-0.04363,0.00097108,0,0
6,GO SYNAPSE MATURATION,0.74555,-0.043733,-0.078718,0,0
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.70989,-0.043736,-0.01015,0,0
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7336,-0.043881,0.015034,0,0
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.39705,-0.044095,0.0044723,0,0
6,GO PATTERN SPECIFICATION PROCESS,0.67486,-0.0442,0.014943,0,0
6,GO EYE MORPHOGENESIS,0.79394,-0.044321,0.034692,0,0
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.50109,-0.044324,-0.056217,0,0
6,GO STARTLE RESPONSE,0.79394,-0.044366,-0.011018,0,0
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.68646,-0.044517,0.02864,0,0
6,GO CELLULAR COMPONENT MORPHOGENESIS,0.47137,-0.044544,0.00035047,0,0
6,GO CELL PROJECTION ASSEMBLY,0.61803,-0.044886,0.0083707,0,0
6,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.37111,-0.045142,-0.017569,0,0
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.5959,-0.045377,0.010395,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.88046,-0.045595,0.011083,0,0
6,GO IMP METABOLIC PROCESS,0.7336,-0.045693,0.0074501,0,0
6,GO GERM CELL DEVELOPMENT,0.34626,-0.045878,-0.033874,0,0
6,GO NEURAL TUBE FORMATION,0.83078,-0.045903,0.059286,0,0
6,GO MAINTENANCE OF CELL NUMBER,0.68646,-0.045988,0.018246,0,0
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.94321,-0.045999,0.10528,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.85555,-0.046053,0.039721,0,0
6,GO VENTRICULAR SYSTEM DEVELOPMENT,0.44264,-0.046273,-0.010849,0,0
6,GO ADHERENS JUNCTION ORGANIZATION,0.83078,-0.046416,0.042182,0,0
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.65188,-0.046598,0.057925,0,0
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.53179,-0.046758,-0.015705,0,0
6,GO NUCLEAR ENVELOPE REASSEMBLY,0.70989,-0.046811,0.0047185,0,0
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.30724,-0.046963,-0.053823,0,0
6,GO OLIGODENDROCYTE DIFFERENTIATION,0.85555,-0.047098,0.021214,0,0
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.62923,-0.04715,0.0043062,0,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.89296,-0.047256,0.037312,0,0
6,GO REGULATION OF MRNA CATABOLIC PROCESS,0.70989,-0.047511,0.017734,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.37964,-0.047757,-0.013979,0,0
6,GO CELL FATE SPECIFICATION,0.76963,-0.047793,-0.0066614,0,0
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.72171,-0.047862,0.016818,0,0
6,GO INTERMEDIATE FILAMENT BASED PROCESS,0.65188,-0.047887,-0.018195,0,0
6,GO CELL CYCLE G1 S PHASE TRANSITION,0.57414,-0.048081,0.011373,0,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.88046,-0.048407,0.049713,0,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.18624,-0.04855,-0.049742,0,0
6,GO ACTIN CROSSLINK FORMATION,0.98106,-0.048738,0.050542,0,0
6,GO RRNA METABOLIC PROCESS,0.29248,-0.048972,-0.026042,0,0
6,GO POSTREPLICATION REPAIR,0.35442,-0.049016,-0.024761,0,0
6,GO RESPONSE TO COCAINE,0.67486,-0.049224,-0.0098761,0,0
6,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.52145,-0.049237,0.0029957,0,0
6,GO NUCLEAR ENVELOPE ORGANIZATION,0.75756,-0.049356,0.026952,0,0
6,GO NEURON RECOGNITION,0.89296,-0.049388,0.0046672,0,0
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.42405,-0.049452,-0.017495,0,0
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.37964,-0.049569,-0.042786,0,0
6,GO TUBULIN DEACETYLATION,0.98106,-0.049639,0.057421,0,0
6,GO CILIUM MOVEMENT,0.53179,-0.04975,-0.048029,0,0
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.72171,-0.049833,0.0060558,0,0
6,GO MATURATION OF LSU RRNA,0.42405,-0.049844,-0.027686,0,0
6,GO NEURON PROJECTION GUIDANCE,0.40594,-0.049891,-0.010498,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.51122,-0.050282,-0.025096,0,0
6,GO TELOMERE CAPPING,0.48117,-0.050339,0.0012178,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.18102,-0.050343,-0.060989,0,0
6,GO TRNA 5 END PROCESSING,0.19156,-0.05038,-0.051281,0,0
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.70989,-0.050397,-0.034722,0,0
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.83078,-0.050446,0.018697,0,0
6,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.75756,-0.050654,-0.0082959,0,0
6,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.76963,-0.050776,-0.016622,0,0
6,GO OOCYTE DIFFERENTIATION,0.20256,-0.050888,-0.045107,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.65188,-0.050933,0.021912,0,0
6,GO TONGUE MORPHOGENESIS,0.50109,-0.050957,-0.045324,0,0
6,GO NEURAL TUBE DEVELOPMENT,0.84314,-0.051019,0.034432,0,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.36271,-0.05102,-0.0014575,0,0
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.5959,-0.051044,-0.0089696,0,0
6,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.5959,-0.051055,-0.015097,0,0
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.78176,-0.051146,-0.0039791,0,0
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.35442,-0.051359,-0.074919,0,0
6,GO POTASSIUM ION HOMEOSTASIS,0.67486,-0.051488,-0.013201,0,0
6,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.93062,-0.051508,0.035645,0,0
6,GO REGULATION OF GOLGI ORGANIZATION,0.81845,-0.051554,0.035894,0,0
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.78176,-0.051663,0.028102,0,0
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.36271,-0.051713,-0.073584,0,0
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.33029,-0.051758,-0.028522,0,0
6,GO GLUTAMATE METABOLIC PROCESS,0.36271,-0.051759,-0.017275,0,0
6,GO REGULATION OF HISTONE UBIQUITINATION,0.79394,-0.051784,0.026546,0,0
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.86799,-0.051855,0.027048,0,0
6,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.99368,-0.051939,0.033664,0,0
6,GO CELL PROLIFERATION IN HINDBRAIN,0.49108,-0.052015,-0.057193,0,0
6,GO SUBSTANTIA NIGRA DEVELOPMENT,0.50109,-0.052076,-0.010536,0,0
6,GO LONG TERM MEMORY,0.93062,-0.052113,0.022095,0,0
6,GO RNA CAPPING,0.2998,-0.05223,-0.019048,0,0
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.75756,-0.052322,0.073994,0,0
6,GO SNRNA TRANSCRIPTION,0.36271,-0.052445,-0.020736,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.23203,-0.052469,-0.019001,0,0
6,GO CYTOKINESIS,0.34626,-0.052609,-0.014966,0,0
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.85555,-0.052657,0.038126,0,0
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.70989,-0.052715,0.016053,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.95582,-0.05272,0.045174,0,0
6,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.15197,-0.052734,-0.077965,0,0
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.27821,-0.052749,-0.026941,0,0
6,GO RESPONSE TO ACETYLCHOLINE,0.65188,-0.053235,-0.012841,0,0
6,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.80618,-0.053353,0.019712,0,0
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.60692,-0.053389,-0.017245,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.79394,-0.053487,0.037582,0,0
6,GO MITOPHAGY,0.70989,-0.053697,0.023617,0,0
6,GO NCRNA 3 END PROCESSING,0.23203,-0.053715,-0.036219,0,0
6,GO PROTEIN DENEDDYLATION,0.56341,-0.053725,-0.014041,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.39705,-0.05378,-0.0056475,0,0
6,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.58498,-0.053788,0.00020461,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.67486,-0.053789,0.0044617,0,0
6,GO OLIGODENDROCYTE DEVELOPMENT,0.83078,-0.053892,0.026747,0,0
6,GO CELLULAR RESPONSE TO PH,0.67486,-0.054181,0.003292,0,0
6,GO ALDITOL METABOLIC PROCESS,0.56341,-0.054458,-0.018991,0,0
6,GO LIMBIC SYSTEM DEVELOPMENT,0.38829,-0.054513,-0.012638,0,0
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.61803,-0.054818,0.010215,0,0
6,GO FOREBRAIN NEURON DIFFERENTIATION,0.5959,-0.054914,0.037613,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.36271,-0.055077,-0.014975,0,0
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.80618,-0.055098,0.031717,0,0
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.16123,-0.055233,-0.050566,0,0
6,GO RESPONSE TO LIGHT STIMULUS,0.62923,-0.055293,0.011143,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.52145,-0.055463,0.0043278,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.64051,-0.055487,0.012005,0,0
6,GO DENDRITE EXTENSION,0.76963,-0.055493,0.068967,0,0
6,GO IRON SULFUR CLUSTER ASSEMBLY,0.2998,-0.055543,-0.033988,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE,0.42405,-0.055681,0.0067247,0,0
6,GO REGULATION OF SYNAPSE ASSEMBLY,0.81845,-0.055789,-0.016995,0,0
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.38829,-0.056117,-0.064014,0,0
6,GO AXON DEVELOPMENT,0.41494,-0.05616,-0.012663,0,0
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.78176,-0.056204,0.00041446,0,0
6,GO SEX DETERMINATION,0.96843,-0.056431,0.0032667,0,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.90549,-0.05655,0.032243,0,0
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.26442,-0.05679,-0.08529,0,0
6,GO NUCLEAR BODY ORGANIZATION,0.36271,-0.057021,-0.0006837,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.30724,-0.057027,-0.016128,0,0
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.86799,-0.057135,0.046452,0,0
6,GO EMBRYONIC PATTERN SPECIFICATION,0.41494,-0.057235,-0.022026,0,0
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.67486,-0.057242,0.060091,0,0
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.65188,-0.057309,-9.1683e-05,0,0
6,GO NCRNA PROCESSING,0.21989,-0.057383,-0.03641,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,1,-0.0574,0.031102,0,0
6,GO TRANSLESION SYNTHESIS,0.35442,-0.058009,-0.017174,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.33821,-0.058101,-0.020167,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.43329,-0.058188,0.013059,0,0
6,GO DETECTION OF VISIBLE LIGHT,0.18102,-0.05819,-0.066225,0,0
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.24463,-0.058445,-0.032608,0,0
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.54223,-0.058474,-0.041552,0,0
6,GO REGULATION OF CELL CYCLE,0.4521,-0.058717,0.0018164,0,0
6,GO REPRODUCTIVE BEHAVIOR,0.99368,-0.059058,0.012349,0,0
6,GO GTP BIOSYNTHETIC PROCESS,0.42405,-0.05963,-0.035633,0,0
6,GO FOREBRAIN DEVELOPMENT,0.40594,-0.059646,-0.0039329,0,0
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.14312,-0.059815,-0.078147,0,0
6,GO HAIR CELL DIFFERENTIATION,0.69814,-0.059877,-0.0088415,0,0
6,GO TELENCEPHALON DEVELOPMENT,0.39705,-0.059879,-0.011024,0,0
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.23827,-0.059885,-0.056403,0,0
6,GO AMINO ACID ACTIVATION,0.11524,-0.059943,-0.046373,0,0
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.5959,-0.059984,0.010754,0,0
6,GO MALE GAMETE GENERATION,0.36271,-0.060197,-0.023278,0,0
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.70989,-0.060222,0.010625,0,0
6,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.57414,-0.060502,-0.0033053,0,0
6,GO RESPONSE TO POTASSIUM ION,0.58498,-0.060593,-0.07595,0,0
6,GO REGULATION OF MRNA BINDING,0.64051,-0.060658,-0.0020392,0,0
6,GO GAMETE GENERATION,0.47137,-0.060846,-0.017126,0,0
6,GO CEREBRAL CORTEX CELL MIGRATION,0.42405,-0.060925,-0.056447,0,0
6,GO CAMERA TYPE EYE DEVELOPMENT,0.55277,-0.060999,0.020501,0,0
6,GO CARDIAC MYOFIBRIL ASSEMBLY,0.48117,-0.061005,-0.023402,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.20256,-0.061234,-0.028566,0,0
6,GO MITOTIC CYTOKINESIS,0.42405,-0.061381,-0.0042924,0,0
6,GO SYNAPTIC VESICLE EXOCYTOSIS,0.49108,-0.061472,-0.0023513,0,0
6,GO AXON EXTENSION,0.35442,-0.061591,-0.017896,0,0
6,GO CELL PART MORPHOGENESIS,0.46168,-0.061651,-0.0092006,0,0
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.36271,-0.061836,-0.053607,0,0
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.36271,-0.062078,-0.0059194,0,0
6,GO TRNA METHYLATION,0.21989,-0.062148,-0.057453,0,0
6,GO RNA METHYLATION,0.50109,-0.062299,-0.026697,0,0
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.62923,-0.062625,-0.008002,0,0
6,GO NUCLEUS ORGANIZATION,0.62923,-0.062639,0.0095003,0,0
6,GO DNA LIGATION,0.33029,-0.062727,-0.054593,0,0
6,GO REGULATION OF CELL CYCLE ARREST,0.23203,-0.062817,-0.023833,0,0
6,GO TELOMERASE RNA LOCALIZATION,0.15655,-0.062937,-0.061487,0,0
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.94321,-0.062951,0.041876,0,0
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.27821,-0.063016,-0.057087,0,0
6,GO DENDRITE SELF AVOIDANCE,0.89296,-0.063183,0.041739,0,0
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.18102,-0.063406,-0.053579,0,0
6,GO SUCKLING BEHAVIOR,0.67486,-0.063416,-0.012166,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.15197,-0.06345,-0.069788,0,0
6,GO PROTEIN HETEROTETRAMERIZATION,0.29248,-0.063499,-0.060813,0,0
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.62923,-0.063599,-0.022072,0,0
6,GO GLIAL CELL FATE COMMITMENT,0.88046,-0.063772,0.077743,0,0
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.58498,-0.063822,0.020329,0,0
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.40594,-0.064024,-0.069418,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.79394,-0.06422,0.028536,0,0
6,GO REGULATION OF SISTER CHROMATID COHESION,0.38829,-0.064344,-0.027099,0,0
6,GO REGULATION OF CENTROSOME CYCLE,0.29248,-0.06438,-0.036694,0,0
6,GO MITOCHONDRION MORPHOGENESIS,0.13885,-0.064681,-0.040623,0,0
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.35442,-0.064688,-0.026208,0,0
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.44264,-0.064799,-0.0087562,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.57414,-0.064942,0.010451,0,0
6,GO REGULATION OF MITOTIC CELL CYCLE,0.34626,-0.065059,-0.0025217,0,0
6,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.42405,-0.065356,-0.027137,0,0
6,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.5959,-0.065519,0.023243,0,0
6,GO COENZYME A METABOLIC PROCESS,0.72171,-0.065594,0.011495,0,0
6,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.37964,-0.065728,-0.0047392,0,0
6,GO NCRNA TRANSCRIPTION,0.197,-0.065836,-0.036963,0,0
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.75756,-0.065885,-0.023549,0,0
6,GO MEMBRANE HYPERPOLARIZATION,0.54223,-0.066007,-0.053474,0,0
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.20256,-0.066103,-0.04116,0,0
6,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.37111,-0.066135,-0.030314,0,0
6,GO FOREBRAIN REGIONALIZATION,0.64051,-0.066248,-0.057525,0,0
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.61803,-0.066454,-0.011682,0,0
6,GO REGULATION OF MITOCHONDRIAL FUSION,0.65188,-0.066486,0.0069372,0,0
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.67486,-0.066507,-0.014995,0,0
6,GO DNA MODIFICATION,0.68646,-0.066516,0.0071896,0,0
6,GO REGULATION OF ORGANELLE ASSEMBLY,0.42405,-0.066746,-0.0068348,0,0
6,GO REGULATION OF CENTRIOLE REPLICATION,0.37111,-0.06678,-0.056724,0,0
6,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.75756,-0.066841,0.0032152,0,0
6,GO PROTEIN AUTOUBIQUITINATION,0.86799,-0.067009,0.023628,0,0
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.84314,-0.067102,0.020528,0,0
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.91805,-0.067103,0.066392,0,0
6,GO TRNA PROCESSING,0.16123,-0.0672,-0.059276,0,0
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.13467,-0.067334,-0.065257,0,0
6,GO REGULATION OF GROWTH HORMONE SECRETION,0.48117,-0.067783,-0.020128,0,0
6,GO METHIONINE BIOSYNTHETIC PROCESS,0.39705,-0.067792,-0.042421,0,0
6,GO SPECIFICATION OF SYMMETRY,0.56341,-0.067846,0.010663,0,0
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.81845,-0.067879,0.025413,0,0
6,GO NEGATIVE REGULATION OF DNA REPLICATION,0.25111,-0.067916,-0.03469,0,0
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.33821,-0.068212,-0.032315,0,0
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.214,-0.068475,-0.070892,0,0
6,GO RRNA 3 END PROCESSING,0.197,-0.068624,-0.076932,0,0
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.48117,-0.068756,-0.0051831,0,0
6,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.41494,-0.068809,0.0087316,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.46168,-0.068837,0.019181,0,0
6,GO REGULATION OF CHROMATIN ORGANIZATION,0.57414,-0.069091,0.018259,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.29248,-0.069095,-0.026685,0,0
6,GO NEGATIVE REGULATION OF BEHAVIOR,0.19156,-0.069298,-0.076924,0,0
6,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.1475,-0.069577,-0.059099,0,0
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.091819,-0.069647,-0.040515,0,0
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.29248,-0.070202,-0.033751,0,0
6,GO L SERINE METABOLIC PROCESS,0.89296,-0.070506,0.0018544,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.44264,-0.070611,0.0030084,0,0
6,GO HINDBRAIN DEVELOPMENT,0.60692,-0.070731,0.0047992,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.52145,-0.070769,-0.0082634,0,0
6,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.7336,-0.07113,0.036549,0,0
6,GO NEURAL PRECURSOR CELL PROLIFERATION,0.55277,-0.071267,0.017072,0,0
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.80618,-0.071398,0.031383,0,0
6,GO TRNA METABOLIC PROCESS,0.1306,-0.071735,-0.056899,0,0
6,GO OOGENESIS,0.17591,-0.071738,-0.064486,0,0
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.39705,-0.071904,-0.078438,0,0
6,GO DNA METABOLIC PROCESS,0.32248,-0.072433,-0.016711,0,0
6,GO MATURATION OF SSU RRNA,0.38829,-0.0725,-0.031038,0,0
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.36271,-0.072556,-0.022099,0,0
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.26442,-0.072628,-0.037022,0,0
6,GO REGULATION OF DNA REPLICATION,0.13467,-0.072653,-0.056522,0,0
6,GO SMOOTHENED SIGNALING PATHWAY,0.4521,-0.072721,-0.0050446,0,0
6,GO MATING BEHAVIOR,0.83078,-0.072786,-0.023213,0,0
6,GO REGULATION OF GENE SILENCING,0.26442,-0.072862,-0.019704,0,0
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.11163,-0.072921,-0.052902,0,0
6,GO REGULATION OF SPINDLE ORGANIZATION,0.16123,-0.073037,-0.050941,0,0
6,GO RESPONSE TO HYDROXYUREA,0.41494,-0.073215,-0.02797,0,0
6,GO RESPONSE TO ELECTRICAL STIMULUS,0.72171,-0.073279,-0.012405,0,0
6,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.43329,-0.073383,-0.01478,0,0
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.38829,-0.073724,-0.022694,0,0
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.43329,-0.073896,-0.035154,0,0
6,GO NCRNA METABOLIC PROCESS,0.20256,-0.07394,-0.034743,0,0
6,GO SYNAPTIC VESICLE ENDOSOMAL PROCESSING,0.69814,-0.074009,0.015721,0,0
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.42405,-0.074117,-0.043464,0,0
6,GO REGULATION OF TORC1 SIGNALING,0.2577,-0.074378,-0.035008,0,0
6,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.077559,-0.074436,-0.059272,0,0
6,GO MRNA METHYLATION,0.23203,-0.074888,-0.058522,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE I,0.47137,-0.074898,-0.0078427,0,0
6,GO NUCLEAR TRANSPORT,0.46168,-0.074928,-0.0053563,0,0
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.23827,-0.07511,-0.03099,0,0
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.60692,-0.075251,0.010164,0,0
6,GO POSTSYNAPSE ORGANIZATION,0.32248,-0.075265,-0.051945,0,0
6,GO MITOCHONDRIAL DNA REPLICATION,0.33029,-0.075274,-0.039009,0,0
6,GO NEUROTRANSMITTER SECRETION,0.47137,-0.075619,-0.0093724,0,0
6,GO NEUROTRANSMITTER TRANSPORT,0.56341,-0.075717,0.0070815,0,0
6,GO RNA 5 END PROCESSING,0.21989,-0.07578,-0.039724,0,0
6,GO EATING BEHAVIOR,0.80618,-0.075977,0.014556,0,0
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.2577,-0.076512,-0.018626,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.46168,-0.076673,-0.0068896,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.49108,-0.076677,-0.0034282,0,0
6,GO CELL PROLIFERATION IN FOREBRAIN,0.30724,-0.076728,-0.068943,0,0
6,GO REGULATION OF CYCLASE ACTIVITY,0.48117,-0.076765,-0.029917,0,0
6,GO DIVALENT METAL ION EXPORT,0.44264,-0.07726,-0.058709,0,0
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.58498,-0.078003,0.0071126,0,0
6,GO REGULATION OF OOGENESIS,0.56341,-0.078254,-0.021223,0,0
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.44264,-0.078332,-0.028527,0,0
6,GO LATERAL VENTRICLE DEVELOPMENT,0.65188,-0.078453,-0.00062709,0,0
6,GO PROTEIN ACETYLATION,0.42405,-0.07855,-0.0036124,0,0
6,GO RRNA TRANSCRIPTION,0.1306,-0.078625,-0.051378,0,0
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.49108,-0.078818,-0.0054423,0,0
6,GO DNA DEPENDENT DNA REPLICATION,0.08881,-0.078855,-0.10236,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.10134,-0.078868,-0.1008,0,0
6,GO REGULATION OF AXONOGENESIS,0.29248,-0.078889,-0.04106,0,0
6,GO MITOTIC RECOMBINATION,0.3148,-0.078906,-0.066449,0,0
6,GO COENZYME A BIOSYNTHETIC PROCESS,0.49108,-0.078923,-0.003814,0,0
6,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.23203,-0.078941,-0.023495,0,0
6,GO PEPTIDYL METHIONINE MODIFICATION,0.28529,-0.07919,-0.050516,0,0
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.38829,-0.079397,-0.070365,0,0
6,GO CELL AGGREGATION,0.96843,-0.079402,0.011764,0,0
6,GO PROTEIN MONOUBIQUITINATION,0.3148,-0.079579,-0.024577,0,0
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.44264,-0.079636,-0.0048407,0,0
6,GO HISTONE MRNA METABOLIC PROCESS,0.23827,-0.079686,-0.033966,0,0
6,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.39705,-0.079728,-0.022277,0,0
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.24463,-0.079949,-0.077915,0,0
6,GO DEMETHYLATION,0.47137,-0.080008,0.0070597,0,0
6,GO REGULATION OF HELICASE ACTIVITY,0.4521,-0.080062,-0.02178,0,0
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.20822,-0.080188,-0.036527,0,0
6,GO SULFUR AMINO ACID METABOLIC PROCESS,0.33821,-0.080221,-0.028285,0,0
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.51122,-0.080256,-0.01568,0,0
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.72171,-0.080397,-0.014685,0,0
6,GO REGULATION OF CELL CYCLE PROCESS,0.2259,-0.080521,-0.02096,0,0
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.27126,-0.080674,-0.017123,0,0
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.15197,-0.080728,-0.12962,0,0
6,GO PROTEIN LOCALIZATION TO SYNAPSE,0.24463,-0.080743,-0.07488,0,0
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.55277,-0.080762,0.0043722,0,0
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.4521,-0.081016,-0.0060133,0,0
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.66333,-0.081068,0.0096531,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.20256,-0.081079,-0.054134,0,0
6,GO NUCLEOTIDE EXCISION REPAIR,0.094909,-0.081199,-0.049511,0,0
6,GO MIRNA METABOLIC PROCESS,0.19156,-0.081309,-0.054197,0,0
6,GO REGULATION OF NUCLEAR DIVISION,0.37964,-0.081556,-0.0071922,0,0
6,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.35442,-0.081701,-0.057875,0,0
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.24463,-0.082063,-0.054917,0,0
6,GO REGULATION OF APPETITE,0.41494,-0.08209,-0.081554,0,0
6,GO REGULATION OF MRNA 3 END PROCESSING,0.2998,-0.08213,-0.013746,0,0
6,GO REGULATION OF CILIUM ASSEMBLY,0.21989,-0.082186,-0.091295,0,0
6,GO NODAL SIGNALING PATHWAY,0.3148,-0.082336,-0.067149,0,0
6,GO ADULT BEHAVIOR,0.57414,-0.082449,-0.016173,0,0
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.42405,-0.082465,0.003443,0,0
6,GO PEPTIDYL ARGININE MODIFICATION,0.39705,-0.082962,-0.04258,0,0
6,GO METENCEPHALON DEVELOPMENT,0.33029,-0.083018,-0.03525,0,0
6,GO CHEMOSENSORY BEHAVIOR,0.57414,-0.083151,-0.054962,0,0
6,GO TETRAHYDROFOLATE INTERCONVERSION,0.08588,-0.083159,-0.11634,0,0
6,GO REGULATION OF CYTOKINESIS,0.24463,-0.083397,-0.041036,0,0
6,GO TRNA MODIFICATION,0.19156,-0.083484,-0.067061,0,0
6,GO NCRNA EXPORT FROM NUCLEUS,0.17591,-0.083562,-0.045056,0,0
6,GO POSITIVE REGULATION OF MITOPHAGY,0.70989,-0.083735,0.01116,0,0
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.35442,-0.083992,-0.037406,0,0
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.4521,-0.08406,-0.013885,0,0
6,GO PHOTORECEPTOR CELL DEVELOPMENT,0.17091,-0.084212,-0.080162,0,0
6,GO PEPTIDYL ARGININE METHYLATION,0.24463,-0.084215,-0.054279,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.57414,-0.084294,-0.06497,0,0
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.13885,-0.084564,-0.050071,0,0
6,GO HISTONE H2A UBIQUITINATION,0.23827,-0.084992,-0.052403,0,0
6,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.36271,-0.085018,0.0019405,0,0
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.19156,-0.085526,-0.043988,0,0
6,GO TRNA TRANSPORT,0.16602,-0.085529,-0.049964,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.85555,-0.085609,0.016999,0,0
6,GO NEURAL RETINA DEVELOPMENT,0.21989,-0.086096,-0.088882,0,0
6,GO THALAMUS DEVELOPMENT,0.57414,-0.086114,-0.029582,0,0
6,GO REGULATION OF TELOMERE MAINTENANCE,0.26442,-0.08612,-0.031386,0,0
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.51122,-0.086177,-0.018062,0,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.98106,-0.086294,0.051007,0,0
6,GO UV DAMAGE EXCISION REPAIR,0.54223,-0.086313,-0.025572,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.15197,-0.086545,-0.055845,0,0
6,GO NON RECOMBINATIONAL REPAIR,0.30724,-0.086613,-0.025529,0,0
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.34626,-0.08665,-0.044282,0,0
6,GO CENTROSOME DUPLICATION,0.23203,-0.086652,-0.058834,0,0
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.94321,-0.086823,0.018027,0,0
6,GO CELL CYCLE PHASE TRANSITION,0.2259,-0.087104,-0.021156,0,0
6,GO PROTEIN NEDDYLATION,0.067497,-0.087438,-0.090471,0,0
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.49108,-0.08787,-0.0084464,0,0
6,GO MICROTUBULE BUNDLE FORMATION,0.39705,-0.087914,-0.067347,0,0
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.68646,-0.087959,-0.010372,0,0
6,GO MACROMOLECULE DEACYLATION,0.91805,-0.088172,0.018957,0,0
6,GO REGULATION OF AXON GUIDANCE,0.88046,-0.088721,0.044731,0,0
6,GO CHROMOSOME LOCALIZATION,0.18624,-0.088725,-0.042624,0,0
6,GO PROTEIN ACYLATION,0.50109,-0.08886,0.0029169,0,0
6,GO DNA METHYLATION OR DEMETHYLATION,0.50109,-0.088917,-0.0070534,0,0
6,GO NEGATIVE REGULATION OF AXONOGENESIS,0.33029,-0.089104,-0.054084,0,0
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.30724,-0.089243,-0.03037,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.23827,-0.089387,-0.02786,0,0
6,GO RECOMBINATIONAL REPAIR,0.1306,-0.090103,-0.073312,0,0
6,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.2998,-0.090109,-0.035129,0,0
6,GO DENDRITE DEVELOPMENT,0.34626,-0.090312,-0.040596,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.29248,-0.090327,-0.026246,0,0
6,GO CELL CYCLE,0.33029,-0.090353,-0.012645,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.045233,-0.090426,-0.13994,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.25111,-0.090855,-0.051107,0,0
6,GO PEPTIDYL LYSINE ACETYLATION,0.41494,-0.091072,-0.0054781,0,0
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.16602,-0.091095,-0.10806,0,0
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.094909,-0.091433,-0.073981,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.74555,-0.091903,0.0097583,0,0
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.23203,-0.091915,-0.033689,0,0
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.29248,-0.091967,-0.040571,0,0
6,GO HISTONE DEACETYLATION,0.57414,-0.092134,0.0043611,0,0
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.4521,-0.092136,-0.023644,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.12662,-0.092149,-0.091728,0,0
6,GO GABAERGIC NEURON DIFFERENTIATION,0.69814,-0.09248,0.072086,0,0
6,GO LYSINE METABOLIC PROCESS,0.84314,-0.092545,-0.0069176,0,0
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.51122,-0.092697,-0.041875,0,0
6,GO P BODY ASSEMBLY,0.53179,-0.092925,0.0023002,0,0
6,GO ORGANELLE ASSEMBLY,0.30724,-0.092939,-0.023572,0,0
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.67486,-0.09298,-0.037164,0,0
6,GO LEFT RIGHT AXIS SPECIFICATION,0.48117,-0.093008,-0.028223,0,0
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.26442,-0.093119,-0.088425,0,0
6,GO MRNA MODIFICATION,0.15655,-0.093252,-0.069522,0,0
6,GO SYNAPTIC MEMBRANE ADHESION,0.33821,-0.093415,-0.12506,0,0
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.62923,-0.093441,-0.026418,0,0
6,GO DOUBLE STRAND BREAK REPAIR,0.17591,-0.093786,-0.055438,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.2577,-0.094291,-0.021407,0,0
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.43329,-0.094302,-0.040527,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.20822,-0.094319,-0.059705,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.214,-0.094386,-0.029659,0,0
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.4521,-0.094429,-0.039473,0,0
6,GO TELENCEPHALON REGIONALIZATION,0.33029,-0.094628,-0.10862,0,0
6,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.19156,-0.094887,-0.096142,0,0
6,GO REGULATION OF CHROMATIN BINDING,0.53179,-0.095278,-0.014197,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.11894,-0.095753,-0.072093,0,0
6,GO MITOTIC DNA REPLICATION,0.55277,-0.095923,-0.032492,0,0
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.10811,-0.095939,-0.065874,0,0
6,GO RNA PROCESSING,0.091819,-0.09599,-0.066037,0,0
6,GO ACROSOME ASSEMBLY,0.41494,-0.095993,-0.040977,0,0
6,GO MEMBRANE DOCKING,0.24463,-0.096027,-0.026843,0,0
6,GO ESTABLISHMENT OF RNA LOCALIZATION,0.20822,-0.09638,-0.034527,0,0
6,GO METHYLATION,0.25111,-0.096392,-0.042259,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.15655,-0.096788,-0.07301,0,0
6,GO RNA INTERFERENCE,0.10811,-0.09683,-0.093544,0,0
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.66333,-0.097023,-0.014542,0,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.19156,-0.097038,-0.11501,0,0
6,GO TRNA WOBBLE BASE MODIFICATION,0.10811,-0.097264,-0.067355,0,0
6,GO REGULATION OF MITOPHAGY,0.41494,-0.097462,-0.011421,0,0
6,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.26442,-0.097778,-0.056611,0,0
6,GO REGULATION OF CHROMOSOME SEPARATION,0.08303,-0.097827,-0.072982,0,0
6,GO MITOTIC CELL CYCLE,0.2259,-0.098009,-0.023142,0,0
6,GO HISTONE H3 K14 ACETYLATION,0.13467,-0.098069,-0.074087,0,0
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.24463,-0.098117,-0.029115,0,0
6,GO MALE MEIOSIS I,0.67486,-0.098149,-0.013759,0,0
6,GO POSITIVE REGULATION OF DNA REPAIR,0.1306,-0.098178,-0.052371,0,0
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.197,-0.098248,-0.031594,0,0
6,GO MITOCHONDRION LOCALIZATION,0.17591,-0.098709,-0.062172,0,0
6,GO MEMBRANE DISASSEMBLY,0.35442,-0.098724,-0.047773,0,0
6,GO POSITIVE REGULATION OF BEHAVIOR,0.34626,-0.098766,-0.052281,0,0
6,GO NEURON MIGRATION,0.29248,-0.098838,-0.055146,0,0
6,GO CEREBELLAR CORTEX DEVELOPMENT,0.21989,-0.099025,-0.069866,0,0
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.214,-0.09903,-0.041837,0,0
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.034576,-0.099115,-0.074111,0,0
6,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.20256,-0.099202,-0.14223,0,0
6,GO RESPONSE TO FOOD,0.11524,-0.099382,-0.12495,0,0
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.17091,-0.099437,-0.092975,0,0
6,GO BRAIN MORPHOGENESIS,0.21989,-0.099491,-0.082778,0,0
6,GO CELL DIVISION,0.26442,-0.099533,-0.028932,0,0
6,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.4521,-0.099538,-0.032354,0,0
6,GO UTP METABOLIC PROCESS,0.1475,-0.09972,-0.084676,0,0
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.12273,-0.099804,-0.077152,0,0
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.058535,-0.099828,-0.076617,0,0
6,GO GASTRIC ACID SECRETION,0.57414,-0.10013,-0.0325,0,0
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.54223,-0.10034,-0.063636,0,0
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.094909,-0.10052,-0.071602,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.11524,-0.10082,-0.07163,0,0
6,GO DNA REPAIR,0.12662,-0.10088,-0.059527,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.2259,-0.10088,-0.11711,0,0
6,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.26442,-0.1009,-0.031938,0,0
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.29248,-0.10093,-0.056593,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.056456,-0.10102,-0.12374,0,0
6,GO HISTONE MONOUBIQUITINATION,0.41494,-0.10109,-0.031017,0,0
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.42405,-0.10131,-0.068839,0,0
6,GO RNA LOCALIZATION,0.15197,-0.10143,-0.040527,0,0
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.21989,-0.1015,-0.035136,0,0
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.41494,-0.1015,-0.016485,0,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.12662,-0.10159,-0.083577,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.60692,-0.10175,-0.042912,0,0
6,GO POSITIVE REGULATION OF ACROSOME REACTION,0.2998,-0.10194,-0.072252,0,0
6,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.098083,-0.10199,-0.065426,0,0
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.27126,-0.10203,-0.1357,0,0
6,GO INTRA S DNA DAMAGE CHECKPOINT,0.35442,-0.1021,-0.044945,0,0
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.51122,-0.10225,-0.045408,0,0
6,GO PROTEIN LOCALIZATION TO CHROMATIN,0.12662,-0.10245,-0.068928,0,0
6,GO TELOMERE ORGANIZATION,0.16602,-0.10247,-0.05266,0,0
6,GO EMBRYONIC EYE MORPHOGENESIS,0.78176,-0.10252,0.031059,0,0
6,GO VIRAL LATENCY,0.08881,-0.10258,-0.070183,0,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.080256,-0.10269,-0.064195,0,0
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.44264,-0.10277,-0.030275,0,0
6,GO RNA STABILIZATION,0.33821,-0.10297,-0.023143,0,0
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.11894,-0.10302,-0.067965,0,0
6,GO DENDRITIC SPINE DEVELOPMENT,0.17591,-0.10313,-0.062895,0,0
6,GO HISTONE UBIQUITINATION,0.23827,-0.10319,-0.049247,0,0
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.5959,-0.10323,-0.0013818,0,0
6,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.26442,-0.10331,-0.087499,0,0
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.19156,-0.10333,-0.075011,0,0
6,GO CELL CYCLE PROCESS,0.21989,-0.10346,-0.02641,0,0
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.16602,-0.10381,-0.078994,0,0
6,GO CARNITINE SHUTTLE,0.214,-0.10417,-0.082041,0,0
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.56341,-0.10428,-0.001905,0,0
6,GO DORSAL VENTRAL AXIS SPECIFICATION,0.25111,-0.10432,-0.088891,0,0
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.76963,-0.10468,-0.028608,0,0
6,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.050584,-0.1048,-0.091946,0,0
6,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.197,-0.10497,-0.055547,0,0
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.43329,-0.10543,-0.05384,0,0
6,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.74555,-0.10564,0.045697,0,0
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.44264,-0.10603,-0.023368,0,0
6,GO MRNA METABOLIC PROCESS,0.069906,-0.10615,-0.060168,0,0
6,GO DNA REPLICATION,0.11894,-0.10616,-0.079391,0,0
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.38829,-0.10639,-0.099983,0,0
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.7336,-0.10663,-0.0039032,0,0
6,GO PROTEIN SUMOYLATION,0.28529,-0.1068,-0.019617,0,0
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.054439,-0.10683,-0.089491,0,0
6,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.1475,-0.10684,-0.089159,0,0
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.2577,-0.10694,-0.11055,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.11163,-0.10708,-0.048382,0,0
6,GO REGULATION OF MICROTUBULE BINDING,0.36271,-0.10713,-0.047861,0,0
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.3148,-0.10748,-0.046611,0,0
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.197,-0.10748,-0.047447,0,0
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.26442,-0.10777,-0.074528,0,0
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.21989,-0.10842,-0.043233,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.12662,-0.10854,-0.11442,0,0
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.3148,-0.1089,-0.053498,0,0
6,GO MITOCHONDRIAL RNA PROCESSING,0.058535,-0.10917,-0.10218,0,0
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.13885,-0.10927,-0.077413,0,0
6,GO AXIS SPECIFICATION,0.27821,-0.1093,-0.028839,0,0
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.18102,-0.10938,-0.063779,0,0
6,GO REGULATION OF RNA BINDING,0.38829,-0.10942,-0.019575,0,0
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.072385,-0.10957,-0.081671,0,0
6,GO MICROTUBULE BASED MOVEMENT,0.13885,-0.11027,-0.088956,0,0
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.2577,-0.11046,-0.061745,0,0
6,GO VIRAL TRANSLATION,0.080256,-0.11062,-0.074761,0,0
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.37111,-0.11074,-0.0024616,0,0
6,GO REGULATION OF CHROMOSOME ORGANIZATION,0.2998,-0.11082,-0.015886,0,0
6,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.95582,-0.11094,0.061371,0,0
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.20256,-0.11106,-0.061165,0,0
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.16123,-0.11119,-0.040043,0,0
6,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.29248,-0.11121,-0.02683,0,0
6,GO RDNA HETEROCHROMATIN ASSEMBLY,0.40594,-0.11122,-0.024436,0,0
6,GO SYNAPTIC VESICLE LOCALIZATION,0.30724,-0.11183,-0.058767,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.19156,-0.11184,-0.059314,0,0
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.41494,-0.11203,-0.022094,0,0
6,GO PALLIUM DEVELOPMENT,0.27126,-0.11213,-0.035483,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.069906,-0.11219,-0.073651,0,0
6,GO REGULATION OF EXIT FROM MITOSIS,0.16602,-0.11224,-0.062015,0,0
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.5959,-0.11229,0.01713,0,0
6,GO INHIBITORY SYNAPSE ASSEMBLY,0.197,-0.11236,-0.12964,0,0
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.32248,-0.11264,-0.049137,0,0
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.12662,-0.11285,-0.072402,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.065157,-0.11294,-0.15402,0,0
6,GO NEGATIVE REGULATION OF CELL DIVISION,0.72171,-0.1132,-0.0015305,0,0
6,GO DNA DOUBLE STRAND BREAK PROCESSING,0.27126,-0.1136,-0.066897,0,0
6,GO MALE MEIOTIC NUCLEAR DIVISION,0.214,-0.11416,-0.074252,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.21989,-0.11449,-0.076359,0,0
6,GO OOCYTE MATURATION,0.21989,-0.11453,-0.072882,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.08881,-0.11454,-0.05018,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.32248,-0.11456,-0.063207,0,0
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.20822,-0.11458,-0.080919,0,0
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.53179,-0.11471,-0.090659,0,0
6,GO ERROR PRONE TRANSLESION SYNTHESIS,0.067497,-0.11477,-0.095474,0,0
6,GO REGULATION OF GONAD DEVELOPMENT,0.52145,-0.11499,-0.035503,0,0
6,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.060677,-0.11502,-0.11594,0,0
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.25111,-0.11539,-0.059748,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.37964,-0.11546,-0.035393,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.42405,-0.11573,-0.071779,0,0
6,GO NEGATIVE REGULATION OF AXON EXTENSION,0.33029,-0.11591,-0.043346,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.08303,-0.11594,-0.14258,0,0
6,GO SYNAPTIC VESICLE PRIMING,0.67486,-0.11597,-0.017391,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.13467,-0.11604,-0.060371,0,0
6,GO GENE SILENCING,0.2577,-0.11622,-0.034281,0,0
6,GO MISMATCH REPAIR,0.11163,-0.1172,-0.087356,0,0
6,GO MEIOTIC CELL CYCLE,0.10134,-0.1173,-0.075537,0,0
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.2577,-0.11761,-0.068104,0,0
6,GO CYSTEINE METABOLIC PROCESS,0.48117,-0.11763,-0.059057,0,0
6,GO EXIT FROM MITOSIS,0.10134,-0.11771,-0.05809,0,0
6,GO NEURON PROJECTION ORGANIZATION,0.197,-0.11803,-0.048861,0,0
6,GO PIRNA METABOLIC PROCESS,0.43329,-0.11825,-0.032728,0,0
6,GO ORGANELLE FISSION,0.17591,-0.11829,-0.039406,0,0
6,GO NEURONAL ION CHANNEL CLUSTERING,0.56341,-0.11847,-0.031846,0,0
6,GO MRNA TRANSPORT,0.13467,-0.11865,-0.053986,0,0
6,GO PEPTIDYL LYSINE MODIFICATION,0.35442,-0.11896,-0.017235,0,0
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.094909,-0.11902,-0.059737,0,0
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.17591,-0.11917,-0.064,0,0
6,GO NUCLEUS LOCALIZATION,0.23203,-0.1192,-0.084743,0,0
6,GO NUCLEAR EXPORT,0.16602,-0.1195,-0.042618,0,0
6,GO DENDRITE MORPHOGENESIS,0.21989,-0.11955,-0.072476,0,0
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.75756,-0.1196,0.02454,0,0
6,GO DOSAGE COMPENSATION,0.32248,-0.11965,-0.055915,0,0
6,GO HIPPOCAMPUS DEVELOPMENT,0.11894,-0.11988,-0.076594,0,0
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.30724,-0.12005,-0.042289,0,0
6,GO CAMERA TYPE EYE MORPHOGENESIS,0.56341,-0.12013,-0.0024523,0,0
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.30724,-0.12048,-0.06496,0,0
6,GO REGULATION OF MICROTUBULE BASED PROCESS,0.12273,-0.12059,-0.058395,0,0
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.20822,-0.12089,-0.055242,0,0
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.67486,-0.12091,-0.055155,0,0
6,GO RNA 3 END PROCESSING,0.056456,-0.12129,-0.081893,0,0
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.058535,-0.12131,-0.125,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.16602,-0.12135,-0.074872,0,0
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.19156,-0.12142,-0.079095,0,0
6,GO COLLECTING DUCT DEVELOPMENT,0.2577,-0.12162,-0.066119,0,0
6,GO HISTONE H4 ACETYLATION,0.27821,-0.12171,-0.026079,0,0
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.08588,-0.12179,-0.11376,0,0
6,GO REGULATION OF DENDRITE DEVELOPMENT,0.24463,-0.12195,-0.047496,0,0
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.094909,-0.122,-0.069343,0,0
6,GO NEURAL CREST FORMATION,0.69814,-0.12218,-0.043898,0,0
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.13885,-0.12249,-0.055103,0,0
6,GO MEIOTIC CELL CYCLE PROCESS,0.08303,-0.12288,-0.079524,0,0
6,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.12273,-0.12372,-0.089304,0,0
6,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.76963,-0.12414,-0.0092104,0,0
6,GO CELL JUNCTION MAINTENANCE,0.3148,-0.12443,-0.048618,0,0
6,GO COMMISSURAL NEURON AXON GUIDANCE,0.39705,-0.12447,-0.077083,0,0
6,GO NUCLEAR MIGRATION,0.26442,-0.12454,-0.079181,0,0
6,GO SPINDLE LOCALIZATION,0.197,-0.12469,-0.049543,0,0
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.098083,-0.12493,-0.065533,0,0
6,GO PROXIMAL DISTAL PATTERN FORMATION,0.2998,-0.12507,-0.096986,0,0
6,GO HOMOLOGOUS RECOMBINATION,0.065157,-0.12514,-0.12635,0,0
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.3148,-0.12516,-0.02956,0,0
6,GO MRNA CLEAVAGE,0.15197,-0.126,-0.063727,0,0
6,GO CENTRIOLE ASSEMBLY,0.17591,-0.12605,-0.087386,0,0
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.098083,-0.12606,-0.079524,0,0
6,GO STRESS GRANULE ASSEMBLY,0.18102,-0.12633,-0.051418,0,0
6,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.17091,-0.12686,-0.066664,0,0
6,GO CILIUM ORGANIZATION,0.197,-0.12721,-0.082045,0,0
6,GO RETINA LAYER FORMATION,0.30724,-0.12733,-0.07283,0,0
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.098083,-0.12738,-0.071816,0,0
6,GO FOREBRAIN NEURON FATE COMMITMENT,0.76963,-0.12785,0.051355,0,0
6,GO CHROMOSOME SEGREGATION,0.10468,-0.12816,-0.079043,0,0
6,GO CEREBRAL CORTEX DEVELOPMENT,0.30724,-0.12828,-0.036606,0,0
6,GO REPLICATION FORK PROCESSING,0.074935,-0.12846,-0.15203,0,0
6,GO FOREBRAIN NEURON DEVELOPMENT,0.49108,-0.129,-0.038231,0,0
6,GO REGULATION OF CHROMATIN ASSEMBLY,0.2577,-0.12926,-0.054951,0,0
6,GO MEIOTIC CHROMOSOME SEGREGATION,0.10134,-0.12958,-0.097248,0,0
6,GO REGULATION OF CHROMOSOME SEGREGATION,0.12273,-0.1296,-0.068042,0,0
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.098083,-0.12979,-0.080698,0,0
6,GO MICROTUBULE BASED PROCESS,0.11163,-0.12987,-0.078624,0,0
6,GO MICROTUBULE SEVERING,0.11894,-0.12991,-0.14834,0,0
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.14312,-0.12998,-0.11674,0,0
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.24463,-0.13007,-0.060623,0,0
6,GO DNA INTEGRITY CHECKPOINT,0.20256,-0.13023,-0.057865,0,0
6,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.02951,-0.13057,-0.13355,0,0
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.021265,-0.13062,-0.10023,0,0
6,GO RNA POLYADENYLATION,0.21989,-0.13063,-0.048942,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0172,-0.13068,-0.12765,0,0
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.10468,-0.13085,-0.058413,0,0
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.36271,-0.13087,-0.073578,0,0
6,GO HINDBRAIN MORPHOGENESIS,0.069906,-0.13102,-0.09675,0,0
6,GO LONG TERM SYNAPTIC DEPRESSION,0.44264,-0.13121,-0.074394,0,0
6,GO HISTONE H2A ACETYLATION,0.10811,-0.13123,-0.10066,0,0
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.11524,-0.13127,-0.067026,0,0
6,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.23827,-0.13128,-0.065358,0,0
6,GO REGULATION OF MRNA POLYADENYLATION,0.11894,-0.13135,-0.065901,0,0
6,GO G2 DNA DAMAGE CHECKPOINT,0.23827,-0.13145,-0.05584,0,0
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.40594,-0.13158,-0.05747,0,0
6,GO REGULATION OF DNA REPAIR,0.15197,-0.13178,-0.059328,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.42405,-0.13193,-0.022469,0,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.29248,-0.13214,-0.046011,0,0
6,GO MITOTIC NUCLEAR DIVISION,0.15197,-0.13241,-0.05307,0,0
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.214,-0.13255,-0.068695,0,0
6,GO METAPHASE PLATE CONGRESSION,0.12273,-0.13275,-0.064166,0,0
6,GO HETEROCHROMATIN ORGANIZATION,0.21989,-0.13349,-0.049529,0,0
6,GO NON MOTILE CILIUM ASSEMBLY,0.074935,-0.13368,-0.11956,0,0
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.1475,-0.13371,-0.076046,0,0
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.10468,-0.13376,-0.11195,0,0
6,GO NEURAL TUBE PATTERNING,0.25111,-0.13411,-0.078931,0,0
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.14312,-0.13435,-0.075602,0,0
6,GO REGULATION OF DENDRITE MORPHOGENESIS,0.16123,-0.13466,-0.074896,0,0
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.25111,-0.13535,-0.13465,0,0
6,GO SISTER CHROMATID COHESION,0.3148,-0.13545,-0.05246,0,0
6,GO HISTONE H3 K9 MODIFICATION,0.13885,-0.13548,-0.078742,0,0
6,GO DENSE CORE GRANULE TRANSPORT,0.48117,-0.1355,-0.038873,0,0
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.11163,-0.13552,-0.053069,0,0
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.55277,-0.13591,-0.029297,0,0
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.20822,-0.13671,-0.064696,0,0
6,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.08588,-0.13722,-0.13048,0,0
6,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.85555,-0.13759,0.020218,0,0
6,GO HIPPO SIGNALING,0.50109,-0.13783,-0.010197,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.17091,-0.13785,-0.072616,0,0
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.1306,-0.13832,-0.053735,0,0
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.098083,-0.13876,-0.065928,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.57414,-0.13898,-0.014299,0,0
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.214,-0.13977,-0.1137,0,0
6,GO RNA EXPORT FROM NUCLEUS,0.10811,-0.13996,-0.07726,0,0
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.15197,-0.14003,-0.057035,0,0
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.08881,-0.14014,-0.12566,0,0
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.54223,-0.14017,-0.022085,0,0
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.16602,-0.14026,-0.080324,0,0
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.08303,-0.14064,-0.087726,0,0
6,GO SPINDLE MIDZONE ASSEMBLY,0.44264,-0.14083,-0.044258,0,0
6,GO CHROMOSOME SEPARATION,0.067497,-0.14094,-0.093598,0,0
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.077559,-0.1412,-0.095482,0,0
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.10468,-0.14137,-0.1924,0,0
6,GO MITOTIC SPINDLE ASSEMBLY,0.197,-0.14139,-0.049931,0,0
6,GO MITOTIC CELL CYCLE CHECKPOINT,0.19156,-0.14141,-0.049049,0,0
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.056456,-0.14172,-0.10266,0,0
6,GO DNA METHYLATION,0.15655,-0.14173,-0.053933,0,0
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.30724,-0.14173,-0.047174,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.49108,-0.14173,-0.0753,0,0
6,GO PROTEIN DEMETHYLATION,0.20256,-0.14182,-0.058975,0,0
6,GO MICROTUBULE POLYMERIZATION,0.11524,-0.1419,-0.083656,0,0
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.08303,-0.14229,-0.084385,0,0
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.48117,-0.14248,-0.022693,0,0
6,GO NEURON FATE COMMITMENT,0.15655,-0.14284,-0.077423,0,0
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.54223,-0.14331,-0.042637,0,0
6,GO REGULATION OF SPINDLE CHECKPOINT,0.062884,-0.14343,-0.12557,0,0
6,GO MICROTUBULE BASED TRANSPORT,0.094909,-0.14409,-0.089749,0,0
6,GO CELL CYCLE CHECKPOINT,0.16602,-0.1441,-0.059178,0,0
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.51122,-0.14411,-0.021454,0,0
6,GO BASE EXCISION REPAIR,0.023112,-0.1444,-0.1065,0,0
6,GO NUCLEAR CHROMOSOME SEGREGATION,0.11524,-0.14465,-0.073849,0,0
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.074935,-0.14494,-0.12877,0,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.79394,-0.14497,0.017749,0,0
6,GO DNA GEOMETRIC CHANGE,0.12273,-0.14521,-0.07395,0,0
6,GO REGULATION OF NEUROBLAST PROLIFERATION,0.40594,-0.1459,-0.053787,0,0
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.1306,-0.14595,-0.10297,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.10134,-0.14607,-0.081288,0,0
6,GO SISTER CHROMATID SEGREGATION,0.10468,-0.14624,-0.073795,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.094909,-0.14628,-0.087008,0,0
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.056456,-0.14648,-0.091219,0,0
6,GO DNA STRAND ELONGATION,0.024086,-0.14684,-0.16126,0,0
6,GO CHROMOSOME ORGANIZATION,0.10811,-0.14888,-0.055447,0,0
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.23827,-0.14904,-0.11775,0,0
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.080256,-0.14926,-0.13624,0,0
6,GO REGULATION OF HIPPO SIGNALING,0.33029,-0.14941,-0.060256,0,0
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.21989,-0.14961,-0.060458,0,0
6,GO RNA SPLICING,0.052482,-0.14975,-0.10132,0,0
6,GO PROTEIN LOCALIZATION TO CILIUM,0.12662,-0.14975,-0.11199,0,0
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.25111,-0.15006,-0.093611,0,0
6,GO POSITIVE REGULATION OF DNA REPLICATION,0.080256,-0.15063,-0.085529,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017954,-0.15066,-0.14048,0,0
6,GO MRNA 3 END PROCESSING,0.072385,-0.15067,-0.094778,0,0
6,GO CELL MIGRATION IN HINDBRAIN,0.40594,-0.15125,-0.035868,0,0
6,GO CORPUS CALLOSUM DEVELOPMENT,0.16602,-0.15159,-0.078319,0,0
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.10811,-0.15218,-0.1027,0,0
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.12273,-0.15225,-0.082534,0,0
6,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.13885,-0.15233,-0.16428,0,0
6,GO CARDIAC CHAMBER FORMATION,0.074935,-0.15289,-0.225,0,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.24463,-0.15303,-0.036084,0,0
6,GO REGULATION OF SYNAPSE MATURATION,0.2259,-0.15346,-0.15592,0,0
6,GO OXIDATIVE DEMETHYLATION,0.080256,-0.15389,-0.11356,0,0
6,GO MRNA PROCESSING,0.052482,-0.15431,-0.098631,0,0
6,GO SPINDLE ASSEMBLY,0.1475,-0.15496,-0.062835,0,0
6,GO HISTONE H4 DEACETYLATION,0.12662,-0.15507,-0.073284,0,0
6,GO PHOTORECEPTOR CELL MAINTENANCE,0.080256,-0.15547,-0.14309,0,0
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.18102,-0.15568,-0.11207,0,0
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.069906,-0.15577,-0.082829,0,0
6,GO DISTAL TUBULE DEVELOPMENT,0.27821,-0.15637,-0.16703,0,0
6,GO MRNA EXPORT FROM NUCLEUS,0.069906,-0.15654,-0.086408,0,0
6,GO MICROTUBULE ANCHORING AT CENTROSOME,0.19156,-0.15726,-0.13395,0,0
6,GO PROTEIN METHYLATION,0.11894,-0.15736,-0.07783,0,0
6,GO REGULATION OF HISTONE METHYLATION,0.13885,-0.15749,-0.063819,0,0
6,GO CEREBELLAR CORTEX MORPHOGENESIS,0.074935,-0.1575,-0.13612,0,0
6,GO COVALENT CHROMATIN MODIFICATION,0.27126,-0.15754,-0.035026,0,0
6,GO LAYER FORMATION IN CEREBRAL CORTEX,0.12273,-0.15789,-0.12809,0,0
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.098083,-0.15795,-0.080896,0,0
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.074935,-0.1583,-0.096027,0,0
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.098083,-0.15832,-0.10129,0,0
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.11524,-0.15872,-0.069489,0,0
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.26442,-0.15985,-0.047523,0,0
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.2259,-0.16009,-0.078369,0,0
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.15197,-0.16094,-0.073338,0,0
6,GO INTRACILIARY RETROGRADE TRANSPORT,0.15197,-0.1613,-0.14774,0,0
6,GO TRANSPORT ALONG MICROTUBULE,0.067497,-0.16175,-0.096178,0,0
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.10811,-0.16194,-0.082818,0,0
6,GO FAT CELL PROLIFERATION,0.11524,-0.16211,-0.12427,0,0
6,GO HISTONE H3 K9 METHYLATION,0.10468,-0.16223,-0.1,0,0
6,GO MICROTUBULE ANCHORING,0.19156,-0.16234,-0.091392,0,0
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.052482,-0.16265,-0.096706,0,0
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.24463,-0.16344,-0.10738,0,0
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.060677,-0.16385,-0.13855,0,0
6,GO HISTONE H3 DEACETYLATION,0.10468,-0.16399,-0.079657,0,0
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.29248,-0.16441,-0.11626,0,0
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.17591,-0.16487,-0.097816,0,0
6,GO SINGLE STRAND BREAK REPAIR,0.050584,-0.16514,-0.11684,0,0
6,GO NUCLEAR PORE ORGANIZATION,0.10811,-0.16523,-0.091353,0,0
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.08881,-0.16534,-0.073178,0,0
6,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.23203,-0.16538,-0.066291,0,0
6,GO CHROMATIN ORGANIZATION,0.197,-0.16681,-0.047956,0,0
6,GO RESPONSE TO L GLUTAMATE,0.077559,-0.16686,-0.14363,0,0
6,GO MAINTENANCE OF ORGANELLE LOCATION,0.18102,-0.16811,-0.093427,0,0
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.067497,-0.16851,-0.074578,0,0
6,GO REGULATION OF NEURON MIGRATION,0.12662,-0.16937,-0.12951,0,0
6,GO REGULATION OF RNA SPLICING,0.065157,-0.17003,-0.093932,0,0
6,GO DNA CONFORMATION CHANGE,0.062884,-0.17109,-0.099321,0,0
6,GO HISTONE H3 K36 METHYLATION,0.11524,-0.17151,-0.12578,0,0
6,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0057394,-0.17175,-0.13754,0,0
6,GO HISTONE H4 K5 ACETYLATION,0.13467,-0.17246,-0.08455,0,0
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.065157,-0.17265,-0.15715,0,0
6,GO EXCITATORY SYNAPSE ASSEMBLY,0.058535,-0.17298,-0.174,0,0
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.38829,-0.17375,-0.091646,0,0
6,GO DENDRITIC SPINE MORPHOGENESIS,0.060677,-0.17377,-0.12455,0,0
6,GO PEPTIDYL LYSINE DIMETHYLATION,0.091819,-0.17387,-0.10721,0,0
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.3148,-0.17388,-0.042922,0,0
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.13885,-0.1742,-0.060783,0,0
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.091819,-0.17428,-0.079717,0,0
6,GO AXO DENDRITIC TRANSPORT,0.08303,-0.17533,-0.096051,0,0
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.08881,-0.1768,-0.090418,0,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.61803,-0.17698,-0.026305,0,0
6,GO HISTONE DEUBIQUITINATION,0.13885,-0.17701,-0.08316,0,0
6,GO CELL DIFFERENTIATION IN SPINAL CORD,0.10134,-0.17711,-0.1334,0,0
6,GO ASTRAL MICROTUBULE ORGANIZATION,0.29248,-0.17744,-0.076241,0,0
6,GO TELENCEPHALON GLIAL CELL MIGRATION,0.18624,-0.17769,-0.095673,0,0
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.15197,-0.17769,-0.12702,0,0
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.16123,-0.17795,-0.086467,0,0
6,GO HISTONE METHYLATION,0.08588,-0.1795,-0.090199,0,0
6,GO INTRACILIARY TRANSPORT,0.094909,-0.1803,-0.13806,0,0
6,GO AXONAL TRANSPORT,0.058535,-0.18041,-0.10378,0,0
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.67486,-0.18051,-0.05363,0,0
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.10811,-0.18203,-0.10134,0,0
6,GO HISTONE H4 K16 ACETYLATION,0.08881,-0.184,-0.10418,0,0
6,GO HISTONE H3 K4 METHYLATION,0.10468,-0.18426,-0.10519,0,0
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.10811,-0.18429,-0.093387,0,0
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.052482,-0.18466,-0.12002,0,0
6,GO HISTONE H2A MONOUBIQUITINATION,0.12662,-0.18497,-0.099137,0,0
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.14312,-0.18549,-0.12341,0,0
6,GO CHROMATIN REMODELING,0.094909,-0.18584,-0.088118,0,0
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.10134,-0.18603,-0.1424,0,0
6,GO PEPTIDYL LYSINE TRIMETHYLATION,0.10134,-0.18611,-0.1044,0,0
6,GO RETINAL ROD CELL DIFFERENTIATION,0.18102,-0.18652,-0.13456,0,0
6,GO CENTROSOME SEPARATION,0.074935,-0.1866,-0.093653,0,0
6,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.056456,-0.18662,-0.093653,0,0
6,GO MITOTIC SPINDLE ORGANIZATION,0.08588,-0.18772,-0.095178,0,0
6,GO SPINDLE ORGANIZATION,0.08588,-0.18785,-0.08113,0,0
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.40594,-0.18813,0.0074416,0,0
6,GO ANTEROGRADE AXONAL TRANSPORT,0.062884,-0.18837,-0.11379,0,0
6,GO MICROTUBULE NUCLEATION,0.197,-0.18976,-0.066271,0,0
6,GO AXO DENDRITIC PROTEIN TRANSPORT,0.080256,-0.19019,-0.13908,0,0
6,GO SPINAL CORD DEVELOPMENT,0.072385,-0.19071,-0.14602,0,0
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.10134,-0.19104,-0.12543,0,0
6,GO DENDRITIC TRANSPORT,0.15197,-0.19155,-0.16111,0,0
6,GO PEPTIDYL LYSINE METHYLATION,0.077559,-0.19261,-0.09666,0,0
6,GO LOOP OF HENLE DEVELOPMENT,0.26442,-0.19307,-0.15558,0,0
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.010572,-0.19313,-0.18372,0,0
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.10134,-0.1936,-0.12874,0,0
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.26442,-0.1944,-0.10548,0,0
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.077559,-0.19448,-0.13984,0,0
6,GO SYNAPTIC VESICLE CLUSTERING,0.14312,-0.19807,-0.1348,0,0
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.098083,-0.1989,-0.10767,0,0
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.017954,-0.19901,-0.20556,0,0
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.17591,-0.19997,-0.077683,0,0
6,GO HISTONE H3 K4 TRIMETHYLATION,0.20256,-0.2,-0.10854,0,0
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.33821,-0.20101,-0.069072,0,0
6,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.25111,-0.20164,-0.08553,0,0
6,GO NEGATIVE REGULATION OF GLIOGENESIS,0.13885,-0.20261,-0.098855,0,0
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.067497,-0.20333,-0.12748,0,0
6,GO MEIOTIC CHROMOSOME SEPARATION,0.08588,-0.20351,-0.17245,0,0
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.10811,-0.20463,-0.1227,0,0
6,GO MICROTUBULE DEPOLYMERIZATION,0.12273,-0.20684,-0.14396,0,0
6,GO SPINAL CORD PATTERNING,0.2259,-0.20708,-0.10608,0,0
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.1475,-0.20743,-0.12334,0,0
6,GO CENTRIOLE CENTRIOLE COHESION,0.077559,-0.20871,-0.18236,0,0
6,GO MITOTIC CHROMOSOME CONDENSATION,0.091819,-0.21181,-0.13742,0,0
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.080256,-0.21189,-0.13812,0,0
6,GO HISTONE H3 K9 DEMETHYLATION,0.10134,-0.21306,-0.12058,0,0
6,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.091819,-0.21308,-0.11341,0,0
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.10811,-0.21437,-0.11067,0,0
6,GO CHROMOSOME CONDENSATION,0.060677,-0.21475,-0.13198,0,0
6,GO POSITIVE REGULATION OF NEURON MIGRATION,0.19156,-0.21646,-0.14013,0,0
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.074935,-0.21669,-0.11013,0,0
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.067497,-0.21722,-0.1165,0,0
6,GO HEART VALVE FORMATION,0.15655,-0.21829,-0.12719,0,0
6,GO NEGATIVE REGULATION OF RNA SPLICING,0.0060238,-0.22022,-0.1574,0,0
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.015104,-0.22317,-0.1357,0,0
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.094909,-0.22657,-0.16514,0,0
6,GO MEIOTIC SPINDLE ORGANIZATION,0.069906,-0.2291,-0.12633,0,0
6,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.08303,-0.23168,-0.13282,0,0
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.006955,-0.25455,-0.17693,0,0
6,GO POSTSYNAPSE ASSEMBLY,0.16123,-0.25587,-0.20519,0,0
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.094909,-0.25749,-0.20255,0,0
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.10811,-0.26249,-0.14792,0,0
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.067497,-0.26482,-0.20173,0,0
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.28529,-0.2669,-0.09542,0,0
6,GO NEURON FATE SPECIFICATION,0.056456,-0.27221,-0.15176,0,0
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.16602,-0.28369,-0.14161,0,0
6,GO LIMB BUD FORMATION,0.054439,-0.28924,-0.25075,0,0
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.18102,-0.28932,-0.20895,0,0
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.067497,-0.32101,-0.2531,0,0
